PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Escribano, BM; Moreno, A; Tasset, I; Tunez, I				Escribano, Begona M.; Moreno, Antonia; Tasset, Inmaculada; Tunez, Isaac			Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats	PLOS ONE			English	Article							HYPERLIPIDEMIC NEPHROPATHY; GLUTATHIONE-PEROXIDASE; PHARMACOLOGICAL AGENT; MELATONIN SECRETION; PLASMA LEPTIN; DAILY RHYTHM; INSULIN; METABOLISM; EXPRESSION; PROTECTION	The principal goal of this study was to determine the effect of the photoperiod on oxidative damage biomarkers in rats submitted to different light/darkness patterns, in a hyperlipidemic nephropathy model (induced by adriamycin), as well as its possible relationship with melatonin and leptin secretion rhythms. To test this hypothesis, six different groups were used (N = 6 rats per group): control (12 h/12h light: dark); exposure to permanent illumination (24 h light); exposure to darkness (22 h dark); injected with adriamycin, 12h/12h light: dark; injected with adriamycin + exposure to permanent illumination and injected with adriamycin + exposure to darkness (22 h dark). The different photoperiods were begun two weeks prior to medication and were maintained up to the day of the animal's sacrifice, ten days after medication. The following parameters were analysed: i) weight evolution; ii) in plasma: urea, creatinine, uric acid, total proteins, albumen, lactate dehydrogenase, creatinine-quinase, aspartate aminotransferase, alanine aminotransferase and total cholesterol; iii) in urine: urea, creatinine, total proteins and microalbumen; iv) biomarkers of oxidative damage in kidneys, heart, liver and brain: lipoperoxides, total glutathione, reduced glutathione, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase; v) melatonin (pineal gland tissue and plasma) and leptin (plasma). From the results obtained it was concluded that the administration of adriamycin generated oxidative stress in renal, cerebral, hepatic and cardiac tissue. Additionally, in the healthy animal, but of a lesser relevance in the adriamycin animal, permanent light worsened the oxidative stress, whereas darkness improved it. This could be related to the circadian rhythm of the inverse release shown by melatonin and leptin, accentuating the release of melatonin in the darkness phase and that of leptin in the light phase. The correlation between melatonin and leptin in the healthy animal seemed to confirm the relationship between both variables and their influence on oxidative damage biomarkers.	[Escribano, Begona M.] Univ Cordoba, Fac Vet Med, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Moreno, Antonia; Tasset, Inmaculada; Tunez, Isaac] Univ Cordoba, Maimonides Inst Biomed Res Cordoba IMIBIC, Dept Biochem & Mol Biol, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba	Tunez, I (corresponding author), Univ Cordoba, Maimonides Inst Biomed Res Cordoba IMIBIC, Dept Biochem & Mol Biol, Cordoba, Spain.	fm2tufii@uco.es	Cuevas, Inmaculada Tasset/R-4509-2019; Escribano, Begoña/GWD-0579-2022	Cuevas, Inmaculada Tasset/0000-0003-0730-6750; Escribano Duran, Begona/0000-0002-0966-0641				AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahmed F, 2013, PHARMACOGN MAG, V9, P130, DOI 10.4103/0973-1296.111265; Alonso-Vale MIC, 2005, AM J PHYSIOL-ENDOC M, V288, pE805, DOI 10.1152/ajpendo.00478.2004; Badary OA, 2000, TOXICOLOGY, V143, P219, DOI 10.1016/S0300-483X(99)00179-1; Baydas G, 2002, NEUROSCI LETT, V323, P195, DOI 10.1016/S0304-3940(02)00144-1; Beltowski J, 2003, ATHEROSCLEROSIS, V170, P21, DOI 10.1016/S0021-9150(03)00236-3; Bocquier F, 1998, REPROD NUTR DEV, V38, P489, DOI 10.1051/rnd:19980501; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Bubenik GA, 1998, BIOL SIGNAL RECEPT, V7, P195; Cagnacci A, 2002, J PINEAL RES, V33, P57, DOI 10.1034/j.1600-079X.2002.01893.x; Dauchy RT, 2013, J AM ASSOC LAB ANIM, V52, P146; Desassis JF, 1997, NEPHRON, V75, P336, DOI 10.1159/000189558; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gan EH, 2010, PROG BRAIN RES, V181, P111, DOI 10.1016/S0079-6123(08)81007-2; Gunduz B, 2002, COMP BIOCHEM PHYS A, V132, P393, DOI 10.1016/S1095-6433(02)00041-7; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Ianas O, 1991, Endocrinologie, V29, P147; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Licinio J, 1998, P NATL ACAD SCI USA, V95, P2541, DOI 10.1073/pnas.95.5.2541; Martin C, 2003, LIFE SCI, V73, P327, DOI 10.1016/S0024-3205(03)00271-6; Mathes AM, 2010, WORLD J GASTROENTERO, V16, P6087, DOI 10.3748/wjg.v16.i48.6087; Montilla PL, 1998, J PINEAL RES, V25, P86, DOI 10.1111/j.1600-079X.1998.tb00544.x; Fonzo LSN, 2009, HIPPOCAMPUS, V19, P869, DOI 10.1002/hipo.20571; Pablos MI, 1998, NEUROCHEM INT, V32, P69, DOI 10.1016/S0197-0186(97)00043-0; Pandi-Perumal SR, 2006, FEBS J, V273, P2813, DOI 10.1111/j.1742-4658.2006.05322.x; PANG SF, 1990, J PINEAL RES, V8, P179, DOI 10.1111/j.1600-079X.1990.tb00678.x; Peliciari-Garcia RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546516; Qin LQ, 2003, LIFE SCI, V73, P2467, DOI 10.1016/S0024-3205(03)00628-3; Rasmussen DD, 1999, ENDOCRINOLOGY, V140, P1009, DOI 10.1210/en.140.2.1009; Reiter RJ, 1997, AGE, V20, P201, DOI 10.1007/s11357-997-0020-2; Reiter RJ, 1998, P W PHARMACOL SOC, V41, P229; Reiter RJ, 1999, ANN NY ACAD SCI, V890, P471, DOI 10.1111/j.1749-6632.1999.tb08028.x; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; REITER RJ, 1995, J PINEAL RES, V18, P1, DOI 10.1111/j.1600-079X.1995.tb00133.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sani M, 2006, COMP BIOCHEM PHYS B, V145, P331, DOI 10.1016/j.cbpb.2006.08.005; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; Sensi S, 1993, Ann Ist Super Sanita, V29, P613; Srinivasan V, 2005, NEUROTOX RES, V7, P293, DOI 10.1007/BF03033887; Ponce IT, 2012, BIOL RHYTHM RES, V43, P351, DOI 10.1080/09291016.2011.593847; Tunez I, 2002, J PHYSIOL BIOCHEM, V58, P109, DOI 10.1007/BF03179846; Tunez I, 2007, MELATONIN PRESENT FU, P315; VANCAUTER E, 1990, HORM RES, V34, P45, DOI 10.1159/000181794; Venkatesan N, 1997, P SOC EXP BIOL MED, V215, P158, DOI 10.3181/00379727-215-44122; Wagner R, 2000, HORM RES, V54, P174, DOI 10.1159/000053255; WARHOLM M, 1985, METHOD ENZYMOL, V113, P499; Wolden-Hanson T, 2000, ENDOCRINOLOGY, V141, P487, DOI 10.1210/en.141.2.487; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Zieba DA, 2007, DOMEST ANIM ENDOCRIN, V33, P358, DOI 10.1016/j.domaniend.2006.06.004	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97713	10.1371/journal.pone.0097713	http://dx.doi.org/10.1371/journal.pone.0097713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852173	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200028
J	Ryu, J; Ahn, S; Kim, SG; Kim, T; Lee, SJ				Ryu, Jeongeun; Ahn, Sungsook; Kim, Seung-Gon; Kim, TaeJoo; Lee, Sang Joon			Interactive Ion-Mediated Sap Flow Regulation in Olive and Laurel Stems: Physicochemical Characteristics of Water Transport via the Pit Structure	PLOS ONE			English	Article							XYLEM HYDRAULIC CONDUCTIVITY; ROOT-GROWTH; CONDUCTANCE; MEMBRANE; INCREASE; VISUALIZATION; RESISTANCE; VESSEL; PLANTS; VULNERABILITY	Sap water is distributed and utilized through xylem conduits, which are vascular networks of inert pipes important for plant survival. Interestingly, plants can actively regulate water transport using ion-mediated responses and adapt to environmental changes. However, ionic effects on active water transport in vascular plants remain unclear. In this report, the interactive ionic effects on sap transport were systematically investigated for the first time by visualizing the uptake process of ionic solutions of different ion compositions (K+/Ca2+) using synchrotron X-ray and neutron imaging techniques. Ionic solutions with lower K+/Ca2+ ratios induced an increased sap flow rate in stems of Olea europaea L. and Laurus nobilis L. The different ascent rates of ionic solutions depending on K+/Ca2+ ratios at a fixed total concentration increases our understanding of ion-responsiveness in plants from a physicochemical standpoint. Based on these results, effective structural changes in the pit membrane were observed using varying ionic ratios of K+/Ca2+. The formation of electrostatically induced hydrodynamic layers and the ion-responsiveness of hydrogel structures based on Hofmeister series increase our understanding of the mechanism of ion-mediated sap flow control in plants.	[Ryu, Jeongeun; Ahn, Sungsook; Kim, Seung-Gon; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea; [Ryu, Jeongeun; Ahn, Sungsook; Kim, Seung-Gon; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Ctr Biofluid & Biomim Res, Pohang, Gyeongbuk, South Korea; [Kim, TaeJoo] KAERI, Div Neutron Sci, Taejon, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Atomic Energy Research Institute (KAERI)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea.	sjlee@postech.ac.kr	Angeles, Guillermo/P-6976-2014; Lee, Sang Joon/AAG-2448-2019		PAL through the abroad beam time program of the Synchrotron Radiation Facility Project of the Ministry of Education, Science and Technology (MEST); National Research Foundation of Korea (MRF) - Korean government (MSIP) [2008-006991]	PAL through the abroad beam time program of the Synchrotron Radiation Facility Project of the Ministry of Education, Science and Technology (MEST); National Research Foundation of Korea (MRF) - Korean government (MSIP)	This work was supported by PAL through the abroad beam time program of the Synchrotron Radiation Facility Project of the Ministry of Education, Science and Technology (MEST) and performed under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2010G722). This work was also supported by the National Research Foundation of Korea (MRF) grant funded by the Korean government (MSIP) (No. 2008-006991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Boyce CK, 2004, P NATL ACAD SCI USA, V101, P17555, DOI 10.1073/pnas.0408024101; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Cherel I, 2004, J EXP BOT, V55, P337, DOI 10.1093/jxb/erh028; Choat B, 2008, NEW PHYTOL, V177, P608, DOI 10.1111/j.1469-8137.2007.02317.x; Choat B, 2006, AM J BOT, V93, P993, DOI 10.3732/ajb.93.7.993; Cochard H, 2010, J EXP BOT, V61, P275, DOI 10.1093/jxb/erp298; Cussler E.L., 1997, DIFFUSION MASS TRANS; Domec JC, 2007, TREE PHYSIOL, V27, P1389, DOI 10.1093/treephys/27.10.1389; Gasco A, 2007, PHYSIOL PLANTARUM, V129, P597, DOI 10.1111/j.1399-3054.2006.00848.x; Gasco A, 2006, PLANT CELL ENVIRON, V29, P1946, DOI 10.1111/j.1365-3040.2006.01570.x; Gilliham M, 2011, J EXP BOT, V62, P2233, DOI 10.1093/jxb/err111; Goodger JQD, 2005, J EXP BOT, V56, P2389, DOI 10.1093/jxb/eri231; Gortan E, 2011, TREE PHYSIOL, V31, P48, DOI 10.1093/treephys/tpq101; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Jansen S, 2011, NEW PHYTOL, V189, P218, DOI 10.1111/j.1469-8137.2010.03448.x; Kim HK, 2010, NEW PHYTOL, V188, P1085, DOI 10.1111/j.1469-8137.2010.03424.x; Kim T, 2008, APPL RADIAT ISOTOPES, V66, P593, DOI 10.1016/j.apradiso.2007.12.006; Lee J, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00055; Lee SJ, 2008, ANN BOT-LONDON, V101, P595, DOI 10.1093/aob/mcm312; Lopez-Portillo J, 2005, PLANT CELL ENVIRON, V28, P1285, DOI 10.1111/j.1365-3040.2005.01366.x; Matsushima U, 2008, J APPL BOT FOOD QUAL, V82, P90; Matsushima U, 2005, NUCL INSTRUM METH A, V542, P76, DOI 10.1016/j.nima.2005.01.014; Matsushima U, 2009, NUCL INSTRUM METH A, V605, P146, DOI 10.1016/j.nima.2009.01.187; Melcher PJ, 2012, METHODS ECOL EVOL, V3, P685, DOI 10.1111/j.2041-210X.2012.00204.x; Menon M, 2007, EUR J SOIL SCI, V58, P802, DOI 10.1111/j.1365-2389.2006.00870.x; Moradi AB, 2009, PLANT SOIL, V318, P243, DOI 10.1007/s11104-008-9834-7; Nakanishi TM, 2009, NEUTRON SCATT APPL T, P305, DOI 10.1007/978-0-387-78693-3_17; Nakanishi TM, 2003, J RADIOANAL NUCL CH, V255, P149, DOI 10.1023/A:1022252419649; Nardini A, 2007, J EXP BOT, V58, P2609, DOI 10.1093/jxb/erm105; Nardini A, 2011, J EXP BOT, V62, P4701, DOI 10.1093/jxb/err208; Nardini A, 2010, TREE PHYSIOL, V30, P628, DOI 10.1093/treephys/tpq017; OBRIEN TP, 1967, PROTOPLASMA, V63, P443, DOI 10.1007/BF01252949; OBRIEN TP, 1970, PROTOPLASMA, V69, P1, DOI 10.1007/BF01276648; Oswald SE, 2008, VADOSE ZONE J, V7, P1035, DOI 10.2136/vzj2007.0156; Plavcova L, 2011, PLANT CELL ENVIRON, V34, P501, DOI 10.1111/j.1365-3040.2010.02258.x; Santiago M, 2013, PLANT PHYSIOL, V163, P999, DOI 10.1104/pp.113.219774; Siebrecht S, 2003, PLANTA, V217, P783, DOI 10.1007/s00425-003-1041-4; Smith KT, 2013, P NATL ACAD SCI USA, V110, pE3739, DOI 10.1073/pnas.1311453110; Strobl M, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/24/243001; Totzke C, 2013, ANN BOT-LONDON, V111, P723, DOI 10.1093/aob/mct014; Trifilo P, 2008, TREE PHYSIOL, V28, P1505, DOI 10.1093/treephys/28.10.1505; Tyree MT, 1999, PLANT PHYSIOL, V120, P11, DOI 10.1104/pp.120.1.11; van Doorn WG, 2011, PLANT PHYSIOL, V157, P1642, DOI 10.1104/pp.111.185314; van Ieperen W, 2000, J EXP BOT, V51, P769, DOI 10.1093/jexbot/51.345.769; van Ieperen W, 2007, TRENDS PLANT SCI, V12, P137, DOI 10.1016/j.tplants.2007.03.001; van Ieperen W, 2006, J EXP BOT, V57, P2743, DOI 10.1093/jxb/erl039; Wheeler JK, 2005, PLANT CELL ENVIRON, V28, P800, DOI 10.1111/j.1365-3040.2005.01330.x; ZIMMERMANN MH, 1978, CAN J BOT, V56, P2286, DOI 10.1139/b78-274; Zwieniecki MA, 2001, SCIENCE, V291, P1059, DOI 10.1126/science.1057175; Zwieniecki MA, 2003, J EXP BOT, V54, P1399, DOI 10.1093/jxb/erg144	52	5	5	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98484	10.1371/journal.pone.0098484	http://dx.doi.org/10.1371/journal.pone.0098484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852943	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200073
J	Nightingale, K; Levy, CS; Hopkins, J; Grey, F; Esper, S; Dalziel, RG				Nightingale, Katie; Levy, Claire S.; Hopkins, John; Grey, Finn; Esper, Suzanne; Dalziel, Robert G.			Expression of Ovine Herpesvirus-2 Encoded MicroRNAs in an Immortalised Bovine - Cell Line	PLOS ONE			English	Article							TARGET; SEQUENCE	Ovine herpesvirus-2 (OvHV-2) infects most sheep, he e it establishes an asymptomatic, latent infection. Infection susceptible hosts e cattle and deer results in malignant catarrhal fever, a fatal lymphoproliferative disease characterised by uncontrolled lymphocyte proliferation and non MHC restricted cytotoxicity. The same cell populations are infected in both cattle and sheep but only in cattle does virus infection cause dysregulation of cell function leading to disease. The mechanism by which OvHV-2 induces this uncontrolled proliferation is unknown. A number of herpesviruses have been shown to encode microRNAs (miRNAs) that have roles in control of both viral and cellular gene expression. We hypothesised that OvHV-2 encodes miRNAs and that these play a role in pathogenesis. Analysis of massively parallel sequencing data from an OvHV-2 persistently-infected bovine lymphoid cell line (BJ1035) identified forty-five possible virus-encoded miRNAs. We previously confirmed the expression of eight OvHV-2 miRNAs by northern hybridization. In this study we used RT-PCR to confirm the expression of an additional twenty-seven OvHV-2-encoded miRNAs. All thirty-five OvHV-2 miRNAs are expressed from the same virus genome strand and the majority (30) are encoded in an approximately 9 kb region that contains no predicted virus open reading frames. Future identification of the cellular and virus targets of these miRNAs will inform our understanding of MCF pathogenesis.	[Dalziel, Robert G.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; Univ Edinburgh, R D SVS, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Dalziel, RG (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	bob.dalziel@roslin.ed.ac.uk	Hopkins, John/C-7756-2013	Hopkins, John/0000-0002-9530-8037; Nightingale, Katie/0000-0001-9958-4699; Grey, Finn/0000-0003-4288-2059; Levy, Claire/0000-0001-9265-6645	University of Edinburgh Principal's Career Development Scholarship; Roslin Institute; Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant; BBSRC [BBS/E/D/20241864] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1232430, BBS/E/D/20241864] Funding Source: researchfish	University of Edinburgh Principal's Career Development Scholarship; Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	KN is funded by a University of Edinburgh Principal's Career Development Scholarship and the Roslin Institute, SE was funded by Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant to The Roslin Institute, FG is a Wellcome Trust Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BUJDOSO R, 1990, IMMUNOLOGY, V69, P45; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Dolken L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001150; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Feederle R, 2011, J VIROL, V85, P9801, DOI 10.1128/JVI.05100-11; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; Glazov EA, 2010, J GEN VIROL, V91, P32, DOI 10.1099/vir.0.014290-0; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Levy CS, 2012, J GEN VIROL, V93, P150, DOI 10.1099/vir.0.037606-0; Levy CS, 2011, THESIS U EDINBURGH; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Meier-Trummer CS, 2010, VET MICROBIOL, V141, P199, DOI 10.1016/j.vetmic.2009.09.009; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; REID HW, 1989, RES VET SCI, V47, P90, DOI 10.1016/S0034-5288(18)31237-2; Riaz A, 2014, J GEN VIROL, V95, P472, DOI 10.1099/vir.0.059303-0; Russell GC, 2009, VET J, V179, P324, DOI 10.1016/j.tvjl.2007.11.007; Schock A, 1998, VET IMMUNOL IMMUNOP, V66, P67, DOI 10.1016/S0165-2427(98)00187-1; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Yao YX, 2007, J VIROL, V81, P7164, DOI 10.1128/JVI.00112-07; Zhao YG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001305; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	33	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97765	10.1371/journal.pone.0097765	http://dx.doi.org/10.1371/journal.pone.0097765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849241	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600057
J	Rutherford, A; Harmon, D; Werfel, J; Gard-Murray, AS; Bar-Yam, S; Gros, A; Xulvi-Brunet, R; Bar-Yam, Y				Rutherford, Alex; Harmon, Dion; Werfel, Justin; Gard-Murray, Alexander S.; Bar-Yam, Shlomiya; Gros, Andreas; Xulvi-Brunet, Ramon; Bar-Yam, Yaneer			Good Fences: The Importance of Setting Boundaries for Peaceful Coexistence	PLOS ONE			English	Article							CIVIL-WAR; ETHNIC-CONFLICT; POLITICAL-SYSTEMS; FEDERALISM; POLARIZATION; DIVERSITY; GEOGRAPHY; DEMOCRACY; TIME; DECENTRALIZATION	We consider the conditions of peace and violence among ethnic groups, testing a theory designed to predict the locations of violence and interventions that can promote peace. Characterizing the model's success in predicting peace requires examples where peace prevails despite diversity. Switzerland is recognized as a country of peace, stability and prosperity. This is surprising because of its linguistic and religious diversity that in other parts of the world lead to conflict and violence. Here we analyze how peaceful stability is maintained. Our analysis shows that peace does not depend on integrated coexistence, but rather on well defined topographical and political boundaries separating groups, allowing for partial autonomy within a single country. In Switzerland, mountains and lakes are an important part of the boundaries between sharply defined linguistic areas. Political canton and circle (sub-canton) boundaries often separate religious groups. Where such boundaries do not appear to be sufficient, we find that specific aspects of the population distribution guarantee either sufficient separation or sufficient mixing to inhibit intergroup violence according to the quantitative theory of conflict. In exactly one region, a porous mountain range does not adequately separate linguistic groups and that region has experienced significant violent conflict, leading to the recent creation of the canton of Jura. Our analysis supports the hypothesis that violence between groups can be inhibited by physical and political boundaries. A similar analysis of the area of the former Yugoslavia shows that during widespread ethnic violence existing political boundaries did not coincide with the boundaries of distinct groups, but peace prevailed in specific areas where they did coincide. The success of peace in Switzerland may serve as a model to resolve conflict in other ethnically diverse countries and regions of the world.	[Rutherford, Alex; Harmon, Dion; Werfel, Justin; Gard-Murray, Alexander S.; Bar-Yam, Shlomiya; Gros, Andreas; Xulvi-Brunet, Ramon; Bar-Yam, Yaneer] New England Complex Syst Inst, Cambridge, MA 02142 USA		Bar-Yam, Y (corresponding author), New England Complex Syst Inst, Cambridge, MA 02142 USA.	yaneer@necsi.edu		Xulvi-Brunet, Ramon/0000-0002-6013-4831	AFOSR [FA9550-09-1-0324]; ONR [N000140910516]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ONR(Office of Naval Research)	This work was supported in part by AFOSR under grant FA9550-09-1-0324 and ONR under grant N000140910516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman Eduardo, 2005, SUSTAINABLE PEACE PO, P173; Alesina A, 2004, J POLIT ECON, V112, P2; Amoretti Ugo M., 2004, FEDERALISM TERRITORI; [Anonymous], 1993, NOUVEAU QUOTIDI 0108; [Anonymous], 1985, GAZETTE LAUSANN 0904; [Anonymous], [No title captured]; [Anonymous], 1980, GAZETTE LAUSANN 0317; [Anonymous], 1987, J GENVE         1002; [Anonymous], 1964, GAZETTE LAUSANN 0304; [Anonymous], 1989, GAZETTE LAUSANN 0406; [Anonymous], 1963, GAZETTE LAUSANN 1007; [Anonymous], 1966, J GENVE         0706; [Anonymous], 1993, GAZETTE LAUSANN 0108; [Anonymous], 1972, CONFLICT REGULATION; [Anonymous], 1972, J GENVE         0717; [Anonymous], 1965, GAZETTE LAUSANN 1013; [Anonymous], 1992, NOUVEAU QUOTIDI 0526; [Anonymous], 1987, J GENVE         1022; [Anonymous], 2000, ETHNIC GROUPS CONFLI; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; Bakke KM, 2006, WORLD POLIT, V59, P1, DOI 10.1353/wp.2007.0013; Bhavnani R, 2009, J CONFLICT RESOLUT, V53, P30, DOI 10.1177/0022002708325945; Blimes RJ, 2006, J CONFLICT RESOLUT, V50, P536, DOI 10.1177/00222706289402; Bohlken AT, 2010, J PEACE RES, V47, P589, DOI 10.1177/0022343310373032; Bovik A, 2009, ESSENTIAL GUIDE TO IMAGE PROCESSING, 2ND EDITION, P1; Braithwaite A, 2010, J PEACE RES, V47, P311, DOI 10.1177/0022343310362164; Braithwaite A, 2010, J PEACE RES, V47, P91, DOI 10.1177/0022343309350008; Brancati D, 2004, WASH QUART, V27, P7, DOI 10.1162/016366004773097687; Brancati D, 2006, INT ORGAN, V60, P651, DOI 10.1017/S002081830606019X; Buhaug H, 2002, J PEACE RES, V39, P417, DOI 10.1177/0022343302039004003; Buhaug H, 2006, POLIT GEOGR, V25, P315, DOI 10.1016/j.polgeo.2006.02.005; Buhaug H, 2009, J CONFLICT RESOLUT, V53, P544, DOI 10.1177/0022002709336457; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Campos NF, 2007, AM J POLIT SCI, V51, P620, DOI 10.1111/j.1540-5907.2007.00271.x; Cederman LE, 2009, J CONFLICT RESOLUT, V53, P487, DOI 10.1177/0022002709336454; Cederman Lars-Erik, 2008, ORDER CONFLICT VIOLE, P242; Christin T, 2006, FEDERALISM GEOGRAPHI; Church C, 2004, POLITICS GOVT SWITZE; Cioffi-Revilla C, 2010, INT STUD REV, V12, P31, DOI 10.1111/j.1468-2486.2009.00911.x; Cohen C., 2003, IMAGINE COEXISTENCE, P267; Cohen FS, 1997, COMP POLIT STUD, V30, P607, DOI 10.1177/0010414097030005004; Collier P, 2008, J EUR ECON ASSOC, V6, P531, DOI 10.1162/JEEA.2008.6.2-3.531; Congleton RD, 2000, COMPETITION STRCTURE, P284; Cunningham DE, 2009, J CONFLICT RESOLUT, V53, P570, DOI 10.1177/0022002709336458; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Dorussen Han, 2007, C DIS STUD CIV WAR T; DUNN JA, 1972, COMP POLIT STUD, V5, P3, DOI 10.1177/001041407200500101; Durmuller Urs, 1991, SOCIOLINGUISTICA, V5, P111; Eck K, 2007, J PEACE RES, V44, P233, DOI 10.1177/0022343307075124; Esman M, 1977, ETHNIC CONFLICT W WO; Esteban J, 2008, J PEACE RES, V45, P163, DOI 10.1177/0022343307087175; Fearon JD, 2007, AM POLIT SCI REV, V101, P187, DOI 10.1017/S0003055407070219; Findley M, 2010, AM POL SCI AS 2009 T; Forsberg E, 2008, J PEACE RES, V45, P283, DOI 10.1177/0022343307087185; Fox J, 2004, RELIG CIVILISATION C; Geller A, 2008, ADV COMPLEX SYST, V11, P321, DOI 10.1142/S0219525908001659; Gerritsen D, 2010, EUR UNION POLIT, V11, P267, DOI 10.1177/1465116510363311; GLASS HE, 1977, PUBLIUS J FEDERALISM, V7, P31; Gleditsch KS, 2007, J PEACE RES, V44, P293, DOI 10.1177/0022343307076637; Gulden T, 2002, 26 CTR SOC EC DYN BR; Gurr TR, 2000, FOREIGN AFF, V79, P52, DOI 10.2307/20049729; Hale HE, 2004, WORLD POLIT, V56, P165, DOI 10.1353/wp.2004.0011; Harff Barbara, 2004, ETHNIC CONFLICT WORL, V2, P83; Hartzell CA, 1999, J CONFLICT RESOLUT, V43, P3, DOI 10.1177/0022002799043001001; Head R.C., 1999, GER HIST, V17, P321; Head Randolph C., 2002, EARLY MODERN DEMOCRA; Hegre H., 2010, APSA 2010 ANN M; Hegre H, 2006, J CONFLICT RESOLUT, V50, P508, DOI 10.1177/0022002706289303; Hof UI, 1991, KOHLHAMMER URBAN TAS, V188; Hug S, 2006, ANN M INT STUD ASS S; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Jarvis A, 2008, HOLE FILLED SRTM VER; Johnson C, 2006, ANN M INT STUD ASS S; KATZ RS, 1984, COMP POLIT STUD, V16, P505, DOI 10.1177/0010414084016004004; Kaufmann CD, 1998, INT SECURITY, V23, P120, DOI 10.2307/2539381; KEECH WR, 1972, COMP POLIT, V4, P387, DOI 10.2307/421559; Kellas JG., 1998, POLITICS NATL ETHNIC, V2nd edn.; Lijphart Arend, 1977, DEMOCRACY PLURAL SOC; Lim M, 2007, SCIENCE, V317, P1540, DOI 10.1126/science.1142734; Linder W, 2010, SWISS DEMOCRACY: POSSIBLE SOLUTIONS TO CONFLICT IN MULTICULTURAL SOCIETIES, 3RD EDITION, P1, DOI 10.1057/9780230274976; Lingzhi Luo, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P442, DOI 10.1109/CSE.2009.333; LUSTICK I, 1979, WORLD POLIT, V31, P325, DOI 10.2307/2009992; Lustick IS, 2009, COMP POLIT, V41, P223, DOI 10.5129/001041509X12911362972070; Lustick IS, 2004, AM POLIT SCI REV, V98, P209, DOI 10.1017/S0003055404001108; Mahmud AS, 2011, PUBLIC CHOICE, V147, P359, DOI 10.1007/s11127-010-9633-6; Martin W, 1931, ESSAY FORMATION CONF; McGarry J., 1993, POLITICS ETHNIC CONF; McGarry John, 2005, POWER SHARING DEMOCR, P263; McRae KD, 1983, CONFLICT RESOLUTION; McRae KD, 1983, CONFLICT COMPROMISE; Meadwell H, 2011, QUAL QUANT, V3, P541; Mitchell K, 1997, ANTIPODE, V29, P101, DOI 10.1111/1467-8330.00038; Nugent Paul, 1996, AFRICAN BOUNDARIES B; Ostby G, 2008, J PEACE RES, V45, P143, DOI 10.1177/0022343307087169; PAP L, 1990, LINGUA, V80, P109, DOI 10.1016/0024-3841(90)90018-G; RABUSHKA A., 1972, POLITICS PLURAL SOC; Raleigh C, 2009, POLIT GEOGR, V28, P224, DOI 10.1016/j.polgeo.2009.05.007; Rappard WE, 1950, PARLIAMENT AFF, V4, P236; Rash F., 2002, J MULTILING MULTICUL, V23, P112; Reynal-Querol M, 2002, J CONFLICT RESOLUT, V46, P29, DOI 10.1177/0022002702046001003; Ross M, 2006, ANNU REV POLIT SCI, V9, P265, DOI 10.1146/annurev.polisci.9.081304.161338; Rost N, 2009, SOC SCI RES, V38, P921, DOI 10.1016/j.ssresearch.2009.06.007; Rothchild Donald S., 2005, SUSTAINABLE PEACE PO, P109; Ruttan L, 2010, ETHNIC INTERACTIONS; Saideman SM, 2002, COMP POLIT STUD, V35, P103, DOI 10.1177/001041400203500108; Sambanis N, 2004, J CONFLICT RESOLUT, V48, P814, DOI 10.1177/0022002704269355; Schou A., 2005, DECENTRALISATION CON, V139, P1; Shearer W, 2008, DETERMINE INDICATORS; Shellman SM, 2008, POLIT ANAL, V16, P464, DOI 10.1093/pan/mpn008; Silberfein M, 2006, CONFLICT MANAG PEACE, V23, P343, DOI 10.1080/07388940600972685; Snyder J., 2000, VOTING VIOLENCE DEMO; Spolaore E., 2008, ECON GOV, V9, P45; Spolaore E, 2008, 5 S FISC FED REG FIS; Steinberg Jonathan, 2016, WHY SWITZERLAND; Steiner J, 1974, CONFLICT RESOLUTION; Stepan A, 1999, J DEMOCR, V10, P19, DOI 10.1353/jod.1999.0072; STEVENSON P, 1990, J MULTILING MULTICUL, V11, P227, DOI 10.1080/01434632.1990.9994413; Stojanovic N, 2010, THESIS MCGILL U; Swissinfo, 2009, CIT SETTL TERR JUR C; Tir J, 2005, J PEACE RES, V42, P545, DOI 10.1177/0022343305056228; Watts RL, 1998, ANNU REV POLIT SCI, V1, P117, DOI 10.1146/annurev.polisci.1.1.117; Weidmann NB, 2009, J CONFLICT RESOLUT, V53, P526, DOI 10.1177/0022002709336456; Welsh David., 1993, SURVIVAL, V35, P63; White DR, 2009, ENCY COMPLEXITY SYST; Wibbels E, 2006, ANNU REV POLIT SCI, V9, P165, DOI 10.1146/annurev.polisci.9.062404.170504; Wilner AS, 2010, FEDERAL GOVERNANCES, p5/6; Wimmer A., 1997, NATIONS NATL, V3, P631, DOI [DOI 10.1111/J.1354-5078.1997.00631.X, 10.1111/j.1354-5078.1997.00631.x]; Wimmer A, 2009, AM SOCIOL REV, V74, P316, DOI 10.1177/000312240907400208; Zimmer O, 2007, CONTESTED NATION HIS	129	11	11	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e95660	10.1371/journal.pone.0095660	http://dx.doi.org/10.1371/journal.pone.0095660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3AL	24847861	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600006
J	Veen, T; Hjernquist, MB; Van Wilgenburg, SL; Hobson, KA; Folmer, E; Font, L; Klaassen, M				Veen, Thor; Hjernquist, Marten B.; Van Wilgenburg, Steven L.; Hobson, Keith A.; Folmer, Eelke; Font, Laura; Klaassen, Marcel			Identifying the African Wintering Grounds of Hybrid Flycatchers Using a Multi-Isotope (delta H-2, delta C-13, delta N-15) Assignment Approach	PLOS ONE			English	Article							MIGRATORY DIRECTION; STABLE HYDROGEN; EVOLUTION; BIRDS; PATTERNS; ORIGINS	Migratory routes and wintering grounds can have important fitness consequences, which can lead to divergent selection on populations or taxa differing in their migratory itinerary. Collared (Ficedula albicollis) and pied (F. hypoleuca) flycatchers breeding in Europe and wintering in different sub-Saharan regions have distinct migratory routes on the eastern and western sides of the Sahara desert, respectively. In an earlier paper, we showed that hybrids of the two species did not incur reduced winter survival, which would be expected if their migration strategy had been a mix of the parent species' strategies potentially resulting in an intermediate route crossing the Sahara desert to different wintering grounds. Previously, we compared isotope ratios and found no significant difference in stable-nitrogen isotope ratios (delta N-15) in wintergrown feathers between the parental species and hybrids, but stable-carbon isotope ratios (delta C-13) in hybrids significantly clustered only with those of pied flycatchers. We followed up on these findings and additionally analyzed the same feathers for stable-hydrogen isotope ratios (delta H-2) and conducted spatially explicit multi-isotope assignment analyses. The assignment results overlapped with presumed wintering ranges of the two species, highlighting the efficacy of the method. In contrast to earlier findings, hybrids clustered with both parental species, though most strongly with pied flycatcher.	[Veen, Thor] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Veen, Thor] Univ Groningen, Theoret Biol Grp, Groningen, Netherlands; [Hjernquist, Marten B.] Uppsala Univ, Uppsala, Uppland, Sweden; [Van Wilgenburg, Steven L.; Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada; [Folmer, Eelke] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Noord Holland, Netherlands; [Font, Laura] Vrije Univ Amsterdam, Deep Earth Cluster, Amsterdam, Noord Holland, Netherlands; [Klaassen, Marcel] Netherlands Inst Ecol, Dept Anim Ecol, Wageningen, Gelderland, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrat Ecol, Geelong, Vic 3217, Australia	University of British Columbia; University of Groningen; Uppsala University; Environment & Climate Change Canada; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Veen, T (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada.	veen@biodiversity.ubc.ca	Hobson, Keith/Q-9306-2019; Klaassen, Marcel/B-4325-2008; KNAW, NIOO-KNAW/A-4320-2012	Klaassen, Marcel/0000-0003-3907-9599; Van Wilgenburg, Steven/0000-0002-6742-4567; KNAW, NIOO-KNAW/0000-0002-3835-159X	Swedish Research Council Formas; zoological foundation; Netherlands Organization for Scientific Research [NWO-ALW 812.04.001, 851.30.003]; NSERC-CREATE Training Program in Biodiversity Research; Marie Curie fellowship and program [PEOPLE-2007-2-1-IEF]; Environment Canada	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); zoological foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NSERC-CREATE Training Program in Biodiversity Research; Marie Curie fellowship and program(European Commission); Environment Canada(CGIAR)	The Swedish Research Council Formas (grants to L. Gustafsson and MBH), zoological foundation (MBH), Netherlands Organization for Scientific Research (grant: NWO-ALW 812.04.001, Rubicon to TV and 851.30.003 to MK), NSERC-CREATE Training Program in Biodiversity Research to TV and the Marie Curie fellowship and program (grant: PEOPLE-2007-2-1-IEF to LF) funded this work. Data analyses were supported by an operating grant to KAH from Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Bensch S, 2006, J AVIAN BIOL, V37, P323, DOI 10.1111/j.2006.0908-8857.03628.x; Bensch S, 1999, EVOLUTION, V53, P1925, DOI 10.1111/j.1558-5646.1999.tb04573.x; BERTHOLD P, 1991, TRENDS ECOL EVOL, V6, P254, DOI 10.1016/0169-5347(91)90072-6; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; BirdLife International and NatureServe, 2011, BIRD SPEC DISTR MAPS; Blondel Jacques, 1993, P135; Bohning-Gaese K, 1998, EVOL ECOL, V12, P767, DOI 10.1023/A:1006538414645; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Costantini D, 2013, CURR ZOOL, V59, P697, DOI 10.1093/czoolo/59.6.697; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cramp S., 1992, HDB BIRDS EUROPE MID; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Flockhart DTT, 2007, EVOL ECOL RES, V9, P887; Flockhart DTT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1087; Gross K., 2011, MVNMLE ML ESTIMATION; Hallworth MT, 2013, AUK, V130, P273, DOI 10.1525/auk.2013.13037; HELBIG AJ, 1991, J EVOLUTION BIOL, V4, P657, DOI 10.1046/j.1420-9101.1991.4040657.x; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hjernquist MB, 2009, J AVIAN BIOL, V40, P102, DOI 10.1111/j.1600-048X.2009.04412.x; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Irwin Darren E., 2005, P27; Irwin DE, 2009, CURR BIOL, V19, pR1111, DOI 10.1016/j.cub.2009.11.011; Macdonald C. A., 2013, Animal Migration, V1, P23, DOI 10.2478/ami-2012-0003; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Mettler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081365; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Prochazka P, 2013, J AVIAN BIOL, V44, P541, DOI 10.1111/j.1600-048X.2013.00185.x; Pulido F, 2003, AVIAN MIGRATION, P53; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; R Core Team, 2012, R LANG ENV STAT COMP; Reichlin TS, 2013, OECOLOGIA, V171, P591, DOI 10.1007/s00442-012-2418-5; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Rolshausen G, 2010, OECOLOGIA, V162, P175, DOI 10.1007/s00442-009-1445-3; Royle JA, 2004, ECOL APPL, V14, P1780; Salewski V, 2002, IBIS, V144, P85, DOI 10.1046/j.0019-1019.2001.00007.x; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; van Noordwijk AJ, 2006, J ORNITHOL, V147, P221, DOI 10.1007/s10336-005-0047-z; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Veen T, 2007, P R SOC B, V274, P707, DOI 10.1098/rspb.2006.0058; Veen T, 2013, MOL ECOL, V22, P4144, DOI 10.1111/mec.12441; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12; Wunder MT., 2007, THESIS	52	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98075	10.1371/journal.pone.0098075	http://dx.doi.org/10.1371/journal.pone.0098075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847717	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600084
J	Wilburn, DB; Bowen, KE; Doty, KA; Arumugam, S; Lane, AN; Feldhoff, PW; Feldhoff, RC				Wilburn, Damien B.; Bowen, Kathleen E.; Doty, Kari A.; Arumugam, Sengodagounder; Lane, Andrew N.; Feldhoff, Pamela W.; Feldhoff, Richard C.			Structural Insights into the Evolution of a Sexy Protein: Novel Topology and Restricted Backbone Flexibility in a Hypervariable Pheromone from the Red-Legged Salamander, Plethodon shermani	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; FEMALE RECEPTIVITY; COURTSHIP PHEROMONE; ALPHA-NEUROTOXINS; NMR; BINDING; TOXIN; VENOM; FAMILY; IDENTIFICATION	In response to pervasive sexual selection, protein sex pheromones often display rapid mutation and accelerated evolution of corresponding gene sequences. For proteins, the general dogma is that structure is maintained even as sequence or function may rapidly change. This phenomenon is well exemplified by the three-finger protein (TFP) superfamily: a diverse class of vertebrate proteins co-opted for many biological functions - such as components of snake venoms, regulators of the complement system, and coordinators of amphibian limb regeneration. All of the > 200 structurally characterized TFPs adopt the namesake "three-finger" topology. In male red-legged salamanders, the TFP pheromone Plethodontid Modulating Factor (PMF) is a hypervariable protein such that, through extensive gene duplication and pervasive sexual selection, individual male salamanders express more than 30 unique isoforms. However, it remained unclear how this accelerated evolution affected the protein structure of PMF. Using LC/MS-MS and multidimensional NMR, we report the 3D structure of the most abundant PMF isoform, PMF-G. The high resolution structural ensemble revealed a highly modified TFP structure, including a unique disulfide bonding pattern and loss of secondary structure, that define a novel protein topology with greater backbone flexibility in the third peptide finger. Sequence comparison, models of molecular evolution, and homology modeling together support that this flexible third finger is the most rapidly evolving segment of PMF. Combined with PMF sequence hypervariability, this structural flexibility may enhance the plasticity of PMF as a chemical signal by permitting potentially thousands of structural conformers. We propose that the flexible third finger plays a critical role in PMF: receptor interactions. As female receptors co-evolve, this flexibility may allow PMF to still bind its receptor(s) without the immediate need for complementary mutations. Consequently, this unique adaptation may establish new paradigms for how receptor: ligand pairs co-evolve, in particular with respect to sexual conflict.	[Wilburn, Damien B.; Bowen, Kathleen E.; Doty, Kari A.; Feldhoff, Pamela W.; Feldhoff, Richard C.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Arumugam, Sengodagounder; Lane, Andrew N.] Univ Louisville, JG Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Feldhoff, RC (corresponding author), Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	rick.feldhoff@louisville.edu			National Science Foundation [IOS-1146899, IOS-1147271]; University of Louisville IRIG; Kentucky Challenge for Excellence; National Institute of Health [P20GM103482]; Direct For Biological Sciences [1146899] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482, P30GM106396] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of Louisville IRIG; Kentucky Challenge for Excellence; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was supported in part by National Science Foundation (Collaborative) grants IOS-1146899 (RCF) and IOS-1147271 (LDH), a National Science Foundation Graduate Research Fellowship to DBW, the University of Louisville IRIG program, the Kentucky Challenge for Excellence, and National Institute of Health to ALN: CoBRE grant P20GM103482. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Albone ES, 1984, MAMMALIAN SEMIOCHEMI; ALBRAND JP, 1995, BIOCHEMISTRY-US, V34, P5923, DOI 10.1021/bi00017a022; ARNOLD SJ, 1976, Z TIERPSYCHOL, V42, P247; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; BILWES A, 1994, J MOL BIOL, V239, P122, DOI 10.1006/jmbi.1994.1357; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Cervenansky C., 1991, P303; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chang C.C., 1979, SNAKE VENOMS, P309; Chouinard AJ, 2013, CHEM SIGNAL, V12, P99, DOI 10.1007/978-1-4614-5927-9_8; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Feldhoff Richard C., 1999, P117; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Garza-Garcia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007123; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; Greenwald J, 1998, BIOCHEMISTRY-US, V37, P16711, DOI 10.1021/bi981939o; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Harms MJ, 2013, P NATL ACAD IN PRESS; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Houck LD, 2007, ANIM BEHAV, V73, P315, DOI 10.1016/j.anbehav.2006.07.008; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; HOUCK LD, 1990, ANIM BEHAV, V39, P729, DOI 10.1016/S0003-3472(05)80384-7; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; JERUSALINSKY D, 1994, TRENDS PHARMACOL SCI, V15, P424, DOI 10.1016/0165-6147(94)90092-2; JOHNSTON RE, 2000, NEUROBIOLOGY TASTE S, P101; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kiemnec-Tyburczy KM, 2012, CHEM SENSES, V37, P335, DOI 10.1093/chemse/bjr105; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Laberge F, 2008, NEUROSCIENCE, V151, P329, DOI 10.1016/j.neuroscience.2007.11.006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Lin YL, 2004, BIOCHEM BIOPH RES CO, V319, P720, DOI 10.1016/j.bbrc.2004.05.064; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; McIntosh PB, 2000, J BIOMOL NMR, V16, P183, DOI 10.1023/A:1008374129366; MELROSE DR, 1971, BRIT VET J, V127, P497, DOI 10.1016/S0007-1935(17)37337-2; Mourier G, 2000, PROTEIN ENG, V13, P217, DOI 10.1093/protein/13.3.217; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Palmer CA, 2010, J MOL EVOL, V70, P427, DOI 10.1007/s00239-010-9342-2; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Wilburn DB, 2012, EVOLUTION, V66, P2227, DOI 10.1111/j.1558-5646.2011.01572.x; Wirsig-Wiechmann CR, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-26; Wirsig-Wiechmann CR, 2002, BRAIN RES, V952, P335, DOI 10.1016/S0006-8993(02)03369-3; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yoshinaga S, 2013, J BIOL CHEM, V288, P16064, DOI 10.1074/jbc.M112.436782	74	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96975	10.1371/journal.pone.0096975	http://dx.doi.org/10.1371/journal.pone.0096975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849290	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600018
J	Yang, Y; Zhao, W; Xu, QW; Wang, XS; Zhang, Y; Zhang, J				Yang, Ying; Zhao, Wei; Xu, Qing-Wen; Wang, Xiao-Song; Zhang, Yu; Zhang, Jun			IQGAP3 Promotes EGFR-ERK Signaling and the Growth and Metastasis of Lung Cancer Cells	PLOS ONE			English	Article							TYROSINE KINASE; HUMAN-BREAST; COPY NUMBER; RECEPTOR; THERAPY; TARGETS; CALMODULIN; EXPRESSION; FAMILY; PROLIFERATION	Proteins of the IQGAP family display complicated and often contradictory activities in tumorigenesis. IQGAP1 has well documented oncogenic potential and IQGAP2 has putative tumor-suppressive function. IQGAP3 is the latest addition to this family and its role in cancer development remains to be defined. Here we demonstrate IQGAP3 expression is markedly increased in lung cancer tissues at both mRNA and protein levels. Overexpression of IQGAP3 promoted tumor cell growth, and migration and invasion, whereas knockdown of IQGAP3 exhibited opposite effects. Moreover, suppression of IQGAP3 in a lung cancer cell line caused a reduction in the tumorigenicity of these cells in lung tissue after intravenous injection. Furthermore, we showed that IQGAP3 is able to interact with ERK1 and enhance its phosphorylation following treatment with EGF. These data suggest that IQGAP3 may contribute to the pathogenesis of lung cancer by modulating EGFR-ERK signaling.	[Yang, Ying; Zhao, Wei; Xu, Qing-Wen; Wang, Xiao-Song; Zhang, Yu; Zhang, Jun] Peking Univ, Hlth Sci Ctr, Dept Immunol, Sch Basic Med Sci,Key Lab Med Immunol,Minist Publ, Beijing 100871, Peoples R China	Peking University	Zhang, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Sch Basic Med Sci,Key Lab Med Immunol,Minist Publ, Beijing 100871, Peoples R China.	zhangyu007@hsc.pku.edu.cn; junzhang@bjmu.edu.cn			National Basic Research Program of China [2011CB946103]; National Natural Sciences Foundation of China [31330025, 30830091]; Beijing Municipal Natural Science Foundation [7122104]; 111 Project of China [B07001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); 111 Project of China(Ministry of Education, China - 111 Project)	This work received support from the National Basic Research Program of China (2011CB946103), National Natural Sciences Foundation of China (31330025 and 30830091), Beijing Municipal Natural Science Foundation (7122104) and the 111 Project of China (B07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicelli A, 2013, INT J MED SCI, V10, P320, DOI 10.7150/ijms.4609; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dy GK, 2002, J CLIN ONCOL, V20, P2881, DOI 10.1200/JCO.2002.11.145; Dy GK, 2002, J CLIN ONCOL, V20, P3016, DOI 10.1200/JCO.2002.02.112; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Hawthorn L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-460; Houwen Li, 2003, Ann Thorac Cardiovasc Surg, V9, P147; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kim H, 2011, FEBS LETT, V585, P723, DOI 10.1016/j.febslet.2011.01.041; Koon N, 2004, NEOPLASIA, V6, P143, DOI 10.1593/neo.03385; Koudelakova V, 2013, BIOMED PAP, V157, P125, DOI 10.5507/bp.2013.034; Kunimoto K, 2009, J CELL PHYSIOL, V220, P621, DOI 10.1002/jcp.21798; Levitzki A, 2003, LUNG CANCER, V41, pS9, DOI 10.1016/S0169-5002(03)00134-X; Lv D, 2011, EUR J CANCER, V47, P2068, DOI 10.1016/j.ejca.2011.04.021; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Nojima H, 2008, NAT CELL BIOL, V10, P971, DOI 10.1038/ncb1757; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Petty RD, 2004, CLIN CANCER RES, V10, P3237, DOI 10.1158/1078-0432.CCR-03-0503; Reinmuth N, 2004, LUNG CANCER, V45, pS177, DOI 10.1016/j.lungcan.2004.07.976; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Vauhkonen H, 2006, CANCER GENET CYTOGEN, V167, P150, DOI 10.1016/j.cancergencyto.2005.11.014; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Watanabe T, 2005, NOVART FDN SYMP, V269, P223; Watanabe T, 2005, NOVART FDN SYMP, V269, P101; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Xu QW, 2012, CANCER RES, V72, P6351, DOI 10.1158/0008-5472.CAN-12-1656; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yu J, 2010, CLIN CANCER RES, V16, P2275, DOI 10.1158/1078-0432.CCR-09-2000	50	50	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97578	10.1371/journal.pone.0097578	http://dx.doi.org/10.1371/journal.pone.0097578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849319	Green Submitted, gold, Green Published			2022-12-27	WOS:000336730600038
J	Dallacqua, RP; Bitondi, MMG				Dallacqua, Rodrigo Pires; Gentile Bitondi, Marcia Maria			Dimorphic Ovary Differentiation in Honeybee (Apis mellifera) Larvae Involves Caste-Specific Expression of Homologs of Ark and Buffy Cell Death Genes	PLOS ONE			English	Article							BCL-2 PROTEIN FAMILY; MOLECULAR DETERMINANTS; DEVELOPMENTAL-STAGES; PATHWAY GENES; BEE; WORKERS; APOPTOSIS; DOMAIN; MITOCHONDRIA; QUEENS	The establishment of the number of repeated structural units, the ovarioles, in the ovaries is one of the critical events that shape caste polyphenism in social insects. In early postembryonic development, honeybee (Apis mellifera) larvae have a pair of ovaries, each one consisting of almost two hundred ovariole primordia. While practically all these ovarioles continue developing in queen-destined larvae, they undergo massive programmed cell death (PCD) in worker-destined larvae. So as to gain insight into the molecular basis of this fundamental process in caste differentiation we used quantitative PCR (qPCR) and fluorescent in situ hybridization (FISH) to investigate the expression of the Amark and Ambuffy genes in the ovaries of the two honeybee castes throughout the fifth larval instar. These are the homologs of ark and buffy Drosophila melanogaster genes, respectively, involved in activating and inhibiting PCD. Caste-specific expression patterns were found during this time-window defining ovariole number. Amark transcript levels were increased when ovariole resorption was intensified in workers, but remained at low levels in queen ovaries. The transcripts were mainly localized at the apical end of all the worker ovarioles, but appeared in only a few queen ovarioles, thus strongly suggesting a function in mediating massive ovariolar cell death in worker larvae. Ambuffy was mainly expressed in the peritoneal sheath cells covering each ovariole. The levels of Ambuffy transcripts increased earlier in the developing ovaries of queens than in workers. Consistent with a protective role against cell death, Ambuffy transcripts were localized in practically all queen ovarioles, but only in few worker ovarioles. The results are indicative of a functional relationship between the expression of evolutionary conserved cell death genes and the morphological events leading to caste-specific ovary differentiation in a social insect.	[Dallacqua, Rodrigo Pires] Univ Fed Mato Grosso do Sul, Setor Biol Geral, Mato Grosso, Brazil; [Gentile Bitondi, Marcia Maria] Univ Sao Paulo, Fac Filosof, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo	Dallacqua, RP (corresponding author), Univ Fed Mato Grosso do Sul, Setor Biol Geral, Campo Grande, Mato Grosso, Brazil.	rodrigo.dallacqua@ufms.br; mmgbit@usp.br	Dallacqua, Rodrigo P/I-6592-2012; Bitondi, Marcia MG/E-8014-2012	Bitondi, Marcia MG/0000-0002-5619-6378	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/03171-5];  [09/15772-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); 	Financial support was provided by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant 11/03171-5), which also provided a Post Doc fellowship to RPD (09/15772-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Azevedo SV, 2011, J INSECT PHYSIOL, V57, P38, DOI 10.1016/j.jinsphys.2010.09.004; Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Bryant B, 2008, INSECT BIOCHEM MOLEC, V38, P331, DOI 10.1016/j.ibmb.2007.11.012; Cameron RC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-903; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Corona M, 1999, J EXP BIOL, V202, P929; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Cruz-Landim C, 2009, ABELHAS MORFOLOGIA F, P15; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2010, ADV EXP MED BIOL, V687, P1; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Doumanis J, 2007, CELL DEATH DIFFER, V14, P907, DOI 10.1038/sj.cdd.4402082; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Evans JD, 2000, GEN BIOL, V2, P1, DOI DOI 10.1186/GB-2000-2-1-RESEARCH0001; Golstein P, 1997, SCIENCE, V275, P1081, DOI 10.1126/science.275.5303.1081; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Hartfelder K, 1997, INVERTEBR REPROD DEV, V31, P237, DOI 10.1080/07924259.1997.9672582; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Humann FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078915; Humann FC, 2011, INSECT BIOCHEM MOLEC, V41, P602, DOI 10.1016/j.ibmb.2011.03.013; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lahm A, 2003, CELL DEATH DIFFER, V10, P10, DOI 10.1038/sj.cdd.4401203; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; Linksvayer TA, 2009, GENETICS, V183, P693, DOI 10.1534/genetics.109.105452; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Monserrate JP, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-63; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Peterson JS, 2007, GENESIS, V45, P396, DOI 10.1002/dvg.20306; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Quinn L, 2003, EMBO J, V22, P3568, DOI 10.1093/emboj/cdg355; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; Reginato R. D., 2003, Braz. J. Biol., V63, P121, DOI 10.1590/S1519-69842003000100016; Reginato RD, 2002, CELL BIOL INT, V26, P243, DOI 10.1006/cbir.2001.0839; Reginato RD, 2001, INVERTEBR REPROD DEV, V39, P127, DOI 10.1080/07924259.2001.9652475; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saunders C, 1999, BIOTECHNIQUES, V26, P186, DOI 10.2144/99262bm01; Schulman JJ, 2013, J BIOL CHEM, V288, P25340, DOI 10.1074/jbc.M113.496570; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SEVERSON DW, 1989, INSECT BIOCHEM, V19, P215, DOI 10.1016/0020-1790(89)90094-2; Snodgrass RE, 1956, ANATOMY HONEY BEE, P290; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Tanner EA, 2011, DEVELOPMENT, V138, P327, DOI 10.1242/dev.057943; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Wu JN, 2010, MECH DEVELOP, V127, P407, DOI 10.1016/j.mod.2010.06.001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611; Zmasek CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008649	66	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98088	10.1371/journal.pone.0098088	http://dx.doi.org/10.1371/journal.pone.0098088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844304	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400093
J	Dallman, TJ; Chattaway, MA; Cowley, LA; Doumith, M; Tewolde, R; Wooldridge, DJ; Underwood, A; Ready, D; Wain, J; Foster, K; Grant, KA; Jenkins, C				Dallman, Timothy J.; Chattaway, Marie A.; Cowley, Lauren A.; Doumith, Michel; Tewolde, Rediat; Wooldridge, David J.; Underwood, Anthony; Ready, Derren; Wain, John; Foster, Kirsty; Grant, Kathie A.; Jenkins, Claire			An Investigation of the Diversity of Strains of Enteroaggregative Escherichia coli Isolated from Cases Associated with a Large Multi-Pathogen Foodborne Outbreak in the UK	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; AGGREGATIVE ADHERENCE; DIARRHEAL DISEASE; FECAL SAMPLES; AGGR REGULON; VIRULENCE; IDENTIFICATION; CHILDREN; GENES; MICROARRAY	Following a large outbreak of foodborne gastrointestinal (GI) disease, a multiplex PCR approach was used retrospectively to investigate faecal specimens from 88 of the 413 reported cases. Gene targets from a range of bacterial GI pathogens were detected, including Salmonella species, Shigella species and Shiga toxin-producing Escherichia coli, with the majority (75%) of faecal specimens being PCR positive for aggR associated with the Enteroaggregative E. coli (EAEC) group. The 20 isolates of EAEC recovered from the outbreak specimens exhibited a range of serotypes, the most frequent being O104:H4 and O131:H27. None of the EAEC isolates had the Shiga toxin (stx) genes. Multilocus sequence typing and single nucleotide polymorphism analysis of the core genome confirmed the diverse phylogeny of the strains. The analysis also revealed a close phylogenetic relationship between the EAEC O104:H4 strains in this outbreak and the strain of E. coli O104:H4 associated with a large outbreak of haemolytic ureamic syndrome in Germany in 2011. Further analysis of the EAEC plasmids, encoding the key enteroaggregative virulence genes, showed diversity with respect to FIB/FII type, gene content and genomic architecture. Known EAEC virulence genes, such as aggR, aat and aap, were present in all but one of the strains. A variety of fimbrial genes were observed, including genes encoding all five known fimbrial types, AAF/1 to AAF/V. The AAI operon was present in its entirety in 15 of the EAEC strains, absent in three and present, but incomplete, in two isolates. EAEC is known to be a diverse pathotype and this study demonstrates that a high level of diversity in strains recovered from cases associated with a single outbreak. Although the EAEC in this study did not carry the stx genes, this outbreak provides further evidence of the pathogenic potential of the EAEC O104:H4 serotype.	[Dallman, Timothy J.; Chattaway, Marie A.; Cowley, Lauren A.; Grant, Kathie A.; Jenkins, Claire] Publ Hlth England, Gastrointestinial Bacteria Reference Unit, London, England; [Doumith, Michel] Publ Hlth England, Antimicrobial Resistance & Healthcare Associated, London, England; [Tewolde, Rediat; Underwood, Anthony] Publ Hlth England, Appl Lab, London, England; [Tewolde, Rediat; Underwood, Anthony] Publ Hlth England, Bioinformat Unit, London, England; [Wooldridge, David J.] Publ Hlth England, Dept Bioanal & Horizon Technol, London, England; [Ready, Derren] Barts & London Hosp Trust, Publ Hlth Lab London, London, England; [Wain, John] Univ E Anglia, Innovat Ctr, Norwich NR4 7TJ, Norfolk, England; [Foster, Kirsty] North East Publ Hlth England Ctr, Newcastle Upon Tyne, Tyne & Wear, England	Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; Barts Health NHS Trust; Public Health England; University of East Anglia	Jenkins, C (corresponding author), Publ Hlth England, Gastrointestinial Bacteria Reference Unit, London, England.	claire.jenkins@phe.gov.uk	Dallman, Timothy J/ABD-6662-2021; Wain, John Richard/B-3446-2013	Underwood, Anthony/0000-0002-8547-4277; Doumith, Michel/0000-0002-8004-0314; Cowley, Lauren/0000-0003-0835-7971; Ready, Derren/0000-0003-4894-3641; Wain, John Richard/0000-0002-1257-1148; Chattaway, Marie Anne/0000-0002-5288-9089				Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Boisen N, 2012, J INFECT DIS, V205, P431, DOI 10.1093/infdis/jir757; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Dallman T, 2012, J CLIN MICROBIOL, V50, P4116, DOI 10.1128/JCM.02047-12; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Hwang J, 2010, INFECT IMMUN, V78, P4068, DOI 10.1128/IAI.00014-10; Inouye M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-338; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; Jenkins C, 2007, EUR J CLIN MICROBIOL, V26, P901, DOI 10.1007/s10096-007-0388-z; Jenkins C, 2005, FEMS MICROBIOL LETT, V253, P119, DOI 10.1016/j.femsle.2005.09.040; Jenkins C, 2006, J MED MICROBIOL, V55, P1493, DOI 10.1099/jmm.0.46683-0; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; King LA, 2012, CLIN INFECT DIS, V54, P1588, DOI 10.1093/cid/cis255; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Moran-Gilad J, 2012, EPIDEMIOL INFECT, V140, P2142, DOI 10.1017/S0950268812001835; Morin N, 2013, INFECT IMMUN, V81, P122, DOI 10.1128/IAI.00676-12; Nataro JP, 2006, CLIN INFECT DIS, V43, P402, DOI 10.1086/505867; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; Nishi J, 2003, J BIOL CHEM, V278, P45680, DOI 10.1074/jbc.M306413200; Nuesch-Inderbinen MT, 2013, J MED MICROBIOL, V62, P1828, DOI 10.1099/jmm.0.065177-0; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Okeke I N, 2001, Lancet Infect Dis, V1, P304, DOI 10.1016/S1473-3099(01)00144-X; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Okeke IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014093; Perry N, 2010, J MED MICROBIOL, V59, P870, DOI 10.1099/jmm.0.018671-0; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Scavia G, 2008, J MED MICROBIOL, V57, P1141, DOI 10.1099/jmm.0.2008/001362-0; Scheutz F, 2011, EUROSURVEILLANCE, V16, P5; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Smith HR, 1997, LANCET, V350, P814, DOI 10.1016/S0140-6736(05)62611-6; Spencer J, 1999, EPIDEMIOL INFECT, V123, P413, DOI 10.1017/S0950268899002976; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Wilson A, 2001, EUR J EPIDEMIOL, V17, P1125, DOI 10.1023/A:1021224915322; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	51	34	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98103	10.1371/journal.pone.0098103	http://dx.doi.org/10.1371/journal.pone.0098103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844597	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000339563400095
J	Rabbani, F; Ajaz, H; Zimmermann, I; Johnsson, M				Rabbani, Faiz; Ajaz, Humayun; Zimmermann, Iwan; Johnsson, Mats			Synthesis, Crystal Structure and Thermal Decomposition of the New Cadmium Selenite Chloride, Cd-4(SeO3)(2)OCl2	PLOS ONE			English	Article							MAGNETIC-PROPERTIES; CL; COPPER(II)	A synthetic study in the Cd-Se-O-Cl system led to formation of the new oxochloride compound Cd-4(SeO3)(2)OCl2 via solid state reactions. The compound crystallizes in the orthorhombic space group Fmmm with cell parameters a = 7.3610(3) angstrom, b = 15.4936(2) angstrom, c = 17.5603(3) angstrom, Z = 8, S = 0.969, F(000) = 2800, R = 0.0185, R-w = 0.0384. Single crystal X-ray data were collected at 293 K. The crystal structure can be considered as layered and the building units are distorted [Cd(1)O-6] octahedra, distorted [Cd(2)O-8] cubes, irregular [Cd(3)O4Cl2] polyhedra and SeO3E trigonal pyramids. There are two crystallographically unique Cl atoms that both are half occupied. Thermogravimetric studies show that the compound starts to decompose at 500 degrees C. The crystal structure of the new compound is closely related to the previously described compound Cd-4(SeO3)(2)Cl-4(H2O).	[Rabbani, Faiz] COMSATS Inst Informat Technol, Dept Chem, Abbottabad, Khyber Pakhtunk, Pakistan; [Ajaz, Humayun] Univ Engn & Technol, Dept Chem, Lahore, Pakistan; [Zimmermann, Iwan; Johnsson, Mats] Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden	COMSATS University Islamabad (CUI); University of Engineering & Technology Lahore; Stockholm University	Johnsson, M (corresponding author), Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden.	mats.johnsson@mmk.su.se		Zimmermann, Iwan/0000-0002-6183-2690; Johnsson, Mats/0000-0003-4319-1540	Higher Education Commission (HEC) in Pakistan; Swedish Research Council	Higher Education Commission (HEC) in Pakistan; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work has been carried out with financial support from the Higher Education Commission (HEC) in Pakistan and from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK J, 1995, Z ANORG ALLG CHEM, V621, P131, DOI 10.1002/zaac.19956210124; Becker R, 2007, J SOLID STATE CHEM, V180, P1051, DOI 10.1016/j.jssc.2006.12.035; Becker R, 2007, ACTA CRYSTALLOGR C, V63, pI4, DOI 10.1107/S0108270106050621; Becker R, 2006, J AM CHEM SOC, V128, P15469, DOI 10.1021/ja064738d; Brandenburg K., 2001, CRYSTAL IMPACT; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Chen WT, 2013, J SOLID STATE CHEM, V204, P153, DOI 10.1016/j.jssc.2013.05.035; Chen WT, 2011, CHINESE J STRUC CHEM, V30, P1798; Farrugia L.J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI [DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020, 10.1107/S0021889812029111]; GALY J, 1979, ACTA CHEM SCAND A, V33, P383, DOI 10.3891/acta.chem.scand.33a-0383; Johnsson M, 2000, CHEM MATER, V12, P2853, DOI 10.1021/cm000218k; Johnsson M, 2007, ACTA CRYSTALLOGR C, V63, pI34, DOI 10.1107/S0108270107012541; Krivovichev SV, 1998, Z KRISTALLOGR, V213, P645, DOI 10.1524/zkri.1998.213.12.645; Mao JG, 2008, INORG CHEM, V47, P8498, DOI 10.1021/ic8005629; Oxford Diffraction Xcalibur CCD System, 2007, CRYSALIS CCD CRYSALI; Nguyen SD, 2011, J AM CHEM SOC, V133, P12422, DOI 10.1021/ja205456b; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sun CF, 2009, J AM CHEM SOC, V131, P9486, DOI 10.1021/ja9030566	18	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97175	10.1371/journal.pone.0097175	http://dx.doi.org/10.1371/journal.pone.0097175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844633	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400015
J	Wang, YL; Thinakaran, G; Kar, S				Wang, Yanlin; Thinakaran, Gopal; Kar, Satyabrata			Overexpression of the IGF-II/M6P Receptor in Mouse Fibroblast Cell Lines Differentially Alters Expression Profiles of Genes Involved in Alzheimer's Disease-Related Pathology	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; AMYLOID PRECURSOR PROTEIN; GROWTH FACTOR-II/MANNOSE-6-PHOSPHATE RECEPTOR; BETA-DEGRADING ENZYMES; FACTOR-II RECEPTOR; CATHEPSIN-D; IGF-II; COGNITIVE IMPAIRMENT; LYSOSOMAL-ENZYMES; SECRETASE SITE	Alzheimer's disease (AD) is the most common type of senile dementia affecting elderly people. The processing of amyloid precursor protein (APP) leading to the generation of beta-amyloid (A beta) peptide contributes to neurodegeneration and development of AD pathology. The endocytic trafficking pathway, which comprises of the endosomes and lysosomes, acts as an important site for A beta generation, and endocytic dysfunction has been linked to increased A beta production and loss of neurons in AD brains. Since insulin-like growth factor-II (IGF-II) receptor plays a critical role in the transport of lysosomal enzymes from the trans-Golgi network to endosomes, it is likely that the receptor may have a role in regulating A beta metabolism in AD pathology. However, very little is known on how altered levels of the IGF-II receptor can influence the expression/function of various molecules involved in AD pathology. To address this issue, we evaluated the expression profiles of 87 selected genes related to AD pathology in mouse fibroblast MS cells that are deficient in murine IGF-II receptor and corresponding MS9II cells overexpressing similar to 500 times the human IGF-II receptors. Our results reveal that an elevation in IGF-II receptor levels alters the expression profiles of a number of genes including APP as well as enzymes regulating A beta production, degradation and clearance mechanisms. Additionally, it influences the expression of various lysosomal enzymes and protein kinases that are involved in A beta toxicity. IGF-II receptor overexpression also alters expression of several genes involved in intracellular signalling as well as cholesterol metabolism, which play a critical role in AD pathology. The altered gene profiles observed in this study closely match with the corresponding protein levels, with a few exceptions. These results, taken together, suggest that an elevation in IGF-II receptor levels can influence the expression profiles of transcripts as well as proteins that are involved in AD pathogenesis.	[Wang, Yanlin; Kar, Satyabrata] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Wang, Yanlin; Kar, Satyabrata] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kar, Satyabrata] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Chicago; University of Chicago; University of Chicago; University of Alberta	Kar, S (corresponding author), Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.	skar@ualberta.ca			Natural Sciences and Engineering Research Council of Canada [203518]; Canadian Institutes of Health Research [MOP-84480]; Alzheimer Society of Canada; Alberta Innovates Health Solutions; National Institutes on Aging [R01AG019070]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Alberta Innovates Health Solutions; National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from Natural Sciences and Engineering Research Council of Canada (#203518) and Canadian Institutes of Health Research (MOP-84480) to SK. YW is a recipient of Doctoral Awards from Alzheimer Society of Canada and a Graduate Studentship Award from Alberta Innovates Health Solutions. GT is supported by R01AG019070 grant from National Institutes on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amritraj A, 2009, NEUROBIOL AGING, V30, P54, DOI 10.1016/j.neurobiolaging.2007.05.004; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Di Bacco A, 2003, ONCOGENE, V22, P5436, DOI 10.1038/sj.onc.1206670; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; El-Shewy HM, 2009, VITAM HORM, V80, P667, DOI 10.1016/S0083-6729(08)00624-9; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; GABEL CA, 1983, P NATL ACAD SCI-BIOL, V80, P775, DOI 10.1073/pnas.80.3.775; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Haque A, 2008, CNS NEUROL DISORD-DR, V7, P270, DOI 10.2174/187152708784936653; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hawkes C, 2007, MOL NEUROBIOL, V35, P329, DOI 10.1007/s12035-007-0021-2; Hawkes C, 2006, J NEUROSCI, V26, P585, DOI 10.1523/JNEUROSCI.2730-05.2006; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Kar S, 2006, NEUROBIOL AGING, V27, P199, DOI 10.1016/j.neurobiolaging.2005.03.005; Kar S, 1997, P NATL ACAD SCI USA, V94, P14054, DOI 10.1073/pnas.94.25.14054; Kindy MS, 2012, J ALZHEIMERS DIS, V29, P827, DOI 10.3233/JAD-2012-111604; Kolsch H, 2002, MOL PSYCHIATR, V7, P899, DOI 10.1038/sj.mp.4001109; KYLE JW, 1988, J BIOL CHEM, V263, P16230; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Leissring MA, 2008, J BIOL CHEM, V283, P29645, DOI 10.1074/jbc.R800022200; Lopez OL, 2003, REV NEUROLOGIA, V37, P155, DOI 10.33588/rn.3702.2002441; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y; Maulik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054605; Maulik M, 2012, HUM MOL GENET, V21, P4857, DOI 10.1093/hmg/dds322; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; MINNITI CP, 1992, J BIOL CHEM, V267, P9000; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Nathalie P, 2008, CURR ALZHEIMER RES, V5, P92, DOI 10.2174/156720508783954721; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; NISHIMOTO I, 1987, J BIOL CHEM, V262, P12120; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roberg K, 1998, AM J PATHOL, V152, P1151; ROGERS SA, 1990, J BIOL CHEM, V265, P9722; Schechter I, 2008, BIOL CHEM, V389, P313, DOI 10.1515/BC.2008.025; Schechter I, 2011, BIOL CHEM, V392, P555, DOI 10.1515/BC.2011.054; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Shibata N, 2006, NEUROSCI LETT, V391, P142, DOI 10.1016/j.neulet.2005.08.048; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sparks DL, 2008, CURR ALZHEIMER RES, V5, P416, DOI 10.2174/156720508785132316; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Sundelof J, 2010, J ALZHEIMERS DIS, V22, P1223, DOI 10.3233/JAD-2010-101023; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tickler AK, 2005, PROTEIN PEPTIDE LETT, V12, P513, DOI 10.2174/0929866054395905; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wood RJ, 2008, J BIOL CHEM, V283, P4165, DOI 10.1074/jbc.M708723200; Zamrini E, 2004, NEUROEPIDEMIOLOGY, V23, P94, DOI 10.1159/000073981; Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232	75	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98057	10.1371/journal.pone.0098057	http://dx.doi.org/10.1371/journal.pone.0098057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846272	Green Submitted, gold, Green Published			2022-12-27	WOS:000339563400088
J	Zhang, YL; Shi, K; Liu, XH; Zhou, YQ; Qin, BQ				Zhang, Yunlin; Shi, Kun; Liu, Xiaohan; Zhou, Yongqiang; Qin, Boqiang			Lake Topography and Wind Waves Determining Seasonal-Spatial Dynamics of Total Suspended Matter in Turbid Lake Taihu, China: Assessment Using Long-Term High-Resolution MERIS Data	PLOS ONE			English	Article							LARGE SHALLOW LAKE; SEDIMENT RESUSPENSION; WATER-QUALITY; SUBMERGED MACROPHYTES; LIGHT; PHYTOPLANKTON; MODEL; ALGAL; VARIABILITY; ALGORITHM	Multiple comprehensive in situ bio-optical investigations were conducted from 2005 to 2010 and covered a large variability of total suspended matter (TSM) in Lake Taihu to calibrate and validate a TSM concentration estimation model based on Medium Resolution Imaging Spectrometer (MERIS) data. The estimation model of the TSM concentration in Lake Taihu was developed using top-of-atmosphere (TOA) radiance of MERIS image data at band 9 in combination with a regional empirical atmospheric correction model, which was strongly correlated with the in situ TSM concentration (r(2) = 0.720, p<0.001, and n = 73). The relative root mean square error (RRMSE) and mean relative error (MRE) were 36.9% and 31.6%, respectively, based on an independent validation dataset that produced reliable estimations of the TSM concentration. The developed algorithm was applied to 50 MERIS images from 2003 to 2011 to obtain a high spatial and temporal heterogeneity of TSM concentrations in Lake Taihu. Seasonally, the highest and lowest TSM concentrations were found in spring and autumn, respectively. Spatially, TSM concentrations were high in the southern part and center of the lake and low in Xukou Bay, East Lake Taihu. The lake topography, including the water depth and distance from the shore, had a significant effect on the TSM spatial distribution. A significant correlation was found between the daily average wind speed and TSM concentration (r(2) = 0.685, p, 0.001, and n = 50), suggesting a critical role of wind speed in the TSM variations in Lake Taihu. In addition, a low TSM concentration was linked to the appearance of submerged aquatic vegetation (SAV). Therefore, TSM dynamics were controlled by the lake topography, wind-driven sediment resuspension and SAV distribution.	[Zhang, Yunlin; Shi, Kun; Liu, Xiaohan; Zhou, Yongqiang; Qin, Boqiang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Taihu Lake Lab Ecosyst Stn, Nanjing, Peoples R China; [Liu, Xiaohan; Zhou, Yongqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YL (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Taihu Lake Lab Ecosyst Stn, Nanjing, Peoples R China.	ylzhang@niglas.ac.cn	Liu, Xiaohan/AGS-6555-2022; Qin, Boqiang/E-5900-2013; Zhang, Yunlin/N-5464-2014	Zhang, Yunlin/0000-0002-3382-4570; Zhou, Yongqiang/0000-0003-1402-345X; Shi, Kun/0000-0002-6124-7512	National Natural Science Foundation of China [41325001, 41230744, 41271355]; Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences [NIGLAS2012135003]; Major Projects on Control and Rectification of Water Body Pollution [2012ZX07101-010]; Provincial Natural Science Foundation of Jiangsu of China [BK2012050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences; Major Projects on Control and Rectification of Water Body Pollution; Provincial Natural Science Foundation of Jiangsu of China(Natural Science Foundation of Jiangsu Province)	This study was jointly funded by the National Natural Science Foundation of China (grants 41325001, 41230744, 41271355), the Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences (NIGLAS2012135003), the Major Projects on Control and Rectification of Water Body Pollution (2012ZX07101-010), and the Provincial Natural Science Foundation of Jiangsu of China (BK2012050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attila J, 2013, REMOTE SENS ENVIRON, V128, P138, DOI 10.1016/j.rse.2012.07.009; Bachmann RW, 2002, HYDROBIOLOGIA, V470, P219, DOI 10.1023/A:1015660922494; Binding CE, 2012, J GREAT LAKES RES, V38, P107, DOI 10.1016/j.jglr.2011.12.003; Carr J, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001103; Chanson H, 2011, ESTUAR COAST SHELF S, V95, P298, DOI 10.1016/j.ecss.2011.09.012; Chen SS, 2009, REMOTE SENS ENVIRON, V113, P2670, DOI 10.1016/j.rse.2009.08.005; Chen ZQ, 2010, ESTUAR COAST SHELF S, V89, P62, DOI 10.1016/j.ecss.2010.05.014; Doerffer R, 2007, INT J REMOTE SENS, V28, P517, DOI 10.1080/01431160600821127; DOERFFER R, 1989, REMOTE SENS ENVIRON, V28, P61, DOI 10.1016/0034-4257(89)90105-3; Doerffer R, 2008, MERIS LAKE WATER PRO; Dong BL, 2014, J GREAT LAK IN PRESS, V40; Duan HT, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044009; Duan HT, 2009, ENVIRON SCI TECHNOL, V43, P3522, DOI 10.1021/es8031852; Duarte CM, 2007, ESTUAR COAST, V30, P652, DOI 10.1007/BF02841962; Eleveld MA, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011121; Fettweis M, 2007, CONT SHELF RES, V27, P1568, DOI 10.1016/j.csr.2007.01.017; Fragoso CR, 2008, ECOL MODEL, V219, P125, DOI 10.1016/j.ecolmodel.2008.08.004; Guanter L, 2010, REMOTE SENS ENVIRON, V114, P467, DOI 10.1016/j.rse.2009.10.004; Hakanson L, 2005, ECOL MODEL, V189, P130, DOI 10.1016/j.ecolmodel.2005.03.015; Havens KE, 2003, HYDROBIOLOGIA, V493, P173, DOI 10.1023/A:1025497621547; Istvanovics V, 2008, AQUAT BOT, V88, P317, DOI 10.1016/j.aquabot.2007.12.008; James WF, 2004, HYDROBIOLOGIA, V515, P193, DOI 10.1023/B:HYDR.0000027328.00153.b2; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Lawson SE, 2007, ESTUAR COAST, V30, P102, DOI 10.1007/BF02782971; Le CF, 2009, REMOTE SENS ENVIRON, V113, P1175, DOI 10.1016/j.rse.2009.02.005; Le Roux JP, 2009, COAST ENG, V56, P479, DOI 10.1016/j.coastaleng.2008.10.007; Liu XH, 2014, HYDROBIOLOGIA, V724, P187, DOI 10.1007/s10750-013-1733-0; Liu XH, 2013, J GEOPHYS RES-BIOGEO, V118, P713, DOI 10.1002/jgrg.20054; Ma RH, 2008, SENSORS-BASEL, V8, P3988, DOI 10.3390/s8063988; Mao ZH, 2012, REMOTE SENS ENVIRON, V124, P819, DOI 10.1016/j.rse.2012.06.014; Nechad B, 2010, REMOTE SENS ENVIRON, V114, P854, DOI 10.1016/j.rse.2009.11.022; Neil C, 2011, REMOTE SENS ENVIRON, V115, P3719, DOI 10.1016/j.rse.2011.09.010; Nguyen HL, 2005, SCI TOTAL ENVIRON, V340, P213, DOI 10.1016/j.scitotenv.2004.07.032; Olmanson LG, 2013, REMOTE SENS ENVIRON, V130, P254, DOI 10.1016/j.rse.2012.11.023; Ondrusek M, 2012, REMOTE SENS ENVIRON, V119, P243, DOI 10.1016/j.rse.2011.12.018; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Schallenberg M, 2004, FRESHWATER BIOL, V49, P143, DOI 10.1046/j.1365-2426.2003.01172.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shen F, 2010, ESTUAR COAST, V33, P1420, DOI 10.1007/s12237-010-9313-2; Sun DY, 2009, IEEE T GEOSCI REMOTE, V47, P2957, DOI 10.1109/TGRS.2009.2014688; Takamura N, 2003, ECOL RES, V18, P381, DOI 10.1046/j.1440-1703.2003.00563.x; [唐军武 Tang Junwu], 2004, [遥感学报, Journal of Remote Sensing], V8, P37; Van den Berg MS, 2003, HYDROBIOLOGIA, V506, P611, DOI 10.1023/B:HYDR.0000008610.97044.39; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; Wang MH, 2011, REMOTE SENS ENVIRON, V115, P841, DOI 10.1016/j.rse.2010.11.012; Xi HY, 2011, ENVIRON MONIT ASSESS, V177, P563, DOI 10.1007/s10661-010-1657-3; Yang W, 2011, REMOTE SENS ENVIRON, V115, P1247, DOI 10.1016/j.rse.2011.01.007; Zhang B, 2008, ENVIRON MONIT ASSESS, V145, P339, DOI 10.1007/s10661-007-0043-2; Zhang MW, 2010, REMOTE SENS ENVIRON, V114, P392, DOI 10.1016/j.rse.2009.09.016; Zhang YL, 2007, FUND APPL LIMNOL, V170, P11, DOI 10.1127/1863-9135/2007/0170-0011; Zhang YL, 2009, IEEE T GEOSCI REMOTE, V47, P1937, DOI [10.1109/TGRS.2008.2011892, 10.1109/TGRS.2009.2011892]; Zhao DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066365; Zhu GW, 2005, J ENVIRON SCI-CHINA, V17, P672	55	57	68	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98055	10.1371/journal.pone.0098055	http://dx.doi.org/10.1371/journal.pone.0098055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846206	gold, Green Submitted, Green Published			2022-12-27	WOS:000339563400087
J	Adamski, MG; Li, Y; Wagner, E; Yu, H; Seales-Bailey, C; Durkin, H; Hao, Q; Soper, SA; Murphy, M; Baird, AE				Adamski, Mateusz G.; Li, Yan; Wagner, Erin; Yu, Hua; Seales-Bailey, Chloe; Durkin, Helen; Hao, Qing; Soper, Steven A.; Murphy, Michael; Baird, Alison E.			Pre-Existing Hypertension Dominates gamma delta T Cell Reduction in Human Ischemic Stroke	PLOS ONE			English	Article							INTERFERON-GAMMA; ESCHERICHIA-COLI; GENE-EXPRESSION; BLOOD-PRESSURE; INTERLEUKIN-17; LYMPHOCYTES; AGE; MECHANISMS; GENERATION; INFECTION	T lymphocytes may play an important role in the evolution of ischemic stroke. Depletion of gamma delta T cells has been found to abrogate ischemia reperfusion injury in murine stroke. However, the role of gamma delta T cells in human ischemic stroke is unknown. We aimed to determine gamma delta T cell counts and gamma delta T cell interleukin 17A (IL-17A) production in the clinical setting of ischemic stroke. We also aimed to determine the associations of gamma delta T cell counts with ischemic lesion volume, measures of clinical severity and with major stroke risk factors. Peripheral blood samples from 43 acute ischemic stroke patients and 26 control subjects matched on race and gender were used for flow cytometry and complete blood count analyses. Subsequently, cytokine levels and gene expression were measured in gamma delta T cells. The number of circulating gamma delta T cells was decreased by almost 50% (p = 0.005) in the stroke patients. gamma delta T cell counts did not correlate with lesion volume on magnetic resonance diffusion-weighted imaging or with clinical severity in the stroke patients, but gamma delta T cells showed elevated levels of IL-17A (p = 0.048). Decreased gamma delta T cell counts were also associated with older age (p = 0.004), pre-existing hypertension (p = 0.0005) and prevalent coronary artery disease (p = 0.03), with pre-existing hypertension being the most significant predictor of gamma delta T cell counts in a multivariable analysis. gamma delta T cells in human ischemic stroke are reduced in number and show elevated levels of IL-17A. A major reduction in gamma delta T lymphocytes also occurs in hypertension and may contribute to the development of hypertension-mediated stroke and vascular disease.	[Adamski, Mateusz G.; Li, Yan; Wagner, Erin; Yu, Hua; Seales-Bailey, Chloe; Hao, Qing; Baird, Alison E.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Adamski, Mateusz G.] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland; [Durkin, Helen] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Soper, Steven A.] Univ N Carolina, Chapel Hill, NC USA; [Murphy, Michael] Louisiana State Univ, Baton Rouge, LA 70803 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Jagiellonian University; Collegium Medicum Jagiellonian University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Louisiana State University System; Louisiana State University	Baird, AE (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.	alison.baird@downstate.edu	Adamski, Mateusz G/K-7634-2016; Adamski, Mateusz/F-6274-2015	Adamski, Mateusz/0000-0002-8340-2181; Hao, Qing/0000-0002-1097-893X	National Institute of Biomedical Imaging and Bioengineering/NIH [R01-EB010087]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010087] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering/NIH (R01-EB010087) to A. E. B., M. M., and S. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski MG, 2013, J BIOMOL SCREEN, V18, P1008, DOI 10.1177/1087057113489882; Andreu-Ballester JC, 2012, CYTOM PART B-CLIN CY, V82B, P238, DOI 10.1002/cyto.b.21020; Bhowmick S, 2009, J LEUKOCYTE BIOL, V86, P1275, DOI 10.1189/jlb.0209107; Bosch JA, 2003, BRAIN BEHAV IMMUN, V17, P251, DOI 10.1016/S0889-1591(03)00054-0; Brunetti ND, 2012, J THROMB THROMBOLYS, V34, P475, DOI 10.1007/s11239-012-0761-3; Chon H, 2004, HYPERTENSION, V43, P947, DOI 10.1161/01.HYP.0000123071.35142.72; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Dumitriu IE, 2012, CIRC RES, V110, P857, DOI 10.1161/CIRCRESAHA.111.261933; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kengne AP, 2007, J HYPERTENS, V25, P1205; Kim CH, 2005, KIDNEY INT, V67, P1462, DOI 10.1111/j.1523-1755.2005.00223.x; Kolbus D, 2013, J INTERN MED, V274, P41, DOI 10.1111/joim.12038; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li GZ, 2005, SCAND J IMMUNOL, V62, P481, DOI 10.1111/j.1365-3083.2005.01683.x; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Nakamura R, 2008, J IMMUNOL, V181, P2071, DOI 10.4049/jimmunol.181.3.2071; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Peterfalvi A, 2009, CEREBROVASC DIS, V28, P490, DOI 10.1159/000236527; RDevelopment C, 2012, R LANG ENV STAT COMP; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roux A, 2013, J IMMUNOL, V191, P1300, DOI 10.4049/jimmunol.1202940; Sahota P, 2013, INT J STROKE, V8, P60, DOI 10.1111/ijs.12022; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Touyz RM, 2012, CURR OPIN NEPHROL HY, V21, P119, DOI 10.1097/MNH.0b013e328350a50f; von Vietinghoff S, 2010, CYTOKINE GROWTH F R, V21, P463, DOI 10.1016/j.cytogfr.2010.10.003; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689; Yu H, 2013, INT J STROKE, V8, pE57, DOI 10.1111/ijs.12175	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97755	10.1371/journal.pone.0097755	http://dx.doi.org/10.1371/journal.pone.0097755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840735	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600069
J	Chao, TF; Lai, YH; Yun, CH; Yen, CH; Wang, KL; Lin, YJ; Chang, SL; Lo, LW; Hu, YF; Hung, CL; Kuo, JY; Yeh, HI; Chen, SA				Chao, Tze-Fan; Lai, Yau-Huei; Yun, Chun-Ho; Yen, Chih-Hsuan; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Hung, Chung-Lieh; Kuo, Jen-Yuan; Yeh, Hung-I; Chen, Shih-Ann			The Association between Atrium Electromechanical Interval and Pericardial Fat	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; CORONARY ATHEROSCLEROSIS; CATHETER ABLATION; FIBRILLATION; ECHOCARDIOGRAPHY; RECURRENCE; DISEASE; VOLUME	Objectives: Pericardial fat (PCF) may induce local inflammation and subsequent structural remodeling of the left atrium (LA). However, the adverse effects of PCF on LA are difficult to be evaluated and quantified. The atrial electromechanical interval determined by transthoracic echocardiogram was shown to be a convenient parameter which can reflect the process of LA remodeling. The goal of the present study was to investigate the association between the electromechanical interval and PCF. Methods and Results: A total of 337 patients with mean age of 51.9 +/- 9.0 years were enrolled. The electromechanical interval (PA-PDI) defined as the time interval from the initiation of the P wave deflection to the peak of the mitral inflow A wave on the pulse wave Doppler imaging was measured for every patient. The amount of PCF was determined by multi-detector computed tomography. The PA-PDI interval was significantly correlated with the amount of PCF (r = 0.641, p value <0.001). Graded prolongation of PA-PDI interval was observed across 3 groups of patients divided according to the tertile values of PCF. The AUC for the PA-PDI interval in predicting an increased amount of PCF (third tertile) was 0.796. At a cutoff value of 130 ms identified by the ROC curve, the sensitivity and specificity of PA-PDI interval in identifying patients with a highest tertile of PCF were 63.4% and 85.3%, respectively. Conclusions: The PA-PDI intervals were longer in patients with an increased amount of PCF. It may be a useful parameter to represent the degree of PCF-related atrial remodeling.	[Chao, Tze-Fan; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Chao, Tze-Fan; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chao, Tze-Fan; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Lai, Yau-Huei; Yen, Chih-Hsuan; Hung, Chung-Lieh; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Lai, Yau-Huei; Yen, Chih-Hsuan; Hung, Chung-Lieh; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Lai, Yau-Huei; Yen, Chih-Hsuan; Hung, Chung-Lieh; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Yun, Chun-Ho] Mackay Mem Hosp, Dept Internal Med, Div Radiol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital	Hung, CL (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	jotaro3791@gmail.com; epsachen@ms41.hinet.net	Kuo, Jen-Yuan/AAX-5448-2021; Chang, Shih-Lin/AGT-1191-2022; Hu, Yu-Feng/V-1401-2019	Hu, Yu-Feng/0000-0001-5715-2070	Taipei Veterans General Hospital, Taiwan [V96C1-049, V97C1-059, V98C1-037, V99C1-120]; National Science Council, Taiwan [NSC95-2314-B-010-017, NSC95-2314-B-010-025, NSC96-2314-B-010-006, NSC96-2628-B-010-036, NSC97-2314-B-010-037-MY3, NSC97-2314-B-010-038, NSC98-2314-B-010-031-MY3]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural grants (V96C1-049, V97C1-059, V98C1-037 and V99C1-120) from Taipei Veterans General Hospital, Taiwan and grants (NSC95-2314-B-010-017, NSC95-2314-B-010-025, NSC96-2314-B-010-006, NSC96-2628-B-010-036, NSC97-2314-B-010-037-MY3, NSC97-2314-B-010-038, NSC98-2314-B-010-031-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Babcock MJ, 2011, OBESITY, V19, P179, DOI 10.1038/oby.2010.121; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Chao TF, 2011, J CARDIOVASC ELECTR, V22, P1325, DOI 10.1111/j.1540-8167.2011.02115.x; Chao TF, 2011, HEART, V97, P225, DOI 10.1136/hrt.2010.212373; De Vos CB, 2009, HEART, V95, P835, DOI 10.1136/hrt.2008.148528; Douglas PS, 2007, J AM SOC ECHOCARDIOG, V20, P787, DOI 10.1016/j.echo.2007.06.011; Konishi M, 2010, ATHEROSCLEROSIS, V209, P573, DOI 10.1016/j.atherosclerosis.2009.10.008; Lin YJ, 2010, AM J CARDIOL, V105, P495, DOI 10.1016/j.amjcard.2009.10.019; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Merckx KL, 2005, J AM SOC ECHOCARDIOG, V18, P940, DOI 10.1016/j.echo.2005.03.022; Nagashima K, 2011, CIRC J, V75, P2559, DOI 10.1253/circj.CJ-11-0554; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Tsao HM, 2011, AM J CARDIOL, V107, P1498, DOI 10.1016/j.amjcard.2011.01.027; VANDENBERG BF, 1995, AM J CARDIOL, V75, P754, DOI 10.1016/S0002-9149(99)80676-6; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045; Yerramasu A, 2012, ATHEROSCLEROSIS, V220, P223, DOI 10.1016/j.atherosclerosis.2011.09.041; Yun CH, 2012, EUR J RADIOL, V81, P749, DOI 10.1016/j.ejrad.2011.01.035	20	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97472	10.1371/journal.pone.0097472	http://dx.doi.org/10.1371/journal.pone.0097472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841847	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600035
J	Chen, YA; Chi, WC; Trinh, NN; Huang, LY; Chen, YC; Cheng, KT; Huang, TL; Lin, CY; Huang, HJ				Chen, Yun-An; Chi, Wen-Chang; Ngoc Nam Trinh; Huang, Li-Yao; Chen, Ying-Chih; Cheng, Kai-Teng; Huang, Tsai-Lien; Lin, Chung-Yi; Huang, Hao-Jen			Transcriptome Profiling and Physiological Studies Reveal a Major Role for Aromatic Amino Acids in Mercury Stress Tolerance in Rice Seedlings	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; SIGNALING PATHWAYS; ENVIRONMENTAL-STRESSES; TRANSGENIC ARABIDOPSIS; PLASMA-MEMBRANE; GENE FAMILY; ROOT-GROWTH; EXPRESSION; KINASE; RESPONSES	Mercury (Hg) is a serious environmental pollution threat to the planet. The accumulation of Hg in plants disrupts many cellular-level functions and inhibits growth and development, but the mechanism is not fully understood. To gain more insight into the cellular response to Hg, we performed a large-scale analysis of the rice transcriptome during Hg stress. Genes induced with short-term exposure represented functional categories of cell-wall formation, chemical detoxification, secondary metabolism, signal transduction and abiotic stress response. Moreover, Hg stress upregulated several genes involved in aromatic amino acids (Phe and Trp) and increased the level of free Phe and Trp content. Exogenous application of Phe and Trp to rice roots enhanced tolerance to Hg and effectively reduced Hg-induced production of reactive oxygen species. Hg induced calcium accumulation and activated mitogen-activated protein kinase. Further characterization of the Hg-responsive genes we identified may be helpful for better understanding the mechanisms of Hg in plants.	[Chen, Yun-An; Chi, Wen-Chang; Ngoc Nam Trinh; Huang, Li-Yao; Chen, Ying-Chih; Cheng, Kai-Teng; Huang, Tsai-Lien; Lin, Chung-Yi; Huang, Hao-Jen] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Chen, Yun-An] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	National Cheng Kung University; National Sun Yat Sen University	Huang, HJ (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	haojen@mail.ncku.edu.tw		Trinh, Ngoc Nam/0000-0002-7983-7270	National Science Council [NSC96-2311-B-006-001, NSC 101-2621-B-006-001-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This project was supported by grants from the National Science Council (including NSC96-2311-B-006-001 and NSC 101-2621-B-006-001-MY3). The National Science Council is the main governmental promotion and funding body of the Republic of China for science research in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Agarwal PK, 2010, MOL BIOL REP, V37, P981, DOI 10.1007/s11033-009-9774-1; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; BEAUFORD W, 1977, PHYSIOL PLANTARUM, V39, P261, DOI 10.1111/j.1399-3054.1977.tb01880.x; Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Bohm PAF, 2006, BIOL PLANTARUM, V50, P315, DOI 10.1007/s10535-006-0029-x; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen YA, 2012, PLANT PHYSIOL BIOCH, V55, P23, DOI 10.1016/j.plaphy.2012.03.008; Chi WC, 2011, PLANT MOL BIOL, V77, P591, DOI 10.1007/s11103-011-9841-6; Christensen JH, 1998, PLANT PHYSIOL, V118, P125, DOI 10.1104/pp.118.1.125; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fridborg I, 1999, PLANT CELL, V11, P1019, DOI 10.1105/tpc.11.6.1019; Fu SF, 2002, PLANT CELL PHYSIOL, V43, P958, DOI 10.1093/pcp/pcf111; Gao LL, 2012, MOL PLANT, V5, P143, DOI 10.1093/mp/ssr062; Heidenreich B, 2001, PLANT CELL ENVIRON, V24, P1227, DOI 10.1046/j.0016-8025.2001.00775.x; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jo WJ, 2008, TOXICOL SCI, V101, P140, DOI 10.1093/toxsci/kfm226; Kang K, 2011, PLANT J, V66, P247, DOI 10.1111/j.1365-313X.2011.04486.x; Katiyar-Agarwal S, 2003, PLANT MOL BIOL, V51, P677, DOI 10.1023/A:1022561926676; Kim JA, 2003, BIOCHEM BIOPH RES CO, V300, P868, DOI 10.1016/S0006-291X(02)02944-3; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li P, 2009, J HAZARD MATER, V168, P591, DOI 10.1016/j.jhazmat.2009.03.031; Lin CY, 2013, PLANT MOL BIOL, V81, P507, DOI 10.1007/s11103-013-0020-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes MS, 2013, METALLOMICS, V5, P1305, DOI 10.1039/c3mt00084b; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Massot N, 2002, PLANT GROWTH REGUL, V37, P105, DOI 10.1023/A:1020511007138; Trinh NN, 2014, PHYSIOL PLANTARUM, V150, P205, DOI 10.1111/ppl.12088; Ouyang J, 2010, PLANT SCI, V179, P374, DOI 10.1016/j.plantsci.2010.06.013; Pitorre D, 2010, PLANTA, V232, P1339, DOI 10.1007/s00425-010-1260-4; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Rea PA, 1999, J EXP BOT, V50, P895, DOI 10.1093/jexbot/50.suppl_1.895; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Ruiz ON, 2011, PLANT BIOTECHNOL J, V9, P609, DOI 10.1111/j.1467-7652.2011.00616.x; Sanjaya, 2008, PLANT CELL ENVIRON, V31, P1074, DOI 10.1111/j.1365-3040.2008.01819.x; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Song W, 1997, PLANT PHYSIOL, V114, P927, DOI 10.1104/pp.114.3.927; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Yeh CM, 2007, J EXP BOT, V58, P659, DOI 10.1093/jxb/erl240; Yokotani N, 2008, PLANTA, V227, P957, DOI 10.1007/s00425-007-0670-4; Zabihi M, 2010, J HAZARD MATER, V174, P251, DOI 10.1016/j.jhazmat.2009.09.044; Zhang WH, 1999, PLANT PHYSIOL, V120, P849, DOI 10.1104/pp.120.3.849; Zhou ZS, 2007, J INORG BIOCHEM, V101, P1, DOI 10.1016/j.jinorgbio.2006.05.011	56	33	35	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e95163	10.1371/journal.pone.0095163	http://dx.doi.org/10.1371/journal.pone.0095163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840062	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600005
J	Eun, CS; Ortiz-Sanchez, JM; Da, LT; Wang, D; McCammon, JA				Eun, Changsun; Ortiz-Sanchez, Juan Manuel; Da, Lintai; Wang, Dong; McCammon, J. Andrew			Molecular Dynamics Simulation Study of Conformational Changes of Transcription Factor TFIIS during RNA Polymerase II Transcriptional Arrest and Reactivation	PLOS ONE			English	Article							ELONGATION-FACTOR TFIIS; FORCE-FIELD; DOMAIN; INITIATION; RESOLUTION; PROTEINS; CLEAVAGE; SERVER; MODEL	Transcription factor IIS (TFIIS) is a protein known for catalyzing the cleavage reaction of the 3'-end of backtracked RNA transcript, allowing RNA polymerase II (Pol II) to reactivate the transcription process from the arrested state. Recent structural studies have provided a molecular basis of protein-protein interaction between TFIIS and Pol II. However, the detailed dynamic conformational changes of TFIIS upon binding to Pol II and the related thermodynamic information are largely unknown. Here we use computational approaches to investigate the conformational space of TFIIS in the Pol II-bound and Pol II-free (unbound) states. Our results reveal two distinct conformations of TFIIS: the closed and the open forms. The closed form is dominant in the Pol II-free (unbound) state of TFIIS, whereas the open form is favorable in the Pol II-bound state. Furthermore, we discuss the free energy difference involved in the conformational changes between the two forms in the presence or absence of Pol II. Additionally, our analysis indicates that hydrophobic interactions and the protein-protein interactions between TFIIS and Pol II are crucial for inducing the conformational changes of TFIIS. Our results provide novel insights into the functional interplay between Pol II and TFIIS as well as mechanism of reactivation of Pol II transcription by TFIIS.	[Eun, Changsun; McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Ortiz-Sanchez, Juan Manuel] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, Frankfurt, Germany; [Da, Lintai; Wang, Dong] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Da, Lintai] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Goethe University Frankfurt; University of California System; University of California San Diego; Hong Kong University of Science & Technology; University of California System; University of California San Diego; University of California System; University of California San Diego	Eun, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	ceun@ucsd.edu; dongwang@ucsd.edu	McCammon, J. Andrew/AAG-1832-2021; Ortiz Sanchez, Juan Manuel/C-9311-2016; Da, Lin-Tai/B-2356-2017	Ortiz Sanchez, Juan Manuel/0000-0003-1217-5740; McCammon, J. Andrew/0000-0003-3065-1456; Da, Lin-Tai/0000-0002-1589-5754	Howard Hughes Medical Institute; National Institute of Health; National Science Foundation; National Biomedical Computational Resource; Center for Theoretical Biological Physics; Fulbright Comission/Generalitat de Catalunya Program; Generalitat de Catalunya; NIH [GM102362]; Sidney Kimmel Foundation; Skaggs School of Pharmacy; Pharmaceutical Sciences, UCSD; Academic Senate Research Award from UCSD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102362] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Biomedical Computational Resource; Center for Theoretical Biological Physics; Fulbright Comission/Generalitat de Catalunya Program; Generalitat de Catalunya(Generalitat de Catalunya); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Foundation; Skaggs School of Pharmacy; Pharmaceutical Sciences, UCSD; Academic Senate Research Award from UCSD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Howard Hughes Medical Institute, the National Institute of Health, the National Science Foundation, the National Biomedical Computational Resource, and the Center for Theoretical Biological Physics. J.M.O.-S. acknowledges the Fulbright Comission/Generalitat de Catalunya Program and the Generalitat de Catalunya for a Fullbright and Beatriu de Pinos postdoctoral grants, respectively. D. W. acknowledges the NIH (GM102362), Kimmel Scholars award from the Sidney Kimmel Foundation for Cancer Research, start-up funds from Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD and Academic Senate Research Award from UCSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Da LT, 2012, J AM CHEM SOC, V134, P2399, DOI 10.1021/ja210656k; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guglielmi B, 2007, P NATL ACAD SCI USA, V104, P16062, DOI 10.1073/pnas.0704534104; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimoaraiso M, 1997, J BIOL CHEM, V272, P26550, DOI 10.1074/jbc.272.42.26550; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729	31	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97975	10.1371/journal.pone.0097975	http://dx.doi.org/10.1371/journal.pone.0097975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842057	gold, Green Published			2022-12-27	WOS:000340948600096
J	Govender, Y; Avenant, C; Verhoog, NJD; Ray, RM; Grantham, NJ; Africander, D; Hapgood, JP				Govender, Yashini; Avenant, Chanel; Verhoog, Nicolette J. D.; Ray, Roslyn M.; Grantham, Nicholas J.; Africander, Donita; Hapgood, Janet P.			The Injectable-Only Contraceptive Medroxyprogesterone Acetate, Unlike Norethisterone Acetate and Progesterone, Regulates Inflammatory Genes in Endocervical Cells via the Glucocorticoid Receptor	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NF-KAPPA-B; FEMALE GENITAL-TRACT; HORMONAL CONTRACEPTION; HIV ACQUISITION; IMMUNE-RESPONSES; DNA-BINDING; EXPRESSION; INFECTION; PROGESTINS	Clinical studies suggest that the injectable contraceptive medroxyprogesterone acetate (MPA) increases susceptibility to infections such as HIV-1, unlike the injectable contraceptive norethisterone enanthate (NET-EN). We investigated the differential effects, molecular mechanism of action and steroid receptor involvement in gene expression by MPA as compared to NET and progesterone (P4) in the End1/E6E7 cell line model for the endocervical epithelium, a key point of entry for pathogens in the female genital mucosa. MPA, unlike NET-acetate (NET-A) and P4, increases mRNA expression of the anti-inflammatory GILZ and I kappa B alpha genes. Similarly, MPA unlike NET-A, decreases mRNA expression of the proinflammatory IL-6, IL-8 and RANTES genes, and IL-6 and IL-8 protein levels. The predominant steroid receptor expressed in the End1/E6E7 and primary endocervical epithelial cells is the glucocorticoid receptor (GR), and GR knockdown experiments show that the anti-inflammatory effects of MPA are mediated by the GR. Chromatin-immunoprecipitation results suggest that MPA, unlike NET-A and P4, represses pro-inflammatory cytokine gene expression in cervical epithelial cells via a mechanism involving recruitment of the GR to cytokine gene promoters, like the GR agonist dexamethasone. This is at least in part consistent with direct effects on transcription, without a requirement for new protein synthesis. Dose response analysis shows that MPA has a potency of similar to 24 nM for transactivation of the anti-inflammatory GILZ gene and similar to 4-20 nM for repression of the pro-inflammatory genes, suggesting that these effects are likely to be relevant at injectable contraceptive doses of MPA. These findings suggest that in the context of the genital mucosa, these GR-mediated glucocorticoid-like effects of MPA in cervical epithelial cells are likely to play a critical role in discriminating between the effects on inflammation caused by different progestins and P4 and hence susceptibility to genital infections, given the predominant expression of the GR in primary endocervical epithelial cells.	[Govender, Yashini; Avenant, Chanel; Verhoog, Nicolette J. D.; Ray, Roslyn M.; Grantham, Nicholas J.; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, Western Provinc, South Africa; [Africander, Donita] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, Western Provinc, South Africa	University of Cape Town; Stellenbosch University	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, Western Provinc, South Africa.	Janet.Hapgood@uct.ac.za	Hapgood, Janet P/P-2549-2018; Ray, Roslyn/AAB-2898-2019	Hapgood, Janet P/0000-0002-4414-4861; Africander, Donita/0000-0002-3429-7100; Verhoog, Nicolette/0000-0002-3786-6452	South African HIV/AIDS Research and Innovation Platform (SHARP)	South African HIV/AIDS Research and Innovation Platform (SHARP)	This work was supported by a grant from the South African HIV/AIDS Research and Innovation Platform (SHARP) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 1999, BRIT J PHARMACOL, V127, P1003, DOI 10.1038/sj.bjp.0702613; Africander D, 2013, BIOCHEM BIOPH RES CO, V433, P305, DOI 10.1016/j.bbrc.2013.02.086; Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Al-Hendy A, 2006, FERTIL STERIL, V86, P686, DOI 10.1016/j.fertnstert.2006.01.052; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Avenant C, 2010, BIOCHEMISTRY-US, V49, P972, DOI 10.1021/bi901956s; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bamberger CM, 1999, J CLIN ENDOCR METAB, V84, P4055, DOI 10.1210/jc.84.11.4055; BARCLAY CG, 1993, AM J OBSTET GYNECOL, V169, P625, DOI 10.1016/0002-9378(93)90634-U; Blish CA, 2011, AM J REPROD IMMUNOL, V65, P302, DOI 10.1111/j.1600-0897.2010.00930.x; Brabin L, 2002, AIDS PATIENT CARE ST, V16, P211, DOI 10.1089/10872910252972267; Bray JD, 2005, J STEROID BIOCHEM, V97, P328, DOI 10.1016/j.jsbmb.2005.06.032; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; CAIRNS C, 1993, DNA CELL BIOL, V12, P695, DOI 10.1089/dna.1993.12.695; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Cvoro A, 2011, J IMMUNOL, V186, P4354, DOI 10.4049/jimmunol.1002205; De Bosscher K, 2008, EUR J PHARMACOL, V583, P290, DOI 10.1016/j.ejphar.2007.11.076; Elovitz M, 2004, AM J OBSTET GYNECOL, V190, P693, DOI 10.1016/j.ajog.2003.10.693; fhi 360 website, EXP ACC INJ CONTR; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; FOTHERBY K, 1983, J STEROID BIOCHEM, V19, P817, DOI 10.1016/0022-4731(83)90017-1; Gillgrass AE, 2003, J VIROL, V77, P9845, DOI 10.1128/JVI.77.18.9845-9851.2003; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Gray RH, 2012, LANCET INFECT DIS, V12, P507, DOI 10.1016/S1473-3099(12)70111-1; Hadley KE, 2011, STEROIDS, V76, P1176, DOI 10.1016/j.steroids.2011.05.007; Hapgood JP, 2014, AM J REPROD IMMUNOL, V71, P505, DOI 10.1111/aji.12214; Hapgood JP, 2013, ENDOCRINOLOGY, V154, P985, DOI 10.1210/en.2013-1066; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Hapgood JP, 2013, J STEROID BIOCHEM, P1; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; Hermoso M, 2003, IUBMB LIFE, V55, P497, DOI 10.1080/15216540310001642072; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Janeway C., 2012, IMMUNOBIOLOGY, V5th; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kaushic C, 2011, AM J REPROD IMMUNOL, V65, P253, DOI 10.1111/j.1600-0897.2010.00965.x; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; KIRTON KT, 1974, CONTRACEPTION, V10, P39, DOI 10.1016/0010-7824(74)90130-9; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Koubovec D, 2004, MOL CELL ENDOCRINOL, V221, P75, DOI 10.1016/j.mce.2004.03.006; Lavreys L, 2004, AIDS, V18, P695, DOI 10.1097/00002030-200403050-00017; Lee B, 1999, J LEUKOCYTE BIOL, V65, P552; Ma H, 2003, METHOD ENZYMOL, V364, P284; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; MacLean R, 2005, INT FAM PLAN PERSPEC, V31, P45; McCoy SI, 2013, AIDS, V27, P1001, DOI 10.1097/QAD.0b013e32835da401; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Morrison CS, 2012, AIDS, V26, P497, DOI 10.1097/QAD.0b013e32834fa13d; Morrison CS, 2012, LANCET INFECT DIS, V12, P2, DOI 10.1016/S1473-3099(11)70254-7; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; Mosmann T., 1983, J IMMUNOL METHODS, V12, P16; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; PARR MB, 1994, LAB INVEST, V70, P369; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Rodriguez-Garcia M, 2013, J REPROD IMMUNOL, V97, P74, DOI 10.1016/j.jri.2012.10.010; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Sitruk-Ware R, 2004, MATURITAS, V47, P277, DOI 10.1016/j.maturitas.2004.01.001; Smit JA, 2013, JAIDS-J ACQ IMM DEF, V62, P363, DOI 10.1097/QAI.0b013e31827e818a; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; STANCZYK FZ, 1990, CONTRACEPTION, V42, P67, DOI 10.1016/0010-7824(90)90093-B; Tomasicchio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062895; Trunova N, 2006, VIROLOGY, V352, P169, DOI 10.1016/j.virol.2006.04.004; USAID website, TECHN BRIEF HORM CON; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; Vladic-Stjernholm Y, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-116; Wand H, 2012, AIDS, V26, P375, DOI 10.1097/QAD.0b013e32834f990f; Wang CC, 2004, AIDS, V18, P205, DOI 10.1097/00002030-200401230-00009; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; WOODWORTH CD, 1993, AM J PATHOL, V142, P1544; [No title captured]; [No title captured]	87	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96497	10.1371/journal.pone.0096497	http://dx.doi.org/10.1371/journal.pone.0096497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840644	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600008
J	Jajamovich, GH; Dyvorne, H; Donnerhack, C; Taouli, B				Jajamovich, Guido H.; Dyvorne, Hadrien; Donnerhack, Claudia; Taouli, Bachir			Quantitative Liver MRI Combining Phase Contrast Imaging, Elastography, and DWI: Assessment of Reproducibility and Postprandial Effect at 3.0 T	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; DIFFUSION-WEIGHTED MRI; CHRONIC HEPATITIS; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; PORTAL-HYPERTENSION; FLOW MEASUREMENTS; ENHANCED MRI; BLOOD-FLOW; FIBROSIS	Purpose: To quantify short-term reproducibility (in fasting conditions) and postprandial changes after a meal in portal vein (PV) flow parameters measured with phase contrast (PC) imaging, liver diffusion parameters measured with multiple b value diffusion-weighted imaging (DWI) and liver stiffness (LS) measured with MR elastography (MRE) in healthy volunteers and patients with liver disease at 3.0 T. Materials and Methods: In this IRB-approved prospective study, 30 subjects (11 healthy volunteers and 19 liver disease patients; 23 males, 7 females; mean age 46.5 y) were enrolled. Imaging included 2D PC imaging, multiple b value DWI and MRE. Subjects were initially scanned twice in fasting state to assess short-term parameter reproducibility, and then scanned 20 min. after a liquid meal. PV flow/velocity, LS, liver true diffusion coefficient (D), pseudodiffusion coefficient (D*), perfusion fraction (PF) and apparent diffusion coefficient (ADC) were measured in fasting and postprandial conditions. Short-term reproducibility was assessed in fasting conditions by measuring coefficients of variation (CV) and Bland-Altman limits of agreement. Differences in MR metrics before and after caloric intake and between healthy volunteers and liver disease patients were assessed. Results: PV flow parameters, D, ADC and LS showed good to excellent short-term reproducibility in fasting state (CV <16%), while PF and D* showed acceptable and poor reproducibility (CV = 20.4% and 51.6%, respectively). PV flow parameters and LS were significantly higher (p<0.04) in postprandial state while liver diffusion parameters showed no significant change (p>0.2). LS was significantly higher in liver disease patients compared to healthy volunteers both in fasting and postprandial conditions (p<0.001). Changes in LS were significantly correlated with changes in PV flow (Spearman rho = 0.48, p = 0.013). Conclusions: Caloric intake had no/minimal/large impact on diffusion/stiffness/portal vein flow, respectively. PC MRI and MRE but not DWI should be performed in controlled fasting state.	[Jajamovich, Guido H.; Dyvorne, Hadrien; Donnerhack, Claudia; Taouli, Bachir] Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Taouli, B (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA.	bachir.taouli@mountsinai.org	Taouli, Bachir/ABB-5044-2020		National Institutes of Health [1R01DK087877, T32CA78207]; GE Healthcare; NATIONAL CANCER INSTITUTE [T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE Healthcare(General ElectricGE Healthcare); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grants 1R01DK087877 and T32CA78207, and by GE Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annet L, 2003, RADIOLOGY, V229, P409, DOI 10.1148/radiol.2292021128; Asbach P, 2008, MAGN RESON MED, V60, P373, DOI 10.1002/mrm.21636; Bellis L, 2003, HEPATOLOGY, V37, P378, DOI 10.1053/jhep.2003.50053; Berzigotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058742; Bureau C, 2008, ALIMENT PHARM THER, V27, P1261, DOI 10.1111/j.1365-2036.2008.03701.x; BURKART DJ, 1995, RADIOLOGY, V194, P801, DOI 10.1148/radiology.194.3.7862982; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; DAUZAT M, 1994, EUR J APPL PHYSIOL, V68, P373, DOI 10.1007/BF00843732; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; GALLAVAN RH, 1985, AM J PHYSIOL, V249, pG301, DOI 10.1152/ajpgi.1985.249.3.G301; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Girometti R, 2007, RADIOL MED, V112, P394, DOI 10.1007/s11547-007-0149-1; Gouya H, 2011, RADIOLOGY, V261, P144, DOI 10.1148/radiol.11101541; Hagiwara M, 2008, RADIOLOGY, V246, P926, DOI 10.1148/radiol.2463070077; Hara AK, 1996, AM J ROENTGENOL, V166, P1311, DOI 10.2214/ajr.166.6.8633438; Hines CDG, 2011, J MAGN RESON IMAGING, V33, P239, DOI 10.1002/jmri.22354; Hines CDG, 2010, J MAGN RESON IMAGING, V31, P725, DOI 10.1002/jmri.22066; Hollingsworth KG, 2006, NMR BIOMED, V19, P231, DOI 10.1002/nbm.1028; Huwart L, 2008, GASTROEN CLIN BIOL, V32, P68, DOI 10.1016/S0399-8320(08)73995-2; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Huwart L, 2007, RADIOLOGY, V245, P458, DOI 10.1148/radiol.2452061673; KASHITANI N, 1995, ABDOM IMAGING, V20, P197, DOI 10.1007/BF00200392; Koinuma M, 2005, J MAGN RESON IMAGING, V22, P80, DOI 10.1002/jmri.20344; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEE SS, 1988, HEPATOLOGY, V8, P647, DOI 10.1002/hep.1840080335; Lee YJ, 2013, J MAGN RESON IMAGING; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Ludwig D, 1998, J HEPATOL, V28, P631, DOI 10.1016/S0168-8278(98)80287-0; Lupsor M, 2008, J GASTROINTEST LIVER, V17, P155; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; OBRIEN S, 1992, GUT, V33, P364, DOI 10.1136/gut.33.3.364; Osman O, 2008, WORLD J GASTROENTERO, V14, P260, DOI 10.3748/wjg.14.260; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Pazahr S, 2013, INVEST RADIOL; Sadek AG, 1996, JMRI-J MAGN RESON IM, V6, P90, DOI 10.1002/jmri.1880060118; Shire NJ, 2011, J MAGN RESON IMAGING, V34, P947, DOI 10.1002/jmri.22716; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; Van Beers BE, 2003, MAGN RESON MED, V49, P692, DOI 10.1002/mrm.10420; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Yin M, 2011, AM J ROENTGENOL, V197, P64, DOI 10.2214/AJR.10.5989; Yzet T, 2010, J MAGN RESON IMAGING, V31, P579, DOI 10.1002/jmri.22079	48	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97355	10.1371/journal.pone.0097355	http://dx.doi.org/10.1371/journal.pone.0097355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840288	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600026
J	Kopatz, A; Eiken, HG; Aspi, J; Kojola, I; Tobiassen, C; Tirronen, KF; Danilov, PI; Hagen, SB				Kopatz, Alexander; Eiken, Hans Geir; Aspi, Jouni; Kojola, Ilpo; Tobiassen, Camilla; Tirronen, Konstantin F.; Danilov, Pjotr I.; Hagen, Snorre B.			Admixture and Gene Flow from Russia in the Recovering Northern European Brown Bear (Ursus arctos)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MICROSATELLITE ANALYSIS; COMPUTER-PROGRAM; DIVERSITY; SOFTWARE; EXTINCTION; CARNIVORE; BEHAVIOR; EXAMPLE	Large carnivores were persecuted to near extinction during the last centuries, but have now recovered in some countries. It has been proposed earlier that the recovery of the Northern European brown bear is supported by migration from Russia. We tested this hypothesis by obtaining for the first time continuous sampling of the whole Finnish bear population, which is located centrally between the Russian and Scandinavian bear populations. The Finnish population is assumed to experience high gene flow from Russian Karelia. If so, no or a low degree of genetic differentiation between Finnish and Russian bears could be expected. We have genotyped bears extensively from all over Finland using 12 validated microsatellite markers and compared their genetic composition to bears from Russian Karelia, Sweden, and Norway. Our fine masked investigation identified two overlapping genetic clusters structured by isolation-by-distance in Finland (pairwise F-ST = 0.025). One cluster included Russian bears, and migration analyses showed a high number of migrants from Russia into Finland, providing evidence of eastern gene flow as an important driver during recovery. In comparison, both clusters excluded bears from Sweden and Norway, and we found no migrants from Finland in either country, indicating that eastern gene flow was probably not important for the population recovery in Scandinavia. Our analyses on different spatial scales suggest a continuous bear population in Finland and Russian Karelia, separated from Scandinavia.	[Kopatz, Alexander; Eiken, Hans Geir; Tobiassen, Camilla; Hagen, Snorre B.] Bioforsk Norwegian Inst Agr & Environm Res, Svanvik, Norway; [Aspi, Jouni] Univ Oulu, Dept Biol, Oulu, Finland; [Kojola, Ilpo] Finnish Game & Fisheries Res Inst, Oulu, Finland; [Tirronen, Konstantin F.; Danilov, Pjotr I.] Russian Acad Sci, Inst Biol, Karelian Res Ctr, Petrozavodsk, Russia	Bioforsk; University of Oulu; Natural Resources Institute Finland (Luke); Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS	Kopatz, A (corresponding author), Bioforsk Norwegian Inst Agr & Environm Res, Svanvik, Norway.	alexander.kopatz@bioforsk.no; snorre.hagen@bioforsk.no	Aspi, Jouni O/B-3087-2012; Kopatz, Alexander/AAC-3967-2022; Hagen, Snorre/O-5220-2015; Tirronen, Konstantin/AAV-9418-2021; Tirronen, Konstantin/A-9590-2014; Kopatz, Alexander/A-3174-2012	Kopatz, Alexander/0000-0002-9139-1179; Hagen, Snorre/0000-0001-8289-7752; Tirronen, Konstantin/0000-0002-8208-5460; Kopatz, Alexander/0000-0002-9139-1179; Eiken, Hans Geir/0000-0002-5368-3648; Aspi, Jouni/0000-0002-2451-3201	Bioforsk	Bioforsk(Bioforsk)	The study was funded by Bioforsk. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen R, 2012, FORENSIC SCI INT-GEN, V6, P798, DOI 10.1016/j.fsigen.2012.03.002; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Belkhir K., 1996, 5171 CNRS UMR; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chestin I, 1999, BEARS STATUS SURVEY; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dalerum F, 2009, BIOL LETTERS, V5, P35, DOI 10.1098/rsbl.2008.0520; Danilov PI, 1994, INT C BEAR RES MANAG, V9, P199; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eiken HG, 2009, FORENS SCI INT-GEN S, V2, P273, DOI 10.1016/j.fsigss.2009.07.007; Ermala Aslak, 2003, Acta Zoologica Lituanica, V13, P15; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Kojola I, 2000, ANN ZOOL FENN, V37, P59; Kojola I, 2004, SUURPETOJEN LUKUMAAR, P1; Kojola I, 2006, ANN ZOOL FENN, V43, P258; Kojola L, 2003, URSUS-SERIES, V14, P17; Kopatz A, 2012, CONSERV GENET, V13, P681, DOI 10.1007/s10592-012-0317-2; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Linacre A, 2011, Forensic Sci Int Genet, V5, P501, DOI 10.1016/j.fsigen.2010.10.017; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Manel S, 2004, MOL ECOL, V13, P1327, DOI 10.1111/j.1365-294X.2004.02074.x; Miller CR, 2003, P NATL ACAD SCI USA, V100, P4334, DOI 10.1073/pnas.0735531100; Mills L. Scott, 2003, P587, DOI 10.1017/CBO9780511615757.018; Nyholm Erik S., 1999, P63; Nyholm ES, 1995, SUOMEN SUURPETOKANNA, P1; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pelletier A, 2012, CAN J ZOOL, V90, P999, DOI 10.1139/Z2012-068; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; PULLIAINEN E, 1983, Z SAUGETIERKD, V48, P290; PULLIAINEN E, 1990, Aquilo Ser Zoologica, V27, P21; Pulliainen E, 1997, INT BEAR NEWS, V6, P10; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; ROUSSET F, 1995, GENETICS, V140, P1413; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schregel J, 2012, MOL ECOL, V21, P3474, DOI 10.1111/j.1365-294X.2012.05631.x; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SWENSON JE, 1994, BIOL CONSERV, V70, P9, DOI 10.1016/0006-3207(94)90293-3; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Wikman M, 2010, RIISTAKANNAT 2010 RI, P1	62	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97558	10.1371/journal.pone.0097558	http://dx.doi.org/10.1371/journal.pone.0097558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839968	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600044
J	Long, LL; Hinman, JR; Chen, CM; Escabi, MA; Chrobak, JJ				Long, Lauren L.; Hinman, James R.; Chen, Chi-Ming; Escabi, Monty A.; Chrobak, James J.			Theta Dynamics in Rat: Speed and Acceleration across the Septotemporal Axis	PLOS ONE			English	Article							HIPPOCAMPAL-THETA; VESTIBULAR LESIONS; GAMMA OSCILLATIONS; RUNNING SPEED; SLOW WAVES; RHYTHM; EEG; FREQUENCY; BEHAVIOR; NEURONS	Theta (6-12 Hz) rhythmicity in the local field potential (LFP) reflects a clocking mechanism that brings physically isolated neurons together in time, allowing for the integration and segregation of distributed cell assemblies. Variation in the theta signal has been linked to locomotor speed, sensorimotor integration as well as cognitive processing. Previously, we have characterized the relationship between locomotor speed and theta power and how that relationship varies across the septotemporal (long) axis of the hippocampus (HPC). The current study investigated the relationship between whole body acceleration, deceleration and theta indices at CA1 and dentate gyrus (DG) sites along the septotemporal axis of the HPC in rats. Results indicate that whole body acceleration and deceleration predicts a significant amount of variability in the theta signal beyond variation in locomotor speed. Furthermore, deceleration was more predictive of variation in theta amplitude as compared to acceleration as rats traversed a linear track. Such findings highlight key variables that systematically predict the variability in the theta signal across the long axis of the HPC. A better understanding of the relative contribution of these quantifiable variables and their variation as a function of experience and environmental conditions should facilitate our understanding of the relationship between theta and sensorimotor/cognitive functions.	[Long, Lauren L.; Hinman, James R.; Chen, Chi-Ming; Escabi, Monty A.; Chrobak, James J.] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Escabi, Monty A.] Univ Connecticut, Storrs, CT USA	University of Connecticut; University of Connecticut	Chrobak, JJ (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	james.chrobak@uconn.edu	Chen, Chi-Ming/G-1321-2010	Chen, Chi-Ming/0000-0003-4419-1593; Escabi, Monty/0000-0001-7271-1061; Hinman, James/0000-0001-7139-1916	National Science Foundation [0090451]	National Science Foundation(National Science Foundation (NSF))	The current work was supported by National Science Foundation 0090451 to J. J. Chrobak and M. A. Escabi (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2012, NEUROSCI BIOBEHAV R, V36, P1579, DOI 10.1016/j.neubiorev.2011.09.005; Ahmed OJ, 2012, J NEUROSCI, V32, P7373, DOI 10.1523/JNEUROSCI.5110-11.2012; Arnolds DEAT, 1977, BRAIN RES, V85, P194; Asaka Y, 2005, P NATL ACAD SCI USA, V102, P13284, DOI 10.1073/pnas.0506515102; Baek JH, 2010, NEUROBIOL LEARN MEM, V94, P402, DOI 10.1016/j.nlm.2010.08.007; BERRY SD, 1978, BRAIN RES BULL, V3, P509, DOI 10.1016/0361-9230(78)90080-1; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bouwman BM, 2005, BRAIN RES BULL, V64, P505, DOI 10.1016/j.brainresbull.2004.10.006; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Cohen BH, 2008, EXPLAINING PSYCHOL S, P571; Cohen J, 2003, APPL MULTIPLE REGRES, P64; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; FEDER R, 1973, EXP NEUROL, V41, P532, DOI 10.1016/0014-4886(73)90291-4; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hinman JR, 2013, J NEUROPHYSIOL, V109, P570, DOI 10.1152/jn.00561.2012; Hinman JR, 2011, J NEUROPHYSIOL, V105, P2675, DOI 10.1152/jn.00837.2010; Jeewajee A, 2008, HIPPOCAMPUS, V18, P340, DOI 10.1002/hipo.20394; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kay LM, 2005, P NATL ACAD SCI USA, V102, P3863, DOI 10.1073/pnas.0407920102; Klemm W R, 1976, Prog Neurobiol, V6, P23, DOI 10.1016/0301-0082(76)90005-8; KVIRKVELIA L, 1987, ACTA PHYSIOL HUNG, V70, P127; Lavenex P, 2006, HIPPOCAMPUS BOOK; Law JR, 2005, J NEUROSCI, V25, P5720, DOI 10.1523/JNEUROSCI.4935-04.2005; Ledberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027575; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Marrelec G, 2007, MAGN RESON IMAGING, V25, P1181, DOI 10.1016/j.mri.2007.02.012; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MCFARLAND WL, 1975, J COMP PHYSIOL PSYCH, V88, P324, DOI 10.1037/h0076177; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Molter C, 2012, NEURON, V75, P889, DOI 10.1016/j.neuron.2012.06.036; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; PAIVA T, 1976, ELECTROEN CLIN NEURO, V40, P470, DOI 10.1016/0013-4694(76)90077-8; Penley SC, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00020; Penley SC, 2012, HIPPOCAMPUS, V22, P1164, DOI 10.1002/hipo.20962; Rivas J, 1996, EXP BRAIN RES, V108, P113; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Russell NA, 2003, J NEUROSCI, V23, P6490; Sabolek HR, 2009, J NEUROPHYSIOL, V101, P1192, DOI 10.1152/jn.90846.2008; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schmidt B, 2013, J NEUROSCI, V33, P6212, DOI 10.1523/JNEUROSCI.2915-12.2013; Schmidt B, 2012, HIPPOCAMPUS, V22, P2114, DOI 10.1002/hipo.22031; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sinnamon HM, 2006, NEUROSCIENCE, V140, P779, DOI 10.1016/j.neuroscience.2006.02.058; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Smith PF, 2005, PROG NEUROBIOL, V75, P391, DOI 10.1016/j.pneurobio.2005.04.004; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; TEITELBAUM H, 1971, PHYSIOL BEHAV, V7, P545, DOI 10.1016/0031-9384(71)90107-7; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VANDERWOLF CH, 1971, PSYCHOL REV, V78, P83, DOI 10.1037/h0030672; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wells CE, 2013, J NEUROSCI, V33, P8650, DOI 10.1523/JNEUROSCI.5040-12.2013; WHISHAW IQ, 1973, BEHAV BIOL, V8, P461, DOI 10.1016/S0091-6773(73)80041-0; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wyble BP, 2004, HIPPOCAMPUS, V14, P662, DOI 10.1002/hipo.20012; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055	78	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97987	10.1371/journal.pone.0097987	http://dx.doi.org/10.1371/journal.pone.0097987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842406	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600098
J	Weaver, AJ; Shepard, JB; Wilkinson, RA; Watkins, RL; Walton, SK; Radke, AR; Wright, TJ; Awel, MB; Cooper, C; Erikson, E; Labib, ME; Voyich, JM; Teintze, M				Weaver, Alan J., Jr.; Shepard, Joyce B.; Wilkinson, Royce A.; Watkins, Robert L.; Walton, Sarah K.; Radke, Amanda R.; Wright, Thomas J.; Awel, Milat B.; Cooper, Catherine; Erikson, Elizabeth; Labib, Mohamed E.; Voyich, Jovanka M.; Teintze, Martin			Antibacterial Activity of THAM Trisphenylguanide against Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							BIOCIDE POLYHEXAMETHYLENE BIGUANIDE; ACANTHAMOEBA-CASTELLANII; INFECTIONS; SUSCEPTIBILITY; ANTISEPTICS; CORECEPTOR; ENCYSTMENT; CXCR4; DRUGS; BIND	This study investigated the potential antibacterial activity of three series of compounds synthesized from 12 linear and branched polyamines with 2-8 amino groups, which were substituted to produce the corresponding guanides, biguanides, or phenylguanides, against Acinetobacter baumannii, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Antibacterial activity was measured for each compound by determining the minimum inhibitory concentration against the bacteria, and the toxicity towards mammalian cells was determined. The most effective compound, THAM trisphenylguanide, was studied in time-to-kill and cytoplasmic leakage assays against methicillin-resistant Staphylococcus aureus (MRSA, USA300) in comparison to chlorhexidine. Preliminary toxicity and MRSA challenge studies in mice were also conducted on this compound. THAM trisphenylguanide showed significant antibacterial activity (MIC similar to 1 mg/L) and selectivity against MRSA relative to all the other bacteria examined. In time-to-kill assays it showed increased antimicrobial activity against MRSA versus chlorhexidine. It induced leakage of cytoplasmic content at concentrations that did not reduce cell viability, suggesting the mechanism of action may involve membrane disruption. Using an intraperitoneal mouse model of invasive MRSA disease, THAM trisphenylguanide reduced bacterial burden locally and in deeper tissues. This study has identified a novel guanide compound with selective microbicidal activity against Staphylococcus aureus, including a methicillin-resistant (MRSA) strain.	[Weaver, Alan J., Jr.; Shepard, Joyce B.; Wilkinson, Royce A.; Walton, Sarah K.; Radke, Amanda R.; Wright, Thomas J.; Awel, Milat B.; Teintze, Martin] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Wilkinson, Royce A.; Watkins, Robert L.; Cooper, Catherine; Erikson, Elizabeth; Voyich, Jovanka M.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Labib, Mohamed E.] Adv BioDevices, Princeton, NJ USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Teintze, M (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	mteintze@montana.edu		Wilkinson, Royce/0000-0001-8831-2081	National Institute of Allergy and Infectious Diseases [AI076965]; National Center for Research Resources [P20RR024237, P20RR020185]; INBRE grant, National Center for Research Resources [P20RR016455]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024237, P20RR016455, P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076965] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); INBRE grant, National Center for Research Resources; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by institutional funds and by the following US Public Health Service grants: AI076965 (M. E. L.) from the National Institute of Allergy and Infectious Diseases, CoBRE grants P20RR024237 (M. T.) and P20RR020185 (C. C., E. E. and J.M.V.) from the National Center for Research Resources. S. K. W., R. L. W., and T.J.W. were supported by fellowships from INBRE grant P20RR016455 from the National Center for Research Resources. M. B. A. was supported by a fellowship funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2006, MICROBIOL-SGM, V152, P989, DOI 10.1099/mic.0.28643-0; Allen MJ, 2004, BIOCHEM BIOPH RES CO, V318, P397, DOI 10.1016/j.bbrc.2004.04.043; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buxbaum A, 2006, J ANTIMICROB CHEMOTH, V58, P193, DOI 10.1093/jac/dkl206; Chopra S, 2010, J ANTIMICROB CHEMOTH, V65, P2598, DOI 10.1093/jac/dkq353; DAVIES GE, 1954, BRIT J PHARM CHEMOTH, V9, P192, DOI 10.1111/j.1476-5381.1954.tb00840.x; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; Grare M, 2010, CLIN MICROBIOL INFEC, V16, P432, DOI 10.1111/j.1469-0691.2009.02837.x; Khunkitti W, 1998, J INFECTION, V36, P43, DOI 10.1016/S0163-4453(98)93054-7; Khunkitti W, 1998, J APPL MICROBIOL, V84, P53; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kratzer C, 2006, J HOSP INFECT, V63, P316, DOI 10.1016/j.jhin.2006.01.024; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Nde CW, 2009, ENVIRON SCI TECHNOL, V43, P8406, DOI 10.1021/es9015475; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shepard JB, 2013, ANTICANCER IN PRESS; Tien HC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-95; Turner NA, 2004, J APPL MICROBIOL, V96, P1287, DOI 10.1111/j.1365-2672.2004.02260.x; Watkins RL, 2013, MICROBES INFECT, V15, P749, DOI 10.1016/j.micinf.2013.05.004; Watkins RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019939; Wilkinson RA, 2013, BIOORG MED CHEM LETT, V23, P2197, DOI 10.1016/j.bmcl.2013.01.107; Wilkinson RA, 2011, ANTIMICROB AGENTS CH, V55, P255, DOI 10.1128/AAC.00709-10; 2002, MMWR MORB MORTAL WKL, V51, P902	28	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97742	10.1371/journal.pone.0097742	http://dx.doi.org/10.1371/journal.pone.0097742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840307	Green Submitted, gold, Green Published			2022-12-27	WOS:000340948600067
J	Murphy, SC; Hermsen, CC; Douglas, AD; Edwards, NJ; Petersen, I; Fahle, GA; Adams, M; Berry, AA; Billman, ZP; Gilbert, SC; Laurens, MB; Leroy, O; Lyke, KE; Plowe, CV; Seilie, AM; Strauss, KA; Teelen, K; Hill, AVS; Sauerwein, RW				Murphy, Sean C.; Hermsen, Cornelus C.; Douglas, Alexander D.; Edwards, Nick J.; Petersen, Ines; Fahle, Gary A.; Adams, Matthew; Berry, Andrea A.; Billman, Zachary P.; Gilbert, Sarah C.; Laurens, Matthew B.; Leroy, Odile; Lyke, Kristen E.; Plowe, Christopher V.; Seilie, Annette M.; Strauss, Kathleen A.; Teelen, Karina; Hill, Adrian V. S.; Sauerwein, Robert W.			External Quality Assurance of Malaria Nucleic Acid Testing for Clinical Trials and Eradication Surveillance	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SEQUENCE-BASED AMPLIFICATION; PLASMODIUM-FALCIPARUM DNA; RAPID DIAGNOSTIC-TESTS; NONREPLICATING SPOROZOITE VACCINE; MEDIATED ISOTHERMAL AMPLIFICATION; T-CELL IMMUNITY; INFECTED MOSQUITOS; ENDEMIC AREA	Nucleic acid testing (NAT) for malaria parasites is an increasingly recommended diagnostic endpoint in clinical trials of vaccine and drug candidates and is also important in surveillance of malaria control and elimination efforts. A variety of reported NAT assays have been described, yet no formal external quality assurance (EQA) program provides validation for the assays in use. Here, we report results of an EQA exercise for malaria NAT assays. Among five centers conducting controlled human malaria infection trials, all centers achieved 100% specificity and demonstrated limits of detection consistent with each laboratory's pre-stated expectations. Quantitative bias of reported results compared to expected results was generally <0.5 log(10) parasites/mL except for one laboratory where the EQA effort identified likely reasons for a general quantitative shift. The within-laboratory variation for all assays was low at <10% coefficient of variation across a range of parasite densities. Based on this study, we propose to create a Molecular Malaria Quality Assessment program that fulfills the need for EQA of malaria NAT assays worldwide.	[Murphy, Sean C.; Billman, Zachary P.; Seilie, Annette M.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Murphy, Sean C.; Billman, Zachary P.; Seilie, Annette M.] Univ Washington, Ctr Emerging & Re Emerging Infect Dis, Seattle, WA 98195 USA; [Hermsen, Cornelus C.; Teelen, Karina; Sauerwein, Robert W.] Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Douglas, Alexander D.; Edwards, Nick J.; Gilbert, Sarah C.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Petersen, Ines; Leroy, Odile] European Vaccine Initiat, Heidelberg, Germany; [Fahle, Gary A.] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Adams, Matthew; Berry, Andrea A.; Laurens, Matthew B.; Lyke, Kristen E.; Plowe, Christopher V.; Strauss, Kathleen A.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Adams, Matthew; Berry, Andrea A.; Laurens, Matthew B.; Lyke, Kristen E.; Plowe, Christopher V.; Strauss, Kathleen A.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Radboud University Nijmegen; University of Oxford; Jenner Institute; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore	Murphy, SC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	murphysc@uw.edu	Douglas, Alexander/E-7040-2012; Laurens, Matthew/E-7293-2013; Billman, Zachary/AAE-4245-2019; Gilbert, Sarah C./H-2857-2019; Sauerwein, Robert/C-8519-2013; Murphy, Sean C./AAC-7531-2019; Hermsen, C.C./L-4368-2015	Douglas, Alexander/0000-0002-5410-7562; Laurens, Matthew/0000-0003-3874-581X; Gilbert, Sarah C./0000-0002-6823-9750; Murphy, Sean C./0000-0002-2048-0131; Berry, Andrea/0000-0003-3140-3868; Edwards, Nick/0000-0002-7030-7839	UW Center for AIDS Research [AI27757]; non-UW labs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	UW Center for AIDS Research; non-UW labs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported using intra-Departmental funds (to SCM) and resources from the UW Center for AIDS Research (AI27757). Testing at non-UW labs was paid for by those institutions using in-house support. No commercial funding was used for this study. Study design, data collection, analysis, decision to publish and preparation of the manuscript were wholly the responsibility of the listed authors and no one else. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Aidoo M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-239; Alemayehu S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-277; Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; Chinkhumba J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-209; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Ciceron L, 1999, J CLIN MICROBIOL, V37, P35, DOI 10.1128/JCM.37.1.35-38.1999; Coleman RE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-121; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102; DAS A, 1995, MOL CELL PROBE, V9, P161, DOI 10.1006/mcpr.1995.0025; Douglas AD, 2013, J INFECT DIS, V208, P340, DOI 10.1093/infdis/jit156; DOWLING MAC, 1966, B WORLD HEALTH ORGAN, V34, P249; Duncan CJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022271; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Fu J, 2009, ANAL SCI, V25, P675, DOI 10.2116/analsci.25.675; Genton B, 2010, VACCINE, V28, P6573, DOI 10.1016/j.vaccine.2010.07.067; GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; Hammami I, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-398; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; JACKSON JB, 1993, J CLIN MICROBIOL, V31, P3123, DOI 10.1128/JCM.31.12.3123-3128.1993; Kho WG, 2003, PARASITOL INT, V52, P229, DOI 10.1016/S1383-5769(03)00028-X; Laurens MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068969; Laurens Matthew B, 2012, Vaccine, V30, P5302, DOI 10.1016/j.vaccine.2012.04.088; Lyke KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013490; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; McMorrow ML, 2010, AM J TROP MED HYG, V82, P151, DOI 10.4269/ajtmh.2010.09-0440; Mens PF, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-80; Mixson-Hayden Tonya, 2010, BMC Res Notes, V3, P88, DOI 10.1186/1756-0500-3-88; Murphy SC, 2012, J CLIN MICROBIOL; Murphy SC, 2013, AM J TROP MED HYG, V89, P824, DOI 10.4269/ajtmh.12-0675; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Nyunt MM, 2009, AM J TROP MED HYG, V80, P528, DOI 10.4269/ajtmh.2009.80.528; Oguike MC, 2011, INT J PARASITOL, V41, P677, DOI 10.1016/j.ijpara.2011.01.004; Padley DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-139; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Poon LLM, 2006, CLIN CHEM, V52, P303; REICHELDERFER PS, 1994, PCR METH APPL, V4, pS141; Richie TL, 2012, HUM VACC IMMUNOTHER, V8, P1564, DOI 10.4161/hv.22129; Roestenbeng M, 2013, AM J TROP MED HYG, V88, P5, DOI 10.4269/ajtmh.2012.12-0613; Roestenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038434; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Safeukui I, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-70; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Schirm J, 2002, J CLIN MICROBIOL, V40, P2973, DOI 10.1128/JCM.40.8.2973-2980.2002; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072, DOI 10.1128/JCM.38.11.4072-4075.2000; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sheehy SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065960; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Swan H, 2005, AM J TROP MED HYG, V73, P850, DOI 10.4269/ajtmh.2005.73.850; Tangin A, 2008, BIOL PHARM BULL, V31, P703, DOI 10.1248/bpb.31.703; Teirlinck AC, 2013, J INFECT DIS, V207, P656, DOI 10.1093/infdis/jis725; Verhage DF, 2005, NETH J MED, V63, P52; Vo TKD, 2007, T ROY SOC TROP MED H, V101, P422, DOI 10.1016/j.trstmh.2006.09.004; Wallace Paul S, 2013, Methods Mol Biol, V943, P49, DOI 10.1007/978-1-60327-353-4_3; Wang CW, 2009, PARASITOL INT, V58, P478, DOI 10.1016/j.parint.2009.07.004; World Health Organization; Foundation for Innovative New Diagnostics TDR, 2012, RDT EV PROGR	76	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97398	10.1371/journal.pone.0097398	http://dx.doi.org/10.1371/journal.pone.0097398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24838112	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800042
J	Ovesen, JL; Fan, YX; Zhang, X; Chen, J; Medvedovic, M; Xia, Y; Puga, A				Ovesen, Jerald L.; Fan, Yunxia; Zhang, Xiang; Chen, Jing; Medvedovic, Mario; Xia, Ying; Puga, Alvaro			Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) Analysis Uncovers Broad Changes in Chromatin Structure Resulting from Hexavalent Chromium Exposure	PLOS ONE			English	Article							DNA CROSS-LINKING; TRANSCRIPTION FACTORS; REPAIR; TOXICITY; ADDUCTS; CANCER; CELLS; CARCINOGENICITY; EPIGENETICS; ACTIVATION	The ability of chromatin to switch back and forth from open euchromatin to closed heterochromatin is vital for transcriptional regulation and genomic stability, but its dynamic structure is subject to disruption by exposure to environmental agents such as hexavalent chromium. Cr(VI) exposure disrupts chromatin remodeling mechanisms and causes chromosomal damage through formation of free radicals, Cr-DNA adducts, and DNA-Cr-protein cross-links. In addition, acute, high-concentration, and chronic, low-concentration exposures to Cr(VI) lead to significantly different transcriptional and genomic stability outcomes. We used mouse hepatoma Hepa-1c1c7 cells to investigate how transcriptional responses to chromium treatment might correlate with structural chromatin changes. We used Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) analysis coupled with deep sequencing to identify regions of the genome that may switch between open and closed chromatin in response to exposure to varying Cr(VI) concentrations. At either Cr(VI) concentration, chromatin domains surrounding binding sites for AP-1 transcription factors become significantly open, whereas BACH2 and CTCF binding sites are open solely at the low and high concentrations, respectively. Parallel gene expression profiling using RNA-seq indicates that the structural chromatin changes caused by Cr(VI) affect gene expression levels in the target areas that vary depending on Cr(VI) concentration, but show no correlation between global changes in the overall transcriptional response and Cr(VI) concentration. Our results suggest that FAIRE may be a useful technique to map chromatin elements targeted by DNA damaging agents for which there is no prior knowledge of their specificity, and to identify subsequent transcriptomic changes induced by those agents.	[Puga, Alvaro] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH 45267 USA	University of Cincinnati; University of Cincinnati	Puga, A (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	Alvaro.Puga@uc.edu		Chen, Jing/0000-0002-6227-7393	National Institutes of Health [5 R01 ES010807, R21 ES020048]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020048, R01ES010807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants 5 R01 ES010807 and R21 ES020048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barchowsky A, 2003, FREE RADICAL BIO MED, V34, P1130, DOI 10.1016/S0891-5849(03)00059-5; Dayan AD, 2001, HUM EXP TOXICOL, V20, P439, DOI 10.1191/096032701682693062; Ding Min, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P129; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2006, CURR OPIN GENET DEV, V16, P171, DOI 10.1016/j.gde.2006.02.003; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kallies A, 2013, IMMUNOL CELL BIOL, V91, P491, DOI 10.1038/icb.2013.32; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KC, 2001, TRENDS ENDOCRIN MET, V12, P191, DOI 10.1016/S1043-2760(01)00392-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Majumder S, 2003, J BIOL CHEM, V278, P26216, DOI 10.1074/jbc.M302887200; MANNING FCR, 1992, MOL CARCINOGEN, V6, P270, DOI 10.1002/mc.2940060409; Morse JL, 2013, CHEM RES TOXICOL, V26, P1591, DOI 10.1021/tx400293s; O'Brien T, 2001, MOL CELL BIOCHEM, V222, P173, DOI 10.1023/A:1017918330073; O'Brien TJ, 2003, MUTAT RES-FUND MOL M, V533, P3, DOI 10.1016/j.mrfmmm.2003.09.006; Ovesen JL, 2014, TOXICOLOGY, V316, P14, DOI 10.1016/j.tox.2013.12.001; Owen-Hughes T, 2012, CURR OPIN CELL BIOL, V24, P296, DOI 10.1016/j.ceb.2012.02.003; Reynolds M, 2004, J BIOL CHEM, V279, P30419, DOI 10.1074/jbc.M402486200; Schnekenburger M, 2007, MOL CELL BIOL, V27, P7089, DOI 10.1128/MCB.00838-07; Shumilla JA, 1999, J BIOL CHEM, V274, P36207, DOI 10.1074/jbc.274.51.36207; Tsai CC, 2004, VITAM HORM, V68, P93; Wang Q, 2013, ENVIRON HEALTH PERSP, V121, P1334, DOI 10.1289/ehp.1307297; WETTERHAHN KE, 1989, SCI TOTAL ENVIRON, V86, P113, DOI 10.1016/0048-9697(89)90199-X; XU J, 1994, CARCINOGENESIS, V15, P1443, DOI 10.1093/carcin/15.7.1443; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+; Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	35	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97849	10.1371/journal.pone.0097849	http://dx.doi.org/10.1371/journal.pone.0097849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837440	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800077
J	La Sorte, FA; Butchart, SHM; Jetz, W; Bohning-Gaese, K				La Sorte, Frank A.; Butchart, Stuart H. M.; Jetz, Walter; Boehning-Gaese, Katrin			Range-Wide Latitudinal and Elevational Temperature Gradients for the World's Terrestrial Birds: Implications under Global Climate Change	PLOS ONE			English	Article							SPECIES RICHNESS; EVOLUTIONARY RESPONSES; MONTANE BIODIVERSITY; MOUNTAIN PASSES; NATAL DISPERSAL; GENE FLOW; PATTERNS; SHIFTS; EXPANSION; TRAITS	Species' geographical distributions are tracking latitudinal and elevational surface temperature gradients under global climate change. To evaluate the opportunities to track these gradients across space, we provide a first baseline assessment of the steepness of these gradients for the world's terrestrial birds. Within the breeding ranges of 9,014 bird species, we characterized the spatial gradients in temperature along latitude and elevation for all and a subset of bird species, respectively. We summarized these temperature gradients globally for threatened and non-threatened species and determined how their steepness varied based on species' geography (range size, shape, and orientation) and projected changes in temperature under climate change. Elevational temperature gradients were steepest for species in Africa, western North and South America, and central Asia and shallowest in Australasia, insular IndoMalaya, and the Neotropical lowlands. Latitudinal temperature gradients were steepest for extratropical species, especially in the Northern Hemisphere. Threatened species had shallower elevational gradients whereas latitudinal gradients differed little between threatened and non-threatened species. The strength of elevational gradients was positively correlated with projected changes in temperature. For latitudinal gradients, this relationship only held for extratropical species. The strength of latitudinal gradients was better predicted by species' geography, but primarily for extratropical species. Our findings suggest threatened species are associated with shallower elevational temperature gradients, whereas steep latitudinal gradients are most prevalent outside the tropics where fewer bird species occur year-round. Future modeling and mitigation efforts would benefit from the development of finer grain distributional data to ascertain how these gradients are structured within species' ranges, how and why these gradients vary among species, and the capacity of species to utilize these gradients under climate change.	[La Sorte, Frank A.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Jetz, Walter] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Boehning-Gaese, Katrin] Senckenberg Gesell Naturforsch, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Boehning-Gaese, Katrin] Goethe Univ, Dept Biol Sci, Frankfurt, Germany	Cornell University; BirdLife International; Yale University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	La Sorte, FA (corresponding author), Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA.	fal42@cornell.edu	Butchart, Stuart/AAJ-1852-2021; Butchart, Stuart HM/Y-2711-2018; Jetz, Walter/ABF-1517-2020; Böhning-Gaese, Katrin/W-2601-2019	Butchart, Stuart/0000-0002-1140-4049; Böhning-Gaese, Katrin/0000-0003-0477-5586; Jetz, Walter/0000-0002-1971-7277	Cornell Lab of Ornithology	Cornell Lab of Ornithology	This work was funded through a postdoctoral fellowship at the Cornell Lab of Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2012, GLOBAL CHANGE BIOL, V18, P2126, DOI 10.1111/j.1365-2486.2012.02683.x; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Baselga A, 2012, J BIOGEOGR, V39, P760, DOI 10.1111/j.1365-2699.2011.02612.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; BirdLife International, 2012, BIRDL CHECKL BIRDS W; BirdLife International and NatureServe, 2012, BIRD SPEC DISTR MAPS; Bocedi G, 2012, METHODS ECOL EVOL, V3, P1008, DOI 10.1111/j.2041-210X.2012.00235.x; Bohning-Gaese K, 2006, AM NAT, V167, P555, DOI 10.1086/501078; Buchanan GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029080; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; DAGUM C, 1980, ECON APPL, V33, P327; DAVIES RB, 1987, BIOMETRIKA, V74, P33, DOI 10.1093/biomet/74.1.33; Dawideit BA, 2009, J ANIM ECOL, V78, P388, DOI 10.1111/j.1365-2656.2008.01504.x; Dexter KG, 2010, J BIOGEOGR, V37, P2137, DOI 10.1111/j.1365-2699.2010.02362.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Early R, 2011, ECOL LETT, V14, P1125, DOI 10.1111/j.1461-0248.2011.01681.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Forero-Medina G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028535; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Freeman BG, P NATL ACAD IN PRESS; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gillies CS, 2011, ECOL APPL, V21, P944, DOI 10.1890/09-2090.1; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Graae BJ, 2012, OIKOS, V121, P3, DOI 10.1111/j.1600-0706.2011.19694.x; Hargrove L, 2011, OIKOS, V120, P1568, DOI 10.1111/j.1600-0706.2011.19284.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hole DG, 2011, CONSERV BIOL, V25, P305, DOI 10.1111/j.1523-1739.2010.01633.x; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Ibarra-Macias A, 2011, BIOL CONSERV, V144, P703, DOI 10.1016/j.biocon.2010.08.006; IPCC Intergovernmental Panel on Climate Change (IPCC), 2013, 5 ASSESSMENT REPORT; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jetz W, 2009, ECOL LETT, V12, P1137, DOI 10.1111/j.1461-0248.2009.01369.x; Jonas CS, 1999, AM J BOT, V86, P333, DOI 10.2307/2656755; Jones P.G., 2009, GENERATING CHARACTER; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kubisch A, 2013, ECOGRAPHY, V36, P873, DOI 10.1111/j.1600-0587.2012.00062.x; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; La Sorte FA, 2007, ECOGRAPHY, V30, P649, DOI 10.1111/j.2007.0906-7590.05084.x; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Laube I, 2013, GLOBAL ECOL BIOGEOGR, V22, P233, DOI 10.1111/j.1466-8238.2012.00798.x; Laube I, 2013, GLOBAL ECOL BIOGEOGR, V22, P223, DOI 10.1111/j.1466-8238.2012.00796.x; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; MacArthur R.H., 1972, pvii; Mao JF, 2013, REMOTE SENS-BASEL, V5, P1484, DOI 10.3390/rs5031484; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; Mokhov II, 2006, IZV ATMOS OCEAN PHY+, V42, P430, DOI 10.1134/S0001433806040037; Moller AP, 2006, GLOBAL CHANGE BIOL, V12, P2005, DOI 10.1111/j.1365-2486.2006.01216.x; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Mustin K, 2013, DIVERS DISTRIB, V19, P815, DOI 10.1111/ddi.12038; Naya DE, 2012, AM NAT, V179, pE172, DOI 10.1086/665646; Nichols J., 2001, DISPERSAL; Nijssen David, 1998, Coenoses, V13, P33; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pigot AL, 2010, ECOL LETT, V13, P705, DOI 10.1111/j.1461-0248.2010.01462.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Reif J, 2012, OIKOS, V121, P1053, DOI 10.1111/j.1600-0706.2011.20008.x; Scherrer D, 2011, INT J BIOMETEOROL, V55, P645, DOI 10.1007/s00484-010-0364-7; Schurr FM, 2012, J BIOGEOGR, V39, P2146, DOI 10.1111/j.1365-2699.2012.02737.x; Sexton JP, 2011, P NATL ACAD SCI USA, V108, P11704, DOI 10.1073/pnas.1100404108; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Somveille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070907; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; Suggitt AJ, 2012, BIOL LETTERS, V8, P590, DOI 10.1098/rsbl.2012.0112; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Udvardy M.D.F., 1975, CLASSIFICATION BIOGE; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Watkinson AR, 2002, DISPERSAL ECOLOGY, P410; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Xu YY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052116; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366	95	25	25	5	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98361	10.1371/journal.pone.0098361	http://dx.doi.org/10.1371/journal.pone.0098361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852009	gold, Green Submitted, Green Published			2022-12-27	WOS:000338323200067
J	Ludwig, G; Nejman, D; Hecht, M; Orlanski, S; Abu-Remaileh, M; Yanuka, O; Sandler, O; Marx, A; Roberts, D; Benvenisty, N; Bergman, Y; Mendelsohn, M; Cedar, H				Ludwig, Guy; Nejman, Deborah; Hecht, Merav; Orlanski, Shari; Abu-Remaileh, Monther; Yanuka, Ofra; Sandler, Oded; Marx, Amichai; Roberts, Douglas; Benvenisty, Nissim; Bergman, Yehudit; Mendelsohn, Monica; Cedar, Howard			Aberrant DNA Methylation in ES Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; CPG ISLAND; NAIVE PLURIPOTENCY; DIFFERENTIATION; GENES; METHYLTRANSFERASES; HYPERMETHYLATION; DEMETHYLATION; DERIVATION	Both mouse and human embryonic stem cells can be differentiated in vitro to produce a variety of somatic cell types. Using a new developmental tracing approach, we show that these cells are subject to massive aberrant CpG island de novo methylation that is exacerbated by differentiation in vitro. Bioinformatics analysis indicates that there are two distinct forms of abnormal de novo methylation, global as opposed to targeted, and in each case the resulting pattern is determined by molecular rules correlated with local pre-existing histone modification profiles. Since much of the abnormal methylation generated in vitro appears to be stably maintained, this modification may inhibit normal differentiation and could predispose to cancer if cells are used for replacement therapy. Excess CpG island methylation is also observed in normal placenta, suggesting that this process may be governed by an inherent program.	[Ludwig, Guy; Nejman, Deborah; Hecht, Merav; Orlanski, Shari; Abu-Remaileh, Monther; Bergman, Yehudit; Cedar, Howard] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Yanuka, Ofra; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Sandler, Oded; Marx, Amichai] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel; [Roberts, Douglas] Agilent Technol, Agilent Labs, Santa Clara, CA USA; [Mendelsohn, Monica] Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Agilent Technologies; Columbia University	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel.	cedar@mail.huji.ac.il	Abu-Remaileh, Monther/M-3747-2016	Abu-Remaileh, Monther/0000-0003-3772-0477	Israel Science Foundation [419/10]; Israel Cancer Research Fund; European Research Council [268614]; Israeli Centers of Research Excellence; Rosetrees Trust; Rosetrees Trust [M31-F1] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; European Research Council(European Research Council (ERC)European Commission); Israeli Centers of Research Excellence; Rosetrees Trust(Rosetrees Trust); Rosetrees Trust(Rosetrees Trust)	This work was supported by the Israel Science Foundation (Grant no. 419/10) (http://www.isf.org.il), Israel Cancer Research Fund (http://www.icrfonline.org), European Research Council (Grant no. 268614) (http://erc.europa.eu), Israeli Centers of Research Excellence (http://www.icore-human-disease.org), The Rosetrees Trust (www.rosetreestrust.co.uk), Lew Sanders and Norton Herrick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder O, 2010, DEVELOPMENT, V137, P2483, DOI 10.1242/dev.048363; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; De Marzo AM, 1999, CANCER RES, V59, P3855; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; LANDEDINER L, 2005, NAT REV GENET, V6, P648; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; POLLACK Y, 1980, P NATL ACAD SCI-BIOL, V77, P6463, DOI 10.1073/pnas.77.11.6463; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; REYNAUD C, 1992, CANCER LETT, V61, P255, DOI 10.1016/0304-3835(92)90296-8; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Sabag O, 2014, NAT STRUCT MOL BIOL, V21, P110, DOI 10.1038/nsmb.2734; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Senner CE, 2012, STEM CELLS, V30, P2732, DOI 10.1002/stem.1249; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Steinfeld I, 2008, BIOINFORMATICS, V24, pI90, DOI 10.1093/bioinformatics/btn279; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	58	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96090	10.1371/journal.pone.0096090	http://dx.doi.org/10.1371/journal.pone.0096090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852222	gold, Green Published, Green Accepted			2022-12-27	WOS:000338323200009
J	Shen, TC; Chung, WS; Lin, CL; Wei, CC; Chen, CH; Chen, HJ; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Chung, CJ				Shen, Te-Chun; Chung, Wei-Sheng; Lin, Cheng-Li; Wei, Chang-Ching; Chen, Chia-Hung; Chen, Hung-Jen; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Chung, Chi-Jung			Does Chronic Obstructive Pulmonary Disease with or without Type 2 Diabetes Mellitus Influence the Risk of Lung Cancer? Result from a Population-Based Cohort Study	PLOS ONE			English	Article							COPD; BURDEN; METAANALYSIS; EMPHYSEMA; SMOKING	Background: Previous studies have suggested that chronic obstructive pulmonary disease (COPD) is an independent risk factor for lung cancer. There are some evidence that people with diabetes are at a risk of developing many forms of cancer, but inconclusive with regard to lung cancer. The aim of this study was to evaluate whether COPD with or without type 2 diabetes mellitus (T2DM) influences the risk of developing lung cancer. Methods: This is a retrospective cohort study consisting of 20,730 subjects newly diagnosed with COPD ("cases"). Their data was collected from the National Health Insurance system of Taiwan from 1998 to 2010. Among these patients, 5,820 patients had T2DM and 14,910 patients did not have T2DM. The retrospective matched control group consisted of 20,729 subjects without either COPD or T2DM. The control group was matched with the cases for sex, age, and index year (the year that the patient was diagnosed with COPD). The subjects were followed until the end of 2011. Results: The findings of our study showed that the risk of lung cancer was higher in the COPD group than in the non-COPD group, with adjusted hazard ratio (HR) of 5.02 [95% confidence interval (CI) = 4.23-5.94] among total case group, adjusted HR was 5.38 (95% CI = 4.52-6.40) in the cohort without T2DM and adjusted HR was 4.05 (95% CI = 3.26-5.03) in the cohort with T2DM. We observed a significantly protective effect from lung cancer (adjusted HR = 0.75, 95% CI = 0.63-0.90) of diabetic cohort than non-diabetic cohort among patients with COPD. Conclusion: Patients with COPD had a significantly higher risk of developing lung cancer than healthy people. However, there was a protective effect of T2DM for lung cancer among patients with COPD. Further investigation may be needed to corroborate the mechanism or bring up reliable reasons.	[Shen, Te-Chun; Chen, Chia-Hung; Chen, Hung-Jen; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Shen, Te-Chun; Wei, Chang-Ching; Chen, Chia-Hung; Chen, Hung-Jen; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ, Taichung, Taiwan; [Shen, Te-Chun] Chu Shang Show Chwan Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Nantou, Taiwan; [Chung, Wei-Sheng] Taichung Hosp, Dept Internal Med, Minist Hlth & Welf, Taichung, Taiwan; [Chung, Wei-Sheng] Cent Taiwan Univ Sci & Technol, Dept Healthcare Adm, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ Hosp, Div Nephrol, Dept Pediat, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Central Taiwan University Science & Technology; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chung, CJ (corresponding author), China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan.	d10326@mail.cmuh.org.tw	Chung, Chi-Jung/G-4755-2013	Shen, Te-Chun/0000-0002-9427-1068	Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH102-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH102-TD-C-111-005]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence	This work was supported by Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH102-TD-B-111-004) and Taiwan Department of Health Cancer Research Center for Excellence (DOH102-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Dubey S, 2008, AM J RESP CRIT CARE, V177, P941, DOI 10.1164/rccm.200801-107UP; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Hall GC, 2005, DIABETES CARE, V28, P590, DOI 10.2337/diacare.28.3.590; Holtzman Michael J, 2005, Proc Am Thorac Soc, V2, P132, DOI 10.1513/pats.200502-015AW; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Kishi K, 2002, EUR RESPIR J, V19, P1093, DOI 10.1183/09031936.02.00264202; Lai SW, 2012, CLIN LUNG CANCER, V13, P143, DOI 10.1016/j.cllc.2011.10.002; Lo SF, 2013, INT J CANCER, V132, P182, DOI 10.1002/ijc.27597; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Petty TL, 2005, CHEST, V128, P1895, DOI 10.1378/chest.128.4.1895; Powell HA, 2013, J THORAC ONCOL, V8, P6, DOI 10.1097/JTO.0b013e318274a7dc; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shen TC, 2014, QJM; Shen TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091821; Shen TC, 2014, AM J RESP CRIT CARE, V189, P496, DOI 10.1164/rccm.201310-1792LE; Smiechowski BB, 2013, DIABETES CARE, V36, P124, DOI 10.2337/dc12-0740; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Thun MJ, 2006, JNCI-J NATL CANCER I, V98, P691, DOI 10.1093/jnci/djj187; van Schayck C P Onno, 2006, Prim Care Respir J, V15, P81, DOI 10.1016/j.pcrj.2006.01.006; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046144; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Wright JL, 2002, CHEST, V122, p301S, DOI 10.1378/chest.122.6_suppl.301S	35	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98290	10.1371/journal.pone.0098290	http://dx.doi.org/10.1371/journal.pone.0098290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854189	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200061
J	Szepesi, Z; Hosy, E; Ruszczycki, B; Bijata, M; Pyskaty, M; Bikbaev, A; Heine, M; Choquet, D; Kaczmarek, L; Wlodarczyk, J				Szepesi, Zsuzsanna; Hosy, Eric; Ruszczycki, Blazej; Bijata, Monika; Pyskaty, Marta; Bikbaev, Arthur; Heine, Martin; Choquet, Daniel; Kaczmarek, Leszek; Wlodarczyk, Jakub			Synaptically Released Matrix Metalloproteinase Activity in Control of Structural Plasticity and the Cell Surface Distribution of GluA1-AMPA Receptors	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMPA-RECEPTORS; DENDRITIC SPINES; NMDA RECEPTORS; EXTRACELLULAR-MATRIX; SILENT SYNAPSES; TRAFFICKING; MATRIX-METALLOPROTEINASE-9; BRAIN; MMP-9	Synapses are particularly prone to dynamic alterations and thus play a major role in neuronal plasticity. Dynamic excitatory synapses are located at the membranous neuronal protrusions called dendritic spines. The ability to change synaptic connections involves both alterations at the morphological level and changes in postsynaptic receptor composition. We report that endogenous matrix metalloproteinase (MMP) activity promotes the structural and functional plasticity of local synapses by its effect on glutamate receptor mobility and content. We used live imaging of cultured hippocampal neurons and quantitative morphological analysis to show that chemical long-term potentiation (cLTP) induces the permanent enlargement of a subset of small dendritic spines in an MMP-dependent manner. We also used a superresolution microscopy approach and found that spine expansion induced by cLTP was accompanied by MMP-dependent immobilization and synaptic accumulation as well as the clustering of GluA1-containing AMPA receptors. Altogether, our results reveal novel molecular and cellular mechanisms of synaptic plasticity.	[Szepesi, Zsuzsanna; Ruszczycki, Blazej; Bijata, Monika; Pyskaty, Marta; Kaczmarek, Leszek; Wlodarczyk, Jakub] Nencki Inst, Dept Mol & Cellular Neurobiol, Warsaw, Poland; [Hosy, Eric; Choquet, Daniel] Dynam Org & Funct Synapses, Interdisciplinary Inst Neurosci, Bordeaux, France; [Bikbaev, Arthur; Heine, Martin] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany	Polish Academy of Sciences; Leibniz Institut fur Neurobiologie (LIN)	Wlodarczyk, J (corresponding author), Nencki Inst, Dept Mol & Cellular Neurobiol, Warsaw, Poland.	jwlodarc@nencki.gov.pl	Choquet, Daniel/K-7893-2018; Ruszczycki, Blazej/AAC-6385-2020; Choquet, Daniel/GOJ-8825-2022; Wlodarczyk, Jakub/A-2253-2015; Kaczmarek, Leszek/B-6171-2008; Kaczmarek, Leszek/AHA-0076-2022	Choquet, Daniel/0000-0003-4726-9763; Ruszczycki, Blazej/0000-0002-0262-1463; Choquet, Daniel/0000-0003-4726-9763; Wlodarczyk, Jakub/0000-0001-8343-2340; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; hosy, eric/0000-0002-2479-5915; Bijata, Monika/0000-0003-0589-4771; Magnowska, Marta/0000-0002-5424-6837	ERA-NET NEURON MODDIFSYN; National Science Centre [Dec-2011/01/D/NZ3/00163]; EU [264173]	ERA-NET NEURON MODDIFSYN; National Science Centre(National Science Centre, Poland); EU(European Commission)	Research was supported by ERA-NET NEURON MODDIFSYN and the National Science Centre (Dec-2011/01/D/NZ3/00163). This work was partially supported by EU FP7 Project, GA No 264173 (Bio-Imagine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Calo L, 2006, J NEUROCHEM, V98, P1, DOI 10.1111/j.1471-4159.2006.03844.x; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Conant K, 2011, J NEUROCHEM, V118, P521, DOI 10.1111/j.1471-4159.2010.07153.x; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dityatev A, 2011, CURR OPIN NEUROBIOL, V21, P353, DOI 10.1016/j.conb.2010.12.006; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Esteban JA, 2008, BRIT J PHARMACOL, V153, pS35, DOI 10.1038/sj.bjp.0707525; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Henley Jeremy M, 2013, Dialogues Clin Neurosci, V15, P11; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kaczmarek L, 2013, CURR PHARM DESIGN, V19, P1085, DOI 10.2174/1381612811319060010; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Kielland A, 2009, NEURON, V62, P84, DOI 10.1016/j.neuron.2009.03.001; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Levenga J, 2012, PROG BRAIN RES, V197, P153, DOI 10.1016/B978-0-444-54299-1.00008-X; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lonskaya I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069136; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Michaluk P, 2009, J NEUROSCI, V29, P6007, DOI 10.1523/JNEUROSCI.5346-08.2009; Mokin M, 2007, J NEUROPHYSIOL, V98, P1278, DOI 10.1152/jn.00212.2007; Molnar E, 2011, SEMIN CELL DEV BIOL, V22, P506, DOI 10.1016/j.semcdb.2011.07.017; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Rybakowski JK, 2013, J AFFECT DISORDERS, V146, P286, DOI 10.1016/j.jad.2012.07.019; Rybakowski JK, 2009, PSYCHIAT GENET, V19, P108, DOI 10.1097/YPG.0b013e32832080be; Samochowiec A, 2010, BRAIN RES, V1327, P103, DOI 10.1016/j.brainres.2010.02.072; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Selemon LD, 2007, NEUROPSYCHOPHARMACOL, V32, P919, DOI 10.1038/sj.npp.1301179; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wiera G, 2013, HIPPOCAMPUS, V23, P529, DOI 10.1002/hipo.22112; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Yu SY, 2008, J NEUROCHEM, V106, P889, DOI 10.1111/j.1471-4159.2008.05461.x; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	95	58	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98274	10.1371/journal.pone.0098274	http://dx.doi.org/10.1371/journal.pone.0098274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853857	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200059
J	DeMiguel, D; Alba, DM; Moya-Sola, S				DeMiguel, Daniel; Alba, David M.; Moya-Sola, Salvador			Dietary Specialization during the Evolution of Western Eurasian Hominoids and the Extinction of European Great Apes	PLOS ONE			English	Article							MIDDLE MIOCENE SITE; PIEROLAPITHECUS-CATALAUNICUS PRIMATES; DENTAL MICROWEAR ANALYSIS; VALLES-PENEDES BASIN; ENAMEL THICKNESS; HISPANOPITHECUS-LAIETANUS; MOLAR MICROWEAR; OURANOPITHECUS-MACEDONIENSIS; OREOPITHECUS-BAMBOLII; QUANTITATIVE-ANALYSIS	Given the central adaptive role of diet, paleodietary inference is essential for understanding the relationship between evolutionary and paleoenvironmental change. Here we rely on dental microwear analysis to investigate the role of dietary specialization in the diversification and extinction of Miocene hominoids from Western Eurasian between 14 and 7 Ma. New microwear results for five extinct taxa are analyzed together with previous data for other Western Eurasian genera. Except Pierolapithecus (that resembles hard-object feeders) and Oreopithecus (a soft-frugivore probably foraging opportunistically on other foods), most of the extinct taxa lack clear extant dietary analogues. They display some degee of sclerocarpy, which is most clearly expressed in Griphopithecus and Ouranopithecus (adapted to more open and arid environments), whereas Anoiapithecus, Dryopithecus and, especially, Hispanopithecus species apparently relied more strongly on soft-frugivory. Thus, contrasting with the prevailing sclerocarpic condition at the beginning of the Eurasian hominoid radiation, soft-and mixed-frugivory coexisted with hard-object feeding in the Late Miocene. Therefore, despite a climatic trend towards cooling and increased seasonality, a progressive dietary diversification would have occurred (probably due to competitive exclusion and increased environmental heterogeneity), although strict folivory did not evolve. Overall, our analyses support the view that the same dietary specializations that enabled Western Eurasian hominoids to face progressive climatic deterioration were the main factor ultimately leading to their extinction when more drastic paleoenvironmental changes took place.	[DeMiguel, Daniel; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Alba, David M.] Univ Turin, Dipartimento Sci Terra, Turin, Italy; [Moya-Sola, Salvador] Univ Autonoma Barcelona, ICREA, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Unitat Antropol Biol, Dept BABVE, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Turin; Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona	DeMiguel, D (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain.	daniel.demiguel@icp.cat	Alba, David/G-9716-2015	Alba, David/0000-0002-8886-5580; Moya-Sola, Salvador/0000-0001-8506-1061; DeMiguel, Daniel/0000-0001-6138-7227	Spanish Ministerio de Economia y Competitividad [CGL2011-28681/BTE, CGL2011-27343, JCI-2011-11697, RYC-2009-04533]; Generalitat de Catalunya [2009 SGR 754 GRC]; ICREA Funding Source: Custom	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	This work was funded by the Spanish Ministerio de Economia y Competitividad (CGL2011-28681/BTE, CGL2011-27343, JCI-2011-11697 (to DDM), and RYC-2009-04533 (to DMA)) and the Generalitat de Catalunya (2009 SGR 754 GRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2003, J HUM EVOL, V45, P145, DOI 10.1016/S0047-2484(03)00091-5; Alba D.M., 2006, Estudios Geologicos (Madrid), V62, P295; Alba DM, 2010, P ROY SOC B-BIOL SCI, V277, P2237, DOI 10.1098/rspb.2010.0218; Alba D.M., 2011, PALEONTOL EVOL MEM E, V6, P95; Alba DM, 2013, J HUM EVOL, V65, P573, DOI 10.1016/j.jhevol.2013.07.003; Alba DM, 2012, EVOL ANTHROPOL, V21, P254, DOI 10.1002/evan.21312; Alba DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039617; Alba DM, 2012, J HUM EVOL, V63, P231, DOI 10.1016/j.jhevol.2012.05.009; Alba DM, 2010, J ANTHROPOL SCI, V88, P11; Alba DM, 2010, J HUM EVOL, V59, P143, DOI 10.1016/j.jhevol.2010.02.002; Alba DM, 2001, HOM EVOLUT CLIMAT CH, V2, P284; Almecija S, 2007, P ROY SOC B-BIOL SCI, V274, P2375, DOI 10.1098/rspb.2007.0750; Almecija S, 2009, J HUM EVOL, V57, P284, DOI 10.1016/j.jhevol.2009.02.008; ALPAGUT B, 1990, J HUM EVOL, V19, P397, DOI 10.1016/0047-2484(90)90052-D; ANDREWS P, 1991, PHILOS T R SOC B, V334, P199, DOI 10.1098/rstb.1991.0109; Andrews P, 1996, BIOL REV, V71, P257, DOI 10.1111/j.1469-185X.1996.tb00749.x; Andrews P, 2007, FOLIA PRIMATOL, V78, P328, DOI 10.1159/000105148; Andrews Peter, 1999, P454; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; BEGUN DR, 1992, AM J PHYS ANTHROPOL, V87, P291, DOI 10.1002/ajpa.1330870306; BEGUN DR, 1990, J HUM EVOL, V19, P255, DOI 10.1016/0047-2484(90)90068-M; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; BEGUN DR, 1992, AM J PHYS ANTHROPOL, V87, P311, DOI 10.1002/ajpa.1330870307; BEGUN DR, 1993, J HUM EVOL, V25, P271, DOI 10.1006/jhev.1993.1049; Bohme M, 2011, J HUM EVOL, V61, P332, DOI 10.1016/j.jhevol.2011.04.012; Casanovas-Vilar I, 2008, J HUM EVOL, V55, P589, DOI 10.1016/j.jhevol.2008.05.004; Casanovas-Vilar I, 2011, P NATL ACAD SCI USA, V108, P5554, DOI 10.1073/pnas.1018562108; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Costeur L, 2005, PALAEONTOGRAPHIA ITA, V90, P303; Daegling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023095; Daegling DJ, 1999, PRIMATES, V40, P559, DOI 10.1007/BF02574831; De Bonis Louis, 1997, P317; De Bonis Louis, 1994, Evolutionary Anthropology, V3, P75, DOI 10.1002/evan.1360030303; Deane AS, 2008, J HUM EVOL, V55, P691, DOI 10.1016/j.jhevol.2008.05.005; DEBONIS L, 1993, J HUM EVOL, V24, P469, DOI 10.1006/jhev.1993.1032; DeMiguel D, 2013, AM J PHYS ANTHROPOL, V151, P573, DOI 10.1002/ajpa.22299; DeMiguel D, 2011, PALAEOGEOGR PALAEOCL, V302, P452, DOI 10.1016/j.palaeo.2011.02.005; DUMONT ER, 1995, J MAMMAL, V76, P1127, DOI 10.2307/1382604; Eastham L, 2009, J VERTEBR PALEONTOL, V29, p91A; El-Zaatari S, 2005, J HUM EVOL, V49, P180, DOI 10.1016/j.jhevol.2005.03.005; Ersoy A, 2008, J HUM EVOL, V54, P518, DOI 10.1016/j.jhevol.2007.08.004; Galbany J, 2005, FOLIA PRIMATOL, V76, P325, DOI 10.1159/000089531; Golpe Posse J.M, 1993, PALEONTOLOGIA EVOLUC, V26, P151; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; Gugel IL, 2001, AM J PHYS ANTHROPOL, V114, P124, DOI 10.1002/1096-8644(200102)114:2&lt;124::AID-AJPA1012&gt;3.0.CO;2-S; Harrison Terry, 1997, P327; Harrison Terry, 2010, P429; KAY RF, 1977, AM J PHYS ANTHROPOL, V46, P327, DOI 10.1002/ajpa.1330460213; Kay Richard F., 1997, P131; Kelley J, 2008, J HUM EVOL, V54, P455, DOI 10.1016/j.jhevol.2007.08.007; King T, 2001, HOM EVOLUT CLIMAT CH, V2, P102; King T, 1999, J HUM EVOL, V36, P3, DOI 10.1006/jhev.1998.0258; Kordos L, 2001, J HUM EVOL, V40, P17, DOI 10.1006/jhev.2000.0437; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Lee-Thorp J, 2006, YEARB PHYS ANTHROPOL, V49, P131, DOI 10.1002/ajpa.20519; Lee-Thorp JA, 2010, PHILOS T R SOC B, V365, P3389, DOI 10.1098/rstb.2010.0059; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; LUCAS PW, 1995, FOLIA PRIMATOL, V64, P30, DOI 10.1159/000156829; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Marmi J, 2012, J HUM EVOL, V62, P412, DOI 10.1016/j.jhevol.2011.12.003; Matson SD, 2012, J HUM EVOL, V63, P127, DOI 10.1016/j.jhevol.2012.04.004; McGraw WS, 2012, AM J PHYS ANTHROPOL, V147, P326, DOI 10.1002/ajpa.21634; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Merceron G, 2013, J HUM EVOL, V65, P185, DOI 10.1016/j.jhevol.2013.05.003; Merceron G, 2012, J HUM EVOL, V63, P150, DOI 10.1016/j.jhevol.2012.04.006; Merceron G, 2010, P ROY SOC B-BIOL SCI, V277, P3105, DOI 10.1098/rspb.2010.0523; Merceron G, 2009, GEODIVERSITAS, V31, P865, DOI 10.5252/g2009n4a865; Merceron G, 2009, J HUM EVOL, V57, P732, DOI 10.1016/j.jhevol.2009.06.009; Mihlbachler MC, 2012, PALAEONTOL ELECTRON, V15; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 2009, P NATL ACAD SCI USA, V106, P9601, DOI 10.1073/pnas.0811730106; Moya-Sola S, 2009, AM J PHYS ANTHROPOL, V139, P126, DOI 10.1002/ajpa.20891; MoyaSola S, 1996, NATURE, V379, P156, DOI 10.1038/379156a0; Nakatsukasa M, 1996, FOLIA PRIMATOL, V66, P15, DOI 10.1159/000157181; Olejniczak AJ, 2008, J HUM EVOL, V54, P187, DOI 10.1016/j.jhevol.2007.09.014; de los Rios MP, 2012, J HUM EVOL, V63, P497, DOI 10.1016/j.jhevol.2012.05.012; Potts Richard, 2004, P237, DOI 10.1017/CBO9780511542299.017; Poulsen JR, 2001, AM J PRIMATOL, V54, P91, DOI 10.1002/ajp.1015; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; Ramdarshan A, 2010, J HUM EVOL, V59, P96, DOI 10.1016/j.jhevol.2010.04.007; Robinson J.G., 1986, SMITHSONIAN CONTRIBU, V27, P1, DOI DOI 10.5479/SI.00810282.431; Rook L, 1996, J HUM EVOL, V30, P3, DOI 10.1006/jhev.1996.0002; Rook L, 2011, PALAEOGEOGR PALAEOCL, V305, P286, DOI 10.1016/j.palaeo.2011.03.010; Schwartz GT, 2000, AM J PHYS ANTHROPOL, V111, P221, DOI 10.1002/(SICI)1096-8644(200002)111:2<221::AID-AJPA8>3.0.CO;2-G; Scott R, 2008, J VERTEBR PALEONTOL, V28, p139A; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Skinner MF, 2004, AM J PHYS ANTHROPOL, V123, P216, DOI 10.1002/ajpa.10314; SKINNER MF, 1995, J PALEOPATHOL, V7, P195; Sola SM, 1997, CR ACAD SCI II A, V324, P141; Sponheimer Matt, 2007, P555, DOI 10.1007/978-3-540-33761-4_18; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Strait DS, 2012, J HUM EVOL, V62, P165, DOI 10.1016/j.jhevol.2011.10.006; Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P391, DOI 10.1002/ajpa.1330800312; Teaford MF, 1996, AM J PHYS ANTHROPOL, V100, P143; TEAFORD MF, 1989, J DENT RES, V68, P1513, DOI 10.1177/00220345890680110901; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; TEAFORD MF, 1985, AM J PHYS ANTHROPOL, V66, P363, DOI 10.1002/ajpa.1330660403; Ungar P., 1992, ANTHROPOL KOZLEM, V34, P141; Ungar P.S., 2005, PALAEONTOGRAPH ITAL, V90, P97; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2013, BLACKW COMPANION ANT, P165; Ungar PS, 2012, J HUM EVOL, V63, P429, DOI 10.1016/j.jhevol.2011.04.006; UNGAR PS, 1995, P NATL ACAD SCI USA, V92, P5479, DOI 10.1073/pnas.92.12.5479; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; Ungar PS, 2006, J HUM EVOL, V50, P78, DOI 10.1016/j.jhevol.2005.08.007; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V94, P339, DOI 10.1002/ajpa.1330940305; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Utescher T, 2011, PALAEOGEOGR PALAEOCL, V304, P351, DOI 10.1016/j.palaeo.2010.09.031; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Ward SC, 2002, CAM S BIO EVOL ANTHR, V33, P385; Youlatos D, 1998, MAMMALIA, V62, P351, DOI 10.1515/mamm.1998.62.3.351; Zanolli C, 2010, ANN U FERRARA MUS SC, V6, P69	122	21	21	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97442	10.1371/journal.pone.0097442	http://dx.doi.org/10.1371/journal.pone.0097442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3AL	24848272	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600029
J	Shi, M; Li, M; Cui, YZ; Adachi, Y; Ikehara, S				Shi, Ming; Li, Ming; Cui, Yunze; Adachi, Yasushi; Ikehara, Susumu			Gr-1 Ab Administered after Bone Marrow Transplantation plus Thymus Transplantation Suppresses Tumor Growth by Depleting Granulocytic Myeloid-Derived Suppressor Cells	PLOS ONE			English	Article							LYMPHOCYTE INFUSION; BEARING MICE; T-CELLS; CANCER; INFLAMMATION; PROGRESSION	It has been shown that allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT) plus thymus transplantation (TT) is effective in treating recipients with malignant tumors. Although TT increases the percentage of T cells in the early term after BMT, the myeloid-derived suppressor cells (MDSCs) are still the dominant population. We used the Gr-1 Ab to deplete the granulocytic MDSCs (G-MDSCs) in tumor-bearing mice that had received BMT+TT. Two weeks after the BMT, the mice injected with Gr-1 Ab showed smaller tumors than those in the control group. In addition, Gr-1 Ab significantly increased the percentages and numbers of CD4(+) and CD8(+) T cells, and decreased the percentages and numbers of MDSCs and G-MDSCs. No side effects of the Gr-1 Ab on recipient or donor thymus were observed. These findings indicate that Gr-1 Ab administered after BMT+TT may enhance the effectiveness of tumor suppression.	[Shi, Ming; Li, Ming; Adachi, Yasushi; Ikehara, Susumu] Kansai Med Univ, Dept Stem Cell Disorders, Hirakata, Osaka, Japan; [Shi, Ming] Guangdong Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Dongguan, Guangdong, Peoples R China; [Cui, Yunze] JIMRO Co Ltd, Takasaki, Gunma, Japan; [Adachi, Yasushi] Toyooka Hosp, Div Clin Pathol, Toyooka, Hyogo, Japan	Kansai Medical University; Guangdong Medical University	Ikehara, S (corresponding author), Kansai Med Univ, Dept Stem Cell Disorders, Hirakata, Osaka, Japan.	ikehara@hirakata.kmu.ac.jp			Otsuka Pharmaceutical Company, Ltd.; Research on Allergic Disease and Immunology Committee from the Health and Labour Sciences Research of the Ministry of Health, Labour and Welfare	Otsuka Pharmaceutical Company, Ltd.(Otsuka Pharmaceutical); Research on Allergic Disease and Immunology Committee from the Health and Labour Sciences Research of the Ministry of Health, Labour and Welfare	This work was mainly supported by the Otsuka Pharmaceutical Company, Ltd., and by grants from the Research on Allergic Disease and Immunology Committee from the Health and Labour Sciences Research of the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ikehara S, 2011, EXPERT REV CLIN IMMU, V7, P205, DOI [10.1586/eci.10.100, 10.1586/ECI.10.100]; Kamiryo Y, 2009, CANCER RES, V69, P5151, DOI 10.1158/0008-5472.CAN-08-2517; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Ribechini E, 2009, EUR J IMMUNOL, V39, P3538, DOI 10.1002/eji.200939530; Ryu T, 2008, BONE MARROW TRANSPL, V41, P659, DOI 10.1038/sj.bmt.1705957; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Shi M, 2013, J IMMUNOL, V190, P2976, DOI 10.4049/jimmunol.1201605; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Suzuki Y, 2005, STEM CELLS, V23, P365, DOI 10.1634/stemcells.2004-0258; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhao F, 2009, IMMUNOLOGY, V128, P141, DOI 10.1111/j.1365-2567.2009.03105.x	20	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97908	10.1371/journal.pone.0097908	http://dx.doi.org/10.1371/journal.pone.0097908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847950	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600067
J	Guo, QF; Olden, JD				Guo, Qinfeng; Olden, Julian D.			Spatial Scaling of Non-Native Fish Richness across the United States	PLOS ONE			English	Article							FRESH-WATER FISHES; SPECIES RICHNESS; HUMAN-POPULATION; INVASIBILITY; DIVERSITY; BIODIVERSITY; COMMUNITY; INVASION; HOMOGENIZATION; PATTERNS	A major goal and challenge of invasion ecology is to describe and interpret spatial and temporal patterns of species invasions. Here, we examined fish invasion patterns at four spatially structured and hierarchically nested scales across the contiguous United States (i.e., from large to small: region, basin, watershed, and sub-watershed). All spatial relationships in both richness and fraction between species groups (e.g., natives vs. exotics) were positive at large scales. However, contrary to predictions using null/neutral models, the patterns at small scales were hump-shaped (unimodal), not simply negative. The fractions of both domestic (introduced among watersheds within the USA) and foreign (introduced from abroad) exotics increased with area across scales but decreased within each scale. The foreign exotics exhibited the highest dominance (lowest evenness) and spatial variation in distribution, followed by domestic exotics and natives, although on average natives still occupy larger areas than domestic and foreign exotics. The results provide new insight into patterns and mechanisms of fish species invasions at multiple spatial scales in the United States.	[Guo, Qinfeng] USDA FS, Eastern Forest Environm Threat Assessment Ctr, Asheville, NC 28804 USA; [Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	United States Department of Agriculture (USDA); United States Forest Service; University of Washington; University of Washington Seattle	Guo, QF (corresponding author), USDA FS, Eastern Forest Environm Threat Assessment Ctr, Asheville, NC 28804 USA.	qguo@fs.fed.us	Olden, Julian D/A-8535-2010	Olden, Julian/0000-0003-2143-1187; Higgs, Dennis/0000-0002-0771-4642	University of Washington	University of Washington(University of Washington)	We thank S. Fei and B. Iannone for helpful discussions on related topics, two anonymous reviewers for comments on the manuscript, J. Wen for assistance with data analyses, and W. Christie for assistance with GIS. Support to JDO was provided in part by the University of Washington H. Mason Keeler Endowed Professorship.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Blanchett S, 2009, P ROY SOC B-BIOL SCI, V276, P2385, DOI 10.1098/rspb.2009.0156; Brown RL, 2003, ECOLOGY, V84, P32, DOI 10.1890/0012-9658(2003)084[0032:DAIOSA]2.0.CO;2; Byers JE, 2003, ECOLOGY, V84, P1428, DOI 10.1890/02-3131; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Clark GF, 2013, ECOLOGY, V94, P25, DOI 10.1890/12-0592.1; Davies KF, 2011, DIVERS DISTRIB, V17, P35, DOI 10.1111/j.1472-4642.2010.00721.x; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; ELTON CS, 1958, ECOLOGY INVASIONS PL; Fridley JD, 2004, ECOLOGY, V85, P3215, DOI 10.1890/03-0676; Fuller PL, 1999, T 63 N AM WILDL NAT; Gido KB, 1999, FRESHWATER BIOL, V42, P387, DOI 10.1046/j.1365-2427.1999.444490.x; Guo QF, 2008, CONSERV BIOL, V22, P666, DOI 10.1111/j.1523-1739.2008.00915.x; Guo QF, 2010, DIVERS DISTRIB, V16, P1034, DOI 10.1111/j.1472-4642.2010.00708.x; Herben T, 2004, ECOLOGY, V85, P3223, DOI 10.1890/03-0648; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lee DC, 1997, PNW405 USDA FOR SERV, P1057; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; McKinney ML, 2002, DIVERS DISTRIB, V8, P311, DOI 10.1046/j.1472-4642.2002.00153.x; Mitchell AL, 2009, BIOL INVASIONS, V11, P1441, DOI 10.1007/s10530-008-9352-9; NatureServe, 2010, DOWNL AN DAT; Oberdorff Thierry, 2011, International Journal of Ecology, V2011, DOI 10.1155/2011/967631; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Olden JD, 2008, GLOBAL ECOL BIOGEOGR, V17, P25, DOI 10.1111/j.1466-8238.2007.00340.x; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Sanchez-Fernandez D, 2008, DIVERS DISTRIB, V14, P754, DOI 10.1111/j.1472-4642.2008.00474.x; SAS Institute, 2011, SAS STAT 9 3 US GUID; Sax DF, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P447; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Tomasetto F, 2013, DIVERS DISTRIB, V19, P49, DOI 10.1111/j.1472-4642.2012.00939.x; Villeger S, 2011, P NATL ACAD SCI USA, V108, P18003, DOI 10.1073/pnas.1107614108; Von Holle B, 2013, BIOL INVASIONS, V15, P417, DOI 10.1007/s10530-012-0297-7; Williamson M., 1996, BIOL INVASIONS	39	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97727	10.1371/journal.pone.0097727	http://dx.doi.org/10.1371/journal.pone.0097727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844226	Green Published, gold			2022-12-27	WOS:000339563400051
J	Jeong, J; Oh, Y; Chun, M; Kralik, JD				Jeong, Jaeseung; Oh, Youngmin; Chun, Miriam; Kralik, Jerald D.			Preference-Based Serial Decision Dynamics: Your First Sushi Reveals Your Eating Order at the Sushi Table	PLOS ONE			English	Article							BRAIN; END	In everyday life, we regularly choose among multiple items serially such as playing music in a playlist or determining priorities in a to-do list. However, our behavioral strategy to determine the order of choice is poorly understood. Here we defined 'the sushi problem' as how we serially choose multiple items of different degrees of preference when multiple sequences are possible, and no particular order is necessarily better than another, given that all items will eventually be chosen. In the current study, participants selected seven sushi pieces sequentially at the lunch table, and we examined the relationship between eating order and preference. We found two dominant selection strategies, with one group selecting in order from most to least preferred, and the other doing the opposite, which were significantly different from patterns generated from a random strategy. Interestingly, we found that more females tended to employ the favorite-first rather than favorite-last strategy. These two choice sequences appear to reflect two opposing behavioral strategies that might provide selective advantages in their own right, while also helping to provide solutions to otherwise unconstrained problems.	[Jeong, Jaeseung; Oh, Youngmin; Chun, Miriam] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kralik, Jerald D.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Korea Advanced Institute of Science & Technology (KAIST); Dartmouth College	Jeong, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	jsjeong@kaist.ac.kr	Jeong, Jaeseung/C-1620-2011		Korea Science and Engineering Foundation (KOSEF) grant from the Korea government (MOST) [R01-2007-000-21094-0, M10644000028-06N4400-02810]	Korea Science and Engineering Foundation (KOSEF) grant from the Korea government (MOST)(Korea Science and Engineering Foundation)	This study was funded by the Korea Science and Engineering Foundation (KOSEF) grant from the Korea government (MOST) (No. R01-2007-000-21094-0 and No. M10644000028-06N4400-02810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2009, ANNU REV PSYCHOL, V60, P475, DOI 10.1146/annurev.psych.60.110707.163536; Berns G., 2005, SATISFACTION SCI FIN; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; DM B, 2012, EVOLUTIONARY PSYCHOL; Do AM, 2008, PSYCHON B REV, V15, P96, DOI 10.3758/PBR.15.1.96; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Hayden BY, 2009, ANIM COGN, V12, P201, DOI 10.1007/s10071-008-0186-8; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Mazur JE, 2005, LEARNING BEHAV; Mischel W, 2011, SOC COGN AFFECT NEUR, V6, P252, DOI 10.1093/scan/nsq081; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; SIMON HA, 1959, AM ECON REV, V49, P253; Stanovich K. E., 2012, OXFORD HDB THINKING, P433, DOI [10.1093/oxfordhb/9780199734689.013.0022, DOI 10.1093/OXFORDHB/9780199734689.013.0022]; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Symmonds M, 2012, NEUROSCIENCE OF PREFERENCE AND CHOICE: COGNITIVE AND NEURAL MECHANISMS, P3, DOI 10.1016/B978-0-12-381431-9.00001-2	19	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96653	10.1371/journal.pone.0096653	http://dx.doi.org/10.1371/journal.pone.0096653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24846274	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400008
J	Lin, LZ; Deng, WG; Tian, Y; Chen, WB; Wang, JS; Fu, LY; Shi, DB; Zhao, MM; Luo, W				Lin, Lianzhu; Deng, Wuguo; Tian, Yun; Chen, Wangbing; Wang, Jingshu; Fu, Lingyi; Shi, Dingbo; Zhao, Mouming; Luo, Wei			Lasiodin Inhibits Proliferation of Human Nasopharyngeal Carcinoma Cells by Simultaneous Modulation of the Apaf-1/Caspase, AKT/MAPK and COX-2/NF-kappa B Signaling Pathways	PLOS ONE			English	Article							SERRA MAXIM. HARA; FACTOR-KAPPA-B; FIBROSARCOMA L929 CELLS; RABDOSIA-SERRA; ENT-KAURANE; CANCER CHEMOPREVENTION; ROSMARINIC ACID; CLINICAL-TRIAL; LEAF; DITERPENOIDS	Rabdosia serra has been widely used for the treatment of the various human diseases. However, the antiproliferative effects and underlying mechanisms of the compounds in this herb remain largely unknown. In this study, an antiproliferative compound against human nasopharyngeal carcinoma (NPC) cells from Rabdosia serra was purified and identified as lasiodin (a diterpenoid). The treatment with lasiodin inhibited cell viability and migration. Lasiodin also mediated the cell morphology change and induced apoptosis in NPC cells. The treatment with lasiodin induced the Apaf-1 expression, triggered the cytochrome-C release, and stimulated the PARP, caspase-3 and caspase-9 cleavages, thereby activating the apoptotic pathways. The treatment with lasiodin also significantly inhibited the phosphorylations of the AKT, ERK1/2, p38 and JNK proteins. The pretreatment with the AKT or MAPK-selective inhibitors considerably blocked the lasiodin-mediated inhibition of cell proliferation. Moreover, the treatment with lasiodin inhibited the COX-2 expression, abrogated NF-kappa B binding to the COX-2 promoter, and promoted the NF-kB translocation from cell nuclei to cytosol. The pretreatment with a COX-2-selective inhibitor abrogated the lasiodin-induced inhibition of cell proliferation. These results indicated that lasiodin simultaneously activated the Apaf-1/caspase-dependent apoptotic pathways and suppressed the AKT/MAPK and COX-2/NF-kappa B signaling pathways. This study also suggested that lasiodin could be a promising natural compound for the prevention and treatment of NPC.	[Lin, Lianzhu; Zhao, Mouming] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Deng, Wuguo; Tian, Yun; Chen, Wangbing; Wang, Jingshu; Fu, Lingyi; Shi, Dingbo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Mouming] S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China; [Luo, Wei] S China Univ Technol, Anal & Test Ctr, Guangzhou, Guangdong, Peoples R China	South China University of Technology; State Key Lab Oncology South China; Sun Yat Sen University; South China University of Technology; South China University of Technology	Deng, WG (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	dengwg@sysucc.org.cn			Science and Technology Planning Project of Guangdong Province in China [2009B011300004]; National Natural Science Foundation of China [31071638, 31101221/C200101]; Fundamental Research Funds for the Central Universities [2014ZB0010]	Science and Technology Planning Project of Guangdong Province in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study is supported by the grants from the Science and Technology Planning Project of Guangdong Province in China (No. 2009B011300004), the National Natural Science Foundation of China (No. 31071638), the National Natural Science Foundation of China (No. 31101221/C200101) and Fundamental Research Funds for the Central Universities (Project No. 2014ZB0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Bai NS, 2010, PLANTA MED, V76, P140, DOI 10.1055/s-0029-1186002; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Blanco AM, 2004, ALCOHOL CLIN EXP RES, V28, p23A, DOI 10.1097/00000374-200408002-00096; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Chen XA, 2000, CHINESE CHEM LETT, V11, P229; Cheng Y, 2009, AUTOPHAGY, V5, P430, DOI 10.4161/auto.5.3.7896; Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; FUJITA E, 1976, EXPERIENTIA, V32, P203, DOI 10.1007/BF01937766; He F, 2009, PHYTOCHEMISTRY, V70, P1462, DOI 10.1016/j.phytochem.2009.07.037; Huang J, 2007, CANCER RES, V67, P1589, DOI 10.1158/0008-5472.CAN-06-2472; Jin HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040355; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kauntz H, 2011, APOPTOSIS, V16, P1042, DOI 10.1007/s10495-011-0631-z; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kucuk O, 2004, J NUTR, V134, p1262S; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Lin LZ, 2013, FOOD CHEM, V139, P902, DOI 10.1016/j.foodchem.2013.01.001; Lin LZ, 2013, FOOD CHEM, V136, P555, DOI 10.1016/j.foodchem.2012.08.048; Lin LZ, 2012, FOOD CHEM, V135, P730, DOI 10.1016/j.foodchem.2012.05.029; Lin LZ, 2012, FOOD CHEM, V131, P1009, DOI 10.1016/j.foodchem.2011.09.105; Lin LZ, 2012, FOOD CHEM, V130, P417, DOI 10.1016/j.foodchem.2011.07.069; Lin LZ, 2011, FOOD CHEM, V129, P884, DOI 10.1016/j.foodchem.2011.05.039; Lin LZ, 2011, COMB CHEM HIGH T SCR, V14, P720, DOI 10.2174/138620711796504352; Lin LZ, 2011, FOOD CHEM, V126, P54, DOI 10.1016/j.foodchem.2010.10.060; Linden KG, 2003, CANCER EPIDEM BIOMAR, V12, p1280S; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Liu PW, 2010, CHROMATOGRAPHIA, V72, P265, DOI 10.1365/s10337-010-1642-6; Liu Y, 2012, BIOL PHARM BULL, V35, P1150, DOI 10.1248/bpb.b12-00197; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Prasad KN, 2010, FOOD CHEM, V118, P62, DOI 10.1016/j.foodchem.2009.04.073; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shu LM, 2010, CANCER METAST REV, V29, P483, DOI 10.1007/s10555-010-9239-y; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Xiao C, 2001, J CHEM RES-S, P148; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Zhang Y, 2005, INT IMMUNOPHARMACOL, V5, P1957, DOI 10.1016/j.intimp.2005.06.016; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	44	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97799	10.1371/journal.pone.0097799	http://dx.doi.org/10.1371/journal.pone.0097799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845412	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400061
J	Paz-Gomez, D; Villanueva-Chimal, E; Navarro, RE				Paz-Gomez, Daniel; Villanueva-Chimal, Emmanuel; Navarro, Rosa E.			The DEAD Box RNA Helicase VBH-1 Is a New Player in the Stress Response in C. elegans	PLOS ONE			English	Article							MATERNAL MESSENGER-RNAS; CAENORHABDITIS-ELEGANS; GERM-LINE; HEAT-SHOCK; LIFE-SPAN; SEX DETERMINATION; STEM-CELLS; PROTEIN; VASA; TRANSLATION	For several years, DEAD box RNA helicase Vasa (DDX4) has been used as a bona fide germline marker in different organisms. C. elegans VBH-1 is a close homolog of the Vasa protein, which plays an important role in gametogenesis, germ cell survival and embryonic development. Here, we show that VBH-1 protects nematodes from heat shock and oxidative stress. Using the germline-defective mutant glp-4(bn2) we found that a potential somatic expression of vbh-1 might be important for stress survival. We also show that the VBH-1 paralog LAF-1 is important for stress survival, although this protein is not redundant with its counterpart. Furthermore, we observed that the mRNAs of the heat shock proteins hsp-1 and sip-1 are downregulated when vbh-1 or laf-1 are silenced. Previously, we reported that in C. elegans, VBH-1 was primarily expressed in P granules of germ cells and in the cytoplasm of all blastomeres. Here we show that during stress, VBH-1 co-localizes with CGH-1 in large aggregates in the gonad core and oocytes; however, VBH-1 aggregates do not overlap with CGH-1 foci in early embryos under the same conditions. These data demonstrate that, in addition to the previously described role for this protein in the germline, VBH-1 plays an important role during the stress response in C. elegans through the potential direct or indirect regulation of stress response mRNAs.	[Paz-Gomez, Daniel; Villanueva-Chimal, Emmanuel; Navarro, Rosa E.] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Navarro, RE (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico.	rnavarro@ifc.unam.mx	Paz-Gomez, Daniel/N-6365-2018	Paz-Gomez, Daniel/0000-0001-5040-1468; Navarro, Rosa/0000-0003-4992-4450	LOREAL/UNESCO; PAPIIT-UNAM [IN225509, IN207412]; CONACYT-MEXICO [50896Q, 103856-Q]; CONACyT-Mexico; CONACyT [103856-Q]	LOREAL/UNESCO; PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACYT-MEXICO(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was supported by grants from LOREAL/UNESCO, PAPIIT-UNAM (IN225509 and IN207412) and CONACYT-MEXICO (50896Q and 103856-Q). This study was performed in partial fulfillment of the requirements for the Ph.D. degree in Biomedical Sciences of DP at the Universidad Nacional Autonoma de Mexico. DP received a Ph.D. fellowship from CONACyT-Mexico and a CONACyT/Grant fellowship (103856-Q) to complete his studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Arsenovic PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044038; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bezares-Calderon LA, 2010, DEV GENES EVOL, V220, P41, DOI 10.1007/s00427-010-0327-3; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; BRENNER S, 1974, GENETICS, V77, P71; Carrera P, 2000, MOL CELL, V5, P181, DOI 10.1016/S1097-2765(00)80414-1; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Clifford R, 2000, DEVELOPMENT, V127, P5265; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Conte Jr D, 2003, CURRENT PROTOCOLS MO; Ding L, 2000, BIOCHEM J, V351, P13, DOI 10.1042/0264-6021:3510013; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; Hashimoto H, 2008, GYNECOL ONCOL, V111, P312, DOI 10.1016/j.ygyno.2008.08.014; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hernandez G, 2004, RNA, V10, P1783, DOI 10.1261/rna.7154104; Hird SN, 1996, DEVELOPMENT, V122, P1303; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hubert A, 2009, DEV BIOL, V330, P358, DOI 10.1016/j.ydbio.2009.04.003; Ihry RJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003085; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Johnstone O, 2005, DEV BIOL, V277, P92, DOI 10.1016/j.ydbio.2004.09.009; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Jud M, 2007, DEV GENES EVOL, V217, P221, DOI 10.1007/s00427-006-0130-3; Jud MC, 2008, DEV BIOL, V318, P38, DOI 10.1016/j.ydbio.2008.02.059; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Li DR, 2012, BIOTECHNIQUES, V52, P173, DOI 10.2144/000113821; Li Y, 2006, CANCER RES, V66, P8520, DOI 10.1158/0008-5472.CAN-05-4364; Linder B, 1996, J BIOL CHEM, V271, P30158, DOI 10.1074/jbc.271.47.30158; Liu HY, 2002, J BIOL CHEM, V277, P2637, DOI 10.1074/jbc.M109016200; Liu NK, 2009, GENE DEV, V23, P2742, DOI 10.1101/gad.1820709; MADURO M, 1995, GENETICS, V141, P977; McGhee James D, 2007, WormBook, P1; Mendenhall AR, 2009, PHYSIOL GENOMICS, V36, P167, DOI 10.1152/physiolgenomics.90278.2008; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Noble SL, 2008, J CELL BIOL, V182, P559, DOI 10.1083/jcb.200802128; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pek JW, 2011, P NATL ACAD SCI USA, V108, P12007, DOI 10.1073/pnas.1106245108; Pek JW, 2011, CURR BIOL, V21, P39, DOI 10.1016/j.cub.2010.11.051; Praitis V, 2001, GENETICS, V157, P1217; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Rajyaguru P, 2009, TRENDS CELL BIOL, V19, P24, DOI 10.1016/j.tcb.2008.11.001; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; Salinas LS, 2007, GENESIS, V45, P533, DOI 10.1002/dvg.20323; Salinas LS, 2012, GENESIS, V50, P801, DOI 10.1002/dvg.22043; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; SCHEDL T, 1988, GENETICS, V119, P43; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; Stiernagle Theresa, 2006, WormBook, P1; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039; Yajima M, 2011, MOL REPROD DEV, V78, P861, DOI 10.1002/mrd.21363; Yajima M, 2011, DEVELOPMENT, V138, P2217, DOI 10.1242/dev.065052; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	77	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97924	10.1371/journal.pone.0097924	http://dx.doi.org/10.1371/journal.pone.0097924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844228	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400071
J	Blankley, S; Graham, CM; Howes, A; Bloom, CI; Berry, MPR; Chaussabel, D; Pascual, V; Banchereau, J; Lipman, M; O'Garra, A				Blankley, Simon; Graham, Christine M.; Howes, Ashleigh; Bloom, Chloe I.; Berry, Matthew P. R.; Chaussabel, Damien; Pascual, Virginia; Banchereau, Jacques; Lipman, Marc; O'Garra, Anne			Identification of the Key Differential Transcriptional Responses of Human Whole Blood Following TLR2 or TLR4 Ligation In-Vitro	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; SYSTEMS BIOLOGY; INNATE IMMUNITY; TNF-ALPHA; INFLAMMATORY RESPONSE; MONONUCLEAR-CELLS; GENE-EXPRESSION; LIPOPOLYSACCHARIDE	The use of human whole blood for transcriptomic analysis has potential advantages over the use of isolated immune cells for studying the transcriptional response to pathogens and their products. Whole blood stimulation can be carried out in a laboratory without the expertise or equipment to isolate immune cells from blood, with the added advantage of being able to undertake experiments using very small volumes of blood. Toll like receptors (TLRs) are a family of pattern recognition receptors which recognise highly conserved microbial products. Using the TLR2 ligand (Pam3CSK4) and the TLR4 ligand (LPS), human whole blood was stimulated for 0, 1, 3, 6, 12 or 24 hours at which times mRNA was isolated and a comparative microarray was undertaken. A common NF kappa B transcriptional programme was identified following both TLR2 and TLR4 ligation which peaked at between 3 to 6 hours including upregulation of many of the NFkB family members. In contrast an interferon transcriptional response was observed following TLR4 but not TLR2 ligation as early as 1 hour post stimulation and peaking at 6 hours. These results recapitulate the findings observed in previously published studies using isolated murine and human myeloid cells indicating that in vitro stimulated human whole blood can be used to interrogate the early transcriptional kinetic response of innate cells to TLR ligands. Our study demonstrates that a transcriptomic analysis of mRNA isolated from human whole blood can delineate both the temporal response and the key transcriptional differences following TLR2 and TLR4 ligation.	[Blankley, Simon; Graham, Christine M.; Howes, Ashleigh; Bloom, Chloe I.; Berry, Matthew P. R.; O'Garra, Anne] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England; [Berry, Matthew P. R.] Imperial Coll Healthcare NHS Trust, Dept Resp Med, London, England; [Chaussabel, Damien; Pascual, Virginia] INSERM, ANRS Ctr Human Vaccines, Baylor Inst Immunol Research, Dallas, TX USA; [Chaussabel, Damien] Benaroya Res Inst, Seattle, WA USA; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Lipman, Marc] UCL, Royal Free London NHS Fdn Trust, Dept Resp Med, London, England; [O'Garra, Anne] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Med, London, England	MRC National Institute for Medical Research; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Benaroya Research Institute; Jackson Laboratory; University of London; University College London; Royal Free London NHS Foundation Trust; Imperial College London	Blankley, S (corresponding author), Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England.	sblankl@nimr.mrc.ac.uk	Chaussabel, Damien/AAX-1909-2020; Bloom, Chloe/ABC-1693-2020; Pascual, Virginia/ABD-3099-2020	Bloom, Chloe/0000-0003-1285-7602; Graham, Christine/0000-0001-9329-6231; Lipman, Marc/0000-0001-7501-4448; O'Garra, Anne/0000-0001-9845-6134; Chaussabel, Damien/0000-0002-6131-7242; Blankley, Simon/0000-0001-9602-9075	Medical Research Council, United Kingdom [U117565642]; MRC Clinical Research Training Fellowship; MRC [MC_U117565642] Funding Source: UKRI; Medical Research Council [MC_U117565642] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SB and AOG are supported by the Medical Research Council, United Kingdom (U117565642). SB is supported by an MRC Clinical Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mageed AB, 1998, CANCER RES, V58, P2335; Aguillon JC, 2001, EUR CYTOKINE NETW, V12, P105; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chen JW, 2010, J IMMUNOL METHODS, V357, P33, DOI 10.1016/j.jim.2010.03.006; Chung TP, 2006, J AM COLL SURGEONS, V203, P585, DOI 10.1016/j.jamcollsurg.2006.06.028; de Kleijn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038255; DEGROOTE D, 1992, CYTOKINE, V4, P239, DOI 10.1016/1043-4666(92)90062-V; Elkon R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-394; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lee DK, 1999, BIOCHEM J, V337, P59, DOI 10.1042/0264-6021:3370059; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Mayringer I, 2000, J IMMUNOL METHODS, V235, P33, DOI 10.1016/S0022-1759(99)00208-2; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Netea MG, 1996, CYTOKINE, V8, P739, DOI 10.1006/cyto.1996.0098; Nguyen TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018889; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; WILSON BMG, 1991, J IMMUNOL METHODS, V139, P233, DOI 10.1016/0022-1759(91)90193-J; Wu C, 2013, P NATL ACAD SCI USA, V110, P7802, DOI 10.1073/pnas.1211776110; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x	34	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97702	10.1371/journal.pone.0097702	http://dx.doi.org/10.1371/journal.pone.0097702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842522	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600059
J	Bobashev, G; Norton, J; Wechsberg, W; Toussova, O				Bobashev, Georgiy; Norton, Jacob; Wechsberg, Wendee; Toussova, Olga			Are You HIV Invincible? A Probabilistic Study of Discordant Couples in the Context of HIV Transmission	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; VIRAL LOAD; INFECTIVITY; INFECTIOUSNESS	A number of factors have been identified that are related to sexual and injecting HIV transmission. We developed a probabilistic mathematical model to put these factors together and interpret risks in the context of individual behavior among injecting drug-using (IDU) couples in St. Petersburg, Russia. Some HIV-discordant couples have unprotected sex and sometimes inject drugs together but stay discordant for a long time, while some individuals acquire HIV on the first encounter. We considered existing estimates of HIV transmission risks through injecting and sexual contacts to develop a predictive survival model for an individual who is exposed to HIV through intimate relationships. We computed simulated survival curves for a number of behavioral scenarios and discussed sources of simulated uncertainty. We then applied the model to a longitudinal study of HIV-discordant couples and validated the model's forecast. Although individual prediction of seroconversion time appeared impossible, the ability to rank behavioral patterns in terms of HIV risk and to estimate the probability of survival HIV-free will be important to educators and counselors.	[Bobashev, Georgiy; Wechsberg, Wendee] RTI Int, Durham, NC 27703 USA; [Norton, Jacob] N Carolina State Univ, Raleigh, NC 27695 USA; [Toussova, Olga] Pavlov Med Univ, St Petersburg, Russia	Research Triangle Institute; University of North Carolina; North Carolina State University; Pavlov First Saint Petersburg State Medical University	Bobashev, G (corresponding author), RTI Int, Durham, NC 27703 USA.	bobashev@rti.org	Toussova, Olga/AAE-5470-2022	Toussova, Olga/0000-0002-2657-9634; Wechsberg, Wendee/0000-0002-5146-6463	University of North Carolina Social and Behavioral Science Research Core (UNC CFAR) [P30 AI50410]; NIH/NIDA [1R01DA025163-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025163] Funding Source: NIH RePORTER	University of North Carolina Social and Behavioral Science Research Core (UNC CFAR); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The pilot study in St. Petersburg was funded by the University of North Carolina Social and Behavioral Science Research Core (UNC CFAR) P30 AI50410. The current study was funded in part by NIH/NIDA grant 1R01DA025163-01. No additional internal or external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, BMJ, V304, P809; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE S, V17; CHIN J, 1992, SCIENCE CHALLENGING AIDS, P33; Hudgens MG, 2001, J ROY STAT SOC C-APP, V50, P1, DOI 10.1111/1467-9876.00216; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Weller SC, 2011, CONDOM EFFECTIVENESS; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Zule WA, 2013, INT J DRUG POLICY, V24, P1, DOI 10.1016/j.drugpo.2012.07.002	15	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e94799	10.1371/journal.pone.0094799	http://dx.doi.org/10.1371/journal.pone.0094799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839972	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600004
J	Bochem, AE; Holleboom, AG; Romijn, JA; Hoekstra, M; Dallinga, GM; Motazacker, MM; Hovingh, GK; Kuivenhoven, JA; Stroes, ESG				Bochem, Andrea E.; Holleboom, Adriaan G.; Romijn, Johannes A.; Hoekstra, Menno; Dallinga, Geesje M.; Motazacker, Mahdi M.; Hovingh, G. Kees; Kuivenhoven, Jan A.; Stroes, Erik S. G.			Adrenal Function in Females with Low Plasma HDL-C Due to Mutations in ABCA1 and LCAT	PLOS ONE			English	Article							CHOLESTERYL ESTER UPTAKE; HIGH-DENSITY-LIPOPROTEIN; ADRENOCORTICOTROPIN STIMULATION; FAMILIAL HYPERCHOLESTEROLEMIA; CORTISOL RESPONSE; SR-BI; STEROIDOGENESIS; INTERLEUKIN-6; RECEPTOR; HORMONE	Introduction: Adrenal steroidogenesis is essential for human survival and depends on the availability of the precursor cholesterol. Male subjects with low plasma levels of high density lipoprotein (HDL) cholesterol are characterized by decreased adrenal function. Whether this is also the case in female subjects with low plasma HDL-C levels is unresolved to date. Findings: 15 female ATP binding cassette transporter AI (ABCAI) and 14 female lecithin-cholesterol acyltransferase (LCAT) were included in the study. HDL-C levels were 38% and 41% lower in ABCA1 and LCAT mutation carriers compared to controls, respectively. Urinary steroid excretion of 17-ketogenic steroids or 17-hydroxy corticosteroids did not differ between 15 female ABCA1 mutation carriers (p = 0.27 vs 0.30 respectively) and 30 matched normolipidemic controls or between 14 female LCAT mutation carriers and 28 matched normolipidemic controls (p = 0.10 and 0.14, respectively). Cosyntropin testing in an unselected subgroup of 8 ABCA1 mutation carriers and 3 LCAT mutation carriers did not reveal differences between carriers and controls. Conclusion: Adrenal function in females with molecularly defined low HDL-C levels is not different from controls. The discrepancy with the finding of impaired steroidogenesis in males with molecularly defined low HDL-C levels underscores the importance of gender specific analyses in cholesterol-related research.	[Bochem, Andrea E.; Holleboom, Adriaan G.; Dallinga, Geesje M.; Hovingh, G. Kees; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Romijn, Johannes A.] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands; [Hoekstra, Menno] Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands; [Dallinga, Geesje M.; Motazacker, Mahdi M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kuivenhoven, Jan A.] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, NL-9700 AB Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Bochem, AE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.e.bochem@amc.nl		Hoekstra, Menno/0000-0001-7463-2893; Holleboom, A.G. (Onno)/0000-0002-2911-2917	Dutch Heart Foundation [2009B027, 2008B070, 2008T070]; Fondation LeDucq; Veni Grants from the Netherlands Organisation for Scientific Research (NWO) [91612122, 91613031]	Dutch Heart Foundation(Netherlands Heart Foundation); Fondation LeDucq(Leducq Foundation); Veni Grants from the Netherlands Organisation for Scientific Research (NWO)	This study was supported by three grants from the Dutch Heart Foundation (numbers 2009B027, 2008B070 and 2008T070). A. E. B. and M. M. M. are supported by a grant from Fondation LeDucq. G. K. H. and A. G. H. are supported by Veni Grants (project numbers 91612122 and 91613031, respectively) from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar S, 2003, FRONT BIOSCI-LANDMRK, V8, pS998, DOI 10.2741/1165; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; AZHAR S, 1989, J LIPID RES, V30, P1799; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; Bochem AE, 2013, J LIPID RES, V54, P1698, DOI 10.1194/jlr.P033449; BORKOWSKI A, 1972, J CLIN INVEST, V51, P1664, DOI 10.1172/JCI106968; BORKOWSKI AJ, 1967, J CLIN INVEST, V46, P797, DOI 10.1172/JCI105580; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; Candini C, 2010, ATHEROSCLEROSIS, V213, P492, DOI 10.1016/j.atherosclerosis.2010.08.062; Clark PM, 1998, CLIN ENDOCRINOL, V49, P287; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Doi SAR, 2006, CLIN CHEM, V52, P746, DOI 10.1373/clinchem.2005.061267; Duivenvoorden R, 2011, J AM COLL CARDIOL, V58, P2481, DOI 10.1016/j.jacc.2010.11.092; Fraser R, 1999, HYPERTENSION, V33, P1364, DOI 10.1161/01.HYP.33.6.1364; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Hoekstra M, 2009, J LIPID RES, V50, P1039, DOI 10.1194/jlr.M800410-JLR200; Holleboom AG, 2010, J LIPID RES, V51, P416, DOI 10.1194/P900038-JLR200; Holleboom AG, 2011, HUM MUTAT, V10; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; ILLINGWORTH DR, 1984, J CLIN ENDOCR METAB, V58, P206, DOI 10.1210/jcem-58-1-206; ILLINGWORTH DR, 1983, METABOLISM, V32, P1045, DOI 10.1016/0026-0495(83)90075-6; ILLINGWORTH DR, 1982, J LAB CLIN MED, V100, P115; ILLINGWORTH DR, 1982, J CLIN ENDOCR METAB, V54, P27, DOI 10.1210/jcem-54-1-27; ILLINGWORTH DR, 1980, J CLIN ENDOCR METAB, V50, P977, DOI 10.1210/jcem-50-5-977; Marik PE, 2005, CRIT CARE MED, V33, P1254, DOI 10.1097/01.CCM.0000164541.12106.57; O'Connor MF, 2007, AM J PHYSIOL-REG I, V293, pR145, DOI 10.1152/ajpregu.00752.2006; Papadopoulos AD, 2000, NEUROIMMUNOMODULAT, V8, P39, DOI 10.1159/000026451; Path G, 1997, J CLIN ENDOCR METAB, V82, P2343, DOI 10.1210/jc.82.7.2343; Puder JJ, 2001, J CLIN ENDOCR METAB, V86, P2403, DOI 10.1210/jc.86.6.2403; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Silva C, 2002, ANN NY ACAD SCI, V966, P68, DOI 10.1111/j.1749-6632.2002.tb04203.x; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; van der Voort PHJ, 2003, INTENS CARE MED, V29, P2199, DOI 10.1007/s00134-003-2021-7; VANDECALSEYDE JF, 1972, CLIN CHIM ACTA, V38, P103, DOI 10.1016/0009-8981(72)90214-8; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; WEYKAMP CW, 1989, CLIN CHEM, V35, P2281; Yaguchi H, 1998, LIFE SCI, V62, P1387, DOI 10.1016/S0024-3205(98)00077-0	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e90967	10.1371/journal.pone.0090967	http://dx.doi.org/10.1371/journal.pone.0090967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842300	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600001
J	Huang, TC; Wang, YC; Chiou, YR; Kao, CH				Huang, Tzung-Chi; Wang, Yao-Ching; Chiou, Yu-Rou; Kao, Chia-Hung			Respiratory Motion Reduction in PET/CT Using Abdominal Compression for Lung Cancer Patients	PLOS ONE			English	Article							ATTENUATION CORRECTION; RADIATION-THERAPY; TUMOR MOTION; CT; IMAGES; THORAX; IMPACT; DELINEATION	Purpose: Respiratory motion causes substantial artifacts in reconstructed PET images when using helical CT as the attenuation map in PET/CT imaging. In this study, we aimed to reduce the respiratory artifacts in PET/CT images of patients with lung tumors using an abdominal compression device. Methods: Twelve patients with lung cancer located in the middle or lower lobe of the lung were recruited. The patients were injected with 370 MBq of F-18-FDG. During PET, the patients assumed two bed positions for 1.5 min/bed. After conducting free-breathing imaging, we obtained images of the patients with abdominal compression by applying the same setup used in the free-breathing scan. The differences in the standardized uptake value (SUV)(max), SUVmean, tumor volume, and the centroid of the tumors between PET and various CT schemes were measured. Results: The SUVmax and SUVmean derived from PET/CT imaging using an abdominal compression device increased for all the lesions, compared with those obtained using the conventional approach. The percentage increases were 18.1% +/- 14% and 17% +/- 16.8% for SUVmax and SUVmean, respectively. PET/CT imaging combined with abdominal compression generally reduced the tumor mismatch between CT and the corresponding attenuation corrected PET images, with an average decrease of 1.9 +/- 1.7 mm over all the cases. Conclusions: PET/CT imaging combined with abdominal compression reduces respiratory artifacts and PET/CT misregistration, and enhances quantitative SUV in tumor. Abdominal compression is easy to set up and is an effective method used in PET/CT imaging for clinical oncology, especially in the thoracic region.	[Huang, Tzung-Chi; Chiou, Yu-Rou] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Huang, Tzung-Chi] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wang, Yao-Ching] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		National Science Council of Taiwan [NSC 102-2221-E-039-010-MY3]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was financially supported by National Science Council of Taiwan (NSC 102-2221-E-039-010-MY3) and by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristophanous M, 2010, INT J RADIAT ONCOL, V82, pe99; Bissonnette JP, 2009, INT J RADIAT ONCOL, V75, P688, DOI 10.1016/j.ijrobp.2008.11.066; Boucher L, 2004, J NUCL MED, V45, P214; Bouilhol G, 2013, PHYS MEDICA, V29, P333, DOI 10.1016/j.ejmp.2012.04.006; Bradley J, 2004, INT J RADIAT ONCOL, V59, P78, DOI 10.1016/j.ijrobp.2003.10.044; Callahan J, 2011, AUSTRALAS PHYS ENG S, V34, P489, DOI 10.1007/s13246-011-0109-x; Cervino LI, 2009, PHYS MED BIOL, V54, P3529, DOI 10.1088/0031-9155/54/11/017; Erdi YE, 2004, J NUCL MED, V45, P1287; Guerrero T, 2004, PHYS MED BIOL, V49, P4147, DOI 10.1088/0031-9155/49/17/022; Hamill JJ, 2008, MED PHYS, V35, P576, DOI 10.1118/1.2829875; Heinzerling JH, 2008, INT J RADIAT ONCOL, V70, P1571, DOI 10.1016/j.ijrobp.2007.12.023; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058886; Huang TC, 2011, PHYS MED BIOL, V56, P2559, DOI 10.1088/0031-9155/56/8/014; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Liu C, 2009, PHYS MED BIOL, V54, P7345, DOI 10.1088/0031-9155/54/24/007; Mok GSP, 2013, IEEE T BIO-MED ENG, V60, P1927, DOI 10.1109/TBME.2013.2245132; Nagamachi S, 2010, ANN NUCL MED, V24, P171, DOI 10.1007/s12149-010-0352-3; Nehmeh SA, 2004, MED PHYS, V31, P3179, DOI 10.1118/1.1809778; Nehmeh SA, 2002, J NUCL MED, V43, P876; Nehmeh SA, 2007, J NUCL MED, V48, P22; Pan TS, 2005, J NUCL MED, V46, P1481; Sun T, 2013, MED PHYS, V40, DOI 10.1118/1.4820976; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064665	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98033	10.1371/journal.pone.0098033	http://dx.doi.org/10.1371/journal.pone.0098033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837352	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800100
J	Ueno, N; Hasebe, T; Kaneko, A; Yamamoto, M; Fujiya, M; Kohgo, Y; Kono, T; Wang, CZ; Yuan, CS; Bissonnette, M; Chang, EB; Musch, MW				Ueno, Nobuhiro; Hasebe, Takumu; Kaneko, Atsushi; Yamamoto, Masahiro; Fujiya, Mikihiro; Kohgo, Yutaka; Kono, Toru; Wang, Chong-Zhi; Yuan, Chun-Su; Bissonnette, Marc; Chang, Eugene B.; Musch, Mark W.			TU-100 (Daikenchuto) and Ginger Ameliorate Anti-CD3 Antibody Induced T Cell-Mediated Murine Enteritis: Microbe-Independent Effects Involving Akt and NF-kappa B Suppression	PLOS ONE			English	Article							TRADITIONAL JAPANESE MEDICINE; TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODY; BETA-GLUCOSIDASE; HERBAL MEDICINE; COLONIC TRANSIT; COMPOUND K; ACTIVATION; EXPRESSION; 6-SHOGAOL	The Japanese traditional medicine daikenchuto (TU-100) has anti-inflammatory activities, but the mechanisms remain incompletely understood. TU-100 includes ginger, ginseng, and Japanese pepper, each component possessing bioactive properties. The effects of TU-100 and individual components were investigated in a model of intestinal T lymphocyte activation using anti-CD3 antibody. To determine contribution of intestinal bacteria, specific pathogen free (SPF) and germ free (GF) mice were used. TU-100 or its components were delivered by diet or by gavage. Anti-CD3 antibody increased jejunal accumulation of fluid, increased TNF alpha, and induced intestinal epithelial apoptosis in both SPF and GF mice, which was blocked by either TU-100 or ginger, but not by ginseng or Japanese pepper. TU-100 and ginger also blocked anti-CD3-stimulated Akt and NF-kappa B activation. A co-culture system of colonic Caco2BBE and Jurkat-1 cells was used to examine Tlymphocyte/epithelial cells interactions. Jurkat-1 cells were stimulated with anti-CD3 to produce TNF alpha that activates epithelial cell NF-kappa B. TU-100 and ginger blocked anti-CD3 antibody activation of Akt in Jurkat cells, decreasing their TNF alpha production. Additionally, TU-100 and ginger alone blocked direct TNF alpha stimulation of Caco2BBE cells and decreased activation of caspase-3 and polyADP ribose. The present studies demonstrate a new anti-inflammatory action of TU-100 that is microbe-independent and due to its ginger component.	[Ueno, Nobuhiro; Hasebe, Takumu; Bissonnette, Marc; Chang, Eugene B.; Musch, Mark W.] Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA; [Ueno, Nobuhiro; Hasebe, Takumu; Fujiya, Mikihiro; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan; [Kaneko, Atsushi; Yamamoto, Masahiro] Tsumura & Co, Tsumura Res Labs, Ami, Ibaraki, Japan; [Kono, Toru] Sapporo Higashi Tokushukai Hosp, Ctr Clin & Biomed Res, Sapporo, Hokkaido, Japan; [Kono, Toru] Asahikawa Med Univ, Div Gastroenterol & Gen Surg, Dept Surg, Asahikawa, Hokkaido, Japan; [Wang, Chong-Zhi; Yuan, Chun-Su] Univ Chicago, Dept Anesthesia & Crit Care, Tang Ctr Herbal Med Res, Chicago, IL 60637 USA	University of Chicago; Asahikawa Medical College; Tsumura & Company; Asahikawa Medical College; University of Chicago	Musch, MW (corresponding author), Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mmusch@medicine.bsd.uchicago.edu	Wang, Chong-Zhi/B-8337-2014; Kohgo, Yutaka/AAN-4863-2020	Wang, Chong-Zhi/0000-0002-0950-2109; Hasebe, Takumu/0000-0002-4333-4428	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30 DK42086, DK47722, DK097268, NCCAM AT004418, AT005362]; National Institutes of Health [CA036745]; Samuel Freedman Research Laboratories for Gastrointestinal Cancer Research; University of Chicago Comprehensive Cancer Center; Tsumura Corporation; NATIONAL CANCER INSTITUTE [R01CA036745, R37CA036745, R01CA164124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418, K01AT005362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047722, P30DK042086, R37DK047722, R01DK097268] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Freedman Research Laboratories for Gastrointestinal Cancer Research; University of Chicago Comprehensive Cancer Center; Tsumura Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): P30 DK42086 (EBC), DK47722 (EBC), DK097268 (EBC), NCCAM AT004418 (CSY) and AT005362 (CSY); the National Institutes of Health: CA036745 (MB); the Samuel Freedman Research Laboratories for Gastrointestinal Cancer Research; and the University of Chicago Comprehensive Cancer Center. The funders had no role in study design, data collection, data analysis, or decision to publish. This work was also supported by grants from the Tsumura Corporation. This funder provided support in the form of salaries for authors AK and MY but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Calixto JB, 2005, PHARMACOL THERAPEUT, V106, P179, DOI 10.1016/j.pharmthera.2004.11.008; CHARPENTIER B, 1992, TRANSPLANTATION, V54, P997, DOI 10.1097/00007890-199212000-00011; Chikakiyo M, 2012, SURG TODAY, V42, P60, DOI 10.1007/s00595-011-0014-7; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Dougherty U, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-111; Dugasani S, 2010, J ETHNOPHARMACOL, V127, P515, DOI 10.1016/j.jep.2009.10.004; Endo M, 2014, J GASTROENTEROL, V49, P1026, DOI 10.1007/s00535-013-0854-6; Horiuchi A, 2010, GASTROENTEROL RES, V3, P151, DOI 10.4021/gr219w; Huang HC, 2011, BIOSCI BIOTECH BIOCH, V75, P1067, DOI 10.1271/bbb.100851; Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e; Iturrino J, 2013, ALIMENT PHARM THER, V37, P776, DOI 10.1111/apt.12264; Iwabu J, 2010, DRUG METAB DISPOS, V38, P2040, DOI 10.1124/dmd.110.033589; Iwasa T, 2012, DIGEST DIS SCI, V57, P2571, DOI 10.1007/s10620-012-2218-0; Jin XL, 2001, DIGEST DIS SCI, V46, P1171, DOI 10.1023/A:1010690624187; Jin Y, 2008, CARCINOGENESIS, V29, P2351, DOI 10.1093/carcin/bgn211; Kaneko A, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/384057; Kim MK, 2005, J MICROBIOL, V43, P456; Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446; Kono T, 2008, J SURG RES, V150, P78, DOI 10.1016/j.jss.2008.02.057; Kono T, 2013, AM J PHYSIOL-GASTR L, V304, pG428, DOI 10.1152/ajpgi.00356.2012; Kono T, 2011, J GASTROENTEROL, V46, P1187, DOI 10.1007/s00535-011-0438-2; Kono T, 2010, J CROHNS COLITIS, V4, P161, DOI 10.1016/j.crohns.2009.09.006; Kono T, 2009, SURGERY, V146, P837, DOI 10.1016/j.surg.2009.06.012; Li XH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/146142; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Masuda Y, 2004, BIOFACTORS, V21, P293, DOI 10.1002/biof.552210157; Miura N, 2005, INT IMMUNOL, V17, P513, DOI 10.1093/intimm/dxh231; Munekage M, 2011, DRUG METAB DISPOS, V39, P1784, DOI 10.1124/dmd.111.040097; Murata P, 2002, LIFE SCI, V70, P2061, DOI 10.1016/S0024-3205(01)01552-1; Musch MW, 2002, J CLIN INVEST, V110, P1739, DOI 10.1172/JCI200215695; Pan MH, 2008, MOL NUTR FOOD RES, V52, P1467, DOI 10.1002/mnfr.200700515; PETERSON MD, 1992, J CELL SCI, V102, P581; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; Radojevic N, 1999, AM J PHYSIOL-REG I, V276, pR715, DOI 10.1152/ajpregu.1999.276.3.R715; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Tang YM, 2010, AM J PATHOL, V176, P158, DOI 10.2353/ajpath.2010.090548; Wang CC, 2003, IN VIVO, V17, P641; Wang CZ, 2012, INT J ONCOL, DOI [10.3892/ijo.2012.1399, DOI 10.3892/IJ0.2012.1399]; Wang L, 2011, J BIOTECHNOL, V156, P125, DOI 10.1016/j.jbiotec.2011.07.024; Wang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028232; Weng CJ, 2012, MOL NUTR FOOD RES, V56, P1304, DOI 10.1002/mnfr.201200173; Wu H, 2010, MOL NUTR FOOD RES, V54, P1296, DOI 10.1002/mnfr.200900409; Yasanoya H, 2011, EVIDENCE BASED COMP, DOI org/10.1155/2011/264286.; Zhang ZY, 2013, INT J MOL SCI, V14, P2980, DOI 10.3390/ijms14022980	46	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97456	10.1371/journal.pone.0097456	http://dx.doi.org/10.1371/journal.pone.0097456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857966	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400017
J	Fennessy, D; Grallert, A; Krapp, A; Cokoja, A; Bridge, AJ; Petersen, J; Patel, A; Tallada, VA; Boke, E; Hodgson, B; Simanis, V; Hagan, IM				Fennessy, Dorota; Grallert, Agnes; Krapp, Andrea; Cokoja, Adisa; Bridge, Alan J.; Petersen, Janni; Patel, Avinash; Tallada, Victor A.; Boke, Elvan; Hodgson, Ben; Simanis, Viesturs; Hagan, Iain M.			Extending the Schizosaccharomyces pombe Molecular Genetic Toolbox	PLOS ONE			English	Article							FISSION YEAST; MARKER CASSETTES; SEPTUM FORMATION; PROTEIN-KINASE; INTEGRATIVE TRANSFORMATION; HETEROLOGOUS MODULES; MITOTIC COMMITMENT; SELECTION MARKER; POLO KINASE; EFFICIENT	Targeted alteration of the genome lies at the heart of the exploitation of S. pombe as a model system. The rate of analysis is often determined by the efficiency with which a target locus can be manipulated. For most loci this is not a problem, however for some loci, such as fin1(+), rates of gene targeting below 5% can limit the scope and scale of manipulations that are feasible within a reasonable time frame. We now describe a simple modification of transformation procedure for directing integration of genomic sequences that leads to a 5-fold increase in the transformation efficiency when antibiotic based dominant selection markers are used. We also show that removal of the pku70(+) and pku80(+) genes, which encode DNA end binding proteins required for the non-homologous end joining DNA repair pathway, increases the efficiency of gene targeting at fin1(+) to around 75-80% (a 16-fold increase). We describe how a natMX6/rpl42(+) cassette can be used for positive and negative selection for integration at a targeted locus. To facilitate the evaluation of the impact of a series of mutations on the function of a gene of interest we have generated three vector series that rely upon different selectable markers to direct the expression of tagged/untagged molecules from distinct genomic integration sites. pINTL and pINTK vectors use ura4(+) selection to direct disruptive integration of leu1(+) and lys1(+) respectively, while pINTH vectors exploit nourseothricin resistance to detect the targeted disruption of a hygromycin B resistance conferring hphMX6 cassette that has been integrated on chromosome III. Finally, we have generated a series of multi-copy expression vectors that use resistance to nourseothricin or kanamycin/G418 to select for propagation in prototrophic hosts. Collectively these protocol modifications and vectors extend the versatility of this key model system.	[Fennessy, Dorota; Grallert, Agnes; Bridge, Alan J.; Petersen, Janni; Patel, Avinash; Tallada, Victor A.; Boke, Elvan; Hodgson, Ben; Hagan, Iain M.] Univ Manchester, Cell Div Grp, Canc Res UK Manchester Inst, Manchester, Lancs, England; [Krapp, Andrea; Cokoja, Adisa; Simanis, Viesturs] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland	Cancer Research UK; University of Manchester; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Simanis, V (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland.	viesturs.simanis@epfl.ch; Iain.Hagan@cruk.manchester.ac.uk	Tallada, Victor/F-5454-2016; Boke, Elvan/O-6725-2017; Bridge, Alan/U-4209-2018	Tallada, Victor/0000-0001-9526-5957; Hagan, Iain/0000-0002-5858-9415; Petersen, Janni/0000-0003-0729-9335; Bridge, Alan/0000-0003-2148-9135; Grallert, Agnes/0000-0002-0127-3495	Swiss National Science Foundation; Ecole polytechnique federale de Lausanne; Cancer Research UK [CRUK] [C147/A6058]; Cancer Research UK [11178, 16406] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole polytechnique federale de Lausanne; Cancer Research UK [CRUK](Cancer Research UK); Cancer Research UK(Cancer Research UK)	Swiss National Science Foundation (www.snf.ch). Ecole polytechnique federale de Lausanne (www.epfl.ch). Cancer Research UK [CRUK] C147/A6058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BARBET N, 1992, GENE, V114, P59, DOI 10.1016/0378-1119(92)90707-V; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BEACH D, 1981, NATURE, V290, P140, DOI 10.1038/290140a0; Bitton DA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.90; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brachmann CB, 1998, YEAST, V14, P115; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; BURLAND TG, 1991, GENE, V100, P241, DOI 10.1016/0378-1119(91)90374-K; CARR AM, 1989, MOL GEN GENET, V218, P41, DOI 10.1007/BF00330563; Chino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009652; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; Drummond DR, 1998, J CELL SCI, V111, P853; EGEL R, 1971, PLANTA, V98, P89, DOI 10.1007/BF00387025; EGEL R, 1994, YEAST, V10, P1347, DOI 10.1002/yea.320101012; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Erler A, 2006, YEAST, V23, P813, DOI 10.1002/yea.1396; FANKHAUSER C, 1994, EMBO J, V13, P3011, DOI 10.1002/j.1460-2075.1994.tb06600.x; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Fujita Y, 2005, YEAST, V22, P193, DOI 10.1002/yea.1201; Germino M, 2006, YEAST, V23, P763, DOI 10.1002/yea.1388; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Grallert A, 2006, GENE DEV, V20, P2421, DOI 10.1101/gad.381306; Grallert A, 2013, CURR BIOL, V23, P213, DOI 10.1016/j.cub.2012.12.039; Grallert A, 2013, NAT CELL BIOL, V15, P88, DOI 10.1038/ncb2633; Grallert A, 2012, NAT CELL BIOL, V14, P738, DOI 10.1038/ncb2514; GRALLERT B, 1993, MOL GEN GENET, V238, P26, DOI 10.1007/BF00279526; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; GRIMM C, 1988, MOL GEN GENET, V215, P87, DOI 10.1007/BF00331308; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hartmuth S, 2009, J CELL SCI, V122, P1737, DOI 10.1242/jcs.049387; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; HOFER F, 1979, CURR GENET, V1, P45, DOI 10.1007/BF00413306; Hoffman RL, 2006, CURR GENET, V49, P414, DOI 10.1007/s00294-006-0065-2; HOTTINGER H, 1982, MOL GEN GENET, V188, P219, DOI 10.1007/BF00332678; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KEENEY JB, 1994, GENETICS, V136, P849; Kelly DA, 2002, BIOTECHNIQUES, V33, P978, DOI 10.2144/02335bm02; Kibe T, 2003, NUCLEIC ACIDS RES, V31, P5054, DOI 10.1093/nar/gkg718; KIKUCHI Y, 1988, CURR GENET, V14, P375, DOI 10.1007/BF00419995; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Krapp A, 2006, J CELL SCI, V119, P2882, DOI 10.1242/jcs.03025; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; Li ZJ, 2010, APPL MICROBIOL BIOT, V87, P2001, DOI 10.1007/s00253-010-2676-2; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loprieno N, 1974, HDB GENETICS, P395; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Miyoshi T, 2003, J BIOL CHEM, V278, P1924, DOI 10.1074/jbc.M208813200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murone M, 1996, EMBO J, V15, P6605, DOI 10.1002/j.1460-2075.1996.tb01051.x; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Petersen J, 2003, CURR BIOL, V13, P590, DOI 10.1016/S0960-9822(03)00205-7; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; REAUME SE, 1949, ARCH BIOCHEM, V22, P331; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schmidt S, 1997, GENE DEV, V11, P1519, DOI 10.1101/gad.11.12.1519; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Snaith HA, 2010, METHOD CELL BIOL, V97, P147, DOI 10.1016/S0091-679X(10)97009-X; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Tay YD, 2013, J CELL SCI, V126, P5052, DOI 10.1242/jcs.135301; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WADDELL S, 1995, NUCLEIC ACIDS RES, V23, P1836, DOI 10.1093/nar/23.10.1836; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002	83	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97683	10.1371/journal.pone.0097683	http://dx.doi.org/10.1371/journal.pone.0097683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848109	Green Published, gold			2022-12-27	WOS:000336730600049
J	Grasso, E; Paparini, D; Hauk, V; Salamone, G; Leiros, CP; Ramhorst, R				Grasso, Esteban; Paparini, Daniel; Hauk, Vanesa; Salamone, Gabriela; Perez Leiros, Claudia; Ramhorst, Rosanna			Differential Migration and Activation Profile of Monocytes after Trophoblast Interaction	PLOS ONE			English	Article							REGULATORY T-CELLS; TOLL-LIKE RECEPTORS; MATERNAL-FETAL INTERFACE; RECURRENT PREGNANCY LOSS; DENDRITIC CELLS; IMMUNE-SYSTEM; MACROPHAGES; INFLAMMATION; EXPRESSION; TOLERANCE	Macrophages at the maternal-placental interface coordinate opposite demands under the control of trophoblast cells such as the response against pathogens on one hand, and apoptotic cell clearance and wound healing with the production of suppressor cytokines. Here, we investigated whether trophoblast cells induce maternal monocyte activation towards an alternative activated macrophage profile and whether bacterial or viral stimuli modulate their migratory properties. We used an in vitro model of the maternal-placental interface represented by co-cultures of CD14+ cells isolated from fertile women with first trimester trophoblast cell line (Swan-71 cells) in the presence or absence of pathogen associated molecular pattern (PAMP) stimuli lipopolysaccharide (LPS), peptidoglycan (PGN) or poly [I: C]). Maternal CD14+ cells showed increased CD16 and CD39 expression, both markers associated to an alternative activation profile, with no changes in CD80 expression after trophoblast cell interaction. These changes were accompanied by increased IL-10 and decreased IL-12 production by CD14+ cells. After stimulation with LPS, PGN or poly [I: C], monocytes co-cultured with trophoblast cells had lower production of TNF-alpha and IL-1 beta compared with non co-cultured monocytes. Interestingly, monocyte migration towards trophoblast cells was prevented in the presence of LPS or PGN but not after 24h of stimulation with poly [I: C]. LPS or PGN also decreased CCR5, CXCL-8 and CCL5 expression. Finally, trophoblast cells co-cultured with monocytes in the presence of pathological stimuli failed to increase chemokine expression, indicating a bidirectional effect. In conclusion, trophoblast might 'instruct' maternal monocytes to express an alternative activation profile and restrain their early recruitment under pathological threats as one of the first strategies to avoid potential tissue damage at the maternal-placental interface.	[Grasso, Esteban; Paparini, Daniel; Hauk, Vanesa; Perez Leiros, Claudia; Ramhorst, Rosanna] Univ Buenos Aires, Sch Sci, Immunopharmacol Lab, Buenos Aires, DF, Argentina; [Grasso, Esteban; Paparini, Daniel; Hauk, Vanesa; Perez Leiros, Claudia; Ramhorst, Rosanna] Univ Buenos Aires, CONICET Natl Res Council, IQUIBICEN, Buenos Aires, DF, Argentina; [Salamone, Gabriela] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Dept Immunol, Buenos Aires, DF, Argentina; [Salamone, Gabriela] Acad Nacl Med Buenos Aires, Inst Estudios Oncol Fdn Maissa, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Buenos Aires National Academy of Medicine	Ramhorst, R (corresponding author), Univ Buenos Aires, Sch Sci, Immunopharmacol Lab, Buenos Aires, DF, Argentina.	rramhorst@qb.fcen.uba.ar		Paparini, Daniel Esteban/0000-0002-3335-4564	CONICET [PIP 2659]; University of Buenos Aires (UBAcyt); ANPCyT [Pto. BID-PICT 2011-0144]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBAcyt)(University of Buenos Aires); ANPCyT(ANPCyT)	This study was supported by grants to CPL and RR from: CONICET (PIP 2659), University of Buenos Aires (UBAcyt 2011-2014 and 2012-2015) and from ANPCyT (Pto. BID-PICT 2011-0144, 2012-2015). We thank Dr. Gil Mor who kindly gave us the Swan-71 cell line. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Baek KH, 2007, TRENDS MOL MED, V13, P310, DOI 10.1016/j.molmed.2007.05.005; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Caballero-Campo P, 2002, MOL HUM REPROD, V8, P375, DOI 10.1093/molehr/8.4.375; Cohen HB, 2013, BLOOD, V122, P1935, DOI 10.1182/blood-2013-04-496216; Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x; Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x; Fraccaroli Laura, 2009, Front Biosci (Elite Ed), V1, P288; Fraccaroli L, 2009, HUM REPROD, V24, P166, DOI 10.1093/humrep/den344; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guerin LR, 2009, HUM REPROD UPDATE, V15, P517, DOI 10.1093/humupd/dmp004; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Huang SJ, 2006, J REPROD IMMUNOL, V72, P60, DOI 10.1016/j.jri.2006.03.002; HUNT JS, 1989, J REPROD IMMUNOL, V16, P1, DOI 10.1016/0165-0378(89)90002-8; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Kayisli UA, 2002, AM J REPROD IMMUNOL, V47, P213, DOI 10.1034/j.1600-0897.2002.01075.x; Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834; Koga K, 2008, REPROD SCI, V15, P231, DOI 10.1177/1933719108316391; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Kwak-Kim J, 2009, J OBSTET GYNAECOL RE, V35, P609, DOI 10.1111/j.1447-0756.2009.01079.x; Larocca L, 2011, MOL CELL ENDOCRINOL, V333, P112, DOI 10.1016/j.mce.2010.11.035; Laskarin G, 2005, HUM REPROD, V20, P1057, DOI 10.1093/humrep/deh740; Laskarin G, 2007, AM J REPROD IMMUNOL, V58, P255, DOI 10.1111/j.1600-0897.2007.00511.x; Leber A, 2010, AM J REPROD IMMUNOL, V63, P445, DOI 10.1111/j.1600-0897.2010.00821.x; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mizuno K, 2005, CLIN EXP IMMUNOL, V142, P461, DOI 10.1111/j.1365-2005.02932.x; Mor G, 2008, ANN NY ACAD SCI, V1127, P121, DOI 10.1196/annals.1434.006; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Nagamatsu T, 2010, AM J REPROD IMMUNOL, V63, P460, DOI 10.1111/j.1600-0897.2010.00813.x; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Park Dong-Wook, 2011, Clin Exp Reprod Med, V38, P179, DOI 10.5653/cerm.2011.38.4.179; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Ramhorst R, 2012, AM J REPROD IMMUNOL, V67, P17, DOI 10.1111/j.1600-0897.2011.01056.x; Rozner AE, 2011, AM J REPROD IMMUNOL, V66, P115, DOI 10.1111/j.1600-0897.2010.00979.x; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Weiss G, 2009, REPROD SCI, V16, P216, DOI 10.1177/1933719108330087; Wood GW, 1999, CYTOKINE, V11, P1038, DOI 10.1006/cyto.1999.0513	44	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97147	10.1371/journal.pone.0097147	http://dx.doi.org/10.1371/journal.pone.0097147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849800	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600023
J	Ximenes, RAD; Martelli, CMT; Amaku, M; Sartori, AMC; de Soarez, PC; Novaes, HMD; Pereira, LMMB; Moreira, RC; Figueiredo, GM; de Azevedo, RS				de Alencar Ximenes, Ricardo Arraes; Turchi Martelli, Celina Maria; Amaku, Marcos; Sartori, Ana Marli C.; de Soarez, Patricia Coelho; Dutilh Novaes, Hillegonda Maria; Moreira Beltrao Pereira, Leila Maria; Moreira, Regina Celia; Figueiredo, Gerusa Maria; de Azevedo, Raymundo Soares		Hepatitis Study Grp	Modelling the Force of Infection for Hepatitis A in an Urban Population-Based Survey: A Comparison of Transmission Patterns in Brazilian Macro-Regions	PLOS ONE			English	Article							RIO-DE-JANEIRO; COST-EFFECTIVENESS ANALYSIS; UNITED-STATES; CHILDHOOD IMMUNIZATION; EPIDEMIOLOGIC PATTERN; UNIVERSAL VACCINATION; VIRUS-INFECTION; RISK-FACTORS; PREVALENCE; CHILDREN	Background: This study aimed to identify the transmission pattern of hepatitis A (HA) infection based on a primary dataset from the Brazilian National Hepatitis Survey in a pre-vaccination context. The national survey conducted in urban areas disclosed two epidemiological scenarios with low and intermediate HA endemicity. Methods: A catalytic model of HA transmission was built based on a national seroprevalence survey (2005 to 2009). The seroprevalence data from 7,062 individuals aged 5-69 years from all the Brazilian macro-regions were included. We built up three models: fully homogeneous mixing model, with constant contact pattern; the highly assortative model and the highly assortative model with the additional component accounting for contacts with infected food/water. Curves of prevalence, force of infection (FOI) and the number of new infections with 99% confidence intervals (CIs) were compared between the intermediate (North, Northeast, Midwest and Federal District) and low (South and Southeast) endemicity areas. A contour plot was also constructed. Results: The anti-HAV IgG seroprevalence was 68.8% (95% CI, 64.8%-72.5%) and 33.7% (95% CI, 32.4%-35.1%) for the intermediate and low endemicity areas, respectively, according to the field data analysis. The models showed that a higher force of infection was identified in the 10- to 19-year-old age cohort (similar to 9,000 infected individuals per year per 100,000 susceptible persons) in the intermediate endemicity area, whereas a higher force of infection occurred in the 15-to 29-year-old age cohort (similar to 6,000 infected individuals per year per 100,000 susceptible persons) for the other macro-regions. Conclusion: Our findings support the shift of Brazil toward intermediate and low endemicity levels with the shift of the risk of infection to older age groups. These estimates of HA force of infection stratified by age and endemicity levels are useful information to characterize the pre-vaccination scenario in Brazil.	[de Alencar Ximenes, Ricardo Arraes; Moreira Beltrao Pereira, Leila Maria] State Univ Pernambuco, Sch Med Sci, Recife, PE, Brazil; [de Alencar Ximenes, Ricardo Arraes; Turchi Martelli, Celina Maria] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil; [Turchi Martelli, Celina Maria] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, Goiania, Go, Brazil; [Amaku, Marcos] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Sch Vet Med, Sao Paulo, Brazil; [Sartori, Ana Marli C.] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil; [de Soarez, Patricia Coelho; Dutilh Novaes, Hillegonda Maria] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil; [Moreira Beltrao Pereira, Leila Maria] Liver Inst Pernambuco IFP, Recife, PE, Brazil; [Moreira, Regina Celia] Adolfo Lutz Inst, Virol Ctr, Sao Paulo, Brazil; [Figueiredo, Gerusa Maria] Univ Sao Paulo, Sch Med, Inst Trop Med, Sao Paulo, Brazil; [de Azevedo, Raymundo Soares] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Adolfo Lutz; Universidade de Sao Paulo; Universidade de Sao Paulo	Ximenes, RAD (corresponding author), State Univ Pernambuco, Sch Med Sci, Recife, PE, Brazil.	ricardo.ximenes@pq.cnpq.br	de Soarez, Patricia Coelho/D-9710-2012; Figueiredo, Gerusa M/B-6660-2014; Novaes, Hillegonda M. D./F-7060-2011; Sartori, Ana Marli Christovam/I-6663-2012; Amaku, Marcos/D-5252-2012; Moreira, Regina C/B-1488-2016; Azevedo, Raymundo S/B-7593-2008	de Soarez, Patricia Coelho/0000-0001-8383-0728; Figueiredo, Gerusa M/0000-0001-9657-9675; Novaes, Hillegonda M. D./0000-0001-9849-0324; Sartori, Ana Marli Christovam/0000-0003-3777-0757; Amaku, Marcos/0000-0003-4752-6774; Moreira, Regina C/0000-0002-8208-8776; Azevedo, Raymundo S/0000-0003-0660-2371; Turchi Martelli, Celina Maria/0000-0002-2491-0688	Ministry of Health of Brazil; National Council of Technological and Scientific Development (CNPq); National Institute of Science and Technology for Health Technology Assessment (IATS); CNPq [306489/2010-4, 308311/2009-4, 306509/2011-3, 307124/2011-8]	Ministry of Health of Brazil; National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology for Health Technology Assessment (IATS); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is part of a project of economic evaluation of the introduction of new vaccines into the Brazilian National Immunization Program, supported by the Ministry of Health of Brazil, the National Council of Technological and Scientific Development (CNPq), and National Institute of Science and Technology for Health Technology Assessment (IATS). The authors are research members from the National Institute of Science and Technology for Health Technology Assessment (IATS). Martelli CMT received research scholarship (CNPq #306489/2010-4), Ximenes RAA scholarship CNPq #308311/2009-4, Novaes HMD scholarship CNPq #306509/2011-3 and Amaku M scholarship CNPq# 307124/2011-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2008, VACCINE, V26, P1697, DOI 10.1016/j.vaccine.2007.12.058; Almeida LM, 2001, EPIDEMIOL INFECT, V127, P327, DOI 10.1017/S0950268801005945; Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907; Amaku M, 2010, MATH POPUL STUD, V17, P91, DOI 10.1080/08898481003689502; Amaku M, 2009, MEM I OSWALDO CRUZ, V104, P897, DOI 10.1590/S0074-02762009000600013; ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; [Anonymous], 2012, Wkly Epidemiol Rec, V87; Armstrong GL, 2002, PEDIATRICS, V109, P839, DOI 10.1542/peds.109.5.839; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Bell BP, 2005, VACCINE, V23, P5798, DOI 10.1016/j.vaccine.2005.03.060; Bell BP, 1998, J INFECT DIS, V178, P1579, DOI 10.1086/314518; Brasil, 2010, EST PREV BAS POP INF; Burnham K.P., 2002, MODEL SELECTION MULT, P60; Clemens SAC, 2000, REV SOC BRAS MED TRO, V33; Ximenes RAD, 2008, INT J EPIDEMIOL, V37, P852, DOI 10.1093/ije/dyn114; Ximenes RAD, 2010, CAD SAUDE PUBLICA, V26, P1693, DOI 10.1590/S0102-311X2010000900003; de Almeida LM, 2002, T ROY SOC TROP MED H, V96, P605, DOI 10.1016/S0035-9203(02)90325-1; Guimaraens Mariana Alves de, 2005, Cad. Saúde Pública, V21, P1531, DOI 10.1590/S0102-311X2005000500026; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126; Halloran ME, 2010, STAT BIOL HEALTH; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, GEOLOGYOFTHEPHILIPPI; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Lafer Manuel Mindlin, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P155, DOI 10.1590/S0036-46652007000300004; Lopez E, 2007, J GASTROENTEROL, V42, P152, DOI 10.1007/s00535-006-1984-x; Luiz RR, 2003, INT J HYG ENVIR HEAL, V206, P575, DOI 10.1078/1438-4639-00255; Marschner IC, 1997, BIOMETRICS, V53, P1384, DOI 10.2307/2533505; Martinelli D, 2010, VACCINE, V28, P6783, DOI 10.1016/j.vaccine.2010.07.069; Matos MAD, 2009, T ROY SOC TROP MED H, V103, P899, DOI 10.1016/j.trstmh.2009.01.013; Ministerio da Saude, 2008, HEP VIR BRAS EST AT; Ministerio da saude, 2013, INF TECN INTR VAC AD; Braga WSM, 2009, REV SOC BRAS MED TRO, V42, P277, DOI 10.1590/S0037-86822009000300008; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REMME J, 1984, INT J EPIDEMIOL, V13, P332, DOI 10.1093/ije/13.3.332; Sartori AMC, 2012, VACCINE, V30, P7489, DOI 10.1016/j.vaccine.2012.10.056; Struchiner CJ, 1999, INT J EPIDEMIOL, V28, P776, DOI 10.1093/ije/28.4.776; Tapia-Conyer R, 1999, AM J TROP MED HYG, V61, P825, DOI 10.4269/ajtmh.1999.61.825; Vacchino MN, 2008, J VIRAL HEPATITIS, V15, P47, DOI 10.1111/j.1365-2893.2008.01029.x; Valentim J, 2008, VACCINE, V26, P6281, DOI 10.1016/j.vaccine.2008.07.021; Van Effelterre TP, 2006, CLIN INFECT DIS, V43, P158, DOI 10.1086/505115; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Vitral CL, 2008, J VIRAL HEPATITIS, V15, P22, DOI 10.1111/j.1365-2893.2008.01024.x; Vitral CL, 2006, MEM I OSWALDO CRUZ, V101, P119, DOI 10.1590/S0074-02762006000200001; Vitral CL, 1998, MEM I OSWALDO CRUZ, V93, P1, DOI 10.1590/S0074-02761998000100001; Vogt TM, 2008, J INFECT DIS, V197, P1282, DOI 10.1086/586899; Yu ALF, 2001, EPIDEMIOL INFECT, V127, P493, DOI 10.1017/S0950268801006124; [No title captured]	48	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e94622	10.1371/journal.pone.0094622	http://dx.doi.org/10.1371/journal.pone.0094622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845598	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400002
J	Lobo, ML; Augusto, J; Antunes, F; Ceita, J; Xiao, LH; Codices, V; Matos, O				Lobo, Maria Luisa; Augusto, Joao; Antunes, Francisco; Ceita, Jose; Xiao, Lihua; Codices, Vera; Matos, Olga			Cryptosporidium spp., Giardia duodenalis, Enterocytozoon bieneusi and Other Intestinal Parasites in Young Children in Lobata Province, Democratic Republic of Sao Tome and Principe	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; HIV-INFECTED PERSONS; MOLECULAR EPIDEMIOLOGY; SOUTH-AFRICA; CLINICAL-MANIFESTATIONS; ZOONOTIC TRANSMISSION; CHILDHOOD DIARRHEA; UGANDAN CHILDREN; PREVALENCE	Rare systemic studies concerning prevalence of intestinal parasites in children have been conducted in the second smallest country in Africa, the Democratic Republic of Sao Tome and Principe. Fecal specimens from 348 children (214 in-hospital attending the Aires de Menezes Hospital and 134 from Agostinho Neto village) in Sao Tome Island were studied by parasitological and molecular methods. Of the 134 children from Agostinho Neto, 52.2% presented intestinal parasites. 32.1% and 20.2% of these children had monoparasitism and polyparasitism, respectively. Ascaris lumbricoides (27.6%), G. duodenalis (7.5%), T. trichiura (4.5%) and Entamoeba coli (10.5%) were the more frequent species identified in the children of this village. Giardia duodenalis (7.5%) and E. bieneusi (5.2%) were identified by PCR. Nested-PCR targeting G. duodenalis TPI identified Assemblage A (60%) and Assemblage B (40%). The E. bieneusi ITS-based sequence identified genotypes K (57.1%), KIN1 (28.6%) and KIN3 (14.3%). Among the 214 in-hospital children, 29.4% presented intestinal parasites. In 22.4% and 7.0% of the parasitized children, respectively, one or more species were concurrently detected. By microscopy, A. lumbricoides (10.3%) and Trichiuris trichiura (6.5%) were the most prevalent species among these children, and Cryptosporidium was detected by PCR in 8.9% of children. GP60 locus analysis identified 6.5% of C. hominis (subtypes IaA27R3 [35.7%], IaA23R3 [14.3%], IeA11G3T3 [28.6%] and IeA11G3T3R1 [21.4%]) and 2.3% of C. parvum (subtypes IIaA16G2R1 [20.0%], IIaA15G2R1 [20.0%], IIdA26G1 [40.0%] and IIdA21G1a [20.0%]). G. duodenalis and E. bieneusi were identified in 0.5% and 8.9% of the in-hospital children, respectively. G. duodenalis Assemblage B was characterized. The E. bieneusi genotypes K (52.6%), D (26.4%), A (10.5%) and KIN1 (10.5%) were identified. Although further studies are required to clarify the epidemiology of these infectious diseases in this endemic region the significance of the present results highlights that it is crucial to strength surveillance on intestinal pathogens.	[Lobo, Maria Luisa; Codices, Vera; Matos, Olga] Univ Nova Lisboa, Inst Higiene & Med Trop, Grp Protozoarios Oportunistas VIH & Outros Protoz, Unidade Parasitol Med,CMDT, P-1200 Lisbon, Portugal; [Augusto, Joao] Hosp Portimao, Ctr Hosp Algarve, Portimao, Portugal; [Antunes, Francisco] Univ Lisbon, Fac Med, P-1699 Lisbon, Portugal; [Ceita, Jose] Hosp Aires Menezes, Sao Tome, Sao Tome & Prin; [Xiao, Lihua] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Centers for Disease Control & Prevention - USA	Matos, O (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Grp Protozoarios Oportunistas VIH & Outros Protoz, Unidade Parasitol Med,CMDT, P-1200 Lisbon, Portugal.	omatos@ihmt.unl.pt	Lobo, Maria/I-3527-2012; Xiao, Lihua/B-1704-2013; Matos, Olga/J-8859-2012; Augusto, João/W-8208-2019	Lobo, Maria/0000-0001-5811-7568; Xiao, Lihua/0000-0001-8532-2727; Matos, Olga/0000-0001-5793-7716; Augusto, João/0000-0003-0040-5270; Antunes, Francisco/0000-0001-7932-1154				Abu Samra N, 2013, ZOONOSES PUBLIC HLTH, V60, P154, DOI 10.1111/j.1863-2378.2012.01507.x; Adamu H, 2010, ACTA TROP, V115, P77, DOI 10.1016/j.actatropica.2010.02.003; Adeoye G O, 2007, Pak J Biol Sci, V10, P2208, DOI 10.3923/pjbs.2007.2208.2212; Akinbo F.O., 2010, FOOYIN J HLTH SCI, V2, P85, DOI [10.1016/S1877-8607(11)60003-9, DOI 10.1016/S1877-8607(11)60003-9]; Akiyoshi DE, 2006, J PARASITOL, V92, P1097, DOI 10.1645/GE-843R.1; Alemu A, 2011, ASIAN PAC J TROP MED, V4, P661, DOI 10.1016/S1995-7645(11)60168-5; Ali SA, 2003, CURR OPIN INFECT DIS, V16, P453, DOI 10.1097/00001432-200310000-00012; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Ayinmode A. B., 2011, Journal of Parasitology Research, V2011, P129542, DOI 10.1155/2011/129542; Azam SA, 2007, TAJ, V20, P1; Belo S., 2005, Parassitologia (Rome), V47, P227; Bern C, 2000, AM J TROP MED HYG, V63, P231, DOI 10.4269/ajtmh.2000.63.231; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Breton J, 2007, J CLIN MICROBIOL, V45, P2580, DOI 10.1128/JCM.02554-06; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Cama VA, 2007, J INFECT DIS, V196, P684, DOI 10.1086/519842; Central Intelligence Agency, CENTR INT AG PUBL; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Ekdahl K, 2005, AM J TROP MED HYG, V72, P825, DOI 10.4269/ajtmh.2005.72.825; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Feng YY, 2009, J CLIN MICROBIOL, V47, P153, DOI 10.1128/JCM.01777-08; Gatei W, 2008, EMERG INFECT DIS, V14, P841, DOI 10.3201/eid1405.071277; Gatei W, 2006, AM J TROP MED HYG, V75, P78, DOI 10.4269/ajtmh.2006.75.78; Gelanew T, 2007, ACTA TROP, V102, P92, DOI 10.1016/j.actatropica.2007.04.003; Gungoren B, 2007, T ROY SOC TROP MED H, V101, P564, DOI 10.1016/j.trstmh.2007.02.011; Heresi G, 1997, Pediatr Rev, V18, P243, DOI 10.1542/pir.18-7-243; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Iqbal J, 2011, J MED MICROBIOL, V60, P647, DOI 10.1099/jmm.0.028001-0; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Kamga HLF, 2011, PAN AFR MED J, V8; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Leav BA, 2002, INFECT IMMUN, V70, P3881, DOI 10.1128/IAI.70.7.3881-3890.2002; Lobo ML, 2012, INT J PARASITOL, V42, P197, DOI 10.1016/j.ijpara.2011.12.002; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; Lobo ML, 2006, APPL ENVIRON MICROB, V72, P7380, DOI 10.1128/AEM.01394-06; Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582; Mahmud MA, 2001, AM J TROP MED HYG, V65, P257, DOI 10.4269/ajtmh.2001.65.257; Maikai BV, 2012, EXP PARASITOL, V131, P452, DOI 10.1016/j.exppara.2012.05.011; Molloy SF, 2010, AM J TROP MED HYG, V82, P608, DOI 10.4269/ajtmh.2010.09-0624; MOODLEY D, 1991, S AFR MED J, V79, P295; Moore SR, 2001, INT J EPIDEMIOL, V30, P1457, DOI 10.1093/ije/30.6.1457; Nazemalhosseini-Mojarad Ehsan, 2012, Gastroenterol Hepatol Bed Bench, V5, P67; Nyarango RM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-237; Ochoa TJ, 2008, CLIN INFECT DIS, V46, P1881, DOI 10.1086/588476; Ojuromi OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035239; Pampiglione S, 1987, Parassitologia, V29, P15; Peng MM, 2003, J EUKARYOT MICROBIOL, V50, P557, DOI 10.1111/j.1550-7408.2003.tb00628.x; Perch M, 2001, ANN TROP PAEDIATR, V21, P313, DOI 10.1080/07430170120093490; Ripert C, 1996, B SOC PATHOL EXOT, V89, P252; Samie A, 2006, EXP PARASITOL, V114, P314, DOI 10.1016/j.exppara.2006.04.007; Samuel L, 2001, AM J PHYSIOL-GASTR L, V280, P1049; Sarfati C, 2006, AM J TROP MED HYG, V74, P162, DOI 10.4269/ajtmh.2006.74.162; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Siwila J, 2011, T ROY SOC TROP MED H, V105, P102, DOI 10.1016/j.trstmh.2010.10.004; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Tellez A, 2003, SCAND J INFECT DIS, V35, P322, DOI 10.1080/00365540310008041; Ten Hove RJ, 2009, J EUKARYOT MICROBIOL, V56, P388, DOI 10.1111/j.1550-7408.2009.00393.x; Tumwine JK, 2005, AM J TROP MED HYG, V73, P921, DOI 10.4269/ajtmh.2005.73.921; Tumwine JK, 2003, AM J TROP MED HYG, V68, P710, DOI 10.4269/ajtmh.2003.68.710; Tumwine JK, 2002, AM J TROP MED HYG, V67, P299, DOI 10.4269/ajtmh.2002.67.299; World Bank, COUNTR; Wumba R, 2010, PARASITE, V17, P321, DOI 10.1051/parasite/2010174321; Xiao LH, 2004, CURR OPIN INFECT DIS, V17, P483, DOI 10.1097/00001432-200410000-00014; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	71	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97708	10.1371/journal.pone.0097708	http://dx.doi.org/10.1371/journal.pone.0097708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846205	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400047
J	Nair, PS; Shetty, SD; Chandrakala, S; Ghosh, K				Nair, Preethi S.; Shetty, Shrimati D.; Chandrakala, S.; Ghosh, Kanjaksha			Mutations in Intron 1 and Intron 22 Inversion Negative Haemophilia A Patients from Western India	PLOS ONE			English	Article							FACTOR-VIII GENE; MISSENSE MUTATIONS; MESSENGER-RNA; IDENTIFICATION; FAMILIES	Despite increased awareness and diagnostic facilities, 70-80% of the haemophilia A (HA) patients still remain undiagnosed in India. Very little data is available on prevalent mutations in HA from this country. We report fifty mutations in seventy one Indian HA patients, of which twenty were novel. Ten novel missense mutations [p.Leu11Pro (p.Leu-8Pro), p.Tyr155Ser (p.Tyr136Ser), p.Ile405Thr (p.Ile386Thr), p.Gly582Val (p.Gly563Val) p.Thr696Ile (p.Thr677Ile), p.Tyr737Cys (p.Tyr718Cys), p.Pro1999Arg (p.Pro1980Arg), p.Ser2082Thr (p.Ser2063Thr), p.Leu2197Trp (p.Leu2178Trp), p.Asp2317Glu (p.Asp2298Glu)] two nonsense [p.Lys396* (p.Lys377*), p.Ser2205* (p.Ser2186*)], one insertion [p.Glu1268_Asp1269ins (p.Glu1249_Asp1250)] and seven deletions [p.Leu882del (p.Leu863del), p.Met701del (p.Met682del), p.Leu1223del (p.Leu1204del), p.Trp1961_Tyr1962del (p.Trp1942_Tyr1943del) p.Glu1988del (p.Glu1969del), p.His1841del (p.His1822del), p.Ser2205del (p.Ser2186del)] were identified. Double mutations (p.Asp2317Glu; p.Thr696Ile) were observed in a moderate HA case. Mutations [p.Arg612Cys (p.Arg593Cys), p.Arg2326Gln (p.Arg2307Gln)] known to be predisposing to inhibitors to factor VIII (FVIII) were identified in two patients. 4.6% of the cases were found to be cross reacting material positive (CRM+ve). A wide heterogeneity in the nature of mutations was seen in the present study which has been successfully used for carrier detection and antenatal diagnosis in 10 families affected with severe to moderate HA.	[Nair, Preethi S.; Shetty, Shrimati D.; Ghosh, Kanjaksha] Natl Inst Immunohaematol ICMR, Dept Thrombosis & Haemostasis, Bombay, Maharashtra, India; [Chandrakala, S.] King Edward Mem Hosp, Dept Haematol, Bombay, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Ghosh, K (corresponding author), Natl Inst Immunohaematol ICMR, Dept Thrombosis & Haemostasis, Bombay, Maharashtra, India.	kanjakshaghosh@hotmail.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Department of Science and Technology, Government of India (DST)	Department of Science and Technology, Government of India (DST)(Department of Science & Technology (India))	Authors are grateful to Department of Science and Technology, Government of India (DST), for funding this study and also the West Bengal University of Health Sciences for including this study in their Ph.D programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghafar A, 2010, HAEMOPHILIA, V16, P551, DOI 10.1111/j.1365-2516.2009.02146.x; Ahmed RPH, 2005, HAEMATOLOGICA, V90, P283; Bicocchi MP, 2005, AM J HEMATOL, V78, P117, DOI 10.1002/ajh.20234; Bogdanova N, 2005, HUM MUTAT, V26, P249, DOI 10.1002/humu.20208; Bovenschen N, 2005, J THROMB HAEMOST, V3, P1257, DOI 10.1111/j.1538-7836.2005.01389.x; Carcao M, 2013, HAEMOPHILIA, V19, P21; Eckhardt CL, 2009, J THROMB HAEMOST, V7, P930, DOI 10.1111/j.1538-7836.2009.03357.x; El-Maarri O, 2005, J THROMB HAEMOST, V3, P332, DOI 10.1111/j.1538-7836.2005.01140.x; El-Maarri O, 2006, BLOOD, V107, P2759, DOI 10.1182/blood-2005-09-3702; Fidanci ID, 2008, BLOOD COAGUL FIBRIN, V19, P383, DOI 10.1097/MBC.0b013e3282f9b193; Ganguly A, 2002, HUM MUTAT, V19, P334, DOI 10.1002/humu.10059; Ghosh K, 2004, J THROMB HAEMOST, V2, P1481, DOI 10.1111/j.1538-7836.2004.00794.x; Ghosh K, 2009, BRIT J HAEMATOL, V145, P433, DOI 10.1111/j.1365-2141.2009.07618.x; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Jayandharan G, 2005, HAEMOPHILIA, V11, P481, DOI 10.1111/j.1365-2516.2005.01121.x; Liu ML, 1998, BRIT J HAEMATOL, V103, P1051, DOI 10.1046/j.1365-2141.1998.01122.x; LOO TW, 1994, J BIOL CHEM, V269, P7243; Nair PS, 2010, HAEMOPHILIA, V16, P970, DOI 10.1111/j.1365-2516.2010.02326.x; Nair PS, 2010, CLIN CHIM ACTA, V411, P2004, DOI 10.1016/j.cca.2010.08.026; Pavlova A, 2013, BLOOD, V121, P3784, DOI 10.1182/blood-2013-03-491761; Pipe SW, 2009, HAEMOPHILIA, V15, P1187, DOI 10.1111/j.1365-2516.2009.02026.x; Roelse JC, 2000, BRIT J HAEMATOL, V108, P241; Schwaab R, 2013, THROMB HAEMOSTASIS, V109, P464, DOI 10.1160/TH12-07-0521; Shetty S, 1998, THROMB HAEMOSTASIS, V79, P881, DOI 10.1055/s-0037-1615084; Stoof SCM, 2013, THROMB HAEMOSTASIS, V109, P440, DOI 10.1160/TH12-06-0383; Waseem NH, 1999, THROMB HAEMOSTASIS, V81, P900	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97337	10.1371/journal.pone.0097337	http://dx.doi.org/10.1371/journal.pone.0097337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845853	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400023
J	Barais, M; Morio, N; Breton, AC; Barraine, P; Calvez, A; Stolper, E; Van Royen, P; Lietard, C				Barais, Marie; Morio, Nathalie; Breton, Amelie Cuzon; Barraine, Pierre; Calvez, Amelie; Stolper, Erik; Van Royen, Paul; Lietard, Claire			"I Can't Find Anything Wrong: It Must Be a Pulmonary Embolism": Diagnosing Suspected Pulmonary Embolism in Primary Care, a Qualitative Study	PLOS ONE			English	Article							HEALTH-CARE; GUT FEELINGS; ERROR; CONSENSUS; MEDICINE; RULES	Background: Before using any prediction rule oriented towards pulmonary embolism (PE), family physicians (FPs) should have some suspicion of this diagnosis. The diagnostic reasoning process leading to the suspicion of PE is not well described in primary care. Objective: to explore the diagnostic reasoning of FPs when pulmonary embolism is suspected. Method: Semi-structured qualitative interviews with 28 FPs. The regional hospital supplied data of all their cases of pulmonary embolism from June to November 2011. The patient's FP was identified where he/she had been the physician who had sent the patient to the emergency unit. The first consecutive 14 FPs who agreed to participate made up the first group. A second group was chosen using a purposeful sampling method. The topic guide focused on the circumstances leading to the suspicion of PE. A thematic analysis was performed, by three researchers, using a grounded theory coding paradigm. Results: In the FPs' experience, the suspicion of pulmonary embolism arose out of four considerations: the absence of indicative clinical signs for diagnoses other than PE, a sudden change in the condition of the patient, a gut feeling that something was seriously wrong and an earlier failure to diagnose PE. The FPs interviewed did not use rules in their diagnostic process. Conclusion: This study illustrated the diagnostic role of gut feelings in the specific context of suspected pulmonary embolism in primary care. The FPs used the sense of alarm as a tool to prevent the diagnostic error of missing a PE. The diagnostic accuracy of gut feelings has yet to be evaluated.	[Barais, Marie; Morio, Nathalie; Breton, Amelie Cuzon; Barraine, Pierre; Calvez, Amelie] Univ Bretagne Occidentale, Fac Med & Sci Sante Brest, Dept Univ Med Gen, Brest, France; [Stolper, Erik] Maastricht Univ, Fac Hlth Med & Life Sci, Caphri Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [Stolper, Erik; Van Royen, Paul] Univ Antwerp, Dept Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Lietard, Claire] Univ Europeenne Bretagne, Fac Med & Sci Sante Brest, Lab Sante Publ, Brest, France	CHU Brest; Universite de Bretagne Occidentale; Maastricht University; University of Antwerp; Universite de Bretagne Occidentale	Barais, M (corresponding author), Univ Bretagne Occidentale, Fac Med & Sci Sante Brest, Dept Univ Med Gen, Brest, France.	marie.barais@gmail.com	, Van Royen Paul/H-7315-2015; barais, marie/H-2888-2018	, Van Royen Paul/0000-0002-9554-1680; 				Abu Hani M, 2007, FAM PRACT, V24, P622, DOI 10.1093/fampra/cmm053; Allen J, 2002, BRIT J GEN PRACT, V52, P526; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Bruyninckx R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-55; Buntinx F, 2011, BRIT J GEN PRACT, V61, P43, DOI 10.3399/bjgp11X548974; Campbell IA, 2003, THORAX, V58, P470; Cook C, 2009, J MAN MANIP THER, V17, P6, DOI 10.1179/106698109790818223; De Neys W, 2008, COGNITION, V106, P1248, DOI 10.1016/j.cognition.2007.06.002; Feddock CA, 2007, AM J MED, V120, P374, DOI 10.1016/j.amjmed.2007.01.023; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Geersing GJ, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6564; Gigerenzer G., 2000, SIMPLE HEURISTICS MA; Granier S, 1998, BRIT MED J, V316, P276, DOI 10.1136/bmj.316.7127.276; Innes AD, 2005, BRIT J GEN PRACT, V55, P47; Koontz NA, 2008, AM J ROENTGENOL, V190, P1156, DOI 10.2214/AJR.07.3268; Le Gal G, 2004, J THROMB HAEMOST, V2, P1244, DOI 10.1111/j.1538-7836.2004.00795.x; Le Reste JY, 2013, EUR J GEN PRACT, V19, P237, DOI 10.3109/13814788.2013.779662; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Meyer G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1421; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schiff GD, 2009, ARCH INTERN MED, V169, P1881, DOI 10.1001/archinternmed.2009.333; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Slovic P, 2002, AFFECT HEURISTIC, P1333; Stolper CF, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-1; Stolper E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-66; Stolper E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-17; Thorne S., 2000, EVIDENCE BASED NURS, V3, P68, DOI [DOI 10.1136/EBN.3.3.68, 10.1136/ebn.3.3.68]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Woolley A, 2013, ANN FAM MED, V11, P60, DOI 10.1370/afm.1433	39	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98112	10.1371/journal.pone.0098112	http://dx.doi.org/10.1371/journal.pone.0098112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24840333	Green Submitted, gold, Green Published			2022-12-27	WOS:000340948600107
J	De Robertis, A; Mennillo, F; Rossi, M; Valensin, S; Tunici, P; Mori, E; Caradonna, N; Varrone, M; Salerno, M				De Robertis, Alessandra; Mennillo, Federica; Rossi, Marco; Valensin, Silvia; Tunici, Patrizia; Mori, Elisa; Caradonna, Nicola; Varrone, Maurizio; Salerno, Massimiliano			Human Sarcoma Growth Is Sensitive to Small-Molecule Mediated AXIN Stabilization	PLOS ONE			English	Article							BETA-CATENIN; SCAFFOLD PROTEIN; WNT ACTIVATION; HIGH-FREQUENCY; COMPLEX; INHIBITION; OSTEOSARCOMA; DEGRADATION; SUPPRESSION; EXPRESSION	Sarcomas are mesenchymal tumors showing high molecular heterogeneity, reflected at the histological level by the existence of more than fifty different subtypes. Genetic and epigenetic evidences link aberrant activation of the Wnt signaling to growth and progression of human sarcomas. This phenomenon, mainly accomplished by autocrine loop activity, is sustained by gene amplification, over-expression of Wnt ligands and co-receptors or epigenetic silencing of endogenous Wnt antagonists. We previously showed that pharmacological inhibition of Wnt signaling mediated by Axin stabilization produced in vitro and in vivo antitumor activity in glioblastoma tumors. Here, we report that targeting different sarcoma cell lines with the Wnt inhibitor/Axin stabilizer SEN461 produces a less transformed phenotype, as supported by modulation of anchorage-independent growth in vitro. At the molecular level, SEN461 treatment enhanced the stability of the scaffold protein Axin1, a key negative regulator of the Wnt signaling with tumor suppressor function, resulting in downstream effects coherent with inhibition of canonical Wnt signaling. Genetic phenocopy of small molecule Axin stabilization, through Axin1 over-expression, coherently resulted in strong impairment of soft-agar growth. Importantly, sarcoma growth inhibition through pharmacological Axin stabilization was also observed in a xenograft model in vivo in female CD-1 nude mice. Our findings suggest the usefulness of Wnt inhibitors with Axin stabilization activity as a potentialyl clinical relevant strategy for certain types of sarcomas.	[De Robertis, Alessandra; Mennillo, Federica; Valensin, Silvia; Salerno, Massimiliano] Siena Biotech Med Res Ctr, Mol Oncol Unit, Siena, Italy; [De Robertis, Alessandra; Mennillo, Federica; Rossi, Marco; Valensin, Silvia; Tunici, Patrizia; Mori, Elisa; Salerno, Massimiliano] Siena Biotech Med Res Ctr, Dept Pharmacol, Siena, Italy; [Rossi, Marco; Tunici, Patrizia] Siena Biotech Med Res Ctr, In Vivo Pharmacol Unit, Siena, Italy; [Mori, Elisa] Siena Biotech Med Res Ctr, Data Anal Unit, Siena, Italy; [Caradonna, Nicola] Siena Biotech Med Res Ctr, MET Profiling Unit, Siena, Italy; [Varrone, Maurizio] Siena Biotech Med Res Ctr, Dept Med Chem, Siena, Italy	Siena Biotech; Siena Biotech; Siena Biotech; Siena Biotech; Siena Biotech; Siena Biotech	Salerno, M (corresponding author), Siena Biotech Med Res Ctr, Mol Oncol Unit, Siena, Italy.	massisal67@gmail.com		SALERNO, Massimiliano/0000-0002-1093-5454	Monte Dei Paschi Foundation	Monte Dei Paschi Foundation	The study was funded by Monte Dei Paschi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen YC, 2010, MOL THER, V18, P828, DOI 10.1038/mt.2009.291; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Robertis A, 2013, MOL CANCER THER, V12, P1180, DOI 10.1158/1535-7163.MCT-12-1176-T; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Dieudonne FX, 2010, CANCER RES, V70, P5399, DOI 10.1158/0008-5472.CAN-10-0090; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Finch AJ, 2009, MOL CELL BIOL, V29, P5306, DOI 10.1128/MCB.01745-08; Gehrke I, 2009, EUR J CANCER, V45, P2759, DOI 10.1016/j.ejca.2009.08.003; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Iwao K, 1999, JPN J CANCER RES, V90, P205, DOI 10.1111/j.1349-7006.1999.tb00734.x; James RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050457; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Leow PC, 2010, INVEST NEW DRUG, V28, P766, DOI 10.1007/s10637-009-9311-z; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Marklein D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052898; Misra RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050153; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Rubin EM, 2010, MOL CANCER THER, V9, P731, DOI 10.1158/1535-7163.MCT-09-0147; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Saito T, 2002, J PATHOL, V196, P445, DOI 10.1002/path.1066; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Stratford EW, 2014, CANCER MED-US, V3, P36, DOI 10.1002/cam4.170; TABONE MD, 1994, J CLIN ONCOL, V12, P2614, DOI 10.1200/JCO.1994.12.12.2614; Tarkkanen M, 2006, EUR J CANCER, V42, P1172, DOI 10.1016/j.ejca.2006.01.035; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vijayakumar S, 2011, CANCER CELL, V19, P601, DOI 10.1016/j.ccr.2011.03.010; Wan XL, 2007, ONCOLOGIST, V12, P1007, DOI 10.1634/theoncologist.12-8-1007; Watson AL, 2013, CANCER DISCOV, V3, P674, DOI 10.1158/2159-8290.CD-13-0081; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9	51	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97847	10.1371/journal.pone.0097847	http://dx.doi.org/10.1371/journal.pone.0097847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842792	Green Submitted, gold, Green Published			2022-12-27	WOS:000340948600082
J	Hung, CS; Wu, YW; Huang, JY; Hsu, PY; Chen, MF				Hung, Chi-Sheng; Wu, Yen-Wen; Huang, Jei-Yie; Hsu, Pei-Ying; Chen, Ming-Fong			Evaluation of Circulating Adipokines and Abdominal Obesity as Predictors of Significant Myocardial Ischemia Using Gated Single-Photon Emission Computed Tomography	PLOS ONE			English	Article							ACID-BINDING PROTEIN; CORONARY-ARTERY-DISEASE; ASYMPTOMATIC POSTMENOPAUSAL WOMEN; PROATRIAL NATRIURETIC PEPTIDE; SERUM CHEMERIN LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE; INFLAMMATION; ADIPOCYTE; ASSOCIATION	Objective: Coronary artery disease (CAD) is associated with abdominal obesity and metabolic syndrome. Adipocytes secrete adipokines, including the newly discovered adipocyte fatty acid binding protein (A-FABP) and chemerin. Adipokines contribute to the pathogenesis of CAD. In patients with CAD, the presence of significant ischemia predicts adverse outcomes. It is unknown whether adipokines can be better predictors of the presence of significant myocardial ischemia than conventional risk factors. This study aimed to compare adipokines with clinical risk factors and abdominal obesity as predictive factors for significant myocardial ischemia. Methods: One hundred and ninety-six adults with suspected, but unproven, CAD were consecutively enrolled. The main measures were clinical and biochemical parameters and stress myocardial perfusion imaging with gated myocardial perfusion single-photon emission computed tomography (SPECT), with computed tomography (CT) attenuation correction. The abdominal visceral fat area was examined using a hybrid SPECT/CT scanner. Serum levels of high-sensitivity C-reactive protein (hs-CRP) and adipokines (adiponectin, A-FABP, and chemerin) were evaluated. Results: A-FABP levels correlated significantly with adiponectin, hs-CRP, body mass index, waist circumference, and visceral fat area. A-FABP was significantly associated with metabolic syndrome (OR 3.2, 95% CI 1.6-6.4, p = 0.001), significant myocardial ischemia (OR 1.9, 95% CI 1.0-3.4, p = 0.05), and stress lung-to-heart ratio (beta = 0.03, p = 0.03) on SPECT. Chemerin was significantly associated with serum triglyceride levels but not with metabolic syndrome, significant ischemia, or stress lung-to-heart ratio on SPECT. A-FABP was better at detecting significant inducible ischemia than other biomarkers, although this was a modest improvement (area under ROC curve 0.579, 95% CI 0.46-0.69). Conclusions: Serum A-FABP concentrations correlate significantly with visceral fat area, metabolic syndrome, and predicted significant myocardial ischemia on SPECT. This may help to more accurately assess CAD risk, especially in patients with metabolic syndrome.	[Hung, Chi-Sheng; Wu, Yen-Wen; Chen, Ming-Fong] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Hung, Chi-Sheng; Wu, Yen-Wen; Huang, Jei-Yie; Chen, Ming-Fong] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Yen-Wen; Huang, Jei-Yie] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei 100, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hsu, Pei-Ying] Natl Taiwan Univ Hosp, Dept Nucl Med, Yun Lin Branch, Douliou City, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Wu, YW (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan.	wuyw0502@gmail.com	Chen, Ming/GVU-8412-2022	WU, YEN-WEN/0000-0003-1520-1166	National Science Council, Taiwan [NSC 101-2314-B-418-012-MY3]; National Taiwan University Hospital, Yunlin Branch [NTUH.YL 98.S017]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Yunlin Branch	This work was supported by research grants from the National Science Council, Taiwan (NSC 101-2314-B-418-012-MY3), and National Taiwan University Hospital, Yunlin Branch (NTUH.YL 98.S017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bao YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019115; Bocek T, 2005, EUR J CLIN INVEST, V35, P450, DOI 10.1111/j.1365-2362.2005.01517.x; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chien CL, 2011, OBESITY FACTS, V4, P372, DOI 10.1159/000333439; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hah YJ, 2011, DIABETES METAB J, V35, P248, DOI 10.4093/dmj.2011.35.3.248; Hong J, 2011, ATHEROSCLEROSIS, V217, P194, DOI 10.1016/j.atherosclerosis.2011.03.002; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Huang CL, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-105; Jin J, 2010, CLIN CHIM ACTA, V411, P1761, DOI 10.1016/j.cca.2010.07.031; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; KOTANI K, 1994, INT J OBESITY, V18, P207; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Li XT, 2012, CORONARY ARTERY DIS, V23, P412, DOI 10.1097/MCA.0b013e3283576a60; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Nishikimi T, 2004, AM J MED, V116, P517, DOI 10.1016/j.amjmed.2003.12.022; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; See R, 2007, J AM COLL CARDIOL, V50, P752, DOI 10.1016/j.jacc.2007.04.066; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; Takahashi M, 2013, ENDOCR J, V60, P37, DOI 10.1507/endocrj.EJ12-0201; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Wang SY, 2011, NUCL MED COMMUN, V32, P113, DOI 10.1097/MNM.0b013e3283422838; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Wu YW, 2012, EUR J NUCL MED MOL I, V39, P399, DOI 10.1007/s00259-011-1994-7; Wu YT, 2013, J WOMENS HEALTH, V22, P439, DOI 10.1089/jwh.2012.4055; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yan Q, 2012, ENDOCRINE, V41, P281, DOI 10.1007/s12020-011-9550-6; Yoon MY, 2012, CLIN MOL HEPATOL, V18, P279, DOI 10.3350/cmh.2012.18.3.279; Zaid G, 2007, INT J CARDIOL, V117, P157, DOI 10.1016/j.ijcard.2006.06.013	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97710	10.1371/journal.pone.0097710	http://dx.doi.org/10.1371/journal.pone.0097710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842767	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600061
J	Geffner, L; Basile, JI; Yokobori, N; Kviatcovsky, D; Garcia, CSY; Ritacco, V; Lopez, B; Sasiain, MD; de la Barrera, S				Geffner, Laura; Ignacio Basile, Juan; Yokobori, Noemi; Kviatcovsky, Denise; Sabio y Garcia, Carmen; Ritacco, Viviana; Lopez, Beatriz; del Carmen Sasiain, Maria; de la Barrera, Silvia			Mycobacterium tuberculosis Multidrug Resistant Strain M Induces an Altered Activation of Cytotoxic CD8(+) T Cells	PLOS ONE			English	Article							HUMAN NK-CELLS; GENE-EXPRESSION; ANTIMICROBIAL ACTIVITY; PLASMA-MEMBRANE; CD8+T CELLS; PERFORIN; INFECTION; GRANULYSIN; ANTIGENS; GRANZYME	In human tuberculosis (TB), CD8(+) T cells contribute to host defense by the release of Th1 cytokines and the direct killing of Mycobacterium tuberculosis (Mtb)-infected macrophages via granule exocytosis pathway or the engagement of receptors on target cells. Previously we demonstrated that strain M, the most prevalent multidrug-resistant (MDR) Mtb strain in Argentine, is a weak inducer of IFN-gamma and elicits a remarkably low CD8-dependent cytotoxic T cell activity (CTL). In contrast, the closely related strain 410, which caused a unique case of MDR-TB, elicits a CTL response similar to H37Rv. In this work we extend our previous study investigating some parameters that can account for this discrepancy. We evaluated the expressions of the lytic molecules perforin, granzyme B and granulysin and the chemokine CCL5 in CD8(+) T cells as well as activation markers CD69 and CD25 and IL-2 expression in CD4(+) and CD8(+) T cells stimulated with strains H37Rv, M and 410. Our results demonstrate that M-stimulated CD8(+) T cells from purified protein derivative positive healthy donors show low intracellular expression of perforin, granzyme B, granulysin and CCL5 together with an impaired ability to form conjugates with autologous M-pulsed macrophages. Besides, M induces low CD69 and IL-2 expression in CD4+ and CD8(+) T cells, being CD69 and IL-2 expression closely associated. Furthermore, IL-2 addition enhanced perforin and granulysin expression as well as the degranulation marker CD107 in M-stimulated CD8(+) T cells, making no differences with cells stimulated with strains H37Rv or 410. Thus, our results highlight the role of IL-2 in M-induced CTL activity that drives the proper activation of CD8(+) T cells as well as CD4(+) T cells collaboration.	[Geffner, Laura; Ignacio Basile, Juan; Yokobori, Noemi; Kviatcovsky, Denise; Sabio y Garcia, Carmen; del Carmen Sasiain, Maria; de la Barrera, Silvia] Natl Acad Med Buenos Aires, CONICET, Inst Expt Med, Lab Inmunol Enfermedades Resp, Buenos Aires, DF, Argentina; [Ritacco, Viviana; Lopez, Beatriz] ANLIS Dr Carlos G Malbran, Inst Nacl Enfermedades Infecciosas, Lab Micobacterias, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	de la Barrera, S (corresponding author), Natl Acad Med Buenos Aires, CONICET, Inst Expt Med, Lab Inmunol Enfermedades Resp, Buenos Aires, DF, Argentina.	sdelab@hematologia.anm.edu.ar	Yokobori, Noemí Kaoru/S-9139-2019; Ritacco, Viviana/E-8135-2011	Yokobori, Noemí Kaoru/0000-0001-8966-0491; Ritacco, Viviana/0000-0003-1217-0229; de la Barrera, Silvia/0000-0003-0644-1686; Kviatcovsky, Denise/0000-0002-9697-0380	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0599, PICT 2011-0572]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-0599 and PICT 2011-0572). The funder has no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Andersen MH, 2006, J INVEST DERMATOL, V126, P32, DOI 10.1038/sj.jid.5700001; Andersson J, 2007, INFECT IMMUN, V75, P5210, DOI 10.1128/IAI.00624-07; Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Antas PRZ, 2002, MEM I OSWALDO CRUZ, V97, P1097, DOI 10.1590/S0074-02762002000800005; Basile JI, 2011, J INFECT DIS, V204, P1054, DOI 10.1093/infdis/jir460; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brites D, 2012, INFECT GENET EVOL, V12, P678, DOI 10.1016/j.meegid.2011.08.010; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Cox MA, 2011, TRENDS IMMUNOL, V32, P180, DOI 10.1016/j.it.2011.01.004; Dagur PK, 2010, MOL IMMUNOL, V47, P943, DOI 10.1016/j.molimm.2009.11.009; DAMBROSIO D, 1993, EUR J IMMUNOL, V23, P2993, DOI 10.1002/eji.1830231140; De la Barrera SS, 2003, CLIN EXP IMMUNOL, V132, P450, DOI 10.1046/j.1365-2249.2003.02176.x; DEIS, 2011, AN 2010 BUEN AIR DIE; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Geffner L, 2009, INFECT IMMUN, V77, P5025, DOI 10.1128/IAI.00224-09; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Kumar MM, 2010, CELL IMMUNOL, V265, P146, DOI 10.1016/j.cellimm.2010.08.004; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; Mahon RN, 2009, INFECT IMMUN, V77, P4574, DOI 10.1128/IAI.00222-09; MARTIN A, 2007, TUBERCULOSIS 2007 BA; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Obata-Onai A, 2002, INT IMMUNOL, V14, P1085, DOI 10.1093/intimm/dxf086; Quintero-Macias L, 2012, IMMUNOL INVEST, V41, P51, DOI 10.3109/08820139.2011.580408; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Ritacco V, 2012, EMERG INFECT DIS, V18, P1802, DOI 10.3201/eid1811.120126; Rolph MS, 2001, EUR J IMMUNOL, V31, P1944, DOI 10.1002/1521-4141(200106)31:6<1944::AID-IMMU1944>3.0.CO;2-R; Sanchez-Ruiz Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027057; Schierlohl P, 2009, EUR J IMMUNOL, V39, P2450, DOI 10.1002/eji.200939515; Smith SM, 2000, INFECT IMMUN, V68, P7144, DOI 10.1128/IAI.68.12.7144-7148.2000; Stegelmann F, 2005, J IMMUNOL, V175, P7474, DOI 10.4049/jimmunol.175.11.7474; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Swanson BJ, 2002, IMMUNITY, V17, P605, DOI 10.1016/S1074-7613(02)00456-9; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; TESTI R, 1989, J IMMUNOL, V143, P1123; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; WHO, 2012, GLOB TUB REP 2012 GE; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; Yokobori N, 2013, INFECT GENET EVOL, V16, P151, DOI 10.1016/j.meegid.2013.01.007; Yokobori N, 2012, FEMS IMMUNOL MED MIC, V66, P363, DOI 10.1111/j.1574-695X.2012.01024.x	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97837	10.1371/journal.pone.0097837	http://dx.doi.org/10.1371/journal.pone.0097837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836916	gold, Green Submitted, Green Published			2022-12-27	WOS:000339614800074
J	Leung, YK; Chan, QKY; Ng, CF; Ma, FMT; Tse, HM; To, KF; Maranchie, J; Ho, SM; Lau, KM				Leung, Yuet-Kin; Chan, Queeny Kwan-Yi; Ng, Chi-Fai; Ma, Fanny Man-Ting; Tse, Ho-Man; To, Ka-Fai; Maranchie, Jodi; Ho, Shuk-Mei; Lau, Kin-Mang			Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; IN-SITU HYBRIDIZATION; HIGH-DOSE TAMOXIFEN; GROUP PROTEIN I(Y); PHASE-II TRIAL; GENE-EXPRESSION; ANDROGEN RECEPTOR; NOBLE RATS; ER-BETA; TRANSDERMAL ESTRADIOL	Fulvestrant (ICI-182,780) has recently been shown to effectively suppress prostate cancer cell growth in vitro and in vivo. But it is unclear whether microRNAs play a role in regulating oncogene expression in fulvestrant-treated prostate cancer. Here, this study reports hsa-miR-765 as the first fulvestrant-driven, ERb-regulated miRNA exhibiting significant tumor suppressor activities like fulvestrant, against prostate cancer cell growth via blockage of cell-cycle progression at the G2/M transition, and cell migration and invasion possibly via reduction of filopodia/intense stress-fiber formation. Fulvestrant was shown to upregulate hsa-miR-765 expression through recruitment of ERb to the 59-regulatory-region of hsa-miR-765. HMGA1, an oncogenic protein in prostate cancer, was identified as a downstream target of hsa-miR-765 and fulvestrant in cell-based experiments and a clinical study. Both the antiestrogen and the hsa-miR-765 mimic suppressed HMGA1 protein expression. In a neo-adjuvant study, levels of hsa-miR-765 were increased and HMGA1 expression was almost completely lost in prostate cancer specimens from patients treated with a single dose (250 mg) of fulvestrant 28 days before prostatectomy. These findings reveal a novel fulvestrant signaling cascade involving ER beta-mediated transcriptional upregulation of hsa-miR-765 that suppresses HMGA1 protein expression as part of the mechanism underlying the tumor suppressor action of fulvestrant in prostate cancer.	[Leung, Yuet-Kin; Ho, Shuk-Mei] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Leung, Yuet-Kin; Ho, Shuk-Mei] Univ Cincinnati, Med Ctr, Inst Canc, Cincinnati, OH 45267 USA; [Chan, Queeny Kwan-Yi; Ma, Fanny Man-Ting; Tse, Ho-Man; To, Ka-Fai; Lau, Kin-Mang] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Ng, Chi-Fai] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [To, Ka-Fai; Lau, Kin-Mang] Chinese Univ Hong Kong, State Key Lab Southern China Oncol, Hong Kong, Hong Kong, Peoples R China; [Maranchie, Jodi] Univ Pittsburgh, Dept Urol, Pittsburgh, PA USA; [Ho, Shuk-Mei] Cincinnati Veteran Affairs Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Ho, SM (corresponding author), Univ Cincinnati, Med Ctr, Ctr Environm Genet, Dept Environm Hlth, Cincinnati, OH 45267 USA.	hosm@uc.edu; kmlau@cuhk.edu.hk	Maranchie, Jodi/AAG-1035-2020; Chi-fai, NG/AAV-8270-2021; Ng, Chi-Fai/E-5134-2011; Leung, Ricky/H-5958-2019	Ng, Chi-Fai/0000-0002-1723-9646; Leung, Ricky/0000-0003-2063-277X; Maranchie, Jodi/0000-0002-8534-9468	Hong Kong University Grant Council [M469107]; Chinese University of Hong Kong Direct Research Grants [CU2041252, CU2041563]; Veterans Affairs Merit Award [I01BX000675]; National Institutes of Health [ES019480, ES020956, ES015584, ES006096, CA112570, CA015776]; Investigator-Sponsored Study Program of AstraZeneca; NATIONAL CANCER INSTITUTE [R01CA112570, R01CA015776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019480, P30ES006096, R01ES015584] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000675] Funding Source: NIH RePORTER	Hong Kong University Grant Council; Chinese University of Hong Kong Direct Research Grants; Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigator-Sponsored Study Program of AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by Hong Kong University Grant Council-General Research Fund (M469107 to KML) and Chinese University of Hong Kong Direct Research Grants (CU2041252 and CU2041563 to KML), a Veterans Affairs Merit Award (I01BX000675 to SMH) and grants from National Institutes of Health (ES019480, ES020956, ES015584, ES006096, CA112570, CA015776 to SMH) and a grant from the Investigator-Sponsored Study Program of AstraZeneca (to JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergan RC, 1999, CLIN CANCER RES, V5, P2366; Bhattacharyya RS, 2006, MOL CANCER THER, V5, P1539, DOI 10.1158/1535-7163.MCT-06-0065; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C; Chadha MK, 2008, PROSTATE, V68, P1461, DOI 10.1002/pros.20813; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fernandes SAF, 2011, INT J ANDROL, V34, P486, DOI 10.1111/j.1365-2605.2010.01109.x; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Blesa JMG, 2010, ANN ONCOL, V21, P1131, DOI 10.1093/annonc/mdq010; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hamilton M, 2003, ACTA ONCOL, V42, P195, DOI 10.1080/02841860310010718; Hassan O, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-9; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ho SM, 2008, NEOPLASIA, V10, P20, DOI 10.1593/neo.07889; Ho SM, 2011, ENDOCRIN METAB CLIN, V40, P591, DOI 10.1016/j.ecl.2011.05.002; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lai JS, 2004, UROLOGY, V64, P814, DOI 10.1016/j.urology.2004.05.036; Lane KE, 1997, CARCINOGENESIS, V18, P1505, DOI 10.1093/carcin/18.8.1505; Langley RE, 2008, BJU INT, V102, P442, DOI 10.1111/j.1464-410X.2008.07583.x; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Lau KM, 2012, ACTA NEUROPATHOL, V123, P553, DOI 10.1007/s00401-011-0934-8; Lau KM, 2000, CANCER RES, V60, P3175; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Nakajima Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001551; Ockrim JL, 2004, J UROLOGY, V172, P2203, DOI 10.1097/01.ju.0000145511.56476.00; Oh William K, 2002, Clin Prostate Cancer, V1, P81, DOI 10.3816/CGC.2002.n.009; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Saini S, 2010, PHARM RES-DORDR, V27, P1014, DOI 10.1007/s11095-010-0086-x; Schaefer A, 2010, UROL ONCOL-SEMIN ORI, V28, P4, DOI 10.1016/j.urolonc.2008.10.021; Schultz JR, 2003, MOL CELL ENDOCRINOL, V201, P165, DOI 10.1016/S0303-7207(02)00415-X; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Sevli S, 2010, PROSTATE CANCER P D, V13, P208, DOI 10.1038/pcan.2010.21; Shazer RL, 2006, BJU INT, V97, P691, DOI 10.1111/j.1464-410X.2006.05974.x; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Stein M, 2012, MED SCI MONITOR, V18, pCR260, DOI 10.12659/MSM.882626; Stein S, 2001, AM J CLIN ONCOL-CANC, V24, P283, DOI 10.1097/00000421-200106000-00015; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Tam NNC, 2010, MOL ENDOCRINOL, V24, P2207, DOI 10.1210/me.2010-0179; Tamimi Y, 1996, BRIT J CANCER, V74, P573, DOI 10.1038/bjc.1996.403; TAMIMI Y, 1993, CANCER RES, V53, P5512; Thompson CJ, 2002, ENDOCRINOLOGY, V143, P2093, DOI 10.1210/en.143.6.2093; von SB, 1989, PROSTATE, V14, P389; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wei JJ, 2011, CLIN CANCER RES, V17, P1297, DOI 10.1158/1078-0432.CCR-10-0993; Zhu XG, 2004, AM J PATHOL, V164, P2003, DOI 10.1016/S0002-9440(10)63760-1; Zou AH, 1999, MOL ENDOCRINOL, V13, P418, DOI 10.1210/me.13.3.418	56	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98037	10.1371/journal.pone.0098037	http://dx.doi.org/10.1371/journal.pone.0098037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837491	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000339614800101
J	Lopez-Cortes, LF; Viciana, P; Giron-Gonzalez, JA; Romero-Palacios, A; Marquez-Solero, M; Martinez-Perez, MA; Lopez-Ruz, MA; de la Torre-Lima, J; Tellez-Perez, F; Delgado-Fernandez, M; Garcia-Lazaro, M; Lozano, F; Mohamed-Balghata, MO				Lopez-Cortes, Luis F.; Viciana, Pompeyo; Giron-Gonzalez, Jose A.; Romero-Palacios, Alberto; Marquez-Solero, Manuel; Martinez-Perez, Maria A.; Lopez-Ruz, Miguel A.; de la Torre-Lima, Javier; Tellez-Perez, Francisco; Delgado-Fernandez, Marcial; Garcia-Lazaro, Milagros; Lozano, Fernando; Mohamed-Balghata, Mohamed O.		Soc Andaluza Enfermedades Infeccio	Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population	PLOS ONE			English	Article							DOUBLE-BLIND; EXPERIENCED PATIENTS; PHARMACOKINETICS; RESISTANCE; EFAVIRENZ; TMC125; SAFETY; NAIVE; INDIVIDUALS; TRIALS	Etravirine (ETV) is recommended in combination with a boosted protease inhibitor plus an optimized background regimen for salvage therapy, but there is limited experience with its use in combination with two nucleos(t)ide reverse-transcriptase inhibitors (NRTIs). This multicenter study aimed to assess the efficacy of this combination in two scenarios: group A) subjects without virologic failure on or no experience with non-nucleoside reverse-transcriptase inhibitors (NNRTIs) switched due to adverse events and group B) subjects switched after a virologic failure on an efavirenz-or nevirapine-based regimen. The primary endpoint was efficacy at 52 weeks analysed by intention-to-treat. Virologic failure was defined as the inability to suppress plasma HIV-RNA to <50 copies/mL after 24 weeks on treatment, or a confirmed viral load >200 copies/mL in patients who had previously achieved a viral suppression or had an undetectable viral load at inclusion. Two hundred eighty seven patients were included. Treatment efficacy rates in group A and B were 88.0% (CI95, 83.9-92.1%) and 77.4% (CI95, 65.0-89.7%), respectively; the rates reached 97.2% (CI95, 95.1-99.3%) and 90.5% (CI95, 81.7-99.3), by on-treatment analysis. The once-a-day ETV treatment was as effective as the twice daily dosing regimen. Grade 1-2 adverse events were observed motivating a treatment switch in 4.2% of the subjects. In conclusion, ETV (once-or twice daily) plus two analogs is a suitable, well-tolerated combination both as a switching strategy and after failure with first generation NNRTIs, ensuring full drug activity.	[Lopez-Cortes, Luis F.; Viciana, Pompeyo] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain; [Giron-Gonzalez, Jose A.] Hosp Univ Puerta del Mar, Cadiz, Spain; [Romero-Palacios, Alberto] Hosp Univ Puerto Real, Cadiz, Spain; [Marquez-Solero, Manuel] Hosp Univ Virgen de la Victoria, Malaga, Spain; [Martinez-Perez, Maria A.] Hosp Univ San Cecilio, Granada, Spain; [Lopez-Ruz, Miguel A.] Hosp Univ Virgen de las Nieves, Granada, Spain; [de la Torre-Lima, Javier] Hosp Costa del Sol, Malaga, Spain; [Tellez-Perez, Francisco] Hosp La Linea, Cadiz, Spain; [Delgado-Fernandez, Marcial] Hosp Univ Carlos Haya, Malaga, Spain; [Garcia-Lazaro, Milagros] Hosp Univ Reina Sofia, Cordoba, Spain; [Lozano, Fernando] Hosp Univ Valme, Seville, Spain; [Mohamed-Balghata, Mohamed O.] Complejo Hospitalario Jaen, Jaen, Spain; [Lopez-Cortes, Luis F.] Hosp Univ Virgen del Rocio, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerto Real; Hospital Virgen de la Victoria; Universidad de Malaga; Hospital Universitario San Cecilio; Hospital Universitario Virgen de las Nieves; Hospital Carlos Haya; Hospital Universitario Reina Sofia - Cordoba; Hospital Valme; Virgen del Rocio University Hospital	Lopez-Cortes, LF (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	lflopez@us.es	Girón-González, José-Antonio/AAG-4199-2020; Girón-González, José-Antonio/H-3990-2014; IBIS, VIH/O-8856-2015; De La Torre-Lima, Javier/B-9904-2019; Lopez.Cortes, Luis Fernando/W-8323-2019	Girón-González, José-Antonio/0000-0002-7482-5828; Girón-González, José-Antonio/0000-0002-7482-5828; De La Torre-Lima, Javier/0000-0003-4718-0320; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Romero Palacios, Alberto/0000-0003-1345-4901; Marquez, Manuel/0000-0002-7901-6966; Tellez, Francisco/0000-0002-9997-6761	Abbott Laboratories (Spain); Bristol-Myers Squibb; Gilead Sciences; Glaxo Smithkline; Roche Pharma S.A.; ViiV Healthcare	Abbott Laboratories (Spain); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Glaxo Smithkline(GlaxoSmithKline); Roche Pharma S.A.; ViiV Healthcare	The authors have read the journal's policy and have the following conflicts: The authors have not conflicts of interest related to this manuscript. However, Luis F. Lopez-Cortes, Pompeyo Viciana, Jose A. Giron-Gonzalez, Manuel Marquez-Solero, Javier de la Torre-Lima, Marcial Delgado-Fernandez, and Fernando Lozano have received honoraria for speaking at symposia organized on behalf of Abbott laboratories (Spain), Bristol-Myers Squibb, Glaxo Smithkline, Gilead Sciences, Janssen-Cilag Espana, Merck Sharp & Dohme Espana, Roche Pharma SA, and ViiV Healthcare. Also, they have received unrestricted funds for research from Abbott Laboratories (Spain), Bristol-Myers Squibb, Bristol-Myers Squibb, Gilead Sciences, Glaxo Smithkline, Roche Pharma S.A., and ViiV Healthcare.	Andries K, 2004, ANTIMICROB AGENTS CH, V48, P4680, DOI 10.1128/AAC.48.12.4680-4686.2004; Boffito M, 2009, JAIDS-J ACQ IMM DEF, V52, P222, DOI 10.1097/QAI.0b013e3181b061d0; Casado JL, 2013, HIV CLIN TRIALS, V14, P1, DOI 10.1410/hct1401-1; Croxtall JD, 2012, DRUGS, V72, P847, DOI 10.2165/11209110-000000000-00000; DeJesus E, 2010, ANTIVIR THER, V15, P711, DOI 10.3851/IMP1562; Estebanez M, 2013, AIDS, V27, P141, DOI 10.1097/QAD.0b013e328358fcc2; European Medicines Agency, 2011, INT PROD INF; Gazzard BG, 2003, AIDS, V17, pF49, DOI 10.1097/00002030-200312050-00001; Gazzard B, 2011, AIDS, V25, P2249, DOI 10.1097/QAD.0b013e32834c4c06; Gruzdev B, 2003, AIDS, V17, P2487, DOI 10.1097/00002030-200311210-00011; Gutierrez-Valencia A, 2012, J ANTIMICROB CHEMOTH, V67, P681, DOI 10.1093/jac/dkr534; Kakuda TN, 2011, CLIN PHARMACOKINET, V50, P25, DOI 10.2165/11534740-000000000-00000; Katlama C, 2010, ANTIVIR THER, V15, P1045, DOI 10.3851/IMP1662; Katlama C, 2009, AIDS, V23, P2289, DOI 10.1097/QAD.0b013e3283316a5e; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Ruxrungtham K, 2008, HIV MED, V9, P883, DOI 10.1111/j.1468-1293.2008.00644.x; Scholler-Gyure M, 2009, CLIN PHARMACOKINET, V48, P561, DOI 10.2165/10895940-000000000-00000; U. S. Food and Drug Administration, 2011, INT FULL PRESCR INF; van Heeswijk RPG, 2013, ANTIVIR THER, V18, P553, DOI 10.3851/IMP2527; Vingerhoets J, 2010, AIDS, V24, P503, DOI 10.1097/QAD.0b013e32833677ac; Waters L, 2011, AIDS, V25, P65, DOI 10.1097/QAD.0b013e328341685b	21	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97262	10.1371/journal.pone.0097262	http://dx.doi.org/10.1371/journal.pone.0097262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836963	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800035
J	Dover, N; Barash, JR; Burke, JN; Hill, KK; Detter, JC; Arnon, SS				Dover, Nir; Barash, Jason R.; Burke, Julianne N.; Hill, Karen K.; Detter, John C.; Arnon, Stephen S.			Arrangement of the Clostridium baratii F7 Toxin Gene Cluster with Identification of a sigma Factor That Recognizes the Botulinum Toxin Gene Cluster Promoters	PLOS ONE			English	Article							NEUROTOXIN COMPLEX; PROTEIN GENES; MOLECULAR CHARACTERIZATION; BACTERIOCIN GENE; EXPRESSION; INFANT; ORGANIZATION; STRAIN; HOMOLOGY; SEQUENCE	Botulinum neurotoxin (BoNT) is the most poisonous substances known and its eight toxin types (A to H) are distinguished by the inability of polyclonal antibodies that neutralize one toxin type to neutralize any of the other seven toxin types. Infant botulism, an intestinal toxemia orphan disease, is the most common form of human botulism in the United States. It results from swallowed spores of Clostridium botulinum (or rarely, neurotoxigenic Clostridium butyricum or Clostridium baratii) that germinate and temporarily colonize the lumen of the large intestine, where, as vegetative cells, they produce botulinum toxin. Botulinum neurotoxin is encoded by the bont gene that is part of a toxin gene cluster that includes several accessory genes. We sequenced for the first time the complete botulinum neurotoxin gene cluster of nonproteolytic C. baratii type F7. Like the type E and the nonproteolytic type F6 botulinum toxin gene clusters, the C. baratii type F7 had an orfX toxin gene cluster that lacked the regulatory botR gene which is found in proteolytic C. botulinum strains and codes for an alternative sigma factor. In the absence of botR, we identified a putative alternative regulatory gene located upstream of the C. baratii type F7 toxin gene cluster. This putative regulatory gene codes for a predicted sigma factor that contains DNA-binding-domain homologues to the DNA-binding domains both of BotR and of other members of the TcdR-related group 5 of the sigma(70) family that are involved in the regulation of toxin gene expression in clostridia. We showed that this TcdR-related protein in association with RNA polymerase core enzyme specifically binds to the C. baratii type F7 botulinum toxin gene cluster promoters. This TcdR-related protein may therefore be involved in regulating the expression of the genes of the botulinum toxin gene cluster in neurotoxigenic C. baratii.	[Dover, Nir; Barash, Jason R.; Burke, Julianne N.; Arnon, Stephen S.] Calif Dept Publ Hlth, Infant Botulism Treatment & Prevent Program, Richmond, CA 94804 USA; [Hill, Karen K.; Detter, John C.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	California Department of Public Health; United States Department of Energy (DOE); Los Alamos National Laboratory	Arnon, SS (corresponding author), Calif Dept Publ Hlth, Infant Botulism Treatment & Prevent Program, Richmond, CA 94804 USA.	Stephen.Arnon@cdph.ca.gov			California Department of Public Health	California Department of Public Health	These studies were supported by the California Department of Public Health. Submission of the manuscript for publication was approved by the California Department of Public Health and by Los Alamos National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash JR, 2005, J CLIN MICROBIOL, V43, P4280, DOI 10.1128/JCM.43.8.4280-4282.2005; Bhandari M, 1997, CURR MICROBIOL, V35, P207, DOI 10.1007/s002849900240; Bradshaw M, 2004, ANAEROBE, V10, P321, DOI 10.1016/j.anaerobe.2004.07.001; Chen Y, 2007, J BACTERIOL, V189, P8643, DOI 10.1128/JB.00784-07; Dineen SS, 2004, FEMS MICROBIOL LETT, V235, P9, DOI 10.1016/j.femsle.2004.04.002; Dover N, 2011, APPL ENVIRON MICROB, V77, P1904, DOI 10.1128/AEM.02422-10; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Dupuy B, 2006, MOL MICROBIOL, V60, P1044, DOI 10.1111/j.1365-2958.2006.05159.x; Dupuy B, 2005, MOL MICROBIOL, V55, P1196, DOI 10.1111/j.1365-2958.2004.04456.x; East AK, 1996, INT J SYST BACTERIOL, V46, P1105, DOI 10.1099/00207713-46-4-1105; Fenicia L, 1999, CLIN INFECT DIS, V29, P1381, DOI 10.1086/313497; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GIMENEZ JA, 1992, INFECT IMMUN, V60, P518; HALL JD, 1985, J CLIN MICROBIOL, V21, P654, DOI 10.1128/JCM.21.4.654-655.1985; Han SO, 2005, J BACTERIOL, V187, P4884, DOI 10.1128/JB.187.14.4884-4889.2005; Hatheway CL, 1996, ADV EXP MED BIOL, V391, P481; HAUSER D, 1995, TOXICON, V33, P515, DOI 10.1016/0041-0101(94)00190-J; HAUSER D, 1994, MOL GEN GENET, V243, P631, DOI 10.1007/BF00279572; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Henderson I, 1996, FEMS MICROBIOL LETT, V140, P151, DOI 10.1016/0378-1097(96)00172-3; HOFFMAN RE, 1982, AM J DIS CHILD, V136, P270, DOI 10.1001/archpedi.1982.03970390084021; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jacobson MJ, 2008, APPL ENVIRON MICROB, V74, P2778, DOI 10.1128/AEM.02828-07; Kubota T, 1998, FEMS MICROBIOL LETT, V158, P215, DOI 10.1016/S0378-1097(97)00525-9; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marvaud JC, 1998, MOL MICROBIOL, V29, P1009, DOI 10.1046/j.1365-2958.1998.00985.x; MIDURA TF, 1972, APPL MICROBIOL, V24, P165, DOI 10.1080/10803920252931230; Nakajima H, 1998, MICROBIOL IMMUNOL, V42, P599, DOI 10.1111/j.1348-0421.1998.tb02330.x; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; PAISLEY JW, 1995, PEDIATR INFECT DIS J, V14, P912; Popoff MR, 2013, TOXICON, V75, P63, DOI 10.1016/j.toxicon.2013.05.003; Raffestin S, 2005, MOL MICROBIOL, V55, P235, DOI 10.1111/j.1365-2958.2004.04377.x; Raffestin S, 2004, ANAEROBE, V10, P93, DOI 10.1016/j.anaerobe.2004.01.001; Raffestin Stephanie, 2009, P1; Raphael BH, 2010, APPL ENVIRON MICROB, V76, P4805, DOI 10.1128/AEM.03109-09; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; SUEN JC, 1988, J CLIN MICROBIOL, V26, P2191, DOI 10.1128/JCM.26.10.2191-2192.1988; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97983	10.1371/journal.pone.0097983	http://dx.doi.org/10.1371/journal.pone.0097983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853378	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200037
J	Lai, YC; Lin, AC; Chiang, MK; Dai, YH; Hsu, CC; Lu, MC; Liau, CY; Chen, YT				Lai, Yi-Chyi; Lin, Ann-Chi; Chiang, Ming-Ko; Dai, Yu-Han; Hsu, Chih-Chieh; Lu, Min-Chi; Liau, Chun-Yi; Chen, Ying-Tsong			Genotoxic Klebsiella pneumoniae in Taiwan	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; CAPSULAR SEROTYPE K1; DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; COLORECTAL-CANCER; GENOMIC HETEROGENEITY; IONIZING-RADIATION; INFECTION; CELLS; ENDOPHTHALMITIS	Background: Colibactin is a nonribosomal peptide-polyketide synthesized by multi-enzyme complexes encoded by the pks gene cluster. Colibactin-producing Escherichia coli have been demonstrated to induce host DNA damage and promote colorectal cancer (CRC) development. In Taiwan, the occurrence of pyogenic liver abscess (PLA) has been suggested to correlate with an increasing risk of CRC, and Klebsiella pneumoniae is the predominant PLA pathogen in Taiwan Methodology/Principal Findings: At the asn tRNA loci of the newly sequenced K. pneumoniae 1084 genome, we identified a 208-kb genomic island, KPHPI208, of which a module identical to the E. coli pks colibactin gene cluster was recognized. KPHPI208 consists of eight modules, including the colibactin module and the modules predicted to be involved in integration, conjugation, yersiniabactin production, microcin production, and unknown functions. Transient infection of BALB/c normal liver cells with K. pneumoniae 1084 increased the phosphorylation of histone H2AX, indicating the induction of host DNA damage. Colibactin was required for the genotoxicity of K. pneumoniae 1084, as it was diminished by deletion of clbA gene and restored to the wild type level by trans-complementation with a clbA coding plasmid. Besides, BALB/c mice infected with K. pneumoniae 1084 exhibited enhanced DNA damage in the liver parenchymal cells when compared to the isogenic clbA deletion mutant. By PCR detection, the prevalence of pks-positive K. pneumoniae in Taiwan is 25.6%, which is higher than that reported in Europe (3.5%), and is significantly correlated with K1 type, which predominantly accounted for PLA in Taiwan. Conclusions: Our knowledge regarding how bacteria contribute to carcinogenesis has just begun. The identification of genotoxic K. pneumoniae and its genetic components will facilitate future studies to elucidate the molecular basis underlying the link between K. pneumoniae, PLA, and CRC.	[Lai, Yi-Chyi; Lu, Min-Chi] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan; [Lai, Yi-Chyi; Lu, Min-Chi] Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Lai, Yi-Chyi; Dai, Yu-Han; Hsu, Chih-Chieh; Lu, Min-Chi] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Lin, Ann-Chi; Chen, Ying-Tsong] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan; [Chiang, Ming-Ko] Natl Chung Cheng Univ, Dept Life Sci, Minxiong, Chia Yi County, Taiwan; [Liau, Chun-Yi; Chen, Ying-Tsong] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; National Health Research Institutes - Taiwan; National Chung Cheng University; National Chung Hsing University; National Chung Hsing University	Chen, YT (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan.	onion@nchu.edu.tw		Chen, Ying-Tsong/0000-0003-1337-4127; LAI, YICHYI/0000-0003-2396-1827	Ministry of Science and Technology (formerly National Science Council) of Taiwan [NSC 101-2311-B-005-002-, 100-2320-B-040-013-, NSC 100-2320-B-040-016-]; National Health Research Institutes [MG-102-PP-15, NHRI-EX103-10327BI]	Ministry of Science and Technology (formerly National Science Council) of Taiwan; National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by the Ministry of Science and Technology (formerly National Science Council) of Taiwan, NSC 101-2311-B-005-002- to Ying-Tsong Chen, 100-2320-B-040-013- to Yi-Chyi Lai, and NSC 100-2320-B-040-016- to Min-Chi Lu, and also in part by intramural grants of the National Health Research Institutes (MG-102-PP-15) to Ying-Tsong Chen and by innovative research grants of National Health Research Institutes (NHRI-EX103-10327BI) to Yi-Chyi Lai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsu WH, 2009, KAOHSIUNG J MED SCI, V25, P98, DOI 10.1016/S1607-551X(09)70048-8; Huang WK, 2012, COLORECTAL DIS, V14, pe794, DOI 10.1111/j.1463-1318.2012.03174.x; Jeong SW, 2012, J GASTROEN HEPATOL, V27, P248, DOI 10.1111/j.1440-1746.2011.06851.x; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Kao WY, 2012, ALIMENT PHARM THER, V36, P467, DOI 10.1111/j.1365-2036.2012.05212.x; Karama Edison Mutsinzi, 2008, International Ophthalmology, V28, P111, DOI 10.1007/s10792-007-9111-4; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Korrapati MC, J PHARM EXP THER, V343, P34; Lagos R, 1999, J BACTERIOL, V181, P212, DOI 10.1128/JB.181.1.212-217.1999; Lai HC, 2010, LIVER INT, V30, P1387, DOI 10.1111/j.1478-3231.2010.02327.x; Lim WC, 2004, J GASTROEN HEPATOL, V19, P945, DOI 10.1111/j.1440-1746.2004.03509.x; Lin AC, 2012, J BACTERIOL, V194, P6316, DOI 10.1128/JB.01548-12; Lin TL, 2008, J BACTERIOL, V190, P515, DOI 10.1128/JB.01219-07; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; Nadasy KA, 2007, CLIN INFECT DIS, V45, pE25, DOI 10.1086/519424; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Paauw A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008662; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suzuki M, 2006, RADIAT RES, V165, P269, DOI 10.1667/RR3508.1; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Tang HL, 2010, EUR J CLIN MICROBIOL, V29, P689, DOI 10.1007/s10096-010-0915-1; THOMPSON W, 1993, INFECT CONT HOSP EP, V14, P203; Tu YC, 2009, INFECT IMMUN, V77, P2657, DOI 10.1128/IAI.01523-08; van Aartsen JJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-59; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Yang CS, 2007, OPHTHALMOLOGY, V114, P876, DOI 10.1016/j.ophtha.2006.12.035; Yeh CC, 2007, J BIOMED SCI, V14, P183, DOI 10.1007/s11373-006-9139-x; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yu WL, 2006, CLIN INFECT DIS, V42, P1351, DOI 10.1086/503420	43	33	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96292	10.1371/journal.pone.0096292	http://dx.doi.org/10.1371/journal.pone.0096292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852749	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200012
J	Golden, AS; Naisilsisili, W; Ligairi, I; Drew, JA				Golden, Abigail S.; Naisilsisili, Waisea; Ligairi, Isikele; Drew, Joshua A.			Combining Natural History Collections with Fisher Knowledge for Community-Based Conservation in Fiji	PLOS ONE			English	Article							TRADITIONAL ECOLOGICAL KNOWLEDGE; MARINE RESOURCE-MANAGEMENT; LIFE-HISTORY; POPULATIONS; PATTERNS	Harnessing the traditional ecological knowledge (TEK) of local communities has the potential to enhance conservation planning in developing regions. Marine protected areas (MPAs) that incorporate traditional beliefs about reef tenure are generally more successful in reaching conservation goals and ensuring the participation of local fishermen on vulnerable tropical reef systems. Fiji possesses a unique system of traditional reef management in which local clans or villages, called mataqali, control individual units of a reef, known as qoliqoli, and make independent management decisions based on traditional beliefs and conservation concerns. This is an example of a system, known as customary marine tenure, which has attracted interest from conservation scientists hoping to set up MPAs in vulnerable regions. As one example of this grassroots participation, Nagigi village on the Fijian island of Vanua Levu has expressed interest in setting up an MPA in part of its qoliqoli because of concerns about overfishing. In response to this interest, we took a two-pronged approach to assessing Nagigi's fishery status and conservation needs, first conducting a fishery-independent species survey using destructive sampling and then focusing on fisheries targets identified through fisher interviews. These interviews allowed us to identify heavily targeted species, assess villagers' understanding of reef dynamics over 30 or 40 years of fisheries expansion, and evaluate village support and expectations for a proposed conservation program. Based on our findings we recommend a temporary closure to be in effect for at least three years, allowing one of the more important fishery targets, Lethrinus harak (Forsskal, 1775; Lethrinidae), to complete at least one generation within the reserve. The methodology of matching the proposed marine protected area with the life histories and ecologies of heavily targeted species identified through fisherman and -woman interviews can offer a template for future conservation projects that seek to synthesize indigenous peoples' needs and knowledge with ecological data.	[Golden, Abigail S.; Drew, Joshua A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Naisilsisili, Waisea] Wildlife Conservat Soc Fiji, Suva, Fiji; [Ligairi, Isikele] Univ S Pacific, Suva, Fiji	Columbia University; University of the South Pacific	Drew, JA (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	jd2977@columbia.edu		Drew, Joshua/0000-0001-9072-0885	Department of Ecology, Evolution and Environmental Biology of Columbia University; Mindlin Foundation	Department of Ecology, Evolution and Environmental Biology of Columbia University; Mindlin Foundation	Funding was provided by the Department of Ecology, Evolution and Environmental Biology of Columbia University and the Mindlin Foundation (http://mindlinfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL A, 1995, DEV CHANGE, V26, P413, DOI 10.1111/j.1467-7660.1995.tb00560.x; Aswani S, 1998, OCEAN COAST MANAGE, V40, P207, DOI 10.1016/S0964-5691(98)00047-7; Aswani S, 2004, ENVIRON CONSERV, V31, P69, DOI 10.1017/S037689290400116X; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; CHAPMAN MD, 1987, AMBIO, V16, P201; Chapman MD, HUMAN ECOLOGY, V15, P267; Cinner JE, 2007, CORAL REEFS, V26, P1035, DOI 10.1007/s00338-007-0213-2; DeMers A, 2012, MAR POLICY, V36, P174, DOI 10.1016/j.marpol.2011.05.001; Drew JA, 2005, CONSERV BIOL, V19, P1286, DOI 10.1111/j.1523-1739.2005.00158.x; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Ebisawa A, 2009, FISHERIES SCI, V75, P553, DOI 10.1007/s12562-009-0061-9; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; FREY DG, 1951, COPEIA, P175, DOI 10.2307/1437557; Gillett R, 2009, FISHERIES EC PACIFIC; Goetze JS, 2013, CORAL REEFS, V32, P121, DOI 10.1007/s00338-012-0970-4; GUNDERMANN N, 1983, PAC SCI, V37, P165; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2010, P ROY SOC B-BIOL SCI, V277, P3715, DOI 10.1098/rspb.2010.1191; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; Johannes RE, 2001, NATL MUS NAT HIST SM, P1, DOI DOI 10.5479/si.00775630.489.1; JOHANNES RE, 1981, WORDS LAGOON; Jones S., 2009, FOOD GENDER FIJI ETH; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Jupiter SD, 2011, J MARINE BIOL, V2011, DOI [10.1155/2011/940765, DOI 10.1155/2011/940765]; Kline MA, 2013, HUM NATURE-INT BIOS, V24, P351, DOI 10.1007/s12110-013-9180-1; Kuster C, 2005, FISH RES, V76, P221, DOI 10.1016/j.fishres.2005.06.011; Lopes PFM, 2011, FISHERIES MANAG ECOL, V18, P400, DOI 10.1111/j.1365-2400.2011.00795.x; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Olds AD, 2014, CONSERVATIO IN PRESS, V28; Randall J.E., 2005, REEF SHORE FISHES S; Richards A, 1994, FIJI FISHERIES AGENC; Roberts CM, 1997, CORAL REEFS, V16, P150, DOI 10.1007/BF03257480; Sabrah Manal M., 2009, World Journal of Fish and Marine Sciences, V1, P121; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; SUDEKUM AE, 1991, FISH B-NOAA, V89, P493; Thornton TF, 2012, ECOL SOC, V17, DOI 10.5751/ES-04714-170308; Unsworth Richard K.F., 2009, Open Marine Biology Journal, V3, P16; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Uthicke S, 1999, B MAR SCI, V64, P129; van Pel H, 1955, REPORT FISHERIES IND; Waterhouse J, 1997, KING PEOPLE FIJI; Zylich K, 2002, FISHERIES CTR WORKIN; [No title captured]	48	22	23	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98036	10.1371/journal.pone.0098036	http://dx.doi.org/10.1371/journal.pone.0098036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849330	gold, Green Submitted, Green Published			2022-12-27	WOS:000336730600079
J	Seo, HH; Park, S; Park, S; Oh, BJ; Back, K; Han, O; Kim, JI; Kim, YS				Seo, Hyo-Hyoun; Park, Sangkyu; Park, Soomin; Oh, Byung-Jun; Back, Kyoungwhan; Han, Oksoo; Kim, Jeong-Il; Kim, Young Soon			Overexpression of a Defensin Enhances Resistance to a Fruit-Specific Anthracnose Fungus in Pepper	PLOS ONE			English	Article							PLANT IMMUNE-SYSTEM; T-DNA INTEGRATION; COLLETOTRICHUM-GLOEOSPORIOIDES; ANTIMICROBIAL PEPTIDES; ANTIFUNGAL ACTION; HOST-DEFENSE; EXPRESSION; GENE; MECHANISM; PROTEINS	Functional characterization of a defensin 1 1 was conducted to evaluate its biotechnological potentiality in transgenic pepper plants against the causal agent of anthracnose disease, Colletotrichum gloeosporioides. To determine antifungal activity, recombinant protein was generated and tested for the activity against C. gloeosporioides, resulting in 50 inhibition of fungal growth at a protein concentration of 0.1 mg.mL(-1). To develop transgenic pepper plants resistant to anthracnose disease, J1-1 cDNA under the control of 35S promoter was introduced into pepper via Agrobacterium-mediated genetic transformation method. Southern and Northern blot analyses confirmed that a single copy of the transgene in elected transgenic plants was normally expressed and also stably transmitted to subsequent generations. The insertion of T-DNA was further analyzed in three independent homozygous lines using inverse PCR, and confirmed the integration of transgene in non-coding region of genomic DNA. Immunoblot results showed that the level of J1-1 proteins, which was not normally accumulated in unripe fruits, accumulated high in transgenic plants but appeared to differ among transgenic lines. Moreover, the expression of jasmonic acid-biosynthetic genes and pathogenesis-related genes were up-regulated in the transgenic lines, which is co-related with the resistance of transgenic plants to anthracnose disease. Consequently, the constitutive expression of J1-1 in transgenic pepper plants provided strong resistance to the anthracnose fungus that associated with highly reduced lesion formation and fungal colonization. These results implied the significance of the antifungal protein J1-1 useful agronomic trait to control fungal disease	[Seo, Hyo-Hyoun] BIO FD&C Co Ltd, Med Nanomat Inst, Inchon, South Korea; [Park, Sangkyu; Back, Kyoungwhan; Han, Oksoo; Kim, Jeong-Il; Kim, Young Soon] Chonnam Natl Univ, Dept Biotechnol, Kwangju, South Korea; [Park, Soomin] Natl Agr Prod Qual Management Serv, Expt Res Inst, Seoul, South Korea; [Oh, Byung-Jun] Jeonnam Bioind Fdn, Biol Control Ctr, Jeollanamdo, South Korea; [Kim, Jeong-Il; Kim, Young Soon] Chonnam Natl Univ, Kumho Life Sci Lab, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kim, JI (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Kwangju, South Korea.	kimji@chonnam.ac.kr; youngskim@chonnam.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00949101]; Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea [309017-5]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (Grant No. PJ00949101), and by Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea (Grant No. 309017-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Naglaa A, 2010, GM Crops, V1, P344, DOI 10.4161/gmcr.1.5.15091; Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Aerts AM, 2007, PLANT CELL REP, V26, P1391, DOI 10.1007/s00299-007-0329-4; Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Chen JJ, 2004, J AGR FOOD CHEM, V52, P2256, DOI 10.1021/jf030662i; Chilton MDM, 2003, PLANT PHYSIOL, V133, P956, DOI 10.1104/pp.103.026104; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; De Coninck B, 2013, FUNGAL BIOL REV, V26, P109, DOI 10.1016/j.fbr.2012.10.002; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dracatos PM, 2014, MOL PLANT PATHOL, V15, P67, DOI 10.1111/mpp.12066; Fan XT, 1998, PLANTA, V204, P444, DOI 10.1007/s004250050278; FilsLycaon BR, 1996, PLANT PHYSIOL, V111, P269, DOI 10.1104/pp.111.1.269; Fritig B, 1998, CURR OPIN IMMUNOL, V10, P16, DOI 10.1016/S0952-7915(98)80025-3; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hayes BME, 2013, ANTIMICROB AGENTS CH, V57, P3667, DOI 10.1128/AAC.00365-13; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim KD, 1999, PHYTOPARASITICA, V27, P97, DOI 10.1007/BF03015074; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; Ko MK, 2007, HORTSCIENCE, V42, P1425, DOI 10.21273/HORTSCI.42.6.1425; Kumar S, 2002, PLANT J, V31, P543, DOI 10.1046/j.1365-313X.2002.01368.x; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Lee SB, 2011, PLANT BIOTECHNOL J, V9, P100, DOI 10.1111/j.1467-7652.2010.00538.x; Lee YH, 2004, PLANT CELL REP, V23, P50, DOI 10.1007/s00299-004-0791-1; Liu YJ, 2006, PROTEINS, V63, P777, DOI 10.1002/prot.20962; MANANDHAR JB, 1995, PLANT DIS, V79, P361, DOI 10.1094/PD-79-0361; Meyer B, 1996, PLANT PHYSIOL, V112, P615, DOI 10.1104/pp.112.2.615; Ntui VO, 2010, PLANT CELL REP, V29, P943, DOI 10.1007/s00299-010-0880-2; Oh BJ, 1998, J PHYTOPATHOL, V146, P301, DOI 10.1111/j.1439-0434.1998.tb04695.x; Oh BJ, 1999, PLANT MOL BIOL, V41, P313, DOI 10.1023/A:1006336203621; Oomen RJFJ, 2011, NEW PHYTOL, V192, P140, DOI 10.1111/j.1469-8137.2011.03792.x; Pakdeevaraporn P, 2005, PLANT BREEDING, V124, P206, DOI 10.1111/j.1439-0523.2004.01065.x; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Pelegrini PB, 2005, INT J BIOCHEM CELL B, V37, P2239, DOI 10.1016/j.biocel.2005.06.011; PEREZ AG, 1993, J PLANT GROWTH REGUL, V12, P163, DOI 10.1007/BF00189648; Sagaram US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018550; Shahzad Z, 2013, NEW PHYTOL, V200, P820, DOI 10.1111/nph.12396; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Tesfaye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058992; Than PP, 2008, J ZHEJIANG UNIV-SC B, V9, P764, DOI 10.1631/jzus.B0860007; Thevissen K, 2003, PEPTIDES, V24, P1705, DOI 10.1016/j.peptides.2003.09.014; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Valente AP, 2013, MOLECULES, V18, P11311, DOI 10.3390/molecules180911311	47	33	34	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97936	10.1371/journal.pone.0097936	http://dx.doi.org/10.1371/journal.pone.0097936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848280	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600070
J	Wado, YD; Afework, MF; Hindin, MJ				Wado, Yohannes Dibaba; Afework, Mesganaw Fantahun; Hindin, Michelle J.			Effects of Maternal Pregnancy Intention, Depressive Symptoms and Social Support on Risk of Low Birth Weight: A Prospective Study from Southwestern Ethiopia	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; PRETERM BIRTH; COGNITIVE FUNCTION; INFANT-MORTALITY; GESTATIONAL-AGE; PRENATAL-CARE; ASSOCIATION; COHORT; DETERMINANTS; VARIABLES	Background: Low birth weight (LBW) is the principal risk factor for neonatal and infant mortality in developing countries. This study examines the effects of unwanted pregnancy, prenatal depression and social support on the risk of low birth weight in rural southwestern Ethiopia. We hypothesized that unwanted pregnancy and prenatal depression increase the risk of low birth weight, while social support mediates this association. Methods: Data for the study comes from a prospective study in which women were followed from pregnancy through to delivery. Six hundred twenty two women were followed and 537 birth weights were measured within 72 hours. Multivariable log binomial regression was used to model the risk of low birth weight. Results: The mean birth weight was 2989 grams (SD +/- 504 grams), and the incidence of LBW was 17.88%. The mean birth weight of babies after unwanted pregnancy was 114 g lower compared to births from intended pregnancy. Similarly, mean birth weight for babies among women with symptoms of antenatal depression was 116 grams lower. Results of unadjusted log-binomial regression showed that unwanted pregnancy, prenatal depression and social support were associated with LBW. The relationship between antenatal depressive symptoms and LBW was mediated by the presence of social support, while the association between LBW and unwanted pregnancy remained after multivariable adjustment. Conclusion: The incidence of low birth weight is high in the study area. Poverty, nonuse of antenatal care, low social support and unwanted pregnancy contribute to this high incidence of low birth weight. Hence, identifying women's pregnancy intention during antenatal care visits, and providing appropriate counseling and social support will help improve birth outcomes.	[Wado, Yohannes Dibaba] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Populat & Family Hlth, Jimma, Ethiopia; [Afework, Mesganaw Fantahun] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Hindin, Michelle J.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Jimma University; Addis Ababa University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wado, YD (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Populat & Family Hlth, Jimma, Ethiopia.	yohannes.dibaba@ju.edu.et		Hindin, Michelle/0000-0001-9941-7639; Wado, Yohannes Dibaba/0000-0002-7200-6116	PhD fellowship - STEP UP Research Programme Consortium; APHRC/the ADDRF Program; STEP UP; Addis Ababa University; Department for International Development (DFID) [201398] Funding Source: researchfish	PhD fellowship - STEP UP Research Programme Consortium; APHRC/the ADDRF Program; STEP UP; Addis Ababa University; Department for International Development (DFID)	This research was partly supported by a PhD fellowship funded in part by the STEP UP Research Programme Consortium through a sub-award grant to the African Population and Health Research Center (APHRC) for the African Doctoral Dissertation Research Fellowships (ADDRF). The authors are very grateful to APHRC/the ADDRF Program and STEP UP for the financial support to conduct this study. The authors are also grateful to Addis Ababa University for its financial support. The funders had no role in design of the study, data collection, analysis, or preparation of the manuscript.	ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Asefa M, 2004, ETHIOP J HLTH SCI, V14, P13; Assefa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039957; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; COLLINS NL, 1993, J PERS SOC PSYCHOL, V65, P1243, DOI 10.1037/0022-3514.65.6.1243; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; CSA and ICF International, 2012, 2011 ETH HLTH DEM SU; Dayan J, 2002, AM J EPIDEMIOL, V155, P293, DOI 10.1093/aje/155.4.293; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; Dubois L, 2006, PEDIATR INT, V48, P470, DOI 10.1111/j.1442-200X.2006.02256.x; EDWARDS CH, 1994, J NUTR, V124, pS1006; Eggleston E, 2001, AM J PUBLIC HEALTH, V91, P808, DOI 10.2105/AJPH.91.5.808; Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432; Evans J, 2007, BRIT J PSYCHIAT, V191, P84, DOI 10.1192/bjp.bp.105.016568; Feldman PJ, 2000, PSYCHOSOM MED, V62, P715, DOI 10.1097/00006842-200009000-00016; Gebremariam A, 2005, East Afr Med J, V82, P554; Gebremedhin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050213; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hediger ML, 2002, PAEDIATR PERINAT EP, V16, P33, DOI 10.1046/j.1365-3016.2002.00393.x; Hirve S S, 1994, Indian Pediatr, V31, P1221; Hohmann-Marriott B, 2009, MATERN CHILD HLTH J, V13, P745, DOI 10.1007/s10995-009-0467-0; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V271, P1340, DOI 10.1001/jama.271.17.1340; Kramer MS, 2005, PAEDIATR PERINAT EP, V19, P445, DOI 10.1111/j.1365-3016.2005.00681.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; M-t Ververs, 2013, PLOS ONE; Manna N, 2013, IOSR JDMS, V4, P33; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Messer LC, 2005, MATERN CHILD HLTH J, V9, P403, DOI 10.1007/s10995-005-0021-7; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; Niemi M, 2013, TROP MED INT HEALTH, V18, P687, DOI 10.1111/tmi.12101; Orr ST, 1996, AM J PREV MED, V12, P459, DOI 10.1016/S0749-3797(18)30268-X; Osler M, 2003, J EPIDEMIOL COMMUN H, V57, P681, DOI 10.1136/jech.57.9.681; Patel V, 2006, BRIT J PSYCHIAT, V188, P284, DOI 10.1192/bjp.bp.105.012096; Rahman A, 2007, ACTA PSYCHIAT SCAND, V115, P481, DOI 10.1111/j.1600-0447.2006.00950.x; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Sable MR, 2000, FAM PLANN PERSPECT, V32, P288, DOI 10.2307/2648197; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; Sen J, 2010, J TROP PEDIATRICS, V56, P254, DOI 10.1093/tropej/fmp102; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; SHARMA R, 1994, J NATL MED ASSOC, V86, P857; Tripathi, 2013, INT J REPROD CONTRAC, V2, P130, DOI [10.5455/2320-1770.ijrcog20130604, DOI 10.5455/2320-1770.IJRCOG20130604]; Tsimbos C, 2011, J BIOSOC SCI, V43, P271, DOI 10.1017/S0021932010000726; UNICF WHO, 2004, LOW BIRTH WEIGHT COU; World Health Organization, 1992, INT STAT CLASS DIS R; Zeleke BM, 2012, PAN AFR MED J, V12	48	55	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96304	10.1371/journal.pone.0096304	http://dx.doi.org/10.1371/journal.pone.0096304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3AL	24848269	Green Submitted, gold, Green Published			2022-12-27	WOS:000336730600010
J	Zheng, J; Xiang, J; Zhou, J; Li, ZW; Hu, ZH; Lo, CM; Wang, WL				Zheng, Jun; Xiang, Jie; Zhou, Jie; Li, Zhiwei; Hu, Zhenhua; Lo, Chung Mau; Wang, Weilin			Liver Grafts for Transplantation from Donors with Diabetes: An Analysis of the Scientific Registry of Transplant Recipients Database	PLOS ONE			English	Article							MARGINAL DONORS; MELLITUS; SURVIVAL; PREVALENCE; STEATOSIS; RISK	Patients with a history of diabetes mellitus (DM) have worse survival than those without DM after liver transplantation. However, the effect of liver grafts from DM donors on the post-transplantation survival of recipients is unclear. Using the Scientific Registry of Transplant Recipients database (2004-2008), 25,413 patients were assessed. Among them, 2,469 recipients received grafts from donors with DM. The demographics and outcome of patients were assessed. Patient survival was assessed using Kaplan-Meier methodology and Cox regression analyses. Recipients from DM donors experienced worse graft survival than recipients from non-DM donors (one-year survival: 81% versus 85%, and five-year survival: 67% versus 74%, P<0.001, respectively). Graft survival was significantly lower for recipients from DM donors with DM duration >5 years (P<0.001) compared with those with DM duration <5 years. Cox regression analyses showed that DM donors were independently associated with worse graft survival (hazard ratio, 1.11; 95% confidence interval, 1.02-1.19). The effect of DM donors was more pronounced on certain underlying liver diseases of recipients. Increases in the risk of graft loss were noted among recipients from DM donors with hepatitis-C virus (HCV) infection, whereas those without HCV experienced similar outcomes compared with recipients from non-DM donors. These data suggest that recipients from DM donors experience significantly worse patient survival after liver transplantation. However, in patients without HCV infection, using DM donors was not independently associated with worse post-transplantation graft survival. Matching these DM donors to recipients without HCV may be safe.	[Zheng, Jun; Xiang, Jie; Zhou, Jie; Li, Zhiwei; Hu, Zhenhua; Wang, Weilin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Jun; Lo, Chung Mau] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Minist Publ Hlth, Key Lab Organ Transplantat, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; University of Hong Kong	Lo, CM (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	chungmlo@hku.hk; zywangwl@163.com			Major State Basic Research Development Program of China (973 Program) [491010-N51308]; National Natural Science Foundation of China [491010-N11180]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (No. 491010-N51308) and National Natural Science Foundation of China (No. 491010-N11180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Blanco JJ, 2001, LIVER TRANSPLANT, V7, P226, DOI 10.1053/jlts.2001.22183; Briceno J, 2007, TRANSPL P, V39, P2297, DOI 10.1016/j.transproceed.2007.07.069; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; John PR, 2001, HEPATOLOGY, V34, P889, DOI 10.1053/jhep.2001.29134; Kim WR, 2013, AM J TRANSPLANT, V13, P73, DOI 10.1111/ajt.12021; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Levine GN, 2006, AM J TRANSPLANT, V6, P1228, DOI 10.1111/j.1600-6143.2006.01277.x; Menon KVN, 2004, AM J TRANSPLANT, V4, P819, DOI 10.1111/j.1600-6143.2004.00433.x; Nadig Satish N, 2007, J Surg Educ, V64, P46, DOI 10.1016/j.cursur.2006.08.001; Nair S, 2002, HEPATOLOGY, V35, P105, DOI 10.1053/jhep.2002.30318; Nocito A, 2006, J HEPATOL, V45, P494, DOI 10.1016/j.jhep.2006.07.017; Samuelson AL, 2010, DIGEST DIS SCI, V55, P2089, DOI 10.1007/s10620-010-1267-5; Shields PL, 1999, TRANSPLANTATION, V68, P530, DOI 10.1097/00007890-199908270-00015; WAHLSTROM HE, 1991, TRANSPLANT P, V23, P1565; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98104	10.1371/journal.pone.0098104	http://dx.doi.org/10.1371/journal.pone.0098104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847864	gold, Green Published			2022-12-27	WOS:000336730600086
J	Gundner, AL; Hahn, I; Sendscheid, O; Aberle, H; Hoch, M				Guendner, Anna Lisa; Hahn, Ines; Sendscheid, Oliver; Aberle, Hermann; Hoch, Michael			The PIKE Homolog Centaurin gamma Regulates Developmental Timing in Drosophila	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE ENHANCER; INSULIN-RESISTANCE; BODY-SIZE; ECDYSONE; GTPASE; METAMORPHOSIS; PROTEIN; GENE; TRANSCRIPTION; DEGRADATION	Phosphoinositide-3-kinase enhancer (PIKE) proteins encoded by the PIKE/CENTG1 gene are members of the gamma subgroup of the Centaurin superfamily of small GTPases. They are characterized by their chimeric protein domain architecture consisting of a pleckstrin homology (PH) domain, a GTPase-activating (GAP) domain, Ankyrin repeats as well as an intrinsic GTPase domain. In mammals, three PIKE isoforms with variations in protein structure and subcellular localization are encoded by the PIKE locus. PIKE inactivation in mice results in a broad range of defects, including neuronal cell death during brain development and misregulation of mammary gland development. PIKE -/- mutant mice are smaller, contain less white adipose tissue, and show insulin resistance due to misregulation of AMP-activated protein kinase (AMPK) and insulin receptor/Akt signaling. here, we have studied the role of PIKE proteins in metabolic regulation in the fly. We show that the Drosophila PIKE homolog, ceng1A, encodes functional GTPases whose internal GAP domains catalyze their GTPase activity. To elucidate the biological function of ceng1A in flies, we introduced a deletion in the ceng1A gene by homologous recombination that removes all predicted functional PIKE domains. We found that homozygous ceng1A mutant animals survive to adulthood. In contrast to PIKE -/- mouse mutants, genetic ablation of Drosophila ceng1A does not result in growth defects or weight reduction. Although metabolic pathways such as insulin signaling, sensitivity towards starvation and mobilization of lipids under high fed conditions are not perturbed in ceng1A mutants, homozygous ceng1A mutants show a prolonged development in second instar larval stage, leading to a late onset of pupariation. In line with these results we found that expression of ecdysone inducible genes is reduced in ceng1A mutants. Together, we propose a novel role for Drosophila Ceng1A in regulating ecdysone signaling-dependent second to third instar larval transition.	[Guendner, Anna Lisa; Hahn, Ines; Sendscheid, Oliver; Hoch, Michael] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany; [Aberle, Hermann] Univ Dusseldorf, Dusseldorf, Germany	University of Bonn; Heinrich Heine University Dusseldorf	Hoch, M (corresponding author), Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany.	m.hoch@uni-bonn.de	Hahn, Ines/V-6607-2019; Aberle, Hermann/L-8461-2017	Hahn, Ines/0000-0001-7703-8160; Aberle, Hermann/0000-0002-4864-6105	German Research Foundation [SFB 645, TR 83]; International Graduate School LIMES Chemical Biology	German Research Foundation(German Research Foundation (DFG)); International Graduate School LIMES Chemical Biology	MH obtained funding from the German Research Foundation (SFB 645 and TR 83). ALG was funded by the International Graduate School LIMES Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2005, INT J BIOL SCI, V1, P44; Ahn JY, 2004, EMBO J, V23, P3995, DOI 10.1038/sj.emboj.7600392; Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Chan CB, 2007, J CELL MOL MED, V11, P39, DOI 10.1111/j.1582-4934.2007.00014.x; Chan Chi Bun, 2012, Adv Biol Regul, V52, P66; Chan CB, 2012, REV NEUROSCIENCE, V23, P153, DOI 10.1515/revneuro-2011-0066; Chan CB, 2011, EMBO J, V30, P4274, DOI 10.1038/emboj.2011.281; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chan CB, 2010, THESCIENTIFICWORLDJO, V10, P613, DOI 10.1100/tsw.2010.64; Chan CB, 2010, DIABETES, V59, P883, DOI 10.2337/db09-1404; Davis MB, 2005, DEV BIOL, V282, P385, DOI 10.1016/j.ydbio.2005.03.019; FLETCHER JC, 1995, DEVELOPMENT, V121, P1411; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Orme MH, 2005, CELL METAB, V2, P277, DOI 10.1016/j.cmet.2005.10.005; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Reiser G, 2004, NEUROREPORT, V15, P147, DOI 10.1097/00001756-200401190-00028; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Rong YS, 2001, GENETICS, V157, P1307; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Tang XL, 2008, NAT CELL BIOL, V10, P698, DOI 10.1038/ncb1732; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Xia CZ, 2003, MOL CELL BIOL, V23, P2476, DOI 10.1128/MCB.23.7.2476-2488.2003; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97332	10.1371/journal.pone.0097332	http://dx.doi.org/10.1371/journal.pone.0097332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845618	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400022
J	Kinsey-Jones, JS; Beale, KE; Cuenco, J; Li, XF; Bloom, SR; O'Byrne, KT; Murphy, KG				Kinsey-Jones, James S.; Beale, Kylie E.; Cuenco, Joy; Li, Xiao Feng; Bloom, Stephen R.; O'Byrne, Kevin T.; Murphy, Kevin G.			Quantification of Rat Kisspeptin Using a Novel Radioimmunoassay	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PROTEIN-COUPLED RECEPTOR; MESSENGER-RNA EXPRESSION; PITUITARY-GONADAL AXIS; ARCUATE NUCLEUS; SEXUAL-DIMORPHISM; GENE-EXPRESSION; FEMALE MOUSE; NEURONS; KISS-1	Kisspeptin is a hypothalamic peptide hormone that plays a pivotal role in pubertal onset and reproductive function. Previous studies have examined hypothalamic kisspeptin mRNA expression, either through in situ hybridisation or real-time RT-PCR, as a means quantifying kisspeptin gene expression. However, mRNA expression levels are not always reflected in levels of the translated protein. Kisspeptin-immunoreactivity (IR) has been extensively examined using immunohistochemistry, enabling detection and localisation of kisspeptin perikaya in the arcuate nucleus (ARC) and anteroventral periventricular nucleus (AVPV). However, quantification of kisspeptin-IR remains challenging. We developed a specific rodent radioimmunoassay assay (RIA) capable of detecting and quantifying kisspeptin-IR in rodent tissues. The RIA uses kisspeptin-10 as a standard and radioactive tracer, combined with a commercially available antibody raised to the kisspeptin-10 fragment. Adult female wistar rat brain samples were sectioned at 300 mm and the ARC and AVPV punch micro-dissected. Brain punches were homogenised in extraction buffer and assayed with rodent kisspeptin-RIA. In accord with the pattern of kisspeptin mRNA expression, kisspeptin-IR was detected in both the ARC (47.1 +/- 6.2 fmol/punch, mean +/- SEM n = 15) and AVPV (7.6 +/- 1.3 fmol/punch, mean +/- SEM n = 15). Kisspeptin-IR was also detectable in rat placenta (1.26 +/- 0.15 fmol/mg). Reverse phase high pressure liquid chromatography analysis showed that hypothalamic kisspeptin-IR had the same elution profile as a synthetic rodent kisspeptin standard. A specific rodent kisspeptin-RIA will allow accurate quantification of kisspeptin peptide levels within specific tissues in rodent experimental models.	[Kinsey-Jones, James S.; Beale, Kylie E.; Cuenco, Joy; Bloom, Stephen R.; Murphy, Kevin G.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Invest Med, London, England; [Li, Xiao Feng; O'Byrne, Kevin T.] Kings Coll London, Sch Med, Div Womens Hlth, London, England	Imperial College London; University of London; King's College London	Murphy, KG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Invest Med, London, England.	k.g.murphy@imperial.ac.uk		Murphy, Kevin/0000-0002-3417-0310	MRC; BBSRC; NIHR; Wellcome trust an Integrative Mammalian Biology (IMB) Capacity Building Award [FP7-HEALTH- 2009- 241592 EurOCHIP]; BBSRC [BB/E52708X/1, BB/J002232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1, BB/J002232/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10337, NF-SI-0513-10080] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR(National Institute for Health Research (NIHR)); Wellcome trust an Integrative Mammalian Biology (IMB) Capacity Building Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Section is funded by grants from the MRC, BBSRC, NIHR, Wellcome trust an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH- 2009- 241592 EurOCHIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Bloom SR, 1982, RADIOIMMUNOASSAY GUT; Brailoiu GC, 2005, J COMP NEUROL, V481, P314, DOI 10.1002/cne.20350; Castellano JM, 2010, AM J PHYSIOL-ENDOC M, V299, pE54, DOI 10.1152/ajpendo.00081.2010; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Desroziers E, 2010, J NEUROENDOCRINOL, V22, P1101, DOI 10.1111/j.1365-2826.2010.02053.x; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hrabovszky E, 2010, EUR J NEUROSCI, V31, P1984, DOI 10.1111/j.1460-9568.2010.07239.x; Iijima N, 2011, J MOL NEUROSCI, V43, P146, DOI 10.1007/s12031-010-9433-y; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kirilov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3492; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mark PJ, 2013, PLACENTA, V34, P657, DOI 10.1016/j.placenta.2013.04.012; Mikkelsen JD, 2009, PEPTIDES, V30, P26, DOI 10.1016/j.peptides.2008.09.004; Mittelman-Smith MA, 2012, ENDOCRINOLOGY, V153, P2800, DOI 10.1210/en.2012-1045; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Murphy KG, 2000, J ENDOCRINOL, V166, P659, DOI 10.1677/joe.0.1660659; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Palkovits M., 1988, MAPS GUIDE MICRODISS; Roa J, 2006, ENDOCRINOLOGY, V147, P2864, DOI 10.1210/en.2005-1463; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Stafford LJ, 2002, CANCER RES, V62, P5399; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thompson EL, 2004, J NEUROENDOCRINOL, V16, P850, DOI 10.1111/j.1365-2826.2004.01240.x; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Yamada S, 2007, ENDOCRINOLOGY, V148, P2226, DOI 10.1210/en.2006-1529	38	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97611	10.1371/journal.pone.0097611	http://dx.doi.org/10.1371/journal.pone.0097611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845101	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400039
J	Maruthi, MN; Bouvaine, S; Tufan, HA; Mohammed, IU; Hillocks, RJ				Maruthi, M. N.; Bouvaine, Sophie; Tufan, Hale A.; Mohammed, Ibrahim U.; Hillocks, Rory J.			Transcriptional Response of Virus-Infected Cassava and Identification of Putative Sources of Resistance for Cassava Brown Streak Disease	PLOS ONE			English	Article							RT-PCR ASSAYS; RNA; DISTINCT	Cassava (Manihot esculenta) is a major food staple in sub-Saharan Africa, which is severely affected by cassava brown streak disease (CBSD). The aim of this study was to identify resistance for CBSD as well as to understand the mechanism of putative resistance for providing effective control for the disease. Three cassava varieties; Kaleso, Kiroba and Albert were inoculated with cassava brown streak viruses by grafting and also using the natural insect vector the whitefly, Bemisia tabaci. Kaleso expressed mild or no disease symptoms and supported low concentrations of viruses, which is a characteristic of resistant plants. In comparison, Kiroba expressed severe leaf but milder root symptoms, while Albert was susceptible with severe symptoms both on leaves and roots. Real-time PCR was used to estimate virus concentrations in cassava varieties. Virus quantities were higher in Kiroba and Albert compared to Kaleso. The Illumina RNA-sequencing was used to further understand the genetic basis of resistance. More than 700 genes were uniquely overexpressed in Kaleso in response to virus infection compared to Albert. Surprisingly, none of them were similar to known resistant gene orthologs. Some of the overexpressed genes, however, belonged to the hormone signalling pathways and secondary metabolites, both of which are linked to plant resistance. These genes should be further characterised before confirming their role in resistance to CBSD.	[Maruthi, M. N.; Bouvaine, Sophie; Tufan, Hale A.; Mohammed, Ibrahim U.; Hillocks, Rory J.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	University of Greenwich	Maruthi, MN (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, Kent, England.	mm02@gre.ac.uk	Gowda, Maruthi M. N./A-3507-2008	Gowda, Maruthi M. N./0000-0002-8060-866X; bouvaine, sophie/0000-0002-0788-3243	African Union Commission [AURG/2/141/2012]; University of Greenwich [E0198]	African Union Commission; University of Greenwich	The authors acknowledge the funding received for part of this work from the African Union Commission through the grant: AURG/2/141/2012. Some of the costs were covered internally by the University of Greenwich by employing HAT for carrying out this work (grant ID E0198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi MM, 2012, J VIROL METHODS, V179, P176, DOI 10.1016/j.jviromet.2011.10.020; Abarshi MM, 2010, J VIROL METHODS, V163, P353, DOI 10.1016/j.jviromet.2009.10.023; Adams IP, 2013, PLANT PATHOL, V62, P233, DOI 10.1111/j.1365-3059.2012.02622.x; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; COOPER JI, 1983, PHYTOPATHOLOGY, V73, P127, DOI 10.1094/Phyto-73-127; Ferguson ME, 2012, THEOR APPL GENET, V124, P685, DOI 10.1007/s00122-011-1739-9; Gedil M., 2012, African Journal of Biotechnology, V11, P15111; Hillocks R., 2002, CASSAVA BIOL PRODUCT, DOI DOI 10.1079/9780851995243.0000; Hillocks RJ, 2003, INT J PEST MANAGE, V49, P225, DOI 10.1080/0967087031000101061; Hillocks RJ, 2001, J PHYTOPATHOL, V149, P389, DOI 10.1046/j.1439-0434.2001.00641.x; Hillocks RJ, 1996, INT J PEST MANAGE, V42, P285, DOI 10.1080/09670879609372008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JENNINGS D. L., 1960, Empire Journal of Experimental Agriculture, V28, P261; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruthi MN, 2005, J PHYTOPATHOL, V153, P307, DOI 10.1111/j.1439-0434.2005.00974.x; Maruthi MN, 2002, VIRUS RES, V86, P71, DOI 10.1016/S0168-1702(02)00051-5; Maruthi MN, 2001, ENTOMOL EXP APPL, V99, P13, DOI 10.1023/A:1018944606924; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; McSween S, 2006, EC IMPACT FOOD 438 S, V40; Mkamilo G. S., 2005, AFR CROP SCI C P, V7, P1311; Mohammed IU, 2012, ADV VIROL, V2012, DOI 10.1155/2012/795697; Monger WA, 2010, ARCH VIROL, V155, P429, DOI 10.1007/s00705-009-0581-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulimbi W., 2012, New Disease Reports, V26, P11, DOI 10.5197/j.2044-0588.2012.026.011; Mware B, 2009, JGMV, V1, P040, DOI [DOI 10.1007/S007050070078, 10.5897/JGMV.9000003, DOI 10.5897/JGMV.9000003]; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; NICHOLS R. F. W., 1950, EAST AFRICAN AGRIC JOUR, V15, P154; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Palukaitis P, 2008, J PLANT PATHOL, V90, P153; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Vanderschuren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045277; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Yadav JS, 2011, MOL PLANT PATHOL, V12, P677, DOI 10.1111/J.1364-3703.2010.00700.X; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	43	56	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96642	10.1371/journal.pone.0096642	http://dx.doi.org/10.1371/journal.pone.0096642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846209	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000339563400007
J	Musafia, B; Oren-Banaroya, R; Noiman, S				Musafia, Boaz; Oren-Banaroya, Rony; Noiman, Silvia			Designing Anti-Influenza Aptamers: Novel Quantitative Structure Activity Relationship Approach Gives Insights into Aptamer - Virus Interaction	PLOS ONE			English	Article							RNA APTAMER; DEXTRAN SULFATE; IN-VITRO; INFLUENZA; POLYMERS; INFECTION; BLOCKING; FUSION; HEMAGGLUTININ; PREDICTION	This study describes the development of aptamers as a therapy against influenza virus infection. Aptamers are oligonucleotides (like ssDNA or RNA) that are capable of binding to a variety of molecular targets with high affinity and specificity. We have studied the ssDNA aptamer BV02, which was designed to inhibit influenza infection by targeting the hemagglutinin viral protein, a protein that facilitates the first stage of the virus' infection. While testing other aptamers and during lead optimization, we realized that the dominant characteristics that determine the aptamer's binding to the influenza virus may not necessarily be sequence-specific, as with other known aptamers, but rather depend on general 2D structural motifs. We adopted QSAR (quantitative structure activity relationship) tool and developed computational algorithm that correlate six calculated structural and physicochemical properties to the aptamers' binding affinity to the virus. The QSAR study provided us with a predictive tool of the binding potential of an aptamer to the influenza virus. The correlation between the calculated and actual binding was R-2 = 0.702 for the training set, and R-2 = 0.66 for the independent test set. Moreover, in the test set the model's sensitivity was 89%, and the specificity was 87%, in selecting aptamers with enhanced viral binding. The most important properties that positively correlated with the aptamer's binding were the aptamer length, 2D-loops and repeating sequences of C nucleotides. Based on the structure-activity study, we have managed to produce aptamers having viral affinity that was more than 20 times higher than that of the original BV02 aptamer. Further testing of influenza infection in cell culture and animal models yielded aptamers with 10 to 15 times greater anti-viral activity than the BV02 aptamer. Our insights concerning the mechanism of action and the structural and physicochemical properties that govern the interaction with the influenza virus are discussed.	[Musafia, Boaz; Oren-Banaroya, Rony] Bio Vent Ltd, Ashqelon, Israel; [Noiman, Silvia] Pontifax Inc, Herzliyya, Israel		Musafia, B (corresponding author), Bio Vent Ltd, Ashqelon, Israel.	boaz@bio-vent.com			Israeli Incubators ATI Technologies; Pontifax, Ltd; Roche Holding, Ltd.; Prof. Ruth Arnon Canada - Israel, Ltd.	Israeli Incubators ATI Technologies; Pontifax, Ltd; Roche Holding, Ltd.; Prof. Ruth Arnon Canada - Israel, Ltd.	No external funding sources for this study. All the study was supported by Bio-Vent's resources. Bio-Vent funders are: Israeli Incubators ATI Technologies (http://www.gefenbiomed.com/ati.php); Pontifax, Ltd; Roche Holding, Ltd. (www.roche.com); Prof. Ruth Arnon Canada - Israel, Ltd. (http://www.canada-israel.com). The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aquino-Jarquin G, 2011, INT J MOL SCI, V12, P9155, DOI 10.3390/ijms12129155; BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; Bernstein DI, 2008, ANTIMICROB AGENTS CH, V52, P2727, DOI 10.1128/AAC.00279-08; Bing T, 2010, BIOORGAN MED CHEM, V18, P1798, DOI 10.1016/j.bmc.2010.01.054; Binning JM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00029; Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547; Cardin RD, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-214; Choi SK, 2012, MOL CELLS, V32, P527; De Clercq E, 2001, J PHARMACOL EXP THER, V297, P1; DELISI C, 1971, P NATL ACAD SCI USA, V68, P2682, DOI 10.1073/pnas.68.11.2682; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Este JA, 1997, MOL PHARMACOL, V52, P98, DOI 10.1124/mol.52.1.98; Fischer NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002720; Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Hayden FG, 2013, INFLUENZA OTHER RESP, V7, P63, DOI 10.1111/irv.12045; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Huynen MA, 1996, J MOL EVOL, V43, P165; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; Jeon SH, 2004, J BIOL CHEM, V279, P48410, DOI 10.1074/jbc.M409059200; Kapetanovic IM, 2008, CHEM-BIOL INTERACT, V171, P165, DOI 10.1016/j.cbi.2006.12.006; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Matsumura T, 2009, GASTROENTEROLOGY, V137, P673, DOI 10.1053/j.gastro.2009.04.048; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-27; NUSSINOV R, 1978, SIAM J APPL MATH, V35, P68, DOI 10.1137/0135006; Park SY, 2011, NUCLEIC ACID THER, V21, P395, DOI 10.1089/nat.2011.0321; Peyret N., 2000, PREDICTION NUCL ACID; Platt M, 2009, INTEGR BIOL-UK, V1, P116, DOI 10.1039/b814892a; Preziosi P, 2011, EXPERT OPIN PHARMACO, V12, P1523, DOI 10.1517/14656566.2011.566557; Rockey WM, 2011, NUCLEIC ACID THER, V21, P299, DOI 10.1089/nat.2011.0313; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sidwell RW, 2000, ANTIVIR RES, V48, P1, DOI 10.1016/S0166-3542(00)00125-X; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Triana-Baltzer GB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007788; Vaillant A, 2006, ANTIMICROB AGENTS CH, V50, P1393, DOI 10.1128/AAC.50.4.1393-1401.2006; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	33	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97696	10.1371/journal.pone.0097696	http://dx.doi.org/10.1371/journal.pone.0097696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846127	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400045
J	Nousiainen, HO; Quintero, IB; Myohanen, TT; Voikar, V; Mijatovic, J; Segerstrale, M; Herrala, AM; Kulesskaya, N; Pulkka, AE; Kivinummi, T; Abo-Ramadan, U; Taira, T; Piepponen, TP; Rauvala, H; Vihko, P				Nousiainen, Heidi O.; Quintero, Ileana B.; Myohanen, Timo T.; Voikar, Vootele; Mijatovic, Jelena; Segerstrale, Mikael; Herrala, Annakaisa M.; Kulesskaya, Natalia; Pulkka, Anitta E.; Kivinummi, Tanja; Abo-Ramadan, Usama; Taira, Tomi; Piepponen, T. Petteri; Rauvala, Heikki; Vihko, Pirkko			Mice Deficient in Transmembrane Prostatic Acid Phosphatase Display Increased GABAergic Transmission and Neurological Alterations	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; SNAP-25; PROTEINS; NEURONS; BRAIN; ENDOPHENOTYPES; LOCALIZATION; HIPPOCAMPUS; TRAFFICKING; INHIBITION	Prostatic acid phosphatase (PAP), the first diagnostic marker and present therapeutic target for prostate cancer, modulates nociception at the dorsal root ganglia (DRG), but its function in the central nervous system has remained unknown. We studied expression and function of TMPAP (the transmembrane isoform of PAP) in the brain by utilizing mice deficient in TMPAP (PAP(-/-) mice). Here we report that TMPAP is expressed in a subpopulation of cerebral GABAergic neurons, and mice deficient in TMPAP show multiple behavioral and neurochemical features linked to hyperdopaminergic dysregulation and altered GABAergic transmission. In addition to increased anxiety, disturbed prepulse inhibition, increased synthesis of striatal dopamine, and augmented response to amphetamine, PAP-deficient mice have enlarged lateral ventricles, reduced diazepam-induced loss of righting reflex, and increased GABAergic tone in the hippocampus. TMPAP in the mouse brain is localized presynaptically, and colocalized with SNARE-associated protein snapin, a protein involved in synaptic vesicle docking and fusion, and PAP-deficient mice display altered subcellular distribution of snapin. We have previously shown TMPAP to reside in prostatic exosomes and we propose that TMPAP is involved in the control of GABAergic tone in the brain also through exocytosis, and that PAP deficiency produces a distinct neurological phenotype.	[Nousiainen, Heidi O.; Quintero, Ileana B.; Herrala, Annakaisa M.; Pulkka, Anitta E.; Vihko, Pirkko] Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; [Nousiainen, Heidi O.; Quintero, Ileana B.; Herrala, Annakaisa M.; Pulkka, Anitta E.; Vihko, Pirkko] Univ Helsinki, Hosp Lab, Helsinki, Finland; [Myohanen, Timo T.; Mijatovic, Jelena; Kivinummi, Tanja; Piepponen, T. Petteri] Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland; [Voikar, Vootele; Segerstrale, Mikael; Kulesskaya, Natalia; Taira, Tomi; Rauvala, Heikki] Univ Helsinki, Neurosci Ctr, Helsinki, Finland; [Voikar, Vootele; Segerstrale, Mikael; Kulesskaya, Natalia; Taira, Tomi] Univ Helsinki, Fac Biol & Environm Sci, Dept Biosci, Helsinki, Finland; [Abo-Ramadan, Usama] Univ Helsinki, Cent Hosp, Dept Neurol, Expt MRI Lab, Helsinki, Finland; [Abo-Ramadan, Usama] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Taira, Tomi] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Vihko, P (corresponding author), Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland.	pirkko.vihko@helsinki.fi	Voikar, Vootele/V-4542-2019; Myohanen, Timo/N-8438-2014	Voikar, Vootele/0000-0003-4201-8666; Quintero, Ileana/0000-0001-7040-1289; Piepponen, Petteri/0000-0002-2318-1612; Myohanen, Timo/0000-0002-9277-6687; Rauvala, Heikki/0000-0001-7809-9811; Kulesskaya, Natalia/0000-0001-5517-8525	Academy of Finland [132201]; Sigrid Juselius Foundation; Biocenter Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocenter Finland	This work was supported by grants from The Academy of Finland, http://www.aka.fi/en-GB/A/, (grant no. 132201 to Prof. P. Vihko), and The Sigrid Juselius Foundation, http://www.sigridjuselius.fi/foundation, (to Prof. P. Vihko). The Behavioral Analysis Unit (V. Voikar) is funded by Biocenter Finland, http://www.biocenter.fi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2006, SYNAPSE, V59, P321, DOI 10.1002/syn.20245; Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; [Anonymous], ALL BRAIN ATL RES; Apostolova L, 2012, NEUROBIOL AGING, V33, P2113, DOI 10.1016/j.neurobiolaging.2011.06.014; Bagga P, 2013, J NEUROCHEM, V127, P365, DOI 10.1111/jnc.12407; Barakauskas VE, 2010, NEUROPSYCHOPHARMACOL, V35, P1226, DOI 10.1038/npp.2009.228; Beyer MK, 2013, MOVEMENT DISORD, V28, P302, DOI 10.1002/mds.25282; BUNNEY BS, 1976, SCIENCE, V192, P391, DOI 10.1126/science.1257777; CARLSSON A, 1973, J NEURAL TRANSM, V34, P79, DOI 10.1007/BF01244661; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Dalaker TO, 2011, MOVEMENT DISORD, V26, P297, DOI 10.1002/mds.23443; Dando R, 2012, J NEUROSCI, V32, P322, DOI 10.1523/JNEUROSCI.4070-11.2012; Dickman DK, 2012, J NEUROSCI, V32, P8716, DOI 10.1523/JNEUROSCI.5465-11.2012; Fatemi SH, 2001, NEUROREPORT, V12, P3257, DOI 10.1097/00001756-200110290-00023; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Jaaro-Peled H, 2010, SCHIZOPHRENIA BULL, V36, P301, DOI 10.1093/schbul/sbp133; Jeans AF, 2007, P NATL ACAD SCI USA, V104, P2431, DOI 10.1073/pnas.0610222104; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Kulesskaya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024755; Lauri SE, 2006, NEURON, V50, P415, DOI 10.1016/j.neuron.2006.03.020; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Mijatovic J, 2008, J NEUROCHEM, V105, P1716, DOI 10.1111/j.1471-4159.2008.05265.x; Myohanen TT, 2008, J COMP NEUROL, V507, P1694, DOI 10.1002/cne.21642; Myohanen TT, 2010, J NEUROCHEM, V113, P1632, DOI 10.1111/j.1471-4159.2010.06723.x; Ohtsuka N, 2013, GENESIS, V51, P234, DOI 10.1002/dvg.22370; Okada M, 1996, NEUROSCI LETT, V212, P53, DOI 10.1016/0304-3940(96)12780-4; Oliver PL, 2009, HUM MOL GENET, V18, P4576, DOI 10.1093/hmg/ddp425; Olopade FE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-19; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; Quintero IB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073072; RUIGROK TJH, 1993, MICROSC RES TECHNIQ, V24, P85, DOI 10.1002/jemt.1070240108; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Schoen SW, 1997, BRAIN RES PROTOC, V1, P33, DOI 10.1016/S1385-299X(96)00006-2; Schubert KO, 2012, MOL PSYCHIATR, V17, P669, DOI 10.1038/mp.2011.123; Street SE, 2013, J NEUROSCI, V33, P11314, DOI 10.1523/JNEUROSCI.0133-13.2013; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Tang X, 2014, HUM BRAIN MAPP; The Jackson Laboratory, 2003, JAX NOTES; Thompson PM, 2003, BIOL PSYCHIAT, V53, P1132, DOI 10.1016/S0006-3223(02)01599-8; Thompson PM, 2003, PROG NEURO-PSYCHOPH, V27, P411, DOI 10.1016/S0278-5846(03)00027-7; Tornberg J, 2007, NEUROPSYCHOPHARMACOL, V32, P911, DOI 10.1038/sj.npp.1301195; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; VIHKO P, 1979, INVEST UROL, V16, P349; Vihko P., 2005, P AACR 96 ANN M AN C; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027; Zhang Z, 2013, J NEUROSCI, V33, P9169, DOI 10.1523/JNEUROSCI.0301-13.2013; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97851	10.1371/journal.pone.0097851	http://dx.doi.org/10.1371/journal.pone.0097851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846136	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400065
J	Somfai, T; Yoshioka, K; Tanihara, F; Kaneko, H; Noguchi, J; Kashiwazaki, N; Nagai, T; Kikuchi, K				Somfai, Tamas; Yoshioka, Koji; Tanihara, Fuminori; Kaneko, Hiroyuki; Noguchi, Junko; Kashiwazaki, Naomi; Nagai, Takashi; Kikuchi, Kazuhiro			Generation of Live Piglets from Cryopreserved Oocytes for the First Time Using a Defined System for In Vitro Embryo Production	PLOS ONE			English	Article							PORCINE OOCYTES; FOLLICULAR-FLUID; MOUSE OOCYTES; DEVELOPMENTAL COMPETENCE; INTRACELLULAR ICE; BOAR SPERMATOZOA; WARMING RATE; FERTILIZATION; BLASTOCYSTS; MATURATION	We report the successful piglet production from cryopreserved oocytes for the first time by using a simple, high capacity vitrification protocol for preservation and a defined system for in vitro embryo production. Immature cumulus-oocyte complexes (COCs) from prepubertal gilts were vitrified in microdrops and stored in liquid nitrogen. After warming, COCs were subjected to in vitro maturation (IVM), fertilization (IVF), and subsequent culture (IVC). Adjusting warmplate temperature to 42 degrees C during warming prevented temperature drops in a medium below 34.0 degrees C and significantly increased the percentage of oocyte survival and thus blastocyst yields obtained from total vitrified oocytes compared with that of warming at 38 degrees C (87.1% vs 66.9% and 4.4% vs 2.7%, respectively). Nuclear maturation and fertilization of oocytes were not affected by vitrification and warming temperature. Blastocyst development on day 7 (day 0 = IVF) of the surviving oocytes after warming at 38 degrees C and 42 degrees C was not different but lower (P<0.05) than those of non-vitrified control oocytes (4.6%, 5.2% and 17.9%, respectively). However, blastocyst cell numbers in the control and vitrified groups were similar irrespective of warming temperature. Omitting porcine follicular fluid (pFF) from IVM medium (POM) did not affect maturation, fertilization and embryo development of vitrified-warmed oocytes. Transfer of blastocysts obtained on day 5 from vitrified oocytes matured either with or without pFF into 4 recipients (2 for each group) resulted in 4 pregnancies and the delivery of a total of 18 piglets. In conclusion, optimization of warming temperature was a key factor for achieving high survival rates, and surviving oocytes could be utilized in vitro using defined media. Using these modifications, live piglets could be obtained from cryopreserved oocytes for the first time.	[Somfai, Tamas] NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Tsukuba, Ibaraki, Japan; [Yoshioka, Koji] Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki 305, Japan; [Tanihara, Fuminori; Kaneko, Hiroyuki; Noguchi, Junko; Kikuchi, Kazuhiro] Natl Inst Agrobiol Sci, Anim Dev & Differentiat Res Unit, Tsukuba, Ibaraki, Japan; [Tanihara, Fuminori; Kikuchi, Kazuhiro] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Sagamihara, Kanagawa, Japan; [Nagai, Takashi] Food & Fertilizer Technol Ctr, Taipei, Taiwan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institute of Agrobiological Sciences - Japan; Yamaguchi University; Azabu University	Somfai, T (corresponding author), NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Tsukuba, Ibaraki, Japan.	somfai@affrc.go.jp		Tanihara, Fuminori/0000-0002-2158-5808	JSPS [25292184, 22380153]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from MAFF [25052C]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from MAFF	This work was supported by a Grant-in-Aid for Scientific Research from JSPS to K.Y. (25292184) and K.K. (22380153), and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from MAFF to K.Y. (25052C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Algriany O, 2004, THERIOGENOLOGY, V62, P1483, DOI 10.1016/j.theriogenology.2004.02.008; Dinnyes A, 2000, BIOL REPROD, V63, P513, DOI 10.1095/biolreprod63.2.513; Egerszegi I, 2013, CRYOBIOLOGY, V67, P287, DOI 10.1016/j.cryobiol.2013.08.009; Grupen CG, 2010, REPROD FERT DEVELOP, V22, P1100, DOI 10.1071/RD09307; HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U; Ju JC, 2004, MOL REPROD DEV, V68, P125, DOI 10.1002/mrd.20054; Karja NWK, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-54; KIKUCHI K, 1993, THERIOGENOLOGY, V39, P593, DOI 10.1016/0093-691X(93)90246-2; Kikuchi K, 1998, THERIOGENOLOGY, V50, P615, DOI 10.1016/S0093-691X(98)00166-6; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; LELAIDIER C, 1995, FERTIL STERIL, V63, P919, DOI 10.1016/S0015-0282(16)57503-7; MCKIERNAN SH, 1994, HUM REPROD, V9, P2123, DOI 10.1093/oxfordjournals.humrep.a138403; Mito T, 2012, REPROD FERT DEVELOP, V24, P443, DOI 10.1071/RD11197; Mullen SF, 2012, THERIOGENOLOGY, V78, P1709, DOI 10.1016/j.theriogenology.2012.06.008; Nagai T, 2006, FRONT BIOSCI-LANDMRK, V11, P2565, DOI 10.2741/1991; NAITO K, 1988, GAMETE RES, V21, P289, DOI 10.1002/mrd.1120210310; PETTERS RM, 1993, J REPROD FERTIL, P61; Pribenszky C, 2012, REPROD DOMEST ANIM, V47, P197, DOI 10.1111/j.1439-0531.2012.02076.x; RATH D, 1995, THERIOGENOLOGY, V44, P529, DOI 10.1016/0093-691X(95)00224-V; Seki S, 2008, BIOL REPROD, V79, P727, DOI 10.1095/biolreprod.108.069401; Seki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036058; Seki S, 2011, REPRODUCTION, V141, P407, DOI 10.1530/REP-10-0438; Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012; Shoukir Y, 1998, HUM REPROD, V13, P676, DOI 10.1093/humrep/13.3.676; Somfai T, 2013, CONTROL PIG REPROD 9, V68, P47; Somfai T, 2009, BIOL REPROD, V80, P42, DOI 10.1095/biolreprod.108.070235; Somfai T, 2013, J REPROD DEVELOP, V59, P378, DOI 10.1262/jrd.2013-015; Somfai T, 2012, J REPROD DEVELOP, V58, P17, DOI 10.1262/jrd.11-140N; Suzuki K, 2002, INT J ANDROL, V25, P84, DOI 10.1046/j.1365-2605.2002.00330.x; Tamas S, 2007, CRYOBIOLOGY, V55, P115, DOI 10.1016/j.cryobiol.2007.06.008; Tseng JK, 2006, THERIOGENOLOGY, V66, P1073, DOI 10.1016/j.theriogenology.2006.03.003; YOSHIDA M, 1992, J REPROD FERTIL, V95, P481, DOI 10.1530/jrf.0.0950481; Yoshioka K, 2003, BIOL REPROD, V69, P2092, DOI 10.1095/biolreprod.103.020081; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Zhou GB, 2009, MOL HUM REPROD, V15, P279, DOI 10.1093/molehr/gap016	36	53	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97731	10.1371/journal.pone.0097731	http://dx.doi.org/10.1371/journal.pone.0097731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844283	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400052
J	Zennaro, C; Mariotti, M; Carraro, M; Pasqualetti, S; Corbelli, A; Armelloni, S; Li, M; Ikehata, M; Clai, M; Artero, M; Messa, P; Boscutti, G; Rastaldi, MP				Zennaro, Cristina; Mariotti, Massimo; Carraro, Michele; Pasqualetti, Sara; Corbelli, Alessandro; Armelloni, Silvia; Li, Min; Ikehata, Masami; Clai, Milan; Artero, Mary; Messa, Piergiorgio; Boscutti, Giuliano; Rastaldi, Maria Pia			Podocyte Developmental Defects Caused by Adriamycin in Zebrafish Embryos and Larvae: A Novel Model of Glomerular Damage	PLOS ONE			English	Article							EXPRESSION; PROTEIN; NEPHRIN; SYSTEM; WT1A	The zebrafish pronephros is gaining popularity in the nephrology community, because embryos are easy to cultivate in multiwell plates, allowing large number of experiments to be conducted in an in vivo model. In a few days, glomeruli reach complete development, with a structure that is similar to that of the mammalian counterpart, showing a fenestrated endothelium and a basement membrane covered by the multiple ramifications of mature podocytes. As a further advantage, zebrafish embryos are permeable to low molecular compounds, and this explains their extensive use in drug efficacy and toxicity experiments. Here we show that low concentrations of adriamycin (i.e. 10 and 20 mu M), when dissolved in the medium of zebrafish embryos at 9 hours post-fertilization and removed after 48 hours (57 hpf), alter the development of podocytes with subsequent functional impairment, demonstrated by onset of pericardial edema and reduction of expression of the podocyte proteins nephrin and wt1. Podocyte damage is morphologically confirmed by electron microscopy and functionally supported by increased clearance of microinjected 70 kDa fluorescent dextran. Importantly, besides pericardial edema and glomerular damage, which persist and worsen after adriamycin removal from the medium, larvae exposed to adriamycin 10 and 20 mu M do not show any myocardiocyte alterations nor vascular changes. The only extra-renal effect is a transient delay of cartilage formation that rapidly recovers once adriamycin is removed. In summary, this low dose adriamycin model can be applied to analyze podocyte developmental defects, such as those observed in congenital nephrotic syndrome, and can be taken in consideration for pharmacological studies of severe early podocyte injury.	[Zennaro, Cristina; Carraro, Michele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Zennaro, Cristina; Corbelli, Alessandro; Armelloni, Silvia; Li, Min; Ikehata, Masami; Rastaldi, Maria Pia] Fdn IRCCS Ca Granda Osped Maggiore Policli, Renal Res Lab, Milan, Italy; [Zennaro, Cristina; Corbelli, Alessandro; Armelloni, Silvia; Li, Min; Ikehata, Masami; Rastaldi, Maria Pia] Fdn Amico Ric Malattie Renali, Milan, Italy; [Mariotti, Massimo] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy; [Mariotti, Massimo] IRCCS Orthoped Inst, Milan, Italy; [Pasqualetti, Sara] Grp Osped San Donato Fdn, Milan, Italy; [Clai, Milan; Artero, Mary; Boscutti, Giuliano] Univ Osped Riuniti Trieste, Azienda Osped, Trieste, Italy; [Corbelli, Alessandro] Mario Negri Inst Pharmacol Res, Dept Cardiovasc Res, Unit Bioimaging, Milan, Italy; [Messa, Piergiorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Nephrol Dialysis & Renal Transplant, Milan, Italy	University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Policlinico San Donato; University of Trieste; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Ca Granda Ospedale Maggiore Policlinico	Zennaro, C (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	czennaro@units.it	Boscutti, Giuliano/AAH-8559-2021; Corbelli, Alessandro/ABG-3900-2020; Li, Min/AFJ-8435-2022; Armelloni, Silvia/AAP-8617-2021; IKEHATA, Masami/HHR-9052-2022; Li, Min/AAL-7828-2021; Li, Min/AAF-5252-2022	Corbelli, Alessandro/0000-0001-8545-8050; Armelloni, Silvia/0000-0001-6431-2642; IKEHATA, Masami/0000-0001-9835-9991; Li, Min/0000-0003-1350-9909; CARRARO, MICHELE/0000-0002-8940-3361; ZENNARO, Cristina/0000-0003-4755-1064	ERA-EDTA/EMBO; "Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale", Rho (Mi); "Fondazione Benefica Kathleen Foreman Casali", Trieste	ERA-EDTA/EMBO; "Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale", Rho (Mi); "Fondazione Benefica Kathleen Foreman Casali", Trieste	This work was conducted thanks to a long-term ERA-EDTA/EMBO fellowship to Dr. Cristina Zennaro. Dr. Zennaro is presently the recipient of a Telethon Foundation research contract. The Laboratory of Renal Pathobiology of Trieste University and the Renal Research Laboratory of Milan Policlinic belong to the "Italian Network to fight FSGS" supported by "Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale", Rho (Mi). Funding was received also from "Fondazione Benefica Kathleen Foreman Casali", Trieste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyaeva NF, 2009, BIOCHEM MOSC-SUPPL S, V3, P343, DOI 10.1134/S1990750809040039; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Chang C, 2014, BIO-MED MATER ENG, V24, P909, DOI 10.3233/BME-130885; Chittiprol S, 2011, AM J PHYSIOL-RENAL, V301, pF660, DOI 10.1152/ajprenal.00234.2011; Ding YH, 2011, CIRC RES, V109, P658, DOI 10.1161/CIRCRESAHA.111.248260; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; Huang CC, 2007, TOXICOL SCI, V100, P486, DOI 10.1093/toxsci/kfm235; Huang JM, 2013, KIDNEY INT, V83, P1193, DOI 10.1038/ki.2013.6; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Puliti A, 2011, AM J PATHOL, V178, P1257, DOI 10.1016/j.ajpath.2010.11.050; Rocke John, 2009, Recent Pat Cardiovasc Drug Discov, V4, P1; Rudiger F, 1999, KIDNEY INT, V56, P1700, DOI 10.1046/j.1523-1755.1999.00729.x; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Simunek T, 2009, PHARMACOL REP, V61, P154; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zennaro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066159; Zheng CX, 2008, KIDNEY INT, V74, P596, DOI 10.1038/ki.2008.203	29	17	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98131	10.1371/journal.pone.0098131	http://dx.doi.org/10.1371/journal.pone.0098131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845233	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400100
J	Zouani, OF; Gocheva, V; Durrieu, MC				Zouani, Omar F.; Gocheva, Veronika; Durrieu, Marie-Christine			Membrane Nanowaves in Single and Collective Cell Migration	PLOS ONE			English	Article							OPTICAL PROFILOMETRY; MATURE OSTEOBLASTS; DYNAMICS; BMP-2; DIFFERENTIATION; CYTOSKELETON; MODULATION; ADHESION; GTPASES; MODEL	We report the characterization of three-dimensional membrane waves for migrating single and collective cells and describe their propagation using wide-field optical profiling technique with nanometer resolution. We reveal the existence of small and large membrane waves the amplitudes of which are in the range of similar to 3-7 nm to similar to 16-25 nm respectively, through the cell. For migrating single-cells, the amplitude of these waves is about 30 nm near the cell edge. Two or more different directions of propagation of the membrane nanowaves inside the same cell can be observed. After increasing the migration velocity by BMP-2 treatment, only one wave direction of propagation exists with an increase in the average amplitude (more than 80 nm near the cell edge). Furthermore for collective-cell migration, these membrane nanowaves are attenuated on the leader cells and poor transmission of these nanowaves to follower cells was observed. After BMP-2 treatment, the membrane nanowaves are transmitted from the leader cell to several rows of follower cells. Surprisingly, the vast majority of the observed membrane nanowaves is shared between the adjacent cells. These results give a new view on how single and collective-cells modulate their motility. This work has significant implications for the therapeutic use of BMPs for the regeneration of skin tissue.	[Zouani, Omar F.; Durrieu, Marie-Christine] Univ Bordeaux 2, Bioingn Tissulaire BioTis, INSERM U1026, F-33076 Bordeaux, France; [Zouani, Omar F.; Durrieu, Marie-Christine] Univ Bordeaux 1, IECB, CNRS, UMR 5248, Pessac, France; [Gocheva, Veronika] Univ Montpellier 2, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Universite de Montpellier	Zouani, OF (corresponding author), Univ Bordeaux 2, Bioingn Tissulaire BioTis, INSERM U1026, F-33076 Bordeaux, France.	omar.zouani@avegem.com	DURRIEU, Marie-Christine/I-4358-2016	DURRIEU, Marie-Christine/0000-0003-0583-9289	Region Aquitaine; "Agence Nationale pour la Recherche" (ANR) [ANR-09-ETEC-001-01]; Advanced Materials in Aquitaine (AMA, GIS)	Region Aquitaine(Region Nouvelle-Aquitaine); "Agence Nationale pour la Recherche" (ANR)(French National Research Agency (ANR)); Advanced Materials in Aquitaine (AMA, GIS)	This work was supported in part by the "Region Aquitaine", the "Agence Nationale pour la Recherche" (ANR, grant number ANR-09-ETEC-001-01; www.agence-nationale-recherche.fr) and Advanced Materials in Aquitaine (AMA, GIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Chen CH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238101; Coelho Neto J, 2005, EXP CELL RES, V303, P207, DOI 10.1016/j.yexcr.2004.09.002; Das RK, 2014, BIOMATERIALS; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Driscoll MK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002392; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hsu TH, 2007, OPT EXPRESS, V15, P76, DOI 10.1364/OE.15.000076; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Lee CH, 2002, OPT LETT, V27, P1773, DOI 10.1364/OL.27.001773; Lei Y, 2012, SMALL; Lei YF, 2013, SMALL, V9, P1086, DOI 10.1002/smll.201202410; Lei YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041163; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Peleg B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018635; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Reed J, 2008, ACS NANO, V2, P841, DOI 10.1021/nn700303f; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Sen S, 2005, BIOPHYS J, V89, P3203, DOI 10.1529/biophysj.105.063826; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Shlomovitz R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.168103; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wang CC, 2006, OPT LETT, V31, P2873, DOI 10.1364/OL.31.002873; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Zouani OF, 2013, BIOL OPEN, V2, P872, DOI 10.1242/bio.20134986; Zouani OF, 2013, SMALL, V9, P3070, DOI 10.1002/smll.201300124; Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007; Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229; Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042	48	3	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97855	10.1371/journal.pone.0097855	http://dx.doi.org/10.1371/journal.pone.0097855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846182	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400066
J	Ahmad, Y; Sharma, NK; Ahmad, MF; Sharma, M; Garg, I; Bhargava, K				Ahmad, Yasmin; Sharma, Narendra K.; Ahmad, Mohammad Faiz; Sharma, Manish; Garg, Iti; Bhargava, Kalpana			Proteomic Identification of Novel Differentiation Plasma Protein Markers in Hypobaric Hypoxia-Induced Rat Model	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; APOLIPOPROTEIN-A-I; INFLAMMATION; ALPHA(1)-MICROGLOBULIN; LIPOCALIN; INSULIN; CANCER; HAPTOGLOBIN; BIOMARKERS; TOLERANCE	Background: Hypobaric hypoxia causes complex changes in the expression of genes, including stress related genes and corresponding proteins that are necessary to maintain homeostasis. Whereas most prior studies focused on single proteins, newer methods allowing the simultaneous study of many proteins could lead to a better understanding of complex and dynamic changes that occur during the hypobaric hypoxia. Methods: In this study we investigated the temporal plasma protein alterations of rat induced by hypobaric hypoxia at a simulated altitude of 7620 m (25,000 ft, 282 mm Hg) in a hypobaric chamber. Total plasma proteins collected at different time points (0, 6, 12 and 24 h), separated by two-dimensional electrophoresis (2-DE) and identified using matrix assisted laser desorption ionization time of flight (MALDI-TOF/TOF). Biological processes that were enriched in the plasma proteins during hypobaric hypoxia were identified using Gene Ontology (GO) analysis. According to their properties and obvious alterations during hypobaric hypoxia, changes of plasma concentrations of Ttr, Prdx-2, Gpx -3, Apo A-I, Hp, Apo-E, Fetub and Nme were selected to be validated by Western blot analysis. Results: Bioinformatics analysis of 25 differentially expressed proteins showed that 23 had corresponding candidates in the database. The expression patterns of the eight selected proteins observed by Western blot were in agreement with 2-DE results, thus confirming the reliability of the proteomic analysis. Most of the proteins identified are related to cellular defense mechanisms involving anti-inflammatory and antioxidant activity. Their presence reflects the consequence of serial cascades initiated by hypobaric hypoxia. Conclusion/Significance: This study provides information about the plasma proteome changes induced in response to hypobaric hypoxia and thus identification of the candidate proteins which can act as novel biomarkers.	[Ahmad, Yasmin; Sharma, Narendra K.; Sharma, Manish; Bhargava, Kalpana] Minist Def, DRDO, DIPAS, Peptide & Prote Div, Delhi, India; [Ahmad, Mohammad Faiz] Jamia Millia Islamia, Dept Chem, New Delhi 110025, India; [Garg, Iti] Minist Def, DRDO, DIPAS, Dept Genom, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Jamia Millia Islamia; Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Ahmad, Y (corresponding author), Minist Def, DRDO, DIPAS, Peptide & Prote Div, Delhi, India.	yasminchem@gmail.com	Garg, Iti/GYU-6396-2022; Sharma, Narendra/D-2451-2017	Sharma, Narendra/0000-0002-8681-3840	Defence Research Development Organization (DRDO), Ministry of Defence, Government of India [TC/321/Task-145 (YA)/DIPAS/2008]	Defence Research Development Organization (DRDO), Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO))	Financial support for this study is provided by a grant from TC/321/Task-145 (YA)/DIPAS/2008, Defence Research Development Organization (DRDO), Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y., 2009, J PROTEOM BIOINFORM, V2, P495, DOI DOI 10.4172/JPB.1000111; Ahmad Y, 2011, FUNCT INTEGR GENOMIC, V11, P407, DOI 10.1007/s10142-011-0234-3; Ahmed FE, 2009, J CHROMATOGR B, V877, P1963, DOI 10.1016/j.jchromb.2009.05.023; Akerstrom Bo, 2011, Patent application number, Patent No. 20110190208; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2003, J INVEST DERMATOL, V121, P640, DOI 10.1046/j.1523-1747.2003.12409.x; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; Belcher JD, 2010, ANTIOXID REDOX SIGN, V12, P233, DOI 10.1089/ars.2009.2822; Bellovino D, 1996, EXP CELL RES, V222, P77, DOI 10.1006/excr.1996.0010; Bora A, 2012, J PROTEOME RES, V11, P3143, DOI 10.1021/pr300057v; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang SI, 2007, CANCER EPIDEM BIOMAR, V16, P228, DOI 10.1158/1055-9965.EPI-06-0567; COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3; Collard CD, 1999, MOL IMMUNOL, V36, P941, DOI 10.1016/S0161-5890(99)00116-9; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coughtrie MWH, 1999, BIOCHEM J, V337, P45, DOI 10.1042/0264-6021:3370045; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Dahl B, 2001, INTENS CARE MED, V27, P394, DOI 10.1007/s001340000837; DEUTSCH J, 1983, METHOD ENZYMAT AN, V3, P190; Duan JX, 2001, FEBS LETT, V499, P127, DOI 10.1016/S0014-5793(01)02544-3; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Elsoe S, 2012, ATHEROSCLEROSIS, V221, P91, DOI 10.1016/j.atherosclerosis.2011.11.031; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; Geiben-Lynn R, 2003, J BIOL CHEM, V278, P1569, DOI 10.1074/jbc.M209964200; George D, 2009, PROG CARDIOVASC DIS, V52, P115, DOI 10.1016/j.pcad.2009.06.005; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Glatt H, 1997, FASEB J, V11, P314, DOI 10.1096/fasebj.11.5.9141497; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; Han CZ, 2005, ENDOCRINE, V26, P19, DOI 10.1385/ENDO:26:1:019; Hernandez R, 2013, NEUROMOL MED, V15, P82, DOI 10.1007/s12017-012-8197-7; HIGHTOWER LE, 1993, MAR ENVIRON RES, V35, P79; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Honda K, 2013, JPN J CLIN ONCOL, V43, P103, DOI 10.1093/jjco/hys200; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Jacobs JM, 2005, J PROTEOME RES, V4, P1073, DOI 10.1021/pr0500657; Kierny MR, 2012, NANO REV, V3, P1; Kitagawa K, 2002, J NEUROSCI RES, V68, P226, DOI 10.1002/jnr.10209; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; Lee SH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-271; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Olsson MG, 2008, FREE RADICAL RES, V42, P725, DOI 10.1080/10715760802337265; Ostos MA, 2001, ARTERIOSCL THROM VAS, V21, P1023, DOI 10.1161/01.ATV.21.6.1023; Padhy G, 2013, HIGH ALT MED BIOL, V14, P289, DOI 10.1089/ham.2012.1095; PETERSON PA, 1971, J BIOL CHEM, V246, P44; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Ren Y, 2013, MOL CELL PROTEOMICS, V12, P485, DOI 10.1074/mcp.M112.018325; Riddell DR, 1997, J BIOL CHEM, V272, P89; Rousseau AS, 2006, AVIAT SPACE ENVIR MD, V77, P551; Sarafian TA, 1997, FREE RADICAL RES, V26, P281, DOI 10.3109/10715769709097806; Schellenberg D, 1998, AM J RESP CRIT CARE, V157, P957, DOI 10.1164/ajrccm.157.3.9706106; Sharma NK, 2013, J PROTEOMICS, V79, P277, DOI 10.1016/j.jprot.2012.12.020; Shau H, 1998, BIOCHEM BIOPH RES CO, V249, P683, DOI 10.1006/bbrc.1998.9129; SHAU HG, 1994, IMMUNOGENETICS, V40, P129; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; Thiemermann C, 2003, J AM SOC NEPHROL, V14, P1833, DOI 10.1097/01.ASN.0000075552.97794.8C; Turko IV, 2003, J BIOL CHEM, V278, P35844, DOI 10.1074/jbc.M303139200; Vyssoulis GP, 2007, AM J HYPERTENS, V20, P1016, DOI 10.1016/j.amjhyper.2007.01.010; Wang JH, 2013, INT J MOL SCI, V14, P19146, DOI 10.3390/ijms140919146; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Wang YF, 2002, LUNG CANCER, V35, P137, DOI 10.1016/S0169-5002(01)00406-8; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; White P, 2000, TRENDS ENDOCRIN MET, V11, P320, DOI 10.1016/S1043-2760(00)00317-9; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x; Yamamoto N, 1997, CANCER RES, V57, P2187; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216	77	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98027	10.1371/journal.pone.0098027	http://dx.doi.org/10.1371/journal.pone.0098027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842778	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600101
J	Beirn, LA; Clarke, BB; Crouch, JA				Beirn, Lisa A.; Clarke, Bruce B.; Crouch, Jo Anne			Influence of Host and Geographic Locale on the Distribution of Colletotrichum cereale Lineages	PLOS ONE			English	Article							BLUEGRASS PUTTING GREEN; ANTHRACNOSE DISEASE; CALIFORNIA POPULATIONS; TURFGRASS; PATHOGEN; GRAMINICOLA; SEVERITY; GRASSES; GENOME	Colletotrichum cereale is an ascomycete inhabitant of cool-season Pooideae grasses. The fungus has increased in frequency over the past decade as a destructive pathogen of Poa annua and Agrostis stolonifera turfgrass. Colletotrichum cereale exists as two lineages, designated clades A and B, but little is known about the distribution of these clades in natural environments, or what role these subdivisions may play in the trajectory of disease outbreaks. In this study, our objective was to determine the frequency of C. cereale clades A and B. To rapidly discriminate between the two C. cereale clades, a real-time PCR assay was developed based on the Apn2 gene. A collection of 700 C. cereale pathogens and endophytes from twenty Pooideae grass genera were genotyped. 87% of the collection was identifed as part of clade A, 11.7% as part of clade B, and 1.3% was a mixture. Colletotrichum cereale from turfgrass hosts in North America were most commonly members of clade A (78%). The overabundance of clade A in turfgrass isolates was directly attributable to the dominance of this lineage from southern sampling sites, irrespective of host. In contrast, 111 C. cereale turfgrass isolates collected from northern sampling sites were evenly distributed between clades A and B. Only 28% of C. cereale from A. stolonifera at northern sampling sites were part of clade A. These data show that environmental factors such as geographic location and host identity likely played a role in the distribution of the major C. cereale clades in North American turfgrass.	[Beirn, Lisa A.; Clarke, Bruce B.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ USA; [Crouch, Jo Anne] USDA ARS, Systemat Mycol & Microbiol Lab, Beltsville, MD 20705 USA	Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Crouch, JA (corresponding author), USDA ARS, Systemat Mycol & Microbiol Lab, Beltsville, MD 20705 USA.	joanne.crouch@ars.usda.gov		Crouch, Jo Anne/0000-0001-6886-8090	Rutgers Center for Turfgrass Science; U.S. Department of Agriculture (USDA) Agriculture Research Service; USDA National Institute of Food and Agriculture; ARS [ARS-0422901] Funding Source: Federal RePORTER	Rutgers Center for Turfgrass Science; U.S. Department of Agriculture (USDA) Agriculture Research Service; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the Rutgers Center for Turfgrass Science, the U.S. Department of Agriculture (USDA) Agriculture Research Service, and the USDA National Institute of Food and Agriculture. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA. USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton A. T., 1981, Canadian Journal of Plant Pathology, V3, P94; Bruehl GW, 1950, USDA TECH B, V1005; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Crouch JA, 2009, FUNGAL DIVERS, V39, P19; Crouch JA, 2006, PHYTOPATHOLOGY, V96, P46, DOI 10.1094/PHYTO-96-0046; Crouch JA, 2014, IMA FUNGUS IN PRESS, V5; Crouch JA, 2005, INT TURF SOC RES J, V10, P86; Crouch JA, 2008, CROP SCI, V48, P1203, DOI 10.2135/cropsci2007.08.0427; Crouch JA, 2008, FUNGAL GENET BIOL, V45, P190, DOI 10.1016/j.fgb.2007.08.004; Crouch JA, 2012, MYCOLOGIA, V104, P1085, DOI 10.3852/11-317; Crouch JA, 2009, MYCOL RES, V113, P1411, DOI 10.1016/j.mycres.2009.09.010; Crouch JA, 2009, MYCOLOGIA, V101, P648, DOI 10.3852/08-231; Crouch JA, 2009, MOL ECOL, V18, P123, DOI 10.1111/j.1365-294X.2008.04008.x; Franco CCD, 2011, PHYTOPATHOLOGY, V101, P923, DOI 10.1094/PHYTO-12-10-0327; Herting VJ, 1982, THESIS U RHODE ISLAN; Hitchcock AS, 1971, MANUAL GRASSES US; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Inguagiato J.C., 2009, INT TURF SOC RES J, V11, P207; Inguagiato J.C., 2010, APPL TURF SCI, V7, P1, DOI [10.1094/ATS-2010-0923-01-RS, DOI 10.1094/ATS-2010-0923-01-RS]; Inguagiato JC, 2008, CROP SCI, V48, P1595, DOI 10.2135/cropsci2007.06.0343; Inguagiato JC, 2012, CROP SCI, V52, P1406, DOI 10.2135/cropsci2011.01.0010; Inguagiato JC, 2009, CROP SCI, V49, P1454, DOI 10.2135/cropsci2008.07.0435; Khan A, 2003, CAN J MICROBIOL, V49, P433, DOI [10.1139/w03-059, 10.1139/W03-059]; Murphy J.A., 2008, GOLF COURSE MANAG, V76, P93; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Roberts JA, 2012, AGRON J, V104, P1176, DOI 10.2134/agronj2011.0269; Roberts JA, 2011, CROP SCI, V51, P1244, DOI 10.2135/cropsci2010.07.0444; Rosada LJ, 2010, J EUKARYOT MICROBIOL, V57, P383, DOI 10.1111/j.1550-7408.2010.00486.x; Selby A.D., 1909, OHIO AGR EXP STA B, V203, P187; SMITH J. DREW, 1954, JOUR SPORTS TURF RES INST, V8, P344; SUTTON BC, 1968, CAN J BOTANY, V46, P873, DOI 10.1139/b68-115; Turgeon JM, 2003, POA ANN PHYSL CULTUR; Vargas JM, 1993, INT TURF SOC RES J, V7, P324; Verkley GJM, 2014, MYCOTA B IN PRESS; Wilson GW, 1914, PHYTOPATHOLOGY, V4, P106; Wolff ET, 1947, THESIS PENN STATE U; Wong FP, 2008, PLANT DIS, V92, P239, DOI 10.1094/PDIS-92-2-0239; Wong FP, 2007, PLANT DIS, V91, P1536, DOI 10.1094/PDIS-91-12-1536; Wong FP, 2007, PLANT DIS, V91, P1547, DOI 10.1094/PDIS-91-12-1547	39	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97706	10.1371/journal.pone.0097706	http://dx.doi.org/10.1371/journal.pone.0097706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842654	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600060
J	Muckenhuber, J; Fernandez, K; Burkert, NT; Grosschadl, F; Freidl, W; Rasky, E				Muckenhuber, Johanna; Fernandez, Karina; Burkert, Nathalie T.; Grosschaedl, Franziska; Freidl, Wolfgang; Rasky, Eva			Trends in Inequalities in Health, Risk and Preventive Behaviour among the Advanced-Age Population in Austria: 1983-2007	PLOS ONE			English	Article							VACCINATION COVERAGE RATES; INFLUENZA VACCINATION; CIGARETTE-SMOKING; LIFE EXPECTANCY; UNITED-STATES; COMPRESSION; MORBIDITY; ADULTS; PREDICTORS; RESOURCES	Background: Although a number of previous research studies have focused on the long-term analysis of the health and health behaviour of the elderly, there is still a shortage of information in relation to the long-term trends regarding health or risk and preventive behaviour in the elderly population taking into account gender differences and differences in educational level. Methods: The database comprised subsamples of the Austrian Micro-Census, including individuals aged 65 years and older, for the years 1983, 1991, 1999, and subsamples of the ATHIS (Austrian Health Interview Survey) 2007. A trend analysis was conducted for four health-related variables with the year of the survey and education as predictors. The analysis was stratified by sex. Results: We found a general trend towards better self-rated health, better preventive and less risk behaviour among the elderly, while the body mass index has been increasing over the years. There are indeed gender differences regarding the trend in smoking behaviour. While the prevalence of male smoking has been steadily decreasing, female smoking prevalence has not changed. At all points in time, individuals with higher education had significantly better self-rated health than those with lower education but the association between education and preventive behaviour significantly decreased over the years. Conclusion: We agree with previous research in concluding that preventive action and health promotion should aim in particular to support older women and men with lower education.	[Muckenhuber, Johanna; Burkert, Nathalie T.; Grosschaedl, Franziska; Freidl, Wolfgang; Rasky, Eva] Med Univ Graz, Dept Social Med & Epidemiol, Graz, Austria; [Fernandez, Karina] Karl Franzens Univ Graz, Dept Business Educ & Dev, Graz, Austria	Medical University of Graz; University of Graz	Muckenhuber, J (corresponding author), Med Univ Graz, Dept Social Med & Epidemiol, Graz, Austria.	johanna.muckenhuber@medunigraz.at		Grossschadl, Franziska/0000-0002-6726-0443				Aiken L. S., 1991, MULTIPLE REGRESSION; Baumert J, 2010, NICOTINE TOB RES, V12, P1220, DOI 10.1093/ntr/ntq172; Blank PR, 2008, MED KLIN, V103, P761, DOI 10.1007/s00063-008-1121-0; Cambois E, 2008, EUR J AGEING, V5, P287, DOI 10.1007/s10433-008-0097-1; Castilla J, 2013, PREV MED, V57, P206, DOI 10.1016/j.ypmed.2013.05.021; Chandola T, 2007, BRIT MED J, V334, P990, DOI 10.1136/bmj.39167.439792.55; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; CSDH, 2008, CLOS GAP GEN HLTH EQ; Dalstra JAA, 2002, J EPIDEMIOL COMMUN H, V56, P927, DOI 10.1136/jech.56.12.927; Doblhammer G, 2001, SOC SCI MED, V52, P385, DOI 10.1016/S0277-9536(00)00141-6; Freidl W, 2001, SOZ PRAVENTIV MED, V46, P106, DOI 10.1007/BF01299727; FRIES JF, 1989, MILBANK Q, V67, P208, DOI 10.2307/3350138; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; Grossschadl F, 2013, EUR J PUBLIC HEALTH, V23, P306, DOI 10.1093/eurpub/cks033; Jimenez-Trujillo I, 2013, HUM VACC IMMUNOTHER, V9, P1326, DOI 10.4161/hv.23926; Johnson W, 2011, AM J EPIDEMIOL, V173, P55, DOI 10.1093/aje/kwq333; Kahn HS, 2008, INT J OBESITY, V32, P136, DOI 10.1038/sj.ijo.0803697; Krokstad S, 2002, J EPIDEMIOL COMMUN H, V56, P375, DOI 10.1136/jech.56.5.375; Kunze U, 2013, VACCINE, V31, P5099, DOI 10.1016/j.vaccine.2013.08.050; Kwong JC, 2007, HLTH REP STAT CAN, P18; Loranta V, 2010, J EPIDEMIOL COMMUNIT, V54, P637; Lu PJ, 2005, ARCH INTERN MED, V165, P1849, DOI 10.1001/archinte.165.16.1849; Marques-Vidal P, 2011, J EPIDEMIOL COMMUN H, V65, P281, DOI 10.1136/jech.2009.099424; Panasiuk L, 2010, ANN AGR ENV MED, V17, P133; Regidor E, 2010, J EPIDEMIOL COMMUNIT, V2010; Rodriguez de Azero M, 2008, EUROPEAN COMMUNICABL, V13; Sardu C, 2006, J EPIDEMIOL COMMUN H, V60, P799, DOI 10.1136/jech.2005.043703; Smith P, 2009, J EPIDEMIOL COMMUN H, V63, P317, DOI 10.1136/jech.2008.078204; Stafford M, 2008, J EPIDEMIOL COMMUN H, V62, P298, DOI 10.1136/jech.2006.058628; Staub K, 2010, EUR J CLIN NUTR, V64, P335, DOI 10.1038/ejcn.2010.7; Stronegger WJ, 1998, ZBL HYG UMWELTMED, V201, P437; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	32	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97400	10.1371/journal.pone.0097400	http://dx.doi.org/10.1371/journal.pone.0097400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24840875	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600029
J	Pasqualetti, V; Altomare, A; Guarino, MPL; Locato, V; Cocca, S; Cimini, S; Palma, R; Alloni, R; De Gara, L; Cicala, M				Pasqualetti, Valentina; Altomare, Annamaria; Guarino, Michele Pier Luca; Locato, Vittoria; Cocca, Silvia; Cimini, Sara; Palma, Rossella; Alloni, Rossana; De Gara, Laura; Cicala, Michele			Antioxidant Activity of Inulin and Its Role in the Prevention of Human Colonic Muscle Cell Impairment Induced by Lipopolysaccharide Mucosal Exposure	PLOS ONE			English	Article							IN-VITRO; FRUCTO-OLIGOSACCHARIDES; OXIDATIVE STRESS; NITRIC-OXIDE; TUMOR-CELLS; CONTRACTILITY; PREBIOTICS; ACID; OLIGOFRUCTOSE; FERMENTATION	Background: Fructans, such as inulin, are dietary fibers which stimulate gastro-intestinal (GI) function acting as prebiotics. Lipopolysaccharide (LPS) impairs GI motility, through production of reactive oxygen species. The antioxidant activity of various fructans was tested and the protective effect of inulin on colonic smooth muscle cell (SMC) impairment, induced by exposure of human mucosa to LPS, was assessed in an ex vivo experimental model. Methods: The antioxidant capacity of fructans was measured in an in vitro system that simulates cooking and digestion processes. Human colonic mucosa and submucosa, obtained from disease-free margins of resected segments for cancer, were sealed between two chambers, with the mucosal side facing upwards with Krebs solution with or without purified LPS from a pathogenic strain of Escherichia coli (O111:B4) and inulin (Frutafit IQ), and the submucosal side facing downwards into Krebs solution. The solutions on the submucosal side were collected following mucosal exposure to Krebs in the absence (N-undernatant) or presence of LPS (LPS-undernatant) or LPS+ inulin (LPS+INU-undernatant). Undernatants were tested for their antioxidant activity and the effects on SMCs contractility. Inulin protective effects on mucosa and submucosa layers were assessed measuring the protein oxidation level in the experimental conditions analyzed. Results: Antioxidant activity of inulin, which was significantly higher compared to simple sugars, remained unaltered despite cooking and digestion processes. Inulin protected the mucosal and submucosal layers against protein oxidation. Following exposure to LPS-undernatant, a significant decrease in maximal acetylcholine (Ach)-induced contraction was observed when compared to the contraction induced in cells incubated with the N-undernatant (4 +/- 1% vs 25 +/- 5% respectively, P<0.005) and this effect was completely prevented by pre-incubation of LPS with Inulin (35 +/- 5%). Conclusions: Inulin protects the human colon mucosa from LPS-induced damage and this effect appears to be related to the protective effect of inulin against LPS-induced oxidative stress.	[Pasqualetti, Valentina; Locato, Vittoria; Cimini, Sara; De Gara, Laura] Univ Campus Biomed Rome, Food Sci & Human Nutr Unit, Rome, Italy; [Altomare, Annamaria; Guarino, Michele Pier Luca; Cocca, Silvia; Palma, Rossella; Cicala, Michele] Univ Campus Biomed Rome, Gastroenterol Unit, Rome, Italy; [Alloni, Rossana] Univ Campus Biomed Rome, Surg Unit, Rome, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy	De Gara, L (corresponding author), Univ Campus Biomed Rome, Food Sci & Human Nutr Unit, Rome, Italy.	l.degara@unicampus.it	Locato, Vittoria/K-8747-2016; Campos, Gustavo R C Ribeiro/O-3981-2017; De Gara, Laura/Y-8420-2019; cimini, sara/ABC-3518-2020; Cicala, Michele/AAC-1681-2019	Locato, Vittoria/0000-0003-0267-5039; Cicala, Michele/0000-0002-5370-2642; Pasqualetti, Valentina/0000-0002-8558-0731; De Gara, Laura/0000-0001-5938-7113; Altomare, Annamaria/0000-0001-8630-7836; CIMINI, Sara/0000-0002-0139-0755; Guarino, Michele Pier Luca/0000-0003-3325-9425; ALLONI, ROSSANA/0000-0001-8877-2141; Cocca, Silvia/0000-0002-0642-8054	University Campus Bio-Medico of Rome	University Campus Bio-Medico of Rome	University Campus Bio-Medico of Rome provided internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alles MS, 1996, BRIT J NUTR, V76, P211, DOI 10.1079/BJN19960026; Ammoscato F, 2013, NEUROGASTROENT MOTIL, V25, P984, DOI 10.1111/nmo.12232; Arrizon J, 2010, FOOD CHEM, V122, P123, DOI 10.1016/j.foodchem.2010.02.028; Avila-Fernandez A, 2011, FOOD CHEM, V129, P380, DOI 10.1016/j.foodchem.2011.04.088; Barbara G, 2004, ALIMENT PHARM THER, V20, P1, DOI 10.1111/j.1365-2036.2004.02036.x; Bercik P, 2004, GASTROENTEROLOGY, V127, P179, DOI 10.1053/j.gastro.2004.04.006; Bouhnik Y, 1996, NUTR CANCER, V26, P21, DOI 10.1080/01635589609514459; Bouhnik Y, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-42; Buddington RK, 1996, AM J CLIN NUTR, V63, P709, DOI 10.1093/ajcn/63.5.709; Busserolles J, 2003, J NUTR, V133, P1903, DOI 10.1093/jn/133.6.1903; Cao W, 2005, AM J PHYSIOL-CELL PH, V289, pC1408, DOI 10.1152/ajpcell.00073.2005; Cullen JJ, 1999, SURGERY, V125, P339, DOI 10.1016/S0039-6060(99)70246-1; De Winter BY, 2010, WORLD J GASTROENTERO, V16, P5523, DOI 10.3748/wjg.v16.i44.5523; De Winter BY, 2005, NEUROGASTROENT MOTIL, V17, P251, DOI 10.1111/j.1365-2982.2004.00618.x; Euler AR, 2005, J PEDIATR GASTR NUTR, V40, P157, DOI 10.1097/00005176-200502000-00014; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Guarino MPL, 2008, J CLIN GASTROENTEROL, V42, pS185, DOI 10.1097/MCG.0b013e31817e1cac; Guarino MPL, 2013, DIGEST LIVER DIS, V45, P1011, DOI 10.1016/j.dld.2013.06.001; Guarner F, 2005, BRIT J NUTR, V93, pS61, DOI 10.1079/BJN20041345; HAGUE A, 1995, INT J CANCER, V60, P400, DOI 10.1002/ijc.2910600322; Han JS, 2004, J AGR FOOD CHEM, V52, P6516, DOI 10.1021/jf0493270; Hidaka H, 1991, BIFIDOBACT MICROFLOR, V10, P65, DOI DOI 10.12938/BIFIDUS1982.10.1_65; Kelly G, 2009, ALTERN MED REV, V14, P36; Kelly G, 2008, ALTERN MED REV, V13, P315; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; Kroyer G, 2010, J VERBRAUCH LEBENSM, V5, P225, DOI 10.1007/s00003-010-0557-3; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Li XM, 2007, J PHARMACEUT BIOMED, V43, P364, DOI 10.1016/j.jpba.2006.06.041; Livingston DP, 2009, CELL MOL LIFE SCI, V66, P2007, DOI 10.1007/s00018-009-0002-x; Locato V, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00152; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mellado-Mojica E, 2012, J AGR FOOD CHEM, V60, P11704, DOI 10.1021/jf303332n; Munjal U, 2009, BRIT J NUTR, V102, P663, DOI 10.1017/S0007114509274770; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rebollar E, 2002, NEUROGASTROENT MOTIL, V14, P633, DOI 10.1046/j.1365-2982.2002.00364.x; Rishi P, 2009, FEMS MICROBIOL ECOL, V69, P222, DOI 10.1111/j.1574-6941.2009.00703.x; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Roman C, 1984, GASTROINTESTINAL MOT, P549; RUMESSEN JJ, 1990, AM J CLIN NUTR, V52, P675, DOI 10.1093/ajcn/52.4.675; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Sayar S, 2005, J AGR FOOD CHEM, V53, P8797, DOI 10.1021/jf051380g; Serpen A, 2008, J CEREAL SCI, V48, P816, DOI 10.1016/j.jcs.2008.06.002; Shi XZ, 2003, GASTROENTEROLOGY, V124, P1369, DOI 10.1016/S0016-5085(03)00263-4; Stoyanova S, 2011, INT J FOOD SCI NUTR, V62, P207, DOI 10.3109/09637486.2010.523416; Takakura K, 1997, ANESTHESIOLOGY, V87, P652, DOI 10.1097/00000542-199709000-00027; Tattoli I, 2004, DIGEST LIVER DIS, V36, P735, DOI 10.1016/j.dld.2004.06.016; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; Van den Ende W, 2011, TRENDS FOOD SCI TECH, V22, P689, DOI 10.1016/j.tifs.2011.07.005; Wechsung E, 1996, Verh K Acad Geneeskd Belg, V58, P711	50	46	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98031	10.1371/journal.pone.0098031	http://dx.doi.org/10.1371/journal.pone.0098031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837182	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800099
J	Lin, YR; Keegan, B; Margolin, D; Lazer, D				Lin, Yu-Ru; Keegan, Brian; Margolin, Drew; Lazer, David			Rising Tides or Rising Stars?: Dynamics of Shared Attention on Twitter during Media Events	PLOS ONE			English	Article							ONLINE; CONSEQUENCES; AUDIENCE; AGENDA	"Media events" generate conditions of shared attention as many users simultaneously tune in with the dual screens of broadcast and social media to view and participate. We examine how collective patterns of user behavior under conditions of shared attention are distinct from other "bursts" of activity like breaking news events. Using 290 million tweets from a panel of 193,532 politically active Twitter users, we compare features of their behavior during eight major events during the 2012 U.S. presidential election to examine how patterns of social media use change during these media events compared to "typical" time and whether these changes are attributable to shifts in the behavior of the population as a whole or shifts from particular segments such as elites. Compared to baseline time periods, our findings reveal that media events not only generate large volumes of tweets, but they are also associated with (1) substantial declines in interpersonal communication, (2) more highly concentrated attention by replying to and retweeting particular users, and (3) elite users predominantly benefiting from this attention. These findings empirically demonstrate how bursts of activity on Twitter during media events significantly alter underlying social processes of interpersonal communication and social interaction. Because the behavior of large populations within socio-technical systems can change so dramatically, our findings suggest the need for further research about how social media responses to media events can be used to support collective sensemaking, to promote informed deliberation, and to remain resilient in the face of misinformation.	[Lin, Yu-Ru] Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA 15260 USA; [Keegan, Brian; Lazer, David] Northeastern Univ, Coll Social Sci & Humanities, Boston, MA USA; [Margolin, Drew] Cornell Univ, Dept Commun, Ithaca, NY USA; [Lazer, David] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northeastern University; Cornell University; Northeastern University	Lin, YR (corresponding author), Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA 15260 USA.	yurulin@pitt.edu	Keegan, Brian/R-3955-2019	Keegan, Brian/0000-0002-7793-398X	Lazer Lab at Northeastern University; MURI [504026]; ARO [504033]	Lazer Lab at Northeastern University; MURI(MURI); ARO	The authors gratefully acknowledge the support of the Lazer Lab at Northeastern University, supported in part by MURI grant #504026 and ARO #504033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday S, 2013, AM BEHAV SCI, V57, P899, DOI 10.1177/0002764213479373; [Anonymous], 2012, TECHNICAL REPORT; [Anonymous], 1991, PERSPECTIVES SOCIALL; Becker H, 2012, P 5 ACM INT C WEB SE, P533, DOI DOI 10.1145/2124295.2124360; Bennett WL, 2008, J COMMUN, V58, P707, DOI 10.1111/j.1460-2466.2008.00410.x; Boyd D., 2010, 43 HAW INT C SYST SC, V2010, P1, DOI DOI 10.1109/HICSS.2010.412; Campbell D. T., 1963, EXPT QUASIEXPERIMENT, P171; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; Coleman S, 2012, J INF TECHNOL POLITI, V9, P1, DOI 10.1080/19331681.2011.635957; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Crane R, 2008, P NATL ACAD SCI USA, V105; Dayan Daniel, 1992, MEDIA EVENTS LIVE BR; Driscoll K, 2013, SELECTED PAPERS INTE, V3; Farrell H, 2012, ANNU REV POLIT SCI, V15, P35, DOI 10.1146/annurev-polisci-030810-110815; Fisher K., 2011, ICWSM, P97; Freelon D, 2013, NEW MEDIA SOC; FUSSELL SR, 1989, J EXP SOC PSYCHOL, V25, P203, DOI 10.1016/0022-1031(89)90019-X; Garrett RK, 2011, HUM COMMUN RES, V37, P255, DOI 10.1111/j.1468-2958.2010.01401.x; Gilbert E., 2012, P SIGCHI C HUM FACT, P2731, DOI [10.1145/2207676.2208670, DOI 10.1145/2207676.2208670]; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gutman E, 2013, FILTERING MENTIONS; Habermas J, 1985, THEORY COMMUNICATIVE; Hodas N, 2012, VISIBILITY DIVIDED A, P249; Hu M., 2012, P SIGCHI C HUMAN FAC, P2751, DOI [10.1145/2207676.2208672, DOI 10.1145/2207676.2208672]; Hughes AL, 2009, INT J EMERG MANAG, V6, P248, DOI 10.1504/IJEM.2009.031564; Kang B., 2012, P IUI 2012, P179, DOI [10.1145/2166966.2166998, DOI 10.1145/2166966.2166998]; Katz E., 1955, PERSONAL INFLUENCE P; Lerman K, 2010, ICWSM, V10, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Lin Y.R., 2013, P 22 INT C WORLD WID, P737, DOI DOI 10.1145/2488388.2488453; Lin Y.R., 2013, P 7 INT C WEBL SOC M, P370; Margolis M, 2000, POLITICS USUAL; Maruyama M, 2014, P 17 ACM C COMP SUPP, P1422, DOI [10.1145/2531602.2531719, DOI 10.1145/2531602.2531719]; Marwick AE, 2011, NEW MEDIA SOC, V13, P114, DOI 10.1177/1461444810365313; Massanari AL, 2011, J INF TECHNOL POLITI, V8, P177, DOI 10.1080/19331681.2011.541702; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; McPherson K., 2012, P ACM 2012 C COMPUTE, DOI [10.1145/2141512.2141569, DOI 10.1145/2141512.2141569]; Messing Solomon, 2012, COMMUNICATION RES; Morozov Evgeny, 2011, NET DELUSION DARK SI; Morris M.R., 2012, P ACM 2012 C COMP SU, P441, DOI [10.1145/, DOI 10.1145/2145204.2145274]; Nichols J., 2012, P 2012 ACM INT C INT, P189, DOI DOI 10.1145/2166966.2166999; Prior M, 2013, ANNU REV POLIT SCI, V16, P101, DOI 10.1146/annurev-polisci-100711-135242; Rainie L, 2012, NETWORKED: THE NEW SOCIAL OPERATING SYSTEM, P1; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Schmierbach M, 2012, COMMUN Q, V60, P317, DOI 10.1080/01463373.2012.688723; Schroeder A., 2008, PRESIDENTIAL DEBATES; Shamma D.A., 2009, P WSM 09, P3; Sharma A., 2013, WALL STREET J; Starbird K, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P241; Tripathy Rudra M., 2010, P ACM INT C INFORM K, P1817, DOI [10.1145/1871437.1871737, DOI 10.1145/1871437.1871737]; Tufekci Z, 2012, J COMMUN, V62, P363, DOI 10.1111/j.1460-2466.2012.01629.x; Twitter, 2012, REST API V1 1 RES; Twitter, 2012, STREAM APIS; Vieweg S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1079, DOI 10.1145/1753326.1753486; Wang Y.-C., 2012, P SIGCHI C HUM FACT, P1115, DOI [10.1145/2207676.2208614, DOI 10.1145/2207676.2208614]; Webster JG, 2012, J COMMUN, V62, P39, DOI 10.1111/j.1460-2466.2011.01616.x; Weisz JD, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P877; Weng J., 2011, P 4 INT AAAI C WEBL, V11, P401; Weng L., 2012, SCI REPORTS, V2; Wright S, 2007, NEW MEDIA SOC, V9, P849, DOI 10.1177/1461444807081230; Wright S, 2012, NEW MEDIA SOC, V14, P244, DOI 10.1177/1461444811410679; Wu F, 2007, P NATL ACAD SCI USA, V104; Yang L., 2012, P 21 INT C WORLD WID, P261, DOI [DOI 10.1145/2187836.2187872, 10.1145/2187836.2187872]	64	66	66	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e94093	10.1371/journal.pone.0094093	http://dx.doi.org/10.1371/journal.pone.0094093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24854030	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000338323200002
J	Nayagam, DAX; Williams, RA; Allen, PJ; Shivdasani, MN; Luu, CD; Salinas-LaRosa, CM; Finch, S; Ayton, LN; Saunders, AL; McPhedran, M; McGowan, C; Villalobos, J; Fallon, JB; Wise, AK; Yeoh, J; Xu, J; Feng, H; Millard, R; McWade, M; Thien, PC; Williams, CE; Shepherd, RK				Nayagam, David A. X.; Williams, Richard A.; Allen, Penelope J.; Shivdasani, Mohit N.; Luu, Chi D.; Salinas-LaRosa, Cesar M.; Finch, Sue; Ayton, Lauren N.; Saunders, Alexia L.; McPhedran, Michelle; McGowan, Ceara; Villalobos, Joel; Fallon, James B.; Wise, Andrew K.; Yeoh, Jonathan; Xu, Jin; Feng, Helen; Millard, Rodney; McWade, Melanie; Thien, Patrick C.; Williams, Chris E.; Shepherd, Robert K.			Chronic Electrical Stimulation with a Suprachoroidal Retinal Prosthesis: A Preclinical Safety and Efficacy Study	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; TRANSRETINAL STIMULATION; MORPHOMETRIC-ANALYSIS; CHRONIC IMPLANTATION; ELECTRODES; CORTEX; ORGANIZATION; PATHOLOGY; UPDATE; TISSUE	Purpose: To assess the safety and efficacy of chronic electrical stimulation of the retina with a suprachoroidal visual prosthesis. Methods: Seven normally-sighted feline subjects were implanted for 96-143 days with a suprachoroidal electrode array and six were chronically stimulated for 70-105 days at levels that activated the visual cortex. Charge balanced, biphasic, current pulses were delivered to platinum electrodes in a monopolar stimulation mode. Retinal integrity/function and the mechanical stability of the implant were assessed monthly using electroretinography (ERG), optical coherence tomography (OCT) and fundus photography. Electrode impedances were measured weekly and electrically-evoked visual cortex potentials (eEVCPs) were measured monthly to verify that chronic stimuli were suprathreshold. At the end of the chronic stimulation period, thresholds were confirmed with multi-unit recordings from the visual cortex. Randomized, blinded histological assessments were performed by two pathologists to compare the stimulated and non-stimulated retina and adjacent tissue. Results: All subjects tolerated the surgical and stimulation procedure with no evidence of discomfort or unexpected adverse outcomes. After an initial post-operative settling period, electrode arrays were mechanically stable. Mean electrode impedances were stable between 11-15 k Omega during the implantation period. Visually-evoked ERGs & OCT were normal, and mean eEVCP thresholds did not substantially differ over time. In 81 of 84 electrode-adjacent tissue samples examined, there were no discernible histopathological differences between stimulated and unstimulated tissue. In the remaining three tissue samples there were minor focal fibroblastic and acute inflammatory responses. Conclusions: Chronic suprathreshold electrical stimulation of the retina using a suprachoroidal electrode array evoked a minimal tissue response and no adverse clinical or histological findings. Moreover, thresholds and electrode impedance remained stable for stimulation durations of up to 15 weeks. This study has demonstrated the safety and efficacy of suprachoroidal stimulation with charge balanced stimulus currents.	[Nayagam, David A. X.; Shivdasani, Mohit N.; Saunders, Alexia L.; McPhedran, Michelle; McGowan, Ceara; Villalobos, Joel; Fallon, James B.; Wise, Andrew K.; Xu, Jin; Feng, Helen; Millard, Rodney; McWade, Melanie; Thien, Patrick C.; Williams, Chris E.; Shepherd, Robert K.] Bion Inst, East Melbourne, Vic, Australia; [Nayagam, David A. X.; Williams, Richard A.; Williams, Chris E.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Williams, Richard A.; Salinas-LaRosa, Cesar M.] St Vincents Hosp Melbourne, Dept Anat Pathol, Fitzroy, Vic, Australia; [Allen, Penelope J.; Luu, Chi D.; Ayton, Lauren N.; Yeoh, Jonathan] Univ Melbourne, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Allen, Penelope J.; Yeoh, Jonathan] Univ Melbourne, Dept Ophthalmol, East Melbourne, Vic, Australia; [Finch, Sue] Univ Melbourne, Ctr Stat Consulting, Parkville, Vic 3052, Australia; [Xu, Jin] Univ Melbourne, HEARing Cooperat Res Ctr, East Melbourne, Vic, Australia; [Wise, Andrew K.; Xu, Jin; Feng, Helen] Univ Melbourne, Dept Otolaryngol, East Melbourne, Vic, Australia; [McWade, Melanie] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Shivdasani, Mohit N.; Fallon, James B.; Wise, Andrew K.; Williams, Chris E.; Shepherd, Robert K.] Univ Melbourne, Med Bion Dept, East Melbourne, Vic, Australia	Bionics Institute; University of Melbourne; St Vincent's Hospital Melbourne; Centre for Eye Research Australia; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Vanderbilt University; University of Melbourne	Nayagam, DAX (corresponding author), Bion Inst, East Melbourne, Vic, Australia.	dnayagam@bionicsinstitute.org	SHIVDASANI, MOHIT/AAN-3438-2020; Wise, Andrew/B-5943-2014; Ayton, Lauren/AAV-2977-2021	SHIVDASANI, MOHIT/0000-0002-0692-4971; Wise, Andrew/0000-0001-9715-8784; Ayton, Lauren/0000-0001-9907-084X; Luu, Chi/0000-0002-7604-7097; Shepherd, Robert/0000-0002-4239-3362; Nayagam, David/0000-0002-4380-6640	Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology; NH&MRC Centre for Clinical Research Excellence [529923]; Bertalli Family Trust; J T Reid Charitable Trust	Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology(Australian Research Council); NH&MRC Centre for Clinical Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); Bertalli Family Trust; J T Reid Charitable Trust	This research was supported by the Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology grant to Bionic Vision Australia (BVA). Both the Bionics Institute and the Centre for Eye Research Australia (CERA) receive Operational Infrastructure Support from the Victorian Government. CERA is supported by the NH&MRC Centre for Clinical Research Excellence (#529923) - Translational Clinical Research in Major Eye Diseases. The Bionics Institute would also like to acknowledge support from the Bertalli Family Trust and the J T Reid Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AK, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.4.1; BRUMMER SB, 1983, ANN NY ACAD SCI, V405, P159, DOI 10.1111/j.1749-6632.1983.tb31628.x; BRUMMER SB, 1977, IEEE T BIO-MED ENG, V24, P59, DOI 10.1109/TBME.1977.326218; Butterwick A, 2007, IEEE T BIO-MED ENG, V54, P2261, DOI 10.1109/TBME.2007.908310; Cicione R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036009; Cohen EL B., 2013, INVESTIGATIONAL DEVI; Cohen ED, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035005; Colodetti L, 2007, EXP EYE RES, V85, P23, DOI 10.1016/j.exer.2007.02.014; Fallon JB, 2014, EUR J NEUROSCI, V39, P811, DOI 10.1111/ejn.12445; Fallon JB, 2009, J COMP NEUROL, V512, P101, DOI 10.1002/cne.21886; Fujikado T, 2011, INVEST OPHTH VIS SCI, V52, P4726, DOI 10.1167/iovs.10-6836; Gekeler F, 2007, GRAEF ARCH CLIN EXP, V245, P230, DOI 10.1007/s00417-006-0339-x; Gueven D, 2005, J NEURAL ENG, V2, pS65, DOI 10.1088/1741-2560/2/1/009; Huang CQ, 1999, IEEE T BIO-MED ENG, V46, P461, DOI 10.1109/10.752943; Humayun MS, 1999, VISION RES, V39, P2569, DOI 10.1016/S0042-6989(99)00052-8; Humayun MS, 1996, ARCH OPHTHALMOL-CHIC, V114, P40, DOI 10.1001/archopht.1996.01100130038006; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; John SE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036011; Kanda H, 2013, ASS RES VIS OPHTH AN; Kandel E., 2000, PRINCIPLES NEURAL SC; Laube T, 2003, GRAEF ARCH CLIN EXP, V241, P1013, DOI 10.1007/s00417-003-0758-x; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Morimoto T, 2011, INVEST OPHTH VIS SCI, V52, P6785, DOI 10.1167/iovs.10-6971; Nayagam DAX, 2013, JOVE-J VIS EXP, DOI 10.3791/50411; Nayagam DAX, 2011, SMALL, V7, P1035, DOI 10.1002/smll.201002083; Nayagam DAX, 2012, ASS RES VIS OPHTH AN; Robblee L S, 1990, NEURAL PROSTHESES FU; ROSE TL, 1990, IEEE T BIO-MED ENG, V37, P1118, DOI 10.1109/10.61038; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Saunders AL, 2014, CLIN EXP OPHTHALMOL, V42, P665, DOI 10.1111/ceo.12287; SHANNON RV, 1992, IEEE T BIO-MED ENG, V39, P424, DOI 10.1109/10.126616; SHEPHERD RK, 1991, ACTA OTO-LARYNGOL, V111, P848, DOI 10.3109/00016489109138421; Shepherd RK, 2013, TRENDS BIOTECHNOL, V31, P562, DOI 10.1016/j.tibtech.2013.07.001; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; Shivdasani MN, 2013, 3 INT C MED BION ENG, P11; Shivdasani MN, 2012, INVEST OPHTH VIS SCI, V53, P6291, DOI 10.1167/iovs.12-9434; Shivdasani MN, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036008; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Terasawa Y, 2013, IEEE ENG MED BIO, P3567, DOI 10.1109/EMBC.2013.6610313; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Villalobos J, 2011, ASS RES VIS OPHTH AN; Villalobos J, 2013, INVEST OPHTH VIS SCI, V54, P3751, DOI 10.1167/iovs.12-10843; Villalobos J, 2012, GRAEF ARCH CLIN EXP, V250, P399, DOI 10.1007/s00417-011-1794-6; Xu Jin, 2009, Cochlear Implants Int, V10 Suppl 1, P115, DOI 10.1179/cim.2009.10.Supplement-1.115; Zhou JA, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/547428; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	49	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97182	10.1371/journal.pone.0097182	http://dx.doi.org/10.1371/journal.pone.0097182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853376	Green Published, gold			2022-12-27	WOS:000338323200018
J	Backman, S; Kollara, A; Haw, R; Stein, L; Brown, TJ				Backman, Stephanie; Kollara, Alexandra; Haw, Robin; Stein, Lincoln; Brown, Theodore J.			Glucocorticoid-Induced Reversal of Interleukin-1 beta-Stimulated Inflammatory Gene Expression in Human Oviductal Cells	PLOS ONE			English	Article							TUBAL INTRAEPITHELIAL CARCINOMA; HUMAN FALLOPIAN-TUBE; OVARIAN-CANCER RISK; NF-KAPPA-B; SEROUS CARCINOMA; FOLLICULAR-FLUID; RECEPTOR; CYTOKINE; ELAFIN; BRCA1	Studies indicate that high-grade serous ovarian carcinoma (HGSOC), the most common epithelial ovarian carcinoma histotype, originates from the fallopian tube epithelium (FTE). Risk factors for this cancer include reproductive parameters associated with lifetime ovulatory events. Ovulation is an acute inflammatory process during which the FTE is exposed to follicular fluid containing both pro- and anti-inflammatory molecules, such as interleukin-1 (IL1), tumor necrosis factor (TNF), and cortisol. Repeated exposure to inflammatory cytokines may contribute to transforming events in the FTE, with glucocorticoids exerting a protective effect. The global response of FTE cells to inflammatory cytokines or glucocorticoids has not been investigated. To examine the response of FTE cells and the ability of glucocorticoids to oppose this response, an immortalized human FTE cell line, OE-E6/E7, was treated with IL1 beta, dexamethasone (DEX), IL1 beta and DEX, or vehicle and genome-wide gene expression profiling was performed. IL1 beta altered the expression of 47 genes of which 17 were reversed by DEX. DEX treatment alone altered the expression of 590 genes, whereas combined DEX and IL1 beta treatment altered the expression of 784 genes. Network and pathway enrichment analysis indicated that many genes altered by DEX are involved in cytokine, chemokine, and cell cycle signaling, including NF kappa B target genes and interacting proteins. Quantitative real time RT-PCR studies validated the gene array data for IL8, IL23A, PI3 and TACC2 in OE-E6/E7 cells. Consistent with the array data, Western blot analysis showed increased levels of PTGS2 protein induced by IL1 beta that was blocked by DEX. A parallel experiment using primary cultured human FTE cells indicated similar effects on PTGS2, IL8, IL23A, PI3 and TACC2 transcripts. These findings support the hypothesis that pro-inflammatory signaling is induced in FTE cells by inflammatory mediators and raises the possibility that dysregulation of glucocorticoid signaling could contribute to increased risk for HGSOC.	[Backman, Stephanie; Kollara, Alexandra; Brown, Theodore J.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Kollara, Alexandra; Brown, Theodore J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Haw, Robin; Stein, Lincoln] Ontario Inst Canc Res Informat & Biocomp, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research	Brown, TJ (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada.	brown@lunenfeld.ca	Brown, Theodore J./E-2192-2013; Haw, Robin/D-1393-2009	Brown, Theodore J./0000-0002-3074-4516; Haw, Robin/0000-0002-2013-7835	CIHR (Canadian Institutes of Health Research) [MOP106679]	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR (Canadian Institutes of Health Research) MOP106679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2011, CANCER DISCOV, V1, P469, DOI 10.1158/2159-8290.CD-11-0260; Almawi WY, 1996, J LEUKOCYTE BIOL, V60, P563, DOI 10.1002/jlb.60.5.563; Ammundsen HB, 2012, ACTA OBSTET GYN SCAN, V91, P1094, DOI 10.1111/j.1600-0412.2012.01472.x; [Anonymous], 2004, PAED PERINATAL DRUG; Baandrup L, 2013, ACTA OBSTET GYN SCAN, V92, P245, DOI 10.1111/aogs.12069; Bingle L, 2001, AM J RESP CELL MOL, V25, P84, DOI 10.1165/ajrcmb.25.1.4341; Buscher U, 1999, HUM REPROD, V14, P162, DOI 10.1093/humrep/14.1.162; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Carlson JW, 2008, J CLIN ONCOL, V26, P4160, DOI 10.1200/JCO.2008.16.4814; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cheng Shan, 2010, Cancer Genomics & Proteomics, V7, P67; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Fotheringham S, 2011, JOVE-J VIS EXP, DOI 10.3791/2728; Gangisetty O, 2004, ONCOGENE, V23, P2559, DOI 10.1038/sj.onc.1207424; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerard N, 2004, J ENDOCRINOL, V180, P203, DOI 10.1677/joe.0.1800203; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gross J., 1998, GRAPH THEORY ITS APP; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; Hunn J, 2012, CLIN OBSTET GYNECOL, V55, P3, DOI 10.1097/GRF.0b013e31824b4611; Johnson ML, 1999, BIOL REPROD, V61, P1581, DOI 10.1095/biolreprod61.6.1581; Karihtala P, 2009, INT J GYNECOL CANCER, V19, P1047, DOI 10.1111/IGC.0b013e3181ad0f0d; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; King AE, 2009, HUM REPROD, V24, P679, DOI 10.1093/humrep/den452; Kollara A, 2006, BIOCHEM BIOPH RES CO, V346, P526, DOI 10.1016/j.bbrc.2006.05.148; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lauffart B, 2003, GENOMICS, V81, P192, DOI 10.1016/S0888-7543(02)00039-3; Lauffart B., 2007, CANC THERAPY, V5, P409; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lee YL, 2001, MOL REPROD DEV, V59, P400, DOI 10.1002/mrd.1046; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Ling L, 2005, FERTIL STERIL, V84, P1095, DOI 10.1016/j.fertnstert.2005.06.006; Lokshin AE, 2006, GYNECOL ONCOL, V102, P244, DOI 10.1016/j.ygyno.2005.12.011; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Maccio A, 2012, CYTOKINE, V58, P133, DOI 10.1016/j.cyto.2012.01.015; McGuire V, 2004, AM J EPIDEMIOL, V160, P613, DOI 10.1093/aje/kwh284; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; McLaughlin JR, 2007, LANCET ONCOL, V8, P26, DOI 10.1016/S1470-2045(06)70983-4; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Monkkonen KS, 2007, MOL HUM REPROD, V13, P845, DOI 10.1093/molehr/gam075; Mulayim N, 2003, AM J OBSTET GYNECOL, V188, P651, DOI 10.1067/mob.2003.135; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Palter SF, 2001, J CLIN ENDOCR METAB, V86, P2660, DOI 10.1210/jc.86.6.2660; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Pujols L, 2009, EUR RESPIR J, V33, P502, DOI 10.1183/09031936.00017408; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Roghanian A, 2006, AM J RESP CELL MOL, V34, P634, DOI 10.1165/rcmb.2005-0405OC; Runnebaum IB, 2005, CLIN CANCER RES, V11, P6325, DOI 10.1158/1078-0432.CCR-05-0182; Seidman JD, 2011, GYNECOL ONCOL, V120, P470, DOI 10.1016/j.ygyno.2010.11.020; Sen R, 2010, COLD SPRING HARB PER, V2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sogaard M, 2006, ACTA OBSTET GYN SCAN, V85, P93, DOI 10.1080/00016340500324621; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; Still IH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-16; Stock SJ, 2009, REPROD SCI, V16, P1125, DOI 10.1177/1933719109341998; Sun HP, 2008, AM J PHYSIOL-CELL PH, V295, pC915, DOI 10.1152/ajpcell.90646.2007; Takayama KI, 2012, MOL ENDOCRINOL, V26, P748, DOI 10.1210/me.2011-1242; Tang SG, 2012, INT J GYNECOL PATHOL, V31, P103, DOI 10.1097/PGP.0b013e31822ea955; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Tone AA, 2008, CLIN CANCER RES, V14, P4067, DOI 10.1158/1078-0432.CCR-07-4959; Tone AA, 2012, CLIN CANCER RES, V18, P4334, DOI 10.1158/1078-0432.CCR-12-0199; Tone AA, 2011, ENDOCR-RELAT CANCER, V18, P221, DOI 10.1530/ERC-10-0235; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Tung KH, 2005, AM J EPIDEMIOL, V161, P321, DOI 10.1093/aje/kwi046; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wang B, 2012, MODEL IDENT CONTROL, V33, P27, DOI 10.4173/mic.2012.1.3; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wanggren K, 2008, HUM REPROD, V23, P2359, DOI 10.1093/humrep/den260; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567; Zhu XO, 2009, MOL ENDOCRINOL, V23, P1839, DOI 10.1210/me.2009-0201	80	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97997	10.1371/journal.pone.0097997	http://dx.doi.org/10.1371/journal.pone.0097997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848801	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600074
J	Couturier, A; Keller, J; Most, E; Ringseis, R; Eder, K				Couturier, Aline; Keller, Janine; Most, Erika; Ringseis, Robert; Eder, Klaus			Niacin in Pharmacological Doses Alters MicroRNA Expression in Skeletal Muscle of Obese Zucker Rats	PLOS ONE			English	Article							NICOTINIC-ACID; GENE-EXPRESSION; FATTY-ACIDS; PLASMA; SUPPLEMENTATION; ADIPONECTIN; CHOLESTEROL; TRANSITION; MECHANISM; PGC-1	Administration of pharmacological niacin doses was recently reported to have pronounced effects on skeletal muscle gene expression and phenotype in obese Zucker rats, with the molecular mechanisms underlying the alteration of gene expression being completely unknown. Since miRNAs have been shown to play a critical role for gene expression through inducing miRNA-mRNA interactions which results in the degradation of specific mRNAs or the repression of protein translation, we herein aimed to investigate the influence of niacin at pharmacological doses on the miRNA expression profile in skeletal muscle of obese Zucker rats fed either a control diet with 30 mg supplemented niacin/kg diet or a high-niacin diet with 780 mg supplemented niacin/kg diet for 4 wk. miRNA microarray analysis revealed that 42 out of a total of 259 miRNAs were differentially expressed (adjusted P-value <0.05), 20 being down-regulated and 22 being up-regulated, between the niacin group and the control group. Using a biostatistics approach, we could demonstrate that the most strongly up-regulated (log2 ratio >= 0.5) and down-regulated (log2 ratio <=-0.5) miRNAs target approximately 1,800 mRNAs. Gene-term enrichment analysis showed that many of the predicted target mRNAs from the most strongly regulated miRNAs were involved in molecular processes dealing with gene transcription such as DNA binding, transcription regulator activity, transcription factor binding and in important regulatory pathways such as Wnt signaling and MAPK signaling. In conclusion, the present study shows for the first time that pharmacological niacin doses alter the expression of miRNAs in skeletal muscle of obese Zucker rats and that the niacin-regulated miRNAs target a large set of genes and pathways which are involved in gene regulatory activity indicating that at least some of the recently reported effects of niacin on skeletal muscle gene expression and phenotype in obese Zucker rats are mediated through miRNA-mRNA interactions.	[Couturier, Aline; Keller, Janine; Most, Erika; Ringseis, Robert; Eder, Klaus] Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Couturier, A (corresponding author), Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany.	aline.couturier@ernaehrung.uni-giessen.de	Ringseis, Robert/AAH-1509-2021		Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	JK is financed by the Deutsche Forschungsgemeinschaft (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao BL, 2010, J NUTR, V140, P1546, DOI 10.3945/jn.110.126359; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; CISTERNAS P, 2013, MOL NEUROBIOL; DISHAO LY, 2010, MITOCHONDRION, V10, P516; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ganji SH, 2003, J NUTR BIOCHEM, V14, P298, DOI 10.1016/S0955-2863(02)00284-X; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Ge Q, 2012, ENDOCRINOLOGY, V153, P5285, DOI 10.1210/en.2012-1623; Gille A, 2008, ANNU REV PHARMACOL, V48, P79, DOI 10.1146/annurev.pharmtox.48.113006.094746; Guyton JR, 1998, AM J CARDIOL, V82, p18U, DOI 10.1016/S0002-9149(98)00767-X; Hemandez C, 2010, CELL METAB, V12, P411, DOI 10.1016/j.cmet.2010.09.001; Hu Y, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-16; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; JUFFER P, 2014, CELL BIOCH BIOPHYS; Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029; Karere GM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-320; Keller J, 2012, ANIMAL, V6, P70, DOI 10.1017/S1751731111001327; Khan M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-85; Kirkland JB, 2009, CURR PHARM DESIGN, V15, P3, DOI 10.2174/138161209787185823; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwiterovich PO, 1998, AM J CARDIOL, V82, p39U, DOI 10.1016/S0002-9149(98)00958-8; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li D, 2013, BRIT J NUTR, V110, P2156, DOI 10.1017/S0007114513001815; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu M, 2012, J CHROMATOGR B, V904, P107, DOI 10.1016/j.jchromb.2012.07.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; National Research Council, 1985, GUIDE CARE USE LAB A; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Plaisance EP, 2008, METABOLISM, V57, P404, DOI 10.1016/j.metabol.2007.10.018; Pohl J, 2002, J LIPID RES, V43, P1390, DOI 10.1194/jlr.M100404-JLR200; QUABBE HJ, 1983, J CLIN ENDOCR METAB, V57, P410, DOI 10.1210/jcem-57-2-410; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Ringseis R, 2013, J NUTR, V143, P125, DOI 10.3945/jn.112.164038; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roepstorff C, 2004, AM J PHYSIOL-ENDOC M, V287, pE696, DOI 10.1152/ajpendo.00001.2004; Lipszyc PS, 2013, OPEN CARDIOVASC MED, V7, P90, DOI 10.2174/1874192401307010090; Scholz K, 2014, EUR J NUTR, V53, P1229, DOI 10.1007/s00394-013-0624-5; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Terao M, 2011, J BIOL CHEM, V286, P4027, DOI 10.1074/jbc.M110.184994; Wanders D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071285; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Weijts BGMW, 2012, EMBO J, V31, P3871, DOI 10.1038/emboj.2012.231; Westphal S, 2007, ATHEROSCLEROSIS, V193, P361, DOI 10.1016/j.atherosclerosis.2006.06.028; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129	52	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98313	10.1371/journal.pone.0098313	http://dx.doi.org/10.1371/journal.pone.0098313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847987	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600108
J	Mihaljevic, JR; Joseph, MB; Orlofske, SA; Paull, SH				Mihaljevic, Joseph R.; Joseph, Maxwell B.; Orlofske, Sarah A.; Paull, Sara H.			The Scaling of Host Density with Richness Affects the Direction, Shape, and Detectability of Diversity-Disease Relationships	PLOS ONE			English	Article							PARASITE TRANSMISSION; COMMUNITY COMPOSITION; INFECTIOUS-DISEASE; SPECIES-DIVERSITY; BIODIVERSITY; RISK; PRODUCTIVITY; PATHOGENS; ECOLOGY; IMPACT	Pathogen transmission responds differently to host richness and abundance, two unique components of host diversity. However, the heated debate around whether biodiversity generally increases or decreases disease has not considered the relationships between host richness and abundance that may exist in natural systems. Here we use a multi-species model to study how the scaling of total host community abundance with species richness mediates diversity-disease relationships. For pathogens with density-dependent transmission, non-monotonic trends emerge between pathogen transmission and host richness when host community abundance saturates with richness. Further, host species identity drives high variability in pathogen transmission in depauperate communities, but this effect diminishes as host richness accumulates. Using simulation we show that high variability in low richness communities and the non-monotonic relationship observed with host community saturation may reduce the detectability of trends in empirical data. Our study emphasizes that understanding the patterns and predictability of host community composition and pathogen transmission mode will be crucial for predicting where and when specific diversity-disease relationships should occur in natural systems.	[Mihaljevic, Joseph R.; Joseph, Maxwell B.; Orlofske, Sarah A.; Paull, Sara H.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Orlofske, Sarah A.] NE Illinois Univ, Dept Biol, Chicago, IL 60625 USA	University of Colorado System; University of Colorado Boulder	Mihaljevic, JR (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	joseph.mihaljevic@colorado.edu	Joseph, Maxwell/Z-5422-2019	Joseph, Maxwell/0000-0002-7745-9990; Mihaljevic, Joseph/0000-0003-2320-5773	NSF [DGE 1144083]; EPA; University of Colorado Graduate School Dissertation Completion Fellowship	NSF(National Science Foundation (NSF)); EPA(United States Environmental Protection Agency); University of Colorado Graduate School Dissertation Completion Fellowship	JRM and MBJ were supported by the NSF Graduate Research Fellowship Program (DGE 1144083). SHP was supported by the EPA Science to Achieve Results graduate fellowship program and a University of Colorado Graduate School Dissertation Completion Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LJS, 2012, NAT RESOUR MODEL, V25, P5, DOI 10.1111/j.1939-7445.2011.00104.x; DeLeo GA, 1996, NATURE, V379, P720, DOI 10.1038/379720a0; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Guo QF, 2006, ECOL LETT, V9, P1284, DOI 10.1111/j.1461-0248.2006.00980.x; Huang ZYX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054341; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Johnson PTJ, 2008, ECOL LETT, V11, P1017, DOI 10.1111/j.1461-0248.2008.01212.x; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Joseph MB, 2013, ECOL LETT, V16, P1405, DOI 10.1111/ele.12180; KEELE L, 2008, SEMIPARAMETRIC REGRE; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Lafferty KD, 2013, TRENDS ECOL EVOL, V28, P503, DOI 10.1016/j.tree.2013.06.012; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Roche B, 2013, AM NAT, V181, P1, DOI 10.1086/668591; Roche B, 2012, PHILOS T R SOC B, V367, P2807, DOI 10.1098/rstb.2011.0364; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Team RC, 2013, R LANGUAGE ENV STAT; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Wood CM, 2012, FISH PHYSIOL, V31B, P1, DOI 10.1016/S1546-5098(11)31023-0; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	33	45	45	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97812	10.1371/journal.pone.0097812	http://dx.doi.org/10.1371/journal.pone.0097812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849581	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600061
J	Tangen, IL; Krakstad, C; Halle, MK; Werner, HMJ; Oyan, AM; Kusonmano, K; Petersen, K; Kalland, KH; Akslen, LA; Trovik, J; Hurtado, A; Salvesen, HB				Tangen, Ingvild Loberg; Krakstad, Camilla; Halle, Mari K.; Werner, Henrica M. J.; Oyan, Anne M.; Kusonmano, Kanthida; Petersen, Kjell; Kalland, Karl Henning; Akslen, Lars A.; Trovik, Jone; Hurtado, Antoni; Salvesen, Helga B.			Switch in FOXA1 Status Associates with Endometrial Cancer Progression	PLOS ONE			English	Article							ESTROGEN-RECEPTOR BINDING; EPIDERMAL GROWTH-FACTOR; POSITIVE BREAST-CANCER; PROSTATE-CANCER; TRANSCRIPTION FACTOR; RAT UTERUS; EXPRESSION; CARCINOMA; ALPHA; SIGNATURES	Background: The transcription factor Forkhead box A1 (FOXA1) is suggested to be important in hormone dependent cancers, although with little data for endometrial cancer. We investigated expression levels of FOXA1 in primary and metastatic endometrial cancer in relation to clinical phenotype, and transcriptional alterations related to FOXA1 status. Methods: Protein expression of FOXA1 was explored by immunohistochemistry in 529 primary and 199 metastatic endometrial carcinoma lesions. mRNA levels from corresponding 158 fresh frozen primary and 42 metastatic lesions were analyzed using Agilent Microarrays (44k) in parallel. Results: Low FOXA1 protein expression in primary tumors significantly correlated with low FOXA1 mRNA, high age, non-endometrioid histology, high grade, loss of ER alpha and PR and poor survival (all p-values <0.05). Through a Connectivity Map search, HDAC inhibitors were suggested as potential treatment for patients with low FOXA1 expression. An increase in FOXA1 expression was observed from primary to metastatic lesions and it correlated with CDKN2A expression in metastases. Conclusion: Low FOXA1 is associated with poor survival and suggests a potential for HDAC inhibitors in endometrial carcinoma. A switch in FOXA1 expression from primary to metastatic lesions is observed and gene expression indicates a link between FOXA1 and CDKN2A in metastatic lesions.	[Tangen, Ingvild Loberg; Krakstad, Camilla; Halle, Mari K.; Werner, Henrica M. J.; Oyan, Anne M.; Kusonmano, Kanthida; Kalland, Karl Henning; Akslen, Lars A.; Trovik, Jone; Salvesen, Helga B.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Tangen, Ingvild Loberg; Krakstad, Camilla; Halle, Mari K.; Werner, Henrica M. J.; Kusonmano, Kanthida; Trovik, Jone; Salvesen, Helga B.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Oyan, Anne M.; Kalland, Karl Henning] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Kusonmano, Kanthida; Petersen, Kjell] Univ Bergen, Computat Biol Unit, Bergen, Norway; [Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Hurtado, Antoni] Univ Oslo, Breast Canc Res Grp, Ctr Mol Med Norway, Oslo, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo	Tangen, IL (corresponding author), Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway.	ith027@k2.uib.no	Akslen, Lars A./AAG-6097-2021; salvesen, Helga B/C-1187-2017; Kusonmano, Kanthida/AAQ-2802-2020; Werner, henrica/ABG-1235-2021; Akslen, Lars A/C-1202-2017; Krakstad, Camilla/AAB-5138-2020; Halle, Mari K/AAT-4856-2020; Kalland, Karl-Henning/B-9445-2017	Akslen, Lars A./0000-0003-2710-9543; salvesen, Helga B/0000-0002-4438-8831; Werner, henrica/0000-0001-5186-8369; Akslen, Lars A/0000-0003-2710-9543; Krakstad, Camilla/0000-0002-0174-8139; Kalland, Karl-Henning/0000-0003-4486-2334; Halle, Mari K/0000-0002-2660-8271; Hurtado, Antoni/0000-0002-0145-4763	Helse Vest; University of Bergen; Norwegian Cancer Society; Research Council of Norway	Helse Vest; University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	This study was supported by Helse Vest, the University of Bergen, the Norwegian Cancer Society and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, CANCER SCI, V103, P806, DOI 10.1111/j.1349-7006.2012.02201.x; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hisamatsu Y, 2012, ANN SURG ONCOL, V19, P1145, DOI 10.1245/s10434-011-2094-4; HUETHUDSON YM, 1990, MOL ENDOCRINOL, V4, P510, DOI 10.1210/mend-4-3-510; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jain RK, 2011, HISTOPATHOLOGY, V58, P766, DOI 10.1111/j.1365-2559.2011.03796.x; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Krakstad C, 2012, BRIT J CANCER, V106, P1682, DOI 10.1038/bjc.2012.91; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li Q, 2013, EMBO J, V32, P858, DOI 10.1038/emboj.2013.35; LINGHAM RB, 1988, MOL ENDOCRINOL, V2, P230, DOI 10.1210/mend-2-3-230; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; MURPHY LJ, 1987, MOL ENDOCRINOL, V1, P445, DOI 10.1210/mend-1-7-445; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Stefansson IM, 2004, J CLIN ONCOL, V22, P1242, DOI 10.1200/JCO.2004.09.034; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; WEISZ A, 1988, MOL ENDOCRINOL, V2, P816, DOI 10.1210/mend-2-9-816; Wik E, 2013, CLIN CANCER RES, V19, P1094, DOI 10.1158/1078-0432.CCR-12-3039	32	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98069	10.1371/journal.pone.0098069	http://dx.doi.org/10.1371/journal.pone.0098069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849812	Green Submitted, gold, Green Published			2022-12-27	WOS:000336730600083
J	Zhang, Z; Ding, LP; Jin, ZT; Gao, GJ; Li, HJ; Zhang, LJ; Zhang, LN; Lu, X; Hu, LH; Lu, BW; Yu, XJ; Hu, TH				Zhang, Zheng; Ding, Liping; Jin, Zhitao; Gao, Guojie; Li, Huijun; Zhang, Lijuan; Zhang, Lina; Lu, Xin; Hu, Lihua; Lu, Bingwei; Yu, Xiongjun; Hu, Taohong			Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling	PLOS ONE			English	Article							HEART-FAILURE; BETA(3)-ADRENERGIC RECEPTOR; CARDIOVASCULAR-SYSTEM; SYNTHASE ACTIVATION; CONTRACTILITY; ENOS; RELEASE; CELLS	Nebivolol, third-generation beta-blocker, may activate beta 3-adrenergic receptor (AR), which has been emerged as a novel and potential therapeutic targets for cardiovascular diseases. However, it is not known whether nebivolol administration plays a cardioprotective effect against myocardial infarction (MI) injury. Therefore, the present study was designed to clarify the effects of nebivolol on MI injury and to elucidate the underlying mechanism. MI model was constructed by left anterior descending (LAD) artery ligation. Nebivolol, beta 3-AR antagonist (SR59230A), Nitro-L-arginine methylester (L-NAME) or vehicle was administered for 4 weeks after MI operation. Cardiac function was monitored by echocardiography. Moreover, the fibrosis and the apoptosis of myocardium were assessed by Masson's trichrome stain and TUNEL assay respectively 4 weeks after MI. Nebivolol administration reduced scar area by 68% compared with MI group (p<0.05). Meanwhile, nebivolol also decreased the myocardial apoptosis and improved the heart function after MI (p<0.05 vs. MI). These effects were associated with increased beta 3-AR expression. Moreover, nebivolol treatment significantly increased the phosphorylation of endothelial NOS (eNOS) and the expression of neuronal NOS (nNOS). Conversely, the cardiac protective effects of nebivolol were abolished by SR and L-NAME. These results indicate that nebivolol protects against MI injury. Furthermore, the cardioprotective effects of nebivolol may be mediated by beta 3-AR-eNOS/nNOS pathway.	[Zhang, Zheng; Ding, Liping; Jin, Zhitao; Gao, Guojie; Li, Huijun; Zhang, Lijuan; Zhang, Lina; Lu, Xin; Hu, Lihua; Lu, Bingwei; Yu, Xiongjun; Hu, Taohong] Chinese Peoples Liberat Army, Artillery Gen Hosp 2, Dept Cardiol, Beijing, Peoples R China		Hu, TH (corresponding author), Chinese Peoples Liberat Army, Artillery Gen Hosp 2, Dept Cardiol, Beijing, Peoples R China.	Hutaohong2010@163.com	Zhang, Li/GWM-7501-2022					Aragon JP, 2011, J AM COLL CARDIOL, V58, P2683, DOI 10.1016/j.jacc.2011.09.033; Braunwald E, 2000, CIRCULATION, V102, P14; Brixius K, 2006, CAN J PHYSIOL PHARM, V84, P1051, DOI 10.1139/Y06-033; Dobre D, 2007, AM HEART J, V154, P109, DOI 10.1016/j.ahj.2007.03.025; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Iwakiri Y, 2002, AM J PHYSIOL-HEART C, V282, pH2084, DOI 10.1152/ajpheart.00675.2001; Karter Yesari, 2007, Recent Pat Cardiovasc Drug Discov, V2, P152; Maffei A, 2007, HYPERTENSION, V50, P652, DOI 10.1161/HYPERTENSIONAHA.107.094458; Martin SR, 2006, CARDIOVASC RES, V70, P97, DOI 10.1016/j.cardiores.2006.02.002; Mercanoglu GO, 2010, ANATOL J CARDIOL, V10, P18; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Rozec B, 2003, ARCH MAL COEUR VAISS, V96, P905; Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002; Skeberdis VA, 2008, J CLIN INVEST, V118, P3219, DOI 10.1172/JCI32519; Sorrentino SA, 2011, J AM COLL CARDIOL, V57, P601, DOI 10.1016/j.jacc.2010.09.037; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Tavernier G, 2003, CARDIOVASC RES, V59, P288, DOI 10.1016/S0008-6363(03)00359-6; Varghese P, 2000, J CLIN INVEST, V106, P697, DOI 10.1172/JCI9323; Zhang Z, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0333-5; Zhang Z, 2011, INFLAMM RES, V60, P37, DOI 10.1007/s00011-010-0232-2	24	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98179	10.1371/journal.pone.0098179	http://dx.doi.org/10.1371/journal.pone.0098179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849208	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600096
J	Liu, YS; Zhang, X; Liu, Y; Jin, XX; Fan, C; Ye, HQ; Ou, ME; Lv, LW; Wu, G; Zhou, YS				Liu, Yunsong; Zhang, Xiao; Liu, Yang; Jin, Xiaoxiao; Fan, Cong; Ye, Hongqiang; Ou, Meng'en; Lv, Longwei; Wu, Gang; Zhou, Yongsheng			Bi-Functionalization of a Calcium Phosphate-Coated Titanium Surface with Slow-Release Simvastatin and Metronidazole to Provide Antibacterial Activities and Pro-Osteodifferentiation Capabilities	PLOS ONE			English	Article							MESENCHYMAL STEM-CELL; IN-VITRO; CLOSTRIDIUM-DIFFICILE; BONE; DIFFERENTIATION; RESISTANCE; IMPLANTS; ADHESION; REGENERATION; MECHANISM	Coating the surface of titanium implants or other bone graft substitute materials with calcium phosphate (Ca-P) crystals is an effective way to enhance the osteoconduction of the implants. Ca-P coating alone cannot confer pro-osteodifferentiation and antibacterial capabilities on implants; however, it can serve as a carrier for biological agents which could improve the performance of implants and bone substitutes. Here, we constructed a novel, bi-functional Ca-P coating with combined pro-osteodifferentiation and antibacterial capabilities. Different concentrations of metronidazole (MNZ) and simvastatin (SIM) were integrated into biomimetic Ca-P coatings on the surface of titanium disks. The biological effects of this bi-functional biomimetic coating on human bone marrow mesenchymal stem cells (hBMMSCs), human adipose derived stromal cells (hASCs), and Porphyromonas gingivalis were assessed in vitro. We observed that Ca-P coatings loaded with both SIM and MNZ display favorable release kinetics without affecting cell proliferation or attachment. In the inhibition zone test, we found that the bi-functional coating showed lasting antibacterial effects when incubated with Porphyromonas gingivalis for 2 and 4 days. Moreover, the osteodifferentiation of hBMMSCs and hASCs were increased when cultured on this bi-functional coating for 7 and 14 days. Both drugs were loaded onto the Ca-P coating at specific concentrations (10 25 M SIM; 10 22 M MNZ) to achieve optimal release kinetics. Considering the safety, stability and low cost of SIM and MNZ, this novel bifunctional Ca-P coating technique represents a promising method to improve the performance of metal implants or other bone substitute materials, and can theoretically be easily translated to clinical applications.	[Liu, Yunsong; Zhang, Xiao; Jin, Xiaoxiao; Fan, Cong; Ye, Hongqiang; Ou, Meng'en; Lv, Longwei; Zhou, Yongsheng] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China; [Liu, Yunsong; Zhou, Yongsheng] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Liu, Yang] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China; [Wu, Gang] Vrije Univ Amsterdam, Res Inst MOVE, Acad Ctr Dentristry Amsterdam ACTA, Dept Oral Implantol & Prosthet Dent, Amsterdam, Netherlands; [Zhou, Yongsheng] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing 100871, Peoples R China	Peking University; Peking University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Peking University	Zhou, YS (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China.	kqzhouysh@hsc.pku.edu.cn	Lv, Longwei/ABA-5055-2020; wu, gang/C-5072-2012	wu, gang/0000-0001-8941-2500	National Natural Science Foundation of China [30901693, 81170937]; Program for New Century Excellent Talents in University from Ministry of Education [BMU20110274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education(Program for New Century Excellent Talents in University (NCET))	This study was supported by grants from the National Natural Science Foundation of China (No. 30901693, No. 81170937), http://www.nsfc.gov.cn/Portal0/default152.htm. This study was also supported by the Program for New Century Excellent Talents in University from Ministry of Education (BMU20110274), http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A16/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt131; Boyanova L, 2004, ANAEROBE, V10, P261, DOI 10.1016/j.anaerobe.2004.06.001; Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386; Gaines S T, 1988, J Bone Joint Surg Am, V70, P1430; Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; He J, 2012, J BIOMED MATER RES A, V100A, P1706, DOI 10.1002/jbm.a.34121; Herberg S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058207; Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015; Huang Z, 2013, BIOMATERIALS, V34, P3303, DOI 10.1016/j.biomaterials.2013.01.054; Kang JM, 2012, ACTA BIOMATER, V8, P1759, DOI 10.1016/j.actbio.2012.01.005; Kunishima H, 2013, J INFECT CHEMOTHER, V19, P360, DOI 10.1007/s10156-013-0553-5; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Leitsch D, 2009, MOL MICROBIOL, V72, P518, DOI 10.1111/j.1365-2958.2009.06675.x; Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Liu YL, 2010, J R SOC INTERFACE, V7, pS631, DOI 10.1098/rsif.2010.0115.focus; Liu YS, 2008, BIOMATERIALS, V29, P3338, DOI 10.1016/j.biomaterials.2008.04.037; Liu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056002; MANKIN HJ, 1983, CLIN ORTHOP RELAT R, P69; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nolan R, 2014, CLIN ORAL IMPLAN RES, V25, P252, DOI 10.1111/clr.12124; Pauly S, 2009, BONE, V45, P505, DOI 10.1016/j.bone.2009.05.010; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Peter B, 2005, BONE, V36, P52, DOI 10.1016/j.bone.2004.10.004; Saran N, 2011, CLIN ORTHOP RELAT R, V469, P1470, DOI 10.1007/s11999-010-1573-4; Sun LM, 2002, J BIOMED MATER RES, V62, P228, DOI 10.1002/jbm.10315; Tavakoli N, 2007, J PHARMACEUT BIOMED, V43, P325, DOI 10.1016/j.jpba.2006.06.002; Uzzan B, 2007, BONE, V40, P1581, DOI 10.1016/j.bone.2007.02.019; van der Wouden EJ, 2001, SCAND J GASTROENTERO, V36, P10, DOI 10.1080/003655201753265055; Wu G, 2010, TISSUE ENG PART C-ME, V16, P1255, DOI [10.1089/ten.tec.2009.0588, 10.1089/ten.TEC.2009.0588]; Wu G, 2010, BIOMATERIALS, V31, P7485, DOI 10.1016/j.biomaterials.2010.06.037; Yang F, 2011, ORAL SURG ORAL MED O, V111, P551, DOI 10.1016/j.tripleo.2010.06.018; Yang XF, 2009, DENT MATER, V25, P473, DOI 10.1016/j.dental.2008.09.007; Yardimci C, 2010, J CHROMATOGR SCI, V48, P95, DOI 10.1093/chromsci/48.2.95; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhou W, 2010, BIOMATERIALS, V31, P3212, DOI 10.1016/j.biomaterials.2010.01.036; Zhou YS, 2010, BIOMATERIALS, V31, P5325, DOI 10.1016/j.biomaterials.2010.03.037	38	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97741	10.1371/journal.pone.0097741	http://dx.doi.org/10.1371/journal.pone.0097741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844416	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400054
J	Xue, P; Crum, CM; Thibodeau, PH				Xue, Peng; Crum, Chelsea M.; Thibodeau, Patrick H.			Regulation of ABCC6 Trafficking and Stability by a Conserved C-terminal PDZ-Like Sequence	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CAUSE PSEUDOXANTHOMA ELASTICUM; RESISTANCE-ASSOCIATED PROTEIN; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS; ATP-BINDING; CRYSTAL-STRUCTURE; APICAL MEMBRANE; CELL-SURFACE; CFTR	Mutations in the ABCC6 ABC-transporter are causative of pseudoxanthoma elasticum (PXE). The loss of functional ABCC6 protein in the basolateral membrane of the kidney and liver is putatively associated with altered secretion of a circulatory factor. As a result, systemic changes in elastic tissues are caused by progressive mineralization and degradation of elastic fibers. Premature arteriosclerosis, loss of skin and vascular tone, and a progressive loss of vision result from this ectopic mineralization. However, the identity of the circulatory factor and the specific role of ABCC6 in disease pathophysiology are not known. Though recessive loss-of-function alleles are associated with alterations in ABCC6 expression and function, the molecular pathologies associated with the majority of PXE-causing mutations are also not known. Sequence analysis of orthologous ABCC6 proteins indicates the C-terminal sequences are highly conserved and share high similarity to the PDZ sequences found in other ABCC subfamily members. Genetic testing of PXE patients suggests that at least one disease-causing mutation is located in a PDZ-like sequence at the extreme C-terminus of the ABCC6 protein. To evaluate the role of this C-terminal sequence in the biosynthesis and trafficking of ABCC6, a series of mutations were utilized to probe changes in ABCC6 biosynthesis, membrane stability and turnover. Removal of this PDZ-like sequence resulted in decreased steady-state ABCC6 levels, decreased cell surface expression and stability, and mislocalization of the ABCC6 protein in polarized cells. These data suggest that the conserved, PDZ-like sequence promotes the proper biosynthesis and trafficking of the ABCC6 protein.	[Xue, Peng; Crum, Chelsea M.; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	thibodea@pitt.edu		Thibodeau, Patrick/0000-0002-6790-144X	University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology; NIH/NIDDK [DK083284]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R56DK083284] Funding Source: NIH RePORTER	University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by faculty development funding from the University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology and by support from the NIH/NIDDK to PHT (DK083284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlanov R, 2012, HUM MUTAT, V33, P750, DOI 10.1002/humu.22041; Azim AC, 1995, GENOMICS, V30, P613, DOI 10.1006/geno.1995.1286; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; BEAR CE, 1991, J BIOL CHEM, V266, P19142; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dorwart MR, 2008, J BIOL CHEM, V283, P8711, DOI 10.1074/jbc.M704328200; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Emi Y, 2012, J CELL SCI, V125, P3133, DOI 10.1242/jcs.099549; Emi Y, 2011, J BIOCHEM, V149, P177, DOI 10.1093/jb/mvq131; Faletra F, 2012, GENE; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Germain DP, 2003, ARTERIOSCL THROM VAS, V23, P836, DOI 10.1161/01.ATV.0000067428.19031.28; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Harris MJ, 2001, J BIOL CHEM, V276, P20876, DOI 10.1074/jbc.M010566200; Hayashi H, 2012, J BIOL CHEM, V287, P15054, DOI 10.1074/jbc.M111.337931; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hu XF, 2003, EUR J HUM GENET, V11, P215, DOI 10.1038/sj.ejhg.5200953; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Jiang QJ, 2006, J INVEST DERMATOL, V126, P1440, DOI 10.1038/sj.jid.5700267; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kocher O, 1999, LAB INVEST, V79, P1161; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kwon SH, 2007, CELL PHYSIOL BIOCHEM, V20, P763, DOI 10.1159/000110436; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Le Saux O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024738; LEBWOHL M, 1993, NEW ENGL J MED, V329, P1240; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Maday S, 2008, TRAFFIC, V9, P1915, DOI 10.1111/j.1600-0854.2008.00805.x; Miksch S, 2005, HUM MUTAT, V26, P235, DOI 10.1002/humu.20206; Milewski MI, 2001, J CELL SCI, V114, P719; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Plomp AS, 2008, MOL VIS, V14, P118; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Schulz V, 2005, HUM BIOL, V77, P367, DOI 10.1353/hub.2005.0054; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sun RH, 2012, J BIOL CHEM, V287, P37564, DOI 10.1074/jbc.M112.394585; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Wegman JJ, 2005, INT J CARDIOL, V100, P389, DOI 10.1016/j.ijcard.2004.07.012; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wilken S, 1996, MOL MICROBIOL, V22, P655, DOI 10.1046/j.1365-2958.1996.d01-1724.x; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhang L, 2012, J BIOL CHEM, V287, P4311, DOI 10.1074/jbc.M111.310300; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	60	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97360	10.1371/journal.pone.0097360	http://dx.doi.org/10.1371/journal.pone.0097360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840500	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000340948600027
J	Postnikoff, CK; Pintwala, R; Williams, S; Wright, AM; Hileeto, D; Gorbet, MB				Postnikoff, Cameron K.; Pintwala, Robert; Williams, Sara; Wright, Ann M.; Hileeto, Denise; Gorbet, Maud B.			Development of a Curved, Stratified, In Vitro Model to Assess Ocular Biocompatibility	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; AIR-LIQUID INTERFACE; LENS CARE SOLUTIONS; END-POINT ANALYSIS; MULTIPURPOSE SOLUTIONS; DRUG ABSORPTION; CULTURE MODEL; EYE IRRITATION; BENZALKONIUM CHLORIDE; CASPASE ACTIVATION	Purpose: To further improve in vitro models of the cornea, this study focused on the creation of a three-dimensional, stratified, curved epithelium; and the subsequent characterization and evaluation of its suitability as a model for biocompatibility testing. Methods: Immortalized human corneal epithelial cells were grown to confluency on curved cellulose filters for seven days, and were then differentiated and stratified using an air-liquid interface for seven days before testing. Varying concentrations of a commercial ophthalmic solution containing benzalkonium chloride (BAK), a known cytotoxic agent, and two relevant ocular surfactants were tested on the model. A whole balafilcon A lens soaked in phosphate buffered saline (BA PBS) was also used to assess biocompatibility and verify the validity of the model. Viability assays as well as flow cytometry were performed on the cells to investigate changes in cell death and integrin expression. Results: The reconstructed curved corneal epithelium was composed of 3-5 layers of cells. Increasing concentrations of BAK showed dose-dependent decreased cell viability and increased integrin expression and cell death. No significant change in viability was observed in the presence of the surfactants. As expected, the BA PBS combination appeared to be very biocompatible with no adverse change in cell viability or integrin expression. Conclusions: The stratified, curved, epithelial model proved to be sensitive to distinct changes in cytotoxicity and is suitable for continued assessment for biocompatibility testing of contact lenses. Our results showed that flow cytometry can provide a quantitative measure of the cell response to biomaterials or cytotoxic compounds for both the supernatant and adherent cell populations. As a specifically designed in vitro model of the corneal epithelium, this quantitative model for biocompatibility at the ocular surface may help improve our understanding of cell-material interactions and reduce the use of animal testing.	[Postnikoff, Cameron K.; Pintwala, Robert; Williams, Sara; Gorbet, Maud B.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Williams, Sara] Alcon CIBAVis, Duluth, GA USA; [Hileeto, Denise; Gorbet, Maud B.] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Gorbet, MB (corresponding author), Univ Waterloo, Waterloo, ON N2L 3G1, Canada.	mgorbet@uwaterloo.ca			Natural Sciences and Engineering Council (NSERC) of Canada; Alcon	Natural Sciences and Engineering Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alcon(Novartis)	This work was supported by a Collaborative Research and Development grant from the Natural Sciences and Engineering Council (NSERC) of Canada and CIBA Vision (now known as Alcon). NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. M. W. from CIBA participated in the study design but did not have a decision role. CIBA Vision/Alcon had no role in data collection and analysis, decision to publish or preparation of the manuscript.	Altman F P, 1976, Prog Histochem Cytochem, V9, P1; ALTMAN FP, 1974, HISTOCHEMISTRY, V38, P155, DOI 10.1007/BF00499663; Andrasko Gary, 2008, Optometry, V79, P444, DOI 10.1016/j.optm.2008.04.097; [Anonymous], 2013, BIOLUMINESCENT CELL; [Anonymous], 2004, BASF TECHNICAL B; ARAIE M, 1987, EXP EYE RES, V44, P73, DOI 10.1016/S0014-4835(87)80027-1; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Ban Y, 2003, EXP EYE RES, V76, P735, DOI 10.1016/S0014-4835(03)00033-2; Barar J, 2008, EXPERT OPIN DRUG DEL, V5, P567, DOI 10.1517/17425247.5.5.567 ; Bradbury DA, 2000, J IMMUNOL METHODS, V240, P79, DOI 10.1016/S0022-1759(00)00178-2; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carnt N, 2007, CORNEAL STAINING IER; Castro-Munozledo F, 2008, EXP EYE RES, V86, P459, DOI 10.1016/j.exer.2007.11.017; Cavet ME, 2009, CONTACT LENS ANTERIO, V32, P171, DOI 10.1016/j.clae.2009.05.002; Chang JE, 2000, PHARMACEUT RES, V17, P670, DOI 10.1023/A:1007569929765; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Choy CKM, 2012, CLIN EXP OPTOM, V95, P198, DOI 10.1111/j.1444-0938.2011.00687.x; Choy CKM, 2009, OPTOMETRY VISION SCI, V86, P447; Debbasch C, 2005, FOOD CHEM TOXICOL, V43, P155, DOI 10.1016/j.fct.2004.09.004; Diaz G, 2007, EUR J HISTOCHEM, V51, P213; Doucet O, 2006, TOXICOL IN VITRO, V20, P499, DOI 10.1016/j.tiv.2005.09.005; Doucet O, 1996, TOXICOL IN VITRO, V10, P305, DOI 10.1016/0887-2333(96)00011-2; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Dutot M, 2008, EUR J PHARM SCI, V33, P138, DOI 10.1016/j.ejps.2007.10.006; Geerling G, 2001, INVEST OPHTH VIS SCI, V42, P948; GEGGEL HS, 1985, INVEST OPHTH VIS SCI, V26, P901; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Glick R, 2006, COMPOSITIONS METHODS; Gonzalez RJ, 2001, TOXICOL IN VITRO, V15, P257, DOI 10.1016/S0887-2333(01)00014-5; Gorbet MB, 2011, MOL VIS, V17, P3458; Gorbet MB, 2010, MOL VIS, V16, P272; Gorbet M, 2013, EYE CONTACT LENS, V39, P42, DOI 10.1097/ICL.0b013e318279bf8c; Greco D, 2010, MOL VIS, V16, P2109; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Hahne M, 2012, J PHARM SCI-US, V101, P2976, DOI 10.1002/jps.23190; HE YG, 1991, CURR EYE RES, V10, P851, DOI 10.3109/02713689109013881; ImmunoChemistry Technologies LLC, 2012, FAM FLICA IN VITR CA; JOHNSON LG, 1993, AM J PHYSIOL, V264, pL560, DOI 10.1152/ajplung.1993.264.6.L560; Jones L, 2013, EYE CONTACT LENS, V39, P29, DOI 10.1097/ICL.0b013e31827d4f25; Khoh-Reiter S, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-5; Kondo M, 1997, AM J RESP CELL MOL, V16, P62, DOI 10.1165/ajrcmb.16.1.8998080; Li DQ, 2005, EXP EYE RES, V80, P581, DOI 10.1016/j.exer.2004.11.011; Liang H, 2011, BRIT J OPHTHALMOL, V95, P869, DOI 10.1136/bjo.2010.189449; Lim MJ, 2009, EYE CONTACT LENS, V35, P287, DOI 10.1097/ICL.0b013e3181b9e92c; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; McCanna DJ, 2008, EYE CONTACT LENS, V34, P6, DOI 10.1097/ICL.0b013e31804fa141; Meloni M, 2011, MOL VIS, V17, P113; Meloni M, 2010, TOXICOL IN VITRO, V24, P276, DOI 10.1016/j.tiv.2009.08.016; MINAMI Y, 1993, INVEST OPHTH VIS SCI, V34, P2316; Molinari BL, 2005, MICRON, V36, P177, DOI 10.1016/j.micron.2004.08.002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Nguyen DH, 2003, ALTERNATIVE TOXICOLO, P147; Noecker R, 2001, ADV THER, V18, P205, DOI 10.1007/BF02853166; OHJI M, 1994, INVEST OPHTH VIS SCI, V35, P479; Owen GR, 2006, SUSPENSION FORMULATI; PAALLYSAHO T, 1992, ACTA OPHTHALMOL, V70, P22; Pauly A, 2011, MOL VIS, V17, P745; Pauly A, 2012, INVEST OPHTH VIS SCI, V53, P8172, DOI 10.1167/iovs.12-10766; Pauly A, 2009, INVEST OPHTH VIS SCI, V50, P1644, DOI 10.1167/iovs.08-2992; Pereira HA, 2004, INVEST OPHTH VIS SCI, V45, P4284, DOI 10.1167/iovs.03-1052; Petrali JP, 2000, J APPL TOXICOL, V21, pS173; Powell CH, 2010, CONTACT LENS ANTERIO, V33, P9, DOI 10.1016/j.clae.2009.10.006; Reichl S, 2005, EUR J PHARM BIOPHARM, V60, P305, DOI 10.1016/j.ejpb.2004.09.016; Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225; Reichl S, 2006, P 5 WORLD M PHARM BI; Reichl S, 2008, J PHARM PHARMACOL, V60, P299, DOI 10.1211/jpp.60.3.0004; Reichl S, 2011, EXPERT OPIN DRUG MET, V7, P559, DOI 10.1517/17425255.2011.562195; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Santodomingo-Rubido J, 2006, OPHTHAL PHYSL OPT, V26, P476, DOI 10.1111/j.1475-1313.2006.00393.x; Schotanus MR, 2011, EXP EYE RES, V93, P735, DOI 10.1016/j.exer.2011.09.005; Smolewski P, 2002, J IMMUNOL METHODS, V265, P111, DOI 10.1016/S0022-1759(02)00074-1; STEPP MA, 1993, INVEST OPHTH VIS SCI, V34, P1829; Stepp MA, 1997, J HISTOCHEM CYTOCHEM, V45, P189, DOI 10.1177/002215549704500205; STJOHN JB, 1970, ANAL BIOCHEM, V37, P409, DOI 10.1016/0003-2697(70)90066-7; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Tanti NC, 2011, OPTOMETRY VISION SCI, V88, P483, DOI 10.1097/OPX.0b013e3182045967; Toropainen E, 2003, EUR J PHARM SCI, V20, P99, DOI 10.1016/S0928-0987(03)00173-8; Toropainen E, 2001, INVEST OPHTH VIS SCI, V42, P2942; Van Goethem F, 2006, TOXICOL IN VITRO, V20, P1, DOI 10.1016/j.tiv.2005.05.002; Xiang CD, 2009, DRUG METAB DISPOS, V37, P992, DOI 10.1124/dmd.108.026286; Yamasaki K, 2009, INVEST OPHTH VIS SCI, V50, P604, DOI 10.1167/iovs.08-2239; York M, 1998, J APPL TOXICOL, V18, P233, DOI 10.1002/(SICI)1099-1263(199807/08)18:4<233::AID-JAT496>3.0.CO;2-Y; Zhao M, 2012, OPHTHALMIC RES, V48, P124, DOI 10.1159/000334981; ZIESKE JD, 1994, EXP CELL RES, V214, P621, DOI 10.1006/excr.1994.1300	85	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96448	10.1371/journal.pone.0096448	http://dx.doi.org/10.1371/journal.pone.0096448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837074	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800017
J	Julia, C; Peneau, S; Andreeva, VA; Mejean, C; Fezeu, L; Galan, P; Hercberg, S				Julia, Chantal; Peneau, Sandrine; Andreeva, Valentina A.; Mejean, Caroline; Fezeu, Leopold; Galan, Pilar; Hercberg, Serge			Weight-Loss Strategies Used by the General Population: How Are They Perceived?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; LOSS PROGRAMS; BODY-IMAGE; GENDER-DIFFERENCES; OBESITY; HEALTH; DIETS; NUTRITION; ADULTS; OVERWEIGHT	Background: The rising prevalence of obesity and the social pressure for thinness increase the prevalence of dieting. However, little is known about the overall perception of dieting strategies actually used by the general population. Objectives: Our main objective was to investigate perceptions of weight-loss practices in an observational study in order to identify the most favourable strategy. Design: Adults from the ongoing Nutrinet-Sante cohort study who had reported engaging in dieting in the three previous years were included in the study. For each diet, detailed information was collected on types of diets, circumstances and perception of the diet, and outcomes. Perceptions were compared across diets using sex-specific mixed effects models. Result: Among the 48 435 subjects who had completed the respective questionnaire, 12 673 (26.7%, 87.8% of women) had followed at least one weight-loss diet in the previous three years. Diet plans prescribed by health professionals and diets conforming to official dietary recommendations were the most favourably perceived among all assessed weight-loss strategies. Alternatively, commercial diet plans and self-imposed dietary restrictions were more negatively perceived (Odds ratios (OR) for adherence difficulty 1.30 (95% confidence interval (0.99;1.7)) in men and OR 1.92 (1.76;2.10) in women compared to official nutritional guidelines; OR 1.06 (0.82;1.38) in men and OR 1.39 (1.26;1.54) in women respectively) compared to official nutritional guidelines. Conclusion: Official dietary recommendations could be useful tools for maintaining a dietary balance while following a weight-loss diet.	[Julia, Chantal; Peneau, Sandrine; Andreeva, Valentina A.; Mejean, Caroline; Fezeu, Leopold; Galan, Pilar; Hercberg, Serge] Univ Paris 07, Univ Paris 05, Univ Paris 13,Nutr Epidemiol Res Team, Sorbonne Paris Cite,Cnam,Epidemiol & biostat Ctr, Bobigny, France; [Julia, Chantal; Hercberg, Serge] Avicenne Hosp, Dept Publ Hlth, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Julia, C (corresponding author), Univ Paris 07, Univ Paris 05, Univ Paris 13,Nutr Epidemiol Res Team, Sorbonne Paris Cite,Cnam,Epidemiol & biostat Ctr, Bobigny, France.	c.julia@uren.smbh.univ-paris13.fr	Serge, Hercberg/F-3038-2017; Peneau, Sandrine/F-2701-2017; Chantal, Julia/F-2805-2017; Andreeva, Valentina/F-2680-2017; Mejean, Caroline/F-2792-2017; HERCBERG, Serge/B-4429-2008; Fezeu, Leopold/F-2804-2017; Galan, Pilar/F-2908-2017	Serge, Hercberg/0000-0002-3168-1350; Peneau, Sandrine/0000-0002-3463-0989; Chantal, Julia/0000-0003-2006-5269; Andreeva, Valentina/0000-0001-9480-5210; Mejean, Caroline/0000-0001-6467-5056; HERCBERG, Serge/0000-0002-3168-1350; Fezeu, Leopold/0000-0002-7589-3179; Galan, Pilar/0000-0003-1706-3107	Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	The Nutrinet-Sante study is supported by the institutions: Ministere de la Sante (DGS), Institut de Veille Sanitaire (InVS), Institut National de la Prevention et de l'Education pour la Sante (INPES), Fondation pour la Recherche Medicale (FRM), Institut de Recherche en Sante Publique (IRESP), Institut National de la Sante et de la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Metiers (CNAM) and Universite Paris 13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence Francaise de Securite Sanitaire des Aliments, 2009, ET IND NATL CONS AL; Agence Nationale de Securite Sanitaire de l'Alimentation dledtA, 2010, EV RISQ LIES PRAT AL; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Andreyeva T, 2010, J AM DIET ASSOC, V110, P535, DOI 10.1016/j.jada.2009.12.029; [Anonymous], 2013, MARCHES MINCEUR HORI; BLACKBURN G, 1995, OBES RES, V3, pS211, DOI 10.1002/j.1550-8528.1995.tb00466.x; Cafri G, 2005, CLIN PSYCHOL-SCI PR, V12, P421, DOI 10.1093/clipsy/bpi053; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V57, P1155; Dalle Grave R, 2005, OBES RES, V13, P1961, DOI 10.1038/oby.2005.241; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Das SK, 2009, OBESITY, V17, P2019, DOI 10.1038/oby.2009.120; Del Corral P, 2011, OBESITY, V19, P1177, DOI 10.1038/oby.2010.298; Del Corral P, 2009, J CLIN ENDOCR METAB, V94, P1602, DOI 10.1210/jc.2008-1057; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Drewnowski A, 1996, J AM DIET ASSOC, V96, P663, DOI 10.1016/S0002-8223(96)00185-X; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Finkler E, 2012, J ACAD NUTR DIET, V112, P75, DOI 10.1016/j.jada.2011.08.034; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; Frost G, 2007, J HUM NUTR DIET, V20, P152, DOI [10.1111/j.1365-277X.2007.00775.x, 10.1111/j.1365-277X.2007.00785.x]; Hamilton M, 2004, Obes Rev, V5, P217, DOI 10.1111/j.1467-789X.2004.00153.x; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Hill AJ, 2004, BRIT J NUTR, V92, pS15, DOI 10.1079/BJN20041135; Jakicic JM, 2009, OBESITY, V17, pS34, DOI 10.1038/oby.2009.386; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Kesse-Guyot E, 2013, J MED INTERNET RES, V15, P148, DOI 10.2196/jmir.2488; Knauper B, 2005, APPETITE, V44, P283, DOI 10.1016/j.appet.2005.01.008; Kruger J, 2004, AM J PREV MED, V26, P402, DOI 10.1016/j.ampere.2004.02.001; Ministere du Travail dledlS, 2011, PROGR NAT NUTR SANT; Nothwehr F, 2006, J NUTR EDUC BEHAV, V38, P249, DOI 10.1016/j.jneb.2005.11.039; Organization WH, 2009, GLOB HLTH RISKS MORT; Phares V, 2004, J YOUTH ADOLESCENCE, V33, P421, DOI 10.1023/B:JOYO.0000037634.18749.20; Pingitore R, 1997, OBES RES, V5, P402, DOI 10.1002/j.1550-8528.1997.tb00662.x; Presnell K, 2004, INT J EAT DISORDER, V36, P389, DOI 10.1002/eat.20045; *PROGR NAT NUTR SA, 2002, SANT VIENT MANG GUID; Puhl R, 2013, INT J OBESITY, V37, P774, DOI 10.1038/ijo.2012.156; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rozin P, 2005, J NUTR EDUC BEHAV, V37, pS107, DOI 10.1016/S1499-4046(06)60209-1; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; SPIELMAN AB, 1992, J AM COLL NUTR, V11, P36; Stubbs RJ, 1998, INT J OBESITY, V22, P980, DOI 10.1038/sj.ijo.0800715; Thomas SL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-34; Tsai AG, 2006, OBESITY, V14, P1283; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; Weiss EC, 2006, AM J PREV MED, V31, P18, DOI 10.1016/j.amepre.2006.03.016; Wing RR, 2010, JAMA-J AM MED ASSOC, V304, P1837, DOI 10.1001/jama.2010.1529; *WORLD HLTH ORG, 2002, WORLD HLTH REP 2002	55	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97834	10.1371/journal.pone.0097834	http://dx.doi.org/10.1371/journal.pone.0097834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24852440	gold, Green Published, Green Submitted			2022-12-27	WOS:000338323200030
J	Sanchez-Puerta, MV; Abbona, CC				Virginia Sanchez-Puerta, M.; Carolina Abbona, Cinthia			The Chloroplast Genome of Hyoscyamus niger and a Phylogenetic Study of the Tribe Hyoscyameae (Solanaceae)	PLOS ONE			English	Article							GROUP-I INTRON; PLANT MITOCHONDRIAL; NICOTIANA-TABACUM; PLASTID GENOMES; TANDEM REPEATS; TREE SELECTION; DNA-SEQUENCES; EVOLUTIONARY; TRANSCRIPTS; ANGIOSPERMS	The tribe Hyoscyameae (Solanaceae) is restricted to Eurasia and includes the genera Archihyoscyamus, Anisodus, Atropa, Atropanthe, Hyoscyamus, Physochlaina, Przewalskia and Scopolia. Even though the monophyly of Hyoscyameae is strongly supported, the relationships of the taxa within the tribe remain unclear. Chloroplast markers have been widely used to elucidate plant relationships at low taxonomic levels. Identification of variable chloroplast intergenic regions has been developed based on comparative genomics of chloroplast genomes, but these regions have a narrow phylogenetic utility. In this study, we present the chloroplast genome sequence of Hyoscyamus niger and make comparisons to other solanaceous plastid genomes in terms of gene order, gene and intron content, editing sites, origins of replication, repeats, and hypothetical open reading frames. We developed and sequenced three variable plastid markers from eight species to elucidate relationships within the tribe Hyoscyameae. The presence of a horizontally transferred intron in the mitochondrial cox1 gene of some species of the tribe is considered here a likely synapomorphy uniting five genera of the Hyoscyameae. Alternatively, the cox1 intron could be a homoplasious character acquired twice within the tribe. A homoplasious inversion in the intergenic plastid spacer trnC-psbM was recognized as a source of bias and removed from the data set used in the phylogenetic analyses. Almost 12 kb of plastid sequence data were not sufficient to completely resolve relationships among genera of Hyoscyameae but some clades were identified. Two alternative hypotheses of the evolution of the genera within the tribe are proposed.	[Virginia Sanchez-Puerta, M.] Univ Nacl Cuyo, CONICET, IBAM, Fac Ciencias Exactas & Nat, RA-5500 Mendoza, Argentina; [Virginia Sanchez-Puerta, M.; Carolina Abbona, Cinthia] Univ Nacl Cuyo, Fac Ciencias Agr, RA-5500 Mendoza, Argentina; [Carolina Abbona, Cinthia] Univ Nacl Cuyo, CONICET, IBAM, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Sanchez-Puerta, MV (corresponding author), Univ Nacl Cuyo, CONICET, IBAM, Fac Ciencias Exactas & Nat, RA-5500 Mendoza, Argentina.	mvsanchezpuerta@fca.uncu.edu.ar		Sanchez-Puerta, Maria Virginia/0000-0003-2511-5093; Abbona, Cinthia/0000-0003-4498-6783	ANCyPT [PICT193]; NIH [FIRCA-BB R03 TW008353-01]; FOGARTY INTERNATIONAL CENTER [R03TW008353] Funding Source: NIH RePORTER	ANCyPT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grant PICT193 from ANCyPT to MVSP and NIH grant FIRCA-BB R03 TW008353-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkatib S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003076; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bremer B, 2000, PLANT SYST EVOL, V225, P43, DOI 10.1007/BF00985458; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; D'ARCY W G, 1992, Novon, V2, P124, DOI 10.2307/3391672; Doyle J. J., 1987, PHYTOCHEM B, P11; FRAZER KA, 2004, NUCL ACIDS RES, V32; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Freyer R, 1995, PLANT MOL BIOL, V29, P679, DOI 10.1007/BF00041158; Gargano D, 2012, GENET RESOUR CROP EV, V59, P419, DOI 10.1007/s10722-011-9692-7; Gemeinholzer B, 2001, SOLANACEAE ADV TAXON, P165; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hirose T, 1999, MOL GEN GENET, V262, P462, DOI 10.1007/s004380051106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jo YD, 2011, PLANT CELL REP, V30, P217, DOI 10.1007/s00299-010-0929-2; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; Knapp S, 1997, B NAT HIST MUS LOND, V27, P11; Kunnimalaiyaan M, 1997, NUCLEIC ACIDS RES, V25, P3681, DOI 10.1093/nar/25.18.3681; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lu An-Ming, 1997, Adansonia, V19, P135; MADDISON WP, 2000, MACCLADE VERSION 4; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Sarkinen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082266; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Sasaki T, 2003, MOL BIOL EVOL, V20, P1028, DOI 10.1093/molbev/msg098; Schmitz-Linneweber C, 2002, MOL BIOL EVOL, V19, P1602, DOI 10.1093/oxfordjournals.molbev.a004222; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TETENYI P, 1987, ANN MO BOT GARD, V74, P600, DOI 10.2307/2399328; Tu TY, 2008, MOL PHYLOGENET EVOL, V49, P561, DOI 10.1016/j.ympev.2008.07.018; Tu TY, 2010, MOL PHYLOGENET EVOL, V57, P1226, DOI 10.1016/j.ympev.2010.09.007; Tu TY, 2005, BOT J LINN SOC, V147, P457, DOI 10.1111/j.1095-8339.2005.00384.x; Uhink CH, 2009, THESIS JOHANNES GUTE; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; XIAO PG, 1983, J ETHNOPHARMACOL, V8, P1, DOI 10.1016/0378-8741(83)90086-7; Yang DZ, 2002, ACTA BOT SIN, V44, P889; Yuan YW, 2006, MOL BIOL EVOL, V23, P2263, DOI 10.1093/molbev/msl099; Yukawa M, 2006, MOL GENET GENOMICS, V275, P367, DOI 10.1007/s00438-005-0092-6; Zhang ZY, 2005, TAXON, V54, P71, DOI 10.2307/25065303; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zwickl DJ., 2006, THESIS	57	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98353	10.1371/journal.pone.0098353	http://dx.doi.org/10.1371/journal.pone.0098353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851862	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200065
J	Yamamuro, A; Kouzuma, A; Abe, T; Watanabe, K				Yamamuro, Ayaka; Kouzuma, Atsushi; Abe, Takashi; Watanabe, Kazuya			Metagenomic Analyses Reveal the Involvement of Syntrophic Consortia in Methanol/Electricity Conversion in Microbial Fuel Cells	PLOS ONE			English	Article							INTERSPECIES HYDROGEN-TRANSFER; WASTE-WATER; SP-NOV.; ELECTRICITY-GENERATION; METHANOL; METABOLISM; BACTERIUM; SEQUENCES; ANODE	Methanol is widely used in industrial processes, and as such, is discharged in large quantities in wastewater. Microbial fuel cells (MFCs) have the potential to recover electric energy from organic pollutants in wastewater; however, the use of MFCs to generate electricity from methanol has not been reported. In the present study, we developed single-chamber MFCs that generated electricity from methanol at the maximum power density of 220 mW m(-2) (based on the projected area of the anode). In order to reveal how microbes generate electricity from methanol, pyrosequencing of 16S rRNA-gene amplicons and Illumina shotgun sequencing of metagenome were conducted. The pyrosequencing detected in abundance Dysgonomonas, Sporomusa, and Desulfovibrio in the electrolyte and anode and cathode biofilms, while Geobacter was detected only in the anode biofilm. Based on known physiological properties of these bacteria, it is considered that Sporomusa converts methanol into acetate, which is then utilized by Geobacter to generate electricity. This speculation is supported by results of shotgun metagenomics of the anode-biofilm microbes, which reconstructed relevant catabolic pathways in these bacteria. These results suggest that methanol is anaerobically catabolized by syntrophic bacterial consortia with electrodes as electron acceptors.	[Yamamuro, Ayaka; Kouzuma, Atsushi; Watanabe, Kazuya] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan; [Abe, Takashi] Niigata Univ, Grad Sch Sci & Technol, Niigata, Niigata, Japan	Tokyo University of Pharmacy & Life Sciences; Niigata University	Watanabe, K (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	kazuyaw@toyaku.ac.jp	Kouzuma, Atsushi/M-4559-2019	Kouzuma, Atsushi/0000-0002-5076-3810	New Energy and Industrial Technology Development Organization (NEDO) of Japan	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2008, INT J SYST EVOL MICR, V58, P1313, DOI 10.1099/ijs.0.65524-0; ANTHONY C, 1990, FEMS MICROBIOL LETT, V87, P209, DOI 10.1016/0378-1097(90)90456-Z; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Breznak JA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P991, DOI 10.1007/0-387-30744-3_34; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cheng S, 2006, ELECTROCHEM COMMUN, V8, P489, DOI 10.1016/j.elecom.2006.01.010; CORDRUWISCH R, 1986, ARCH MICROBIOL, V144, P163, DOI 10.1007/BF00414728; Dimroth P, 1998, ARCH MICROBIOL, V170, P69, DOI 10.1007/s002030050616; Gore D, 2011, BIOCOMPX, V1, P23; He Z, 2005, ENVIRON SCI TECHNOL, V39, P5262, DOI 10.1021/es0502876; HEIJTHUIJSEN JHFG, 1986, FEMS MICROBIOL ECOL, V38, P57, DOI 10.1016/0378-1097(86)90042-X; Hippler B, 1999, FEBS LETT, V449, P165, DOI 10.1016/S0014-5793(99)00429-9; Hofstad T, 2000, INT J SYST EVOL MICR, V50, P2189, DOI 10.1099/00207713-50-6-2189; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KELLY DP, 1994, MICROBIOL-SGM, V140, P1419, DOI 10.1099/00221287-140-6-1419; Kim JR, 2007, BIORESOURCE TECHNOL, V98, P2568, DOI 10.1016/j.biortech.2006.09.036; Kodama Y, 2012, INT J SYST EVOL MICR, V62, P3055, DOI 10.1099/ijs.0.039040-0; Kouzuma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077443; LANGRAND G, 1990, BIOTECHNOL LETT, V12, P581, DOI 10.1007/BF01030756; Lefebvre O, 2011, APPL MICROBIOL BIOT, V89, P259, DOI 10.1007/s00253-010-2881-z; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g; LJUNGDAHL LG, 1969, ANNU REV MICROBIOL, V23, P515, DOI 10.1146/annurev.mi.23.100169.002503; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Marcus AK, 2007, BIOTECHNOL BIOENG, V98, P1171, DOI 10.1002/bit.21533; MINAMI K, 1991, J FERMENT BIOENG, V71, P270, DOI 10.1016/0922-338X(91)90280-T; Miyahara M, 2013, J BIOSCI BIOENG, V115, P176, DOI 10.1016/j.jbiosc.2012.09.003; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Newton GJ, 2009, APPL ENVIRON MICROB, V75, P7674, DOI 10.1128/AEM.01142-09; Poehlein A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00734-13; Pritchett MA, 2005, MOL MICROBIOL, V56, P1183, DOI 10.1111/j.1365-2958.2005.04616.x; REED TB, 1973, SCIENCE, V182, P1299, DOI 10.1126/science.182.4119.1299; Rozendal RA, 2008, TRENDS BIOTECHNOL, V26, P450, DOI 10.1016/j.tibtech.2008.04.008; Segura D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040036; Shimoyama T, 2009, MICROBES ENVIRON, V24, P188, DOI 10.1264/jsme2.ME09108; STUPPERICH E, 1993, APPL ENVIRON MICROB, V59, P3110, DOI 10.1128/AEM.59.9.3110-3116.1993; Sun D, 2012, BIOTECHNOL BIOENG, V109, P405, DOI 10.1002/bit.23348; SWAIN HM, 1978, J APPL BACTERIOL, V45, P147, DOI 10.1111/j.1365-2672.1978.tb04209.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Verseveld H.W., 1987, MICROBIAL GROWTH C1, P282; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2008, J BIOSCI BIOENG, V106, P528, DOI 10.1263/jbb.106.528; Watanabe K, 2011, APPL MICROBIOL BIOT, V92, P1307, DOI 10.1007/s00253-011-3598-3; Wiegel J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P290, DOI 10.1007/0-387-30745-1_16; Xie CH, 2005, INT J SYST EVOL MICR, V55, P1233, DOI 10.1099/ijs.0.63406-0; Zhao F, ENV SCI TECHNOL, V42, P4971	48	24	25	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98425	10.1371/journal.pone.0098425	http://dx.doi.org/10.1371/journal.pone.0098425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852573	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200071
J	Zhao, Y; Xu, T; Shen, CY; Xu, GH; Chen, SX; Song, LZ; Li, MJ; Wang, LL; Zhu, Y; Lv, WT; Gong, ZZ; Liu, CM; Deng, X				Zhao, Yan; Xu, Tao; Shen, Chun-Ying; Xu, Guang-Hui; Chen, Shi-Xuan; Song, Li-Zhen; Li, Mei-Jing; Wang, Li-Li; Zhu, Yan; Lv, Wei-Tao; Gong, Zhi-Zhong; Liu, Chun-Ming; Deng, Xin			Identification of a Retroelement from the Resurrection Plant Boea hygrometrica That Confers Osmotic and Alkaline Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							GENOMIC DNA FRAGMENTS; CRATEROSTIGMA-PLANTAGINEUM; RAMONDA-SERBICA; DEHYDRATION TOLERANCE; DESICCATION TOLERANCE; HABERLEA-RHODOPENSIS; STRESS RESPONSES; ABIOTIC STRESSES; BIBAC LIBRARY; SMALL RNAS	Functional genomic elements, including transposable elements, small RNAs and non-coding RNAs, are involved in regulation of gene expression in response to plant stress. To identify genomic elements that regulate dehydration and alkaline tolerance in Boea hygrometrica, a resurrection plant that inhabits drought and alkaline Karst areas, a genomic DNA library from B. hygrometrica was constructed and subsequently transformed into Arabidopsis using binary bacterial artificial chromosome (BIBAC) vectors. Transgenic lines were screened under osmotic and alkaline conditions, leading to the identification of Clone L1-4 that conferred osmotic and alkaline tolerance. Sequence analyses revealed that L1-4 contained a 49-kb retroelement fragment from B. hygrometrica, of which only a truncated sequence was present in L1-4 transgenic Arabidopsis plants. Additional subcloning revealed that activity resided in a 2-kb sequence, designated Osmotic and Alkaline Resistance 1 (OAR1). In addition, transgenic Arabidopsis lines carrying an OAR1-homologue also showed similar stress tolerance phenotypes. Physiological and molecular analyses demonstrated that OAR1-transgenic plants exhibited improved photochemical efficiency and membrane integrity and biomarker gene expression under both osmotic and alkaline stresses. Short transcripts that originated from OAR1 were increased under stress conditions in both B. hygrometrica and Arabidopsis carrying OAR1. The relative copy number of OAR1 was stable in transgenic Arabidopsis under stress but increased in B. hygrometrica. Taken together, our results indicated a potential role of OAR1 element in plant tolerance to osmotic and alkaline stresses, and verified the feasibility of the BIBAC transformation technique to identify functional genomic elements from physiological model species.	[Zhao, Yan; Xu, Tao; Shen, Chun-Ying; Xu, Guang-Hui; Chen, Shi-Xuan; Song, Li-Zhen; Li, Mei-Jing; Wang, Li-Li; Zhu, Yan; Lv, Wei-Tao; Deng, Xin] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Song, Li-Zhen; Liu, Chun-Ming] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Gong, Zhi-Zhong] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; China Agricultural University	Deng, X (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	deng@ibcas.ac.cn	Xin, deng/AAH-4009-2020; Gong, Zhizhong/AAS-4796-2021		National Natural Science Foundation of China [31270312, 30970431]; National High Technology Research and Development Program of China (863 Program) [2007AA021403]; National Basic Research Program of China (973 Program) [2012CB114302]; Ministry of Agriculture of China [2009ZX08009-060B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the National Natural Science Foundation of China (31270312 and 30970431), the National High Technology Research and Development Program of China (863 Program, 2007AA021403), the National Basic Research Program of China (973 Program, 2012CB114302), and the Ministry of Agriculture of China (2009ZX08009-060B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INSECT MOL BIOL, V11, P307, DOI 10.1046/j.1365-2583.2002.00339.x; Abraham Edit, 2011, Acta Biologica Szegediensis, V55, P53; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Bui Q.T., 2012, PLANT TRANSPOSABLE E, P273, DOI 10.1007/978-3-642-31842-9_14; Chang YL, 2003, THEOR APPL GENET, V106, P269, DOI 10.1007/s00122-002-1074-2; Chang YL, 2011, GENOME, V54, P437, DOI [10.1139/G11-011, 10.1139/g11-011]; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Correa R, 2012, NEW PHYTOL, V193, P494, DOI 10.1111/j.1469-8137.2011.03949.x; Deng X, 2003, PLANT SCI, V165, P851, DOI 10.1016/S0168-9452(03)00284-X; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drazic G, 1999, J PLANT PHYSIOL, V154, P379, DOI 10.1016/S0176-1617(99)80184-9; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flavell AJ, 1997, GENETICA, V100, P185, DOI 10.1023/A:1018385713293; Furini A, 1997, EMBO J, V16, P3599, DOI 10.1093/emboj/16.12.3599; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Georgieva K, 2007, PLANTA, V225, P955, DOI 10.1007/s00425-006-0396-8; Georgieva K, 2010, ANN BOT-LONDON, V105, P117, DOI 10.1093/aob/mcp274; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Hamilton CM, 1999, PLANT J, V18, P223, DOI 10.1046/j.1365-313X.1999.00433.x; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hilbricht T, 2008, NEW PHYTOL, V179, P877, DOI 10.1111/j.1469-8137.2008.02480.x; Jiang GQ, 2007, PLANTA, V225, P1405, DOI 10.1007/s00425-006-0449-z; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Leigh F, 2003, MOL GENET GENOMICS, V269, P464, DOI 10.1007/s00438-003-0850-2; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu CC, 2011, ENVIRON EXP BOT, V71, P174, DOI 10.1016/j.envexpbot.2010.11.012; Liu X, 2009, PLANT SCI, V176, P90, DOI 10.1016/j.plantsci.2008.09.012; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; McCubbin AG, 2000, GENOME, V43, P820, DOI 10.1139/gen-43-5-820; Petrova G, 2014, PLANT SYST EVOL, V300, P29, DOI 10.1007/s00606-013-0857-z; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]; Quartacci MF, 2002, J EXP BOT, V53, P2159, DOI 10.1093/jxb/erf076; Rakic T, 2009, PLANT ECOL, V203, P13, DOI 10.1007/s11258-008-9498-7; Rangwala SH, 2006, PLOS GENET, V2, P270, DOI 10.1371/journal.pgen.0020036; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Shapiro JA, 2005, BIOESSAYS, V27, P122, DOI 10.1002/bies.20192; Shibata D, 2000, TRENDS PLANT SCI, V5, P354, DOI 10.1016/S1360-1385(00)01689-7; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Smith-Espinoza CJ, 2005, MOL GENET GENOMICS, V274, P364, DOI 10.1007/s00438-005-0027-2; Song J, 2003, THEOR APPL GENET, V107, P958, DOI 10.1007/s00122-003-1334-9; Suoniemi A, 1996, PLANT MOL BIOL, V31, P295, DOI 10.1007/BF00021791; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang WQ, 2010, PLANT MOL BIOL, V72, P91, DOI 10.1007/s11103-009-9553-3; WARDLAW IF, 1967, AUST J BIOL SCI, V20, P309, DOI 10.1071/BI9670309; Wei Yuan, 2012, African Journal of Biotechnology, V11, P14561; Xu WB, 2009, NOVON, V19, P559, DOI 10.3417/2008014; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang HB, 2012, NAT PROTOC, V7, P479, DOI 10.1038/nprot.2011.456; Zhang ZN, 2013, BIOLOGIA, V68, P651, DOI 10.2478/s11756-013-0204-4; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6	59	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98098	10.1371/journal.pone.0098098	http://dx.doi.org/10.1371/journal.pone.0098098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851859	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200045
J	Lee, SY; Yu, J; Ahn, KM; Kim, KW; Shin, YH; Lee, KS; Hong, SA; Jung, YH; Lee, E; Yang, SI; Seo, JH; Kwon, JW; Kim, BJ; Kim, HB; Kim, WK; Song, DJ; Jang, GC; Shim, JY; Lee, SY; Kwon, JY; Choi, SJ; Lee, KJ; Park, HJ; Won, HS; Yoo, HS; Kang, MJ; Kim, HY; Hong, SJ				Lee, So-Yeon; Yu, Jinho; Ahn, Kang-Mo; Kim, Kyung Won; Shin, Youn Ho; Lee, Kyung-shin; Hong, Seo Ah; Jung, Young-ho; Lee, Eun; Yang, Song-I; Seo, Ju-hee; Kwon, Ji-Won; Kim, Byoung-Ju; Kim, Hyo-Bin; Kim, Woo-Kyung; Song, Dae Jin; Jang, Gwang Cheon; Shim, Jung Yeon; Lee, Soo-Young; Kwon, Ja-Young; Choi, Suk-Joo; Lee, Kyung-Ju; Park, Hee Jin; Won, Hye-Sung; Yoo, Ho-Sung; Kang, Mi-Jin; Kim, Hyung-Young; Hong, Soo-Jong			Additive Effect between IL-13 Polymorphism and Cesarean Section Delivery/Prenatal Antibiotics Use on Atopic Dermatitis: A Birth Cohort Study (COCOA)	PLOS ONE			English	Article							GASTROINTESTINAL MICROBIOTA; INTESTINAL MICROBIOTA; ALLERGIC RHINITIS; KOREAN CHILDREN; DELIVERY; ECZEMA; INTERLEUKIN-13; SENSITIZATION; GENES; RISK	Background: Although cesarean delivery and prenatal exposure to antibiotics are likely to affect the gut microbiome in infancy, their effect on the development of atopic dermatitis (AD) in infancy is unclear. The influence of individual genotypes on these relationships is also unclear. To evaluate with a prospective birth cohort study whether cesarean section, prenatal exposure to antibiotics, and susceptible genotypes act additively to promote the development of AD in infancy. Methods: The Cohort for Childhood of Asthma and Allergic Diseases (COCOA) was selected from the general Korean population. A pediatric allergist assessed 412 infants for the presence of AD at 1 year of age. Their cord blood DNA was subjected to interleukin (IL)-13 (rs20541) and cluster-of-differentiation (CD) 14 (rs2569190) genotype analysis. Results: The combination of cesarean delivery and prenatal exposure to antibiotics associated significantly and positively with AD (adjusted odds ratio, 5.70; 95% CI, 1.19-27.3). The association between cesarean delivery and AD was significantly modified by parental history of allergic diseases or risk-associated IL-13 (rs20541) and CD14 (rs2569190) genotypes. There was a trend of interaction between IL-13 (rs20541) and delivery mode with respect to the subsequent risk of AD. (P for interaction = 0.039) Infants who were exposed prenatally to antibiotics and were born by cesarean delivery had a lower total microbiota diversity in stool samples at 6 months of age than the control group. As the number of these risk factors increased, the AD risk rose (trend p<0.05). Conclusion: Cesarean delivery and prenatal antibiotic exposure may affect the gut microbiota, which may in turn influence the risk of AD in infants. These relationships may be shaped by the genetic predisposition.	[Lee, So-Yeon] Hallym Univ, Coll Med, Dept Pediat, Anyang, South Korea; [Yu, Jinho; Hong, Seo Ah; Jung, Young-ho; Lee, Eun; Yang, Song-I; Hong, Soo-Jong] Asan Med Ctr, Childhood Asthma Atopy Ctr, Seoul, South Korea; [Ahn, Kang-Mo; Shim, Jung Yeon] Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Kim, Kyung Won] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Shin, Youn Ho] CHA Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Lee, Kyung-shin; Yoo, Ho-Sung; Kang, Mi-Jin] Asan Inst Life Sci, Seoul, South Korea; [Seo, Ju-hee] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea; [Kwon, Ji-Won] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam, South Korea; [Kim, Byoung-Ju; Kim, Hyo-Bin; Kim, Woo-Kyung] Inje Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Song, Dae Jin] Korea Univ, Guro Hosp, Dept Pediat, Seoul, South Korea; [Jang, Gwang Cheon] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Pediat, Goyang, South Korea; [Lee, Soo-Young] Ajou Univ, Sch Med, Dept Pediat, Suwon 441749, South Korea; [Kwon, Ja-Young] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Choi, Suk-Joo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Kyung-Ju; Park, Hee Jin] CHA Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Won, Hye-Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Hyung-Young] Kosin Univ, Coll Med, Dept Pediat, Pusan, South Korea	Hallym University; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Yonsei University; Yonsei University Health System; Pochon Cha University; National Cancer Center - Korea (NCC); Seoul National University (SNU); Inje University; Korea University; Korea University Medicine (KU Medicine); NHIS Ilsan Hospital; Ajou University; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Pochon Cha University; University of Ulsan; Asan Medical Center	Hong, SJ (corresponding author), Asan Med Ctr, Childhood Asthma Atopy Ctr, Seoul, South Korea.	sjhong@amc.seoul.kr	Hong, Soo-Jong/AAR-1788-2020; Ahn, Kangmo/F-4609-2014; Yu, Jinho/P-4293-2014; Hong, Seo Ah/E-7628-2015	Hong, Soo-Jong/0000-0003-1409-2113; Yu, Jinho/0000-0002-1226-8077; Kim, Kyung Won/0000-0003-4529-6135; Song, Dae Jin/0000-0003-0647-3186; Kwon, Ja-Young/0000-0003-3009-6325; Kim, Byoung-Ju/0000-0003-0271-9417	Research of Korea Centers for Disease Control and Prevention [2008-E33030-00, 2009-E33033-00, 2011-E33021-00, 2012-E33012-00]	Research of Korea Centers for Disease Control and Prevention	This research was supported by a fund (2008-E33030-00, 2009-E33033-00, 2011-E33021-00, 2012-E33012-00) from the Research of Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arshad SH, 2008, BRIT J DERMATOL, V158, P1315, DOI 10.1111/j.1365-2133.2008.08565.x; Dom S, 2010, CLIN EXP ALLERGY, V40, P1378, DOI 10.1111/j.1365-2222.2010.03538.x; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Eggesbo M, 2003, J ALLERGY CLIN IMMUN, V112, P420, DOI 10.1067/mai.2003.1610; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; He JQ, 2003, GENES IMMUN, V4, P385, DOI 10.1038/sj.gene.6363985; Hong SJ, 2007, J ALLERGY CLIN IMMUN, V119, P398, DOI 10.1016/j.jaci.2006.10.031; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Kim BS, 2012, ANAEROBE, V18, P310, DOI 10.1016/j.anaerobe.2012.01.003; Kim HB, 2008, CLIN EXP ALLERGY, V38, P774, DOI 10.1111/j.1365-2222.2008.02965.x; Kim HB, 2012, J KOREAN MED SCI, V27, P1320, DOI 10.3346/jkms.2012.27.11.1320; Kim WK, 2012, J ALLERGY CLIN IMMUN, V130, P421, DOI 10.1016/j.jaci.2012.04.052; Laubereau B, 2004, ARCH DIS CHILD, V89, P993, DOI 10.1136/adc.2003.043265; Litonjua AA, 2005, J ALLERGY CLIN IMMUN, V115, P1056, DOI 10.1016/j.jaci.2005.02.006; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; McKeever TM, 2002, AM J RESP CRIT CARE, V166, P827, DOI 10.1164/rccm.200202-158OC; Namkung JH, 2011, EXP DERMATOL, V20, P915, DOI [10.1111/j.1600-0625.2010.01148.x, 10.1111/j.1600-0625.2011.01357.x]; Orrhage K, 1999, ACTA PAEDIATR, V88, P47; Pistiner M, 2008, J ALLERGY CLIN IMMUN, V122, P274, DOI 10.1016/j.jaci.2008.05.007; Sengler C, 2003, CLIN EXP ALLERGY, V33, P166, DOI 10.1046/j.1365-2222.2003.01549.x; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vercelli D, 2003, CURR OPIN ALLERGY CL, V3, P343, DOI 10.1097/01.all.0000092603.76804.e4; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P277, DOI 10.1016/j.jaci.2006.04.034; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	29	36	36	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96603	10.1371/journal.pone.0096603	http://dx.doi.org/10.1371/journal.pone.0096603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848505	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600012
J	Malik, N; Wang, XT; Shah, S; Efthymiou, AG; Yan, B; Heman-Ackah, S; Zhan, M; Rao, M				Malik, Nasir; Wang, Xiantao; Shah, Sonia; Efthymiou, Anastasia G.; Yan, Bin; Heman-Ackah, Sabrina; Zhan, Ming; Rao, Mahendra			Comparison of the Gene Expression Profiles of Human Fetal Cortical Astrocytes with Pluripotent Stem Cell Derived Neural Stem Cells Identifies Human Astrocyte Markers and Signaling Pathways and Transcription Factors Active in Human Astrocytes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PRECURSOR CELLS; NEURONS; EFFICIENT; PROTEIN; DIFFERENTIATION; GLIOGENESIS; SPECIFICATION; MAINTENANCE; ACTIVATION	Astrocytes are the most abundant cell type in the central nervous system (CNS) and have a multitude of functions that include maintenance of CNS homeostasis, trophic support of neurons, detoxification, and immune surveillance. It has only recently been appreciated that astrocyte dysfunction is a primary cause of many neurological disorders. Despite their importance in disease very little is known about global gene expression for human astrocytes. We have performed a microarray expression analysis of human fetal astrocytes to identify genes and signaling pathways that are important for astrocyte development and maintenance. Our analysis confirmed that the fetal astrocytes express high levels of the core astrocyte marker GFAP and the transcription factors from the NFI family which have been shown to play important roles in astrocyte development. A group of novel markers were identified that distinguish fetal astrocytes from pluripotent stem cell-derived neural stem cells (NSCs) and NSC-derived neurons. As in murine astrocytes, the Notch signaling pathway appears to be particularly important for cell fate decisions between the astrocyte and neuronal lineages in human astrocytes. These findings unveil the repertoire of genes expressed in human astrocytes and serve as a basis for further studies to better understand astrocyte biology, especially as it relates to disease.	[Malik, Nasir; Wang, Xiantao; Shah, Sonia; Efthymiou, Anastasia G.; Heman-Ackah, Sabrina; Rao, Mahendra] NIAMS, NIH, Bethesda, MD 20892 USA; [Yan, Bin] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Zhan, Ming] Weill Cornell Med Coll, Methodist Hosp Res Inst, Houston, TX USA; [Rao, Mahendra] NIH Ctr Regenerat Med, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Hong Kong Baptist University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; National Institutes of Health (NIH) - USA	Malik, N (corresponding author), NIAMS, NIH, Bethesda, MD 20892 USA.	malikn@mail.nih.gov		Efthymiou, Anastasia/0000-0002-1769-5078; /0000-0002-2168-3379	National Institutes of Health (NIH) Common Fund	National Institutes of Health (NIH) Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health (NIH) Common Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Boncinelli E, 1995, CIBA F SYMP, V193, P100; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campanelli James T, 2008, BMC Dev Biol, V8, P102, DOI 10.1186/1471-213X-8-102; Dai Q, 2013, DEVELOPMENT, V140, P1892, DOI 10.1242/dev.087502; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Ebner-Bennatan S, 2012, J BIOL CHEM, V287, P27614, DOI 10.1074/jbc.M112.342519; Efthymiou A, 2014, J BIOMOL SCREEN, V19, P32, DOI 10.1177/1087057113501869; Eiraku M, 2002, J BIOL CHEM, V277, P25400, DOI 10.1074/jbc.M110793200; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fu H, 2009, J NEUROSCI, V29, P11399, DOI 10.1523/JNEUROSCI.0160-09.2009; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hsieh FY, 2013, DEV BIOL, V375, P1, DOI 10.1016/j.ydbio.2013.01.007; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Kohyama J, 2010, J CELL BIOL, V189, P159, DOI 10.1083/jcb.200908048; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Li KR, 2009, J MOL NEUROSCI, V37, P288, DOI 10.1007/s12031-008-9146-7; Li MJ, 2010, BIOINFORMATICS, V26, P2897, DOI 10.1093/bioinformatics/btq540; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Liu W, 2012, J INVEST DERMATOL, V132, P2828, DOI 10.1038/jid.2012.211; Lu PPY, 2012, J NEUROSCI, V32, P8012, DOI 10.1523/JNEUROSCI.5633-11.2012; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mi HY, 1999, J NEUROSCI, V19, P1049; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; Morrow T, 2001, DEVELOPMENT, V128, P3585; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shu TZ, 2003, J NEUROSCI, V23, P203; Singh SK, 2011, J BIOL CHEM, V286, P7315, DOI 10.1074/jbc.M110.152421; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Yamashita N, 1997, BRAIN RES, V778, P388, DOI 10.1016/S0006-8993(97)01025-1; Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]; Yeh CY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-139	50	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96139	10.1371/journal.pone.0096139	http://dx.doi.org/10.1371/journal.pone.0096139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848099	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600009
J	Velasco, V; Sherwood, JS; Rojas-Garcia, PP; Logue, CM				Velasco, Valeria; Sherwood, Julie S.; Rojas-Garcia, Pedro P.; Logue, Catherine M.			Multiplex Real-Time PCR for Detection of Staphylococcus aureus, mecA and Panton-Valentine Leukocidin (PVL) Genes from Selective Enrichments from Animals and Retail Meat	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BLOOD CULTURE BOTTLES; METHICILLIN-RESISTANT; UNITED-STATES; RAPID IDENTIFICATION; CLINICAL-SAMPLES; REACTION ASSAY; MRSA; PREVALENCE; POULTRY	The aim of this study was to compare a real-time PCR assay, with a conventional culture/PCR method, to detect S. aureus, mecA and Panton-Valentine Leukocidin (PVL) genes in animals and retail meat, using a two-step selective enrichment protocol. A total of 234 samples were examined (77 animal nasal swabs, 112 retail raw meat, and 45 deli meat). The multiplex real-time PCR targeted the genes: nuc (identification of S. aureus), mecA (associated with methicillin resistance) and PVL (virulence factor), and the primary and secondary enrichment samples were assessed. The conventional culture/PCR method included the two-step selective enrichment, selective plating, biochemical testing, and multiplex PCR for confirmation. The conventional culture/PCR method recovered 95/234 positive S. aureus samples. Application of real-time PCR on samples following primary and secondary enrichment detected S. aureus in 111/234 and 120/234 samples respectively. For detection of S. aureus, the kappa statistic was 0.68-0.88 (from substantial to almost perfect agreement) and 0.29-0.77 (from fair to substantial agreement) for primary and secondary enrichments, using real-time PCR. For detection of mecA gene, the kappa statistic was 0-0.49 (from no agreement beyond that expected by chance to moderate agreement) for primary and secondary enrichment samples. Two pork samples were mecA gene positive by all methods. The real-time PCR assay detected the mecA gene in samples that were negative for S. aureus, but positive for Staphylococcus spp. The PVL gene was not detected in any sample by the conventional culture/PCR method or the real-time PCR assay. Among S. aureus isolated by conventional culture/PCR method, the sequence type ST398, and multi-drug resistant strains were found in animals and raw meat samples. The real-time PCR assay may be recommended as a rapid method for detection of S. aureus and the mecA gene, with further confirmation of methicillin-resistant S. aureus (MRSA) using the standard culture method.	[Velasco, Valeria; Sherwood, Julie S.] N Dakota State Univ, Dept Vet & Microbiol Sci, Fargo, ND 58105 USA; [Velasco, Valeria] Univ Concepcion, Dept Anim Sci, Chillan, Chile; [Rojas-Garcia, Pedro P.] Univ Concepcion, Lab Anim Physiol & Endocrinol, Chillan, Chile; [Logue, Catherine M.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Coll Vet Med, Ames, IA 50011 USA	North Dakota State University Fargo; Universidad de Concepcion; Universidad de Concepcion; Iowa State University	Logue, CM (corresponding author), Iowa State Univ, Dept Vet Microbiol & Prevent Med, Coll Vet Med, Ames, IA 50011 USA.	cmlogue@iastate.edu		Logue, Catherine/0000-0002-6098-2662	Dean's Office, College of Agriculture, North Dakota State University; Dean's Office, College of Veterinary Medicine, Iowa State University	Dean's Office, College of Agriculture, North Dakota State University; Dean's Office, College of Veterinary Medicine, Iowa State University	This study was funded through the Dean's Office, College of Agriculture, North Dakota State University and The Dean's Office, College of Veterinary Medicine, Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MEC, 2007, VET MICROBIOL, V122, P185, DOI 10.1016/j.vetmic.2007.01.001; Aydin A, 2011, FOODBORNE PATHOG DIS, V8, P63, DOI 10.1089/fpd.2010.0613; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Buyukcangaz E, 2013, FOODBORNE PATHOG DIS, V10, P608, DOI 10.1089/fpd.2012.1427; Costa AM, 2005, DIAGN MICR INFEC DIS, V51, P13, DOI 10.1016/j.diagmicrobio.2004.08.014; Danial J, 2011, J MED MICROBIOL, V60, P323, DOI 10.1099/jmm.0.025288-0; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; De Medici D, 2003, APPL ENVIRON MICROB, V69, P3456, DOI 10.1128/AEM.69.6.3456-3461.2003; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Ebert MD, 2009, EMERG RADIOL, V16, P159, DOI 10.1007/s10140-008-0706-5; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Hagen RM, 2005, INT J MED MICROBIOL, V295, P77, DOI 10.1016/j.ijmm.2004.12.008; HARTMAN B, 1981, ANTIMICROB AGENTS CH, V19, P726, DOI 10.1128/AAC.19.5.726; Higashide M, 2006, INT J ANTIMICROB AG, V27, P500, DOI 10.1016/j.ijantimicag.2006.01.009; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; Kassem II, 2008, J CLIN MICROBIOL, V46, P3868, DOI 10.1128/JCM.01035-08; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kilic A, 2010, DIAGN MICR INFEC DIS, V66, P349, DOI 10.1016/j.diagmicrobio.2009.11.010; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Makgotlho PE, 2009, FEMS IMMUNOL MED MIC, V57, P104, DOI 10.1111/j.1574-695X.2009.00585.x; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; McDonald RR, 2005, J CLIN MICROBIOL, V43, P6147, DOI 10.1128/JCM.43.12.6147-6149.2005; Moore D. S, 2007, BASIC PRACTICE STAT; Morcillo A, 2012, FOODBORNE PATHOG DIS, V9, P207, DOI 10.1089/fpd.2011.0982; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; Paule SM, 2005, AM J CLIN PATHOL, V124, P404, DOI 10.1309/6EA3U9V8NCLLGKQN; Persoons D, 2009, EMERG INFECT DIS, V15, P452, DOI 10.3201/eid1503.080696; RYFFEL C, 1990, GENE, V94, P137, DOI 10.1016/0378-1119(90)90481-6; Soderquist B, 2012, APMIS, V120, P427, DOI 10.1111/j.1600-0463.2011.02849.x; Thomas LC, 2007, J MICROBIOL METH, V68, P296, DOI 10.1016/j.mimet.2006.09.003; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; Van De Griend P, 2009, EMERG INFECT DIS, V15, P1582, DOI 10.3201/eid1510.080877; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x; Wertheim H, 2001, J CLIN MICROBIOL, V39, P2660, DOI 10.1128/JCM.39.7.2660-2662.2001; Zhang Wanjiang, 2011, Vet J, V190, pe125, DOI 10.1016/j.tvjl.2011.02.006	42	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97617	10.1371/journal.pone.0097617	http://dx.doi.org/10.1371/journal.pone.0097617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849624	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600041
J	Elhassan, N; Gebremeskel, EI; Elnour, MA; Isabirye, D; Okello, J; Hussien, A; Kwiatksowski, D; Hirbo, J; Tishkoff, S; Ibrahim, ME				Elhassan, Nuha; Gebremeskel, Eyoab Iyasu; Elnour, Mohamed Ali; Isabirye, Dan; Okello, John; Hussien, Ayman; Kwiatksowski, Dominic; Hirbo, Jibril; Tishkoff, Sara; Ibrahim, Muntaser E.			The Episode of Genetic Drift Defining the Migration of Humans out of Africa Is Derived from a Large East African Population Size	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; HUMAN-EVOLUTION; HISTORY; ORIGIN; SELECTION; MODELS	Human genetic variation particularly in Africa is still poorly understood. This is despite a consensus on the large African effective population size compared to populations from other continents. Based on sequencing of the mitochondrial Cytochrome C Oxidase subunit II (MT-CO2), and genome wide microsatellite data we observe evidence suggesting the effective size (Ne) of humans to be larger than the current estimates, with a foci of increased genetic diversity in east Africa, and a population size of east Africans being at least 2-6 fold larger than other populations. Both phylogenetic and network analysis indicate that east Africans possess more ancestral lineages in comparison to various continental populations placing them at the root of the human evolutionary tree. Our results also affirm east Africa as the likely spot from which migration towards Asia has taken place. The study reflects the spectacular level of sequence variation within east Africans in comparison to the global sample, and appeals for further studies that may contribute towards filling the existing gaps in the database. The implication of these data to current genomic research, as well as the need to carry out defined studies of human genetic variation that includes more African populations; particularly east Africans is paramount.	[Elhassan, Nuha; Gebremeskel, Eyoab Iyasu; Elnour, Mohamed Ali; Hussien, Ayman; Ibrahim, Muntaser E.] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum, Sudan; [Gebremeskel, Eyoab Iyasu] Eritrea Inst Technol, Dept Biol, Mai Nefhi, Eritrea; [Isabirye, Dan; Okello, John] Makerere Univ, Dept Biochem, Kampala, Uganda; [Kwiatksowski, Dominic] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford, England; [Hirbo, Jibril; Tishkoff, Sara] Univ Penn, Sch Med, Dept Genet & Biol, Philadelphia, PA 19104 USA; [Hirbo, Jibril; Tishkoff, Sara] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Khartoum; Makerere University; University of Oxford; Wellcome Centre for Human Genetics; University of Pennsylvania; University of Pennsylvania	Ibrahim, ME (corresponding author), Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum, Sudan.	mibrahim@iend.org	Okello, John B A/B-5157-2018	Okello, John B A/0000-0002-5889-1905	EVIMalaR FP7 EC research fund; MalariaGen consortium; African Development Fund (ADF) through the National Board for Higher Education - Eritrea	EVIMalaR FP7 EC research fund; MalariaGen consortium; African Development Fund (ADF) through the National Board for Higher Education - Eritrea	The study is partially funded by EVIMalaR FP7 EC research fund, the MalariaGen consortium and the African Development Fund (ADF) through the National Board for Higher Education - Eritrea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime C, 2013, MOL BIOL EVOL, V30, P2629, DOI 10.1093/molbev/mst156; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Eller E, 2001, AM J PHYS ANTHROPOL, V116, P1, DOI 10.1002/ajpa.1096; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Eriksson A, 2011, G3-GENES GENOM GENET, V1, P479, DOI 10.1534/g3.111.001016; Erlich HA, 1996, SCIENCE, V274, P1552, DOI 10.1126/science.274.5292.1552; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Gebremeskel EI, 2014, EUR J HUM GENET, V22, P1387, DOI 10.1038/ejhg.2014.41; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hassan HY, 2008, AM J PHYS ANTHROPOL, V137, P316, DOI 10.1002/ajpa.20876; HENN BM, 2008, MOL BIOL EVOL, P1; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Laval G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010284; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rannala B, 2003, GENETICS, V164, P1645; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; Scheinfeldt LB, 2010, P NATL ACAD SCI USA, V107, P8931, DOI 10.1073/pnas.1002563107; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Steiner UK, 2012, P NATL ACAD SCI USA, V109, P4684, DOI 10.1073/pnas.1018096109; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Templeton AR, 1996, GENETICS, V144, P1263; TEMPLETON AR, 1994, EXS, V68, P91; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Turner TF, 2006, P R SOC B, V273, P3065, DOI 10.1098/rspb.2006.3677; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; United Nations, 2012, POP DIV WORLD POP PR; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354	55	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97674	10.1371/journal.pone.0097674	http://dx.doi.org/10.1371/journal.pone.0097674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845801	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400043
J	Kim, EY; Kim, JW; Kim, WK; Han, BS; Park, SG; Chung, BH; Lee, SC; Bae, KH				Kim, Eun Young; Kim, Ji Won; Kim, Won Kon; Han, Baek Soo; Park, Sung Goo; Chung, Bong Hyun; Lee, Sang Chul; Bae, Kwang-Hee			Selection of Aptamers for Mature White Adipocytes by Cell SELEX Using Flow Cytometry	PLOS ONE			English	Article							PROMOTES ADIPOGENIC DIFFERENTIATION; IN-VITRO; TYROSINE PHOSPHATASE; HIGH-AFFINITY; RNA LIGANDS; OBESITY; BROWN; ACETYLATION; GENERATION; ENRICHMENT	Background: Adipose tissue, mainly composed of adipocytes, plays an important role in metabolism by regulating energy homeostasis. Obesity is primarily caused by an abundance of adipose tissue. Therefore, specific targeting of adipose tissue is critical during the treatment of obesity, and plays a major role in overcoming it. However, the knowledge of cell-surface markers specific to adipocytes is limited. Methods and Results: We applied the CELL SELEX (Systematic Evolution of Ligands by EXponential enrichment) method using flow cytometry to isolate molecular probes for specific recognition of adipocytes. The aptamer library, a mixture of FITC-tagged single-stranded random DNAs, is used as a source for acquiring molecular probes. With the increasing number of selection cycles, there was a steady increase in the fluorescence intensity toward mature adipocytes. Through 12 rounds of SELEX, enriched aptamers showing specific recognition toward mature 3T3-L1 adipocyte cells were isolated. Among these, two aptamers (MA-33 and 91) were able to selectively bind to mature adipocytes with an equilibrium dissociation constant (Kd) in the nanomolar range. These aptamers did not bind to preadipocytes or other cell lines (such as HeLa, HEK-293, or C2C12 cells). Additionally, it was confirmed that MA-33 and 91 can distinguish between mature primary white and primary brown adipocytes. Conclusions: These selected aptamers have the potential to be applied as markers for detecting mature white adipocytes and monitoring adipogenesis, and could emerge as an important tool in the treatment of obesity.	[Kim, Eun Young; Kim, Ji Won; Kim, Won Kon; Han, Baek Soo; Lee, Sang Chul; Bae, Kwang-Hee] KRIBB, Res Ctr Integrated Cellul, Taejon, South Korea; [Park, Sung Goo] KRIBB, Med Prote Res Ctr, Taejon, South Korea; [Chung, Bong Hyun] KRIBB, Bioconvergence Res Inst, BioNanotechnol Res Ctr, Taejon, South Korea; [Kim, Ji Won; Lee, Sang Chul; Bae, Kwang-Hee] Univ Sci & Technol UST Korea, Dept Funct Genom, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Lee, SC (corresponding author), KRIBB, Res Ctr Integrated Cellul, Taejon, South Korea.	lesach@kribb.re.kr; khbae@kribb.re.kr		Bae, Kwang-Hee/0000-0002-5868-2556	Korea Research Institute of Bioscience and Biotechnology (KRIBB); National Research Foundation of Korea [2012M3A9C7050101, 2013M3A9A7046301, 2011-0020507]	Korea Research Institute of Bioscience and Biotechnology (KRIBB); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) and from the Research Program (grants 2012M3A9C7050101, 2013M3A9A7046301, 2011-0020507, and Global Frontier R&D Program) through the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2012, NATURE, V488, P286, DOI 10.1038/488286a; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia Laura, 2009, V535, P59, DOI 10.1007/978-1-59745-557-2_5; Cinti S, 2011, ANN MED, V43, P104, DOI 10.3109/07853890.2010.535557; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ELLINGTON AD, 1992, NATURE, V355, P850, DOI 10.1038/355850a0; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; FELSTED RL, 1983, CANCER RES, V43, P2754; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Hanke W, 2004, DERMATOL SURG, V30, P967, DOI 10.1111/j.1524-4725.2004.30300.x; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Humphryes PC, 2012, CLIN VACCINE IMMUNOL, V19, P587, DOI 10.1128/CVI.05622-11; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Jung H, 2009, BIOCHEM BIOPH RES CO, V383, P252, DOI 10.1016/j.bbrc.2009.04.001; Kamal AM, 2013, J PROTEOMICS, V94, P327, DOI 10.1016/j.jprot.2013.10.005; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kim EY, 2013, BIOCHEM BIOPH RES CO, V441, P77, DOI 10.1016/j.bbrc.2013.10.016; Kim EY, 2012, J LIPID RES, V53, P1864, DOI 10.1194/jlr.M026567; Kim WK, 2008, ENDOCR J, V55, P827, DOI 10.1507/endocrj.K08E-115; Kim WK, 2012, INT J BIOCHEM CELL B, V44, P327, DOI 10.1016/j.biocel.2011.11.004; Kim WK, 2011, MOL BIOL CELL, V22, P4883, DOI 10.1091/mbc.E11-03-0175; Kim WK, 2009, J CELL SCI, V122, P4160, DOI 10.1242/jcs.053009; Kwon YN, 2011, SPECTROSC-BIOMED APP, V26, P329, DOI 10.1155/2011/707216; Layzer JM, 2007, OLIGONUCLEOTIDES, V17, P1, DOI 10.1089/oli.2006.0059; Lee YH, 2004, J LIPID RES, V45, P1162, DOI 10.1194/jlr.D300028-JLR200; Leva S, 2002, CHEM BIOL, V9, P351, DOI 10.1016/S1074-5521(02)00111-4; Liu JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037559; Liu J, 2011, CURR MED CHEM, V18, P4117, DOI 10.2174/092986711797189619; Malaguarnera R, 2012, ENDOCRINOLOGY, V153, P2152, DOI 10.1210/en.2011-1843; Mayer G, 2010, NAT PROTOC, V5, P1993, DOI 10.1038/nprot.2010.163; Mendonsa SD, 2004, J AM CHEM SOC, V126, P20, DOI 10.1021/ja037832s; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Park Anna, 2014, World J Stem Cells, V6, P33, DOI 10.4252/wjsc.v6.i1.33; Raddatz MSL, 2008, ANGEW CHEM INT EDIT, V47, P5190, DOI 10.1002/anie.200800216; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Rosen ED, 2000, GENE DEV, V14, P1293; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Sood J, 2011, INDIAN J ANAESTH, V55, P220, DOI 10.4103/0019-5049.82652; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Simaeys D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013770; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wu AY, 2012, J TRANSL MED, V10, P3; Xiao ZY, 2008, CHEM-EUR J, V14, P1769, DOI 10.1002/chem.200701330; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	13	15	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97747	10.1371/journal.pone.0097747	http://dx.doi.org/10.1371/journal.pone.0097747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844710	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400056
J	Valente, DS; Zanella, RK; Doncatto, LF; Padoin, AV				Valente, Denis Souto; Zanella, Rafaela Koehler; Doncatto, Leo Francisco; Padoin, Alexandre Vontobel			Incidence and Risk Factors of Striae Distensae Following Breast Augmentation Surgery: A Cohort Study	PLOS ONE			English	Article							MAMMAPLASTY; GRAVIDARUM; THERAPY; STRETCH; TRIAL	Background: The significant increase in the popularity of breast augmentation surgeries has led to an increase in the number and types of complications; among these is the postoperative occurrence of Striae Distensae (SD). The objective of this study was to investigate the incidence of SD and describing its occurrence in association with age, breast implant volume, history of SD, history of pregnancies and breastfeeding, body mass index (BMI), changes in postoperative weight, smoking habits, and use of oral contraceptives. Methods: A cohort study was conducted and the patient data from a specific social group that underwent augmentation mammaplasty with silicone breast implants in a private clinic was analyzed. Results: 563 patients entered the cohort, while 538 completed the study. The SD incidence was 7.06%. The risk was almost the double at 22-28 years of age and triple in women of 21 years of age or less. The women who did not use oral contraceptives were 2.59 times more likely of developing SD. A higher incidence of SD was observed among those with normal or low BMI values, smokers, and in those who had implants larger than 300 ml. Conclusions: Young age, larger implant volumes, smoking, and normal or low BMI values were the risk factors responsible for the development of SD; while using oral contraceptives was found to be a protective factor.	[Valente, Denis Souto] Mae de Deus Hlth Syst, Div Plast Surg, Porto Alegre, RS, Brazil; [Zanella, Rafaela Koehler] Mae de Deus Hlth Syst, Div Dermatol Surg, Porto Alegre, RS, Brazil; [Doncatto, Leo Francisco] Lutheran Univ Brazil ULBRA, ULBRA Sch Med, Canoas, RS, Brazil; [Padoin, Alexandre Vontobel] Pontificia Univ Catolica Rio Grande do Sul, Dept Med, Porto Alegre, RS, Brazil	Universidade Luterana do Brasil; Pontificia Universidade Catolica Do Rio Grande Do Sul	Valente, DS (corresponding author), Mae de Deus Hlth Syst, Div Plast Surg, Porto Alegre, RS, Brazil.	denisvalente@denisvalente.com.br	Valente, Denis Souto/AAP-8806-2021; Padoin, Alexandre V/M-7660-2013	Valente, Denis Souto/0000-0001-6101-5087; Padoin, Alexandre V/0000-0002-9754-4818				Adams WP, 2012, PLAST RECONSTR SURG, V130, p598E, DOI 10.1097/PRS.0b013e318262f607; American Society of Plastic Surgeons, 2013, REP 2012 PLAST SURG; Atwal GSS, 2006, BRIT J DERMATOL, V155, P965, DOI 10.1111/j.1365-2133.2006.07427.x; Basile FV, 2012, AESTHET PLAST SURG, V36, P894, DOI 10.1007/s00266-012-9902-5; Dancey A, 2012, J PLAST RECONSTR AES, V65, P213, DOI 10.1016/j.bjps.2011.09.011; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Ehlers RS, 2003, STAT INFERENCE, V210; Elsaie ML, 2009, DERMATOL SURG, V35, P563, DOI 10.1111/j.1524-4725.2009.01094.x; Feldman Evan M, 2009, J Plast Reconstr Aesthet Surg, V62, pe330, DOI 10.1016/j.bjps.2007.11.058; Har-Shai Y, 1999, ANN PLAS SURG, V42, P193, DOI 10.1097/00000637-199902000-00015; Huang GJ, 2008, PLAST RECONSTR SURG, V122, p90E, DOI 10.1097/PRS.0b013e31817d64f6; Keramidas E, 2008, AESTHET PLAST SURG, V32, P377, DOI 10.1007/s00266-007-9053-2; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Mahabir RC, 2001, PLAST RECONSTR SURG, V108, P753, DOI 10.1097/00006534-200109010-00024; Naidu NS, 2013, AESTHET PLAST SURG, V37, P189, DOI 10.1007/s00266-012-0040-x; Namnoum JD, 2013, J PLAST RECONSTR AES, V66, P1165, DOI 10.1016/j.bjps.2013.04.046; Orrego JPC, 2003, PAEDIATRICA, V5, P40; Osman H, 2008, BJOG-INT J OBSTET GY, V115, P1138, DOI 10.1111/j.1471-0528.2008.01796.x; Robinson C, 1997, PLAST RECONSTR SURG, V99, P274, DOI 10.1097/00006534-199701000-00068; SNYDER GB, 1981, PLAST RECONSTR SURG, V67, P699, DOI 10.1097/00006534-198105000-00032; Cordeiro RCT, 2010, INT J DERMATOL, V49, P30, DOI 10.1111/j.1365-4632.2008.04005.x; Wilhelmi BJ, 1998, ANN PLAS SURG, V41, P215, DOI 10.1097/00000637-199808000-00019; ZHENG P, 1985, BRIT J DERMATOL, V112, P185, DOI 10.1111/j.1365-2133.1985.tb00082.x	23	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97493	10.1371/journal.pone.0097493	http://dx.doi.org/10.1371/journal.pone.0097493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844230	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400031
J	Xu, W; Hu, XL; Chen, ZT; Zheng, XP; Zhang, CJ; Wang, G; Chen, Y; Zhou, XL; Tang, XX; Luo, LS; Xu, X; Pan, WS				Xu, Wen; Hu, Xinlei; Chen, Zhongting; Zheng, Xiaoping; Zhang, Chenjing; Wang, Gang; Chen, Yu; Zhou, Xinglu; Tang, Xiaoxiao; Luo, Laisheng; Xu, Xiang; Pan, Wensheng			Normal Fibroblasts Induce E-Cadherin Loss and Increase Lymph Node Metastasis in Gastric Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; MESENCHYMAL TRANSITION; CISPLATIN RESISTANCE; TUMOR PROGRESSION; GROWTH; CELLS; INHIBITION; INVASION; PROMOTES; EMT	Background: A tumor is considered a heterogeneous complex in a three-dimensional environment that is flush with pathophysiological and biomechanical signals. Cell-stroma interactions guide the development and generation of tumors. Here, we evaluate the contributions of normal fibroblasts to gastric cancer. Methodology/Principal Findings: By coculturing normal fibroblasts in monolayers of BGC-823 gastric cancer cells, tumor cells sporadically developed short, spindle-like morphological characteristics and demonstrated enhanced proliferation and invasive potential. Furthermore, the transformed tumor cells demonstrated decreased tumor formation and increased lymphomatic and intestinal metastatic potential. Non-transformed BGC-823 cells, in contrast, demonstrated primary tumor formation and delayed intestinal and lymph node invasion. We also observed E-cadherin loss and the upregulation of vimentin expression in the transformed tumor cells, which suggested that the increase in metastasis was induced by epithelial-to-mesenchymal transition. Conclusion: Collectively, our data indicated that normal fibroblasts sufficiently induce epithelial-to-mesenchymal transition in cancer cells, thereby leading to metastasis.	[Xu, Wen; Zhang, Chenjing; Wang, Gang; Zhou, Xinglu; Tang, Xiaoxiao; Luo, Laisheng; Pan, Wensheng] Zhejiang Univ, Sch Med, Dept Gastroenterol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Xinlei] Zhejiang Univ, Sch Med, Dept Orthoped, Affiliated Hosp 2,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhongting] Zhejiang Univ, Sch Med, Dept Pharm, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Xiaoping] Qujiang Peoples Hosp, Dept Pathol, Quzhou, Peoples R China; [Chen, Yu] Zhejiang Acad Tradit Chinese Med, Expt Anim Res Ctr, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiang] Zhejiang Univ, Sch Med, Dept Pharm, Affiliated Hosp 2,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Wensheng] Zhejiang Univ, Sch Med, Dept Gastroenterol, Affiliated Hosp 2,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Pan, WS (corresponding author), Zhejiang Univ, Sch Med, Dept Gastroenterol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	wspan223@163.com	Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019		National Health Key Special Fund [200802112]; National Science Fund Committee [81372302, 81272120]; Health Department Fund [2007A093]; Key Project of Zhejiang Province [2013C030445 2009C030125]; Natural Science Fund of Zhejiang Province [Y2080001, Y12H160121, Z2080514]; Traditional Chinese Medicine Bureau Fund [2007ZA019]	National Health Key Special Fund; National Science Fund Committee; Health Department Fund; Key Project of Zhejiang Province; Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Traditional Chinese Medicine Bureau Fund	This research was supported by grants from the National Health Key Special Fund (http://program.most.gov.cn; No.200802112), the National Science Fund Committee (http://www.nsfc.gov.cn; general project No.81372302 No.81272120), the Health Department Fund (http://program.most.gov.cn; No.2007A093), the Key Project of Zhejiang Province (http://www.zjkjt.gov.cn; No.2013C030445 2009C030125). The Natural Science Fund of Zhejiang Province (http://www.zjnsf.gov.cn; No.Y2080001, Y12H160121, and Z2080514), and the Traditional Chinese Medicine Bureau Fund (http://wst.zj.gov.cn; No.2007ZA019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bougen NM, 2013, CANCER LETT, V332, P19, DOI 10.1016/j.canlet.2012.12.012; Boyd SC, 2013, J INVEST DERMATOL, V133, P1269, DOI 10.1038/jid.2012.421; Buda A, 2011, CELL COMMUN ADHES, V18, P131, DOI 10.3109/15419061.2011.636465; Chen XB, 2012, MOL BIOL REP, V39, P6707, DOI 10.1007/s11033-012-1494-2; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063854; Cho HJ, 2011, CANCER LETT, V311, P48, DOI 10.1016/j.canlet.2011.06.024; Fromigue O, 2003, ONCOGENE, V22, P8487, DOI 10.1038/sj.onc.1206918; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Guo S, 2013, INT J CLIN ONCOL; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Kamikihara T, 2012, PATHOL INT, V62, P161, DOI 10.1111/j.1440-1827.2011.02774.x; Kim HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016694; KODERA Y, 1994, CANCER CHEMOTH PHARM, V34, P203; Le TVT, 2010, ARCH PHARM RES, V33, P1127, DOI 10.1007/s12272-010-0720-5; Li YH, 2013, EXP MOL PATHOL, V94, P430, DOI 10.1016/j.yexmp.2013.02.001; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Maccario C, 2012, CARCINOGENESIS, V33, P2172, DOI 10.1093/carcin/bgs244; MARTZ E, 1972, J CELL PHYSIOL, V79, P189, DOI 10.1002/jcp.1040790205; Menke A, 2001, CANCER RES, V61, P3508; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Myong NH, 2012, KOREAN J PATHOL, V46, P341, DOI 10.4132/KoreanJPathol.2012.46.4.341; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Osada T, 1996, HEPATOLOGY, V24, P1460, DOI 10.1002/hep.510240627; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ren J, 2013, J CELL BIOCHEM, V114, P1395, DOI 10.1002/jcb.24481; Romer AM, 2013, ANTICANCER RES, V33, P1525; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Shen CH, 2011, J BUON, V16, P733; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Siebzehnrubl FA, 2013, EMBO MOL MED; Tanaka M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-237; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Udagawa T, 2010, CURR OPIN PHARMACOL, V10, P369, DOI 10.1016/j.coph.2010.06.010; Yamaguchi K, 2013, GASTRIC CANCER, V16, P175, DOI 10.1007/s10120-012-0167-0; Yang SM, 2013, TOXICOLOGY, V306, P162, DOI 10.1016/j.tox.2013.02.014; Zhang H, 2013, J CANCER RES CLIN, V139, P1033, DOI 10.1007/s00432-012-1363-3; Zhang K, 2013, INT J MOL MED; Zubeldia IG, 2013, EXP CELL RES, V319, P12, DOI 10.1016/j.yexcr.2012.11.004	43	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97306	10.1371/journal.pone.0097306	http://dx.doi.org/10.1371/journal.pone.0097306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845259	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400020
J	Arora, M; Austin, C; Sarrafpour, B; Hernandez-Avila, M; Hu, H; Wright, RO; Tellez-Rojo, MM				Arora, Manish; Austin, Christine; Sarrafpour, Babak; Hernandez-Avila, Mauricio; Hu, Howard; Wright, Robert O.; Maria Tellez-Rojo, Martha			Determining Prenatal, Early Childhood and Cumulative Long-Term Lead Exposure Using Micro-Spatial Deciduous Dentine Levels	PLOS ONE			English	Article							MATERNAL BONE-LEAD; BLOOD; TEETH; CHILDREN; PREGNANCY; PLASMA; BIOMARKER; TOOTH	The aim of this study was to assess the validity of micro-spatial dentine lead (Pb) levels as a biomarker for accurately estimating exposure timing over the prenatal and early childhood periods and long-term cumulative exposure to Pb. In a prospective pregnancy cohort sub-sample of 85 subjects, we compared dentine Pb levels measured using laser ablation-inductively coupled plasma mass spectrometry with Pb concentrations in maternal blood collected in the second and third trimesters, maternal bone, umbilical cord blood, and childhood serial blood samples collected from the ages of 3 months to >= 6 years. We found that Pb levels (as Pb-208:Ca-43) in dentine formed at birth were significantly associated with cord blood Pb (Spearman rho = 0.69; n = 27; p<0.0001). The association of prenatal dentine Pb with maternal patella Pb (Spearman rho = 0.48; n = 59; p<0.0001) was stronger than that observed for tibia Pb levels (Spearman rho = 0.35; n = 41; p<0.03). When assessing postnatal exposure, we found that Pb levels in dentine formed at 3 months were significantly associated with Pb concentrations in children's blood collected concurrently (Spearman rho = 0.64; n = 55; p<0.0001). We also found that mean Pb concentrations in secondary dentine (that is formed from root completion to tooth shedding) correlated positively with cumulative blood lead index (Spearman rho = 0.38; n = 75; p<0.0007). Overall, our results support that micro-spatial measurements of Pb in dentine can be reliably used to reconstruct Pb exposure timing over the prenatal and early childhood periods, and secondary dentine holds the potential to estimate long-term exposure up to the time the tooth is shed.	[Arora, Manish; Austin, Christine; Wright, Robert O.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Arora, Manish; Austin, Christine; Sarrafpour, Babak] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia; [Hernandez-Avila, Mauricio] Natl Inst Publ Hlth, Off Director, Cuernavaca, Morelos, Mexico; [Hu, Howard] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Maria Tellez-Rojo, Martha] Natl Inst Publ Hlth, Ctr Evaluat Res & Surveys, Div Stat, Cuernavaca, Morelos, Mexico	Icahn School of Medicine at Mount Sinai; University of Sydney; Instituto Nacional de Salud Publica; University of Toronto; Instituto Nacional de Salud Publica	Arora, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.	manish.arora@mssm.edu	Hu, Howard/AAV-5360-2021	Wright, Robert/0000-0003-1180-6459; Hu, Howard/0000-0002-3676-2707; Austin, Christine/0000-0002-9966-0492	NIEHS [R00ES019597, P42ES05947, R01ES07821, P42ES00000, R01ES013744, R01ES014930]; Australian NHMRC [APP1028372]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007821, R01ES014930, R00ES019597, R01ES020268, P42ES016454, R01ES013744, P30ES023515, P42ES005947] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by funding from NIEHS grants R00ES019597 (Arora), P42ES05947 (Hu), R01ES07821 (Hu), P42ES00000 (Hu), R01ES07821 (Hu, Wright) R01ES013744 (Wright), R01ES014930 (Wright), and Australian NHMRC grant APP1028372 (Arora). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora M, 2006, SCI TOTAL ENVIRON, V371, P55, DOI 10.1016/j.scitotenv.2006.07.035; Arora M, 2013, CURR OPIN PEDIATR, V25, P261, DOI 10.1097/MOP.0b013e32835e9084; Arora M, 2012, ENVIRON SCI TECHNOL, V46, P5118, DOI 10.1021/es203569f; Austin C, 2013, NATURE, V498, P216, DOI 10.1038/nature12169; Berkovitz BKB., 2018, ORAL ANATOMY HISTOLO, V5th ed.; Chuang HY, 2001, ENVIRON HEALTH PERSP, V109, P527, DOI 10.2307/3454713; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P26, DOI [10.1289/ehp.11868, 10.1289/ehp.1171c26]; GonzalezCossio T, 1997, PEDIATRICS, V100, P856, DOI 10.1542/peds.100.5.856; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; GULSON B, 1994, ARCH ENVIRON HEALTH, V49, P279, DOI 10.1080/00039896.1994.9937480; Hare D, 2011, J DENT, V39, P397, DOI 10.1016/j.jdent.2011.03.004; Hernandez-Avila M, 2002, ARCH ENVIRON HEALTH, V57, P482, DOI 10.1080/00039890209601441; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; MCMICHAEL AJ, 1994, AM J EPIDEMIOL, V140, P489, DOI 10.1093/oxfordjournals.aje.a117275; NEEDLEMAN HL, 1972, NATURE, V235, P111, DOI 10.1038/235111a0; NEEDLEMAN HL, 1974, NEW ENGL J MED, V290, P245, DOI 10.1056/NEJM197401312900504; Nie LH, 2011, BIOMARKERS, V16, P517, DOI 10.3109/1354750X.2011.604133; RABINOWITZ MB, 1995, B ENVIRON CONTAM TOX, V55, P853; Roels H, 1995, ENVIRON RES, V69, P75, DOI 10.1006/enrs.1995.1027; Tellez-Rojo MM, 2004, AM J EPIDEMIOL, V160, P668, DOI 10.1093/aje/kwh271; Zhang AM, 2012, ENVIRON HEALTH PERSP, V120, P445, DOI 10.1289/ehp.1103736	22	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97805	10.1371/journal.pone.0097805	http://dx.doi.org/10.1371/journal.pone.0097805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841926	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600076
J	Cheng, JH; Zhang, LF; Gao, F; Bai, YG; Boscolo, M; Huang, XF; Zhang, X				Cheng, Jiu-Hua; Zhang, Li-Fan; Gao, Fang; Bai, Yun-Gang; Boscolo, Marco; Huang, Xiao-Feng; Zhang, Xiang			Mechanics and Composition of Middle Cerebral Arteries from Simulated Microgravity Rats with and without 1-h/d-Gx Gravitation	PLOS ONE			English	Article							MESENTERIC SMALL ARTERIES; DAILY -G(X) GRAVITATION; ORTHOSTATIC INTOLERANCE; MYOGENIC TONE; SPACEFLIGHT; HYPERTENSION; VASOCONSTRICTOR; REACTIVITY; RESISTANCE; PERFUSION	Background: To elucidate further from the biomechanical aspect whether microgravity-induced cerebral vascular maladaptation might be a contributing factor to postflight orthostatic intolerance and the underlying mechanism accounting for the potential effectiveness of intermittent artificial gravity (IAG) in preventing this adverse effect. Methodology/Principal Findings: Middle cerebral arteries (MCAs) were isolated from 28-day SUS (tail-suspended, head-down tilt rats to simulate microgravity effect), S+D (SUS plus 1-h/d-G(x) gravitation by normal standing to simulate IAG), and CON (control) rats. Vascular myogenic reactivity and circumferential stress-strain and axial force-pressure relationships and overall stiffness were examined using pressure arteriography and calculated. Acellular matrix components were quantified by electron microscopy. The results demonstrate that myogenic reactivity is susceptible to previous pressure-induced, serial constrictions. During the first-run of pressure increments, active MCAs from SUS rats can strongly stiffen their wall and maintain the vessels at very low strains, which can be prevented by the simulated IAG countermeasure. The strains are 0.03 and 0.14 respectively for SUS and S+D, while circumferential stress being kept at 0.5 (10(6) dyn/cm(2)). During the second-run pressure steps, both the myogenic reactivity and active stiffness of the three groups declined. The distensibility of passive MCAs from S+D is significantly higher than CON and SUS, which may help to attenuate the vasodilatation impairment at low levels of pressure. Collagen and elastin percentages were increased and decreased, respectively, in MCAs from SUS and S+D as compared with CON; however, elastin was higher in S+D than SUS rats. Conclusions: Susceptibility to previous myogenic constrictions seems to be a self-limiting protective mechanism in cerebral small resistance arteries to prevent undue cerebral vasoconstriction during orthostasis at 1-G environment. Alleviating of active stiffening and increasing of distensibility of cerebral resistance arteries may underlie the countermeasure effectiveness of IAG.	[Cheng, Jiu-Hua; Zhang, Li-Fan; Gao, Fang; Bai, Yun-Gang] Fourth Mil Med Univ, Dept Aerosp Physiol, Minist Educ, Xian 710032, Peoples R China; [Cheng, Jiu-Hua; Zhang, Li-Fan; Gao, Fang; Bai, Yun-Gang] Fourth Mil Med Univ, Minist Educ, Key Lab Aerosp Med, Xian 710032, Peoples R China; [Huang, Xiao-Feng] Fourth Mil Med Univ, Sch Basic Med Sci, Cent Lab, Xian 710032, Peoples R China; [Boscolo, Marco; Zhang, Xiang] Cranfield Univ, Dept Aerosp Engn, Cranfield MK43 0AL, Beds, England	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Cranfield University	Zhang, LF (corresponding author), Fourth Mil Med Univ, Dept Aerosp Physiol, Minist Educ, Xian 710032, Peoples R China.	zhanglf@fmmu.edu.cn	Zhang, Xiang/ABI-2024-2020	Zhang, Xiang/0000-0001-8454-3931	National Natural Science Foundation of China [30470649, 31070839]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos: 30470649 and 31070839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeille P, 2008, AM J PHYSIOL-HEART C, V295, pH1846, DOI 10.1152/ajpheart.509.2008; Blaber AP, 2011, STROKE, V42, P1844, DOI 10.1161/STROKEAHA.110.610576; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; Cheng Jiu-Hua, 2009, Shengli Xuebao, V61, P386; Coulson RJ, 2002, AM J PHYSIOL-HEART C, V283, pH2268, DOI 10.1152/ajpheart.00542.2002; Delp MD, 2000, AM J PHYSIOL-HEART C, V278, pH1866, DOI 10.1152/ajpheart.2000.278.6.H1866; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Gao Fang, 2012, Shengli Xuebao, V64, P107; GAZENKO OG, 1981, ACTA ASTRONAUT, V8, P907, DOI 10.1016/0094-5765(81)90061-8; Geary GG, 1998, J APPL PHYSIOL, V85, P1615, DOI 10.1152/jappl.1998.85.5.1615; Hargens AR, 2009, RESP PHYSIOL NEUROBI, V169, pS30, DOI 10.1016/j.resp.2009.07.005; Hargens AR, 2012, EUR J APPL PHYSL, DOI [10.1007/s00421-00012-02523-00425, DOI 10.1007/S00421-00012-02523-00425]; HAYASHI K, 1980, BIORHEOLOGY, V17, P211; HEISTAD DD, 1992, J HYPERTENS, V10, pS71; HUMPHREY J, 2001, CARDIOVASCULAR SOLID; Intengan HD, 1999, HYPERTENSION, V33, P569, DOI 10.1161/01.HYP.33.1.569; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; Lin Le-Jian, 2009, Shengli Xuebao, V61, P27; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; OSOL G, 1985, AM J PHYSIOL, V249, pH914, DOI 10.1152/ajpheart.1985.249.5.H914; Rowell L, 1993, HUMAN CARDIOVASCULAR; Sides MB, 2005, AVIAT SPACE ENVIR MD, V76, P877; Sun B, 2004, J APPL PHYSIOL, V97, P1022, DOI 10.1152/japplphysiol.00188.2004; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Timoshenko SP, 1934, THEORY ELASTICITY; WATENPAUGH DE, 1996, HDB PHYSIOL SECT 4, V1, P631; Wilkerson MK, 2005, AM J PHYSIOL-HEART C, V288, pH1652, DOI 10.1152/ajpheart.00925.2004; Wilkerson MK, 2002, AM J PHYSIOL-HEART C, V282, pH328, DOI 10.1152/ajpheart.00727.2001; Xie MJ, 2005, AM J PHYSIOL-HEART C, V289, pH1265, DOI 10.1152/ajpheart.00074.2005; Young L., 2009, ARTIFICIAL GRAVITY R, P1; Zhang LF, 2003, J APPL PHYSIOL, V95, P207, DOI 10.1152/japplphysiol.00969.2002; Zhang LF, 2001, AVIAT SPACE ENVIR MD, V72, P567; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang LF, 2013, EUR J APPL PHYSL, DOI [10.1007/s00421-00013-02597-00428, DOI 10.1007/S00421-00013-02597-00428]; Zhang LN, 2001, J APPL PHYSIOL, V90, P2296, DOI 10.1152/jappl.2001.90.6.2296; Zuj KA, 2012, AM J PHYSIOL-HEART C, V302, pH2592, DOI 10.1152/ajpheart.00029.2012	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97737	10.1371/journal.pone.0097737	http://dx.doi.org/10.1371/journal.pone.0097737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840155	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600066
J	Eckert, N; Wrensch, F; Gartner, S; Palanisamy, N; Goedecke, U; Jager, N; Pohlmann, S; Winkler, M				Eckert, Nadine; Wrensch, Florian; Gaertner, Sabine; Palanisamy, Navaneethan; Goedecke, Ulrike; Jaeger, Nils; Poehlmann, Stefan; Winkler, Michael			Influenza A Virus Encoding Secreted Gaussia Luciferase as Useful Tool to Analyze Viral Replication and Its Inhibition by Antiviral Compounds and Cellular Proteins	PLOS ONE			English	Article							NIEMANN-PICK C1; IN-VIVO; NEURAMINIDASE INHIBITOR; RESISTANT INFLUENZA; REPORTER VIRUS; IFITM PROTEINS; CACO-2 CELLS; DENGUE VIRUS; MDCK CELLS; INFECTION	Reporter genes inserted into viral genomes enable the easy and rapid quantification of virus replication, which is instrumental to efficient in vitro screening of antiviral compounds or in vivo analysis of viral spread and pathogenesis. Based on a published design, we have generated several replication competent influenza A viruses carrying either fluorescent proteins or Gaussia luciferase. Reporter activity could be readily quantified in infected cultures, but the virus encoding Gaussia luciferase was more stable than viruses bearing fluorescent proteins and was therefore analyzed in detail. Quantification of Gaussia luciferase activity in the supernatants of infected culture allowed the convenient and highly sensitive detection of viral spread, and enzymatic activity correlated with the number of infectious particles released from infected cells. Furthermore, the Gaussia luciferase encoding virus allowed the sensitive quantification of the antiviral activity of the neuraminidase inhibitor (NAI) zanamivir and the host cell interferon-inducible transmembrane (IFITM) proteins 1-3, which are known to inhibit influenza virus entry. Finally, the virus was used to demonstrate that influenza A virus infection is sensitive to a modulator of endosomal cholesterol, in keeping with the concept that IFITMs inhibit viral entry by altering cholesterol levels in the endosomal membrane. In sum, we report the characterization of a novel influenza A reporter virus, which allows fast and sensitive detection of viral spread and its inhibition, and we show that influenza A virus entry is sensitive to alterations of endosomal cholesterol levels.	[Eckert, Nadine; Wrensch, Florian; Gaertner, Sabine; Palanisamy, Navaneethan; Goedecke, Ulrike; Jaeger, Nils; Poehlmann, Stefan; Winkler, Michael] German Primate Ctr, Infect Biol Unit, Gottingen, Germany	Deutsches Primatenzentrum (DPZ)	Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.	SPoehlmann@dpz.eu; MWinkler@dpz.eu	Palanisamy, Navaneethan/AAL-1462-2020; Pöhlmann, Stefan/H-2395-2011	Palanisamy, Navaneethan/0000-0003-0369-2316; Pöhlmann, Stefan/0000-0001-6086-9136; Wrensch, Florian/0000-0002-7258-5453; Winkler, Michael/0000-0002-6198-554X	Leibniz Graduate School EIDIS; Leibniz Foundation	Leibniz Graduate School EIDIS; Leibniz Foundation	This work was supported by the Leibniz Graduate School EIDIS (FW) and the Leibniz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Ataei F, 2009, PHOTOCHEM PHOTOBIOL, V85, P1162, DOI 10.1111/j.1751-1097.2009.00583.x; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Kupcsik L, 2011, METHODS MOL BIOL, V740, P13, DOI 10.1007/978-1-61779-108-6_3; Li F, 2010, J VIROL, V84, P12075, DOI 10.1128/JVI.00046-10; Machado AV, 2006, VIROLOGY, V345, P73, DOI 10.1016/j.virol.2005.09.050; Machado AV, 2003, VIROLOGY, V313, P235, DOI 10.1016/S0042-6822(03)00289-7; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; MIKI T, 1992, J MOL BIOL, V225, P39, DOI 10.1016/0022-2836(92)91024-J; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Mostafa A, 2013, J VIROL METHODS, V193, P603, DOI 10.1016/j.jviromet.2013.07.021; Neumann G, 2000, J VIROL, V74, P547, DOI 10.1128/JVI.74.1.547-551.2000; Okomo-Adhiambo M, 2013, INFLUENZA OTHER RESP, V7, P44, DOI [10.1111/irv.12113, 10.1111/irv.12051]; Osterhaus A, 2011, PHILOS T R SOC B, V366, P2766, DOI 10.1098/rstb.2011.0102; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Pan WQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3369; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shoemaker CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056265; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Sun XJ, 2013, ADV EXP MED BIOL, V790, P72, DOI 10.1007/978-1-4614-7651-1_4; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tisdale M, 2000, REV MED VIROL, V10, P45, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;45::AID-RMV265&gt;3.0.CO;2-R; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; Triana-Baltzer GB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007838; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Winkler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043337; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	58	40	41	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97695	10.1371/journal.pone.0097695	http://dx.doi.org/10.1371/journal.pone.0097695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842154	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600057
J	Meininger, V; Pradat, PF; Corse, A; Al-Sarraj, S; Brooks, BR; Caress, JB; Cudkowicz, M; Kolb, SJ; Lange, D; Leigh, PN; Meyer, T; Milleri, S; Morrison, KE; Orrell, RW; Peters, G; Rothstein, JD; Shefner, J; Lavrov, A; Williams, N; Overend, P; Price, J; Bates, S; Bullman, J; Krull, D; Berges, A; Abila, B; Meno-Tetang, G; Wurthner, J				Meininger, Vincent; Pradat, Pierre-Francois; Corse, Andrea; Al-Sarraj, Safa; Brooks, Benjamin Rix; Caress, James B.; Cudkowicz, Merit; Kolb, Stephen J.; Lange, Dale; Leigh, P. Nigel; Meyer, Thomas; Milleri, Stefano; Morrison, Karen E.; Orrell, Richard W.; Peters, Gary; Rothstein, Jeffrey D.; Shefner, Jeremy; Lavrov, Arseniy; Williams, Nicola; Overend, Phil; Price, Jeffrey; Bates, Stewart; Bullman, Jonathan; Krull, David; Berges, Alienor; Abila, Bams; Meno-Tetang, Guy; Wurthner, Jens			Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial	PLOS ONE			English	Article							OUTCOME MEASURE; MUSCLE; EXPRESSION; ALS; MARKER; DEXPRAMIPEXOLE; DENERVATION; MECHANISMS; DIAGNOSIS	The neurite outgrowth inhibitor, Nogo-A, has been shown to be overexpressed in skeletal muscle in amyotrophic lateral sclerosis (ALS); it is both a potential biomarker and therapeutic target. We performed a double-blind, two-part, dose-escalation study, in subjects with ALS, assessing safety, pharmacokinetics (PK) and functional effects of ozanezumab, a humanized monoclonal antibody against Nogo-A. In Part 1, 40 subjects were randomized (3:1) to receive single dose intravenous ozanezumab (0.01, 0.1, 1, 5, or 15 mg/kg) or placebo. In Part 2, 36 subjects were randomized (3:1) to receive two repeat doses of intravenous ozanezumab (0.5, 2.5, or 15 mg/kg) or placebo, approximately 4 weeks apart. The primary endpoints were safety and tolerability (adverse events [AEs], vital signs, electrocardiogram (ECG), and clinical laboratory tests). Secondary endpoints included PK, immunogenicity, functional endpoints (clinical and electrophysiological), and biomarker parameters. Overall, ozanezumab treatment (0.01-15 mg/kg) was well tolerated. The overall incidence of AEs in the repeat dose 2.5 mg/kg and 15 mg/kg ozanezumab groups was higher than in the repeat dose placebo group and repeat dose 0.5 mg/kg ozanezumab group. The majority were considered not related to study drug by the investigators. Six serious AEs were reported in three subjects receiving ozanezumab; none were considered related to study drug. No study drug-related patterns were identified for ECG, laboratory, or vital signs parameters. One subject (repeat dose 15 mg/kg ozanezumab) showed a weak, positive anti-ozanezumab-antibody result. PK results were generally consistent with monoclonal antibody treatments. No apparent treatment effects were observed for functional endpoints or muscle biomarkers. Immunohistochemical staining showed dose-dependent co-localization of ozanezumab with Nogo-A in skeletal muscle. In conclusion, single and repeat dose ozanezumab treatment was well tolerated and demonstrated co-localization at the site of action. These findings support future studies with ozanezumab in ALS. [GRAPHICS] .					Shefner, Jeremy/ABF-2901-2020; CUDKOWICZ, MERIT/GWM-6585-2022; Meno-Tetang, Guy/AAS-1849-2021; Leigh, Peter/AAD-5638-2019	CUDKOWICZ, MERIT/0000-0002-7075-1681; Morrison, Karen Elaine/0000-0003-0216-5717; Meyer, Thomas/0000-0002-2736-7350; Caress, James/0000-0002-5814-6083	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was funded by GlaxoSmithKline. Their role included study concept and design, funding of participating centers, analysis of data, development and funding of the final report and manuscript.	Askanas V, 2007, ANN NEUROL, V62, P676, DOI 10.1002/ana.21245; Bellingham MC, 2011, CNS NEUROSCI THER, V17, P4, DOI 10.1111/j.1755-5949.2009.00116.x; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; Dupuis L, 2002, NEUROBIOL DIS, V10, P358, DOI 10.1006/nbdi.2002.0522; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Jokic N, 2005, ANN NEUROL, V57, P553, DOI 10.1002/ana.20420; Jokic N, 2006, EMBO REP, V7, P1162, DOI 10.1038/sj.embor.7400826; Magnusson C, 2003, MOL CELL NEUROSCI, V22, P298, DOI 10.1016/S1044-7431(02)00036-2; Miller RG, 2009, NEUROLOGY, V73, P1218, DOI 10.1212/WNL.0b013e3181bc0141; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Pandya RS, 2013, CELL MOL LIFE SCI, V70, P4729, DOI 10.1007/s00018-013-1415-0; Pradat PF, 2007, ANN NEUROL, V62, P15, DOI 10.1002/ana.21122; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rothstein JD, 1996, CURR OPIN NEUROBIOL, V6, P679, DOI 10.1016/S0959-4388(96)80103-6; Sanjak M, 2010, AMYOTROPH LATERAL SC, V11, P383, DOI 10.3109/17482960903486083; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Shefner JM, 2011, NEUROLOGY, V77, P235, DOI 10.1212/WNL.0b013e318225aabf; Sorenson EJ, 2003, NEUROLOGY, V61, P1503; Tagerud S, 2007, ANN NEUROL, V62, P676, DOI 10.1002/ana.21187; Talbot Kevin, 2009, Pract Neurol, V9, P303, DOI 10.1136/jnnp.2009.188151; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Weinmann O, 2006, MOL CELL NEUROSCI, V32, P161, DOI 10.1016/j.mcn.2006.03.007; Wojcik S, 2006, Acta Myol, V25, P116	28	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97803	10.1371/journal.pone.0097803	http://dx.doi.org/10.1371/journal.pone.0097803			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841795	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000340948600075
J	Chen, JW; Gao, XX; Wang, BZ; Chen, FF; Wu, N; Zhang, YY				Chen, Jiwu; Gao, Xiuxia; Wang, Bangzheng; Chen, Fenfen; Wu, Na; Zhang, Yuanyuan			Proteomic Approach to Reveal the Proteins Associated with Encystment of the Ciliate Euplotes encysticus	PLOS ONE			English	Article							MICROTUBULAR ORGANELLES; VENTRAL CORTEX; HYPORTRICHIDA; MORPHOGENESIS; MORPHOLOGY; CYST; RNA	In order to identify and reveal the proteins related to encystment of the ciliate Euplotes encysticus, we analyzed variation in the abundance of the proteins isolated from the resting cyst comparing with proteins in the vegetative cell. 2-D electrophoresis, MALDI-TOF MS techniques and Bioinformatics were used for proteome separation, quantification and identification. The comparative proteomics studies revealed 26 proteins with changes on the expression in the resting cysts, including 12 specific proteins and 14 differential proteins. 12 specific proteins and 10 out of the 14 differential proteins were selected and identified by MALDI-TOF MS. The identified specific proteins with known functions included type II cytoskeletal 1, keratin, Nop16 domain containing protein, protein arginine n-methyltransferase, epsilon-trimethyllysine hydroxylase and calpain-like protein. The identified differential proteins with known functions included Lysozyme C, keratinocyte growth factor, lysozyme homolog AT-2, formate acetyltransferase, alpha S1 casein and cold-shock protein. We discussed the functions of these proteins as well as their contribution in the process of encystment. These identified proteins covered a wide range of molecular functions, including gene regulation, RNA regulation, proteins degradation and oxidation resistance, stress response, material transport and cytoskeleton organization. Therefore, differential expression of these proteins was essential for cell morphological and physiological changes during encystment. This suggested that the peculiar proteins and differential proteins might play important roles in the process of the vegetative cells transforming into the resting cysts. These observations may be novel findings that bring new insights into the detailed mechanisms of dormancy.	[Chen, Jiwu; Gao, Xiuxia; Wang, Bangzheng; Chen, Fenfen; Wu, Na; Zhang, Yuanyuan] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Chen, JW (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	jwchen@bio.ecnu.edu.cn			National Natural Science Foundation of China [31071875]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (31071875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz H, 2011, TRENDS PARASITOL, V27, P450, DOI 10.1016/j.pt.2011.06.003; Baradaran M, 2011, IRAN RED CRESCENT ME, V13, P719; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; CALVO P, 1986, ARCH PROTISTENKD, V132, P201, DOI 10.1016/S0003-9365(86)80035-5; Erlandsen SL, 1996, J EUKARYOT MICROBIOL, V43, P416, DOI 10.1111/j.1550-7408.1996.tb05053.x; Ermolenko DN, 2002, CELL MOL LIFE SCI, V59, P1902, DOI 10.1007/PL00012513; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Galetovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027634; GUTIERREZ J C, 1990, Microbios Letters, V43, P57; GUTIERREZ JC, 1990, BIOSYSTEMS, V24, P17, DOI 10.1016/0303-2647(90)90025-V; Gutierrez Juan Carlos, 2001, International Microbiology, V4, P151; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Inamitsu M, 2006, FEBS LETT, V580, P6603, DOI 10.1016/j.febslet.2006.11.008; Jiang W, 2005, BIOCHEM BIOPH RES CO, V329, P522, DOI 10.1016/j.bbrc.2005.01.153; Keller UAD, 2004, EUR J CELL BIOL, V83, P607; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Liu W, 2010, MOL BIOCHEM PARASIT, V169, P20, DOI 10.1016/j.molbiopara.2009.09.004; Lou Hui-Ling, 2007, Acta Zoologica Sinica, V53, P742; McCann KB, 2006, INT DAIRY J, V16, P316, DOI 10.1016/j.idairyj.2005.05.005; Plaga W, 2000, FEBS LETT, V466, P45, DOI 10.1016/S0014-5793(99)01752-4; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stairs CW, 2011, MOL BIOL EVOL, V28, P2087, DOI 10.1093/molbev/msr032; Tourancheau AB, 1999, PROTIST, V150, P137, DOI 10.1016/S1434-4610(99)70017-9; Vaz FM, 2001, J BIOL CHEM, V276, P33512, DOI 10.1074/jbc.M105929200; Verni F, 2011, ITAL J ZOOL, V78, P134, DOI 10.1080/11250003.2011.560579; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; [运迷霞 Yun Mixia], 2011, [中国细胞生物学学报, Chinese Journal of Cell Biology], V33, P397; Zhou Su-Juan, 2008, Acta Zoologica Sinica, V54, P299	30	13	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97362	10.1371/journal.pone.0097362	http://dx.doi.org/10.1371/journal.pone.0097362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837719	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800040
J	Naldi, I; Taranta, M; Gherardini, L; Pelosi, G; Viglione, F; Grimaldi, S; Pani, L; Cinti, C				Naldi, Ilaria; Taranta, Monia; Gherardini, Lisa; Pelosi, Gualtiero; Viglione, Federica; Grimaldi, Settimio; Pani, Luca; Cinti, Caterina			Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study	PLOS ONE			English	Article							DNA METHYLTRANSFERASE INHIBITORS; 5-AZA-2'-DEOXYCYTIDINE DECITABINE; CARRIER ERYTHROCYTES; RADIATION-THERAPY; CELLS; METHYLATION; EXPRESSION; DNMT1; TRIAL; PROGRESSION	Epigenetic events are critical contributors to the pathogenesis of cancer, and targeting epigenetic mechanisms represents a novel strategy in anticancer therapy. Classic demethylating agents, such as 5-Aza-2'-deoxycytidine (Decitabine), hold the potential for reprograming somatic cancer cells demonstrating high therapeutic efficacy in haematological malignancies. On the other hand, epigenetic treatment of solid tumours often gives rise to undesired cytotoxic side effects. Appropriate delivery systems able to enrich Decitabine at the site of action and improve its bioavailability would reduce the incidence of toxicity on healthy tissues. In this work we provide preclinical evidences of a safe, versatile and efficient targeted epigenetic therapy to treat hormone sensitive (LNCap) and hormone refractory (DU145) prostate cancers. A novel Decitabine formulation, based on the use of engineered erythrocyte (Erythro-Magneto-Hemagglutinin Virosomes, EMHVs) drug delivery system (DDS) carrying this drug, has been refined. Inside the EMHVs, the drug was shielded from the environment and phosphorylated in its active form. The novel magnetic EMHV DDS, endowed with fusogenic protein, improved the stability of the carried drug and exhibited a high efficiency in confining its delivery at the site of action in vivo by applying an external static magnetic field. Here we show that Decitabine loaded into EMHVs induces a significant tumour mass reduction in prostate cancer xenograft models at a concentration, which is seven hundred times lower than the therapeutic dose, suggesting an improved pharmacokinetics/pharmacodynamics of drug. These results are relevant for and discussed in light of developing personalised autologous therapies and innovative clinical approach for the treatment of solid tumours.	[Naldi, Ilaria; Taranta, Monia; Gherardini, Lisa; Cinti, Caterina] CNR, Inst Clin Physiol, Expt Oncol Unit, Siena, Italy; [Pelosi, Gualtiero; Viglione, Federica] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Grimaldi, Settimio] CNR, Inst Translat Pharmacol, Rome, Italy; [Pani, Luca] CNR, Inst Translat Pharmacol, Cagliari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Cinti, C (corresponding author), CNR, Inst Clin Physiol, Expt Oncol Unit, Siena, Italy.	ccinti@ifc.cnr.it	Pelosi, Gualtiero/F-7696-2015; Pani, Luca/AAM-9467-2020	Pelosi, Gualtiero/0000-0001-7472-2186; Pani, Luca/0000-0001-9273-2839; Cinti, Caterina/0000-0001-8049-0369; gherardini, lisa/0000-0002-7003-4295	Consiglio Nazionale delle Ricerche (CNR); European Community	Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR)); European Community(European Commission)	This work was supported by Consiglio Nazionale delle Ricerche (CNR) funding and by European Community funding for POR CReO FESR 2007-2013, BANDO UNICO R&S-ANNO 2012 of Regione Toscana-Project acronym Title: ACTILA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswal BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053003; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Chu SH, 2012, MOL MED REP, V5, P138, DOI 10.3892/mmr.2011.620; Cinti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017132; Fialova B, 2013, ONCOL REP, V29, P2039, DOI 10.3892/or.2013.2344; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gnanapragasam VJ, 2012, BJU INT, V109, P648, DOI 10.1111/j.1464-410X.2011.10596.x; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Goering Wolfgang, 2012, Methods Mol Biol, V863, P47, DOI 10.1007/978-1-61779-612-8_4; Graham JS, 2009, EUR J CANCER, V45, P1129, DOI 10.1016/j.ejca.2009.01.003; Hagelgans A, 2013, EXP MOL PATHOL, V94, P458, DOI 10.1016/j.yexmp.2013.03.006; Hamidi M, 2007, J CONTROL RELEASE, V118, P145, DOI 10.1016/j.jconrel.2006.06.032; Heidenreich A, 2004, CANCER-AM CANCER SOC, V101, P948, DOI 10.1002/cncr.20455; Hu CMJ, 2012, ADV HEALTHC MATER, V1, P537, DOI 10.1002/adhm.201200138; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Kim HJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-39; Kirchin Miles A, 2003, Top Magn Reson Imaging, V14, P426, DOI 10.1097/00002142-200310000-00007; Lande C, 2012, CARDIOVASC HEMATOL D; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lenka G, 2013, INT J ONCOL, V43, P1960, DOI 10.3892/ijo.2013.2117; Li W, 2013, MINI-REV MED CHEM, V13, P643, DOI 10.2174/1389557511313050003; Liu ZF, 2006, RAPID COMMUN MASS SP, V20, P1117, DOI 10.1002/rcm.2423; Magnani M, 2012, THER DELIV, V3, P405, DOI 10.4155/TDE.12.6; Millan CG, 2004, BLOOD CELL MOL DIS, V33, P132, DOI 10.1016/j.bcmd.2004.06.004; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Momparler RL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00188; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; Niemirowicz K, 2012, ADV MED SCI-POLAND, V57, P196, DOI 10.2478/v10039-012-0031-9; Patra A, 2011, CLIN EPIGENETICS, V2, P339, DOI 10.1007/s13148-010-0019-x; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Sabatino MA, 2013, EPIGENETICS-US, V8, P656, DOI 10.4161/epi.24916; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Sartor AO, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-18; Schmitges J, 2011, THER ADV UROL, V3, P173, DOI 10.1177/1756287211418722; Scosyrev E, 2012, CANCER-AM CANCER SOC, V118, P3062, DOI 10.1002/cncr.26392; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Taranta MN, 2011, BIOANALYSIS BIOMEDIC, V2011, ps5; Tian J, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.395574; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Vijayaraghavalu S, 2013, CANCER LETT, V331, P122, DOI 10.1016/j.canlet.2012.12.009; Yadav N, 2012, MINERVA UROL NEFROL, V64, P35; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	48	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98101	10.1371/journal.pone.0098101	http://dx.doi.org/10.1371/journal.pone.0098101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851905	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200046
J	Rong, Y; Walston, S; Welliver, MX; Chakravarti, A; Quick, AM				Rong, Yi; Walston, Steve; Welliver, Meng Xu; Chakravarti, Arnab; Quick, Allison M.			Improving Intra-Fractional Target Position Accuracy Using a 3D Surface Surrogate for Left Breast Irradiation Using the Respiratory-Gated Deep-Inspiration Breath-Hold Technique	PLOS ONE			English	Article							MAMMARY LYMPH-NODES; DOSIMETRIC IMPACT; CANCER PATIENTS; IMAGING-SYSTEM; HEART-DISEASE; ORGAN MOTION; RADIOTHERAPY; RADIATION; MORTALITY; REDUCTION	Purpose: To evaluate the use of 3D optical surface imaging as a surrogate for respiratory gated deep-inspiration breath-hold (DIBH) for left breast irradiation. Material and Methods: Patients with left-sided breast cancer treated with lumpectomy or mastectomy were selected as candidates for DIBH treatment for their external beam radiation therapy. Treatment plans were created on both free breathing (FB) and DIBH computed tomography (CT) simulation scans to determine dosimetric benefits from DIBH. The Real-time Position Management (RPM) system was used to acquire patient's breathing trace during DIBH CT acquisition and treatment delivery. The reference 3D surface models from FB and DIBH CT scans were generated and transferred to the "AlignRT" system for patient positioning and real-time treatment monitoring. MV Cine images were acquired during treatment for each beam as quality assurance for intra-fractional position verification. The chest wall excursions measured on these images were used to define the actual target position during treatment, and to investigate the accuracy and reproducibility of RPM and AlignRT. Results: Reduction in heart dose can be achieved using DIBH for left breast/chest wall radiation. RPM was shown to have inferior correlation with the actual target position, as determined by the MV Cine imaging. Therefore, RPM alone may not be an adequate surrogate in defining the breath-hold level. Alternatively, the AlignRT surface imaging demonstrated a superior correlation with the actual target positioning during DIBH. Both the vertical and magnitude real-time deltas (RTDs) reported by AlignRT can be used as the gating parameter, with a recommended threshold of +/- 3 mm and 5 mm, respectively. Conclusion: The RPM system alone may not be sufficient for the required level of accuracy in left-sided breast/CW DIBH treatments. The 3D surface imaging can be used to ensure patient setup and monitor inter-and intra-fractional motions. Furthermore, the target position accuracy during DIBH treatment can be improved by AlignRT as a superior surrogate, in addition to the RPM system.	[Rong, Yi; Walston, Steve; Welliver, Meng Xu; Chakravarti, Arnab; Quick, Allison M.] Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Rong, Y (corresponding author), Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA.	yi.rong@osumc.edu	Quick, Allison/AAH-8533-2020; Quick, Allison/AAH-7715-2020	Quick, Allison/0000-0002-2260-6586; 	NIH/NCI/CTEP [1R01CA169368]; NIH/NCI [1RC2CA148190, 1U10CA180850-01]; OSU-CCC Funds; NATIONAL CANCER INSTITUTE [U10CA180850, R01CA169368, RC2CA148190, P30CA016058] Funding Source: NIH RePORTER	NIH/NCI/CTEP; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OSU-CCC Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Arnab Chakravarti was supported by NIH/NCI/CTEP 1R01CA169368; NIH/NCI 1RC2CA148190; NIH/NCI 1U10CA180850-01; and OSU-CCC Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Alderliesten T, 2013, INT J RADIAT ONCOL, V85, P536, DOI 10.1016/j.ijrobp.2012.04.004; Arthur DW, 2000, INT J RADIAT ONCOL, V48, P139, DOI 10.1016/S0360-3016(00)00633-7; Betgen A, 2013, RADIOTHER ONCOL, V106, P225, DOI 10.1016/j.radonc.2012.12.016; Bouillon K, 2011, J AM COLL CARDIOL, V57, P445, DOI 10.1016/j.jacc.2010.08.638; Cervino LI, 2009, PHYS MED BIOL, V54, P6853, DOI 10.1088/0031-9155/54/22/007; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Djajaputra D, 2005, MED PHYS, V32, P65, DOI 10.1118/1.1828251; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Furuya T, 2013, J RADIAT RES, V54, P157, DOI 10.1093/jrr/rrs064; Gierga DP, 2012, INT J RADIAT ONCOL, V84, pE663, DOI 10.1016/j.ijrobp.2012.07.2379; Gutt R, 2008, CLIN BREAST CANCER, V8, P443, DOI 10.3816/CBC.2008.n.054; Hjelstuen MHB, 2012, ACTA ONCOL, V51, P333, DOI 10.3109/0284186X.2011.618510; Korreman SS, 2005, RADIOTHER ONCOL, V76, P311, DOI 10.1016/j.radonc.2005.07.009; Lu HM, 2000, INT J RADIAT ONCOL, V47, P895, DOI 10.1016/S0360-3016(00)00512-5; Mageras GS, 2004, SEMIN RADIAT ONCOL, V14, P65, DOI 10.1053/j.semradonc.2003.10.009; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; Meeks SL, 2005, SEMIN RADIAT ONCOL, V15, P192, DOI 10.1016/j.semradonc.2005.01.004; Mege A, 2011, CANCER RADIOTHER, V15, P495, DOI 10.1016/j.canrad.2011.06.003; Nemoto K, 2009, JPN J RADIOL, V27, P259, DOI 10.1007/s11604-009-0336-1; Peng JL, 2010, MED PHYS, V37, P5421, DOI 10.1118/1.3483783; Pepin EW, 2011, MED PHYS, V38, P1912, DOI 10.1118/1.3556588; Qi XS, 2010, INT J RADIAT ONCOL, V78, P609, DOI 10.1016/j.ijrobp.2009.11.053; Remouchamps VM, 2003, INT J RADIAT ONCOL, V55, P392, DOI 10.1016/S0360-3016(02)04143-3; Remouchamps VM, 2003, INT J RADIAT ONCOL, V56, P704, DOI 10.1016/S0360-3016(03)00010-5; RUTQVIST LE, 1990, BRIT J CANCER, V61, P866, DOI 10.1038/bjc.1990.193; Schoffel PJ, 2007, PHYS MED BIOL, V52, P3949, DOI 10.1088/0031-9155/52/13/019; Sixel KE, 2001, INT J RADIAT ONCOL, V49, P199, DOI 10.1016/S0360-3016(00)01455-3; Stranzl H, 2009, STRAHLENTHER ONKOL, V185, P155, DOI 10.1007/s00066-009-1939-2; Tang X, 2013, CLIN EXPERI IN PRESS; Vikstrom J, 2011, ACTA ONCOL, V50, P42, DOI 10.3109/0284186X.2010.512923; Wagner TH, 2007, MED DOSIM, V32, P111, DOI 10.1016/j.meddos.2007.01.008; Yue NJ, 2007, MED PHYS, V34, P2789, DOI 10.1118/1.2739815	34	36	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97933	10.1371/journal.pone.0097933	http://dx.doi.org/10.1371/journal.pone.0097933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853144	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200035
J	Lin, YJ; Chen, YT; Hsu, SN; Peng, CH; Tang, CY; Yen, TC; Hsieh, WP				Lin, Yen-Jen; Chen, Yu-Tin; Hsu, Shu-Ni; Peng, Chien-Hua; Tang, Chuan-Yi; Yen, Tzu-Chen; Hsieh, Wen-Ping			HaplotypeCN: Copy Number Haplotype Inference with Hidden Markov Model and Localized Haplotype Clustering	PLOS ONE			English	Article							SNP; POPULATION; POLYMORPHISM; MUTATIONS; DISEASE; GENES	Copy number variation (CNV) has been reported to be associated with disease and various cancers. Hence, identifying the accurate position and the type of CNV is currently a critical issue. There are many tools targeting on detecting CNV regions, constructing haplotype phases on CNV regions, or estimating the numerical copy numbers. However, none of them can do all of the three tasks at the same time. This paper presents a method based on Hidden Markov Model to detect parent specific copy number change on both chromosomes with signals from SNP arrays. A haplotype tree is constructed with dynamic branch merging to model the transition of the copy number status of the two alleles assessed at each SNP locus. The emission models are constructed for the genotypes formed with the two haplotypes. The proposed method can provide the segmentation points of the CNV regions as well as the haplotype phasing for the allelic status on each chromosome. The estimated copy numbers are provided as fractional numbers, which can accommodate the somatic mutation in cancer specimens that usually consist of heterogeneous cell populations. The algorithm is evaluated on simulated data and the previously published regions of CNV of the 270 HapMap individuals. The results were compared with five popular methods: PennCNV, genoCN, COKGEN, QuantiSNP and cnvHap. The application on oral cancer samples demonstrates how the proposed method can facilitate clinical association studies. The proposed algorithm exhibits comparable sensitivity of the CNV regions to the best algorithm in our genome-wide study and demonstrates the highest detection rate in SNP dense regions. In addition, we provide better haplotype phasing accuracy than similar approaches. The clinical association carried out with our fractional estimate of copy numbers in the cancer samples provides better detection power than that with integer copy number states.	[Lin, Yen-Jen; Chen, Yu-Tin; Tang, Chuan-Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Hsu, Shu-Ni; Hsieh, Wen-Ping] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Tang, Chuan-Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Peng, Chien-Hua] Chang Gung Mem Hosp, Dept Resource Ctr Clin Res, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Nucl Med & Mol Imaging Ctr, Taoyuan, Taiwan	National Tsing Hua University; National Tsing Hua University; Providence University - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hsieh, WP (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	wphsieh@stat.nthu.edu.tw			National Council of Science [NSC99-2118-M-007-006]	National Council of Science	This work was supported by the National Council of Science [NSC99-2118-M-007-006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chen H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001060; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Huang YT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-194; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; Mangs AH, 2007, CURR GENOMICS, V8, P129, DOI 10.2174/138920207780368141; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Olshen AB, 2011, BIOINFORMATICS, V27, P2038, DOI 10.1093/bioinformatics/btr329; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Pique-Regi R, 2009, BIOINFORMATICS, V25, P1223, DOI 10.1093/bioinformatics/btp119; Podlaha O, 2012, TRENDS GENET, V28, P155, DOI 10.1016/j.tig.2012.01.003; Rasmussen M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simon-Sanchez J, 2008, HUM MUTAT, V29, P315, DOI 10.1002/humu.20626; Smith AG, 2012, TISSUE ANTIGENS, V79, P359, DOI 10.1111/j.1399-0039.2012.01868.x; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yavas G, 2010, BIOCOMPUT-PAC SYM, P371; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96841	10.1371/journal.pone.0096841	http://dx.doi.org/10.1371/journal.pone.0096841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849202	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600017
J	Ochiai, Y; Hoshi, T; Rekimoto, J				Ochiai, Yoichi; Hoshi, Takayuki; Rekimoto, Jun			Three-Dimensional Mid-Air Acoustic Manipulation by Ultrasonic Phased Arrays	PLOS ONE			English	Article							LEVITATION	The essence of levitation technology is the countervailing of gravity. It is known that an ultrasound standing wave is capable of suspending small particles at its sound pressure nodes. The acoustic axis of the ultrasound beam in conventional studies was parallel to the gravitational force, and the levitated objects were manipulated along the fixed axis (i.e. one-dimensionally) by controlling the phases or frequencies of bolted Langevin-type transducers. In the present study, we considered extended acoustic manipulation whereby millimetre-sized particles were levitated and moved three-dimensionally by localised ultrasonic standing waves, which were generated by ultrasonic phased arrays. Our manipulation system has two original features. One is the direction of the ultrasound beam, which is arbitrary because the force acting toward its centre is also utilised. The other is the manipulation principle by which a localised standing wave is generated at an arbitrary position and moved three-dimensionally by opposed and ultrasonic phased arrays. We experimentally confirmed that expanded-polystyrene particles of 0.6 mm, 1 mm, and 2 mm in diameter could be manipulated by our proposed method.	[Ochiai, Yoichi; Rekimoto, Jun] Univ Tokyo, Grad Sch Interdisciplinary Informat Studies, Tokyo, Japan; [Hoshi, Takayuki] Nagoya Inst Technol, Ctr Fostering Young & Innovat Researchers, Nagoya, Aichi, Japan; [Rekimoto, Jun] Sony CSL, Tokyo, Japan	University of Tokyo; Nagoya Institute of Technology	Ochiai, Y (corresponding author), Univ Tokyo, Grad Sch Interdisciplinary Informat Studies, Tokyo, Japan.	yoichi.ochiai@me.com			Japan Society for the Promotion Science	Japan Society for the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is funded by Japan Society for the Promotion Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gor'kov L.P., 1962, SOV PHYS DOKL, V6, P773, DOI DOI 10.1039/C004504G; Hoshi T., 2012, P ADV COMP ENT C, P502; Hoshi T, 2010, IEEE T HAPTICS, V3, P155, DOI [10.1109/ToH.2010.4, 10.1109/TOH.2010.4]; Kozuka T, 2007, JPN J APPL PHYS 1, V46, P4948, DOI 10.1143/JJAP.46.4948; Nyborg WL, 1967, J ACOUST SOC AM, V42, P497; Weber RJK, 2012, EUR BIOPHYS J BIOPHY, V41, P397, DOI 10.1007/s00249-011-0767-3; WHYMARK RR, 1975, ULTRASONICS, V13, P251, DOI 10.1016/0041-624X(75)90072-4; Xie WJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2396893	8	68	69	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97590	10.1371/journal.pone.0097590	http://dx.doi.org/10.1371/journal.pone.0097590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849371	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600039
J	Viaene, L; Thijs, L; Jin, Y; Liu, YP; Gu, YM; Meijers, B; Claes, K; Staessen, J; Evenepoel, P				Viaene, Liesbeth; Thijs, Lutgarde; Jin, Yu; Liu, Yanping; Gu, Yumei; Meijers, Bjorn; Claes, Kathleen; Staessen, Jan; Evenepoel, Pieter			Heritability and Clinical Determinants of Serum Indoxyl Sulfate and p-Cresyl Sulfate, Candidate Biomarkers of the Human Microbiome Enterotype	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; BACTERIAL METABOLITES; RESISTANT STARCH; OXIDATIVE STRESS; UREMIC SOLUTES; GUT MICROBIOME; PROTEIN; CRESYLSULPHATE; MORTALITY	Background: Indoxyl sulfate and p-cresyl sulfate are unique microbial co-metabolites. Both co-metabolites have been involved in the pathogenesis of accelerated cardiovascular disease and renal disease progression. Available evidence suggests that indoxyl sulfate and p-cresyl sulfate may be considered candidate biomarkers of the human enterotype and may help to explain the link between diet and cardiovascular disease burden. Objective and Design: Information on clinical determinants and heritability of indoxyl sulfate and p-cresyl sulfate serum is non-existing. To clarify this issue, the authors determined serum levels of indoxyl sulfate and p-cresyl sulfate in 773 individuals, recruited in the frame of the Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO study). Results: Serum levels of indoxyl sulfate and p-cresyl sulfate amounted to 3.1 (2.4-4.3) and 13.0 (7.4-21.5) mu M, respectively. Regression analysis identified renal function, age and sex as independent determinants of both co-metabolites. Both serum indoxyl sulfate (h(2) = 0.17) and p-cresyl sulfate (h(2) = 0.18) concentrations showed moderate but significant heritability after adjustment for covariables, with significant genetic and environmental correlations for both co-metabolites. Limitations: Family studies cannot provide conclusive evidence for a genetic contribution, as confounding by shared environmental effects can never be excluded. Conclusions: The heritability of indoxyl sulfate and p-cresyl sulfate is moderate. Besides genetic host factors and environmental factors, also renal function, sex and age influence the serum levels of these co-metabolites.	[Viaene, Liesbeth; Meijers, Bjorn; Claes, Kathleen; Evenepoel, Pieter] Katholieke Univ Leuven Hosp, Div Nephrol Dialysis & Renal Transplantat, Dept Med, Louvain, Belgium; [Thijs, Lutgarde; Jin, Yu; Liu, Yanping; Gu, Yumei; Staessen, Jan] Univ Louvain, Dept Cardiovasc Dis, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Louvain, Belgium; [Staessen, Jan] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Maastricht University	Evenepoel, P (corresponding author), Katholieke Univ Leuven Hosp, Div Nephrol Dialysis & Renal Transplantat, Dept Med, Louvain, Belgium.	Pieter.Evenepoel@uz.kuleuven.ac.be	liu, yan/HGV-1365-2022; Meijers, Bjorn/D-6169-2018; Staessen, Jan A/A-1065-2011; P, Evenepoel/D-9597-2018; liu, yan/HCI-5542-2022	Meijers, Bjorn/0000-0002-2846-2026; Staessen, Jan A/0000-0002-3026-1637; P, Evenepoel/0000-0002-2846-2026; Thijs, Lutgarde/0000-0002-8108-2356	European Union [IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093 InGenious HyperCare, HEALTH-F4-2007-201550 HyperGenes, HEALTH-F7-2011-278249 EU-MASCARA]; European Research Council Advanced Research Grant [294713 EPLORE]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0575.06, G.0734.09]; Katholieke Universiteit Leuven, Belgium [OT/00/25, OT/05/49]	European Union(European Commission); European Research Council Advanced Research Grant; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); Katholieke Universiteit Leuven, Belgium(KU Leuven)	The European Union (grants IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093 InGenious HyperCare, HEALTH-F4-2007-201550 HyperGenes and HEALTH-F7-2011-278249 EU-MASCARA), and the European Research Council Advanced Research Grant 294713 EPLORE, the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (grants G.0575.06 and G.0734.09), and the Katholieke Universiteit Leuven, Belgium (grants OT/00/25 and OT/05/49) supported the Studies Coordinating Centre (Leuven, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bammens B, 2004, AM J CLIN NUTR, V80, P1536, DOI 10.1093/ajcn/80.6.1536; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Benjamin JL, 2011, INFLAMM BOWEL DIS; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Birkett A, 1996, AM J CLIN NUTR, V63, P766, DOI 10.1093/ajcn/63.5.766; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; CURTIUS HC, 1976, J CHROMATOGR, V126, P569, DOI 10.1016/S0021-9673(01)84102-9; Dallongeville J, 1998, J NUTR, V128, P1450; de Loor H, 2009, J CHROMATOGR A, V1216, P4684, DOI 10.1016/j.chroma.2009.04.015; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Francois IEJA, 2012, BRIT J NUTR, V108, P2229, DOI 10.1017/S0007114512000372; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Jacobs DM, 2012, J AGR FOOD CHEM, V60, P3078, DOI 10.1021/jf2044247; Le Leu RK, 2007, CARCINOGENESIS, V28, P240, DOI 10.1093/carcin/bgl245; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; Lou YJ, 2011, TOXICOL LETT, V201, P72, DOI 10.1016/j.toxlet.2010.12.007; Meijers BKI, 2010, NEPHROL DIAL TRANSPL, V25, P219, DOI 10.1093/ndt/gfp414; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Melamed ML, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-134; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Patel KP, 2012, CLIN J AM SOC NEPHRO, V7, P982, DOI 10.2215/CJN.12491211; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Shivanna S, 2013, NY TIMES        1026, V127, P365; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Tiihonen K, 2010, AGEING RES REV, V9, P107, DOI 10.1016/j.arr.2009.10.004; Tumur Z, 2009, AM J NEPHROL, V29, P551, DOI 10.1159/000191468; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Wang CP, 2010, ATHEROSCLEROSIS, V211, P579, DOI 10.1016/j.atherosclerosis.2010.03.036; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Windey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052387; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580	43	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e79682	10.1371/journal.pone.0079682	http://dx.doi.org/10.1371/journal.pone.0079682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24850265	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600001
J	Yamada, A; Minamiguchi, S; Sakai, Y; Horimatsu, T; Muto, M; Chiba, T; Boland, CR; Goel, A				Yamada, Atsushi; Minamiguchi, Sachiko; Sakai, Yoshiharu; Horimatsu, Takahiro; Muto, Manabu; Chiba, Tsutomu; Boland, C. Richard; Goel, Ajay			Colorectal Advanced Neoplasms Occur through Dual Carcinogenesis Pathways in Individuals with Coexisting Serrated Polyps	PLOS ONE			English	Article							NORMAL COLONIC-MUCOSA; DNA METHYLATION; CANCER; HYPERMETHYLATION; CLASSIFICATION; MULTIPLICITY; FEATURES; LESIONS; FIELD; RISK	Background: Individuals with serrated polyps (SP) are at higher risk for synchronous colorectal advanced neoplasms (AN) and cancers. However, it remains unclear whether there is a unique involvement of the serrated pathway and/or the classical adenoma-carcinoma sequence in this setting. Methods: Colorectal ANs, which include tubular adenomas >= 10 mm, adenomas with villous histology, high-grade intraepithelial neoplasms, and cancers, were collected retrospectively. The groups included ANs with (AN+SP) or without (AN-only) coexisting SPs. Clinicopathological findings were compared between groups. BRAF and KRAS mutations in ANs and SPs, and methylation levels at long interspersed element-1 (LINE-1) in adjacent mucosa were determined by pyrosequencing. Results: Seventy-five ANs from 40 patients in the AN+SP group, and 179 ANs from 119 patients in the AN-only group were analyzed. There were no significant differences in clinicopathological findings between the two groups, except that intraepithelial neoplasia in the AN+SP group was more likely to be located in the right colon (P = 0.018). BRAF mutations were significantly more frequent in the AN+SP group (P = 0.003), while KRAS mutations showed no significant differences between groups (P = 0.142). The majority of high-grade intraepithelial neoplasms in both groups showed a contiguous component of conventional adenoma. Individuals with large and right-sided SPs had significantly more conventional adenomas compared to those without such SPs (P = 0.027 and P = 0.031, respectively). Adjacent mucosa from individuals with multiple and large SPs showed significantly lower methylation levels at LINE-1 compared to individuals without such associated SPs (P = 0.049 and P = 0.015, respectively). Conclusion: Our data suggest that both the adenoma-carcinoma sequence and the serrated pathway are operational in individuals with coexisting ANs and SPs. The reduced methylation levels at LINE-1 in the background mucosa suggest the possibility of an underlying 'field defect'.	[Yamada, Atsushi; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab, Dallas, TX USA; [Yamada, Atsushi; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Minamiguchi, Sachiko] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan; [Horimatsu, Takahiro] Kyoto Univ Hosp, Dept Expt Therapeut, Inst Adv Clin & Translat Sci iACT, Kyoto 606, Japan; [Muto, Manabu] Kyoto Univ Hosp, Dept Therapeut Oncol, Kyoto 606, Japan	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Boland, CR (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab, Dallas, TX USA.	rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu		Goel, Ajay/0000-0003-1396-6341; Horimatsu, Takahiro/0000-0002-4188-9059	National Cancer Institute, National Institutes of Health [R01 CA72851, CA129286]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA129286, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA129286 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute to CRB and AG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Axon A, 2005, ENDOSCOPY, V37, P570, DOI 10.1055/s-2005-861352; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Hiraoka S, 2010, GASTROENTEROLOGY, V139, P1503, DOI 10.1053/j.gastro.2010.07.011; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; Kamiyama H, 2012, ONCOGENE, V31, P5029, DOI 10.1038/onc.2011.652; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Li D, 2009, AM J GASTROENTEROL, V104, P695, DOI 10.1038/ajg.2008.166; Lin OS, 2005, ARCH INTERN MED, V165, P382, DOI 10.1001/archinte.165.4.382; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Nakagawa H, 2001, CANCER RES, V61, P6991; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rosty C, 2013, AM J SURG PATHOL, V37, P434, DOI 10.1097/PAS.0b013e318270f748; Schreiner MA, 2010, GASTROENTEROLOGY, V139, P1497, DOI 10.1053/j.gastro.2010.06.074; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Silviera ML, 2012, CANCER PREV RES, V5, P374, DOI 10.1158/1940-6207.CAPR-11-0336; Snover DC, 2010, WHO CLASSIFICATION T, P160; Sobin L, 2009, TNM CLASSIFICATION M; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Vu HT, 2011, DIS COLON RECTUM, V54, P1216, DOI 10.1097/DCR.0b013e318228f8a9; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Worthley DL, 2010, ONCOGENE, V29, P1653, DOI 10.1038/onc.2009.449; Yamada A, 2011, HEPATO-GASTROENTEROL, V58, P45; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	29	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98059	10.1371/journal.pone.0098059	http://dx.doi.org/10.1371/journal.pone.0098059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849572	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600081
J	Zhang, W; Kan, SL; Zhao, H; Li, ZY; Wang, XQ				Zhang, Wei; Kan, Sheng-long; Zhao, Hong; Li, Zhen-yu; Wang, Xiao-quan			Molecular Phylogeny of Tribe Theeae (Theaceae s.s.) and Its Implications for Generic Delimitation	PLOS ONE			English	Article							APTEROSPERMA-OBLATA THEACEAE; DNA; SEQUENCES; MIOCENE; HYBRIDIZATION; ANGIOSPERMS; CHARACTERS; INFERENCE; TORTOISE; WOODS	Tribe Theeae, which includes some economically important and widely grown plants, such as beverage tea and a number of woody ornamentals, is the largest member of the Theaceae family. Using five genomic regions (chloroplast: atpI-H, matK, psbA5'R-ALS-11F, rbcL; nuclear: LEAFY) and 30 species representing four of the five genera in this tribe (Apterosperma, Camellia, Polyspora, and Pyrenaria s.l.), we investigated the phylogeny of Theeae and assessed the delimitation of genera in the tribe. Our results showed that Polyspora was monophyletic and the sister of the three other genera of Theeae investigated, Camellia was paraphyletic and Pyrenaria was polyphyletic. The inconsistent phylogenetic placement of some species of Theeae between the nuclear and chloroplast trees suggested widespread hybridization between Camellia and Pyrenaria, Polyspora and Parapyrenaria. These results indicate that hybridization, rather than morphological homoplasy, has confused the current classification of Theeae. In addition, the phylogenetic placement and possible allies of Laplacea are also discussed.	[Zhang, Wei; Kan, Sheng-long; Zhao, Hong] Shandong Univ Weihai, Marine Coll, Weihai, Peoples R China; [Zhang, Wei; Li, Zhen-yu; Wang, Xiao-quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Shandong University; Chinese Academy of Sciences; Institute of Botany, CAS	Li, ZY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	lizy@ibcas.ac.cn; xiaoq_wang@ibcas.ac.cn	ZHANG, WEI/AAJ-2716-2020		National Natural Science Foundation of China [31300194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported National Natural Science Foundation of China (Grant No. 31300194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN WL, 1973, J HERED, V64, P356, DOI 10.1093/oxfordjournals.jhered.a108440; Airy-Shaw HK, 1936, KEW B, V1936, P496; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Bentham G, 1862, GENERA PLANTARUM, V1, P177; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Chang H.T., 1998, FLORA REIPUBLICAE PO, V49; De Candolle AP, 1824, PRODROMUS SYSTEMATIS, V1, P523; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; Frohlich MW, 1997, INT J PLANT SCI, V158, pS131, DOI 10.1086/297513; Fu LG, 1992, RED LIST ENDANGERED; GROTE PJ, 1992, AM J BOT, V79, P744, DOI 10.2307/2444939; GROTE PJ, 1989, BOT GAZ, V150, P190, DOI 10.1086/337764; GU Z, 1988, Acta Botanica Yunnanica, V10, P291; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; Jeong EK, 2004, J PLANT RES, V117, P183, DOI 10.1007/s10265-004-0144-8; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; KENG H, 1980, Gardens' Bulletin (Singapore), V33, P303; KENG H, 1972, Gardens' Bulletin (Singapore), V26, P127; KENG H., 1962, Univiversity of California Publications in Botany, V33, P269; KONDO K, 1977, BIOTROPICA, V9, P86, DOI 10.2307/2387663; Kondo K, 1979, AM CAMELLIA YB, V34, P42; Li C.-Y., 2003, COLLECT RES, V16, P71, DOI [10.6693/CAR.2003.16.8, DOI 10.6693/CAR.2003.16.8]; LI GT, 1990, GUIHAIA, V10, P127; Li MM, 2013, J SYST EVOL, V51, P396, DOI 10.1111/jse.12017; Li R, 2011, NORD J BOT, V29, P780, DOI 10.1111/j.1756-1051.2011.01175.x; Lim JD, 2010, GEOSCI J, V14, P11, DOI 10.1007/s12303-010-0002-8; Luna I, 2004, CLADISTICS, V20, P223, DOI 10.1111/j.1096-0031.2004.00024.x; Maizel A, 2005, SCIENCE, V308, P260, DOI 10.1126/science.1108229; Melchior H., 1925, NATURLICHEN PFLANZEN, V2nd ed., P109; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Ming T. L., 2000, MONOGRAPH GENUS CAME; Ming TL, 2007, FLORA CHINA, V12; Nylander JAA., 2004, BIOINFORMATICS; Parks C.R., 1990, INT CAMELLIA J, V22, P37; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prince Linda M., 2007, Aliso, V24, P105; Prince LM, 2001, AM J BOT, V88, P2309, DOI 10.2307/3558391; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sang T, 2000, SYST BIOL, V49, P422, DOI 10.1080/10635159950127321; SANTAMOUR FRANK S., 1963, MORRIS ARBOR BULL, V14, P51; Sauquet H, 2013, CR PALEVOL, V12, P355, DOI 10.1016/j.crpv.2013.07.003; Schonenberger J, 2005, INT J PLANT SCI, V166, P265, DOI 10.1086/427198; SEALY J. R., 1958, A Revision of the Genus Camellia.; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shen SK, 2010, PLANT SPEC BIOL, V25, P158, DOI 10.1111/j.1442-1984.2010.00278.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Simura T., 1953, JAPAN J BREED, V2, P205; Su YJ, 2008, BIOCHEM SYST ECOL, V36, P619, DOI 10.1016/j.bse.2008.05.008; Suzuki M, 1996, IAWA J, V17, P365, DOI 10.1163/22941932-90000634; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Szyszylowicz IV, 1895, NATURL PFLANZ, P175; Takhtajan A, 1997, DIVERSITY CLASSIFICA; Thakor BH, 1998, THESIS U N CAROLINA; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsou CH, 1998, AM J BOT, V85, P1531, DOI 10.2307/2446480; Tsou CH, 1997, AM J BOT, V84, P369, DOI 10.2307/2446010; Wang YH, 2006, PLANT SYST EVOL, V260, P39, DOI 10.1007/s00606-006-0426-9; Wei Zhongxin, 1997, Acta Botanica Yunnanica, V19, P143; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; Yang Jun-Bo, 2006, Acta Botanica Yunnanica, V28, P29; Yang Shi-Xiong, 1995, Acta Botanica Yunnanica, V17, P192; Yang SX, 2004, PLANT SYST EVOL, V248, P45, DOI 10.1007/s00606-004-0178-3; Ye CX., 1990, ACTA SCI NAT UNIV S, V29, P74; Ye CX, 1990, GUIHAIA, V10, P99; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Zhang Wen-Ju, 1999, Acta Botanica Yunnanica, V21, P184	77	25	27	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98133	10.1371/journal.pone.0098133	http://dx.doi.org/10.1371/journal.pone.0098133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848365	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600090
J	Li, SD; Kennedy, M; Payne, S; Kennedy, K; Seewaldt, VL; Pizzo, SV; Bachelder, RE				Li, Shenduo; Kennedy, Margaret; Payne, Sturgis; Kennedy, Kelly; Seewaldt, Victoria L.; Pizzo, Salvatore V.; Bachelder, Robin E.			Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-RESISTANCE; DOCETAXEL	Although many tumors regress in response to neoadjuvant chemotherapy, residual tumor cells are detected in most cancer patients post-treatment. These residual tumor cells are thought to remain dormant for years before resuming growth, resulting in tumor recurrence. Considering that recurrent tumors are most often responsible for patient mortality, there exists an urgent need to study signaling pathways that drive tumor dormancy/recurrence. We have developed an in vitro model of tumor dormancy/recurrence. Short-term exposure of tumor cells (breast or prostate) to chemotherapy at clinically relevant doses enriches for a dormant tumor cell population. Several days after removing chemotherapy, dormant tumor cells regain proliferative ability and establish colonies, resembling tumor recurrence. Tumor cells from "recurrent'' colonies exhibit increased chemotherapy resistance, similar to the therapy resistance of recurrent tumors in cancer patients. Previous studies using long-term chemotherapy selection models identified acquired mutations that drive tumor resistance. In contrast, our short term chemotherapy exposure model enriches for a slow-cycling, dormant, chemo-resistant tumor cell sub-population that can resume growth after drug removal. Studying unique signaling pathways in dormant tumor cells enriched by short-term chemotherapy treatment is expected to identify novel therapeutic targets for preventing tumor recurrence.	[Li, Shenduo; Kennedy, Margaret; Payne, Sturgis; Kennedy, Kelly; Pizzo, Salvatore V.; Bachelder, Robin E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Seewaldt, Victoria L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Bachelder, RE (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	robin.bachelder@duke.edu			National Cancer Institute [R21 CA141223, R01 CA155664]; Department of Defense Congressionally Directed Medical Research [W81XWH-12-1-0478, W81XWH-13-1-0404]; NATIONAL CANCER INSTITUTE [R21CA141223, R01CA155664] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Congressionally Directed Medical Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute R21 CA141223, www.cancer.gov; National Cancer Institute R01 CA155664, www.cancer.gov; Department of Defense Congressionally Directed Medical Research W81XWH-12-1-0478, cdmrp.army.mil/; Department of Defense Congressionally Directed Medical Research W81XWH-13-1-0404, cdmrp.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunsvig PF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-197; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kuczynski EA, 2013, NAT REV CLIN ONCOL, V10, P571, DOI 10.1038/nrclinonc.2013.158; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lin WC, 2014, CANCER RES, V74, P2138, DOI 10.1158/0008-5472.CAN-13-3437; Liu JB, 2008, AM J PHYSIOL-HEART C, V295, pH2541, DOI 10.1152/ajpheart.01052.2008; Moore N, 2012, STEM CELLS DEV, V21, P1822, DOI 10.1089/scd.2011.0477; Puhr M, 2012, AM J PATHOL, V181, P2188, DOI 10.1016/j.ajpath.2012.08.011; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Williams KP, 2013, CANCER LETT, V337, P77, DOI 10.1016/j.canlet.2013.05.017	14	43	44	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98021	10.1371/journal.pone.0098021	http://dx.doi.org/10.1371/journal.pone.0098021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845582	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400082
J	Monecke, S; Muller, E; Dorneanu, OS; Vremera, T; Ehricht, R				Monecke, Stefan; Mueller, Elke; Dorneanu, Olivia Simona; Vremera, Teodora; Ehricht, Ralf			Molecular Typing of MRSA and of Clinical Staphylococcus aureus Isolates from Iasi, Romania	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; GENETIC DIVERSITY; HEALTH-CARE; COMMUNITY; STRAINS; EPIDEMIOLOGY; SUSCEPTIBILITY; CLONES; COLONIZATION	Romania is one of the countries with the highest prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the world. To obtain data on affiliation of MRSA to strains and clonal complexes and on the population of methicillin susceptible S. aureus (MSSA), clinical isolates from bloodstream infections, skin and soft tissue infections as well as from screening swabs were collected at hospitals in Ia?i, a city in the North-Eastern part of Romania. Isolates were characterised by microarray hybridisation. Nearly half of all isolates (47%), and about one third (34%) of bloodstream isolates were MRSA. The prevalence of the Panton-Valentine leukocidin (PVL) was also high (31% among MRSA, 14% among MSSA). The most common MRSA strain was a PVL-negative CC1-MRSA-IV that might have emerged locally, as a related MSSA was also common. PVL-positive CC8-MRSA-IV ("USA300") and PVL-negative ST239-like MRSA-III were also frequently found while other MRSA strains were only sporadically detected. Among MSSA, PVL-positive CC121 as well as PVL-negative CC1, CC22 and CC45 predominated. Although this study provides only a snapshot of S. aureus/MRSA epidemiology in Romania, it confirms the high burden of MRSA and PVL on Romanian healthcare settings.	[Monecke, Stefan] Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Monecke, Stefan; Mueller, Elke; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Dorneanu, Olivia Simona; Vremera, Teodora] Univ Med & Pharm Grigore T Popa Iasi, Dept Microbiol, Iasi, Romania	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Alere; Grigore T Popa University of Medicine & Pharmacy	Monecke, S (corresponding author), Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany.	monecke@rocketmail.com	Dorneanu, Olivia/AAV-7263-2021	Dorneanu, Olivia/0000-0001-7720-4499	CNCSIS -UEFISCSU [PNII - IDEI, ID_1586/2008]	CNCSIS -UEFISCSU(Consiliul National al Cercetarii Stiintifice (CNCS))	Most of the isolates were collected during project number PNII - IDEI code ID_1586/2008 supported by CNCSIS -UEFISCSU. There was no external funding for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamot HV, 2012, J CLIN MICROBIOL, V50, P3111, DOI 10.1128/JCM.01352-12; Akpaka Patrick E, 2011, J Med Case Rep, V5, P157, DOI 10.1186/1752-1947-5-157; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Bara AC, 2002, CROAT MED J, V43, P446; Baranovich T, 2010, CLIN MICROBIOL INFEC, V16, P575, DOI 10.1111/j.1469-0691.2009.02891.x; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; Chini V, 2006, CLIN MICROBIOL INFEC, V12, P29, DOI 10.1111/j.1469-0691.2005.01295.x; Cirkovic I, 2012, J MED MICROBIOL; Cirlan Maria, 2005, Infection Genetics and Evolution, V5, P335, DOI 10.1016/j.meegid.2004.09.005; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; Dorneanu O, 2006, J PREVENTIVE MED, V14, P66; Dorobat Olga Mihaela, 2010, Bacteriol Virusol Parazitol Epidemiol, V55, P83; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V60, P402, DOI 10.1093/jac/dkm206; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Holt E, 2010, LANCET, V376, P1211, DOI 10.1016/S0140-6736(10)61864-8; Ionescu R, 2010, MICROB DRUG RESIST, V16, P263, DOI 10.1089/mdr.2010.0059; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Krcmery V, 1999, J HOSP INFECT, V43, pS269, DOI 10.1016/S0195-6701(99)90098-1; Lakey CK, 1996, J ADV NURS, V23, P1045, DOI 10.1046/j.1365-2648.1996.10826.x; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Megevand C, 2010, CLIN MICROBIOL INFEC, V16, P1414, DOI 10.1111/j.1469-0691.2009.03090.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2012, EUR J CLIN MICROBIOL, V31, P1497, DOI 10.1007/s10096-011-1469-6; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nashev D, 2007, EUROSURVEILLANCE, V12; Nastase E, 2010, Rev Med Chir Soc Med Nat Iasi, V114, P1162; NEJMA MB, 2008, DIAGN MICROBIOL INFE; Nica Maria, 2010, Bacteriol Virusol Parazitol Epidemiol, V55, P161; Nimmo GR, 2006, MED J AUSTRALIA, V184, P384, DOI 10.5694/j.1326-5377.2006.tb00287.x; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; R Core Team, 2021, R LANGUAGE ENV STAT; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Szekely E, 2008, ACTA MICROBIOL IMM H, V55, P1, DOI 10.1556/AMicr.55.2008.1.1; Szekely E, 2012, REV ROMANA MED LAB, V20, P371; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vorobieva V, 2008, APMIS, V116, P877, DOI 10.1111/j.1600-0463.2008.01092.x; Vremera T, 2011, MED-SURG J, V115, P927; Weber S, 2010, GENETIC FINGERPRINTI	53	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97833	10.1371/journal.pone.0097833	http://dx.doi.org/10.1371/journal.pone.0097833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846009	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400064
J	Moyo, SJ; Blomberg, B; Hanevik, K; Kommedal, O; Vainio, K; Maselle, SY; Langeland, N				Moyo, Sabrina J.; Blomberg, Bjorn; Hanevik, Kurt; Kommedal, Oyvind; Vainio, Kirsti; Maselle, Samuel Y.; Langeland, Nina			Genetic Diversity of Circulating Rotavirus Strains in Tanzania Prior to the Introduction of Vaccination	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; HIV-INFECTION; MOLECULAR CHARACTERIZATION; CHILDREN; DIARRHEA; GASTROENTERITIS; GENOTYPES; VIRUSES; IMPLEMENTATION; EPIDEMIOLOGY	Background: Tanzania currently rolls out vaccination against rotavirus-diarrhea, a major cause of child illness and death. As the vaccine covers a limited number of rotavirus variants, this study describes the molecular epidemiology of rotavirus among children under two years in Dar es Salaam, Tanzania, prior to implementation of vaccination. Methods: Stool specimens, demographic and clinical information, were collected from 690 children admitted to hospital due to diarrhea (cases) and 545 children without diarrhea (controls) during one year. Controls were inpatient or children attending child health clinics. Rotavirus antigen was detected using ELISA and positive samples were typed by multiplex semi-nested PCR and sequencing. Results: The prevalence of rotavirus was higher in cases (32.5%) than in controls (7.7%, P<0.001). The most common G genotypes were G1 followed by G8, G12, and G4 in cases and G1, G12 and G8 in controls. The Tanzanian G1 variants displayed 94% similarity with the Rotarix vaccine G1 variant. The commonest P genotypes were P[8], P[4] and P[6], and the commonest G/P combination G1 P[8] (n = 123), G8 P[4] and G12 P[6]. Overall, rotavirus prevalence was higher in cool (23.9%) than hot months (17.1%) of the year (P = 0.012). We also observed significant seasonal variation of G genotypes. Rotavirus was most frequently found in the age group of four to six months. The prevalence of rotavirus in cases was lower in stunted children (28.9%) than in non-stunted children (40.1%, P = 0.003) and lower in HIV-infected (15.4%, 4/26) than in HIV-uninfected children (55.3%, 42/76, P<0.001). Conclusion: This pre-vaccination study shows predominance of genotype G1 in Tanzania, which is phylogenetically distantly related to the vaccine strains. We confirm the emergence of genotype G8 and G12. Rotavirus infection and circulating genotypes showed seasonal variation. This study also suggests that rotavirus may not be an opportunistic pathogen in children infected with HIV.	[Moyo, Sabrina J.; Blomberg, Bjorn; Hanevik, Kurt; Langeland, Nina] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Moyo, Sabrina J.; Maselle, Samuel Y.] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Blomberg, Bjorn; Hanevik, Kurt] Haukeland Hosp, Ctr Trop Infect Dis, N-5021 Bergen, Norway; [Kommedal, Oyvind] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Vainio, Kirsti] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Langeland, Nina] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway	University of Bergen; Muhimbili University of Health & Allied Sciences; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH); University of Bergen; Haukeland University Hospital	Moyo, SJ (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	Sabrina.moyo@med.uib.no	Hanevik, Kurt/I-1159-2012; Blomberg, Bjorn/B-9605-2015	Hanevik, Kurt/0000-0002-1466-2326; Moyo, sabrina/0000-0003-4735-1513; Blomberg, Bjorn/0000-0001-5647-4297	University of Bergen, Norway	University of Bergen, Norway	This study was funded by the University of Bergen, Norway. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrad MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-320; Agocs Mary, 2011, Morbidity and Mortality Weekly Report, V60, P514; Aladin F, 2010, J CLIN VIROL, V47, P340, DOI 10.1016/j.jcv.2010.01.004; Aminu M, 2010, J INFECT DIS, V202, pS198, DOI 10.1086/653570; Arora R, 2011, INFECT GENET EVOL, V11, P504, DOI 10.1016/j.meegid.2011.01.005; Atchison CJ, 2010, P ROY SOC B-BIOL SCI, V277, P933, DOI 10.1098/rspb.2009.1755; Rossita ARB, 2007, DIAGN MICR INFEC DIS, V57, P59, DOI 10.1016/j.diagmicrobio.2006.11.005; Becker-Dreps S, 2011, PEDIATR INFECT DIS J, V30, P243, DOI 10.1097/INF.0b013e3181f87ffe; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; BROOKFIELD DSK, 1979, J INFECTION, V1, P249, DOI 10.1016/S0163-4453(79)91285-4; CEGIELSKI JP, 1994, PEDIATR AIDS HIV INF, V5, P296; Chandrahasen C, 2010, J MED VIROL, V82, P897, DOI 10.1002/jmv.21739; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Cunliffe NA, 2001, LANCET, V358, P550, DOI 10.1016/S0140-6736(01)05706-3; Cunliffe NA, 2009, EMERG INFECT DIS, V15, P87, DOI 10.3201/eid1501.080427; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468; Esona MD, 2010, J INFECT DIS, V202, pS49, DOI 10.1086/653552; EUROROTA, 2009, EUR ROT DET TYP METH; Ezeamama AE, 2012, J INFECT DIS, V205, P1486, DOI 10.1093/infdis/jis234; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; HOSHINO Y, 1985, P NATL ACAD SCI USA, V82, P8701, DOI 10.1073/pnas.82.24.8701; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Japhet MO, 2012, J MED VIROL, V84, P1489, DOI 10.1002/jmv.23343; Kapikian A. Z., 2001, FIELDS VIROLOGY, V2, P1787; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kiulia NM, 2008, J TROP PEDIATRICS, V54, P401, DOI 10.1093/tropej/fmn052; Laird AR, 2003, J CLIN MICROBIOL, V41, P3100, DOI 10.1128/JCM.41.7.3100-3111.2003; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; MHALU F S, 1988, NIPH (National Institute of Public Health) Annals (Oslo), V11, P3; Moyo SJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-359; Nordgren J, 2012, EMERG INFECT DIS, V18, P589, DOI 10.3201/eid1804.110973; OFFIT PA, 1986, J VIROL, V60, P491, DOI 10.1128/JVI.60.2.491-496.1986; OSHITANI H, 1994, J INFECT DIS, V169, P897, DOI 10.1093/infdis/169.4.897; Page NA, 2009, J MED VIROL, V81, P106, DOI 10.1002/jmv.21362; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Parashar UD, 2009, NEW ENGL J MED, V360, P1063, DOI 10.1056/NEJMp0810154; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Paulke-Korinek M, 2010, PEDIATR INFECT DIS J, V29, P319, DOI 10.1097/INF.0b013e3181c18434; PAVIA AT, 1992, PEDIATR INFECT DIS J, V11, P996, DOI 10.1097/00006454-199211120-00002; Pietsch C, 2009, J CLIN MICROBIOL, V47, P3569, DOI 10.1128/JCM.01471-09; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; SAM NE, 1992, APMIS, V100, P790, DOI 10.1111/j.1699-0463.1992.tb04001.x; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Staat MA, 2010, PEDIATR INFECT DIS J, V29, P1083, DOI 10.1097/INF.0b013e3181fb8f7b; Steyer A, 2007, J MED VIROL, V79, P626, DOI 10.1002/jmv.20811; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Trimis G, 2011, VACCINE, V29, P7292, DOI 10.1016/j.vaccine.2011.07.092; Wang FT, 2010, PEDIATRICS, V125, pE208, DOI 10.1542/peds.2009-1246; WATERLOW JC, 1977, B WORLD HEALTH ORGAN, V55, P489; YPATH, 2012, VACC ACC DEL GLOB PR	60	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97562	10.1371/journal.pone.0097562	http://dx.doi.org/10.1371/journal.pone.0097562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844631	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400035
J	Chen, T; Cai, MX; Li, YY; He, ZX; Shi, XC; Song, W; Wang, YH; Xi, Y; Kang, YM; Tian, ZJ				Chen, Ting; Cai, Meng-Xin; Li, You-You; He, Zhi-Xiong; Shi, Xiu-Chao; Song, Wei; Wang, You-Hua; Xi, Yue; Kang, Yu-Ming; Tian, Zhen-Jun			Aerobic Exercise Inhibits Sympathetic Nerve Sprouting and Restores beta-Adrenergic Receptor Balance in Rats with Myocardial Infarction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ALTERED CONTRACTILE RESPONSE; ISCHEMIA-REPERFUSION INJURY; VENTRICULAR-FIBRILLATION; HEART-FAILURE; UP-REGULATION; SUDDEN-DEATH; IN-VIVO; STIMULATION; BETA(3)-ADRENOCEPTOR	Background: Cardiac sympathetic nerve sprouting and the dysregulation of beta-adrenergic receptor (beta-AR) play a critical role in the deterioration of cardiac function after myocardial infarction (MI). Growing evidence indicates that exercise provides protection against MI. The aims of this study were to investigate whether aerobic exercise following MI could inhibit sympathetic nerve sprouting and restore the balance of beta 3-AR/beta 1-AR. Methods: Male Sprague-Dawley rats were divided into three groups: sham-operated control group (SC), MI group (MI), and MI with aerobic exercise group (ME). The rats in ME group were assigned to 8 weeks of exercise protocol (16 m/min, 50 min/d, 5 d/wk). The expression of nerve growth factor (NGF), the sympathetic nerve marker-tyrosine hydroxylase (TH), the nerve sprouting marker-growth associated protein 43 (GAP43), and beta 1- and beta 2-AR expression in the peri-infarct area of the left ventricle (LV) were measured by Western blot and immunohistochemistry, while beta 3-AR expression was determined by Western blot and immunofluorescence. Endothelial nitric oxide synthase (NOS2), phospho-NOS2 (p-NOS2), and neuronal nitric oxide synthase (NOS1) were measured by Western blot. Results: MI increased LV end-diastolic pressure (LVEDP), and decreased LV systolic pressure (LVSP). Compared with the MI group, aerobic exercise significantly decreased LVEDP and increased LVSP. The protein expression of TH, GAP43 and NGF was significantly increased after MI, which was normalized by exercise. Compared with the SC group, the ratios of beta 2-AR/beta 1-AR and beta 3-AR/beta 1-AR were elevated in the MI group, and the protein expression of beta 3-AR and NOS1 increased after MI. Compared with the MI group, the ratios of beta 2-AR/beta 1-AR and beta 3-AR/beta 1-AR were normalized in the ME group, while the protein expression of beta 3-AR and NOS1 significantly increased, and NOS2 was activated by exercise. Conclusions: Aerobic exercise inhibits cardiac sympathetic nerve sprouting, restores beta 3-AR/beta 1-AR balance and increases beta 3-AR expression through the activation of NOS2 and NOS1 after myocardial infarction.	[Chen, Ting; Cai, Meng-Xin; He, Zhi-Xiong; Shi, Xiu-Chao; Song, Wei; Wang, You-Hua; Xi, Yue; Tian, Zhen-Jun] Shaanxi Normal Univ, Inst Sports & Exercise Biol, Xian, Shaanxi, Peoples R China; [Chen, Ting] Tibet Univ Nationalities, Dept Sports & Exercise, Xian Yang, Shaanxi, Peoples R China; [Li, You-You] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Shaanxi, Peoples R China; [Li, You-You] Fourth Mil Med Univ, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Kang, Yu-Ming] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Sch Med, Dept Physiol & Pathophysiol, Xian 710049, Shaanxi, Peoples R China	Shaanxi Normal University; Xizang Minzu University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Tian, ZJ (corresponding author), Shaanxi Normal Univ, Inst Sports & Exercise Biol, Xian, Shaanxi, Peoples R China.	tianzhenjun1965@yahoo.cn			National Natural Science Foundation of China [81360297, 31040045, 81100174, 31171141]; National Basic Research Program of China [2012CB517805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (Grant No. 81360297, 31040045, 81100174 and 31171141) and National Basic Research Program of China (No. 2012CB517805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajijola OA, 2012, J AM COLL CARDIOL, V59, P962, DOI 10.1016/j.jacc.2011.11.031; Amour J, 2007, ANESTHESIOLOGY, V107, P452, DOI 10.1097/01.anes.0000278909.40408.24; [Anonymous], 2002, AM J PHYSL REGUL INT, VIII, P283; Aragon JP, 2011, J AM COLL CARDIOL, V58, P2683, DOI 10.1016/j.jacc.2011.09.033; Nguyen BL, 2012, CARDIOVASC PATHOL, V21, P143, DOI 10.1016/j.carpath.2011.08.001; Billman GE, 1997, CIRCULATION, V96, P1914, DOI 10.1161/01.CIR.96.6.1914; Billman GE, 2006, AM J PHYSIOL-HEART C, V290, pH2590, DOI 10.1152/ajpheart.01220.2005; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Calvert JW, 2011, CIRC RES, V108, P1448, DOI 10.1161/CIRCRESAHA.111.241117; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Cheng HJ, 2001, CIRC RES, V89, P599, DOI 10.1161/hh1901.098042; de Waard MC, 2007, CIRC RES, V100, P1079, DOI 10.1161/01.RES.0000262655.16373.37; de Waard MC, 2010, J MOL CELL CARDIOL, V48, P1041, DOI 10.1016/j.yjmcc.2010.02.005; French JP, 2008, FASEB J, V22, P2862, DOI 10.1096/fj.07-102541; Giallauria F, 2013, EUR J NUCL MED MOL I, V40, P315, DOI 10.1007/s00259-012-2302-x; Heusch G, 2011, J AM COLL CARDIOL, V58, P2692, DOI 10.1016/j.jacc.2011.09.034; HOCHMAN JS, 1982, CIRCULATION, V65, P1446, DOI 10.1161/01.CIR.65.7.1446; Holycross BJ, 2007, AM J PHYSIOL-HEART C, V293, pH2702, DOI 10.1152/ajpheart.00763.2007; Houle MS, 2001, J APPL PHYSIOL, V91, P1627, DOI 10.1152/jappl.2001.91.4.1627; Kimura K, 2012, CIRC RES, V110, P325, DOI 10.1161/CIRCRESAHA.111.257253; Kraljevic J, 2013, CARDIOVASC RES, V99, P55, DOI 10.1093/cvr/cvt080; Kulandavelu S, 2012, J AM COLL CARDIOL, V59, P1988, DOI 10.1016/j.jacc.2012.01.058; Leosco D, 2008, CARDIOVASC RES, V78, P385, DOI 10.1093/cvr/cvm109; Lu J, 2012, J MOL NEUROSCI, V48, P448, DOI 10.1007/s12031-012-9720-x; Mann N, 2012, CIRCULATION, V126, P2625, DOI 10.1161/CIRCULATIONAHA.111.060376; Marshall KD, 2013, J APPL PHYSIOL, V114, P131, DOI 10.1152/japplphysiol.01059.2012; Martinez DG, 2011, HYPERTENSION, V58, P1049, DOI 10.1161/HYPERTENSIONAHA.111.176644; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Ren CY, 2008, AUTON NEUROSCI-BASIC, V144, P22, DOI 10.1016/j.autneu.2008.08.004; Ribeiro F, 2012, REV PORT CARDIOL, V31, P135, DOI 10.1016/j.repc.2011.12.009; Roof SR, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0332-6; Sasano T, 2008, J AM COLL CARDIOL, V51, P2266, DOI 10.1016/j.jacc.2008.02.062; Saygili E, 2010, J MOL CELL CARDIOL, V49, P79, DOI 10.1016/j.yjmcc.2010.01.019; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Ursino MG, 2009, PHARMACOL RES, V59, P221, DOI 10.1016/j.phrs.2009.01.002; Veras-Silva AS, 1997, AM J PHYSIOL-HEART C, V273, pH2627, DOI 10.1152/ajpheart.1997.273.6.H2627; Waring C.D., 2012, EUR HEART J; Watts VL, 2013, J MOL CELL CARDIOL, V62, P8, DOI 10.1016/j.yjmcc.2013.04.025; Xu XH, 2008, J MOL CELL CARDIOL, V44, P114, DOI 10.1016/j.yjmcc.2007.10.004; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3	43	14	20	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97810	10.1371/journal.pone.0097810	http://dx.doi.org/10.1371/journal.pone.0097810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842290	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600078
J	Hum, JM; Day, RN; Bidwell, JP; Wang, YX; Pavalko, FM				Hum, Julia M.; Day, Richard N.; Bidwell, Joseph P.; Wang, Yingxiao; Pavalko, Fredrick M.			Mechanical Loading in Osteocytes Induces Formation of a Src/Pyk2/MBD2 Complex That Suppresses Anabolic Gene Expression	PLOS ONE			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; SARACATINIB AZD0530; CELL-PROLIFERATION; BONE TURNOVER; FLUID-FLOW; SRC; PROTEIN; STRESS; BINDING	Mechanical stimulation of the skeleton promotes bone gain and suppresses bone loss, ultimately resulting in improved bone strength and fracture resistance. The molecular mechanisms directing anabolic and/or anti-catabolic actions on the skeleton during loading are not fully understood. Identifying molecular mechanisms of mechanotransduction (MTD) signaling cascades could identify new therapeutic targets. Most research into MTD mechanisms is typically focused on understanding the signaling pathways that stimulate new bone formation in response to load. However, we investigated the structural, signaling and transcriptional molecules that suppress the stimulatory effects of loading. The high bone mass phenotype of mice with global deletion of either Pyk2 or Src suggests a role for these tyrosine kinases in repression of bone formation. We used fluid shear stress as a MTD stimulus to identify a novel Pyk2/Src-mediated MTD pathway that represses mechanically-induced bone formation. Our results suggest Pyk2 and Src function as molecular switches that inhibit MTD in our mechanically stimulated osteocyte culture experiments. Once activated by oscillatory fluid shear stress (OFSS), Pyk2 and Src translocate to and accumulate in the nucleus, where they associate with a protein involved in DNA methylation and the interpretation of DNA methylation patterns -methyl-CpG-binding domain protein 2 (MBD2). OFSS-induced Cox-2 and osteopontin expression was enhanced in Pyk2 KO osteoblasts, while inhibition of Src enhanced osteocalcin expression in response to OFSS. We found that Src kinase activity increased in the nucleus of osteocytes in response to OFSS and an interaction activated between Src (Y418) and Pyk2 (Y402) increased in response to OFSS. Thus, as a mechanism to prevent an over-reaction to physical stimulation, mechanical loading may induce the formation of a Src/Pyk2/MBD2 complex in the nucleus that functions to suppress anabolic gene expression.	[Hum, Julia M.; Day, Richard N.; Pavalko, Fredrick M.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Bidwell, Joseph P.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Wang, Yingxiao] Univ Calif San Diego, Sch Engn, San Diego, CA 92103 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego	Pavalko, FM (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.	fpavalko@iupui.edu			NIH [5R01AR052682]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Grant support was provided by NIH 5R01AR052682 (https://public.era.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bidwell JP, 2011, SCI SIGNAL, V3, ppe51; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; DAVIDPFEUTY T, 1993, J CELL SCI, V105, P613; DELMAS PD, 1990, J BONE MINER RES, V5, P3, DOI 10.1002/jbmr.5650050103; Faure C, 2007, J CELL SCI, V120, P3034, DOI 10.1242/jcs.009613; Faure C, 2013, CELL MOL LIFE SCI, V70, P137, DOI 10.1007/s00018-012-1075-5; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Guignandon A, 2006, BIOCHEM BIOPH RES CO, V343, P407, DOI 10.1016/j.bbrc.2006.02.162; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hannon RA, 2012, BONE, V50, P885, DOI 10.1016/j.bone.2011.12.017; Hannon RA, 2010, J BONE MINER RES, V25, P463, DOI 10.1359/jbmr.090830; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HORNE WC, 1992, J CELL BIOL, V119, P1003, DOI 10.1083/jcb.119.4.1003; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Kannus P, 1996, J BONE MINER RES, V11, P79; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Leonhardt H, 2000, J CELL BIOCHEM, P78; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Miller JD, 2007, ORTHOPAEDIC BASIC SC, P129; Missbach M, 1999, BONE, V24, P437, DOI 10.1016/S8756-3282(99)00020-4; MONTGOMERY RJ, 1988, MICROVASC RES, V35, P295, DOI 10.1016/0026-2862(88)90084-2; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nicolella D. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P330; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Ossovskaya V, 2008, FEBS LETT, V582, P2402, DOI 10.1016/j.febslet.2008.06.004; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; Sakai K, 1999, J BONE MINER RES, V14, P2089, DOI 10.1359/jbmr.1999.14.12.2089; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6; Smalt R, 1997, ADV EXP MED BIOL, V433, P311; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tate MLK, 1998, AM J MED SCI, V316, P189, DOI 10.1097/00000441-199809000-00007; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wolf G, 1996, NUTR REV, V54, P332, DOI 10.1111/j.1753-4887.1996.tb03798.x; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Young SRL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016026; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102	60	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97942	10.1371/journal.pone.0097942	http://dx.doi.org/10.1371/journal.pone.0097942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841674	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600094
J	Jiang, JF; Lu, YF; Li, JG; Li, L; He, X; Shao, HL; Dong, YH				Jiang, Jiafeng; Lu, Yufang; Li, Jiangang; Li, Ling; He, Xin; Shao, Hanliang; Dong, Yuanhua			Effect of Seed Treatment by Cold Plasma on the Resistance of Tomato to Ralstonia solanacearum (Bacterial Wilt)	PLOS ONE			English	Article							CALCIUM NUTRITION; STEM ROT; GERMINATION; GROWTH; BORON; SUSCEPTIBILITY; INACTIVATION; SEVERITY; ROOT	This study investigated the effect of cold plasma seed treatment on tomato bacterial wilt, caused by Ralstonia solanacearum (R. solanacearum), and the regulation of resistance mechanisms. The effect of cold plasma of 80W on seed germination, plant growth, nutrient uptake, disease severity, hydrogen peroxide (H2O2) concentration and activities of peroxidase (POD; EC 1.11.1.7), polyphenol oxidase (PPO; EC 1.10.3.2) and phenylalanine ammonia lyase (PAL; EC 4.3.1.5) were examined in tomato plants. Plasma treatment increased tomato resistance to R. solanacearum with an efficacy of 25.0%. Plasma treatment significantly increased both germination and plant growth in comparison with the control treatment, and plasma- treated plants absorbed more calcium and boron than the controls. In addition, H2O2 levels in treated plants rose faster and reached a higher peak, at 2.579 mu M gFW(-1), 140% greater than that of the control. Activities of POD (421.3 U gFW(-1)), PPO (508.8 U gFW(-1)) and PAL (707.3 U gFW(-1)) were also greater in the treated plants than in the controls (103.0 U gFW(-1), 166.0 U gFW(-1) and 309.4 U gFW(-1), respectively). These results suggest that plasma treatment affects the regulation of plant growth, H2O2 concentration, and POD, PPO and PAL activity in tomato, resulting in an improved resistance to R. solanacearum. Consequently, cold plasma seed treatment has the potential to control tomato bacterial wilt caused by R. solanacearum.	[Jiang, Jiafeng; Li, Jiangang; Li, Ling; He, Xin; Dong, Yuanhua] Chinese Acad Sci, Key Lab Soil Environm & Pollut Remediat, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China; [Lu, Yufang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Jiang, Jiafeng; Lu, Yufang; Li, Ling; He, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Shao, Hanliang] Changzhou ZhongKe ChangTai Plasma Technol Co Ltd, Changzhou, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dong, YH (corresponding author), Chinese Acad Sci, Key Lab Soil Environm & Pollut Remediat, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China.	yhdong@issas.ac.cn			Chinese academy of sciences [KSCX2-EW-B-6]; National Science & Technology Pillar Program [2012BAD05B04]; Jiangsu Province Science and Technology Support Program, China [BE2013452]	Chinese academy of sciences(Chinese Academy of Sciences); National Science & Technology Pillar Program; Jiangsu Province Science and Technology Support Program, China	This research was supported by the innovation key program of the Chinese academy of sciences (KSCX2-EW-B-6), National Science & Technology Pillar Program (2012BAD05B04) and Jiangsu Province Science and Technology Support Program, China (BE2013452). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios N.G., 2005, PLANT PATHOLOGY; BATEMAN DF, 1965, PHYTOPATHOLOGY, V55, P734; Bormashenko E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00741; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Chau TT, 1996, BIOMATERIALS, V17, P1273, DOI 10.1016/S0142-9612(96)80003-2; Deora A, 2011, CAN J PLANT PATHOL, V33, P475, DOI 10.1080/07060661.2011.620630; FINGER A, 1994, J SCI FOOD AGR, V66, P293, DOI 10.1002/jsfa.2740660306; Goodman R. N., 1994, HYPERSENSITIVE REACT; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Heller LC, 2012, LETT APPL MICROBIOL, V54, P126, DOI 10.1111/j.1472-765X.2011.03186.x; Henselova M, 2012, BIOLOGIA, V67, P490, DOI 10.2478/s11756-012-0046-5; Hury S, 1998, LETT APPL MICROBIOL, V26, P417; Jiang JF, 2013, EUR J PLANT PATHOL, V136, P547, DOI 10.1007/s10658-013-0186-7; Jiang JF, 2014, PLASMA SCI TECHNOL, V16, DOI 10.1088/1009-0630/16/1/12; KAR RK, 1987, PHYSIOL PLANTARUM, V70, P729, DOI 10.1111/j.1399-3054.1987.tb04331.x; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Li JG, 2013, ANTON LEEUW INT J G, V103, P11, DOI 10.1007/s10482-012-9781-4; Li SM, 2008, ANN MICROBIOL, V58, P573, DOI 10.1007/BF03175560; McGarvey JA, 1999, PHYTOPATHOLOGY, V89, P1233, DOI 10.1094/PHYTO.1999.89.12.1233; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NELSON CL, 1989, CURR MICROBIOL, V18, P275, DOI 10.1007/BF01570305; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rivard CL, 2010, PLANT DIS, V94, P1015, DOI 10.1094/PDIS-94-8-1015; ROBERTS DP, 1988, J BACTERIOL, V170, P1445, DOI 10.1128/jb.170.4.1445-1451.1988; Rose S, 2003, PLANT DIS, V87, P1462, DOI 10.1094/PDIS.2003.87.12.1462; Ruiz JM, 1999, PHYSIOL PLANTARUM, V106, P151, DOI 10.1034/j.1399-3054.1999.106201.x; Sera B, 2010, IEEE T PLASMA SCI, V38, P2963, DOI 10.1109/TPS.2010.2060728; Sera B, 2009, PLASMA SCI TECHNOL, V11, P750, DOI 10.1088/1009-0630/11/6/22; Simoglou KB, 2006, CROP PROT, V25, P657, DOI 10.1016/j.cropro.2005.09.007; Sugimoto T, 2008, PLANT DIS, V92, P1559, DOI 10.1094/PDIS-92-11-1559; Tensmeyer L G, 1981, J Parenter Sci Technol, V35, P93; van Elsas JD, 2001, CAN J MICROBIOL, V47, P842, DOI 10.1139/cjm-47-9-842; VOLPIN H, 1991, PHYTOPATHOLOGY, V81, P1390, DOI 10.1094/Phyto-81-1390; Yamazaki H, 1996, SOIL SCI PLANT NUTR, V42, P203, DOI 10.1080/00380768.1996.10414705; Yin MQ, 2005, PLASMA SCI TECHNOL, V7, P3143, DOI 10.1088/1009-0630/7/6/017; Zivkovic S, 2004, SEED SCI TECHNOL, V32, P693	36	67	70	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97753	10.1371/journal.pone.0097753	http://dx.doi.org/10.1371/journal.pone.0097753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840508	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600068
J	Yang, XL; Gao, H; Zhang, J; Xu, XJ; Liu, XY; Wu, XR; Wei, LP; Zhang, YH				Yang, Xiaoling; Gao, Hua; Zhang, Jie; Xu, Xiaojing; Liu, Xiaoyan; Wu, Xiru; Wei, Liping; Zhang, Yuehua			ATP1A3 Mutations and Genotype-Phenotype Correlation of Alternating Hemiplegia of Childhood in Chinese Patients	PLOS ONE			English	Article							ONSET DYSTONIA-PARKINSONISM; DE-NOVO MUTATIONS; CRYSTAL-STRUCTURE; SEQUENCING DATA; GENE MUTATION; SWISS-MODEL; WEB SERVER; MIGRAINE; IDENTIFICATION; ENVIRONMENT	Alternating hemiplegia of childhood (AHC) is a rare and severe neurological disorder. ATP1A3 was recently identified as the causative gene. Here we report the first genetic study in Chinese AHC cohort. We performed whole-exome sequencing on three trios and three unrelated patients, and screened additional 41 typical cases and 100 controls by PCR-Sanger sequencing. ATP1A3 mutations were detected in 95.7% of typical AHC patients. At least 93.3% were de novo. Four late onset, atypical AHC patients were also mutation positive, suggesting the need for testing ATP1A3 mutations in atypical cases. Totally, 13 novel missense mutations (T370N, G706R, L770R, T771N, T771I, S772R, L802P, D805H, M806K, P808L, I810N, L839P and G893R) were identified in our study. By homology modeling of the mutant protein structures and calculation of an extensive list of molecular features, we identified two statistically significant molecular features, solvent accessibility and distance to metal ion, that distinguished disease-associated mutations from neutral variants. A logistic regression classifier achieved 92.9% accuracy by the average of 100 times of five-fold cross validations. Genotype-phenotype correlation analysis showed that patients with epilepsy were more likely to carry E815K mutation. In summary, ATP1A3 is the major pathogenic gene of AHC in Chinese patients; mutations have distinctive molecular features that discriminate them from neutral variants and are correlated with phenotypes.	[Yang, Xiaoling; Xu, Xiaojing; Liu, Xiaoyan; Wu, Xiru; Zhang, Yuehua] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Gao, Hua; Wei, Liping] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat, Beijing 100871, Peoples R China; [Zhang, Jie; Wei, Liping] Natl Inst Biol Sci, Beijing, Peoples R China	Peking University; Peking University; National Institute of Biological Sciences, Beijing	Wei, LP (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat, Beijing 100871, Peoples R China.	weilp@mail.cbi.pku.edu.cn; zhangyhd@hotmail.com		GAO, Hua/0000-0002-1029-1476; Zhang, Yuehua/0000-0003-1432-5423	Key Construction Program of the National "985'' Project [BMU20120308]; National Outstanding Young Investigator Award [31025014]; Ministry of Science and Technology of China 973 grant [2012CB837600]; Doctoral Fund of Ministry of Education of China [20130001110071]	Key Construction Program of the National "985'' Project; National Outstanding Young Investigator Award; Ministry of Science and Technology of China 973 grant; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by Key Construction Program of the National "985'' Project (No: BMU20120308), National Outstanding Young Investigator Award (No: 31025014), Ministry of Science and Technology of China 973 grant (No: 2012CB837600), and Doctoral Fund of Ministry of Education of China (No: 20130001110071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; AMERY WK, 1983, HEADACHE, V23, P70, DOI 10.1111/j.1526-4610.1983.hed2302070.x; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; CHURCH J, 1980, CAN J PHYSIOL PHARM, V58, P254, DOI 10.1139/y80-044; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Cooper DN, 1996, HUM GENET, V98, P629, DOI 10.1007/s004390050272; de Vries B, 2006, NEUROPEDIATRICS, V37, P302, DOI 10.1055/s-2006-924609; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Fons C, 2012, EUR J PAEDIATR NEURO, V16, P10, DOI 10.1016/j.ejpn.2011.08.006; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haan J, 2000, CEPHALALGIA, V20, P696, DOI 10.1046/j.0333-1024.2000.00095.x; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Ishii A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056120; Kors EE, 2004, NEUROPEDIATRICS, V35, P293, DOI 10.1055/s-2004-821082; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mikati MA, 2000, PEDIATR NEUROL, V23, P134, DOI 10.1016/S0887-8994(00)00157-0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Nielsen R, 2013, INTRODUCTION TO POPULATION GENETICS: THEORY AND APPLICATIONS, P1; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Roubergue A, 2013, MOVEMENT DISORD, V28, P1457, DOI 10.1002/mds.25396; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sweney MT, 2009, PEDIATRICS, V123, pe534, DOI 10.1542/peds.2008-2027; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; VERRETT S, 1971, PEDIATRICS, V47, P675; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ye ZQ, 2007, BIOINFORMATICS, V23, P1444, DOI 10.1093/bioinformatics/btm119; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	40	38	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97274	10.1371/journal.pone.0097274	http://dx.doi.org/10.1371/journal.pone.0097274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842602	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600020
J	Rodrigues, RS; Brum, ALG; Paes, MV; Povoa, TF; Basilio-de-Oliveira, CA; Marchiori, E; Borghi, DP; Ramos, GV; Bozza, FA				Rodrigues, Rosana Souza; Garcia Brum, Ana Livia; Paes, Marciano Viana; Povoa, Tiago Fajardo; Basilio-de-Oliveira, Carlos Alberto; Marchiori, Edson; Borghi, Danielle Provencano; Ramos, Grazielle Viana; Bozza, Fernando Augusto			Lung in Dengue: Computed Tomography Findings	PLOS ONE			English	Article							DIFFUSE ALVEOLAR HEMORRHAGE; IMMUNOCOMPETENT PATIENTS; VIRUS-INFECTION; PLASMA LEAKAGE; FEVER; MANIFESTATIONS; LEPTOSPIROSIS; AMERICA	Background: Dengue is the most important mosquito-borne viral disease in the world. Dengue virus infection may be asymptomatic or lead to undifferentiated fever, dengue fever with or without warning signs, or severe dengue. Lower respiratory symptoms are unusual and lung-imaging data in patients with dengue are scarce. Methodology/Principal Findings: To evaluate lung changes associated with dengue infection, we retrospectively analyzed 2,020 confirmed cases of dengue. Twenty-nine of these patients (11 females and 18 males aged 16-90 years) underwent chest computed tomography (CT), which yielded abnormal findings in 17 patients: 16 patients had pleural effusion (the sole finding in six patients) and 11 patients had pulmonary abnormalities. Lung parenchyma involvement ranged from subtle to moderate unilateral and bilateral abnormalities. The most common finding was ground-glass opacity in eight patients, followed by consolidation in six patients. Less common findings were airspace nodules (two patients), interlobular septal thickening (two patients), and peribronchovascular interstitial thickening (one patient). Lung histopathological findings in four fatal cases showed thickening of the alveolar septa, hemorrhage, and interstitial edema. Conclusions/Significance: In this largest series involving the use of chest CT to evaluate lung involvement in patients with dengue, CT findings of lower respiratory tract involvement were uncommon. When abnormalities were present, pleural effusion was the most frequent finding and lung involvement was often mild or moderate and bilateral. Extensive lung abnormalities are infrequent even in severe disease and when present should lead physicians to consider other diagnostic possibilities.	[Rodrigues, Rosana Souza; Garcia Brum, Ana Livia; Ramos, Grazielle Viana; Bozza, Fernando Augusto] DOr Inst Res & Educ, Rio De Janeiro, RJ, Brazil; [Rodrigues, Rosana Souza; Marchiori, Edson] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Paes, Marciano Viana; Povoa, Tiago Fajardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Basilio-de-Oliveira, Carlos Alberto] Fed Univ State Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Borghi, Danielle Provencano] Corpo Bombeiros Mil Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Ramos, Grazielle Viana; Bozza, Fernando Augusto] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas IPEC, Rio De Janeiro, RJ, Brazil	IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Rodrigues, RS (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, RJ, Brazil.	rosana.souzarodrigues@gmail.com; bozza.fernando@gmail.com	Marchiori, Edson/C-1205-2013; Rodrigues, Rosana Souza/N-9866-2013; Bozza, Fernando A/A-2618-2013	Rodrigues, Rosana Souza/0000-0002-9952-3834; Bozza, Fernando A/0000-0003-4878-0256; Marchiori, Edson/0000-0001-8797-7380; Paes, Marciano/0000-0002-2266-2801	D'Or Institute for Research and Education	D'Or Institute for Research and Education	D'Or Institute for Research and Education has supported the work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2006, INDIAN PEDIATR, V43, P334; Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Ejaz K, 2011, SAUDI MED J, V32, P46; Elicker BM, 2010, EMERG RADIOL, V17, P299, DOI 10.1007/s10140-010-0859-x; Ellis T, 2008, VECTOR-BORNE ZOONOT, V8, P541, DOI 10.1089/vbz.2007.0241; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Gluecker T, 1999, RADIOGRAPHICS, V19, P1507, DOI 10.1148/radiographics.19.6.g99no211507; Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halsey ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001638; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Marchiori E, 2002, J THORAC IMAG, V17, P151, DOI 10.1097/00005382-200204000-00007; Marchiori E, 2012, RESP MED, V106, P1807, DOI 10.1016/j.rmed.2012.07.014; Marchiori E, 2011, EUR J RADIOL, V77, P80, DOI 10.1016/j.ejrad.2009.06.017; Marchiori E, 2011, LUNG, V189, P1, DOI 10.1007/s00408-010-9273-0; Marchiori E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-8; Mergo PJ, 1999, J THORAC IMAG, V14, P122, DOI 10.1097/00005382-199904000-00011; Mustafa B, 2010, Med J Malaysia, V65, P291; PRAMULJO HS, 1991, PEDIATR RADIOL, V21, P100, DOI 10.1007/BF02015615; Sharma S K, 2007, J Assoc Physicians India, V55, P729; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; von Ranke FM, 2013, LUNG, V191, P9, DOI 10.1007/s00408-012-9431-7; Wang CC, 2007, AM J TROP MED HYG, V77, P291, DOI 10.4269/ajtmh.2007.77.291; World Health Organization, 2012, HDB CLIN MAN DENG; World Health Organization, 2009, DENGUE GUIDELINES DI	31	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96313	10.1371/journal.pone.0096313	http://dx.doi.org/10.1371/journal.pone.0096313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836605	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800014
J	Gjelsvik, B; Heyerdahl, F; Lunn, D; Hawton, K				Gjelsvik, Bergljot; Heyerdahl, Fridtjof; Lunn, Daniel; Hawton, Keith			Change in Access to Prescribed Medication following an Episode of Deliberate Self-Poisoning: A Multilevel Approach	PLOS ONE			English	Article							HARM; POLYPHARMACY; DEATH; TIME	Objective: Patients with a history of deliberate self-poisoning (DSP) are prescribed a greater amount of medication than the general public. DSP is the most robust risk factor for repeat episodes of DSP and subsequent death by suicide, and one might therefore expect that access to prescribed medication would be reduced following an episode of DSP. However, it is unclear whether access to prescribed medication changes after an episode of DSP. The objectives of this study were to investigate changes in 1) overall, psychotropic, non-psychotropic and the psychotropic subgroup antidepressant prescribed medication availability in DSP patients following an episode of DSP, 2) prescribing of the medication ingested in the episode, and 3) potential effects of gender, age and repeater status on such change. Methods: The design was longitudinal. We included 171 patients admitted for DSP between January 2006 and March 2007. Data on patients' prescriptions prior to admission were retrieved from The Norwegian Prescription Database. The outcome measure was the difference between medication load in the year following compared to the year prior to the DSP episode. Results: There was a significant increase in total medication load following DSP, including both psychotropic and non-psychotropic medication. Antidepressant medication load remained stable. There was a tendency for access to drugs ingested in the episode to increase following the episode, albeit not significantly. Medication load increased with age across all medication groups irrespective of time period and gender. Conclusions: The findings show that physicians do not curb prescribing to patients who have recently deliberately self-poisoned. Moreover, they highlight the need for cautious and judicious prescribing for these patients, in combination with psychological and social interventions.	[Gjelsvik, Bergljot] Univ Oslo, Dept Psychol, Oslo, Norway; [Heyerdahl, Fridtjof] Oslo Univ Hosp, Dept Acute Med, Oslo, Norway; [Lunn, Daniel] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Hawton, Keith] Univ Oxford, Ctr Suicide Res, Dept Psychiat, Oxford, England	University of Oslo; University of Oslo; University of Oxford; University of Oxford	Gjelsvik, B (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	bergljot.gjelsvik@psykologi.uio.no			Ministry of Education and Research; Ministry of Health and Care in Norway; National Institute for Health Research [NF-SI-0508-10053] Funding Source: researchfish	Ministry of Education and Research; Ministry of Health and Care in Norway; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded jointly by the Ministry of Education and Research and The Ministry of Health and Care in Norway. Professor Keith Hawton is a UK National Institute for Health Research senior investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; Bjornaas MA, 2009, CLIN TOXICOL, V47, P116, DOI 10.1080/15563650701771981; de Leo D, 1999, INT J PSYCHIAT MED, V29, P149, DOI 10.2190/E87K-FG03-CHEE-UJD3; Deisenhammer EA, 2009, J CLIN PSYCHIAT, V70, P19, DOI 10.4088/JCP.07m03904; Furlanetto LM, 2005, J AFFECT DISORDERS, V86, P87, DOI 10.1016/j.jad.2004.12.011; Gjelsvik B, 2013, J CLIN PSYCHIAT, V74, P630, DOI 10.4088/JCP.12l08298; Gjelsvik Bergljot, 2012, J Clin Psychiatry, V73, pe548, DOI 10.4088/JCP.11m07209; Gvion Y, 2011, ARCH SUICIDE RES, V15, P93, DOI 10.1080/13811118.2011.565265; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; HAWTON K, 2005, PREVENTION TREATMENT, P279; Hoiseth G, 2007, INT J LEGAL MED, V121, P403, DOI 10.1007/s00414-006-0139-1; Hovstadius B, 2012, CLIN GERIATR MED, V28, P159, DOI 10.1016/j.cger.2012.01.001; International language for drug utilization research, 2013, INT LANGUAGE DRUG UT; Kjosavik SR, 2009, PHARMACOEPIDEM DR S, V18, P572, DOI 10.1002/pds.1756; National Institute for Health and Clinical Excellence, 2011, SELF HARM LONG TERM; Neutel CI, 2012, PHARMACOEPIDEM DR S, V21, P172; Neutel CI, 2012, PHARMACOEPIDEM DR S, V21, P199, DOI 10.1002/pds.2214; Prescott K, 2009, BRIT J CLIN PHARMACO, V68, P260, DOI 10.1111/j.1365-2125.2009.03458.x; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859	20	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98086	10.1371/journal.pone.0098086	http://dx.doi.org/10.1371/journal.pone.0098086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24854351	Green Published, gold			2022-12-27	WOS:000338323200043
J	Zhao, YQ; Fu, D; Chen, K; Li, GD; Cai, ZD; Shi, Y; Yin, XB				Zhao, Yiqiong; Fu, Dong; Chen, Kai; Li, Guodong; Cai, Zhengdong; Shi, Yan; Yin, Xiaobing			Outcome of Hemiarthroplasty and Total Hip Replacement for Active Elderly Patients with Displaced Femoral Neck Fractures: A Meta-Analysis of 8 Randomized Clinical Trials	PLOS ONE			English	Article							INTERNAL-FIXATION; INTRACAPSULAR FRACTURE; BIPOLAR HEMIARTHROPLASTY; INDEPENDENT PATIENTS; FOLLOW-UP; ARTHROPLASTY; DISLOCATION; HEAD; EPIDEMIOLOGY; MOBILE	Background: Displaced fracture of the femoral neck has been a common clinical problem, especially in aged patients. However, the optimal treatment choice remains controversial. The purpose of this study is to conduct a systematic review of randomized clinical trials assessing the results of hemiarthroplasty and total hip replacement in patients undergoing either alternative using meta-analysis. Methods: A literature search for randomized clinical trials was conducted through Medline, Embase and Cochrane library between 1969 and 2013 with no restrictions. Additional relevant articles were referred as source of information by way of manual searches on major orthopedic journals. Upon the search, two authors independently evaluated study quality and relevant data was extracted. Results: A total of 8 studies with 983 patients were included in this meta-analysis. After pooling the available data, a significant dominance of Harris hip score was found for total hip replacement compared with hemiarthroplasty (SMD: -7.11, 95%: -10.70,-3.53) one year postoperatively and the advantage kept over (SMD: -6.91, 95%: -12.98, -0.85) two years after surgery. A trend toward a higher dislocation rate was found in total hip replacement group (RR: 0.46, 95%: 0.21, 1.02), of which the difference was considered insignificant. The risk of revision in group hemiarthroplasty appeared to be more than two folds higher than that after total hip replacement (RR: 4.14, 95%CI: 2.09, 8.19). Conclusion: Even though there is a higher rate of dislocation after total hip replacement, this disadvantage could be accounted for, on the basis of a better functional score and the lower revision rate. However, from the results, it stands to reason that total hip replacement should be strongly suggested in elderly active patients with femoral neck fracture.	[Zhao, Yiqiong; Fu, Dong; Chen, Kai; Li, Guodong; Cai, Zhengdong; Shi, Yan; Yin, Xiaobing] Tongji Univ, Peoples Hosp 10, Shanghai, Peoples R China	Tongji University	Yin, XB (corresponding author), Tongji Univ, Peoples Hosp 10, Shanghai, Peoples R China.	fudongshenanfang@126.com	Fan, Lin/L-3606-2014					Avery PP, 2011, J BONE JOINT SURG BR, V93B, P1045, DOI 10.1302/0301-620X.93B8.27132; Baker RP, 2006, J BONE JOINT SURG AM, V88A, P2583, DOI 10.2106/JBJS.E.01373; Berry DJ, 2005, J BONE JOINT SURG AM, V87A, P2456, DOI 10.2106/JBJS.D.02860; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Bjornelv GMW, 2012, OSTEOPOROSIS INT, V23, P1711, DOI 10.1007/s00198-011-1772-1; Cadossi M, 2013, BONE JOINT J, V95B, P609, DOI 10.1302/0301-620X.95B5.31083; Enocson A, 2008, ACTA ORTHOP, V79, P211, DOI 10.1080/17453670710014996; Enocson A, 2009, ACTA ORTHOP, V80, P184, DOI 10.3109/17453670902930024; Giannini S, 2011, AGING CLIN EXP RES, V23, P40; Goh SK, 2009, J ARTHROPLASTY, V24, P400, DOI 10.1016/j.arth.2007.12.009; Halley D, 2004, J BONE JOINT SURG AM, V86A, P827, DOI 10.2106/00004623-200404000-00025; Hedbeck CJ, 2011, J BONE JOINT SURG AM, V93A, P445, DOI 10.2106/JBJS.J.00474; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Johansson T, 2000, ACTA ORTHOP SCAND, V71, P597, DOI 10.1080/000164700317362235; Jonsson B, 1996, ACTA ORTHOP SCAND, V67, P431, DOI 10.3109/17453679608996662; Keating JF, 2006, J BONE JOINT SURG AM, V88A, P249, DOI 10.2106/JBJS.E.00215; Liao L, 2012, ARCH ORTHOP TRAUM SU, V132, P1021, DOI 10.1007/s00402-012-1485-8; Macaulay William, 2008, HSS J, V4, P48, DOI 10.1007/s11420-007-9061-4; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001708.pub2; Parker MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub4; Parker MJ, 2002, J BONE JOINT SURG BR, V84B, P1150, DOI 10.1302/0301-620X.84B8.13522; Poignard A, 2011, CLIN ORTHOP RELAT R, V469, P3148, DOI 10.1007/s11999-011-1987-7; Ravikumar KJ, 2000, INJURY, V31, P793, DOI 10.1016/S0020-1383(00)00125-X; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Rodriguez-Merchan EC, 2002, CLIN ORTHOP RELAT R, P72; SOREIDE O, 1982, ACTA ORTHOP SCAND, V53, P791, DOI 10.3109/17453678208992294; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suh KT, 2004, CLIN ORTHOP RELAT R, P162; Tidermark J, 2003, J BONE JOINT SURG BR, V85B, P380, DOI 10.1302/0301-620X.85B3.13609; van den Bekerom MPJ, 2010, J BONE JOINT SURG BR, V92B, P1422, DOI 10.1302/0301-620X.92B10.24899; WOO RYG, 1982, J BONE JOINT SURG AM, V64, P1295, DOI 10.2106/00004623-198264090-00004; Wu RL, 1999, BIOMETRICS, V55, P355	32	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98071	10.1371/journal.pone.0098071	http://dx.doi.org/10.1371/journal.pone.0098071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854195	gold, Green Published			2022-12-27	WOS:000338323200042
J	Blogowski, W; Deskur, A; Budkowska, M; Salata, D; Madej-Michniewicz, A; Dabkowski, K; Dolegowska, B; Starzynska, T				Blogowski, Wojciech; Deskur, Anna; Budkowska, Marta; Salata, Daria; Madej-Michniewicz, Anna; Dabkowski, Krzysztof; Dolegowska, Barbara; Starzynska, Teresa			Selected Cytokines in Patients with Pancreatic Cancer: A Preliminary Report	PLOS ONE			English	Article							STEM-CELLS; INDUCED IMMUNOSUPPRESSION; ALLOGRAFT FUNCTION; ANGIOGENESIS; CARCINOMA; INVASIVENESS; EPIDEMIOLOGY; GROWTH; INJURY	Background/Aims: Recent experimental studies have suggested that various cytokines may be important players in the development and progression of pancreatic cancer. However, these findings have not yet been verified in a clinical setting. Methods: In this study, we examined the levels of a broad panel of cytokines, including interleukin (IL)-1, IL-6, IL-8, IL-10, IL-2, IL-17, and IL-23, as well as tumor necrosis factor alpha (TNF alpha) and granulocyte-colony stimulating factor (G-CSF) in patients with pancreatic adenocarcinoma (n = 43), other pancreatic malignancies (neuroendocrine [n = 10] and solid pseudopapillary tumors [n = 3]), and healthy individuals (n = 41). Results: We found that there were higher levels of IL-6, IL-8, IL-10 and TNFa in patients with pancreatic cancer compared to healthy controls (for all, at least p<0.03). Cancer patients had lower IL-23 concentrations than healthy individuals and patients diagnosed with other types of malignancies (for both, p = 0.002). Levels of IL-6, IL-8, IL-10, and IL-23 were significantly associated with the direct number of circulating bone marrow (BM)-derived mesenchymal or very small embryonic/epiblast-like stem cells (SCs) in patients with pancreatic cancer. Moreover, our study identified a potential ability of IL-6, IL-8, IL-10, IL-23, and TNF alpha levels to enable discrimination of pancreatic cancer from other pancreatic tumors and diseases, including acute and chronic pancreatitis and post-pancreatitis cysts (with sensitivity and specificity ranging between 70%-82%). Conclusions: Our study i) supports the significance of selected cytokines in the clinical presentation of pancreatic cancer, ii) highlights numerous associations between selected interleukins and intensified BMSCs trafficking in patients with pancreatic cancer, and iii) preliminarily characterizes the diagnostic potential of several cytokines as potential novel clinical markers of pancreatic cancer in humans.	[Blogowski, Wojciech] Univ Zielona Gora, Dept Publ Hlth, Zielona Gora, Poland; [Deskur, Anna; Madej-Michniewicz, Anna; Dabkowski, Krzysztof; Starzynska, Teresa] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Budkowska, Marta; Salata, Daria; Dolegowska, Barbara] Pomeranian Med Univ, Dept Med Analyt, Szczecin, Poland	University of Zielona Gora; Pomeranian Medical University; Pomeranian Medical University	Blogowski, W (corresponding author), Univ Zielona Gora, Dept Publ Hlth, Zielona Gora, Poland.	drannab@wp.pl	Budkowska, Marta/T-4526-2019; Dolegowska, Barbara/O-4851-2014; Deskur, Anna/B-6580-2016; Budkowska, Marta/A-2298-2016; Dąbkowski, Krzysztof/AAI-3889-2020; Starzynska, Teresa/B-1549-2015	Dolegowska, Barbara/0000-0003-3138-1013; Deskur, Anna/0000-0001-6809-5243; Budkowska, Marta/0000-0002-8228-278X; Dąbkowski, Krzysztof/0000-0002-5386-9004; Starzynska, Teresa/0000-0001-5573-2397	Polish Ministry of Science and Higher Education [402 423038]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was financed by a grant awarded by the Polish Ministry of Science and Higher Education (402 423038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EV, 2013, GASTROENTEROLOGY, V144, P1241, DOI 10.1053/j.gastro.2013.01.072; Bellone G, 1999, AM J PATHOL, V155, P537, DOI 10.1016/S0002-9440(10)65149-8; Benatar T, 2008, CANCER IMMUNOL IMMUN, V57, P1757, DOI 10.1007/s00262-008-0502-9; Benatar T, 2010, CANCER IMMUNOL IMMUN, V59, P805, DOI 10.1007/s00262-009-0802-8; Blogowski W, 2014, INNATE IMMUN-LONDON, V20, P126, DOI 10.1177/1753425913482018; Blogowski W, 2012, CLIN J AM SOC NEPHRO, V7, P1843, DOI 10.2215/CJN.02200312; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Dolegowska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029779; Dolegowska B, 2010, NEPHROL DIAL TRANSPL, V25, P4061, DOI 10.1093/ndt/gfq320; Dolegowska B, 2010, J AM COLL SURGEONS, V211, P587, DOI 10.1016/j.jamcollsurg.2010.06.391; Hayata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053131; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kuwada Y, 2003, INT J ONCOL, V22, P765; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Malvicini M, 2011, MOL ONCOL, V5, P242, DOI 10.1016/j.molonc.2011.03.007; Marchesi F, 2012, CURR PHARM DESIGN, V18, P2432, DOI 10.2174/13816128112092432; Matsuo Y, 2004, PANCREAS, V28, P344, DOI 10.1097/00006676-200404000-00025; Matsuo Y, 2012, CURR PHARM DESIGN, V18, P2416, DOI 10.2174/13816128112092416; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Mroczko B, 2005, CLIN CHEM LAB MED, V43, P146, DOI 10.1515/CCLM.2005.024; Ni C, 2013, CLIN TRANSL ONCOL, V15, P253, DOI 10.1007/s12094-012-0927-7; Oberstein PE, 2013, THER ADV GASTROENTER, V6, P321, DOI 10.1177/1756283X13478680; Quail DF, 2012, CURR STEM CELL RES T, V7, P197; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Sakamoto H, 2012, JPN J CLIN ONCOL, V42, P105, DOI 10.1093/jjco/hyr178; Schultz NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067059; Sordi Valeria, 2010, Rev Diabet Stud, V7, P132, DOI 10.1900/RDS.2010.7.132; Starzynska T, 2013, J CELL MOL MED, V17, P792, DOI 10.1111/jcmm.12065; Tjomsland V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070874; Tjomsland V, 2011, NEOPLASIA, V13, P664, DOI 10.1593/neo.11332; Vizio B, 2010, CANCER SCI, V101, P2448, DOI 10.1111/j.1349-7006.2010.01692.x; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xu DH, 2010, J SURG ONCOL, V102, P469, DOI 10.1002/jso.21530; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Zhang YQ, 2013, CANCER RES, V73, P6359, DOI 10.1158/0008-5472.CAN-13-1558-T	39	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97613	10.1371/journal.pone.0097613	http://dx.doi.org/10.1371/journal.pone.0097613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849506	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600040
J	Jia, Y; Domenico, J; Swasey, C; Wang, MQ; Gelfand, EW; Lucas, JJ				Jia, Yi; Domenico, Joanne; Swasey, Christina; Wang, Meiqin; Gelfand, Erwin W.; Lucas, Joseph J.			Modulated Expression of Genes Encoding Estrogen Metabolizing Enzymes by G1-Phase Cyclin-Dependent Kinases 6 and 4 in Human Breast Cancer Cells	PLOS ONE			English	Article							ETS2 TRANSCRIPTION FACTOR; ALDO-KETO REDUCTASES; DEHYDROGENASE ISOFORMS; STEROID-HORMONE; REVEALS ROLES; G(1) PHASE; MAST-CELLS; RECEPTOR; CDK6; PROLIFERATION	G1-phase cell cycle defects, such as alterations in cyclin D1 or cyclin-dependent kinase (cdk) levels, are seen in most tumors. For example, increased cyclin D1 and decreased cdk6 levels are seen in many human breast tumors. Overexpression of cdk6 in breast tumor cells in culture has been shown to suppress proliferation, unlike the growth stimulating effects of its close homolog, cdk4. In addition to directly affecting proliferation, alterations in cdk6 or cdk4 levels in breast tumor cells also differentially influence levels of numerous steroid metabolic enzymes (SMEs), including those involved in estrogen metabolism. Overexpression of cdk6 in tumor cell lines having low cdk6 resulted in decreased levels of mRNAs encoding aldo-keto reductase (AKR)1C1, AKR1C2 and AKR1C3, which are hydroxysteroid dehydrogenases (HSDs) involved in steroid hormone metabolism. In contrast, increasing cdk4 dramatically increased these transcript levels, especially those encoding AKR1C3, an enzyme that converts estrone to 17 beta-estradiol, a change that could result in a pro-estrogenic state favoring tumor growth. Effects on other estrogen metabolizing enzymes, including cytochrome P450 (CYP) 19 aromatase, 17 beta-HSD2, and CYP1B1 transcripts, were also observed. Interactions of cdk6 and cdk4, but not cyclin D1, with the promoter region of a cdk-regulated gene, 17 beta-HSD2, were detected. The results uncover a previously unsuspected link between the cell cycle and hormone metabolism and differential roles for cdk6 and cdk4 in a novel mechanism for pre-receptor control of steroid hormone action, with important implications for the origin and treatment of steroid hormone-dependent cancers.	[Jia, Yi; Domenico, Joanne; Swasey, Christina; Wang, Meiqin; Gelfand, Erwin W.; Lucas, Joseph J.] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA	National Jewish Health	Gelfand, EW (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA.	GelfandE@NJHealth.org		CIRERA SALINAS, DANIEL/0000-0003-2171-5032	DoD from the Department of the Army [W81XWH-08-1-0630 (BC073945)]; University of Colorado Cancer Center; Colorado Bioscience Discovery Evaluation Grant Program from State of Colorado/National Jewish Health; Eugene F. and Easton M. Crawford Charitable Lead Unitrust	DoD from the Department of the Army; University of Colorado Cancer Center; Colorado Bioscience Discovery Evaluation Grant Program from State of Colorado/National Jewish Health; Eugene F. and Easton M. Crawford Charitable Lead Unitrust	This research was supported in part by DoD Grant W81XWH-08-1-0630 (BC073945) from the Department of the Army and by the University of Colorado Cancer Center, Colorado Bioscience Discovery Evaluation Grant Program from State of Colorado/National Jewish Health and a fellowship from The Eugene F. and Easton M. Crawford Charitable Lead Unitrust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L., 1996, ONCOGENE, V12, P2315; An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Bagella L, 2006, J CELL BIOCHEM, V99, P978, DOI 10.1002/jcb.20981; Bauman DR, 2005, MOL PHARMACOL, V67, P60, DOI 10.1124/mol.104.006569; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Byrns MC, 2009, CHEM-BIOL INTERACT, V178, P221, DOI 10.1016/j.cbi.2008.10.024; Chilosi M, 1998, AM J PATHOL, V152, P209; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; DUBIK D, 1992, ONCOGENE, V7, P1587; Easton J, 1998, CANCER RES, V58, P2624; Ericson KK, 2003, MOL CANCER RES, V1, P654; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Grossel MJ, 1999, J BIOL CHEM, V274, P29960, DOI 10.1074/jbc.274.42.29960; Grossel MJ, 2006, J CELL BIOCHEM, V97, P485, DOI 10.1002/jcb.20712; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Ito K, 2013, ONCOGENE IN PRESS; Jansson A, 2009, J STEROID BIOCHEM, V114, P64, DOI 10.1016/j.jsbmb.2008.12.012; Kang KW, 2008, J CLIN PHARMACOL, V48, P1430, DOI 10.1177/0091270008323262; Kasten M, 2001, ONCOGENE, V20, P1832, DOI 10.1038/sj.onc.1204295; Li GM, 2005, CELL IMMUNOL, V238, P10, DOI 10.1016/j.cellimm.2005.12.001; Li GM, 2009, INT ARCH ALLERGY IMM, V150, P122, DOI 10.1159/000218115; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lin HK, 2004, STEROIDS, V69, P795, DOI 10.1016/j.steroids.2004.09.014; Lucas JJ, 2004, MOL CANCER RES, V2, P105; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Matushansky I, 2000, BLOOD, V96, P2755, DOI 10.1182/blood.V96.8.2755.h8002755_2755_2764; McInnes C, 2008, DRUG DISCOV TODAY, V13, P875, DOI 10.1016/j.drudis.2008.06.012; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Milne SA, 2003, J CLIN ENDOCR METAB, V88, P1825, DOI 10.1210/jc.2002-021368; Nagasawa M, 2001, ONCOGENE, V20, P2889, DOI 10.1038/sj.onc.1204396; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Novotna R, 2008, TOXICOL LETT, V181, P1, DOI 10.1016/j.toxlet.2008.06.858; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Penning TM, 2009, ANN NY ACAD SCI, V1155, P33, DOI 10.1111/j.1749-6632.2009.03700.x; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Rotllan N, 2012, CHOLESTEROL, DOI 10.1155/2012/847849; Sasano Hironobu, 2006, Breast Cancer, V13, P129, DOI 10.2325/jbcs.13.129; Shimada T, 1996, CANCER RES, V56, P2979; Sissung TM, 2006, MOL CANCER RES, V4, P135, DOI 10.1158/1541-7786.MCR-05-0101; Stoffel-Wagner B, 2003, EPILEPSY RES, V54, P11, DOI 10.1016/S0920-1211(03)00036-6; Tay SP, 2010, J BIOL CHEM, V285, P29231, DOI 10.1074/jbc.M110.108241; Timmermann S, 1997, CELL GROWTH DIFFER, V8, P361; Tomita T, 2004, PATHOLOGY, V36, P566, DOI 10.1080/00313020400011342; Wang X, 2011, AM J PATHOL, V178, P345, DOI 10.1016/j.ajpath.2010.11.032; Yang SJ, 2001, MOL ENDOCRINOL, V15, P2093, DOI 10.1210/me.15.12.2093; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97448	10.1371/journal.pone.0097448	http://dx.doi.org/10.1371/journal.pone.0097448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848372	Green Submitted, gold, Green Published			2022-12-27	WOS:000336730600030
J	Koenker, H; Kilian, A				Koenker, Hannah; Kilian, Albert			Recalculating the Net Use Gap: A Multi-Country Comparison of ITN Use versus ITN Access	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; RANDOMIZED CONTROLLED-TRIAL; BED-NETS; UNIVERSAL COVERAGE; MOSQUITO NETS; MALARIA TRANSMISSION; PREGNANT-WOMEN; OWNERSHIP; CHILDREN; POSSESSION	Use of insecticide treated nets is widely recognized as one of the main interventions to prevent malaria and high use rates are a central goal of malaria programs. The gap between household ownership of at least one ITN and population use of ITN has in the past been seen as evidence for failure to achieve appropriate net use. However, past studies compared net use with ownership of at least one net, not access to sufficient nets within households. This study recalculates the net use gap in recent large household surveys using the comparison indicator of 'access to nets within the household' as now recommended by Roll Back Malaria and the World Health Organization. Data from 41 Demographic Health Surveys (DHS) and Malaria Indicator Surveys (MIS) (2005-2012) in sub-Saharan Africa were used. For each dataset three indicators were calculated: population access to ITN, population use of ITN, and household ownership of at least one ITN. The ITN use gap was expressed as the difference between one and the ratio of use to access. The median proportion of users compared to those with access was high, at 82.1%. Even at population access levels below 50%, a median 80.6% used an ITN given they had access, and this rate increased to 91.2% for access rates above 50%. Linear regression of use against access showed that 89.0% of household members with access to nets used them the night before. These results clearly show that previous interpretations of the net use gap as a failure of behavioral change communication interventions were not justified and that the gap was instead primarily driven by lack of intra-household access. They also demonstrate the usefulness of the newly recommended ITN indicators; access to an ITN within the household provides a much more accurate comparison of ITN use than ownership.	[Koenker, Hannah] Johns Hopkins Univ, Sch Publ Hlth, Ctr Commun Programs, Baltimore, MD 21218 USA; [Kilian, Albert] Trop Hlth LLP, Montagut, Spain	Johns Hopkins University	Koenker, H (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Ctr Commun Programs, Baltimore, MD 21218 USA.	hkoenker@jhuccp.org			United States Agency for International Development (USAID) [GHS-A-00-09-00014-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement No. GHS-A-00-09-00014-00 for the NetWorks Project. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong IA, 1999, J BIOSOC SCI, V31, P79, DOI 10.1017/S0021932099000796; Ahmed SM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-357; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], TROP MED INT HLTH; [Anonymous], HLTH POLICY PLAN; [Anonymous], HOUS SURV IND MAL CO; [Anonymous], MAL BEH CHANG COMM I; [Anonymous], PLOSONE IN PRESS; Baume CA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-265; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Baume CA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-153; Beer N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-606; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Bennett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037927; Bowen HL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-36; Deribew A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-99; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Eng JLV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-133; Fernando SD, 2009, T ROY SOC TROP MED H, V103, P1204, DOI 10.1016/j.trstmh.2008.10.018; Galvin KT, 2011, J MULTIDISCIP HEALTH, V4, P73, DOI 10.2147/JMDH.S15917; Garley AE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-119; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Gunasekaran K, 2009, ACTA TROP, V112, P149, DOI 10.1016/j.actatropica.2009.07.013; Hetzel MW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-192; Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176; Kilian A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-314; Kilian A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-259; Koenker H, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-218; Koenker HM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-203; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Loha E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-23; Loll DK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-337; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Monroe A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-82; Ndjinga JK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-279; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Rickard DG, 2011, PROG COMM HLTH PARTN, V5, P123, DOI 10.1353/cpr.2011.0018; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Stevens ER, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-162; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Thwing JI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-86; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; West PA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-273; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X	53	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97496	10.1371/journal.pone.0097496	http://dx.doi.org/10.1371/journal.pone.0097496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848768	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600033
J	Lombarts, KMJMH; Plochg, T; Thompson, CA; Arah, OA				Lombarts, Kiki M. J. M. H.; Plochg, Thomas; Thompson, Caroline A.; Arah, Onyebuchi A.		DUQuE Project Consortium	Measuring Professionalism in Medicine and Nursing: Results of a European Survey	PLOS ONE			English	Article							QUALITY IMPROVEMENT; PHYSICIANS; CARE; RESPONSIBILITY; HOSPITALS; SAFETY; SCALE	Background: Leveraging professionalism has been put forward as a strategy to drive improvement of patient care. We investigate professionalism as a factor influencing the uptake of quality improvement activities by physicians and nurses working in European hospitals. Objective: To (i) investigate the reliability and validity of data yielded by using the self-developed professionalism measurement tool for physicians and nurses, (ii) describe their levels of professionalism displayed, and (iii) quantify the extent to which professional attitudes would predict professional behaviors. Methods and Materials: We designed and deployed survey instruments amongst 5920 physicians and nurses working in European hospitals. This was conducted under the cross-sectional multilevel study "Deepening Our Understanding of Quality Improvement in Europe" (DUQuE). We used psychometric and generalized linear mixed modelling techniques to address the aforementioned objectives. Results: In all, 2067 (response rate 69.8%) physicians and 2805 nurses (94.8%) representing 74 hospitals in 7 European countries participated. The professionalism instrument revealed five subscales of professional attitude and one scale for professional behaviour with moderate to high internal consistency and reliability. Physicians and nurses display equally high professional attitude sum scores (11.8 and 11.9 respectively out of 16) but seem to have different perceptions towards separate professionalism aspects. Lastly, professionals displaying higher levels of professional attitudes were more involved in quality improvement actions (physicians: b = 0.019, P<0.0001; nurses: b = 0.016, P<0.0001) and more inclined to report colleagues' underperformance (physicians - odds ratio (OR) 1.12, 95% CI 1.01-1.24; nurses - OR 1.11, 95% CI 1.01-1.23) or medical errors (physicians - OR 1.14, 95% CI 1.01-1.23; nurses - OR 1.43, 95% CI 1.22-1.67). Involvement in QI actions was found to increase the odds of reporting incompetence or medical errors. Conclusion: A tool that reliably and validly measures European physicians' and nurses' commitment to professionalism is now available. Collectively leveraging professionalism as a quality improvement strategy may be beneficial to patient care quality.	[Lombarts, Kiki M. J. M. H.; Arah, Onyebuchi A.] Univ Amsterdam, Acad Med Ctr, Profess Performance Res Grp, Ctr Evidence Based Educ, NL-1105 AZ Amsterdam, Netherlands; [Plochg, Thomas] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Thompson, Caroline A.; Arah, Onyebuchi A.] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Thompson, Caroline A.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Arah, Onyebuchi A.] UCLA Ctr Hlth Policy Res, Los Angeles, CA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California Los Angeles; Palo Alto Medical Foundation Research Institute; University of California System; University of California Los Angeles	Lombarts, KMJMH (corresponding author), Univ Amsterdam, Acad Med Ctr, Profess Performance Res Grp, Ctr Evidence Based Educ, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.lombarts@amc.uva.nl	Pfaff, Holger/D-2630-2009; Car, Mate/F-2184-2017	Pfaff, Holger/0000-0001-9154-6575; Car, Mate/0000-0002-7005-0500; Thompson, Caroline/0000-0001-9990-9756; Arah, Onyebuchi/0000-0002-9067-1697; Eiras, Margarida/0000-0001-5759-7336; Lombarts, Kiki/0000-0001-6167-0620; Groene, Oliver/0000-0002-1099-2950; Mannion, Russell/0000-0002-0680-8049	European Commission [241822]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The DUQuE project was funded by the European Commission's Seventh Framework Program FP7/2007-2013 under the grant agreement number [241822]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Nurse Association, 2001, COD ETH NURS; Arah OA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025983; Arnold L, 2002, ACAD MED, V77, P502, DOI 10.1097/00001888-200206000-00006; Brennan TA, 2002, ACAD MED, V77, P973, DOI 10.1097/00001888-200210000-00008; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Cassel CK, 2012, ANN INTERN MED, V157, P290, DOI 10.7326/0003-4819-157-4-201208210-00012; Classen DC, 2002, ACAD MED, V77, P963, DOI 10.1097/00001888-200210000-00007; Conway PH, 2012, JAMA-J AM MED ASSOC, V308, P979, DOI 10.1001/jama.2012.9844; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cruess RL, 2008, PERSPECT BIOL MED, V51, P579, DOI 10.1353/pbm.0.0045; DesRoches CM, 2010, JAMA-J AM MED ASSOC, V304, P187, DOI 10.1001/jama.2010.921; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Gallagher TH, 2005, ARCH INTERN MED, V165, P1819, DOI 10.1001/archinte.165.16.1819; Groene O, 2009, QUAL SAF HEALTH CARE, V18, pI69, DOI 10.1136/qshc.2008.029447; Groene O, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-281; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Ho MJ, 2012, MED EDUC, V46, P245, DOI 10.1111/j.1365-2923.2011.04149.x; Jha V, 2007, MED EDUC, V41, P822, DOI 10.1111/j.1365-2923.2007.02804.x; Lombarts KMJMH, 2009, ANESTHESIOLOGY, V111, P709, DOI 10.1097/ALN.0b013e3181b76516; Lombarts MJMH, 2009, QUAL SAF HEALTH CARE, V18, pI28, DOI 10.1136/qshc.2008.029363; Plochg T, 2014, IJQHC           0309, V9; Roland M, 2011, BMJ QUAL SAF, V20, P515, DOI 10.1136/bmjqs.2010.048173; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Stevens J. P, 1992, APPL MULTIVARIATE ST; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Veloski J, 2006, MED TEACH, V28, P117, DOI 10.1080/01421590600622665; Ward J, 2009, J NURS MEAS, V17, P73, DOI 10.1891/1061-3749.17.1.73; Weis D, 2009, J NURS MEAS, V17, P221, DOI 10.1891/1061-3749.17.3.221; Wilkinson TJ, 2009, ACAD MED, V84, P551, DOI 10.1097/ACM.0b013e31819fbaa2	29	23	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97069	10.1371/journal.pone.0097069	http://dx.doi.org/10.1371/journal.pone.0097069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849320	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600019
J	Tani, M; Ishii, D; Ito, S; Hariyama, T; Shimomura, M; Okumura, K				Tani, Marie; Ishii, Daisuke; Ito, Shuto; Hariyama, Takahiko; Shimomura, Masatsugu; Okumura, Ko			Capillary Rise on Legs of a Small Animal and on Artificially Textured Surfaces Mimicking Them	PLOS ONE			English	Article							WATER-UPTAKE; TRANSPORT; PAPER	The wharf roach Ligia exotica is a small animal that lives by the sea and absorbs water from the sea through its legs by virtue of a remarkable array of small blades of micron scale. We find that the imbibition dynamics on the legs is rather complex on a microscopic scale, but on a macroscopic scale the imbibition length seems to simply scale linearly with elapsed time. This unusual dynamics of imbibition, which usually slows down with time, is advantageous for long-distance water transport and results from repetition of unit dynamics. Inspired by the remarkable features, we study artificially textured surfaces mimicking the structure on the legs of the animal. Unlike the case of the wharf roach, the linear dynamics were not reproduced on the artificial surfaces, which may result from more subtle features on the real legs that are not faithfully reflected on the artificial surfaces. Instead, the nonlinear dynamics revealed that hybrid structures on the artificial surfaces speed up the water transport compared with non-hybrid ones. In addition, the dynamics on the artificial surfaces turn out to be well described by a composite theory developed here, with the theory giving useful guiding principles for designing hybrid textured surfaces for rapid imbibition and elucidating physical advantages of the microscopic design on the legs.	[Tani, Marie; Okumura, Ko] Ochanomizu Univ, Fac Sci, Dept Phys, Bunkyo Ku, Tokyo 112, Japan; [Ishii, Daisuke] Nagoya Inst Technol, Ctr Fostering Young & Innovat Researchers, Fac Engn, Showa Ku, Nagoya, Aichi, Japan; [Ito, Shuto] Nagoya Inst Technol, Dept Life & Mat Engn, Fac Engn, Showa Ku, Nagoya, Aichi, Japan; [Hariyama, Takahiko] Hamamatsu Univ Sch Med, Dept Biol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Shimomura, Masatsugu] Tohoku Univ, WPI Adv Inst Mat Res WPI AIMR, Aoba Ku, Sendai, Miyagi 980, Japan; [Ishii, Daisuke; Hariyama, Takahiko; Shimomura, Masatsugu; Okumura, Ko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Ochanomizu University; Nagoya Institute of Technology; Nagoya Institute of Technology; Hamamatsu University School of Medicine; Tohoku University; Japan Science & Technology Agency (JST)	Okumura, K (corresponding author), Ochanomizu Univ, Fac Sci, Dept Phys, Bunkyo Ku, Tokyo 112, Japan.	okumura@phys.ocha.ac.jp	Okumura, Ko/A-2132-2011; Ito, Shuto/AAD-6654-2019	Okumura, Ko/0000-0002-8554-7173; Ito, Shuto/0000-0003-2939-1693; Tani, Marie/0000-0002-5062-8520	JSPS [24686076, 24244066]; MEXT, Japan [24120004]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partly supported by Grant-in-Aid for Young Scientists (A) (No. 24686076) of JSPS, Grant-in-Aid for Scientific Research on Innovative Areas "Engineering Neo-Biomimetics" (No. 24120004) of MEXT, Japan, and Grant-in-Aid for Scientific Research (A) (No. 24244066) of JSPS. The funders had no role in study design, data collection adn analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GOUTTES BULLES PERLE; Balankin AS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.056101; Bico J, 2001, EUROPHYS LETT, V55, P214, DOI 10.1209/epl/i2001-00402-x; Blow ML, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/46/464125; Chu KH, 2010, NAT MATER, V9, P413, DOI [10.1038/nmat2726, 10.1038/NMAT2726]; Courbin L, 2007, NAT MATER, V6, P661, DOI 10.1038/nmat1978; Gau H, 1999, SCIENCE, V283, P46, DOI 10.1126/science.283.5398.46; Hamamoto-Kurosaki M, 2009, EUR PHYS J E, V30, P283, DOI 10.1140/epje/i2009-10526-3; Horiguchi H, 2007, BIOL BULL-US, V213, P196, DOI 10.2307/25066635; Ishii D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03024; Ishino C, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/56005; Kim J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.264501; Kwon TH, 1996, PHYS REV E, V54, P685, DOI 10.1103/PhysRevE.54.685; Lafuma A, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/56001; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Lagubeau G, 2011, NAT PHYS, V7, P395, DOI 10.1038/NPHYS1925; Liu MJ, 2010, ACCOUNTS CHEM RES, V43, P368, DOI 10.1021/ar900205g; Malvadkar NA, 2010, NAT MATER, V9, P1023, DOI 10.1038/NMAT2864; Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105; Miranda AM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.086101; Obara N, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.020601; Ohzono T, 2009, SOFT MATTER, V5, P4658, DOI 10.1039/b912235d; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Ponomarenko A, 2011, J FLUID MECH, V666, P146, DOI 10.1017/S0022112010005276; Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Reis PM, 2010, SCIENCE, V330, P1231, DOI 10.1126/science.1195421; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; TANG LH, 1994, J PHYS II, V4, P881, DOI 10.1051/jp2:1994172; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447	31	17	17	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96813	10.1371/journal.pone.0096813	http://dx.doi.org/10.1371/journal.pone.0096813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849071	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600016
J	Wang, Z; Ji, CY; Wu, LY; Qiu, JX; Li, Q; Shao, Z; Chen, G				Wang, Zhong; Ji, Chengyuan; Wu, Lingyun; Qiu, Jiaoxue; Li, Qi; Shao, Zhong; Chen, Gang			Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; DEFICITS; VASOSPASM; RECOVERY	Tert-butylhydroquinone (tBHQ), an Nrf2 activator, has demonstrated neuroprotection against brain trauma and ischemic stroke in vivo. However, little work has been done with respect to its effect on early brain injury (EBI) after subarachnoid hemorrhage (SAH). At the same time, as an oral medication, it may have extensive clinical applications for the treatment of SAH-induced cognitive dysfunction. This study was undertaken to evaluate the influence of tBHQ on EBI, secondary deficits of learning and memory, and the Keap1/Nrf2/ARE pathway in a rat SAH model. SD rats were divided into four groups: (1) Control group (n = 40); (2) SAH group (n = 40); (3) SAH+ vehicle group (n = 40); and (4) SAH+ tBHQ group (n = 40). All SAH animals were subjected to injection of autologous blood into the prechiasmatic cistern once in 20 s. In SAH+ tBHQ group, tBHQ was administered via oral gavage at a dose of 12.5 mg/kg at 2 h, 12 h, 24 h, and 36 h after SAH. In the first set of experiments, brain samples were extracted and evaluated 48 h after SAH. In the second set of experiments, changes in cognition and memory were investigated in a Morris water maze. Results shows that administration of tBHQ after SAH significantly ameliorated EBI-related problems, such as brain edema, blood-brain barrier (BBB) impairment, clinical behavior deficits, cortical apoptosis, and neurodegeneration. Learning deficits induced by SAH was markedly alleviated after tBHQ therapy. Treatment with tBHQ markedly up-regulated the expression of Keap1, Nrf2, HO-1, NQO1, and GST alpha 1 after SAH. In conclusion, the administration of tBHQ abated the development of EBI and cognitive dysfunction in this SAH model. Its action was probably mediated by activation of the Keap1/Nrf2/ARE pathway.	[Wang, Zhong; Ji, Chengyuan; Wu, Lingyun; Qiu, Jiaoxue; Li, Qi; Shao, Zhong; Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Chen, G (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.	nju_neurosurgery@163.com	Wu, Ling/GZN-2235-2022	Chen, Gang/0000-0002-0758-1907	National Natural Science Foundation of China [81171105, 81271300, 81371279]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81171105, 81271300, and 81371279, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; de Rooij NK, 2013, STROKE, V44, P43, DOI 10.1161/STROKEAHA.112.674291; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Haug T, 2007, NEUROSURGERY, V60, P649, DOI 10.1227/01.NEU.0000255414.70807.A0; HUTTER BO, 1993, NEUROSURGERY, V33, P999; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Le W, 1999, J NEUROSCI RES, V56, P652; Lu H, 2009, J CLIN NEUROSCI, V16, P684, DOI 10.1016/j.jocn.2008.04.021; Mavaddat N, 1999, J NEUROSURG, V91, P402, DOI 10.3171/jns.1999.91.3.0402; Negi G, 2011, J PINEAL RES, V50, P124, DOI 10.1111/j.1600-079X.2010.00821.x; Niture SK, 2013, FREE RADIC IN PRESS; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; STENHOUSE LM, 1991, J NEUROL NEUROSUR PS, V54, P909, DOI 10.1136/jnnp.54.10.909; Takata K, 2008, EXP NEUROL, V213, P336, DOI 10.1016/j.expneurol.2008.06.009; Yamaguchi M, 2004, STROKE, V35, P1750, DOI 10.1161/01.STR.0000129898.68350.9f; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	27	24	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97685	10.1371/journal.pone.0097685	http://dx.doi.org/10.1371/journal.pone.0097685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848277	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600050
J	Zhu, LD; Liu, J; Liang, FJ; Rayner, S; Xiong, JH				Zhu, Lida; Liu, Juan; Liang, Fengji; Rayner, Simon; Xiong, Jianghui			Predicting Response to Preoperative Chemotherapy Agents by Identifying Drug Action on Modeled MicroRNA Regulation Networks	PLOS ONE			English	Article							BREAST-CANCER; DIFFERENTIAL EXPRESSION; SMALL MOLECULES; GENES; MIRNAS; PACLITAXEL; RISK; CYCLOPHOSPHAMIDE; IDENTIFICATION; FLUOROURACIL	Identifying patients most responsive to specific chemotherapy agents in neoadjuvant settings can help to maximize the benefits of treatment and minimize unnecessary side effects. Metagene approaches that predict response based on gene expression signatures derived from an associative analysis of clinical data can identify chance associations caused by the heterogeneity of a tumor, leading to reproducibility issues in independent validations. In this study, to incorporate information from drug mechanisms of action, we explore the potential of microRNA regulation networks as a new feature space for identifying predictive markers. We introduce a measure we term the CoMi (Context-specific-miRNA-regulation) pattern to represent a descriptive feature of the miRNA regulation network in the transcriptome. We examine whether the modifications to the CoMi pattern on specific biological processes are a useful representation of drug action by predicting the response to neoadjuvant Paclitaxel treatment in breast cancer and show that the drug counteracts the CoMi network dysregulation induced by tumorigenesis. We then generate a quantitative testbed to investigate the ability of the CoMi pattern to distinguish FDA approved breast cancer drugs from other FDA approved drugs not related to breast cancer. We also compare the ability of the CoMi and metagene methods to predict response to neoadjuvant Paclitaxel treatment in clinical cohorts. We find the CoMi method outperforms the metagene method, achieving area under curve (AUC) values of 0.78 and 0.66 respectively. Furthermore, several of the predicted CoMi features highlight the network-based mechanism of drug resistance. Thus, our study suggests that explicitly modeling the drug action using network biology provides a promising approach for predictive marker discovery.	[Zhu, Lida; Liu, Juan] Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China; [Liang, Fengji; Xiong, Jianghui] China Astronaut Res & Training Ctr ACC, State Key Lab Space Med Fundamentals & Applicat S, Beijing, Peoples R China; [Rayner, Simon] Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China; [Xiong, Jianghui] Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese University of Hong Kong, Shenzhen	Liu, J (corresponding author), Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China.	liujuan@whu.edu.cn; s.raynere@wh.iov.cn; laserxiong@gmail.com			Chinese Scientific and Technological Major Special Project [2012ZX09301003-002-003]; National Natural Science Foundation of China [61272274, 91129708]; Program for New Century Excellent Talents in Universities [NCET-10-0644]; Open Research Fund of State Key Laboratory of Hybrid Rice (Wuhan University) [KF201301]; State Key Lab of Space Medicine Fundamentals and Application [SMFA09A07, SMFA10A03]; Shenzhen [JCYJ20120619151640947]	Chinese Scientific and Technological Major Special Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Open Research Fund of State Key Laboratory of Hybrid Rice (Wuhan University); State Key Lab of Space Medicine Fundamentals and Application; Shenzhen	This work was supported by the grant from the Chinese Scientific and Technological Major Special Project (2012ZX09301003-002-003), the National Natural Science Foundation of China (61272274, 91129708), Program for New Century Excellent Talents in Universities (NCET-10-0644), and the Open Research Fund of State Key Laboratory of Hybrid Rice (Wuhan University) (KF201301), the grant from State Key Lab of Space Medicine Fundamentals and Application (SMFA09A07, SMFA10A03) and a grant from Shenzhen (JCYJ20120619151640947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-Moshe NB, 2012, NUCLEIC ACIDS RES, V40, P10614, DOI 10.1093/nar/gks841; Besemann C, 2006, SOURCE CODE BIOL MED, V1, DOI 10.1186/1751-0473-1-8; Blattner C, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.68; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Huang L, 2012, BIOCHEM BIOPH RES CO, V425, P127, DOI 10.1016/j.bbrc.2012.07.025; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jiang W, 2012, SCI REP-UK, V2, DOI 10.1038/srep00282; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn610; Lida Zhu, 2011, 2011 IEEE International Conference on Systems Biology (ISB), P292, DOI 10.1109/ISB.2011.6033168; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Manavalan TT, 2011, CANCER LETT, V313, P26, DOI 10.1016/j.canlet.2011.08.018; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Redova M, 2011, BIOCHEM BIOPH RES CO, V405, P153, DOI 10.1016/j.bbrc.2011.01.019; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Seemanov E, 2007, JNCI-J NATL CANCER I, V99, P1875, DOI 10.1093/jnci/djm251; Shigemizu D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002347; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Slattery ML, 2011, GENE CHROMOSOME CANC, V50, P196, DOI 10.1002/gcc.20844; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Steffen J, 2006, INT J CANCER, V119, P472, DOI 10.1002/ijc.21853; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; VandenBoom TG, 2008, CURR GENOMICS, V9, P97, DOI 10.2174/138920208784139555; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Weigelt B, 2012, NAT REV CLIN ONCOL, V9, P58, DOI 10.1038/nrclinonc.2011.125; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xiong JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013937; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Zhou YM, 2010, P NATL ACAD SCI USA, V107, P7904, DOI 10.1073/pnas.0908441107	62	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98140	10.1371/journal.pone.0098140	http://dx.doi.org/10.1371/journal.pone.0098140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848634	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600092
J	Koga, M; Satoh, T; Takasaki, I; Kawamura, Y; Yoshida, M; Kaida, D				Koga, Mitsunori; Satoh, Takayuki; Takasaki, Ichiro; Kawamura, Yumi; Yoshida, Minoru; Kaida, Daisuke			U2 snRNP Is Required for Expression of the 3 ' End of Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; NUCLEAR RETENTION; ANTITUMOR SUBSTANCES; MAMMALIAN-CELLS; TRANSCRIPTION; ELONGATION; SPLICEOSTATIN; DEGRADATION; COMPLEX	Pre-mRNA in eukaryotes is subjected to mRNA processing, which includes capping, polyadenylation, and splicing. Transcription and mRNA processing are coupled, and this coupling stimulates mRNA processing; however, the effects of mRNA processing on transcription are not fully understood. In this study, we found that inhibition of U2 snRNP by a splicing inhibitor, spliceostatin A (SSA), or by an antisense oligonucleotide to U2 snRNA, caused gene-specific 3'-end down-regulation. Removal of SSA from the culture media restored expression of the 3' ends of genes, suggesting that U2 snRNP is required for expression of the 3' end of genes. Finally, we found that SSA treatment caused accumulation of Pol II near the 5' end of 3'-end down regulated genes, such as CDK6, SMEK2 and EGFR, indicating that SSA treatment led to transcription elongation arrest on these genes. These findings suggest that U2 snRNP is important for production of full length mRNA probably through regulation of transcription elongation, and that a novel checkpoint mechanism prevents pre-mRNA from accumulating as a result of splicing deficiencies, and thereby prevents production of aberrant proteins that might be translated from pre-mRNAs through the arrest of transcription elongation.	[Koga, Mitsunori; Satoh, Takayuki; Kaida, Daisuke] Toyama Univ, Frontier Res Core Life Sci, Toyama 930, Japan; [Takasaki, Ichiro] Toyama Univ, Life Sci Res Ctr, Div Mol Genet Res, Toyama 930, Japan; [Kawamura, Yumi] RIKEN Ctr Sustainable Resource Sci, Mol Ligand Target Res Team, Wako, Saitama, Japan; [Yoshida, Minoru] RIKEN, Chem Genet Lab, Wako, Saitama, Japan; [Yoshida, Minoru] CREST, JST, Kawaguchi, Saitama, Japan	University of Toyama; University of Toyama; RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Kaida, D (corresponding author), Toyama Univ, Frontier Res Core Life Sci, Toyama 930, Japan.	kaida@med.u-toyama.ac.jp	Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674; Kaida, Daisuke/0000-0003-4014-5231	Program to Disseminate Tenure Tracking System, JST; JSPS [23870010, 25711001]; Sumitomo Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sagawa Foundation for Promotion of Cancer Research; Kowa Life Science Foundation; Human Frontier Science Program [RGY0080/2013]; Grants-in-Aid for Scientific Research [21228003] Funding Source: KAKEN	Program to Disseminate Tenure Tracking System, JST; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sagawa Foundation for Promotion of Cancer Research; Kowa Life Science Foundation; Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program to Disseminate Tenure Tracking System, JST, and Grants-in-Aid from JSPS (23870010, 25711001), the Sumitomo Foundation, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Sagawa Foundation for Promotion of Cancer Research, Kowa Life Science Foundation and Human Frontier Science Program (RGY0080/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brody Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000573; Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Furumai R, 2010, CANCER SCI, V101, P2483, DOI 10.1111/j.1349-7006.2010.01686.x; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gowher H, 2012, P NATL ACAD SCI USA, V109, P2370, DOI 10.1073/pnas.1121538109; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Hagiwara M, 2007, J BIOCHEM, V142, P11, DOI 10.1093/jb/mvm123; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kim S, 2011, N KOREAN REV, V7, P3; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Martins SB, 2011, NAT STRUCT MOL BIOL, V18, P1115, DOI 10.1038/nsmb.2124; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nakajima H, 1996, J ANTIBIOT, V49, P1204; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Takemura R, 2011, GENES CELLS, V16, P1035, DOI 10.1111/j.1365-2443.2011.01548.x; Tomecki R, 2010, CHEMBIOCHEM, V11, P938, DOI 10.1002/cbic.201000025; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	39	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98015	10.1371/journal.pone.0098015	http://dx.doi.org/10.1371/journal.pone.0098015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845214	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400080
J	Legleye, S; Beck, F; Spilka, S; Chau, N				Legleye, Stephane; Beck, Francois; Spilka, Stanislas; Chau, Nearkasen			Correction of Body-Mass Index Using Body-Shape Perception and Socioeconomic Status in Adolescent Self-Report Surveys	PLOS ONE			English	Article							CHILD OVERWEIGHT; MEASURED BMI; WEIGHT; OBESITY; HEIGHT; PREVALENCE; HEALTH; DISSATISFACTION; IMAGE; ACCURACY	Objectives: To propose a simple correction of body-mass index (BMI) based on self-reported weight and height (reported BMI) using gender, body shape perception and socioeconomic status in an adolescent population. Methods: 341 boys and girls aged 17-18 years were randomly selected from a representative sample of 2165 French adolescents living in Paris surveyed in 2010. After an anonymous self-administered pen-and-paper questionnaire asking for height, weight, body shape perception (feeling too thin, about the right weight or too fat) and socioeconomic status, subjects were measured and weighed. BMI categories were computed according to Cole's cut-offs. Reported BMIs were corrected using linear regressions and ROC analyses and checked with cross-validation and multiple imputations to handle missing values. Agreement between actual and corrected BMI values was estimated with Kappa indexes and Intraclass correlation coefficients (ICC). Results: On average, BMIs were underreported, especially among girls. Kappa indexes between actual and reported BMI were low, especially for girls: 0.56 95% CI = [0.42-0.70] for boys and 0.45 95% CI = [0.30-0.60] for girls. The regression of reported BMI by gender and body shape perception gave the most balanced results for both genders: the Kappa and ICC obtained were 0.63 95% CI = [0.50-0.76] and 0.67, 95% CI = [0.58-0.74] for boys; 0.65 95% CI = [0.52-0.78] and 0.74, 95% CI = [0.66-0.81] for girls. The regression of reported BMI by gender and socioeconomic status led to similar corrections while the ROC analyses were inaccurate. Conclusions: Using body shape perception, or socioeconomic status and gender is a promising way of correcting BMI in self-administered questionnaires, especially for girls.	[Legleye, Stephane] INED, Paris, France; [Legleye, Stephane; Chau, Nearkasen] Univ Paris 11, INSERM, U669, Paris, France; [Legleye, Stephane; Chau, Nearkasen] Univ Paris 05, UMR S0669, Paris, France; [Beck, Francois] INPES, St Denis, France; [Beck, Francois] Univ Paris 05, Equipe Cesames Cermes3, Ctr Rech Med, CNRS,UMR 8211,Inserm,U988,EHESS, Paris, France; [Spilka, Stanislas] OFDT, French Monitoring Ctr Drugs & Drug Addict, St Denis, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Legleye, S (corresponding author), INED, Paris, France.	Stephane.legleye@ined.fr	Legleye, Stéphane/L-3546-2019	Legleye, Stéphane/0000-0002-1704-2499; Beck, Francois/0000-0002-4880-1638	OFDT; INED	OFDT; INED	The study was funded by the OFDT and the INED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2008, BODY IMAGE, V5, P261, DOI 10.1016/j.bodyim.2008.03.005; BECK F, 2006, METHODES ENQUETES SO, P56; Benach J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2154; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Bostrom G, 1997, INT J EPIDEMIOL, V26, P860, DOI 10.1093/ije/26.4.860; Brener ND, 2003, J ADOLESCENT HEALTH, V32, P281, DOI 10.1016/S1054-139X(02)00708-5; Brettschneider Anna-Kristin, 2011, BMC Res Notes, V4, P414, DOI 10.1186/1756-0500-4-414; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Chau N, 2013, BMC PUBLIC IN PRESS; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dauphinot V, 2009, J EPIDEMIOL COMMUN H, V63, P128, DOI 10.1136/jech.2008.077800; Dauphinot V, 2006, QUESTIONS EC SANTE, P1; de Leeuw E. D., 2008, INT HDB SURVEY METHO; Dupuy M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-442; Emery C, 2007, PRESSE MED, V36, P832, DOI 10.1016/j.lpm.2006.12.031; Etile F, 2007, HEALTH ECON, V16, P945, DOI 10.1002/hec.1251; Gil J, 2011, ECON HUM BIOL, V9, P78, DOI 10.1016/j.ehb.2010.05.016; Godart N.T., 2013, OPEN J EPIDEMIOL, V03, P53, DOI [10.4236/ojepi.2013.32009, DOI 10.4236/0JEPI.2013.32009, DOI 10.4236/OJEPI.2013.32009]; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697; Hayden-Wade HA, 2005, OBES RES, V13, P1381, DOI 10.1038/oby.2005.167; Henrion R, 2002, B ACAD NATL MED, V185, P445; Himes JH, 2005, ANN EPIDEMIOL, V15, P272, DOI 10.1016/j.annepidem.2004.08.010; Himes JH, 2009, PEDIATRICS, V124, pS3, DOI 10.1542/peds.2008-3586D; *INSEE, 2009, PCS 2003 NIV 1 LIST; Jansen W, 2008, J ADOLESCENT HEALTH, V42, P128, DOI 10.1016/j.jadohealth.2007.07.015; Julia C., 2010, Bulletin Epidemiologique Hebdomadaire, P69; Kurth BM, 2010, OBESITY FACTS, V3, P181, DOI 10.1159/000314638; Kurth BM, 2008, DTSCH ARZTEBL INT, V105, P406, DOI 10.3238/arztebl.2008.0406; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legleye S, 2013, INT J DRUG POLICY; Legleye S, 2012, J ADOLESCENT HEALTH, V50, P395, DOI 10.1016/j.jadohealth.2011.08.004; Legleye S, 2011, ADDICTION, V106, P1520, DOI 10.1111/j.1360-0443.2011.03447.x; Lien N, 2001, J EPIDEMIOL COMMUN H, V55, P731, DOI 10.1136/jech.55.10.731; Lioret S, 2009, OBESITY, V17, P1092, DOI 10.1038/oby.2008.619; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; McCabe MP, 2010, EAT BEHAV, V11, P156, DOI 10.1016/j.eatbeh.2010.01.005; McCabe MP, 2003, J SOC PSYCHOL, V143, P5, DOI 10.1080/00224540309598428; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Olivardia R., 2004, PSYCHOL MEN MASCULIN, V5, P112, DOI [10.1037/1524-9220.5.2.112, DOI 10.1037/1524-9220.5.2.112]; Perrin EM, 2010, INT J EAT DISORDER, V43, P447, DOI 10.1002/eat.20710; Pitrou I, 2010, OBESITY, V18, P809, DOI 10.1038/oby.2009.278; Pope HG, 1999, INT J EAT DISORDER, V26, P65, DOI 10.1002/(SICI)1098-108X(199907)26:1<65::AID-EAT8>3.3.CO;2-4; Rasmussen F, 2007, EUR J CLIN NUTR, V61, P870, DOI 10.1038/sj.ejcn.1602595; Rey J. M., 1992, INT J METH PSYCH RES, V2, P1; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Rubin DB, 2004, MULTIPLE IMPUTATION; Saint-Pol, 2010, CORPS DESIRABLE HOMM; Salanave B, 2009, INT J PEDIATR OBES, V4, P66, DOI 10.1080/17477160902811207; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Sherry B, 2007, ARCH PEDIAT ADOL MED, V161, P1154, DOI 10.1001/archpedi.161.12.1154; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96768	10.1371/journal.pone.0096768	http://dx.doi.org/10.1371/journal.pone.0096768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844229	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400011
J	Nan, HY; Cao, D; Zhang, DY; Li, Y; Lu, SJ; Tang, LL; Yuan, XH; Liu, BH; Kong, FJ				Nan, Haiyang; Cao, Dong; Zhang, Dayong; Li, Ying; Lu, Sijia; Tang, Lili; Yuan, Xiaohui; Liu, Baohui; Kong, Fanjiang			GmFT2a and GmFT5a Redundantly and Differentially Regulate Flowering through Interaction with and Upregulation of the bZIP Transcription Factor GmFDL19 in Soybean	PLOS ONE			English	Article							MAP-BASED CLONING; LOCUS-T; PHOTOPERIOD RESPONSE; GENETIC-VARIATION; MATURITY; TIME; PROTEIN; FT; ACTIVATION; SIGNALS	FLOWERING LOCUS T (FT) is the key flowering integrator in Arabidopsis (Arabidopsis thaliana), and its homologs encode florigens in many plant species regardless of their photoperiodic response. Two FT homologs, GmFT2a and GmFT5a, are involved in photoperiod-regulated flowering and coordinately control flowering in soybean. However, the molecular and genetic understanding of the roles played by GmFT2a and GmFT5a in photoperiod-regulated flowering in soybean is very limited. In this study, we demonstrated that GmFT2a and GmFT5a were able to promote early flowering in soybean by overexpressing these two genes in the soybean cultivar Williams 82 under noninductive long-day (LD) conditions. The soybean homologs of several floral identity genes, such as GmAP1, GmSOC1 and GmLFY, were significantly upregulated by GmFT2a and GmFT5a in a redundant and differential pattern. A bZIP transcription factor, GmFDL19, was identified as interacting with both GmFT2a and GmFT5a, and this interaction was confirmed by yeast two-hybridization and bimolecular fluorescence complementation (BiFC). The overexpression of GmFDL19 in soybean caused early flowering, and the transcription levels of the flowering identity genes were also upregulated by GmFDL19, as was consistent with the upregulation of GmFT2a and GmFT5a. The transcription of GmFDL19 was also induced by GmFT2a. The results of the electrophoretic mobility shift assay (EMSA) indicated that GmFDL19 was able to bind with the cis-elements in the promoter of GmAP1a. Taken together, our results suggest that GmFT2a and GmFT5a redundantly and differentially control photoperiod-regulated flowering in soybean through both physical interaction with and transcriptional upregulation of the bZIP transcription factor GmFDL19, thereby inducing the expression of floral identity genes.	[Nan, Haiyang; Cao, Dong; Lu, Sijia; Tang, Lili; Yuan, Xiaohui; Liu, Baohui; Kong, Fanjiang] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin, Peoples R China; [Nan, Haiyang; Lu, Sijia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Dayong] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China; [Li, Ying] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jiangsu Academy of Agricultural Sciences; Northeast Forestry University - China	Liu, BH (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin, Peoples R China.	liubh@iga.ac.cn; kongfj@iga.ac.cn	Kong, Fanjiang/AGQ-2334-2022	Kong, Fanjiang/0000-0001-7138-1478	National Natural Science Foundation of China [31071445, 31171579, 31201222, 31371643]; Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences [XDA08030108]; Heilongjiang Natural Science Foundation of China [ZD201001, JC201313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences; Heilongjiang Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province)	National Natural Science Foundation of China (31071445, 31171579, 31201222 and 31371643); the Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; the "Hundred Talents" Program of the Chinese Academy of Sciences; the Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences (XDA08030108); and the Heilongjiang Natural Science Foundation of China (ZD201001, JC201313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Blazquez MA, 2000, J CELL SCI, V113, P3547; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Chi YJ, 2011, J PLANT PHYSIOL, V168, P2251, DOI 10.1016/j.jplph.2011.08.007; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Flores T, 2008, TRANSGENIC RES, V17, P839, DOI 10.1007/s11248-008-9167-6; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; Meng QC, 2007, SEED SCI RES, V17, P297, DOI 10.1017/S0960258507836282; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Mimida N, 2001, GENES CELLS, V6, P327, DOI 10.1046/j.1365-2443.2001.00425.x; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Na XF, 2013, PLANT CELL REP, V32, P1219, DOI 10.1007/s00299-013-1419-0; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheen J, 2002, SCIENCE, V296, P1650, DOI 10.1126/science.1071883; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Tsubokura Y, 2013, AGRONOMY-BASEL, V3, P117, DOI 10.3390/agronomy3010117; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xia ZJ, 2012, PLANT SYST EVOL, V298, P1217, DOI 10.1007/s00606-012-0628-2; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yoo SJ, 2010, PLANT J, V63, P241, DOI 10.1111/j.1365-313X.2010.04234.x; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yoo SY, 2004, MOL CELLS, V17, P95; Zhong XF, 2012, MOL BIOL REP, V39, P6967, DOI 10.1007/s11033-012-1524-0	53	83	101	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97669	10.1371/journal.pone.0097669	http://dx.doi.org/10.1371/journal.pone.0097669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845624	Green Submitted, gold, Green Published			2022-12-27	WOS:000339563400042
J	Arya, VB; Senniappan, S; Demirbilek, H; Alam, S; Flanagan, SE; Ellard, S; Hussain, K				Arya, Ved Bhushan; Senniappan, Senthil; Demirbilek, Huseyin; Alam, Syeda; Flanagan, Sarah E.; Ellard, Sian; Hussain, Khalid			Pancreatic Endocrine and Exocrine Function in Children following Near-Total Pancreatectomy for Diffuse Congenital Hyperinsulinism	PLOS ONE			English	Article							SULFONYLUREA RECEPTOR SUR1; 95-PERCENT PANCREATECTOMY; GLUCOSE-METABOLISM; HYPOGLYCEMIA; INFANCY; NESIDIOBLASTOSIS; MUTATIONS; MANAGEMENT; GENE	Context: Congenital hyperinsulinism (CHI), the commonest cause of persistent hypoglycaemia, has two main histological subtypes: diffuse and focal. Diffuse CHI, if medically unresponsive, is managed with near-total pancreatectomy. Post-pancreatectomy, in addition to persistent hypoglycaemia, there is a very high risk of diabetes mellitus and pancreatic exocrine insufficiency. Setting: International referral centre for the management of CHI. Patients: Medically unresponsive diffuse CHI patients managed with near-total pancreatectomy between 1994 and 2012. Intervention: Near-total pancreatectomy. Main Outcome Measures: Persistent hypoglycaemia post near-total pancreatectomy, insulin-dependent diabetes mellitus, clinical and biochemical (faecal elastase 1) pancreatic exocrine insufficiency. Results: Of more than 300 patients with CHI managed during this time period, 45 children had medically unresponsive diffuse disease and were managed with near-total pancreatectomy. After near-total pancreatectomy, 60% of children had persistent hypoglycaemia requiring medical interventions. The incidence of insulin dependent diabetes mellitus was 96% at 11 years after surgery. Thirty-two patients (72%) had biochemical evidence of severe pancreatic exocrine insufficiency (Faecal elastase 1,100 mg/g). Clinical exocrine insufficiency was observed in 22 (49%) patients. No statistically significant difference in weight and height standard deviation score (SDS) was found between untreated subclinical pancreatic exocrine insufficiency patients and treated clinical pancreatic exocrine insufficiency patients. Conclusions: The outcome of diffuse CHI patients after near-total pancreatectomy is very unsatisfactory. The incidence of persistent hypoglycaemia and insulin-dependent diabetes mellitus is very high. The presence of clinical rather than biochemical pancreatic exocrine insufficiency should inform decisions about pancreatic enzyme supplementation.	[Arya, Ved Bhushan; Senniappan, Senthil; Demirbilek, Huseyin; Alam, Syeda; Hussain, Khalid] Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Endocrinol, London, England; [Arya, Ved Bhushan; Senniappan, Senthil; Demirbilek, Huseyin; Hussain, Khalid] UCL, Inst Child Hlth, London, England; [Demirbilek, Huseyin] Ankara Pediat Hematol & Oncol Training Hosp, Dept Paediat Endocrinol, Ankara, Turkey; [Flanagan, Sarah E.; Ellard, Sian] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Exeter	Hussain, K (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Endocrinol, London, England.	Khalid.Hussain@ucl.ac.uk	Demirbilek, Huseyin/AAK-6434-2021	Ellard, Sian/0000-0002-7620-5526; Flanagan, Sarah/0000-0002-8670-6340	Medical Research Council [G1001821] Funding Source: Medline; MRC [G1001821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aynsley-Green A, 2000, ARCH DIS CHILD-FETAL, V82, pF98, DOI 10.1136/fn.82.2.F98; Beltrand J, 2012, DIABETES CARE, V35, P198, DOI 10.2337/dc11-1296; Cade A, 1998, ARCH DIS CHILD, V79, P435, DOI 10.1136/adc.79.5.435; Cherian MP, 2005, J PEDIATR ENDOCR MET, V18, P1441; DUNGER DB, 1988, J PEDIATR SURG, V23, P112, DOI 10.1016/S0022-3468(88)80136-2; Flanagan SE, 2013, AM J HUM GENET, V92, P131, DOI 10.1016/j.ajhg.2012.11.017; Keller J, 2009, BEST PRACT RES CL GA, V23, P425, DOI 10.1016/j.bpg.2009.02.013; LANGER JC, 1984, J PEDIATR SURG, V19, P786, DOI 10.1016/S0022-3468(84)80369-3; LEIBOWITZ G, 1995, J CLIN ENDOCR METAB, V80, P386, DOI 10.1210/jc.80.2.386; Loser C, 1996, GUT, V39, P580, DOI 10.1136/gut.39.4.580; Lovvorn HN, 1999, J PEDIATR SURG, V34, P786, DOI 10.1016/S0022-3468(99)90374-3; Ludwig A, 2011, SEMIN PEDIATR SURG, V20, P45, DOI 10.1053/j.sempedsurg.2010.10.005; MacMullen CM, 2011, DIABETES, V60, P1797, DOI 10.2337/db10-1631; Meissner T, 2003, EUR J ENDOCRINOL, V149, P43, DOI 10.1530/eje.0.1490043; Rahier J, 2000, ARCH DIS CHILD-FETAL, V82, pF108, DOI 10.1136/fn.82.2.F108; Rother K I, 2001, Pediatr Diabetes, V2, P115, DOI 10.1034/j.1399-5448.2001.002003115.x; Shilyansky J, 1997, J PEDIATR SURG, V32, P342, DOI 10.1016/S0022-3468(97)90207-4; Stein J, 1996, CLIN CHEM, V42, P222; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Verkarre V, 1998, J CLIN INVEST, V102, P1286, DOI 10.1172/JCI4495	21	52	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98054	10.1371/journal.pone.0098054	http://dx.doi.org/10.1371/journal.pone.0098054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840042	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600105
J	Feldblum, PJ; Enosse, S; Dube, K; Arnaldo, P; Muluana, C; Banze, R; Nhanala, A; Cunaca, J; Chen, PL; Robb, ML; Thompson, R				Feldblum, Paul J.; Enosse, Sonia; Dube, Karine; Arnaldo, Paulo; Muluana, Chadreque; Banze, Reginaldo; Nhanala, Aristides; Cunaca, Joana; Chen, Pai-Lien; Robb, Merlin L.; Thompson, Ricardo			HIV Prevalence and Incidence in a Cohort of Women at Higher Risk for HIV Acquisition in Chokwe, Southern Mozambique	PLOS ONE			English	Article								Background: Reliable HIV incidence estimates for Mozambique are limited. We conducted a prospective HIV incidence study as part of a clinical research site development initiative in Chokwe district, Gaza Province, southern Mozambique. Methods: Between June 2010 and October 2012, we recruited women at sites where women at higher risk of HIV infection would likely be found. We enrolled and tested 1,429 sexually active women in the screening phase and 479 uninfected women in the prospective phase. Participants were scheduled for 12+ months follow-up, when they underwent face-to-face interviews, HIV counseling and testing, and pregnancy testing. We observed a total of 373.1 woman-years (WY) of follow-up, with mean (median) of 9.4 (9.7) women-months per participant. Results: The prevalence of HIV was 29.4% (95% confidence interval [CI]: 27.0-31.8%). In multivariable logistic regression analysis, factors that remained significantly associated with prevalent HIV were: older age (OR: 0.6; 95% CI: 0.4-0.7), lower educational level (OR: 0.4; 95% CI: 0.3-0.7), and using hormonal contraception (OR: 0.6; 95% CI: 0.4-0.7) or condoms (OR: 0.5; 95% CI: 0.3-0.7). We observed an HIV incidence rate of 4.6 per 100 WY (95% CI: 2.7, 7.3). The HIV incidence was 4.8 per 100 WY (95% CI: 2.5, 8.3) in women aged 18-24 years, 4.5 per 100 WY (95% CI: 1.2, 11.4) in women aged 25-29 years and 3.2 per 100 WY (95% CI: 0.1, 18.0) in the 30-35 years stratum. None of the demographic factors or time-varying behavioral factors examined was significantly associated with incident HIV infection in bivariable analysis at p <= 0.10. Conclusions: We found a high HIV incidence among sexually active young women in Chokwe, Mozambique. HIV prevention programs should be strengthened in the area, with more comprehensive reproductive health services, regular HIV testing, condom promotion, and messaging about multiple sexual partners.	[Feldblum, Paul J.; Chen, Pai-Lien] FHI 360, Durham, NC 27701 USA; [Enosse, Sonia; Arnaldo, Paulo; Muluana, Chadreque; Banze, Reginaldo; Nhanala, Aristides; Cunaca, Joana; Thompson, Ricardo] Natl Inst Hlth, Chokwe Hlth Res & Training Ctr, Ctr Invest & Treino Saude Chokwe, Hygiene, Mozambique; [Dube, Karine] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Robb, Merlin L.] Henry M Jackson Fdn Adv Mil Med Inc HJF, United States Mil HIV Res Program MHRP, Bethesda, MD USA	FHI 360; University of North Carolina; University of North Carolina Chapel Hill; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR)	Feldblum, PJ (corresponding author), FHI 360, Durham, NC 27701 USA.	pfeldblum@fhi360.org		Arnaldo, Paulo/0000-0001-8747-5209; Enosse, Sonia Maria Mauricio/0000-0002-2586-2083	United States Agency for International Development (USAID); United States Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; USAID [GHO A 00 09 00016-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); United States Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; USAID(United States Agency for International Development (USAID))	This work is made possible by the the United States Agency for International Development (USAID) and by the United States Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). Financial assistance was provided by USAID to FHI 360 under the terms of the Preventive Technologies Agreement No. GHO A 00 09 00016-00. The views expressed are those of the authors and should not be construed to represent the positions of FHI 360, USAID, the United States Army, the United States Department of Defense, or the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WORLD AIDS DAY 2014; Collins C J L., 2006, MOZAMBIQUES HIV AIDS; Crush J., 2010, MIGRATION POLICY SER, V53; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, NAT SURV PREV BEH RI; Speizer IS, 2008, AIDS EDUC PREV, V20, P531, DOI 10.1521/aeap.2008.20.6.531; Zango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063427	8	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97547	10.1371/journal.pone.0097547	http://dx.doi.org/10.1371/journal.pone.0097547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842811	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600042
J	Jackson, D; Vandermeer, J; Perfecto, I; Philpott, SM				Jackson, Doug; Vandermeer, John; Perfecto, Ivette; Philpott, Stacy M.			Population Responses to Environmental Change in a Tropical Ant: The Interaction of Spatial and Temporal Dynamics	PLOS ONE			English	Article							COFFEE BERRY BORER; SELF-ORGANIZATION; LECANICILLIUM-LECANII; ENTOMOGENOUS FUNGUS; SIZE DISTRIBUTIONS; HEMILEIA-VASTATRIX; ARBOREAL ANT; MUTUALISM; PATTERNS; SCALE	Spatial structure can have a profound, but often underappreciated, effect on the temporal dynamics of ecosystems. Here we report on a counterintuitive increase in the population of a tree-nesting ant, Azteca sericeasur, in response to a drastic reduction in the number of potential nesting sites. This surprising result is comprehensible when viewed in the context of the self-organized spatial dynamics of the ants and their effect on the ants' dispersal-limited natural enemies. Approximately 30% of the trees in the study site, a coffee agroecosystem in southern Mexico, were pruned or felled over a two-year period, and yet the abundance of the ant nests more than doubled over the seven-year study. Throughout the transition, the spatial distribution of the ants maintained a power-law distribution - a signal of spatial self organization - but the local clustering of the nests was reduced post-pruning. A cellular automata model incorporating the changed spatial structure of the ants and the resulting partial escape from antagonists reproduced the observed increase in abundance, highlighting how self-organized spatial dynamics can profoundly influence the responses of ecosystems to perturbations.	[Jackson, Doug; Vandermeer, John] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Vandermeer, John; Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Philpott, Stacy M.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Santa Cruz	Jackson, D (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	dougjack@dougjackson.net	Philpott, Stacy/M-3486-2019; Philpott, Stacy M/F-2330-2011	Philpott, Stacy/0000-0002-8338-3806; Philpott, Stacy M/0000-0002-8338-3806	NSF [DEB-0349388, DEB-1020096]; Graham Environmental Sustainability Institute; Direct For Biological Sciences [1262086] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Graham Environmental Sustainability Institute; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NSF grant to J.V. and I. P.: DEB-0349388; NSF grant to S. P.: DEB-1020096; Graham Environmental Sustainability Institute Doctoral Fellowship to D.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak P., 1996, NATURE WORKS; Bascompte J, 1998, TRENDS ECOL EVOL, V13, P173, DOI 10.1016/S0169-5347(98)01325-1; CONNELL J H, 1971, P298; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Haase P, 1995, J VEG SCI, V10, P433; Holldobler B., 1990, pi; Jackson D., 2012, Tropical and Subtropical Agroecosystems, V15, P389; Jackson D., 2009, Open Ecology Journal, V2, P62, DOI 10.2174/1874213000902010062; Jackson D, 2014, OIKOS, V123, P751, DOI 10.1111/j.1600-0706.2013.00827.x; Jackson D, 2012, BIOL CONTROL, V61, P89, DOI 10.1016/j.biocontrol.2012.01.004; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jensen H.J., 1998, SELF ORG CRITICALITY; Jimenez-Soto E, 2013, ENVIRON ENTOMOL, V42, P915, DOI 10.1603/EN12202; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2011, ECOL LETT, V14, P29, DOI 10.1111/j.1461-0248.2010.01553.x; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liere H, 2008, ENVIRON ENTOMOL, V37, P143, DOI 10.1603/0046-225X(2008)37[143:COAMIB]2.0.CO;2; Liere H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045508; Liere H, 2010, OIKOS, V119, P1394, DOI 10.1111/j.1600-0706.2010.17985.x; Pardee GL, 2011, ENVIRON ENTOMOL, V40, P581, DOI 10.1603/EN11015; Pascual M, 1999, ECOLOGY, V80, P2225, DOI 10.1890/0012-9658(1999)080[2225:FITPDS]2.0.CO;2; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Perfecto I, 2008, ECOLOGY, V89, P915, DOI 10.1890/06-2121.1; Perfecto I, 2006, AGR ECOSYST ENVIRON, V117, P218, DOI 10.1016/j.agee.2006.04.007; Philpott SM, 2006, BIODIVERS CONSERV, V15, P139, DOI 10.1007/s10531-004-4247-2; Philpott SM, 2012, ECOLOGY, V93, P992, DOI 10.1890/11-1431.1; Philpott SM, 2009, ENVIRON ENTOMOL, V38, P790, DOI 10.1603/022.038.0331; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Ruiz J, 2010, REV BIOL TROP, V58, P991; STAUFFER D, 1994, INTRO PERCOLATION TH; Strassmann JE, 2007, P NATL ACAD SCI USA, V104, P8619, DOI 10.1073/pnas.0701285104; Uno S, 2007, THESIS U MICHIGAN AN; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; Vandermeer J, 2009, PLANT PATHOL, V58, P636, DOI 10.1111/j.1365-3059.2009.02067.x; Vandermeer J, 2008, NATURE, V451, P457, DOI 10.1038/nature06477; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8	40	5	6	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97809	10.1371/journal.pone.0097809	http://dx.doi.org/10.1371/journal.pone.0097809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842117	Green Published, gold			2022-12-27	WOS:000340948600077
J	Fujii, S; Watanabe, H; Oohashi, H; Hirashima, M; Nozaki, D; Taga, G				Fujii, Shinya; Watanabe, Hama; Oohashi, Hiroki; Hirashima, Masaya; Nozaki, Daichi; Taga, Gentaro			Precursors of Dancing and Singing to Music in Three- to Four-Months-Old Infants	PLOS ONE			English	Article							SPEECH; BEAT; SYNCHRONIZATION; EVOLUTION; ENTRAINMENT; MOVEMENTS; RESPONSES; RHYTHM; PERCEPTION; IMITATION	Dancing and singing to music involve auditory-motor coordination and have been essential to our human culture since ancient times. Although scholars have been trying to understand the evolutionary and developmental origin of music, early human developmental manifestations of auditory-motor interactions in music have not been fully investigated. Here we report limb movements and vocalizations in three- to four-months-old infants while they listened to music and were in silence. In the group analysis, we found no significant increase in the amount of movement or in the relative power spectrum density around the musical tempo in the music condition compared to the silent condition. Intriguingly, however, there were two infants who demonstrated striking increases in the rhythmic movements via kicking or arm-waving around the musical tempo during listening to music. Monte-Carlo statistics with phase-randomized surrogate data revealed that the limb movements of these individuals were significantly synchronized to the musical beat. Moreover, we found a clear increase in the formant variability of vocalizations in the group during music perception. These results suggest that infants at this age are already primed with their bodies to interact with music via limb movements and vocalizations.	[Fujii, Shinya] Heart & Stroke Fdn Canadian Partnership Stroke Re, Sunnybrook Res Inst, Toronto, ON, Canada; [Watanabe, Hama; Oohashi, Hiroki; Hirashima, Masaya; Nozaki, Daichi; Taga, Gentaro] Univ Tokyo, Bunkyo Ku, Grad Sch Educ, Tokyo 113, Japan; [Fujii, Shinya; Oohashi, Hiroki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Tokyo; Japan Society for the Promotion of Science	Fujii, S (corresponding author), Heart & Stroke Fdn Canadian Partnership Stroke Re, Sunnybrook Res Inst, Toronto, ON, Canada.	sfujii@sri.utoronto.ca		Nozaki, Daichi/0000-0002-1338-8337	Japan Society for the Promotion of Science [22-7777, 23700682, 20670001, 24119002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was supported by a Grant for the Fellows of the Japan Society for the Promotion of Science (No. 22-7777) awarded to S. F., a Grant-in-Aid for Scientific Research (No. 23700682) awarded to H. W., and a Grant-in-Aid for Scientific Research (No. 20670001 and 24119002) awarded to G. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma P., 2020, PRAAT DOING PHONETIC; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; Darwin C., 1871, P423; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Ellis DPW, 2007, J NEW MUSIC RES, V36, P51, DOI 10.1080/09298210701653344; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fujii S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00771; Fujioka T, 2010, J NEUROSCI, V30, P3458, DOI 10.1523/JNEUROSCI.3086-09.2010; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; HADDERSALGRA M, 1992, EARLY HUM DEV, V28, P201, DOI 10.1016/0378-3782(92)90167-F; Hannon EE, 2005, COGNITIVE PSYCHOL, V50, P354, DOI 10.1016/j.cogpsych.2004.09.003; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Kato M., 2013, J MOTOR LEARNING DEV, V1, P79, DOI [10.1123/jmld.1.4.79, DOI 10.1123/JMLD.1.4.79]; Kawahara H, 1999, SPEECH COMMUN, V27, P187, DOI 10.1016/S0167-6393(98)00085-5; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Kotilahti K, 2010, HUM BRAIN MAPP, V31, P595, DOI 10.1002/hbm.20890; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Kung SJ, 2013, J COGNITIVE NEUROSCI, V25, P401, DOI 10.1162/jocn_a_00325; Masataka N, 2007, DEVELOPMENTAL SCI, V10, P35, DOI 10.1111/j.1467-7687.2007.00561.x; Masataka N, 2009, PHYS LIFE REV, V6, P11, DOI 10.1016/j.plrev.2008.08.003; Mase M, 2005, PHYSIOL MEAS, V26, P911, DOI 10.1088/0967-3334/26/6/003; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MICHEL GF, 1986, DEV PSYCHOBIOL, V19, P247, DOI 10.1002/dev.420190310; Mithen S., 2005, SINGING NEANDERTHALS; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Patel AD, 2009, ANN NY ACAD SCI, V1169, P459, DOI 10.1111/j.1749-6632.2009.04581.x; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Perani D, 2010, P NATL ACAD SCI USA, V107, P4758, DOI 10.1073/pnas.0909074107; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; PRECHTL HFR, 1986, EARLY HUM DEV, V14, P233, DOI 10.1016/0378-3782(86)90184-2; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Stefanics G, 2009, CLIN NEUROPHYSIOL, V120, P304, DOI 10.1016/j.clinph.2008.11.020; Stupacher J, 2013, BRAIN COGNITION, V82, P127, DOI 10.1016/j.bandc.2013.03.003; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; TAGA G, 1991, BIOL CYBERN, V65, P147, DOI 10.1007/BF00198086; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tierney A, 2013, J NEUROSCI, V33, P14981, DOI 10.1523/JNEUROSCI.0612-13.2013; Trainor LJ, 1998, INFANT BEHAV DEV, V21, P77, DOI 10.1016/S0163-6383(98)90055-8; TREHUB SE, 1989, CAN J PSYCHOL, V43, P217, DOI 10.1037/h0084223; TREHUB SE, 1993, ADV CHILD DEV BEHAV, V24, P1, DOI 10.1016/S0065-2407(08)60298-0; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; Watanabe H, 2011, J EXP PSYCHOL HUMAN, V37, P1157, DOI 10.1037/a0021936; Watanabe H, 2009, INFANT BEHAV DEV, V32, P79, DOI 10.1016/j.infbeh.2008.10.003; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	58	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97680	10.1371/journal.pone.0097680	http://dx.doi.org/10.1371/journal.pone.0097680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24837135	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800061
J	Chen, Y; Yang, SJ; Yao, WJ; Zhu, HY; Xu, XL; Meng, GL; Zhang, W				Chen, Yun; Yang, Shengju; Yao, Wenjuan; Zhu, Hongyan; Xu, Xiaole; Meng, Guoliang; Zhang, Wei			Prostacyclin Analogue Beraprost Inhibits Cardiac Fibroblast Proliferation Depending on Prostacyclin Receptor Activation through a TGF beta-Smad Signal Pathway	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; CREB-BINDING-PROTEIN; SMOOTH-MUSCLE-CELLS; MYOCARDIAL FIBROSIS; MOLECULAR PATHWAYS; TYROSINE NITRATION; PROSTAGLANDIN I-2; MICE LACKING; ANGIOTENSIN	Previous studies showed that prostacyclin inhibited fibrosis. However, both receptors of prostacyclin, prostacyclin receptor (IP) and peroxisome proliferator-activated receptor (PPAR), are abundant in cardiac fibroblasts. Here we investigated which receptor was vital in the anti-fibrosis effect of prostacyclin. In addition, the possible mechanism involved in protective effects of prostacyclin against cardiac fibrosis was also studied. We found that beraprost, a prostacyclin analogue, inhibited angiotensin II (Ang II)-induced neonatal rat cardiac fibroblast proliferation in a concentration-dependent and time-dependent manner. Beraprost also suppressed Ang II-induced collagen I mRNA expression and protein synthesis in cardiac fibroblasts. After IP expression was knocked down by siRNA, Ang II-induced proliferation and collagen I synthesis could no longer be rescued by beraprost. However, treating cells with different specific inhibitors of PPAR subtypes prior to beraprost and Ang II stimulation, all of the above attenuating effects of beraprost were still available. Moreover, beraprost significantly blocked transforming growth factor beta (TGF beta) expression as well as Smad2 phosphorylation and reduced Smad-DNA binding activity. Beraprost also increased phosphorylation of cAMP response element binding protein (CREB) at Ser133 in the nucleus. Co-immunoprecipitation analysis revealed that beraprost increased CREB but decreased Smad2 binding to CREB-binding protein (CBP) in nucleus. In conclusion, beraprost inhibits cardiac fibroblast proliferation by activating IP and suppressing TGF beta-Smad signal pathway.	[Chen, Yun; Yao, Wenjuan; Zhu, Hongyan; Xu, Xiaole; Meng, Guoliang; Zhang, Wei] Nantong Univ, Sch Pharm, Dept Pharmacol, Nantong, Jiangsu, Peoples R China; [Yang, Shengju] Nantong Univ, Affiliated Hosp, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Meng, GL (corresponding author), Nantong Univ, Sch Pharm, Dept Pharmacol, Nantong, Jiangsu, Peoples R China.	mengguoliang@ntu.edu; zwei@ntu.edu.cn			National Natural Science Foundation of China [81202879, 81202467, 81200079]; Nature Science Foundation of Jiangsu Province University [12KJB310012, 11KJB350004]; Nature Science Foundation of Nantong City [BK2011044]; Nature Science Foundation of Nantong University [13ZY004]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province University; Nature Science Foundation of Nantong City; Nature Science Foundation of Nantong University; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81202879, 81202467, 81200079), Nature Science Foundation of Jiangsu Province University (Grant Nos. 12KJB310012, 11KJB350004), Nature Science Foundation of Nantong City (Grant No. BK2011044), Nature Science Foundation of Nantong University (Grant No. 13ZY004), and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin S, 2013, NEUROCHEM INT, V63, P322, DOI 10.1016/j.neuint.2013.06.012; Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; Baarsma HA, 2013, BRIT J PHARMACOL, V169, P590, DOI 10.1111/bph.12098; Bai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072120; Barbieri SS, 2012, CIRCULATION, V126, P1373, DOI 10.1161/CIRCULATIONAHA.112.097295; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Binello E, 2014, J NEUROONCOL; Birrane G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053819; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chan EC, 2010, J MOL CELL CARDIOL, V49, P176, DOI 10.1016/j.yjmcc.2010.04.006; Chao HH, 2010, J NUTR BIOCHEM, V21, P580, DOI 10.1016/j.jnutbio.2009.03.003; Chen HH, 2009, AM J PHYSIOL-RENAL, V297, pF1109, DOI 10.1152/ajprenal.00057.2009; Cheng CF, 2012, J CELL PHYSIOL, V227, P239, DOI 10.1002/jcp.22726; Dai Y, 2013, HYPERTENSION, V61, P751, DOI 10.1161/HYPERTENSIONAHA.111.00654; Dobaczewski M, 2012, J CARDIOVASC TRANSL, V5, P837, DOI 10.1007/s12265-012-9406-3; Dorris SL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/926968; Elnakish MT, 2013, J PATHOL, V229, P347, DOI 10.1002/path.4111; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Haack KKV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078695; Hara A, 2005, CIRCULATION, V112, P84, DOI 10.1161/CIRCULATIONAHA.104.527077; Harding P, 2011, LIFE SCI, V89, P671, DOI 10.1016/j.lfs.2011.07.025; He CY, 2010, AM J PATHOL, V176, P2542, DOI 10.2353/ajpath.2010.090783; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hou XY, 2013, EUR J PHARMACOL, V715, P196, DOI 10.1016/j.ejphar.2013.05.021; Jiang DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079215; Jin LH, 2011, J BIOL CHEM, V286, P31473, DOI 10.1074/jbc.M111.266023; Kaneshige T, 2007, J VET MED SCI, V69, P1271, DOI 10.1292/jvms.69.1271; Katusic ZS, 2012, TRENDS PHARMACOL SCI, V33, P559, DOI 10.1016/j.tips.2012.05.005; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Li Y, 2012, AM J RESP CELL MOL, V46, P372, DOI 10.1165/rcmb.2010-0428OC; Lian WS, 2013, CURR VASC PHARM; Lin H, 2008, J CELL PHYSIOL, V214, P434, DOI 10.1002/jcp.21214; Lu D, 2012, FASEB J, V26, P2580, DOI 10.1096/fj.12-204677; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Marathe HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069037; Matsuda Satoru, 2013, Cancers (Basel), V5, P1261, DOI 10.3390/cancers5041261; Meng GL, 2009, J CARDIOVASC PHARM, V54, P16, DOI 10.1097/FJC.0b013e3181a98b31; Nakayama K, 2013, J BIOL CHEM, V288, P22584, DOI 10.1074/jbc.M112.421636; Nasu T, 2012, AM J PHYSIOL-RENAL, V302, pF1616, DOI 10.1152/ajprenal.00538.2011; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Ng HK, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-188; Ogo T, 2013, AM J RESP CELL MOL, V48, P733, DOI 10.1165/rcmb.2012-0049OC; Rossoni G, 2006, PHARMACOL RES, V53, P359, DOI 10.1016/j.phrs.2006.01.004; Shahbaz AU, 2010, J HYPERTENS, V28, pS25, DOI 10.1097/01.hjh.0000388491.35836.d2; Song BS, 2009, REPROD FERT DEVELOP, V21, P400, DOI 10.1071/RD08180; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Stratton R, 2002, FASEB J, V16, P1949, DOI 10.1096/fj.02-0204fje; Sue YM, 2009, AM J PHYSIOL-CELL PH, V297, pC321, DOI 10.1152/ajpcell.00069.2009; Sun DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041857; Sun Y, 2005, METH MOLEC MED, V117, P273; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Tsai CT, 2007, CIRC RES, V100, P1476, DOI 10.1161/01.RES.0000268497.93085.e1; Tsai MC, 2009, CIRC RES, V105, P471, DOI 10.1161/CIRCRESAHA.109.193656; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Xu Q, 2013, BIOMED RES-TOKYO, V34, P241; Yamabayashi C, 2012, AM J RESP CELL MOL, V47, P170, DOI 10.1165/rcmb.2011-0350OC; Yang J, 2010, CIRC RES, V107, P252, DOI 10.1161/CIRCRESAHA.109.209940; Yu H, 1997, HYPERTENSION, V30, P1047, DOI 10.1161/01.HYP.30.5.1047; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhou TB, 2013, J RECEPT SIG TRANSD, V33, P349, DOI 10.3109/10799893.2013.838786; Zou MH, 2011, AM J PATHOL, V179, P2835, DOI 10.1016/j.ajpath.2011.08.041	64	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98483	10.1371/journal.pone.0098483	http://dx.doi.org/10.1371/journal.pone.0098483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852754	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200072
J	Das, U; Manna, K; Sinha, M; Datta, S; Das, DK; Chakraborty, A; Ghosh, M; Das Saha, K; Dey, S				Das, Ujjal; Manna, Krishnendu; Sinha, Mahuya; Datta, Sanjukta; Das, Dipesh Kr; Chakraborty, Anindita; Ghosh, Mahua; Das Saha, Krishna; Dey, Sanjit			Role of Ferulic Acid in the Amelioration of Ionizing Radiation Induced Inflammation: A Murine Model	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; ANTIOXIDANT STATUS; GENE-EXPRESSION; ACTIVATION; INVOLVEMENT; DAMAGE; INTERLEUKIN-1	Ionizing radiation is responsible for oxidative stress by generating reactive oxygen species (ROS), which alters the cellular redox potential. This change activates several redox sensitive enzymes which are crucial in activating signaling pathways at molecular level and can lead to oxidative stress induced inflammation. Therefore, the present study was intended to assess the anti-inflammatory role of ferulic acid (FA), a plant flavonoid, against radiation-induced oxidative stress with a novel mechanistic viewpoint. FA was administered (50 mg/kg body wt) to Swiss albino mice for five consecutive days prior to exposing them to a single dose of 10 Gy Co-60 gamma-irradiation. The dose of FA was optimized from the survival experiment and 50 mg/kg body wt dose showed optimum effect. FA significantly ameliorated the radiation induced inflammatory response such as phosphorylation of IKK alpha/beta and I kappa B alpha and consequent nuclear translocation of nuclear factor kappa B (NF-kappa B). FA also prevented the increase of cycloxygenase-2 (Cox-2) protein, inducible nitric oxide synthase-2 (iNOS-2) gene expression, lipid peroxidation in liver and the increase of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in serum. It was observed that exposure to radiation results in decreased activity of superoxide dismutase (SOD), catalase (CAT) and the pool of reduced glutathione (GSH) content. However, FA treatment prior to irradiation increased the activities of the same endogenous antioxidants. Thus, pretreatment with FA offers protection against gamma radiation induced inflammation.	[Das, Ujjal; Manna, Krishnendu; Sinha, Mahuya; Das, Dipesh Kr; Dey, Sanjit] Univ Calcutta, Ctr Nanosci & Nanotechnol, Dept Physiol, Kolkata, W Bengal, India; [Das, Ujjal; Manna, Krishnendu; Sinha, Mahuya; Das, Dipesh Kr; Dey, Sanjit] Univ Calcutta, CPEPA, Kolkata, W Bengal, India; [Datta, Sanjukta; Ghosh, Mahua] Univ Calcutta, Dept Chem Technol, Kolkata, W Bengal, India; [Chakraborty, Anindita] UGC DAE CSR, Ctr Kolkata, Dept Radiat Biol, Kolkata, W Bengal, India; [Das Saha, Krishna] IICB, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; University of Calcutta; UGC DAE Consortium for Scientific Research; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Dey, S (corresponding author), Univ Calcutta, Ctr Nanosci & Nanotechnol, Dept Physiol, Kolkata, W Bengal, India.	sanjitdey2003@yahoo.com	Dey, Sanjit/AAM-6497-2020	Dey, Sanjit/0000-0001-6534-0522; Manna, Krishnendu/0000-0002-5782-1585	Life Science Research Board (LSRB); CSIR; Coconut Development Board; West Bengal DBT; Department of Science and technology (DST); UGC, Government India; CRNN	Life Science Research Board (LSRB); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Coconut Development Board; West Bengal DBT; Department of Science and technology (DST)(Department of Science & Technology (India)); UGC, Government India; CRNN	SD acknowledges the support of funding by Life Science Research Board (LSRB), CSIR, Coconut Development Board, and West Bengal DBT for funding. SD acknowledges the support of Department of Science and technology (DST) for PURSE scheme to the Department of Physiology and UGC, Government India, for support under CPEPA scheme granted and CRNN to University of Calcutta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BRACH MA, 1991, J CLIN INVEST, V88, P691, DOI 10.1172/JCI115354; Buege J A, 1978, Methods Enzymol, V52, P302; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; CHEN QL, 1995, J BIOL CHEM, V270, P28499, DOI 10.1074/jbc.270.48.28499; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Das DKR, 2013, INT J RADIAT BIOL, V89, P471, DOI 10.3109/09553002.2013.767989; FAJARDO LF, 1978, AM J SURG PATHOL, V2, P159, DOI 10.1097/00000478-197806000-00005; Giusti AM, 1998, INT J RADIAT BIOL, V74, P595, DOI 10.1080/095530098141177; GOYAL PK, 1983, STRAHLENTHER ONKOL, V159, P239; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Hensley ML, 1999, J CLIN ONCOL, V17, P3333, DOI 10.1200/JCO.1999.17.10.3333; INGOLD JA, 1965, AMER J ROENTGENOL RA, V93, P200; Jagetia GC, 2005, LIFE SCI, V77, P780, DOI 10.1016/j.lfs.2005.01.015; Kesh SB, 2013, LIFE SCI, V92, P938, DOI 10.1016/j.lfs.2013.03.015; Krasteva Ilina, 2004, Acta Pharmaceutica (Zagreb), V54, P151; LEWIN K, 1973, ARCH PATHOL, V96, P21; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma ZC, 2011, INT J RADIAT BIOL, V87, P130, DOI 10.3109/09553002.2011.523510; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; NEMOTO K, 1995, RADIAT RES, V141, P223, DOI 10.2307/3579052; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; PARASASSI T, 1994, INT J RADIAT BIOL, V65, P329, DOI 10.1080/09553009414550391; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; REED GB, 1966, AM J PATHOL, V48, P597; SCHMIDT KN, 1995, J BIOL CHEM, V270, P27136, DOI 10.1074/jbc.270.45.27136; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Selim NS, 2010, APPL RADIAT ISOTOPES, V68, P1018, DOI 10.1016/j.apradiso.2010.01.020; Sinha M, 2012, FREE RADICAL RES, V46, P842, DOI 10.3109/10715762.2012.684245; Srinivasan M, 2006, TOXICOLOGY, V228, P249, DOI 10.1016/j.tox.2006.09.004; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; van Buerck L, 2012, MOL CELL ENDOCRINOL, V362, P139, DOI 10.1016/j.mce.2012.06.001; Yumoto I, 2000, J BACTERIOL, V182, P1903, DOI 10.1128/JB.182.7.1903-1909.2000; Yvonne YC, 2005, J BIOL CHEM, V270, P11727	44	60	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97599	10.1371/journal.pone.0097599	http://dx.doi.org/10.1371/journal.pone.0097599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854039	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200022
J	Gingery, A; Subramaniam, M; Pitel, KS; Reese, JM; Cicek, M; Lindenmaier, LB; Ingle, JN; Goetz, MP; Turner, RT; Iwaniec, UT; Spelsberg, TC; Hawse, JR				Gingery, Anne; Subramaniam, Malayannan; Pitel, Kevin S.; Reese, Jordan M.; Cicek, Muzaffer; Lindenmaier, Laurence B.; Ingle, James N.; Goetz, Matthew P.; Turner, Russell T.; Iwaniec, Urszula T.; Spelsberg, Thomas C.; Hawse, John R.			The Effects of a Novel Hormonal Breast Cancer Therapy, Endoxifen, on the Mouse Skeleton	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; BONE-MINERAL DENSITY; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; AMERICAN SOCIETY; ZOLEDRONIC ACID; TAMOXIFEN; RALOXIFENE; METABOLISM; OSTEOCLAST	Endoxifen has recently been identified as the predominant active metabolite of tamoxifen and is currently being developed as a novel hormonal therapy for the treatment of endocrine sensitive breast cancer. Based on past studies in breast cancer cells and model systems, endoxifen classically functions as an anti-estrogenic compound. Since estrogen and estrogen receptors play critical roles in mediating bone homeostasis, and endoxifen is currently being implemented as a novel breast cancer therapy, we sought to comprehensively characterize the in vivo effects of endoxifen on the mouse skeleton. Two month old ovariectomized C57BL/6 mice were treated with vehicle or 50 mg/kg/day endoxifen hydrochloride via oral gavage for 45 days. Animals were analyzed by dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, micro-computed tomography and histomorphometry. Serum from control and endoxifen treated mice was evaluated for bone resorption and bone formation markers. Gene expression changes were monitored in osteoblasts, osteoclasts and the cortical shells of long bones from endoxifen treated mice and in a human fetal osteoblast cell line. Endoxifen treatment led to significantly higher bone mineral density and bone mineral content throughout the skeleton relative to control animals. Endoxifen treatment also resulted in increased numbers of osteoblasts and osteoclasts per tissue area, which was corroborated by increased serum levels of bone formation and resorption markers. Finally, endoxifen induced the expression of osteoblast, osteoclast and osteocyte marker genes. These studies are the first to examine the in vivo and in vitro impacts of endoxifen on bone and our results demonstrate that endoxifen increases cancellous as well as cortical bone mass in ovariectomized mice, effects that may have implications for postmenopausal breast cancer patients.	[Gingery, Anne; Subramaniam, Malayannan; Pitel, Kevin S.; Reese, Jordan M.; Cicek, Muzaffer; Spelsberg, Thomas C.; Hawse, John R.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Reese, Jordan M.; Goetz, Matthew P.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Lindenmaier, Laurence B.; Turner, Russell T.; Iwaniec, Urszula T.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Skeletal Biol Lab, Corvallis, OR 97331 USA; [Ingle, James N.; Goetz, Matthew P.] Mayo Clin, Dept Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Oregon State University; Mayo Clinic	Hawse, JR (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	hawse.john@mayo.edu	Goetz, Matthew P/AAH-2333-2020	Harrington, Jon/0000-0003-1293-5201; Gingery, Anne/0000-0002-1690-7382	NIH [AR063596, T32AR056950]; Mayo Clinic Breast Cancer [SPORE: P50CA116201]; Breast Cancer Research Foundation; Susan G. Komen for the Cure [KG100142]; Paul Calabresi K12 award NCI [CA90628]; Mayo Clinic Graduate School; Mayo Foundation; NATIONAL CANCER INSTITUTE [P50CA116201, P30CA015083, K12CA090628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR063596, T32AR056950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Breast Cancer; Breast Cancer Research Foundation; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Paul Calabresi K12 award NCI; Mayo Clinic Graduate School; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work presented here was supported by two NIH training grants: AR063596 (AG) and T32AR056950 (AG), the Mayo Clinic Breast Cancer SPORE: P50CA116201 (JNI, MPG and JRH), a Breast Cancer Research Foundation grant (JNI), Susan G. Komen for the Cure KG100142 (JRH), a Paul Calabresi K12 award NCI CA90628 (JRH), a generous gift from Bruce and Martha Atwater (TCS, JRH, MPG, JNI), the Mayo Clinic Graduate School (JMR) and the Mayo Foundation (TCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara T, 2010, ONCOLOGY-BASEL, V79, P376, DOI 10.1159/000323489; Amir E, 2011, JNCI-J NATL CANCER I, V103, P1299, DOI 10.1093/jnci/djr242; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2003, World Health Organ Tech Rep Ser, V921, P1; [Anonymous], 2010, CLIN GUID PREV TREAT; Arnett TR, 1996, J ENDOCRINOL, V149, P503, DOI 10.1677/joe.0.1490503; Becker T, 2012, J AM GERIATR SOC, V60, P1761, DOI 10.1111/j.1532-5415.2012.04107.x; Bensamoun SF, 2006, BONE, V39, P1244, DOI 10.1016/j.bone.2006.05.021; Bijl MJ, 2009, BREAST CANCER RES TR, V118, P125, DOI 10.1007/s10549-008-0272-2; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; Brufsky AM, 2009, CLIN BREAST CANCER, V9, P77, DOI 10.3816/CBC.2009.n.015; Cano A, 2008, OSTEOPOROSIS INT, V19, P793, DOI 10.1007/s00198-007-0498-6; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Choleris E, 2008, CURR OPIN INVEST DR, V9, P760; Cicek M, 2007, CANCER RES, V67, P10106, DOI 10.1158/0008-5472.CAN-07-1362; Cicek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017522; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deshmane V, 2007, J CLIN ONCOL, V25, P4967, DOI 10.1200/JCO.2006.09.5992; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Eidtmann H, 2010, ANN ONCOL, V21, P2188, DOI 10.1093/annonc/mdq217; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; EVANS G, 1994, ENDOCRINOLOGY, V134, P2283, DOI 10.1210/en.134.5.2283; Evans GL, 1996, ENDOCRINOLOGY, V137, P4139, DOI 10.1210/en.137.10.4139; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Goetz MP, 2013, CLIN CANCER RES, V19, P500, DOI 10.1158/1078-0432.CCR-12-2153; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Goldstein SR, 2000, HUM REPROD UPDATE, V6, P212, DOI 10.1093/humupd/6.3.212; HARRIS SA, 1995, J CELL BIOCHEM, V59, P193, DOI 10.1002/jcb.240590209; Hawse JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054613; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Iwaniec Urszula T., 2008, V447, P325, DOI 10.1007/978-1-59745-242-7_21; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; Ligibel JA, BREAST CANC RES TREA, V134, P1305; Parra-Palau JL, 2010, CANCER RES, V70, P8537, DOI 10.1158/0008-5472.CAN-10-1701; LONNING PE, 1992, CLIN PHARMACOKINET, V22, P327, DOI 10.2165/00003088-199222050-00002; Maran A., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P83; McClung MR, 2006, MENOPAUSE, V13, P377, DOI 10.1097/01.gme.0000188736.69617.4f; Migliaccio S, 2007, CLIN INTERV AGING, V2, P55, DOI 10.2147/ciia.2007.2.1.55; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; Newman WG, 2008, CLIN CANCER RES, V14, P5913, DOI 10.1158/1078-0432.CCR-07-5235; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Paridaens R, 2000, Clin Breast Cancer, V1 Suppl 1, pS19, DOI 10.3816/CBC.2000.s.004; Qu Q, 1999, J CELL BIOCHEM, V73, P500, DOI 10.1002/(SICI)1097-4644(19990615)73:4<500::AID-JCB8>3.0.CO;2-E; Ramalho AC, 2002, EUR CYTOKINE NETW, V13, P39; Rizzoli R, OSTEOPOROS INT, V23, P2567; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; STEWART PJ, 1986, ENDOCRINOLOGY, V118, P125, DOI 10.1210/endo-118-1-125; Sugiyama T, 2010, ENDOCRINOLOGY, V151, P5582, DOI 10.1210/en.2010-0645; Taranta A, 2002, BONE, V30, P368, DOI 10.1016/S8756-3282(01)00685-8; Tou LQ, 2001, MOL CELL ENDOCRINOL, V183, P71, DOI 10.1016/S0303-7207(01)00594-9; TURNER RT, 1987, J BONE MINER RES, V2, P449; TURNER RT, 1988, ENDOCRINOLOGY, V122, P1146, DOI 10.1210/endo-122-3-1146; van den Wijngaard A, 2000, MOL ENDOCRINOL, V14, P623, DOI 10.1210/me.14.5.623; Van Poznak C, 2010, J CLIN ONCOL, V28, P967, DOI 10.1200/JCO.2009.24.5902; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Wegman P, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1640; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wu XL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2844; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933; Yang NN, 1996, ENDOCRINOLOGY, V137, P2075, DOI 10.1210/en.137.5.2075	70	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98219	10.1371/journal.pone.0098219	http://dx.doi.org/10.1371/journal.pone.0098219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853369	gold, Green Published			2022-12-27	WOS:000338323200056
J	Gong, YH; Yin, XX; Wang, YX; Li, YB; Qin, G; Liu, LQ; Zhou, W; Song, FJ; Dong, XX; Cao, SY; Yang, C; Yang, HJ; Xie, J; Liu, JA; Lu, ZX				Gong, Yanhong; Yin, Xiaoxv; Wang, Yunxia; Li, Yongbin; Qin, Geng; Liu, Liqun; Zhou, Wei; Song, Fujian; Dong, Xiaoxin; Cao, Shiyi; Yang, Chen; Yang, Huajie; Xie, Jun; Liu, Junan; Lu, Zuxun			Social Determinants of Community Health Services Utilization among the Users in China: A 4-Year Cross-Sectional Study	PLOS ONE			English	Article							CARE SERVICES; SYSTEM REFORM; ACCESS; INEQUALITIES; PERFORMANCE; INSURANCE	Background: To identify social factors determining the frequency of community health service (CHS) utilization among CHS users in China. Methods: Nationwide cross-sectional surveys were conducted in 2008, 2009, 2010, and 2011. A total of 86,116 CHS visitors selected from 35 cities were interviewed. Descriptive analysis and multinomial logistic regression analysis were employed to analyze characteristics of CHS users, frequency of CHS utilization, and the socio-demographic and socio-economic factors influencing frequency of CHS utilization. Results: Female and senior CHS clients were more likely to make 3-5 and >= 6 CHS visits (as opposed to 1-2 visits) than male and young clients, respectively. CHS clients with higher education were less frequent users than individuals with primary education or less in 2008 and 2009; in later surveys, CHS clients with higher education were the more frequent users. The association between frequent CHS visits and family income has changed significantly between 2008 and 2011. In 2011, income status did not have a discernible effect on the likelihood of making >= 6 CHS visits, and it only had a slight effect on making 3-5 CHS visits. Conclusion: CHS may play an important role in providing primary health care to meet the demands of vulnerable populations in China. Over time, individuals with higher education are increasingly likely to make frequent CHS visits than individuals with primary school education or below. The gap in frequency of CHS utilization among different economic income groups decreased from 2008 to 2011.	[Gong, Yanhong; Yin, Xiaoxv; Wang, Yunxia; Li, Yongbin; Dong, Xiaoxin; Cao, Shiyi; Yang, Chen; Yang, Huajie; Xie, Jun; Liu, Junan; Lu, Zuxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan, Hubei, Peoples R China; [Qin, Geng; Liu, Liqun; Zhou, Wei] Natl Hlth & Family Planning Commisson Peoples Rep, Dept Maternal & Child Hlth Care & Community Hlth, Beijing, Peoples R China; [Song, Fujian] Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Huazhong University of Science & Technology; University of East Anglia	Liu, JA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan, Hubei, Peoples R China.	lja10_11@163.com; zuxunlu@yahoo.com	Song, Fujian/B-3516-2013	Liu, Junan/0000-0003-1740-1161	National Natural Science Foundation of China [71373090]; Ministry of Health of the People's Republic of China [NPM040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of the People's Republic of China	This research was funded by National Natural Science Foundation of China (No. 71373090) and Ministry of Health of the People's Republic of China (No. NPM040). Additionally, the authors thank the Bureaus of Health and the Community Health Institutions for participating in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 2008, HEALTH AFFAIR, V27, P920, DOI 10.1377/hlthaff.27.4.920; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Cheng SH, 1998, SOC SCI MED, V47, P613, DOI 10.1016/S0277-9536(98)00103-8; CUNNINGHAM PJ, 1995, SOC SCI MED, V40, P393, DOI 10.1016/0277-9536(94)E0072-Z; Dunlop S, 2000, SOC SCI MED, V51, P123, DOI 10.1016/S0277-9536(99)00424-4; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; Girma F, 2011, ETHIOP J HEALTH SCI, V21, P85; Habicht J, 2005, SOC SCI MED, V60, P777, DOI 10.1016/j.socscimed.2004.06.026; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; LOVE D, 1995, HEALTH SERV RES, V29, P629; Luo LX, 2004, CHINESE GEN PRACTICE, V7, P1272; Luo LX, 2004, CHINESE GEN PRACTICE, V7, P1283; [罗秀娟 Luo Xiujuan], 2010, [中国全科医学, Chinese General Practice], V13, P2790; Luo XJ, 2010, CHINESE GEN PRACTICE, V13, P2797; National Health and Family Planning Commission of the People's Republic of China, 2012, STAT B DEV HLTH SERV; National Health and Family Planning Commisson of the People's Republic of China, 2004, CHIN HLTH STAT YB 20; Oliveira LS, 2012, CIENC SAUDE COLETIVA, V17, P3047, DOI 10.1590/S1413-81232012001100021; Parry J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e248; POPAY J, 1993, SOC SCI MED, V36, P21, DOI 10.1016/0277-9536(93)90302-K; SAEED AAW, 1984, TROP GEOGR MED, V36, P267; Saurina C, 2012, EUR J HEALTH ECON, V13, P419, DOI 10.1007/s10198-011-0313-3; Su YS, 2008, GAP PUBLIC HLTH PRIM; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Van der Heyden JHA, 2003, HEALTH POLICY, V65, P153, DOI 10.1016/S0168-8510(02)00213-0; Wong ST, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-91; Yang YS, 2009, CHINA ECON REV, V20, P620, DOI 10.1016/j.chieco.2009.04.004; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	30	11	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98095	10.1371/journal.pone.0098095	http://dx.doi.org/10.1371/journal.pone.0098095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24854502	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338323200044
J	Sharrow, DJ; Clark, SJ; Raftery, AE				Sharrow, David J.; Clark, Samuel J.; Raftery, Adrian E.			Modeling Age-Specific Mortality for Countries with Generalized HIV Epidemics	PLOS ONE			English	Article							ADULT MORTALITY; PROBABILISTIC PROJECTIONS; POPULATION PROJECTIONS; DEATH; IMPACT	Background: In a given population the age pattern of mortality is an important determinant of total number of deaths, age structure, and through effects on age structure, the number of births and thereby growth. Good mortality models exist for most populations except those experiencing generalized HIV epidemics and some developing country populations. The large number of deaths concentrated at very young and adult ages in HIV-affected populations produce a unique 'humped' age pattern of mortality that is not reproduced by any existing mortality models. Both burden of disease reporting and population projection methods require age-specific mortality rates to estimate numbers of deaths and produce plausible age structures. For countries with generalized HIV epidemics these estimates should take into account the future trajectory of HIV prevalence and its effects on age-specific mortality. In this paper we present a parsimonious model of age-specific mortality for countries with generalized HIV/AIDS epidemics. Methods and Findings: The model represents a vector of age-specific mortality rates as the weighted sum of three independent age-varying components. We derive the age-varying components from a Singular Value Decomposition of the matrix of age-specific mortality rate schedules. The weights are modeled as a function of HIV prevalence and one of three possible sets of inputs: life expectancy at birth, a measure of child mortality, or child mortality with a measure of adult mortality. We calibrate the model with 320 five-year life tables for each sex from the World Population Prospects 2010 revision that come from the 40 countries of the world that have and are experiencing a generalized HIV epidemic. Cross validation shows that the model is able to outperform several existing model life table systems. Conclusions: We present a flexible, parsimonious model of age-specific mortality for countries with generalized HIV epidemics. Combined with the outputs of existing epidemiological and demographic models, this model makes it possible to project future age-specific mortality profiles and number of deaths for countries with generalized HIV epidemics.	[Sharrow, David J.; Clark, Samuel J.; Raftery, Adrian E.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Clark, Samuel J.] Univ Colorado, IBS, Boulder, CO 80309 USA; [Clark, Samuel J.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Raftery, Adrian E.] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Clark, Samuel J.] London Sch Hyg & Trop Med, ALPHA Network, London WC1, England; [Clark, Samuel J.] INDEPTH Network, Accra, Ghana	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; University of Witwatersrand; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; INDEPTH Network	Clark, SJ (corresponding author), Univ Washington, Dept Sociol, Seattle, WA 98195 USA.	work@samclark.net	Clark, Samuel J/A-8419-2009	Clark, Samuel J/0000-0002-4929-6231	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD054511, R01 HD070936, K01 HD057246]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070936, R24HD042828, R01HD054511, K01HD057246] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants R01 HD054511, R01 HD070936, and K01 HD057246 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema L, 2011, DEMOGRAPHY, V48, P815, DOI 10.1007/s13524-011-0040-5; [Anonymous], 2011, WORLD POP PROSP 2010; [Anonymous], 1983, REGIONAL MODEL LIFE; Blacker J, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200406002-00003; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; Clark Samuel J, 2002, INDEPTH MORT PATT AF, V1, P83; Clark SJ, 2001, INVESTIGATION IMPACT; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; Guillot M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001299; Heuveline P, 2011, INT HANDB POPUL, V2, P511, DOI 10.1007/978-90-481-9996-9_24; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lutz W, 2010, PHILOS T R SOC B, V365, P2779, DOI 10.1098/rstb.2010.0133; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Ngom P, 2003, TECHNICAL REPORT; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; Raftery A, 2012, BMA BAYESIAN MODEL A; Raftery AE, 2013, DEMOGRAPHY, V50, P777, DOI 10.1007/s13524-012-0193-x; Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Sharrow DJ, 2013, DEMOGR RES, V29, P1039, DOI 10.4054/DemRes.2013.29.39; Sharrow DJ, 2013, HIV LIFE TABLES HIV; Timaeus IM, 2004, DEMOGRAPHY, V41, P757, DOI 10.1353/dem.2004.0037; UNAIDS, 2012, TECHNICAL REPORT; United Nations Department of International Economic and Social Aff airs, 1982, MOD LIF TABL DEV COU; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wheldon MC, 2013, J AM STAT ASSOC, V108, P96, DOI 10.1080/01621459.2012.737729; Wilmoth J, 2012, POP STUD-J DEMOG, V66, P1, DOI 10.1080/00324728.2011.611411	34	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96447	10.1371/journal.pone.0096447	http://dx.doi.org/10.1371/journal.pone.0096447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24853081	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200014
J	Yu, TL; Lin, HD; Weng, CF				Yu, Teng-Lang; Lin, Hung-Du; Weng, Ching-Feng			A New Phylogeographic Pattern of Endemic Bufo bankorensis in Taiwan Island Is Attributed to the Genetic Variation of Populations	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; ARC-CONTINENT COLLISION; MITOCHONDRIAL-DNA; TOAD; CONSEQUENCES; DIFFERENTIATION; DIVERGENCE; GLACIATION; CYPRINIDAE; DISPERSAL	Aim: To comprehend the phylogeographic patterns of genetic variation in anurans at Taiwan Island, this study attempted to examine (1) the existence of various geological barriers (Central Mountain Ranges, CMRs); and (2) the genetic variation of Bufo bankorensis using mtDNA sequences among populations located in different regions of Taiwan, characterized by different climates and existing under extreme conditions when compared available sequences of related species B. gargarizans of mainland China. Methodology/Principal Findings: Phylogenetic analyses of the dataset with mitochondrial DNA (mtDNA) D-loop gene (348 bp) recovered a close relationship between B. bankorensis and B. gargarizans, identified three distinct lineages. Furthermore, the network of mtDNA D-loop gene (564 bp) amplified (279 individuals, 27 localities) from Taiwan Island indicated three divergent clades within B. bankorensis (Clade W, E and S), corresponding to the geography, thereby verifying the importance of the CMRs and Kaoping River drainage as major biogeographic barriers. Mismatch distribution analysis, neutrality tests and Bayesian skyline plots revealed that a significant population expansion occurred for the total population and Clade W, with horizons dated to approximately 0.08 and 0.07 Mya, respectively. These results suggest that the population expansion of Taiwan Island species B. bankorensis might have resulted from the release of available habitat in post-glacial periods, the genetic variation on mtDNA showing habitat selection, subsequent population dispersal, and co-distribution among clades. Conclusions: The multiple origins (different clades) of B. bankorensis mtDNA sequences were first evident in this study. The divergent genetic clades found within B. bankorensis could be independent colonization by previously diverged lineages; inferring B. bankorensis originated from B. gargarizans of mainland China, then dispersal followed by isolation within Taiwan Island. Highly divergent clades between W and E of B. bankorensis, implies that the CMRs serve as a genetic barrier and separated the whole island into the western and eastern phylogroups.	[Yu, Teng-Lang; Weng, Ching-Feng] Natl Dong Hwa Univ, Dept Life Sci & Inst Biotechnol, Hualien, Taiwan; [Lin, Hung-Du] Natl Tainan First Senior High Sch, Affiliated Sch, Tainan, Taiwan	National Dong Hwa University	Weng, CF (corresponding author), Natl Dong Hwa Univ, Dept Life Sci & Inst Biotechnol, Hualien, Taiwan.	cfweng@mail.ndhu.edu.tw		Weng, Ching-Feng/0000-0002-9747-8697	Yushan National Park; Taroko National Park Headquarters	Yushan National Park; Taroko National Park Headquarters	We are grateful to the Yushan National Park and Taroko National Park Headquarters grants for Ching-Feng Weng. We thank our field assistants, particularly Ho-Tsung Chu, Kou-Wei Li and Li-Hsuen Chen, and Institutes granted access to collections including Kenting National Park, Taroko National Park, Yangmingshan National Park and Yushan National Park Headquarters. We address sincerely thank to senior Professor Sin-Che Lee and Dr. Chien-Hsien Kuo for incredible advice, and Hui-Ling Chang and Yu-Bao Wang for technical assistance. We would like to extend our thanks to all staff of the Yushan National Park involved in the B. bankorensis collaboration. Of course, this work also dedicates a memorial to the animals of Taiwan.	[Anonymous], 1966, B DEP ARCHAEOLOGY AN; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, MIGRATE DOCUMENTATIO; Bollmer JL, 2006, MOL PHYLOGENET EVOL, V39, P237, DOI 10.1016/j.ympev.2005.11.014; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Chen CC, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-48; Clegg S, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P293; Creer S, 2001, MOL ECOL, V10, P1967, DOI 10.1046/j.0962-1083.2001.01332.x; Degani G, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-18; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1994, GENETICS, V136, P343; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frost DR., 2022, AMPHIBIAN SPECIES WO; Fu JZ, 2005, MOL PHYLOGENET EVOL, V37, P202, DOI 10.1016/j.ympev.2005.03.023; Fu YX, 1997, GENETICS, V147, P915; Goudie AS, 1999, ENV HIST CHANGE, P10; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Harrison S, 1996, TRENDS ECOL EVOL, V11, P180, DOI 10.1016/0169-5347(96)20008-4; Hebenstreit R, 2006, QUATERN INT, V147, P76, DOI 10.1016/j.quaint.2005.09.009; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hisai N, 1987, MISCELLANEOUS REPORT, V18, P1; Hu YL, 2007, BIOCHEM GENET, V45, P697, DOI 10.1007/s10528-007-9107-9; Huang CY, 1997, TECTONOPHYSICS, V281, P31, DOI 10.1016/S0040-1951(97)00157-1; Huang WS, 1996, ZOOL STUD, V35, P128; Igawa T, 2006, MOL PHYLOGENET EVOL, V38, P250, DOI 10.1016/j.ympev.2005.09.003; Inger R. F, 1972, EVOLUTION GENUS BUFO; Inger RF, 1972, BUFO EURASIA; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Jang-Liaw NH, 2008, ZOOL SCI, V25, P68, DOI 10.2108/zsj.25.68; Jang-Liaw NH, 2009, ZOOL SCI, V26, P608, DOI 10.2108/zsj.26.608; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; KAWAMURA T, 1982, JPN J GENET, V57, P677; KAWAMURA T, 1980, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V4, P1; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Kusano T, 1995, J HERPETOL, V29, P633, DOI 10.2307/1564755; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin HD, 2008, J FISH BIOL, V72, P2011, DOI 10.1111/j.1095-8649.2008.01836.x; Lin HC, 2008, CONSERV GENET, V9, P1089, DOI 10.1007/s10592-007-9418-8; Lin HD, 2012, MOL PHYLOGENET EVOL, V62, P251, DOI 10.1016/j.ympev.2011.09.022; Liu TK, 2000, TECTONOPHYSICS, V320, P69, DOI 10.1016/S0040-1951(00)00028-7; Liu WZ, 2000, MOL PHYLOGENET EVOL, V14, P423, DOI 10.1006/mpev.1999.0716; Lue GY, 1982, AMPHIBIANS TAIWAN, P1; Lue KY, 1990, WILDLIFE DATA BANK T; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Masta SE, 2003, MOL ECOL, V12, P1541, DOI 10.1046/j.1365-294X.2003.01829.x; MATSUI M, 1986, COPEIA, P561; MATSUI M, 1984, Contributions from the Biological Laboratory Kyoto University, V26, P209; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; NEI M, 1983, GENETICS, V105, P207; Nei M., 1987, MOL EVOLUTIONARY GEN; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; NISHIOKA M, 1990, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V10, P53; Ono YG, 2005, QUATERN INT, V138, P79, DOI 10.1016/j.quaint.2005.02.007; Oshida T, 2006, J MAMMAL, V87, P247, DOI 10.1644/05-MAMM-A-123R1.1; Oshida T, 2011, BIOL J LINN SOC, V102, P404, DOI 10.1111/j.1095-8312.2010.01576.x; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prohl H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-146; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe G, 2006, MOL PHYLOGENET EVOL, V39, P335, DOI 10.1016/j.ympev.2005.08.021; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Shih HT, 2006, J BIOGEOGR, V33, P980, DOI 10.1111/j.1365-2699.2006.01472.x; Sibuet JC, 2004, TECTONOPHYSICS, V379, P159, DOI 10.1016/j.tecto.2003.10.022; Smith MA, 2004, MOL ECOL, V13, P3723, DOI 10.1111/j.1365-294X.2004.02301.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENG LS, 1990, TECTONOPHYSICS, V183, P57, DOI 10.1016/0040-1951(90)90188-E; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toda M, 1998, HERPETOLOGICA, V54, P73; TZENG C-S, 1986, Journal of Taiwan Museum, V39, P127; VENCES M, 2007, AMPHIBIAN BIOL, V7; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang CF, 2011, ZOOL J LINN SOC-LOND, V161, P613, DOI 10.1111/j.1096-3642.2010.00646.x; Wang HY, 1999, MOL ECOL, V8, P1879, DOI 10.1046/j.1365-294x.1999.00787.x; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; Wang JP, 2000, MOL ECOL, V9, P1483, DOI 10.1046/j.1365-294x.2000.01023.x; Wang TY, 2007, ZOOL STUD, V46, P569; Wang TY, 2007, ZOOL STUD, V46, P547; Watanabe K, 2007, ICHTHYOL RES, V54, P253, DOI 10.1007/s10228-007-0398-y; Yeh WB, 2004, ANN ENTOMOL SOC AM, V97, P613, DOI 10.1603/0013-8746(2004)097[0613:GDOLAC]2.0.CO;2; YU HT, 1995, BIOL J LINN SOC, V55, P69, DOI 10.1111/j.1095-8312.1995.tb01050.x; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhao E, 1993, HERPETOLOGY CHINA, V10; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	101	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98029	10.1371/journal.pone.0098029	http://dx.doi.org/10.1371/journal.pone.0098029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853679	Green Submitted, gold, Green Published			2022-12-27	WOS:000338323200039
J	Zheng, SH; Jiang, X; Wu, LB; Wang, ZH; Huang, LF				Zheng, Sihao; Jiang, Xue; Wu, Labin; Wang, Zenghui; Huang, Linfang			Chemical and Genetic Discrimination of Cistanches Herba Based on UPLC-QTOF/MS and DNA Barcoding	PLOS ONE			English	Article							DIODE-ARRAY DETECTION; PHENYLPROPANOID GLYCOSIDES; PHENYLETHANOID GLYCOSIDES; CONSTITUENTS; IDENTIFICATION; DESERTICOLA; TUBULOSA; OLIGOGLYCOSIDES; FINGERPRINT; FTIR	Cistanches Herba (Rou Cong Rong), known as "Ginseng of the desert", has a striking curative effect on strength and nourishment, especially in kidney reinforcement to strengthen yang. However, the two plant origins of Cistanches Herba, Cistanche deserticola and Cistanche tubulosa, vary in terms of pharmacological action and chemical components. To discriminate the plant origin of Cistanches Herba, a combined method system of chemical and genetic -UPLC-QTOF/MS technology and DNA barcoding-were firstly employed in this study. The results indicated that three potential marker compounds (isomer of campneoside II, cistanoside C, and cistanoside A) were obtained to discriminate the two origins by PCA and OPLS-DA analyses. DNA barcoding enabled to differentiate two origins accurately. NJ tree showed that two origins clustered into two clades. Our findings demonstrate that the two origins of Cistanches Herba possess different chemical compositions and genetic variation. This is the first reported evaluation of two origins of Cistanches Herba, and the finding will facilitate quality control and its clinical application.	[Zheng, Sihao; Jiang, Xue; Wu, Labin; Wang, Zenghui; Huang, Linfang] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Huang, LF (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China.	lfhuang@implad.ac.cn			National Natural Science Foundation of China [81274013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from the National Natural Science Foundation of China (No. 81274013, website: www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2009, SPECTROSC SPECT ANAL, V29, P1502, DOI 10.3964/j.issn.1000-0593(2009)06-1502-06; [陈培 CHEN Pei], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1399; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Gan XY, 2011, NO HORTICULTURE, P141; Gu XY, 2013, W CHIN MED, V26, P17; Han Jian-ping, 2010, Yaoxue Xuebao, V45, P126; Han LF, 2012, PHYTOCHEM ANALYSIS, V23, P668, DOI 10.1002/pca.2371; He Y, 1997, Zhong Yao Cai, V20, P117; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; [黄林芳 Huang Linfang], 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P318; Huang LX, 2011, XINJIANG J TRADITION, V29, P54; Huang M, 2004, HUBEI J TRADITIONAL, V26, P54; Jiang X, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/942384; Jiang Y, 2009, J CHROMATOGR A, V1216, P2156, DOI 10.1016/j.chroma.2008.04.040; Jiang Y, 2009, J CHROMATOGR A, V1216, P1970, DOI 10.1016/j.chroma.2008.07.031; KOBAYASHI H, 1987, CHEM PHARM BULL, V35, P3309; KOBAYASHI H, 1985, CHEM PHARM BULL, V33, P3645; KOBAYASHI H, 1984, CHEM PHARM BULL, V32, P3009; KOBAYASHI H, 1984, CHEM PHARM BULL, V32, P3880; KOBAYASHI H, 1985, CHEM PHARM BULL, V33, P1452; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; [雷丽 Lei Li], 2003, [中草药, Chinese Traditional and Herbal Drugs], V34, P473; Li JS, 2000, SHIZHEN MED MATERIA, V11, P317; Li L, 2008, FOOD CHEM, V108, P702, DOI 10.1016/j.foodchem.2007.10.082; [刘晓明 LIU Xiaoming], 2011, [中国药学杂志, Chinese Pharmaceutical Journal], V46, P1053; Liu YG, 2009, WORLD SCI TECHNOLOGY, V11, P439; Lu DY, 2013, J SEP SCI, V36, P1945, DOI 10.1002/jssc.201300135; [马志国 MA Zhi guo], 2011, [中国药学杂志, Chinese Pharmaceutical Journal], V46, P899; Masssart DL, 1988, DATA HANDLING SCI TE; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Morikawa T, 2010, CHEM PHARM BULL, V58, P1403, DOI 10.1248/cpb.58.1403; Morikawa T, 2010, BIOORGAN MED CHEM, V18, P1882, DOI 10.1016/j.bmc.2010.01.047; Moriya Akira, 1995, Natural Medicines, V49, P383; Moriya Akira, 1995, Natural Medicines, V49, P394; Shi HM, 2009, BIOL PHARM BULL, V32, P142, DOI 10.1248/bpb.32.142; Shimoda H, 2009, AM J CHINESE MED, V37, P1125, DOI 10.1142/S0192415X09007545; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tu PF, 1996, J CHINESE MED MAT, V19, P420; Tu PF, 2011, J CHINESE PHARM, V46, P882; Wu LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064178; [谢洁娜 Xie Jiena], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P268; Xu R, 2010, SPECTROSC SPECT ANAL, V30, P897, DOI 10.3964/j.issn.1000-0593(2010)04-0897-04; [徐荣 XU Rong], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1703; Xu XQ, 2013, SHIZHEN MED MATERIA, V24, P881; Yamada P, 2010, PLANTA MED, V76, P1512, DOI 10.1055/s-0030-1249775; [杨瀚春 YANG Hanchun], 2008, [药学服务与研究, Pharmaceutical Care and Research], V8, P255; Yoshikawa M, 2006, BIOORGAN MED CHEM, V14, P7468, DOI 10.1016/j.bmc.2006.07.018; Zhang HJ, IDENTIFICATION CISTA, V183; Zhang Mian, 2004, Zhong Yao Cai, V27, P400; Zhang Yong, 1994, Zhongguo Zhongyao Zazhi, V19, P169; Zhu SY, 2001, J CHIN MED MAT, V24, P24	51	34	37	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98061	10.1371/journal.pone.0098061	http://dx.doi.org/10.1371/journal.pone.0098061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854031	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200041
J	Bolbecker, AR; Westfall, DR; Howell, JM; Lackner, RJ; Carroll, CA; O'Donnell, BF; Hetrick, WP				Bolbecker, Amanda R.; Westfall, Daniel R.; Howell, Josselyn M.; Lackner, Ryan J.; Carroll, Christine A.; O'Donnell, Brian F.; Hetrick, William P.			Increased Timing Variability in Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TEMPORAL PROCESSING DYSFUNCTION; COGNITIVE DYSMETRIA; CEREBELLAR VERMIS; 1ST-EPISODE SCHIZOPHRENIA; MAJOR DEPRESSION; HEALTHY-SUBJECTS; TIME-ESTIMATION; VOLUME; MORPHOMETRY	Theoretical and empirical evidence suggests that impaired time perception and the neural circuitry underlying internal timing mechanisms may contribute to severe psychiatric disorders, including psychotic and mood disorders. The degree to which alterations in temporal perceptions reflect deficits that exist across psychosis-related phenotypes and the extent to which mood symptoms contribute to these deficits is currently unknown. In addition, compared to schizophrenia, where timing deficits have been more extensively investigated, sub-second timing has been studied relatively infrequently in bipolar disorder. The present study compared sub-second duration estimates of schizophrenia (SZ), schizoaffective disorder (SA), non-psychotic bipolar disorder (BDNP), bipolar disorder with psychotic features (BDP), and healthy non-psychiatric controls (HC) on a well-established time perception task using sub-second durations. Participants included 66 SZ, 37 BDNP, 34 BDP, 31 SA, and 73 HC who participated in a temporal bisection task that required temporal judgements about auditory durations ranging from 300 to 600 milliseconds. Timing variability was significantly higher in SZ, BDP, and BDNP groups compared to healthy controls. The bisection point did not differ across groups. These findings suggest that both psychotic and mood symptoms may be associated with disruptions in internal timing mechanisms. Yet unexpected findings emerged. Specifically, the BDNP group had significantly increased variability compared to controls, but the SA group did not. In addition, these deficits appeared to exist independent of current symptom status. The absence of between group differences in bisection point suggests that increased variability in the SZ and bipolar disorder groups are due to alterations in perceptual timing in the sub-second range, possibly mediated by the cerebellum, rather than cognitive deficits.	[Bolbecker, Amanda R.; Lackner, Ryan J.; Carroll, Christine A.; O'Donnell, Brian F.; Hetrick, William P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Bolbecker, Amanda R.; O'Donnell, Brian F.; Hetrick, William P.] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Bolbecker, Amanda R.; Westfall, Daniel R.; Howell, Josselyn M.; O'Donnell, Brian F.; Hetrick, William P.] Larue D Carter Mem Hosp, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Hetrick, WP (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	whetrick@indiana.edu			National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institute of Mental Health [R01 MH074983, 2MH074983]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074983] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a 2007 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Grant awarded to Amanda R. Bolbecker and National Institute of Mental Health grants R01 MH074983 and 2MH074983 to William P. Hetrick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2008, BIOL PSYCHIAT, V64, P81, DOI 10.1016/j.biopsych.2008.01.003; Andreasen NC, 1999, ARCH GEN PSYCHIAT, V56, P781, DOI 10.1001/archpsyc.56.9.781; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Bolbecker AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019824; Bolbecker AR, 2011, BIPOLAR DISORD, V13, P99, DOI 10.1111/j.1399-5618.2011.00895.x; Bolbecker AR, 2009, BIPOLAR DISORD, V11, P19, DOI 10.1111/j.1399-5618.2008.00642.x; Bottmer C, 2005, PSYCHIAT RES-NEUROIM, V140, P239, DOI 10.1016/j.pscychresns.2005.02.011; Bschor T, 2004, ACTA PSYCHIAT SCAND, V109, P222, DOI 10.1046/j.0001-690X.2003.00244.x; Canales-Rodriguez EJ, 2013, BIOL PSYCHIAT; Carroll CA, 2008, BRAIN COGNITION, V67, P150, DOI 10.1016/j.bandc.2007.12.005; Carroll CA, 2009, BRAIN COGNITION, V71, P345, DOI 10.1016/j.bandc.2009.06.009; Carroll CA, 2009, BRAIN COGNITION, V70, P181, DOI 10.1016/j.bandc.2009.02.001; Crespo-Facorro B, 1999, AM J PSYCHIAT, V156, P386; Davalos DB, 2005, J NEUROPSYCH CLIN N, V17, P517, DOI 10.1176/appi.neuropsych.17.4.517; Elvevag B, 2003, PSYCHOL MED, V33, P1249, DOI 10.1017/S0033291703008122; Fatemi SH, 2013, TRANSL PSYCHIAT, V3, DOI [10.1038/tp.2013.64, 10.1038/tp.2013.46]; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; First M., 1997, SCID 2 PERSONALITY Q; First M.B., 2016, STRUCTURED CLIN INTE; First MB, 2001, STRUCTURED CLIN INTE; Freeman WJ, 2008, INTEGR PSYCHOL BEHAV, V42, P137, DOI 10.1007/s12124-007-9049-0; Glahn DC, 2006, BIPOLAR DISORD, V8, P117, DOI 10.1111/j.1399-5618.2006.00296.x; Henze R, 2010, J NEUROIMAGING; Ichimiya T, 2001, BIOL PSYCHIAT, V49, P20, DOI 10.1016/S0006-3223(00)01081-7; IVRY R, 1993, ANN NY ACAD SCI, V682, P214, DOI 10.1111/j.1749-6632.1993.tb22970.x; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Jacobsen LK, 1997, AM J PSYCHIAT, V154, P1663, DOI 10.1176/ajp.154.12.1663; Jokiranta E, 2013, PSYCHIAT RES, V207, P203, DOI 10.1016/j.psychres.2013.01.005; Kasparek T, 2010, HUM BRAIN MAPP, V31, P300, DOI 10.1002/hbm.20865; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KEELE SW, 1990, ANN NY ACAD SCI, V608, P179, DOI 10.1111/j.1749-6632.1990.tb48897.x; Kenny E. M., 2013, MOL PSYCHIAT; Kim D, 2013, J AFFECT DISORDERS, V150, P499, DOI 10.1016/j.jad.2013.04.050; Kim JJ, 2000, AM J PSYCHIAT, V157, P542, DOI 10.1176/appi.ajp.157.4.542; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Loeber RT, 1999, SCHIZOPHR RES, V37, P81, DOI 10.1016/S0920-9964(98)00137-6; Loeber RT, 2001, AM J PSYCHIAT, V158, P952, DOI 10.1176/appi.ajp.158.6.952; Mahlber R, 2008, EUR PSYCHIAT, V23, P430, DOI 10.1016/j.eurpsy.2007.07.001; Maloku E, 2010, P NATL ACAD SCI USA, V107, P4407, DOI 10.1073/pnas.0914483107; Molina V, 2010, EUR ARCH PSYCHIAT CL; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morris Sarah E, 2012, Dialogues Clin Neurosci, V14, P29; Nopoulos PC, 1999, BIOL PSYCHIAT, V46, P703, DOI 10.1016/S0006-3223(99)00093-1; Penney TB, 2005, BRAIN COGNITION, V58, P109, DOI 10.1016/j.bandc.2004.09.012; Penney TB, 2008, PSYCHOL SCI, V19, P1103, DOI 10.1111/j.1467-9280.2008.02210.x; Rasser PE, 2010, NEUROIMAGE, V53, P1175, DOI 10.1016/j.neuroimage.2010.07.018; REYES MG, 1981, LANCET, V2, P700; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmidt H, 2011, J ABNORM PSYCHOL, V120, P476, DOI 10.1037/a0023387; Simonsen C, 2011, SCHIZOPHRENIA BULL, V37, P73, DOI 10.1093/schbul/sbp034; Smith MJ, 2008, SCHIZOPHR RES, V106, P294, DOI 10.1016/j.schres.2008.07.015; Stahl SM, 2013, CNS SPECTRUMS, V18, P65, DOI 10.1017/S1092852913000084; STEINBERG JL, 1995, PSYCHIAT RES-NEUROIM, V61, P15, DOI 10.1016/0925-4927(95)02574-H; Striano T, 2006, INTERACT STUD, V7, P251, DOI 10.1075/is.7.2.08str; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Torrent C, 2007, ACTA PSYCHIAT SCAND, V116, P453, DOI 10.1111/j.1600-0447.2007.01072.x; Tracy JI, 1998, PERCEPT MOTOR SKILL, V86, P515, DOI 10.2466/pms.1998.86.2.515; Tran KD, 1998, AM J PSYCHIAT, V155, P1288, DOI 10.1176/ajp.155.9.1288; Trevarthen C, 2005, BRAIN DEV-JPN, V27, pS25, DOI 10.1016/j.braindev.2005.03.016; Turgeon M, 2012, PSYCHIAT RES, V197, P13, DOI 10.1016/j.psychres.2012.03.003; VOLKOW ND, 1992, AM J PSYCHIAT, V149, P686; Volz HP, 2001, NEUROREPORT, V12, P313, DOI 10.1097/00001756-200102120-00026; Volz HP, 2000, SCHIZOPHR RES, V46, P45, DOI 10.1016/S0920-9964(99)00236-4; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	67	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97964	10.1371/journal.pone.0097964	http://dx.doi.org/10.1371/journal.pone.0097964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848559	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600072
J	Hammarstrom, A; Haukenes, I; Wiklund, AF; Lehti, A; Wiklund, M; Evengard, B; Stalnacke, BM				Hammarstrom, Anne; Haukenes, Inger; Wiklund, Anncristine Fjellman; Lehti, Arja; Wiklund, Maria; Evengard, Birgitta; Stalnacke, Britt-Marie			Low-Educated Women with Chronic Pain Were Less Often Selected to Multidisciplinary Rehabilitation Programs	PLOS ONE			English	Article							WIDESPREAD MUSCULOSKELETAL PAIN; CARDIAC REHABILITATION; SOCIOECONOMIC-STATUS; DEPRESSION SCALE; HOSPITAL ANXIETY; GENDER BIAS; NECK PAIN; FOLLOW-UP; HEALTH; CARE	Background: There is a lack of research about a potential education-related bias in assessment of patients with chronic pain. The aim of this study was to analyze whether low-educated men and women with chronic pain were less often selected to multidisciplinary rehabilitation than those with high education. Methods: The population consisted of consecutive patients (n = 595 women, 266 men) referred during a three-year period from mainly primary health care centers for a multidisciplinary team assessment at a pain rehabilitation clinic at a university hospital in Northern Sweden. Patient data were collected from the Swedish Quality Registry for Pain Rehabilitation National Pain Register. The outcome variable was being selected by the multidisciplinary team assessment to a multidisciplinary rehabilitation program. The independent variables were: sex, age, born outside Sweden, education, pain severity as well as the hospital, anxiety and depression scale (HADS). Results: Low-educated women were less often selected to multidisciplinary rehabilitation programs than high-educated women (OR 0.55, CI 0.30-0.98), even after control for age, being born outside Sweden, pain intensity and HADS. No significant findings were found when comparing the results between high-and low-educated men. Conclusion: Our findings can be interpreted as possible discrimination against low-educated women with chronic pain in hospital referrals to pain rehabilitation. There is a need for more gender-theoretical research emphasizing the importance of taking several power dimensions into account when analyzing possible bias in health care.	[Hammarstrom, Anne; Haukenes, Inger; Lehti, Arja] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hammarstrom, Anne; Haukenes, Inger; Wiklund, Anncristine Fjellman; Lehti, Arja; Wiklund, Maria; Stalnacke, Britt-Marie] Umea Univ, Umea Ctr Gender Studies Med, Umea, Sweden; [Haukenes, Inger] Norwegian Inst Publ Hlth, Dept Publ Mental Hlth, Div Mental Hlth, Bergen, Norway; [Wiklund, Anncristine Fjellman; Wiklund, Maria; Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Evengard, Birgitta] Umea Univ, Div Infect Dis, Dept Clin Microbiol, Umea, Sweden	Umea University; Umea University; Norwegian Institute of Public Health (NIPH); Umea University; Umea University	Hammarstrom, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	anne.hammarstrom@umu.se		Hammarstrom, Anne/0000-0002-4095-7961	Swedish Research Council [344-2009-5839]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (grant no: 344-2009-5839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apesoa-Varano EC, 2010, AM J GERIAT PSYCHIAT, V18, P586, DOI 10.1097/JGP.0b013e3181d145ea; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Beswick AD, 2005, J ADV NURS, V49, P538, DOI 10.1111/j.1365-2648.2004.03327.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bjoornsdoottir SV, 2013, SCAND J RHEUMATOL, V42, P59, DOI 10.3109/03009742.2012.697916; Bosner S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-45; Boman KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057556; Borkhoff CM, 2008, CAN MED ASSOC J, V178, P681, DOI 10.1503/cmaj.071168; Carr JL, 2005, CHRONIC ILLN, V1, P121, DOI 10.1179/174239505X44826; Cosco TD, 2012, J PSYCHOSOM RES, V72, P180, DOI 10.1016/j.jpsychores.2011.06.008; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Friedrich M, 2009, PHYS THER, V89, P786, DOI 10.2522/ptj.20080100; Hamberg K, 2002, J WOMEN HEALTH GEN-B, V11, P653, DOI 10.1089/152460902760360595; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Holmner EP, 2013, AM J PHYS MED REHAB, V92, P77, DOI 10.1097/PHM.0b013e318278b28e; Jensen IB, 2005, PAIN, V115, P273, DOI 10.1016/j.pain.2005.03.005; Jordan Kevin D, 2011, J Pain Palliat Care Pharmacother, V25, P231, DOI 10.3109/15360288.2011.596922; Kapral MK, 2002, STROKE, V33, P268, DOI 10.1161/hs0102.101169; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Lofmark U, 2007, NEUROEPIDEMIOLOGY, V28, P135, DOI 10.1159/000102141; Macfarlane GJ, 2009, ANN RHEUM DIS, V68, P1591, DOI 10.1136/ard.2008.093088; Melville MR, 1999, HEART, V82, P373, DOI 10.1136/hrt.82.3.373; Merrick D, 2012, J REHABIL MED, V44, P764, DOI 10.2340/16501977-1022; Noone JH, 2008, SOCIOL HEALTH ILL, V30, P711, DOI 10.1111/j.1467-9566.2008.01095.x; Nyberg F, 2008, INT J DERMATOL, V47, P144, DOI 10.1111/j.1365-4632.2008.03485.x; Nyberg V, 2011, J REHABIL MED, V43, P50, DOI 10.2340/16501977-0631; Overland S, 2012, EUR J PAIN, V16, P611, DOI 10.1016/j.ejpain.2011.08.005; Perruccio AV, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-83; Raine R, 2000, J Health Serv Res Policy, V5, P237; Risberg G, 2004, THESIS UMEA U; Ruiz-Cantero MT, 2007, J EPIDEMIOL COMMUN H, V61, P46, DOI 10.1136/jech.2007.062034; SBU, 2010, CHRON PAIN REH; SBU, 2006, 177 SBU SWED COUNC T; Scascighini L, 2008, RHEUMATOLOGY, V47, P670, DOI 10.1093/rheumatology/ken021; Shields SA, 2008, SEX ROLES, V59, P301, DOI 10.1007/s11199-008-9501-8; Springer KW, 2012, SOC SCI MED, V74, P1661, DOI 10.1016/j.socscimed.2012.03.001; Stubbs D, 2010, PAIN MED, V11, P232, DOI 10.1111/j.1526-4637.2009.00760.x; Toivanen S, 2011, AM J IND MED, V54, P780, DOI 10.1002/ajim.20982; van den Bos GAM, 2002, J EPIDEMIOL COMMUN H, V56, P943, DOI 10.1136/jech.56.12.943; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; Winjhoven HA, 2006, CLIN J PAIN, V22, P717; Zigmond AS, 1983, PSYCHIAT SCAND, V76, P361, DOI [DOI 10.1111/J.1600-0447.1983.TB09716.X, DOI 10.1111/J.1600-0447.1983.TB09716.X.PUBMED:6880820]	42	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97134	10.1371/journal.pone.0097134	http://dx.doi.org/10.1371/journal.pone.0097134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3AL	24849625	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600022
J	Saben, JL; Bales, ES; Jackman, MR; Orlicky, D; MacLean, PS; McManaman, JL				Saben, Jessica L.; Bales, Elise S.; Jackman, Matthew R.; Orlicky, David; MacLean, Paul S.; McManaman, James L.			Maternal Obesity Reduces Milk Lipid Production in Lactating Mice by Inhibiting Acetyl-CoA Carboxylase and Impairing Fatty Acid Synthesis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MEDIUM-CHAIN TRIGLYCERIDES; MAMMARY-GLAND; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DIETARY-FAT; METABOLISM; OXIDATION; LIVER; ADIPOPHILIN	Maternal metabolic and nutrient trafficking adaptations to lactation differ among lean and obese mice fed a high fat (HF) diet. Obesity is thought to impair milk lipid production, in part, by decreasing trafficking of dietary and de novo synthesized lipids to the mammary gland. Here, we report that de novo lipogenesis regulatory mechanisms are disrupted in mammary glands of lactating HF-fed obese (HF-Ob) mice. HF feeding decreased the total levels of acetyl-CoA carboxylase-1 (ACC), and this effect was exacerbated in obese mice. The relative levels of phosphorylated (inactive) ACC, were elevated in the epithelium, and decreased in the adipose stroma, of mammary tissue from HF-Ob mice compared to those of HF-fed lean (HF-Ln) mice. Mammary gland levels of AMP-activated protein kinase (AMPK), which catalyzes formation of inactive ACC, were also selectively elevated in mammary glands of HF-Ob relative to HF-Ln dams or to low fat fed dams. These responses correlated with evidence of increased lipid retention in mammary adipose, and decreased lipid levels in mammary epithelial cells, of HF-Ob dams. Collectively, our data suggests that maternal obesity impairs milk lipid production, in part, by disrupting the balance of de novo lipid synthesis in the epithelial and adipose stromal compartments of mammary tissue through processes that appear to be related to increased mammary gland AMPK activity, ACC inhibition, and decreased fatty acid synthesis.	[Saben, Jessica L.; Bales, Elise S.; McManaman, James L.] Univ Colorado, Div Basic Reprod Sci, Aurora, CO USA; [Saben, Jessica L.; McManaman, James L.] Univ Colorado, Grad Program Reprod Sci, Aurora, CO USA; [Jackman, Matthew R.; MacLean, Paul S.; McManaman, James L.] Univ Colorado, Ctr Human Nutr, Aurora, CO USA; [Jackman, Matthew R.; MacLean, Paul S.] Univ Colorado, Dept Med, Div Endocrinol Diabet & Metab, Aurora, CO USA; [Orlicky, David] Univ Colorado, Dept Pathol, Aurora, CO USA; [MacLean, Paul S.; McManaman, James L.] Univ Colorado, Dept Physiol & Biophys, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Div Basic Reprod Sci, Anschutz Med Campus, Aurora, CO USA.	jim.mcmanaman@ucdenver.edu			National Institutes of Health [R21-HD050863, 2R01-HD045962, P01-HD38129, R01-HD075285, DK-038088]; Colorado Clinical Translational Sciences Institute [TL1RR025778]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075285, P01HD038129] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD050863] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R01DK038088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Clinical Translational Sciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants R21-HD050863, 2R01-HD045962 and P01-HD38129 (JLM), R01-HD075285 (JLM and PSM), and DK-038088 (PSM), and a Colorado Clinical Translational Sciences Institute Predoctoral T32 Training Grant TL1RR025778 (JLS, JLM, PSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2004, Obes Rev, V5, P21, DOI 10.1111/j.1467-789X.2004.00121.x; Aoki N, 1999, BIOSCI BIOTECH BIOCH, V63, P1749, DOI 10.1271/bbb.63.1749; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bartok CJ, 2009, INT J PEDIATR OBES, V4, P196, DOI 10.3109/17477160902763309; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Butz DE, 2007, AM J PHYSIOL-REG I, V293, pR669, DOI 10.1152/ajpregu.00005.2007; Carlson CL, 1999, J APPL PHYSIOL, V86, P669, DOI 10.1152/jappl.1999.86.2.669; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chong BM, 2011, J BIOL CHEM; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Commerford SR, 2001, AM J PHYSIOL-REG I, V280, pR1680, DOI 10.1152/ajpregu.2001.280.6.R1680; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Dils R. R., 1983, Biochemistry of lactation, P141; DOLE VP, 1960, J BIOL CHEM, V235, P2595; Flint DJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1179, DOI 10.1152/ajpendo.00433.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; GIOVANNINI M, 1991, J INT MED RES, V19, P351, DOI 10.1177/030006059101900501; Gluckman PD, 2008, FRONT HORM RES, V36, P61, DOI 10.1159/000115337; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Guesnet P, 2011, BIOCHIMIE, V93, P7, DOI 10.1016/j.biochi.2010.05.005; Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hilson JA, 2004, J HUM LACT, V20, P18, DOI 10.1177/0890334403261345; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Jackman MR, 2010, AM J PHYSIOL-REG I, V299, pR1097, DOI 10.1152/ajpregu.00549.2009; Kola B, 2008, FRONT HORM RES, V36, P198, DOI 10.1159/000115366; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Madsen AN, 2010, J ENDOCRINOL, V206, P287, DOI 10.1677/JOE-10-0004; Martin-Hidalgo A, 2005, J LIPID RES, V46, P658, DOI 10.1194/jlr.M400370-JLR200; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; McFadden JW, 2009, BIOCHEM BIOPH RES CO, V390, P388, DOI 10.1016/j.bbrc.2009.09.017; MELLENBERGER RW, 1973, BIOCHEM J, V136, P741, DOI 10.1042/bj1360741; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; Novak EM, 2011, AM J PHYSIOL-ENDOC M, V301, pE807, DOI 10.1152/ajpendo.00225.2011; Odle J, 1997, J NUTR, V127, P1061, DOI 10.1093/jn/127.6.1061; Olson LK, 2010, INT J OBESITY, V34, P1415, DOI 10.1038/ijo.2010.51; Rasmussen KM, 2007, ANNU REV NUTR, V27, P103, DOI 10.1146/annurev.nutr.27.061406.093738; Rasmussen KM, 1998, J NUTR, V128, p390S, DOI 10.1093/jn/128.2.390S; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; Rudolph MC, 2007, J MAMMARY GLAND BIOL, V12, P269, DOI 10.1007/s10911-007-9061-5; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Rudolph MC, 2010, AM J PHYSIOL-ENDOC M, V299, pE918, DOI 10.1152/ajpendo.00376.2010; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Russell TD, 2011, J CELL SCI, V124, P3247, DOI 10.1242/jcs.082974; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; SILVERMAN J, 1992, LAB ANIM, V26, P127, DOI 10.1258/002367792780745832; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; SMITH S, 1966, BIOCHIM BIOPHYS ACTA, V116, P23, DOI 10.1016/0005-2760(66)90089-0; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; St-Onge MP, 2002, J NUTR, V132, P329; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Travers MT, 1997, J MOL ENDOCRINOL, V19, P99, DOI 10.1677/jme.0.0190099; VERNON RG, 1987, J ANIM SCI, V64, P1395, DOI 10.2527/jas1987.6451395x; VERNON RG, 1989, P NUTR SOC, V48, P23, DOI 10.1079/PNS19890006; Vernon RG, 1997, J MAMMARY GLAND BIOL, V2, P231, DOI 10.1023/A:1026380220364; Wahlig JL, 2012, OBESITY, V20, P65, DOI 10.1038/oby.2011.196; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X; Zhao JP, 2009, PROSTAG LEUKOTR ESS, V81, P349, DOI 10.1016/j.plefa.2009.09.005	66	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98066	10.1371/journal.pone.0098066	http://dx.doi.org/10.1371/journal.pone.0098066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849657	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600082
J	Sarkar, G; Curran, GL; Sarkaria, JN; Lowe, VJ; Jenkins, RB				Sarkar, Gobinda; Curran, Geoffry L.; Sarkaria, Jann N.; Lowe, Val J.; Jenkins, Robert B.			Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via Intravenous Route to the Brain	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; CANCER RESISTANCE PROTEIN; INCREASING DRUG-DELIVERY; BLOOD-BRAIN; IN-VIVO; BARRIER DISRUPTION; THERAPEUTIC ENZYME; TROJAN HORSE; ULTRASOUND; RECEPTOR	Background: Rapid pre-clinical evaluation of chemotherapeutic agents against brain cancers and other neurological disorders remains largely unattained due to the presence of the blood-brain barrier (BBB), which limits transport of most therapeutic compounds to the brain. A synthetic peptide carrier, K16ApoE, was previously developed that enabled transport of target proteins to the brain by mimicking a ligand-receptor system. The peptide carrier was found to generate transient BBB permeability, which was utilized for non-covalent delivery of cisplatin, methotrexate and other compounds to the brain. Approach: Brain delivery of the chemotherapeutics and other agents was achieved either by injecting the carrier peptide and the drugs separately or as a mixture, to the femoral vein. A modification of the method comprised injection of K16ApoE pre-mixed with cetuximab, followed by injection of a 'small-molecule' drug. Principal findings: Seven-of-seven different small molecules were successfully delivered to the brain via K16ApoE. Depending on the method, brain uptake with K16ApoE was 0.72-1.1% for cisplatin and 0.58-0.92% for methotrexate (34-50-fold and 54-92 fold greater for cisplatin and methotrexate, respectively, with K16ApoE than without). Visually intense brain-uptake of Evans Blue, Light Green SF and Crocein scarlet was also achieved. Direct intracranial injection of EB show locally restricted distribution of the dye in the brain, whereas K16ApoE-mediated intravenous injection of EB resulted in the distribution of the dye throughout the brain. Experiments with insulin suggest that ligand-receptor signaling intrinsic to the BBB provides a natural means for passive transport of some molecules across the BBB. Significance: The results suggest that the carrier peptide can non-covalently transport various chemotherapeutic agents to the brain. Thus, the method offers an avenue for pre-clinical evaluation of various small and large therapeutic molecules against brain tumors and other neurological disorders.	[Sarkar, Gobinda; Jenkins, Robert B.] Mayo Clin & Mayo Fdn, Dept Expt Pathol, Rochester, MN 55905 USA; [Curran, Geoffry L.] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; [Sarkaria, Jann N.] Mayo Clin & Mayo Fdn, Dept Radiat Oncol, Rochester, MN 55905 USA; [Lowe, Val J.] Mayo Clin & Mayo Fdn, Dept Nucl Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sarkar, G (corresponding author), Mayo Clin & Mayo Fdn, Dept Expt Pathol, 200 1st St SW, Rochester, MN 55905 USA.	sarkar.gobinda@mayo.edu; rjenkins@mayo.edu			Mayo Clinic; Bernie and Edith Waterman Foundation; Ting Tsung and Wei Fong Chao Family Foundation	Mayo Clinic; Bernie and Edith Waterman Foundation; Ting Tsung and Wei Fong Chao Family Foundation	This work has been funded by the Mayo Clinic and by Bernie and Edith Waterman and the Ting Tsung and Wei Fong Chao Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, J PHARMACOL EXP THER, V334, P147, DOI 10.1124/jpet.110.167601; Allard E, 2009, BIOMATERIALS, V30, P2302, DOI 10.1016/j.biomaterials.2009.01.003; Angelov L, 2009, J CLIN ONCOL, V27, P3503, DOI 10.1200/JCO.2008.19.3789; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Bartus RT, 1996, EXP NEUROL, V142, P14, DOI 10.1006/exnr.1996.0175; Bellavance MA, 2008, AAPS J, V10, P166, DOI 10.1208/s12248-008-9018-7; Blanchette M, 2011, METHODS MOL BIOL, V686, P447, DOI 10.1007/978-1-60761-938-3_23; Boado RJ, 2010, J PHARMACOL EXP THER, V333, P961, DOI 10.1124/jpet.109.165092; Carlson SK, 2006, MOL IMAGING BIOL, V8, P324, DOI 10.1007/s11307-006-0058-z; Carman AJ, 2011, J NEUROSCI, V31, P13272, DOI 10.1523/JNEUROSCI.3337-11.2011; Choi JJ, 2010, IEEE T BIO-MED ENG, V57, P145, DOI 10.1109/TBME.2009.2034533; Cosolo W.C., 1989, AM J PHYSIOL, V256, P443; Cote J, 2010, NEUROPEPTIDES, V44, P177, DOI 10.1016/j.npep.2009.12.009; CROWLE AJ, 1977, J IMMUNOL METHODS, V17, P379, DOI 10.1016/0022-1759(77)90122-3; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Deng CX, 2010, THER DELIV, V1, P819, DOI 10.4155/TDE.10.66; Dhanikula RS, 2008, MOL PHARM, V5, P105, DOI 10.1021/mp700086j; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; GREIG NH, 1990, CANCER CHEMOTH PHARM, V25, P320, DOI 10.1007/BF00686230; Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45; Hdeib A, 2011, EXPERT OPIN BIOL TH, V11, P799, DOI 10.1517/14712598.2011.579097; Hynynen K, 2006, J NEUROSURG, V105, P445, DOI 10.3171/jns.2006.105.3.445; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Karkan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002469; Kioi M, 2006, TECHNOL CANCER RES T, V5, P239, DOI 10.1177/153303460600500307; Kudawara I, 2013, J CHEMOTHERAPY, V25, P41, DOI 10.1179/1973947812Y.0000000055; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Lee JH, 2011, CANCER BIOL THER, V11, P108, DOI 10.4161/cbt.11.1.14526; Lillehei KO, 1996, NEUROSURGERY, V39, P1191, DOI 10.1097/00006123-199612000-00023; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022598; Meng Y, 2014, MOL THER, V22, P547, DOI 10.1038/mt.2013.267; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; Minami T, 1998, TOXICOLOGY, V130, P107, DOI 10.1016/S0300-483X(98)00103-6; Mittal A, 2009, J HAZARD MATER, V163, P568, DOI 10.1016/j.jhazmat.2008.07.005; Mouzon A, 2013, CHEMOTHERAPY, V59, P85, DOI 10.1159/000351133; Sands MS, 2014, MOL THER, V22, P483, DOI 10.1038/mt.2014.12; Sarkar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028881; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Siegal T, 2002, CLIN PHARMACOKINET, V41, P171, DOI 10.2165/00003088-200241030-00002; Siegal T, 2013, NEURO-ONCOLOGY, V15, P656, DOI 10.1093/neuonc/not016; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Stopa B, 2006, INT J BIOL MACROMOL, V40, P1, DOI 10.1016/j.ijbiomac.2006.05.002; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Waterhouse Rikki N, 2003, Mol Imaging Biol, V5, P376, DOI 10.1016/j.mibio.2003.09.014; Zhou JB, 2013, P NATL ACAD SCI USA, V110, P11751, DOI 10.1073/pnas.1304504110; Zlokovic BV, 2000, ENDOCRINOLOGY, V141, P1434, DOI 10.1210/en.141.4.1434	49	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97655	10.1371/journal.pone.0097655	http://dx.doi.org/10.1371/journal.pone.0097655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847943	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600047
J	Wang, XF; Chen, Y; Truesdell, S; Xu, LX; Cao, J; Guan, WJ				Wang, Xuefang; Chen, Yong; Truesdell, Samuel; Xu, Liuxiong; Cao, Jie; Guan, Wenjiang			The Large-Scale Deployment of Fish Aggregation Devices Alters Environmentally-Based Migratory Behavior of Skipjack Tuna in the Western Pacific Ocean	PLOS ONE			English	Article							FISHERIES; OBESUS	Fish aggregation devices (FADs) have been used extensively in the tuna purse seine fishery since the 1980s. This long-term modification of natural habitat has generated discussions as to whether FADs impact movement patterns of tuna species. We examined this question using data collected from the skipjack tuna (Katsuwonus pelamis) fishery. We used the longitudinal gravitational center of catch (G) to examine temporal variability in skipjack movement in the Western and Central Pacific Ocean, and related this to El Nino Southern Oscillation (ENSO) events. We found that in most cases G for free-swimming school sets changed with the onset of ENSO events, while G for floating-object-associated school sets remained relatively constant. This suggests that skipjack exhibit distinguishable behavioral strategies in response to ENSO events: they either react by moving long distances or they associate with floating objects. There has been no previous attempt to evaluate the interaction between FADs and the environmentally-determined movement of skipjack; this study shows evidence of an interaction, which should be considered when managing skipjack populations.	[Wang, Xuefang; Xu, Liuxiong; Guan, Wenjiang] Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China; [Wang, Xuefang; Xu, Liuxiong; Guan, Wenjiang] Natl Engn Res Ctr Ocean Fisheries, Shanghai, Peoples R China; [Wang, Xuefang; Chen, Yong; Xu, Liuxiong; Guan, Wenjiang] Minist Educ, Key Lab Sustainable Exploitat Ocean Fisheries Res, Shanghai, Peoples R China; [Chen, Yong; Truesdell, Samuel; Cao, Jie] Univ Maine, Sch Marine Sci, Orono, ME USA	Shanghai Ocean University; National Engineering Research Center for Oceanic Fisheries; University of Maine System; University of Maine Orono	Xu, LX (corresponding author), Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China.	lxxu@shou.edu.cn	Cao, Jie/AGM-7735-2022	CAO, JIE/0000-0002-6250-586X	National High Technology Research and Development Program of China [2012AA092302]; Shanghai Ocean University International Center for Marine Sciences [3606120001]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Ocean University International Center for Marine Sciences	This study was partially sponsored by the National High Technology Research and Development Program of China (No. 2012AA092302). The involvement of Y. Chen, S. Truesdell and J. Cao in this project were supported by the Shanghai Ocean University International Center for Marine Sciences (No. 3606120001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, USE FADS TUNA FISHER; Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Blackburn M, 1969, B JAP SOC FISH OCEAN, V9-11, P221; Bromhead D, 2000, REV IMPACT FISH AGGR; Dagorn L, 2007, MAR BIOL, V151, P595, DOI 10.1007/s00227-006-0511-1; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Dufour P, 1973, DOC SCI CENT RECH OC, V4, P99; Fogarty MJ, 1998, ECOL APPL, V8, pS6, DOI 10.2307/2641359; Fonteneau A., 2000, PECHE THONIERE DISPO, V28, P15; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gillett R. D., 2003, SURVEY PURSE SEINE F; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; Harley S, 2009, 5 REG SESS WCPFC SCI; Heino M, 2002, B MAR SCI, V70, P639; ICCAT, 2008, REC ICCAT AM REC MUL; Itano D, 2005, 1 M WCPFC SCI COMM N; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Leroy B, 2013, AQUAT LIVING RESOUR, V26, P49, DOI 10.1051/alr/2012033; Menard F, 2000, AQUAT LIVING RESOUR, V13, P233, DOI 10.1016/S0990-7440(00)01066-4; Menard F, 2000, ICES J MAR SCI, V57, P525, DOI 10.1006/jmsc.2000.0717; PITCHER TJ, 1995, SCI MAR, V59, P295; SAKAGAWA G, 2000, PECHE THONIERE DISPO, P371; Schaefer KM, 2010, MAR BIOL, V157, P2625, DOI 10.1007/s00227-010-1524-3; Wang XF, 2012, AQUAT ECOL, V46, P343, DOI 10.1007/s10452-012-9405-0; WCPFC, 2008, 5 REG SESS WCPFC TEC; WCPFC, 2004, 6 SESS WCPFC PREP C; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x	29	8	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98226	10.1371/journal.pone.0098226	http://dx.doi.org/10.1371/journal.pone.0098226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849561	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600100
J	Wu, XL; Zhou, B; Yin, C; Guo, Y; Lin, Y; Pan, L; Wang, B				Wu, Xinliang; Zhou, Bin; Yin, Chao; Guo, Yong; Lin, Ying; Pan, Li; Wang, Bin			Characterization of Natural Antisense Transcript, Sclerotia Development and Secondary Metabolism by Strand-Specific RNA Sequencing of Aspergillus flavus	PLOS ONE			English	Article							AFLATOXIN PRODUCTION; GENE-EXPRESSION; BINDING PROTEIN; SWISS-MODEL; GENOME; VEA; DNA; IDENTIFICATION; BIOSYNTHESIS; CONIDIATION	Aspergillus flavus has received much attention owing to its severe impact on agriculture and fermented products induced by aflatoxin. Sclerotia morphogenesis is an important process related to A. flavus reproduction and aflatoxin biosynthesis. In order to obtain an extensive transcriptome profile of A. flavus and provide a comprehensive understanding of these physiological processes, the isolated mRNA of A. flavus CA43 cultures was subjected to high-throughput strand-specific RNA sequencing (ssRNA-seq). Our ssRNA-seq data profiled widespread transcription across the A. flavus genome, quantified vast transcripts (73% of total genes) and annotated precise transcript structures, including untranslated regions, upstream open reading frames (ORFs), alternative splicing variants and novel transcripts. We propose natural antisense transcripts in A. flavus might regulate gene expression mainly on the post-transcriptional level. This regulation might be relevant to tune biological processes such as aflatoxin biosynthesis and sclerotia development. Gene Ontology annotation of differentially expressed genes between the mycelia and sclerotia cultures indicated sclerotia development was related closely to A. flavus reproduction. Additionally, we have established the transcriptional profile of aflatoxin biosynthesis and its regulation model. We identified potential genes linking sclerotia development and aflatoxin biosynthesis. These genes could be used as targets for controlled regulation of aflatoxigenic strains of A. flavus.	[Wu, Xinliang; Zhou, Bin; Yin, Chao; Guo, Yong; Lin, Ying; Pan, Li; Wang, Bin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Wang, B (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	btbinwang@scut.edu.cn			National Natural Science Foundation of China [31100026]; 863 (Hi-tech research and development program of China) program [2012AA022108]; Guangdong Provincial Department of Science and Technology Research Project [2012B010900028, 2012A080800013]; Guangdong Provincial Natural Science Foundation of China [S2011040003020]; Fundamental Research Funds for the Central Universities [2012ZM0080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 (Hi-tech research and development program of China) program(National High Technology Research and Development Program of China); Guangdong Provincial Department of Science and Technology Research Project; Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors wish to acknowledge the financial support by National Natural Science Foundation of China (Project 31100026), the 863 (Hi-tech research and development program of China) program (contract NO. 2012AA022108), Guangdong Provincial Department of Science and Technology Research Project (NO. 2012B010900028 and 2012A080800013). Part of this work was supported by Guangdong Provincial Natural Science Foundation of China (No. S2011040003020) and the Fundamental Research Funds for the Central Universities (NO. 2012ZM0080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen AA, 2003, CURR OPIN CELL BIOL, V15, P281, DOI 10.1016/S0955-0674(03)00041-3; Arentshorst M, 2012, METHODS MOL BIOL, V835, P133, DOI 10.1007/978-1-61779-501-5_9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAYMAN P, 1993, CAN J BOT, V71, P23, DOI 10.1139/b93-003; BENNETT JW, 1978, MYCOLOGIA, V70, P104, DOI 10.2307/3758691; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cary JW, 2007, APPL MICROBIOL BIOT, V76, P1107, DOI 10.1007/s00253-007-1081-y; Chang PK, 2007, LETT APPL MICROBIOL, V44, P131, DOI 10.1111/j.1472-765X.2006.02056.x; Chang PK, 2007, APPL MICROBIOL BIOT, V77, P917, DOI 10.1007/s00253-007-1224-1; Chang PK, 2002, MYCOPATHOLOGIA, V153, P41, DOI 10.1023/A:1015211915310; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chen NS, 2006, GENOME RES, V16, P606, DOI 10.1101/gr.4515306; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COTTY PJ, 1988, PHYTOPATHOLOGY, V78, P1250, DOI 10.1094/Phyto-78-1250; COTTY PJ, 1989, PHYTOPATHOLOGY, V79, P808, DOI 10.1094/Phyto-79-808; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Donaldson ME, 2012, MOL MICROBIOL, V85, P405, DOI 10.1111/j.1365-2958.2012.08125.x; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Georgiou CD, 2006, INTEGR COMP BIOL, V46, P691, DOI 10.1093/icb/icj034; Horn BW, 1999, APPL ENVIRON MICROB, V65, P1444; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Jiu Jiang Yu W. C. N., 2011, Mycology - An International Journal on Fungal Biology, V2, P218; Jorgensen TR, 2011, APPL ENVIRON MICROB, V77, P5270, DOI 10.1128/AEM.00118-11; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang SL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-738; LITTLEY ER, 1992, CAN J BOT, V70, P772, DOI 10.1139/b92-098; Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Mamanova L, 2011, NAT PROTOC, V6, P1736, DOI 10.1038/nprot.2011.399; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Payne GA, 2006, MED MYCOL, V44, pS9, DOI 10.1080/13693780600835716; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Rollins JA, 1998, APPL ENVIRON MICROB, V64, P2539; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sibthorp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-847; Smith CA, 2008, CURR GENET, V54, P241, DOI 10.1007/s00294-008-0215-9; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilkinson JR, 2007, APPL MICROBIOL BIOT, V74, P1308, DOI 10.1007/s00253-006-0768-9; WILLETTS HJ, 1992, MYCOL RES, V96, P801, DOI 10.1016/S0953-7562(09)81027-7; Yamada O, 1999, J BIOSCI BIOENG, V87, P424, DOI 10.1016/S1389-1723(99)80089-9; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu J, 2006, Mycotoxin Res, V22, P16, DOI 10.1007/BF02954552; Yu Jiujiang, 2005, Revista Iberoamericana de Micologia, V22, P194; Yu JJ, 2011, FEMS MICROBIOL LETT, V322, P145, DOI 10.1111/j.1574-6968.2011.02345.x; Yu JJ, 2004, FEMS MICROBIOL LETT, V237, P333, DOI 10.1016/j.femsle.2004.06.054; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652; Zhoug Sen, 1998, World J Gastroenterol, V4, P434	81	13	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97814	10.1371/journal.pone.0097814	http://dx.doi.org/10.1371/journal.pone.0097814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849659	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600062
J	Kim, M; Lee, EJ; Seo, JH; Kim, TW				Kim, Mijin; Lee, Eun Ji; Seo, Je Hyun; Kim, Tae-Woo			Relationship of Spontaneous Retinal Vein Pulsation with Ocular Circulatory Cycle	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; INTRACRANIAL-PRESSURE; VENOUS PULSATION; FREQUENCY; PHASE; FLOW; CAT	Purpose: To determine the timing of spontaneous venous pulsation (SVP) relative to the ocular circulatory cycle by using the movie tool of confocal scanning laser ophthalmoloscope. Methods: A video recording of the fundus was obtained using a confocal scanning laser ophthalmoscope (Spectralis HRA, Heidelberg Engineering, Heidelberg, Germany) at 8 frames/s in 47 eyes (15 glaucoma patients and 32 glaucoma suspects) with visible pulsation of both the central retinal artery (CRA) and vein (CRV). The timing of the maximum and minimum diameters of the CRA (CRA(max) and CRA(min), respectively) and CRV (CRVmax and CRVmin, respectively) was identified during four pulse cycles. The interval between CRVmin and CRA(min), and between CRVmax and CRA(max) was expressed as the number of frames and as a percentage of the ocular circulatory cycle. Results: The ocular circulatory cycle (from one CRA(max) to the next) lasted 7.7 +/- 1.0 frames (958.8 +/- 127.2 ms, mean +/- SD), with a mean pulse rate of 62.6 beats/min. The diameter of the CRA was increased for 2.4 +/- 0.5 frames (301.9 +/- 58.8 ms) and decreased for 5.3 +/- 0.9 frames (656.9 +/- 113.5 ms). CRVmax occurred 1.0 +/- 0.2 frames after CRA(max) (equivalent to 13.0% of the ocular circulatory cycle), while CRVmin occurred 1.1 +/- 0.4 frames after CRA(min) (equivalent to 14.6% of the ocular circulatory cycle). Conclusions: During SVP, the diameter of the CRV began to decrease at early diastole, and the reduction persisted until early systole. This finding supports that CRV collapse occurs during ocular diastole.	[Kim, Mijin] Konyang Univ, Kims Eye Hosp, Myung Gok Eye Res Inst, Dept Ophthalmol, Seoul, South Korea; [Kim, Mijin; Lee, Eun Ji; Kim, Tae-Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Seo, Je Hyun] Pusan Natl Univ, Yangsan Hosp, Dept Ophthalmol, Pusan 609735, South Korea	Konyang University; Seoul National University (SNU); Pusan National University; Pusan National University Hospital	Kim, TW (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	twkim7@snu.ac.kr		Seo, Je Hyun/0000-0003-3127-7160; Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea - Korean Government [2013R1A1A1A05004781]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	Supported by National Research Foundation of Korea Grant funded by the Korean Government (2013R1A1A1A05004781). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTARIWALA R, 1994, INVEST OPHTH VIS SCI, V35, P1019; Bailliart P, 1918, ANN OCUL, V155, P453; Baurmann M, 1925, DTSCH OPHTHALMOL GES, V45, P53; Coccius EA, 1853, UEBER ANWENDUNG AUGE; DARDENNE G, 1969, EUR NEUROL, V2, P193, DOI 10.1159/000113796; Davson H, 1996, PHYSL CSF BLOOD BRAI, P697; Duke-Elder WS, 1926, J PHYSIOL-LONDON, V61, P409, DOI 10.1113/jphysiol.1926.sp002303; Elliot R H, 1921, Br J Ophthalmol, V5, P481, DOI 10.1136/bjo.5.11.481; Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4; GLUCKSBERG MR, 1993, MICROVASC RES, V45, P158, DOI 10.1006/mvre.1993.1015; Harder B, 2007, BRIT J OPHTHALMOL, V91, P401, DOI 10.1136/bjo.2006.103341; Hayashi S, 1998, J BIOMECH ENG-T ASME, V120, P468, DOI 10.1115/1.2798016; Jonas JB, 2005, OPHTHALMOLOGY, V112, P948, DOI 10.1016/j.ophtha.2004.11.014; Jonas JB, 2003, BRIT J OPHTHALMOL, V87, P949, DOI 10.1136/bjo.87.8.949; Jonas JB, 2012, INVEST OPHTH VIS SCI, V53, P6045, DOI 10.1167/iovs.12-10623; Jones HC, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-1; Kain S, 2010, BRIT J OPHTHALMOL, V94, P854, DOI 10.1136/bjo.2009.169813; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legler U, 2007, CLIN EXP OPHTHALMOL, V35, P870, DOI 10.1111/j.1442-9071.2007.01641.x; Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2; Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098; LOW HT, 1995, MED BIOL ENG COMPUT, V33, P545, DOI 10.1007/BF02522512; MEYERSCHWICKERATH R, 1995, GRAEF ARCH CLIN EXP, V233, P783, DOI 10.1007/BF00184090; Morgan WH, 2005, INVEST OPHTH VIS SCI, V46, P1307, DOI 10.1167/iovs.04-1126; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan W, 2012, INVEST OPHTH VIS SCI, V53, P6880, DOI 10.1167/iovs.12-10943; Morgan WH, 2012, INVEST OPHTH VIS SCI, V53, P4676, DOI 10.1167/iovs.12-9837; Nicolela MT, 2007, BRIT J OPHTHALMOL, V91, P405, DOI 10.1136/bjo.2006.107797; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97943	10.1371/journal.pone.0097943	http://dx.doi.org/10.1371/journal.pone.0097943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844298	Green Submitted, gold, Green Published			2022-12-27	WOS:000339563400073
J	Sunguya, BF; Poudel, KC; Mlunde, LB; Urassa, DP; Yasuoka, J; Jimba, M				Sunguya, Bruno F.; Poudel, Krishna C.; Mlunde, Linda B.; Urassa, David P.; Yasuoka, Junko; Jimba, Masamine			Poor Nutrition Status and Associated Feeding Practices among HIV-Positive Children in a Food Secure Region in Tanzania: A Call for Tailored Nutrition Training	PLOS ONE			English	Article							DAR-ES-SALAAM; ANTIRETROVIRAL THERAPY; INSECURITY; UNDERNUTRITION; HIV/AIDS; MALNUTRITION; INFECTION; CONTEXT; GROWTH; DIETS	Undernutrition among HIV-positive children can be ameliorated if they are given adequate foods in the right frequency and diversity. Food insecurity is known to undermine such efforts, but even in food rich areas, people have undernutrition. As yet no study has examined feeding practices and their associations with nutrition status among as HIV-positive children in regions with high food production. We therefore examined the magnitude of undernutrition and its association with feeding practices among HIV-positive children in a high food production region in Tanzania. Methods: We conducted this mixed-method study among 748 children aged 6 months-14 years attending 9 of a total of 32 care and treatment centers in Tanga region, Tanzania. We collected quantitative data using a standard questionnaire and qualitative data through seven focus group discussions (FGDs). Results: HIV-positive children had high magnitudes of undernutrition. Stunting, underweight, wasting, and thinness were prevalent among 61.9%, 38.7%, 26.0%, and 21.1% of HIV-positive children, respectively. They also had poor feeding practices: 88.1% were fed at a frequency below the recommendations, and 62.3% had a low level of dietary diversity. Lower feeding frequency was associated with stunting (beta = 0.11, p = 0.016); underweight (beta = 0.12, p = 0.029); and thinness (beta = 0.11, p = 0.026). Lower feeding frequency was associated with low wealth index (beta = 0.06, p<0.001), food insecurity (beta = 20.05, p<0.001), and caregiver's education. In the FGDs, participants discussed the causal relationships among the key associations; undernutrition was mainly due to low feeding frequency and dietary diversity. Such poor feeding practices resulted from poor nutrition knowledge, food insecurity, low income, and poverty. Conclusion: Feeding practices and nutrition status were poor among HIV-positive children even in food rich areas. Improving feeding frequency may help to ameliorate undernutrition. To improve it, tailored interventions should target children of poor households, the food insecure, and caregivers who have received only a low level of education.	[Sunguya, Bruno F.; Mlunde, Linda B.; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Poudel, Krishna C.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Publ Hlth, Amherst, MA 01003 USA; [Urassa, David P.] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania	University of Tokyo; University of Massachusetts System; University of Massachusetts Amherst; Muhimbili University of Health & Allied Sciences	Yasuoka, J (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	jyasuoka@post.harvard.edu	Jimba, Masamine/AAF-5630-2020; Yasuoka, Junko/GVT-8950-2022	Sunguya, Bruno/0000-0003-3625-0725	Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences [MU/01/1022/0130/21]; Ministry of Health, Labor and Welfare of Japan [H24-Chikyukibo-Ippan-008]	Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study is funded by a grant from the Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences (Ref. No: MU/01/1022/0130/21), and the Ministry of Health, Labor and Welfare of Japan (Research Grant No: H24-Chikyukibo-Ippan-008). Funders did not have influence on the results or conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; [Anonymous], 1978, GROWTH CHART INT US; [Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2009, GUIDELINES INTEGRATE; Bachou H, 2006, SEVERE MALNUTRITION; Belachew T, 2013, PLOS ONE, V8; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bilinsky Paula, 2007, HOUSEHOLD FOOD INSEC, V3; Broeck J, 2009, EUR J PEDIATR, V168, P247, DOI 10.1007/s00431-008-0796-9; Buonomo E, 2012, INT J ENV RES PUB HE, V9, P421, DOI 10.3390/ijerph9020421; Choi Eun-Suil, 2008, Nutr Res Pract, V2, P308, DOI 10.4162/nrp.2008.2.4.308; FAO, 1999, DEV FOOD INS VULN MA; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; ICF Macro, 2011, MICR RES 2010 TANZ D; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Kadiyala S, 2012, PUBLIC HEALTH NUTR, P1; Katz MH, 1999, MULTIVARIABLE ANAL P; Keenan DP, 2001, J NUTR EDUC, V33, pS49, DOI 10.1016/S1499-4046(06)60069-9; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Mpontshane N, 2008, J NUTR, V138, P1705, DOI 10.1093/jn/138.9.1705; Mullie P, 2010, EUR J CLIN NUTR, V64, P231, DOI 10.1038/ejcn.2009.145; NACP Tanzania TURo Health Mo Programme NAC Health Mo Programme NAC, 2009, NATL GUIDELINE MANAG; Nagata JM, 2012, AIDS CARE, V24, P728, DOI 10.1080/09540121.2011.630358; NBS ORC- Macro, 2010, TANZ DEM HLTH SURV 2; NBS ORC-Macro, 2005, TANZ DEM HLTH SURV 2; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Palwala M, 2009, FOOD NUTR BULL, V30, P317, DOI 10.1177/156482650903000402; Patton M. Q., 2001, QUALITATIVE RES EVAL; Paul KH, 2012, MATERN CHILD NUTR, V8, P225, DOI 10.1111/j.1740-8709.2010.00265.x; Paul KH, 2011, FOOD NUTR BULL, V32, P244, DOI 10.1177/156482651103200308; Saaka M, 2013, INT J POPULATION RES; Saloojee H, 2007, SCAND J PUBLIC HEALT, V35, P96, DOI 10.1080/14034950701356435; Shi L, 2011, J TROP PEDIATRICS, V57, P91, DOI 10.1093/tropej/fmq053; Shi L, 2010, PUBLIC HEALTH NUTR, V13, P556, DOI 10.1017/S1368980009991364; Sunguya B F P, 2006, Tanzan Health Res Bull, V8, P189; Sunguya Bruno F, 2013, Front Public Health, V1, P37, DOI 10.3389/fpubh.2013.00037; Sunguya BF, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-352; Sunguya BF, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-66; Sunguya BF, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-60; Sunguya BF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-869; Swindale A., 2006, FHI 360FANTA; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) ICF International, 2013, TANZ HIV AIDS MAL IN, DOI Dares Salaam, Tanzania, and Calverton, Maryland, USA; Tiyou A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-51; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Vitolo MR, 2010, J NUTR, V140, P2002, DOI 10.3945/jn.110.125211; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Weiser SD, 2012, J ACQUIR IMMUNE DEFI; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; World Health Organisation, 2003, NUTR REQ PEOPL LIV H; World Health Organization, 2005, NUTR HIV AIDS; World Health Organization, 2006, WHO CAS DEF HIV SURV; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS; Yeung S, 2000, J TROP PEDIATRICS, V46, P107, DOI 10.1093/tropej/46.2.107	60	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98308	10.1371/journal.pone.0098308	http://dx.doi.org/10.1371/journal.pone.0098308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24846016	gold, Green Published			2022-12-27	WOS:000339563400104
J	Wang, N; Zhang, WW; Cui, J; Zhang, HM; Chen, X; Li, RD; Wu, NN; Chen, X; Wen, S; Zhang, JH; Yin, LJ; Deng, F; Liao, Z; Zhang, ZL; Zhang, Q; Yan, ZJ; Liu, W; Ye, JX; Deng, YL; Wang, ZL; Qiao, M; Luu, HH; Haydon, RC; Shi, LL; Liang, HJ; He, TC				Wang, Ning; Zhang, Wenwen; Cui, Jing; Zhang, Hongmei; Chen, Xiang; Li, Ruidong; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Deng, Fang; Liao, Zhan; Zhang, Zhonglin; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Ye, Jixing; Deng, Youlin; Wang, Zhongliang; Qiao, Min; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.; Liang, Houjie; He, Tong-Chuan			The piggyBac Transposon-Mediated Expression of SV40 T Antigen Efficiently Immortalizes Mouse Embryonic Fibroblasts (MEFs)	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; MARROW STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; ADIPOSE-TISSUE; TUMOR-GROWTH; NEURAL STEM; PLAYS; FETAL	Mouse embryonic fibroblasts (MEFs) are mesenchymal stem cell (MSC)-like multipotent progenitor cells and can undergo self-renewal and differentiate into to multiple lineages, including bone, cartilage and adipose. Primary MEFs have limited life span in culture, which thus hampers MEFs' basic research and translational applications. To overcome this challenge, we investigate if piggyBac transposon-mediated expression of SV40 T antigen can effectively immortalize mouse MEFs and that the immortalized MEFs can maintain long-term cell proliferation without compromising their multipotency. Using the piggyBac vector MPH86 which expresses SV40 T antigen flanked with flippase (FLP) recognition target (FRT) sites, we demonstrate that mouse embryonic fibroblasts (MEFs) can be efficiently immortalized. The immortalized MEFs (piMEFs) exhibit an enhanced proliferative activity and maintain long-term cell proliferation, which can be reversed by FLP recombinase. The piMEFs express most MEF markers and retain multipotency as they can differentiate into osteogenic, chondrogenic and adipogenic lineages upon BMP9 stimulation in vitro. Stem cell implantation studies indicate that piMEFs can form bone, cartilage and adipose tissues upon BMP9 stimulation, whereas FLP-mediated removal of SV40 T antigen diminishes the ability of piMEFs to differentiate into these lineages, possibly due to the reduced expansion of progenitor populations. Our results demonstrate that piggyBac transposon-mediated expression of SV40 T can effectively immortalize MEFs and that the reversibly immortalized piMEFs not only maintain long-term cell proliferation but also retain their multipotency. Thus, the high transposition efficiency and the potential footprint-free natures may render piggyBac transposition an effective and safe strategy to immortalize progenitor cells isolated from limited tissue supplies, which is essential for basic and translational studies.	[Wang, Ning; Liang, Houjie] Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China; [Wang, Ning; Liang, Houjie] Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing, Peoples R China; [Wang, Ning; Zhang, Wenwen; Cui, Jing; Zhang, Hongmei; Chen, Xiang; Li, Ruidong; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Deng, Fang; Liao, Zhan; Zhang, Zhonglin; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Ye, Jixing; Deng, Youlin; Wang, Zhongliang; Qiao, Min; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.; He, Tong-Chuan] Univ Chicago, Med Ctr, Mol Oncol Lab, Dept Orthopaed Surg, Chicago, IL 60637 USA; [Zhang, Wenwen; Cui, Jing; Zhang, Hongmei; Li, Ruidong; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Deng, Youlin; Wang, Zhongliang; Qiao, Min; He, Tong-Chuan] Chongqing Med Univ, Minist Educ Key Lab Diagnost Med, Affiliated Hosp, Chongqing, Peoples R China; [Zhang, Wenwen] Binzhou Med Univ, Dept Lab Med, Affiliated Hosp, Yantai, Shandong, Peoples R China; [Deng, Fang] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [Liao, Zhan] Cent S Univ, Dept Orthopaed Surg, Xiang Ya Hosp, Changsha, Hunan, Peoples R China; [Zhang, Zhonglin] Wuhan Univ, Dept Surg, Zhongnan Hosp, Wuhan 430072, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China	Army Medical University; Army Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Binzhou Medical University; Army Medical University; Central South University; Wuhan University; Chongqing University	Liang, HJ (corresponding author), Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China.	lianghoujie@sina.com; tche@uchicago.edu		Yin, Liang-jun/0000-0002-9244-4965; Chen, Xiang/0000-0001-7628-516X; Deng, Fang/0000-0002-7927-5394	National Institutes of Health [AT004418, AR50142, AR054381]; 973 Program of Ministry of Science and Technology (MOST) of China [2011CB707900]; National Natural Science Foundation of China [81172115, 81272364]; University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054381, K08AR050142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of Ministry of Science and Technology (MOST) of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The reported work was supported in part by research grants from the National Institutes of Health (AT004418, AR50142, and AR054381 to TCH, RCH and HHL), the 973 Program of Ministry of Science and Technology (MOST) of China (#2011CB707900 to TCH), and the National Natural Science Foundation of China (#81172115 and #81272364 to HL). This work was also supported in part by The University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant Number UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Kim A, 2011, MOL CELL BIOCHEM, V354, P301, DOI 10.1007/s11010-011-0832-3; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Li M, 2013, INT J MED SCI, V10, P1035, DOI 10.7150/ijms.6639; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Liu Z, 2004, J NEUROTRAUM, V21, P1479, DOI 10.1089/neu.2004.21.1479; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luther G, 2011, CURR GENE THER, V11, P229; Luther GA, 2013, CANCER LETT, V336, P222, DOI 10.1016/j.canlet.2013.05.002; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ringe J, 2008, J TISSUE ENG REGEN M, V2, P136, DOI 10.1002/term.75; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shenaq DS, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/519028; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang XJ, 2014, J BIOMED MATER RES A, V102, P1017, DOI 10.1002/jbm.a.34764; Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	75	58	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97316	10.1371/journal.pone.0097316	http://dx.doi.org/10.1371/journal.pone.0097316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845466	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400021
J	Brosseau, L; Rahman, P; Poitras, S; Toupin-April, K; Paterson, G; Smith, C; King, J; Casimiro, L; De Angelis, G; Loew, L; Cavallo, S; Mc Ewan, J				Brosseau, Lucie; Rahman, Prinon; Poitras, Stephane; Toupin-April, Karine; Paterson, Gail; Smith, Christine; King, Judy; Casimiro, Lynn; De Angelis, Gino; Loew, Laurianne; Cavallo, Sabrina; Mc Ewan, Jessica			A Systematic Critical Appraisal of Non-Pharmacological Management of Rheumatoid Arthritis with Appraisal of Guidelines for Research and Evaluation II	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; BRITISH HEALTH-PROFESSIONALS; AGREE II; QUALITY; VALIDITY; SOCIETY; DISEASE; TRIALS	Clinical practice guidelines (CPGs) have been developed to summarize evidence about the management of rheumatoid arthritis (RA) and facilitate the uptake of evidence-based knowledge by consumers, health professionals, health administrators and policy makers. The objectives of this review was to assess the quality of CPGS on non-pharmacological management of RA with a standardized and validated instrument - the Appraisal of Guidelines for Research and Evaluation (AGREE II) tool and summarize the key recommendations from these CPGs. Scientific literature databases from 2001 to 2013 were systematically searched and a total of 13 CPGs for RA was identified. Only a minority of AGREE II domains were effectively addressed by the CPGS. Scope and purpose was effectively addressed in 10 out of 13 CPGs, stakeholder involvement in 11 CPGs, rigor of development in 6 CPGs, clarity/presentation in 9 CPGs, editorial independence in 1 CPGs, and applicability in none of the CPGs. The overall quality of the included CPGs according to the 7-point AGREE II scoring system was 4.8 +/- 1.04. Patient education/self-management, aerobic, dynamic and stretching exercises were the commonly recommended for the non-pharmacological management of RA by the high-quality CPGs. The general clinical management recommendations tended to be similar among high-quality CPGs. Non-pharmacological management interventions were superficially addressed in more than half of the selected CPGs. CPGs creators should use the AGREE II criteria when developing guidelines. Innovative and effective methods of CPGs implementation to users are needed to ultimately enhance the quality of life of arthritic individuals. In addition, it was difficult to establish between strongly recommended, recommended and weakly recommended, as there is no consensus between the strength of the recommendations between the appraised CPGs.	[Brosseau, Lucie; Poitras, Stephane; Smith, Christine; King, Judy; Casimiro, Lynn; De Angelis, Gino; Loew, Laurianne] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada; [Rahman, Prinon] Dalhousie Univ, Dept Epidemiol & Community Hlth, Halifax, NS, Canada; [Toupin-April, Karine] Inst Populat Hlth, Ctr Global Hlth, Ottawa, ON, Canada; [Casimiro, Lynn] Montfort Hosp, Dept Acad Affairs, Ottawa, ON, Canada; [Paterson, Gail] Arthrit Soc, Ottawa, ON, Canada; [Mc Ewan, Jessica] Univ Ottawa Lib, Ottawa, ON, Canada; [Cavallo, Sabrina] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada	University of Ottawa; Dalhousie University; University of Ottawa; University of Ottawa; University of Ottawa; Universite de Montreal	Brosseau, L (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada.	Lucie.Brosseau@uottawa.ca	Cavallo, Sabrina/AAX-8970-2020; King, Judy/L-1070-2018; Cavallo, Sabrina/AAN-9872-2021	King, Judy/0000-0003-4530-9987; Loew, Laurianne/0000-0002-7059-8859; De Angelis, Gino/0000-0003-2099-9870; Poitras, Stephane/0000-0002-8049-958X	Canadian Institutes of Health Research's (CIHR) Community Outreach Program for Non-Governmental Organizations; CIHR Institute of Musculoskeletal Health and Arthritis Community Outreach Grant [ICS-123828]	Canadian Institutes of Health Research's (CIHR) Community Outreach Program for Non-Governmental Organizations(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Musculoskeletal Health and Arthritis Community Outreach Grant(Canadian Institutes of Health Research (CIHR))	The authors are thankful for the financial support of the Canadian Institutes of Health Research's (CIHR) Community Outreach Program for Non-Governmental Organizations. This project was funded by the CIHR Institute of Musculoskeletal Health and Arthritis Community Outreach Grant: #ICS-123828. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2005, ARCH DIS CHILD, V90, P837, DOI 10.1136/adc.2005.071761; [Anonymous], 2011, MAN EARL RHEUM ARTHR; Brooks D, 2005, PHYSIOTHER CAN, V57, P123; Brosseau L, 2004, PHYS THER, V84, P934; Brosseau L, 2004, PHYS THER, V84, P1016; Brosseau L, 2011, HLTH ED J, V71, P397, DOI DOI 10.1177/0017896911419346]; Brosseau Lucie, 2004, Physiotherapy Theory and Practice, V20, P91, DOI 10.1080/09593980490453057; Brosseau L, 2012, HEALTH EDUC J, V71, P255, DOI 10.1177/0017896910387317; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Davis DA, 1997, CAN MED ASSOC J, V157, P408; Forestier R, 2009, JOINT BONE SPINE, V76, P691, DOI 10.1016/j.jbspin.2009.01.017; Gossec L, 2006, JOINT BONE SPINE, V73, P396, DOI 10.1016/j.jbspin.2006.01.008; Grossman JH, 1990, CLIN PRACTICE GUIDEL, V38; Hurdowar A, 2007, J EVAL CLIN PRACT, V13, P657, DOI 10.1111/j.1365-2753.2007.00708.x; Hurkmans EJ, 2011, ACTA REUMATOL PORT, V36, P146; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jawaheer D, 2006, ARTHRITIS RHEUM-US, V54, P3087, DOI 10.1002/art.22120; Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328; Luqmani R, 2006, RHEUMATOLOGY, V45, P1167, DOI 10.1093/rheumatology/kel215a; Luqmani R, 2009, RHEUMATOLOGY, V48, P436, DOI 10.1093/rheumatology/ken450a; Macedo LG, 2010, J CLIN EPIDEMIOL, V63, P920, DOI 10.1016/j.jclinepi.2009.10.005; Maetzel A, 2004, ANN RHEUM DIS, V63, P395, DOI 10.1136/ard.2003.006031; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Myasoedova Elena, 2010, Curr Rheumatol Rep, V12, P379, DOI 10.1007/s11926-010-0117-y; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Pencharz JN, 2002, ARTHRITIS RES, V4, P36, DOI 10.1186/ar381; Poitras S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2339; Regnaux JP, 2012, COCHRANE DATABASE SY, V2012; Royal Australian College of General Practitioners, 2009, CLIN GUID DIAGN MAN; Sackett DL, 2007, CLIN ORTHOP RELAT R, P3, DOI 10.1097/BLO.06013e31802fba1e; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Simons WR, 2012, J OCCUP ENVIRON MED, V54, P48, DOI 10.1097/JOM.0b013e31823c13e7; Straus SE, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P1, DOI 10.1002/9781118413555; Symmons DPM, 2002, BEST PRACT RES CL RH, V16, P707, DOI 10.1053/berh.2002.0257; The National Institute for Health and Clinical Excellence (NICE), 2009, RHEUM ARTHR NAT CLIN; Toupin KA, 2013, ADDRESSING UNMET NEE, P122; Ward MM, 2009, NAT REV RHEUMATOL, V5, P302, DOI 10.1038/nrrheum.2009.90	42	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e95369	10.1371/journal.pone.0095369	http://dx.doi.org/10.1371/journal.pone.0095369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840205	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600006
J	Henriksen, OM; Jensen, LT; Krabbe, K; Guldberg, P; Teerlink, T; Rostrup, E				Henriksen, Otto M.; Jensen, Lars T.; Krabbe, Katja; Guldberg, Per; Teerlink, Tom; Rostrup, Egill			Resting Brain Perfusion and Selected Vascular Risk Factors in Healthy Elderly Subjects	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ASYMMETRIC DIMETHYLARGININE; ALZHEIMERS-DISEASE; CARDIOVASCULAR-DISEASE; HOMOCYSTEINE; PLASMA; METAANALYSIS; DEMENTIA; QUANTIFICATION; VARIABILITY	Background and Purpose: Both cerebral hypoperfusion and vascular risk factors have been implicated in early aging of the brain and the development of neurodegenerative disease. However, the current knowledge of the importance of cardiovascular health on resting brain perfusion is limited. The aim of the present study was to elucidate the relation between brain perfusion variability and risk factors of endothelial dysfunction and atherosclerosis in healthy aged subjects. Methods: Thirty-eight healthy subjects aged 50-75 years old were included. Mean global brain perfusion was measured using magnetic resonance phase contrast mapping and regional brain perfusion by use of arterial spin labeling. Results: Mean global brain perfusion was inversely correlated with caffeine and hematocrit, and positively with end-tidal P-CO2. Furthermore, the mean global brain perfusion was inversely correlated with circulating homocysteine, but not with asymmetric dimethylarginine, dyslipidemia or the carotid intima-media thickness. The relative regional brain perfusion was associated with circulating homocysteine, with a relative parietal hypoperfusion and a frontal hyperperfusion. No effect on regional brain perfusion was observed for any of the other risk factors. A multiple regression model including homocysteine, caffeine, hematocrit and end-tidal P-CO2, explained nearly half of the observed variability. Conclusion: Both intrinsic and extrinsic factors influenced global cerebral perfusion variation between subjects. Further, the results suggest that the inverse relation between homocysteine and brain perfusion is owing to other mechanisms, than reflected by asymmetric dimethylarginine, and that homocysteine may be a marker of cerebral perfusion in aging brains.	[Henriksen, Otto M.; Rostrup, Egill] Copenhagen Univ Hosp, Glostrup Hosp, Sect Clin Physiol & Nucl Med, Funct Imaging Unit,Dept Diagnost, Glostrup, Denmark; [Henriksen, Otto M.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Henriksen, Otto M.; Rostrup, Egill] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Jensen, Lars T.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark; [Krabbe, Katja] Copenhagen Univ Hosp, Glostrup Hosp, Sect Radiol, Dept Diagnost, Glostrup, Denmark; [Guldberg, Per] Danish Canc Soc, Inst Canc Biol, Copenhagen, Denmark; [Teerlink, Tom] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Metab Lab, Amsterdam, Netherlands	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Danish Cancer Society; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Henriksen, OM (corresponding author), Copenhagen Univ Hosp, Glostrup Hosp, Sect Clin Physiol & Nucl Med, Funct Imaging Unit,Dept Diagnost, Glostrup, Denmark.	ohen0009@regionh.dk	Rostrup, Egill/D-8622-2017	Rostrup, Egill/0000-0001-5015-5244	Danish Council for Independent Research - Medical Sciences; Center of Healthy Aging grant from Nordeafonden	Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Center of Healthy Aging grant from Nordeafonden	This work was supported by the Danish Council for Independent Research - Medical Sciences (http://fivu.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council-1/the-danish-council-for-independent-research-medical-sciences) and by the Center of Healthy Aging grant from the Nordeafonden (https://www.nordeafonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayata C, 2013, J CEREB BLOOD FLOW M; Blackwell S, 2010, ANN CLIN BIOCHEM, V47, P17, DOI 10.1258/acb.2009.009196; Cacciapuoti F, 2011, J THROMB THROMBOLYS, V32, P82, DOI 10.1007/s11239-011-0550-4; Chappell MA, 2013, MAGN RESON MED, V69, P1466, DOI 10.1002/mrm.24372; Cherbuin N, 2007, DEMENT GERIATR COGN, V24, P348, DOI 10.1159/000109150; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Cohen RA, 2009, J CLIN EXP NEUROPSYC, V31, P96, DOI 10.1080/13803390802014594; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Jong S, 2006, ANAL BIOCHEM, V353, P287, DOI 10.1016/j.ab.2006.03.010; de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793; Demuth K, 2002, ATHEROSCLEROSIS, V165, P167, DOI 10.1016/S0021-9150(02)00205-8; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Eskelinen MH, 2010, J ALZHEIMERS DIS, V20, pS167, DOI 10.3233/JAD-2010-1404; Henriksen OM, 2013, CLIN PHYSL IN PRESS; Henriksen OM, 2013, J CEREBR BLOOD F MET, V33, P787, DOI 10.1038/jcbfm.2013.17; Henriksen OM, 2012, J MAGN RESON IMAGING, V35, P1290, DOI 10.1002/jmri.23579; Jennings JR, 2013, STROKE, V44, P2480, DOI 10.1161/STROKEAHA.113.001716; Lim MH, 2009, STROKE, V40, P3216, DOI 10.1161/STROKEAHA.109.558403; Nilsson K, 2000, AGING-CLIN EXP RES, V12, P199, DOI 10.1007/BF03339837; Norager CB, 2006, CLIN ENDOCRINOL, V65, P223, DOI 10.1111/j.1365-2265.2006.02579.x; Notsu Y, 2009, AM J HYPERTENS, V22, P257, DOI 10.1038/ajh.2008.346; Ostergaard L, 2013, NEUROBIOL AGING, V34, P1018, DOI 10.1016/j.neurobiolaging.2012.09.011; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Pase MP, 2012, STROKE, V43, P2803, DOI 10.1161/STROKEAHA.112.666727; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Rocha MS, 2012, ATHEROSCLEROSIS, V222, P509, DOI 10.1016/j.atherosclerosis.2012.03.009; RUBBA P, 1993, STROKE, V24, P1154, DOI 10.1161/01.STR.24.8.1154; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Sojkova J, 2010, STROKE, V41, P273, DOI 10.1161/STROKEAHA.109.566810; Stuhlinger MC, 2003, CIRCULATION, V108, P933, DOI 10.1161/01.CIR.0000085067.55901.89; TANG C, 1993, JMRI-J MAGN RESON IM, V3, P377, DOI 10.1002/jmri.1880030213; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; ten Dam VH, 2005, STROKE, V36, P1633, DOI 10.1161/01.STR.0000173162.88600.29; Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913; Vernooij MW, 2008, J CEREBR BLOOD F MET, V28, P412, DOI 10.1038/sj.jcbfm.9600526; Wald DS, 2011, ALZHEIMERS DEMENT, V7, P412, DOI 10.1016/j.jalz.2010.08.234; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wendell CR, 2009, STROKE, V40, P3180, DOI 10.1161/STROKEAHA.109.557280; Zhang FY, 1998, AM J PHYSIOL-REG I, V274, pR1704, DOI 10.1152/ajpregu.1998.274.6.R1704	39	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97363	10.1371/journal.pone.0097363	http://dx.doi.org/10.1371/journal.pone.0097363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840730	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600028
J	Jin, HN; Nikolau, BJ				Jin, Huanan; Nikolau, Basil J.			Evaluating PHA Productivity of Bioengineered Rhodosprillum rubrum	PLOS ONE			English	Article							POLY-BETA-HYDROXYBUTYRATE; BACTERIUM RHODOSPIRILLUM-RUBRUM; POLYHYDROXYALKANOATE BIOSYNTHESIS; PSEUDOMONAS-OLEOVORANS; RALSTONIA-EUTROPHA; EXPRESSION; FERMENTATION; DEGRADATION; HYDRATASE; ROLES	This study explored the potential of using Rhodosprillum rubrum as the biological vehicle to convert chemically simple carbon precursors to a value-added bio-based product, the biopolymer PHA. R. rubrum strains were bioengineered to overexpress individually or in various combinations, six PHA biosynthetic genes (phaC1, phaA, phaB, phaC2, phaC3, and phaJ), and the resulting nine over-expressing strains were evaluated to assess the effect on PHA content, and the effect on growth. These experiments were designed to genetically evaluate: 1) the role of each apparently redundant PHA polymerase in determining PHA productivity; 2) identify the key gene(s) within the pha biosynthetic operon that determines PHA productivity; and 3) the role of phaJ to support PHA productivity. The result of overexpressing each PHA polymerase-encoding gene indicates that phaC1 and phaC2 are significant contributors to PHA productivity, whereas phaC3 has little effect. Similarly, over-expressing individually or in combination the three PHA biosynthesis genes located in the pha operon indicates that phaB is the key determinant of PHA productivity. Finally, analogous experiments indicate that phaJ does not contribute significantly to PHA productivity. These bioengineering strains achieved PHA productivity of up to 30% of dry biomass, which is approximately 2.5-fold higher than the non-engineered control strain, indicating the feasibility of using this approach to produce value added bio-based products.	[Jin, Huanan; Nikolau, Basil J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Jin, Huanan; Nikolau, Basil J.] Iowa State Univ, Ctr Metab Biol, Ames, IA USA; [Nikolau, Basil J.] Iowa State Univ, Ctr Biorenewable Chem, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Nikolau, BJ (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	dimmas@iastate.edu			U.S. National Science Foundation [EEC-0813570]; Bioeconomy Institute of Iowa State University	U.S. National Science Foundation(National Science Foundation (NSF)); Bioeconomy Institute of Iowa State University	This work was supported by the U.S. National Science Foundation (www.nsf.gov), through its Engineering Research Center Program (Award No. EEC-0813570), which is supporting the Center for Biorenewable Chemicals (CBiRC), headquartered at Iowa State University and includes Rice University, the University of California, Irvine, the University of New Mexico, the University of Virginia, and the University of Wisconsin-Madison. Support was also provided by the Bioeconomy Institute of Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich S, 2001, BIOTECHNIQUES, V30, P846, DOI 10.2144/01304rr02; BRANDL H, 1989, INT J BIOL MACROMOL, V11, P49, DOI 10.1016/0141-8130(89)90040-8; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; Brigham CJ, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-26; Choi D, 2010, APPL BIOCHEM BIOTECH, V160, P1032, DOI 10.1007/s12010-009-8560-9; Clemente T, 2000, APPL MICROBIOL BIOT, V53, P420, DOI 10.1007/s002530051636; Do YS, 2007, BIOTECHNOL BIOENG, V97, P279, DOI 10.1002/bit.21226; DOI Y, 1992, FEMS MICROBIOL LETT, V103, P103, DOI 10.1111/j.1574-6968.1992.tb05827.x; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Fukui T, 2001, BIOMACROMOLECULES, V2, P148, DOI 10.1021/bm0056052; Guehenneux G, 2005, FUEL, V84, P733, DOI 10.1016/j.fuel.2004.11.005; Han J, 2004, FEMS MICROBIOL LETT, V239, P195, DOI 10.1016/j.femsle.2004.08.044; He YP, 1999, J BIOL CHEM, V274, P10840, DOI 10.1074/jbc.274.16.10840; Henstra AM, 2007, CURR OPIN BIOTECH, V18, P200, DOI 10.1016/j.copbio.2007.03.008; HUSTEDE E, 1992, FEMS MICROBIOL LETT, V93, P285, DOI 10.1016/0378-1097(92)90476-5; Jarboe LR, 2011, APPL MICROBIOL BIOT, V91, P1519, DOI 10.1007/s00253-011-3495-9; Jendrossek D, 2009, J BACTERIOL, V191, P3195, DOI 10.1128/JB.01723-08; Jin HN, 2012, J BACTERIOL, V194, P5522, DOI 10.1128/JB.01111-12; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; Kim YB, 2001, ADV BIOCHEM ENG BIOT, V71, P51; Kraak MN, 1997, J BACTERIOL, V179, P4985, DOI 10.1128/jb.179.16.4985-4991.1997; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; LIANG JH, 1991, J BACTERIOL, V173, P6903, DOI 10.1128/jb.173.21.6903-6909.1991; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Maurer S, 2013, J PHYS CHEM B, V117, P13872, DOI 10.1021/jp403893n; Nikolau BJ, 2008, PLANT J, V54, P536, DOI 10.1111/j.1365-313X.2008.03484.x; OEDING V, 1973, BIOCHEM J, V134, P239, DOI 10.1042/bj1340239; Pfennig N, 1978, TAXONOMY RHODOSPIRIL, P17; Potter M, 2002, MICROBIOL-SGM, V148, P2413, DOI 10.1099/00221287-148-8-2413; Purkrtova Z, 2008, CR BIOL, V331, P746, DOI 10.1016/j.crvi.2008.07.016; Reiser SE, 2000, APPL MICROBIOL BIOT, V53, P209, DOI 10.1007/s002530050010; Ruiz JA, 2001, APPL ENVIRON MICROB, V67, P225, DOI 10.1128/AEM.67.1.225-230.2001; Sambrook J., 2001, MOL CLONING LAB MANU; SENIOR PJ, 1971, BIOCHEM J, V125, P55, DOI 10.1042/bj1250055; Steinbuchel A, 2001, ADV BIOCHEM ENG BIOT, V71, P81; Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1; TAL S, 1985, CAN J MICROBIOL, V31, P608, DOI 10.1139/m85-115; Zhang YP, 2001, J BACTERIOL, V183, P6159, DOI 10.1128/JB.183.21.6159-6168.2001	39	8	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96621	10.1371/journal.pone.0096621	http://dx.doi.org/10.1371/journal.pone.0096621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840941	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600010
J	Kim, MW; Ahn, KH; Ryu, KJ; Hong, SC; Lee, JS; Nava-Ocampo, AA; Oh, MJ; Kim, HJ				Kim, Min Woo; Ahn, Ki Hoon; Ryu, Ki-Jin; Hong, Soon-Cheol; Lee, Ji Sung; Nava-Ocampo, Alejandro A.; Oh, Min-Jeong; Kim, Hai-Joong			Preventive Effects of Folic Acid Supplementation on Adverse Maternal and Fetal Outcomes	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; NEURAL-TUBE DEFECTS; FOLATE CONCENTRATIONS; PREGNANCY OUTCOMES; SERUM FOLATE; HOMOCYSTEINE; WOMEN; PREECLAMPSIA; BIRTH; HYPERHOMOCYSTEINEMIA	Although there is accumulating evidence regarding the additional protective effect of folic acid against adverse pregnancy outcomes other than neural tube defects, these effects have not been elucidated in detail. We evaluated whether folic acid supplementation is associated with favorable maternal and fetal outcomes. This was a secondary analysis of 215 pregnant women who were enrolled in our prior study. With additional data from telephone interviews regarding prenatal folic acid supplementation, existing demographic, maternal and fetal data were statistically analyzed. The concentration of folic acid in maternal blood was significantly higher following folic acid supplementation (24.6 ng/mL vs. 11.8 ng/mL). In contrast, homocysteine level in maternal blood decreased with folic acid supplementation (5.5 mmol/mL vs. 6.8 mmol/mL). The rates of both preeclampsia (odds ratio [OR], 0.27; 95% confidence interval [CI], 0.09-0.76) and small for gestational age (SGA; 9.2% vs. 20.0%; OR, 0.42; 95% CI, 0.18-0.99) were lower in the folic acid supplementation group than those in the control group. Other pregnancy outcomes had no association with folic acid supplementation. The findings indicate that folic acid supplementation may help to prevent preeclampsia and SGA. Further studies are warranted to elucidate the favorable effects of folic acid supplementation on pregnancy outcomes.	[Kim, Min Woo; Ahn, Ki Hoon; Ryu, Ki-Jin; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Lee, Ji Sung] Soonchunhyang Univ, Med Ctr, Biostat Consulting Unit, Seoul, South Korea; [Nava-Ocampo, Alejandro A.] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Nava-Ocampo, Alejandro A.] Pharmacol Res & Appl Solut PharmaReasons, Toronto, ON, Canada	Korea University; Korea University Medicine (KU Medicine); Soonchunhyang University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Hong, SC (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea.	novak082@naver.com	Rhim, Sonny H./W-9532-2019; Nava-Ocampo, Alejandro/K-3850-2012		Korea University College of Medicine [K1220211]; National Research Foundation of Korea - Ministry of Education, Science and Technology [2012-0003134]; harmacological Research and Applied Solutions- PharmaReasons	Korea University College of Medicine; National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); harmacological Research and Applied Solutions- PharmaReasons	This study was supported by grant No. K1220211 from Korea University College of Medicine and a grant (2012-0003134) from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. harmacological Research and Applied Solutions- PharmaReasons provided support in the form of a salary for author AANO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bukowski R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000061; BURKE G, 1992, NEW ENGL J MED, V326, P69; Charles DHM, 2005, PAEDIATR PERINAT EP, V19, P112, DOI 10.1111/j.1365-3016.2005.00633.x; Chiaffarino F, 2010, Minerva Ginecol, V62, P293; Christian P, 2010, JAMA-J AM MED ASSOC, V304, P2716, DOI 10.1001/jama.2010.1861; CNATTINGIUS S, 1993, AM J OBSTET GYNECOL, V168, P16, DOI 10.1016/S0002-9378(12)90878-9; Colapinto CK, 2012, APPL PHYSIOL NUTR ME, V37, P284, DOI [10.1139/h11-161, 10.1139/H11-161]; Czeizel AE, 2010, EUR J OBSTET GYN R B, V148, P135, DOI 10.1016/j.ejogrb.2009.10.016; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; Falcao S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.003; GOLDENBERG RL, 1992, OBSTET GYNECOL, V79, P719; IYENGAR L, 1975, AM J OBSTET GYNECOL, V122, P332, DOI 10.1016/0002-9378(75)90179-9; Kim MW, 2012, J OBSTET GYNAECOL, V32, P520, DOI 10.3109/01443615.2012.693984; Krishnaveni GV, 2009, DIABETOLOGIA, V52, P2350, DOI 10.1007/s00125-009-1499-0; Lane IR, 2011, J OBSTET GYNAECOL, V31, P581, DOI 10.3109/01443615.2011.594917; McDowell IFW, 2000, J NUTR, V130, p369S, DOI 10.1093/jn/130.2.369S; McNulty B, 2011, HUM REPROD, V26, P1530, DOI 10.1093/humrep/der078; McNulty H, 2008, P NUTR SOC, V67, P232, DOI 10.1017/S0029665108007076; Mislanova C, 2011, REPRODUCTION, V142, P467, DOI 10.1530/REP-10-0484; Rajkovic A, 1999, OBSTET GYNECOL, V94, P355, DOI 10.1016/S0029-7844(99)00304-X; Scholl TO, 1996, AM J CLIN NUTR, V63, P520, DOI 10.1093/ajcn/63.4.520; Scott J, 2011, ANN NUTR METAB, V59, P46, DOI 10.1159/000332127; SHOHAMVARDI I, 1994, EUR J OBSTET GYN R B, V53, P95, DOI 10.1016/0028-2243(94)90214-3; Solanky N, 2010, PLACENTA, V31, P134, DOI 10.1016/j.placenta.2009.11.017; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; STEEGERSTHEUNISSEN RPM, 1992, LANCET, V339, P1122, DOI 10.1016/0140-6736(92)90725-I; Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994; van der Molen EF, 2000, BRIT J OBSTET GYNAEC, V107, P785; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Wang J, 2000, BRIT J OBSTET GYNAEC, V107, P935, DOI 10.1111/j.1471-0528.2000.tb11095.x; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Williams PJ, 2011, BIOL REPROD, V84, P1148, DOI 10.1095/biolreprod.110.088351; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y	35	30	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97273	10.1371/journal.pone.0097273	http://dx.doi.org/10.1371/journal.pone.0097273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842467	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600019
J	Wille, S; Schumacher, P; Paas, J; Tenholte, D; Eminaga, O; Muller, U; Muthen, N; Mehner, J; Cornely, O; Engelmann, U				Wille, Sebastian; Schumacher, Pauline; Paas, Jenny; Tenholte, Dirk; Eminaga, Okyaz; Mueller, Ute; Muthen, Noemi; Mehner, Jan; Cornely, Oliver; Engelmann, Udo			Catheterless Long-Term Ambulatory Urodynamic Measurement Using a Novel Three-Device System	PLOS ONE			English	Article							DETRUSOR OVERACTIVITY; BLADDER; PRESSURE; BIOCOMPATIBILITY; SYMPTOMS	Aims: Long-term urodynamics are required because bladder-emptying disorders are often not clearly revealed by conventional urodynamics. Patients with severe clinical overactive bladder symptoms, for instance, often show normal results. This may be due to the short evaluation time and psychological factors that complicate conventional urodynamics. This study aimed to develop an ambulatory three-component urodynamic measurement system that is easy to operate, registers urodynamic parameters for several days, and has no negative impact on the patient. Methods: We developed an intravesical capsule combined with a hand-held device to register voiding desire and micturition, and an alarm pad device that detects urine loss. Recently, the intravesical capsule and its proven function were detailed in the literature. Here, we present detailed in vitro results using a female bladder model. The flexible capsule was C-shaped to minimize the risk of expulsion from the bladder during micturition. Results of biocompatibility evaluation of the intravesical capsule, which is called Wille Capsule (WiCa) are described. Results: The WiCa with an oval nose and a maximum outer diameter of 5.5 mm was easily inserted through a 25-French cystoscope. Removing the WiCa by grasping the nose using the female model with bladder was easily conducted. Expulsion of the WiCa during voiding was avoided through a novel C-shaped device design. Based on in vitro cytotoxicity studies, the capsule is a promising and safe device. Conclusion: Our novel system is an innovative minimally-invasive tool for accurate long-term urodynamic measurement, and does not require inserting a transurethral catheter.	[Wille, Sebastian; Paas, Jenny; Eminaga, Okyaz; Engelmann, Udo] Univ Cologne, Dept Urol, D-50931 Cologne, Germany; [Schumacher, Pauline; Muthen, Noemi; Cornely, Oliver] ZKS Koln Zentrum Klin Studien, Cologne, Germany; [Tenholte, Dirk; Mehner, Jan] Tech Univ Chemnitz, Fac Elect Engn & Informat Technol, Chemnitz, Germany; [Mueller, Ute] BMP Lab Med Mat Prufung GmbH, Aachen, Germany; [Cornely, Oliver] Univ Cologne, Fac Med, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Cologne; University of Cologne; Technische Universitat Chemnitz; University of Cologne	Wille, S (corresponding author), Univ Cologne, Dept Urol, D-50931 Cologne, Germany.	sebastian.wille@uk-koeln.de	Cornely, Oliver A./J-5095-2013; Eminaga, Okyaz/ABH-7208-2020	Cornely, Oliver A./0000-0001-9599-3137; /0000-0003-0861-3138	German Federal Ministry of Research and Education (BMBF) [01KN1106]; Center for Clinical Trial Cologne (ZKS Koln)	German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Center for Clinical Trial Cologne (ZKS Koln)	SW, PS, JP, NM, and OAC are supported by the German Federal Ministry of Research and Education (BMBF grant 01KN1106). The project was supported by the Center for Clinical Trial Cologne (ZKS Koln). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V62, P28, DOI 10.1016/j.urology.2003.09.050; Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x; BMP GmbH, 2012, INV REP B0343 12 CYT, P1; BMP GmbH, 2013, INV REP B0133 13 CYT, P1; Braden M, 1995, Eur J Prosthodont Restor Dent, V3, P163; Clasbrummel B, 2005, CHIR GASTROENTEROL, V21, P38, DOI 10.1159/000089346; Digesu GA, 2003, NEUROUROL URODYNAM, V22, P105, DOI 10.1002/nau.10099; Hashim H, 2006, J UROLOGY, V175, P191, DOI 10.1016/S0022-5347(05)00067-4; Jourand P, 2010, SENSOR ACTUAT A-PHYS, V162, P160, DOI 10.1016/j.sna.2010.01.035; Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7; Radley SC, 2001, J UROLOGY, V166, P2253, DOI 10.1016/S0022-5347(05)65545-0; Schnakenberg U, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 1, P191, DOI 10.1515/bmte.2002.47.s1a.191; Vijayananthan A, 2008, BIOMED IMAGING INTER, V4, P5; Wang CC, 2008, IEEE T BIOMED CIRC S, V2, P44, DOI 10.1109/TBCAS.2008.921601; Wille S, 2013, EUR UROL, V63, P966, DOI 10.1016/j.eururo.2013.01.029	15	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96280	10.1371/journal.pone.0096280	http://dx.doi.org/10.1371/journal.pone.0096280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840482	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600007
J	Singh, S; Sharma, A; Arora, SK				Singh, Sukhvinder; Sharma, Aman; Arora, Sunil K.			High Producer Haplotype (CAG) of-863C/A,-308G/A and-238G/A Polymorphisms in the Promoter Region of TNF-alpha Gene Associate with Enhanced Apoptosis of Lymphocytes in HIV-1 Subtype C Infected Individuals from North India	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; VIRUS-INFECTION; LIPODYSTROPHY; RISK; SUSCEPTIBILITY; PATHOGENESIS; CHEMOKINES; SECRETION; ALLELE; COHORT	Introduction: The natural history of HIV-1 infection and its progression towards AIDS vary considerably among individuals. Host genetic factors may be one of the possible reasons for variable HIV-1 disease progression. Single nucleotide polymorphisms (SNPs) in the promoter region of TNF-alpha gene can influence its production. The aim of the present study was to determine the association of functional TNF-alpha SNPs and its associated parameters related to apoptosis that may influence the rate of HIV-1 disease progression. Methods: Therapy naive, 100 HIV slow progressors (SPs), 100 HIV fast progressors (FPs), 50 HIV exposed but seronegative individuals (ESNs) and 260 healthy controls from same ethnic origin were recruited. Genotyping of TNF-alpha variants (-863C/A, -308G/A and -238G/A) was done using PCR-RFLP. CD4 counts were determined by flow cytometry. Plasma viral load was estimated by COBAS AMPLICOR HIV-1 monitor test. Plasma TNF-alpha concentration was estimated by Human CBA Th1/Th2 cytokine kit. The lymphocyte mitochondrial membrane potential was measured by JC-1 dye by flow cytometry. Results: Genotype and allele frequency of TNF-alpha. -238G/A and -863C/A was not significantly different in HIV-1-infected patients when compared to controls, while that of TNF-alpha -308G/A variant (high TNF-alpha producer) was significantly higher in FPs compared to SPs (p<0.01, OR=3.43). Haplotype analyses also showed that carriers of high TNF-alpha producing haplotype CAG was significantly more common among FPs compared to SPs (p<0.01, OR=3). The circulating TNF-alpha levels in blood also correlated well with genotypes. The lymphocyte mitochondrial membrane potential of FPs having CAG haplotype was significantly low as compared to wild type (CGG) haplotype (417 +/- 22 vs 571 +/- 28, p<0.01). Conclusion: High producer haplotype, CAG of TNF-alpha gene associates with enhanced apoptosis of lymphocytes in HIV-1 infected individuals, hence faster progression to ADS. However, further functional studies are needed to confirm this association and this knowledge may help clinicians to better understand the disease outcome.	[Singh, Sukhvinder; Arora, Sunil K.] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India; [Sharma, Aman] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Arora, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India.	arora.sunil@pgimer.edu.in	Singh, Sukhvinder/I-8846-2019; Arora, Sunil K/V-9083-2019		Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	The authors gratefully acknowledge Indian Council of Medical Research, New Delhi, India for providing senior research fellowship to Mr. Sukhvinder Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Barker E, 1998, BLOOD, V92, P3105, DOI 10.1182/blood.V92.9.3105.421k46_3105_3114; Barrett S, 2003, J MED VIROL, V71, P212, DOI 10.1002/jmv.10472; Brinkman BMN, 1997, J INFECT DIS, V175, P188, DOI 10.1093/infdis/175.1.188; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; Chaudhari DV, 2013, INDIAN J MED MICROBI, V31, P166, DOI 10.4103/0255-0857.115250; Deghaide NHS, 2009, AIDS, V23, P1641, DOI 10.1097/QAD.0b013e32832e5591; Delgado JC, 2003, IMMUNOGENETICS, V55, P497, DOI 10.1007/s00251-003-0604-7; Erikstrup C, 2007, AIDS, V21, P2283, DOI 10.1097/QAD.0b013e3282f153ed; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Fernandez-Ortega C, 2004, BIOCHEM BIOPH RES CO, V325, P1075, DOI 10.1016/j.bbrc.2004.10.142; Heijmans BT, 2002, GENES IMMUN, V3, P225, DOI 10.1038/sj.gene.6363859; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Hornung F, 2000, J IMMUNOL, V164, P6180, DOI 10.4049/jimmunol.164.12.6180; Jang WH, 2001, CANCER LETT, V166, P41, DOI 10.1016/S0304-3835(01)00438-4; Kim YJ, 2003, HUM MOL GENET, V12, P2541, DOI 10.1093/hmg/ddg262; Knuchel MC, 1998, AIDS RES HUM RETROV, V14, P305, DOI 10.1089/aid.1998.14.305; Kumar N, 2012, HUM IMMUNOL, V73, P566, DOI 10.1016/j.humimm.2012.01.012; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; Marzocchetti A, 2011, AIDS RES HUM RETROV, V27, P1300, DOI 10.1089/aid.2010.0172; Maxwell JR, 2008, HUM MOL GENET, V17, P3532, DOI 10.1093/hmg/ddn245; Merino AM, 2013, IMMUNOGENETICS, V65, P543, DOI 10.1007/s00251-013-0700-2; Nolan D, 2003, AIDS, V17, P121, DOI 10.1097/00002030-200301030-00017; Sachdeva Naresh, 2005, MedGenMed, V7, P68, DOI 10.1186/1758-2652-7-3-68; Sharma S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-165; Silva MM, 2010, INT J IMMUNOGENET, V37, P379, DOI 10.1111/j.1744-313X.2010.00937.x; Simpson PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040100; Sternfeld T, 2009, HIV MED, V10, P512, DOI 10.1111/j.1468-1293.2009.00723.x; Tayebi S., 2012, HEPATITIS RES TREATM, V24, P1, DOI DOI 10.1155/2012/493219; Telenti A, 2008, CURR OPIN HIV AIDS, V3, P28, DOI 10.1097/COH.0b013e3282f18ac0; Veloso S, 2010, BMC MED GENET, V11, P63; Werth VP, 2002, J INVEST DERMATOL, V119, P617, DOI 10.1046/j.1523-1747.2002.01869.x; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195	33	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98020	10.1371/journal.pone.0098020	http://dx.doi.org/10.1371/journal.pone.0098020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837009	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800098
J	Aref-Eshghi, E; Zhang, YH; Hart, D; Valdes, AM; Furey, A; Martin, G; Sun, G; Rahman, P; Arden, N; Spector, TD; Zhai, GJ				Aref-Eshghi, Erfan; Zhang, Yuhua; Hart, Deborah; Valdes, Ana M.; Furey, Andrew; Martin, Glynn; Sun, Guang; Rahman, Proton; Arden, Nigel; Spector, Tim D.; Zhai, Guangju			SMAD3 Is Associated with the Total Burden of Radiographic Osteoarthritis: The Chingford Study	PLOS ONE			English	Article							THORACIC AORTIC-ANEURYSM; KNEE OSTEOARTHRITIS; FAMILIAL AGGREGATION; ARTICULAR-CARTILAGE; JOINT INVOLVEMENT; TGF-BETA; MUTATION; WOMEN; RISK; DIFFERENTIATION	Background: A newly-described syndrome called Aneurysm-Osteoarthritis Syndrome (AOS) was recently reported. AOS presents with early onset osteoarthritis (OA) in multiple joints, together with aneurysms in major arteries, and is caused by rare mutations in SMAD3. Because of the similarity of AOS to idiopathic generalized OA (GOA), we hypothesized that SMAD3 is also associated with GOA and tested the hypothesis in a population-based cohort. Methods: Study participants were derived from the Chingford study. Kellgren-Lawrence (KL) grades and the individual features of osteophytes and joint space narrowing (JSN) were scored from radiographs of hands, knees, hips, and lumbar spines. The total KL score, osteophyte score, and JSN score were calculated and used as indicators of the total burden of radiographic OA. Forty-one common SNPs within SMAD3 were genotyped using the Illumina HumanHap610Q array. Linear regression modelling was used to test the association between the total KL score, osteophyte score, and JSN score and each of the 41 SNPs, with adjustment for patient age and BMI. Permutation testing was used to control the false positive rate. Results: A total of 609 individuals were included in the analysis. All were Caucasian females with a mean age of 60.9 +/- 5.8. We found that rs3825977, with a minor allele (T) frequency of 20%, in the last intron of SMAD3, was significantly associated with total KL score (beta = 0.14, P-permutation = 0.002). This association was stronger for the total JSN score (beta = 0.19, P-permutation = 0.002) than for total osteophyte score (beta = 0.11, P-permutation = 0.02). The T allele is associated with a 1.47-fold increased odds for people with 5 or more joints to be affected by radiographic OA (P-permutation = 0.046). Conclusion: We found that SMAD3 is significantly associated with the total burden of radiographic OA. Further studies are required to reveal the mechanism of the association.	[Aref-Eshghi, Erfan; Zhang, Yuhua; Furey, Andrew; Martin, Glynn; Sun, Guang; Rahman, Proton; Zhai, Guangju] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Hart, Deborah; Valdes, Ana M.; Spector, Tim D.; Zhai, Guangju] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Arden, Nigel] Univ Oxford, Oxford, England; [Arden, Nigel] Univ Oxford, Biobank, Oxford, England	Memorial University Newfoundland; University of London; King's College London; University of Oxford; University of Oxford	Zhai, GJ (corresponding author), Mem Univ Newfoundland, Fac Med, St John, NF, Canada.	guangju.zhai@med.mun.ca		Valdes, Ana M./0000-0003-1141-4471; Martin, Glynn/0000-0002-5527-213X	Newfoundland and Labrador RDC Ignite program; Memorial University of Newfoundland; Dean's Fellowship of Faculty of Medicine, Memorial University of Newfoundland; Welcome Trust; Arthritis Research UK	Newfoundland and Labrador RDC Ignite program; Memorial University of Newfoundland; Dean's Fellowship of Faculty of Medicine, Memorial University of Newfoundland; Welcome Trust(Wellcome Trust); Arthritis Research UK(Versus Arthritis)	The study was supported financially by Newfoundland and Labrador RDC Ignite program, and Memorial University of Newfoundland. EAE was supported by The Dean's Fellowship of Faculty of Medicine, Memorial University of Newfoundland. The Chingford Study was supported by Welcome Trust and Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2004, DEV DYNAM, V230, P685, DOI 10.1002/dvdy.20100; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Arthritis community research & evaluation unit Toronto Western Research Institute, 2010, PREV ARTHR RHEUM DIS; Bijkerk C, 1999, ARTHRITIS RHEUM, V42, P1729, DOI 10.1002/1529-0131(199908)42:8<1729::AID-ANR23>3.0.CO;2-H; Bucsi L, 1998, OSTEOARTHR CARTILAGE, V6, P31, DOI 10.1016/S1063-4584(98)80009-5; Burnett S, 1994, RADIOGRAPHIC ATLAS O; Centers for Disease Control and Prevention, 2010, NAT PUBL HLTH AG OST; Charcot J, 1881, NEW SYD SOC CLIN LEC; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cooper C, 1996, J RHEUMATOL, V23, P1938; Doerge RW, 1996, GENETICS, V142, P285; Felson DT, 2004, RADIOL CLIN N AM, V42, P1, DOI 10.1016/S0033-8389(03)00161-1; Finnson Kenneth W, 2012, Front Biosci (Schol Ed), V4, P251; GOOD P, 1994, PRACTICAL GUIDE RESA; Hannan MT, 2000, J RHEUMATOL, V27, P1513; HART DJ, 1993, J RHEUMATOL, V20, P331; Hilhorst-Hofstee Y, 2013, CLIN GENET, V83, P337, DOI 10.1111/j.1399-0004.2012.01931.x; Hirsch R, 1998, ARTHRITIS RHEUM, V41, P1227, DOI 10.1002/1529-0131(199807)41:7<1227::AID-ART13>3.0.CO;2-N; Jiang LY, 2013, RHEUMATOL INT, V33, P1763, DOI 10.1007/s00296-012-2593-z; Jordan KM, 2006, ANN RHEUM DIS, V65, P871, DOI 10.1136/ard.2005.042895; Kellgren JH, 1963, ATLAS STANDARD RADIO; Knuppel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068941; Livshits G, 2007, ANN RHEUM DIS, V66, P623, DOI 10.1136/ard.2006.060236; Loughlin J, 2011, CURR OPIN RHEUMATOL, V23, P479, DOI 10.1097/BOR.0b013e3283493ff0; Meulenbelt I, 2012, OSTEOARTHR CARTILAGE, V20, P218, DOI 10.1016/j.joca.2012.01.007; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Pritzker K. P. H, 2003, OSTEOARTHRITIS, P49; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Riyazi N, 2005, ANN RHEUM DIS, V64, P438, DOI 10.1136/ard.2004.024661; Spector TD, 1996, BRIT MED J, V312, P940; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Valdes AM, 2011, NAT REV RHEUMATOL, V7, P23, DOI 10.1038/nrrheum.2010.191; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; van de Laar IMBH, 2012, J MED GENET, V49, P47, DOI 10.1136/jmedgenet-2011-100382; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Walker LC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2785; Wischmeijer A, 2013, AM J MED GENET A, V161A, P1028, DOI 10.1002/ajmg.a.35852; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yao JY, 2003, EUR J HUM GENET, V11, P714, DOI 10.1038/sj.ejhg.5201034	40	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97786	10.1371/journal.pone.0097786	http://dx.doi.org/10.1371/journal.pone.0097786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852296	Green Accepted, gold, Green Published			2022-12-27	WOS:000338323200029
J	Qin, Q; Lu, J; Zhu, HC; Xu, LP; Cheng, HY; Zhan, LL; Yang, X; Zhang, C; Sun, XC				Qin, Qin; Lu, Jing; Zhu, Hongcheng; Xu, Liping; Cheng, Hongyan; Zhan, Liangliang; Yang, Xi; Zhang, Chi; Sun, Xinchen			PARP-1 Val762Ala Polymorphism and Risk of Cancer: A Meta-Analysis Based on 39 Case-Control Studies	PLOS ONE			English	Article							DNA-REPAIR GENES; PARP-1 VAL762ALA POLYMORPHISM; POLY(ADP-RIBOSE) POLYMERASE GENE; SINGLE-NUCLEOTIDE POLYMORPHISMS; SQUAMOUS-CELL CARCINOMA; NON-HODGKIN-LYMPHOMA; HUMAN BREAST-CANCER; CYCLE-CONTROL GENES; CHINESE POPULATION; BLADDER-CANCER	Background: Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear chromatin-associated enzyme involved in several important cellular processes, particularly in the DNA repair system. PARP-1 rs1136410: C>T is among the most studied polymorphisms and likely involved in human carcinogenesis. However, results from previous studies are inconclusive. Thus, a meta-analysis was conducted to derive a more precise estimation of the effects of this enzyme. Methodology and Principal Findings: A comprehensive search was conducted in the PubMed and EMBASE databases until December 9, 2013. A total of 39 studies with 16,783 cancer cases and 23,063 control subjects were included in the meta-analysis on the basis of the inclusion and exclusion criteria. No significant association between the PARP-1 Val762Ala polymorphism and cancer risk was found when all of the studies were pooled into the analysis (VA + AA vs. VV: OR = 1.03, 95% CI = 0.95-1.11). The subgroup analysis of cancer types revealed that the -762Ala allele was associated with increased risk of gastric, cervical, and lung cancers and a decreased risk of glioma. In addition, a significantly increased risk of cancer associated with the polymorphism was observed in Asian descendents (VA + AA vs. VV: OR = 1.17, 95% CI = 1.09-1.25; AA vs. VV: OR = 1.28, 95% CI = 1.08-1.51; VA vs. VV: OR = 1.12, 95% CI = 1.04-1.20; AA vs. VA + VV: OR = 1.09, 95% CI = 1.03-1.39). These results also indicated that a joint effect between PARP-1 Val762Ala and XRCC1 Arg399Gln could be involved in the risk of cancer development (OR = 3.53, 95% CI = 1.30-9.59). Conclusion: The present meta-analysis provides evidence that the PARP-1 Val762Ala may be involved in cancer development at least in some ethnic groups (Asian) or some specific cancer types (gastric, cervical, and lung cancers, and glioma).	[Qin, Qin; Lu, Jing; Zhu, Hongcheng; Xu, Liping; Cheng, Hongyan; Zhan, Liangliang; Yang, Xi; Zhang, Chi; Sun, Xinchen] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Sun, XC (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China.	shuizhuqq@njmu.edu.cn	Qin, Qin/GVT-5910-2022; qin, qin x/GXG-6164-2022	Zhu, Hongcheng/0000-0001-7444-5123	Research and Innovation Project for College Graduates of Jiangsu Province [CXZZ12_0588]; Natural Science Foundation of China [81272504]; Innovation Team [LJ201123]; Jiangsu Provincial Natural Science Fund [BK2011854]; "333" Project of Jiangsu Province [BRA2012210]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231801]; Key Academic Discipline of Jiangsu Province "Medical Aspects of Specific Environments"; Six Major Talent Peak Project of Jiangsu Province [2013-WSN-040]	Research and Innovation Project for College Graduates of Jiangsu Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team; Jiangsu Provincial Natural Science Fund; "333" Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Key Academic Discipline of Jiangsu Province "Medical Aspects of Specific Environments"; Six Major Talent Peak Project of Jiangsu Province	Research and Innovation Project for College Graduates of Jiangsu Province (No. CXZZ12_0588), the Natural Science Foundation of China (No. 81272504), the Innovation Team (No. LJ201123), Jiangsu Provincial Natural Science Fund (No. BK2011854), "333" Project of Jiangsu Province (No. BRA2012210), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (No. JX10231801), the Key Academic Discipline of Jiangsu Province "Medical Aspects of Specific Environments", and the Six Major Talent Peak Project of Jiangsu Province (No. 2013-WSN-040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt SI, 2007, CANCER RES, V67, P1395, DOI 10.1158/0008-5472.CAN-06-1390; Bieche I, 1996, CLIN CANCER RES, V2, P1163; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cao WH, 2007, MUTAT RES-GEN TOX EN, V632, P20, DOI 10.1016/j.mrgentox.2007.04.011; Chiang FY, 2008, CLIN CANCER RES, V14, P5919, DOI 10.1158/1078-0432.CCR-08-0906; Choi JE, 2003, CANCER EPIDEM BIOMAR, V12, P947; Cottet F, 2000, J MOL MED, V78, P431, DOI 10.1007/s001090050488; Dent P, 2013, CANCER BIOL THER, V14, P873, DOI 10.4161/cbt.26160; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Gao R, 2010, CANCER BIOL THER, V10, P13, DOI 10.4161/cbt.10.1.12172; Ghabreau L, 2004, INT J CANCER, V109, P317, DOI 10.1002/ijc.11731; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Haiman CA, 2008, HUM MOL GENET, V17, P825, DOI 10.1093/hmg/ddm354; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hosono S, 2013, INT J GYNECOL CANCER, V23, P1561, DOI 10.1097/IGC.0b013e3182a80a7e; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang Jun, 2009, V471, P305, DOI 10.1007/978-1-59745-416-2_16; Jin XM, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-38; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Landi S, 2006, CANCER RES, V66, P11062, DOI 10.1158/0008-5472.CAN-06-1039; Li CY, 2007, CANCER-AM CANCER SOC, V110, P867, DOI 10.1002/cncr.22861; Li CY, 2006, CARCINOGENESIS, V27, P1894, DOI 10.1093/carcin/bgl042; Li Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0505-z; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; Masutani M, 2005, CELL MOL LIFE SCI, V62, P769, DOI 10.1007/s00018-004-4509-x; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; Miao XP, 2006, GASTROENTEROLOGY, V131, P420, DOI 10.1053/j.gastro.2006.05.050; Nakao M, 2012, J EPIDEMIOL, V22, P477, DOI 10.2188/jea.JE20120010; Pabalan N, 2012, MOL BIOL REP, V39, P11061, DOI 10.1007/s11033-012-2009-x; Pan XF, 2012, ASIAN PAC J CANCER P, V13, P5637, DOI 10.7314/APJCP.2012.13.11.5637; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Roszak A, 2013, MOL DIAGN THER, V17, P239, DOI 10.1007/s40291-013-0036-5; Santonocito C, 2012, CLIN CHIM ACTA, V413, P1519, DOI 10.1016/j.cca.2012.06.013; Santos LS, 2012, ONCOL REP, V28, P1859, DOI 10.3892/or.2012.1975; Shen M, 2006, HUM GENET, V119, P659, DOI 10.1007/s00439-006-0177-2; Shiokawa M, 2005, JPN J CLIN ONCOL, V35, P97, DOI 10.1093/jjco/hyi028; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stern MC, 2007, CANCER EPIDEM BIOMAR, V16, P2363, DOI 10.1158/1055-9965.EPI-07-0268; Wang ML, 2010, DNA CELL BIOL, V29, P303, DOI 10.1089/dna.2009.0969; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Wang XF, 2012, EUR J HUM GENET, V20, P790, DOI 10.1038/ejhg.2011.276; Wen YY, 2012, ASIAN PAC J CANCER P, V13, P2139, DOI 10.7314/APJCP.2012.13.5.2139; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu XF, 2006, AM J HUM GENET, V78, P464, DOI 10.1086/500848; Xue XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071157; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037446; Yosunkaya E, 2010, BRIT J NEUROSURG, V24, P561, DOI 10.3109/02688697.2010.489655; Yu HP, 2012, GENET EPIDEMIOL, V36, P56, DOI 10.1002/gepi.20663; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan H, 2012, EXP THER MED, V3, P719, DOI 10.3892/etm.2012.476; Zaremba T, 2009, BRIT J CANCER, V101, P256, DOI 10.1038/sj.bjc.6605166; Zhai XJ, 2006, ONCOL REP, V15, P247; Zhang LH, 2012, ONCOL LETT, V3, P351, DOI 10.3892/ol.2011.463; Zhang QB, 2009, MOL BIOL REP, V36, P1461, DOI 10.1007/s11033-008-9336-y; Zhang XM, 2005, CANCER RES, V65, P722; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653	59	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98022	10.1371/journal.pone.0098022	http://dx.doi.org/10.1371/journal.pone.0098022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853559	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200038
J	Ryall, B; Carrara, M; Zlosnik, JEA; Behrends, V; Lee, XY; Wong, Z; Lougheed, KE; Williams, HD				Ryall, Ben; Carrara, Marta; Zlosnik, James E. A.; Behrends, Volker; Lee, Xiaoyun; Wong, Zhen; Lougheed, Kathryn E.; Williams, Huw D.			The Mucoid Switch in Pseudomonas aeruginosa Represses Quorum Sensing Systems and Leads to Complex Changes to Stationary Phase Virulence Factor Regulation	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; CONTROLS CYANIDE PRODUCTION; SIGMA-FACTOR ALGU; HYDROGEN-CYANIDE; LUNG-FUNCTION; SMALL RNAS; CONVERSION; ALGINATE; GENES; EXPRESSION	The opportunistic pathogen Pseudomonas aeruginosa chronically infects the airways of Cystic Fibrosis (CF) patients during which it adapts and undergoes clonal expansion within the lung. It commonly acquires inactivating mutations of the anti-sigma factor MucA leading to a mucoid phenotype, caused by excessive production of the extracellular polysaccharide alginate that is associated with a decline in lung function. Alginate production is believed to be the key benefit of mucA mutations to the bacterium in the CF lung. A phenotypic and gene expression characterisation of the stationary phase physiology of mucA22 mutants demonstrated complex and subtle changes in virulence factor production, including cyanide and pyocyanin, that results in their down-regulation upon entry into stationary phase but, (and in contrast to wildtype strains) continued production in prolonged stationary phase. These findings may have consequences for chronic infection if mucoid P. aeruginosa were to continue to make virulence factors under non-growing conditions during infection. These changes resulted in part from a severe down-regulation of both AHL- and AQ (PQS)-dependent quorum sensing systems. In trans expression of the cAMP-dependent transcription factor Vfr restored both quorum sensing defects and virulence factor production in early stationary phase. Our findings have implications for understanding the evolution of P. aeruginosa during CF lung infection and it demonstrates that mucA22 mutation provides a second mechanism, in addition to the commonly occurring lasR mutations, of down-regulating quorum sensing during chronic infection this may provide a selection pressure for the mucoid switch in the CF lung.	[Ryall, Ben; Carrara, Marta; Zlosnik, James E. A.; Behrends, Volker; Lee, Xiaoyun; Wong, Zhen; Lougheed, Kathryn E.; Williams, Huw D.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London, England; [Behrends, Volker] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London, England	Imperial College London; Imperial College London	Williams, HD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London, England.	h.d.williams@imperial.ac.uk		Williams, Huw/0000-0003-2225-6413; Zlosnik, James/0000-0002-9708-9034; Behrends, Volker/0000-0003-4855-5497	BBSRC	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BBSRC PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RD, 2010, J CYST FIBROS, V9, P158, DOI 10.1016/j.jcf.2009.12.003; Behrends V, 2010, MOL BIOSYST, V6, P562, DOI 10.1039/b918710c; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Boucher JC, 2000, MOL MICROBIOL, V36, P341, DOI 10.1046/j.1365-2958.2000.01846.x; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Broderick KE, 2008, J INFECT DIS, V197, P457, DOI 10.1086/525282; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Carterson AJ, 2004, J BACTERIOL, V186, P6837, DOI 10.1128/JB.186.20.6837-6844.2004; CASTRIC PA, 1983, CAN J MICROBIOL, V29, P1344, DOI 10.1139/m83-209; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Cody WL, 2009, J BACTERIOL, V191, P2993, DOI 10.1128/JB.01156-08; Cunningham L, 1997, MOL MICROBIOL, V24, P579, DOI 10.1046/j.1365-2958.1997.3561728.x; ELSTON HR, 1967, AM J CLIN PATHOL, V48, P519, DOI 10.1093/ajcp/48.5_ts.519; Enderby B, 2009, PEDIATR PULM, V44, P142, DOI 10.1002/ppul.20963; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Filiatrault MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055594; Firoved AM, 2003, J BACTERIOL, V185, P1071, DOI 10.1128/JB.185.3.1071-1081.2003; Firoved AM, 2002, J BACTERIOL, V184, P1057, DOI 10.1128/jb.184.4.1057-1064.2002; Fletcher MP, 2007, ENVIRON MICROBIOL, V9, P2683, DOI 10.1111/j.1462-2920.2007.01380.x; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Gilchrist FJ, 2011, EUR RESPIR J, V38, P409, DOI 10.1183/09031936.00166510; GOLDFARB WB, 1967, ANN SURG, V165, P104, DOI 10.1097/00000658-196701000-00014; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GOVAN JRW, 1988, BACTERIAL INFECT OD; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Jones AK, 2010, J BACTERIOL, V192, P5709, DOI 10.1128/JB.00526-10; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Lenney W, 2011, EUR RESPIR J, V37, P482, DOI 10.1183/09031936.00122810; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; MARTIN DW, 1994, J BACTERIOL, V176, P6688, DOI 10.1128/JB.176.21.6688-6696.1994; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; MOHR CD, 1992, J BACTERIOL, V174, P6624, DOI 10.1128/JB.174.20.6624-6633.1992; MOHR CD, 1990, MOL MICROBIOL, V4, P2103, DOI 10.1111/j.1365-2958.1990.tb00571.x; Morici LA, 2007, J BACTERIOL, V189, P7752, DOI 10.1128/JB.01797-06; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; OHMAN DE, 1990, PSEUDOMONAS BIOTRANS; Pedersen S S, 1992, APMIS Suppl, V28, P1; PEDERSEN SS, 1992, APMIS, V100, P326, DOI 10.1111/j.1699-0463.1992.tb00879.x; Pessi G, 2000, J BACTERIOL, V182, P6940, DOI 10.1128/JB.182.24.6940-6949.2000; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Rowen DW, 2000, MOL MICROBIOL, V36, P314, DOI 10.1046/j.1365-2958.2000.01830.x; Ryall B, 2008, EUR RESPIR J, V32, P740, DOI 10.1183/09031936.00159607; Sanderson K, 2008, EUR RESPIR J, V32, P329, DOI 10.1183/09031936.00152407; Sautter R, 2012, GENE, V498, P242, DOI 10.1016/j.gene.2011.11.005; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; SCHURR MJ, 1994, J BACTERIOL, V176, P3375, DOI 10.1128/jb.176.11.3375-3382.1994; SIMPSON JA, 1989, FREE RADICAL BIO MED, V6, P347, DOI 10.1016/0891-5849(89)90078-6; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stutz MD, 2011, EUR RESPIR J, V37, P553, DOI 10.1183/09031936.00024210; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Williams HD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00120; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; WOODS DE, 1991, J INFECT DIS, V163, P143, DOI 10.1093/infdis/163.1.143; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu WH, 2004, J BACTERIOL, V186, P7575, DOI 10.1128/JB.186.22.7575-7585.2004; Zlosnik JEA, 2006, MICROBIOL-SGM, V152, P1407, DOI 10.1099/mic.0.28396-0; Zlosnik JEA, 2004, LETT APPL MICROBIOL, V38, P360, DOI 10.1111/j.1472-765X.2004.01489.x	62	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96166	10.1371/journal.pone.0096166	http://dx.doi.org/10.1371/journal.pone.0096166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852379	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200010
J	Siva, AB; Panneerdoss, S; Sailasree, P; Singh, DK; Kameshwari, DB; Shivaji, S				Siva, Archana B.; Panneerdoss, Subbarayalu; Sailasree, Purnima; Singh, Durgesh K.; Kameshwari, Duvurri B.; Shivaji, Sisinthy			Inhibiting Sperm Pyruvate Dehydrogenase Complex and Its E3 Subunit, Dihydrolipoamide Dehydrogenase Affects Fertilization in Syrian Hamsters	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; PHOSPHOLIPASE-C ZETA; SIGNALING PATHWAYS; ACROSOME REACTION; INTRACELLULAR PH; IDIOPATHIC INFERTILITY; METABOLIC ENZYME; CALCIUM INFLUX; BOVINE SPERM; CAPACITATION	Background/Aims: The importance of sperm capacitation for mammalian fertilization has been confirmed in the present study via sperm metabolism. Involvement of the metabolic enzymes pyruvate dehydrogenase complex (PDHc) and its E3 subunit, dihydrolipoamide dehydrogenase (DLD) in hamster in vitro fertilization (IVF) via in vitro sperm capacitation is being proposed through regulation of sperm intracellular lactate, pH and calcium. Methodology and Principal Findings: Capacitated hamster spermatozoa were allowed to fertilize hamster oocytes in vitro which were then assessed for fertilization, microscopically. PDHc/DLD was inhibited by the use of the specific DLD-inhibitor, MICA (5-methoxyindole-2-carboxylic acid). Oocytes fertilized with MICA-treated (MT) [and thus PDHc/DLD-inhibited] spermatozoa showed defective fertilization where 2 nd polar body release and pronuclei formation were not observed. Defective fertilization was attributable to capacitation failure owing to high lactate and low intracellular pH and calcium in MT-spermatozoa during capacitation. Moreover, this defect could be overcome by alkalinizing spermatozoa, before fertilization. Increasing intracellular calcium in spermatozoa pre-IVF and in defectively-fertilized oocytes, post-fertilization rescued the arrest seen, suggesting the role of intracellular calcium from either of the gametes in fertilization. Parallel experiments carried out with control spermatozoa capacitated in medium with low extracellular pH or high lactate substantiated the necessity of optimal sperm intracellular lactate levels, intracellular pH and calcium during sperm capacitation, for proper fertilization. Conclusions: This study confirms the importance of pyruvate/lactate metabolism in capacitating spermatozoa for successful fertilization, besides revealing for the first time the importance of sperm PDHc/DLD in fertilization, via the modulation of sperm intracellular lactate, pH and calcium during capacitation. In addition, the observations made in the IVF studies in hamsters suggest that capacitation failures could be a plausible cause of unsuccessful fertilization encountered during human assisted reproductive technologies, like IVF and ICSI. Our studies indicate a role of sperm capacitation in the post-penetration events during fertilization.	[Siva, Archana B.; Panneerdoss, Subbarayalu; Sailasree, Purnima; Singh, Durgesh K.; Kameshwari, Duvurri B.; Shivaji, Sisinthy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Siva, AB (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	abs@ccmb.res.in; shivas@ccmb.res.in			Council for Scientific and Industrial Research, Government of India	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	SP and DKS thank Council for Scientific and Industrial Research, Government of India, for the Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; Ambrosini A, 2003, MOL HUM REPROD, V9, P381, DOI 10.1093/molehr/gag056; ASCH R, 1995, HUM REPROD, V10, P1897, DOI 10.1093/oxfordjournals.humrep.a136204; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Barroso G, 2009, FERTIL STERIL, V92, P835, DOI 10.1016/j.fertnstert.2009.06.030; BAVISTER BD, 1989, GAMETE RES, V23, P139, DOI 10.1002/mrd.1120230202; CHANG MC, 1984, J ANDROL, V5, P45; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; Demyda-Peyras S, 2013, REPROD FERTIL DEV; Douglas T, 2013, PATERNAL INFLUENCES; Fissore RA, 1999, MOL HUM REPROD, V5, P189, DOI 10.1093/molehr/5.3.189; Fraire-Zamora JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1688, DOI 10.1152/ajpcell.00141.2004; FRASER LR, 1988, GAMETE RES, V20, P491, DOI 10.1002/mrd.1120200409; Gawecka JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056385; Harrison RAP, 2005, THERIOGENOLOGY, V63, P342, DOI 10.1016/j.theriogenology.2004.09.016; Hereng TH, 2011, HUM REPROD, V26, P3249, DOI 10.1093/humrep/der317; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Irvine DS, 2000, J ANDROL, V21, P33; Jha KN, 2003, CELL MOL BIOL, V49, P329; Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899; Johnson MT, 1997, P NATL ACAD SCI USA, V94, P14512, DOI 10.1073/pnas.94.26.14512; Kashir J, 2010, HUM REPROD UPDATE, V16, P690, DOI 10.1093/humupd/dmq018; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kumar M, 2013, CLINICS, V68, P5, DOI 10.6061/clinics/2013(Sup01)02; Kumar V, 2008, BIOL REPROD, V79, P190, DOI 10.1095/biolreprod.107.066704; Liu DY, 1998, HUM REPROD, V13, P905, DOI 10.1093/humrep/13.4.905; Liu Tao, 2010, Front Biosci (Elite Ed), V2, P566, DOI 10.2741/e115; McPartlin LA, 2009, BIOL REPROD, V81, P199, DOI 10.1095/biolreprod.108.074880; Mehta A, 2014, UROL CLIN N AM, V41, P169, DOI 10.1016/j.ucl.2013.08.005; Miao YL, 2012, P NATL ACAD SCI USA, V109, P4169, DOI 10.1073/pnas.1112333109; Mitra K, 2005, J BIOL CHEM, V280, P25743, DOI 10.1074/jbc.M500310200; Mitra K, 2004, BIOL REPROD, V70, P887, DOI 10.1095/biolreprod.103.022780; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Oehninger S, 2011, INT J ANDROL, V34, pE319, DOI 10.1111/j.1365-2605.2011.01143.x; Panneerdoss S, 2012, J ANDROL, V33, P699, DOI 10.2164/jandrol.111.013151; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P511, DOI 10.1071/RD07169; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Ren DJ, 2010, PHYSIOLOGY, V25, P165, DOI 10.1152/physiol.00049.2009; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Ruffenach S, 2009, SPERM CAPACITATION; Santi CM, 1998, J GEN PHYSIOL, V112, P33, DOI 10.1085/jgp.112.1.33; SUAREZ SS, 1991, BIOL REPROD, V44, P375, DOI 10.1095/biolreprod44.2.375; Tesarik J, 2004, HUM REPROD, V19, P611, DOI 10.1093/humrep/deh127; Tesarik J, 2002, HUM REPROD, V17, P184, DOI 10.1093/humrep/17.1.184; TUCKER MJ, 1987, J IN VITRO FERTIL EM, V4, P245, DOI 10.1007/BF01533766; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VREDENBURGHWILBERG WL, 1995, MOL REPROD DEV, V40, P490, DOI 10.1002/mrd.1080400413; Wakai T, 2011, COLD SPRING HARB PER, V3; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; WORKING PK, 1983, J EXP ZOOL, V227, P97, DOI 10.1002/jez.1402270114; Yanagimachi R., 1994, P189; Young C, 2009, FERTIL STERIL, V91, P2230, DOI 10.1016/j.fertnstert.2008.05.021	54	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97916	10.1371/journal.pone.0097916	http://dx.doi.org/10.1371/journal.pone.0097916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852961	Green Submitted, gold, Green Published			2022-12-27	WOS:000338323200033
J	Williams, JP; Kim, I; Ito, E; Shi, W; Yue, SJ; Siu, LL; Waldron, J; O'Sullivan, B; Yip, KW; Liu, FF				Williams, Justin P.; Kim, Inki; Ito, Emma; Shi, Wei; Yue, Shijun; Siu, Lillian L.; Waldron, John; O'Sullivan, Brian; Yip, Kenneth W.; Liu, Fei-Fei			Pre-Clinical Characterization of Dacomitinib (PF-00299804), an Irreversible Pan-ErbB Inhibitor, Combined with Ionizing Radiation for Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; EGFR INHIBITORS; LUNG-CANCER; GASTRIC-CANCER; VARIANT III; RADIOTHERAPY; COMBINATION; RESISTANCE; THERAPY	Epidermal growth factor receptor (EGFR) is over-expressed in nearly all cases of squamous cell carcinoma of the head and neck (SCCHN), and is an important driver of disease progression. EGFR targeted therapies have demonstrated clinical benefit for SCCHN treatment. In this report, we investigated the pre-clinical efficacy of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, both alone and in combination with ionizing radiation (IR), a primary curative modality for SCCHN. One normal oral epithelial (NOE) and three SCCHN (FaDu, UT-SCC-8, UT-SCC-42a) cell lines were used to conduct cell viability, clonogenic survival, cell cycle, and immunoblotting assays in vitro, using increasing doses of Dacomitinib (10-500 nM), both with and without IR (2-4 Gy). The FaDu xenograft model was utilized for tumor growth delay assays in vivo, and immunohistochemical analyses were conducted on extracted tumors. A dose-dependent reduction in cell viability and clonogenic survival after Dacomitinib treatment was observed in all three SCCHN models. Treatment led to a significant reduction in EGFR signalling, with a subsequent decrease in phosphorylation of downstream targets such as ERK, AKT, and mTOR. In vivo, Dacomitinib treatment delayed tumor growth, while decreasing phospho-EGFR and Ki-67 immunoexpression. These effects were further enhanced when combined with IR, both in vitro and in vivo. The preclinical data support the further evaluations of Dacomitinib combined with IR for the future management of patients with SCCHN.	[Williams, Justin P.; Ito, Emma; Shi, Wei; Yue, Shijun; Siu, Lillian L.; Yip, Kenneth W.; Liu, Fei-Fei] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Kim, Inki] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Siu, Lillian L.] Princess Margaret Canc Ctr, Div Med Oncol, Toronto, ON, Canada; [Siu, Lillian L.; Waldron, John; O'Sullivan, Brian; Liu, Fei-Fei] Univ Toronto, Toronto, ON, Canada; [Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Waldron, John; O'Sullivan, Brian; Liu, Fei-Fei] Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ulsan; Asan Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Liu, FF (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca		O'Sullivan, Brian/0000-0001-8887-843X; Waldron, John/0000-0002-1050-7329; Liu, Fei-Fei/0000-0003-4344-6486; Spence, Tara/0000-0001-7098-4103	Pfizer Canada Inc.; Princess Margaret Cancer Foundation; Princess Margaret Cancer Centre Head and Neck Translational Research Program	Pfizer Canada Inc.; Princess Margaret Cancer Foundation(University of Toronto); Princess Margaret Cancer Centre Head and Neck Translational Research Program	This work was partially funded by a grant from Pfizer Canada Inc. Additional funding was provided by the Joe's Team Fund, through the Princess Margaret Cancer Foundation and the Princess Margaret Cancer Centre Head and Neck Translational Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ather F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056112; Baumann M, 2004, RADIOTHER ONCOL, V72, P257, DOI 10.1016/j.radonc.2004.07.007; Boehm AL, 2008, MOL PHARMACOL, V73, P1632, DOI 10.1124/mol.107.044636; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chau NG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-11; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Egloff AM, 2008, SEMIN ONCOL, V35, P286, DOI 10.1053/j.seminoncol.2008.03.008; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Ford AC, 2003, HEAD NECK-J SCI SPEC, V25, P67, DOI 10.1002/hed.10224; Fury MG, 2011, J NATL COMPR CANC NE, V9, P681, DOI 10.6004/jnccn.2011.0056; Galizia G, 2007, WORLD J SURG, V31, P1458, DOI 10.1007/s00268-007-9016-4; Gonzales AJ, 2008, MOL CANCER THER, V7, P1880, DOI 10.1158/1535-7163.MCT-07-2232; GRANDIS JR, 1993, CANCER RES, V53, P3579; Gupta AK, 2002, CLIN CANCER RES, V8, P885; Haikonen J, 2003, INT J CANCER, V103, P784, DOI 10.1002/ijc.10890; Harari PM, 2004, INT J RADIAT ONCOL, V58, P976, DOI 10.1016/j.ijrobp.2003.09.097; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hui ABY, 2013, CLIN CANCER RES, V19, P2154, DOI 10.1158/1078-0432.CCR-12-3572; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kato H, 2010, CLIN CANCER RES, V16, P898, DOI 10.1158/1078-0432.CCR-09-1945; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler-Ragy J, 2006, EUR J CANCER, V42, P109, DOI 10.1016/j.ejca.2005.08.034; Martin V, 2012, HISTOL HISTOPATHOL, V27, P785, DOI 10.14670/HH-27.785; Nam HJ, 2012, MOL CANCER THER, V11, P439, DOI 10.1158/1535-7163.MCT-11-0494; Ooi A, 2004, MODERN PATHOL, V17, P895, DOI 10.1038/modpathol.3800137; Ou SHI, 2012, CRIT REV ONCOL HEMAT, V83, P407, DOI 10.1016/j.critrevonc.2011.11.010; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Pogorzelski M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.62; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Shi W, 2009, J CLIN ONCOL, V27, P6213, DOI 10.1200/JCO.2009.23.1670; Shin DM, 2013, HEAD NECK-J SCI SPEC, V35, P443, DOI 10.1002/hed.21910; Shintani Satoru, 2003, Am J Clin Oncol, V26, pe150, DOI 10.1097/01.coc.0000091356.25759.69; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Solomon B, 2003, INT J RADIAT ONCOL, V55, P713, DOI 10.1016/S0360-3016(02)04357-2; Sriuranpong V, 2003, CANCER RES, V63, P2948; Strojan P, 2013, HEAD NECK; Suzuki M, 2005, HUM PATHOL, V36, P1127, DOI 10.1016/j.humpath.2005.08.007; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Tejani MA, 2010, BIOL-TARGETS THER, V4, P173; Thariat J, 2007, INT J CLIN ONCOL, V12, P99, DOI 10.1007/s10147-006-0663-5; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Yip KW, 2005, CLIN CANCER RES, V11, P8131, DOI 10.1158/1078-0432.CCR-05-1266; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11	55	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98557	10.1371/journal.pone.0098557	http://dx.doi.org/10.1371/journal.pone.0098557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853121	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200075
J	Wood, DA; Fisher, RN; Vandergast, AG				Wood, Dustin A.; Fisher, Robert N.; Vandergast, Amy G.			Fuzzy Boundaries: Color and Gene Flow Patterns among Parapatric Lineages of the Western Shovel-Nosed Snake and Taxonomic Implication	PLOS ONE			English	Article							EVOLUTIONARY PROCESSES; BIOLOGICAL DIVERSITY; ELAPHE-OBSOLETA; CONSERVATION; PHYLOGEOGRAPHY; POPULATION; SOFTWARE; DIFFERENTIATION; HYBRIDIZATION; DIVERGENCE	Accurate delineation of lineage diversity is increasingly important, as species distributions are becoming more reduced and threatened. During the last century, the subspecies category was often used to denote phenotypic variation within a species range and to provide a framework for understanding lineage differentiation, often considered incipient speciation. While this category has largely fallen into disuse, previously recognized subspecies often serve as important units for conservation policy and management when other information is lacking. In this study, we evaluated phenotypic subspecies hypotheses within shovel-nosed snakes on the basis of genetic data and considered how evolutionary processes such as gene flow influenced possible incongruence between phenotypic and genetic patterns. We used both traditional phylogenetic and Bayesian clustering analyses to infer range-wide genetic structure and spatially explicit analyses to detect possible boundary locations of lineage contact. Multilocus analyses supported three historically isolated groups with low to moderate levels of contemporary gene exchange. Genetic data did not support phenotypic subspecies as exclusive groups, and we detected patterns of discordance in areas where three subspecies are presumed to be in contact. Based on genetic and phenotypic evidence, we suggested that species-level diversity is underestimated in this group and we proposed that two species be recognized, Chionactis occipitalis and C. annulata. In addition, we recommend retention of two subspecific designations within C. annulata (C. a. annulata and C. a. klauberi) that reflect regional shifts in both genetic and phenotypic variation within the species. Our results highlight the difficultly in validating taxonomic boundaries within lineages that are evolving under a time-dependent, continuous process.	[Wood, Dustin A.; Fisher, Robert N.; Vandergast, Amy G.] US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA 92101 USA	United States Department of the Interior; United States Geological Survey	Wood, DA (corresponding author), US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA 92101 USA.	dawood@usgs.gov	Fisher, Robert/AAA-7301-2022	Fisher, Robert/0000-0002-2956-3240; Wood, Dustin/0000-0002-7668-9911; Vandergast, Amy/0000-0002-7835-6571	USGS; USFWS; Arizona Game and Fish Department; US Geological Survey, Western Ecological Research Center	USGS(United States Geological Survey); USFWS(US Fish & Wildlife Service); Arizona Game and Fish Department; US Geological Survey, Western Ecological Research Center(United States Geological Survey)	This project was funded by the Science Support Partnership between USGS and USFWS, Arizona Game and Fish Department, and by the US Geological Survey, Western Ecological Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; Avise John C., 1994, pi; Bailey R. G., 1995, MISCELLANEOUS PUBLIC, V1391; BAIRd S. F., 1859, US MEXICAN BOUNDARY, P1; BALL RM, 1992, AUK, V109, P626; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Ballentine B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010229; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bowen BW, 1999, MOL ECOL, V8, pS5, DOI 10.1046/j.1365-294X.1999.00798.x; BULL CM, 1991, ANNU REV ECOL SYST, V22, P19, DOI 10.1146/annurev.es.22.110191.000315; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Carvalho SB, 2011, DIVERS DISTRIB, V17, P408, DOI 10.1111/j.1472-4642.2011.00752.x; Center for Biological Diversity, 2004, PET LIST TUCS SHOV N; Chan LM, 2012, MOL ECOL, V21, P3839, DOI 10.1111/j.1365-294X.2012.05651.x; Cracraft J., 1983, Current Ornithology, V1, P159; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Darwin C., 1859, ORIGINS SPECIES MEAN; de Queiroz K, 1998, ENDLESS FORMS, P57; Degner JF, 2010, MOL ECOL, V19, P2501, DOI 10.1111/j.1365-294X.2010.04661.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fitzpatrick BM, 2008, MOL ECOL, V17, P4107, DOI 10.1111/j.1365-294X.2008.03885.x; FROST DR, 1990, HERPETOLOGICA, V46, P87; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Gavrilets S, 2000, EVOLUTION, V54, P1126; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Haig Susan M., 2010, Ornithological Monographs, V67, P24; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hallowell E, 1854, P ACAD NATURAL SCI, V7, P91; Hamilton MB, 1999, BIOTECHNIQUES, V27, P500, DOI 10.2144/99273st03; Hawlitschek O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042970; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; King TL, 2006, MOL ECOL, V15, P4331, DOI 10.1111/j.1365-294X.2006.03080.x; Klauber L. M., 1951, Transactions of the San Diego Society for Natural History, V11, P141; Kodandaramaiah U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041058; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Mahrdt CR, 2001, CATALOG AM AMPHIB RE, V731, P1; MANTEL N, 1967, CANCER RES, V27, P209; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; MAYR E, 1982, AUK, V99, P593; Mayr E., 1954, EVOLUTION PROCESS, P157; McNab WH, 2005, DESCRIPTION ECOLOGIC, P80; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Nadachowska K, 2009, MOL BIOL EVOL, V26, P829, DOI 10.1093/molbev/msp004; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Peakall R., 2012, BIOINFORMATICS; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 5; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reilly SB, 2012, MOL ECOLOGY; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santamaria L, 2012, EVOL APPL, V5, P202, DOI 10.1111/j.1752-4571.2011.00229.x; SMITH HOBART M., 1950, UNIV KANSAS SCI BULL, V33, P313; Stickel William H., 1941, BULL CHICAGO ACAD SCI, V6, P135; Stickel William H., 1943, PROC BIOL SOC WASHINGTON, V56, P109; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; U.S. Fish and Wildlife Service, 2012, FED REGISTER, p[77, 70018]; U.S. Fish and Wildlife Service, 2011, FED REGISTER, V76, P66396; U.S. Fish and Wildlife Service, 2010, FED REGISTER, V75, P16050; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandewege MW, 2012, J HERPETOL, V46, P56, DOI 10.1670/09-220; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Wood DA, 2008, CONSERV GENET, V9, P1489, DOI 10.1007/s10592-007-9482-0; Wood DA, 2013, DIVERS DISTRIB, V19, P722, DOI 10.1111/ddi.12022; Wright S, 1931, GENETICS, V16, P0097; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	85	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97494	10.1371/journal.pone.0097494	http://dx.doi.org/10.1371/journal.pone.0097494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848638	gold, Green Submitted, Green Published			2022-12-27	WOS:000336730600032
J	Benoit-Bird, KJ; McManus, MA				Benoit-Bird, Kelly J.; McManus, Margaret A.			A Critical Time Window for Organismal Interactions in a Pelagic Ecosystem	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; MARINE PREDATOR; ZOOPLANKTON COMMUNITIES; VERTICAL MIGRATION; SOUND-SCATTERING; HAWAIIAN WATERS; DIEL MIGRATION; BERING-SEA; PATTERNS; AVAILABILITY	To measure organismal coherence in a pelagic ecosystem, we used moored sensors to describe the vertical dynamics of each step in the food chain in shelf waters off the west shore of Oahu, Hawaii. Horizontally extensive, intense aggregations of phytoplankton, zooplankton, and micronekton exhibited strong diel patterns in abundance and vertical distribution, resulting in a highly variable potential for interaction amongst trophic levels. Only around dusk did zooplankton layers overlap with phytoplankton layers. Shortly after sunset, micronekton ascended from the deep, aggregating on the island's shelf. Short-lived departures in migration patterns were detected in depth, vertical distribution, density, and total abundance of micronekton when zooplankton layers were present with typical patterns resuming within one hour. Layers of zooplankton began to disappear within 20 minutes of the arrival of micronekton with no layers present after 50 minutes. The effects of zooplankton layers cascaded even further up the food chain, affecting many behaviors of dolphins observed at dusk including their depth, group size, and inter-individual spacing. As a result of these changes in behavior, during a 30-minute window just after dusk, the number of feeding events observed for each dolphin and consequently the feeding time for each individual more than doubled when zooplankton layers were present. Dusk is a critical period for interactions amongst species in this system from phytoplankton to top predators. Our observations that short time windows can drive the structure and function of a complex suite of organisms highlight the importance of explicitly adding a temporal dimension at a scale relevant to individual organisms to our descriptions of heterogeneity in ocean ecosystems.	[Benoit-Bird, Kelly J.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [McManus, Margaret A.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	Oregon State University; University of Hawaii System; University of Hawaii Manoa	Benoit-Bird, KJ (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	kbenoit@coas.oregonstate.edu	McManus, Margaret Anne/AAA-2604-2020		US Office of Naval Research [N00014-08-1-1212, N00014-08-1-1210]	US Office of Naval Research(Office of Naval Research)	This work was funded by the US Office of Naval Research, awards #N00014-08-1-1212 (MAM), and #N00014-08-1-1210 (KJBB); http://www.onr.navy.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1993, ECOLOGY, V74, P258, DOI 10.2307/1939521; Alldredge AL, 2002, MAR ECOL PROG SER, V233, P1, DOI 10.3354/meps233001; [Anonymous], ECOLOGY PREDATOR PRE; Bell AV, 2009, THEOR POPUL BIOL, V76, P52, DOI 10.1016/j.tpb.2009.03.008; Benoit-Bird KJ, 2008, MAR ECOL PROG SER, V367, P109, DOI 10.3354/meps07571; Benoit-Bird KJ, 2006, MAR ECOL PROG SER, V319, P1, DOI 10.3354/meps319001; Benoit-Bird KJ, 2012, BIOL LETTERS, V8, P813, DOI 10.1098/rsbl.2012.0232; Benoit-Bird KJ, 2011, MAR ECOL PROG SER, V443, P217, DOI 10.3354/meps09408; Benoit-Bird KJ, 2010, CONT SHELF RES, V30, P17, DOI 10.1016/j.csr.2009.08.001; Benoit-Bird KJ, 2009, ICES J MAR SCI, V66, P582, DOI 10.1093/icesjms/fsp013; Benoit-Bird KJ, 2009, J ACOUST SOC AM, V125, P125, DOI 10.1121/1.2967480; Benoit-Bird KJ, 2004, DEEP-SEA RES PT I, V51, P707, DOI 10.1016/j.dsr.2004.01.004; Benoit-Bird KJ, 2003, J ACOUST SOC AM, V114, P1888, DOI 10.1121/1.1612484; Benoit-Bird KJ, 2013, GEOPHYS RES IN PRESS; Beyer JE, 1995, ICES COUNC M, V14; CLARKE TA, 1980, FISH B-NOAA, V78, P619; Dupuch A, 2009, ANIM BEHAV, V78, P705, DOI 10.1016/j.anbehav.2009.05.033; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; ENRIGHT JT, 1977, LIMNOL OCEANOGR, V22, P856, DOI 10.4319/lo.1977.22.5.0856; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Foote K.G, 1987, ICES COOP RES REP, V144; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; Freon P, 1996, ICES J MAR SCI, V53, P459; Goss C, 1997, MAR ECOL PROG SER, V154, P41, DOI 10.3354/meps154041; Grunbaum D, 2002, HYDROBIOLOGIA, V480, P175, DOI 10.1023/A:1021296103358; Hampton SE, 2004, OECOLOGIA, V138, P475, DOI 10.1007/s00442-003-1446-6; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Holliday D. V, 1977, OCEAN SOUND SCATT PR, P619; HOLLIDAY DV, 1995, ICES J MAR SCI, V52, P279, DOI 10.1016/1054-3139(95)80044-1; HORNE JK, 1995, OIKOS, V74, P18, DOI 10.2307/3545670; Hunt G.L. Jr, 1990, Polar Research, V8, P43, DOI 10.1111/j.1751-8369.1990.tb00374.x; Hunt GL, 2008, DEEP-SEA RES PT II, V55, P1919, DOI 10.1016/j.dsr2.2008.04.032; Kang M, 2002, ICES J MAR SCI, V59, P794, DOI 10.1006/jmsc.2002.1229; Korneliussen RJ, 2000, ICES J MAR SCI, V57, P1204, DOI 10.1006/jmsc.2000.0806; Krebs J.R., 1978, P23; LASKER R, 1975, FISH B-NOAA, V73, P453; Leising AW, 2001, MAR ECOL PROG SER, V216, P167, DOI 10.3354/meps216167; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LOBEL PS, 1978, PAC SCI, V32, P193; MACKAS D, 1976, J EXP MAR BIOL ECOL, V25, P77, DOI 10.1016/0022-0981(76)90077-0; MacLennan D.N., 1992, SPRINGER SCI BUS MED; McManus MA, 2012, ESTUAR COAST, P1; Medwin H., 1997, FUNDAMENTALS ACOUSTI, DOI [10.1016/B978-0-12-487570-8.X5000-4, DOI 10.1016/B978-0-12-487570-8.X5000-4]; Nachman G, 1981, J ANIM ECOL, P435; RINGELBERG J, 1995, J MAR BIOL ASSOC UK, V75, P15, DOI 10.1017/S0025315400015162; ROSE GA, 1990, ECOLOGY, V71, P33, DOI 10.2307/1940245; Roughgarden J, 1974, AM NAT, P649; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Sevadjian J, 2012, CONT SHELF RES; Sevadjian JC, 2014, CONT SHELF RES, V72, P138, DOI 10.1016/j.csr.2013.09.018; Sevadjian JC, 2010, MAR ECOL PROG SER, V409, P95, DOI 10.3354/meps08614; Sigler MF, 2012, DEEP-SEA RES PT II, V65-70, P292, DOI 10.1016/j.dsr2.2012.02.017; SIH A, 1984, AM NAT, V123, P143, DOI 10.1086/284193; Silvertown J, 1992, J ECOL, P527; Simila T, 1996, CAN J FISH AQUAT SCI, V53, P769, DOI 10.1139/cjfas-53-4-769; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Stanton TK, 1998, J ACOUST SOC AM, V103, P236, DOI 10.1121/1.421110; Sullivan JM, 2010, CONT SHELF RES, V30, P50, DOI 10.1016/j.csr.2009.07.009; WILLIAMSON CE, 1989, OECOLOGIA, V79, P76, DOI 10.1007/BF00378242; WILLIAMSON CE, 1990, HYDROBIOLOGIA, V198, P125, DOI 10.1007/BF00048629; Womble JN, 2006, MAR ECOL PROG SER, V325, P281, DOI 10.3354/meps325281	63	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97763	10.1371/journal.pone.0097763	http://dx.doi.org/10.1371/journal.pone.0097763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844981	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400058
J	Bossers, WJR; Scherder, EJA; Boersma, F; Hortobagyi, T; van der Woude, LHV; van Heuvelen, MJG				Bossers, Willem J. R.; Scherder, Erik J. A.; Boersma, Froukje; Hortobagyi, Tibor; van der Woude, Lucas H. V.; van Heuvelen, Marieke J. G.			Feasibility of a Combined Aerobic and Strength Training Program and Its Effects on Cognitive and Physical Function in Institutionalized Dementia Patients. A Pilot Study	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; OLDER-ADULTS; ALZHEIMERS-DISEASE; PERFORMANCE-MEASURES; EXERCISE PROGRAM; BODY STRENGTH; PEOPLE; IMPAIRMENT; MOBILITY; BALANCE	Objectives: We examined the feasibility of a combined aerobic and strength training program in institutionalized dementia patients and studied the effects on cognitive and physical function. Methods: Thirty-three patients with dementia, recruited from one nursing home, participated in this non-randomized pilot study (25 women; age = 85.2 +/- 4.9 years; Mini Mental State Examination = 16.8 +/- 4.0). In phase 1 of the study, seventeen patients in the Exercise group (EG) received a combined aerobic and strength training program for six weeks, five times per week, 30 minutes per session, in an individually supervised format and successfully concluded the pre and posttests. In phase 2 of the study, sixteen patients in the Social group (SG) received social visits at the same frequency, duration, and format and successfully concluded the pre and posttests. Results: Indices of feasibility showed that the recruitment and adherence rate, respectively were 46.2% and 86.3%. All EG patients completed the exercise program according to protocol without adverse events. After the six-week program, no significant differences on cognitive function tests were found between the EG and SG. There was a moderate effect size in favor for the EG for the Visual Memory Span Forward; a visual attention test. There were significant differences between groups in favor for the EG with moderate to large effects for the physical tests Walking Speed (p=.003), Six-Minute Walk Test (p=.031), and isometric quadriceps strength (p=.012). Conclusions: The present pilot study showed that it is feasible to conduct a combined aerobic and strength training program in institutionalized patients with dementia. The selective cognitive visual attention improvements and more robust changes in motor function in favor of EG vs. SG could serve as a basis for large randomized clinical trials.	[Bossers, Willem J. R.; Scherder, Erik J. A.; Hortobagyi, Tibor; van der Woude, Lucas H. V.; van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Scherder, Erik J. A.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Boersma, Froukje] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen	Bossers, WJR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	w.j.r.bossers@umcg.nl	van der Woude, Lucas H/E-7986-2018	van der Woude, Lucas H/0000-0002-8472-334X				Bassuk SS, 1999, ANN INTERN MED, V131, P165, DOI 10.7326/0003-4819-131-3-199908030-00002; Blankevoort CG, 2013, PHYS THER, V93, P69, DOI 10.2522/ptj.20110164; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Bossers WJR, 2012, DEMENT GER COGN D EX, V2, P589, DOI 10.1159/000345038; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Brown AD, 2010, NEUROBIOL AGING, V31, P2047, DOI 10.1016/j.neurobiolaging.2008.11.002; Brucki SMD, 2004, BRAZ J MED BIOL RES, V37, P1771, DOI 10.1590/S0100-879X2004001200002; Chandler JM, 1998, ARCH PHYS MED REHAB, V79, P24, DOI 10.1016/S0003-9993(98)90202-7; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Enright Paul L, 2003, Respir Care, V48, P783; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Fiser WM, 2010, J GERONTOL A-BIOL, V65, P1332, DOI 10.1093/gerona/glq137; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Frandin K, 1995, SCAND J REHABIL MED, V27, P231; GURALNIK JM, 1994, AGING-CLIN EXP RES, V6, P410, DOI 10.1007/BF03324272; Hammes J, 1973, STROOP KLEUR WOORD T; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; HINRICHSEN GA, 1994, GERONTOLOGIST, V34, P95, DOI 10.1093/geront/34.1.95; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; Jarnlo Gun-Britt, 2003, Physiotherapy Theory and Practice, V19, P35, DOI 10.1080/09593980307969; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Krist L, 2013, CLIN INTERV AGING, V8, P443, DOI 10.2147/CIA.S42136; LaRoche DP, 2011, GAIT POSTURE, V33, P668, DOI 10.1016/j.gaitpost.2011.02.022; Lindeboom J, 1989, AMSTERDAM DEMENTIA S; Liu-Ambrose T, 2009, BRIT J SPORT MED, V43, P25, DOI 10.1136/bjsm.2008.055616; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Luteijn F, 1983, HANDLEIDING GRONINGE; Mangione KK, 2010, J AM GERIATR SOC, V58, P1911, DOI 10.1111/j.1532-5415.2010.03076.x; Nation DA, 2011, MED HYPOTHESES, V76, P847, DOI 10.1016/j.mehy.2011.02.034; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; ORY MG, 1993, J AM GERIATR SOC, V41, P283, DOI 10.1111/j.1532-5415.1993.tb06707.x; Perri R, 2014, J ALZHEIMERS DIS, V39, P669, DOI 10.3233/JAD-131337; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293; Rhodes RE, 1999, SPORTS MED, V28, P397, DOI 10.2165/00007256-199928060-00003; Rogers SD, 2008, J AGING PHYS ACTIV, V16, P61, DOI 10.1123/japa.16.1.61; Rosen VM, 1997, J EXP PSYCHOL GEN, V126, P211, DOI 10.1037/0096-3445.126.3.211; ROSSITERFORNOFF JE, 1995, J GERONTOL A-BIOL, V50, pM291, DOI 10.1093/gerona/50A.6.M291; Schafer JH, 2005, J AM GERIATR SOC, V53, P381, DOI 10.1111/j.1532-5415.2005.53153.x; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Steinberg M, 2009, INT J GERIATR PSYCH, V24, P680, DOI 10.1002/gps.2175; Tak ECPM, 2012, J AGING PHYS ACTIV, V20, P32, DOI 10.1123/japa.20.1.32; Tappen RM, 1997, J GERONTOL A-BIOL, V52, pM52, DOI 10.1093/gerona/52A.1.M52; Thomas VS, 2003, J GERONTOL A-BIOL, V58, P746; Verkerke GJ, 2003, MED BIOL ENG COMPUT, V41, P283, DOI 10.1007/BF02348432; Volkers KM, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-38; Vreugdenhil A, 2012, SCAND J CARING SCI, V26, P12, DOI 10.1111/j.1471-6712.2011.00895.x; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wiesmann M, 2013, J CEREBR BLOOD F MET, V33, P1696, DOI 10.1038/jcbfm.2013.159; Wilson B, 1987, RIVERMEAD BEHAV MEMO; Yaguez L, 2011, INT J GERIATR PSYCH, V26, P173, DOI 10.1002/gps.2510	54	36	36	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97577	10.1371/journal.pone.0097577	http://dx.doi.org/10.1371/journal.pone.0097577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844772	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400036
J	Fliedner, SMJ; Engel, T; Lendvai, NK; Shankavaram, U; Nolting, S; Wesley, R; Elkahloun, AG; Ungefroren, H; Oldoerp, A; Lampert, G; Lehnert, H; Timmers, H; Pacak, K				Fliedner, Stephanie M. J.; Engel, Tobias; Lendvai, Nikoletta K.; Shankavaram, Uma; Noelting, Svenja; Wesley, Robert; Elkahloun, Abdel G.; Ungefroren, Hendrik; Oldoerp, Angela; Lampert, Gary; Lehnert, Hendrik; Timmers, Henri; Pacak, Karel			Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas-Effect of Different Statins on Mouse Pheochromocytoma Cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; MEVALONATE PATHWAY; MELANOMA-CELLS; SPORADIC PHEOCHROMOCYTOMA; REDUCTASE INHIBITORS; GERMLINE MUTATIONS; RET PROTOONCOGENE; SOMATIC MUTATIONS; INDUCE APOPTOSIS; DOWN-REGULATION	To date, malignant pheochromocytomas and paragangliomas (PHEOs/PGLs) cannot be effectively cured and thus novel treatment strategies are urgently needed. Lovastatin has been shown to effectively induce apoptosis in mouse PHEO cells (MPC) and the more aggressive mouse tumor tissue-derived cells (MTT), which was accompanied by decreased phosphorylation of mitogen-activated kinase (MAPK) pathway players. The MAPK pathway plays a role in numerous aggressive tumors and has been associated with a subgroup of PHEOs/PGLs, including K-RAS-, RET-, and NF1-mutated tumors. Our aim was to establish whether MAPK signaling may also play a role in aggressive, succinate dehydrogenase (SDH) B mutation-derived PHEOs/PGLs. Expression profiling and western blot analysis indicated that specific aspects of MAPK-signaling are active in SDHB PHEOs/PGLs, suggesting that inhibition by statin treatment could be beneficial. Moreover, we aimed to assess whether the anti-proliferative effect of lovastatin on MPC and MTT differed from that exerted by fluvastatin, simvastatin, atorvastatin, pravastatin, or rosuvastatin. Simvastatin and fluvastatin decreased cell proliferation most effectively and the more aggressive MTT cells appeared more sensitive in this respect. Inhibition of MAPK1 and 3 phosphorylation following treatment with fluvastatin, simvastatin, and lovastatin was confirmed by western blot. Increased levels of CASP-3 and PARP cleavage confirmed induction of apoptosis following the treatment. At a concentration low enough not to affect cell proliferation, spontaneous migration of MPC and MTT was significantly inhibited within 24 hours of treatment. In conclusion, lipophilic statins may present a promising therapeutic option for treatment of aggressive human paragangliomas by inducing apoptosis and inhibiting tumor spread.	[Fliedner, Stephanie M. J.; Engel, Tobias; Lendvai, Nikoletta K.; Noelting, Svenja; Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Fliedner, Stephanie M. J.; Ungefroren, Hendrik; Oldoerp, Angela; Lehnert, Hendrik] Univ Med Ctr Schleswig Holstein, Dept Med 1, Lubeck, Germany; [Engel, Tobias; Timmers, Henri] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Shankavaram, Uma] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Noelting, Svenja] Queen Mary Univ London, William Harvey Res Inst, Dept Endocrinol, London, England; [Noelting, Svenja] Queen Mary Univ London, Barts & London Sch Med, Barts Canc Inst, London, England; [Wesley, Robert] NIH, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Elkahloun, Abdel G.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Kiel; Schleswig Holstein University Hospital; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Queen Mary University London; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Fliedner, SMJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA.	Stephanie.fliedner@uksh.de	Fliedner, Stephanie MJ/D-3406-2012; Timmers, Henri JLM/A-4641-2010; Engel, Tobias GP/E-5807-2016	Engel, Tobias GP/0000-0002-3105-4867; Nolting, Svenja/0000-0002-7064-590X; Fliedner, Stephanie/0000-0001-5515-8196	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA; 1st Department of Medicine, University Medical Center Schleswig-Holstein, Lubeck, Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); 1st Department of Medicine, University Medical Center Schleswig-Holstein, Lubeck, Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding was provided by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA and the 1st Department of Medicine, University Medical Center Schleswig-Holstein, Lubeck, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; Ayala-Ramirez M, 2012, J CLIN ENDOCR METAB, V97, P4040, DOI 10.1210/jc.2012-2356; Bouterfa HL, 2000, ANTICANCER RES, V20, P2761; Brouwers FM, 2006, J CLIN ENDOCR METAB, V91, P4505, DOI 10.1210/jc.2006-0423; Burnichon N, 2012, HUM MOL GENET, V21, P5397, DOI 10.1093/hmg/dds374; Burnichon N, 2011, HUM MOL GENET, V20, P3974, DOI 10.1093/hmg/ddr324; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Collisson EA, 2003, MOL CANCER THER, V2, P941; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Crona J, 2013, J CLIN ENDOCR METAB, V98, pE1266, DOI 10.1210/jc.2012-4257; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; ENG C, 1995, J MED GENET, V32, P934, DOI 10.1136/jmg.32.12.934; Gauthaman K, 2009, BRIT J PHARMACOL, V157, P962, DOI 10.1111/j.1476-5381.2009.00241.x; Gauthaman K, 2009, J CELL BIOCHEM, V106, P975, DOI 10.1002/jcb.22092; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Giubellino A, 2013, ENDOCRINOLOGY, V154, P646, DOI 10.1210/en.2012-1854; Glynn SA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-9; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; Hrascan R, 2008, J NEUROENDOCRINOL, V20, P1015, DOI 10.1111/j.1365-2826.2008.01755.x; Kidera Yasuhiro, 2010, J Exp Clin Cancer Res, V29, P127, DOI 10.1186/1756-9966-29-127; Kochuparambil ST, 2011, J PHARMACOL EXP THER, V336, P496, DOI 10.1124/jpet.110.174870; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Lai EW, 2009, J CLIN ENDOCR METAB, V94, P2952, DOI 10.1210/jc.2009-0309; Leszczynska A, 2011, ACTA BIOCHIM POL, V58, P635; Lin Y, 2013, ONCOTARGETS THER, V6, P1559, DOI 10.2147/OTT.S53813; Mandel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056591; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Mohammed A, 2012, INT J CANCER, V131, P1951, DOI 10.1002/ijc.27456; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Neuvonen PJ, 2008, CLIN PHARMACOKINET, V47, P463, DOI 10.2165/00003088-200847070-00003; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Nolting S, 2012, J MOL ENDOCRINOL, V49, P79, DOI 10.1530/JME-12-0028; Ogunwobi OO, 2008, AM J GASTROENTEROL, V103, P825, DOI 10.1111/j.1572-0241.2007.01773.x; Osmak M, 2012, CANCER LETT, V324, P1, DOI 10.1016/j.canlet.2012.04.011; Pelaia G, 2012, CELL PROLIFERAT, V45, P557, DOI 10.1111/j.1365-2184.2012.00846.x; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Qi XF, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.44; Sekine Y, 2008, BIOCHEM BIOPH RES CO, V372, P356, DOI 10.1016/j.bbrc.2008.05.043; Shankavaram U, 2013, NEOPLASIA, V15, P435, DOI 10.1593/neo.122132; Shi YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045354; SINENSKY M, 1990, J BIOL CHEM, V265, P19937; Takeda I, 2007, CANCER SCI, V98, P890, DOI 10.1111/j.1349-7006.2007.00471.x; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; Welander J, 2012, HUM MOL GENET, V21, P5406, DOI 10.1093/hmg/dds402; Wong WWL, 2001, CLIN CANCER RES, V7, P2067; Wu HT, 2009, NEUROSURGERY, V65, P1087, DOI 10.1227/01.NEU.0000360130.52812.1D; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411; Zhang SL, 2011, ANTICANCER RES, V31, P3259; Ziegler CG, 2013, MOL CELL ENDOCRINOL, V371, P189, DOI 10.1016/j.mce.2012.12.011	54	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97712	10.1371/journal.pone.0097712	http://dx.doi.org/10.1371/journal.pone.0097712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846270	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400048
J	Berry, MS; Sweeney, MM; Morath, J; Odum, AL; Jordan, KE				Berry, Meredith S.; Sweeney, Mary M.; Morath, Justice; Odum, Amy L.; Jordan, Kerry E.			The Nature of Impulsivity: Visual Exposure to Natural Environments Decreases Impulsive Decision-Making in a Delay Discounting Task	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; SELF-CONTROL; PROBABILISTIC REWARDS; FADING PROCEDURE; FUTURE; BIODIVERSITY; CHOICE; REINFORCEMENT; MONEY; ADOLESCENTS	The benefits of visual exposure to natural environments for human well-being in areas of stress reduction, mood improvement, and attention restoration are well documented, but the effects of natural environments on impulsive decision-making remain unknown. Impulsive decision-making in delay discounting offers generality, predictive validity, and insight into decision-making related to unhealthy behaviors. The present experiment evaluated differences in such decision-making in humans experiencing visual exposure to one of the following conditions: natural (e. g., mountains), built (e. g., buildings), or control (e. g., triangles) using a delay discounting task that required participants to choose between immediate and delayed hypothetical monetary outcomes. Participants viewed the images before and during the delay discounting task. Participants were less impulsive in the condition providing visual exposure to natural scenes compared to built and geometric scenes. Results suggest that exposure to natural environments results in decreased impulsive decision-making relative to built environments.	[Berry, Meredith S.; Sweeney, Mary M.; Morath, Justice; Odum, Amy L.; Jordan, Kerry E.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Berry, MS (corresponding author), Univ Montana, Dept Soc & Conservat, Missoula, MT 59812 USA.	meredith.berry@umontana.edu	Odum, Amy L./A-9641-2010	Sweeney, Mary Margaret/0000-0001-6931-4321	Cambridge Center for Behavioral Studies	Cambridge Center for Behavioral Studies	The Cambridge Center for Behavioral Studies supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Anokhin AP, 2011, BEHAV GENET, V41, P175, DOI 10.1007/s10519-010-9384-7; Arbuthnott KD, 2010, ANAL SOC ISS PUB POL, V10, P4, DOI 10.1111/j.1530-2415.2009.01196.x; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Baumann AA, 2012, BEHAV PROCESS, V90, P408, DOI 10.1016/j.beproc.2012.04.005; Beck RC, 2009, EXP CLIN PSYCHOPHARM, V17, P345, DOI 10.1037/a0017078; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Berto R, 2008, J ENVIRON PSYCHOL, V28, P185, DOI 10.1016/j.jenvp.2007.11.004; Bickel WK, 2011, BIOL PSYCHIAT, V69, P260, DOI 10.1016/j.biopsych.2010.08.017; Black AC, 2011, ADDICT BEHAV, V36, P125, DOI 10.1016/j.addbeh.2010.08.014; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Chivian E, 2008, SUSTAINING LIFE HUMA; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Dixon MR, 2009, J APPL BEHAV ANAL, V42, P243, DOI 10.1901/jaba.2009.42-243; Dixon MR, 2004, J APPL BEHAV ANAL, V37, P101, DOI 10.1901/jaba.2004.37-101; Dixon MR, 2001, J APPL BEHAV ANAL, V34, P491, DOI 10.1901/jaba.2001.34-491; Dixon MR, 1998, J APPL BEHAV ANAL, V31, P203, DOI 10.1901/jaba.1998.31-203; Dixon MR, 2000, J APPL BEHAV ANAL, V33, P611, DOI 10.1901/jaba.2000.33-611; Du WJ, 2002, PSYCHOL REC, V52, P479, DOI 10.1007/BF03395199; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fisher WW, 2000, BEHAV MODIF, V24, P3, DOI 10.1177/0145445500241001; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hardisty DJ, 2009, J EXP PSYCHOL GEN, V138, P329, DOI 10.1037/a0016433; Hirsh JB, 2010, EMOTION, V10, P717, DOI 10.1037/a0019466; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Leopold Aldo, 1949, S COUNTY ALMANAC; LOGUE AW, 1981, BEHAV ANAL LETT, V1, P131; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Madden GJ., 2010, IMPULSIVITY BEHAV NE, P11, DOI [10.1037/12069-001, DOI 10.1037/12069-000]; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; MAZUR JE, 1978, J EXP ANAL BEHAV, V30, P11, DOI 10.1901/jeab.1978.30-11; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; Morrison KL, 2014, BEHAV THERA IN PRESS; Muir John, 1894, MOUNTAINS CALIFORNIA; Neef NA, 2001, J APPL BEHAV ANAL, V34, P397, DOI 10.1901/jaba.2001.34-397; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Odum AL, 2011, BEHAV PROCESS, V87, P1, DOI 10.1016/j.beproc.2011.02.007; Ohmura Y, 2006, EXP CLIN PSYCHOPHARM, V14, P318, DOI 10.1037/1064-1297.14.3.318; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Purcell T, 2001, ENVIRON BEHAV, V33, P93, DOI 10.1177/00139160121972882; Rachlin H, 2006, J EXP ANAL BEHAV, V85, P425, DOI 10.1901/jeab.2006.85-05; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; RAGOTZY SP, 1988, J EXP ANAL BEHAV, V49, P191, DOI 10.1901/jeab.1988.49-191; Rodzon K, 2011, BEHAV PROCESS, V86, P164, DOI 10.1016/j.beproc.2010.09.007; Rudd M, 2012, PSYCHOL SCI, V23, P1130, DOI 10.1177/0956797612438731; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHWEITZER JB, 1988, J EXP ANAL BEHAV, V50, P173, DOI 10.1901/jeab.1988.50-173; Sharma L, 2013, J PERS SOC PSYCHOL, V104, P559, DOI 10.1037/a0031181; Simpson CA, 2000, PSYCHOL REC, V50, P3, DOI 10.1007/BF03395339; Takahashi T, 2007, NEUROENDOCRINOL LETT, V28, P131; Takahashi T, 2007, PHYSICA A, V385, P637, DOI 10.1016/j.physa.2007.07.020; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; Thoreau D, 1864, THE MAINE WOODS, P39; ULRICH RS, 1981, ENVIRON BEHAV, V13, P523, DOI 10.1177/0013916581135001; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	65	54	58	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97915	10.1371/journal.pone.0097915	http://dx.doi.org/10.1371/journal.pone.0097915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24841421	Green Submitted, gold, Green Published			2022-12-27	WOS:000340948600093
J	Doppler, H; Bastea, LI; Borges, S; Spratley, SJ; Pearce, SE; Storz, P				Doeppler, Heike; Bastea, Ligia I.; Borges, Sahra; Spratley, Samantha J.; Pearce, Sarah E.; Storz, Peter			Protein Kinase D Isoforms Differentially Modulate Cofilin-Driven Directed Cell Migration	PLOS ONE			English	Article							INVASIVE TUMOR-CELLS; NF-KAPPA-B; PROSTATE-CANCER; PHOSPHATASE SLINGSHOT; ACTIN REORGANIZATION; MEDIATED ACTIVATION; LIM-KINASE; IN-VIVO; PHOSPHORYLATION; MOTILITY	Background: Protein kinase D (PKD) enzymes regulate cofilin-driven actin reorganization and directed cell migration through both p21-activated kinase 4 (PAK4) and the phosphatase slingshot 1L (SSH1L). The relative contributions of different endogenous PKD isoforms to both signaling pathways have not been elucidated, sufficiently. Methodology/Principal Findings: We here analyzed two cell lines (HeLa and MDA-MB-468) that express the subtypes protein kinase D2 (PKD2) and protein kinase D3 (PKD3). We show that under normal growth conditions both isoforms can form a complex, in which PKD3 is basally-active and PKD2 is inactive. Basal activity of PKD3 mediates PAK4 activity and downstream signaling, but does not significantly inhibit SSH1L. This signaling constellation was required for facilitating directed cell migration. Activation of PKD2 and further increase of PKD3 activity leads to additional phosphorylation and inhibition of endogenous SSH1L. Net effect is a dramatic increase in phospho-cofilin and a decrease in cell migration, since now both PAK4 and SSH1L are regulated by the active PKD2/PKD3 complex. Conclusions/Significance: Our data suggest that PKD complexes provide an interface for both cofilin regulatory pathways. Dependent on the activity of involved PKD enzymes signaling can be balanced to guarantee a functional cofilin activity cycle and increase cell migration, or imbalanced to decrease cell migration. Our data also provide an explanation of how PKD isoforms mediate different effects on directed cell migration.	[Doeppler, Heike; Bastea, Ligia I.; Borges, Sahra; Spratley, Samantha J.; Pearce, Sarah E.; Storz, Peter] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			NIH [GM086435, CA140182]; Mayo Clinic Center for Individualized Medicine; Breast Cancer SPORE DRP award [CA116201-08-DRP5]; NATIONAL CANCER INSTITUTE [R01CA140182, P50CA116201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Individualized Medicine; Breast Cancer SPORE DRP award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grants GM086435 and CA140182, and a grant from the Mayo Clinic Center for Individualized Medicine, as well as a Breast Cancer SPORE DRP award (CA116201-08-DRP5) - all to PS. The content is solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bastea LI, 2013, BIOCHEM J, V455, P251, DOI 10.1042/BJ20130281; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Christoforides C, 2012, DEV CELL, V23, P560, DOI 10.1016/j.devcel.2012.08.008; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Doppler H, 2013, J BIOL CHEM, V288, P455, DOI 10.1074/jbc.M112.397448; Doeppler HR, 2013, J BIOL CHEM; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Ikebe C, 1997, GENOMICS, V46, P504, DOI 10.1006/geno.1997.5060; Jaggi M, 2005, CANCER RES, V65, P483; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; MIZUNO K, 1994, ONCOGENE, V9, P1605; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mullin MJ, 2006, J BIOL CHEM, V281, P25089, DOI 10.1074/jbc.M603591200; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Onishi Y, 2012, INT J ONCOL, V40, P1839, DOI 10.3892/ijo.2012.1400; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Storz P, 2009, CELL CYCLE, V8, P1975; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tan MQ, 2009, ARTERIOSCL THROM VAS, V29, P1376, DOI 10.1161/ATVBAHA.109.191585; Tania N, 2011, BIOPHYS J, V100, P1883, DOI 10.1016/j.bpj.2011.02.036; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Young SH, 2012, AM J PHYSIOL-GASTR L, V303, pG356, DOI 10.1152/ajpgi.00025.2012; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Zou ZP, 2012, J CELL SCI, V125, P4800, DOI 10.1242/jcs.106542	52	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98090	10.1371/journal.pone.0098090	http://dx.doi.org/10.1371/journal.pone.0098090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840177	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600106
J	Duan, DN; Zhang, SX; Li, XL; Guo, H; Chen, MM; Zhang, YQ; Han, JY; Lv, YJ				Duan, Dianning; Zhang, Shuxia; Li, Xiaolin; Guo, Hua; Chen, Mengmeng; Zhang, Yaqun; Han, Junyuan; Lv, Yingjun			Activation of the TLR/MyD88/NF-kappa B Signal Pathway Contributes to Changes in IL-4 and IL-12 Production in Piglet Lymphocytes Infected with Porcine Circovirus Type 2 In Vitro	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; NF-KAPPA-B; SYNDROME PMWS; ALVEOLAR MACROPHAGES; PIGS; APOPTOSIS; PCV2; INOCULATION; INTERFERON; DISEASE	Porcine circovirus type 2 (PCV2) causes immunosuppression in pigs. One causative factor is an imbalance in cytokine levels in the blood and lymphoid tissues. Many studies have reported changes in cytokine production, but the regulatory mechanisms involved have not yet been elucidated. In this study, we investigated alteration and regulation of IL-4 and IL-12 production in lymphocytes following incubation with PCV2 in vitro. The levels of IL-4 decreased and levels of IL-12 increased in lymphocyte supernatants, and the DNA-binding activity of NF-kappa B and the expression of p65 in the nucleus and p-I kappa B in the cytoplasm of lymphocytes increased after incubation with PCV2. However, these effects were reversed when lymphocytes were coincubated with PCV2 and the NF-kappa B inhibitor BAY11-7082. In addition, the expression of MyD88 protein increased and the expression of mRNA for the toll-like receptors (TLRs) TLR2, TLR3, TLR4 and TLR9 was upregulated when lymphocytes were incubated with PCV2. However, no change was seen in TLR7 and TLR8 mRNA expression. In conclusion, this study showed that PCV2 induced a decrease in IL-4 and an increase in IL-12 production in lymphocytes, and these changes were regulated by the TLR-MyD88-NF-kappa B signal pathway.	[Duan, Dianning; Zhang, Shuxia; Li, Xiaolin; Guo, Hua; Chen, Mengmeng; Zhang, Yaqun; Han, Junyuan; Lv, Yingjun] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Lv, YJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	lyj@njau.edu.cn			Natural Science Foundation of China [31172292, 31101786]; Natural Science Foundation of Jiangsu province [BK2011646]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported and by a grant (31172292, 31101786) from the Natural Science Foundation of China and by a grant (BK2011646) from the Natural Science Foundation of Jiangsu province and by A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 1998, J VET DIAGN INVEST, V10, P3, DOI 10.1177/104063879801000102; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Chang HW, 2007, VET MICROBIOL, V122, P72, DOI 10.1016/j.vetmic.2007.01.013; Chang HW, 2006, VET IMMUNOL IMMUNOP, V110, P207, DOI 10.1016/j.vetimm.2005.09.016; Darwich L, 2003, J GEN VIROL, V84, P2117, DOI 10.1099/vir.0.19124-0; Ellis J, 2004, VET MICROBIOL, V98, P159, DOI 10.1016/j.vetmic.2003.10.008; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Karuppannan AK, 2011, VIROLOGY, V410, P248, DOI 10.1016/j.virol.2010.11.009; Kekarainen T, 2008, J GEN VIROL, V89, P760, DOI 10.1099/vir.0.83354-0; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Krakowka S, 2007, CAN VET J, V48, P716; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Liu CH, 2009, VET MICROBIOL, V136, P266, DOI 10.1016/j.vetmic.2008.11.016; Lv YJ, 2013, RES VET SCI, V95, P1235, DOI 10.1016/j.rvsc.2013.08.006; Lv YJ, 2012, RES VET SCI, V93, P1525, DOI 10.1016/j.rvsc.2012.04.003; Mandrioli L, 2004, VET IMMUNOL IMMUNOP, V97, P25, DOI 10.1016/j.vetimm.2003.08.017; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miguel JC, 2010, VET IMMUNOL IMMUNOP, V135, P314, DOI 10.1016/j.vetimm.2010.01.002; Rosell C, 1999, J COMP PATHOL, V120, P59, DOI 10.1053/jcpa.1998.0258; Segales J, 2002, VET QUART, V24, P109, DOI 10.1080/01652176.2002.9695132; Shi KC, 2010, VET MICROBIOL, V140, P155, DOI 10.1016/j.vetmic.2009.07.021; Song S, 2013, DEV COMP IMMUNOL, V39, P265, DOI 10.1016/j.dci.2012.10.001; Wang XW, 2007, VET MICROBIOL, V121, P215, DOI 10.1016/j.vetmic.2006.11.027; Wei L, 2008, VIROLOGY, V378, P177, DOI 10.1016/j.virol.2008.05.013; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Zhang HL, 2013, ARCH VIROL, V158, P2285, DOI 10.1007/s00705-013-1750-3	28	32	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97653	10.1371/journal.pone.0097653	http://dx.doi.org/10.1371/journal.pone.0097653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841678	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600054
J	Koch, N; Kobler, O; Thomas, U; Qualmann, B; Kessels, MM				Koch, Nicole; Kobler, Oliver; Thomas, Ulrich; Qualmann, Britta; Kessels, Michael M.			Terminal Axonal Arborization and Synaptic Bouton Formation Critically Rely on Abp1 and the Arp2/3 Complex	PLOS ONE			English	Article							ACTIN-BINDING-PROTEIN; F-ACTIN; NEURONAL CONNECTIVITY; MOTOR-NEURONS; DISCS-LARGE; DROSOPHILA; GROWTH; CYTOSKELETON; ENDOCYTOSIS; WASP	Neuronal network formation depends on properly timed and localized generation of presynaptic as well as postsynaptic structures. Although of utmost importance for understanding development and plasticity of the nervous system and neurodegenerative diseases, the molecular mechanisms that ensure the fine-control needed for coordinated establishment of pre-and postsynapses are still largely unknown. We show that the F-actin-binding protein Abp1 is prominently expressed in the Drosophila nervous system and reveal that Abp1 is an important regulator in shaping glutamatergic neuromuscular junctions (NMJs) of flies. STED microscopy shows that Abp1 accumulations can be found in close proximity of synaptic vesicles and at the cell cortex in nerve terminals. Abp1 knock-out larvae have locomotion defects and underdeveloped NMJs that are characterized by a reduced number of both type Ib synaptic boutons and branches of motornerve terminals. Abp1 is able to indirectly trigger Arp2/3 complex-mediated actin nucleation and interacts with both WASP and Scar. Consistently, Arp2 and Arp3 loss-of-function also resulted in impairments of bouton formation and arborization at NMJs, i. e. fully phenocopied abp1 knock-out. Interestingly, neuron-and muscle-specific rescue experiments revealed that synaptic bouton formation critically depends on presynaptic Abp1, whereas the NMJ branching defects can be compensated for by restoring Abp1 functions at either side. In line with this presynaptic importance of Abp1, also presynaptic Arp2 and Arp3 are crucial for the formation of type Ib synaptic boutons. Interestingly, presynaptic Abp1 functions in NMJ formation were fully dependent on the Arp2/3 complex, as revealed by suppression of Abp1-induced synaptic bouton formation and branching of axon terminals upon presynaptic Arp2 RNAi. These data reveal that Abp1 and Arp2/3 complex-mediated actin cytoskeletal dynamics drive both synaptic bouton formation and NMJ branching. Our data furthermore shed light on an intense bidirectional functional crosstalk between pre-and postsynapses during the development of synaptic contacts.	[Koch, Nicole; Qualmann, Britta; Kessels, Michael M.] Univ Jena, Jena Univ Hosp, Inst Biochem 1, Jena, Germany; [Koch, Nicole; Kessels, Michael M.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Res Grp Membrane Trafficking & Cytoskeleton, Magdeburg, Germany; [Kobler, Oliver; Thomas, Ulrich] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Res Grp Funct Genet Synapse, Magdeburg, Germany	Friedrich Schiller University of Jena; Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN)	Thomas, U (corresponding author), Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Res Grp Funct Genet Synapse, Magdeburg, Germany.	Ulrich.Thomas@ifn-magdeburg.de; Britta.Qualmann@med.uni-jena.de; Michael.Kessels@med.uni-jena.de		Kobler, Oliver/0000-0001-7173-9919	DFG [SFB854, KE685/2-3, KE685/3-1, QU116/3-2]	DFG(German Research Foundation (DFG))	This work was supported by DFG SFB854 to UT as well as by DFG grants KE685/2-3 and 3-1 to MMK and QU116/3-2 to MMK and BQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Connert S, 2006, EMBO J, V25, P1611, DOI 10.1038/sj.emboj.7601053; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Goldstein LSB, 1994, DROSOPHILA MELANOGAS; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Gorczyca D, 2007, J NEUROSCI, V27, P1033, DOI 10.1523/JNEUROSCI.3160-06.2007; Haag N, 2012, J NEUROSCI, V32, P17842, DOI 10.1523/JNEUROSCI.0843-12.2012; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; Hatan M, 2011, J CELL BIOL, V192, P307, DOI 10.1083/jcb.201007095; Johnson C, 2012, GENES BRAIN BEHAV, V11, P848, DOI 10.1111/j.1601-183X.2012.00822.x; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Koch N, 2012, J CELL SCI, V125, P3578, DOI 10.1242/jcs.101451; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mise-Omata S, 2003, BIOCHEM BIOPH RES CO, V301, P704, DOI 10.1016/S0006-291X(02)02972-8; Nahm M, 2010, J NEUROSCI, V30, P8138, DOI 10.1523/JNEUROSCI.0256-10.2010; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Pawson C, 2008, J NEUROSCI, V28, P11111, DOI 10.1523/JNEUROSCI.0833-08.2008; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Qurashi A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-18; Ramachandran P, 2009, DEV NEUROBIOL, V69, P583, DOI 10.1002/dneu.20728; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rodriguez-Mesa E, 2012, DEV DYNAM, V241, P608, DOI 10.1002/dvdy.23742; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P1, DOI 10.1016/S0074-7742(06)75001-2; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Schulz C, 2001, DEV GENES EVOL, V211, P581, DOI 10.1007/s00427-001-0194-z; Spradling AC, 1999, GENETICS, V153, P135; Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhao L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003450; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	52	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97692	10.1371/journal.pone.0097692	http://dx.doi.org/10.1371/journal.pone.0097692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841972	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600056
J	Mora, L; de Zamaroczy, M				Mora, Liliana; de Zamaroczy, Miklos			In Vivo Processing of DNase Colicins E2 and E7 Is Required for Their Import into the Cytoplasm of Target Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; CELLULAR FUNCTIONS; CRYSTAL-STRUCTURE; IMMUNITY PROTEIN; R-DOMAIN; D TRNASE; IDENTIFICATION; TRANSLOCATION; OMPT	DNase colicins E2 and E7, both of which appropriate the BtuB/Tol translocation machinery to cross the outer membrane, undergo a processing step as they enter the cytoplasm. This endoproteolytic cleavage is essential for their killing action. A processed form of the same size, 18.5 kDa, which corresponds to the C-terminal catalytic domain, was detected in the cytoplasm of bacteria treated with either of the two DNase colicins. The inner-membrane protease FtsH is necessary for the processing that allows the translocation of the colicin DNase domain into the cytoplasm. The processing occurs near residue D420, at the same position as the FtsH-dependent cleavage in RNase colicins E3 and D. The cleavage site is located 30 amino acids upstream of the DNase domain. In contrast, the previously reported periplasm-dependent colicin cleavage, located at R452 in colicin E2, was shown to be generated by the outer-membrane protease OmpT and we show that this cleavage is not physiologically relevant for colicin import. Residue R452, whose mutated derivatives led to toxicity defect, was shown to have no role in colicin processing and translocation, but it plays a key role in the catalytic activity, as previously reported for other DNase colicins. Membrane associated forms of colicins E2 and E7 were detected on target cells as proteinase K resistant peptides, which include both the receptor-binding and DNase domains. A similar, but much less proteinase K-resistant form was also detected with RNase colicin E3. These colicin forms are not relevant for colicin import, but their detection on the cell surface indicates that whole nuclease-colicin molecules are found in a stable association with the outer-membrane receptor BtuB of the target cells.	[Mora, Liliana; de Zamaroczy, Miklos] CNRS, Inst Biol Physicochim, UPR 9073, Paris, France	Centre National de la Recherche Scientifique (CNRS)	de Zamaroczy, M (corresponding author), CNRS, Inst Biol Physicochim, UPR 9073, Paris, France.	zamaroczy@ibpc.fr			Centre National de la Recherche Scientifique (CNRS, Paris, France) [UPR 9073]	Centre National de la Recherche Scientifique (CNRS, Paris, France)(Centre National de la Recherche Scientifique (CNRS))	The work was supported by UPR 9073 funds from the Centre National de la Recherche Scientifique (CNRS, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Ayuso-Tejedor S, 2010, J STRUCT BIOL, V171, P117, DOI 10.1016/j.jsb.2010.05.001; BENEDETTI H, 1992, EMBO J, V11, P441, DOI 10.1002/j.1460-2075.1992.tb05073.x; BENEDETTI H, 1991, J MOL BIOL, V217, P429, DOI 10.1016/0022-2836(91)90747-T; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; COLE ST, 1985, MOL GEN GENET, V198, P465, DOI 10.1007/BF00332940; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; de Zamaroczy M, 2012, BIOCHEM SOC T, V40, P1486, DOI 10.1042/BST20120173; de Zamaroczy M, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P255, DOI 10.1007/978-1-4419-7692-5_14; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; DUCHE D, 1995, J BACTERIOL, V177, P4935, DOI 10.1128/jb.177.17.4935-4939.1995; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; Duche D, 2009, J BIOCHEM, V145, P95, DOI 10.1093/jb/mvn149; Duquesne K, 2010, METHODS MOL BIOL, V601, P205, DOI 10.1007/978-1-60761-344-2_13; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; James R, 1996, MICROBIOL-SGM, V142, P1569, DOI 10.1099/13500872-142-7-1569; Kleanthous C, 1999, NAT STRUCT BIOL, V6, P243, DOI 10.1038/6683; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kolade OO, 2002, BIOCHIMIE, V84, P439, DOI 10.1016/S0300-9084(02)01451-7; Kramer RA, 2000, FEBS LETT, V468, P220, DOI 10.1016/S0014-5793(00)01231-X; Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x; KRONE WJA, 1986, J BACTERIOL, V166, P260, DOI 10.1128/jb.166.1.260-268.1986; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Lazdunski C, 2000, INT J MED MICROBIOL, V290, P337; Liao CC, 2001, BIOCHEM BIOPH RES CO, V284, P556, DOI 10.1006/bbrc.2001.5016; Masi M, 2007, J BACTERIOL, V189, P2667, DOI 10.1128/JB.01448-06; Mora L, 2008, J BIOL CHEM, V283, P4993, DOI 10.1074/jbc.M706846200; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Papadakos G, 2012, Q REV BIOPHYS, V45, P57, DOI 10.1017/S0033583511000114; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P203; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Sharma O, 2007, J BIOL CHEM, V282, P23163, DOI 10.1074/jbc.M703004200; Sharma O, 2007, J BACTERIOL, V189, P363, DOI 10.1128/JB.01344-06; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Tan Y, 1997, MOL BIOL EVOL, V14, P666, DOI 10.1093/oxfordjournals.molbev.a025806; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Walker D, 2007, J BIOL CHEM, V282, P31389, DOI 10.1074/jbc.M705883200; Walker DC, 2002, NUCLEIC ACIDS RES, V30, P3225, DOI 10.1093/nar/gkf420; WATSON R, 1981, J BACTERIOL, V147, P569, DOI 10.1128/JB.147.2.569-577.1981	53	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96549	10.1371/journal.pone.0096549	http://dx.doi.org/10.1371/journal.pone.0096549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840776	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600009
J	Rueda-Martinez, C; Lamas, O; Mataro, MJ; Robledo-Carmona, J; Sanchez-Espin, G; Jimenez-Navarro, M; Such-Martinez, M; Fernandez, B				Rueda-Martinez, Carmen; Lamas, Oscar; Mataro, Maria Jose; Robledo-Carmona, Juan; Sanchez-Espin, Gemma; Jimenez-Navarro, Manuel; Such-Martinez, Miguel; Fernandez, Borja			Selection of Reference Genes for Quantitative Real Time PCR (qPCR) Assays in Tissue from Human Ascending Aorta	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; VALVE; EXPRESSION; ANEURYSMS; NORMALIZATION; PATTERNS; MODEL; EFFICIENCY; MESSENGER	Dilatation of the ascending aorta (AAD) is a prevalent aortopathy that occurs frequently associated with bicuspid aortic valve (BAV), the most common human congenital cardiac malformation. The molecular mechanisms leading to AAD associated with BAV are still poorly understood. The search for differentially expressed genes in diseased tissue by quantitative real-time PCR (qPCR) is an invaluable tool to fill this gap. However, studies dedicated to identify reference genes necessary for normalization of mRNA expression in aortic tissue are scarce. In this report, we evaluate the qPCR expression of six candidate reference genes in tissue from the ascending aorta of 52 patients with a variety of clinical and demographic characteristics, normal and dilated aortas, and different morphologies of the aortic valve (normal aorta and normal valve n = 30; dilated aorta and normal valve n = 10; normal aorta and BAV n = 4; dilated aorta and BAV n = 8). The expression stability of the candidate reference genes was determined with three statistical algorithms, GeNorm, NormFinder and Bestkeeper. The expression analyses showed that the most stable genes for the three algorithms employed were CDKN1 beta, POLR2A and CASC3, independently of the structure of the aorta and the valve morphology. In conclusion, we propose the use of these three genes as reference genes for mRNA expression analysis in human ascending aorta. However, we suggest searching for specific reference genes when conducting qPCR experiments with new cohort of samples.	[Rueda-Martinez, Carmen; Lamas, Oscar; Mataro, Maria Jose; Robledo-Carmona, Juan; Sanchez-Espin, Gemma; Jimenez-Navarro, Manuel; Such-Martinez, Miguel] Hosp Clin Univ Virgen de la Victoria, Inst Invest Biomed Malaga IBIMA, UGC Corazon, Malaga, Spain; [Jimenez-Navarro, Manuel] Univ Malaga, Fac Med, Dept Med, E-29071 Malaga, Spain; [Fernandez, Borja] Univ Malaga, Fac Ciencias, Inst Invest Biomed Malaga IBIMA, Dept Biol Anim, E-29071 Malaga, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga	Fernandez, B (corresponding author), Univ Malaga, Fac Ciencias, Inst Invest Biomed Malaga IBIMA, Dept Biol Anim, E-29071 Malaga, Spain.	borjafe@uma.es	Such, Miguel/J-4959-2016; Corujo, Francisco Borja Fernández/AAG-8258-2020; Sánchez-Espín, Gemma/E-7688-2018; jimenez-navarro, manuel/AAJ-3236-2020	Such, Miguel/0000-0002-1521-7419; Corujo, Francisco Borja Fernández/0000-0001-9179-910X; Sánchez-Espín, Gemma/0000-0001-5292-8335; Rueda Martinez, Carmen/0000-0002-3278-8475; Jimenez Navarro, Manuel Francisco/0000-0002-6759-0514	Consejeria de Salud, Junta de Andalucia, Spain [PI-0689/2010]; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain [P10-CTS-06068]; Red de Investigacion Cardiovascular (RIC) from Redes Tematicas de Investigacion Cooperativa (RETIC)	Consejeria de Salud, Junta de Andalucia, Spain(Junta de Andalucia); Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain(Junta de Andalucia); Red de Investigacion Cardiovascular (RIC) from Redes Tematicas de Investigacion Cooperativa (RETIC)	This work was supported in part by grants PI-0689/2010 (Consejeria de Salud, Junta de Andalucia, Spain), P10-CTS-06068 (Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain), and Red de Investigacion Cardiovascular (RIC) from Redes Tematicas de Investigacion Cooperativa (RETIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Boyum J, 2004, J THORAC CARDIOV SUR, V127, P686, DOI 10.1016/j.jtcvs.2003.11.049; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067360; Cotrufo M, 2005, J THORAC CARDIOV SUR, V130, P504, DOI 10.1016/j.jtcvs.2005.01.016; Della Corte A, 2008, J THORAC CARDIOV SUR, V135, P8, DOI 10.1016/j.jtcvs.2007.09.009; Fedak PWM, 2008, EUR HEART J, V29, P432, DOI 10.1093/eurheartj/ehm609; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Folkersen L, 2011, MOL MED, V17, P1365, DOI 10.2119/molmed.2011.00286; Gomez D, 2011, CARDIOVASC RES, V89, P446, DOI 10.1093/cvr/cvq291; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Henn D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054132; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jackson V, 2012, J THORAC CARDIOV SUR, V144, P459, DOI 10.1016/j.jtcvs.2011.08.043; LeMaire SA, 2005, J SURG RES, V123, P40, DOI 10.1016/j.jss.2004.06.007; LeMaire SA, 2011, NAT REV CARDIOL, V8, P103, DOI 10.1038/nrcardio.2010.187; Losenno KL, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/145202; Majumdar R, 2007, CARDIOVASC PATHOL, V16, P144, DOI 10.1016/j.carpath.2006.12.001; Maleki S, 2013, J MOL MED, V91, P129, DOI 10.1007/s00109-012-0942-8; Moniotte S, 2001, J MOL CELL CARDIOL, V33, P2121, DOI 10.1006/jmcc.2001.1475; Noutsias M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-3; Paloschi V, 2011, ARTERIOSCL THROM VAS, V31, P691, DOI 10.1161/ATVBAHA.110.218461; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister Christina, 2011, BMC Res Notes, V4, P275, DOI 10.1186/1756-0500-4-275; Phillippi JA, 2010, ANN THORAC SURG, V90, P1893, DOI 10.1016/j.athoracsur.2010.07.069; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robledo-Carmona J, 2013, INT J CARDIOL, V168, P3443, DOI 10.1016/j.ijcard.2013.04.180; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sciacca S, 2013, HEART VESSELS, V28, P268, DOI 10.1007/s00380-012-0238-5; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vesentini Nicoletta, 2012, BMC Res Notes, V5, P124, DOI 10.1186/1756-0500-5-124; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Zyzynska-Granica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051547	48	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97449	10.1371/journal.pone.0097449	http://dx.doi.org/10.1371/journal.pone.0097449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841551	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600033
J	Liu, T; Zhang, WN; Cao, LJ; Zhang, Y				Liu, Ting; Zhang, Wei-Nan; Cao, Liujuan; Zhang, Yu			Question Popularity Analysis and Prediction in Community Question Answering Services	PLOS ONE			English	Article								With the blooming of online social media applications, Community Question Answering (CQA) services have become one of the most important online resources for information and knowledge seekers. A large number of high quality question and answer pairs have been accumulated, which allow users to not only share their knowledge with others, but also interact with each other. Accordingly, volumes of efforts have been taken to explore the questions and answers retrieval in CQA services so as to help users to finding the similar questions or the right answers. However, to our knowledge, less attention has been paid so far to question popularity in CQA. Question popularity can reflect the attention and interest of users. Hence, predicting question popularity can better capture the users' interest so as to improve the users' experience. Meanwhile, it can also promote the development of the community. In this paper, we investigate the problem of predicting question popularity in CQA. We first explore the factors that have impact on question popularity by employing statistical analysis. We then propose a supervised machine learning approach to model these factors for question popularity prediction. The experimental results show that our proposed approach can effectively distinguish the popular questions from unpopular ones in the Yahoo! Answers question and answer repository.	[Liu, Ting; Zhang, Wei-Nan; Zhang, Yu] Harbin Inst Technol, Res Ctr Social Comp & Informat Retrieval, Harbin 150006, Heilongjiang, Peoples R China; [Cao, Liujuan] Xiamen Univ, Sch Informat Sci & Technol, Dept Comp Sci, Xiamen, Fujian, Peoples R China	Harbin Institute of Technology; Xiamen University	Cao, LJ (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Dept Comp Sci, Xiamen, Fujian, Peoples R China.	caoliujuan@gmail.com; zhangyu@ir.hit.edu.cn			Natural Science Foundation of China [61133012, 61073129, 61073126]; Fundamental Research Funds for the Central Universities [2013121026, 2011121052]; Xiamen University 985 Project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Xiamen University 985 Project	This work was supported by the Natural Science Foundation of China (Grant No. 61133012, 61073129, 61073126) and the Fundamental Research Funds for the Central Universities (No. 2013121026 and No. 2011121052) and Xiamen University 985 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agichtein E., 2008, PROC INT C WEB SEARC, P183; Bendersky Michael, 2008, P 31 ANN INT ACM SIG, P491, DOI DOI 10.1145/1390334.1390419; Bian J., 2008, P 17 INT C WORLD WID, P467, DOI DOI 10.1145/1367497.1367561; Bian Jiang, 2009, P 18 INT C WORLD WID, DOI DOI 10.1145/1526709.1526717; Chen BC, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P781; Freund Y., 1996, ICML 13 INT C INT C; Gao Y., 2017, ACM MULTIMEDIA, P1517; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gao Yue, 2010, P INT C MULT, P123; GUPTA M, 2012, 75 ANN M AM SOC INF; Hong L., 2011, WWW, P57, DOI DOI 10.1145/1963192.1963222; JEON J, 2006, P 29 ANN INT ACM SIG, P228, DOI DOI 10.1145/1148170.1148212; Ji RR, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037688; Lerman K., 2010, P 19 INT C WORLD WID, P621, DOI DOI 10.1145/1772690.1772754; Lerman K, 2007, IEEE INTERNET COMPUT, V11, P16, DOI 10.1109/MIC.2007.136; Li B., 2012, WWW, P775, DOI DOI 10.1145/2187980.2188200; QUAN X, 2012, 11 INT C COGN INF CO, P109; Richardson M., 2007, P 16 INT C WORLD WID, P521, DOI [DOI 10.1145/1242572.1242643, 10.1145/1242572.1242643]; RODGERS JL, 1988, 13 WAYS LOOK CORRELA, V42, P59; Suryanto MA, 2009, P 2 ACM INT C WEB SE, P142, DOI DOI 10.1145/1498759.1498820; Szabo G, 2010, COMMUN ACM, V53, P80, DOI 10.1145/1787234.1787254; Wang XJ, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P179, DOI 10.1145/1571941.1571974; Witten I.H., 2002, ACM SIGMOD REC, V31, P76, DOI 10.1145/507338.507355; Yang J., 2010, ICWSM; Yu B, 2011, LECT NOTES COMPUT SC, V6589, P317; ZHANG WN, 2012, COLING 2012, P3105; ZHANG WN, 2013, PLOS ONE; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]	28	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e85236	10.1371/journal.pone.0085236	http://dx.doi.org/10.1371/journal.pone.0085236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837851	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800001
J	Ghosh, A; Birngruber, T; Sattler, W; Kroath, T; Ratzer, M; Sinner, F; Pieber, TR				Ghosh, Arijit; Birngruber, Thomas; Sattler, Wolfgang; Kroath, Thomas; Ratzer, Maria; Sinner, Frank; Pieber, Thomas R.			Assessment of Blood-Brain Barrier Function and the Neuroinflammatory Response in the Rat Brain by Using Cerebral Open Flow Microperfusion (cOFM)	PLOS ONE			English	Article							TNF-ALPHA; IN-VIVO; NEURODEGENERATIVE DISORDERS; ENDOTHELIAL-CELLS; LIPOPOLYSACCHARIDE; CYTOKINE; TRANSPORT; INFLAMMATION; EXPRESSION; MICRODIALYSIS	Blood-brain barrier (BBB) impairment in systemic inflammation leads to neuroinflammation. Several factors including cytokines, chemokines and signal transduction molecules are implicated in BBB dysfunction in response to systemic inflammation. Here, we have adopted a novel in vivo technique; namely, cerebral open flow microperfusion (cOFM), to perform time-dependent cytokine analysis (TNF-alpha, IL-6 and IL-10) in the frontal cortex of the rat brain in response to a single peripheral administration of lipopolysaccharide (LPS). In parallel, we monitored BBB function using sodium fluorescein as low molecular weight reporter in the cOFM sample. In response to the systemic LPS administration, we observed a rapid increase of TNF-alpha in the serum and brain, which coincides with the BBB disruption. Brain IL-6 and IL-10 synthesis was delayed by approximately 1 h. Our data demonstrate that cOFM can be used to monitor changes in brain cytokine levels and BBB disruption in a rat sepsis model.	[Ghosh, Arijit; Sinner, Frank; Pieber, Thomas R.] Med Univ Graz, Div Endocrinol & Metab, Graz, Austria; [Birngruber, Thomas; Kroath, Thomas; Ratzer, Maria; Sinner, Frank; Pieber, Thomas R.] Joanneum Res, HEALTH, Inst Biomed & Hlth Sci, Graz, Austria; [Sattler, Wolfgang] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	Medical University of Graz; Medical University of Graz	Sinner, F (corresponding author), Med Univ Graz, Div Endocrinol & Metab, Graz, Austria.	ca.health@joanneum.at		Pieber, Thomas/0000-0003-3554-0405	Austrian Science Fund FWF [F 3007] Funding Source: Medline; Austrian Science Fund (FWF) [F 3007] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Asai S, 1996, ANAL BIOCHEM, V237, P182, DOI 10.1006/abio.1996.0226; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Birngruber T, 2013, CLIN EXP PHARMACOL P, V40, P864, DOI 10.1111/1440-1681.12174; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Deng YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087420; Dohgu S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-167; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; FABRY Z, 1993, J NEUROIMMUNOL, V47, P23, DOI 10.1016/0165-5728(93)90281-3; Fannin RD, 2005, PHYSIOL GENOMICS, V21, P92, DOI 10.1152/physiolgenomics.00190.2004; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Ghezzi P, 2000, CYTOKINE, V12, P1205, DOI 10.1006/cyto.2000.0697; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Godbout JP, 2004, J NEUROIMMUNOL, V147, P141, DOI 10.1016/j.jneuroim.2003.10.031; Harden LM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-22; He F, 2011, NEUROSCIENCE, V188, P35, DOI 10.1016/j.neuroscience.2011.04.025; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Jacob A, 2011, NEUROCHEM INT, V58, P472, DOI 10.1016/j.neuint.2011.01.004; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Jancalek R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-11; Jin L, 2013, ANTIMICROB AGENTS CH, V57, P4336, DOI 10.1128/AAC.00765-13; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; KENDRICK KM, 1990, J NEUROSCI METH, V34, P35, DOI 10.1016/0165-0270(90)90040-M; LI L, 1994, J IMMUNOL, V153, P3967; Lord R, 2001, CYTOKINE, V13, P155, DOI 10.1006/cyto.2000.0815; McNay EC, 2004, J NEUROSCI METH, V132, P35, DOI 10.1016/j.jneumeth.2003.08.014; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nonaka N, 2004, BRAIN RES, V1016, P58, DOI 10.1016/j.brainres.2004.04.066; Osburg B, 2002, AM J PHYSIOL-ENDOC M, V283, pE899, DOI 10.1152/ajpendo.00436.2001; Pan W, 2001, Arch Physiol Biochem, V109, P350, DOI 10.1076/apab.109.4.350.4238; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Reyes TM, 1999, BRAIN RES, V851, P215, DOI 10.1016/S0006-8993(99)02189-7; Riese Jutta, 2003, Surg Infect (Larchmt), V4, P11, DOI 10.1089/109629603764655236; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Sjogren S, 2002, BRIT J DERMATOL, V146, P375, DOI 10.1046/j.1365-2133.2002.04621.x; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Steiner AA, 2006, BLOOD, V107, P4000, DOI 10.1182/blood-2005-11-4743; Tsao N, 2001, J MED MICROBIOL, V50, P812, DOI 10.1099/0022-1317-50-9-812; Ullen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064034; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang X, 2008, CYTOKINE, V43, P15, DOI 10.1016/j.cyto.2008.04.009; WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wilson JX, 2003, CAN J NEUROL SCI, V30, P98, DOI 10.1017/S031716710005335X; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9; Zhao CH, 2007, NEUROBIOL DIS, V26, P36, DOI 10.1016/j.nbd.2006.11.012; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	60	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98143	10.1371/journal.pone.0098143	http://dx.doi.org/10.1371/journal.pone.0098143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852285	Green Submitted, gold, Green Published			2022-12-27	WOS:000338323200049
J	Goo, YK; Ji, SY; Shin, HI; Moon, JH; Cho, SH; Lee, WJ; Kim, JY				Goo, Youn-Kyoung; Ji, So-Young; Shin, Hyun-Il; Moon, Jun-Hye; Cho, Shin-Hyung; Lee, Won-Ja; Kim, Jung-Yeon			First Evaluation of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Vivax Malaria Endemic Regions in the Republic of Korea	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; POPULATIONS; VARIANTS; SENSITIVITY; RESISTANCE; PRIMAQUINE; MUTATIONS; SELECTION	Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and affects more than 400 million people worldwide. This deficiency is believed to protect against malaria because its global distribution is similar. However, this genetic disorder may be associated with potential hemolytic anemia after treatment with anti-malarials, primaquine or other 8-aminoquinolines. Although primaquine is used for malaria prevention, no study has previously investigated the prevalence of G6PD variants and G6PD deficiency in the Republic of Korea (ROK). Methods: Two commercialized test kits (Trinity G-6-PDH and CareStart G6PD test) were used for G6PD deficiency screening. The seven common G6PD variants were investigated by DiaPlexC kit in blood samples obtained living in vivax malaria endemic regions in the ROK. Results: Of 1,044 blood samples tested using the CareStart G6PD test, none were positive for G6PD deficiency. However, a slightly elevated level of G6PD activity was observed in 14 of 1,031 samples tested with the Trinity G-6-PDH test. Forty-nine of the 298 samples with non-specific amplification by DiaPlexC kit were confirmed by sequencing to be negative for the G6PD variants. Conclusions: No G6PD deficiency was observed using phenotypic- or genetic-based tests in individuals residing in vivax malaria endemic regions in the ROK. Because massive chemoprophylaxis using primaquine has been performed in the ROK military to kill hypnozoites responsible for relapse and latent stage vivax malaria, further regular monitoring is essential for the safe administration of primaquine.	[Goo, Youn-Kyoung; Ji, So-Young; Shin, Hyun-Il; Moon, Jun-Hye; Cho, Shin-Hyung; Lee, Won-Ja; Kim, Jung-Yeon] Osong Hlth Technol Adm, Korea CDC, NIH, Div Malaria & Parasit Dis, Osong, South Korea; [Goo, Youn-Kyoung] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Taegu, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University	Kim, JY (corresponding author), Osong Hlth Technol Adm, Korea CDC, NIH, Div Malaria & Parasit Dis, Osong Saeng Myeong 2 Ro, Osong, South Korea.	jykim-malaria@nih.go.kr			Asia Pacific Malaria Elimination Network (APMEN) [107-05]; Korea National Institute of Health [4837-302-210-13]	Asia Pacific Malaria Elimination Network (APMEN); Korea National Institute of Health	This study was supported by the extramural fund of the Asia Pacific Malaria Elimination Network (APMEN; project number 107-05) and the intramural fund of the Korea National Institute of Health (Grant no. 4837-302-210-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; BEUTLER E, 1995, BLOOD CELL MOL DIS, V21, P64, DOI 10.1006/bcmd.1995.0010; BLACKWELL RQ, 1968, VOX SANG, V14, P299, DOI 10.1111/j.1423-0410.1968.tb04628.x; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; DERN RJ, 1981, J LAB CLIN MED, V97, P750; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Huang YX, 2008, MOL GENET METAB, V93, P44, DOI 10.1016/j.ymgme.2007.08.122; Jiang WY, 2006, HUM GENET, V119, P463, DOI 10.1007/s00439-005-0126-5; Khim N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-171; KIM M K, 1992, Journal of Korean Medical Science, V7, P71; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LaMonte G, 2012, CELL HOST MICROBE, V12, P187, DOI 10.1016/j.chom.2012.06.007; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010; Phompradit P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-368; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Silao CL, 1999, PEDIATR INT, V41, P138, DOI 10.1046/j.1442-200X.1999.4121035.x; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Than AM, 2005, INT J HEMATOL, V82, P119, DOI 10.1532/IJH97.05028; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; Wagner G, 1996, HUM BIOL, V68, P383	27	19	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97390	10.1371/journal.pone.0097390	http://dx.doi.org/10.1371/journal.pone.0097390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853873	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200021
J	Xie, XZ; Kagawa, T; Takano, M				Xie, Xianzhi; Kagawa, Takatoshi; Takano, Makoto			The Phytochrome B/Phytochrome C Heterodimer Is Necessary for Phytochrome C-Mediated Responses in Rice Seedlings	PLOS ONE			English	Article							RED-LIGHT; SIGNALING MECHANISMS; RESONANCE RAMAN; GENE FAMILY; ARABIDOPSIS; EXPRESSION; PHOTORECEPTORS; AGROBACTERIUM; CHROMOPHORE; SEQUENCES	Background: PhyC levels have been observed to be markedly lower in phyB mutants than in Arabidopsis or rice wild type etiolated seedlings, but the mechanism of this phenomenon has not been fully elucidated. Results: In the present study, we investigated the mechanism by which phyB affects the protein concentration and photo-sensing abilities of phyC and demonstrated that rice phyC exists predominantly as phyB/phyC heterodimers in etiolated seedlings. PHYC-GFP protein was detected when expressed in phyA phyC mutants, but not in phyA phyB mutants, suggesting that phyC requires phyB for its photo-sensing abilities. Interestingly, when a mutant PHYB gene that has no chromophore binding site, PHYB(C364A), was introduced into phyB mutants, the phyC level was restored. Moreover, when PHYB(C364A) was introduced into phyA phyB mutants, the seedlings exhibited de-etiolation under both far-red light (FR) and red light (R) conditions, while the phyA phyB mutants were blind to both FR and R. These results are the first direct evidence that phyC is responsible for regulating seedling de-etiolation under both FR and R. These findings also suggest that phyB is indispensable for the expression and function of phyC, which depends on the formation of phyB/phyC heterodimers. Significance: The present report clearly demonstrates the similarities and differences in the properties of phyC between Arabidopsis and rice and will advance our understanding of phytochrome functions in monocots and dicots.	[Xie, Xianzhi; Kagawa, Takatoshi; Takano, Makoto] Natl Inst Agrobiol Sci, Photobiol & Photosynthesis Res Unit, Tsukuba, Ibaraki, Japan; [Xie, Xianzhi] Shandong Acad Agr Sci, Shandong Rice Res Inst, Jinan, Shandong, Peoples R China	National Institute of Agrobiological Sciences - Japan; Shandong Academy of Agricultural Sciences	Takano, M (corresponding author), Natl Inst Agrobiol Sci, GMO Res Ctr, Tsukuba, Ibaraki, Japan.	mtakano@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries; Rice Genome Programs [IP1006, SY1108]; Genomics for Agricultural Innovation [GPN0003]	Ministry of Agriculture, Forestry, and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Rice Genome Programs; Genomics for Agricultural Innovation	This work was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries, the Rice Genome Programs IP1006 and SY1108, and the Genomics for Agricultural Innovation GPN0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2000, MOL BIOL EVOL, V17, P362, DOI 10.1093/oxfordjournals.molbev.a026316; Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Basu D, 2000, PLANT MOL BIOL, V44, P27, DOI 10.1023/A:1006488119301; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Clough RC, 1999, PLANT J, V17, P155, DOI 10.1046/j.1365-313X.1999.00360.x; Debrieux D, 2010, PLANT MOL BIOL, V73, P687, DOI 10.1007/s11103-010-9649-9; DEHESH K, 1991, MOL GEN GENET, V225, P305, DOI 10.1007/BF00269863; Eichenberg K, 2000, FEBS LETT, V470, P107, DOI 10.1016/S0014-5793(00)01301-6; Franklin KA, 2003, PLANT CELL, V15, P1981, DOI 10.1105/tpc.015164; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Fuse T., 2001, PLANT BIOTECHNOL, V18, P219, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.219; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hennig L, 2001, J BIOL CHEM, V276, P7913, DOI 10.1074/jbc.M009793200; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirschfeld M, 1998, GENETICS, V149, P523; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; JONES AM, 1986, BIOCHEMISTRY-US, V25, P2987, DOI 10.1021/bi00358a038; Kagawa T, 2007, FEBS LETT, V581, P368, DOI 10.1016/j.febslet.2006.12.041; KAY SA, 1989, NUCLEIC ACIDS RES, V17, P2865, DOI 10.1093/nar/17.7.2865; Kim JI, 2005, LIGHT SENSING IN PLANTS, P57, DOI 10.1007/4-431-27092-2_6; Kiyota S, 2012, PLANT PHYSIOL BIOCH, V51, P10, DOI 10.1016/j.plaphy.2011.10.002; LAGARIAS JC, 1985, J BIOL CHEM, V260, P2415; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Mroginski MA, 2007, ACCOUNTS CHEM RES, V40, P258, DOI 10.1021/ar6000523; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; NAKAZAWA M, 1991, PLANT CELL PHYSIOL, V32, P1187; Neff MM, 2000, GENE DEV, V14, P257; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Palecanda L, 2001, PLANT MOL BIOL, V46, P89, DOI 10.1023/A:1010686805488; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Sharrock RA, 2004, P NATL ACAD SCI USA, V101, P11500, DOI 10.1073/pnas.0404286101; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; Smith Harry, 1994, Seminars in Cell Biology, V5, P315, DOI 10.1006/scel.1994.1038; Tahir M, 1998, PLANT PHYSIOL, V118, P1535; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Takano M, 2001, PLANT CELL, V13, P521, DOI 10.1105/tpc.13.3.521; Takano M, 2009, P NATL ACAD SCI USA, V106, P14705, DOI 10.1073/pnas.0907378106; Trupkin SA, 2007, PLANT MOL BIOL, V63, P669, DOI 10.1007/s11103-006-9115-x; Ulijasz AT, 2011, CURR OPIN PLANT BIOL, V14, P498, DOI 10.1016/j.pbi.2011.06.002; Wagner D, 1996, PLANT CELL, V8, P859, DOI 10.1105/tpc.8.5.859; Wang HY, 2005, CURR TOP DEV BIOL, V68, P227, DOI 10.1016/S0070-2153(05)68008-8; Wolf I, 2011, PLANT CELL PHYSIOL, V52, P361, DOI 10.1093/pcp/pcq194; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437	52	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97264	10.1371/journal.pone.0097264	http://dx.doi.org/10.1371/journal.pone.0097264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853557	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200019
J	Olson, MA; Lee, MS				Olson, Mark A.; Lee, Michael S.			Evaluation of Unrestrained Replica-Exchange Simulations Using Dynamic Walkers in Temperature Space for Protein Structure Refinement	PLOS ONE			English	Article							GUIDED LANGEVIN DYNAMICS; MOLECULAR-DYNAMICS; STRUCTURE SELECTION; I-TASSER; PREDICTION; FORCE	A central problem of computational structural biology is the refinement of modeled protein structures taken from either comparative modeling or knowledge-based methods. Simulations are commonly used to achieve higher resolution of the structures at the all-atom level, yet methodologies that consistently yield accurate results remain elusive. In this work, we provide an assessment of an adaptive temperature-based replica exchange simulation method where the temperature clients dynamically walk in temperature space to enrich their population and exchanges near steep energetic barriers. This approach is compared to earlier work of applying the conventional method of static temperature clients to refine a dataset of conformational decoys. Our results show that, while an adaptive method has many theoretical advantages over a static distribution of client temperatures, only limited improvement was gained from this strategy in excursions of the downhill refinement regime leading to an increase in the fraction of native contacts. To illustrate the sampling differences between the two simulation methods, energy landscapes are presented along with their temperature client profiles.	[Olson, Mark A.] USAMRIID, Dept Cell Biol & Biochem Mol & Translat Sci, Frederick, MD USA; [Olson, Mark A.] Johns Hopkins Univ, Zanvyl Krieger Sch Arts & Sci, Adv Acad Programs, Baltimore, MD USA; [Lee, Michael S.] US Army Res Lab, Computat Sci Div, Aberdeen Proving Ground, MD USA	United States Army Medical Research Institute of Infectious Diseases; Johns Hopkins University; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Olson, MA (corresponding author), USAMRIID, Dept Cell Biol & Biochem Mol & Translat Sci, Frederick, MD USA.	molson@compbiophys.org			U.S. Department of Defense Threat Reduction Agency [CBCALL12-LS6-2-0036]; Army Research Lab	U.S. Department of Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Army Research Lab(United States Department of DefenseUS Army Research Laboratory (ARL))	Funding of this research was provided by the U.S. Department of Defense Threat Reduction Agency Grant CBCALL12-LS6-2-0036 to MAO and the Army Research Lab to MSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chaudhury S, 2012, J CHEM THEORY COMPUT, V8, P677, DOI 10.1021/ct200529b; Chen JH, 2007, PROTEINS, V67, P922, DOI 10.1002/prot.21345; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Ishikawa Y, 2001, CHEM PHYS LETT, V333, P199, DOI 10.1016/S0009-2614(00)01342-7; Katzgraber G, 2006, J STAT MECH-THEORY E; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Larsen AB, 2013, J CHEM INF MODEL; Lee MS, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3603964; Lee MS, 2010, J CHEM THEORY COMPUT, V6, P2477, DOI 10.1021/ct100062b; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; MacCallum JL, 2011, PROTEINS, V79, P74, DOI 10.1002/prot.23131; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mirjalili V, 2014, PROTEINS, V82, P196, DOI 10.1002/prot.24336; Mirjalili V, 2013, J CHEM THEORY COMPUT, V9, P1294, DOI 10.1021/ct300962x; Nugent T, 2013, PROTEINS; Olson MA, 2013, J COMPUT CHEM, V34, P1785, DOI 10.1002/jcc.23325; Olson MA, 2013, PROTEINS, V81, P469, DOI 10.1002/prot.24204; Olson MA, 2011, J COMPUT CHEM, V32, P3014, DOI 10.1002/jcc.21883; Predescu C, 2004, J CHEM PHYS, V120, P4119, DOI 10.1063/1.1644093; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Spill YG, 2013, J COMPUT CHEM, V34, P132, DOI 10.1002/jcc.23113; Trebst S, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2186639; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Yeh IC, 2008, J PHYS CHEM B, V112, P15064, DOI 10.1021/jp802469g; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang WH, 2013, J CHEM THEORY COMPUT, V9, P2849, DOI 10.1021/ct400191b; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhou RH, 2002, P NATL ACAD SCI USA, V99, P12777, DOI 10.1073/pnas.142430099	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96638	10.1371/journal.pone.0096638	http://dx.doi.org/10.1371/journal.pone.0096638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848767	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600014
J	Otaki, Y; Watanabe, T; Takahashi, H; Hirayama, A; Narumi, T; Kadowaki, S; Honda, Y; Arimoto, T; Shishido, T; Miyamoto, T; Konta, T; Shibata, Y; Fukao, A; Daimon, M; Ueno, Y; Kato, T; Kayama, T; Kubota, I				Otaki, Yoichiro; Watanabe, Tetsu; Takahashi, Hiroki; Hirayama, Atushi; Narumi, Taro; Kadowaki, Shinpei; Honda, Yuki; Arimoto, Takanori; Shishido, Tetsuro; Miyamoto, Takuya; Konta, Tsuneo; Shibata, Yoko; Fukao, Akira; Daimon, Makoto; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa; Kubota, Isao			Association of Heart-Type Fatty Acid-Binding Protein with Cardiovascular Risk Factors and All-Cause Mortality in the General Population: The Takahata Study	PLOS ONE			English	Article							HIGHLY SENSITIVE ASSAY; CARDIAC TROPONIN-T; ONGOING MYOCARDIAL DAMAGE; BRAIN NATRIURETIC PEPTIDE; INSULIN-RESISTANCE; PROGNOSTIC VALUE; I LEVELS; FAILURE; CANCER; MECHANISMS	Background: Despite many recent advances in medicine, preventing the development of cardiovascular diseases remains a challenge. Heart-type fatty acid-binding protein (H-FABP) is a marker of ongoing myocardial damage and has been reported to be a useful indicator for future cardiovascular events. However, it remains to be determined whether H-FABP can predict all-cause and cardiovascular deaths in the general population. Methods and Results: This longitudinal cohort study included 3,503 subjects who participated in a community-based health checkup with a 7-year follow-up. Serum H-FABP was measured in registered subjects. The results demonstrated that higher H-FABP levels were associated with increasing numbers of cardiovascular risk factors, including hypertension, diabetes mellitus, obesity, and metabolic syndrome. There were 158 deaths during the follow-up period, including 50 cardiovascular deaths. Deceased subjects had higher H-FABP levels compared to surviving subjects. Multivariate Cox proportional hazard regression analysis revealed that H-FABP is an independent predictor of all-cause and cardiovascular deaths after adjustments for confounding factors. Subjects were divided into four quartiles according to H-FABP level, and Kaplan-Meier analysis demonstrated that the highest H-FABP quartile was associated with the greatest risks for all-cause and cardiovascular deaths. Net reclassification index and integrated discrimination index were significantly increased by addition of H-FABP to cardiovascular risk factors. Conclusions: H-FABP level was increased in association with greater numbers of cardiovascular risk factors and was an independent risk factor for all-cause and cardiovascular deaths. H-FABP could be a useful indicator for the early identification of high-risk subjects in the general population.	[Otaki, Yoichiro; Watanabe, Tetsu; Takahashi, Hiroki; Hirayama, Atushi; Narumi, Taro; Kadowaki, Shinpei; Honda, Yuki; Arimoto, Takanori; Shishido, Tetsuro; Miyamoto, Takuya; Konta, Tsuneo; Shibata, Yoko; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Fukao, Akira; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa] Yamagata Univ, Sch Med, Global Ctr Excellence Program Study Grp, Yamagata 99023, Japan; [Daimon, Makoto] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Aomori, Japan	Yamagata University; Yamagata University; Hirosaki University	Watanabe, T (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	tewatana@med.id.yamagata-u.ac.jp	Daimon, Makoto/AAY-1289-2020; Ueno, Yoshiyuki/R-9242-2019; Konta, Tsuneo/AAO-9286-2021	Daimon, Makoto/0000-0002-3775-1719; Ueno, Yoshiyuki/0000-0001-5623-4250; Narumi, Taro/0000-0001-6466-9457	21st 9 Century Center of Excellence (COE); Global COE program of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [25460737] Funding Source: KAKEN	21st 9 Century Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid from the 21st 9 Century Center of Excellence (COE) and the Global COE program of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2012, NAT REV CARDIOL, V9, P347, DOI 10.1038/nrcardio.2012.37; Arimoto T, 2005, J CARD FAIL, V11, P56, DOI 10.1016/j.cardfail.2004.03.005; Arimoto T, 2007, J CARD FAIL, V13, P34, DOI 10.1016/j.cardfail.2006.09.002; Braga JR, 2013, CIRC-HEART FAIL, V6, P193, DOI 10.1161/CIRCHEARTFAILURE.112.000075; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chiu YT, 2005, INT J CARDIOL, V100, P401, DOI 10.1016/j.ijcard.2004.08.026; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Daidoji H, 2012, J CARD FAIL, V18, P556, DOI 10.1016/j.cardfail.2012.04.006; de Antonio M, 2012, AM HEART J, V163, P821, DOI 10.1016/j.ahj.2012.03.004; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Eggers KM, 2013, J AM COLL CARDIOL, V61, P1906, DOI 10.1016/j.jacc.2012.12.048; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; GLATZ JFC, 1985, CHEM PHYS LIPIDS, V38, P115, DOI 10.1016/0009-3084(85)90061-1; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hernandez AF, 2012, JAMA-J AM MED ASSOC, V308, P2097, DOI 10.1001/jama.2012.14795; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jee SH, 2005, YONSEI MED J, V46, P449, DOI 10.3349/ymj.2005.46.4.449; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Leistner DM, 2012, CLIN CHEM, V58, P200, DOI 10.1373/clinchem.2011.174292; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Matsumoto S, 2013, CIRC J, V77, P1026, DOI 10.1253/circj.CJ-12-0999; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meng XZ, 2006, FORENSIC SCI INT, V160, P11, DOI 10.1016/j.forsciint.2005.08.008; Mervaala E, 2000, HYPERTENSION, V35, P360, DOI 10.1161/01.HYP.35.1.360; Narumi T, 2012, EXP DIABETES RES, DOI 10.1155/2012/815098; Niizeki T, 2005, CIRC J, V69, P922, DOI 10.1253/circj.69.922; Niizeki T, 2007, J CARD FAIL, V13, P120, DOI 10.1016/j.cardfail.2006.10.014; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Stengel B, 2010, J NEPHROL, V23, P253; Tsutamoto T, 1997, CIRCULATION, V96, P509; Ueshima H, 2006, CIRC J, V70, P1249; Viswanathan K, 2010, J AM COLL CARDIOL, V55, P2590, DOI 10.1016/j.jacc.2009.12.062; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	45	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e94834	10.1371/journal.pone.0094834	http://dx.doi.org/10.1371/journal.pone.0094834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847804	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600005
J	Zager, RA; Johnson, ACM; Frostad, KB				Zager, Richard A.; Johnson, Ali C. M.; Frostad, Kirsten B.			Rapid Renal Alpha-1 Antitrypsin Gene Induction in Experimental and Clinical Acute Kidney Injury	PLOS ONE			English	Article							HUMAN MONOCYTES; ALPHA(1)-ANTITRYPSIN; EXPRESSION; BIOMARKER; ACCUMULATION; DISEASE; PROTEIN; LIVER	Alpha-1-antitrypsin (AAT) is a hepatic stress protein with protease inhibitor activity. Recent evidence indicates that ischemic or toxic injury can evoke selective changes within kidney that resemble a hepatic phenotype. Hence, we tested the following: i) Does acute kidney injury (AKI) up-regulate the normally renal silent AAT gene? ii) Does rapid urinary AAT excretion result? And iii) Can AAT's anti-protease/anti-neutrophil elastase (NE) activity protect injured proximal tubule cells? CD-1 mice were subjected to ischemic or nephrotoxic (glycerol, maleate, cisplatin) AKI. Renal functional and biochemical assessments were made 4-72 hrs later. Rapidly following injury, 5-10 fold renal cortical and isolated proximal tubule AAT mRNA and protein increases occurred. These were paralleled by rapid (>100 fold) increases in urinary AAT excretion. AKI also induced marked increases in renal cortical/isolated proximal tubule NE mRNA. However, sharp NE protein levels declines resulted, which strikingly correlated (r, -0.94) with rising AAT protein levels (reflecting NE complexing by AAT/destruction). NE addition to HK-2 cells evoked similar to 95% cell death. AAT completely blocked this NE toxicity, as well as Fe induced oxidant HK-2 cell attack. Translational relevance of experimental AAT gene induction was indicated by similar to 100-1000 fold urinary AAT increases in 22 AKI patients (matching urine NGAL increases). We conclude: i) AKI rapidly up-regulates the renal cortical/proximal tubule AAT gene; ii) NE gene induction also results; iii) AAT can confer cytoprotection, potentially by blocking/reducing cytotoxic NE accumulation; and iv) marked increases in urinary AAT excretion in AKI patients implies clinical relevance of the AKI-AAT induction pathway.	[Zager, Richard A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Zager, RA (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	dzager@fhcrc.org			National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 2008, SCAND J CLIN LAB INV, V68, P78, DOI 10.1080/00365510802145059; Bonventre JV, 2010, CURR OPIN CRIT CARE, V16, P556, DOI 10.1097/MCC.0b013e32834008d3; Churg A, 2001, LAB INVEST, V81, P1119, DOI 10.1038/labinvest.3780324; Daemen MARC, 2000, CIRCULATION, V102, P1420, DOI 10.1161/01.CIR.102.12.1420; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Goldstein S, 2012, EXPERT REV CLIN IMMU, V8, P397, DOI [10.1586/eci.12.33, 10.1586/ECI.12.33]; Hu CB, 2002, AM J PHYSIOL-LUNG C, V282, pL757, DOI 10.1152/ajplung.00271.2001; Hunt JM, 2012, CURR MOL MED, V12, P827; Janciauskiene SM, 2007, J BIOL CHEM, V282, P8573, DOI 10.1074/jbc.M607976200; Kaushal GP, 2013, AM J PHYSIOL-RENAL, V304, pF1150, DOI 10.1152/ajprenal.00014.2013; Makris K, 2012, CLIN CHEM LAB MED, V50, P1519, DOI 10.1515/cclm-2012-0227; McCullough PA, 2013, CONTRIB NEPHROL, V182, P13, DOI 10.1159/000349963; McLean C, 2009, BIOL-TARGETS THER, V3, P63; MILLAND J, 1990, AM J PHYSIOL, V259, pG340, DOI 10.1152/ajpgi.1990.259.3.G340; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Negishi K, 2009, AM J PATHOL, V174, P1154, DOI 10.2353/ajpath.2009.080644; Nita IM, 2007, INT J BIOCHEM CELL B, V39, P1165, DOI 10.1016/j.biocel.2007.02.017; Noiri E, 2009, AM J PHYSIOL-RENAL, V296, pF669, DOI 10.1152/ajprenal.90513.2008; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; ROGERS J, 1983, BIOCHEM BIOPH RES CO, V116, P375, DOI 10.1016/0006-291X(83)90532-6; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; SCHREIBER G, 1989, ANN NY ACAD SCI, V557, P61; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Ware LB, 2011, AM J PHYSIOL-RENAL, V300, pF628, DOI 10.1152/ajprenal.00654.2010; ZAGER RA, 1994, KIDNEY INT, V45, P1760, DOI 10.1038/ki.1994.229; Zager RA, 1998, J AM SOC NEPHROL, V9, P1670; ZAGER RA, 1993, CIRC RES, V72, P837, DOI 10.1161/01.RES.72.4.837; Zager RA, 2012, AM J PHYSIOL-RENAL, V303, pF1460, DOI 10.1152/ajprenal.00426.2012; Zager RA, 2012, AM J PHYSIOL-RENAL, V303, pF139, DOI 10.1152/ajprenal.00168.2012; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147	32	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98380	10.1371/journal.pone.0098380	http://dx.doi.org/10.1371/journal.pone.0098380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848503	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600112
J	Murciano-Calles, J; Marin-Argany, M; Cobos, ES; Villegas, S; Martinez, JC				Murciano-Calles, Javier; Marin-Argany, Marta; Cobos, Eva S.; Villegas, Sandra; Martinez, Jose C.			The Impact of Extra-Domain Structures and Post-Translational Modifications in the Folding/Misfolding Behaviour of the Third PDZ Domain of MAGUK Neuronal Protein PSD-95	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; TIGHT JUNCTION PROTEIN; BETA-SHEET; SUPERTERTIARY STRUCTURE; AMYLOID FIBRILS; IN-VITRO; ZO-1; DIMERIZATION; CLAUDINS; KINASES	The modulation of binding affinities and specificities by post-translational modifications located out from the binding pocket of the third PDZ domain of PSD-95 (PDZ3) has been reported recently. It is achieved through an intra-domain electrostatic network involving some charged residues in the beta 2-beta 3 loop (were a succinimide modification occurs), the alpha 3 helix (an extra-structural element that links the PDZ3 domain with the following SH3 domain in PSD-95, and contains the phosphorylation target Tyr397), and the ligand peptide. Here, we have investigated the main structural and thermodynamic aspects that these structural elements and their related post-translational modifications display in the folding/misfolding pathway of PDZ3 by means of site-directed mutagenesis combined with calorimetry and spectroscopy. We have found that, although all the assayed mutations generate proteins more prone to aggregation than the wild-type PDZ3, those directly affecting the alpha 3 helix, like the E401R substitution or the truncation of the whole alpha 3 helix, increase the population of the DSC-detected intermediate state and the misfolding kinetics, by organizing the supramacromolecular structures at the expense of the two beta-sheets present in the PDZ3 fold. However, those mutations affecting the beta 2-beta 3 loop, included into the prone-to-aggregation region composed by a single beta-sheet comprising beta 2 to beta 4 chains, stabilize the trimeric intermediate previously shown in the wild-type PDZ3 and slow-down aggregation, also making it partly reversible. These results strongly suggest that the alpha 3 helix protects to some extent the PDZ3 domain core from misfolding. This might well constitute the first example where an extra-element, intended to link the PDZ3 domain to the following SH3 in PSD-95 and in other members of the MAGUK family, not only regulates the binding abilities of this domain but it also protects PDZ3 from misfolding and aggregation. The influence of the post-translational modifications in this regulatory mechanism is also discussed.	[Murciano-Calles, Javier; Cobos, Eva S.; Martinez, Jose C.] Univ Granada, Dept Quim Fis, Granada, Spain; [Murciano-Calles, Javier; Cobos, Eva S.; Martinez, Jose C.] Univ Granada, Inst Biotecnol, Fac Ciencias, Granada, Spain; [Marin-Argany, Marta; Villegas, Sandra] Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	University of Granada; University of Granada; Autonomous University of Barcelona	Villegas, S (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain.	sandra.villegas@uab.cat; jcmh@ugr.es	S. Cobos, Eva/H-7703-2015; Martinez, Jose C./J-8721-2012; Murciano-Calles, Javier/J-8897-2012; Villegas, Sandra/D-8789-2011; Villegas, Sandra/ABF-8206-2021	S. Cobos, Eva/0000-0002-4622-8698; Martinez, Jose C./0000-0003-2657-2456; Murciano-Calles, Javier/0000-0002-8667-1651; Villegas, Sandra/0000-0001-8644-4304; Villegas, Sandra/0000-0001-8644-4304; Argany, Meysam/0000-0001-6577-4443	Andalusian Regional Government [CVI-05915]; Spanish Ministry of Science and Education [BIO2009-13261-C02, BIO2012-39922-C02]; FEDER; Instituto de Salud Carlos III [PI13-01330]; Generalitat de Catalunya [SGR09-0761]; Spanish Ministry of Science and Education; PIF (UAB) fellowship	Andalusian Regional Government; Spanish Ministry of Science and Education(Spanish Government); FEDER(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Science and Education(Spanish Government); PIF (UAB) fellowship	This research was supported by grants CVI-05915, from the Andalusian Regional Government; BIO2009-13261-C02 and BIO2012-39922-C02, from the Spanish Ministry of Science and Education and FEDER; PI13-01330 from Instituto de Salud Carlos III and SGR09-0761 from the Generalitat de Catalunya. J.M-C. received a postdoctoral contract from the Spanish Ministry of Science and Education. M. M-A. was supported by a PIF (UAB) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; Camara-Artigas A, 2010, J STRUCT BIOL, V170, P565, DOI 10.1016/j.jsb.2010.03.005; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hasty J, 2001, NATURE, V411, P30, DOI 10.1038/35075182; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kalia LV, 2003, NEUROPHARMACOLOGY, V45, P720, DOI 10.1016/S0028-3908(03)00313-7; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; Korkin D, 2006, PLOS COMPUT BIOL, V2, P1365, DOI 10.1371/journal.pcbi.0020153; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Marin-Argany M, 2012, BIOPHYS J, V103, P738, DOI 10.1016/j.bpj.2012.07.029; Murciano-Calles J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090030; Murciano-Calles J, 2014, BIOPHYS CHEM, V185, P1, DOI 10.1016/j.bpc.2013.10.005; Murciano-Calles J, 2011, BIOPHYS CHEM, V158, P104, DOI 10.1016/j.bpc.2011.05.018; Murciano-Calles J, 2010, BIOPHYS J, V99, P263, DOI 10.1016/j.bpj.2010.04.003; Orpiszewski J, 1999, J MOL BIOL, V289, P413, DOI 10.1006/jmbi.1999.2768; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Smith A, 2006, AGENDA, V42, P9; Takemoto L, 2001, EXP EYE RES, V72, P559, DOI 10.1006/exer.2001.0983; Tompa P, 2012, NAT CHEM BIOL, V8, P597, DOI 10.1038/nchembio.1009; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; Villegas V, 2000, PROTEIN SCI, V9, P1700, DOI 10.1110/ps.9.9.1700; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Wu JW, 2007, J BIOL CHEM, V282, P35988, DOI 10.1074/jbc.M703826200; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583	34	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98124	10.1371/journal.pone.0098124	http://dx.doi.org/10.1371/journal.pone.0098124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845085	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400099
J	Quinnan, GV; Onabajo, O; Zhang, PF; Yan, LY; Mattapallil, JJ; Zhang, ZQ; Dong, M; Lu, M; Montefiori, D; LaBranche, C; Broder, CC				Quinnan, Gerald V., Jr.; Onabajo, Olusegun; Zhang, Pengfei; Yan, Lianying; Mattapallil, Joseph J.; Zhang, Zhiqiang; Dong, Ming; Lu, Min; Montefiori, David; LaBranche, Celia; Broder, Christopher C.			Immunization of Rabbits with Highly Purified, Soluble, Trimeric Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces a Vigorous B Cell Response and Broadly Cross-Reactive Neutralization	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; CORECEPTOR-BINDING-SITE; HIV-1 INFECTION; ENV CLONES; VACCINE; GP120; EPITOPES; POTENT; EXPRESSION; COMPLEX	Previously we described induction of cross-reactive HIV-1 neutralizing antibody responses in rabbits using a soluble HIV-1 gp140 envelope glycoprotein (Env) in an adjuvant containing monophosphoryl lipid A (MPL) and QS21 (AS02(A)). Here, we compared different forms of the same HIV-1 strain R2 Env for antigenic and biophysical characteristics, and in rabbits characterized the extent of B cell induction for specific antibody expression and secretion and neutralizing responses. The forms of this Env that were produced in and purified from stably transformed 293T cells included a primarily dimeric gp140, a trimeric gp140 appended to a GCN4 trimerization domain (gp140-GCN4), gp140-GCN4 with a 15 amino acid flexible linker between the gp120 and gp41 ectodomain (gp140-GCN4-L), also trimeric, and a gp140 with the flexible linker purified from cell culture supernatants as either dimer (gp140-L(D)) or monomer (gp140-L(M)). Multimeric states of the Env proteins were assessed by native gel electrophoresis and analytical ultracentrifugation. The different forms of gp140 bound broadly cross-reactive neutralizing (BCN) human monoclonal antibodies (mAbs) similarly in ELISA and immunoprecipitation assays. All Envs bound CD4i mAbs in the presence and absence of sCD4, as reported for the R2 Env. Weak neutralization of some strains of HIV-1 was seen after two additional doses in AS02A. Rabbits that were given a seventh dose of gp140-GCN4-L developed BCN responses that were weak to moderate, similar to our previous report. The specificity of these responses did not appear similar to that of any of the known BCN human mAbs. Induction of spleen B cell and plasma cells producing immunoglobulins that bound trimeric gp140-GCN4-L was vigorous, based on ELISpot and flow cytometry analyses. The results demonstrate that highly purified gp140-GCN4-L trimer in adjuvant elicits BCN responses in rabbits accompanied by vigorous B cell induction.	[Quinnan, Gerald V., Jr.; Zhang, Pengfei; Zhang, Zhiqiang; Dong, Ming] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Onabajo, Olusegun; Yan, Lianying; Mattapallil, Joseph J.; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD USA; [Lu, Min] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Montefiori, David; LaBranche, Celia] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University	Quinnan, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	gerald.quinnan@usuhs.edu	Broder, Christopher/E-1169-2013	Mattapallil, Joseph/0000-0002-7412-9507	National Institutes of Health [AI078412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by National Institutes of Health Grant AI078412; website: http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chan YP, 2012, J VIROL, V86, P11457, DOI 10.1128/JVI.01318-12; Chow YH, 2002, BIOCHEMISTRY-US, V41, P7176, DOI 10.1021/bi025646d; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Dong M, 2003, J VIROL, V77, P3119, DOI 10.1128/JVI.77.5.3119-3130.2003; GERSHONI JM, 1993, FASEB J, V7, P1185, DOI 10.1096/fasebj.7.12.7690724; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Kwong PD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17407; Lee S, 1997, J VIROL, V71, P6037, DOI 10.1128/JVI.71.8.6037-6043.1997; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Mirzabekov T, 1999, J BIOL CHEM, V274, P28745, DOI 10.1074/jbc.274.40.28745; Ohagen A, 2000, AIDS RES HUM RETROV, V16, P27, DOI 10.1089/088922200309575; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Quinnan GV, 2005, J VIROL, V79, P3358, DOI 10.1128/JVI.79.6.3358-3369.2005; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Zhang MY, 2010, MABS-AUSTIN, V2, P266, DOI 10.4161/mabs.2.3.11416; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhang PF, 2002, J VIROL, V76, P644, DOI 10.1128/JVI.76.2.644-655.2002	37	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98060	10.1371/journal.pone.0098060	http://dx.doi.org/10.1371/journal.pone.0098060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846288	gold, Green Submitted, Green Published			2022-12-27	WOS:000339563400089
J	Zhang, XL; Xie, J; Li, GN; Chen, QH; Xu, BA				Zhang, Xinlin; Xie, Jun; Li, Guannan; Chen, Qinhua; Xu, Biao			Head-to-Head Comparison of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies	PLOS ONE			English	Article							BARE-METAL STENTS; LONG-TERM OUTCOMES; RANDOMIZED-TRIALS; DIABETES-MELLITUS; FOLLOW-UP; EFFICACY	Background: The relative short-, long- and overall-term efficacy and safety of sirolimus-eluting stents (SES, Cypher) compared with paclitaxel-eluting stents (PES, Taxus) in large head-to-head comparisons still remain to be defined. Methods: We searched Pubmed, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) for articles comparing outcomes of interest between SES and PES without language restriction. Short- (<= 1 year), long- (>1 year), and overall-term (the longest follow-up of each study) outcomes were evaluated. The primary endpoint was target lesion revascularization (TLR). Other outcomes of interest were target vessel revascularization (TVR), myocardial infarction, all-cause death, cardiac death, stent thrombosis, major adverse cardiac events (MACEs), restenosis and late lumen loss. Results: Seventy-six studies including more than 15000 patients in randomized controlled trials and over 70000 patients in adjusted observational studies were included. At overall-term follow-up, SES significantly reduced TLR (relative risk [RR]: 0.61; 95% confidence interval [CI]: 0.49-0.76), TVR (RR: 0.67; 95% CI: 0.54-0.83), MACE (RR: 0.79; 95% CI: 0.72-0.87), myocardial infarction (RR: 0.85; 95% CI: 0.73-0.99), in-segment restenosis (RR: 0.50; 95% CI: 0.38-0.65), and in-segment late lumen loss (weighted mean difference [WMD]: 20.19; 95% CI: 20.24-20.14) in randomized controlled trials compared with PES. In addition, lower rates of death (RR: 0.91; 95% CI: 0.83-1.00), any stent thrombosis (RR: 0.62; 95% CI: 0.45-0.86), definite stent thrombosis (RR: 0.59; 95% CI: 0.45-0.77) were found in patients receiving SES in adjusted observational studies. Largely similar results were found at short-and long-term follow-up, and in patients with diabetes, acute myocardial infarction or long lesions. Conclusions: SES significantly reduced the short-, long-and overall-term risk of TLR/TVR, MACE, and restenosis, and overall-term risk of myocardial infarction in randomized controlled trials, as compared with PES. Lower rates of death and stent thrombosis were also observed in observational studies in SES-treated patients.	[Zhang, Xinlin; Xie, Jun; Li, Guannan; Chen, Qinhua; Xu, Biao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Xu, BA (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China.	xubiao@medmail.com.cn	xie, jun/C-2193-2017	xie, jun/0000-0002-9385-3242	National Natural Science Foundation of China [81070195, 81270281, 81200148]; Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Funds for Distinguished Young Scientists in Nanjing	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Funds for Distinguished Young Scientists in Nanjing	This work was supported by grants from the National Natural Science Foundation of China (research grants 81070195, 81270281 and 81200148), Jiangsu Key Laboratory for Molecular Medicine of Nanjing University (research grant 2008), and Funds for Distinguished Young Scientists in Nanjing (Xie Jun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Egger M, 2001, SYSTEMATIC REV HLTH, V357; Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Lupi A, 2011, CIRC J, V75, P280, DOI 10.1253/circj.CJ-10-0186; Mahmud E, 2008, J AM COLL CARDIOL, V51, P2385, DOI 10.1016/j.jacc.2008.03.028; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Wallace EL, 2012, AM J CARDIOL, V109, P932, DOI 10.1016/j.amjcard.2011.11.021; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]	26	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97934	10.1371/journal.pone.0097934	http://dx.doi.org/10.1371/journal.pone.0097934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844284	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400072
J	Kim, YJ; Cho, HJ; Shin, WC; Song, HA; Yoon, JH; Kim, CH				Kim, Yoon-Ju; Cho, Hyung-Ju; Shin, Woo-Chul; Song, Hyun-Ah; Yoon, Joo-Heon; Kim, Chang-Hoon			Hypoxia-Mediated Mechanism of MUC5AC Production in Human Nasal Epithelia and Its Implication in Rhinosinusitis	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; MUCIN GENE-EXPRESSION; GROWTH-FACTOR GENE; RETINOIC ACID; TRANSCRIPTIONAL ACTIVATION; CHRONIC SINUSITIS; FACTOR-1; CELLS; STIMULATION; PHENOTYPE	Background: Excessive mucus production is typical in various upper airway diseases. In sinusitis, the expression of MUC5AC, a major respiratory mucin gene, increases. However, the mechanisms leading to mucus hypersecretion in sinusitis have not been characterized. Hypoxia due to occlusion of the sinus ostium is one of the major pathologic mechanisms of sinusitis, but there have been no reports regarding the mechanism of hypoxia-induced mucus hypersecretion. Methods and Findings: This study aims to identify whether hypoxia may induce mucus hypersecretion and elucidate its mechanism. Normal human nasal epithelial (NHNE) cells and human lung mucoepidermoid carcinoma cell line (NCI-H292) were used. Sinus mucosa from patients was also tested. Anoxic condition was in an anaerobic chamber with a 95% N-2/5% CO2 atmosphere. The regulatory mechanism of MUC5AC by anoxia was investigated using RT-PCR, real-time PCR, western blot, ChIP, electrophoretic mobility shift, and luciferase assay. We show that levels of MUC5AC mRNA and the corresponding secreted protein increase in anoxic cultured NHNE cells. The major transcription factor for hypoxia-related signaling, HIF-1 alpha, is induced during hypoxia, and transfection of a mammalian expression vector encoding HIF-1 alpha results in increased MUC5AC mRNA levels under normoxic conditions. Moreover, hypoxia-induced expression of MUC5AC mRNA is down-regulated by transfected HIF-1 alpha siRNA. We found increased MUC5AC promoter activity under anoxic conditions, as indicated by a luciferase reporter assay, and mutation of the putative hypoxia-response element in MUC5AC promoter attenuated this activity. Binding of over-expressed HIF-1 alpha to the hypoxia-response element in the MUC5AC promoter was confirmed. In human sinusitis mucosa, which is supposed to be hypoxic, expression of MUC5AC and HIF-1 alpha is higher than in control mucosa. Conclusion: The results indicate that anoxia up-regulates MUC5AC by the HIF-1 alpha signaling pathway in human nasal epithelia and suggest that hypoxia might be a pathogenic mechanism of mucus hypersecretion in sinusitis.	[Cho, Hyung-Ju; Yoon, Joo-Heon; Kim, Chang-Hoon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Cho, Hyung-Ju; Yoon, Joo-Heon; Kim, Chang-Hoon] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea; [Kim, Yoon-Ju; Yoon, Joo-Heon] Yonsei Univ, Coll Med, BK Project Med Sci 21, Seoul, South Korea; [Kim, Yoon-Ju; Song, Hyun-Ah; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul, South Korea; [Shin, Woo-Chul] Hana ENT Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, CH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	entman@yuhs.ac	Kim, Chang-Hoon/D-7205-2016; rchnds, rchnds/D-7595-2016; Yoon, Joo-Heon/E-5781-2016	Kim, Chang-Hoon/0000-0003-1238-6396; Yoon, Joo-Heon/0000-0003-2404-7156	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0008442, 2012R1A1A2042476, 2012-0000803]; Yonsei University College of Medicine [6-2011-0140]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Yonsei University College of Medicine(General Electric)	This research was supported by grants 2010-0008442 and 2012R1A1A2042476 to C. H. Kim, and 2012-0000803 to J.H. Yoon, from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology. This study was also supported by a faculty research grant from the Yonsei University College of Medicine for 2011 (6-2011-0140) to C. H. Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenmyr L, 2011, CLIN PHYSIOL FUNCT I, V31, P435, DOI 10.1111/j.1475-097X.2011.01039.x; Ali MS, 2005, OTOLARYNG HEAD NECK, V133, P423, DOI 10.1016/j.otohns.2005.06.005; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; AUST R, 1974, ACTA OTO-LARYNGOL, V78, P264, DOI 10.3109/00016487409126354; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Ding GQ, 2007, AM J RHINOL, V21, P359, DOI 10.2500/ajr.2007.21.3037; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Georgy Mary S, 2012, Allergy Asthma Proc, V33 Suppl 1, P24, DOI 10.2500/aap.2012.33.3538; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Koo JS, 2002, EXP LUNG RES, V28, P315, DOI 10.1080/01902140252964393; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Matsune S, 2003, ACTA OTO-LARYNGOL, V123, P519, DOI 10.1080/0036554021000028113; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Neruntarat C, 2003, OTOLARYNG HEAD NECK, V129, P353, DOI 10.1016/S0194-5998(03)00636-3; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 1998, J LAB CLIN MED, V131, P207, DOI 10.1016/S0022-2143(98)90091-9; Steinke JW, 2008, CURR OPIN ALLERGY CL, V8, P16, DOI 10.1097/ACI.0b013e3282f3f488; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Yoon JH, 1997, AM J RESP CELL MOL, V16, P724, DOI 10.1165/ajrcmb.16.6.9191474; Yoon JH, 2000, ANN OTO RHINOL LARYN, V109, P594, DOI 10.1177/000348940010900612; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhu Li, 2002, Biological Procedures Online, V4, P1, DOI 10.1251/bpo28	32	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98136	10.1371/journal.pone.0098136	http://dx.doi.org/10.1371/journal.pone.0098136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840724	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600109
J	Ma, TT; Huang, YM; Wang, C; Zhao, MH; Chen, M				Ma, Tian-Tian; Huang, Yi-Min; Wang, Chen; Zhao, Ming-Hui; Chen, Min			Coagulation and Fibrinolysis Index Profile in Patients with ANCA-Associated Vasculitis	PLOS ONE			English	Article							SYSTEMIC NECROTIZING VASCULITIS; WEGENERS-GRANULOMATOSIS; RISK-FACTORS; THROMBOSIS; COMPLEMENT; REMISSION	Background: Previous studies observed the high prevalence of venous thromboembolism in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The current study analyzed the coagulation and fibrinolysis index profile in AAV patients. Methods: The current study recruited 321 AAV patients in active stage and 78 AAV patients in quiescent stage. Coagulation and fibrinolysis index profiles in these AAV patients were analysed, and their associations with various clinical and pathological parameters were further investigated. Results: The circulating levels of D-dimer, fibrin degradation products and platelet count were significantly higher in AAV patients in active stage compared with those in remission [0.8 (0.4, 1.5) mg/L vs. 0.28 (0.2, 0.55) mg/L, P<0.05; 5.6 (5.0, 10.0) mg/L vs. 1.9 (1.2, 2.8) mg/L, P<0.05; 269 +/- 127 x 10(9)/L vs. 227 +/- 80 x 10(9)/L, P<0.05, respectively]. Among the 321 AAV patients in active stage, compared with patients with normal levels of D-dimer, patients with elevated D-dimer levels had significantly higher levels of initial serum creatinine, erythrocyte sedimentation rate, C reactive protein and the Birmingham Vasculitis Activity Scores (P = 0.014, P<0.001, P<0.001, P = 0.002, respectively). Moreover, correlation analysis showed that the levels of D-dimer correlated with erythrocyte sedimentation rate and C reactive protein levels (r = 0.384, P<0.001; r = 0.380, P<0.001, respectively). Conclusion: Patients with active AAV are in hypercoagulable states, and circulating levels of D-dimer are associated with disease activity of AAV.	[Ma, Tian-Tian; Huang, Yi-Min; Wang, Chen; Zhao, Ming-Hui; Chen, Min] Peking Univ, Hosp 1, Inst Nephrol, Dept Med,Renal Div, Beijing 100871, Peoples R China; [Ma, Tian-Tian; Huang, Yi-Min; Wang, Chen; Zhao, Ming-Hui; Chen, Min] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Ma, Tian-Tian; Huang, Yi-Min; Wang, Chen; Zhao, Ming-Hui; Chen, Min] Peking Univ, Key Lab Chron Kidney Dis Prevent & Treatment, Minist Educ, Beijing 100871, Peoples R China; [Zhao, Ming-Hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University	Chen, M (corresponding author), Peking Univ, Hosp 1, Inst Nephrol, Dept Med,Renal Div, Beijing 100871, Peoples R China.	leimeng@public3.bta.net.cn	Huang, Yimin/GLU-9606-2022	Huang, Yimin/0000-0003-4348-5688	Chinese 973 project [2012CB517702]; National Natural Science Fund [81370829, 81021004]; "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China [2011BAI10B04]	Chinese 973 project(National Basic Research Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China	This study is supported by a grant of Chinese 973 project (No. 2012CB517702), two grants of the National Natural Science Fund (No. 81370829 and No. 81021004), and "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China (No. 2011BAI10B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril A, 2003, SEMIN ARTHRITIS RHEU, V33, P106, DOI 10.1016/S0049-0172(03)00083-0; BIEMOND BJ, 1995, THROMB HAEMOSTASIS, V73, P223; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Cockwell P, 2000, NEPHRON, V85, P287, DOI 10.1159/000045679; Diamantopoulos AP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00024; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Hergesell O, 1996, THROMB HAEMOSTASIS, V75, P892; Hilhorst M, 2013, J RHEUMATOL, V40, P2042, DOI 10.3899/jrheum.130200; Hong Y, 2012, J AM SOC NEPHROL, V23, P49, DOI 10.1681/ASN.2011030298; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kallenberg CGM, 2013, KIDNEY INT, V83, P16, DOI 10.1038/ki.2012.371; Kambas K, 2013, ANN RHEUM D IN PRESS; Kambas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045427; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kroneman R, 1990, BLOOD COAGUL FIBRIN, V1, P91; LUQMANI RA, 1994, Q J MED, V87, P671; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Merkel PA, 2005, ANN INTERN MED, V142, P620, DOI 10.7326/0003-4819-142-8-200505030-00011; Monach PA, 2013, J RHEUMATOL, V40, P1935, DOI 10.3899/jrheum.131069; ROWBOTHAM BJ, 1987, THROMB HAEMOSTASIS, V57, P59; Springer J, 2013, CURR OPIN RHEUMATOL, V25, P19, DOI 10.1097/BOR.0b013e32835ad3ca; Stassen PM, 2008, RHEUMATOLOGY, V47, P530, DOI 10.1093/rheumatology/ken035; Stone JH, 2005, NEW ENGL J MED, V352, P351; Von Scheven E, 2003, ARTHRIT RHEUM-ARTHR, V49, P862, DOI 10.1002/art.11454	25	33	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97843	10.1371/journal.pone.0097843	http://dx.doi.org/10.1371/journal.pone.0097843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842719	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600081
J	Manconi, A; Orro, A; Manca, E; Armano, G; Milanesi, L				Manconi, Andrea; Orro, Alessandro; Manca, Emanuele; Armano, Giuliano; Milanesi, Luciano			GPU-BSM: A GPU-Based Tool to Map Bisulfite-Treated Reads	PLOS ONE			English	Article							DNA METHYLATION; ALIGNMENT TOOL; ACCURATE; EFFICIENT; ALIGNER; ULTRAFAST	Cytosine DNA methylation is an epigenetic mark implicated in several biological processes. Bisulfite treatment of DNA is acknowledged as the gold standard technique to study methylation. This technique introduces changes in the genomic DNA by converting cytosines to uracils while 5-methylcytosines remain nonreactive. During PCR amplification 5-methylcytosines are amplified as cytosine, whereas uracils and thymines as thymine. To detect the methylation levels, reads treated with the bisulfite must be aligned against a reference genome. Mapping these reads to a reference genome represents a significant computational challenge mainly due to the increased search space and the loss of information introduced by the treatment. To deal with this computational challenge we devised GPU-BSM, a tool based on modern Graphics Processing Units. Graphics Processing Units are hardware accelerators that are increasingly being used successfully to accelerate general-purpose scientific applications. GPU-BSM is a tool able to map bisulfite-treated reads from whole genome bisulfite sequencing and reduced representation bisulfite sequencing, and to estimate methylation levels, with the goal of detecting methylation. Due to the massive parallelization obtained by exploiting graphics cards, GPU-BSM aligns bisulfite-treated reads faster than other cutting-edge solutions, while outperforming most of them in terms of unique mapped reads.	[Manconi, Andrea; Orro, Alessandro; Milanesi, Luciano] CNR, Inst Biomed Technol, Segrate, Mi, Italy; [Manca, Emanuele; Armano, Giuliano] Univ Cagliari, Dept Elect & Elect Engn, Cagliari, Ca, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Cagliari	Manconi, A (corresponding author), CNR, Inst Biomed Technol, Segrate, Mi, Italy.	andrea.manconi@itb.cnr.it	Armano, Giuliano/AAA-9145-2022; Milanesi, Luciano/AAE-7230-2019; Orro, Alessandro/ABA-3542-2020	Armano, Giuliano/0000-0002-8597-1433; Milanesi, Luciano/0000-0002-1201-3939; 	MIUR [PB05]; MIUR HIRMA [RBAP11YS7K]; EU; Sardinia Region	MIUR(Ministry of Education, Universities and Research (MIUR)); MIUR HIRMA(Ministry of Education, Universities and Research (MIUR)); EU(European Commission); Sardinia Region(Regione Sardegna)	This work was supported by the MIUR (PB05) "InterOmics''; MIUR HIRMA (RBAP11YS7K); EU FP7 "MIMOMICS'' and the Sardinia Region "PAIN'' Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SY, 2011, J HUM GENET, V56, P406, DOI 10.1038/jhg.2011.43; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Harris EY, 2012, BIOINFORMATICS, V28, P1795, DOI 10.1093/bioinformatics/bts264; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jelinek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022110; Klus Petr, 2012, BMC Res Notes, V5, P27, DOI 10.1186/1756-0500-5-27; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CM, 2012, BIOINFORMATICS, V28, P878, DOI 10.1093/bioinformatics/bts061; Liu YC, 2012, BIOINFORMATICS, V28, P1830, DOI 10.1093/bioinformatics/bts276; Liu Yongchao, 2010, BMC Res Notes, V3, P93, DOI 10.1186/1756-0500-3-93; Luo RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065632; Manavski SA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S10; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mu JC, 2012, BIOINFORMATICS, V28, P2366, DOI 10.1093/bioinformatics/bts450; Otto C, 2012, BIOINFORMATICS, V28, P1698, DOI 10.1093/bioinformatics/bts254; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Shi HX, 2010, PROCEDIA COMPUT SCI, V1, P1123, DOI 10.1016/j.procs.2010.04.125; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; White T., 2012, HADOOP DEFINITIVE GU; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xi YX, 2012, BIOINFORMATICS, V28, P430, DOI 10.1093/bioinformatics/btr668; Yung LS, 2011, BIOINFORMATICS, V27, P1309, DOI 10.1093/bioinformatics/btr114	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97277	10.1371/journal.pone.0097277	http://dx.doi.org/10.1371/journal.pone.0097277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842718	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600021
J	Parolini, C; Vik, R; Busnelli, M; Bjorndal, B; Holm, S; Brattelid, T; Manzini, S; Ganzetti, GS; Dellera, F; Halvorsen, B; Aukrust, P; Sirtori, CR; Nordrehaug, JE; Skorve, J; Berge, RK; Chiesa, G				Parolini, Cinzia; Vik, Rita; Busnelli, Marco; Bjorndal, Bodil; Holm, Sverre; Brattelid, Trond; Manzini, Stefano; Ganzetti, Giulia S.; Dellera, Federica; Halvorsen, Bente; Aukrust, Pal; Sirtori, Cesare R.; Nordrehaug, Jan E.; Skorve, Jon; Berge, Rolf K.; Chiesa, Giulia			A Salmon Protein Hydrolysate Exerts Lipid-Independent Anti-Atherosclerotic Activity in ApoE-Deficient Mice	PLOS ONE			English	Article							CHOLESTEROL ACYLTRANSFERASE ACTIVITY; N-3 FATTY-ACIDS; FISH-PROTEIN; CARDIOVASCULAR-DISEASE; TRANSGENIC MICE; HDL CHOLESTEROL; ADIPOSE-TISSUE; LIVER; PLASMA; INFLAMMATION	Fish consumption is considered health beneficial as it decreases cardiovascular disease (CVD)-risk through effects on plasma lipids and inflammation. We investigated a salmon protein hydrolysate (SPH) that is hypothesized to influence lipid metabolism and to have anti-atherosclerotic and anti-inflammatory properties. 24 female apolipoprotein (apo) E-/- mice were divided into two groups and fed a high-fat diet with or without 5% (w/w) SPH for 12 weeks. The atherosclerotic plaque area in aortic sinus and arch, plasma lipid profile, fatty acid composition, hepatic enzyme activities and gene expression were determined. A significantly reduced atherosclerotic plaque area in the aortic arch and aortic sinus was found in the 12 apoE(-/-) mice fed 5% SPH for 12 weeks compared to the 12 casein-fed control mice. Immunohistochemical characterization of atherosclerotic lesions in aortic sinus displayed no differences in plaque composition between mice fed SPH compared to controls. However, reduced mRNA level of Icam1 in the aortic arch was found. The plasma content of arachidonic acid (C20:4n-6) and oleic acid (C18:1n-9) were increased and decreased, respectively. SPH-feeding decreased the plasma concentration of IL-1 beta, IL-6, TNF-alpha and GM-CSF, whereas plasma cholesterol and triacylglycerols (TAG) were unchanged, accompanied by unchanged mitochondrial fatty acid oxidation and acyl-CoA: cholesterol acyltransferase (ACAT)-activity. These data show that a 5% (w/w) SPH diet reduces atherosclerosis in apoE(-/-) mice and attenuate risk factors related to atherosclerotic disorders by acting both at vascular and systemic levels, and not directly related to changes in plasma lipids or fatty acids.	[Parolini, Cinzia; Busnelli, Marco; Manzini, Stefano; Ganzetti, Giulia S.; Dellera, Federica; Sirtori, Cesare R.; Chiesa, Giulia] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Vik, Rita; Bjorndal, Bodil; Skorve, Jon; Berge, Rolf K.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Holm, Sverre; Halvorsen, Bente; Aukrust, Pal] Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Brattelid, Trond] NIFES, Natl Inst Nutr & Seafood Res, Bergen, Norway; [Nordrehaug, Jan E.; Berge, Rolf K.] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway	University of Milan; University of Bergen; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital	Parolini, C (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	cinzia.parolini@unimi.it; rita.vik@k2.uib.no	Busnelli, Marco/AAO-6981-2021; Parolini, Cinzia/G-8984-2012; Manzini, Stefano/H-7123-2014; Bjørndal, Bodil/H-6143-2017; Bjørndal, Bodil/HDN-4287-2022; Chiesa, Giulia/G-8987-2012	Busnelli, Marco/0000-0003-3245-2872; Parolini, Cinzia/0000-0002-5699-0918; Manzini, Stefano/0000-0002-1232-2635; Bjørndal, Bodil/0000-0001-9718-5117; Chiesa, Giulia/0000-0001-5553-1210; Holm, Sverre/0000-0003-1064-3926	NordForsk [070010]; Research Council of Norway [190287/110]; European Community [201668]	NordForsk; Research Council of Norway(Research Council of Norway); European Community(European Commission)	This work was supported by grants from NordForsk, grant no. 070010, MitoHealth; the Research Council of Norway, grant no. 190287/110; and the European Community's Seventh Framework Programme (FP7/2007-2013) AtheroRemo, grant no. 201668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; Bjorndal B, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-143; Bjorndal B, 2012, METABOLISM, V61, P1461, DOI 10.1016/j.metabol.2012.03.012; BREMER J, 1981, BIOCHIM BIOPHYS ACTA, V665, P628, DOI 10.1016/0005-2760(81)90282-4; Chalamaiah M, 2012, FOOD CHEM, V135, P3020, DOI 10.1016/j.foodchem.2012.06.100; Chen W, 2004, LIFE SCI, V74, P1889, DOI 10.1016/j.lfs.2003.08.041; Cinq-Mars CD, 2008, J AGR FOOD CHEM, V56, P410, DOI 10.1021/jf072277p; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; DEMBINSKAKIEC A, 1986, WIEN KLIN WOCHENSCHR, V98, P198; Duarte J, 2006, IMMUNOBIOLOGY, V211, P341, DOI 10.1016/j.imbio.2005.12.002; Elvevoll EO, 2008, ATHEROSCLEROSIS, V200, P396, DOI 10.1016/j.atherosclerosis.2007.12.021; FIELD FJ, 1991, LIPIDS, V26, P1; Grimstad T, 2012, J NUTR SCI, V1, P1; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Harnedy PA, 2012, J FUNCT FOODS, V4, P6, DOI 10.1016/j.jff.2011.09.001; JACQUES H, 1995, CAN J CARDIOL, V11, pG63; Jung UJ, 2008, AM J CLIN NUTR, V87, p2003S, DOI 10.1093/ajcn/87.6.2003S; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kleemann R., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P441, DOI 10.2174/156800605774962077; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Murakami S, 1998, LIFE SCI, V64, P83, DOI 10.1016/S0024-3205(98)00536-0; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; Raatz SK, 2013, NUTRIENTS, V5, P1081, DOI 10.3390/nu5041081; Rein D, 2006, J NUTR, V136, P2331, DOI 10.1093/jn/136.9.2331; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; SABESIN SM, 1981, CIRCULATION, V64, P72; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; SKORVE J, 1993, J LIPID RES, V34, P1177; Strand E, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-82; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Vigerust NF, 2013, EUR J NUTR, V52, P1315, DOI 10.1007/s00394-012-0441-2; Wergedahl H, 2004, J NUTR, V134, P1320, DOI 10.1093/jn/134.6.1320; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; ZHANG XZ, 1993, BRIT J NUTR, V69, P767, DOI 10.1079/BJN19930077; Zhu CF, 2010, APPL PHYSIOL NUTR ME, V35, P797, DOI 10.1139/H10-075	39	34	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97598	10.1371/journal.pone.0097598	http://dx.doi.org/10.1371/journal.pone.0097598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840793	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600049
J	Vieira, HGS; Grynberg, P; Bitar, M; Pires, SD; Hilario, HO; Macedo, AM; Machado, CR; de Andrade, HM; Franco, GR				Santos Vieira, Helaine Graziele; Grynberg, Priscila; Bitar, Maina; Pires, Simone da Fonseca; Hilario, Heron Oliveira; Macedo, Andrea Mara; Machado, Carlos Renato; de Andrade, Helida Monteiro; Franco, Gloria Regina			Proteomic Analysis of Trypanosoma cruzi Response to Ionizing Radiation Stress	PLOS ONE			English	Article							MESSENGER-RNA; GLUTAMATE-DEHYDROGENASE; PROTEIN ABUNDANCE; GENE-EXPRESSION; AU-RICH; MECHANISMS; OXIDATION; ELEMENTS; REVEALS; DAMAGE	Trypanosoma cruzi, the causative agent of Chagas disease, is extremely resistant to ionizing radiation, enduring up to 1.5 kGy of gamma rays. Ionizing radiation can damage the DNA molecule both directly, resulting in double-strand breaks, and indirectly, as a consequence of reactive oxygen species production. After a dose of 500 Gy of gamma rays, the parasite genome is fragmented, but the chromosomal bands are restored within 48 hours. Under such conditions, cell growth arrests for up to 120 hours and the parasites resume normal growth after this period. To better understand the parasite response to ionizing radiation, we analyzed the proteome of irradiated (4, 24, and 96 hours after irradiation) and non-irradiated T. cruzi using two-dimensional differential gel electrophoresis followed by mass spectrometry for protein identification. A total of 543 spots were found to be differentially expressed, from which 215 were identified. These identified protein spots represent different isoforms of only 53 proteins. We observed a tendency for overexpression of proteins with molecular weights below predicted, indicating that these may be processed, yielding shorter polypeptides. The presence of shorter protein isoforms after irradiation suggests the occurrence of post-translational modifications and/or processing in response to gamma radiation stress. Our results also indicate that active translation is essential for the recovery of parasites from ionizing radiation damage. This study therefore reveals the peculiar response of T. cruzi to ionizing radiation, raising questions about how this organism can change its protein expression to survive such a harmful stress.	[Santos Vieira, Helaine Graziele; Grynberg, Priscila; Bitar, Maina; Hilario, Heron Oliveira; Macedo, Andrea Mara; Machado, Carlos Renato; Franco, Gloria Regina] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Pires, Simone da Fonseca; de Andrade, Helida Monteiro] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Grynberg, Priscila] Embrapa Recursos Genet & Biotecnol Brasilia, Brasilia, DF, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Franco, GR (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	gfrancoufmg@gmail.com	Grynberg, Priscila/AAX-3019-2020; Machado, Carlos Renato/H-1043-2015; MACHADO, CARLOS/AAW-1492-2020; Macedo, Andréa M/C-1506-2013; SANTOS VIEIRA, HELAINE GRAZIELE/AAE-7564-2022; Santos Vieira, Helaine Graziele/S-3236-2018	Grynberg, Priscila/0000-0003-4009-9538; Machado, Carlos Renato/0000-0002-8724-3165; SANTOS VIEIRA, HELAINE GRAZIELE/0000-0002-1114-9439; Santos Vieira, Helaine Graziele/0000-0002-1114-9439; Hilario, Heron/0000-0002-2548-1053	CNPq; FAPEMIG; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian governmental funding agencies: CNPq, FAPEMIG and CAPES. The student HGSV received a scholarship from CNPq during the course of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061795; Anitori RP, 2012, IONIZING RAD RESISTA, P25; Appukuttan D, 2006, APPL ENVIRON MICROB, V72, P7873, DOI 10.1128/AEM.01362-06; Barderi P, 1998, BIOCHEM J, V330, P951, DOI 10.1042/bj3300951; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; BENACHENHOULAHFA N, 1993, J MOL EVOL, V36, P335; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; Buckner Frederick S, 2010, Curr Opin Infect Dis, V23, P609, DOI 10.1097/QCO.0b013e3283402956; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Clayton J, 2010, NATURE, V465, pS12, DOI 10.1038/nature09224; Conte L, 2003, MOL BIOL CELL, V14, P3529, DOI 10.1091/mbc.E03-04-0228; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; Daly Michael J, 2007, PLoS Biol, V5, pe92; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Diniz LD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002367; Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Grynberg P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029596; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HUTCHINSON F, 1985, PROG NUCLEIC ACID RE, V32, P115, DOI 10.1016/S0079-6603(08)60347-5; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krisko A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012765; Krisko A, 2012, P NATL ACAD SCI USA, V109, P2354, DOI 10.1073/pnas.1119762109; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Machado FS, 2012, CARDIOL REV, V20, P53, DOI 10.1097/CRD.0b013e31823efde2; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Parodi-Talice A, 2007, J MASS SPECTROM, V42, P1422, DOI 10.1002/jms.1267; Passos-Silva DG, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/840768; Regis-Da-Silva CG, 2006, MOL BIOCHEM PARASIT, V149, P191, DOI 10.1016/j.molbiopara.2006.05.012; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Robinson CK, 2011, J BACTERIOL, V193, P1653, DOI 10.1128/JB.01310-10; Sghaier H, 2013, ANN MICROBIOL, V63, P1483, DOI 10.1007/s13213-013-0612-2; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875; Zinoviev A, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/813718	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97526	10.1371/journal.pone.0097526	http://dx.doi.org/10.1371/journal.pone.0097526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842666	Green Published, gold			2022-12-27	WOS:000340948600040
J	Pai, VJ; Wang, B; Li, XY; Wu, L; Kang, JX				Pai, Victor J.; Wang, Bin; Li, Xiangyong; Wu, Lin; Kang, Jing X.			Transgenic Mice Convert Carbohydrates to Essential Fatty Acids	PLOS ONE			English	Article							OMEGA-3; RATIO	Transgenic mice (named "Omega mice'') were engineered to carry both optimized fat-1 and fat-2 genes from the roundworm Caenorhabditis elegans and are capable of producing essential omega-6 and omega-3 fatty acids from saturated fats or carbohydrates. When maintained on a high-saturated fat diet lacking essential fatty acids or a high-carbohydrate, no-fat diet, the Omega mice exhibit high tissue levels of both omega-6 and omega-3 fatty acids, with a ratio of similar to 1:1. This study thus presents an innovative technology for the production of both omega-6 and omega-3 essential fatty acids, as well as a new animal model for understanding the true impact of fat on human health.	[Pai, Victor J.; Wang, Bin; Li, Xiangyong; Kang, Jing X.] Massachusetts Gen Hosp, Lab Lipid Med & Technol, Boston, MA 02114 USA; [Pai, Victor J.; Wang, Bin; Li, Xiangyong; Wu, Lin; Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA USA; [Wu, Lin] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Kang, JX (corresponding author), Massachusetts Gen Hosp, Lab Lipid Med & Technol, Boston, MA 02114 USA.	kang.jing@mgh.harvard.edu		Pai, Victor/0000-0001-9710-7821	Fortune Education Foundation; Sansun Life Sciences	Fortune Education Foundation; Sansun Life Sciences	This study was supported by funding from the Fortune Education Foundation and Sansun Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Institute of Medicine of the National Academies, 2002, DIET REF INT EN CARB, P335; Joint WHO/FAO Expert Consultation, 2003, WHO TECHN REP SER, V916, P81; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2007, NAT BIOTECHNOL, V25, P505, DOI 10.1038/nbt0507-505; Kang JX, 2011, WORLD REV NUTR DIET, V102, P22, DOI 10.1159/000327787; Kang JX, 2011, BIOTECHNOL ADV, V29, P388, DOI 10.1016/j.biotechadv.2011.02.003; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; LEAF A, 1987, AM J CLIN NUTR, V45, P1048, DOI 10.1093/ajcn/45.5.1048; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; VOLPE JJ, 1976, PHYSIOL REV, V56, P339, DOI 10.1152/physrev.1976.56.2.339; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799	18	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97637	10.1371/journal.pone.0097637	http://dx.doi.org/10.1371/journal.pone.0097637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836606	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800058
J	Makino, K; Jinnin, M; Aoi, J; Kajihara, I; Makino, T; Fukushima, S; Sakai, K; Nakayama, K; Emoto, N; Yanagisawa, M; Ihn, H				Makino, Katsunari; Jinnin, Masatoshi; Aoi, Jun; Kajihara, Ikko; Makino, Takamitsu; Fukushima, Satoshi; Sakai, Keisuke; Nakayama, Kazuhiko; Emoto, Noriaki; Yanagisawa, Masashi; Ihn, Hironobu			Knockout of Endothelial Cell-Derived Endothelin-1 Attenuates Skin Fibrosis but Accelerates Cutaneous Wound Healing	PLOS ONE			English	Article							BLEOMYCIN-INDUCED SCLERODERMA; GROWTH-FACTOR-BETA; SYSTEMIC-SCLEROSIS; BOSENTAN TREATMENT; BLOOD-PRESSURE; ANIMAL-MODEL; MICE; COLLAGEN; REGENERATION; REPAIR	Endothelin (ET)-1 is known for the most potent vasoconstrictive peptide that is released mainly from endothelial cells. Several studies have reported ET-1 signaling is involved in the process of wound healing or fibrosis as well as vasodilation. However, little is known about the role of ET-1 in these processes. To clarify its mechanism, we compared skin fibrogenesis and wound repair between vascular endothelial cell-specific ET-1 knockout mice and their wild-type littermates. Bleomycin-injected fibrotic skin of the knockout mice showed significantly decreased skin thickness and collagen content compared to that of wild-type mice, indicating that bleomycin-induced skin fibrosis is attenuated in the knockout mice. The mRNA levels of transforming growth factor (TGF)-beta were decreased in the bleomycin-treated skin of ET-1 knockout mice. On the other hand, skin wound healing was accelerated in ET-1 knockout mice, which was indicated by earlier granulation tissue reduction and re-epithelialization in these mice. The mRNA levels of TGF-beta, tumor necrosis factor (TNF)-alpha and connective tissue growth factor (CTGF) were reduced in the wound of ET-1 knockout mice. In endothelial ET-1 knockout mouse, the expression of TNF-alpha, CTGF and TGF-beta was down-regulated. Bosentan, an antagonist of dual ET receptors, is known to attenuate skin fibrosis and accelerate wound healing in systemic sclerosis, and such contradictory effect may be mediated by above molecules. The endothelial cell-derived ET-1 is the potent therapeutic target in fibrosis or wound healing, and investigations of the overall regulatory mechanisms of these pathological conditions by ET-1 may lead to a new therapeutic approach.	[Makino, Katsunari; Jinnin, Masatoshi; Aoi, Jun; Kajihara, Ikko; Makino, Takamitsu; Fukushima, Satoshi; Sakai, Keisuke; Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto, Japan; [Nakayama, Kazuhiko; Emoto, Noriaki] Kobe Pharmaceut Univ, Kobe, Hyogo 658, Japan; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Yanagisawa, Masashi] Univ Tsukuba, Ctr Behav Mol Genet, Tsukuba, Ibaraki, Japan	Kumamoto University; Kobe Pharmaceutical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tsukuba; University of Tsukuba	Makino, K (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto, Japan.	mjin@kumamoto-u.ac.jp		Fukushima, Satoshi/0000-0002-0622-7682; Emoto, Noriaki/0000-0001-6673-2616	Japanese Ministry of Education, Science, Sports and Culture; Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant for scientific research from the Japanese Ministry of Education, Science, Sports and Culture, and by project research on intractable diseases from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anggrahini DW, 2009, CARDIOVASC RES, V82, P143, DOI 10.1093/cvr/cvp026; Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2; Ernst C, 2006, J NEUROSCI METH, V150, P138, DOI 10.1016/j.jneumeth.2005.06.018; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Giordano N, 2010, INT J IMMUNOPATH PH, V23, P1185, DOI 10.1177/039463201002300422; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Han GW, 2011, AM J PATHOL, V179, P1768, DOI 10.1016/j.ajpath.2011.06.003; Horstmeyer A, 2005, FEBS J, V272, P6297, DOI 10.1111/j.1742-4658.2005.05016.x; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; Koch RM, 2000, WOUND REPAIR REGEN, V8, P179, DOI 10.1046/j.1524-475x.2000.00179.x; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Peng HM, 2012, PFLUG ARCH EUR J PHY, V464, P415, DOI 10.1007/s00424-012-1150-7; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; Rodriguez-Pascual F, 2003, CIRC RES, V92, P1288, DOI 10.1161/01.RES.0000078491.79697.7F; Sauter G, 2004, J CARDIOVASC PHARM, V44, pS165, DOI 10.1097/01.fjc.0000166245.28368.ae; SHAH M, 1994, J CELL SCI, V107, P1137; Simonson MS, 2011, J BIOL CHEM, V286, P11003, DOI 10.1074/jbc.M110.190793; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Tanaka C, 2010, ARTHRITIS RHEUM-US, V62, P1723, DOI 10.1002/art.27428; Watts SW, 2010, AM J PHYSIOL-REG I, V298, pR254, DOI 10.1152/ajpregu.00584.2009; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; Yamamoto T, 2006, ARCH DERMATOL RES, V297, P333, DOI 10.1007/s00403-005-0635-z; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183	36	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97972	10.1371/journal.pone.0097972	http://dx.doi.org/10.1371/journal.pone.0097972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853267	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200036
J	Hombrebueno, JR; Chen, M; Penalva, RG; Xu, HP				Hombrebueno, Jose R.; Chen, Mei; Penalva, Rosana G.; Xu, Heping			Loss of Synaptic Connectivity, Particularly in Second Order Neurons Is a Key Feature of Diabetic Retinal Neuropathy in the Ins2(Akita) Mouse	PLOS ONE			English	Article							AMACRINE CELLS; OSCILLATORY POTENTIALS; RAT; RETINOPATHY; MODEL; NEURODEGENERATION; ABNORMALITIES; INFLAMMATION; THRESHOLD; PATHOLOGY	Retinal neurodegeneration is a key component of diabetic retinopathy (DR), although the detailed neuronal damage remains ill-defined. Recent evidence suggests that in addition to amacrine and ganglion cell, diabetes may also impact on other retinal neurons. In this study, we examined retinal degenerative changes in Ins2(Akita) diabetic mice. In scotopic electroretinograms (ERG), b-wave and oscillatory potentials were severely impaired in 9-month old Ins2(Akita) mice. Despite no obvious pathology in fundoscopic examination, optical coherence tomography (OCT) revealed a progressive thinning of the retina from 3 months onwards. Cone but not rod photoreceptor loss was observed in 3-month-old diabetic mice. Severe impairment of synaptic connectivity at the outer plexiform layer (OPL) was detected in 9-month old Ins2(Akita) mice. Specifically, photoreceptor presynaptic ribbons were reduced by 25% and postsynaptic boutons by 70%, although the density of horizontal, rod- and cone-bipolar cells remained similar to non-diabetic controls. Significant reductions in GABAergic and glycinergic amacrine cells and Brn3a(+) retinal ganglion cells were also observed in 9-month old Ins2(Akita) mice. In conclusion, the Ins2(Akita) mouse develops cone photoreceptor degeneration and the impairment of synaptic connectivity at the OPL, predominately resulting from the loss of postsynaptic terminal boutons. Our findings suggest that the Ins2(Akita) mouse is a good model to study diabetic retinal neuropathy.	[Hombrebueno, Jose R.; Chen, Mei; Penalva, Rosana G.; Xu, Heping] Queens Univ, Ctr Med Expt, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Xu, HP (corresponding author), Queens Univ, Ctr Med Expt, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	heping.xu@qub.ac.uk	Xu, Heping/A-4430-2008	Xu, Heping/0000-0003-4000-931X; Romero Hombrebueno, Jose/0000-0003-1094-2977	Diabetes UK [11/0004230]	Diabetes UK(Diabetes UK)	This work was supported by Diabetes UK (11/0004230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; BLOODWORTH JMB, 1962, DIABETES, V11, P1; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen HL, 2008, DOC OPHTHALMOL, V117, P129, DOI 10.1007/s10633-008-9114-0; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061381; Gao W, 2011, J BIOMED SCI ENG, V4, P657, DOI [DOI 10.4236/JBISE.2011.410082, 10.4236/jbise.2011.410082]; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; Han ZC, 2013, INVEST OPHTH VIS SCI, V54, P574, DOI 10.1167/iovs.12-10959; Hombrebueno JR, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.2.3; Hombrebueno JR, 2010, BRAIN RES, V1321, P60, DOI 10.1016/j.brainres.2010.01.051; Ishikawa A, 1996, CURR EYE RES, V15, P63, DOI 10.3109/02713689609017612; Kamal A, 2005, BRAIN RES, V1053, P126, DOI 10.1016/j.brainres.2005.06.036; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Knott EJ, 2011, EXP EYE RES, V92, P155, DOI 10.1016/j.exer.2010.10.009; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Kurtenbach A, 2006, VISUAL NEUROSCI, P23651; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; McLenachan S, 2013, CLIN EXP OPHTHALMOL, V41, P582, DOI 10.1111/ceo.12084; Murray AR, 2013, INVEST OPHTH VIS SCI, V54, P1689, DOI 10.1167/iovs.12-10921; Ozawa Yoko, 2011, Exp Diabetes Res, V2011, P108328, DOI 10.1155/2011/108328; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Preet A, 2006, MOL CELL BIOCHEM, V289, P137, DOI 10.1007/s11010-006-9156-0; Ramsey DJ, 2006, INVEST OPHTH VIS SCI, V47, P5116, DOI 10.1167/iovs.06-0364; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; ROY MS, 1986, ARCH OPHTHALMOL-CHIC, V104, P225; Seki M, 2004, DIABETES, V53, P2412, DOI 10.2337/diabetes.53.9.2412; Smith SB, 2008, INVEST OPHTH VIS SCI, V49, P4154, DOI 10.1167/iovs.08-1824; Szabadfi K, 2012, CELL TISSUE RES, V348, P37, DOI 10.1007/s00441-012-1349-0; Tregear SJ, 1997, EYE, V11, P537, DOI 10.1038/eye.1997.140; TRICK GL, 1988, OPHTHALMOLOGY, V95, P693; Tzekov R, 1999, SURV OPHTHALMOL, V44, P53, DOI 10.1016/S0039-6257(99)00063-6; Vagaja NN, 2013, BRIT J OPHTHALMOL, V97, P1343, DOI 10.1136/bjophthalmol-2013-303201; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; WACHTMEISTER L, 1978, INVEST OPHTH VIS SCI, V17, P1176; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WOLTER JR, 1961, AM J OPHTHALMOL, V51, P1123; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Yamato T, 2004, DIABETES NUTR METAB, V17, P128; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	48	61	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97970	10.1371/journal.pone.0097970	http://dx.doi.org/10.1371/journal.pone.0097970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848689	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600073
J	Kaminski, R; Wollebo, HS; Datta, PK; White, MK; Amini, S; Khalili, K				Kaminski, Rafal; Wollebo, Hassen S.; Datta, Prasun K.; White, Martyn K.; Amini, Shohreh; Khalili, Kamel			Interplay of Rad51 with NF-kappa B Pathway Stimulates Expression of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION FACTOR; DNA-DAMAGE; BINDING PROTEIN; GENE-EXPRESSION; REL DOMAIN; IN-VITRO; ACTIVATION; CELLS	Transcription from the HIV-1 promoter is controlled by a series of ubiquitous and inducible cellular proteins with the ability to enter the nucleus and interact with the promoter. A DNA sequence spanning nucleotides -120 to -80, which supports the association of the inducible NF-kappa B transcription factor, has received much attention. Here we demonstrate that the interplay between Rad51, a key regulator of the homologous recombination pathway of DNA repair and whose level is induced upon HIV-1 infection, with the NF-kappa B pathway, augments transcription of the viral promoter. Evidently, stimulation of the NF-kappa B pathway by PMA and/or TSA promotes association of Rad51 with the LTR DNA sequence and that the p65 subunit of NF-kappa B is important for this event. Our results also demonstrate that, similar to p65, Rad51 utilizes the NF-kappa B pathway to position itself in the nucleus as ectopic expression of an I kappa B mutant impedes its nuclear appearance and transcriptional activity upon the HIV-1 LTR. Treatment of peripheral blood mononuclear cells with small molecules that inhibit Rad51 activity results in greater than 50% decrease in the HIV-1 infection of cells. These observations provide evidence for the involvement of DNA repair factors in control of HIV-1 gene activation and offer a new avenue for the development of anti-viral therapeutics that affect viral gene transcription in latently infected cells.	[Kaminski, Rafal; Wollebo, Hassen S.; Datta, Prasun K.; White, Martyn K.; Amini, Shohreh; Khalili, Kamel] Temple Univ Sch Med, Dept Neurosci, Ctr Neurovirol, Philadelphia, PA 19140 USA; [Amini, Shohreh] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Khalili, K (corresponding author), Temple Univ Sch Med, Dept Neurosci, Ctr Neurovirol, Philadelphia, PA 19140 USA.	kamel.khalili@temple.edu	Kaminski, Rafal/V-3516-2018	Kaminski, Rafal/0000-0001-8827-6658; Wollebo, Hassen/0000-0003-2285-3496; Datta, Prasun/0000-0001-5133-253X	National Institutes of Health (NIH) [R01 MH092371]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, R01MH093271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033213] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant number R01 MH092371 awarded by the National Institutes of Health (NIH) to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Benezra M, 2003, J BIOL CHEM, V278, P26333, DOI 10.1074/jbc.M303076200; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chipitsyna G, 2006, J CELL PHYSIOL, V207, P605, DOI 10.1002/jcp.20612; Chipitsyna G, 2004, ONCOGENE, V23, P2664, DOI 10.1038/sj.onc.1207417; Churchill M, 2013, CURR OPIN HIV AIDS, V8, P165, DOI 10.1097/COH.0b013e32835fc601; Cole Ruth, 1997, P117; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Cosnefroy O, 2012, J VIROL, V86, P513, DOI 10.1128/JVI.05425-11; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Featherstone C, 1999, CURR BIOL, V9, pR759, DOI 10.1016/S0960-9822(00)80005-6; Feldman I, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.033; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gorrill TS, 2005, VIROLOGY, V335, P1, DOI 10.1016/j.virol.2005.02.006; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Harte MT, 2013, ONCOGENE IN PRESS; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang F, 2012, J MED CHEM, V55, P3011, DOI 10.1021/jm201173g; Jayathilaka K, 2008, P NATL ACAD SCI USA, V105, P15848, DOI 10.1073/pnas.0808046105; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Mbonye U, 2011, CURR HIV RES, V9, P554, DOI 10.2174/157016211798998736; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; PHARES W, 1992, J VIROL, V66, P7490, DOI 10.1128/JVI.66.12.7490-7498.1992; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Raj GV, 1996, J VIROL, V70, P5944, DOI 10.1128/JVI.70.9.5944-5953.1996; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; REDDY EP, 1992, PATHOBIOLOGY, V60, P219; Rom I, 2010, CELL CYCLE, V9, P3715, DOI 10.4161/cc.9.18.12930; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Sweet T, 2003, J CELL BIOCHEM, V90, P884, DOI 10.1002/jcb.10701; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; TAYLOR JP, 1992, EMBO J, V11, P3395, DOI 10.1002/j.1460-2075.1992.tb05418.x; TAYLOR JP, 1994, ADV NEUROIMMUNOL, V4, P291, DOI 10.1016/S0960-5428(06)80270-6; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; VALERIE K, 1988, NATURE, V333, P78, DOI 10.1038/333078a0; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Volcic M, 2012, NUCLEIC ACIDS RES, V40, P181, DOI 10.1093/nar/gkr687; WALLACE BM, 1992, SCIENCE, V257, P1211, DOI 10.1126/science.1519057; Wollebo HS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-264; Wu LX, 2013, RADIAT RES, V179, P160, DOI 10.1667/RR3034.1; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Yong VW, 1997, PROTOCOLS NEURAL CEL, P117	55	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98304	10.1371/journal.pone.0098304	http://dx.doi.org/10.1371/journal.pone.0098304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847939	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600107
J	Mann, AJ; Noulin, N; Catchpole, A; Stittelaar, KJ; de Waal, L; Kroeze, EJBV; Hinchcliffe, M; Smith, A; Montomoli, E; Piccirella, S; Osterhaus, ADME; Knight, A; Oxford, JS; Lapini, G; Cox, R; Lambkin-Williams, R				Mann, Alex J.; Noulin, Nicolas; Catchpole, Andrew; Stittelaar, Koert J.; de Waal, Leon; Kroeze, Edwin J. B. Veldhuis; Hinchcliffe, Michael; Smith, Alan; Montomoli, Emanuele; Piccirella, Simona; Osterhaus, Albert D. M. E.; Knight, Alastair; Oxford, John S.; Lapini, Giulia; Cox, Rebecca; Lambkin-Williams, Rob			Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge	PLOS ONE			English	Article							IMMUNE-RESPONSES; VIRUS-INFECTION; ANIMAL-MODELS; EFFICACY; TRANSMISSION; IMMUNIZATION; IMMUNOGENICITY; HEMAGGLUTININ; PROSPECTS; MUCOSAL	We investigated the protective efficacy of two intranasal chitosan (CSN and TM-CSN) adjuvanted H5N1 Influenza vaccines against highly pathogenic avian Influenza (HPAI) intratracheal and intranasal challenge in a ferret model. Six groups of 6 ferrets were intranasally vaccinated twice, 21 days apart, with either placebo, antigen alone, CSN adjuvanted antigen, or TMCSN adjuvanted antigen. Homologous and intra-subtypic antibody cross-reacting responses were assessed. Ferrets were inoculated intratracheally (all treatments) or intranasally (CSN adjuvanted and placebo treatments only) with clade 1 HPAI A/Vietnam/1194/2004 (H5N1) virus 28 days after the second vaccination and subsequently monitored for morbidity and mortality outcomes. Clinical signs were assessed and nasal as well as throat swabs were taken daily for virology. Samples of lung tissue, nasal turbinates, brain, and olfactory bulb were analysed for the presence of virus and examined for histolopathological findings. In contrast to animals vaccinated with antigen alone, the CSN and TM-CSN adjuvanted vaccines induced high levels of antibodies, protected ferrets from death, reduced viral replication and abrogated disease after intratracheal challenge, and in the case of CSN after intranasal challenge. In particular, the TM-CSN adjuvanted vaccine was highly effective at eliciting protective immunity from intratracheal challenge; serologically, protective titres were demonstrable after one vaccination. The 2-dose schedule with TM-CSN vaccine also induced cross-reactive antibodies to clade 2.1 and 2.2 H5N1 viruses. Furthermore ferrets immunised with TM-CSN had no detectable virus in the respiratory tract or brain, whereas there were signs of virus in the throat and lungs, albeit at significantly reduced levels, in CSN vaccinated animals. This study demonstrated for the first time that CSN and in particular TM-CSN adjuvanted intranasal vaccines have the potential to protect against significant mortality and morbidity arising from infection with HPAI H5N1 virus.	[Mann, Alex J.; Noulin, Nicolas; Catchpole, Andrew; Oxford, John S.; Lambkin-Williams, Rob] Retroscreen Virol, London, England; [Stittelaar, Koert J.; de Waal, Leon; Kroeze, Edwin J. B. Veldhuis; Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands; [Hinchcliffe, Michael; Smith, Alan] Archimedes Dev Ltd, Nottingham, England; [Montomoli, Emanuele; Lapini, Giulia] Univ Siena, I-53100 Siena, Italy; [Montomoli, Emanuele; Piccirella, Simona] VisMederi LifeSci Srl, Siena, Italy; [Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Knight, Alastair] Evicom, Teddington, Middx, England; [Cox, Rebecca] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Cox, Rebecca] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway	University of Siena; Erasmus University Rotterdam; Erasmus MC; University of Bergen; University of Bergen; Haukeland University Hospital	Mann, AJ (corresponding author), Retroscreen Virol, London, England.	a.mann@retroscreen.com	MONTOMOLI, EMANUELE/Q-2122-2015; Lambkin-Williams, Rob/L-2397-2019; Lambkin-Williams, Robert/P-5963-2016	MONTOMOLI, EMANUELE/0000-0001-7595-4974; Lambkin-Williams, Rob/0000-0003-2107-0174; Lambkin-Williams, Robert/0000-0003-2107-0174; Cox, Rebecca Jane/0000-0002-8341-4078; Mann, Alexander/0000-0002-3744-4604	FP7 EU grant [202083]	FP7 EU grant	This work was supported by an FP7 EU grant (Grant Agreement number 202083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Buricchi F, 2012, EUR J IMMUNOL; CHMP, 1997, CHMPBWP21496 EMEA; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; EMEA, 2007, GUID INFL VACC PREP; Forrest HL, 2009, VACCINE, V27, P4187, DOI 10.1016/j.vaccine.2009.04.050; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Gustin KM, 2011, J INFECT DIS, V204, P1491, DOI 10.1093/infdis/jir596; Heffernan MJ, 2011, BIOMATERIALS, V32, P926, DOI 10.1016/j.biomaterials.2010.09.058; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jabbal-Gill I, 2012, EXPERT OPIN DRUG DEL, V9, P1051, DOI 10.1517/17425247.2012.697455; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Mann A, 2006, VACCINE, V24, P4290, DOI 10.1016/j.vaccine.2006.03.004; de Jong MD, 2008, PEDIATR INFECT DIS J, V27, pS54, DOI 10.1097/INF.0b013e3181684d2d; Middleton D, 2009, J VIROL, V83, P7770, DOI 10.1128/JVI.00241-09; Palmer DF, 1975, IMMUNOLOGY SERIES, V6, P25; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Rockman S, 2010, HUM VACCINES, V6, P792, DOI 10.4161/hv.6.10.12915; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sahni JK, 2008, J PHARM PHARMACOL, V60, P1111, DOI 10.1211/jpp.60.9.0001; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P43; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Stittelaar KJ, 2011, VACCINE, V29, P9265, DOI 10.1016/j.vaccine.2011.09.049; Suguitan AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021942; Svindland SC, 2012, INFLUENZA OTHER RESP, V6, P90, DOI 10.1111/j.1750-2659.2011.00271.x; van den Brand JMA, 2012, VET PATHOL, V49, P562, DOI 10.1177/0300985811429812; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, 2012, INFL HUM AN INT; WHO/PED, 2003, CUM NUMB CONF HUM CA	41	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e93761	10.1371/journal.pone.0093761	http://dx.doi.org/10.1371/journal.pone.0093761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24850536	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600003
J	Abeysekara, NS; Bhattacharyya, MK				Abeysekara, Nilwala S.; Bhattacharyya, Madan K.			Analyses of the Xylem Sap Proteomes Identified Candidate Fusarium virguliforme Proteinacious Toxins	PLOS ONE			English	Article							SUDDEN-DEATH SYNDROME; CERATO-PLATANIN; RICH PROTEINS; GLYCINE-MAX; 1ST MEMBER; SOLANI; DEFENSE; EXPRESSION; FAMILY; PURIFICATION	Background: Sudden death syndrome (SDS) caused by the ascomycete fungus, Fusarium virguliforme, exhibits root necrosis and leaf scorch or foliar SDS. The pathogen has never been identified from the above ground diseased foliar tissues. Foliar SDS is believed to be caused by host selective toxins, including FvTox1, secreted by the fungus. This study investigated if the xylem sap of F. virguliforme-infected soybean plants contains secreted F. virguliforme-proteins, some of which could cause foliar SDS development. Results: Xylem sap samples were collected from five biological replications of F. virguliforme-infected and uninfected soybean plants under controlled conditions. We identified five F. virguliforme proteins from the xylem sap of the F. virguliforme-infected soybean plants by conducting LC-ESI-MS/MS analysis. These five proteins were also present in the excreted proteome of the pathogen in culture filtrates. One of these proteins showed high sequence identity to ceratoplatanin, a phytotoxin produced by Ceratocystis fimbriata f. sp. platani to cause canker stain disease in the plane tree. Of over 500 soybean proteins identified in this study, 112 were present in at least 80% of the sap samples collected from F. virguliforme-infected and - uninfected control plants. We have identified four soybean defense proteins from the xylem sap of F. virguliforme-infected soybean plants. The data have been deposited to the ProteomeXchange with identifier PXD000873. Conclusion: This study confirms that a few F. virguliforme proteins travel through the xylem, some of which could be involved in foliar SDS development. We have identified five candidate proteinaceous toxins, one of which showed high similarity to a previously characterized phytotoxin. We have also shown the presence of four soybean defense proteins in the xylem sap of F. virguliforme-infected soybean plants. This study laid the foundation for studying the molecular basis of foliar SDS development in soybean and possible defense mechanisms that may be involved in conferring immunity against F. virguliforme and other soybean pathogens.	[Abeysekara, Nilwala S.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Abeysekara, Nilwala S.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Iowa State University; Iowa State University	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	mbhattac@iastate.edu			United Soybean Board (USB)	United Soybean Board (USB)	The authors are thankful to United Soybean Board (USB) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2008, PLANT CELL PHYSIOL, V49, P767, DOI 10.1093/pcp/pcn049; Alvarez S, 2006, J PROTEOME RES, V5, P963, DOI 10.1021/pr050471q; Anderson TR, 1998, PLANT DIS, V82, P448, DOI 10.1094/PDIS.1998.82.4.448D; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Aoki Takayuki, 2005, Mycoscience, V46, P162, DOI 10.1007/s10267-005-0235-y; Babadoost M, 1997, 512 RPD; Bernardi R, 2011, FOREST PATHOL, V41, P255, DOI 10.1111/j.1439-0329.2010.00668.x; BILES CL, 1991, PLANT PHYSIOL, V96, P597, DOI 10.1104/pp.96.2.597; Brar HK, 2012, MOL PLANT MICROBE IN, V25, P817, DOI 10.1094/MPMI-12-11-0317; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Butzen S, 2010, CROP INSIGHTS, V19, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A, 2009, BLAST2GO TUTORIAL; Dafoe NJ, 2009, PHYTOCHEMISTRY, V70, P856, DOI 10.1016/j.phytochem.2009.04.016; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Djordjevic MA, 2007, J PROTEOME RES, V6, P3771, DOI 10.1021/pr0606833; Fontana F, 2008, J PLANT PATHOL, V90, P295; Hartman GL, 1997, PLANT DIS, V81, P515, DOI 10.1094/PDIS.1997.81.5.515; Houterman PM, 2007, MOL PLANT PATHOL, V8, P215, DOI 10.1111/J.1364-3703.2007.00384.X; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ji J, 2006, PLANT BIOLOGY, V8, P597, DOI 10.1055/s-2006-924175; Jin H, 1996, PHYTOPATHOLOGY, V86, P277, DOI 10.1094/Phyto-86-277; Kav Nat N. V., 2007, Current Proteomics, V4, P28; Kehr J, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-11; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Krishnan HB, 2011, PLANTA, V233, P921, DOI 10.1007/s00425-011-1352-9; Lee J, 2006, MOL PLANT PATHOL, V7, P405, DOI 10.1111/j.1364-3703.2006.00350.x; Li S, 1999, PLANT CELL REP, V18, P375, DOI 10.1007/s002990050589; Li SX, 2000, PLANT PHYSIOL BIOCH, V38, P803, DOI 10.1016/S0981-9428(00)01180-3; Ligat L, 2011, PROTEOMICS, V11, P1798, DOI 10.1002/pmic.201000781; LIGHTFOOT DA, 2007, Patent No. 7288386; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Nakajima T, 1996, JARQ-JPN AGR RES Q, V30, P31; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2006, CELL BIOCHEM BIOPHYS, V44, P512, DOI 10.1385/CBB:44:3:512; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ploper LD, 1993, AVANCE AGROINDUSTRIA; Pos Veronika, 2005, Acta Biologica Szegediensis, V49, P31; Pudake RN, 2013, CURR GENET, DOI 10-1007/s00294-013-0392-z; Rep M, 2003, FEBS LETT, V534, P82, DOI 10.1016/S0014-5793(02)03788-2; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; ROY KW, 1989, PHYTOPATHOLOGY, V79, P191, DOI 10.1094/Phyto-79-191; RUPE JC, 1989, PLANT DIS, V73, P581, DOI 10.1094/PD-73-0581; Sakuta C, 2000, PLANT CELL PHYSIOL, V41, P627, DOI 10.1093/pcp/41.5.627; Scala A, 2004, J PLANT PATHOL, V86, P27; SCHAAF J, 1995, PLANT PHYSIOL, V108, P949, DOI 10.1104/pp.108.3.949; SELABUURLAGE MB, 1993, PLANT PHYSIOL, V101, P857, DOI 10.1104/pp.101.3.857; SIMMONS CR, 1994, CRIT REV PLANT SCI, V13, P325, DOI 10.1080/07352680490484569; Srivastava SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081832; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Subramanian S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-119; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WOLOSHUK CP, 1991, PLANT CELL, V3, P619, DOI 10.1105/tpc.3.6.619; Wrather JA, 2006, J NEMATOL, V38, P173; Wrather JA, 2011, SOYBEAN DIS LOSS EST; Zhou WC, 2006, PROTEOMICS, V6, P4599, DOI 10.1002/pmic.200600052	56	38	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e93667	10.1371/journal.pone.0093667	http://dx.doi.org/10.1371/journal.pone.0093667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845418	gold, Green Submitted, Green Published			2022-12-27	WOS:000339563400001
J	Ahtola, E; Stjerna, S; Yrttiaho, S; Nelson, CA; Leppanen, JM; Vanhatalo, S				Ahtola, Eero; Stjerna, Susanna; Yrttiaho, Santeri; Nelson, Charles A.; Leppanen, Jukka M.; Vanhatalo, Sampsa			Dynamic Eye Tracking Based Metrics for Infant Gaze Patterns in the Face-Distractor Competition Paradigm	PLOS ONE			English	Article							FEARFUL FACES; ATTENTION DISENGAGEMENT; VISUAL-ATTENTION; CHILDREN; DURATION; LOOKING; BIAS	Objective: To develop new standardized eye tracking based measures and metrics for infants' gaze dynamics in the face-distractor competition paradigm. Method: Eye tracking data were collected from two samples of healthy 7-month-old (total n = 45), as well as one sample of 5-month-old infants (n = 22) in a paradigm with a picture of a face or a non-face pattern as a central stimulus, and a geometric shape as a lateral stimulus. The data were analyzed by using conventional measures of infants' initial disengagement from the central to the lateral stimulus (i.e., saccadic reaction time and probability) and, additionally, novel measures reflecting infants gaze dynamics after the initial disengagement (i.e., cumulative allocation of attention to the central vs. peripheral stimulus). Results: The results showed that the initial saccade away from the centrally presented stimulus is followed by a rapid re-engagement of attention with the central stimulus, leading to cumulative preference for the central stimulus over the lateral stimulus over time. This pattern tended to be stronger for salient facial expressions as compared to non-face patterns, was replicable across two independent samples of 7-month-old infants, and differentiated between 7 and 5 month-old infants. Conclusion: The results suggest that eye tracking based assessments of infants' cumulative preference for faces over time can be readily parameterized and standardized, and may provide valuable techniques for future studies examining normative developmental changes in preference for social signals. Significance: Standardized measures of early developing face preferences may have potential to become surrogate biomarkers of neurocognitive and social development.	[Ahtola, Eero; Stjerna, Susanna; Vanhatalo, Sampsa] Univ Helsinki, Cent Hosp, Dept Childrens Clin Neurophysiol, Helsinki, Finland; [Ahtola, Eero] Aalto Univ, Dept Biomed Engn & Computat Sci, Helsinki, Finland; [Yrttiaho, Santeri; Leppanen, Jukka M.] Univ Tampere, Infant Cognit Lab, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Nelson, Charles A.] Childrens Hosp, Labs Cognit Neurosci, Boston, MA 02115 USA; [Nelson, Charles A.] Harvard Univ, Sch Med, Boston, MA USA; [Vanhatalo, Sampsa] Univ Helsinki, Dept Neurol Sci, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Aalto University; Tampere University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Helsinki	Ahtola, E (corresponding author), Univ Helsinki, Cent Hosp, Dept Childrens Clin Neurophysiol, Helsinki, Finland.	eero.ahtola@hus.fi		Yrttiaho, Santeri/0000-0002-5724-1222	Helsinki University Hospital; Juselius Foundation; Paivi and Sakari Sohlberg Foundation; Academy of Finland [218284]; European Community [FP7-PEOPLE-2009-IOF, 254235, 283763]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078829] Funding Source: NIH RePORTER	Helsinki University Hospital; Juselius Foundation; Paivi and Sakari Sohlberg Foundation; Academy of Finland(Academy of Finland); European Community(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Helsinki University Hospital, Juselius Foundation, Paivi and Sakari Sohlberg Foundation, Academy of Finland (#218284 and 218284), as well as the European Community's Seventh Framework Programme (FP7-PEOPLE-2009-IOF, grant agreements #254235 and #283763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLIN RN, 1975, PERCEPT PSYCHOPHYS, V17, P293, DOI 10.3758/BF03203214; Blaga OA, 2006, DEV PSYCHOL, V42, P1069, DOI 10.1037/0012-1649.42.6.1069; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Chawarska K, 2010, ARCH GEN PSYCHIAT, V67, P178, DOI 10.1001/archgenpsychiatry.2009.194; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Csibra G, 1998, INT J PSYCHOPHYSIOL, V29, P201, DOI 10.1016/S0167-8760(98)00016-6; Eastwood JD, 2008, VIS COGN, V16, P248, DOI 10.1080/13506280701434383; Elsabbagh M, 2009, J CHILD PSYCHOL PSYC, V50, P637, DOI 10.1111/j.1469-7610.2008.02051.x; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Forssman L, 2013, J CHILD PSYCHOL PSYC; Frank MC, 2012, INFANCY, V17, P355, DOI 10.1111/j.1532-7078.2011.00086.x; Frank MC, 2009, COGNITION, V110, P160, DOI 10.1016/j.cognition.2008.11.010; Frischen A, 2008, PSYCHOL BULL, V134, P662, DOI 10.1037/0033-2909.134.5.662; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Green CR, 2009, EUR J NEUROSCI, V29, P1302, DOI 10.1111/j.1460-9568.2009.06668.x; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Holmboe K, 2008, J EXP CHILD PSYCHOL, V100, P89, DOI 10.1016/j.jecp.2007.09.004; Hunnius S, 2006, INFANT BEHAV DEV, V29, P108, DOI 10.1016/j.infbeh.2005.08.007; Hunnius S, 2007, PROG BRAIN RES, V164, P187, DOI 10.1016/S0079-6123(07)64010-2; Hunnius S, 2008, DEV NEUROPSYCHOL, V33, P521, DOI 10.1080/87565640802101508; Isler JR, 2012, DEVELOPMENTAL SCI, V15, P260, DOI 10.1111/j.1467-7687.2011.01122.x; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; JOHNSON MH, 1991, J COGNITIVE NEUROSCI, V3, P335, DOI 10.1162/jocn.1991.3.4.335; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Leppanen JM, BEHAV RES METHODS; Leppanen J, 2010, INT J BEHAV DEV, V34, P547, DOI 10.1177/0165025410365804; Leppanen JM, 2011, J CHILD PSYCHOL PSYC, V52, P1144, DOI 10.1111/j.1469-7610.2011.02391.x; Matsuzawa M, 1997, INFANT BEHAV DEV, V20, P449, DOI 10.1016/S0163-6383(97)90035-7; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; Morgante JD, 2012, INFANCY, V17, P9, DOI 10.1111/j.1532-7078.2011.00089.x; Nakano T, 2010, P ROY SOC B-BIOL SCI, V277, P2935, DOI 10.1098/rspb.2010.0587; Peltola MJ, 2008, DEVELOPMENTAL SCI, V11, P60, DOI 10.1111/j.1467-7687.2007.00659.x; Peltola MJ, 2013, INFANCY, V18, P905, DOI 10.1111/infa.12013; Peltola MJ, 2011, PSYCHOPHYSIOLOGY, V48, P1291, DOI 10.1111/j.1469-8986.2011.01188.x; Peltola MJ, 2009, EMOTION, V9, P560, DOI 10.1037/a0015806; Perez-Edgar K, 2010, DEV PSYCHOL, V46, P1723, DOI 10.1037/a0021064; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Richmond J, 2009, DEVELOPMENTAL SCI, V12, P549, DOI 10.1111/j.1467-7687.2009.00795.x; Ro T, 2007, VIS COGN, V15, P322, DOI 10.1080/13506280600590434; Shic F, 2008, WASH DC 30 ANN M COG; Shic F, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P111, DOI 10.1145/1344471.1344500; Stjerna S, 2012, JOVE-J VIS EXP, DOI 10.3791/3774; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Wass SV, 2013, BEHAV RES METHODS, V45, P229, DOI 10.3758/s13428-012-0245-6; Wass S, 2011, CURR BIOL, V21, P1543, DOI 10.1016/j.cub.2011.08.004	45	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97299	10.1371/journal.pone.0097299	http://dx.doi.org/10.1371/journal.pone.0097299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24845102	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400019
J	Hasan, NA; Young, BA; Minard-Smith, AT; Saeed, K; Li, H; Heizer, EM; McMillan, NJ; Isom, R; Abdullah, AS; Bornman, DM; Faith, SA; Choi, SY; Dickens, ML; Cebula, TA; Colwell, RR				Hasan, Nur A.; Young, Brian A.; Minard-Smith, Angela T.; Saeed, Kelly; Li, Huai; Heizer, Esley M.; McMillan, Nancy J.; Isom, Richard; Abdullah, Abdul Shakur; Bornman, Daniel M.; Faith, Seth A.; Choi, Seon Young; Dickens, Michael L.; Cebula, Thomas A.; Colwell, Rita R.			Microbial Community Profiling of Human Saliva Using Shotgun Metagenomic Sequencing	PLOS ONE			English	Article							PERIODONTAL-DISEASE; HAEMOPHILUS-PARAINFLUENZAE; SUBGINGIVAL PLAQUE; ORAL MICROBIOME; DIVERSITY; BACTERIAL; HEALTH; RISK; ENDOCARDITIS; INFLAMMATION	Human saliva is clinically informative of both oral and general health. Since next generation shotgun sequencing (NGS) is now widely used to identify and quantify bacteria, we investigated the bacterial flora of saliva microbiomes of two healthy volunteers and five datasets from the Human Microbiome Project, along with a control dataset containing short NGS reads from bacterial species representative of the bacterial flora of human saliva. GENIUS, a system designed to identify and quantify bacterial species using unassembled short NGS reads was used to identify the bacterial species comprising the microbiomes of the saliva samples and datasets. Results, achieved within minutes and at greater than 90% accuracy, showed more than 175 bacterial species comprised the bacterial flora of human saliva, including bacteria known to be commensal human flora but also Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, and Gamma proteobacteria. Basic Local Alignment Search Tool (BLASTn) analysis in parallel, reported ca. five times more species than those actually comprising the in silico sample. Both GENIUSand BLAST analyses of saliva samples identified major genera comprising the bacterial flora of saliva, but GENIUS provided a more precise description of species composition, identifying to strain in most cases and delivered results at least 10,000 times faster. Therefore, GENIUS offers a facile and accurate system for identification and quantification of bacterial species and/or strains in metagenomic samples.	[Hasan, Nur A.; Saeed, Kelly; Li, Huai; Isom, Richard; Abdullah, Abdul Shakur; Choi, Seon Young; Cebula, Thomas A.; Colwell, Rita R.] CosmosID, College Pk, MD 20742 USA; [Hasan, Nur A.; Choi, Seon Young; Colwell, Rita R.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Young, Brian A.; Minard-Smith, Angela T.; Heizer, Esley M.; McMillan, Nancy J.; Bornman, Daniel M.; Faith, Seth A.; Dickens, Michael L.] Battelle Mem Inst, Columbus, OH USA; [Cebula, Thomas A.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Colwell, Rita R.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Colwell, Rita R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; Battelle Memorial Institute; Johns Hopkins University; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Colwell, RR (corresponding author), CosmosID, College Pk, MD 20742 USA.	rcolwell@umiacs.umd.edu	hasan, nur a/AAX-3881-2021	hasan, nur a/0000-0003-0175-8879; Faith, Seth/0000-0002-0441-9859; Colwell, Rita R./0000-0001-5432-1502	NIH [1RO1A139129-01, 2RO1A1039129-11A2]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study was provided, in part, by NIH Grants 1RO1A139129-01 and 2RO1A1039129-11A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano S, 2008, J DENT RES, V87, P334, DOI 10.1177/154405910808700418; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Buduneli N, 2005, J CLIN PERIODONTOL, V32, P174, DOI 10.1111/j.1600-051X.2005.00670.x; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; França Alex Vianey Callado, 2004, Arq. Gastroenterol., V41, P199, DOI 10.1590/S0004-28032004000300012; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Garrity GM, 2009, STAND GENOMIC SCI, V1, P78, DOI 10.4056/sigs.1491; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779; Gonzalez Antonio, 2011, Dialogues Clin Neurosci, V13, P55; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Hu S, 2007, EXPERT REV PROTEOMIC, V4, P531, DOI 10.1586/14789450.4.4.531; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kinane D F, 2000, Ann R Australas Coll Dent Surg, V15, P42; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lazarevic V, 2010, J INTEGRATED OMICS, V1, P28; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; LYNN DJ, 1977, MEDICINE, V56, P115, DOI 10.1097/00005792-197703000-00003; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Marcotte H, 1998, MICROBIOL MOL BIOL R, V62, P71, DOI 10.1128/MMBR.62.1.71-109.1998; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036427; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Michalowicz BS, 2000, J PERIODONTOL, V71, P1699, DOI 10.1902/jop.2000.71.11.1699; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pai RK, 2004, PACE, V27, P1008, DOI 10.1111/j.1540-8159.2004.00575.x; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Parahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P46, DOI 10.1128/CMR.00028-08; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Roda RP, 2008, MED ORAL PATOL ORAL, V13, pE355; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ratnayake Lasantha, 2011, J Med Case Rep, V5, P448, DOI 10.1186/1752-1947-5-448; Refulio Z, 2013, J PERIODONTAL IMPLAN, V43, P96, DOI 10.5051/jpis.2013.43.2.96; Saremi A, 2005, DIABETES CARE, V28, P27, DOI 10.2337/diacare.28.1.27; Schiff E, 2003, J CLIN GASTROENTEROL, V36, P369, DOI 10.1097/00004836-200304000-00020; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Slots J, 2011, PERIODONTOL 2000, V55, P48, DOI 10.1111/j.1600-0757.2010.00361.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1987, J CLIN PERIODONTOL, V14, P588, DOI 10.1111/j.1600-051X.1987.tb01520.x; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Watanabe T, 1998, FEMS IMMUNOL MED MIC, V22, P241, DOI 10.1111/j.1574-695X.1998.tb01212.x; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749; Yamamoto ML, 2013, CANCER RES, V73, P4222, DOI 10.1158/0008-5472.CAN-13-0022; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Young EA, 2000, BIOL PSYCHIAT, V48, P70, DOI 10.1016/S0006-3223(00)00842-8; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	73	83	88	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97699	10.1371/journal.pone.0097699	http://dx.doi.org/10.1371/journal.pone.0097699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846174	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400046
J	Luo, HJ; Deng, WQ; Zou, K				Luo, Hua-Jun; Deng, Wei-Qiao; Zou, Kun			Protonated Form: The Potent Form of Potassium-Competitive Acid Blockers	PLOS ONE			English	Article							GASTRIC H,K ATPASE; PUMP INHIBITORS; H,K-ATPASE; MECHANISM; VESICLES; GENERATION; MANAGEMENT; SORAPRAZAN; TRANSPORT; TAK-438	Potassium-competitive acid blockers (P-CABs) are highly safe and active drugs targeting H+,K+-ATPase to cure acid-related gastric diseases. In this study, we for the first time investigate the interaction mechanism between the protonated form of P-CABs and human H+,K+-ATPase using homology modeling, molecular docking, molecular dynamics and binding free energy calculation methods. The results explain why P-CABs have higher activities with higher pKa values or at lower pH. With positive charge, the protonated forms of P-CABs have more competitive advantage to block potassium ion into luminal channel and to bind with H+,K+-ATPase via electrostatic interactions. The binding affinity of the protonated form is more favorable than that of the neutral P-CABs. In particular, Asp139 should be a very important binding site for the protonated form of P-CABs through hydrogen bonds and electrostatic interactions. These findings could promote the rational design of novel P-CABs.	[Luo, Hua-Jun; Deng, Wei-Qiao; Zou, Kun] China Three Gorges Univ, Coll Chem & Life Sci, Hubei Key Lab Nat Prod Res & Dev, Yichang, Hubei, Peoples R China; [Deng, Wei-Qiao] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Liaoning, Peoples R China	China Three Gorges University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Zou, K (corresponding author), China Three Gorges Univ, Coll Chem & Life Sci, Hubei Key Lab Nat Prod Res & Dev, Yichang, Hubei, Peoples R China.	kzou_ctgu@163.com	Deng, Wei-Qiao/AAB-6502-2020	Deng, Wei-Qiao/0000-0002-3671-5951				Abe K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1154; Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson K, 2005, PHARMACOL THERAPEUT, V108, P294, DOI 10.1016/j.pharmthera.2005.05.005; [Anonymous], 2013, ACD I LAB VERS 12 01; [Anonymous], 2012, DESM MOL DYN SYST VE; [Anonymous], 2010, GLID VERS 5 6; [Anonymous], 2012, MAESTR VERS 9 3; [Anonymous], 2010, LIGPREP VERS 2 4; Arikawa Y, 2012, J MED CHEM, V55, P4446, DOI 10.1021/jm300318t; Asano S, 1997, J BIOL CHEM, V272, P17668, DOI 10.1074/jbc.272.28.17668; BEIL W, 1986, BRIT J PHARMACOL, V88, P19, DOI 10.1111/j.1476-5381.1986.tb09466.x; BELL NJV, 1992, DIGESTION, V51, P59, DOI 10.1159/000200917; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bytzer P, 2003, AM J GASTROENTEROL, V98, pS31, DOI 10.1016/S0002-9270(03)00013-3; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dent J, 2008, AM J GASTROENTEROL, V103, P20, DOI 10.1111/j.1572-0241.2007.01544.x; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gedda K, 2007, BIOCHEM PHARMACOL, V73, P198, DOI 10.1016/j.bcp.2006.09.020; HALL K, 1990, BIOCHEMISTRY-US, V29, P701, DOI 10.1021/bi00455a016; Hori Y, 2010, J PHARMACOL EXP THER, V335, P231, DOI 10.1124/jpet.110.170274; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jain KS, 2007, BIOORGAN MED CHEM, V15, P1181, DOI 10.1016/j.bmc.2006.07.068; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE J, 1974, BIOCHEM BIOPH RES CO, V60, P825, DOI 10.1016/0006-291X(74)90315-5; Lee JW, 1998, Pyrimidine derivatives and processes for the preparation thereof, Patent No. [US005750531A, 005750531]; Li H, 2013, EXPERT OPIN THER PAT, V23, P99, DOI 10.1517/13543776.2013.741121; Li W, 2011, INT J PHARMACEUT, V408, P157, DOI 10.1016/j.ijpharm.2011.01.059; MAEDA M, 1990, J BIOL CHEM, V265, P9027; MAEDA M, 1988, BIOCHEM BIOPH RES CO, V157, P203, DOI 10.1016/S0006-291X(88)80033-0; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matsukawa J, 2011, BIOCHEM PHARMACOL, V81, P1145, DOI 10.1016/j.bcp.2011.02.009; MUNSON KB, 1991, J BIOL CHEM, V266, P18976; Munson K, 2007, BIOCHEMISTRY-US, V46, P5398, DOI 10.1021/bi062305h; Murphy RB, 2000, J COMPUT CHEM, V21, P1442, DOI 10.1002/1096-987X(200012)21:16<1442::AID-JCC3>3.0.CO;2-O; Philipp DM, 1999, J COMPUT CHEM, V20, P1468, DOI 10.1002/(SICI)1096-987X(19991115)20:14<1468::AID-JCC2>3.0.CO;2-0; Robinson M, 2002, PHARM THER J, V27, P202; Sachs G, 2006, ALIMENT PHARM THERAP, V23, P2, DOI 10.1111/j.1365-2036.2006.02943.x; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarpignato C., 2007, DRUG DISCOV TODAY, V4, P155; Scarpignato C, 2008, CURR OPIN PHARMACOL, V8, P677, DOI 10.1016/j.coph.2008.09.004; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Schrodinger LLC, 2010, MACROMODEL VERS 9 8; SCOTT CK, 1987, BIOCHEM PHARMACOL, V36, P97, DOI 10.1016/0006-2952(87)90386-8; Senn-Bilfinger J, 2006, TETRAHEDRON LETT, V47, P3321, DOI 10.1016/j.tetlet.2006.02.156; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shin JM, 2006, DIGEST DIS SCI, V51, P823, DOI 10.1007/s10620-005-9042-8; Shin JM, 2011, J PHARMACOL EXP THER, V339, P412, DOI 10.1124/jpet.111.185314; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Simon WA, 2007, J PHARMACOL EXP THER, V321, P866, DOI 10.1124/jpet.107.120428; Vagin O, 2002, BIOCHEMISTRY-US, V41, P12755, DOI 10.1021/bi025921w; Vagin O, 2001, BIOCHEMISTRY-US, V40, P7480, DOI 10.1021/bi0105328; WOLOSIN JM, 1985, AM J PHYSIOL, V248, pG595, DOI 10.1152/ajpgi.1985.248.6.G595; Yoon YA, 2010, BIOORG MED CHEM LETT, V20, P5735, DOI 10.1016/j.bmcl.2010.08.007	60	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97688	10.1371/journal.pone.0097688	http://dx.doi.org/10.1371/journal.pone.0097688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845980	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400044
J	Paul, P; Simm, S; Mirus, O; Scharf, KD; Fragkostefanakis, S; Schleiff, E				Paul, Puneet; Simm, Stefan; Mirus, Oliver; Scharf, Klaus-Dieter; Fragkostefanakis, Sotirios; Schleiff, Enrico			The Complexity of Vesicle Transport Factors in Plants Examined by Orthology Search	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEIN; CLATHRIN-ASSOCIATED PROTEINS; ARABIDOPSIS POLLEN TUBES; PLASMA-MEMBRANE PROTEINS; AP-3 ADAPTER COMPLEX; RING FINGER PROTEIN; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; GOLGI-APPARATUS	Vesicle transport is a central process to ensure protein and lipid distribution in eukaryotic cells. The current knowledge on the molecular components and mechanisms of this process is majorly based on studies in Saccharomyces cerevisiae and Arabidopsis thaliana, which revealed 240 different proteinaceous factors either experimentally proven or predicted to be involved in vesicle transport. In here, we performed an orthologue search using two different algorithms to identify the components of the secretory pathway in yeast and 14 plant genomes by using the 'core-set' of 240 factors as bait. We identified 4021 orthologues and (co-) orthologues in the discussed plant species accounting for components of COP-II, COP-I, Clathrin Coated Vesicles, Retromers and ESCRTs, Rab GTPases, Tethering factors and SNAREs. In plants, we observed a significantly higher number of (co-) orthologues than yeast, while only 8 tethering factors from yeast seem to be absent in the analyzed plant genomes. To link the identified (co-) orthologues to vesicle transport, the domain architecture of the proteins from yeast, genetic model plant A. thaliana and agriculturally relevant crop Solanum lycopersicum has been inspected. For the orthologous groups containing (co-) orthologues from yeast, A. thaliana and S. lycopersicum, we observed the same domain architecture for 79% (416/527) of the (co-) orthologues, which documents a very high conservation of this process. Further, publically available tissue-specific expression profiles for a subset of (co-) orthologues found in A. thaliana and S. lycopersicum suggest that some (co-) orthologues are involved in tissue-specific functions. Inspection of localization of the (co-) orthologues based on available proteome data or localization predictions lead to the assignment of plastid-as well as mitochondrial localized (co-) orthologues of vesicle transport factors and the relevance of this is discussed.	[Paul, Puneet; Simm, Stefan; Mirus, Oliver; Scharf, Klaus-Dieter; Fragkostefanakis, Sotirios; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60054 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Cluster Excellence Frankfurt, D-60054 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60054 Frankfurt, Germany.	Schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017; Simm, Stefan/AAX-4991-2020; Fragkostefanakis, Sotirios/AFR-5656-2022; Paul, Puneet/ABC-6326-2020	Schleiff, Enrico/0000-0002-0518-3489; Fragkostefanakis, Sotirios/0000-0001-5311-7868; Paul, Puneet/0000-0001-8220-8021	Deutsche Forschungsgemeinschaft [SFB807-P17]; SPOT-ITN/Marie Curie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SPOT-ITN/Marie Curie	The work was supported by grants from the Deutsche Forschungsgemeinschaft SFB807-P17 to ES and from SPOT-ITN/Marie Curie to ES and KDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Aker J, 2006, J STRUCT BIOL, V156, P62, DOI 10.1016/j.jsb.2006.03.004; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; ANAI T, 1991, GENE, V108, P259, DOI 10.1016/0378-1119(91)90442-E; Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Anders N, 2008, PLANT CELL, V20, P142, DOI 10.1105/tpc.107.056515; Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Andersson MX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-40; Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; ANUNTALABHOCHAI S, 1991, PLANT J, V1, P167, DOI 10.1111/j.1365-313X.1991.00167.x; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Asaoka R., 2012, PLANT J; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; BARLOWE C, 1993, J BIOL CHEM, V268, P873; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; BarPeled M, 1997, PLANT PHYSIOL, V114, P315, DOI 10.1104/pp.114.1.315; BARPELED M, 1995, PLANT CELL, V7, P667, DOI 10.1105/tpc.7.6.667; Barth M, 2004, J CELL SCI, V117, P2051, DOI 10.1242/jcs.01062; Bassham DC, 1998, PLANT PHYSIOL, V117, P407, DOI 10.1104/pp.117.2.407; BASSHAM DC, 1995, P NATL ACAD SCI USA, V92, P7262, DOI 10.1073/pnas.92.16.7262; Bassham Diane C, 2008, Arabidopsis Book, V6, pe0116, DOI 10.1199/tab.0116; Batoko H, 2001, CURR BIOL, V11, pR423, DOI 10.1016/S0960-9822(01)00251-2; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Belles-Boix E, 2000, J EXP BOT, V51, P1761, DOI 10.1093/jexbot/51.351.1761; Ben-Menachem R, 2011, PROTEOMICS, V11, P4468, DOI 10.1002/pmic.201100199; Bergmann DC, 2001, TRENDS PLANT SCI, V6, P235, DOI 10.1016/S1360-1385(01)01959-8; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Borghese R, 2004, APPL ENVIRON MICROB, V70, P6595, DOI 10.1128/AEM.70.11.6595-6602.2004; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cai Y, 2012, TRAFFIC, V13, P1023, DOI 10.1111/j.1600-0854.2012.01360.x; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Chatre L, 2005, PLANT PHYSIOL, V139, P1244, DOI 10.1104/pp.105.067447; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Chen Y, 2005, J MOL BIOL, V350, P92, DOI 10.1016/j.jmb.2005.04.061; Chong YT, 2010, NEW PHYTOL, V185, P401, DOI 10.1111/j.1469-8137.2009.03070.x; Chow CM, 2008, PLANT CELL, V20, P101, DOI 10.1105/tpc.107.052001; Coe JGS, 1999, MOL BIOL CELL, V10, P2407, DOI 10.1091/mbc.10.7.2407; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065; Cosson P, 1996, EMBO J, V15, P1792, DOI 10.1002/j.1460-2075.1996.tb00528.x; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Du SY, 2012, PLANT MOL BIOL, V80, P519, DOI 10.1007/s11103-012-9965-3; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; Ebersberger I, 2013, NUCL ACIDS RES; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enami K, 2009, PLANT CELL PHYSIOL, V50, P280, DOI 10.1093/pcp/pcn197; ESPENSHADE P, 1995, J CELL BIOL, V131, P311, DOI 10.1083/jcb.131.2.311; Faso C, 2009, PLANT CELL, V21, P3655, DOI 10.1105/tpc.109.068262; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Feraru E, 2012, PLANT CELL, V24, P3074, DOI 10.1105/tpc.112.098152; Feraru E, 2010, PLANT CELL, V22, P2812, DOI 10.1105/tpc.110.075424; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Franco-Zorrilla JM, 2002, PLANT PHYSIOL, V128, P418, DOI 10.1104/pp.010323; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Garcia C, 2010, PLANT J, V63, P73, DOI 10.1111/j.1365-313X.2010.04225.x; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gebbie LK, 2005, J EXP BOT, V56, P1079, DOI 10.1093/jxb/eri099; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; GERICH B, 1995, P NATL ACAD SCI USA, V92, P3229, DOI 10.1073/pnas.92.8.3229; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; GIMENO RE, 1995, J CELL BIOL, V131, P325, DOI 10.1083/jcb.131.2.325; GRIFF IC, 1992, J BIOL CHEM, V267, P12106; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Guermonprez H, 2008, J EXP BOT, V59, P3087, DOI 10.1093/jxb/ern162; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Haffani YZ, 2006, PLANT SIGNAL BEHAV, V1, P251, DOI 10.4161/psb.1.5.3324; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; Halachmi N, 1996, J NEUROCHEM, V66, P889; Hanson PI, 2000, NAT STRUCT BIOL, V7, P347, DOI 10.1038/75103; Hanton SL, 2008, PLANT MOL BIOL, V67, P283, DOI 10.1007/s11103-008-9317-5; Happel N, 2004, PLANT J, V37, P678, DOI 10.1111/j.1365-313X.2003.01995.x; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hashiguchi Y, 2010, PLANT CELL, V22, P159, DOI 10.1105/tpc.109.069294; Hashimoto K, 2008, J EXP BOT, V59, P3523, DOI 10.1093/jxb/ern202; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Huang CF, 1999, J BIOL CHEM, V274, P3819, DOI 10.1074/jbc.274.6.3819; Hummel M, 2012, PROTEOMICS, V12, P1024, DOI 10.1002/pmic.201100413; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Hwang I, 2009, CURR OPIN PLANT BIOL, V12, P660, DOI 10.1016/j.pbi.2009.09.012; Ibl V, 2012, J PROTEOME RES, V11, P397, DOI 10.1021/pr200845n; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishikawa T, 2005, J GEN APPL MICROBIOL, V51, P73, DOI 10.2323/jgam.51.73; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jaillais Y, 2007, CELL, V130, P1057, DOI 10.1016/j.cell.2007.08.040; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jia DJ, 2009, J INTEGR PLANT BIOL, V51, P762, DOI 10.1111/j.1744-7909.2009.00858.x; Jiang DH, 2009, PLANT CELL, V21, P1733, DOI 10.1105/tpc.109.067967; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Johansen JN, 2009, J EXP BOT, V60, P3179, DOI 10.1093/jxb/erp153; Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049; Kato N, 2010, PLANT PHYSIOL, V152, P590, DOI 10.1104/pp.109.148700; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Khan NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059898; Kirasak K, 2010, PROTOPLASMA, V241, P51, DOI 10.1007/s00709-010-0105-0; KIRCHHAUSEN T, 1991, J BIOL CHEM, V266, P11153; Kitakura S, 2011, PLANT CELL, V23, P1920, DOI 10.1105/tpc.111.083030; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Koh EJ, 2009, PLANT MOL BIOL, V70, P113, DOI 10.1007/s11103-009-9460-7; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kosodo Y, 2003, BIOSCI BIOTECH BIOCH, V67, P448, DOI 10.1271/bbb.67.448; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Kwon SI, 2010, PLANT J, V64, P151, DOI 10.1111/j.1365-313X.2010.04315.x; Lam SK, 2011, P NATL ACAD SCI USA, V108, pE51, DOI 10.1073/pnas.1103526108; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Latijnhouwers M, 2005, CURR OPIN PLANT BIOL, V8, P632, DOI 10.1016/j.pbi.2005.09.014; Latijnhouwers M, 2007, J EXP BOT, V58, P4373, DOI 10.1093/jxb/erm304; LEBAS M, 1994, PLANT PHYSIOL, V106, P809, DOI 10.1104/pp.106.2.809; Lee FJS, 1997, J BIOL CHEM, V272, P30998, DOI 10.1074/jbc.272.49.30998; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; Leshem Y, 2010, J EXP BOT, V61, P2615, DOI 10.1093/jxb/erq099; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Li LX, 2013, PLANT J, V76, P781, DOI 10.1111/tpj.12347; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Lobstein E, 2004, PLANT PHYSIOL, V135, P1480, DOI 10.1104/pp.103.037747; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; Luo YJ, 2013, PLANT J, V75, P377, DOI 10.1111/tpj.12207; Lupas A, 1997, CURR OPIN STRUC BIOL, V7, P388, DOI 10.1016/S0959-440X(97)80056-5; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; Maldonado-Mendoza IE, 1997, PLANT MOL BIOL, V35, P865, DOI 10.1023/A:1005923829224; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Mehrshahi P, 2013, P NATL ACAD SCI USA, V110, P12126, DOI 10.1073/pnas.1306331110; Meiling-Wesse K, 2005, J BIOL CHEM, V280, P33669, DOI 10.1074/jbc.M501701200; Meyer D, 2009, PLANT J, V57, P986, DOI 10.1111/j.1365-313X.2008.03743.x; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mitra SK, 2009, J PROTEOME RES, V8, P2752, DOI 10.1021/pr801044y; Morsomme P, 2002, DEV CELL, V2, P307, DOI 10.1016/S1534-5807(02)00133-8; Mulkidjanian AY, 2005, BIOCHEMISTRY-MOSCOW+, V70, P251, DOI 10.1007/s10541-005-0108-1; NAKAJIMA H, 1991, J CELL BIOL, V113, P245, DOI 10.1083/jcb.113.2.245; Nakamura N, 1997, J BIOL CHEM, V272, P11344; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Nakano RT, 2009, PLANT CELL, V21, P3672, DOI 10.1105/tpc.109.068270; NAKAYAMA Y, 1991, EUR J BIOCHEM, V202, P569, DOI 10.1111/j.1432-1033.1991.tb16409.x; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; NEHRBASS U, 1990, CELL, V61, P979, DOI 10.1016/0092-8674(90)90063-K; Niihama M, 2005, CURR BIOL, V15, P555, DOI 10.1016/j.cub.2005.02.021; Nodzynski T, 2013, MOL PLANT, V6, P1849, DOI 10.1093/mp/sst044; Nothwehr SF, 1997, J CELL SCI, V110, P1063; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Orci L, 2000, P NATL ACAD SCI USA, V97, P10400, DOI 10.1073/pnas.190292497; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; Paul P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-189; Peng JL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-25; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; PHAN HL, 1994, EMBO J, V13, P1706, DOI 10.1002/j.1460-2075.1994.tb06435.x; PIPER RC, 1994, EUR J CELL BIOL, V65, P305; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; RAD MR, 1995, J CELL SCI, V108, P1605; Ram RJ, 2002, MOL BIOL CELL, V13, P1484, DOI 10.1091/mbc.01-10-0495; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Renna L, 2005, PLANT MOL BIOL, V58, P109, DOI 10.1007/s11103-005-4618-4; Reyes FC, 2011, CURR OPIN PLANT BIOL, V14, P666, DOI 10.1016/j.pbi.2011.07.009; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Robinson DG, 2007, CRIT REV PLANT SCI, V26, P199, DOI 10.1080/07352680701495820; Robinson DG, 2011, PLANT CELL, V23, P846, DOI 10.1105/tpc.110.082099; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rojo E, 2003, MOL BIOL CELL, V14, P361, DOI 10.1091/mbc.E02-08-0509; Rojo E, 2001, DEV CELL, V1, P303, DOI 10.1016/S1534-5807(01)00024-7; ROSSI G, 1995, MOL BIOL CELL, V6, P1769, DOI 10.1091/mbc.6.12.1769; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Sanderfoot AA, 1998, P NATL ACAD SCI USA, V95, P9920, DOI 10.1073/pnas.95.17.9920; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Scheele U, 2002, FEBS LETT, V514, P355, DOI 10.1016/S0014-5793(02)02439-0; Scheuring D, 2011, PLANT CELL, V23, P3463, DOI 10.1105/tpc.111.086918; Schiller M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-123; SCHIMMOLLER F, 1993, J CELL SCI, V106, P823; Schlueter JA, 2008, J HERED, V99, P390, DOI 10.1093/jhered/esn010; Schlueter SD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r111; Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Shirakawa M, 2010, PLANT J, V64, P924, DOI 10.1111/j.1365-313X.2010.04394.x; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Sjolander K, 2011, BRIEF BIOINFORM, V12, P413, DOI 10.1093/bib/bbr036; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Soldatova O, 2005, MOL GENET GENOMICS, V273, P311, DOI 10.1007/s00438-005-1129-6; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Spang A, 2008, CELL MOL LIFE SCI, V65, P2781, DOI 10.1007/s00018-008-8349-y; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Spitzer C, 2009, PLANT CELL, V21, P749, DOI 10.1105/tpc.108.064865; Srivastava A, 2000, GENETICS, V156, P105; Stachowiak JC, 2013, NAT CELL BIOL, V15, P1019, DOI 10.1038/ncb2832; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Supek F, 2002, J CELL BIOL, V158, P1029, DOI 10.1083/jcb.200207053; Sutter JU, 2006, TRAFFIC, V7, P627, DOI 10.1111/j.1600-0854.2006.00414.x; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Synek L, 2006, PLANT J, V48, P54, DOI 10.1111/j.1365-313X.2006.02854.x; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; Szumlanski AL, 2009, PLANT CELL, V21, P526, DOI 10.1105/tpc.108.060277; Tai WCS, 2001, FEBS LETT, V500, P177, DOI 10.1016/S0014-5793(01)02599-6; Takagi J, 2013, PLANT CELL, V25, P4658, DOI 10.1105/tpc.113.118158; Takahashi H, 2010, PLANT CELL PHYSIOL, V51, P1777, DOI 10.1093/pcp/pcq137; Takatsu H, 2001, BIOCHEM BIOPH RES CO, V284, P1083, DOI 10.1006/bbrc.2001.5081; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Tanaka H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003540; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thellmann M, 2010, PLANT PHYSIOL, V154, P720, DOI 10.1104/pp.110.154286; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tyrrell M, 2007, PLANT J, V51, P1099, DOI 10.1111/j.1365-313X.2007.03206.x; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Uemura T, 2012, P NATL ACAD SCI USA, V109, P1784, DOI 10.1073/pnas.1115146109; Uemura T, 2010, PLANT J, V64, P864, DOI 10.1111/j.1365-313X.2010.04372.x; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Villarejo A, 2005, NAT CELL BIOL, V7, P1224, DOI 10.1038/ncb1330; Wadskog I, 2004, MOL BIOL CELL, V15, P1436, DOI 10.1091/mbc.E03-02-0114; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Whyte JRC, 2002, J CELL SCI, V115, P2627; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yamazaki M, 2008, PLANT CELL PHYSIOL, V49, P142, DOI 10.1093/pcp/pcn006; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhang Y, 2010, PLANT PHYSIOL, V152, P2200, DOI 10.1104/pp.109.142349; Zhang Y, 2013, NEW PHYTOL, V199, P74, DOI 10.1111/nph.12236; Zhang ZJ, 2011, PROTEOMICS, V11, P1780, DOI 10.1002/pmic.201000648; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655; Zheng HQ, 2005, PLANT CELL, V17, P2020, DOI 10.1105/tpc.105.031112; Zheng HY, 2002, PLANT PHYSIOL, V129, P530, DOI 10.1104/pp.003970; Zhu JH, 2002, PLANT CELL, V14, P3009, DOI 10.1105/tpc.006981; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013; Zwiewka M, 2011, CELL RES, V21, P1711, DOI 10.1038/cr.2011.99; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	293	28	28	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97745	10.1371/journal.pone.0097745	http://dx.doi.org/10.1371/journal.pone.0097745			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844592	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400055
J	Brenner, MH; Andreeva, E; Theorell, T; Goldberg, M; Westerlund, H; Leineweber, C; Hanson, LLM; Imbernon, E; Bonnaud, S				Brenner, M. Harvey; Andreeva, Elena; Theorell, Tores; Goldberg, Marcel; Westerlund, Hugo; Leineweber, Constanze; Hanson, Linda L. Magnusson; Imbernon, Ellen; Bonnaud, Sophie			Organizational Downsizing and Depressive Symptoms in the European Recession: The Experience of Workers in France, Hungary, Sweden and the United Kingdom	PLOS ONE			English	Article							PSYCHOSOCIAL WORKING-CONDITIONS; MINOR PSYCHIATRIC MORBIDITY; INVOLUNTARY JOB LOSS; MENTAL-HEALTH; SICKNESS ABSENCE; CIVIL-SERVANTS; UNEMPLOYMENT; JUSTICE; EMPLOYEES; STRESS	Background: Organizational downsizing has become highly common during the global recession of the late 2000s with severe repercussions on employment. We examine whether the severity of the downsizing process is associated with a greater likelihood of depressive symptoms among displaced workers, internally redeployed workers and lay-off survivors. Methods: A cross-sectional survey involving telephone interviews was carried out in France, Hungary, Sweden and the United Kingdom. The study analyzes data from 758 workers affected by medium-and large-scale downsizing, using multiple logistic regression. Main Results: Both unemployment and surviving layoffs were significantly associated with depressive symptoms, as compared to reemployment, but the perceived procedural justice of a socially responsible downsizing process considerably mitigated the odds of symptoms. Perception of high versus low justice was assessed along several downsizing dimensions. In the overall sample, chances to have depressive symptoms were significantly reduced if respondents perceived the process as transparent and understandable, fair and unbiased, well planned and democratic; if they trusted the employer's veracity and agreed with the necessity for downsizing. The burden of symptoms was significantly greater if the process was perceived to be chaotic. We further tested whether perceived justice differently affects the likelihood of depressive symptoms among distinct groups of workers. Findings were that the odds of symptoms largely followed the same patterns of effects across all groups of workers. Redeploying and supporting surplus employees through the career change process-rather than forcing them to become unemployed-makes a substantial difference as to whether they will suffer from depressive symptoms. Conclusions: While depressive symptoms affect both unemployed and survivors, a just and socially responsible downsizing process is important for the emotional health of workers.	[Brenner, M. Harvey] Univ N Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Behav & Community Hlth, Ft Worth, TX 76107 USA; [Brenner, M. Harvey; Andreeva, Elena] Tech Univ Berlin, Fak 7, FG Epidemiol, Berlin, Germany; [Theorell, Tores; Westerlund, Hugo; Leineweber, Constanze; Hanson, Linda L. Magnusson] Stockholm Univ, Inst Stress Res, S-10691 Stockholm, Sweden; [Goldberg, Marcel; Bonnaud, Sophie] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Populat Based Cohorts Res Platform, F-94807 Villejuif, France; [Goldberg, Marcel; Bonnaud, Sophie] Univ Versailles St Quentin, Dept Publ Hlth, Villejuif, France; [Imbernon, Ellen] Inst Veille Sanit, Dept Sante Travail, St Maurice, France	University of North Texas System; University of North Texas Health Science Center; Technical University of Berlin; Stockholm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institute of Public Health Surveillance	Brenner, MH (corresponding author), Univ N Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Behav & Community Hlth, Ft Worth, TX 76107 USA.	harvey.brenner@unthsc.edu	Leineweber, Constanze/G-7052-2012; Leineweber, Constanze/Z-1330-2019; Westerlund, Hugo/A-3049-2012; Hanson, Linda L Magnusson/D-2435-2017; Goldberg, Marcel/I-7834-2012; Brenner, M. Harvey/AAM-4109-2020	Leineweber, Constanze/0000-0001-8433-2405; Westerlund, Hugo/0000-0002-8806-5698; Hanson, Linda L Magnusson/0000-0002-2908-1903; Goldberg, Marcel/0000-0002-6161-5880; Theorell, Tores/0000-0003-1956-7931	European Community Program for Employment and Social Solidarity [VC/2007/0482]	European Community Program for Employment and Social Solidarity	The data collection was financially supported by the European Community Program for Employment and Social Solidarity (2007-2013), service contract #VC/2007/0482. The authors and investigators do not belong to the European public service. The results and opinions presented in this paper do not represent the official position of the European Commission.	Appelbaum S.H., 1997, CAREER DEV INT, V2, P278, DOI [DOI 10.1108/13620439710178639, 10.1108/13620439710178639]; Bartley M, 2001, J EPIDEMIOL COMMUN H, V55, P776, DOI 10.1136/jech.55.11.776; Bech P, 2011, KLIN PSYKOMETRI CLIN; Brand JE, 2008, RES AGING, V30, P701, DOI 10.1177/0164027508322574; Breslin FC, 2003, SCAND J WORK ENV HEA, V29, P5, DOI 10.5271/sjweh.698; Campbell Richard, 2002, New Solut, V12, P177, DOI 10.2190/3MBW-HQXR-QR1Y-3AU7; Cascio WF, 2005, ACAD MANAGE EXEC, V19, P39, DOI 10.5465/AME.2005.19417906; Cascio WF, 2002, RESPONSIBLE RESTRUCT, P91; Catalano R, 2000, SOC SCI QUART, V81, P477; Catalano R, 2011, ANNU REV PUBL HEALTH, V32, P431, DOI 10.1146/annurev-publhealth-031210-101146; Colquitt JA, 2001, J APPL PSYCHOL, V86, P386, DOI 10.1037//0021-9010.86.3.386; Cropanzano R, 2001, J VOCAT BEHAV, V58, P164, DOI 10.1006/jvbe.2001.1791; Devine K, 2003, HUM RESOURCE MANAGE, V42, P109, DOI 10.1002/hrm.10071; DEW MA, 1992, PSYCHOL MED, V22, P751, DOI 10.1017/S0033291700038198; DOOLEY D, 1994, AM J COMMUN PSYCHOL, V22, P745, DOI 10.1007/BF02521557; Dooley D, 2000, J HEALTH SOC BEHAV, V41, P421, DOI 10.2307/2676295; Dooley D, 1996, ANNU REV PUBL HEALTH, V17, P449, DOI 10.1146/annurev.pu.17.050196.002313; Dragano N, 2005, J EPIDEMIOL COMMUN H, V59, P694, DOI 10.1136/jech.2005.035089; Elovainio M, 2002, AM J PUBLIC HEALTH, V92, P105, DOI 10.2105/AJPH.92.1.105; European Commission, 2012, RESTR EUR 2011; FARLEY JE, 1991, HOSP COMMUNITY PSYCH, V42, P624; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P450, DOI 10.1136/jech.56.6.450; Gallo WT, 2006, INT ARCH OCC ENV HEA, V80, P109, DOI 10.1007/s00420-006-0108-5; Gallo WT, 2006, J GERONTOL B-PSYCHOL, V61, pS221, DOI 10.1093/geronb/61.4.S221; Greubel J, 2011, IND HEALTH, V49, P353, DOI 10.2486/indhealth.MS1211; GROVES RM, 1990, ANNU REV SOCIOL, V16, P221, DOI 10.1146/annurev.so.16.080190.001253; Grunberg L, 2001, J Occup Health Psychol, V6, P15, DOI 10.1037/1076-8998.6.1.15; Grynderup MB, 2013, OCCUP ENVIRON MED, V70, P380, DOI 10.1136/oemed-2012-101000; Hansen G.B., 2009, GUIDE WORKER DISPLAC; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430; Horvath B, 2010, HUNGARIAN STAT REV, V88, P125; HOSMER DW, 2000, WILEY PS TX, P1; Hurley RF, 2006, HARVARD BUS REV, V84, P55; ILO, 2010, GLOB EMPL TRENDS, P9; Jenkins R, 1996, OCCUP MED-OXFORD, V46, P209, DOI 10.1093/occmed/46.3.209; Jones A, 2009, BT DOUBLES JOB CUTS; Judge GG, 1985, THEORY PRACTICE ECON, P25; Juul S, 2006, INTRO STATA HLTH RES, P198; Kasl SV, 2000, SOCIAL EPIDEMIOLOGY, P118; KESSLER RC, 1987, PSYCHOL MED, V17, P949, DOI 10.1017/S0033291700000763; Kets de Vries M, 1996, EUROPEAN MANAGEMENT, V14, P111; Kinsten A, 2007, SWEDISH LONGITUDINAL; Kivimaki M, 2007, OCCUP ENVIRON MED, V64, P659, DOI 10.1136/oem.2006.031310; Kivimaki M, 2000, BRIT MED J, V320, P971, DOI 10.1136/bmj.320.7240.971; Kivimaki M, 1997, J APPL PSYCHOL, V82, P858, DOI 10.1037/0021-9010.82.6.858; Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P27, DOI 10.1136/oem.60.1.27; Kivimaki M, 2003, PSYCHOL MED, V33, P319, DOI 10.1017/S0033291702006591; Laaksonen M, 2006, INT ARCH OCC ENV HEA, V79, P205, DOI 10.1007/s00420-005-0054-7; Lang J, 2011, J APPL PSYCHOL, V96, P602, DOI 10.1037/a0022463; Leineweber C, 2013, EUR J PUBLIC HEALTH, V23, P710, DOI 10.1093/eurpub/cks064; Leventhal G., 1976, ADV EXP SOC PSYCHOL, P91, DOI DOI 10.1016/S0065-2601(08)60059-3; Leventhal G.S., 1980, JUSTICE SOCIAL INTER, P167, DOI DOI 10.1016/S0883-9026(03)00011-9; Magnusson Hanson LL, 2013, SCAND J PUBLIC HLTH; Mandal B, 2008, J MENT HEALTH POLICY, V11, P167; Mathers CD, 2003, 54 WHO, P52; Moore S, 2004, J OCCUP HEALTH PSYCH, V9, P247, DOI 10.1037/1076-8998.9.3.247; Noer D.M., 1993, HEALING WOUNDS OVERC; Novo M, 2001, SOC SCI MED, V53, P293, DOI 10.1016/S0277-9536(00)00340-3; Oksanen T, 2010, J EPIDEMIOL COMMUN H, V64, P684, DOI 10.1136/jech.2008.086074; Osthus S, 2012, SOC SCI MED, V75, P946, DOI 10.1016/j.socscimed.2012.04.036; Pepper L, 2003, AM J IND MED, V44, P481, DOI 10.1002/ajim.10303; Pilling J, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-3; Quinlan M, 2007, INT J LAW PSYCHIAT, V30, P385, DOI 10.1016/j.ijlp.2007.06.010; Quinlan M, 2009, INT J HEALTH SERV, V39, P1, DOI 10.2190/HS.39.1.a; Sanderson K, 2008, DISABIL REHABIL, V30, P1289, DOI 10.1080/09638280701654690; Schweiger D., 1987, ACADEMY MANAGEMENT E, V1, P127, DOI DOI 10.5465/AME.1987.4275830; Susanszky E, 2007, MENTALHIGIENE PSZICH, V8, P259; Thomas C, 2005, J EPIDEMIOL COMMUN H, V59, P243, DOI 10.1136/jech.2004.019778; Tsutsumi A, 2001, SCAND J WORK ENV HEA, V27, P146, DOI 10.5271/sjweh.602; TYLER TR, 1992, ADV EXP SOC PSYCHOL, V25, P115, DOI 10.1016/S0065-2601(08)60283-X; Wallington D, 2009, HLTH RESTRUCTURING I, P154; WILSON SH, 1993, PUBLIC HEALTH, V107, P153, DOI 10.1016/S0033-3506(05)80436-6; Ybema JF, 2010, SOC SCI MED, V70, P1609, DOI 10.1016/j.socscimed.2010.01.027; Ylipaavalniemi J, 2005, SOC SCI MED, V61, P111, DOI 10.1016/j.socscimed.2004.11.038	75	29	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97063	10.1371/journal.pone.0097063	http://dx.doi.org/10.1371/journal.pone.0097063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24841779	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600015
J	Johns, DJ; Lindroos, AK; Jebb, SA; Sjostrom, L; Carlsson, LMS; Ambrosini, GL				Johns, David J.; Lindroos, Anna Karin; Jebb, Susan A.; Sjostrom, Lars; Carlsson, Lena M. S.; Ambrosini, Gina L.			Tracking of a Dietary Pattern and Its Components over 10-Years in the Severely Obese	PLOS ONE			English	Article							PHYSICAL-ACTIVITY INTERVENTIONS; CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; LIFE-STYLE; AMSTERDAM-GROWTH; CHILDHOOD; ENERGY; ADOLESCENCE; CONSUMPTION; STABILITY	Understanding how dietary intake changes over time is important for studies of diet and disease and may inform interventions to improve dietary intakes. We investigated how a dietary pattern (DP) tracked over 10-years in the Swedish Obese Subjects (SOS) study control group. Dietary intake was assessed at multiple time-points in 2037 severely obese individuals (BMI 4164 kg/m(2)). Reduced rank regression was used to derive a dietary pattern using dietary energy density (kJ/g), saturated fat (%) and fibre density (mg/kJ) as response variables and score respondents at each follow-up. Tracking coefficients for the DP, its key foods and macronutrient response variables and corrected for time-dependent and time-independent covariates were calculated using generalised estimating equations to take into account all available data. The DP tracking coefficient was moderate for women (0.40; 95% CI: 0.38-0.42) and men (0.38; 95% CI: 0.35-0.41). Of the eleven foods key to this DP, fruit and vegetable intakes had the strongest tracking coefficient for both sexes. Fast food and candy had the lowest tracking coefficients for women and men respectively. Scores for an energy dense, high saturated fat, low fibre density DP appear moderately stable over a 10-year period in this severely obese population. Furthermore, some food groups appear more amenable to change while others, often the most healthful, appear more stable and may require intervention before adulthood.	[Johns, David J.; Jebb, Susan A.; Ambrosini, Gina L.] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Sjostrom, Lars; Carlsson, Lena M. S.] Univ Gothenburg, Inst Med, Gothenburg, Sweden; [Lindroos, Anna Karin] Natl Food Adm Toxicol Lab, Uppsala, Sweden	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of Gothenburg	Johns, DJ (corresponding author), Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England.	david.johns@mrc-hnr.cam.ac.uk	Ambrosini, Gina/E-7107-2010; Carlsson, Lena/F-7570-2018	Ambrosini, Gina/0000-0003-1001-4265; Carlsson, Lena/0000-0003-4145-6242; Jebb, Susan/0000-0001-9190-2920	UK Medical Research Council [U105960389]; MRC PhD studentship; MRC [MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_U105960389] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a programme grant from the UK Medical Research Council (U105960389 Nutrition and Health) and a MRC PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini GL, 2013, OBESITY; Borland SE, 2008, EUR J CLIN NUTR, V62, P119, DOI 10.1038/sj.ejcn.1602684; Collins CE, 2011, PUBLIC HEALTH NUTR, V14, P168, DOI 10.1017/S1368980010001916; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026; Gondoni LA, 2011, JAMA-J AM MED ASSOC, V305, P563, DOI 10.1001/jama.2011.82; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Hemmingsson E, 2011, JAMA-J AM MED ASSOC, V305, P563, DOI 10.1001/jama.2011.83; Hjartaker A, 2001, EUR J PUBLIC HEALTH, V11, P141, DOI 10.1093/eurpub/11.2.141; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Imamura F, 2009, AM J CLIN NUTR, V90, P1075, DOI 10.3945/ajcn.2009.28009; Johnson L, 2008, AM J CLIN NUTR, V87, P846, DOI 10.1093/ajcn/87.4.846; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Li J, 2008, J NUTR, V138, P94, DOI 10.1093/jn/138.1.94; Lien N, 2001, PREV MED, V33, P217, DOI 10.1006/pmed.2001.0874; Lindroos AK, 1999, EUR J CLIN NUTR, V53, P375, DOI 10.1038/sj.ejcn.1600732; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; Mikkilae V, 2007, BRIT J NUTR, V98, P218, DOI 10.1017/S0007114507691831; Mishra GD, 2006, BRIT J NUTR, V96, P735, DOI 10.1079/BJN20061871; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Northstone K, 2008, BRIT J NUTR, V99, P1099, DOI 10.1017/S0007114507842802; Pearson N, 2011, PREV MED, V53, P268, DOI 10.1016/j.ypmed.2011.07.014; Post GB, 2001, BRIT J NUTR, V85, P375, DOI 10.1079/BJN2000249; Prevost AT, 1997, BRIT J NUTR, V78, P873, DOI 10.1079/BJN19970206; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1987, INT J OBESITY, V11, P87; te Velde SJ, 2007, BRIT J NUTR, V98, P431, DOI 10.1017/S0007114507721451; Totland TH, 2013, PUBLIC HEALTH NUTR, V16, P673, DOI 10.1017/S1368980012003060; Twisk J, 2009, APPL LONGITUDINAL DA; Twisk JWR, 1996, ANN EPIDEMIOL, V6, P246, DOI 10.1016/1047-2797(96)00003-8; Twisk JWR, 1997, AM J EPIDEMIOL, V145, P888, DOI 10.1093/oxfordjournals.aje.a009048; Wang YF, 2002, J NUTR, V132, P430, DOI 10.1093/jn/132.3.430; Weismayer C, 2006, J NUTR, V136, P1582, DOI 10.1093/jn/136.6.1582	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97457	10.1371/journal.pone.0097457	http://dx.doi.org/10.1371/journal.pone.0097457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841709	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600034
J	Kristensen, LJ; Birkebaek, NH; Mose, AH; Hohwu, L; Thastum, M				Kristensen, Lene J.; Birkebaek, Niels H.; Mose, Anne H.; Hohwu, Lena; Thastum, Mikael			Symptoms of Emotional, Behavioral, and Social Difficulties in the Danish Population of Children and Adolescents with Type 1 Diabetes - Results of a National Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; CHRONICALLY ILL CHILDREN; CHRONIC PHYSICAL ILLNESS; DEPRESSIVE SYMPTOMS; METABOLIC-CONTROL; MENTAL-DISORDERS; GLYCEMIC CONTROL; YOUNG ADULTHOOD; ADAPTIVE STYLE; HEALTH	Objective: To assess the prevalence of psychological difficulties in Danish children and adolescents with type 1 diabetes using both child/adolescent and caregiver reports, and to investigate associations between these symptoms and metabolic control, adherence, and quality of life. Research Design and Method:: A total of 786 children and adolescents (8-17 years) recruited through the Danish Registry of Childhood Diabetes completed subscales of the Beck's Youth Inventories (BYI-Y), while 910 caregivers completed the Strength and Difficulties Questionnaire (SDQ). The participants also completed questionnaires assessing adherence and quality of life. BYI-Y and SDQ responses were compared with results from normative samples. Results: Children with diabetes generally reported a lower level of symptoms of depression and anxiety, while older adolescents in most cases were comparable to the normative samples. However, the numbers of patients with elevated scores were similar to normative groups, especially regarding the proportion of participants with 'Extremely elevated' scores. Caregivers of children and adolescents with diabetes generally reported the prevalence of elevated scores on the SDQ to exceed the prevalence observed in the norm sample - particularly with regard to older boys. Both BYI-Y and SDQ responses were significantly correlated with HbA(1c), adherence, and quality of life. Conclusions: This study finds Danish children and adolescents with diabetes to report lower or comparable levels of emotional difficulties compared to norms, while caregiver reports are less positive. The results therefore support the value of a multi-informant approach to the assessment of symptoms of psychological difficulty in girls and boys with diabetes.	[Kristensen, Lene J.; Thastum, Mikael] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark; [Birkebaek, Niels H.; Mose, Anne H.] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus N, Denmark; [Hohwu, Lena] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kristensen, LJ (corresponding author), Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark.	lenej@psy.au.dk	; Thastum, Mikael/A-3443-2008	Birkebaek, Niels/0000-0001-6268-6464; Kristensen, Lene Juel/0000-0003-1364-3737; Hohwu, Lena/0000-0002-9887-7745; Thastum, Mikael/0000-0001-8582-5682	Novo Nordisk A/S [494887]	Novo Nordisk A/S(Novo Nordisk)	Novo Nordisk A/S supported the work ('Psychosocial aspects of diabetes - Grant number: 494887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas S, 2009, J ENDOCRINOL INVEST, V32, P325, DOI 10.1007/BF03345721; Armstrong B, 2011, J PEDIATR PSYCHOL, V36, P1052, DOI 10.1093/jpepsy/jsr039; Beck J. S., 2012, BECK YOUTH INVENTORI, V2nd; Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536; CANNING EH, 1994, PSYCHOSOM MED, V56, P104, DOI 10.1097/00006842-199403000-00005; CANNING EH, 1992, PEDIATRICS, V90, P692; CANNING EH, 1992, J AM ACAD CHILD PSY, V31, P1120, DOI 10.1097/00004583-199211000-00021; Cohen J., 1988, STAT POWER ANAL BEHA; Dantzer C, 2003, CLIN PSYCHOL REV, V23, P787, DOI 10.1016/S0272-7358(03)00069-2; de Wit M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-10; de Wit M, 2011, PEDIATR DIABETES, V12, P172, DOI 10.1111/j.1399-5448.2010.00673.x; Duke DC, 2008, J PEDIATR PSYCHOL, V33, P719, DOI 10.1093/jpepsy/jsn012; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4; Grey M, 1994, Pediatr Nurs, V20, P17; Helgeson VS, 2007, J PEDIATR PSYCHOL, V32, P794, DOI 10.1093/jpepsy/jsm020; Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079; Herzer M, 2010, J PEDIATR PSYCHOL, V35, P415, DOI 10.1093/jpepsy/jsp063; Hohwu L, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2595; Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087; Horsch A, 2007, J TRAUMA STRESS, V20, P881, DOI 10.1002/jts.20247; Hysing M, 2007, J CHILD PSYCHOL PSYC, V48, P785, DOI 10.1111/j.1469-7610.2007.01755.x; Insabella G, 2007, PEDIATR DIABETES, V8, P228, DOI 10.1111/j.1399-5448.2007.00266.x; Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x; Kohler L, 2001, AR BRA MEN KAN BLI A; Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36; Kristensen LJ, 2012, DIABETES CARE, V35, P2161, DOI 10.2337/dc11-2342; Lawrence JM, 2012, J PEDIATR-US, V161, P201, DOI 10.1016/j.jpeds.2012.01.016; Leonard Barbara J, 2002, J Pediatr Nurs, V17, P28, DOI 10.1053/jpdn.2002.30931; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Niclasen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032025; Nielsen A., 2001, BORN BORNEFAMILIERS; Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Peyrot M, 2009, PEDIATR DIABETES, V10, P37, DOI 10.1111/j.1399-5448.2009.00612.x; Phipps S, 2002, PSYCHOSOM MED, V64, P34, DOI 10.1097/00006842-200201000-00006; Pinquart M, 2011, J PEDIATR PSYCHOL, V36, P375, DOI 10.1093/jpepsy/jsq104; Rewers A, 2002, JAMA-J AM MED ASSOC, V287, P2511, DOI 10.1001/jama.287.19.2511; Reynolds KA, 2011, ANN BEHAV MED, V42, P29, DOI 10.1007/s12160-011-9262-4; Stewart SM, 2005, PEDIATRICS, V115, P1315, DOI 10.1542/peds.2004-1717; Thastum M, 2009, SCAND J PSYCHOL, V50, P47, DOI 10.1111/j.1467-9450.2008.00690.x; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; Whittemore Robin, 2002, Pediatr Diabetes, V3, P135, DOI 10.1034/j.1399-5448.2002.30303.x	47	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97543	10.1371/journal.pone.0097543	http://dx.doi.org/10.1371/journal.pone.0097543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842772	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600041
J	Masi, G; Iacobone, M; Sinigaglia, A; Mantelli, B; Pennelli, G; Castagliuolo, I; Palu, G; Barzon, L				Masi, Giulia; Iacobone, Maurizio; Sinigaglia, Alessandro; Mantelli, Barbara; Pennelli, Gianmaria; Castagliuolo, Ignazio; Palu, Giorgio; Barzon, Luisa			Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization	PLOS ONE			English	Article							JAW TUMOR SYNDROME; PRIMARY HYPERPARATHYROIDISM; PAF1 COMPLEX; HPT-JT; SUPPRESSOR; HRPT2; TRANSCRIPTION; ASSOCIATION; REPRESSION; DELETION	Mutations of the Cell Division Cycle 73 (CDC73) tumor suppressor gene (previously known as HRPT2), encoding for parafibromin, are associated with the Hyperparathyroidism-Jaw Tumor (HPT-JT) syndrome, an autosomal dominant disease whose clinical manifestations are mainly parathyroid tumors and, less frequently, ossifying fibromas of the jaws, uterine and renal tumors. Most mutations of CDC73 are nonsense or frameshift, while missense mutations are rare and generally affect the N-terminal domain of parafibromin, a region that is still poorly characterized. The aim of this study was to characterize a novel somatic CDC73 missense mutation (Ile60Asn) identified in the mandibular tumor of a HPT-JT patient carrying a germline CDC73 inactivating mutation. Immunostaining of the tumor showed reduced nuclear parafibromin immunoreactivity. Western blotting and confocal microscopy of transfected cells demonstrated that the Ile60Asn mutant parafibromin was less expressed than the wild-type protein and exhibited impaired nucleolar localization. Treatment of transfected cells with translation and proteasome inhibitors demonstrated a decreased stability of the Ile60An mutant, partially due to an increase in proteasomal degradation. Overexpression of the Ile60Asn mutant led to increased cell proliferation and to accumulation in the G2/M phase of cell cycle. Moreover, mutant parafibromin lost the ability to down-regulate c-myc expression. In conclusion, our study shows that a missense mutation in the N-terminus of parafibromin, identified in an ossifying fibroma from a HPT-JT patient, stimulated cell proliferation and impaired parafibromin expression and nucleolar localization, suggesting a relevant role of the N-terminal domain for parafibromin function.	[Masi, Giulia; Sinigaglia, Alessandro; Mantelli, Barbara; Castagliuolo, Ignazio; Palu, Giorgio; Barzon, Luisa] Univ Padua, Dept Mol Med, Padua, Italy; [Sinigaglia, Alessandro] IRCCS, Ist Oncol Veneto, Padua, Italy; [Iacobone, Maurizio] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Pennelli, Gianmaria] Univ Padua, Dept Med, Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua	Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	luisa.barzon@unipd.it	Pennelli, Gianmaria/J-9937-2016; castagliuolo, ignazio/K-9963-2016; Iacobone, Maurizio/K-8714-2016; Barzon, Luisa/K-7961-2016; Masi, Giulia/K-1577-2016	Pennelli, Gianmaria/0000-0003-0210-165X; castagliuolo, ignazio/0000-0001-9888-7030; Barzon, Luisa/0000-0003-0720-8456; Masi, Giulia/0000-0001-9138-9186; Mantelli, Barbara/0000-0002-6345-5702; sinigaglia, alessandro/0000-0002-2386-1757; Iacobone, Maurizio/0000-0002-6057-4642	University of Padova	University of Padova	This work has been supported by funds from University of Padova to Prof. Luisa Barzon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrich CG, 2012, J BIOL CHEM, V287, P10863, DOI 10.1074/jbc.M111.325647; Bricaire L, 2013, J CLIN ENDOCR METAB, V98, pE403, DOI 10.1210/jc.2012-2789; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cascon A, 2011, GENE CHROMOSOME CANC, V50, P922, DOI 10.1002/gcc.20911; Chen HK, 2012, ACTA CRYSTALLOGR D, V68, P953, DOI 10.1107/S0907444912017325; Domingues R, 2012, CLIN ENDOCRINOL, V76, P33, DOI 10.1111/j.1365-2265.2011.04184.x; Hahn MA, 2007, FEBS LETT, V581, P5070, DOI 10.1016/j.febslet.2007.09.050; Iacobone M, 2009, LANGENBECK ARCH SURG, V394, P817, DOI 10.1007/s00423-009-0511-y; Juhlin CC, 2011, VIRCHOWS ARCH, V459, P47, DOI 10.1007/s00428-010-1032-3; Lin L, 2008, P NATL ACAD SCI USA, V105, P17420, DOI 10.1073/pnas.0710725105; Lin L, 2007, MOL CANCER RES, V5, P183, DOI 10.1158/1541-7786.MCR-06-0129; Masi G, 2008, ENDOCR-RELAT CANCER, V15, P1115, DOI 10.1677/ERC-08-0066; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Newey PJ, 2009, J INTERN MED, V266, P84, DOI 10.1111/j.1365-2796.2009.02107.x; Newey PJ, 2010, HUM MUTAT, V31, P295, DOI 10.1002/humu.21188; Panicker LM, 2010, ENDOCR-RELAT CANCER, V17, P513, DOI 10.1677/ERC-09-0272; Pazienza V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082292; Porter SE, 2005, EUKARYOT CELL, V4, P209, DOI 10.1128/EC.4.1.209-220.2005; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Wang PF, 2008, MOL CELL BIOL, V28, P2930, DOI 10.1128/MCB.00654-07; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991	23	21	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97994	10.1371/journal.pone.0097994	http://dx.doi.org/10.1371/journal.pone.0097994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842573	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600099
J	Mummalaneni, S; Qian, J; Phan, THT; Rhyu, MR; Heck, GL; DeSimone, JA; Lyall, V				Mummalaneni, Shobha; Qian, Jie; Phan, Tam-Hao T.; Rhyu, Mee-Ra; Heck, Gerard L.; DeSimone, John A.; Lyall, Vijay			Effect of ENaC Modulators on Rat Neural Responses to NaCl	PLOS ONE			English	Article							TASTE RECEPTOR CELL; EPITHELIAL NA+ CHANNEL; CHORDA TYMPANI RESPONSES; SODIUM TASTE; AMILORIDE; CAMP; SWEET; SALTY; KCL; PH	The effects of small molecule ENaC activators N,N,N-trimethyl-2-((4-methyl-2-((4-methyl-1H-indol-3-yl)thio) pentanoyl)oxy)ethanaminium iodide (Compound 1) and N-(2-hydroxyethyl)-4-methyl-2-((4-methyl-1H-indol-3-yl) thio) pentanamide (Compound 2), were tested on the benzamil (Bz)-sensitive NaCl chorda tympani (CT) taste nerve response under open-circuit conditions and under +/- 60 mV applied lingual voltage-clamp, and compared with the effects of known physiological activators (8-CPT-cAMP, BAPTA-AM, and alkaline pH), and an inhibitor (ionomycin+Ca2+) of ENaC. The NaCl CT response was enhanced at -60 mV and suppressed at +60 mV. In every case the CT response (r) versus voltage (V) curve was linear. All ENaC activators increased the open-circuit response (r(o)) and the voltage sensitivity (kappa, negative of the slope of the r versus V curve) and ionomycin+Ca2+ decreased r(o) and kappa to zero. Compound 1 and Compound 2 expressed a sigmoidal-saturating function of concentration (0.25-1 mM) with a half-maximal response concentration (k) of 0.49 and 1.05 mM, respectively. Following treatment with 1 mM Compound 1, 8-CPT-cAMP, BAPTA-AM and pH 10.3, the Bz-sensitive NaCl CT response to 100 mM NaCl was enhanced and was equivalent to the Bz-sensitive CT response to 300 mM NaCl. Plots of kappa versus r(o) in the absence and presence of the activators or the inhibitor were linear, suggesting that changes in the affinity of Na+ for ENaC under different conditions are fully compensated by changes in the apical membrane potential difference, and that the observed changes in the Bz-sensitive NaCl CT response arise exclusively from changes in the maximum CT response (r(m)). The results further suggest that the agonists enhance and ionomycin+Ca2+ decreases ENaC function by increasing or decreasing the rate of release of Na+ from its ENaC binding site to the receptor cell cytosol, respectively. Irrespective of agonist type, the Bz-sensitive NaCl CT response demonstrated a maximum response enhancement limit of about 75% over control value.	[Mummalaneni, Shobha; Qian, Jie; Phan, Tam-Hao T.; Heck, Gerard L.; DeSimone, John A.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Rhyu, Mee-Ra] Korea Food Res Inst, Songnam, Gyeonggi Do, South Korea	Virginia Commonwealth University; Korea Food Research Institute (KFRI)	Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.	vlyall@vcu.edu			NIDCD [DC-005981, DC-011569]; Korea Food Research Institute (KFRI) [E094101, E0111501]; Senomyx; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569, R01DC005981] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Korea Food Research Institute (KFRI); Senomyx; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by NIDCD grants DC-005981 (V. L.), DC-011569 (V. L.), Korea Food Research Institute (KFRI) grants E094101 (M. R.), E0111501 (M. R.) and research support from Senomyx (J.A.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chraibi A, 2001, J MEMBRANE BIOL, V183, P15, DOI 10.1007/s00232-001-0049-6; Coleman J, 2011, J NEUROPHYSIOL, V106, P2606, DOI 10.1152/jn.00196.2010; DeSimone JA, 2001, J NEUROPHYSIOL, V86, P2638, DOI 10.1152/jn.2001.86.5.2638; DeSimone JA, 2008, SENSES COMPREHENSIVE, V4, P281; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3221, DOI 10.1152/jn.00129.2012; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3206, DOI 10.1152/jn.00916.2011; Eylam S, 2005, AM J PHYSIOL-REG I, V288, pR1361, DOI 10.1152/ajpregu.00796.2004; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Gu YC, 2008, J EXP BIOL, V211, P3167, DOI 10.1242/jeb.019646; Halpern BP, 1998, CHEM SENSES, V23, P501, DOI 10.1093/chemse/23.5.501; Halpern BP, 1998, NEUROSCI BIOBEHAV R, V23, P5, DOI 10.1016/S0149-7634(97)00063-8; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hendricks SJ, 2000, J NEUROPHYSIOL, V84, P1531, DOI 10.1152/jn.2000.84.3.1531; HERNESS MS, 1992, COMP BIOCHEM PHYS A, V103, P269, DOI 10.1016/0300-9629(92)90578-E; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Kim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089062; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Lyall V, 2004, J PHYSIOL-LONDON, V556, P159, DOI 10.1113/jphysiol.2003.057745; Lyall V, 2002, J GEN PHYSIOL, V120, P793, DOI 10.1085/jgp.20028656; Lyall V, 2002, J NEUROPHYSIOL, V87, P399, DOI 10.1152/jn.00331.2001; Lyall V, 1999, AM J PHYSIOL-CELL PH, V277, pC800, DOI 10.1152/ajpcell.1999.277.4.C800; Lyall V, 2001, AM J PHYSIOL-CELL PH, V281, pC1005, DOI 10.1152/ajpcell.2001.281.3.C1005; Lyall V, 2009, J NEUROPHYSIOL, V102, P1591, DOI 10.1152/jn.91301.2008; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; OSSEBAARD CA, 1995, CHEM SENSES, V20, P37, DOI 10.1093/chemse/20.1.37; Robins GG, 2013, J PHYSIOL BIOCHEM, V69, P419, DOI 10.1007/s13105-012-0223-6; ROTHERMEL JD, 1983, J BIOL CHEM, V258, P2125; Schnizler M, 2000, PFLUG ARCH EUR J PHY, V439, P579, DOI 10.1007/s004240050981; Shigemura N, 2013, J NEUROSCI, V33, P6267, DOI 10.1523/JNEUROSCI.5599-12.2013; Sturz GR, 2011, CHEM SENSES, V36, P375, DOI 10.1093/chemse/bjq146; Tahara Y, 2013, European Patent Application, Patent No. [10857834.5, 108578345]; YE Q, 1991, SCIENCE, V254, P724, DOI 10.1126/science.1948054; Yusuke A, 2012, Salty taste enhancer, Patent No. [WO 2012121273 A1, 2012121273]	40	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98049	10.1371/journal.pone.0098049	http://dx.doi.org/10.1371/journal.pone.0098049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839965	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600104
J	Rossi, EA; Chang, CH; Goldenberg, DM				Rossi, Edmund A.; Chang, Chien-Hsing; Goldenberg, David M.			Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA; MONOCLONAL-ANTIBODY; CLINICAL-TRIAL; PHASE-I/II; DOUBLE-BLIND; IN-VIVO; EPRATUZUMAB; CD22; THERAPY	The humanized anti-CD22 antibody, epratuzumab, has demonstrated therapeutic activity in clinical trials of lymphoma, leukemia and autoimmune diseases, treating currently over 1500 cases of non-Hodgkin lymphoma, acute lymphoblastic leukemias, Waldenstrom's macroglobulinemia, Sjogren's syndrome, and systemic lupus erythematosus. Because epratuzumab reduces on average only 35% of circulating B cells in patients, and has minimal antibody-dependent cellular cytotoxicity and negligible complement-dependent cytotoxicity when evaluated in vitro, its therapeutic activity may not result completely from B-cell depletion. We reported recently that epratuzumab mediates Fc/FcR-dependent membrane transfer from B cells to effector cells via trogocytosis, resulting in a substantial reduction of multiple BCR modulators, including CD22, CD19, CD21, and CD79b, as well as key cell adhesion molecules, including CD44, CD62L, and beta 7 integrin, on the surface of B cells in peripheral blood mononuclear cells obtained from normal donors or SLE patients. Rituximab has clinical activity in lupus, but failed to achieve primary endpoints in a Phase III trial. This is the first study of trogocytosis mediated by bispecific antibodies targeting neighboring cell-surface proteins, CD22, CD20, and CD19, as demonstrated by flow cytometry and immunofluorescence microscopy. We show that, compared to epratuzumab, a bispecific hexavalent antibody comprising epratuzumab and veltuzumab (humanized anti-CD20 mAb) exhibits enhanced trogocytosis resulting in major reductions in B-cell surface levels of CD19, CD20, CD21, CD22, CD79b, CD44, CD62L and beta 7-integrin, and with considerably less immunocompromising B-cell depletion that would result with anti-CD20 mAbs such as veltuzumab or rituximab, given either alone or in combination with epratuzumab. A CD22/CD19 bispecific hexavalent antibody, which exhibited enhanced trogocytosis of some antigens and minimal B-cell depletion, may also be therapeutically useful. The bispecific antibody is a candidate for improved treatment of lupus and other autoimmune diseases, offering advantages over administration of the two parental antibodies in combination.	[Rossi, Edmund A.; Chang, Chien-Hsing; Goldenberg, David M.] Immunomedics Inc, Morris Plains, NJ 07950 USA; [Rossi, Edmund A.; Chang, Chien-Hsing; Goldenberg, David M.] IBC Pharmaceut Inc, Morris Plains, NJ USA; [Goldenberg, David M.] Ctr Mol Med & Immunol, Morris Plains, NJ USA	Immunomedics Inc	Goldenberg, DM (corresponding author), Immunomedics Inc, Morris Plains, NJ 07950 USA.	dmg.gscancer@att.net						Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Carnahan J, 2003, CLIN CANCER RES, V9, p3982S; Carnahan J, 2007, MOL IMMUNOL, V44, P1331, DOI 10.1016/j.molimm.2006.05.007; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Dorner T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1942; Goldenberg DM, 2006, EXPERT REV ANTICANC, V6, P1341, DOI 10.1586/14737140.6.10.1341; Goldenberg DM, 2006, ARTHRITIS RHEUM-US, V54, P2344, DOI 10.1002/art.21937; Goldenberg DM, 2010, LEUKEMIA LYMPHOMA, V51, P747, DOI 10.3109/10428191003672123; Gunnarsson I, 2013, LUPUS, V22, P381, DOI 10.1177/0961203312471574; Gupta P, 2010, BLOOD, V116, P3258, DOI 10.1182/blood-2010-03-276857; Haas KM, 2006, J IMMUNOL, V177, P3063, DOI 10.4049/jimmunol.177.5.3063; John BJ, 2003, J IMMUNOL, V170, P3534, DOI 10.4049/jimmunol.170.7.3534; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Lajaunias F, 2002, J IMMUNOL, V168, P6078, DOI 10.4049/jimmunol.168.12.6078; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Leonard JP, 2007, ONCOGENE, V26, P3704, DOI 10.1038/sj.onc.1210370; Leonard JP, 2008, CANCER-AM CANCER SOC, V113, P2714, DOI 10.1002/cncr.23890; Leonard JP, 2005, J CLIN ONCOL, V23, P5044, DOI 10.1200/JCO.2005.13.821; Leonard JP, 2003, J CLIN ONCOL, V21, P3051, DOI 10.1200/JCO.2003.01.082; Leonard JP, 2004, CLIN CANCER RES, V10, P5327, DOI 10.1158/1078-0432.CCR-04-0294; LEUNG SO, 1994, HYBRIDOMA, V13, P469, DOI 10.1089/hyb.1994.13.469; Looney RJ, 2010, DRUGS, V70, P529, DOI 10.2165/11535420-000000000-00000; Losman MJ, 1997, CANCER-AM CANCER SOC, V80, P2660, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2660::AID-CNCR43>3.3.CO;2-I; Mills DM, 2004, J IMMUNOL, V172, P195, DOI 10.4049/jimmunol.172.1.195; Mok MY, 2010, INT J RHEUM DIS, V13, P3, DOI 10.1111/j.1756-185X.2009.01458.x; Mysler EF, 2013, ARTHRITIS RHEUM; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nitschke L, 2009, IMMUNOL REV, V230, P128, DOI 10.1111/j.1600-065X.2009.00801.x; Onodera T, 2008, J IMMUNOL, V180, P907, DOI 10.4049/jimmunol.180.2.907; Raetz EA, 2008, J CLIN ONCOL, V26, P3756, DOI 10.1200/JCO.2007.15.3528; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; Richards S, 2008, IMMUNOL REV, V224, P183, DOI 10.1111/j.1600-065X.2008.00652.x; Rossi DL, 2011, BIOTECHNOL PROGR, V27, P766, DOI 10.1002/btpr.584; Rossi EA, 2013, BLOOD, V122, P3020, DOI 10.1182/blood-2012-12-473744; Rossi EA, 2013, BIOCONJUGATE CHEM, V24, P63, DOI 10.1021/bc300488f; Rossi EA, 2009, BLOOD, V113, P6161, DOI 10.1182/blood-2008-10-187138; Samardzic T, 2002, EUR J IMMUNOL, V32, P2481, DOI 10.1002/1521-4141(200209)32:9<2481::AID-IMMU2481>3.0.CO;2-C; SHARKEY RM, 1995, CANCER RES, V55, pS5935; Sprent J, 2005, SCI STKE, V2005, pe8, DOI DOI 10.1126/STKE.2732005PE8; Steinfeld SD, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2018; Szczepanik M, 2003, J IMMUNOL, V171, P6225, DOI 10.4049/jimmunol.171.11.6225; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Wallace D, 2010, ANN RHEUM DIS     S3, P558; Wallace DJ, 2013, RHEUMATOLOGY, V52, P1313, DOI 10.1093/rheumatology/ket129; Wallace DJ, 2013, ANN RHEUM DIS, DOI 10. 1136/annrheumdis-2012-202760	50	21	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98315	10.1371/journal.pone.0098315	http://dx.doi.org/10.1371/journal.pone.0098315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841238	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600112
J	Sepulveda, M; Sabat, P; Porter, WP; Farina, JM				Sepulveda, Maritza; Sabat, Pablo; Porter, Warren P.; Miguel Farina, Jose			One Solution for Two Challenges: The Lizard Microlophus atacamensis Avoids Overheating by Foraging in Intertidal Shores	PLOS ONE			English	Article							RUIN LIZARDS; BODY-SIZE; GEOGRAPHIC-VARIATION; SCELOPORUS-MERRIAMI; LIFE-HISTORIES; BEHAVIORAL THERMOREGULATION; THERMAL CONSTRAINTS; LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; ACTIVITY PATTERNS	In lizards, one of the most important behavioral mechanisms to cope with spatial and temporal variations in thermal resources observed is activity time. The longer a lizard can maintain activity, the more time it has to forage and reach larger adult body size. We studied the behavioral adjustments to different climatic regimens on daily and seasonal scales in three natural populations of the lizard Microlophus atacamensis along a latitudinal temperature and rainfall gradient. We also used Niche Mapper to determinate the amount of thermally suitable time for activity for this species. Abundance and daily activity patterns varied greatly over the year for the three populations. In summer and spring, the daily activity times were greater, and were reduced in fall and winter seasons. In summer, when stressful heat loads should prohibit activity over a midday gap, lizards did not show bimodal patterns of activity. Instead, they move to the cooler intertidal habitat. Abundance and thermal quality in the southernmost coolest site was lower, and the potential annual activity time decreases with latitude. Contrary to expectations, lizards from this locality showed the largest body sizes possibly due to diet and/or time to sexual maturation. Our results indicate that the intertidal habitat is a key factor that influences daily and seasonal activity of M. atacamensis lizards. While this habitat is not climatically optimal for lizards, it allows them to behaviorally extend their activity window and gain access to food in the intertidal areas.	[Sepulveda, Maritza] Univ Valparaiso, Fac Ciencias, Inst Biol, Ctr Invest & Gest Recursos Nat CIGREN, Valparaiso, Chile; [Sabat, Pablo] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Porter, Warren P.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Miguel Farina, Jose] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Miguel Farina, Jose] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Universidad de Valparaiso; Universidad de Chile; University of Wisconsin System; University of Wisconsin Madison; Pontificia Universidad Catolica de Chile; Brown University	Sepulveda, M (corresponding author), Univ Valparaiso, Fac Ciencias, Inst Biol, Ctr Invest & Gest Recursos Nat CIGREN, Valparaiso, Chile.	maritza.sepulveda@uv.cl	Sabat, Pablo/E-8829-2012		Beca Universidad de Chile [PG/3/2006]; Fondecyt [1040783, 105096]	Beca Universidad de Chile; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by funding from Beca Universidad de Chile PG/3/2006 to MS, Fondecyt Grant number 1040783 to JMF, and Fondecyt Grant number 105096 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Adolph SC, 1996, OIKOS, V77, P267, DOI 10.2307/3546065; ADOLPH SC, 1993, AM NAT, V142, P273, DOI 10.1086/285538; Angilletta MJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P11; Avery R.A., 1982, Biology of Reptilia, V12, P93; Bertolucci C, 2002, HORM BEHAV, V41, P414, DOI 10.1006/hbeh.2002.1781; Bertolucci C, 1999, BEHAV ECOL SOCIOBIOL, V46, P200, DOI 10.1007/s002650050610; Carothers JH, 1998, REV CHIL HIST NAT, V71, P39; Catenazzi A, 2005, COPEIA, P713, DOI 10.1643/0045-8511(2005)005[0713:SAGEIA]2.0.CO;2; Cowles Raymond Bridgman, 1944, BULL AMER MUS NAT HIST, V83, P261; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; DIAZ JA, 1991, J BIOGEOGR, V18, P291, DOI 10.2307/2845399; Diaz JA, 2004, FUNCT ECOL, V18, P867, DOI 10.1111/j.0269-8463.2004.00916.x; Donoso-Barros R., 1966, REPTILES CHILE; DUNHAM AE, 1989, PHYSIOL ZOOL, V62, P335, DOI 10.1086/physzool.62.2.30156174; Ellis DJ, 2007, J COMP PHYSIOL A, V193, P695, DOI 10.1007/s00359-007-0224-z; Farina JM, 2008, J ANIM ECOL, V77, P458, DOI 10.1111/j.1365-2656.2008.01361.x; Farina JM, 2003, ECOL APPL, V13, P1533, DOI 10.1890/02-5216; Foa A, 2003, FRONT BIOSCI, V8, pS236, DOI 10.2741/1037; FOA A, 1994, BEHAV ECOL SOCIOBIOL, V34, P267; Foa A, 2001, J BIOL RHYTHM, V16, P574, DOI 10.1177/074873001129002268; GRANT BW, 1990, ECOLOGY, V71, P2323, DOI 10.2307/1938643; GRANT BW, 1992, AM ZOOL, V32, P154; GRANT BW, 1988, ECOLOGY, V69, P167, DOI 10.2307/1943171; GRANT BW, 1990, ECOLOGY, V71, P1765, DOI 10.2307/1937584; Gunderson AR, 2012, FUNCT ECOL, V26, P783, DOI 10.1111/j.1365-2435.2012.01987.x; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; Huey R.B., 1982, Biology of Reptilia, V12, P25; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kerr GD, 2008, J ZOOL, V275, P79, DOI 10.1111/j.1469-7998.2008.00413.x; Labra A, 2001, ECOSCIENCE, V8, P413, DOI 10.1080/11956860.2001.11682669; MCCULLOUGH EC, 1971, ECOLOGY, V52, P1008, DOI 10.2307/1933806; NAGY KA, 1984, ECOLOGY, V65, P588, DOI 10.2307/1941421; Niewiarowski PH, 2001, AM NAT, V157, P421, DOI 10.1086/319321; Ortiz JC, 1980, ACTAS PRIMERA REUNIO, P355; Porter W.P., 2006, METHOD SYSTEM CALCUL; PORTER WP, 1973, OECOLOGIA, V13, P1, DOI 10.1007/BF00379617; Sears MW, 2004, INTEGR COMP BIOL, V44, P433, DOI 10.1093/icb/44.6.433; Sears MW, 2005, OECOLOGIA, V143, P25, DOI 10.1007/s00442-004-1767-0; Sepulveda M, 2008, J THERM BIOL, V33, P141, DOI 10.1016/j.jtherbio.2007.07.002; SINERVO B, 1994, ECOLOGY, V75, P776, DOI 10.2307/1941734; *STATS INC, 2001, STATISTICA; Tracy CR, 1999, ECOLOGY, V80, P259, DOI 10.1890/0012-9658(1999)080[0259:DIBSAC]2.0.CO;2; Vidal M, 2002, REV CHIL HIST NAT, V75, P283; Vitt LJ, 1999, FUNCT ECOL, V13, P670, DOI 10.1046/j.1365-2435.1999.00357.x; Wikelski M, 1997, ECOLOGY, V78, P2204, DOI 10.2307/2265956; Wikelski M, 2000, OECOLOGIA, V124, P107, DOI 10.1007/s004420050030; Winne CT, 2004, FUNCT ECOL, V18, P314, DOI 10.1111/j.0269-8463.2004.00819.x; Zar JH, 1999, BIOSTATISTICAL ANAL	50	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97735	10.1371/journal.pone.0097735	http://dx.doi.org/10.1371/journal.pone.0097735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839969	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600064
J	Sharma, N; Jung, CH; Bhalla, PL; Singh, MB				Sharma, Niharika; Jung, Chol-Hee; Bhalla, Prem L.; Singh, Mohan B.			RNA Sequencing Analysis of the Gametophyte Transcriptome from the Liverwort, Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; DE-NOVO CHARACTERIZATION; GENE ORGANIZATION; ROOT TRANSCRIPTOME; NONCODING RNA; LAND PLANTS; GENOME; DNA; EVOLUTION; REVEALS	The liverwort Marchantia polymorpha is a member of the most basal lineage of land plants (embryophytes) and likely retains many ancestral morphological, physiological and molecular characteristics. Despite its phylogenetic importance and the availability of previous EST studies, M. polymorpha's lack of economic importance limits accessible genomic resources for this species. We employed Illumina RNA-Seq technology to sequence the gametophyte transcriptome of M. polymorpha. cDNA libraries from 6 different male and female developmental tissues were sequenced to delineate a global view of the M. polymorpha transcriptome. Approximately 80 million short reads were obtained and assembled into a non-redundant set of 46,533 transcripts (>= 200 bp) from 46,070 loci. The average length and the N50 length of the transcripts were 757 bp and 471 bp, respectively. Sequence comparison of assembled transcripts with non-redundant proteins from embryophytes resulted in the annotation of 43% of the transcripts. The transcripts were also compared with M. polymorpha expressed sequence tags (ESTs), and approximately 69.5% of the transcripts appeared to be novel. Twenty-one percent of the transcripts were assigned GO terms to improve annotation. In addition, 6,112 simple sequence repeats (SSRs) were identified as potential molecular markers, which may be useful in studies of genetic diversity. A comparative genomics approach revealed that a substantial proportion of the genes (35.5%) expressed in M. polymorpha were conserved across phylogenetically related species, such as Selaginella and Physcomitrella, and identified 580 genes that are potentially unique to liverworts. Our study presents an extensive amount of novel sequence information for M. polymorpha. This information will serve as a valuable genomics resource for further molecular, developmental and comparative evolutionary studies, as well as for the isolation and characterization of functional genes that are involved in sex differentiation and sexual reproduction in this liverwort.	[Sharma, Niharika; Bhalla, Prem L.; Singh, Mohan B.] Univ Melbourne, Plant Mol Biol & Biotechnol Lab, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia; [Jung, Chol-Hee] Univ Melbourne, Victorian Life Sci Computat Initiat, Carlton, Vic 3053, Australia	University of Melbourne; University of Melbourne	Singh, MB (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Lab, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia.	mohan@unimelb.edu.au	Jung, Cholhee/S-8670-2019; Sharma, Niharika/AAE-7843-2019	Singh, Mohan/0000-0001-9427-8975; Sharma, Niharika/0000-0001-6707-4467; Bhalla, Prem/0000-0002-2910-0393	Australian Research Council [ARC DP0988972, ARCDP1097262]	Australian Research Council(Australian Research Council)	Financial support from the Australian Research Council in the form of the ARC Discovery grants ARC DP0988972 and ARCDP1097262 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Fujisawa M, 2001, GENETICS, V159, P981; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gordo SMC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-168; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kohchi T, 2010, PLANT AN GEN 18 C; Kozik A, 2008, PLANT AN GEN 16 C; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin HN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-41; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagai J, 1999, DNA Res, V6, P1, DOI 10.1093/dnares/6.1.1; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nishiyama R, 2000, DNA RES, V7, P165, DOI 10.1093/dnares/7.3.165; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Pires ND, 2013, P NATL ACAD SCI USA, V110, P9571, DOI 10.1073/pnas.1305457110; Pires ND, 2012, PHILOS T R SOC B, V367, P508, DOI 10.1098/rstb.2011.0252; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sharma N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-915; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	53	17	17	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97497	10.1371/journal.pone.0097497	http://dx.doi.org/10.1371/journal.pone.0097497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841988	Green Published, gold			2022-12-27	WOS:000340948600036
J	Noh, JW; Jo, M; Huh, T; Cheon, J; Kwon, YD				Noh, Jin-Won; Jo, Minkyung; Huh, Taewook; Cheon, Jooyoung; Kwon, Young Dae			Gender Differences and Socioeconomic Status in Relation to Overweight among Older Korean People	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; CENTRAL OBESITY; PREVALENCE; ASSOCIATION; POPULATION; ADULTS; MEN; CONSUMPTION; INEQUALITY	Background: The ever-increasing older population and its association with serious overweight problems have garnered much attention. The correlation between being overweight and socioeconomic status factors could be helpful for understanding the inequalities among the overweight population. We examined the correlation between being overweight and some key variables, such as demographics, socioeconomic status, general health status, and health behavior in a large sample of older individuals, by each gender. Methods: We used data from the 2008 Korean Longitudinal Study of Aging and it included 8,157 participants who were 45 years or older. To understand the relationship between the overweight participants in accordance to demographic and socioeconomic characteristics, health status, and health behaviors, a weighted chi-square test and logistic regression analysis were conducted by separating variables related to overweight, according to the genders. Results: The number of people in the normal group was 6,347 (77.8%), while the people who were considered overweight were 1,810 (22.2%). Women (n = 4,583) constituted 52.7% of the subject, 24.9% of whom were classified as overweight. Meanwhile, 20.6% of the 47.3% (n = 3,574) of the sample who were men were classified as overweight. Participants between the ages of 45 and 64 with chronic diseases were more likely to be overweight. Men in the 4th quartile of household income were more likely to be overweight than those who were in the 1st quartile, in contrast, while unemployed women with lower education levels and urban residents were at greater risk for being overweight. Conclusions: Among the men, health status and health behavior appeared to show a correlation with being overweight; however, among women, socioeconomic status factors were strongly related to being overweight. These findings appear to support the association of gender-specifics with the prevalence of being overweight.	[Noh, Jin-Won] Eulji Univ, Dept Healthcare Management, Songnam, South Korea; [Jo, Minkyung] Korea Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Huh, Taewook] Korean Womens Dev Inst, Strategy Dept Women Friendly Policy, Seoul, South Korea; [Cheon, Jooyoung] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea	Eulji University; Korea University; Korea University Medicine (KU Medicine); University System of Maryland; University of Maryland Baltimore; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832; Cheon, Jooyoung/0000-0001-9622-0937				Ball K, 2003, INT J OBESITY, V27, P394, DOI 10.1038/sj.ijo.0802237; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Ball K, 2002, INT J OBESITY, V26, P559, DOI 10.1038/sj.ijo.0801960; Cho Juhee, 2006, Prev Chronic Dis, V3, pA79; Grujic V, 2009, VOJNOSANIT PREGL, V66, P705, DOI 10.2298/VSP0909705G; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; Hajian-Tilaki KO, 2007, OBES REV, V8, P3, DOI 10.1111/j.1467-789X.2006.00235.x; Jitnarin N, 2010, NUTRIENTS, V2, P60, DOI [10.3390/nu20100060, 10.3390/nu2010060]; Kim IH, 2011, J KOREAN MED SCI, V26, P250, DOI 10.3346/jkms.2011.26.2.250; Kim JY, 2010, J KOREAN MED SCI, V25, P1560, DOI 10.3346/jkms.2010.25.11.1560; Kim O, 2012, PSYCHOL REP, V111, P963, DOI 10.2466/18.06.13.PR0.111.6.963-970; Korean National Statistical Office, 2012, POP PROJ KOR; KweonGuYoung, 2005, [Korean Journal of Social Welfare, 한국사회복지학], V57, P93; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; 김미영, 2012, Journal of Obesity & Metabolic Syndrome, V21, P18; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Padez C, 2006, PUBLIC HEALTH, V120, P946, DOI 10.1016/j.puhe.2006.05.023; Park HS, 2008, OBES REV, V9, P104, DOI 10.1111/j.1467-789X.2007.00421.x; Park H, 2011, MATURITAS, V70, P65, DOI 10.1016/j.maturitas.2011.05.014; Reas DL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-269; Martin AR, 2008, APPETITE, V51, P266, DOI 10.1016/j.appet.2008.02.021; Rodriguez-Martin A, 2009, NUTR HOSP, V24, P144; Roskam AJR, 2008, PUBLIC HEALTH NUTR, V11, P1256, DOI 10.1017/S1368980008002747; Sabanayagam C, 2009, ASIA-PAC J PUBLIC HE, V21, P487, DOI 10.1177/1010539509343957; Santos R, 2008, AM J HUM BIOL, V20, P78, DOI 10.1002/ajhb.20680; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J, 2009, OBESITY, V17, P2223, DOI 10.1038/oby.2009.64; Sund ER, 2010, SOC SCI MED, V70, P1194, DOI 10.1016/j.socscimed.2010.01.007; Tchicaya Anastase, 2012, BMC Res Notes, V5, P467, DOI 10.1186/1756-0500-5-467; Vernay M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-215; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029	31	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97990	10.1371/journal.pone.0097990	http://dx.doi.org/10.1371/journal.pone.0097990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24836697	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800096
J	Yaita, K; Aoki, K; Suzuki, T; Nakaharai, K; Yoshimura, Y; Harada, S; Ishii, Y; Tachikawa, N				Yaita, Kenichiro; Aoki, Kotaro; Suzuki, Takumitsu; Nakaharai, Kazuhiko; Yoshimura, Yukihiro; Harada, Sohei; Ishii, Yoshikazu; Tachikawa, Natsuo			Epidemiology of Extended-Spectrum beta-Lactamase Producing Escherichia coli in the Stools of Returning Japanese Travelers, and the Risk Factors for Colonization	PLOS ONE			English	Article							GRAM-NEGATIVE BACILLI; ENTEROBACTERIACEAE; PREVALENCE; DISSEMINATION; ENVIRONMENT; EMERGENCE; HEALTH; GENES; SMART	Objective: Travel overseas has recently been considered a risk factor for colonization with drug-resistant bacteria. The purpose of this study was to establish the epidemiology and risk factors associated with the acquisition of drug-resistant bacteria by Japanese travelers. Methods: Between October 2011 and September 2012, we screened the stools of 68 Japanese returning travelers for extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. All specimens were sampled for clinical reasons. Based on the results, the participants were divided into an ESBL-producing E. coli positive group (18 cases; 26%) and an ESBL-producing E. coli negative group (50 cases; 74%), and a case-control study was performed. Microbiological analyses of ESBL-producing strains, including susceptibility tests, screening tests for metallo-beta-lactamase, polymerase chain reaction amplification and sequencing of bla(CTX-M) genes, multilocus sequence typing, and whole genome sequencing, were also conducted. Results: In a univariate comparison, travel to India was a risk factor (Odds Ratio 13.6, 95% Confidence Interval 3.0-75.0, p<0.0001). There were no statistical differences in the characteristics of the travel, such as backpacking, purpose of travel, interval between travel return and sampling stool, and duration of travel. Although 10 of 13 analyzed strains (77%) produced CTX-M-15, no ST131 clone was detected. Conclusion: We must be aware of the possibilities of acquiring ESBL-producing E. coli during travel in order to prevent the spread of these bacteria not only in Japan but globally.	[Yaita, Kenichiro; Suzuki, Takumitsu; Nakaharai, Kazuhiko; Yoshimura, Yukihiro; Tachikawa, Natsuo] Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa, Japan; [Aoki, Kotaro; Ishii, Yoshikazu] Toho Univ, Sch Med, Dept Microbiol & Infect Dis, Tokyo, Japan; [Harada, Sohei] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Infect Dis, Tokyo, Japan	Toho University; Japanese Foundation for Cancer Research	Yaita, K (corresponding author), Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa, Japan.	kyaita81@gmail.com		Harada, Sohei/0000-0003-3073-6564	Grants-in-Aid for Scientific Research [25461524] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Brink AJ, 2012, SURG INFECT, V13, P43, DOI 10.1089/sur.2011.074; Chong Y, 2011, EUR J CLIN MICROBIOL, V30, P83, DOI 10.1007/s10096-010-1057-1; Clinical and Laboratory Standards Institute, 2011, M7A9 CLIN LAB STAND; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Deresinski S, 2011, CLIN INFECT DIS, V52, pI; Donnenberg MS, 2009, MANDELL DOUGLAS BENN, P2815; Ensor VM, 2006, J ANTIMICROB CHEMOTH, V58, P1260, DOI 10.1093/jac/dkl422; Freeman JT, 2008, CLIN INFECT DIS, V47, P689, DOI 10.1086/590941; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Hawser SP, 2009, ANTIMICROB AGENTS CH, V53, P3280, DOI 10.1128/AAC.00426-09; Islam S, 2012, PEDIATR INFECT DIS J, V31, P1103, DOI 10.1097/INF.0b013e3182610e20; Kanda Y., 2012, BONE MARROW TRANSPL, V47, P1; Kimura S, 2005, DIAGN MICR INFEC DIS, V53, P241, DOI 10.1016/j.diagmicrobio.2005.05.017; Laupland KB, 2008, J INFECTION, V57, P441, DOI 10.1016/j.jinf.2008.09.034; Luvsansharav UO, 2011, J INFECT CHEMOTHER, V17, P722, DOI 10.1007/s10156-011-0225-2; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Ostholm-Balkhed A, 2013, J ANTIMICROB CHEMOTH, V68, P2144, DOI 10.1093/jac/dkt167; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2539, DOI 10.1128/AAC.00061-09; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Shibata N, 2006, ANTIMICROB AGENTS CH, V50, P791, DOI 10.1128/AAC.50.2.791-795.2006; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Tangden T, 2010, ANTIMICROB AGENTS CH, V54, P3564, DOI 10.1128/AAC.00220-10; Tham J, 2012, SCAND J INFECT DIS, V44, P573, DOI 10.3109/00365548.2011.653582; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Weisenberg SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045141; Woodford N, 2011, J TRAVEL MED, V18, P297, DOI 10.1111/j.1708-8305.2011.00541.x; Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0	30	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98000	10.1371/journal.pone.0098000	http://dx.doi.org/10.1371/journal.pone.0098000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836896	gold, Green Submitted, Green Published			2022-12-27	WOS:000339614800097
J	Zhang, L; Zhang, C; Wu, PZ; Chen, YP; Li, MR; Jiang, HW; Wu, GJ				Zhang, Lin; Zhang, Chao; Wu, Pingzhi; Chen, Yaping; Li, Meiru; Jiang, Huawu; Wu, Guojiang			Global Analysis of Gene Expression Profiles in Physic Nut (Jatropha curcas L.) Seedlings Exposed to Salt Stress	PLOS ONE			English	Article							ARABINOGALACTAN PROTEINS; ABIOTIC STRESS; TRANSCRIPTOME ANALYSIS; SIGNAL-TRANSDUCTION; SALINITY TOLERANCE; ARABIDOPSIS ROOTS; DROUGHT; MECHANISMS; RESPONSES; ETHYLENE	Background: Salt stress interferes with plant growth and production. Plants have evolved a series of molecular and morphological adaptations to cope with this abiotic stress, and overexpression of salt response genes reportedly enhances the productivity of various crops. However, little is known about the salt responsive genes in the energy plant physic nut (Jatropha curcas L.). Thus, excavate salt responsive genes in this plant are informative in uncovering the molecular mechanisms for the salt response in physic nut. Methodology/Principal Findings: We applied next-generation Illumina sequencing technology to analyze global gene expression profiles of physic nut plants (roots and leaves) 2 hours, 2 days and 7 days after the onset of salt stress. A total of 1,504 and 1,115 genes were significantly up and down-regulated in roots and leaves, respectively, under salt stress condition. Gene ontology (GO) analysis of physiological process revealed that, in the physic nut, many "biological processes'' were affected by salt stress, particular those categories belong to "metabolic process'', such as "primary metabolism process'', "cellular metabolism process'' and "macromolecule metabolism process''. The gene expression profiles indicated that the associated genes were responsible for ABA and ethylene signaling, osmotic regulation, the reactive oxygen species scavenging system and the cell structure in physic nut. Conclusions/Significance: The major regulated genes detected in this transcriptomic data were related to trehalose synthesis and cell wall structure modification in roots, while related to raffinose synthesis and reactive oxygen scavenger in leaves. The current study shows a comprehensive gene expression profile of physic nut under salt stress. The differential expression genes detected in this study allows the underling the salt responsive mechanism in physic nut with the aim of improving its salt resistance in the future.	[Zhang, Lin; Zhang, Chao; Wu, Pingzhi; Chen, Yaping; Li, Meiru; Jiang, Huawu; Wu, Guojiang] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Zhang, Lin; Zhang, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, GJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	wugj@scbg.ac.cn	zhang, chao/C-4732-2012	zhang, chao/0000-0001-5287-4701	National Basic Research Program of China (973 Program) [2010CB126603]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-28]; CAS/SAFEA International Partnership Program for Creative Research Teams	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	The work was supported by grants from the National Basic Research Program of China (973 Program) (2010CB126603) (http://www.973.gov.cn/), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-28) (http://www.cas.cn/), and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2008, BIOMASS BIOENERG, V32, P1063, DOI 10.1016/j.biombioe.2008.03.003; Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chen S, 2012, GENE, V504, P203, DOI 10.1016/j.gene.2012.05.023; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; da Silva EN, 2011, SCI AGR, V68, P62, DOI 10.1590/S0103-90162011000100010; da Silva EN, 2009, PESQUI AGROPECU BRAS, V44, P437, DOI 10.1590/S0100-204X2009000500002; da Silva EN, 2009, REV CIENC AGRON, V40, P240; Diaz-Lopez L, 2012, PLANT PHYSIOL BIOCH, V54, P34, DOI 10.1016/j.plaphy.2012.02.005; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; Farrokhi N, 2006, PLANT BIOTECHNOL J, V4, P145, DOI 10.1111/j.1467-7652.2005.00169.x; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Geilfus CM, 2011, PLANT SIGNAL BEHAV, V6, P1279, DOI 10.4161/psb.6.9.16760; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hermans C, 2010, PLANT PHYSIOL, V152, P904, DOI 10.1104/pp.109.149849; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jiang HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036522; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Jithesh MN, 2006, J GENET, V85, P237, DOI 10.1007/BF02935340; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Kwon Y, 2007, PLANT J, V49, P184, DOI 10.1111/j.1365-313X.2006.02950.x; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Neto MCL, 2014, J PLANT PHYSIOL, V171, P23, DOI 10.1016/j.jplph.2013.09.002; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Mohsenzadeh S, 2011, AFR J BIOTECHNOL, V10, P8160; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; OOMS JJJ, 1993, PLANT PHYSIOL, V102, P1185, DOI 10.1104/pp.102.4.1185; Peters S, 2007, J EXP BOT, V58, P1947, DOI 10.1093/jxb/erm056; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Silva EN, 2010, J ARID ENVIRON, V74, P1130, DOI 10.1016/j.jaridenv.2010.05.036; Singh K, 2011, OMICS, V15, P913, DOI 10.1089/omi.2011.0098; van Hengel AJ, 2001, PLANT PHYSIOL, V125, P1880, DOI 10.1104/pp.125.4.1880; Vandenbussche F, 2012, NEW PHYTOL, V194, P895, DOI 10.1111/j.1469-8137.2012.04100.x; Vera-Estrella R, 2005, PLANT PHYSIOL, V139, P1507, DOI 10.1104/pp.105.067850; Wong CE, 2006, PLANT PHYSIOL, V140, P1437, DOI 10.1104/pp.105.070508; Xiong Liming, 2002, Arabidopsis Book, V1, pe0048, DOI 10.1199/tab.0048; Xiong WD, 2013, GENE, V524, P124, DOI 10.1016/j.gene.2013.04.047; Xu XJ, 2009, MOL CELLS, V27, P423, DOI 10.1007/s10059-009-0060-9; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu T, 2000, PLANT PHYSIOL, V124, P1472, DOI 10.1104/pp.124.4.1472	70	43	47	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97878	10.1371/journal.pone.0097878	http://dx.doi.org/10.1371/journal.pone.0097878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837971	Green Submitted, gold, Green Published			2022-12-27	WOS:000339614800080
J	Ozdemir, K; Acar, S				Ozdemir, Kerem; Acar, Sumeyra			Plasmid Profile and Pulsed-Field Gel Electrophoresis Analysis of Salmonella enterica Isolates from Humans in Turkey	PLOS ONE			English	Article							ENTERITIDIS; RESISTANCE; TYPHIMURIUM; DIVERSITY	This study was conducted for typing Salmonella enterica subspecies enterica strains in Turkey using pulsed-field gel electrophoresis (PFGE) and plasmid DNA profile analysis. Fourty-two strains were isolated from clinical samples obtained from unrelated patients with acute diarrhea. The samples were collected from state hospitals and public health laboratories located at seven provinces in different regions of Turkey at different times between 2004 and 2010. The strains were determined to belong to 4 different serovars. The Salmonella enterica strains belonged to the serovars Salmonella Enteritidis (n = 23), Salmonella Infantis (n = 14), Salmonella Munchen (n = 2), and Salmonella Typhi (n = 3). Forty-two Salmonella enterica strains were typed with PFGE methods using XbaI restriction enzyme and plasmid analysis. At the end of typing, 11 different PFGE band profiles were obtained. Four different PFGE profiles (type 1, 4, 9, and 10) were found among serotype S. Enteritidis species, 3 different PFGE profiles (type 3, 5, 6) were found among S. Infantis species, 2 different PFGE profiles were found among S. Typhi species (type 2 and 11), and 2 different PFGE profiles were found among S. Munchen species (type 7, 8). The UPGMA dendrogram was built on the PFGE profiles. In this study, it was determined that 4 strains of 42 Salmonella enterica strains possess no plasmid, while the isolates have 1-3 plasmids ranging from 5.0 to 150 kb and making 12 different plasmid profiles (P1-P12). In this study, we have applied the analysis of the PFGE patterns and used bioinformatics methods to identify both inter and intra serotype relationships of 4 frequently encountered serotypes for the first time in Turkey.	[Ozdemir, Kerem] Yuzuncu Yil Univ, Fac Sci, Dept Biol, Van, Turkey; [Acar, Sumeyra] Publ Hlth Inst Turkey, Ankara, Turkey	Yuzuncu Yil University; Refik Saydam Hifzissihha Merkezi Baskanligi	Ozdemir, K (corresponding author), Yuzuncu Yil Univ, Fac Sci, Dept Biol, Van, Turkey.	kerem@yyu.edu.tr						Abbassi-Ghozzi I, 2011, PATHOL BIOL, V59, P207, DOI 10.1016/j.patbio.2010.06.001; Adesiyun A, 2000, Rev Panam Salud Publica, V8, P342, DOI 10.1590/S1020-49892000001000004; Aksoycan N, 1974, MIKROBIYOL BUL, V8, P153; Aktas Z, 2007, INT J ANTIMICROB AG, V30, P541, DOI 10.1016/j.ijantimicag.2007.06.034; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Ammari S, 2009, J INFECT DEV COUNTR, V3, P41; Bayramova M, 2007, THESIS ANKARA U TURK; Ben Aissa R, 2008, EPIDEMIOL INFECT, V136, P468, DOI 10.1017/S0950268807008916; Boxrud D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06; Cardinale E, 2005, J APPL MICROBIOL, V99, P968, DOI 10.1111/j.1365-2672.2005.02618.x; Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V52, P10; Erdem Birsel, 2004, Mikrobiyoloji Bulteni, V38, P173; Fonseca EL, 2006, J CLIN MICROBIOL, V44, P2767, DOI 10.1128/JCM.01916-05; Fontana J, 2003, EMERG INFECT DIS, V9, P496, DOI 10.3201/eid0904.020423; Gatto A. J., 2006, EPIDEMIOL INFECT, V25, P1; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kerouanton A, 2007, FOODBORNE PATHOG DIS, V4, P293, DOI 10.1089/fpd.2007.0090; Kilic A, 2010, INTERNAL MED, V49, P31, DOI 10.2169/internalmedicine.49.2743; Koort JMK, 2002, J CLIN MICROBIOL, V40, P3497, DOI 10.1128/JCM.40.9.3497-3498.2002; Kubota K, 2005, J CLIN MICROBIOL, V43, P1205, DOI 10.1128/JCM.43.3.1205-1209.2005; Levent B, 2010, 34 TURK MICR C 7 11, P234; LINTON AH, 1981, J APPL BACTERIOL, V50, P115, DOI 10.1111/j.1365-2672.1981.tb00876.x; Merino Luis A., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P119, DOI 10.1590/S0036-46652003000300001; OLSEN JE, 1994, J MED MICROBIOL, V40, P15, DOI 10.1099/00222615-40-1-15; Onyango MD, 2009, J INFECT DEV COUNTR, V3, P685; Otgun SN, 2011, EUR J CLIN MICROBIOL, V30, P1229, DOI 10.1007/s10096-011-1217-y; Parker CT, 2010, APPL ENVIRON MICROB, V76, P3723, DOI 10.1128/AEM.03053-09; Ridley AM, 1998, J CLIN MICROBIOL, V36, P2314, DOI 10.1128/JCM.36.8.2314-2321.1998; Seno M, 2004, J INFECTION, V49, P291, DOI 10.1016/j.jinf.2003.09.002; Soyer Y, 2010, FOODBORNE PATHOG DIS, V7, P707, DOI 10.1089/fpd.2009.0424; Taban B, 2007, THESIS HACETTEPE U A; Tekeli A, 2006, NEW MICROBIOL, V29, P251; Us E, 2011, MIKROBIYOL BUL, V45, P210; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Wu W, 2010, BMC MICROBIOL, V10, P1471; Zou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059224	36	24	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e95976	10.1371/journal.pone.0095976	http://dx.doi.org/10.1371/journal.pone.0095976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852084	gold, Green Submitted, Green Published			2022-12-27	WOS:000338323200008
J	Smits, EJ; Tolonen, AJ; Cluitmans, L; van Gils, M; Conway, BA; Zietsma, RC; Leenders, KL; Maurits, NM				Smits, Esther J.; Tolonen, Antti J.; Cluitmans, Luc; van Gils, Mark; Conway, Bernard A.; Zietsma, Rutger C.; Leenders, Klaus L.; Maurits, Natasha M.			Standardized Handwriting to Assess Bradykinesia, Micrographia and Tremor in Parkinson's Disease	PLOS ONE			English	Article							COORDINATION; DIAGNOSIS; IMPAIRMENT; MOVEMENTS; ACCURACY; WRIST; HAND; ARM	Objective: To assess whether standardized handwriting can provide quantitative measures to distinguish patients diagnosed with Parkinson's disease from age- and gender-matched healthy control participants. Design: Exploratory study. Pen tip trajectories were recorded during circle, spiral and line drawing and repeated character 'elelelel' and sentence writing, performed by Parkinson patients and healthy control participants. Parkinson patients were tested after overnight withdrawal of anti-Parkinsonian medication. Setting: University Medical Center Groningen, tertiary care, the Netherlands. Participants: Patients with Parkinson's disease (n = 10; mean age 69.0 years; 6 male) and healthy controls (n = 10; mean age 68.1 years; 6 male). Interventions: Not applicable. Main Outcome Measures: Movement time and velocity to detect bradykinesia and the size of writing to detect micrographia. A rest recording to investigate the presence of a rest-tremor, by frequency analysis. Results: Mean disease duration in the Parkinson group was 4.4 years and the patients were in modified Hoehn-Yahr stages 1-2.5. In general, Parkinson patients were slower than healthy control participants. Median time per repetition, median velocity and median acceleration of the sentence task and median velocity of the elel task differed significantly between Parkinson patients and healthy control participants (all p < 0.0014). Parkinson patients also wrote smaller than healthy control participants and the width of the 'e' in the elel task was significantly smaller in Parkinson patients compared to healthy control participants (p < 0.0014). A rest-tremor was detected in the three patients who were clinically assessed as having rest-tremor. Conclusions: This study shows that standardized handwriting can provide objective measures for bradykinesia, tremor and micrographia to distinguish Parkinson patients from healthy control participants.	[Smits, Esther J.; Leenders, Klaus L.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Tolonen, Antti J.; Cluitmans, Luc; van Gils, Mark] VTT Tech Res Ctr Finland, Tampere, Finland; [Conway, Bernard A.] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Zietsma, Rutger C.] Manus Neurodynam Ltd, Newcastle, NSW, Australia	University of Groningen; VTT Technical Research Center Finland; University of Strathclyde	Smits, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	e.j.smits@umcg.nl	Conway, Bernard/A-9625-2016; Smits, Esther/F-9651-2018	Conway, Bernard/0000-0002-0069-0131; Smits, Esther/0000-0002-1356-7255; van Gils, Mark/0000-0002-0029-1771; Maurits, Natasha/0000-0001-6231-7044	EC [262291]; Manus Neurodynamica Ltd, Newcastle, United Kingdom	EC(European CommissionEuropean Commission Joint Research Centre); Manus Neurodynamica Ltd, Newcastle, United Kingdom	This study is part of the DiPAR project for which funding was received from the EC in the FP7-SME-201001 programme (grant agreement 262291). VTT and UMCG collaborated as subcontracted RTD performers. Manus Neurodynamica Ltd, Newcastle, United Kingdom provided support in the form of salaries for author RZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alty JE, 2012, MOVEMENT DISORD, V27, pS91; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Bajaj NPS, 2012, J NEUROL, V259, P2335, DOI 10.1007/s00415-012-6495-5; Broderick MP, 2009, EXP BRAIN RES, V197, P223, DOI 10.1007/s00221-009-1925-z; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; Dounskaia N, 2009, NEUROPSYCHOLOGIA, V47, P2504, DOI 10.1016/j.neuropsychologia.2009.04.020; Eshuis SA, 2009, EUR J NUCL MED MOL I, V36, P454, DOI 10.1007/s00259-008-0989-5; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Grosset DG, 2008, J NEUROL NEUROSUR PS, V79, P615, DOI 10.1136/jnnp.2008.144741; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Inlu A, 2006, ISBMDA LECT NOTES CO, V4345, P441; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Keresztenyi Z, 2009, INT J REHABIL RES, V32, P53, DOI 10.1097/MRR.0b013e32830d369c; Massano J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008870; MCLENNAN JE, 1972, J NEUROL SCI, V15, P141, DOI 10.1016/0022-510X(72)90002-0; Moroney R, 2008, J COMPUT NEUROSCI, V25, P501, DOI 10.1007/s10827-008-0091-9; Ondo WG, 2007, MOVEMENT DISORD, V22, P2130, DOI 10.1002/mds.21733; Ponsen MM, 2008, PARKINSONISM RELAT D, V14, P199, DOI 10.1016/j.parkreldis.2007.07.019; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Rosenblum S, 2013, J NEUROL, V260, P2357, DOI 10.1007/s00415-013-6996-x; Saunders-Pullman R, 2008, MOVEMENT DISORD, V23, P531, DOI 10.1002/mds.21874; Scanlon BK, 2013, J CLIN NEUROSCI, V20, P827, DOI 10.1016/j.jocn.2012.06.015; Shukla AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000628; Stanley K, 2010, PARKINSONISM RELAT D, V16, P233, DOI 10.1016/j.parkreldis.2009.12.007; Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507; Van Gemmert AWA, 2001, BRAIN COGNITION, V47, P504, DOI 10.1006/brcg.2001.1328; Zietsma RC, 2010, THESIS U STRATHCLYDE	28	75	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97614	10.1371/journal.pone.0097614	http://dx.doi.org/10.1371/journal.pone.0097614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854199	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000338323200023
J	Suld, K; Valdmann, H; Laurimaa, L; Soe, E; Davison, J; Saarma, U				Sueld, Karmen; Valdmann, Harri; Laurimaa, Leidi; Soe, Egle; Davison, John; Saarma, Urmas			An Invasive Vector of Zoonotic Disease Sustained by Anthropogenic Resources: The Raccoon Dog in Northern Europe	PLOS ONE			English	Article							WOLF CANIS-LUPUS; NYCTEREUTES-PROCYONOIDES; ESTONIA; MAMMALS; IMPACT; DIET	The raccoon dog (Nyctereutes procyonoides) is an introduced species in Europe with a continually expanding range. Since the species is capable of affecting local ecosystems and is a vector for a number of severe zoonotic diseases, it is important to understand its food habits. Raccoon dog diet was studied in Estonia by examining the contents of 223 stomach samples collected during the coldest period of the year, August to March, in 2010-2012. The most frequently consumed food categories were anthropogenic plants (e.g. cereals, fruits; FO = 56.1%) and carrion (e.g. carcasses of artiodactyls and carnivores; FO = 48.4%). Carrion was also the only food category that was consumed significantly more frequently by raccoon dogs exhibiting symptoms of sarcoptic mange than by uninfected animals. Small mammals, which represent intermediate hosts for the zoonotic tapeworm Echinococcus multilocularis, were more commonly recorded in samples also containing anthropogenic plants than expected by chance. Comparison of raccoon dog and red fox (Vulpes vulpes) diet in Estonia revealed higher overlap than found elsewhere in Europe, with 'carrion' and 'anthropogenic plants' making up the bulk of both species' diet; however, raccoon dogs were more omnivorous than red foxes. Our results suggest that while the use of most food categories reflects the phenology of natural food sources, 'anthropogenic plants' and 'carrion' provide an essential resource for raccoon dogs during the coldest period of the year, with the latter resource especially important for individuals infected with sarcoptic mange. Since both of these food categories and small mammals are often found at supplementary feeding sites for wild boar (Sus scrofa), this game management practice may facilitate high densities of mesocarnivores and promote the spread of some severe zoonotic diseases, including alveolar echinococcosis, trichinellosis, rabies and sarcoptic mange.	[Sueld, Karmen; Valdmann, Harri; Laurimaa, Leidi; Soe, Egle; Davison, John; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	Urmas.Saarma@ut.ee	Saarma, Urmas/AAC-9813-2019; Saarma, Urmas/J-6448-2015	Saarma, Urmas/0000-0002-3222-571X; Saarma, Urmas/0000-0002-3222-571X	Estonian Research Council [IUT 20-32, ESF 8793]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); Estonian Doctoral School of Ecology and Environmental Sciences	Estonian Research Council(Estonian Research Council); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by grants from the Estonian Research Council (grants IUT 20-32 and ESF 8793), from the European Union through the European Regional Development Fund (Centre of Excellence FIBIR), and from the Estonian Doctoral School of Ecology and Environmental Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aul J, 1957, EESTI NSV IMETAJAD, P256; Baltrunaite Laima, 2006, Acta Zoologica Lituanica, V16, P46, DOI 10.1080/13921657.2006.10512709; Baltrunaite Laima, 2002, Acta Zoologica Lituanica, V12, P362; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bornstein Set, 2001, P107, DOI 10.1002/9780470377000.ch5; Davidson RK, 2012, TRENDS PARASITOL, V28, P239, DOI 10.1016/j.pt.2012.03.004; Eckert J., 2001, WHO OIE MANUAL ECHIN; ERLICH PR, 1989, BIOL INVASIONS GLOBA, P315; Genovesi P, 2012, INTEGR ZOOL, V7, P247, DOI 10.1111/j.1749-4877.2012.00309.x; HELLE E, 1995, J MAMMAL, V76, P1036, DOI 10.2307/1382597; Jedrzejewska B., 1998, PREDATION VERTEBRATE, V135; Kaal M, 1981, EESTI IMETAJATE MAAR; KAUHALA K, 1993, Z SAUGETIERKD, V58, P129; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kauhala K, 1996, WILDLIFE BIOL, V2, P197, DOI 10.2981/wlb.1996.019; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kubarsepp Marko, 2003, Acta Zoologica Lituanica, V13, P28; Laanetu N., 1986, Eesti Ulukid, V4, P15; Miller I, 2004, WILD ANIMAL TRICHINE, P174; Moks E, 2006, J WILDLIFE DIS, V42, P359, DOI 10.7589/0090-3558-42.2.359; Moks E, 2005, EMERG INFECT DIS, V11, P1973, DOI 10.3201/eid1112.050339; Naaber J., 1971, EESTI LODUS, V14, P449; Naaber J., 1974, EESTI NSV JAHIMEESTE, P102; Neronov VM, 2008, INTEGR ZOOL, V3, P83, DOI 10.1111/j.1749-4877.2008.00084.x; Newman TJ, 2002, CAN J ZOOL, V80, P154, DOI [10.1139/z01-216, 10.1139/Z01-216]; Niin E, 2008, VACCINE, V26, P3556, DOI 10.1016/j.vaccine.2008.04.056; Oja R, 2011, THESIS U TARTU; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Partel A, 2013, B OIE, V3, P58; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; POZIO E, 1995, INT J PARASITOL, V25, P1247, DOI 10.1016/0020-7519(95)00042-Z; Ratsepp M, 2005, THESIS U TARTU; Remonti L, 2005, PARASITOL RES, V97, P431, DOI 10.1007/s00436-005-1481-9; Sato Y, 2000, WILDLIFE SOC B, V28, P311; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Sidorovich VE, 2011, ANAL VERTEBRATE PRED, P429; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Sutor A, 2010, ACTA THERIOL, V55, P165, DOI 10.4098/j.at.0001-7051.035.2009; Teerink BJ, 1991, HAIR W EUROPEAN MAMM, P223; Tumanov I. L., 2003, BIOL CHARACTERISTICS; Valdmann H, 2005, ACTA THERIOL, V50, P521, DOI 10.1007/BF03192645; Vulla E, 2009, ANN ZOOL FENN, V46, P395, DOI 10.5735/086.046.0601; XIAO YJ, 1995, ACTA AGR SCAND A-AN, V45, P186, DOI 10.1080/09064709509415850	43	37	37	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96358	10.1371/journal.pone.0096358	http://dx.doi.org/10.1371/journal.pone.0096358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852942	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200013
J	Switz, NA; D'Ambrosio, MV; Fletcher, DA				Switz, Neil A.; D'Ambrosio, Michael V.; Fletcher, Daniel A.			Low-Cost Mobile Phone Microscopy with a Reversed Mobile Phone Camera Lens	PLOS ONE			English	Article								The increasing capabilities and ubiquity of mobile phones and their associated digital cameras offer the possibility of extending low-cost, portable diagnostic microscopy to underserved and low-resource areas. However, mobile phone microscopes created by adding magnifying optics to the phone's camera module have been unable to make use of the full image sensor due to the specialized design of the embedded camera lens, exacerbating the tradeoff between resolution and field of view inherent to optical systems. This tradeoff is acutely felt for diagnostic applications, where the speed and cost of image-based diagnosis is related to the area of the sample that can be viewed at sufficient resolution. Here we present a simple and low-cost approach to mobile phone microscopy that uses a reversed mobile phone camera lens added to an intact mobile phone to enable high quality imaging over a significantly larger field of view than standard microscopy. We demonstrate use of the reversed lens mobile phone microscope to identify red and white blood cells in blood smears and soil-transmitted helminth eggs in stool samples.	[D'Ambrosio, Michael V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94704 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	D'Ambrosio, MV (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94704 USA.	mdambrosio@berkeley.edu		Switz, Neil/0000-0002-3639-4588	Microsoft Research; Intel Corporation	Microsoft Research(Microsoft); Intel Corporation(Intel Corporation)	The authors have the following interests: This study was funded in part by Microsoft Research and Intel Corporation. Daniel Fletcher and Neil Switz are inventors on US Patent Application 20110009163, "High Numerical Aperture Telemicroscopy Apparatus", filed January 13th, 2011. Co-author Daniel Fletcher is a co-founder of CellScope, Inc., a company commercializing a cellphone-based otoscope. Co-authors Daniel Fletcher and Neil Switz hold shares in CellScope, Inc. The shares belonging to Neil Switz are held by The Regents of the University of California and disposition is determined by them according to a fixed formula. Cellscope, Inc. neither had nor has any involvement with the project described in this paper. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bogoch II, 2013, AM J TROP MED HYG, V88, P626, DOI 10.4269/ajtmh.12-0742; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Chen C, 2013, US Patent Application, Patent No. [2013/0021680 A1, 20130021680]; Ford BJ., 1985, SINGLE LENS STORY SI; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Steenblik R, 2005, US Patent, Patent No. [6,847,480 B2, 6847480]; van Cittert PH, 1934, P K AKAD WET-AMSTERD, V37, P290; van Cittert PH, 1954, PROD NED K ACAD WET, V57, P103; Zheng GA, 2013, NAT PHOTONICS, V7, P739, DOI [10.1038/NPHOTON.2013.187, 10.1038/nphoton.2013.187]; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	12	124	129	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e95330	10.1371/journal.pone.0095330	http://dx.doi.org/10.1371/journal.pone.0095330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854188	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200003
J	Dehury, B; Patra, MC; Maharana, J; Sahu, J; Sen, P; Modi, MK; Choudhury, MD; Barooah, M				Dehury, Budheswar; Patra, Mahesh Chandra; Maharana, Jitendra; Sahu, Jagajjit; Sen, Priyabrata; Modi, Mahendra Kumar; Choudhury, Manabendra Dutta; Barooah, Madhumita			Structure-Based Computational Study of Two Disease Resistance Gene Homologues (Hm1 and Hm2) in Maize (Zea mays L.) with Implications in Plant-Pathogen Interactions	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; RECOGNITION; SERVER; EVOLUTION; REDUCTASE; WEB; PLATFORM; MODELS; ORIGIN	The NADPH-dependent HC-toxin reductases (HCTR1 and 2) encoded by enzymatic class of disease resistance homologous genes (Hm1 and Hm2) protect maize by detoxifying a cyclic tetrapeptide, HC-toxin, secreted by the fungus Cochliobolus carbonum race 1(CCR1). Unlike the other classes' resistance (R) genes, HCTR-mediated disease resistance is an inimitable mechanism where the avirulence (Avr) component from CCR1 is not involved in toxin degradation. In this study, we attempted to decipher cofactor (NADPH) recognition and mode of HC-toxin binding to HCTRs through molecular docking molecular dynamics (MD) simulations and binding free energy calculation methods. The rationality and the stability of docked complexes were validated by 30-ns MD simulation. The binding free energy decomposition of enzyme-cofactor complex was calculated to find the driving force behind cofactor recognition. The overall binding free energies of HCTR1-NADPH and HCTR2-NADPH were found to be -616.989 and -16.9749 kJ mol(-1) respectively. The binding free energy decomposition revealed that the binding of NADPH to the HCTR1 is mainly governed by van der Waals and nonpolar interactions, whereas electrostatic terms play dominant role in stabilizing the binding mode between HCTR2 and NADPH. Further, docking analysis of HC-toxin with HCTR-NADPH complexes showed a distinct mode of binding and the complexes were stabilized by a strong network of hydrogen bond and hydrophobic interactions. This study is the first in silico attempt to unravel the biophysical and biochemical basis of cofactor recognition in enzymatic class of R genes in cereal crop maize.	[Dehury, Budheswar; Sahu, Jagajjit; Sen, Priyabrata; Modi, Mahendra Kumar; Barooah, Madhumita] Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India; [Dehury, Budheswar; Choudhury, Manabendra Dutta] Assam Univ, Dept Life Sci & Bioinformat, Silchar, Assam, India; [Patra, Mahesh Chandra; Maharana, Jitendra] Orissa Univ Agr & Technol, Dept Bioinformat, BIF Ctr, Bhubaneswar 751003, Orissa, India; [Patra, Mahesh Chandra] Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal 132001, Haryana, India; [Maharana, Jitendra] Cent Inland Fisheries Res Inst, Biotechnol Lab, Kolkata, W Bengal, India	Assam Agricultural University; Assam University; Orissa University of Agriculture & Technology; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Inland Fisheries Research Institute	Barooah, M (corresponding author), Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India.	m17barooah@yahoo.co.in	Choudhury, Manabendra/AAP-1817-2021; DEHURY, BUDHESWAR/G-9330-2017; Maharana, Jitendra/B-5210-2014; Sen, Priyabrata/AAD-8490-2019; Sahu, Jagajjit/J-6696-2019; Patra, Mahesh/I-9746-2014	DEHURY, BUDHESWAR/0000-0002-9726-8454; Maharana, Jitendra/0000-0003-4628-5956; Sahu, Jagajjit/0000-0001-7468-5696; Modi, Mahendra Kumar/0000-0001-5509-4612; Barooah, Madhumita/0000-0002-3768-5336; Patra, Mahesh/0000-0003-0471-6236; Dutta Choudhury, Manabendra/0000-0002-9472-0572	Bioinformatics Initiative Division, Department of Electronics and Information Technology (DeitY), Ministry of Communications & Information Technology, Government of India; Biotechnology Information System Network (BTISNET), Department of Biotechnology, Government of India	Bioinformatics Initiative Division, Department of Electronics and Information Technology (DeitY), Ministry of Communications & Information Technology, Government of India; Biotechnology Information System Network (BTISNET), Department of Biotechnology, Government of India	The authors acknowledge the financial support from Bioinformatics Initiative Division, Department of Electronics and Information Technology (DeitY), Ministry of Communications & Information Technology, Government of India as well as Biotechnology Information System Network (BTISNET), Department of Biotechnology, Government of India. The authors are also grateful to Assam Agricultural University for providing necessary infrastructure to carry out this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balint-Kurti Peter J., 2009, P229, DOI 10.1007/978-0-387-79418-1_12; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Biswas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045525; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chintamanani S, 2008, MOL PLANT MICROBE IN, V21, P79, DOI 10.1094/MPMI-21-1-0079; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dehury B, 2013, J MOL GRAPH MODEL, V45, P50, DOI 10.1016/j.jmgm.2013.08.011; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Gargouri M, 2009, ACTA CRYSTALLOGR D, V65, P989, DOI 10.1107/S0907444909025013; Han F, 1997, MOL PLANT MICROBE IN, V10, P234, DOI 10.1094/MPMI.1997.10.2.234; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; McGuffin LJ, 2013, NUCLEIC ACIDS RES, V41, pW368, DOI 10.1093/nar/gkt294; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Multani DS, 1998, P NATL ACAD SCI USA, V95, P1686, DOI 10.1073/pnas.95.4.1686; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Petit P, 2007, J MOL BIOL, V368, P1345, DOI 10.1016/j.jmb.2007.02.088; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shao H, 2007, J MOL BIOL, V369, P265, DOI 10.1016/j.jmb.2007.03.040; Sindhu A, 2008, P NATL ACAD SCI USA, V105, P1762, DOI 10.1073/pnas.0711406105; Sparla F, 2004, J MOL BIOL, V340, P1025, DOI 10.1016/j.jmb.2004.06.005; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Ullstrup AJ, 1941, PHYTOPATHOLOGY, V31, P508; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Walton JD, 2006, PHYTOCHEMISTRY, V67, P1406, DOI 10.1016/j.phytochem.2006.05.033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang LQ, 2002, GENETICS, V162, P851	53	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97852	10.1371/journal.pone.0097852	http://dx.doi.org/10.1371/journal.pone.0097852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847713	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600064
J	Enlund, E; Fischer, S; Handrick, R; Otte, K; Debatin, KM; Wabitsch, M; Fischer-Posovszky, P				Enlund, Eveliina; Fischer, Simon; Handrick, Rene; Otte, Kerstin; Debatin, Klaus-Michael; Wabitsch, Martin; Fischer-Posovszky, Pamela			Establishment of Lipofection for Studying miRNA Function in Human Adipocytes	PLOS ONE			English	Article							MICRORNAS; DELIVERY	miRNA dysregulation has recently been linked to human obesity and its related complications such as type 2 diabetes. In order to study miRNA function in human adipocytes, we aimed for the modulation of mature miRNA concentration in these cells. Adipocytes, however, tend to be resistant to transfection and there is often a need to resort to viral transduction or electroporation. Our objective therefore was to identify an efficient, non-viral transfection reagent capable of delivering small RNAs into these cells. To achieve this, we compared the efficiencies of three transfection agents, Lipofectamine 2000, ScreenFect A and BPEI 1.2 k in delivering fluorescent-labelled siRNA into human Simpson-Golabi-Behmel syndrome (SGBS) preadipocytes and adipocytes. Downregulation of a specific target gene in response to miRNA mimic overexpression was assayed in SGBS cells and also in ex vivo differentiated primary human adipocytes. Our results demonstrated that while all three transfection agents were able to internalize the oligos, only lipofection resulted in the efficient downregulation of a specific target gene both in SGBS cells and in primary human adipocytes. Lipofectamine 2000 outperformed ScreenFect A in preadipocytes, but in adipocytes the two reagents gave comparable results making ScreenFect A a notable new alternative for the gold standard Lipofectamine 2000.	[Enlund, Eveliina; Wabitsch, Martin; Fischer-Posovszky, Pamela] Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany; [Fischer, Simon; Handrick, Rene; Otte, Kerstin] Univ Appl Sci Biberach, Inst Appl Biotechnol, Biberach, Germany; [Debatin, Klaus-Michael] Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, D-89069 Ulm, Germany	Ulm University; Ulm University	Fischer-Posovszky, P (corresponding author), Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany.	pamela.fischer@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886; Fischer-Posovszky, Pamela/0000-0003-3402-9840	European Society for Paediatric Endocrinology (ESPE-Research Unit Grant); Ministry of Science, Research and Arts Baden-Wuerttemberg; European Social Fund Baden-Wuerttemberg; International Graduate School in Molecular Medicine Ulm; "Cooperative Research Training Group Pharmaceutical Biotechnology" stated by the Postgraduate Scholarships Act of the Ministry for Science, Research and Arts of the federal state government of Baden-Wuerttemberg, Germany	European Society for Paediatric Endocrinology (ESPE-Research Unit Grant); Ministry of Science, Research and Arts Baden-Wuerttemberg; European Social Fund Baden-Wuerttemberg(European Social Fund (ESF)); International Graduate School in Molecular Medicine Ulm; "Cooperative Research Training Group Pharmaceutical Biotechnology" stated by the Postgraduate Scholarships Act of the Ministry for Science, Research and Arts of the federal state government of Baden-Wuerttemberg, Germany	This project was supported by the European Society for Paediatric Endocrinology (ESPE-Research Unit Grant). PFP was also funded by the Ministry of Science, Research and Arts Baden-Wuerttemberg and the European Social Fund Baden-Wuerttemberg. EE was financed by the International Graduate School in Molecular Medicine Ulm. SF was funded by "Cooperative Research Training Group Pharmaceutical Biotechnology" stated by the Postgraduate Scholarships Act of the Ministry for Science, Research and Arts of the federal state government of Baden-Wuerttemberg, Germany. SF was a member of the International Graduate School in Molecular Medicine Ulm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2009, MACROMOL BIOSCI, V9, P1247, DOI 10.1002/mabi.200900249; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fischer S, 2013, J BIOTECHNOL, V168, P589, DOI 10.1016/j.jbiotec.2013.08.027; Fischer-Posovszky P, 2012, MOL CELL ENDOCRINOL, V358, P135, DOI 10.1016/j.mce.2012.03.018; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; Hauner H, 2000, METH MOL B, V155, P239; Iwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033402; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	18	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98023	10.1371/journal.pone.0098023	http://dx.doi.org/10.1371/journal.pone.0098023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849298	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600078
J	Huntelmann, B; Staab, J; Herrmann-Lingen, C; Meyer, T				Huentelmann, Bettina; Staab, Julia; Herrmann-Lingen, Christoph; Meyer, Thomas			A Conserved Motif in the Linker Domain of STAT1 Transcription Factor Is Required for Both Recognition and Release from High-Affinity DNA-Binding Sites	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; NUCLEAR IMPORT; SIGNAL-TRANSDUCTION; IFN-GAMMA; ACTIVATION; INACTIVATION; DETERMINES; DIMERS; ALPHA; DEPHOSPHORYLATION	Binding to specific palindromic sequences termed gamma-activated sites (GAS) is a hallmark of gene activation by members of the STAT (signal transducer and activator of transcription) family of cytokine-inducible transcription factors. However, the precise molecular mechanisms involved in the signal-dependent finding of target genes by STAT dimers have not yet been very well studied. In this study, we have characterized a sequence motif in the STAT1 linker domain which is highly conserved among the seven human STAT proteins and includes surface-exposed residues in close proximity to the bound DNA. Using site-directed mutagenesis, we have demonstrated that a lysine residue in position 567 of the full-length molecule is required for GAS recognition. The substitution of alanine for this residue completely abolished both binding to high-affinity GAS elements and transcriptional activation of endogenous target genes in cells stimulated with interferon-c (IFN gamma), while the time course of transient nuclear accumulation and tyrosine phosphorylation were virtually unchanged. In contrast, two glutamic acid residues (E559 and E563) on each monomer are important for the dissociation of dimeric STAT1 from DNA and, when mutated to alanine, result in elevated levels of tyrosine-phosphorylated STAT1 as well as prolonged IFN gamma-stimulated nuclear accumulation. In conclusion, our data indicate that the kinetics of signal-dependent GAS binding is determined by an array of glutamic acid residues located at the interior surface of the STAT1 dimer. These negatively charged residues appear to align the long axis of the STAT1 dimer in a position perpendicular to the DNA, thereby facilitating the interaction between lysine 567 and the phosphodiester backbone of a bound GAS element, which is a prerequisite for transient gene induction.	[Huentelmann, Bettina; Staab, Julia; Herrmann-Lingen, Christoph; Meyer, Thomas] Univ Gottingen, Klin Psychosomat Med & Psychotherapie, D-37073 Gottingen, Germany	University of Gottingen	Meyer, T (corresponding author), Univ Gottingen, Klin Psychosomat Med & Psychotherapie, D-37073 Gottingen, Germany.	thomas.meyer@med.uni-goettingen.de	Herrmann-Lingen, Christoph/ABC-9496-2021		Deutsche Forschungsgemeinschaft [TM1648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research on this subject was funded by a grant from the Deutsche Forschungsgemeinschaft to TM (TM1648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Koch V, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-22; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Meyer T, 2004, J BIOL CHEM, V279, P18998, DOI 10.1074/jbc.M400766200; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Meyer T, 2010, METHODS MOL BIOL, V647, P139, DOI 10.1007/978-1-60761-738-9_8; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Speil J, 2011, BIOPHYS J, V101, P2592, DOI 10.1016/j.bpj.2011.10.006; Staab J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069903; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	45	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97633	10.1371/journal.pone.0097633	http://dx.doi.org/10.1371/journal.pone.0097633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847715	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600044
J	Sui, XB; Xu, YH; Yang, J; Fang, Y; Lou, HZ; Han, WD; Zhang, ML; Chen, W; Wang, KF; Li, D; Jin, W; Lou, F; Zheng, Y; Hu, H; Gong, L; Zhou, XY; Pan, Q; Pan, HM; Wang, X; He, C				Sui, Xinbing; Xu, Yinghua; Yang, Jie; Fang, Yong; Lou, Haizhou; Han, Weidong; Zhang, Maolin; Chen, Wei; Wang, Kaifeng; Li, Da; Jin, Wei; Lou, Fang; Zheng, Yu; Hu, Hong; Gong, Liu; Zhou, Xiaoyun; Pan, Qin; Pan, Hongming; Wang, Xian; He, Chao			Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation	PLOS ONE			English	Article							LKB1-AMPK PATHWAY; PROTEIN-KINASE; LEUKEMIA; GROWTH; LIVER; RISK; TRANSFORMATION; PROLIFERATION; METABOLISM; INDUCTION	Colorectal cancer (CRC) is still the third most common cancer and the second most common causes of cancer-related death around the world. Metformin, a biguanide, which is widely used for treating diabetes mellitus, has recently been shown to have a suppressive effect on CRC risk and mortality, but not all laboratory studies suggest that metformin has antineoplastic activity. Here, we investigated the effect of metformin and AMPK activator AICAR on CRC cells proliferation. As a result, metformin did not inhibit cell proliferation or induce apoptosis for CRC cell lines in vitro and in vivo. Different from metformin, AICAR emerged antitumor activity and sensitized anticancer effect of 5-FU on CRC cells in vitro and in vivo. In further analysis, we show that AMPK activation may be a key molecular mechanism for the additive effect of AICAR. Taken together, our results suggest that metformin has not antineoplastic activity for CRC cells as a single agent but AMPK activator AICAR can induce apoptosis and enhance the cytotoxic effect of 5-FU through AMPK activation.	[Sui, Xinbing; Xu, Yinghua; Yang, Jie; Fang, Yong; Lou, Haizhou; Han, Weidong; Chen, Wei; Wang, Kaifeng; Li, Da; Jin, Wei; Lou, Fang; Zheng, Yu; Hu, Hong; Gong, Liu; Zhou, Xiaoyun; Pan, Qin; Pan, Hongming; Wang, Xian] Zhejiang Univ, Dept Med Oncol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Sui, Xinbing; Xu, Yinghua; Fang, Yong; Lou, Haizhou; Han, Weidong; Zhang, Maolin; Pan, Hongming; Wang, Xian; He, Chao] Biomed Res Ctr, Hangzhou, Zhejiang, Peoples R China; [Sui, Xinbing; Xu, Yinghua; Fang, Yong; Lou, Haizhou; Han, Weidong; Zhang, Maolin; Pan, Hongming; Wang, Xian; He, Chao] Key Lab Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Zhang, Maolin; He, Chao] Zhejiang Univ, Dept Colorectal Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Pan, HM (corresponding author), Zhejiang Univ, Dept Med Oncol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	drpanhm@aliyun.com; wangxzju@163.com; drhechao@yahoo.com.cn			National Natural Science Foundation of China [81301891, 81272593]; Zhejiang Provincial Natural Science Foundation of China [LQ13H160008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study is supported by grants from National Natural Science Foundation of China (grant No. 81301891 and 81272593) and Zhejiang Provincial Natural Science Foundation of China (grant No. LQ13H160008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar S, 2012, CANCER-AM CANCER SOC, V118, P1202, DOI 10.1002/cncr.26439; Berstein LM, 2013, CELL CYCLE, V12, P3681, DOI 10.4161/cc.26868; Bodmer M, 2012, LUNG CANCER, V78, P133, DOI 10.1016/j.lungcan.2012.08.010; Bodmer M, 2012, CANCER EPIDEM BIOMAR, V21, P280, DOI 10.1158/1055-9965.EPI-11-0992-T; Bonanni B, 2012, J CLIN ONCOL, V30, P2593, DOI 10.1200/JCO.2011.39.3769; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Chae HD, 2012, STEM CELLS, V30, P140, DOI 10.1002/stem.778; Cossor FI, 2012, J CLIN ONCOL S, V30; Cufi S, 2013, ONCOTARGET, V4, P1484, DOI 10.18632/oncotarget.1234; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Harris D, 2013, CURR ONCOL, V20, pE532, DOI 10.3747/co.20.1499; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Karpinski P, 2008, J APPL GENET, V49, P1, DOI 10.1007/BF03195243; Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Lo AKF, 2013, J PATHOL, V230, P336, DOI 10.1002/path.4201; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Martelli AM, 2012, EXPERT OPIN THER TAR, V16, P729, DOI 10.1517/14728222.2012.694869; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Morgillo F, 2013, CLIN CANCER RES, V19, P3508, DOI 10.1158/1078-0432.CCR-12-2777; Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Phoenix KN, 2009, BREAST CANCER RES TR, V113, P101, DOI 10.1007/s10549-008-9916-5; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Ryu JH, 2008, BIOCHEM BIOPH RES CO, V366, P438, DOI 10.1016/j.bbrc.2007.11.134; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Spillane S, 2014, CANCER EPIDEMIOL, pS1877; Takahashi H, 2013, J GASTROEN HEPATOL, V28, P41, DOI 10.1111/jgh.12240; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Vakana E, 2011, ONCOTARGET, V2, P1322; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Zang Y, 2009, J BIOL CHEM, V284, P6175, DOI 10.1074/jbc.M806887200; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081264	45	38	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97781	10.1371/journal.pone.0097781	http://dx.doi.org/10.1371/journal.pone.0097781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849329	gold, Green Submitted, Green Published			2022-12-27	WOS:000336730600059
J	Kiba, A; Galis, I; Hojo, Y; Ohnishi, K; Yoshioka, H; Hikichi, Y				Kiba, Akinori; Galis, Ivan; Hojo, Yuko; Ohnishi, Kouhei; Yoshioka, Hirofumi; Hikichi, Yasufumi			SEC14 Phospholipid Transfer Protein Is Involved in Lipid Signaling-Mediated Plant Immune Responses in Nicotiana benthamiana	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; PHOSPHATIDIC-ACID ACCUMULATION; NITRIC-OXIDE; POLYPHOSPHOINOSITIDE METABOLISM; DISEASE RESISTANCE; EFFECTOR MOLECULES; DEFENSE RESPONSES; INNATE IMMUNITY; RAPID TURNOVER; PATHOGEN	We previously identified a gene related to the SEC14-gene phospholipid transfer protein superfamily that is induced in Nicotiana benthamiana (NbSEC14) in response to infection with Ralstonia solanacearum. We here report that NbSEC14 plays a role in plant immune responses via phospholipid-turnover. NbSEC14-silencing compromised expression of defense-related PR-4 and accumulation of jasmonic acid (JA) and its derivative JA-Ile. Transient expression of NbSEC14 induced PR-4 gene expression. Activities of diacylglycerol kinase, phospholipase C and D, and the synthesis of diacylglycerol and phosphatidic acid elicited by avirulent R. solanacearum were reduced in NbSEC14-silenced plants. Accumulation of signaling lipids and activation of diacylglycerol kinase and phospholipases were enhanced by transient expression of NbSEC14. These results suggest that the NbSEC14 protein plays a role at the interface between lipid signaling-metabolism and plant innate immune responses.	[Kiba, Akinori; Hikichi, Yasufumi] Kochi Univ, Fac Agr, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 783, Japan; [Galis, Ivan; Hojo, Yuko] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nankoku, Kochi, Japan; [Yoshioka, Hirofumi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Def Plant Pathogen Interact, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kochi University; Okayama University; Kochi University; Nagoya University	Kiba, A (corresponding author), Kochi Univ, Fac Agr, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 783, Japan.	akiba@kochi-u.ac.jp	Galis, Ivan/F-5734-2011; Ohnishi, Kouhei/AAN-9527-2020	Galis, Ivan/0000-0001-9840-8845	Ministry of Education, Culture, Sports, Science and Technology, Japan [16780031, 18780029, 15028214, 16380037]; Asahi Glass Foundation; Agricultural Chemical Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; Agricultural Chemical Foundation	This work was supported by Grants in Aid for Scientific Research to AK (16780031 and 18780029) and YH (15028214 and 16380037) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. AK is also grateful for financial support from the Asahi Glass Foundation, and Agricultural Chemical Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bankaitis VA, 2007, ADV ENZYME REGUL, V47, P27, DOI 10.1016/j.advenzreg.2006.12.007; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; DROBAK BK, 1994, PLANT J, V6, P389, DOI 10.1046/j.1365-313X.1994.06030389.x; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Fukumoto K, 2013, J INTEGR PLANT BIOL, V55, P775, DOI 10.1111/jipb.12057; Gechev TS, 2005, J CELL BIOL, V168, P17, DOI 10.1083/jcb.200409170; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Helling D, 2006, PLANT CELL, V18, P3519, DOI 10.1105/tpc.106.047373; Huitema E, 2005, MOL PLANT MICROBE IN, V18, P183, DOI 10.1094/MPMI-18-0183; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katou Shinpei, 2003, Journal of General Plant Pathology, V69, P161; Kiba A, 2012, J PLANT PHYSIOL, V169, P1017, DOI 10.1016/j.jplph.2012.04.002; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Laxalt AM, 2001, PLANT J, V26, P237, DOI 10.1046/j.1365-313X.2001.01023.x; Laxalt AM, 2007, J BIOL CHEM, V282, P21160, DOI 10.1074/jbc.M701212200; Maimbo M, 2007, PLANT PHYSIOL, V145, P1588, DOI 10.1104/pp.107.105353; Maimbo M, 2010, PLANT PHYSIOL, V152, P2023, DOI 10.1104/pp.109.148189; Monks DE, 2001, PLANT CELL, V13, P1205, DOI 10.1105/tpc.13.5.1205; Munnik T, 2000, PLANT J, V22, P147, DOI 10.1046/j.1365-313x.2000.00725.x; Munnik T, 1998, PLANTA, V207, P133, DOI 10.1007/s004250050465; MUNNIK T, 1994, BIOCHEM J, V298, P269, DOI 10.1042/bj2980269; MUNNIK T, 1994, PLANTA, V193, P89, DOI 10.1007/BF00191611; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075124; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; OHASHI M, 1995, NATURE, V377, P544, DOI 10.1038/377544a0; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Pejchar P, 2010, NEW PHYTOL, V188, P150, DOI 10.1111/j.1469-8137.2010.03349.x; Peterman TK, 2004, PLANT PHYSIOL, V136, P3080, DOI 10.1104/pp.104.045369; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Testerink C, 2007, J EXP BOT, V58, P3905, DOI 10.1093/jxb/erm243; TOYODA K, 1993, PLANT CELL PHYSIOL, V34, P729, DOI 10.1093/oxfordjournals.pcp.a078476; TOYODA K, 1992, PLANT CELL PHYSIOL, V33, P445; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Vossen JH, 2010, PLANT J, V62, P224, DOI 10.1111/j.1365-313X.2010.04136.x; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wimalasekera R, 2010, MOL PLANT, V3, P610, DOI 10.1093/mp/ssq005; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Yoshioka H, 2009, MOL CELLS, V28, P321, DOI 10.1007/s10059-009-0156-2; Young SA, 1996, PLANT CELL, V8, P1079, DOI 10.1105/tpc.8.6.1079; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992; Zien CA, 2001, BBA-MOL CELL BIOL L, V1530, P236, DOI 10.1016/S1388-1981(01)00091-9; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	63	30	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98150	10.1371/journal.pone.0098150	http://dx.doi.org/10.1371/journal.pone.0098150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845602	gold, Green Submitted, Green Published			2022-12-27	WOS:000339563400102
J	Koopmann, TT; Adriaens, ME; Moerland, PD; Marsman, RF; Westerveld, ML; Lal, S; Zhang, TF; Simmons, CQ; Baczko, I; dos Remedios, C; Bishopric, NH; Varro, A; George, AL; Lodder, EM; Bezzina, CR				Koopmann, Tamara T.; Adriaens, Michiel E.; Moerland, Perry D.; Marsman, Roos F.; Westerveld, Margriet L.; Lal, Sean; Zhang, Taifang; Simmons, Christine Q.; Baczko, Istvan; dos Remedios, Cristobal; Bishopric, Nanette H.; Varro, Andras; George, Alfred L., Jr.; Lodder, Elisabeth M.; Bezzina, Connie R.			Genome-Wide Identification of Expression Quantitative Trait Loci (eQTLs) in Human Heart	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; COMMON GENETIC-VARIATION; CORONARY-ARTERY-DISEASE; QT INTERVAL DURATION; ATRIAL-FIBRILLATION; RISK-FACTOR; VENTRICULAR-FIBRILLATION; CARDIAC REPOLARIZATION; ASSOCIATION ANALYSIS; FAMILY-HISTORY	In recent years genome-wide association studies (GWAS) have uncovered numerous chromosomal loci associated with various electrocardiographic traits and cardiac arrhythmia predisposition. A considerable fraction of these loci lie within inter-genic regions. The underlying trait-associated variants likely reside in regulatory regions and exert their effect by modulating gene expression. Hence, the key to unraveling the molecular mechanisms underlying these cardiac traits is to interrogate variants for association with differential transcript abundance by expression quantitative trait locus (eQTL) analysis. In this study we conducted an eQTL analysis of human heart. For a total of 129 left ventricular samples that were collected from non-diseased human donor hearts, genome-wide transcript abundance and genotyping was determined using microarrays. Each of the 18,402 transcripts and 897,683 SNP genotypes that remained after pre-processing and stringent quality control were tested for eQTL effects. We identified 771 eQTLs, regulating 429 unique transcripts. Overlaying these eQTLs with cardiac GWAS loci identified novel candidates for studies aimed at elucidating the functional and transcriptional impact of these loci. Thus, this work provides for the first time a comprehensive eQTL map of human heart: a powerful and unique resource that enables systems genetics approaches for the study of cardiac traits.	[Koopmann, Tamara T.; Adriaens, Michiel E.; Marsman, Roos F.; Westerveld, Margriet L.; Lodder, Elisabeth M.; Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Lal, Sean; dos Remedios, Cristobal] Univ Sydney, Bosch Inst, Dept Anat, Muscle Res Unit, Sydney, NSW 2006, Australia; [Zhang, Taifang; Bishopric, Nanette H.] Univ Miami, Sch Med, Dept Med, Miami, FL USA; [Simmons, Christine Q.; George, Alfred L., Jr.] Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN USA; [Baczko, Istvan; Varro, Andras] Univ Szeged, Fac Med, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Bishopric, Nanette H.] Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Sydney; University of Miami; Vanderbilt University; Szeged University; University of Miami	Bezzina, CR (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Expt Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.r.bezzina@amc.uva.nl	Lodder, Elisabeth/X-5385-2019; Baczko, István/I-7752-2019; Moerland, Perry/AAG-1425-2020; Varro, Andras/M-2647-2016	Lodder, Elisabeth/0000-0001-6017-3796; Baczko, István/0000-0002-9588-0797; Moerland, Perry/0000-0002-2357-3659; Adriaens, Michiel/0000-0002-4472-7119; Bezzina, Connie/0000-0002-0633-3514	Netherlands CardioVascular Research Initiative (CVON PREDICT): the Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development; Royal Netherlands Academy of Sciences; NIH [HL068880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068880] Funding Source: NIH RePORTER	Netherlands CardioVascular Research Initiative (CVON PREDICT): the Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the support from the Netherlands CardioVascular Research Initiative (CVON PREDICT): the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences. Tissue collections performed at Vanderbilt University were supported by NIH grant HL068880 (A. L. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Gaunt TR, 2012, CIRC-CARDIOVASC GENE, V5, P630, DOI 10.1161/CIRCGENETICS.112.962852; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Hawe E, 2003, ANN HUM GENET, V67, P97, DOI 10.1046/j.1469-1809.2003.00017.x; Hernandez DG, 2012, NEUROBIOL DIS, V47, P20, DOI 10.1016/j.nbd.2012.03.020; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kolder ICRM, 2012, J MOL CELL CARDIOL, V52, P620, DOI 10.1016/j.yjmcc.2011.12.014; Kooij V, 2010, BASIC RES CARDIOL, V105, P289, DOI 10.1007/s00395-009-0053-z; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; MYERS RH, 1990, AM HEART J, V120, P963, DOI 10.1016/0002-8703(90)90216-K; Nerbonne JM, 2002, J CARDIOVASC ELECTR, V13, P406, DOI 10.1046/j.1540-8167.2002.00406.x; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nolte IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006138; Owen SA, 2013, PHARMACOGENOMICS J, V13, P227, DOI 10.1038/tpj.2012.7; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; R Core Team, 2012, R LANG ENV STAT COMP; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sharma S, 2003, CARDIOLOGY, V100, P73, DOI 10.1159/000073042; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Smith JG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001304; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tsubakihara M, 2004, PROTEOMICS, V4, P261, DOI 10.1002/pmic.200300539; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wessels JAM, 2006, ARTHRITIS RHEUM, V54, P1087, DOI 10.1002/art.21726; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	60	36	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97380	10.1371/journal.pone.0097380	http://dx.doi.org/10.1371/journal.pone.0097380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846176	Green Accepted, gold, Green Published			2022-12-27	WOS:000339563400026
J	Lee, HJ; Kim, KS; Ahn, J; Bae, HM; Lim, I; Kim, SU				Lee, Hong J.; Kim, Kwang S.; Ahn, Jin; Bae, Hye M.; Lim, Inja; Kim, Seung U.			Human Motor Neurons Generated from Neural Stem Cells Delay Clinical Onset and Prolong Life in ALS Mouse Model	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DIRECTED DIFFERENTIATION; RAT MODEL; TRANSPLANTATION; SURVIVAL; RECOVERY; DELIVERY; IDENTITY; THERAPY; DISEASE	Amyotrophic lateral sclerosis (ALS) is the most common adult onset motor neuron disease. The etiology and pathogenic mechanisms of the disease remain unknown, and there is no effective treatment. Here we show that intrathecal transplantation of human motor neurons derived from neural stem cells (NSCs) in spinal cord of the SOD1G93A mouse ALS model delayed disease onset and extended life span of the animals. When HB1.F3.Olig2 (F3.Olig2) cells, stable immortalized human NSCs encoding the human Olig2 gene, were treated with sonic hedgehog (Shh) protein for 5-7 days, the cells expressed motor neuron cell type-specific phenotypes Hb9, Isl-1 and choline acetyltransferase (ChAT). These F3.Olig2-Shh human motor neurons were transplanted intrathecally in L5-L6 spinal cord of SOD1G93A mice, and at 4 weeks post-transplantation, transplanted F3.Olig2-Shh motor neurons expressing the neuronal phenotype markers NF, MAP2, Hb9, and ChAT were found in the ventral horn of the spinal cord. Onset of clinical signs in ALS mice with F3.Olig2-Shh motor neuron implants was delayed for 7 days and life span of animals was significantly extended by 20 days. Our results indicate that this treatment modality of intrathecal transplantation of human motor neurons derived from NSCs might be of value in the treatment of ALS patients without significant adverse effects.	[Lee, Hong J.; Kim, Kwang S.; Ahn, Jin; Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea; [Kim, Kwang S.; Bae, Hye M.; Lim, Inja] Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; University of British Columbia	Kim, SU (corresponding author), Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea.	sukim@mail.ubc.ca			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A12021412010000100]; Canadian Myelin Research Initiative	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Canadian Myelin Research Initiative	This study was supported by grants from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A12021412010000100), and Canadian Myelin Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel SH, 2008, NEUROLOGY, V71, P1326, DOI 10.1212/01.wnl.0000327668.43541.22; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Hefferan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042614; Hwang DH, 2009, GENE THER, V16, P1234, DOI 10.1038/gt.2009.80; Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kaspar BK, 2008, MOL THER, V16, P1905, DOI 10.1038/mt.2008.216; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kim H, 2010, NEUROSCI LETT, V468, P190, DOI 10.1016/j.neulet.2009.10.074; Kim KS, 2011, P NATL ACAD SCI USA, V108, P4876, DOI 10.1073/pnas.1019743108; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kim WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084292; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mitrecic D, 2010, CELL TRANSPLANT, V19, P537, DOI 10.3727/096368910X498269; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Papadeas ST, 2009, CURR OPIN BIOTECH, V20, P545, DOI 10.1016/j.copbio.2009.09.003; Riley J, 2012, NEUROSURGERY, V71, P405, DOI 10.1227/NEU.0b013e31825ca05f; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Silani V, 2010, CNS NEUROL DISORD-DR, V9, P314, DOI 10.2174/187152710791292666; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Teng YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004579; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zheng CY, 2004, ANN NEUROL, V56, P564, DOI 10.1002/ana.20223	34	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97518	10.1371/journal.pone.0097518	http://dx.doi.org/10.1371/journal.pone.0097518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844281	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400032
J	Peh, KSH; Sonke, B; Sene, O; Djuikouo, MNK; Nguembou, CK; Taedoumg, H; Begne, SK; Lewis, SL				Peh, Kelvin S. -H.; Sonke, Bonaventure; Sene, Olivier; Djuikouo, Marie-Noel K.; Nguembou, Charlemagne K.; Taedoumg, Hermann; Begne, Serge K.; Lewis, Simon L.			Mixed-Forest Species Establishment in a Monodominant Forest in Central Africa: Implications for Tropical Forest Invasibility	PLOS ONE			English	Article							RAIN-FOREST; WOOD DENSITY; DIVERSITY; BIOMASS; EXTINCTION; RICHNESS; HISTORY; BIRDS; TREES; BIODIVERSITY	Background: Traits of non-dominant mixed-forest tree species and their synergies for successful co-occurrence in monodominant Gilbertiodendron dewevrei forest have not yet been investigated. Here we compared the tree species diversity of the monodominant forest with its adjacent mixed forest and then determined which fitness proxies and life history traits of the mixed-forest tree species were most associated with successful co-existence in the monodominant forest. Methodology/Principal Findings: We sampled all trees (diameter in breast height [dbh]>= 10 cm) within 661 ha topographically homogenous areas of intact central African forest in SE Cameroon, three independent patches of G. dewevrei-dominated forest and three adjacent areas (450-800 m apart). Monodominant G. dewevrei forest had lower sample-controlled species richness, species density and population density than its adjacent mixed forest in terms of stems with dbh >= 10 cm. Analysis of a suite of population-level characteristics, such as relative abundance and geographical distribution, and traits such as wood density, height, diameter at breast height, fruit/seed dispersal mechanism and light requirement-revealed after controlling for phylogeny, species that co-occur with G. dewevrei tend to have higher abundance in adjacent mixed forest, higher wood density and a lower light requirement. Conclusions/Significance: Our results suggest that certain traits (wood density and light requirement) and population-level characteristics (relative abundance) may increase the invasibility of a tree species into a tropical closed-canopy system. Such knowledge may assist in the pre-emptive identification of invasive tree species.	[Peh, Kelvin S. -H.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Peh, Kelvin S. -H.; Begne, Serge K.; Lewis, Simon L.] Univ Leeds, Sch Geog, Ecol & Global Change Grp, Leeds LS2 9JT, W Yorkshire, England; [Peh, Kelvin S. -H.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Sonke, Bonaventure; Taedoumg, Hermann] Univ Yaounde I, Higher Teachers Training Coll, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Sene, Olivier] Inst Agr Res Dev, Yaounde, Cameroon; [Djuikouo, Marie-Noel K.] Univ Buea, Dept Bot & Plant Physiol, Buea, Cameroon; [Nguembou, Charlemagne K.] African Forest Forum, Nairobi, Kenya; [Begne, Serge K.] Cameroon Biodivers Conservat Soc, Yaounde, Cameroon; [Lewis, Simon L.] UCL, Dept Geog, London, England	University of Southampton; University of Leeds; University of Cambridge; University of Yaounde I; University of London; University College London	Peh, KSH (corresponding author), Univ Southampton, Inst Life Sci, Southampton, Hants, England.	kelvin.peh@gmail.com	Peh, Kelvin/C-3408-2013	Peh, Kelvin/0000-0002-2921-1341; Lewis, Simon/0000-0002-8066-6851	European Union; AXA Fellowship; Southampton University's IFLS Fellowship; Royal Society University Research Fellowship; T-Forces project - European Research Council; EU program GEOCARBON; Phillip Leverhulme Prize; Natural Environment Research Council [NE/D000300/1] Funding Source: researchfish	European Union(European Commission); AXA Fellowship(AXA Research Fund); Southampton University's IFLS Fellowship; Royal Society University Research Fellowship(Royal Society of London); T-Forces project - European Research Council; EU program GEOCARBON; Phillip Leverhulme Prize; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KSHP was supported by the European Union Marie Curie EST Fellowship, AXA Fellowship and Southampton University's IFLS Fellowship. SLL was supported by a Royal Society University Research Fellowship, T-Forces project funded by the European Research Council, the EU program GEOCARBON, and a Phillip Leverhulme Prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Banasiak SE, 2009, BIOL INVASIONS, V11, P215, DOI 10.1007/s10530-008-9226-1; Brown S, 1997, ESTIMATING BIOMASS B; Burnham K. P., 1998, MODEL SELECTION INFE; Cassey P, 2008, WILDLIFE RES, V35, P193, DOI 10.1071/WR07109; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2007, ESTIMATES STAT ESTIM; Condit R, 1998, TROPICAL FOREST CENS; CONNELL JH, 1989, AM NAT, V134, P88, DOI 10.1086/284967; Conway D, 1992, THESIS U ABERDEEN AB; Djuikouo MNK, 2010, AFR J ECOL, V48, P1053, DOI 10.1111/j.1365-2028.2010.01212.x; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; GARTNER BL, 1989, BIOTROPICA, V21, P303, DOI 10.2307/2388280; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Harcourt AH, 2002, J BIOGEOGR, V29, P445, DOI 10.1046/j.1365-2699.2002.00685.x; HART TB, 1989, AM NAT, V133, P613, DOI 10.1086/284941; Hart TB, 1985, THESIS MICHIGAN STAT; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; Kyereh B, 1999, J ECOL, V87, P772, DOI 10.1046/j.1365-2745.1999.00386.x; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lozon Joseph D., 1997, Environmental Reviews, V5, P131, DOI 10.1139/er-5-2-131; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P492; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P159; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Marcon E, 2012, OIKOS, V121, P516, DOI 10.1111/j.1600-0706.2011.19267.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McGinley M, 2008, ENCY EARTH; Menard S, 2002, SAGE U PAPERS SERIES; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Parmentier I, 2007, J ECOL, V95, P1058, DOI 10.1111/j.1365-2745.2007.01273.x; Peh KSH, 2012, J VEG SCI, V23, P223, DOI 10.1111/j.1654-1103.2011.01352.x; Peh KSH, 2011, J ECOL, V99, P891, DOI 10.1111/j.1365-2745.2011.01827.x; Peh KSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016996; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Phillips O, 2002, FIELD MANUAL PLOT ES, DOI [10.13140/RG.2.1.1735.7202, DOI 10.13140/RG.2.1.1735.7202]; Poorter L, 2005, J ECOL, V93, P256, DOI 10.1111/j.1365-2745.2004.00956.x; Poorter L, 2012, PLANT ECOL, V213, P707, DOI 10.1007/s11258-012-0032-6; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Development Core Team, 2010, LANG ENV STAT COMP; Read J, 2000, J BIOGEOGR, V27, P233, DOI 10.1046/j.1365-2699.2000.00407.x; Richards PW, 1996, TROPICAL RAIN FOREST, V2; RICHARDSON DM, 1990, J VEG SCI, V1, P629, DOI 10.2307/3235569; Sonke B, 2004, SCRIPTA BOT BELGICA, V32; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Tanentzap AJ, 2009, OIKOS, V118, P300, DOI 10.1111/j.1600-0706.2008.17069.x; Torti SD, 2001, AM NAT, V157, P141, DOI 10.1086/318629; van Gelder HA, 2006, NEW PHYTOL, V171, P367, DOI 10.1111/j.1469-8137.2006.01757.x; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; VanderMeer PJ, 1996, J ECOL, V84, P19, DOI 10.2307/2261696; Veltman CJ, 1996, AM NAT, V147, P542, DOI 10.1086/285865; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230	58	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97585	10.1371/journal.pone.0097585	http://dx.doi.org/10.1371/journal.pone.0097585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844914	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000339563400037
J	Wang, HQ; Tu, MF; Fu, R; Wu, YH; Liu, H; Xing, LM; Shao, ZH				Wang, Huaquan; Tu, Meifeng; Fu, Rong; Wu, Yuhong; Liu, Hong; Xing, Limin; Shao, Zonghong			The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China	PLOS ONE			English	Article							VIRAL-HEPATITIS; EPIDEMIOLOGY; VIRUS; CELLS	Hepatitis-associated aplastic anemia (HAAA) is a variant of severe aplastic anemia (SAA) in which bone marrow failure follows an acute attack of hepatitis. Its pathogenesis is poorly understood. We investigated the prevalence of HAAA among cases of newly diagnosed SAA presenting to our hospital between January 1998 and February 2013, and analyzed the clinical and immune characteristics of HAAA and non-hepatitis-associated SAA (non-HASAA) patients. The prevalence of HAAA among cases of SAA was 3.8% (36/949), and the majority of patients (33/36) were seronegative for a known hepatitis virus. Compared with non-HASAA patients, HAAA patients had a larger proportion of CD8+ T cells, a lower ratio of CD4+/CD8+ T cells, and a smaller proportion of CD4+CD25+ regulatory T cells. There was no significant difference in peripheral blood count, bone marrow cellularity, or the number of blood transfusions received between HAAA and non-HASAA patients. HAAA patients had a higher early infection rate and more infection-related mortality in the first 2 years after diagnosis than non-HASAA patients, and their 2-year survival rate was lower. The results demonstrate that HAAA patients have a more severe T cell imbalance and a poorer prognosis than non-HASAA patients.	[Wang, Huaquan; Fu, Rong; Wu, Yuhong; Liu, Hong; Xing, Limin; Shao, Zonghong] Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China; [Tu, Meifeng] Peking Univ, Sch Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Lymphoma,Beijing Canc Hosp & Ins, Beijing 100871, Peoples R China	Tianjin Medical University; Peking University	Shao, ZH (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China.	shaozonghong@sina.com	Wang, Huaquan/AAN-6917-2021		Natural Science Foundation of China [30971286, 30971285, 81170472, 81370607]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is partly supported by Natural Science Foundation of China (No. 30971286, 30971285, 81170472, 81370607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BAUMELOU E, 1993, BLOOD, V81, P1471; Brown KE, 1997, NEW ENGL J MED, V336, P1059, DOI 10.1056/NEJM199704103361504; Cengiz C, 2007, DIGEST DIS SCI, V52, P2438, DOI 10.1007/s10620-006-9280-4; Gonzalez-Casas R, 2009, ALIMENT PHARM THER, V30, P436, DOI 10.1111/j.1365-2036.2009.04060.x; HAGLER L, 1975, MEDICINE, V54, P139, DOI 10.1097/00005792-197554020-00003; HIBBS JR, 1992, JAMA-J AM MED ASSOC, V267, P2051; Ikawa Y, 2013, BRIT J HAEMATOL, V161, P599, DOI 10.1111/bjh.12259; Ikeda T, 2012, J PEDIAT HEMATOL ONC, V34, P375, DOI 10.1097/MPH.0b013e31822bf699; Locasciulli A, 2010, BRIT J HAEMATOL, V149, P890, DOI 10.1111/j.1365-2141.2010.08194.x; Lu J, 2004, BLOOD, V103, P4588, DOI 10.1182/blood-2003-11-3959; Osugi Y, 2007, HAEMATOLOGICA, V92, P1687, DOI 10.3324/haematol.11359; Pardi DS, 1998, AM J GASTROENTEROL, V93, P468, DOI 10.1111/j.1572-0241.1998.468_1.x; Rauff B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-87; Safadi R, 2001, BONE MARROW TRANSPL, V27, P183, DOI 10.1038/sj.bmt.1702749; Shi J, 2012, BLOOD, V120, P1624, DOI 10.1182/blood-2011-11-390708; Xu BY, 2013, P NATL ACAD SCI USA, V110, P10264, DOI 10.1073/pnas.1303744110	16	23	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98142	10.1371/journal.pone.0098142	http://dx.doi.org/10.1371/journal.pone.0098142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845454	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400101
J	Andrew, EVW; Pell, C; Angwin, A; Auwun, A; Daniels, J; Mueller, I; Phuanukoonnon, S; Pool, R				Andrew, Erin V. W.; Pell, Christopher; Angwin, Angeline; Auwun, Alma; Daniels, Job; Mueller, Ivo; Phuanukoonnon, Suparat; Pool, Robert			Factors Affecting Attendance at and Timing of Formal Antenatal Care: Results from a Qualitative Study in Madang, Papua New Guinea	PLOS ONE			English	Article							PREGNANT-WOMEN; SULFADOXINE-PYRIMETHAMINE; MATERNAL MORTALITY; RURAL MALAWI; SOUTH-AFRICA; MALARIA; HEALTH; PERCEPTIONS; SERVICES; PERSPECTIVES	Background: Appropriate antenatal care (ANC) is key for the health of mother and child. However, in Papua New Guinea (PNG), only a third of women receive any ANC during pregnancy. Drawing on qualitative research, this paper explores the influences on ANC attendance and timing of first visit in the Madang region of Papua New Guinea. Methods: Data were collected in three sites utilizing several qualitative methods: free-listing and sorting of terms and definitions, focus group discussions, in-depth interviews, observation in health care facilities and case studies of pregnant women. Respondents included pregnant women, their relatives, biomedical and traditional health providers, opinion leaders and community members. Results: Although generally reported to be important, respondents' understanding of the procedures involved in ANC was limited. Factors influencing attendance fell into three main categories: accessibility, attitudes to ANC, and interpersonal issues. Although women saw accessibility (distance and cost) as a barrier, those who lived close to health facilities and could easily afford ANC also demonstrated poor attendance. Attitudes were shaped by previous experiences of ANC, such as waiting times, quality of care, and perceptions of preventative care and medical interventions during pregnancy. Interpersonal factors included relationships with healthcare providers, pregnancy disclosure, and family conflict. A desire to avoid repeat clinic visits, ideas about the strength of the fetus and parity were particularly relevant to the timing of first ANC visit. Conclusions: This long-term in-depth study (the first of its kind in Madang, PNG) shows how socio-cultural and economic factors influence ANC attendance. These factors must be addressed to encourage timely ANC visits: interventions could focus on ANC delivery in health facilities, for example, by addressing healthcare staff's attitudes towards pregnant women.	[Andrew, Erin V. W.; Pell, Christopher; Mueller, Ivo; Pool, Robert] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Pell, Christopher; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Angwin, Angeline; Auwun, Alma; Daniels, Job; Mueller, Ivo; Phuanukoonnon, Suparat] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Mueller, Ivo] Royal Melbourne Hosp, Walter & Eliza Hall Inst, Infect & Immun Div, Parkville, Vic 3050, Australia	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam; PNG Institute Of Medical Research; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Andrew, EVW (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	erinvwandrew@gmail.com		Pell, Christopher/0000-0001-9405-5851	Malaria in Pregnancy (MiP) Consortium - Bill and Melinda Gates Foundation [OPP46099]	Malaria in Pregnancy (MiP) Consortium - Bill and Melinda Gates Foundation	This research was supported and endorsed by the Malaria in Pregnancy (MiP) Consortium, which is funded by a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org), Grant OPP46099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2001, J MIDWIFERY WOM HEAL, V46, P240, DOI 10.1016/S1526-9523(01)00138-6; Adetunji JA, 1996, SOC SCI MED, V43, P1561, DOI 10.1016/S0277-9536(96)00052-4; Ager A, 2005, HEALTH POLICY PLANN, V20, P176, DOI 10.1093/heapol/czi021; [Anonymous], 2008, WORLDWIDE PREVALENCE; Atuyambe L, 2008, COPING RESPONSES PRE; Atuyambe L, 2009, J ADOLESCENCE, V32, P781, DOI 10.1016/j.adolescence.2008.10.012; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; BMJ Evidence Centre, 2011, BEST PRACT ROUT ANT; BRABIN BJ, 1990, ANN TROP MED PARASIT, V84, P1; Campbell J., 2011, STATE WORLDS MIDWIFE; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Chapman RR, 2006, MED ANTHROPOL Q, V20, P487, DOI 10.1525/maq.2006.20.4.487; Chapman Rachel R, 2004, Med Anthropol, V23, P229, DOI 10.1080/01459740490487107; Chapman RR, 2003, SOC SCI MED, V57, P355, DOI 10.1016/S0277-9536(02)00363-5; Choudhury N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-15; Davis-Floyd Robbie E., 1997, CHILDBIRTH AUTHORITA, P55; Davy C, 2009, PRIMARY HLTH CARE KN; Davy CP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-268; Dowswell T, 2010, COCHRANE DATABASE SY, P10; Duke T, 1999, LANCET, V354, P1291, DOI 10.1016/S0140-6736(99)00335-9; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Garner P., 1990, Health Policy and Planning, V5, P49, DOI 10.1093/heapol/5.1.49; Government of Papua New Guinea, 2010, NAT HLTH PLAN 2011 2; Griffiths P, 2001, J BIOSOC SCI, V33, P339, DOI 10.1017/S002193200100339X; Grossmann-Kendall F, 2001, REPROD HEALTH MATTER, V9, P90, DOI 10.1016/S0968-8080(01)90095-3; Hill Z, 2007, PUBLIC HEALTH NUTR, V10, P827, DOI 10.1017/S1368980007382554; Hinton R, 2010, WOMEN STUD INT FORUM, V33, P180, DOI 10.1016/j.wsif.2009.12.006; Kabakian-Khasholian T, 2000, SOC SCI MED, V51, P103, DOI 10.1016/S0277-9536(99)00443-8; Karel HS, 1999, PACIFIC HLTH DIALOG, V6, P326; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Klufio C, 1993, POPULATION FAMILY HL; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Larsen Gail L., 2004, Papua New Guinea Medical Journal, V47, P202; Launiala A, 2007, T ROY SOC TROP MED H, V101, P980, DOI 10.1016/j.trstmh.2007.04.005; Launiala A, 2006, ACTA TROP, V98, P111, DOI 10.1016/j.actatropica.2005.12.008; MARSHALL LB, 1985, SOC SCI MED, V21, P341, DOI 10.1016/0277-9536(85)90111-X; Mathole T, 2004, MIDWIFERY, V20, P122, DOI 10.1016/j.midw.2003.10.003; Matsuoka S, 2010, HEALTH POLICY, V95, P255, DOI 10.1016/j.healthpol.2009.12.011; Mbonye AK, 2006, HEALTH POLICY, V77, P279, DOI 10.1016/j.healthpol.2005.07.020; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Mrisho M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-10; Mubyazi GM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-54; Mueller Ivo, 2008, Papua New Guinea Medical Journal, V51, P12; Mumtaz Z, 2007, SOCIOL HEALTH ILL, V29, P1, DOI 10.1111/j.1467-9566.2007.00519.x; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Regmi K., 2009, BR J MIDWIFERY, V17, P382, DOI [10.12968/bjom.2009.17.6.42608, DOI 10.12968/BJOM.2009.17.6.42608, DOI 10.12968/BJ0M.2009.17.6.42608]; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sanga K, 2010, AUST NZ J OBSTET GYN, V50, P21, DOI 10.1111/j.1479-828X.2009.01116.x; SHARP PT, 1982, PAPUA NEW GUINEA MED, V25, P108; Simkhada B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-34; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; Strauss A, 1997, GROUNDED THEORY PRAC; Tautz S, 2000, SOC SCI MED, V50, P689, DOI 10.1016/S0277-9536(99)00321-4; Tinoco-Ojanguren R, 2008, SOC SCI MED, V66, P1057, DOI 10.1016/j.socscimed.2007.11.006; Tolhurst R, 2008, MIDWIFERY, V24, P83, DOI 10.1016/j.midw.2006.09.003; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Waiswa Peter, 2008, BMC Pregnancy Childbirth, V8, P21, DOI 10.1186/1471-2393-8-21; Wardlow H, 2004, SIGNS J WOMEN CULTUR, V29; World Bank, 2011, REPR HLTH GLANC PAP; World Health Organization, 2010, COUNTR COOP STRAT PN; World Health Organization, 2002, ANT CAR RAND TRIAL M	65	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e93025	10.1371/journal.pone.0093025	http://dx.doi.org/10.1371/journal.pone.0093025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842484	Green Published, gold			2022-12-27	WOS:000340948600002
J	Elziere, L; Sar, C; Venteo, S; Bourane, S; Puech, S; Sonrier, C; Boukhadaoui, H; Fichard, A; Pattyn, A; Valmier, J; Carroll, P; Mechaly, I				Elziere, Lucie; Sar, Chamroeun; Venteo, Stephanie; Bourane, Steeve; Puech, Sylvie; Sonrier, Corinne; Boukhadaoui, Hassan; Fichard, Agnes; Pattyn, Alexandre; Valmier, Jean; Carroll, Patrick; Mechaly, Ilana			CaMKK-CaMK1a, a New Post-Traumatic Signalling Pathway Induced in Mouse Somatosensory Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ROOT GANGLION NEURONS; NEUROTROPHIC FACTOR; KINASE-I; RECEPTOR COMPONENTS; AXONAL REGENERATION; NEUROPATHIC PAIN; GENE-EXPRESSION; GDNF; AXOTOMY	Neurons innervating peripheral tissues display complex responses to peripheral nerve injury. These include the activation and suppression of a variety of signalling pathways that together influence regenerative growth and result in more or less successful functional recovery. However, these responses can be offset by pathological consequences including neuropathic pain. Calcium signalling plays a major role in the different steps occurring after nerve damage. As part of our studies to unravel the roles of injury-induced molecular changes in dorsal root ganglia (DRG) neurons during their regeneration, we show that the calcium calmodulin kinase CaMK1a is markedly induced in mouse DRG neurons in several models of mechanical peripheral nerve injury, but not by inflammation. Intrathecal injection of NRTN or GDNF significantly prevents the post-traumatic induction of CaMK1a suggesting that interruption of target derived factors might be a starter signal in this de novo induction. Inhibition of CaMK signalling in injured DRG neurons by pharmacological means or treatment with CaMK1a siRNA resulted in decreased velocity of neurite growth in vitro. Altogether, the results suggest that CaMK1a induction is part of the intrinsic regenerative response of DRG neurons to peripheral nerve injury, and is thus a potential target for therapeutic intervention to improve peripheral nerve regeneration.	[Elziere, Lucie; Sar, Chamroeun; Venteo, Stephanie; Puech, Sylvie; Sonrier, Corinne; Boukhadaoui, Hassan; Fichard, Agnes; Pattyn, Alexandre; Valmier, Jean; Carroll, Patrick; Mechaly, Ilana] INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France; [Fichard, Agnes; Valmier, Jean; Mechaly, Ilana] Univ Montpellier 2, Dept BioMV, Montpellier, France; [Bourane, Steeve] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Salk Institute	Mechaly, I (corresponding author), INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France.	imechaly@univ-montp2.fr	Carroll, Patrick/C-2933-2012; Alexandre, Pattyn/ABF-1346-2020; Carroll, Patrick/AAL-7773-2021; Bourane, Steeve/AAI-6143-2020	Carroll, Patrick/0000-0003-3287-8195; Bourane, Steeve/0000-0002-9805-2196; Pattyn, Alexandre/0000-0003-1215-1482	AFM (Association Francaise contre les Myopathies); MESR (Ministere de l'enseignement superieur et de la recherche)	AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); MESR (Ministere de l'enseignement superieur et de la recherche)(Ministry of Research, France)	This work was supported by grants from AFM (Association Francaise contre les Myopathies) and MESR (Ministere de l'enseignement superieur et de la recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; Averill S, 2004, EUR J NEUROSCI, V19, P1437, DOI 10.1111/j.1460-9568.2004.03241.x; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bennett DLH, 2000, J NEUROSCI, V20, P427, DOI 10.1523/JNEUROSCI.20-01-00427.2000; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bolsover SR, 2005, CELL CALCIUM, V37, P395, DOI 10.1016/j.ceca.2005.01.007; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Coggeshall RE, 1997, NEUROSCIENCE, V77, P1115, DOI 10.1016/S0306-4522(96)00528-3; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; Detrait ER, 2000, J NEUROSCI RES, V62, P566, DOI 10.1002/1097-4547(20001115)62:4<566::AID-JNR11>3.3.CO;2-W; Eddleman CS, 1998, J NEUROSCI, V18, P4029; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Gold BG, 1997, NEUROSCIENCE, V76, P1153, DOI 10.1016/S0306-4522(96)00416-2; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hirata A, 2002, BRAIN RES, V944, P146, DOI 10.1016/S0006-8993(02)02739-7; Hoebeeck J, 2005, LAB INVEST, V85, P24, DOI 10.1038/labinvest.3700209; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Ivanavicius SP, 2007, PAIN, V128, P272, DOI 10.1016/j.pain.2006.12.022; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012; Kamata A, 2007, NEUROSCI RES, V57, P86, DOI 10.1016/j.neures.2006.09.013; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Mechaly I, 2006, MOL CELL NEUROSCI, V32, P217, DOI 10.1016/j.mcn.2006.04.004; Mohiuddin L, 1999, NEUROSCIENCE, V91, P265, DOI 10.1016/S0306-4522(98)00582-X; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Neal AP, 2010, J NEUROSCI, V30, P2807, DOI 10.1523/JNEUROSCI.5984-09.2010; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Parikh P, 2011, P NATL ACAD SCI USA, V108, pE99, DOI 10.1073/pnas.1100426108; Patodia S, 2012, CELL TISSUE RES, V349, P15, DOI 10.1007/s00441-012-1416-6; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005; Ramer MS, 2003, EUR J NEUROSCI, V18, P2713, DOI 10.1111/j.1460-9568.2003.03012.x; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Schmutzler BS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-22; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Shadiack AM, 2001, J NEUROSCI, V21, P363, DOI 10.1523/JNEUROSCI.21-02-00363.2001; Smith DS, 1997, J NEUROSCI, V17, P646; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; Szpara ML, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-100; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Tedeschi A, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmo1.2011.00060; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venteo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029852; Vogelaar CF, 2003, EUR J PHARMACOL, V480, P233, DOI 10.1016/j.ejphar.2003.08.110; Wang R, 2003, NEUROSCIENCE, V121, P815, DOI 10.1016/S0306-4522(03)00491-3; Wang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028908; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	69	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97736	10.1371/journal.pone.0097736	http://dx.doi.org/10.1371/journal.pone.0097736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840036	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600065
J	Fioresi, M; Simoes, MR; Furieri, LB; Broseghini, GB; Vescovi, MVA; Stefanon, I; Vassallo, DV				Fioresi, Mirian; Simoes, Maylla Ronacher; Furieri, Lorena Barros; Broseghini-Filho, Gilson Bras; Vescovi, Marcos Vinicius A.; Stefanon, Ivanita; Vassallo, Dalton Valentim			Chronic Lead Exposure Increases Blood Pressure and Myocardial Contractility in Rats	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; NITRIC-OXIDE; INDUCED HYPERTENSION; REST CONTRACTIONS; ATPASE ACTIVITY; AORTA; SYSTEM; PB2+; CA2+	We investigated the cardiovascular effects of lead exposure, emphasising its direct action on myocardial contractility. Male Wistar rats were sorted randomly into two groups: control (Ct) and treatment with 100 ppm of lead (Pb) in the drinking water. Blood pressure (BP) was measured weekly. At the end of the treatment period, the animals were anaesthetised and haemodynamic parameters and contractility of the left ventricular papillary muscles were recorded. Blood and tissue samples were properly stored for further biochemical investigations. Statistical analyses were considered to be significant at p < 0.05. The lead concentrations in the blood reached approximately 13 mu g/dL, while the bone was the site of the highest deposition of this metal. BP in the Pb-treated group was higher from the first week of lead exposure and remained at the same level over the next four weeks. Haemodynamic evaluations revealed increases in systolic (Ct: 96 +/- 3.79 vs. Pb: 116 +/- 1.37 mmHg) and diastolic blood pressure (Ct: 60 +/- 2.93 vs. Pb: 70 +/- 3.38 mmHg), left ventricular systolic pressure (Ct: 104 +/- 5.85 vs. Pb: 120 +/- 2.51 mmHg) and heart rate (Ct: 307 +/- 10 vs. Pb: 348 +/- 16 bpm). Lead treatment did not alter the force and time derivatives of the force of left ventricular papillary muscles that were contracting isometrically. However, our results are suggestive of changes in the kinetics of calcium (Ca++) in cardiomyocytes increased transarcolemmal Ca++ influx, low Ca++ uptake by the sarcoplasmic reticulum and high extrusion by the sarcolemma. Altogether, these results show that despite the increased Ca++ influx that was induced by lead exposure, the myocytes had regulatory mechanisms that prevented increases in force, as evidenced in vivo by the increased systolic ventricular pressure.	[Fioresi, Mirian; Simoes, Maylla Ronacher; Furieri, Lorena Barros; Broseghini-Filho, Gilson Bras; Stefanon, Ivanita; Vassallo, Dalton Valentim] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Fioresi, Mirian; Furieri, Lorena Barros] Univ Fed Espirito Santo, Dept Nursing, Vitoria, ES, Brazil; [Vassallo, Dalton Valentim] Hlth Sci Ctr Vitoria EMESCAM, Vitoria, ES, Brazil; [Vescovi, Marcos Vinicius A.] Univ Fed Espirito Santo, Dept Chem, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; Universidade Federal do Espirito Santo	Fioresi, M (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	mirianfioresi@hotmail.com	Fioresi, Mirian/O-6625-2019; Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Vassallo, Dalton/0000-0002-4463-4174; Stefanon, Ivanita/0000-0003-2638-5183	Capes; FAPESp; CNPq	Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Our study received financial support from Capes, FAPESp CNPq. (http://www.capes.gov.br/; http://www.cnpq.br/; http://www.fapes.es.gov.br/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2007, TOX PROF LEAD; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; BOSCOLO P, 1988, ENVIRON HEALTH PERSP, V78, P101, DOI 10.2307/3430508; Carmignani M, 2000, LIFE SCI, V68, P401, DOI 10.1016/S0024-3205(00)00954-1; Carmignani M, 1999, IMMUNOPHARMACOLOGY, V44, P105, DOI 10.1016/S0162-3109(99)00115-0; Courtois E, 2003, J AM SOC NEPHROL, V14, P1464, DOI 10.1097/01.ASN.0000064947.14997.69; Den HE, 2006, J HUM HYPERTENS, V16, P563; Farmand F, 2005, ENVIRON RES, V98, P33, DOI 10.1016/j.envres.2004.05.016; Fioresi M, 2013, BRAZ J MED BIOL RES, V46, P178, DOI 10.1590/1414-431X20122190; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; Grizzo LT, 2008, TOXICOL SCI, V103, P207, DOI 10.1093/toxsci/kfn018; Heydari A, 2006, TOXICOL LETT, V166, P88, DOI 10.1016/j.toxlet.2006.05.014; KHALILMANESH F, 1993, AM J HYPERTENS, V6, P723, DOI 10.1093/ajh/6.9.723; KoreckovaSysalova J, 1997, BIOL TRACE ELEM RES, V56, P321, DOI 10.1007/BF02785303; Lee DI, 2009, MOL PHARMACOL, V75, P774, DOI 10.1124/mol.108.052597; LEITE CM, 1995, CAN J PHYSIOL PHARM, V73, P638, DOI 10.1139/y95-081; LEITE CM, 1988, BRAZ J MED BIOL RES, V21, P859; Marques M, 2001, J AM SOC NEPHROL, V12, P2594, DOI 10.1681/ASN.V12122594; Ministerio da saude Brasil, 2006, AT SAUD TRAB EXP CHU; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Okoshi M P, 1994, Arq Bras Cardiol, V63, P501; Oliveira EM, 2000, BRAZ J MED BIOL RES, V33, P755, DOI 10.1590/S0100-879X2000000700005; PIRKLE JL, 1985, AM J EPIDEMIOL, V121, P246, DOI 10.1093/oxfordjournals.aje.a113995; Prasad AM, 2007, AM J PHYSIOL-CELL PH, V292, pC2269, DOI 10.1152/ajpcell.00441.2006; Qi M, 1997, AM J PHYSIOL-HEART C, V272, pH2416, DOI 10.1152/ajpheart.1997.272.5.H2416; Quintanar-Escorza MA, 2007, TOXICOL APPL PHARM, V220, P1, DOI 10.1016/j.taap.2006.10.016; Quintanar-Escorza MA, 2010, TOXICOL IN VITRO, V24, P1338, DOI 10.1016/j.tiv.2010.05.002; Raeymaekers L, 2011, BIOPHYS J, V100, P1216, DOI 10.1016/j.bpj.2011.01.024; Roncal C, 2007, AM J PHYSIOL-RENAL, V293, pF1391, DOI 10.1152/ajprenal.00216.2007; Ryall JG, 2008, AM J PHYSIOL-HEART C, V294, pH2587, DOI 10.1152/ajpheart.00985.2007; Sharifi AM, 2004, TOXICOL LETT, V153, P233, DOI 10.1016/j.toxlet.2004.04.013; Silveira EA, 2010, BRAZ J MED BIOL RES, V43, P492, DOI 10.1590/S0100-879X2010007500027; Simoes MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018730; Stefanon I, 2009, BRAZ J MED BIOL RES, V42, P902, DOI 10.1590/S0100-879X2009005000015; Stokke MK, 2010, CARDIOVASC RES, V86, P63, DOI 10.1093/cvr/cvp401; Sun HW, 2009, ENVIRON TECHNOL, V30, P1051, DOI 10.1080/09593330903055643; Valencia I, 2001, PHARMACOL TOXICOL, V89, P177, DOI 10.1111/j.0901-9928.2001.890406.x; Vassallo DV, 2008, BRAZ J MED BIOL RES, V41, P789, DOI 10.1590/S0100-879X2008000900008; VASSALLO DV, 1988, ACTA PHYSIOL PHARM L, V38, P87; Vassallo DV, 1988, ACTA PHYSL PHARM LAT, V29, P131; Vaziri ND, 1997, KIDNEY INT, V52, P1042, DOI 10.1038/ki.1997.426; Vaziri ND, 1999, KIDNEY INT, V56, P1492, DOI 10.1046/j.1523-1755.1999.00670.x; Vupputuri S, 2003, HYPERTENSION, V41, P463, DOI 10.1161/01.HYP.0000055015.39788.29; World Health Organization, 2011, CARD DIS; Zhang LF, 2007, TOXICOL LETT, V170, P104, DOI 10.1016/j.toxlet.2007.02.004; Zhang LF, 2005, TOXICOL LETT, V159, P71, DOI 10.1016/j.toxlet.2005.04.009	46	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96900	10.1371/journal.pone.0096900	http://dx.doi.org/10.1371/journal.pone.0096900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841481	Green Submitted, gold, Green Published			2022-12-27	WOS:000340948600013
J	Lambrechts, D; Roeffaers, M; Goossens, K; Hofkens, J; Van de Putte, T; Schrooten, J; Van Oosterwyck, H				Lambrechts, Dennis; Roeffaers, Maarten; Goossens, Karel; Hofkens, Johan; Van de Putte, Tom; Schrooten, Jan; Van Oosterwyck, Hans			A Causal Relation between Bioluminescence and Oxygen to Quantify the Cell Niche	PLOS ONE			English	Article							FIREFLY LUCIFERASE; PARTICLES; SUBSTRATE; HYPOXIA; LUMINESCENCE; FLUORESCENCE; GENE	Bioluminescence imaging assays have become a widely integrated technique to quantify effectiveness of cell-based therapies by monitoring fate and survival of transplanted cells. To date these assays are still largely qualitative and often erroneous due to the complexity and dynamics of local micro-environments (niches) in which the cells reside. Here, we report, using a combined experimental and computational approach, on oxygen that besides being a critical niche component responsible for cellular energy metabolism and cell-fate commitment, also serves a primary role in regulating bioluminescent light kinetics. We demonstrate the potential of an oxygen dependent Michaelis-Menten relation in quantifying intrinsic bioluminescence intensities by resolving cell-associated oxygen gradients from bioluminescent light that is emitted from three-dimensional (3D) cell-seeded hydrogels. Furthermore, the experimental and computational data indicate a strong causal relation of oxygen concentration with emitted bioluminescence intensities. Altogether our approach demonstrates the importance of oxygen to evolve towards quantitative bioluminescence and holds great potential for future microscale measurement of oxygen tension in an easily accessible manner.	[Lambrechts, Dennis; Schrooten, Jan] Katholieke Univ Leuven, Dept Met & Mat Engn, Leuven, Belgium; [Lambrechts, Dennis; Schrooten, Jan; Van Oosterwyck, Hans] Katholieke Univ Leuven, Div Skeletal Tissue Engn Leuven, Leuven, Belgium; [Roeffaers, Maarten] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, Leuven, Belgium; [Goossens, Karel] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Hofkens, Johan] Katholieke Univ Leuven, Leuven, Belgium; [Van de Putte, Tom] TiGenix NV, Leuven, Belgium; [Van Oosterwyck, Hans] Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; University of Texas System; University of Texas Austin; KU Leuven; KU Leuven	Schrooten, J (corresponding author), Katholieke Univ Leuven, Dept Met & Mat Engn, Leuven, Belgium.	Jan.Schrooten@mtm.kuleuven.be; Hans.VanOosterwyck@mech.kuleuven.be	Velde, Greetje Vande/O-9161-2016; Hofkens, Johan/AAL-4204-2020; Roeffaers, Maarten/D-9328-2011; Hofkens, Johan/AAP-9255-2020; Roeffaers, Maarten/AAB-8874-2020; Van Oosterwyck, Hans/C-2528-2016; Hofkens, Johan/D-4284-2017	Velde, Greetje Vande/0000-0002-5633-3993; Roeffaers, Maarten/0000-0001-6582-6514; Van Oosterwyck, Hans/0000-0002-2142-9717; Hofkens, Johan/0000-0002-9101-0567; Lambrechts, Dennis/0000-0002-2373-2795	agency for Innovation by Science and Technology (IWT-Vlaanderen) [090727]; Research Foundation-Flanders (FWO-Vlaanderen) [G.0858.12]; Flemish Government through long-term structural funding "Methusalem'' (CASAS Methusalem grant); Hercules Foundation [HER/08/021]; Research Foundation Flanders (FWO-Vlaanderen); Belgian American Educational Foundation (BAEF)	agency for Innovation by Science and Technology (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders (FWO-Vlaanderen)(FWO); Flemish Government through long-term structural funding "Methusalem'' (CASAS Methusalem grant); Hercules Foundation; Research Foundation Flanders (FWO-Vlaanderen)(FWO); Belgian American Educational Foundation (BAEF)	This work was supported by the agency for Innovation by Science and Technology (IWT-Vlaanderen, project number 090727) and the Research Foundation-Flanders (FWO-Vlaanderen, project number G.0858.12). The authors also gratefully acknowledge financial support from the Flemish Government through long-term structural funding "Methusalem'' (CASAS Methusalem grant) and from the Hercules Foundation (HER/08/021). KG acknowledges the Research Foundation Flanders (FWO-Vlaanderen) and the Belgian American Educational Foundation (BAEF) for postdoctoral research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Berthold F, 2011, CHEMILUMINESCENCE AND BIOLUMINESCENCE: PAST, PRESENT AND FUTURE, P113; BOGUSH GH, 1988, J NON-CRYST SOLIDS, V104, P95, DOI 10.1016/0022-3093(88)90187-1; Chen SL, 1996, J COLLOID INTERF SCI, V180, P237, DOI 10.1006/jcis.1996.0295; Crank J, 1979, MATH DIFFUSION, P28; DENBURG JL, 1969, ARCH BIOCHEM BIOPHYS, V134, P381, DOI 10.1016/0003-9861(69)90297-5; Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005; Fraga H, 2005, FEBS J, V272, P5206, DOI 10.1111/j.1742-4658.2005.04895.x; Fraga H, 2008, PHOTOCH PHOTOBIO SCI, V7, P146, DOI 10.1039/b719181b; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GANDELMAN O, 1994, J BIOLUM CHEMILUM, V9, P363, DOI 10.1002/bio.1170090603; GANDELMAN OA, 1993, J PHOTOCH PHOTOBIO B, V19, P187, DOI 10.1016/1011-1344(93)87083-Y; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Graf C, 2003, LANGMUIR, V19, P6693, DOI 10.1021/la0347859; Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; Khalil Ashraf A, 2013, Int J Mol Imaging, V2013, P287697, DOI 10.1155/2013/287697; KOPELMAN R, 1988, SCIENCE, V241, P1620, DOI 10.1126/science.241.4873.1620; Lambrechts D, 2013, BIOMATERIALS, V34, P922, DOI 10.1016/j.biomaterials.2012.10.019; Leskovac V, 2003, COMPREHENSIVE ENZYME, P11; Masalov VM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/27/275718; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Moriyama EH, 2008, PHOTOCH PHOTOBIO SCI, V7, P675, DOI 10.1039/b719231b; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Shinde R, 2006, BIOCHEMISTRY-US, V45, P11103, DOI 10.1021/bi060475o; Timmins GS, 2001, J EXP BIOL, V204, P2795; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Weiss MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014026; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944	40	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97572	10.1371/journal.pone.0097572	http://dx.doi.org/10.1371/journal.pone.0097572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840204	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600046
J	Murakami, H; Tomaru, T; Nishiyama, Y; Moriyama, T; Niizato, T; Gunji, YP				Murakami, Hisashi; Tomaru, Takenori; Nishiyama, Yuta; Moriyama, Toru; Niizato, Takayuki; Gunji, Yukio-Pegio			Emergent Runaway into an Avoidance Area in a Swarm of Soldier Crabs	PLOS ONE			English	Article							INFORMATION; MICTYRIDAE; BRACHYURA; BEHAVIOR	Emergent behavior that arises from a mass effect is one of the most striking aspects of collective animal groups. Investigating such behavior would be important in order to understand how individuals interact with their neighbors. Although there are many experiments that have used collective animals to investigate social learning or conflict between individuals and society such as that between a fish and a school, reports on mass effects are rare. In this study, we show that a swarm of soldier crabs could spontaneously enter a water pool, which are usually avoided, by forming densely populated part of a swarm at the edge of the water pool. Moreover, we show that the observed behavior can be explained by the model of collective behavior based on inherent noise that is individuals' different velocities in a directed group. Our results suggest that inherent noise, which is widely seen in collective animals, can contribute to formation and/or maintenance of a swarm and that the dense swarm can enter the pool by means of enhanced inherent noise.	[Murakami, Hisashi; Tomaru, Takenori] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan; [Nishiyama, Yuta] Osaka Univ, Sci & Technol Entrepreneurship Lab E Square, Osaka, Japan; [Moriyama, Toru] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 386, Japan; [Niizato, Takayuki] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Gunji, Yukio-Pegio] Waseda Univ, Sch Fundamental Sci & Engn, Dept Intermedia Art & Sci, Tokyo, Japan	Kobe University; Osaka University; Shinshu University; University of Tsukuba; Waseda University	Murakami, H (corresponding author), Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan.	hssh415@gmail.com	Moriyama, Toru/AAX-9780-2020	Moriyama, Toru/0000-0001-8711-5676	Kobe University;  [JSPS24320008]; Grants-in-Aid for Scientific Research [13J03561, 25280091] Funding Source: KAKEN	Kobe University; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Kobe University funding and JSPS24320008 (organized by Hiroyuki Miyoshi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Bode NWF, 2011, J R SOC INTERFACE, V8, P301, DOI 10.1098/rsif.2010.0397; Bradshaw C, 1999, MAR BIOL, V135, P83, DOI 10.1007/s002270050604; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cavagna A, 2013, P R SOC B, V280, P1471, DOI DOI 10.1098/RSPB.2012.2484); Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Davie PJF, 2010, CRUSTACEANA MONOGR, V11, P83; Dunlop R, 2006, APPL ANIM BEHAV SCI, V97, P255, DOI 10.1016/j.applanim.2005.06.018; Goldstone RL, 2009, TOP COGN SCI, V1, P412, DOI 10.1111/j.1756-8765.2009.01038.x; Gunji YP, 2012, PASSIVELY ACTIVE ACT, P169; Gunji YP, 2011, ADV ARTIFICIAL LIFE, P294; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Helbing D, 1997, PHYS REV E, V56, P2527, DOI 10.1103/PhysRevE.56.2527; Hemelrijk CK, 2010, ETHOLOGY, V116, P1099, DOI 10.1111/j.1439-0310.2010.01818.x; Kunz H, 2003, ARTIF LIFE, V9, P237, DOI 10.1162/106454603322392451; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Murakami H, 2012, IJALR, V3, P35; Niizato T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035615; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Pike TW, 2010, BEHAV ECOL, V21, P570, DOI 10.1093/beheco/arq025; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Romanczuk P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.010602; SHIH JT, 1995, ZOOL STUD, V34, P96; Shirakawa T., 2011, NANO COMMUN NETW, V2, P99, DOI [10.1016/j.nancom.2011.05.002, DOI 10.1016/J.NANCOM.2011.05.002]; Strandburg-Peshkin A, 2010, CURR BIOL, V23, P711; Takeda S, 2005, J ZOOL, V266, P197, DOI 10.1017/S0952836905006783; Takeda S, 2004, J CRUSTACEAN BIOL, V24, P327, DOI 10.1651/C-2436; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106	33	23	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97870	10.1371/journal.pone.0097870	http://dx.doi.org/10.1371/journal.pone.0097870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839970	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600084
J	Amendola, E; Zhan, Y; Mattucci, C; Castroflorio, E; Calcagno, E; Fuchs, C; Lonetti, G; Silingardi, D; Vyssotski, AL; Farley, D; Ciani, E; Pizzorusso, T; Giustetto, M; Gross, CT				Amendola, Elena; Zhan, Yang; Mattucci, Camilla; Castroflorio, Enrico; Calcagno, Eleonora; Fuchs, Claudia; Lonetti, Giuseppina; Silingardi, Davide; Vyssotski, Alexei L.; Farley, Dominika; Ciani, Elisabetta; Pizzorusso, Tommaso; Giustetto, Maurizio; Gross, Cornelius T.			Mapping Pathological Phenotypes in a Mouse Model of CDKL5 Disorder	PLOS ONE			English	Article							PROTEIN S6 PHOSPHORYLATION; CPG-BINDING PROTEIN-2; RETT-SYNDROME; MECP2; EXPRESSION; MUTATIONS; MICE; RECOMBINASE; POTENTIALS; DEFICIENCY	Mutations in cyclin-dependent kinase-like 5 (CDKL5) cause early-onset epileptic encephalopathy, a neurodevelopmental disorder with similarities to Rett Syndrome. Here we describe the physiological, molecular, and behavioral phenotyping of a Cdkl5 conditional knockout mouse model of CDKL5 disorder. Behavioral analysis of constitutive Cdkl5 knockout mice revealed key features of the human disorder, including limb clasping, hypoactivity, and abnormal eye tracking. Anatomical, physiological, and molecular analysis of the knockout uncovered potential pathological substrates of the disorder, including reduced dendritic arborization of cortical neurons, abnormal electroencephalograph (EEG) responses to convulsant treatment, decreased visual evoked responses (VEPs), and alterations in the Akt/rpS6 signaling pathway. Selective knockout of Cdkl5 in excitatory and inhibitory forebrain neurons allowed us to map the behavioral features of the disorder to separable cell-types. These findings identify physiological and molecular deficits in specific forebrain neuron populations as possible pathological substrates in CDKL5 disorder.	[Amendola, Elena; Zhan, Yang; Mattucci, Camilla; Farley, Dominika; Gross, Cornelius T.] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Castroflorio, Enrico; Calcagno, Eleonora; Giustetto, Maurizio] Univ Turin, Dept Neurosci, Turin, Italy; [Castroflorio, Enrico; Calcagno, Eleonora; Giustetto, Maurizio] Univ Turin, Natl Inst Neurosci, Turin, Italy; [Fuchs, Claudia; Ciani, Elisabetta] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Lonetti, Giuseppina; Silingardi, Davide; Pizzorusso, Tommaso] CNR, Inst Neurosci, Pisa, Italy; [Lonetti, Giuseppina; Pizzorusso, Tommaso] Univ Florence, NEUROFARBA, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy; [Vyssotski, Alexei L.] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Vyssotski, Alexei L.] ETH, Swiss Fed Inst Technol, Zurich, Switzerland	European Molecular Biology Laboratory (EMBL); University of Turin; University of Turin; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Florence; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gross, CT (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy.	gross@embl.it	CASTROFLORIO, ENRICO/I-6767-2019; giustetto, maurizio/D-6606-2011; Farley, Dominika/S-5391-2018; Amendola, Elena/P-2434-2016; Ciani, Elisabetta/AAL-6462-2020; Pizzorusso, Tommaso/D-1399-2013	CASTROFLORIO, ENRICO/0000-0002-6953-5420; giustetto, maurizio/0000-0003-1323-4060; Farley, Dominika/0000-0001-9173-324X; Pizzorusso, Tommaso/0000-0001-5614-0668; Vyssotski, Alexei/0000-0002-9021-1471; ciani, elisabetta/0000-0003-3130-5168; Zhan, Yang/0000-0002-1150-6344	EMBL; Italian Telethon Foundation [GGP09196, GGP10162]; Epigenomics Flagship Project EPIGEN; MIUR-CNR; AIRETT onlus; International Rett Syndrome Foundation (ISRF); International Foundation for CDKL5 Research (IFCR); ISRF	EMBL; Italian Telethon Foundation(Fondazione Telethon); Epigenomics Flagship Project EPIGEN; MIUR-CNR(Ministry of Education, Universities and Research (MIUR)); AIRETT onlus; International Rett Syndrome Foundation (ISRF); International Foundation for CDKL5 Research (IFCR); ISRF	The research was supported by EMBL (E. A. and C. T. G.), the Italian Telethon Foundation (grant GGP09196, T. P. and M. G.; grant GGP10162, E. C., T. P., and M. G.), Epigenomics Flagship Project EPIGEN, MIUR-CNR to T. P., AIRETT onlus (T. P. and M. G.), the International Rett Syndrome Foundation (ISRF, M. G.), and a fellowship from the International Foundation for CDKL5 Research (IFCR) in collaboration with ISRF (E. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DD, 1999, PEDIATR NEUROL, V20, P125, DOI 10.1016/S0887-8994(98)00124-6; Bahi-Buisson N, 2008, BRAIN, V131, P2647, DOI 10.1093/brain/awn197; Belichenko NP, 2008, J COMP NEUROL, V508, P184, DOI 10.1002/cne.21673; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Brankack J, 2010, BRAIN RES, V1322, P59, DOI 10.1016/j.brainres.2010.01.069; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang Q, 2010, NEURON, V49, P341; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Evans JC, 2005, EUR J HUM GENET, V13, P1113, DOI 10.1038/sj.ejhg.5201451; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fehr S, 2013, EUR J HUM GENET, V21, P266, DOI 10.1038/ejhg.2012.156; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Grosso S, 2007, BRAIN DEV-JPN, V29, P239, DOI 10.1016/j.braindev.2006.09.001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kishi N, 2005, J CHILD NEUROL, V20, P753; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pizzorusso T, 1999, EUR J NEUROSCI, V11, P204, DOI 10.1046/j.1460-9568.1999.00417.x; Pizzorusso T, 1997, VISION RES, V37, P389, DOI 10.1016/S0042-6989(96)00172-1; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Rogers DC, 1999, MAMM GENOME, V8, P711; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Russo S, 2009, NEUROGENETICS, V10, P241, DOI 10.1007/s10048-009-0177-1; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schauwecker PE, 2011, EPILEPSY RES, V97, P1, DOI 10.1016/j.eplepsyres.2011.09.005; Stuss DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031896; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	41	104	109	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e91613	10.1371/journal.pone.0091613	http://dx.doi.org/10.1371/journal.pone.0091613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24838000	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000339614800002
J	Matheson, AI; Manhart, LE; Pavlinac, PB; Means, AR; Akullian, A; Levine, GA; Jacobson, J; Shutes, E; Walson, JL				Matheson, Alastair I.; Manhart, Lisa E.; Pavlinac, Patricia B.; Means, Arianna R.; Akullian, Adam; Levine, Gillian A.; Jacobson, Julie; Shutes, Erin; Walson, Judd L.			Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin	PLOS ONE			English	Article							UPDATED SYSTEMATIC ANALYSIS; NATIONAL CAUSES; TRACHOMA; HEALTH; TRENDS	Background: As new interventions to reduce childhood mortality are identified, careful consideration must be given to identifying populations that could benefit most from them. Promising reductions in childhood mortality reported in a large cluster randomized trial of mass drug administration (MDA) of azithromycin (AZM) prompted the development of visually compelling, easy-to-use tools that synthesize country-specific data on factors that would influence both potential AZM benefit and MDA implementation success. Methodology/Principal Findings: We assessed the opportunity to reduce mortality and the feasibility of implementing such a program, creating Opportunity and Feasibility Indices, respectively. Countries with high childhood mortality were included. A Country Ranking Index combined key variables from the previous two Indices and applied a scoring system to identify high-priority countries. We compared four scenarios with varying weights given to each variable. Twenty-five countries met inclusion criteria. We created easily visualized tools to display the results of the Opportunity and Feasibility Indices. The Opportunity Index revealed substantial variation in the opportunity for an MDA of AZM program to reduce mortality, even among countries with high overall childhood mortality. The Feasibility Index demonstrated that implementing such a program would be most challenging in the countries that could see greatest benefit. Based on the Country Ranking Index, Equatorial Guinea would benefit the most from the MZA of AZM in three of the four scenarios we tested. Conclusions/Significance: These visually accessible tools can be adapted or refined to include other metrics deemed important by stakeholders, and provide a quantitative approach to prioritization for intervention implementation. The need to explicitly state metrics and their weighting encourages thoughtful and transparent decision making. The objective and data-driven approach promoted by the three Indices may foster more efficient use of resources.	[Matheson, Alastair I.; Manhart, Lisa E.; Pavlinac, Patricia B.; Means, Arianna R.; Akullian, Adam; Levine, Gillian A.; Walson, Judd L.] Univ Washington, Seattle, WA 98195 USA; [Jacobson, Julie; Shutes, Erin] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation	Matheson, AI (corresponding author), Univ Washington, Seattle, WA 98195 USA.	alastair.matheson@gmail.com	Walson, Judd/HGC-4359-2022; Walson, Judd/R-7269-2019	Walson, Judd/0000-0003-4836-720X	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was completed by Strategic Analysis, Research, and Training Program (START) at the University of Washington. START is a collaborative effort with, and is funded by, the Bill & Melinda Gates Foundation. The funder commissioned the study but did not have exclusive control of the design, data collection and analysis, decision to pursue publication, conclusions, or preparation of the manuscript.	[Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 2013, 2013 GLOB PEAC IND; [Anonymous], 2012, FIN GLOB HLTH 2012 E; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carter Center, 2010, PLANN TRACH EL DISTR; Feldbaum H, 2010, EPIDEMIOL REV, V32, P82, DOI 10.1093/epirev/mxq006; Hermes E, 2013, EULER HERMES COUNTRY; International Coalition for Trachoma Control, 2011, 2020 INSIGHT; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Malhotra-Kumar S, 2009, LANCET, V374, P449, DOI 10.1016/S0140-6736(09)61447-1; McCoy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034749; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Transparency International, 2013, CORR PERC IND 2013; UNICEF, 2013, PNEUM CONJ VACC CURR; UNICEF, 2013, ROT VACC CURR SUPPL; United Nations (Department of Economic and Social Affairs), 2013, TOT POP BOTH SEX WOR; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2006, TRACH CONTR GUID PRO; World Health Organisation, 2013, NEGL TROP DIS PREV C; World Health Organization, 2013, IMM COV; Zaric GS, 2007, MED DECIS MAKING, V27, P71, DOI 10.1177/0272989X06297395	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96658	10.1371/journal.pone.0096658	http://dx.doi.org/10.1371/journal.pone.0096658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837459	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800019
J	Shan, GG; Wilding, GE				Shan, Guogen; Wilding, Gregory E.			Powerful Exact Unconditional Tests for Agreement between Two Raters with Binary Endpoints	PLOS ONE			English	Article							DETECTING TRENDS; WEIGHTED KAPPA; MATCHED-PAIRS; RELIABILITY; COEFFICIENT; STATISTICS; PARADOXES	Asymptotic and exact conditional approaches have often been used for testing agreement between two raters with binary outcomes. The exact conditional approach is guaranteed to respect the test size as compared to the traditionally used asymptotic approach based on the standardized Cohen's kappa coefficient. An alternative to the conditional approach is an unconditional strategy which relaxes the restriction of fixed marginal totals as in the conditional approach. Three exact unconditional hypothesis testing procedures are considered in this article: an approach based on maximization, an approach based on the conditional p-value and maximization, and an approach based on estimation and maximization. We compared these testing procedures based on the commonly used Cohen's kappa with regards to test size and power. We recommend the following two exact approaches for use in practice due to power advantages: the approach based on conditional p-value and maximization and the approach based on estimation and maximization.	[Shan, Guogen] Univ Nevada, Dept Environm & Occupat Hlth, Epidemiol & Biostat Program, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Wilding, Gregory E.] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shan, GG (corresponding author), Univ Nevada, Dept Environm & Occupat Hlth, Epidemiol & Biostat Program, Sch Community Hlth Sci, Las Vegas, NV 89154 USA.	guogen.shan@unlv.edu	Shan, Guogen/GQI-3293-2022					Andres AM, 2008, COMMUN STAT-THEOR M, V37, P760, DOI 10.1080/03610920701669884; BARNARD GA, 1945, NATURE, V156, P177, DOI 10.1038/156177a0; BASU D, 1977, J AM STAT ASSOC, V72, P355, DOI 10.2307/2286800; Boschloo RD, 1970, STAT NEERL, V24, P1, DOI [10.1111/j.1467-9574.1970.tb00104.x, DOI 10.1111/J.1467-9574.1970.TB00104.X]; Brusco MJ, 2008, BRIT J MATH STAT PSY, V61, P439, DOI 10.1348/000711007X227058; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Fang K.T., 2001, ORTHOGONAL UNIFORM E; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fisher R., 1970, STAT METHODS RES WOR; Fleiss J.L., 2013, STAT METHODS RATES P; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Fleiss JL, 2003, BOOK SERIES WILEY SE, V3rd, DOI [10.1002/0471445428, DOI 10.1198/TECH.2004.S812, DOI 10.1002/0471445428]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lloyd CJ, 2008, BIOMETRICS, V64, P716, DOI 10.1111/j.1541-0420.2007.00936.x; Lloyd CJ, 2008, STAT MED, V27, P3540, DOI 10.1002/sim.3229; Lloyd CJ, 2008, AUST NZ J STAT, V50, P329, DOI 10.1111/j.1467-842X.2008.00520.x; Mehta CR, 1998, BIOMETRICS, V54, P1615, DOI 10.2307/2533685; Shan GG, 2014, STAT PROBABIL LETT, V85, P129, DOI 10.1016/j.spl.2013.11.010; Shan GG, 2013, HUM HERED, V76, P10, DOI 10.1159/000353205; Shan GG, 2013, COMPUT STAT DATA AN, V57, P246, DOI 10.1016/j.csda.2012.04.021; Shan GG, 2012, STAT MED, V31, P155, DOI 10.1002/sim.4411; Shoukri MM, 1996, STAT MED, V15, P1409; Smedmark V, 2000, MANUAL THER, V5, P97, DOI 10.1054/math.2000.0234; STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537; UMESH UN, 1989, EDUC PSYCHOL MEAS, V49, P835, DOI 10.1177/001316448904900407	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97386	10.1371/journal.pone.0097386	http://dx.doi.org/10.1371/journal.pone.0097386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837970	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800041
J	Keller, J; Sanchez-Dalmau, BF; Villoslada, P				Keller, Johannes; Sanchez-Dalmau, Bernardo F.; Villoslada, Pablo			Lesions in the Posterior Visual Pathway Promote Trans-Synaptic Degeneration of Retinal Ganglion Cells	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; TRANSNEURONAL RETROGRADE DEGENERATION; NERVE-FIBER LAYER; DAMAGE; SYSTEM	Objective: Retrograde trans-synaptic degeneration of retinal ganglion cell layer (GCL) has been proposed as one of the mechanisms contributing to permanent disability after visual pathway damage. We set out to test this mechanism taking advantage of the new methods for imaging the macula with high resolution by optical coherence tomography (OCT) in patients with lesions in the posterior visual pathway. Additionally, we explored the association between thinning of GCL as an imaging marker of visual impairment such as visual field defects. Methods: Retrospective case note review of patients with retrogeniculate lesions studied by spectral domain OCT of the macula and quadrant pattern deviation (PD) of the visual fields. Results: We analysed 8 patients with either hemianopia or quadrantanopia due to brain lesions (stroke = 5; surgery = 2; infection = 1). We found significant thinning of the GCL in the projecting sector of the retina mapping to the brain lesion. Second, we found strong correlation between the PD of the visual field quadrant and the corresponding macular GCL sector for the right (R = 0.792, p<0.001) and left eyes (R = 0.674, p<0.001). Conclusions: The mapping between lesions in the posterior visual pathway and their projection in the macula GCL sector corroborates retrograde trans-synaptic neuronal degeneration after brain injury as a mechanism of damage with functional consequences. This finding supports the use of GCL thickness as an imaging marker of trans-synaptic degeneration in the visual pathway after brain lesions.	[Villoslada, Pablo] Hosp Clin Barcelona, Inst Ophthalmol, Barcelona, Spain; Hosp Clin Barcelona, Ctr Neuroimmunol, Inst Biomed Res August Pi Sunyer IDIBAPS, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Villoslada, P (corresponding author), Hosp Clin Barcelona, Inst Ophthalmol, Barcelona, Spain.	pvilloslada@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019	Keller, Johannes/0000-0003-0367-2227; Sanchez-Dalmau, Bernardo F./0000-0001-8950-9759	Instituto de Salud Carlos III, Spain [PS09/00259, RD12/0032/0001]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This work was supported by grants from the Instituto de Salud Carlos III, Spain (FIS program PS09/00259, and RETICS program RD12/0032/0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk LJ, 2014, J NEUROL NEUROSURG P; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Gabilondo I, 2013, J NEUROL NEUROSUR PS, V84, P824, DOI 10.1136/jnnp-2012-304854; Hood DC, 2008, J GLAUCOMA, V17, P519, DOI 10.1097/IJG.0b013e3181629a02; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P537, DOI 10.1136/bjo.56.7.537; Jacob M, 2009, AM J OPHTHALMOL, V147, P64, DOI 10.1016/j.ajo.2008.07.016; Jindahra P, 2012, NEURO-OPHTHALMOLOGY, V36, P79, DOI 10.3109/01658107.2012.674615; Jindahra P, 2012, BRAIN, V135, P534, DOI 10.1093/brain/awr324; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Kardon RH, 2011, J NEURO-OPHTHALMOL, V31, P353, DOI 10.1097/WNO.0b013e318238b9cb; Mehta JS, 2005, AM J OPHTHALMOL, V140, P727, DOI 10.1016/j.ajo.2005.03.059; MILLER NR, 1981, ARCH OPHTHALMOL-CHIC, V99, P1654; Ohkubo S, 2012, JPN J OPHTHALMOL, V56, P68, DOI 10.1007/s10384-011-0093-4; Park HYL, 2013, OPHTHALMOLOGY, V120, P1292, DOI 10.1016/j.ophtha.2012.11.021; VANBUREN JM, 1963, J NEUROL NEUROSUR PS, V26, P402	17	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97444	10.1371/journal.pone.0097444	http://dx.doi.org/10.1371/journal.pone.0097444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857938	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400016
J	Kruizinga, I; Visser, JC; van Batenburg-Eddes, T; Carter, AS; Jansen, W; Raat, H				Kruizinga, Ingrid; Visser, Janne C.; van Batenburg-Eddes, Tamara; Carter, Alice S.; Jansen, Wilma; Raat, Hein			Screening for Autism Spectrum Disorders with the Brief Infant-Toddler Social and Emotional Assessment	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; ASSESSMENT ITSEA; EARLY-CHILDHOOD; DIAGNOSIS; RELIABILITY; PREVALENCE	Objective: Using parent-completed questionnaires in (preventive) child health care can facilitate the early detection of psychosocial problems and psychopathology, including autism spectrum disorders (ASD). A promising questionnaire for this purpose is the Brief Infant-Toddler Social and Emotional Assessment (BITSEA). The screening accuracy with regard to ASD of the BITSEA Problem and Competence scales and a newly calculated Autism score were evaluated. Method: Data, that was collected between April 2010 and April 2011, from a community sample of 2-year-olds (N = 3127), was combined with a sample of preschool children diagnosed with ASD (N = 159). For the total population and for subgroups by child's gender, area under the Receiver Operating Characteristic (ROC) curve was examined, and across a range of BITSEA Problem, Competence and Autism scores, sensitivity, specificity, positive and negative likelihood ratio's, diagnostic odds ratio and Youden's index were reported. Results: The area under the ROC curve (95% confidence interval, [95%CI]) of the Problem scale was 0.90(0.87-0.92), of the Competence scale 0.93(0.91-0.95), and of the Autism score 0.95(0.93-0.97). For the total population, the screening accuracy of the Autism score was significantly better, compared to the Problem scale. The screening accuracy of the Competence scale was significantly better for girls (AUC = 0.97; 95%CI = 0.95-0.98) than for boys (AUC = 0.91; 95%CI = 0.88-0.94). Conclusion: The results indicate that the BITSEA scales and newly calculated Autism score have good discriminative power to differentiate children with and without ASD. Therefore, the BITSEA may be helpful in the early detection of ASD, which could have beneficial effects on the child's development.	[Kruizinga, Ingrid; Raat, Hein] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Visser, Janne C.] Karakter Univ, Ctr Nijmegen, Nijmegen, Netherlands; [van Batenburg-Eddes, Tamara] Vrije Univ Amsterdam, Dept Psychol & Educ, Amsterdam, Netherlands; [Carter, Alice S.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; [Jansen, Wilma] Rotterdam Municipal Hlth Serv GGD Rotterdam Rijnm, Dept Youth Policy, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; University of Massachusetts System; University of Massachusetts Boston	Raat, H (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl	Jansen, Wilma/ABD-5066-2020; Carter, Alice/AAF-4694-2020	Jansen, Wilma/0000-0002-4453-9054; Carter, Alice/0000-0001-9861-1560	ZonMw, The Netherlands Organization for Health Research and Development [80-82435-98-8058]	ZonMw, The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study is funded by a grant from the funding body ZonMw, The Netherlands Organization for Health Research and Development (www.zonmw.nl), project number: 80-82435-98-8058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; Bornstein MH, 2010, DEV PSYCHOPATHOL, V22, P717, DOI 10.1017/S0954579410000416; Briggs-Gowan M.J., 2002, BRIEF INFANT TODDLER; Briggs-Gowan MJ, 2008, PEDIATRICS, V121, P957, DOI 10.1542/peds.2007-1948; Briggs-Gowan MJ, 2006, J AM ACAD CHILD PSY, V45, P849, DOI 10.1097/01.chi.0000220849.48650.59; Briggs-Gowan MJ, 1998, INF MENTAL HLTH J, V19, P422, DOI 10.1002/(SICI)1097-0355(199824)19:4<422::AID-IMHJ5>3.0.CO;2-U; Briggs-Gowan MJ, 2004, J PEDIATR PSYCHOL, V29, P143, DOI 10.1093/jpepsy/jsh017; Carter AS, 2003, J ABNORM CHILD PSYCH, V31, P495, DOI 10.1023/A:1025449031360; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dawson G, 2008, DEV PSYCHOPATHOL, V20, P775, DOI 10.1017/S0954579408000370; Dietz C, 2006, J AUTISM DEV DISORD, V36, P713, DOI 10.1007/s10803-006-0114-1; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Haapsamo H, 2009, INT J CIRCUMPOL HEAL, V68, P386, DOI 10.3402/ijch.v68i4.17365; Karabekiroglu K, 2010, INFANT BEHAV DEV, V33, P503, DOI 10.1016/j.infbeh.2010.07.001; Karabekiroglu K, 2009, INFANT BEHAV DEV, V32, P291, DOI 10.1016/j.infbeh.2009.03.003; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kruizinga I, 2012, PLOS ONE, P7; Kruizinga I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072602; Laurent de Angulo MS, 2005, ONTWIKKELING SONDERZ; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Oosterling IJ, 2010, J CHILD PSYCHOL PSYC, V51, P250, DOI 10.1111/j.1469-7610.2009.02150.x; Oosterling IJ, 2009, J AUTISM DEV DISORD, V39, P897, DOI 10.1007/s10803-009-0692-9; Robins DL, 2001, J AUTISM DEV DISORD, V31, P131, DOI 10.1023/A:1010738829569; Sandler AD, 2001, PEDIATRICS, V107, P1221; Scheeringa MS, 2001, CHILD PSYCHIAT HUM D, V32, P71, DOI 10.1023/A:1017511714145; Seida JK, 2009, DEV MED CHILD NEUROL, V51, P95, DOI 10.1111/j.1469-8749.2008.03211.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Swinkels SHN, 2006, J AUTISM DEV DISORD, V36, P723, DOI 10.1007/s10803-006-0115-0; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Yirmiya N, 2010, J CHILD PSYCHOL PSYC, V51, P432, DOI 10.1111/j.1469-7610.2010.02214.x	37	23	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97630	10.1371/journal.pone.0097630	http://dx.doi.org/10.1371/journal.pone.0097630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24851868	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200025
J	Salojin, KV; Hamman, BD; Chang, WC; Jhaver, KG; Al-Shami, A; Crisostomo, J; Wilkins, C; Digeorge-Foushee, AM; Allen, J; Patel, N; Gopinathan, S; Zhou, J; Nouraldeen, A; Jessop, TC; Bagdanoff, JT; Augeri, DJ; Read, R; Vogel, P; Wilson, SA; Platt, KA; Carson, KG; Main, A; Zambrowicz, BP; Oravecz, T				Salojin, Konstantin V.; Hamman, Brian D.; Chang, Wei Chun; Jhaver, Kanchan G.; Al-Shami, Amin; Crisostomo, Jeannette; Wilkins, Carrie; Digeorge-Foushee, Ann Marie; Allen, Jason; Patel, Nita; Gopinathan, Suma; Zhou, Julia; Nouraldeen, Amr; Jessop, Theodore C.; Bagdanoff, Jeffrey T.; Augeri, David J.; Read, Robert; Vogel, Peter; Wilson, Swaffield Alan; Platt, Kenneth A.; Carson, Kenneth G.; Main, Alan; Zambrowicz, Brian P.; Oravecz, Tamas			Genetic Deletion of Mst1 Alters T Cell Function and Protects against Autoimmunity	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; IMMUNE-RESPONSES; ACTIVATION; APOPTOSIS; MICE; KINASE; ENCEPHALOMYELITIS; DEATH	Mammalian sterile 20-like kinase 1 (Mst1) is a MAPK kinase kinase kinase which is involved in a wide range of cellular responses, including apoptosis, lymphocyte adhesion and trafficking. The contribution of Mst1 to Ag-specific immune responses and autoimmunity has not been well defined. In this study, we provide evidence for the essential role of Mst1 in T cell differentiation and autoimmunity, using both genetic and pharmacologic approaches. Absence of Mst1 in mice reduced T cell proliferation and IL-2 production in vitro, blocked cell cycle progression, and elevated activation-induced cell death in Th1 cells. Mst1 deficiency led to a CD4(+) T cell development path that was biased toward Th2 and immunoregulatory cytokine production with suppressed Th1 responses. In addition, Mst1(-/-) B cells showed decreased stimulation to B cell mitogens in vitro and deficient Ag-specific Ig production in vivo. Consistent with altered lymphocyte function, deletion of Mst1 reduced the severity of experimental autoimmune encephalomyelitis (EAE) and protected against collagen-induced arthritis development. Mst1(-/-) CD4(+) T cells displayed an intrinsic defect in their ability to respond to encephalitogenic antigens and deletion of Mst1 in the CD4(+) T cell compartment was sufficient to alleviate CNS inflammation during EAE. These findings have prompted the discovery of novel compounds that are potent inhibitors of Mst1 and exhibit desirable pharmacokinetic properties. In conclusion, this report implicates Mst1 as a critical regulator of adaptive immune responses, Th1/Th2-dependent cytokine production, and as a potential therapeutic target for immune disorders.	[Salojin, Konstantin V.; Hamman, Brian D.; Chang, Wei Chun; Jhaver, Kanchan G.; Al-Shami, Amin; Crisostomo, Jeannette; Wilkins, Carrie; Digeorge-Foushee, Ann Marie; Allen, Jason; Patel, Nita; Gopinathan, Suma; Zhou, Julia; Nouraldeen, Amr; Jessop, Theodore C.; Bagdanoff, Jeffrey T.; Augeri, David J.; Read, Robert; Vogel, Peter; Wilson, Swaffield Alan; Platt, Kenneth A.; Carson, Kenneth G.; Main, Alan; Zambrowicz, Brian P.; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX 77381 USA	Lexicon Pharmaceuticals	Salojin, KV (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX 77381 USA.	ksalojin@gmail.com	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545; Gopinathan, Suma/0000-0001-5261-1901	Lexicon Pharmaceuticals, Inc.	Lexicon Pharmaceuticals, Inc.	The work described in this paper was funded by Lexicon Pharmaceuticals, Inc. The authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals approved the decision to publish this manuscript.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Augeri D.J., 2012, US Pat, Patent No. [US 2012/0225857A1, 20120225857]; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Baird AM, 1998, J LEUKOCYTE BIOL, V63, P669, DOI 10.1002/jlb.63.6.669; Bettelli E, 1998, J IMMUNOL, V161, P3299; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CAMBIAGGI C, 1992, IMMUNOGENETICS, V36, P117, DOI 10.1007/BF00215288; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Choi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008011; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fujii K, 2001, J IMMUNOL, V167, P1198, DOI 10.4049/jimmunol.167.3.1198; Fuller KG, 2004, METH MOLEC MED, V102, P339; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hildeman D, 2007, CURR OPIN IMMUNOL, V19, P516, DOI 10.1016/j.coi.2007.05.005; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kandula S, 2004, J IMMUNOL, V173, P4443, DOI 10.4049/jimmunol.173.7.4443; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin JL, 2001, ONCOGENE, V20, P6559, DOI 10.1038/sj.onc.1204818; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Liu L, 2005, J EXP MED, V202, P1341, DOI 10.1084/jem.20051359; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; McKallip RJ, 2002, INT IMMUNOL, V14, P1015, DOI 10.1093/intimm/dxf068; Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nakano K, 2007, APOPTOSIS, V12, P45, DOI 10.1007/s10495-006-0488-8; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Okamoto K, NATURE, V464, P1381; Pino PA, 2011, J VIS EXP FEB, V2, P2348; Rao P, 2004, METH MOLEC MED, V102, P363; Saijo K, 1997, J EXP MED, V185, P351, DOI 10.1084/jem.185.2.351; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki K, 2000, INT IMMUNOL, V12, P123, DOI 10.1093/intimm/12.2.123; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tan CY, 2011, CELL IMMUNOL, V271, P210, DOI 10.1016/j.cellimm.2011.08.006; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Wang Yanming, 2004, Novartis Found Symp, V259, P3; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Wehrens EJ, 2013, NAT REV RHEUMATOL, V9, P34, DOI 10.1038/nrrheum.2012.149; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zhang J, 2001, J IMMUNOL, V166, P4981, DOI 10.4049/jimmunol.166.8.4981; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	61	36	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98151	10.1371/journal.pone.0098151	http://dx.doi.org/10.1371/journal.pone.0098151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852423	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200050
J	Xie, BQ; Wang, W; Zhang, WQ; Guo, XH; Yang, MF; Wang, L; He, ZX; Tian, YQ				Xie, Bo-Qia; Wang, Wei; Zhang, Wen-Qian; Guo, Xin-Hua; Yang, Min-Fu; Wang, Li; He, Zuo-Xiang; Tian, Yue-Qin			Ventilation/Perfusion Scintigraphy in Children with Post-Infectious Bronchiolitis Obliterans: A Pilot Study	PLOS ONE			English	Article							HIGH-RESOLUTION CT; PULMONARY-FUNCTION; PERFUSION; SPECT	Purpose: Childhood post-infectious bronchiolitis obliterans (BO) is an infrequent lung disease leading to narrowing and/or complete obliteration of small airways. Ventilation and perfusion (V/Q) scan can provide both regional and global pulmonary information. However, only few retrospective researches investigating post-infectious BO involved V/Q scan, the clinical value of this method is unknown. This preliminary prospective study was aimed to evaluate the correlation of V/Q scan with disease severity, pulmonary function test results, and prognosis in children with post-infectious BO. Methods: Twenty-five post-infectious BO children (18 boys and 7 girls; mean age, 41 months) underwent V/Q scan and pulmonary function tests. Patients were followed after their inclusion. Ventilation index and perfusion index obtained from V/Q scan were used to measure pulmonary abnormalities. Spearman's rank correlation test of ventilation index and perfusion index on disease severity, lung function tests indices, and follow-up results were performed. Results: The median follow-up period was 4.6 years (range, 2.2 to 5.0 years). Ventilation index and perfusion index were both correlated with disease severity (r = 0.72, p<0.01 and r = 0.73, p<0.01), but only ventilation index was related to pulmonary function tests results (all p<0.05). In addition, Spearman test yielded significant correlations between perfusion index and prognosis (r = 0.77, p<0.01), and ventilation index and prognosis (r = 0.63, p = 0.01). Conclusions: For children with post-infectious BO, the present study preliminarily indicated that the degree of ventilation and perfusion abnormalities evaluated by V/Q scan may be used to assess disease severity, and may be predictive of patient's outcome.	[Xie, Bo-Qia] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China; [Wang, Wei] Capital Med Univ, Beijing Childrens Hosp, Dept Resp, Beijing, Peoples R China; [Zhang, Wen-Qian] Capital Med Univ, Chaoyang Hosp, Inst Resp Dis, Dept Thorac Surg, Beijing, Peoples R China; [Xie, Bo-Qia; Guo, Xin-Hua; Wang, Li; He, Zuo-Xiang; Tian, Yue-Qin] Chinese Acad Med Sci, Fu Wai Hosp, Natl Ctr Cardiovascular Dis, Dept Nucl Med,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Xie, Bo-Qia; Guo, Xin-Hua; Wang, Li; He, Zuo-Xiang; Tian, Yue-Qin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, Min-Fu] Capital Med Univ, Chaoyang Hosp, Dept Nucl Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Tian, YQ (corresponding author), Chinese Acad Med Sci, Fu Wai Hosp, Natl Ctr Cardiovascular Dis, Dept Nucl Med,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	dr.yueqintian@gmail.com						[Anonymous], 1950, THORAX, V5, P222; Chan P W, 2000, Respirology, V5, P369, DOI 10.1046/j.1440-1843.2000.00277.x; Colom AJ, 2009, PEDIATR PULM, V44, P1065, DOI 10.1002/ppul.21080; Donnelly LF, 1997, PEDIATR RADIOL, V27, P920, DOI 10.1007/s002470050272; Frey U, 2010, EUROPEAN RESP MONOGR, V47; Hansell DM, 1997, RADIOLOGY, V203, P721, DOI 10.1148/radiology.203.3.9169694; HOSHINO Y, 1994, AM J PHYSIOL, V267, pL120, DOI 10.1152/ajplung.1994.267.2.L120; Katier N, 2005, CHEST, V128, P1822, DOI 10.1378/chest.128.3.1822; King GG, 2010, SEMIN NUCL MED, V40, P467, DOI 10.1053/j.semnuclmed.2010.07.006; Kurland G, 2005, PEDIATR PULM, V39, P193, DOI 10.1002/ppul.20145; Moonnumakal SP, 2008, CURR OPIN PEDIATR, V20, P272, DOI 10.1097/MOP.0b013e3282ff62e9; Navalkissoor S, 2010, NUCL MED COMMUN, V31, P896, DOI 10.1097/MNM.0b013e32833dad0c; PADLEY SPG, 1993, CLIN RADIOL, V47, P236, DOI 10.1016/S0009-9260(05)81129-8; Parker JA, 2012, J NUCL MED TECHNOL, V40, P57, DOI 10.2967/jnmt.111.101386; Subspecialty Group of Respiratory Diseases The Society of Pediatrics Chinese Medical Association, 2012, CHINESE J PEDIAT, V50, P743; Washko GR, 2012, RESPIROLOGY, V17, P432, DOI 10.1111/j.1440-1843.2011.02117.x; Yang CF, 1997, AM J ROENTGENOL, V168, P1045, DOI 10.2214/ajr.168.4.9124113; Yilmaz O, 2009, RESPIROLOGY, V14, P295, DOI 10.1111/j.1440-1843.2008.01456.x; Yuksel H, 2009, TUBERK TORAK, V57, P376; [郑劲平 Zheng Jinping], 2002, [中华儿科杂志, Chinese Journal of Pediatrics], V40, P103; Zophel K, 2009, ANN NUCL MED, V23, P1, DOI 10.1007/s12149-008-0187-3	21	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98381	10.1371/journal.pone.0098381	http://dx.doi.org/10.1371/journal.pone.0098381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852165	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200068
J	Bhanothu, V; Theophilus, JP; Rozati, R				Bhanothu, Venkanna; Theophilus, Jane P.; Rozati, Roya			Use of Endo-Ovarian Tissue Biopsy and Pelvic Aspirated Fluid for the Diagnosis of Female Genital Tuberculosis by Conventional versus Molecular Methods	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-BOVIS BCG; CLINICAL-SAMPLES; INFERTILITY; PCR; SEQUENCE; MPB64; GENE; IDENTIFICATION; CULTURE	Background: Til date, none of the diagnostic techniques available for the detection of female genital tuberculosis (FGTB) are 100% accurate. We therefore, proposed to use the endometrial tissue biopsies (ETBs), ovarian tissue biopsies (OTBs) and pelvic aspirated fluids (PAFs) for the diagnosis of FGTB among infertile women by conventional versus molecular methods. Methodology/Principal Findings: A total of 302 specimens were collected both from 202 infertile women highly suspected of having FGTB on laparoscopy examination and 100 control women of reproductive age. Out of 302 specimens, 150 (49.67%) were ETBs, 95 (31.46%) were OTBs and 57 (18.87%) were PAFs. All specimens were tested by conventional techniques, later compared with multi-gene PCR for the detection of Mycobacterium tuberculosis (MTB) and correlated with laparoscopic findings. The presence of MTB DNA was observed in 49.5% of ETBs, 33.17% of OTBs and 5.44% of PAF specimens collected from highly suspected FGTB patients. All women of control group were confirmed as negative for tuberculosis. The conventional methods showed 99% to 100% specificity with a low sensitivity, ranging from 21.78% to 42.08% while hematoxylin and eosin staining showed a sensitivity of 51.48%. Multi-gene PCR was found to have much higher sensitivity of 70.29% with MTB64 gene, 86.63% with 19 kDa antigen gene at species and TRC4 element at regional MTB complex and 88.12% with 32 kDa protein gene at genus level. The specificity of multi-gene PCR was 100%. Compared with culturing and Ziehl-Neelsen's staining, multi-gene PCR demonstrated improvement in the detection of FGTB (chi(2) = 214.612, 1 df, McNemar's test value <0.0001). Conclusions Significance: We suggest site specific sampling, irrespective of sample type and amplification of the 19 kDa antigen gene in combination with TRC4 element as a successful multi-gene PCR for the diagnosis of FGTB and differentiation of mycobacterial infection among endo-ovarian tissue biopsies and PAFs taken from infertile women.	[Bhanothu, Venkanna; Theophilus, Jane P.] Osmania Univ, Dept Zool, Hyderabad 500007, Andhra Pradesh, India; [Rozati, Roya] MHRT Hosp & Res Ctr, Dept Reprod Med, Hyderabad, Andhra Pradesh, India	Osmania University	Bhanothu, V (corresponding author), Osmania Univ, Dept Zool, Hyderabad 500007, Andhra Pradesh, India.	venkanna_82@yahoo.co.uk	Bhanothu, Venkanna/AAN-8183-2020	Bhanothu, Venkanna/0000-0002-2591-3426	UGC-BSR, New Delhi, India	UGC-BSR, New Delhi, India	We are thankful to Prof. Surya Satyanarayana Singh, Coordinator, DBT-ISLARE for logistic support at CFRD, OU, Hyderabad and Prof. Vemu Lakshmi, Head, Dept of Microbiology for culture and staining facilities at NIMS, Hyderabad. Fellowship was provided by UGC-BSR Scheme, New Delhi, India. Mr. Prabhakar Badhini, Scientist, J K Agrigenetics Ltd, Hyderabad provided special chemicals. We also thankful to Mr. Pendli Kalyan Reddy, Assistant Director, Dept of Tribal Welfare, Andhra Pradesh for linguistic proofreadings and Ms. Sunitha, MHRT Hospital and Research Centre, Hyderabad for specimen collection. We are also thankful to anonymous reviewers for their supportive comments.	Abebe M, 2004, INT J GYNECOL OBSTET, V84, P241, DOI 10.1016/j.ijgo.2003.11.002; Aka N, 1997, J Obstet Gynaecol Res, V23, P337; ASHBRIDGE KR, 1989, NUCLEIC ACIDS RES, V17, P1249, DOI 10.1093/nar/17.3.1249; Barani R, 2012, J INFECT DEV COUNTR, V6, P46, DOI 10.3855/jidc.1302; Barouni AS, 2004, BRAZ J MICROBIOL, V35, P29, DOI 10.1590/S1517-83822004000100004; Ben Youssef L B, 1985, J Gynecol Obstet Biol Reprod (Paris), V14, P59; Bhanu NV, 2005, J MED MICROBIOL, V54, P927, DOI 10.1099/jmm.0.45943-0; BHARGAVA DK, 1992, AM J GASTROENTEROL, V87, P109; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P950; Chakrabarti A. K., 1998, Indian Journal of Tuberculosis, V45, P101; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P2697, DOI 10.1128/JCM.43.6.2697-2702.2005; CLARRIDGE JE, 1993, J CLIN MICROBIOL, V31, P2049, DOI 10.1128/JCM.31.8.2049-2056.1993; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crookham JN, 1991, HAZARDOUS CHEM HISTO; Dam P, 2006, GYNECOL OBSTET INVES, V61, P223, DOI 10.1159/000091498; DelPortillo P, 1996, J CLIN MICROBIOL, V34, P324, DOI 10.1128/JCM.34.2.324-328.1996; Eastwood JB, 2001, J AM SOC NEPHROL, V12, P1307, DOI 10.1681/ASN.V1261307; FALK V, 1980, AM J OBSTET GYNECOL, V138, P974, DOI 10.1016/0002-9378(80)91090-X; FAUVILLEDUFAUX M, 1992, EUR J CLIN MICROBIOL, V11, P797, DOI 10.1007/BF01960878; Fletcher HA, 2003, MICROBIOL-SGM, V149, P143, DOI 10.1099/mic.0.25961-0; Ganoza CA, 2008, J MED MICROBIOL, V57, P1094, DOI 10.1099/jmm.0.2008/001339-0; Gogate S, 1994, J OBSTET GYN INDIA, V44, P282; Grizzle WE, 2011, CANCER BIOMARK, V9, P531, DOI 10.3233/CBM-2011-0183; HARBOE M, 1986, INFECT IMMUN, V52, P293, DOI 10.1128/IAI.52.1.293-302.1986; Hirano K, 2004, J CLIN MICROBIOL, V42, P390, DOI 10.1128/JCM.42.1.390-392.2004; Jahromi BN, 2001, INT J GYNECOL OBSTET, V75, P269, DOI 10.1016/S0020-7292(01)00494-5; Jassawalla MJ, 2006, J OBSTET GYN INDIA, V56, P203; Jindal UN, 2012, HUM REPROD, V27, P1368, DOI 10.1093/humrep/des076; Kaser M, 2009, APPL ENVIRON MICROB, V75, P5667, DOI 10.1128/AEM.00446-09; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; Kassim I., 2004, SHERRIS MED MICROBIO, V4th; Kent PT, 1985, GUIDE LEVEL 3 LAB; Khan Nawaz, 2005, Journal of Postgraduate Medical Institute, V19, P97; Khanna A, 2011, SINGAP MED J, V52, P864; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; Krenacs T, 2005, J CLIN PATHOL, V58, P897, DOI 10.1136/jcp.2004.023788; Kumar P, 2008, J CLIN MICROBIOL, V46, P4068, DOI 10.1128/JCM.01162-08; Lantheaume S, 2003, Gynecol Obstet Fertil, V31, P624, DOI 10.1016/S1297-9589(03)00179-6; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; LI HY, 1993, INFECT IMMUN, V61, P1730, DOI 10.1128/IAI.61.5.1730-1734.1993; MUIR DG, 1980, AM J OBSTET GYNECOL, V138, P913, DOI 10.1016/0002-9378(80)91082-0; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; MUSTAFA AS, 1995, TUBERCLE LUNG DIS, V76, P336, DOI 10.1016/S0962-8479(05)80033-4; Narayanan S, 1997, CURR SCI INDIA, V73, P259; Narayanan S, 2001, J CLIN MICROBIOL, V39, P2006, DOI 10.1128/JCM.39.5.2006-2008.2001; National Committee for Clinical Laboratory Standards, 2001, APPR GUID PROT LAB W; Neonakis IK, 2011, SCAND J INFECT DIS, V43, P564, DOI 10.3109/00365548.2011.568523; Parandaman V, 2000, INDIAN J MED RES, V112, P47; Parikh FR, 1997, FERTIL STERIL, V67, P497, DOI 10.1016/S0015-0282(97)80076-3; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; PUNNONEN R, 1983, INT J FERTIL, V28, P235; Rajamaheshwari N., 2009, IND J MED MICROBIO, V27, P361, DOI 10.4103/0255-0857.55461; Rattan A, 1990, Indian J Pediatr, V57, P673, DOI 10.1007/BF02728711; Raut VS, 2001, INT J GYNECOL OBSTET, V72, P165, DOI 10.1016/S0020-7292(00)00328-3; Reeta Mani, 2003, Indian Journal of Tuberculosis, V50, P161; Restrepo BI, 2007, CLIN INFECT DIS, V45, P436, DOI 10.1086/519939; Revel A, 2002, HUM REPROD, V17, P1947, DOI 10.1093/humrep/17.8.1947; SCHAEFER G, 1959, P ROY SOC MED, V52, P947, DOI 10.1177/003591575905201112; Scrimin F, 2010, ARCH GYNECOL OBSTET, V281, P1079, DOI 10.1007/s00404-009-1325-4; Sharma JB, 2008, ARCH GYNECOL OBSTET, V278, P359, DOI 10.1007/s00404-008-0586-7; Sharma K, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-25; Sheehan D, 1980, THEORY PRACTICE HIST, P235; SIMON HB, 1977, AM J MED, V63, P410, DOI 10.1016/0002-9343(77)90279-0; SWEET RL, 1979, AM J OBSTET GYNECOL, V134, P68, DOI 10.1016/0002-9378(79)90798-1; TAKEWAKI S, 1993, J CLIN MICROBIOL, V31, P446, DOI 10.1128/JCM.31.2.446-450.1993; Thangappah RBP, 2011, INDIAN J MED RES, V134, P40; Tripathy S. N., 1998, Indian Journal of Tuberculosis, V45, P193; Tripathy SN, 2002, INT J GYNECOL OBSTET, V76, P159, DOI 10.1016/S0020-7292(01)00525-2; Van GIESON I., 1889, NEW YORK MED J, V50, P57; VARMA TR, 1991, INT J GYNECOL OBSTET, V35, P1, DOI 10.1016/0020-7292(91)90056-B; Vodegel RM, 2004, BMC DERMATOL SALINE, V4, P1; Weigert K., 1904, Z WISS MIKROSK, V2, P1; YAMAGUCHI R, 1989, INFECT IMMUN, V57, P283, DOI 10.1128/IAI.57.1.283-288.1989	73	16	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98005	10.1371/journal.pone.0098005	http://dx.doi.org/10.1371/journal.pone.0098005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849122	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600076
J	Lee, Y; Lee, JJ; Kim, S; Lee, SC; Han, J; Heu, W; Park, K; Kim, HJ; Cheong, HK; Kim, D; Kim, HS; Lee, KW				Lee, Yuno; Lee, Joong-jae; Kim, Songmi; Lee, Sang-Chul; Han, Jieun; Heu, Woosung; Park, Keunwan; Kim, Hyun Jung; Cheong, Hae-Kap; Kim, Dongsup; Kim, Hak-Sung; Lee, Keun Woo			Dissecting the Critical Factors for Thermodynamic Stability of Modular Proteins Using Molecular Modeling Approach	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; FORCE-FIELD; FREE-ENERGY; BINDING; DENATURATION; SOLVATION; RECEPTORS; DESIGN; UREA	Repeat proteins have recently attracted much attention as alternative scaffolds to immunoglobulin antibodies due to their unique structural and biophysical features. In particular, repeat proteins show high stability against temperature and chaotic agents. Despite many studies, structural features for the stability of repeat proteins remain poorly understood. Here we present an interesting result from in silico analyses pursuing the factors which affect the stability of repeat proteins. Previously developed repebody structure based on variable lymphocytes receptors (VLRs) which consists of leucine-rich repeat (LRR) modules was used as initial structure for the present study. We constructed extra six repebody structures with varying numbers of repeat modules and those structures were used for molecular dynamics simulations. For the structures, the intramolecular interactions including backbone H-bonds, van der Waals energy, and hydrophobicity were investigated and then the radius of gyration, solvent-accessible surface area, ratio of secondary structure, and hydration free energy were also calculated to find out the relationship between the number of LRR modules and stability of the protein. Our results show that the intramolecular interactions lead to more compact structure and smaller surface area of the repebodies, which are critical for the stability of repeat proteins. The other features were also well compatible with the experimental results. Based on our observations, the repebody-5 was proposed as the best structure from the all repebodies in structure optimization process. The present study successfully demonstrated that our computer-based molecular modeling approach can significantly contribute to the experiment-based protein engineering challenge.	[Lee, Yuno; Kim, Songmi; Lee, Keun Woo] GNU, RINS, Div Appl Life Sci, SSAC,PMBBRC,Program BK21, Jinju, South Korea; [Lee, Joong-jae; Lee, Sang-Chul; Han, Jieun; Heu, Woosung; Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Park, Keunwan; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Hyun Jung; Cheong, Hae-Kap] Korea Basic Sci Inst, Div Magnet Resonance Res, Cheongwon, Chungbuk, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI)	Kim, HS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea.	hskim76@kaist.ac.kr; kwlee@gnu.ac.kr	Kim, Dongsup/C-1612-2011; Kim, Hak-Sung/C-1929-2011	Lee, Joong-jae/0000-0002-3121-1420; LEE, Sangchul/0000-0002-7002-1179	National Research Foundation of Korea (NRF) - Korean Government; Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the NRF - Ministry of Education, Science and Technology (MEST) of Republic of Korea [2010-0029084]; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ009486]	National Research Foundation of Korea (NRF) - Korean Government; Pioneer Research Center Program; Management of Climate Change Program through the NRF - Ministry of Education, Science and Technology (MEST) of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2012-Fostering Core Leaders of the Future Basic Science Program). This research was supported by Pioneer Research Center Program (2009-0081539) and Management of Climate Change Program (2010-0029084) through the NRF funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksel T, 2009, METHOD ENZYMOL, V455, P95, DOI 10.1016/S0076-6879(08)04204-3; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Harvey S.C., 1988, DYNAMICS PROTEINS NU; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karino Y, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3535560; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109; Low C, 2008, P NATL ACAD SCI USA, V105, P3779, DOI 10.1073/pnas.0710657105; Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Stumpe MC, 2007, J AM CHEM SOC, V129, P16126, DOI 10.1021/ja076216j; Van der Spoel D, 2006, GROMACS USER MANUAL, V4, P9747; Villa A, 2002, J COMPUT CHEM, V23, P548, DOI 10.1002/jcc.10052; Yang C, 2011, BIOCHEMISTRY	32	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98243	10.1371/journal.pone.0098243	http://dx.doi.org/10.1371/journal.pone.0098243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849801	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600102
J	Duan, P; Sun, SL; Li, B; Huang, CT; Xu, Y; Han, XF; Xing, Y; Yan, WH				Duan, Ping; Sun, Shiling; Li, Bo; Huang, Chuntian; Xu, Yan; Han, Xuefei; Xing, Ying; Yan, Wenhai			miR-29a Modulates Neuronal Differentiation through Targeting REST in Mesenchymal Stem Cells	PLOS ONE			English	Article							ADULT BONE-MARROW; PROGENITOR CELLS; STROMAL CELLS; NEURAL PRECURSORS; SILENCING FACTOR; IN-VITRO; GENES; MICRORNAS; PLASTICITY; SPECIFICATION	Objective: To investigate the modulation of microRNAs (miRNAs) upon the neuronal differentiation of mesenchymal stem cells (MSCs) through targeting RE-1 Silencing Factor (REST), a mature neuronal gene suppressor in neuronal and unneuronal cells. Methods: Rat bone marrow derived-MSCs were induced into neuron-like cells (MSC-NCs) by DMSO and BHA in vitro. The expression of neuron specific enolase (NSE), microtubule-associated protein tau (Tau), REST and its target genes, including synaptosomal-associated protein 25 (SNAP25) and L1 cell adhesion molecular (L1CAM), were detected in MSCs and MSC-NCs. miRNA array analysis was conducted to screen for the upregulated miRNAs after neuronal differentiation. TargetScan was used to predict the relationship between these miRNAs and REST gene, and dual luciferase reporter assay was applied to validate it. Gain and loss of function experiments were used to study the role of miR-29a upon neuronal differentiation of MSCs. The knockdown of REST was conducted to show that miR-29a affected this process through targeting REST. Results: MSCs were induced into neuron-like cells which presented neuronal cell shape and expressed NSE and Tau. The expression of REST declined and the expression of SNAP25 and L1CAM increased upon the neuronal differentiation of MSCs. Among 14 upregulated miRNAs, miR-29a was validated to target REST gene. During the neuronal differentiation of MSCs, miR-29a inhibition blocked the downregulation of REST, as well as the upregulation of SNAP25, L1CAM, NSE and Tau. REST knockdown rescued the effect of miR-29a inhibition on the expression of NSE and Tau. Meanwhile, miR-29a knockin significantly decreased the expression of REST and increased the expression of SNAP25 and L1CMA in MSCs, but did not significantly affect the expression of NSE and Tau. Conclusion: miR-29a regulates neurogenic markers through targeting REST in mesenchymal stem cells, which provides advances in neuronal differentiation research and stem cell therapy for neurodegenerative diseases.	[Duan, Ping; Li, Bo; Huang, Chuntian; Xu, Yan; Han, Xuefei; Yan, Wenhai] Zhengzhou Univ, Inst Basic Med, Zhengzhou 450052, Henan, Peoples R China; [Sun, Shiling] Henan Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Henan, Peoples R China; [Xing, Ying] Xinxiang Med Univ, Dept Physiol, Xinxiang, Henan, Peoples R China	Zhengzhou University; Henan University of Traditional Chinese Medicine; Xinxiang Medical University	Xing, Y (corresponding author), Xinxiang Med Univ, Dept Physiol, Xinxiang, Henan, Peoples R China.	xingy@zzu.edu.cn; yanwhzzu@163.com			National Natural Science Foundation of China [81171250, 31100790]; Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhengzhou University	This work was supported by a grant from National Natural Science Foundation of China (Grant number: 81171250, 31100790) and a grant from Zhengzhou University 211 project-phase II'-the basic and clinical research of Stem Cells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Chang SJ, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-65; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; Duan P, 2012, IN VITRO CELL DEV-AN, V48, P251, DOI 10.1007/s11626-012-9494-z; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Han R, 2012, NEUROSCI LETT, V515, P147, DOI 10.1016/j.neulet.2012.03.032; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057621; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liu Bin, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P702, DOI 10.3881/j.issn.1000-503X.2009.06.009; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Mareschi K, 2009, CYTOTHERAPY, V11, P534, DOI 10.1080/14653240902974024; Paratore S, 2006, GENES BRAIN BEHAV, V5, P209, DOI 10.1111/j.1601-183X.2005.00159.x; Ratnayake U, 2012, BRAIN BEHAV IMMUN, V26, P1288, DOI 10.1016/j.bbi.2012.08.011; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schmitt MJ, 2013, CURR MOL MED, V13, P572; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shu SY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-9; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Trzaska KA, 2008, MOL CELL NEUROSCI, V39, P285, DOI 10.1016/j.mcn.2008.07.006; Van Damme An, 2002, Current Gene Therapy, V2, P195; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yang YX, 2008, EXP CELL RES, V314, P2257, DOI 10.1016/j.yexcr.2008.04.008	42	27	28	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97684	10.1371/journal.pone.0097684	http://dx.doi.org/10.1371/journal.pone.0097684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841827	Green Submitted, gold, Green Published			2022-12-27	WOS:000340948600055
J	Huang, Y; Zhang, XJ; Du, Q; Wang, FY; Zhao, XM; Zhang, WL; Tong, DW				Huang, Yong; Zhang, Xiujuan; Du, Qian; Wang, Fengyu; Zhao, Xiaomin; Zhang, Wenlong; Tong, Dewen			Preclinical Detection of Porcine Circovirus Type 2 Infection Using an Ultrasensitive Nanoparticle DNA Probe-Based PCR Assay	PLOS ONE			English	Article							REAL-TIME PCR; MONOCLONAL-ANTIBODIES; PIGS; PCV2; QUANTIFICATION; AMPLIFICATION; EPITOPES; STRAINS; SERUM; FIELD	Porcine circovirus type 2 (PCV2) has emerged as one of the most important pathogens affecting swine production globally. Preclinical identification of PCV2 is very important for effective prophylaxis of PCV2-associated diseases. In this study, we developed an ultrasensitive nanoparticle DNA probe-based PCR assay (UNDP-PCR) for PCV2 detection. Magnetic microparticles coated with PCV2 specific DNA probes were used to enrich PCV2 DNA from samples, then gold nanoparticles coated with PCV2 specific oligonucleotides were added to form a sandwich nucleic acid-complex. After the complex was formed, the oligonucleotides were released and characterized by PCR. This assay exhibited about 500-fold more sensitive than conventional PCR, with a detection limit of 2 copies of purified PCV2 genomic DNA and 10 viral copies of PCV2 in serum. The assay has a wide detection range for all of PCV2 genotypes with reliable reproducibility. No cross-reactivity was observed from the samples of other related viruses including porcine circovirus type 1, porcine parvovirus, porcine pseudorabies virus, porcine reproductive and respiratory syndrome virus and classical swine fever virus. The positive detection rate of PCV2 specific UNDP-PCR in 40 preclinical field samples was 27.5%, which appeared greater than that by conventional and real-time PCR and appeared application potency in evaluation of the viral loads levels of preclinical infection samples. The UNDP-PCR assay reported here can reliably rule out false negative results from antibody-based assays, provide a nucleic acid extraction free, specific, ultrasensitive, economic and rapid diagnosis method for preclinical PCV2 infection in field, which may help prevent large-scale outbreaks.	[Huang, Yong; Zhang, Xiujuan; Du, Qian; Wang, Fengyu; Zhao, Xiaomin; Zhang, Wenlong; Tong, Dewen] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Tong, DW (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	dwtong@nwsuaf.edu.cn	du, qian/GYJ-7090-2022; Huang, Yong/G-9365-2011		scientific and technological project in Shaanxi province [2012K02-05]; international science and technology cooperation fund of Northwest AF University [A213021310]; national training programs of innovation and entrepreneurship for undergraduates [1210712038]; scientific research program of Northwest AF University [QN2011064, ZD2013009, Z111021103]	scientific and technological project in Shaanxi province; international science and technology cooperation fund of Northwest AF University; national training programs of innovation and entrepreneurship for undergraduates; scientific research program of Northwest AF University	This study was funded by grants from the scientific and technological project in Shaanxi province (Grant No. 2012K02-05), international science and technology cooperation fund of Northwest A&F University (Grant No. A213021310), and national training programs of innovation and entrepreneurship for undergraduates (Grant No. 1210712038), and the scientific research program of Northwest A&F University (No. QN2011064 & ZD2013009 & Z111021103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Chen HT, 2008, J VIROL METHODS, V149, P264, DOI 10.1016/j.jviromet.2008.01.023; de Boisseson C, 2004, J GEN VIROL, V85, P293, DOI 10.1099/vir.0.19536-0; Ellis J, 2004, VET MICROBIOL, V98, P159, DOI 10.1016/j.vetmic.2003.10.008; Finsterbusch T, 2009, VIRUS RES, V143, P177, DOI 10.1016/j.virusres.2009.02.009; Huang Y, 2013, VIRUS RES, V175, P78, DOI 10.1016/j.virusres.2013.03.014; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Kim EY, 2008, NANOMEDICINE-UK, V3, P293, DOI 10.2217/17435889.3.3.293; Kim Jin H, 2002, J Vet Sci, V3, P31; Lefebvre DJ, 2008, J GEN VIROL, V89, P177, DOI 10.1099/vir.0.83280-0; Mahe D, 2000, J GEN VIROL, V81, P1815, DOI 10.1099/0022-1317-81-7-1815; McIntosh KA, 2009, VET MICROBIOL, V133, P23, DOI 10.1016/j.vetmic.2008.06.010; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Niemeyer CM, 2007, NAT PROTOC, V2, P1918, DOI 10.1038/nprot.2007.267; Opriessnig T, 2006, CLIN VACCINE IMMUNOL, V13, P923, DOI 10.1128/CVI.00074-06; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Saha D, 2012, VET MICROBIOL, V157, P13, DOI 10.1016/j.vetmic.2011.11.030; Segales J, 2005, VET MICROBIOL, V111, P223, DOI 10.1016/j.vetmic.2005.10.008; SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144; Shao Meng, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P19; [时乐 Shi Le], 2012, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V21, P6; Shuai J, 2007, VIRUS GENES, V35, P619, DOI 10.1007/s11262-007-0121-0; Vlasakova M, 2012, J VIROL METHODS, V179, P311, DOI 10.1016/j.jviromet.2011.11.014; Xu XG, 2012, J VIROL METHODS, V183, P69, DOI 10.1016/j.jviromet.2012.03.034; Xu XR, 2008, ANTIVIR RES, V78, P188, DOI 10.1016/j.antiviral.2007.12.012; Zhao Xiao-jie, 2010, Journal of Fisheries of China, V34, P1, DOI 10.3724/SP.J.1231.2010.06155	26	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97869	10.1371/journal.pone.0097869	http://dx.doi.org/10.1371/journal.pone.0097869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842840	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600083
J	Wu, J; Han, YR; Xu, J; Lu, Y; Cong, HL; Zheng, JY; Sun, H				Wu, Jing; Han, Yuerong; Xu, Judy; Lu, Yang; Cong, Hongliang; Zheng, Junyi; Sun, He			Chronic Stable Angina Is Associated with Lower Health-Related Quality of Life: Evidence from Chinese Patients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-DISEASE; FOLLOW-UP; PECTORIS; POPULATION; SYMPTOMS; EUROQOL; STATES; FRAMINGHAM; TRIAL	Objectives: To compare health-related quality of life (HRQoL) between patients with stable angina and the general population in China and to examine factors associated with HRQoL among patients with stable angina. Methods: A cross-sectional HRQoL survey of stable angina patients recruited from 4 hospitals (n = 411) and the general population recruited from 3 Physical Examination Centers (n = 549) was conducted from July to December, 2011 in two large cities, Tianjin and Chengdu. HRQoL was assessed using the EQ-5D, EQ-VAS, and SF-6D instruments. The health status specific to patients with stable angina was assessed using the Seattle Angina Questionnaire (SAQ). Information on socio-demographic, clinical, and lifestyle factors were also collected. Nested regressions were performed to explore how these factors were associated with HRQoL in patients with stable angina. Results: Compared with the general population (44.2 +/- 10 years, 49.9% females), stable angina patients (68.1 +/- 12 years, 50.4% females) had significantly lower HRQoL scores in EQ-5D utility index (0.75 +/- 0.19 vs. 0.90 +/- 0.20, p < 0.05), SF-6D utility index (0.68 +/- 0.12 vs. 0.85 +/- 0.11, p < 0.05), and EQ-VAS (71.2 +/- 12.3 vs. 83.9 +/- 10.9, p < 0.05). The differences remained (-0.05 for EQ-5D, -9.27 for EQ-VAS and -0.13 for SF-6D) after controlling for socio-economic characteristics. SAQ scores showed that stable angina patients experienced impaired disease-specific health status, especially in angina stability (40.5 +/- 34.6). Nested regressions indicated stable angina-specific health status explained most of the variation in HRQoL, among which disease perception, physical limitation, and angina stability were the strongest predictors. More physical exercise and better sleep were positively related with HRQoL. Conclusions: Compared to the general population, stable angina patients were associated with lower HRQoL and lower health utility scores, which were largely impacted by clinical symptoms. Further studies are needed to characterize the influence of geographic and cultural factors on the variations of health-related utility in stable angina patients.	[Wu, Jing; Han, Yuerong; Sun, He] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Xu, Judy] Southwest Univ Finance & Econ, Sch Publ Adm, Chengdu, Peoples R China; [Lu, Yang] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Cong, Hongliang; Zheng, Junyi] Tianjin Chest Hosp, Tianjin, Peoples R China	Tianjin University; Southwestern University of Finance & Economics - China; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Wu, J (corresponding author), Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China.	jingwu@tju.edu.cn; henrysunusa@gmail.com		Lu, Yang/0000-0003-2905-7302; Wu, Jing/0000-0002-6012-2785	Innovation Research Fund of Tianjin University, China	Innovation Research Fund of Tianjin University, China	This study was supported by Innovation Research Fund of Tianjin University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australia Pharmaceutical Benefits Advisory Committee, 2006, GUID PREP SUBM PBAC; Beltrame JF, 2009, ARCH INTERN MED, V169, P1491, DOI 10.1001/archinternmed.2009.295; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Center for Health Statistics and Information Ministry of Health, 2009, ANAL REPORT NATL HLT; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; ELVEBACK LR, 1986, MAYO CLIN PROC, V61, P896, DOI 10.1016/S0025-6196(12)62612-3; Gandjour A, 1999, PHARMACOECONOMICS, V16, P141, DOI 10.2165/00019053-199916020-00003; Gardner AW, 2011, ANGIOLOGY, V62, P461, DOI 10.1177/0003319711399897; GIBBONS RJ, 2002, ACC AHA 2002 GUIDELI; Goldsmith KA, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-96; Hemingway H, 2008, CIRCULATION, V117, P1526, DOI 10.1161/CIRCULATIONAHA.107.720953; Jin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041550; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; Kardas P, 2007, VASC HEALTH RISK MAN, V3, P235, DOI 10.2147/vhrm.2007.3.2.235; Kiessling A, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-13; Kimble LP, 2011, J ADV NURS, V67, P1000, DOI 10.1111/j.1365-2648.2010.05564.x; Kimble LP, 2003, PAIN, V101, P45, DOI 10.1016/S0304-3959(02)00319-6; Lam CLK, 2008, VALUE HEALTH, V11, P295, DOI 10.1111/j.1524-4733.2007.00233.x; Le Grande MR, 2012, PSYCHOL HEALTH MED, V17, P709, DOI 10.1080/13548506.2012.661865; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li MH, 2010, CHINESE PHARM EC, V3, P22; Liu SH, 2003, THESIS TIANJIN MED U; Liu XT, 1997, CHINESE J ERGONOMICS, V2, P49; Luo Nan, 2003, Health Qual Life Outcomes, V1, P7, DOI 10.1186/1477-7525-1-7; McGillion M, 2008, CURR CARDIOL REV, V4, P1, DOI 10.2174/157340308783565393; Miklaucich M, 1998, J ADV NURS, V28, P1207, DOI 10.1046/j.1365-2648.1998.00828.x; National Bureau of Statistics of China, NAT DAT SEARCH; National Institute for Clinical Excellence, 2008, GUID METH HLTH TECHN; National Institute for Health and Clinical Excellence, 2012, MAN STABL ANG; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f; The Task Force on the Management of stable angina pectoris of the European Society of Cardiology European Society of Cardiology (ESC), 2006, GUID MAN STABL ANG P; Vicari RM, 2005, J AM COLL CARDIOL, V46, P1803, DOI 10.1016/j.jacc.2005.07.047; Walters Stephen J, 2003, Health Qual Life Outcomes, V1, P4, DOI 10.1186/1477-7525-1-4; Wang H, 2005, QUAL LIFE RES, V14, P119, DOI 10.1007/s11136-004-0612-6; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Werdan K, 2012, CLIN RES CARDIOL, V101, P365, DOI 10.1007/s00392-011-0402-4; WIKLUND I, 1991, CLIN CARDIOL, V14, P204, DOI 10.1002/clc.4960140306; Zhao FL, 2010, QUAL LIFE RES, V19, P1273, DOI 10.1007/s11136-010-9697-2; Zhao FL, 2010, VALUE HEALTH, V13, P649, DOI 10.1111/j.1524-4733.2010.00728.x	43	12	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97294	10.1371/journal.pone.0097294	http://dx.doi.org/10.1371/journal.pone.0097294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842793	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600022
J	Laurent, VM; Duperray, A; Rajan, VS; Verdier, C				Laurent, Valerie M.; Duperray, Alain; Rajan, Vinoth Sundar; Verdier, Claude			Atomic Force Microscopy Reveals a Role for Endothelial Cell ICAM-1 Expression in Bladder Cancer Cell Adherence	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; N-CADHERIN; SPECTROSCOPY; STRENGTH; MIGRATION; BONDS; EXTRAVASATION; METASTASIS; CARCINOMA; SELECTIN	Cancer metastasis is a complex process involving cell-cell interactions mediated by cell adhesive molecules. In this study we determine the adhesion strength between an endothelial cell monolayer and tumor cells of different metastatic potentials using Atomic Force Microscopy. We show that the rupture forces of receptor-ligand bonds increase with retraction speed and range between 20 and 70 pN. It is shown that the most invasive cell lines (T24, J82) form the strongest bonds with endothelial cells. Using ICAM-1 coated substrates and a monoclonal antibody specific for ICAM-1, we demonstrate that ICAM-1 serves as a key receptor on endothelial cells and that its interactions with ligands expressed by tumor cells are correlated with the rupture forces obtained with the most invasive cancer cells (T24, J82). For the less invasive cancer cells (RT112), endothelial ICAM-1 does not seem to play any role in the adhesion process. Moreover, a detailed analysis of the distribution of rupture forces suggests that ICAM-1 interacts preferentially with one ligand on T24 cancer cells and with two ligands on J82 cancer cells. Possible counter receptors for these interactions are CD43 and MUC1, two known ligands for ICAM-1 which are expressed by these cancer cells.	[Laurent, Valerie M.; Verdier, Claude] Univ Grenoble Alpes, LIPHY, F-38000 Grenoble, France; [Laurent, Valerie M.; Verdier, Claude] CNRS, LIPHY, F-38000 Grenoble, France; [Duperray, Alain; Rajan, Vinoth Sundar] INSERM, IAB, F-38000 Grenoble, France; [Duperray, Alain; Rajan, Vinoth Sundar] Univ Grenoble Alpes, IAB, F-38000 Grenoble, France; [Duperray, Alain; Rajan, Vinoth Sundar] CHU Grenoble, IAB, F-38000 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Laurent, VM (corresponding author), Univ Grenoble Alpes, LIPHY, F-38000 Grenoble, France.	valerie.laurent@ujf-grenoble.fr	Verdier, Claude/C-1419-2008; Duperray, Alain/E-8428-2012; Laurent, Valerie M./K-6506-2015	Verdier, Claude/0000-0003-3706-7148; Duperray, Alain/0000-0002-2719-252X; 	Nanosciences Foundation; ANR Transmig; La Ligue contre le cancer; LabeX Tec21	Nanosciences Foundation; ANR Transmig(French National Research Agency (ANR)); La Ligue contre le cancer(Ligue nationale contre le cancer); LabeX Tec21	The sources of funding that have supported the work are Nanosciences Foundation, ANR Transmig, La Ligue contre le cancer, LabeX Tec21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Buitrago D, 2012, ANN SURG ONCOL, V19, P973, DOI 10.1245/s10434-011-2029-0; Canetta E, 2005, BIORHEOLOGY, V42, P321; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Champelovier P, 2003, CLIN CANCER RES, V9, P4562; Chotard-Ghodsnia R, 2007, J BIOMECH, V40, P335, DOI 10.1016/j.jbiomech.2006.01.001; Chu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064187; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Geng Y, 2012, FRONT ONCOL, V2, P1, DOI 10.2389/fonc.2012.00076; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Haddad O, 2010, EXP CELL RES, V316, P615, DOI 10.1016/j.yexcr.2009.11.015; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; Laidler P, 2000, ACTA BIOCHIM POL, V47, P1159, DOI 10.18388/abp.2000_3968; Lascombe I, 2006, CLIN CANCER RES, V12, P2780, DOI 10.1158/1078-0432.CCR-05-2387; Lekka M, 2011, J MOL RECOGNIT, V24, P833, DOI 10.1002/jmr.1123; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Pincet F, 2005, BIOPHYS J, V89, P4374, DOI 10.1529/biophysj.105.067769; Pittet P, 2008, J CELL SCI, V121, P877, DOI 10.1242/jcs.024877; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Regimbald LH, 1996, CANCER RES, V56, P4244; Roche Y, 2003, THROMB HAEMOSTASIS, V89, P1089, DOI 10.1055/s-0037-1613412; ROSENSTEIN Y, 1991, NATURE, V354, P233, DOI 10.1038/354233a0; Sans E, 2001, J IMMUNOL, V166, P544, DOI 10.4049/jimmunol.166.1.544; Santamaria M, 1996, CANCER RES, V56, P3526; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Strell C, 2008, CELL COMMUN SIGNAL, V6, P1; van Buul JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011336; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wojcikiewicz E, 2003, BIOL P, V6, P1; Wojcikiewicz EP, 2006, BIOMACROMOLECULES, V7, P3188, DOI 10.1021/bm060559c; Yamada M, 2006, CLIN EXP IMMUNOL, V143, P216, DOI 10.1111/j.1365-2249.2005.02989.x; Zhang XH, 2004, AM J PHYSIOL-HEART C, V286, pH359, DOI 10.1152/ajpheart.00491.2003; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhang XH, 2006, EXP BIOL MED, V231, P1306, DOI 10.1177/153537020623100804	44	38	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98034	10.1371/journal.pone.0098034	http://dx.doi.org/10.1371/journal.pone.0098034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857933	Green Submitted, gold, Green Published			2022-12-27	WOS:000336839400035
J	Reybroeck, W; De Vleeschouwer, M; Marchand, S; Sinnaeve, D; Heylen, K; De Block, J; Madder, A; Martins, JC; Heyndrickx, M				Reybroeck, Wim; De Vleeschouwer, Matthias; Marchand, Sophie; Sinnaeve, Davy; Heylen, Kim; De Block, Jan; Madder, Annemieke; Martins, Jose C.; Heyndrickx, Marc			Cyclic Lipodepsipeptides Produced by Pseudomonas spp. Naturally Present in Raw Milk Induce Inhibitory Effects on Microbiological Inhibitor Assays for Antibiotic Residue Screening	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; INDIVIDUAL COWS; PSYCHROTROPHIC BACTERIA; SPECIFICITY RATES; PSEUDOPHOMIN-B; TESTS; TOLAASII; SAMPLES; FLUORESCENS; MASTITIS	Two Pseudomonas strains, identified as closely related to Pseudomonas tolaasii, were isolated from milk of a farm with frequent false-positive Delvotest results for screening putative antibiotic residues in raw milk executed as part of the regulatory quality programme. Growth at 5 to 7 degrees C of these isolates in milk resulted in high lipolysis and the production of bacterial inhibitors. The two main bacterial inhibitors have a molecular weight of 1168.7 and 1140.7 Da respectively, are heat-tolerant and inhibit Geobacillus stearothermophilus var. calidolactis, the test strain of most of the commercially available microbiological inhibitor tests for screening of antibiotic residues in milk. Furthermore, these bacterial inhibitors show antimicrobial activity against Staphylococcus aureus, Bacillus cereus and B. subtilis and also interfere negatively with yoghurt production. Following their isolation and purification with RP-HPLC, the inhibitors were identified by NMR analysis as cyclic lipodepsipeptides of the viscosin group. Our findings bring to light a new challenge for quality control in the dairy industry. By prolonging the refrigerated storage of raw milk, the keeping quality of milk is influenced by growth and metabolic activities of psychrotrophic bacteria such as pseudomonads. Besides an increased risk of possible spoilage of long shelf-life milk, the production at low temperature of natural bacterial inhibitors may also result in false-positive results for antibiotic residue screening tests based on microbial inhibitor assays thus leading to undue production loss.	[Reybroeck, Wim; Marchand, Sophie; De Block, Jan; Heyndrickx, Marc] Inst Agr & Fisheries Res ILVO, Technol & Food Sci Unit, Melle, Belgium; [De Vleeschouwer, Matthias; Sinnaeve, Davy; Martins, Jose C.] Univ Ghent, UGent, Dept Organ Chem, NMR & Struct Anal Unit, B-9000 Ghent, Belgium; [De Vleeschouwer, Matthias; Madder, Annemieke] Univ Ghent, UGent, Dept Organ Chem, Organ & Biomimet Chem Res Unit, B-9000 Ghent, Belgium; [Heylen, Kim] Univ Ghent, UGent, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium; [Heyndrickx, Marc] Univ Ghent, UGent, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium	Institute For Agricultural & Fisheries Research; Ghent University; Ghent University; Ghent University; Ghent University	Reybroeck, W (corresponding author), Inst Agr & Fisheries Res ILVO, Technol & Food Sci Unit, Melle, Belgium.	Wim.Reybroeck@ilvo.vlaanderen.be	Martins, José C/A-3495-2008; Sinnaeve, Davy/F-2293-2013; Heyndrickx, Marc/AAM-1353-2020; Heylen, Kim/G-4085-2011	Sinnaeve, Davy/0000-0003-2556-5895; Heyndrickx, Marc/0000-0002-2913-2686; Madder, Annemieke/0000-0003-0179-7608; De Vleeschouwer, Matthias/0000-0001-6889-1928; Martins, Jose/0000-0001-7350-2253	Fund for Scientific Research Flanders (FWO-Vlaanderen) [G.0901.10, G.0422.13]; FFEU-ZWAP initiative of the Flemish Government; Hercules foundation	Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); FFEU-ZWAP initiative of the Flemish Government; Hercules foundation	The Fund for Scientific Research Flanders (FWO-Vlaanderen) is funding the Ph.D. fellowship of Matthias De Vleeschouwer and the postdoctoral mandate of Davy Sinnaeve and joint research projects to Annemieke Madder and Jose C. Martins (G.0901.10 and G.0422.13). The FFEU-ZWAP initiative of the Flemish Government and the Hercules foundation were funding the 700 MHz and 500 MHz high-field NMR equipment respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew SM, 1997, J DAIRY SCI, V80, P3050, DOI 10.3168/jds.S0022-0302(97)76272-6; Andrew SM, 2001, J DAIRY SCI, V84, P100, DOI 10.3168/jds.S0022-0302(01)74457-8; Andrew SM, 2000, J DAIRY SCI, V83, P2992, DOI 10.3168/jds.S0022-0302(00)75200-3; [Anonymous], 1991, BULLETIN, V265, P26; [Anonymous], 2005, 6730 ISO; [Anonymous], 2002, OFF J EUR COMM L, V221, P8; [Anonymous], 2004, 7932 ISO; [Anonymous], 1997, 96593 AOAC; [Anonymous], 2006, 4832 ISO; [Anonymous], 1986, VOORSCHRIFTEN CHEM F; [Anonymous], 1989, 6B INT DAIR FED; Bassarello C, 2004, J NAT PROD, V67, P811, DOI 10.1021/np0303557; Both PT, 1999, MICROBIOLOGIE VOEDIN, P216; CARLSSON A, 1989, J DAIRY SCI, V72, P3166, DOI 10.3168/jds.S0022-0302(89)79475-3; CARLSSON A, 1992, J FOOD PROTECT, V55, P374, DOI 10.4315/0362-028X-55.5.374; Carlsson A, 1991, THESIS U AGR SCI UPP; Carlsson A, 1987, MILCHWISSENSCHAFT, V42, P283; Chan V, 2002, J EXP MICROBIOL IMMU, V2, P130; Commission E., 2004, OFF J EUR UNION, V139, P55; Coraiola M, 2006, BBA-BIOMEMBRANES, V1758, P1713, DOI 10.1016/j.bbamem.2006.06.023; CULLOR JS, 1992, VET MED-US, V87, P477; De Jonghe V, 2010, THESIS GHENT U GENT; Deeth H. C., 1983, Developments in Dairy Chemistry, V2, P195; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; DRIESSEN FM, 1977, NETH MILK DAIRY J, V31, P40; DUTHIE AH, 1976, J MILK FOOD TECHNOL, V39, P774, DOI 10.4315/0022-2747-39.11.774; EC (European Commission), 2004, OFF J EUR UNION L, VL226, P22; EGAN J, 1984, IRISH J FOOD SCI TEC, V8, P115; Emanuele MC, 1998, FEBS LETT, V433, P317, DOI 10.1016/S0014-5793(98)00933-8; Gerard J, 1997, J NAT PROD, V60, P223, DOI 10.1021/np9606456; GINN RE, 1982, J FOOD PROTECT, V45, P571, DOI 10.4315/0362-028X-45.6.571; GOUDSWAARD J, 1978, TIJDSCHR DIERGENEESK, V103, P445; GRIFFITHS MW, 1981, J APPL BACTERIOL, V50, P289, DOI 10.1111/j.1365-2672.1981.tb00894.x; Halbert RW, 1996, J FOOD PROTECT, V59, P886; Hillerton JE, 1999, J DAIRY SCI, V82, P704, DOI 10.3168/jds.S0022-0302(99)75287-2; Kang JH, 2005, J DAIRY SCI, V88, P908, DOI 10.3168/jds.S0022-0302(05)72757-0; Kang JH, 2001, J FOOD PROTECT, V64, P1211, DOI 10.4315/0362-028X-64.8.1211; KITCHEN BJ, 1981, J DAIRY RES, V48, P167, DOI 10.1017/S0022029900021580; Korhonen H, 1995, BOVINE UDDER MASTITI, P76; KOSIKOWSKI FV, 1963, J DAIRY SCI, V46, P89, DOI 10.3168/jds.S0022-0302(63)88979-1; Lavermicocca P, 1997, PHYSIOL MOL PLANT P, V50, P129, DOI 10.1006/pmpp.1996.0078; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062946; Lo Cantore P, 2006, MOL PLANT MICROBE IN, V19, P1113, DOI 10.1094/MPMI-19-1113; Marchand S, 2009, ENVIRON MICROBIOL, V11, P467, DOI 10.1111/j.1462-2920.2008.01785.x; Mayra-Makinen A, 1990, SCAND DAIRY INF, V2, P38; McPhee J.D., 2002, ENCY DAIRY SCI, V4, P2340; MORTISHIRESMITH RJ, 1991, TETRAHEDRON, V47, P3645, DOI 10.1016/S0040-4020(01)80877-2; Mullan W.M.A., 2003, MAJOR ANTIMICROBIAL; Mullan WMA, 2003, INHIBITORS MILK; Munsch P, 2002, MICROBIOL RES, V157, P311, DOI 10.1078/0944-5013-00159; Munsch-Alatossava P, 2006, MICROBIOL RES, V161, P334, DOI 10.1016/j.micres.2005.12.004; Naser S, 2005, J CLIN MICROBIOL, V43, P2224, DOI 10.1128/JCM.43.5.2224-2230.2005; Nielsen TH, 2002, APPL ENVIRON MICROB, V68, P3416, DOI 10.1128/AEM.68.7.3416-3423.2002; NUTKINS JC, 1991, J AM CHEM SOC, V113, P2621, DOI 10.1021/ja00007a040; Okada Y., 1986, Journal of the Japan Veterinary Medical Association, V39, P97; Pan Y, 2007, AUST J DAIRY TECHNOL, V62, P31; Pedras MSC, 2003, PHYTOCHEMISTRY, V62, P1105, DOI 10.1016/S0031-9422(02)00617-9; Peng JT, 1986, THESIS U LEEDS LEEDS; POLYCHRONIADOU A, 1988, J DAIRY RES, V55, P585, DOI 10.1017/S0022029900033379; Quail JW, 2002, ACTA CRYSTALLOGR C, V58, po268, DOI 10.1107/S0108270102004432; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Rademaker JLW, 2009, A VANLEEUWENHOEK S, V95, P125, DOI [10.1007/s10482-009-9328-5, DOI 10.1007/S10482-009-9328-5]; RAINEY PB, 1991, PHYSIOL MOL PLANT P, V39, P57, DOI 10.1016/0885-5765(91)90031-C; Reybroeck W, 1997, MONOGRAPH RESIDUES C, P109; Reybroeck W., 2012, P EURORESIDUE 7 C RE, P197; Rokni-Zadeh H, 2012, APPL ENVIRON MICROB, V78, P4826, DOI 10.1128/AEM.00335-12; Rombaut R, 2006, INT DAIRY J, V16, P1362, DOI 10.1016/j.idairyj.2006.06.011; Romnee JM, 1999, LAIT, V79, P341, DOI 10.1051/lait:1999329; Ron EZ, 2001, ENVIRON MICROBIOL, V3, P229, DOI 10.1046/j.1462-2920.2001.00190.x; Rossignol G, 2009, RES MICROBIOL, V160, P337, DOI 10.1016/j.resmic.2009.04.004; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Scaloni A, 2004, BIOCHEM J, V384, P25, DOI 10.1042/BJ20040422; SCHIFFMANN AP, 1992, MILCHWISSENSCHAFT, V47, P770; Sinnaeve D, 2012, CHEM SCI, V3, P1284, DOI 10.1039/c2sc01088g; Sinnaeve D, 2009, CHEM-EUR J, V15, P12653, DOI 10.1002/chem.200901885; Sinnaeve D, 2009, TETRAHEDRON, V65, P4173, DOI 10.1016/j.tet.2009.03.045; STADHOUDERS J, 1963, NED MELK ZUI, V17, P96; Suhren G, 1995, SYMPOSIUM ON RESIDUES OF ANTIMICROBIAL DRUGS AND OTHER INHIBITORS IN MILK, P159; Tayeb LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/j.resmic.2005.02.009; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran H, 2007, NEW PHYTOL, V175, P731, DOI 10.1111/j.1469-8137.2007.02138.x; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VANEENENNAAM AL, 1993, J DAIRY SCI, V76, P3041, DOI 10.3168/jds.S0022-0302(93)77644-4; WOLIN AG, 1958, J DAIRY SCI, V41, P34, DOI 10.3168/jds.S0022-0302(58)90863-4; Zvirdauskiene R, 2007, FOOD CONTROL, V18, P541, DOI 10.1016/j.foodcont.2006.01.003; 2003, 4833 ISO	87	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98266	10.1371/journal.pone.0098266	http://dx.doi.org/10.1371/journal.pone.0098266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853676	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200058
J	Kraitsy, K; Uecal, M; Grossauer, S; Bruckmann, L; Pfleger, F; Ropele, S; Fazekas, F; Gruenbacher, G; Patz, S; Absenger, M; Porubsky, C; Smolle-Juettner, F; Tezer, I; Molcanyi, M; Fasching, U; Schaefer, U				Kraitsy, Klaus; Uecal, Muammer; Grossauer, Stefan; Bruckmann, Lukas; Pfleger, Florentina; Ropele, Stefan; Fazekas, Franz; Gruenbacher, Gerda; Patz, Silke; Absenger, Markus; Porubsky, Christian; Smolle-Juettner, Freyja; Tezer, Irem; Molcanyi, Marek; Fasching, Ulrike; Schaefer, Ute			Repetitive Long-Term Hyperbaric Oxygen Treatment (HBOT) Administered after Experimental Traumatic Brain Injury in Rats Induces Significant Remyelination and a Recovery of Sensorimotor Function	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SOMATOSENSORY-EVOKED POTENTIALS; ISCHEMIA-REPERFUSION INJURY; FLUID-PERCUSSION INJURY; MITOCHONDRIAL-FUNCTION; CEREBRAL-ISCHEMIA; HEAD-INJURY; THERAPY; MODEL	Cells in the central nervous system rely almost exclusively on aerobic metabolism. Oxygen deprivation, such as injury-associated ischemia, results in detrimental apoptotic and necrotic cell loss. There is evidence that repetitive hyperbaric oxygen therapy (HBOT) improves outcomes in traumatic brain-injured patients. However, there are no experimental studies investigating the mechanism of repetitive long-term HBOT treatment-associated protective effects. We have therefore analysed the effect of long-term repetitive HBOT treatment on brain trauma-associated cerebral modulations using the lateral fluid percussion model for rats. Trauma-associated neurological impairment regressed significantly in the group of HBO-treated animals within three weeks post trauma. Evaluation of somatosensory-evoked potentials indicated a possible remyelination of neurons in the injured hemisphere following HBOT. This presumption was confirmed by a pronounced increase in myelin basic protein isoforms, PLP expression as well as an increase in myelin following three weeks of repetitive HBO treatment. Our results indicate that protective long-term HBOT effects following brain injury is mediated by a pronounced remyelination in the ipsilateral injured cortex as substantiated by the associated recovery of sensorimotor function.	[Kraitsy, Klaus; Uecal, Muammer; Pfleger, Florentina; Gruenbacher, Gerda; Patz, Silke; Fasching, Ulrike; Schaefer, Ute] Med Univ Graz, Res Unit Expt Neurotraumatol, Graz, Austria; [Grossauer, Stefan; Bruckmann, Lukas] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Ropele, Stefan; Fazekas, Franz] Med Univ Graz, Clin Div Gen Neurol, Graz, Austria; [Absenger, Markus] Med Univ Graz, Med Res Ctr, Core Facil Microscopy, Graz, Austria; [Porubsky, Christian; Smolle-Juettner, Freyja; Tezer, Irem] Med Univ Graz, Dept Surg, Div Thorac & Hyperbar Surg, Graz, Austria; [Molcanyi, Marek] Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; [Molcanyi, Marek] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Cologne; University of Cologne	Schaefer, U (corresponding author), Med Univ Graz, Res Unit Expt Neurotraumatol, Graz, Austria.	ute.schaefer@medunigraz.at						Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Asou Hiroaki, 1995, Keio Journal of Medicine, V44, P47; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; Bentz K, 2010, CELL PHYSIOL BIOCHEM, V26, P821, DOI 10.1159/000323991; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Brkic P, 2012, BRAIN INJ; Butt AM, 1997, J NEUROSCI RES, V48, P588; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Campbell J.N., 2011, J NEUROTRAUMA; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; Chang CF, 2000, EXP NEUROL, V166, P298, DOI 10.1006/exnr.2000.7506; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; Crawford AH, 2013, J COMP PATHOL, V149, P242, DOI 10.1016/j.jcpa.2013.05.004; Cummins FJ, 2010, J CARDIOVASC TRANSL, V3, P683, DOI 10.1007/s12265-010-9221-7; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; DeBruin LS, 2006, BIOCHEM CELL BIOL, V84, P993, DOI 10.1139/O06-180; Dell'Acqua ML, 2012, NEUROPATH APPL NEURO, V38, P454, DOI 10.1111/j.1365-2990.2011.01228.x; DEROSBO NK, 1991, DEV NEUROSCI-BASEL, V13, P34; Eovaldi B, 2010, NEUROPSYCH DIS TREAT, V6, P785, DOI 10.2147/NDT.S16071; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Furlonger A J, 2000, Crit Care Resusc, V2, P246; Gambi D, 1996, ITAL J NEUROL SCI, V17, P23, DOI 10.1007/BF01995706; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Huchzermeyer C, 2013, J CEREBR BLOOD F MET, V33, P263, DOI 10.1038/jcbfm.2012.165; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; IULIANO BA, 1994, J NEUROL SCI, V123, P186, DOI 10.1016/0022-510X(94)90222-4; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kao HK, 2009, PULM PHARMACOL THER, V22, P473, DOI 10.1016/j.pupt.2009.04.006; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Lee LC, 2012, AM J PHYS MED REHAB, V91, P528, DOI 10.1097/PHM.0b013e31824ad556; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Michalski D, 2009, BRAIN RES, V1303, P161, DOI 10.1016/j.brainres.2009.09.038; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; MINK RB, 1995, STROKE, V26, P2307, DOI 10.1161/01.STR.26.12.2307; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; MONDELLI M, 1989, ITAL J NEUROL SCI, V10, P433, DOI 10.1007/BF02334949; Morelli A, 2011, CELL BIOCHEM BIOPHYS, V61, P179, DOI 10.1007/s12013-011-9174-8; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; NEUBAUER RA, 1993, J NEUROSURG, V78, P687; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Ohguri T, 2007, INT J RADIAT ONCOL, V67, P248, DOI 10.1016/j.ijrobp.2006.08.009; Ostrowski RP, 2006, STROKE, V37, P1314, DOI 10.1161/01.STR.0000217310.88450.c3; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Prakash A, 2012, J PEDIATR NEUROSCI, V7, P4, DOI 10.4103/1817-1745.97610; Puri V, 2005, MUSCLE NERVE, V32, P230, DOI 10.1002/mus.20316; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Ren HJ, 2001, CHINESE MED J-PEKING, V114, P387; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; ROBERTSON A, 1993, ACTA NEUROPATHOL, V86, P163, DOI 10.1007/BF00334883; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; SHIBASAKI H, 1982, ANN NEUROL, V12, P355, DOI 10.1002/ana.410120407; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; Smith G, 2012, BALLET REV, V40, P18; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; STANLEY GP, 1991, BRAIN, V114, P1827, DOI 10.1093/brain/114.4.1827; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yi JH, 2007, BRAIN RES, V1154, P200, DOI 10.1016/j.brainres.2007.04.011; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	89	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97750	10.1371/journal.pone.0097750	http://dx.doi.org/10.1371/journal.pone.0097750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848795	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600054
J	Moll, J; Weingartner, JH; Bado, P; Basilio, R; Sato, JR; Melo, BR; Bramati, IE; de Oliveira-Souza, R; Zahn, R				Moll, Jorge; Weingartner, Julie H.; Bado, Patricia; Basilio, Rodrigo; Sato, Joao R.; Melo, Bruno R.; Bramati, Ivanei E.; de Oliveira-Souza, Ricardo; Zahn, Roland			Voluntary Enhancement of Neural Signatures of Affiliative Emotion Using fMRI Neurofeedback	PLOS ONE			English	Article							HUMAN BRAIN ACTIVITY; REAL-TIME FMRI; FUNCTIONAL MRI; INDIVIDUAL-DIFFERENCES; NATURAL IMAGES; ACTIVATION; SELF; CLASSIFICATION; COOPERATION; OXYTOCIN	In Ridley Scott's film "Blade Runner", empathy-detection devices are employed to measure affiliative emotions. Despite recent neurocomputational advances, it is unknown whether brain signatures of affiliative emotions, such as tenderness/affection, can be decoded and voluntarily modulated. Here, we employed multivariate voxel pattern analysis and real-time fMRI to address this question. We found that participants were able to use visual feedback based on decoded fMRI patterns as a neurofeedback signal to increase brain activation characteristic of tenderness/affection relative to pride, an equally complex control emotion. Such improvement was not observed in a control group performing the same fMRI task without neurofeedback. Furthermore, the neurofeedback-driven enhancement of tenderness/affection-related distributed patterns was associated with local fMRI responses in the septohypothalamic area and frontopolar cortex, regions previously implicated in affiliative emotion. This demonstrates that humans can voluntarily enhance brain signatures of tenderness/affection, unlocking new possibilities for promoting prosocial emotions and countering antisocial behavior.	[Moll, Jorge; Weingartner, Julie H.; Bado, Patricia; Basilio, Rodrigo; Sato, Joao R.; Melo, Bruno R.; Bramati, Ivanei E.; de Oliveira-Souza, Ricardo; Zahn, Roland] DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil; [Moll, Jorge; Weingartner, Julie H.; Bado, Patricia; Basilio, Rodrigo; Sato, Joao R.; Melo, Bruno R.; Bramati, Ivanei E.; de Oliveira-Souza, Ricardo; Zahn, Roland] DOr Inst Res & Educ IDOR, Neuroinformat Workgrp, Rio De Janeiro, Brazil; [Bado, Patricia] Univ Fed Rio de Janeiro, ICB, Rio De Janeiro, Brazil; [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil; [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro, Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil; [Zahn, Roland] Kings Coll London, Inst Psychiat, Ctr Affect Disorders, London WC2R 2LS, England	IDOR - Instituto D'Or de Ensino e Pesquisa; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Universidade Federal do ABC (UFABC); University of London; King's College London	Moll, J (corresponding author), DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil.	jorge.moll@idor.org	Moll, Jorge/AAF-8388-2021; Zahn, Roland/O-8944-2019; BADO, PATRICIA/AAF-6217-2021; Zahn, Roland/C-4665-2008	Moll, Jorge/0000-0002-4297-591X; Zahn, Roland/0000-0002-8447-1453; BADO, PATRICIA/0000-0001-8543-2547; Zahn, Roland/0000-0002-8447-1453; Sato, Joao Ricardo/0000-0002-7503-9781	FAPERJ Sediadas grant; INNT grant; CAPES; CNPq; IDOR; MRC [G0902304]; FAPESP, Brazil [2013/10498-6]; Medical Research Council [G0902304] Funding Source: researchfish	FAPERJ Sediadas grant(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INNT grant; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); IDOR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by FAPERJ Sediadas and INNT grants, CAPES, CNPq and by intramural grants from IDOR; R.Z. was supported by an MRC clinician scientist award (G0902304). J.R.S. was supported by FAPESP (grant number 2013/10498-6), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J, 2002, NEUROSCIENTIST, V8, P335, DOI 10.1177/107385840200800409; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BISHOP MP, 1963, SCIENCE, V140, P394, DOI 10.1126/science.140.3565.394; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; COX RW, 1995, MAGNET RESON MED, V33, P230, DOI 10.1002/mrm.1910330213; De Oliveira-Souza R, 2008, CRIM JUSTICE BEHAV, V35, P427, DOI 10.1177/0093854807310853; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; GORMAN DG, 1992, ARCH NEUROL-CHICAGO, V49, P308, DOI 10.1001/archneur.1992.00530270128029; Green AE, 2006, BRAIN RES, V1096, P125, DOI 10.1016/j.brainres.2006.04.024; Green S, 2012, ARCH GEN PSYCHIAT, V69, P1014, DOI 10.1001/archgenpsychiatry.2012.135; Harmelech T, 2013, J NEUROSCI, V33, P9488, DOI 10.1523/JNEUROSCI.5911-12.2013; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hsu M, 2008, SCIENCE, V320, P1092, DOI 10.1126/science.1153651; Hyman SE, 2007, AM J BIOETHICS, V7, P8, DOI 10.1080/15265160601063969; Hyman SE, 2011, NEURON, V69, P595, DOI 10.1016/j.neuron.2011.02.012; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; IRVIN RW, 1990, PHYSIOL BEHAV, V48, P693, DOI 10.1016/0031-9384(90)90213-N; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; MILLER NE, 1978, ANNU REV PSYCHOL, V29, P373, DOI 10.1146/annurev.ps.29.020178.002105; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Moll J, 2012, J NEUROSCI, V32, P12499, DOI 10.1523/JNEUROSCI.6508-11.2012; Moll J, 2011, NEUROIMAGE, V54, P1735, DOI 10.1016/j.neuroimage.2010.08.026; Morey RA, 2012, NEUROIMAGE, V60, P683, DOI 10.1016/j.neuroimage.2011.12.069; Morrone-Strupinsky JV, 2007, PERS INDIV DIFFER, V42, P1267, DOI 10.1016/j.paid.2006.10.005; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Panksepp J, 2011, SCIENCE, V334, P1358, DOI 10.1126/science.1216480; Papageorgiou TD, 2013, P NATL ACAD SCI USA, V110, P13630, DOI 10.1073/pnas.1210738110; Phan KL, 2004, NEUROREPORT, V15, P527, DOI 10.1097/00001756-200403010-00029; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Sato JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081658; Sato JR, 2008, NEUROIMAGE, V42, P1473, DOI 10.1016/j.neuroimage.2008.06.024; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Vapnik V. N., 1998, NATURE STAT LEARNING; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zaborszky L, 2008, NEUROIMAGE, V42, P1127, DOI 10.1016/j.neuroimage.2008.05.055; Zahn R, 2009, NEUROSCI LETT, V457, P107, DOI 10.1016/j.neulet.2009.03.090; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080; Zarahn E, 1997, NEUROIMAGE, V457, P107; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	66	31	32	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97343	10.1371/journal.pone.0097343	http://dx.doi.org/10.1371/journal.pone.0097343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847819	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600025
J	Schutte, HJ; Jansen, S; Schafroth, MU; Goslings, JC; van der Velde, N; de Rooij, SEJA				Schutte, Hermien Janneke; Jansen, Sofie; Schafroth, Matthias U.; Goslings, J. Carel; van der Velde, Nathalie; de Rooij, Sophia E. J. A.			SSRIs Increase Risk of Blood Transfusion in Patients Admitted for Hip Surgery	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANTIDEPRESSANTS; ASSOCIATION; MORTALITY	Background: Recent studies have shown that an increased bleeding tendency can be caused by Selective Serotonin Reuptake Inhibitors (SSRI) use. We aimed to investigate the occurrence and risk of blood transfusion in SSRI users compared to non-SSRI users in a cohort of patients admitted for hip-surgery. Methods: We conducted a retrospective cohort study of patients who underwent planned or emergency hip surgery from 1996 to 2011 in the Academic Medical Center in Amsterdam. Primary outcome measure was risk of blood transfusion. Secondary outcome measures were pre- and postoperative hemoglobin level. Multivariate logistic regression was used to adjust for potential confounders. Results: One-hundred and fourteen SSRI users were compared to 1773 non-SSRI users. Risk of blood transfusion during admission was increased for SSRI users in multivariate analyses (OR 1.7 [95% CI 1.1-2.5]). Also, pre-operative hemoglobin levels were lower in SSRI users (7.8 +/- 1.0 mmol/L) compared to non-SSRI users (8.0 +/- 1.0 mmol/L) (p=0.042)), as were postoperative hemoglobin levels (6.2 +/- 1.0 mmol/L vs. 6.4 +/- 1.0 mmol/L respectively) (p=0.017)). Conclusions: SSRI users undergoing hip surgery have an increased risk for blood transfusion during admission, potentially explained by a lower hemoglobin level before surgery. SSRI use should be considered as a potential risk indicator for increased blood loss in patients admitted for hip surgery. These results need to be confirmed in a prospective study.	[Schutte, Hermien Janneke; Jansen, Sofie; van der Velde, Nathalie; de Rooij, Sophia E. J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med, Geriatr Med Sect, NL-1105 AZ Amsterdam, Netherlands; [Schafroth, Matthias U.] Univ Amsterdam, Acad Med Ctr, Dept Orthoped Surg, NL-1105 AZ Amsterdam, Netherlands; [Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Trauma Unit, Dept Surg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Rooij, SEJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med, Geriatr Med Sect, NL-1105 AZ Amsterdam, Netherlands.	s.e.derooij@amc.uva.nl		van der Velde, Nathalie/0000-0002-6477-6209				Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; Auerbach AD, 2013, JAMA INTERN MED, V173, P1075, DOI 10.1001/jamainternmed.2013.714; Carvajal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019819; Centraal Begeleidings Orgaan, 2011, BLOOD TRANSF GUID; Centraal Begeleidings Orgaan, 2004, BLOOD TRANSF GUID; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cobain TJ, 2007, TRANSFUSION MED, V17, P1, DOI 10.1111/j.1365-3148.2006.00709.x; College van zorgverzekeringen, 2012, AANT GEBR 2007 2011; COOK EH, 1994, J NEUROCHEM, V63, P465; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Jansen S, 2012, EUROPEAN GERIATRIC M, V3, pS2; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Morel-Kopp MC, 2009, J THROMB HAEMOST, V7, P573, DOI 10.1111/j.1538-7836.2009.03278.x; Movig KLL, 2003, ARCH INTERN MED, V163, P2354, DOI 10.1001/archinte.163.19.2354; NARANJO CA, 1995, DRUG AGING, V7, P184, DOI 10.2165/00002512-199507030-00004; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Radovanovic I, 2012, ACTA ORTHOP BELG, V78, P187; Rogers MAM, 2007, J WOMENS HEALTH, V16, P1412, DOI 10.1089/jwh.2007.0397; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Shander A, 2009, SURG INFECT, V10, P277, DOI 10.1089/sur.2007.055; Takeuchi K, 2011, J PHARMACOL EXP THER, V338, P850, DOI 10.1124/jpet.111.183293; Targownik LE, 2009, AM J GASTROENTEROL, V104, P1475, DOI 10.1038/ajg.2009.128; van Haelst IMM, 2010, ANESTHESIOLOGY, V112, P631, DOI 10.1097/ALN.0b013e3181cf8fdf; Vidal X, 2008, DRUG SAFETY, V31, P159, DOI 10.2165/00002018-200831020-00005; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wu WC, 2012, ANN SURG, V255, P708, DOI 10.1097/SLA.0b013e31824a55b9; Ziegelstein RC, 2009, INTERN MED J, V39, P38, DOI 10.1111/j.1445-5994.2008.01794.x	28	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e95906	10.1371/journal.pone.0095906	http://dx.doi.org/10.1371/journal.pone.0095906			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848000	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600008
J	Dickerson, F; Stallings, C; Origoni, A; Katsafanas, E; Schweinfurth, LAB; Savage, CLG; Yolken, R				Dickerson, Faith; Stallings, Cassie; Origoni, Andrea; Katsafanas, Emily; Schweinfurth, Lucy A. B.; Savage, Christina L. G.; Yolken, Robert			Association between Cytomegalovirus Antibody Levels and Cognitive Functioning in Non-Elderly Adults	PLOS ONE			English	Article							INFECTIONS; VIRUS; HERPESVIRUSES; SCHIZOPHRENIA; EXPOSURE; CMV	Background: Elevated levels of antibodies to Cytomegalovirus (CMV) have been associated with cognitive impairment, but the quantitative relationship between CMV antibody levels and domains of cognitive functioning in younger adults has not been established. Methods: We measured IgG class antibodies to Cytomegalovirus in 521 individuals, mean age 32.8 years. Participants were selected for the absence of psychiatric disorder and of a serious medical condition that could affect brain functioning. Cognitive functioning was measured with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the Wisconsin Card Sorting Test, Trail Making Test part A, and the WAIS III Letter Number Sequencing subtest. Linear regression analyses were used to measure the quantitative association between cognitive scores and Cytomegalovirus IgG antibody level. Logistic regression analyses were used to measure the odds of low cognitive scores and elevated antibody levels defined as an antibody level > = 50th, 75th, and 90th percentile of the group. Results: Higher levels of CMV antibodies were associated with lower performance on RBANS Total (coefficient -1.03, p<.0002), Delayed Memory (coefficient -0.94, p<.001), Visuospatial/Constructional (coefficient -1.77, p<5x10(-7)), and Letter Number Sequencing (coefficient -0.15, p<.03). There was an incremental relationship between the level of CMV antibody elevation and the odds of a low RBANS Total score. The odds of a low total cognitive score were 1.63 (95th % CI 1.01, 2.64; p<.045), 2.22 (95th % CI 1.33, 3.70; p<.002), and 2.46 (95th % CI 1.24, 4.86; p<.010) with a CMV antibody level greater than or equal to the 50th, 75th, and 90th percentile respectively. Conclusions: Higher levels of Cytomegalovirus antibodies are associated with lower levels of cognitive functioning in non-elderly adults. Methods for the prevention and treatment of CMV infection should be evaluated to determine if they result in an improvement in cognitive functioning in otherwise healthy adults.	[Dickerson, Faith; Stallings, Cassie; Origoni, Andrea; Katsafanas, Emily; Schweinfurth, Lucy A. B.; Savage, Christina L. G.] Sheppard Pratt Hlth Syst, Stanley Res Program, Baltimore, MD 21285 USA; [Yolken, Robert] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Dickerson, F (corresponding author), Sheppard Pratt Hlth Syst, Stanley Res Program, Baltimore, MD 21285 USA.	Fdickerson@sheppardpratt.org	yolken, robert/AAW-2556-2021; Dickerson, Faith/C-8311-2019	Dickerson, Faith/0000-0003-3800-2864	Stanley Medical Research Institute [07R-1690]; NIH [PA50 MH94268]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Stanley Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant 07R-1690 from the Stanley Medical Research Institute and grant PA50 MH94268 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; [Anonymous], 2008, J CLIN VIROL, V41, P173; Bale JF, 2012, SEMIN PEDIATR NEUROL, V19, P101, DOI 10.1016/j.spen.2012.02.008; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Belo F, 2012, BMJ CASE REP; Bennett JM, 2012, BRAIN BEHAV IMMUN, V26, P739, DOI 10.1016/j.bbi.2011.11.007; Borglum AD, 2013, MOL PSYCHIAT; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; CHOU SW, 1989, J INFECT DIS, V160, P16, DOI 10.1093/infdis/160.1.16; Dickerson F, 2008, BRAIN BEHAV IMMUN, V22, P1103, DOI 10.1016/j.bbi.2008.04.156; Dickerson FB, 2003, ARCH GEN PSYCHIAT, V60, P466, DOI 10.1001/archpsyc.60.5.466; Elliott Sean P, 2011, Infect Disord Drug Targets, V11, P432; First M. B., 1998, STRUCTURED CLIN INTE; FORGHANI B, 1980, J MED VIROL, V6, P119; Gow AJ, 2013, NEUROBIOL AGING, V34, P1846, DOI 10.1016/j.neurobiolaging.2013.01.011; Griffiths Paul, 2004, Herpes, V11 Suppl 2, p95A; Heaton R.K., 1993, WISCONSIN CARD SORTI; Kilgour AHM, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-33; Kongs SK, 2000, WISCONSIN CARD SORTI; McVoy MA, 2013, CLIN INFECT DIS, V57, pS196, DOI 10.1093/cid/cit587; Nakamichi K, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-200; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reitan RM., 1979, TRAIL MAKING TEST MA; Rothschild DM, 1999, J NEUROSCI RES, V57, P429, DOI 10.1002/(SICI)1097-4547(19990815)57:4<429::AID-JNR2>3.3.CO;2-4; SCHUPFER PC, 1986, PEDIATR INFECT DIS J, V5, P677, DOI 10.1097/00006454-198611000-00015; Soderberg-Naucler C, 2014, EXPERT REV ANTI-INFE, V12, P211, DOI 10.1586/14787210.2014.870472; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Tarter KD, 2013, J INFECT DIS; Wechsler D, 1997, WECSHLER ADULT INTEL	29	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e95510	10.1371/journal.pone.0095510	http://dx.doi.org/10.1371/journal.pone.0095510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846058	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400004
J	Durinovic-Bello, I; Gersuk, VH; Ni, C; Wu, R; Thorpe, J; Jospe, N; Sanda, S; Greenbaum, CJ; Nepom, GT				Durinovic-Bello, Ivana; Gersuk, Vivian H.; Ni, Chester; Wu, Rebecca; Thorpe, Jerill; Jospe, Nicholas; Sanda, Srinath; Greenbaum, Carla J.; Nepom, Gerald T.			Avidity-Dependent Programming of Autoreactive T Cells in T1D	PLOS ONE			English	Article							CLASS-II TETRAMERS; INSULIN GENE; THYMOCYTE SELECTION; HUMAN THYMUS; IN-VIVO; LOCUS; SUSCEPTIBILITY; PROINSULIN; EXPRESSION; TOLERANCE	Fate determination for autoreactive T cells relies on a series of avidity-dependent interactions during T cell selection, represented by two general types of signals, one based on antigen expression and density during T cell development, and one based on genes that interpret the avidity of TCR interaction to guide developmental outcome. We used proinsulin-specific HLA class II tetramers to purify and determine transcriptional signatures for autoreactive T cells under differential selection in type 1 diabetes (T1D), in which insulin (INS) genotypes consist of protective and susceptible alleles that regulate the level of proinsulin expression in the thymus. Upregulation of steroid nuclear receptor family 4A (NR4A) and early growth response family genes in proinsulin-specific T cells was observed in individuals with susceptible INS-VNTR genotypes, suggesting a mechanism for avidity-dependent fate determination of the T cell repertoire in T1D. The NR4A genes act as translators of TCR signal strength that guide central and peripheral T cell fate decisions through transcriptional modification. We propose that maintenance of an NR4A-guided program in low avidity autoreactive T cells in T1D reflects their prior developmental experience influenced by proinsulin expression, identifying a pathway permissive for autoimmunity.	[Durinovic-Bello, Ivana; Gersuk, Vivian H.; Ni, Chester; Wu, Rebecca; Thorpe, Jerill; Sanda, Srinath; Greenbaum, Carla J.; Nepom, Gerald T.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Jospe, Nicholas] Univ Rochester, Sch Med, Rochester, NY USA; [Nepom, Gerald T.] Univ Washington, Sch Med, Seattle, WA USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Rochester; University of Washington; University of Washington Seattle	Durinovic-Bello, I (corresponding author), Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA.	ivanadbello@gmail.com; jnepom@benaroyaresearch.org		Nepom, Gerald/0000-0002-8063-1464	Juvenile Diabetes Research Foundation, JDRF-BRI Center for Translational Research [4-2007-1058]; Life Sciences Discovery Fund, Program in Autoimmune Disease Intervention [2087550]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation, JDRF-BRI Center for Translational Research; Life Sciences Discovery Fund, Program in Autoimmune Disease Intervention; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has the following funding sources: Juvenile Diabetes Research Foundation, JDRF-BRI Center for Translational Research [4-2007-1058; (completed); www.jdrf.org]; Life Sciences Discovery Fund, Program in Autoimmune Disease Intervention [2087550; (completed); www.lsdfa.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Durinovic-Bello I, 2002, J AUTOIMMUN, V18, P55, DOI 10.1006/jaut.2001.0566; Durinovic-Bello I, 2010, GENES IMMUN, V11, P188, DOI 10.1038/gene.2009.108; Durinovic-Bello I, 2006, P NATL ACAD SCI USA, V103, P11683, DOI 10.1073/pnas.0603682103; DurinovicBello I, 1996, DIABETES, V45, P795, DOI 10.2337/diabetes.45.6.795; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; Gebe JA, 2009, J IMMUNOL, V183, P59, DOI 10.4049/jimmunol.0804046; Gersuk VH, 2006, J IMMUNOL METHODS, V317, P64, DOI 10.1016/j.jim.2006.09.003; James EA, 2009, J VIS EXP, V6, P1167; James EA, 2008, DIABETES, V57, P1788, DOI 10.2337/db08-0530; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stead JDH, 2000, HUM MOL GENET, V9, P2929, DOI 10.1093/hmg/9.20.2929; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Yang JB, 2008, J AUTOIMMUN, V31, P30, DOI 10.1016/j.jaut.2008.02.001; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98074	10.1371/journal.pone.0098074	http://dx.doi.org/10.1371/journal.pone.0098074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844227	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400091
J	Migita, K; Izumi, Y; Jiuchi, Y; Kozuru, H; Kawahara, C; Nakamura, M; Nakamura, T; Agematsu, K; Masumoto, J; Yasunami, M; Kawakami, A; Eguchi, K				Migita, Kiyoshi; Izumi, Yasumori; Jiuchi, Yuka; Kozuru, Hideko; Kawahara, Chieko; Nakamura, Minoru; Nakamura, Tadashi; Agematsu, Kazunaga; Masumoto, Junya; Yasunami, Michio; Kawakami, Atsushi; Eguchi, Katsumi			Serum Amyloid A Induces NLRP-3-Mediated IL-1 beta Secretion in Neutrophils	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; TYROSINE KINASE; RECEPTOR; ACTIVATION; CRYSTALS; BINDING	Background/Aims: Serum amyloid A (SAA) is an acute phase reactant with significant immunological activities, including effects on cytokine synthesis and neutrophil chemotaxis. Neutrophils can also release cytokines with proinflammatory properties. IL-1 beta is a key proinflammatory cytokine, the secretion of which is controlled by inflammasome. We investigated the proinflammatory effects of SAA in vitro in relation to the NLRP3 inflammasome in neutrophils. Methodology/Principal Findings: Human neutrophils isolated form healthy subjects were stimulated with serum amyloid A (SAA). The cellular supernatants were analyzed by western blot using anti-IL-1 beta or anti-caspase-1 antibodies. IL-1 beta or Nod-like receptor family, pyrin domain containing 3 (NLRP3) mRNA expressions were analyzed by real-time PCR or reverse transcription-PCR (RT-PCR) method. SAA stimulation induced pro-IL-1 beta mRNA expression in neutrophils. Furthermore, SAA engaged the caspase-1-activating inflammasome, resulting in the production of active IL-1 beta. SAA-induced pro-IL-1 beta expression was marginally suppressed by the Syk specific inhibitor, R406, and SAA-induced pro-IL-1 beta processing in neutrophils was prevented by R406. Furthermore, SAA-induced NLRP3 mRNA expression was completely blocked by R406. Analysis of intracellular signaling revealed that SAA stimulation activated the tyrosine kinase Syk and mitogen-activated protein kinase (MAPK). Conclusions/Significance: These results demonstrate that the innate neutrophil immune response against SAA involves a two-step activation process: an initial signal promoting expression of pro-IL-1 beta and a second signal involving Syk-dependent activation of the NLRP3 inflammasome and caspase-1, allowing processing of pro-IL-1 beta and secretion of mature IL-1 beta.	[Migita, Kiyoshi; Izumi, Yasumori; Jiuchi, Yuka; Kozuru, Hideko; Kawahara, Chieko; Nakamura, Minoru] Nagasaki Med Ctr, Dept Rheumatol, Omura, Nagasaki, Japan; [Migita, Kiyoshi; Izumi, Yasumori; Jiuchi, Yuka; Kozuru, Hideko; Kawahara, Chieko; Nakamura, Minoru] Nagasaki Med Ctr, Clin Res Ctr, Omura, Nagasaki, Japan; [Nakamura, Tadashi] Shinto Kumamoto Hosp, Dept Rheumatol, Kumamoto, Japan; [Agematsu, Kazunaga] Shinshu Univ, Dept Infect & Host Def, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Masumoto, Junya] Ehime Univ, Dept Pathol, Grad Sch Med, Toon, Ehime, Japan; [Masumoto, Junya] Proteosci Ctr, Toon, Ehime, Japan; [Yasunami, Michio] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Kawakami, Atsushi] Nagasaki Univ Hosp, Dept Rheumatol, Nagasaki, Japan; [Eguchi, Katsumi] Sasebo City Gen Hosp, Dept Rheumatol, Sasebo, Nagasaki, Japan	Shinshu University; Ehime University; Nagasaki University; Nagasaki University	Migita, K (corresponding author), Nagasaki Med Ctr, Dept Rheumatol, Omura, Nagasaki, Japan.	migita@nmc.hosp.go.jp			National Hospital Organization (multi-centre clinical studies for evidenced-based medicine)	National Hospital Organization (multi-centre clinical studies for evidenced-based medicine)	The study was supported by a grant from the National Hospital Organization (multi-centre clinical studies for evidenced-based medicine). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Cai H, 2007, J IMMUNOL, V178, P1852, DOI 10.4049/jimmunol.178.3.1852; Cunnane G, 1999, BEST PRACT RES CL RH, V13, P615, DOI 10.1053/berh.1999.0049; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; He Y, 2014, J BIOL CHEM, V289, P1142, DOI 10.1074/jbc.M113.515080; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; Lee MS, 2006, J IMMUNOL, V177, P5585, DOI 10.4049/jimmunol.177.8.5585; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Popa-Nita O, 2009, J IMMUNOL, V183, P2104, DOI 10.4049/jimmunol.0900906; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; Sollberger G, 2013, INNATE IMMUN; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003	34	33	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96703	10.1371/journal.pone.0096703	http://dx.doi.org/10.1371/journal.pone.0096703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846290	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400009
J	Yang, DH; Lee, JW; Lee, J; Moon, EY				Yang, Dong-Hee; Lee, Jae-Wook; Lee, Jiyoung; Moon, Eun-Yi			Dynamic Rearrangement of F-Actin Is Required to Maintain the Antitumor Effect of Trichostatin A	PLOS ONE			English	Article							CANCER-CHEMOTHERAPY; INDUCED APOPTOSIS; CYTOSKELETON; RESISTANCE; DEPOLYMERIZATION; REORGANIZATION; GELSOLIN	Actin plays a role in various processes in eukaryotic cells, including cell growth and death. We investigated whether the antitumor effect of trichostatin A (TSA) is associated with the dynamic rearrangement of F-actin. TSA is an antitumor drug that induces hyper-acetylation of histones by inhibiting histone deacetylase. HeLa human cervical cancer cells were used to measure the antitumor effect of TSA. The percent cell survival was determined by an MTT assay. Hypodiploid cell formation was assessed by flow cytometry. Collapse of the mitochondrial membrane potential (MMP) was identified by a decrease in the percentage of cells with red MitoProbe J-aggregate (JC-1) fluorescence. Cell survival was reduced by treatment with TSA, as judged by an MTT assay and staining with propidium iodide, FITC-labeled annexin V, or 49,6-diamidino-2-phenylindole (DAPI). TSA also induced an MMP collapse, as judged by the measurement of intracellular red JC-1 fluorescence. In addition, the F-actin depolymerizers cytochalasin D (CytoD) and latrunculin B (LatB) induced an MMP collapse and increased apoptotic cell death in HeLa cells. However, our data show that apoptotic cell death and the MMP collapse induced by TSA were decreased by the co-treatment of cells with CytoD and LatB. These findings demonstrate that the dynamic rearrangement of F-actin might be necessary for TSA-induced HeLa cell apoptosis involving a TSA-induced MMP collapse. They also suggest that actin cytoskeleton dynamics play an important role in maintaining the therapeutic effects of antitumor agents in tumor cells. They further suggest that maintaining the MMP could be a novel strategy for increasing drug sensitivity in TSA-treated tumors.	[Yang, Dong-Hee; Lee, Jae-Wook; Lee, Jiyoung; Moon, Eun-Yi] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Sejong University	Moon, EY (corresponding author), Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	eunyimoon@sejong.ac.kr			Mid-career Researcher Program through National Research Foundation of Korea (NRF) [2012-R1A2A2A01005449]; National Nuclear R&D Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST), Korea [2010-00018545, 2012-M2B2A9A03051296]	Mid-career Researcher Program through National Research Foundation of Korea (NRF); National Nuclear R&D Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST), Korea	This work was supported by grants from Mid-career Researcher Program (#2012-R1A2A2A01005449) and National Nuclear R&D Program (#2010-00018545 and #2012-M2B2A9A03051296) through National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2003, ANN NY ACAD SCI, V1010, P493, DOI 10.1196/annals.1299.090; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Cicchillitti L, 2008, MOL CANCER THER, V7, P2070, DOI 10.1158/1535-7163.MCT-07-2370; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Emmenegger U, 2010, NATURE, V468, P637, DOI 10.1038/468637a; Genesca M, 2006, APOPTOSIS, V11, P563, DOI 10.1007/s10495-006-4937-1; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Harms C, 2004, MOL CELL NEUROSCI, V25, P69, DOI 10.1016/j.mcn.2003.09.012; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Kotiadis VN, 2012, J CELL SCI, V125, P2288, DOI 10.1242/jcs.099390; Levee MG, 1996, AM J PHYSIOL-CELL PH, V271, pC1981, DOI 10.1152/ajpcell.1996.271.6.C1981; Moon EY, 2004, EUR J IMMUNOL, V34, P2119, DOI 10.1002/eji.200424962; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI 10.1016/j.mito.2011.09.001; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Torgerson RR, 1998, J CELL SCI, V111, P2911; Tsai JC, 2005, LASER SURG MED, V36, P398, DOI 10.1002/lsm.20179; van der Heijden M, 2008, APOPTOSIS, V13, P404, DOI 10.1007/s10495-007-0173-6; Yamazaki Y, 2000, EXP CELL RES, V259, P64, DOI 10.1006/excr.2000.4970	23	24	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97352	10.1371/journal.pone.0097352	http://dx.doi.org/10.1371/journal.pone.0097352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846135	Green Submitted, gold, Green Published			2022-12-27	WOS:000339563400025
J	Lansky, A; Finlayson, T; Johnson, C; Holtzman, D; Wejnert, C; Mitsch, A; Gust, D; Chen, R; Mizuno, Y; Crepaz, N				Lansky, Amy; Finlayson, Teresa; Johnson, Christopher; Holtzman, Deborah; Wejnert, Cyprian; Mitsch, Andrew; Gust, Deborah; Chen, Robert; Mizuno, Yuko; Crepaz, Nicole			Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections	PLOS ONE			English	Article							METROPOLITAN-AREAS; USERS; PREVALENCE; US; HEALTH	Background: Injection drug use provides an efficient mechanism for transmitting bloodborne viruses, including human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Effective targeting of resources for prevention of HIV and HCV infection among persons who inject drugs (PWID) is based on knowledge of the population size and disparity in disease burden among PWID. This study estimated the number of PWID in the United States to calculate rates of HIV and HCV infection. Methods: We conducted meta-analysis using data from 4 national probability surveys that measured lifetime (3 surveys) or past-year (3 surveys) injection drug use to estimate the proportion of the United States population that has injected drugs. We then applied these proportions to census data to produce population size estimates. To estimate the disease burden among PWID by calculating rates of disease we used lifetime population size estimates of PWID as denominators and estimates of HIV and HCV infection from national HIV surveillance and survey data, respectively, as numerators. We calculated rates of HIV among PWID by gender-, age-, and race/ethnicity. Results: Lifetime PWID comprised 2.6% (95% confidence interval: 1.8%-3.3%) of the U. S. population aged 13 years or older, representing approximately 6,612,488 PWID (range: 4,583,188-8,641,788) in 2011. The population estimate of past-year PWID was 0.30% (95% confidence interval: 0.19 %-0.41%) or 774,434 PWID (range: 494,605-1,054,263). Among lifetime PWID, the 2011 HIV diagnosis rate was 55 per 100,000 PWID; the rate of persons living with a diagnosis of HIV infection in 2010 was 2,147 per 100,000 PWID; and the 2011 HCV infection rate was 43,126 per 100,000 PWID. Conclusion: Estimates of the number of PWID and disease rates among PWID are important for program planning and addressing health inequities.	[Lansky, Amy; Finlayson, Teresa; Johnson, Christopher; Wejnert, Cyprian; Mitsch, Andrew; Gust, Deborah; Chen, Robert; Mizuno, Yuko; Crepaz, Nicole] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Holtzman, Deborah] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lansky, A (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	ALansky@cdc.gov	Chen, Robert T/AIA-8164-2022	Chen, Robert T/0000-0002-3094-8367				[Anonymous], 2004, SUDAAN REL 9 1; Armstrong GL, 2007, ARCH INTERN MED, V167, P166, DOI 10.1001/archinte.167.2.166; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Belani Hrishikesh, 2012, Morbidity and Mortality Weekly Report, V61, P1; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Centers for Diease Control and Prevention, 2011, HIV SURV REP, V23; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Centers for Disease Control and Prevention, 2011, VER HEP SURV US; Centers for Disease Control and Prevention, 2011, 7 CDCP; Coady MH, 2007, AIDS BEHAV, V11, P854, DOI 10.1007/s10461-007-9248-1; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; McQuillan GM, 2010, JAIDS-J ACQ IMM DEF, V53, P117, DOI 10.1097/QAI.0b013e3181b3a8e3; Perez CM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-76; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rao SR, 2008, HEALTH SERV OUTCOME, V8, P98, DOI 10.1007/s10742-008-0032-0; Salazar LF, 2007, AIDS BEHAV, V11, pS70, DOI 10.1007/s10461-007-9239-2; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2010, 9789241599580 UNAIDS; Watson J C, 1998, MMWR Recomm Rep, V47, P1	23	170	170	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97596	10.1371/journal.pone.0097596	http://dx.doi.org/10.1371/journal.pone.0097596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840662	gold, Green Published			2022-12-27	WOS:000340948600048
J	Schroder-Braunstein, J; Gras, J; Brors, B; Schwarz, S; Szikszai, T; Lasitschka, F; Wabnitz, G; Heidtmann, A; Lee, YS; Schiessling, S; Leowardi, C; Al-Saeedi, M; Ulrich, A; Engelke, A; Winter, J; Samstag, Y; Giese, T; Meuer, S				Schroeder-Braunstein, Jutta; Gras, Judith; Brors, Benedikt; Schwarz, Sonja; Szikszai, Timea; Lasitschka, Felix; Wabnitz, Guido; Heidtmann, Antje; Lee, Young-Seon; Schiessling, Serin; Leowardi, Christine; Al-Saeedi, Mohammed; Ulrich, Alexis; Engelke, Antonia; Winter, Johannes; Samstag, Yvonne; Giese, Thomas; Meuer, Stefan			Initiation of an Inflammatory Response in Resident Intestinal Lamina Propria Cells - Use of a Human Organ Culture Model	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; BOWEL-DISEASE; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; T-LYMPHOCYTES; HUMAN GUT; MACROPHAGES; MUCOSAL	Resident human lamina propria immune cells serve as powerful effectors in host defense. Molecular events associated with the initiation of an intestinal inflammatory response in these cells are largely unknown. Here, we aimed to characterize phenotypic and functional changes induced in these cells at the onset of intestinal inflammation using a human intestinal organ culture model. In this model, healthy human colonic mucosa was depleted of epithelial cells by EDTA treatment. Following loss of the epithelial layer, expression of the inflammatory mediators IL1B, IL6, IL8, IL23A, TNFA, CXCL2, and the surface receptors CD14, TLR2, CD86, CD54 was rapidly induced in resident lamina propria cells in situ as determined by qRT-PCR and immunohistology. Gene microarray analysis of lamina propria cells obtained by laser-capture microdissection provided an overview of global changes in gene expression occurring during the initiation of an intestinal inflammatory response in these cells. Bioinformatic analysis gave insight into signalling pathways mediating this inflammatory response. Furthermore, comparison with published microarray datasets of inflamed mucosa in vivo (ulcerative colitis) revealed a significant overlap of differentially regulated genes underlining the in vivo relevance of the organ culture model. Furthermore, genes never been previously associated with intestinal inflammation were identified using this model. The organ culture model characterized may be useful to study molecular mechanisms underlying the initiation of an intestinal inflammatory response in normal mucosa as well as potential alterations of this response in inflammatory bowel disease.	[Schroeder-Braunstein, Jutta; Gras, Judith; Schwarz, Sonja; Szikszai, Timea; Wabnitz, Guido; Heidtmann, Antje; Lee, Young-Seon; Schiessling, Serin; Samstag, Yvonne; Giese, Thomas; Meuer, Stefan] Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Lasitschka, Felix] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Schiessling, Serin; Leowardi, Christine; Al-Saeedi, Mohammed; Ulrich, Alexis] Univ Heidelberg Hosp, Dept Surg, Heidelberg, Germany; [Szikszai, Timea] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany; [Engelke, Antonia] Salem Hosp, Dept Surg, Heidelberg, Germany; [Winter, Johannes] St Vincentius Hosp, Dept Surg, Speyer, Germany; [Lee, Young-Seon] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Hannover Medical School	Schroder-Braunstein, J (corresponding author), Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany.	jutta.schroeder-braunstein@urz.uni-heidelberg.de	Brors, Benedikt/E-5620-2013	Brors, Benedikt/0000-0001-5940-3101; Wabnitz, Guido/0000-0001-5101-9885	Deutsche Forschungsgemeinschaft [SFB 938]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SFB 938, project O, M, and Z2) (www.dkfz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autschbach F, 1998, AM J PATHOL, V153, P121, DOI 10.1016/S0002-9440(10)65552-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; Carrasco A, 2013, J IMMUNOL METHODS, V389, P29, DOI 10.1016/j.jim.2012.12.006; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Clark PM, 2012, INFLAMM BOWEL DIS, V18, P2315, DOI 10.1002/ibd.22958; Coron E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004713; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; DEMARIA R, 1993, EUR J IMMUNOL, V23, P3104, DOI 10.1002/eji.1830231209; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Faubion WA, 2013, AM J GASTROENTEROL, V108, P1891, DOI 10.1038/ajg.2013.354; Fiocchi C, 2011, CURR OPIN GASTROEN, V27, P317, DOI 10.1097/MOG.0b013e3283483986; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Granlund AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056818; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lorrot M, 2007, ARCH PEDIATRIE, V14, pS145, DOI 10.1016/S0929-693X(07)80018-2; Mahida YR, 1997, CLIN EXP IMMUNOL, V109, P377, DOI 10.1046/j.1365-2249.1997.4481346.x; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; MORISE K, 1994, J GASTROENTEROL, V29, P257, DOI 10.1007/BF02358363; Oberhuber G, 1997, SCAND J GASTROENTERO, V32, P48, DOI 10.3109/00365529709025062; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Phalipon A, 2003, CRIT REV IMMUNOL, V23, P371, DOI 10.1615/CritRevImmunol.v23.i56.20; PIRZER UC, 1990, EUR J IMMUNOL, V20, P2339, DOI 10.1002/eji.1830201025; QIAO L, 1993, GASTROENTEROLOGY, V105, P814, DOI 10.1016/0016-5085(93)90899-N; QIAO L, 1991, GASTROENTEROLOGY, V101, P1529, DOI 10.1016/0016-5085(91)90388-2; Qiao L, 1996, EUR J IMMUNOL, V26, P922, DOI 10.1002/eji.1830260430; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Rugtveit J, 1997, CLIN EXP IMMUNOL, V110, P104, DOI 10.1046/j.1365-2249.1997.5071404.x; RYAN GB, 1977, AM J PATHOL, V86, P183; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Sido B, 2000, J EXP MED, V192, P907, DOI 10.1084/jem.192.6.907; Sido B, 2008, GASTROENTEROLOGY, V134, P179, DOI 10.1053/j.gastro.2007.11.001; Smith PD, 1997, J IMMUNOL METHODS, V202, P1, DOI 10.1016/S0022-1759(96)00204-9; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Smythies LE, 2010, J BIOL CHEM, V285, P19593, DOI 10.1074/jbc.M109.069955; Stallmach Andreas, 2004, Int J Colorectal Dis, V19, P308, DOI 10.1007/s00384-003-0554-4; Takada Y, 2010, J IMMUNOL, V184, P1014, DOI 10.4049/jimmunol.0901196; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Team RC, 2013, R LANGUAGE ENV STAT; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zahn A, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-13	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97780	10.1371/journal.pone.0097780	http://dx.doi.org/10.1371/journal.pone.0097780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841635	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600074
J	Valiathan, R; Miguez, MJ; Patel, B; Arheart, KL; Asthana, D				Valiathan, Ranjini; Miguez, Maria J.; Patel, Bijal; Arheart, Kristopher L.; Asthana, Deshratn			Tobacco Smoking Increases Immune Activation and Impairs T-Cell Function in HIV Infected Patients on Antiretrovirals: A Cross-Sectional Pilot Study	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; CIGARETTE-SMOKING; MICROBIAL TRANSLOCATION; PERIPHERAL-BLOOD; LYMPHOCYTE SUBSETS; FLOW-CYTOMETRY; PLASMA-LEVELS; INDIVIDUALS; POPULATION; BIOMARKERS	Background: The influence of tobacco smoking on the immune system of HIV infected individuals is largely unknown. We investigated the impact of tobacco smoking on immune activation, microbial translocation, immune exhaustion and T-cell function in HIV infected individuals. Method: HIV infected smokers and non-smokers (n = 25 each) with documented viral suppression on combination antiretroviral therapy and HIV uninfected smokers and non-smokers (n = 15 each) were enrolled. Markers of immune activation (CD38 and HLA-DR) and immune exhaustion (PD1, Tim3 and CTLA4) were analyzed in peripheral blood mononuclear cells (PBMCs) by flow cytometry. Plasma markers of microbial translocation (soluble-CD14 - sCD14 and lipopolysaccharide - LPS) were measured. Antigen specific functions of CD4+ and CD8+ T-cells were measured, by flow cytometry, in PBMCs after 6 hours stimulation with Cytomegalovirus, Epstein-Barr virus and Influenza Virus (CEF) peptide pool. Results: Compared to non-smokers, smokers of HIV infected and uninfected groups showed significantly higher CD4+ and CD8+ T-cell activation with increased frequencies of CD38+ HLA-DR+ cells with a higher magnitude in HIV infected smokers. Expressions of immune exhaustion markers (PD1, Tim3 and CTLA4) either alone or in combinations were significantly higher in smokers, especially on CD4+ T-cells. Compared to HIV uninfected non-smokers, microbial translocation (sCD14 and LPS) was higher in smokers of both groups and directly correlated with CD4+ and CD8+ T-cell activation. Antigen specific T-cell function showed significantly lower cytokine response of CD4+ and CD8+ T-cells to CEF peptide-pool stimulation in smokers of both HIV infected and uninfected groups. Conclusions: Our results suggest that smoking and HIV infection independently influence T-cell immune activation and function and together they present the worst immune profile. Since smoking is widespread among HIV infected individuals, studies are warranted to further evaluate the cumulative effect of smoking on impairment of the immune system and accelerated disease progression.	[Valiathan, Ranjini; Asthana, Deshratn] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Asthana, Deshratn] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Valiathan, Ranjini; Patel, Bijal; Asthana, Deshratn] Univ Miami, Miller Sch Med, Lab Clin & Biol Studies, Miami, FL 33136 USA; [Miguez, Maria J.] Florida Int Univ, Sch Integrated Sci & Humanities, Miami, FL 33199 USA; [Arheart, Kristopher L.] Univ Miami, Miller Sch Med, Div Biostat, Dept Publ Hlth Sci, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; State University System of Florida; Florida International University; University of Miami	Asthana, D (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	DAsthan@med.miami.edu			Laboratory for Clinical and Biological Studies at the University of Miami; Florida Department of Health; James and Esther King Biomedical Research Program [10KG-10]	Laboratory for Clinical and Biological Studies at the University of Miami; Florida Department of Health; James and Esther King Biomedical Research Program	This study was supported by the research and training funds of the Laboratory for Clinical and Biological Studies at the University of Miami. The authors would also like to acknowledge the support received from the Florida Department of Health and the James and Esther King Biomedical Research Program (grant 10KG-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Qouzi A, 2002, CLIN DIAGN LAB IMMUN, V9, P279, DOI 10.1128/CDLI.9.2.279-281.2002; Allen JN, 1996, J ALLERGY CLIN IMMUN, V97, P1366, DOI 10.1016/S0091-6749(96)70206-3; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Ashman M, 2007, CYTOM PART B-CLIN CY, V72B, P380, DOI 10.1002/cyto.b.20178; Baroncelli S, 2009, J CLIN VIROL, V46, P367, DOI 10.1016/j.jcv.2009.09.011; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; CAIAFFA WT, 1994, AM J RESP CRIT CARE, V150, P1493, DOI 10.1164/ajrccm.150.6.7952605; Charlesworth JC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-29; Chng WJ, 2004, CLIN DIAGN LAB IMMUN, V11, P168, DOI 10.1128/CDLI.11.1.168-173.2004; CHOONG ML, 1995, ANN CLIN BIOCHEM, V32, P532, DOI 10.1177/000456329503200603; Conley LJ, 1996, AIDS, V10, P1121, DOI 10.1097/00002030-199609000-00010; de Heens GLT, 2009, CYTOKINE, V47, P157, DOI 10.1016/j.cyto.2009.05.006; Freiberg MS, 2010, ALCOHOL RES HEALTH, V33, P237; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; HOLT PG, 1987, THORAX, V42, P241, DOI 10.1136/thx.42.4.241; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kuschner WG, 1996, EUR RESPIR J, V9, P1989, DOI 10.1183/09031936.96.09101989; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Patel RR, 2008, DRUGS, V68, P1511, DOI 10.2165/00003495-200868110-00004; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Pilakka-Kanthikeel S, 2012, PEDIATR INFECT DIS J, V31, P583, DOI 10.1097/INF.0b013e31824da0f5; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Salazar-Gonzalez JF, 1998, J INFECT DIS, V178, P423, DOI 10.1086/515629; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sopori ML, 1998, J NEUROIMMUNOL, V83, P148, DOI 10.1016/S0165-5728(97)00231-2; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tewari AK, 2011, PROTEOMICS, V11, P2051, DOI 10.1002/pmic.201000159; TOLLERUD DJ, 1989, AM REV RESPIR DIS, V139, P1446, DOI 10.1164/ajrccm/139.6.1446; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x	45	69	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97698	10.1371/journal.pone.0097698	http://dx.doi.org/10.1371/journal.pone.0097698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842313	gold, Green Published			2022-12-27	WOS:000340948600058
J	Oliver, V; De Rantere, D; Ritchie, R; Chisholm, J; Hecker, KG; Pang, DSJ				Oliver, Vanessa; De Rantere, Debbie; Ritchie, Rheanne; Chisholm, Jessica; Hecker, Kent G.; Pang, Daniel S. J.			Psychometric Assessment of the Rat Grimace Scale and Development of an Analgesic Intervention Score	PLOS ONE			English	Article							PAIN SCALE; FACIAL EXPRESSIONS; POSTOPERATIVE PAIN; BEHAVIOR; LAPAROTOMY; CARPROFEN; DURATION; MOUSE; MICE; DOGS	Our limited ability to assess spontaneous pain in rodent models of painful human conditions may be associated with a translational failure of promising analgesic compounds in to clinical use. If measurement of spontaneous pain behaviours can be used to generate an analgesic intervention score their use could expand to guide the use of analgesics, as mandated by regulatory bodies and ethical and welfare obligations. One such measure of spontaneous pain, the Rat Grimace Scale (RGS), has recently been described and shown to exhibit reliability. However, reliability of measurement scores is context and content specific, and further testing required to assess translation to a heterogenous setting (different model, raters, environment). The objectives of this study were to perform reliability testing with the Rat Grimace Scale in a heterogenous setting and generate an analgesic intervention score for its use. In a randomised, blinded study, sixteen adult female rats received one of three analgesia treatments (0.05 mg/kg buprenorphine subcutaneously, 1 mg/kg meloxicam subcutaneously, 0.2 mg/kg oral buprenorphine in jelly) peri-operatively (telemetry unit implantation surgery). Rats were video-recorded (before, 1-6 and 12 hours post-operatively) and images collected for independent scoring by three blinded raters using the RGS, and five experts based on "pain/no pain'' assessment. Scores were used to calculate inter- and intra-rater reliability with an intraclass correlation coefficient and generate an analgesic intervention score with receiver operating characteristic curve analysis. The RGS scores showed very good inter-and intra-rater reliability (0.85 [0.78-0.90 95% CI] and 0.83 [0.76-0.89], respectively). An analgesic intervention threshold of greater than 0.67 was determined. These data demonstrate that the RGS is a useful tool which can be successfully employed in a heterogenous setting, and has the potential to guide analgesic intervention.	[Oliver, Vanessa; De Rantere, Debbie; Chisholm, Jessica; Hecker, Kent G.; Pang, Daniel S. J.] Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada; [Ritchie, Rheanne] Univ Calgary, Fac Biol Sci, Dept Zool, Calgary, AB, Canada; [Pang, Daniel S. J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Pang, DSJ (corresponding author), Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada.	dsjpang@ucalgary.ca		Chisholm, Jessica/0000-0002-4410-4843; Hecker, Kent/0000-0001-9129-6166; Pang, Daniel/0000-0002-6420-477X	NSERC; University of Calgary Faculty of Veterinary Medicine as part of the Investigative Medicine student rotation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Calgary Faculty of Veterinary Medicine as part of the Investigative Medicine student rotation	Daniel Pang was supported by an NSERC Discovery Grant. Vanessa Oliver was supported by the University of Calgary Faculty of Veterinary Medicine as part of the Investigative Medicine student rotation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1991, PRACTICAL STAT MED R, P396; Biau DJ, 2010, STAT MED, V29, P1900, DOI 10.1002/sim.3947; Brondani JT, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-143; Holton LL, 1998, J SMALL ANIM PRACT, V39, P469, DOI 10.1111/j.1748-5827.1998.tb03681.x; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Matsumiya LC, 2012, J AM ASSOC LAB ANIM, V51, P42; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Mogil JS, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-34; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028; Morton CM, 2005, AM J VET RES, V66, P2154, DOI 10.2460/ajvr.2005.66.2154; National Centre for the Replacement Refinement and Reduction of Animals in Research, 2008, RESP US AN BIOSC RES; National Research Council, 2011, GUIDE CARE USE LAB A; Office of Laboratory Animal Welfare, 2002, PUBL HLTH SERV POL H; Olfert ED, 1993, GUIDE CARE USE EXPT; Ponterotto JG, 2007, PERCEPT MOTOR SKILL, V105, P997, DOI 10.2466/PMS.105.3.997-1014; Reid J, 2007, ANIM WELFARE, V16, P97; Rialland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049480; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2000, RES VET SCI, V69, P283, DOI 10.1053/rvsc.2000.0430; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Streiner DL, 2007, CAN J PSYCHIAT, V52, P121, DOI 10.1177/070674370705200210; STREINER DL, 1993, CAN J PSYCHIAT, V38, P140, DOI 10.1177/070674379303800214; Streiner DL, 2008, RELIABILITY GENERALI, P167; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	31	56	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97882	10.1371/journal.pone.0097882	http://dx.doi.org/10.1371/journal.pone.0097882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24838111	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800081
J	Munnix, MC; Schafer, R; Guhr, T				Muennix, Michael C.; Schaefer, Rudi; Guhr, Thomas			A Random Matrix Approach to Credit Risk	PLOS ONE			English	Article							SECURITIES; MODEL	We estimate generic statistical properties of a structural credit risk model by considering an ensemble of correlation matrices. This ensemble is set up by Random Matrix Theory. We demonstrate analytically that the presence of correlations severely limits the effect of diversification in a credit portfolio if the correlations are not identically zero. The existence of correlations alters the tails of the loss distribution considerably, even if their average is zero. Under the assumption of randomly fluctuating correlations, a lower bound for the estimation of the loss distribution is provided.	[Muennix, Michael C.; Schaefer, Rudi; Guhr, Thomas] Univ Duisburg Essen, Fac Phys, Essen, Germany	University of Duisburg Essen	Munnix, MC (corresponding author), Univ Duisburg Essen, Fac Phys, Essen, Germany.	michael@muennix.com	Muennix, Michael/AAK-8377-2020		Studienstiftung des deutschen Volkes	Studienstiftung des deutschen Volkes	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MCM acknowledges Financial support from Studienstiftung des deutschen Volkes.	Abul-Magd AY, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/17/175207; [Anonymous], 2004, CREDIT RISK MODELLIN; Asvanunt A, 2009, CORPORATE DEFAULT PR; Asvanunt A, 2009, POINT CONDITIONAL RE; Becker A, 2012, ARXIV12033188; Bielecki TR, 2005, CREDIT RISK MODELING; Biroli G, 2007, ARXIV07100802; BLACK F, 1976, J FINANC, V31, P351, DOI 10.2307/2326607; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; BLUHM CHRISTIAN, 2002, INTRO CREDIT RISK MO; Burda Z, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041129; Burda Z, 2011, QUANT FINANC, V11, P1103, DOI 10.1080/14697688.2010.484025; Credit Suisse First Boston, 1997, TECHNICAL REPORT; Darrell D, 2003, PRINC SER FINANC, P1; Duffie D, 1999, REV FINANC STUD, V12, P687, DOI 10.1093/rfs/12.4.687; Giesecke K, 2004, CREDIT RISK MODELS M, V2, P487; Glasserman P, 2003, WORKING PAPER; Guhr T., 1998, Physics Reports, V299, P189, DOI 10.1016/S0370-1573(97)00088-4; Gupton G., 1997, CREDITMETRICS TECHNI; Hull John, 2000, J DERIV, V8, P29, DOI DOI 10.3905/J0D.2000.319115); Jarrow RA, 1997, REV FINANC STUD, V10, P481, DOI 10.1093/rfs/10.2.481; JARROW RA, 1995, J FINANC, V50, P53, DOI 10.2307/2329239; Katz YA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016116; Koivusalo AFR, 2012, J CREDIT RISK, V8, P31; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; McKinsey & Company, 1998, CRED PORTF VIEW APPR; McNeil A. J., 2005, QUANTITATIVE RISK MA; Mehta ML., 2004, RANDOM MATRICES; MERTON RC, 1974, J FINANC, V29, P449, DOI 10.2307/2978814; Olver FWJ, 1974, ASYMPTOTICS SPECIAL, P37; Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471; Potters M, 2005, ACTA PHYS POL B, V36, P2767; Rosenow B, 2009, J RISK MANAGEMENT FI, V3, P16; Schafer R, 2013, ECON MODEL, V30, P1, DOI 10.1016/j.econmod.2012.08.033; Schafer R, 2007, PHYSICA A, V383, P533, DOI 10.1016/j.physa.2007.04.053; Schonbucher, 2001, J RISK FINANCE, V3, P45, DOI DOI 10.1108/EB043482; Schonbucher P.J., 2003, CREDIT DERIVATIVES P; Watson GN, 1944, TREATISE THEORY BESS, P183; Wishart J, 1928, BIOMETRIKA, V20A, P32, DOI 10.2307/2331939	39	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98030	10.1371/journal.pone.0098030	http://dx.doi.org/10.1371/journal.pone.0098030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24853864	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200040
J	Wang, SX; Wu, MQ; Yao, G; Zhang, JJ; Zhou, J				Wang, Shixuan; Wu, Maoqing; Yao, Gang; Zhang, Jingjing; Zhou, Jing			The Cytoplasmic Tail of FPC Antagonizes the Full-Length Protein in the Regulation of mTOR Pathway	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIA; CELL-GROWTH; RAG GTPASES; GENE; FIBROCYSTIN; COMPLEX; PKHD1; PHOSPHORYLATION; RAPTOR	FPC (fibrocystin or polyductin) is a single transmembrane receptor-like protein, responsible for the human autosomal recessive polycystic kidney disease (ARPKD). It was recently proposed that FPC undergoes a Notch-like cleavage and subsequently the cleaved carboxy(C)-terminal fragment translocates to the nucleus. To study the functions of the isolated C-tail, we expressed the intracellular domain of human FPC (hICD) in renal epithelial cells. By 3-dimensional (3D) tubulogenesis assay, we found that in contrast to tubule-like structures formed from control cells, hICD-expressing cells exclusively formed cyst-like structures. By western blotting, we showed that the Akt/mTOR pathway, indicated by increased phosphorylation of Akt at serine 473 and S6 kinase 1 at threonine 389, was constitutively activated in hICD-expressing cells, similar to that in FPC knockdown cells and ARPKD kidneys. Moreover, application of mTOR inhibitor rapamycin reduced the size of the cyst-like structures formed by hICD-expressing cells. Application of either LY294002 or wortmannin inhibited the activation of both S6K1 and Akt. Expression of full-length FPC inhibited the activation of S6 and S6 kinase whereas co-expression of hICD with full-length FPC antagonized the inhibitory effect of full-length FPC on mTOR. Taken together, we propose that FPC modulates the PI3K/Akt/mTOR pathway and the cleaved C-tail regulates the function of the full-length protein.	[Wang, Shixuan] Brigham & Womens Hosp, Dept Med & Ctr Polycyst Kidney Dis, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wang, SX (corresponding author), Brigham & Womens Hosp, Dept Med & Ctr Polycyst Kidney Dis, Div Renal, 75 Francis St, Boston, MA 02115 USA.	shwang@gru.edu; jzhou@partners.org		Wang, Shixuan/0000-0002-3088-0745	National Institutes of Health [P50DK074030]; March of Dimes [1-FY12-527]; Young Investigator Career Development Award from the Polycystic Kidney Disease Foundation [03YI08c]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Young Investigator Career Development Award from the Polycystic Kidney Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding sources: the National Institutes of Health (P50DK074030) and March of Dimes (1-FY12-527) to JZ, the Young Investigator Career Development Award from the Polycystic Kidney Disease Foundation (03YI08c) to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj/cdd/4400978; Edelstein CL, 2005, CELL CYCLE, V4, P1550, DOI 10.4161/cc.4.11.2185; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Goilav B, 2008, PEDIATR NEPHROL, V23, P1473, DOI 10.1007/s00467-008-0851-9; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hiesberger T, 2006, J BIOL CHEM, V281, P34357, DOI 10.1074/jbc.M606740200; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kaimori JY, 2007, HUM MOL GENET, V16, P942, DOI 10.1093/hmg/ddm039; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073173; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Menezes LFC, 2004, KIDNEY INT, V66, P1345, DOI 10.1111/j.1523-1755.2004.00844.x; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Xiong HQ, 2002, GENOMICS, V80, P96, DOI 10.1006/geno.2002.6802; Yao G, 2014, HUM MOL GENET; Yao G, 2013, KIDNEY INT, V83, P426, DOI 10.1038/ki.2012.379; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang JJ, 2010, HUM MOL GENET, V19, P3306, DOI 10.1093/hmg/ddq233; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101; Zhou J, 2008, AUTOSOMAL DOMINANT P; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e95630	10.1371/journal.pone.0095630	http://dx.doi.org/10.1371/journal.pone.0095630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851866	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200005
J	Wernike, K; Holsteg, M; Schirrmeier, H; Hoffmann, B; Beer, M				Wernike, Kerstin; Holsteg, Mark; Schirrmeier, Horst; Hoffmann, Bernd; Beer, Martin			Natural Infection of Pregnant Cows with Schmallenberg Virus - A Follow-Up Study	PLOS ONE			English	Article							AKABANE VIRUS; CONGENITAL-ABNORMALITIES; CATTLE; ORTHOBUNYAVIRUS; ARTHROGRYPOSIS; NETHERLANDS; INOCULATION; ANTIBODIES; BELGIUM; BOVINE	Schmallenberg virus (SBV), an orthobunyavirus discovered in European livestock in late 2011 for the first time, causes premature or stillbirth and severe fetal malformation when cows and ewes are infected during pregnancy. Therefore, cattle of two holdings in the initially most affected area in Germany were closely monitored to describe the consequence for fetuses and newborn calves. Seventy-one calves whose mothers were naturally infected during the first five months of pregnancy were clinically, virologically, and serologically examined. One calve showed typical malformation, another one, born without visible abnormalities, was dead. Two cows aborted during the studied period; spleen and brain samples or meconium swabs were tested by real-time PCR, in none of the fetuses SBV-specific RNA was detectable and the tested fetal sera were negative in a commercially available antibody ELISA. In contrast, in nine clinically healthy calves high SBV-antibody titers were measurable before colostrum intake, and in meconium swabs of six of these animals viral RNA was present as well. The mothers of all nine seropositive calves were presumably infected between days 47 and 162 of gestation, which is within the critical timeframe for fetal infection suggested for SBV and related viruses.	[Wernike, Kerstin; Schirrmeier, Horst; Hoffmann, Bernd; Beer, Martin] FLI, Inst Diagnost Virol, Greifswald, Germany; [Holsteg, Mark] Chamber Agr North Rhine Westphalia, Bovine Hlth Serv, Bonn, Germany	Friedrich Loeffler Institute	Beer, M (corresponding author), FLI, Inst Diagnost Virol, Greifswald, Germany.	martin.beer@fli.bund.de			Germany Federal Ministry of Food, Agriculture and consumer protection; European Union [2012/349/EU]	Germany Federal Ministry of Food, Agriculture and consumer protection; European Union(European Commission)	This study was supported by the Germany Federal Ministry of Food, Agriculture and consumer protection and the European Union as outlined in Council Decision 2012/349/EU concerning a financial contribution by the Union for studies on Schmallenberg virus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, VET REC, V170, P217; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; Bouwstra RJ, 2013, VET MICROBIOL, V165, P102, DOI 10.1016/j.vetmic.2013.03.004; Breard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053446; Conraths FJ, 2013, NEW ZEAL VET J, V61, P63, DOI 10.1080/00480169.2012.738403; De Regge N, 2013, VET MICROBIOL, V162, P595, DOI 10.1016/j.vetmic.2012.11.029; Dominguez M, 2012, VET REC, V171, DOI 10.1136/vr.100883; Elbers ARW, 2012, EMERG INFECT DIS, V18, P1065, DOI 10.3201/eid1807.120323; European Food Safety Authority, 2012, EFSA J, V10, P2768, DOI DOI 10.2903/J.EFSA.2012.2768; Garigliany MM, 2012, EMERG INFECT DIS, V18, P1512, DOI 10.3201/eid1809.120716; Garigliany MM, 2012, EMERG INFECT DIS, V18, P1005, DOI 10.3201/eid1806.120104; HARTLEY WJ, 1977, AUST VET J, V53, P319, DOI 10.1111/j.1751-0813.1977.tb00240.x; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; KIRKLAND PD, 1988, VET REC, V122, P582, DOI 10.1136/vr.122.24.582; KONNO S, 1982, VET PATHOL, V19, P246, DOI 10.1177/030098588201900304; KUROGI H, 1975, ARCH VIROL, V47, P71, DOI 10.1007/BF01315594; KUROGI H, 1977, INFECT IMMUN, V17, P338, DOI 10.1128/IAI.17.2.338-343.1977; Meroc E, 2012, TRANSBOUND EMERG DIS; Meroc E., 2013, TRANSBOUND EMERG DIS; PARSONSON IM, 1975, AUST VET J, V51, P585, DOI 10.1111/j.1751-0813.1975.tb09398.x; St George T. D., 2004, Infectious diseases of livestock. Volume Two, P1029; van Maanen C, 2012, VET REC, V171, P299, DOI 10.1136/vr.101061; Veldhuis A.M., 2013, VET MICROBIOL; Wernike K, 2014, PREV VET MED; Wernike K., 2013, EPIDEMIOL INFECT, P1	25	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98223	10.1371/journal.pone.0098223	http://dx.doi.org/10.1371/journal.pone.0098223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853555	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200057
J	Chen, CC; Chien, WF; Lin, NC; Yeh, KC				Chen, Chyi-chuann; Chien, Wei-Fu; Lin, Nai-Chun; Yeh, Kuo-Chen			Alternative Functions of Arabidopsis YELLOW STRIPE-LIKE3: From Metal Translocation to Pathogen Defense	PLOS ONE			English	Article							SALICYLIC-ACID; YELLOW-STRIPE; CROSS-TALK; PHYTOSIDEROPHORE TRANSPORTER; IRON PHYTOSIDEROPHORES; SIGNALING PATHWAYS; ION HOMEOSTASIS; ARABIDOPSIS; NICOTIANAMINE; PLANTS	YELLOW STRIPE-LIKE1 (YSL1) and YSL3 are involved in iron (Fe) and copper (Cu) translocation. Previously, we reported that upregulation of YSL1 and YSL3 under excess Cu caused high accumulation of Cu in the siz1 mutant, impaired in small ubiquitin-like modifier (SUMO) E3 ligase. Interestingly, the siz1 mutant contains high levels of salicylic acid (SA), involved in plant defense against biotrophic pathogens. In this study, we found that YSL1 and YSL3 were upregulated by SA. SA-regulated YSL3 but not YSL1 depended on NONEXPRESSOR OF PR1 (NPR1). Susceptibility to the pathogen Pseudomonas syringe pv. tomato (Pst) DC3000 was greater for ysl3 than the wild type. Also, during Pst DC3000 infection, YSL3 was positively regulated by SA signaling through NPR1 and the upregulation was enhanced in the coi1 mutant that defective in the jasmonic acid (JA) receptor, CORONATINE INSENSITIVE1. This line of evidence indicates that the regulation of YSL3 is downstream of SA signaling and interplays with JA signaling for involvement in pathogen-induced defense. We provide new insights into the biological function of the metal transporter YSL3 in plant pathogen defense.	[Chen, Chyi-chuann; Chien, Wei-Fu; Yeh, Kuo-Chen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lin, Nai-Chun] Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Yeh, KC (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	kcyeh@gate.sinica.edu.tw	Yeh, Kuo-Chen/AAG-4485-2021	Yeh, Kuo-Chen/0000-0002-3791-3423; LIN, NAI-CHUN/0000-0002-6485-9776	Academia Sinica; National Science Council, Taiwan [NSC 97-2311-B-001-008-MY3, NSC 101-2311-B-001-014-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and the National Science Council, Taiwan (NSC 97-2311-B-001-008-MY3 and NSC 101-2311-B-001-014-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen CC, 2011, PLANT PHYSIOL, V156, P2225, DOI 10.1104/pp.111.178996; Chu HH, 2010, PLANT PHYSIOL, V154, P197, DOI 10.1104/pp.110.159103; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Conte SS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00283; Conte SS, 2012, CURR TOP MEMBR, V69, P295, DOI 10.1016/B978-0-12-394390-3.00011-2; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; Divol F, 2013, PLANT CELL, V25, P1040, DOI 10.1105/tpc.112.107672; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Harada E, 2007, FEBS LETT, V581, P4298, DOI 10.1016/j.febslet.2007.08.011; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; KING EO, 1954, J LAB CLIN MED, V44, P301; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Le Jean M, 2005, PLANT J, V44, P769, DOI 10.1111/j.1365-313X.2005.02569.x; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Roberts LA, 2004, PLANT PHYSIOL, V135, P112, DOI 10.1104/pp.103.037572; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Schaaf G, 2005, PLANT CELL PHYSIOL, V46, P762, DOI 10.1093/pcp/pci081; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Victoria FD, 2012, GENOME, V55, P883, DOI 10.1139/gen-2012-0064; VONWIREN N, 1994, PLANT PHYSIOL, V106, P71, DOI 10.1104/pp.106.1.71; WALTER A, 1995, J PLANT NUTR, V18, P1577, DOI 10.1080/01904169509365005; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Xin XF, 2013, ANN REV PHYTOPATHOL; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881; Yoo CY, 2006, PLANT PHYSIOL, V142, P1548, DOI 10.1104/pp.106.088831; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014	46	18	19	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98008	10.1371/journal.pone.0098008	http://dx.doi.org/10.1371/journal.pone.0098008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845074	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400079
J	Figley, SA; Liu, Y; Karadimas, SK; Satkunendrarajah, K; Fettes, P; Spratt, SK; Lee, G; Ando, D; Surosky, R; Giedlin, M; Fehlings, MG				Figley, Sarah A.; Liu, Yang; Karadimas, Spyridon K.; Satkunendrarajah, Kajana; Fettes, Peter; Spratt, S. Kaye; Lee, Gary; Ando, Dale; Surosky, Richard; Giedlin, Martin; Fehlings, Michael G.			Delayed Administration of a Bio-Engineered Zinc-Finger VEGF-A Gene Therapy Is Neuroprotective and Attenuates Allodynia Following Traumatic Spinal Cord Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPERIMENTAL DIABETIC-NEUROPATHY; TRANSCRIPTION FACTOR; FUNCTIONAL RECOVERY; CHRONIC PAIN; INTRASPINAL INJECTION; NEUROLOGICAL FUNCTION; RECEPTOR EXPRESSION; CONTUSION INJURY; BLOOD-FLOW	Following spinal cord injury (SCI) there are drastic changes that occur in the spinal microvasculature, including ischemia, hemorrhage, endothelial cell death and blood-spinal cord barrier disruption. Vascular endothelial growth factor-A (VEGF-A) is a pleiotropic factor recognized for its pro-angiogenic properties; however, VEGF has recently been shown to provide neuroprotection. We hypothesized that delivery of AdV-ZFP-VEGF - an adenovirally delivered bio-engineered zinc-finger transcription factor that promotes endogenous VEGF-A expression - would result in angiogenesis, neuroprotection and functional recovery following SCI. This novel VEGF gene therapy induces the endogenous production of multiple VEGF-A isoforms; a critical factor for proper vascular development and repair. Briefly, female Wistar rats - under cyclosporin immunosuppression - received a 35 g clip-compression injury and were administered AdV-ZFP-VEGF or AdV-eGFP at 24 hours post-SCI. qRT-PCR and Western Blot analysis of VEGF-A mRNA and protein, showed significant increases in VEGF-A expression in AdV-ZFP-VEGF treated animals (p<0.001 and p<0.05, respectively). Analysis of NF200, TUNEL, and RECA-1 indicated that AdV-ZFP-VEGF increased axonal preservation (p<0.05), reduced cell death (p<0.01), and increased blood vessels (p<0.01), respectively. Moreover, AdV-ZFP-VEGF resulted in a 10% increase in blood vessel proliferation (p<0.001). Catwalk (TM) analysis showed AdV-ZFP-VEGF treatment dramatically improves hindlimb weight support (p<0.05) and increases hindlimb swing speed (p<0.02) when compared to control animals. Finally, AdV-ZFP-VEGF administration provided a significant reduction in allodynia (p<0.01). Overall, the results of this study indicate that AdV-ZFP-VEGF administration can be delivered in a clinically relevant time-window following SCI (24 hours) and provide significant molecular and functional benefits.	[Figley, Sarah A.; Liu, Yang; Karadimas, Spyridon K.; Satkunendrarajah, Kajana; Fettes, Peter; Fehlings, Michael G.] Univ Hlth Network, Dept Genet & Dev, Toronto Western Res Inst, Toronto, ON, Canada; [Figley, Sarah A.; Liu, Yang; Karadimas, Spyridon K.; Satkunendrarajah, Kajana; Fettes, Peter; Fehlings, Michael G.] Univ Hlth Network, Spinal Program, Krembil Neurosci Ctr, Toronto, ON, Canada; [Figley, Sarah A.; Karadimas, Spyridon K.; Giedlin, Martin; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Spratt, S. Kaye; Lee, Gary; Ando, Dale; Surosky, Richard] Sangamo BioSci, Dept Therapeut Dev, Pt Richmond, CA USA; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sangamo Therapeutics, Inc.; University of Toronto	Fehlings, MG (corresponding author), Univ Hlth Network, Dept Genet & Dev, Toronto Western Res Inst, Toronto, ON, Canada.	michael.fehlings@uhn.on.ca		Fehlings, Michael/0000-0002-5722-6364	Sangamo BioSciences; Krembil Chair in Neural Repair and Regeneration	Sangamo BioSciences; Krembil Chair in Neural Repair and Regeneration	This study was supported by Sangamo BioSciences and the Krembil Chair in Neural Repair and Regeneration (held by Dr. Michael G. Fehlings). The funders had no role in data collection, data analysis, or decision to publish; however, they did participate in some aspects of study design and reviewed the manuscript prior to publication.	Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bearden SE, 2004, MICROCIRCULATION, V11, P633, DOI 10.1080/10739680490517659; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Bruce JC, 2002, EXP NEUROL, V178, P33, DOI 10.1006/exnr.2002.8026; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Choi BH, 2007, J NEUROSURG-SPINE, V7, P54, DOI 10.3171/SPI-07/07/054; Dai QS, 2004, CIRCULATION, V110, P2467, DOI 10.1161/01.CIR.0000145139.53840.49; Defrin R, 2001, PAIN, V89, P253, DOI 10.1016/S0304-3959(00)00369-9; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Flynn JR, 2011, NEUROPHARMACOLOGY, V60, P809, DOI 10.1016/j.neuropharm.2011.01.016; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Glaser J, 2006, J NEUROSCI RES, V84, P724, DOI 10.1002/jnr.20982; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Hoheisel U, 2003, BRAIN RES, V974, P134, DOI 10.1016/S0006-8993(03)02571-X; HOLM S, 1979, SCAND J STAT, V6, P65; Jin KL, 2000, NEUROSCIENCE, V99, P577, DOI 10.1016/S0306-4522(00)00207-4; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Leypold BG, 2007, SPINE, V32, P373, DOI 10.1097/01.brs.0000253964.10701.00; Ling X, 2007, J NEUROSCI RES, V85, P2175, DOI 10.1002/jnr.21362; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu XZ, 1997, J NEUROSCI, V17, P5395; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Mabon PJ, 2000, EXP NEUROL, V166, P52, DOI 10.1006/exnr.2000.7488; Naldini Antonella, 2005, Current Drug Targets - Inflammation and Allergy, V4, P3, DOI 10.2174/1568010053622830; Nesic O, 2010, J NEUROTRAUM, V27, P1793, DOI 10.1089/neu.2010.1351; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2003, INTERACTION NEUROPIL, P81; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Osterberg A, 2010, EUR J PAIN, V14, P104, DOI 10.1016/j.ejpain.2009.03.003; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Price SA, 2006, DIABETES, V55, P1847, DOI 10.2337/db05-1060; Raab S, 2007, ACTA NEUROPATHOL, V113, P607, DOI 10.1007/s00401-007-0228-3; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tsao MN, 1999, J NEUROPATH EXP NEUR, V58, P1051, DOI 10.1097/00005072-199910000-00003; Vierck CJ, 2000, PAIN, V89, P1, DOI 10.1016/S0304-3959(00)00463-2; Waxman SG, 1999, MUSCLE NERVE, V22, P1177, DOI 10.1002/(SICI)1097-4598(199909)22:9<1177::AID-MUS3>3.3.CO;2-G; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Yezierski RP, 1996, J CEREBR BLOOD F MET, V16, P996, DOI 10.1097/00004647-199609000-00025; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Yu J, 2006, FASEB J, V20, P479, DOI 10.1096/fj.04-3670fje	71	21	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96137	10.1371/journal.pone.0096137	http://dx.doi.org/10.1371/journal.pone.0096137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846143	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400005
J	Hu, LW; Yen, JH; Shen, YT; Wu, KY; Wu, MJ				Hu, Ling-Wei; Yen, Jui-Hung; Shen, Yi-Ting; Wu, Kuan-Yi; Wu, Ming-Jiuan			Luteolin Modulates 6-Hydroxydopamine-Induced Transcriptional Changes of Stress Response Pathways in PC12 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEME OXYGENASE-1 EXPRESSION; OXIDATIVE STRESS; ER STRESS; DNA-DAMAGE; LIPID-PEROXIDATION; GENE-EXPRESSION; CELLULAR-MODEL; DEATH	The neurotoxin 6-hydroxydopamine (6-OHDA), which causes transcriptional changes associated with oxidative and proteotoxic stress, has been widely used to generate an experimental model of Parkinson's disease. The food-derived compound luteolin has multi-target actions including antioxidant, anti-inflammatory and neurotrophic activities. The aim of this study is to investigate how luteolin affects 6-OHDA-mediated stress response pathways. The results showed that when PC12 cells were pre-treated with luteolin (20 mu M) 30 min prior to 6-OHDA (100 mu M) exposure, 6-OHDA-induced ROS overproduction, cytotoxicity, caspase-3 activation, and mRNA expression of BIM, TRB3 and GADD34 were significantly attenuated. Moreover, 6-OHDA-mediated cell cycle arrest and transcription of p53 target genes, p21, GADD45 alpha and PUMA, were reduced by luteolin. Luteolin also significantly down-regulated 6-OHDA-mediated unfolded protein response (UPR), leading to decreases in phospho-eIF2 alpha, ATF4, GRP78 and CHOP. In addition, luteolin attenuated 6-OHDA-induced Nrf2-mediated HO-1 and GCLC. Taken together, these results suggest that diminishing intracellular ROS formation and down-regulation of p53, UPR and Nrf2-ARE pathways may be involved in the neuroprotective effect of luteolin.	[Hu, Ling-Wei; Wu, Kuan-Yi; Wu, Ming-Jiuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Shen, Yi-Ting] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan	Chia Nan University of Pharmacy & Science; Tzu Chi University; Chia Nan University of Pharmacy & Science	Wu, MJ (corresponding author), Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan.	imwu@mail.chna.edu.tw			National Science Council, Taiwan, ROC [NSC-99-2320-B-041-005-MY3, NSC 102-2320-B-041-003-MY3]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by grants NSC-99-2320-B-041-005-MY3 and NSC 102-2320-B-041-003-MY3 from the National Science Council, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa YO, 2010, FREE RADICAL RES, V44, P410, DOI 10.3109/10715760903536349; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Biswas SC, 2005, NEUROCHEM RES, V30, P839, DOI 10.1007/s11064-005-6877-5; Blum D, 2000, NEUROSCI LETT, V283, P193, DOI 10.1016/S0304-3940(00)00948-4; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Cai QY, 1997, CANCER LETT, V119, P99, DOI 10.1016/S0304-3835(97)00261-9; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; CARMICHAEL J, 1987, CANCER RES, V47, P936; Cheng HY, 2010, PHYTOTHER RES, V24, pS102, DOI 10.1002/ptr.2940; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; De Araujo DP, 2011, INT J NEUROSCI, V121, P51, DOI 10.3109/00207454.2010.535934; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gelinas S, 2004, NEUROTOX RES, V6, P141, DOI 10.1007/BF03033216; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Guo DJ, 2013, PHARM BIOL, V51, P190, DOI 10.3109/13880209.2012.716852; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Holtz WA, 2005, ANTIOXID REDOX SIGN, V7, P639, DOI 10.1089/ars.2005.7.639; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2012, INT J BIOCHEM CELL B, V44, P1295, DOI 10.1016/j.biocel.2012.04.023; Hoozemans Jeroen J. N., 2009, V7, P111, DOI 10.1007/978-1-4020-9434-7_5; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jennings P, 2013, ARCH TOXICOL, V87, P49, DOI 10.1007/s00204-012-0919-y; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee C, 2011, TOXICOLOGY, V283, P118, DOI 10.1016/j.tox.2011.03.004; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Lin LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043304; Lin MH, 2014, TOXICOLOGY, V315, P24, DOI 10.1016/j.tox.2013.11.007; Lin YP, 2012, PHYTOCHEMISTRY, V84, P102, DOI 10.1016/j.phytochem.2012.07.020; Liu R, 2009, NEUROSCIENCE, V162, P1232, DOI 10.1016/j.neuroscience.2009.05.009; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Morse E, 2010, AM J PHYSIOL-RENAL, V299, pF965, DOI 10.1152/ajprenal.00236.2010; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pavlica S, 2010, LIFE SCI, V86, P79, DOI 10.1016/j.lfs.2009.10.017; Pedrosa R, 2002, BRIT J PHARMACOL, V137, P1305, DOI 10.1038/sj.bjp.0704982; Pereira C, 2013, ISRN CELL BIOL, V2013, P22, DOI DOI 10.1155/2013/256404; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Reisman D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/808934; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Ryu EJ, 2005, NEUROBIOL DIS, V18, P54, DOI 10.1016/j.nbd.2004.08.016; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Schipper HM, 2000, EXP GERONTOL, V35, P821, DOI 10.1016/S0531-5565(00)00148-0; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shay KP, 2008, IUBMB LIFE, V60, P362, DOI 10.1002/iub.40; Spencer JPE, 2010, P NUTR SOC, V69, P244, DOI 10.1017/S0029665110000054; Su JD, 2012, FREE RADICAL BIO MED, V52, P126, DOI 10.1016/j.freeradbiomed.2011.10.002; Sun XT, 2013, J NEUROSCI, V33, P2398, DOI 10.1523/JNEUROSCI.2292-12.2013; Taylor JM, 2013, NEUROCHEM INT, V62, P803, DOI 10.1016/j.neuint.2012.12.016; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tsai FS, 2007, LIFE SCI, V80, P1692, DOI 10.1016/j.lfs.2007.01.055; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; West JD, 2012, CHEM RES TOXICOL, V25, P2036, DOI 10.1021/tx300264x; Wu MJ, 2005, J AGR FOOD CHEM, V53, P6305, DOI 10.1021/jf050511a; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamuro A, 2006, NEUROCHEM RES, V31, P657, DOI 10.1007/s11064-006-9062-6; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Zenkov NK, 2013, BIOCHEMISTRY-MOSCOW+, V78, P19, DOI 10.1134/S0006297913010033; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041226; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	84	42	44	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97880	10.1371/journal.pone.0097880	http://dx.doi.org/10.1371/journal.pone.0097880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846311	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400069
J	Silva, FD; Ramos, RN; de Almeida, DC; Bassi, EJ; Gonzales, RP; Miyagi, SPH; Maranduba, CP; Sant'Anna, OABE; Marques, MM; Barbuto, JAM; Camara, NOS; Maranduba, CMD				Silva, Fernando de Sa; Ramos, Rodrigo Nalio; de Almeida, Danilo Candido; Bassi, Enio Jose; Gonzales, Roberto Pereira; Harumi Miyagi, Sueli Patricia; Maranduba, Claudineia Pereira; Brazil Esteves Sant'Anna, Osvaldo Augusto; Marques, Marcia Martins; Marzagao Barbuto, Jose Alexandre; Saraiva Camara, Niels Olsen; da Costa Maranduba, Carlos Magno			Mesenchymal Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHEDs) Induce Immune Modulatory Profile in Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							IN-VITRO; MATURATION; RESPONSES	Background: Mesenchymal stem cells have prominent immune modulatory properties, which may have clinical applications; however their major source, bone marrow, is of limited availability. On the other hand, mesenchymal stem cells derived from human exfoliated deciduous teeth (SHEDs) are readily accessible, but their immune regulatory properties have not been completely investigated. This study was designed, therefore, to evaluate the SHEDs influence on DCs differentiation, maturation, ability to activate T cells and to expand CD4(+)Foxp3(+) T cells. Methodology/Principal Findings: The experiments were based in cellular co-culture during differentiation and maturation of monocyte derived-DCs (moDCs), with, or not, presence of SHEDs. After co-culture with SHEDs, (moDCs) presented lower expression of BDCA-1 and CD11c, in comparison to DC cultivated without SHEDs. CD40, CD80, CD83 and CD86 levels were also decreased in mature DCs (mDCs) after co-cultivation with SHEDs. To assess the ability of SHEDs-exposed moDCs to modulate T cell responses, the former were separated from SHEDs, and co-cultured with peripheral blood lymphocytes. After 5 days, the proliferation of CD4(+) and CD8(+) T cells was evaluated and found to be lower than that induced by moDCs cultivated without SHEDs. In addition, an increase in the proportion of CD4(+)Foxp3(+)IL-10(+) T cells was observed among cells stimulated by mature moDCs that were previously cultivated with SHEDs. Soluble factors released during co-cultures also showed a reduction in the pro-inflammatory cytokines (IL-2, TNF-alpha and IFN-gamma), and an increase in the anti-inflammatory molecule IL-10. Conclusion/Significance: This study shows that SHEDs induce an immune regulatory phenotype in moDCs cells, evidenced by changes in maturation and differentiation rates, inhibition of lymphocyte stimulation and ability to expand CD4(+)Foxp3(+) T cells. Further characterization and validation of this phenomenon could support the use of SHEDs, directly or indirectly for immune modulation in the clinical practice.	[Silva, Fernando de Sa; Ramos, Rodrigo Nalio; de Almeida, Danilo Candido; Bassi, Enio Jose; Gonzales, Roberto Pereira; Marzagao Barbuto, Jose Alexandre; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Silva, Fernando de Sa; Harumi Miyagi, Sueli Patricia] Univ Sao Paulo, Dept Dent, Sao Paulo, Brazil; [Marques, Marcia Martins] Butantan Inst, Immunochem Lab, Sao Paulo, Brazil; [Silva, Fernando de Sa; Maranduba, Claudineia Pereira; Brazil Esteves Sant'Anna, Osvaldo Augusto; da Costa Maranduba, Carlos Magno] Univ Juiz Fora, Inst Biomed Sci, Juiz De Fora, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade Federal de Juiz de Fora	Silva, FD (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.	fernando.silva@ufjf.edu.br	de Almeida, Danilo/AAK-2399-2021; Barbuto, Jose A. M./H-5299-2011; Bassi, Ênio José/P-9937-2019; Marques, Márcia M/F-3780-2012; Camara, Niels OS/G-8336-2011; camara, niels olsen saraiva/AAX-3269-2020; de Almeida, Danilo Candido/R-2646-2019; Bassi, Ênio José/I-3616-2016; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Ramos, Rodrigo N/K-3553-2012; Silva, Fernando/D-7736-2012	Barbuto, Jose A. M./0000-0001-9526-6781; Bassi, Ênio José/0000-0002-7956-5746; Marques, Márcia M/0000-0002-9398-1252; Camara, Niels OS/0000-0001-5436-1248; camara, niels olsen saraiva/0000-0001-5436-1248; de Almeida, Danilo Candido/0000-0003-3661-2124; Bassi, Ênio José/0000-0002-7956-5746; Ramos, Rodrigo N/0000-0003-1249-4733; Silva, Fernando/0000-0003-0821-5535	Agency of the Sao Paulo Research Foundation (FAPESP) [02/02270-2, 10/09491-9]; CNPq	Agency of the Sao Paulo Research Foundation (FAPESP); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work has received financial support from the Agency of the Sao Paulo Research Foundation (FAPESP, grant numbers: 02/02270-2 and 10/09491-9) and from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alipour R, 2013, IRAN J ALLERGY ASTHM, V12, P331; Angelot F, 2009, HAEMATOL-HEMATOL J, V94, P1502, DOI 10.3324/haematol.2009.010934; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Choi YS, 2012, IMMUNOL INVEST, V41, P214, DOI 10.3109/08820139.2011.619022; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Lai HY, 2010, TISSUE ENG PT A, V16, P2987, DOI 10.1089/ten.tea.2009.0731; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Oliveira BL, 2009, CELL IMMUNOL, V258, P107, DOI 10.1016/j.cellimm.2009.03.019; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramos RN, 2012, J LEUKOCYTE BIOL, V92, P673, DOI 10.1189/jlb.0112048; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Silva FD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/758102; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yamaza T, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt5; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhao ZG, 2012, IMMUNOL INVEST, V41, P183, DOI 10.3109/08820139.2011.607877; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	31	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98050	10.1371/journal.pone.0098050	http://dx.doi.org/10.1371/journal.pone.0098050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846008	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400084
J	Naugler, WE				Naugler, Willscott E.			Bile Acid Flux Is Necessary for Normal Liver Regeneration	PLOS ONE			English	Article							EXTERNAL BILIARY DRAINAGE; C-JUN; RAT-LIVER; PARTIAL-HEPATECTOMY; MESSENGER-RNA; KINASE; HOMEOSTASIS; EXPRESSION; RECEPTOR; MICE	Background & Aims: Many signals governing liver regeneration (LR) following 2/3 partial hepatectomy (PH) are recognized, but the primary signal(s) remains unknown. The aim of the study was to confirm that the remnant liver after PH lacks capacity to secrete the BA pool returning via the enterohepatic ciruculation (EHC), which may in turn stimulate LR. Methods: After standard PH, BA flux was documented and BA signaling (Fgf15) and synthesis (Cyp7a) determined by qPCR. Rat biliary fistula (BF) and Asbt knockout mouse models interrupted the EHC prior to PH, and standard assays for LR employed along with complete RNA sequencing. CCl4 intoxication after BF tested the hypothesis in an alternate injury model. Results: BA rise in systemic blood immediately following PH, confirming that the remnant liver cannot handle the BA returning via portal circulation. When the BA pool is drained prior to PH in the rat BF model, LR is markedly attenuated, a phenomenon reversed with duodenal BA replacement. Hepatocyte proliferation is similarly attenuated after PH in the Asbt knockout mouse as well as after CCl4(4) intoxication in rats with BF. Complete RNA sequencing in the rat PH model shows that early c-jun and AP-1 gene expression pathways are down regulated in the absence of BA, coincident with attenuated LR. Conclusions: Absent BA return to the liver after PH or CCl4 injury markedly attenuates LR, though hepatocyte proliferation still occurs, inferring that BA flux and signaling are not the sole signals governing LR. Transcriptional networks involving c-jun and AP-1 are involved in the BA-specific effects on hepatocyte proliferation.	[Naugler, Willscott E.] Oregon Hlth & Sci Ctr, Dept Med, Div GI & Hepatol, Portland, OR 97239 USA; [Naugler, Willscott E.] Oregon Hlth & Sci Ctr, Oregon Stem Cell Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Naugler, WE (corresponding author), Oregon Hlth & Sci Ctr, Dept Med, Div GI & Hepatol, Portland, OR 97239 USA.	nauglers@ohsu.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), "Role of Bile Acids in the Initiation of Liver Regeneration" [DK083507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK083507] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), "Role of Bile Acids in the Initiation of Liver Regeneration"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The author and study were funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; DK083507), "Role of Bile Acids in the Initiation of Liver Regeneration.'' The author would like to thank the NIH for funding this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Doignon I, 2011, J HEPATOL, V54, P481, DOI 10.1016/j.jhep.2010.07.012; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dong XS, 2010, J HUAZHONG U SCI-MED, V30, P55, DOI 10.1007/s11596-010-0110-8; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gerloff T, 1999, GASTROENTEROLOGY, V117, P1408, DOI 10.1016/S0016-5085(99)70291-X; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; HARDISON WGM, 1981, AM J PHYSIOL, V241, pG337, DOI 10.1152/ajpgi.1981.241.4.G337; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang J, 2013, AM J PATHOL; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; IYOMASA S, 1992, EUR SURG RES, V24, P265, DOI 10.1159/000129215; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; MOOLTEN FL, 1967, SCIENCE, V158, P272, DOI 10.1126/science.158.3798.272; Otao R, 2012, BRIT J SURG, V99, P1569, DOI 10.1002/bjs.8906; PANDAK WM, 1991, J BIOL CHEM, V266, P3416; Paranjpe S, 2007, HEPATOLOGY; Pean N, 2013, HEPATOLOGY, V58, P1451, DOI 10.1002/hep.26463; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SUZUKI H, 1994, HEPATOLOGY, V20, P1318, DOI 10.1016/0270-9139(94)90774-9; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TSUDA H, 1990, LIVER, V10, P28; Uriarte I, 2013, GUT; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200; Zhang LS, 2012, HEPATOLOGY, V56, P2336, DOI 10.1002/hep.25905; Zhang LS, 2009, MOL ENDOCRINOL, V23, P137, DOI 10.1210/me.2008-0198	41	40	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97426	10.1371/journal.pone.0097426	http://dx.doi.org/10.1371/journal.pone.0097426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841254	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600031
J	Valdez, DJ; Cortez, MV; Della Costa, NS; Leche, A; Hansen, C; Navarro, JL; Martella, MB				Valdez, Diego J.; Vera Cortez, Marilina; Della Costa, Natalia S.; Leche, Alvina; Hansen, Cristian; Navarro, Joaquin L.; Martella, Monica B.			Seasonal Changes in Plasma Levels of Sex Hormones in the Greater Rhea (Rhea americana), a South American Ratite with a Complex Mating System	PLOS ONE			English	Article							EMU DROMAIUS-NOVAEHOLLANDIAE; STRUTHIO-CAMELUS; BIRDS; TESTOSTERONE; CORTICOSTERONE; INCUBATION; SIZE; ENVIRONMENT; CHALLENGE; ENDOCRINE	Seasonal rhythm in sex hormones has been extensively studied in birds, as well as its relationship with the type of mating system. The Greater Rhea (Rhea americana), a South American ratite species, reproduces seasonally and has a complex mating system: female-defense polygyny and sequential polyandry. The present study aimed at analyzing the endocrine basis of reproduction in this species and its relationship with its mating system. We used HPLC and electrochemiluminescence techniques to identify and measure plasma testosterone and estradiol levels. Annual oscillations in sex hormones, testosterone and estradiol, in adult males and females were observed. Lower levels of these hormones were exhibited during the non reproductive season (February to July), whereas their maximum values were reached in September for males and November-December for females. These fluctuations reflect the seasonal changes in gonadal function. By contrast, no significant sex hormones oscillations were observed in juvenile males and females (negative control of seasonal changes). Greater rheas maintain high testosterone and estradiol levels throughout the reproductive period. The high testosterone levels during incubation and chick rearing did not inhibit parental behavior in males, which appears not to conform to the "Challenge Hypothesis". In females, the high estradiol levels throughout the reproductive season would be needed to sustain their long egg-laying period.	[Valdez, Diego J.; Vera Cortez, Marilina; Della Costa, Natalia S.; Leche, Alvina; Navarro, Joaquin L.; Martella, Monica B.] Univ Nacl Cordoba, Ctr Zool Aplicada, Inst Diversidad & Ecol Anim IDEA CONICET, RA-5000 Cordoba, Argentina; [Hansen, Cristian] Lab Anal Clin Especializados, Cordoba, Argentina	National University of Cordoba	Valdez, DJ (corresponding author), Univ Nacl Cordoba, Ctr Zool Aplicada, Inst Diversidad & Ecol Anim IDEA CONICET, RA-5000 Cordoba, Argentina.	dvaldez@efn.uncor.edu		Leche, Alvina/0000-0002-8667-3374; Valdez, Diego Javier/0000-0002-4467-6761	Secretaria de Ciencia y Tecnologia of the Universidad Nacional de Cordoba (SECyT, UNC); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) PICT [PROYECTO 1170]; Agencia Nacional de promocion cientifica y tecnologica (ANPCyT), Argentina	Secretaria de Ciencia y Tecnologia of the Universidad Nacional de Cordoba (SECyT, UNC); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) PICT(FONCyT); Agencia Nacional de promocion cientifica y tecnologica (ANPCyT), Argentina(ANPCyT)	Funding was provided by grants from the Secretaria de Ciencia y Tecnologia of the Universidad Nacional de Cordoba (SECyT, UNC), and Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) PICT 2012, No PROYECTO 1170, Agencia Nacional de promocion cientifica y tecnologica (ANPCyT), Argentina, to M. B. Martella. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2011, WILLIAMS TXB ENDOCRI, V12th, P868; Blache D, 2001, J NEUROENDOCRINOL, V13, P998, DOI 10.1046/j.1365-2826.2001.00722.x; Blas J, 2010, GEN COMP ENDOCR, V168, P22, DOI 10.1016/j.ygcen.2010.03.020; BRUNING D F, 1974, Living Bird, V13, P251; COCKREM JF, 1994, GEN COMP ENDOCR, V94, P113, DOI 10.1006/gcen.1994.1065; Codenotti TL, 2001, WILSON BULL, V113, P85, DOI 10.1676/0043-5643(2001)113[0085:MBOTMG]2.0.CO;2; DEGEN AA, 1994, GEN COMP ENDOCR, V93, P21, DOI 10.1006/gcen.1994.1003; di Rienzo J., 2011, INFOSTAT STAT SOFTWA; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; Fernandez GJ, 1995, J AVIAN BIOL, V26, P321, DOI 10.2307/3677047; Fernandez GJ, 2003, WILSON BULL, V115, P467, DOI 10.1676/03-060; Fernandez GJ, 2003, AUK, V120, P418, DOI 10.1093/auk/120.2.418; Fernandez GJ, 1998, AUK, V115, P340, DOI 10.2307/4089192; Fraire HJR, 2006, BRIT POULTRY SCI, V47, P375, DOI 10.1080/00071660600753805; Garamszegi LZ, 2005, HORM BEHAV, V47, P389, DOI 10.1016/j.yhbeh.2004.11.008; Giordano PF, 2008, BIRD CONSERV INT, V18, P63, DOI 10.1017/S0959270908000075; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; HANDFORD P, 1985, BIOL J LINN SOC, V25, P77, DOI 10.1111/j.1095-8312.1985.tb00387.x; Hillgarth Nigella, 1997, P143; Hirschenhauser K, 2003, HORM BEHAV, V43, P508, DOI 10.1016/S0018-506X(03)00027-8; IUCN, 2013, IUCN RED LIST THREAT; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kimwele CN, 2003, MOL ECOL, V12, P229, DOI 10.1046/j.1365-294X.2003.01727.x; Koren L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032496; Labaque MC, 2010, BRIT POULTRY SCI, V51, P838, DOI 10.1080/00071668.2010.528376; Leche A, 2009, GEN COMP ENDOCR, V162, P188, DOI 10.1016/j.ygcen.2009.03.014; Leska A, 2007, REPROD BIOL, V7, P99; Malecki IA, 1998, ANIM REPROD SCI, V53, P143, DOI 10.1016/S0378-4320(98)00110-9; Martella M. B., 2006, PROYECTO NANDU MANEJ; Martella MB, 1994, J ORNITHOL, V135, P123; Martella MB, 1998, OSTRICH, V69, P259; McQueen SM, 1999, GEN COMP ENDOCR, V114, P11, DOI 10.1006/gcen.1998.7229; MENAKER M, 1968, P NATL ACAD SCI USA, V60, P146, DOI 10.1073/pnas.60.1.146; Nakane Y, 2010, CELL TISSUE RES, V342, P341, DOI 10.1007/s00441-010-1073-6; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Navarro JL, 2002, ARCH GEFLUGELKD, V66, P124; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; POTTER MA, 1992, GEN COMP ENDOCR, V87, P416, DOI 10.1016/0016-6480(92)90049-P; RAMOS C, 1992, HORM BEHAV, V26, P586, DOI 10.1016/0018-506X(92)90024-P; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Sales J, 2000, ARCH GEFLUGELKD, V64, P207; Sales J., 2009, Journal of Threatened Taxa, V1, P9; Sales J, 2006, AVIAN POULT BIOL REV, V17, P105, DOI 10.3184/147020606783438759; Taylor EL, 2000, BEHAV ECOL SOCIOBIOL, V47, P359, DOI 10.1007/s002650050677; Wikelski M, 1999, J COMP PHYSIOL A, V185, P463, DOI 10.1007/s003590050407; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Yoshimura T, 2010, ANIM SCI J, V81, P403, DOI 10.1111/j.1740-0929.2010.00777.x	47	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97334	10.1371/journal.pone.0097334	http://dx.doi.org/10.1371/journal.pone.0097334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837464	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800038
J	Petriv, OI; Heyries, KA; VanInsberghe, M; Walker, D; Hansen, CL				Petriv, Oleh I.; Heyries, Kevin A.; VanInsberghe, Michael; Walker, David; Hansen, Carl L.			Methods for Multiplex Template Sampling in Digital PCR Assays	PLOS ONE			English	Article							COPY NUMBER; MATERNAL BLOOD; DNA; QUANTIFICATION; QUANTITATION; DESIGN; GENE	The efficient use of digital PCR (dPCR) for precision copy number analysis requires high concentrations of target molecules that may be difficult or impossible to obtain from clinical samples. To solve this problem we present a strategy, called Multiplex Template Sampling (MTS), that effectively increases template concentrations by detecting multiple regions of fragmented target molecules. Three alternative assay approaches are presented for implementing MTS analysis of chromosome 21, providing a 10-fold concentration enhancement while preserving assay precision.	[Petriv, Oleh I.; Heyries, Kevin A.; VanInsberghe, Michael; Walker, David; Hansen, Carl L.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Hansen, Carl L.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Hansen, CL (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada.	chansen@phas.ubc.ca			Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Fluidigm; Genome BC; Western Diversification; CIHR; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fluidigm; Genome BC; Western Diversification; CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), Fluidigm, Genome BC, and Western Diversification. Salary support for C.L.H. was provided by CIHR and the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos AT, 2011, TISSUE ANTIGENS, V77, P143, DOI 10.1111/j.1399-0039.2010.01588.x; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Giese H, 2009, J FORENSIC SCI, V54, P1287, DOI 10.1111/j.1556-4029.2009.01200.x; Heyries KA, 2011, NAT METHODS, V8, P649, DOI [10.1038/NMETH.1640, 10.1038/nmeth.1640]; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hiromadnikova I, 2006, DNA CELL BIOL, V25, P635, DOI 10.1089/dna.2006.25.635; Lo YM, 2011, J PATHOL, V225, P318, DOI 10.1002/path.2960; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Rachlin J, 2005, NUCLEIC ACIDS RES, V33, pW544, DOI 10.1093/nar/gki377; Ramakrishnan Ramesh, 2013, Methods Mol Biol, V949, P423, DOI 10.1007/978-1-62703-134-9_27; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Shi XL, 2010, ELECTROPHORESIS, V31, P528, DOI 10.1002/elps.200900362; Shibuya K, 2004, GENOMICS, V83, P679, DOI 10.1016/j.ygeno.2003.09.024; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Varley KE, 2009, COLD SPRING HARB PRO; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Whale AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058177; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108	22	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98341	10.1371/journal.pone.0098341	http://dx.doi.org/10.1371/journal.pone.0098341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854517	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200063
J	Budiharjo, A; Chowdhury, SP; Dietel, K; Beator, B; Dolgova, O; Fan, B; Bleiss, W; Ziegler, J; Schmid, M; Hartmann, A; Borriss, R				Budiharjo, Anto; Chowdhury, Soumitra Paul; Dietel, Kristin; Beator, Barbara; Dolgova, Olga; Fan, Ben; Bleiss, Wilfrid; Ziegler, Joerg; Schmid, Michael; Hartmann, Anton; Borriss, Rainer			Transposon Mutagenesis of the Plant-Associated Bacillus amyloliquefaciens ssp plantarum FZB42 Revealed That the nfrA and RBAM17410 Genes Are Involved in Plant-Microbe-Interactions	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; ROOT COLONIZATION; BIOFILM FORMATION; SUBTILIS; GROWTH; BIOCONTROL; EXPRESSION; STRESS; TRANSCRIPTOME; LEVEL	Bacillus amyloliquefaciens ssp. plantarum FZB42 represents the prototype of Gram-positive plant growth promoting and biocontrol bacteria. In this study, we applied transposon mutagenesis to generate a transposon library, which was screened for genes involved in multicellular behavior and biofilm formation on roots as a prerequisite of plant growth promoting activity. Transposon insertion sites were determined by rescue-cloning followed by DNA sequencing. As in B. subtilis, the global transcriptional regulator DegU was identified as an activator of genes necessary for swarming and biofilm formation, and the DegU-mutant of FZB42 was found impaired in efficient root colonization. Direct screening of 3,000 transposon insertion mutants for plant-growth-promotion revealed the gene products of nfrA and RBAM_017140 to be essential for beneficial effects exerted by FZB42 on plants. We analyzed the performance of GFP-labeled wild-type and transposon mutants in the colonization of lettuce roots using confocal laser scanning microscopy. While the wild-type strain heavily colonized root surfaces, the nfrA mutant did not colonize lettuce roots, although it was not impaired in growth in laboratory cultures, biofilm formation and swarming motility on agar plates. The RBAM17410 gene, occurring in only a few members of the B. subtilis species complex, was directly involved in plant growth promotion. None of the mutant strains were affected in producing the plant growth hormone auxin. We hypothesize that the nfrA gene product is essential for overcoming the stress caused by plant response towards bacterial root colonization.	[Budiharjo, Anto; Beator, Barbara; Fan, Ben; Bleiss, Wilfrid; Borriss, Rainer] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Chowdhury, Soumitra Paul; Schmid, Michael; Hartmann, Anton] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Microbe Plant Interact, Neuherberg, Germany; [Dietel, Kristin; Dolgova, Olga; Borriss, Rainer] ABiTEP GmbH, Berlin, Germany; [Ziegler, Joerg] Leibniz Inst Pflanzenbiochem, Abt Mol Signalverarbeitung, Halle, Germany	Humboldt University of Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Pflanzenbiochemie	Borriss, R (corresponding author), Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.	rainer.borriss@rz.hu-berlin.de	Budiharjo, Anto/GRY-3134-2022; Hartmann, Anton/D-8070-2013; Borriss, Rainer/C-5026-2012; Chowdhury, Soumitra Paul/AAA-5346-2020; Hartmann, Anton/AAN-8922-2020; Schmid, Michael/D-7105-2013; Ziegler, Jörg/W-7645-2019	Borriss, Rainer/0000-0003-3726-1004; Chowdhury, Soumitra Paul/0000-0002-8576-8857; Budiharjo, Anto/0000-0002-4815-5138	German Ministry for Education and Research [PATHCONTROL 0315654A, PATHCONTROL 0315654C]; European Union [312117]; ABiTEP GmbH	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); ABiTEP GmbH	German Ministry for Education and Research (PATHCONTROL 0315654A and C) to RB and AH (http://www.genomik-transfer.de/index.php?section = verbund&fkz = 0315654). European Union's Seventh Framework Programme (FP/2007-2013) under Grant agreement n o312117 to RB (http://www.biofector.info/). ABiTEP GmbH provided support in the form of salaries for authors KD, OD & RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Borriss R, 2011, BACTERIA IN AGROBIOLOGY: PLANT GROWTH RESPONSES, P41, DOI 10.1007/978-3-642-20332-9_3; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; Calvio C, 2008, J BACTERIOL, V190, P5720, DOI 10.1128/JB.00455-08; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chin-A-Woeng TFC, 2000, MOL PLANT MICROBE IN, V13, P1340, DOI 10.1094/MPMI.2000.13.12.1340; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Dietel K, 2013, PLANT PATHOLOGY J, V29, P59, DOI 10.5423/PPJ.OA.10.2012.0155; DUBNAU D, 1994, RES MICROBIOL, V145, P403, DOI 10.1016/0923-2508(94)90088-4; Fan B, 2012, J MICROBIOL, V50, P38, DOI 10.1007/s12275-012-1439-4; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Idriss EE, 2002, MICROBIOL-SGM, V148, P2097, DOI 10.1099/00221287-148-7-2097; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Koumoutsi A, 2007, APPL ENVIRON MICROB, V73, P6953, DOI 10.1128/AEM.00565-07; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Le Breton Y, 2006, APPL ENVIRON MICROB, V72, P327, DOI 10.1128/AEM.72.1.327-333.2006; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mariappan A, 2012, J MOL MICROB BIOTECH, V22, P114, DOI 10.1159/000338804; Moch C, 2000, J BACTERIOL, V182, P4384, DOI 10.1128/JB.182.16.4384-4393.2000; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Ostrowski A, 2011, J BACTERIOL, V193, P4821, DOI 10.1128/JB.00223-11; PIRSON A, 1950, PLANTA, V38, P431, DOI 10.1007/BF01928941; Rudrappa T, 2007, PLANTA, V226, P283, DOI 10.1007/s00425-007-0480-8; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Schadt HS, 2009, J AM CHEM SOC, V131, P3481, DOI 10.1021/ja809283u; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Streker K, 2005, J BACTERIOL, V187, P2249, DOI 10.1128/JB.187.7.2249-2256.2005; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; WELLER DM, 1988, ANNU REV PHYTOPATHOL, V26, P379, DOI 10.1146/annurev.py.26.090188.002115; Weng J, 2013, APPL MICROBIOL BIOT, V97, P8823, DOI 10.1007/s00253-012-4572-4	39	16	20	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98267	10.1371/journal.pone.0098267	http://dx.doi.org/10.1371/journal.pone.0098267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847778	Green Published, gold			2022-12-27	WOS:000336730600105
J	Song, Y; Zhu, LA; Wang, SL; Leng, L; Bucala, R; Lu, LJ				Song, Yang; Zhu, Li-an; Wang, Su-li; Leng, Lin; Bucala, Richard; Lu, Liang-Jing			Multi-Dimensional Health Assessment Questionnaire in China: Reliability, Validity and Clinical Value in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							DISEASE-ACTIVITY SCORE; QUALITY-OF-LIFE; RAPID3 ROUTINE ASSESSMENT; WORK DISABILITY; INDEX DATA; FUNCTIONAL STATUS; REVISED CRITERIA; SWEDISH VERSION; MDHAQ; SCALE	Objective: To evaluate the psychometric properties and clinical utility of Chinese Multidimensional Health Assessment Questionnaire (MDHAQ-C) in patients with rheumatoid arthritis (RA) in China. Methods: 162 RA patients were recruited in the evaluation process. The reliability of the questionnaire was tested by internal consistency and item analysis. Convergent validity was assessed by correlations of MDHAQ-C with Health Assessment Questionnaire (HAQ), the 36-item Short-Form Health Survey (SF-36) and the Hospital anxiety and depression scales (HAD). Discriminant validity was tested in groups of patients with varied disease activities and functional classes. To evaluate the clinical values, correlations were calculated between MDHAQ-C and indices of clinical relevance and disease activity. Agreement with the Disease Activity Score (DAS28) and Clinical Disease Activity Index (CDAI) was estimated. Results: The Cronbach's alpha was 0.944 in the Function scale (FN) and 0.768 in the scale of psychological status (PS). The item analysis indicated all the items of FN and PS are correlated at an acceptable level. MDHAQ-C correlated with the questionnaires significantly in most scales and scores of scales differed significantly in groups of different disease activity and functional status. MDHAQ-C has moderate to high correlation with most clinical indices and high correlation with a spearman coefficient of 0.701 for DAS 28 and 0.843 for CDAI. The overall agreement of categories was satisfying. Conclusion: MDHAQ-C is a reliable, valid instrument for functional measurement and a feasible, informative quantitative index for busy clinical settings in Chinese RA patients.	[Song, Yang; Wang, Su-li; Lu, Liang-Jing] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China; [Zhu, Li-an; Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, Rheumatol Sect, New Haven, CT 06510 USA	Shanghai Jiao Tong University; Yale University	Lu, LJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China.	lianzhu20032003@hotmail.com; lu_liangjing@medmail.com.cn		Lu, Liangjing/0000-0001-9116-6038	National Natural Sciences Foundation of China [81373209, 30671946, 81072469]; Shanghai Natural Sciences Foundation [09ZR1417600]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Sciences Foundation(Natural Science Foundation of Shanghai)	This work was supported by grants from National Natural Sciences Foundation of China (No. 81373209; No. 30671946; No. 81072469) and Shanghai Natural Sciences Foundation (No. 09ZR1417600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkela-Kautiainen M, 2005, J RHEUMATOL, V32, P1426; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Chiou CF, 2004, ARTHRIT RHEUM-ARTHR, V51, P358, DOI 10.1002/art.20400; Chung CP, 2006, ANN RHEUM DIS, V65, P1653, DOI 10.1136/ard.2005.048439; Ehrlich-Jones L, 2011, ARTHRIT CARE RES, V63, P1700, DOI 10.1002/acr.20616; Ekback M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-168; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Josefsson KA, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-178; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; Krishnan E, 2005, ANN RHEUM DIS, V64, P1350, DOI 10.1136/ard.2005.037903; Kwoh CK, 2001, ARTHRIT RHEUM-ARTHR, V45, P372, DOI 10.1002/1529-0131(200108)45:4<372::AID-ART350>3.0.CO;2-D; Lee J, 2012, ARTHRIT CARE RES, V64, P488, DOI 10.1002/acr.21582; Leung C M, 1993, Int J Psychosom, V40, P29; Li Lu, 2002, Zhonghua Yufang Yixue Zazhi, V36, P109; Li R, 2012, RHEUMATOLOGY, V51, P721, DOI 10.1093/rheumatology/ker370; Lillegraven S, 2007, BEST PRACT RES CL RH, V21, P827, DOI 10.1016/j.berh.2007.05.004; Maska L, 2011, ARTHRIT CARE RES, V63, pS4, DOI 10.1002/acr.20620; PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805; Pincus T, 2008, RHEUMATOLOGY, V47, P345, DOI 10.1093/rheumatology/kem364; Pincus T, 2006, J RHEUMATOL, V33, P834; Pincus T, 2005, J RHEUMATOL, V32, P1432; Pincus T, 2003, BEST PRACT RES CL RH, V17, P753, DOI 10.1016/S1521-6942(03)00077-9; PINCUS T, 1993, RHEUM DIS CLIN N AM, V19, P123; Pincus T, 2008, J RHEUMATOL, V35, P2136, DOI 10.3899/jrheum.080182; Pincus T, 2007, BULL HOSP JT DIS, V65, P150; Pincus T, 2012, BULL HOSP JT DIS, V70, pS30; Pincus T, 2010, ARTHRIT CARE RES, V62, P181, DOI 10.1002/acr.20066; Pioro Mathilde H., 1996, Current Opinion in Rheumatology, V8, P101, DOI 10.1097/00002281-199603000-00003; Pollard L, 2005, CLIN EXP RHEUMATOL, V23, pS43; Power M, 2005, QUAL LIFE RES, V14, P2197, DOI 10.1007/s11136-005-7380-9; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sokka T, 2001, J RHEUMATOL, V28, P1718; Wagner E, 2007, RHEUMATOL INT, V27, P1041, DOI 10.1007/s00296-007-0343-4; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047373; Yazici Y, 2008, J RHEUMATOL, V35, P603; YELIN E, 1980, ANN INTERN MED, V93, P551, DOI 10.7326/0003-4819-93-4-551	41	3	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97952	10.1371/journal.pone.0097952	http://dx.doi.org/10.1371/journal.pone.0097952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848431	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600071
J	Yaqoob, U; Jagavelu, K; Shergill, U; de Assuncao, T; Cao, S; Shah, VH				Yaqoob, Usman; Jagavelu, Kumaravelu; Shergill, Uday; de Assuncao, Thiago; Cao, Sheng; Shah, Vijay H.			FGF21 Promotes Endothelial Cell Angiogenesis through a Dynamin-2 and Rab5 Dependent Pathway	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FATTY LIVER-DISEASE; FACTOR RECEPTOR; INTRACELLULAR TRAFFICKING; ENDOCYTOSIS; ACTIVATION; PROTEINS; PHOSPHORYLATION; INTERNALIZATION; PERMEABILITY	Binding of angiogenic molecules with cognate receptor tyrosine kinases (RTK) is required for angiogenesis however the precise link between RTK binding, endocytosis, and signaling requires further investigation. Here, we use FGFR1 as a model to test the effects of the large GTPase and endocytosis regulatory molecule dynamin-2 on angiogenic signaling in context of distinct FGF ligands. In vitro, overexpression of dominant negative dynamin-2 (DynK44A) attenuates FGFR1 activation of Erk and tubulogenesis by FGF2. Furthermore, we identify FGF21, a non-classical, FGF ligand implicated in diverse human pathologies as an angiogenic molecule acting through FGFR1 and beta-Klotho coreceptor. Disruption of FGFR1 activation of ERK by FGF21 is achieved by perturbation of the function of both dynamin-2 and Rab5 GTPase. In vivo, mice harboring endothelial selective overexpression of DynK44A, show impaired angiogenesis in response to FGF21. In conclusion, dynamin dependent endocytosis of FGFR1 is required for in vitro and in vivo angiogenesis in response to FGF2 and the non-classical FGF ligand, FGF21. These studies extend our understanding of the relationships between RTK binding, internalization, endosomal targeting, and angiogenic signaling.	[Yaqoob, Usman; Jagavelu, Kumaravelu; Shergill, Uday; de Assuncao, Thiago; Cao, Sheng; Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Cao, S (corresponding author), Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA.	cao.sheng@mayo.edu; shah.vijay@mayo.edu	Jagavelu, Kumaravelu/L-8053-2019	Jagavelu, Kumaravelu/0000-0002-9235-0600	NIH [DK59615, DK084567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK059615, R01DK059615, P30DK084567] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants to VS (DK59615, DK084567-Clinical Core and Cell Biology Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cariello M, 2014, HEPTAOLOGY; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carracedo J, 2012, MECH AGEING DEV, V133, P647, DOI 10.1016/j.mad.2012.09.002; Chen Y, 2013, SMALL GTPASES, V4; Chu HH, 2011, P NATL ACAD SCI USA, V108, P13444, DOI 10.1073/pnas.1110121108; Citores L, 1999, MOL BIOL CELL, V10, P3835, DOI 10.1091/mbc.10.11.3835; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004; Elfenbein A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002495; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gaengel K, 2013, NAT CELL BIOL, V15, P233, DOI 10.1038/ncb2705; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Harris KP, 2011, CURR BIOL, V21, pR841, DOI 10.1016/j.cub.2011.08.061; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Hausott B, 2011, NEUROSCIENCE, V188, P13, DOI 10.1016/j.neuroscience.2011.04.064; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Huebert RC, 2011, AM J PATHOL, V179, P1851, DOI 10.1016/j.ajpath.2011.06.045; Hyndman KA, 2011, AM J PHYSIOL-RENAL, V301, pF118, DOI 10.1152/ajprenal.00534.2010; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jagavelu K, 2010, HEPATOLOGY, V52, P590, DOI 10.1002/hep.23739; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lee MY, 2014, DEVELOPMENT, V141, P1465, DOI 10.1242/dev.104539; LI GP, 1993, J BIOL CHEM, V268, P24475; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mohammadi M., 2013, COLD SPRING HARB PER, V5; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Ridyard MS, 2003, J BIOL CHEM, V278, P13803, DOI 10.1074/jbc.M210245200; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shilo BZ, 2011, EMBO J, V30, P3516, DOI 10.1038/emboj.2011.269; SOROKIN A, 1994, J BIOL CHEM, V269, P17056; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wang ZM, 2011, J CELL BIOL, V192, P101, DOI 10.1083/jcb.201003027; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Zern BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011017; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	57	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98130	10.1371/journal.pone.0098130	http://dx.doi.org/10.1371/journal.pone.0098130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848261	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600089
J	Han, F; Sun, W; Ling, QH				Han, Fei; Sun, Wei; Ling, Qing-Hua			A Novel Strategy for Gene Selection of Microarray Data Based on Gene-to-Class Sensitivity Information	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; SUPPORT VECTOR MACHINES; CANCER CLASSIFICATION; SAMPLE CLASSIFICATION; EXPRESSION DATA; CLASS DISCOVERY; EXTRACTION; PREDICTION; DIAGNOSIS; TUMOR	To obtain predictive genes with lower redundancy and better interpretability, a hybrid gene selection method encoding prior information is proposed in this paper. To begin with, the prior information referred to as gene-to-class sensitivity (GCS) of all genes from microarray data is exploited by a single hidden layered feedforward neural network (SLFN). Then, to select more representative and lower redundant genes, all genes are grouped into some clusters by K-means method, and some low sensitive genes are filtered out according to their GCS values. Finally, a modified binary particle swarm optimization (BPSO) encoding the GCS information is proposed to perform further gene selection from the remainder genes. For considering the GCS information, the proposed method selects those genes highly correlated to sample classes. Thus, the low redundant gene subsets obtained by the proposed method also contribute to improve classification accuracy on microarray data. The experiments results on some open microarray data verify the effectiveness and efficiency of the proposed approach.	[Han, Fei; Sun, Wei; Ling, Qing-Hua] Jiangsu Univ, Sch Comp Sci & Commun Engn, Zhenjiang, Peoples R China; [Ling, Qing-Hua] Jiangsu Univ Sci & Technol, Sch Comp Sci & Engn, Zhenjiang, Peoples R China	Jiangsu University; Jiangsu University of Science & Technology	Han, F (corresponding author), Jiangsu Univ, Sch Comp Sci & Commun Engn, Zhenjiang, Peoples R China.	hanfei@mail.ujs.edu.cn			National Natural Science Foundation of China [61271385, 60702056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 61271385, 60702056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bermejo P, 2011, PATTERN RECOGN LETT, V32, P701, DOI 10.1016/j.patrec.2010.12.016; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Cao HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042755; Cheng-San Yang, 2008, IAENG International Journal of Computer Science, V35, P285; Cho JH, 2003, FEBS LETT, V551, P3, DOI 10.1016/S0014-5793(03)00819-6; Chu F, 2005, INT J NEURAL SYST, V15, P475, DOI 10.1142/S0129065705000396; Chuang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037018; Chuang LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021036; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Giugno R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069873; Goldberg D., 1989, GENETIC ALGORITHMS I; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gutkin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006416; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han F, 2008, INFORM SCIENCES, V178, P907, DOI 10.1016/j.ins.2007.09.008; Han F, 2006, NEUROCOMPUTING, V69, P2369, DOI 10.1016/j.neucom.2006.02.013; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang HY, 2010, P NATL ACAD SCI USA, V107, P6823, DOI 10.1073/pnas.0912043107; Huang TM, 2005, ARTIF INTELL MED, V35, P185, DOI 10.1016/j.artmed.2005.01.006; Kennedy J, 1997, IEEE SYS MAN CYBERN, P4104, DOI 10.1109/ICSMC.1997.637339; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Khan J, 2001, NAT MED, V7, P637; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Li LP, 2001, BIOINFORMATICS, V17, P1131, DOI 10.1093/bioinformatics/17.12.1131; Li LP, 2001, COMB CHEM HIGH T SCR, V4, P727; [李颖新 Li Yingxin], 2005, [计算机研究与发展, Journal of Computer Research and Development], V42, P1796, DOI 10.1360/crad20051024; Liu QZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008250; Maldonado S, 2009, INFORM SCIENCES, V179, P2208, DOI 10.1016/j.ins.2009.02.014; O'Hagan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048862; Oliveira PR, 1996, P IEEE WORKSH CYB VI, P112; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saraswathi S, 2011, IEEE ACM T COMPUT BI, V8, P452, DOI 10.1109/TCBB.2010.13; Shen Q, 2007, TALANTA, V71, P1679, DOI 10.1016/j.talanta.2006.07.047; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Soria-Olivas E, 2011, IEEE T NEURAL NETWOR, V22, P505, DOI 10.1109/TNN.2010.2103956; Tong DL, 2009, PROC THE EIGHTH INTE, P12; Varma S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-126; Wang DF, 2012, PLOS ONE, V7, P29, DOI 10.1371/journal.pone.0028805; Wang XS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-391; Werbos P., 1974, THESIS; Wong L, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013010014; Yang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-228; Yang SX, 2013, COMMUNICATIONS IN CO, V375, P88; Zalik KR, 2008, PATTERN RECOGN LETT, V29, P1385, DOI 10.1016/j.patrec.2008.02.014; Zhang JG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-370	52	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97530	10.1371/journal.pone.0097530	http://dx.doi.org/10.1371/journal.pone.0097530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844313	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400033
J	Scheepers, RA; Lombarts, KMJMH; van Aken, MAG; Heineman, MJ; Arah, OA				Scheepers, Renee A.; Lombarts, Kiki M. J. M. H.; van Aken, Marcel A. G.; Heineman, Maas Jan; Arah, Onyebuchi A.			Personality Traits Affect Teaching Performance of Attending Physicians: Results of a Multi-Center Observational Study	PLOS ONE			English	Article							STEREOTYPE THREAT; WORKING-MEMORY; 5-FACTOR MODEL; MEDICAL-EDUCATION; JOB-PERFORMANCE; BIG-5 INVENTORY; RESIDENTS; ASSESSMENTS; MECHANISMS; SPECIALTY	Background: Worldwide, attending physicians train residents to become competent providers of patient care. To assess adequate training, attending physicians are increasingly evaluated on their teaching performance. Research suggests that personality traits affect teaching performance, consistent with studied effects of personality traits on job performance and academic performance in medicine. However, up till date, research in clinical teaching practice did not use quantitative methods and did not account for specialty differences. We empirically studied the relationship of attending physicians' personality traits with their teaching performance across surgical and non-surgical specialties. Method: We conducted a survey across surgical and non-surgical specialties in eighteen medical centers in the Netherlands. Residents evaluated attending physicians' overall teaching performance, as well as the specific domains learning climate, professional attitude, communication, evaluation, and feedback, using the validated 21-item System for Evaluation of Teaching Qualities (SETQ). Attending physicians self-evaluated their personality traits on a 5-point scale using the validated 10-item Big Five Inventory (BFI), yielding the Five Factor model: extraversion, conscientiousness, neuroticism, agreeableness and openness. Results: Overall, 622 (77%) attending physicians and 549 (68%) residents participated. Extraversion positively related to overall teaching performance (regression coefficient, B: 0.05, 95% CI: 0.01 to 0.10, P = 0.02). Openness was negatively associated with scores on feedback for surgical specialties only (B: 20.10, 95% CI: 20.15 to 20.05, P < 0.001) and conscientiousness was positively related to evaluation of residents for non-surgical specialties only (B: 0.13, 95% CI: 0.03 to 0.22, p = 0.01). Conclusions: Extraverted attending physicians were consistently evaluated as better supervisors. Surgical attending physicians who display high levels of openness were evaluated as less adequate feedback-givers. Non-surgical attending physicians who were conscientious seem to be good at evaluating residents. These insights could contribute to future work on development paths of attending physicians in medical education.	[Scheepers, Renee A.; Lombarts, Kiki M. J. M. H.; Heineman, Maas Jan; Arah, Onyebuchi A.] Univ Amsterdam, Acad Med Ctr, Ctr Evidence Based Educ, Profess Performance Res Grp, NL-1105 AZ Amsterdam, Netherlands; [van Aken, Marcel A. G.] Univ Utrecht, Dept Dev Psychol, Utrecht, Netherlands; [Heineman, Maas Jan] Univ Amsterdam, Acad Med Ctr, Board Directors, NL-1105 AZ Amsterdam, Netherlands; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California Los Angeles	Scheepers, RA (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Evidence Based Educ, Profess Performance Res Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.a.scheepers@amc.nl		Scheepers, Renee/0000-0001-5750-3686; Arah, Onyebuchi/0000-0002-9067-1697; Lombarts, Kiki/0000-0001-6167-0620	Dutch Ministry of Health; Academic Medical Centre, Amsterdam; Faculty of Health and Life Sciences of the University of Maastricht	Dutch Ministry of Health; Academic Medical Centre, Amsterdam; Faculty of Health and Life Sciences of the University of Maastricht	This study is part of the research project Quality of Clinical Teachers and Residency Training Programs, which is co-financed by the Dutch Ministry of Health, the Academic Medical Centre, Amsterdam, and the Faculty of Health and Life Sciences of the University of Maastricht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland OG, 2005, QUAL SAF HEALTH CARE, V14, P13, DOI 10.1136/qshc.2002.003657; [Anonymous], 2000, MED TEACH, V22, P549, DOI 10.1080/01421590050175505; [Anonymous], 1985, PERSONALITY INDIVIDU, DOI 13877; Arah OA, 2012, MED EDUC, V46, P381, DOI 10.1111/j.1365-2923.2011.04176.x; Arah OA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025983; Backstrom M, 2009, J RES PERS, V43, P335, DOI 10.1016/j.jrp.2008.12.013; Bakker AB, 2012, J VOCAT BEHAV, V80, P555, DOI 10.1016/j.jvb.2011.08.008; Baldwin DC, 2008, J INTERPROF CARE, V22, P573, DOI 10.1080/13561820802364740; Barnsley J, 1999, CAN FAM PHYSICIAN, V45, P935; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Barrick MR, 2005, HUM PERFORM, V18, P359, DOI 10.1207/s15327043hup1804_3; Beckman TJ, 2005, J GEN INTERN MED, V20, P1159, DOI 10.1111/j.1525-1497.2005.0258.x; Beckman TJ, 2004, J GEN INTERN MED, V19, P971, DOI 10.1111/j.1525-1497.2004.40066.x; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Beilock SL, 2006, PERS SOC PSYCHOL B, V32, P1059, DOI 10.1177/0146167206288489; Boerebach BCM, 2012, J SURG EDUC, V69, P511, DOI 10.1016/j.jsurg.2012.04.003; Brocke B, 1997, PERS INDIV DIFFER, V22, P447, DOI 10.1016/S0191-8869(96)00226-7; Chin MH, 1997, J GEN INTERN MED, V12, P523, DOI 10.1046/j.1525-1497.1997.07105.x; Connolly JJ, 2007, INT J SELECT ASSESS, V15, P110, DOI 10.1111/j.1468-2389.2007.00371.x; Denissen JJA, 2008, J PERS ASSESS, V90, P152, DOI 10.1080/00223890701845229; Dodaj A, 2012, EUR J PSYCHOL, V8, P651, DOI 10.5964/ejop.v8i4.462; Doherty EM, 2011, MED EDUC, V45, P132, DOI 10.1111/j.1365-2923.2010.03760.x; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Farnan JM, 2012, ACAD MED, V87, P428, DOI 10.1097/ACM.0b013e31824822cc; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Ferguson E, 2003, BRIT MED J, V326, P429, DOI 10.1136/bmj.326.7386.429; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Ferguson E, 2013, HEALTH PSYCHOL REV, V7, pS32, DOI 10.1080/17437199.2010.547985; Fleischer AB, 2001, J AM ACAD DERMATOL, V44, P224, DOI 10.1067/mjd.2001.110396; GALLAGHER DJ, 1990, PERS INDIV DIFFER, V11, P1053, DOI 10.1016/0191-8869(90)90133-C; Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419; Hindman BJ, 2014, ANESTHESIA ANALGESIA, V116, P1342; Hojat M, 2013, MED TEACH, V35, pE1267, DOI 10.3109/0142159X.2013.785654; IRBY DM, 1991, ACAD MED, V66, P54, DOI 10.1097/00001888-199101000-00017; Komarraju M, 2012, J ORG PSYCHOL, V12; LESTER D, 1989, PSYCHOL REP, V64, P189, DOI 10.2466/pr0.1989.64.1.189; Lievens F, 2002, MED EDUC, V36, P1050, DOI 10.1046/j.1365-2923.2002.01328.x; Lombarts KMJMH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015202; Lombarts KMJM, 2009, ANESTHESIOLOGY, V111; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MORGENSTERN FS, 1974, ERGONOMICS, V17, P211, DOI 10.1080/00140137408931340; Mount MK, 1998, HUM PERFORM, V11, P145, DOI 10.1207/s15327043hup1102&3_3; MURRAY HG, 1990, J EDUC PSYCHOL, V82, P250, DOI 10.1037/0022-0663.82.2.250; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Oancia T, 2000, MED EDUC, V34, P250; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Ozer DJ, 1989, PERSONALITY PSYCHOL, P24; Padhye V, 2013, ONLINE INT INTERDISC, V3; Radmacher SA, 2001, J PSYCHOL, V135, P259, DOI 10.1080/00223980109603696; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rydell R, 2009, J PERS SOC PSYCHOL, V96, P966; Salgado JF, 1997, J APPL PSYCHOL, V82, P30, DOI 10.1037/0021-9010.82.1.30; Schmader T, 2003, J PERS SOC PSYCHOL, V85, P440, DOI 10.1037/0022-3514.85.3.440; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Steinert Y, 2006, MED TEACH, V28, P497, DOI 10.1080/01421590600902976; Sternberg G, 1990, PERSONALITY INDIVIDU, V11, P663; Sutkin Gary, 2008, Acad Med, V83, P452, DOI 10.1097/ACM.0b013e31816bee61; Taub JM, 1998, INT J NEUROSCI, V94, P145, DOI 10.3109/00207459808986443; Tong EMW, 2010, J PERS, V78, DOI 10.1111/j.1467-6494.2010.00620.x; van der Leeuw R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019142; van der Leeuw RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-65; Vazire S, 2010, SOC PERSONAL PSYCHOL, V4, P605, DOI 10.1111/j.1751-9004.2010.00280.x; Zhang LF, 2007, PERS INDIV DIFFER, V43, P669, DOI 10.1016/j.paid.2007.01.009	63	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98107	10.1371/journal.pone.0098107	http://dx.doi.org/10.1371/journal.pone.0098107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844725	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400096
J	Amaral, ACKB; Holder, MW				Amaral, Andre C. K. B.; Holder, Michael W.			Timing of Antimicrobial Therapy after Identification of Ventilator-Associated Condition Is Not Associated with Mortality in Patients with Ventilator-Associated Pneumonia: A Cohort Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; SURVEILLANCE DEFINITIONS; ANTIBIOTIC-TREATMENT; IMPACT; APPROPRIATENESS; MANAGEMENT; INITIATION; INFECTION; EVENTS	Purpose: Delays in antimicrobial therapy increase mortality in ventilator-associated pneumonia (VAP). The more objective ventilator-associated complications (VAC) are increasingly used for quality reporting. It is unknown if delays in antimicrobial administration, after patients meet VAC criteria, leads to worse outcomes. Materials and Methods: Cohort of 81 episodes of antimicrobial treatment for VAP. We compared mortality, superinfections and treatment failures conditional on the timing of identification of VAC. Results: 60% of patients with VAC had an identifiable episode at least 48 before the initiation of antimicrobials. Antimicrobial administration after the identification of VAC was not associated with intensive care unit (ICU) mortality (OR 0.71, 95% CI 0.11-4.48, p = 0.701) compared to immediate antimicrobial administration. Similarly, the risk of treatment failure or superinfection was not affected by the timing of administration of antimicrobials in VAC (HR 0.95, 95% CI 0.42-2.19, p = 0.914). Conclusions: We observed no signal of harm associated with the timing to initiate antimicrobials after the identification of a VAC. The identification of VAC should not lead clinicians to start antimicrobials before a diagnosis of VAP can be established.	[Amaral, Andre C. K. B.; Holder, Michael W.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Amaral, Andre C. K. B.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Holder, Michael W.] Univ Aberdeen, Sch Med, Aberdeen AB9 2ZD, Scotland	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Aberdeen	Amaral, ACKB (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada.	andrecarlos.amaral@sunnybrook.ca		Holder, Michael/0000-0001-9828-9153				AlvarezLerma F, 1996, INTENS CARE MED, V22, P387, DOI 10.1007/BF01712153; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Baker A. M., 2003, Journal of Bronchology, V10, P7, DOI 10.1097/00128594-200301000-00003; Bekaert M, 2011, AM J RESP CRIT CARE; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Dupont H, 2001, INTENS CARE MED, V27, P355, DOI 10.1007/s001340000640; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Klompas M, 2013, CURR OPIN CRIT CARE, V19, P424, DOI 10.1097/MCC.0b013e3283636bc9; Klompas M, 2012, CRIT CARE MED, V40, P3154, DOI 10.1097/CCM.0b013e318260c6d9; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062; Klompas M, 2010, AM J INFECT CONTROL, V38, P237, DOI 10.1016/j.ajic.2009.10.003; Kollef MH, 1998, CHEST, V113, P412, DOI 10.1378/chest.113.2.412; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Luna CM, 1997, CHEST, V111, P676, DOI 10.1378/chest.111.3.676; Luna CM, 2006, EUR RESPIR J, V27, P158, DOI 10.1183/09031936.06.00049105; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Magill SS, 2012, CLIN INFECT DIS, V54, P378, DOI 10.1093/cid/cir833; Metersky ML, 2006, CHEST, V130, P16, DOI 10.1378/chest.130.1.16; Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005; Moscucci M, 2005, J AM COLL CARDIOL, V45, P1759, DOI 10.1016/j.jacc.2005.01.055; Mueller EW, 2005, J TRAUMA, V58, P94, DOI 10.1097/01.TA.0000141890.29032.9A; Muller MP, 2010, JAMA-J AM MED ASSOC, V304, P1116, DOI 10.1001/jama.2010.1301; Muscedere J, 2008, J CRIT CARE, V23, P126, DOI 10.1016/j.jcrc.2007.11.014; Muscedere J, 2008, J CRIT CARE, V23, P138, DOI 10.1016/j.jcrc.2007.12.008; Muscedere J, 2013, CHEST, V144, P1453, DOI 10.1378/chest.13-0853; Stevens J P, 2013, CRIT CARE MED; TORRES A, 1990, AM REV RESPIR DIS, V142, P523, DOI 10.1164/ajrccm/142.3.523; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84	33	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97575	10.1371/journal.pone.0097575	http://dx.doi.org/10.1371/journal.pone.0097575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840503	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600047
J	Chin, Y; Lim, SH; Zorlu, Y; Ahsen, V; Kiew, LV; Chung, LY; Dumoulin, F; Lee, HB				Chin, Yunni; Lim, Siang Hui; Zorlu, Yunus; Ahsen, Vefa; Kiew, Lik Voon; Chung, Lip Yong; Dumoulin, Fabienne; Lee, Hong Boon			Improved Photodynamic Efficacy of Zn(II) Phthalocyanines via Glycerol Substitution	PLOS ONE			English	Article							IN-VITRO; PHOTOPHYSICAL PROPERTIES; THERAPY; CANCER; DERIVATIVES; PHOTOSENSITIZERS; BACTERIOCHLORIN; PLATINUM(II); COMPLEXES; MG(II)	Phthalocyanines are excellent photosensitizers for photodynamic therapy as they have strong absorbance in the near infrared region which is most relevant for in vivo activation in deeper tissular regions. However, most phthalocyanines present two major challenges, ie, a strong tendency to aggregate and low water-solubility, limiting their effective usage clinically. In the present study, we evaluated the potential enhancement capability of glycerol substitution on the photodynamic properties of zinc (II) phthalocyanines (ZnPc). Three glycerol substituted ZnPc, 1-3, (tetra peripherally, tetra non-peripherally and mono iodinated tri non-peripherally respectively) were evaluated in terms of their spectroscopic properties, rate of singlet oxygen generation, partition coefficient (log P), intracellular uptake, photo-induced cytotoxicity and vascular occlusion efficiency. Tetrasulfonated ZnPc (ZnPcS4) was included as a reference compound. Here, we showed that 1-3 exhibited 10-100 nm red-shifted absorption peaks with higher molar absorptivity, and at least two-fold greater singlet oxygen generation rates compared to ZnPcS4. Meanwhile, phthalocyanines 1 and 2 showed more hydrophilic log P values than 3 consistent with the number of glycerol attachments but 3 was most readily taken up by cells compared to the rest. Both phthalocyanines 2 and 3 exhibited potent phototoxicity against MCF-7, HCT-116 and HSC-2 cancer cell-lines with IC50 ranging 2.8-3.2 mM and 0.04-0.06 mu M respectively, while 1 and ZnPcS4 (up to 100 mu M) failed to yield determinable IC50 values. In terms of vascular occlusion efficiency, phthalocyanine 3 showed better effects than 2 by causing total occlusion of vessels with diameter similar to 70 mu m of the chorioallantoic membrane. Meanwhile, no detectable vascular occlusion was observed for ZnPcS4 with treatment under similar experimental conditions. These findings provide evidence that glycerol substitution, in particular in structures 2 and 3, is able to improve the photodynamic properties of ZnPc.	[Chin, Yunni; Kiew, Lik Voon] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Lim, Siang Hui; Chung, Lip Yong] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Chin, Yunni; Lim, Siang Hui; Lee, Hong Boon] Canc Res Initiat Fdn CARIF, Drug Discovery Lab, Subang Jaya, Selangor, Malaysia; [Zorlu, Yunus; Ahsen, Vefa; Dumoulin, Fabienne] Gebze Inst Technol, Dept Chem, TR-41400 Gebze, Kocaeli, Turkey	Universiti Malaya; Universiti Malaya; Gebze Technical University	Lim, SH (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	sianghui.lim@carif.com.my; fdumoulin@gyte.edu.tr	CHUNG, LIP YONG/B-7764-2010; Zorlu, Yunus/AAA-9320-2020; KIEW, LIK VOON/B-8789-2010; Dumoulin, Fabienne/AAA-9838-2019	CHUNG, LIP YONG/0000-0002-3596-768X; Zorlu, Yunus/0000-0003-2811-1872; KIEW, LIK VOON/0000-0002-6855-9631; Dumoulin, Fabienne/0000-0002-0388-8338; , LEE/0000-0002-0768-2222	Ministry of Higher Education of Malaysia (HIR/MoHE) [UM.C/625/1/HIR/MOHE/MED/17, UM.C/625/1/HIR/MOHE/MED/33]; Scientific and Technological Research Council of Turkey TUBITAK [106T376, 111T031]; University of Malaya [PG042-2012B]	Ministry of Higher Education of Malaysia (HIR/MoHE); Scientific and Technological Research Council of Turkey TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); University of Malaya(Universiti Malaya)	These works were supported by the Ministry of Higher Education of Malaysia (HIR/MoHE grants, UM.C/625/1/HIR/MOHE/MED/17 and UM.C/625/1/HIR/MOHE/MED/33), the Scientific and Technological Research Council of Turkey TUBITAK (projects 106T376 and 111T031) and the Postgraduate Research Grant (PPP) from University of Malaya (PG042-2012B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroyd R, 2001, PHOTOCHEM PHOTOBIOL, V74, P656, DOI 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO;2; Allen CM, 2002, PHOTOCHEM PHOTOBIOL, V76, P208, DOI 10.1562/0031-8655(2002)076<0208:PPOADO>2.0.CO;2; Allison RR, 2010, PHOTODIAGN PHOTODYN, V7, P61, DOI 10.1016/j.pdpdt.2010.02.001; Allison RR, 2004, PHOTODIAGN PHOTODYN, V1, P27, DOI 10.1016/S1572-1000(04)00007-9; Arslanoglu Y, 2012, SPECTROCHIM ACTA A, V95, P407, DOI 10.1016/j.saa.2012.04.004; AYE KT, 1995, INORG CHIM ACTA, V235, P307, DOI 10.1016/0020-1693(95)90072-E; Azenha EG, 2002, CHEM PHYS, V280, P177, DOI 10.1016/S0301-0104(02)00485-8; Biyiklioglu Z, 2012, SYNTHETIC MET, V162, P1156, DOI 10.1016/j.synthmet.2012.04.032; Brown, 1999, Expert Opin Investig Drugs, V8, P1967, DOI 10.1517/13543784.8.12.1967; Canlica M, 2012, POLYHEDRON, V31, P704, DOI 10.1016/j.poly.2011.10.024; Dumoulin F, 2011, TETRAHEDRON LETT, V52, P4395, DOI 10.1016/j.tetlet.2011.06.010; Dumoulin F, 2010, COORDIN CHEM REV, V254, P2792, DOI 10.1016/j.ccr.2010.05.002; Erdogmus A, 2010, J MOL STRUCT, V977, P26, DOI 10.1016/j.molstruc.2010.04.048; Gorman A, 2004, J AM CHEM SOC, V126, P10619, DOI 10.1021/ja047649e; Hajri A, 2002, PHOTOCHEM PHOTOBIOL, V75, P140, DOI 10.1562/0031-8655(2002)075<0140:IVAIVE>2.0.CO;2; Huang YY, 2010, J MED CHEM, V53, P4018, DOI 10.1021/jm901908s; Konan YN, 2002, J PHOTOCH PHOTOBIO B, V66, P89, DOI 10.1016/S1011-1344(01)00267-6; Kozhevnikov DN, 2009, INORG CHEM, V48, P4179, DOI 10.1021/ic802401j; Lange N, 2001, INVEST OPHTH VIS SCI, V42, P38; Lim SH, 2011, PHOTOCHEM PHOTOBIOL, V87, P1152, DOI 10.1111/j.1751-1097.2011.00939.x; Lim SH, 2010, J MED CHEM, V53, P2865, DOI 10.1021/jm901823u; Lim SH, 2010, PHOTOCHEM PHOTOBIOL, V86, P397, DOI 10.1111/j.1751-1097.2009.00684.x; Lo PC, 2003, TETRAHEDRON LETT, V44, P1967, DOI 10.1016/S0040-4039(03)00061-3; Maduray K, 2011, J PHOTOCH PHOTOBIO B, V103, P98, DOI 10.1016/j.jphotobiol.2011.01.020; Margaron P, 1996, PHOTOCHEM PHOTOBIOL, V63, P217, DOI 10.1111/j.1751-1097.1996.tb03017.x; Miller JN, 2005, ENCY ANAL SCI, P163; Nyokong T, 2004, J PORPHYR PHTHALOCYA, V8, P1083, DOI 10.1142/S1088424604000453; Nyokong T, 2007, COORDIN CHEM REV, V251, P1707, DOI 10.1016/j.ccr.2006.11.011; Obata M, 2009, J MED CHEM, V52, P2747, DOI 10.1021/jm8015427; Ogunbayo TB, 2009, POLYHEDRON, V28, P2710, DOI 10.1016/j.poly.2009.05.026; Sekkat N, 2012, MOLECULES, V17, P98, DOI 10.3390/molecules17010098; Serra AC, 2008, J PHOTOCH PHOTOBIO B, V92, P59, DOI 10.1016/j.jphotobiol.2008.04.006; Sharman WM, 1999, DRUG DISCOV TODAY, V4, P507, DOI 10.1016/S1359-6446(99)01412-9; SIBILLE A, 1995, GASTROENTEROLOGY, V108, P337, DOI 10.1016/0016-5085(95)90058-6; Tuncel S, 2011, DALTON T, V40, P4067, DOI 10.1039/c0dt01260b; Wang AJ, 2011, J INCL PHENOM MACRO, V71, P1, DOI 10.1007/s10847-010-9918-x; Wieder ME, 2006, PHOTOCH PHOTOBIO SCI, V5, P727, DOI 10.1039/b602830f; Zorlu Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P312, DOI 10.1039/b817348f; Zorlu Y, 2010, TETRAHEDRON, V66, P3248, DOI 10.1016/j.tet.2010.02.079	39	41	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97894	10.1371/journal.pone.0097894	http://dx.doi.org/10.1371/journal.pone.0097894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840576	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600088
J	Dumont, C; Irenge, LM; Magazani, EK; Garin, D; Muyembe, JJT; Bentahir, M; Gala, JL				Dumont, Catherine; Irenge, Leonid M.; Magazani, Edmond K.; Garin, Daniel; Muyembe, Jean-Jacques T.; Bentahir, Mostafa; Gala, Jean-Luc			Simple Technique for in Field Samples Collection in the Cases of Skin Rash Illness and Subsequent PCR Detection of Orthopoxviruses and Varicella Zoster Virus	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN MONKEYPOX; WEST-AFRICAN; CONGO BASIN; SMALLPOX; ASSAY; IDENTIFICATION; INFECTION; VARIOLA; DIFFERENTIATION	Background: In case of outbreak of rash illness in remote areas, clinically discriminating monkeypox (MPX) from severe form of chickenpox and from smallpox remains a concern for first responders. Objective: The goal of the study was therefore to use MPX and chickenpox outbreaks in Democratic Republic of Congo (DRC) as a test case for establishing a rapid and specific diagnosis in affected remote areas. Methods: In 2008 and 2009, successive outbreaks of presumed MPX skin rash were reported in Bena Tshiadi, Yangala and Ndesha healthcare districts of the West Kasai province (DRC). Specimens consisting of liquid vesicle dried on filter papers or crusted scabs from healing patients were sampled by first responders. A field analytical facility was deployed nearby in order to carry out a real-time PCR (qPCR) assay using genus consensus primers, consensus orthopoxvirus (OPV) and smallpox-specific probes spanning over the 14 kD fusion protein encoding gene. A PCR-restriction fragment length polymorphism was used on-site as backup method to confirm the presence of monkeypox virus (MPXV) in samples. To complete the differential diagnosis of skin rash, chickenpox was tested in parallel using a commercial qPCR assay. In a post-deployment step, a MPXV-specific pyrosequencing was carried out on all biotinylated amplicons generated on-site in order to confirm the on-site results. Results: Whereas MPXV proved to be the agent causing the rash illness outbreak in the Bena Tshiadi, VZV was the causative agent of the disease in Yangala and Ndesha districts. In addition, each on-site result was later confirmed by MPXV-specific pyrosequencing analysis without any discrepancy. Conclusion: This experience of rapid on-site dual use DNA-based differential diagnosis of rash illnesses demonstrates the potential of combining tests specifically identifying bioterrorism agents and agents causing natural outbreaks. This opens the way to rapid on-site DNA-based identification of a broad spectrum of causative agents in remote areas.	[Dumont, Catherine] Royal Mil Acad, Brussels, Belgium; [Irenge, Leonid M.; Bentahir, Mostafa; Gala, Jean-Luc] Belgian Armed Forces, ACOS Ops&Trg, Def Labs Dept, Peutie, Belgium; [Dumont, Catherine; Irenge, Leonid M.; Bentahir, Mostafa; Gala, Jean-Luc] Catholic Univ Louvain, Inst Rech Expt & Clin, Ctr Appl Mol Technol, B-1200 Brussels, Belgium; [Magazani, Edmond K.] Minist Sante Publ, Gombe, DEM REP CONGO; [Garin, Daniel] Serv Sante Armees, Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Muyembe, Jean-Jacques T.] Inst Natl Rech Biomed, Lab Natl Sante Publ, Kinshasa, DEM REP CONGO	Universite Catholique Louvain; Institute Nacional de Recherche Biomedical	Gala, JL (corresponding author), Belgian Armed Forces, ACOS Ops&Trg, Def Labs Dept, Peutie, Belgium.	jean-luc.gala@uclouvain.be			Department Management of Scientific and Technological Research of Defense IRSD/RSTD [MED 05, MED 08]	Department Management of Scientific and Technological Research of Defense IRSD/RSTD	This work was funded by the Department Management of Scientific and Technological Research of Defense IRSD/RSTD (grants MED 05 and MED 08),http://www.irsd.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitichou M, 2008, J VIROL METHODS, V153, P190, DOI 10.1016/j.jviromet.2008.07.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambroise J, 2013, BIOINFORMATICS, V29, P1963, DOI 10.1093/bioinformatics/btt339; [Anonymous], 1984, Bull World Health Organ, V62, P703; Berche P, 2001, TRENDS MICROBIOL, V9, P15, DOI 10.1016/S0966-842X(00)01855-2; Bray M, 2009, AM J TROP MED HYG, V80, P499, DOI 10.4269/ajtmh.2009.80.499; Cann JA, 2013, J COMP PATHOL, V148, P6, DOI 10.1016/j.jcpa.2012.06.007; De Benedictis P, 2011, J CLIN MICROBIOL, V49, P1932, DOI 10.1128/JCM.02015-10; Deng YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023400; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Diven DG, 2001, J AM ACAD DERMATOL, V44, P1, DOI 10.1067/mjd.2001.109302; DOWNIE AW, 1947, LANCET, V252, P550; Durant JF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-288; Eshoo MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006342; FOSTER SO, 1972, B WORLD HEALTH ORGAN, V46, P569; Gala JLIL, 2011, MED BIOD C MUN; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Irenge LM, 2010, APPL MICROBIOL BIOT, V88, P1179, DOI 10.1007/s00253-010-2848-0; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; JEZEK Z, 1988, ACTA TROP, V45, P297; Klietmann WF, 2001, CLIN MICROBIOL REV, V14, P364, DOI 10.1128/CMR.14.2.364-381.2001; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Li Y, 2010, J VIROL METHODS, V169, P223, DOI 10.1016/j.jviromet.2010.07.012; MacNeil A, 2009, CLIN INFECT DIS, V48, pE6, DOI 10.1086/595552; MacNeil A, 2009, AM J TROP MED HYG, V80, P503, DOI 10.4269/ajtmh.2009.80.503; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Putkuri N, 2009, J MED VIROL, V81, P146, DOI 10.1002/jmv.21385; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Saijo M, 2008, JPN J INFECT DIS, V61, P140; Scaramozzino N, 2007, CLIN CHEM, V53, P606, DOI 10.1373/clinchem.2006.068635; Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756; Shchelkunov SN, 2011, J VIROL METHODS, V175, P163, DOI 10.1016/j.jviromet.2011.05.002; STAGLES MJ, 1985, T ROY SOC TROP MED H, V79, P192, DOI 10.1016/0035-9203(85)90333-5; Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06	38	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96930	10.1371/journal.pone.0096930	http://dx.doi.org/10.1371/journal.pone.0096930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841633	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600014
J	Kukutla, P; Lindberg, BG; Pei, D; Rayl, M; Yu, WQ; Steritz, M; Faye, I; Xu, JN				Kukutla, Phanidhar; Lindberg, Bo G.; Pei, Dong; Rayl, Melanie; Yu, Wanqin; Steritz, Matthew; Faye, Ingrid; Xu, Jiannong			Insights from the Genome Annotation of Elizabethkingia anophelis from the Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; TONB-DEPENDENT TRANSPORTERS; CARBOHYDRATE-ACTIVE ENZYMES; MULTIDRUG EFFLUX PUMPS; ANTIBIOTIC-RESISTANCE; CHRYSEOBACTERIUM-MENINGOSEPTICUM; PATHOGEN FLAVOBACTERIUM; ISOPRENOID BIOSYNTHESIS; BACTEROIDES-FRAGILIS; DIPTERA-CULICIDAE	Elizabethkingia anophelis is a dominant bacterial species in the gut ecosystem of the malaria vector mosquito Anopheles gambiae. We recently sequenced the genomes of two strains of E. anophelis, R26(T) and Ag1, isolated from different strains of A. gambiae. The two bacterial strains are identical with a few exceptions. Phylogenetically, Elizabethkingia is closer to Chryseobacterium and Riemerella than to Flavobacterium. In line with other Bacteroidetes known to utilize various polymers in their ecological niches, the E. anophelis genome contains numerous TonB dependent transporters with various substrate specificities. In addition, several genes belonging to the polysaccharide utilization system and the glycoside hydrolase family were identified that could potentially be of benefit for the mosquito carbohydrate metabolism. In agreement with previous reports of broad antibiotic resistance in E. anophelis, a large number of genes encoding efflux pumps and blactamases are present in the genome. The component genes of resistance-nodulation-division type efflux pumps were found to be syntenic and conserved in different taxa of Bacteroidetes. The bacterium also displays hemolytic activity and encodes several hemolysins that may participate in the digestion of erythrocytes in the mosquito gut. At the same time, the OxyR regulon and antioxidant genes could provide defense against the oxidative stress that is associated with blood digestion. The genome annotation and comparative genomic analysis revealed functional characteristics associated with the symbiotic relationship with the mosquito host.	[Kukutla, Phanidhar; Pei, Dong; Yu, Wanqin; Steritz, Matthew; Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Lindberg, Bo G.; Rayl, Melanie; Faye, Ingrid] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	New Mexico State University; Stockholm University	Faye, I (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	ingrid.faye@su.se; jxu@nmsu.edu	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370; KUKUTLA, PHANIDHAR/0000-0002-4790-386X	National Institute of General Medical Sciences; National Institutes of Health [1SC2GM092789, 1SC1AI112786]; National Science Foundation [DMS-1222592]; NMSU Howard Hughes Medical Institute (HHMI) research scholars program; Research Infrastructure - Integrating Activity project - European Community (INFRAVEC) FP7 Infrastructures [228421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI112786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092789] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NMSU Howard Hughes Medical Institute (HHMI) research scholars program; Research Infrastructure - Integrating Activity project - European Community (INFRAVEC) FP7 Infrastructures; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JX was supported by grants from the National Institute of General Medical Sciences, the National Institutes of Health (1SC2GM092789, 1SC1AI112786) and National Science Foundation (DMS-1222592). MS was an undergraduate research scholar supported by the NMSU Howard Hughes Medical Institute (HHMI) research scholars program. IF was supported by a grant from the Research Infrastructure - Integrating Activity project supported by the European Community (INFRAVEC) FP7 Infrastructures (grant agreement number: 228421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2012, J BACTERIOL, V194, P5449, DOI 10.1128/JB.01173-12; Alvarez-Ortega C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00007; Amer MZ, 2011, J INFECT DEV COUNTR, V5, P745, DOI 10.3855/jidc.1570; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BILLINGSLEY PF, 1991, J MED ENTOMOL, V28, P865, DOI 10.1093/jmedent/28.6.865; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Bolam DN, 2012, CURR OPIN STRUC BIOL, V22, P563, DOI 10.1016/j.sbi.2012.06.006; Brown SD, 2012, J BACTERIOL, V194, P5991, DOI 10.1128/JB.01243-12; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clark SE, 2009, VET RES, V40, DOI 10.1051/vetres/2009038; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Di Pentima MC, 1998, CLIN INFECT DIS, V26, P1169, DOI 10.1086/520309; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Frank T, 2013, LANCET, V381, P1876, DOI 10.1016/S0140-6736(13)60318-9; Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Gonzalez LJ, 2012, ANTIMICROB AGENTS CH, V56, P1686, DOI 10.1128/AAC.05835-11; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Heuston S, 2012, MICROBIOL-SGM, V158, P1389, DOI 10.1099/mic.0.051599-0; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Hogfors-Ronnholm E, 2010, MICROB PATHOGENESIS, V49, P369, DOI 10.1016/j.micpath.2010.08.002; Horsfall LE, 2011, FEBS J, V278, P1252, DOI 10.1111/j.1742-4658.2011.08046.x; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427; Jiang JJ, 2012, J BACTERIOL, V194, P5481, DOI 10.1128/JB.01275-12; Junnila A, 2010, ACTA TROP, V115, P227, DOI 10.1016/j.actatropica.2010.04.002; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; KAWAI Y, 1988, EUR J BIOCHEM, V171, P73, DOI 10.1111/j.1432-1033.1988.tb13760.x; Kim KK, 2005, INT J SYST EVOL MICR, V55, P1287, DOI 10.1099/ijs.0.63541-0; Kolton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076704; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Kukutla P, 2013, GENOME ANNOUNC, V1; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lee M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040460; Lin XH, 2012, INT J ANTIMICROB AG, V40, P186, DOI 10.1016/j.ijantimicag.2012.03.020; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Liu MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037630; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Matyi SA, 2013, GENOME ANNOUNC, V1; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Michel C, 2005, J APPL MICROBIOL, V99, P323, DOI 10.1111/j.1365-2672.2005.02592.x; Mirus O, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-68; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Neuner EA, 2012, J ANTIMICROB CHEMOTH, V67, P1558, DOI 10.1093/jac/dks053; Ngwa CJ, 2013, J MED ENTOMOL, V50, P404, DOI 10.1603/ME12180; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; Rocha ER, 2003, ANAEROBE, V9, P165, DOI 10.1016/S1075-9964(03)00118-5; Rossolini GM, 2001, ANTIMICROB AGENTS CH, V45, P837, DOI 10.1128/AAC.45.3.837-844.2001; Saavedra MJ, 2003, ANTIMICROB AGENTS CH, V47, P2330, DOI 10.1128/AAC.47.7.2330-2333.2003; Saidijam M, 2006, CURR DRUG TARGETS, V7, P793, DOI 10.2174/138945006777709575; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; SCHLEIN Y, 1995, J MED ENTOMOL, V32, P882, DOI 10.1093/jmedent/32.6.882; Schmieder R, 2012, FUTURE MICROBIOL, V7, P73, DOI [10.2217/fmb.11.135, 10.2217/FMB.11.135]; Simm AM, 2001, FEBS LETT, V509, P350, DOI 10.1016/S0014-5793(01)03152-0; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Souza JA, 2007, COMP BIOCHEM PHYS A, V147, P993, DOI 10.1016/j.cbpa.2007.03.008; Stoczko M, 2006, ANTIMICROB AGENTS CH, V50, P1973, DOI 10.1128/AAC.01551-05; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Teo J, 2013, LANCET, V382, P855, DOI 10.1016/S0140-6736(13)61858-9; Terenius O, 2012, FEMS MICROBIOL ECOL, V80, P556, DOI 10.1111/j.1574-6941.2012.01317.x; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Wexler HM, 2012, ANAEROBE, V18, P200, DOI 10.1016/j.anaerobe.2011.12.017; Wong K, 2014, TRENDS BIOCHEM SCI, V39, P8, DOI 10.1016/j.tibs.2013.11.002; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yum JH, 2010, J MICROBIOL, V48, P358, DOI 10.1007/s12275-010-9308-5; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0	97	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97715	10.1371/journal.pone.0097715	http://dx.doi.org/10.1371/journal.pone.0097715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842809	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600062
J	Zhi, JJ; Jing, CW; Lin, SP; Zhang, C; Liu, QK; DeGloria, SD; Wu, JP				Zhi, Junjun; Jing, Changwei; Lin, Shengpan; Zhang, Cao; Liu, Qiankun; DeGloria, Stephen D.; Wu, Jiaping			Estimating Soil Organic Carbon Stocks and Spatial Patterns with Statistical and GIS-Based Methods	PLOS ONE			English	Article							PADDY SOILS; LAND-USE; STORAGE; MANAGEMENT; NITROGEN; DATABASE; CHINA	Accurately quantifying soil organic carbon (SOC) is considered fundamental to studying soil quality, modeling the global carbon cycle, and assessing global climate change. This study evaluated the uncertainties caused by up- scaling of soil properties from the county scale to the provincial scale and from lower- level classification of Soil Species to Soil Group, using four methods: the mean, median, Soil Profile Statistics (SPS), and pedological professional knowledge based (PKB) methods. For the SPS method, SOC stock is calculated at the county scale by multiplying the mean SOC density value of each soil type in a county by its corresponding area. For the mean or median method, SOC density value of each soil type is calculated using provincial arithmetic mean or median. For the PKB method, SOC density value of each soil type is calculated at the county scale considering soil parent materials and spatial locations of all soil profiles. A newly constructed 1:50,000 soil survey geographic database of Zhejiang Province, China, was used for evaluation. Results indicated that with soil classification levels up- scaling from Soil Species to Soil Group, the variation of estimated SOC stocks among different soil classification levels was obviously lower than that among different methods. The difference in the estimated SOC stocks among the four methods was lowest at the Soil Species level. The differences in SOC stocks among the mean, median, and PKB methods for different Soil Groups resulted from the differences in the procedure of aggregating soil profile properties to represent the attributes of one soil type. Compared with the other three estimation methods (i.e., the SPS, mean and median methods), the PKB method holds significant promise for characterizing spatial differences in SOC distribution because spatial locations of all soil profiles are considered during the aggregation procedure.	[Zhi, Junjun; Lin, Shengpan; Zhang, Cao; Liu, Qiankun] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jing, Changwei; Wu, Jiaping] Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China; [DeGloria, Stephen D.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY USA	Zhejiang University; Zhejiang University; Cornell University	Wu, JP (corresponding author), Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China.	jw67@zju.edu.cn	Zhi, Junjun/GVU-3721-2022; DeGloria, Stephen D/B-8513-2015; Wu, Jiaping/AAD-8800-2022; Zhi, Junjun/GVU-3746-2022	DeGloria, Stephen D/0000-0002-3343-6607; Lin, Shengpan/0000-0002-7458-7559	National Natural Science Foundation of China [30771253]; Key Project of the Science and Technology Department of Zhejiang Province [2006C22026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Science and Technology Department of Zhejiang Province	This study was supported by the National Natural Science Foundation of China (No. 30771253) and the Key Project of the Science and Technology Department of Zhejiang Province (No. 2006C22026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro-Fuentes J, 2014, PLANT SOIL, V376, P31, DOI 10.1007/s11104-012-1167-x; Arnold R. W., 1995, SOILS GLOBAL CHANGE, P257; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Batjes NH, 2000, GEODERMA, V97, P135, DOI 10.1016/S0016-7061(00)00031-8; Batjes NH, 2006, GEODERMA, V132, P361, DOI 10.1016/j.geoderma.2005.05.013; BOHN HL, 1976, SOIL SCI SOC AM J, V40, P468, DOI 10.2136/sssaj1976.03615995004000030045x; BOLIN B, 1977, SCIENCE, V196, P613, DOI 10.1126/science.196.4290.613; Cole C.V., 1998, POTENTIAL US CROPLAN; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192, DOI 10.2136/sssaj1993.03615995005700010034x; Fang JY, 1996, STUDY KEY ISSUES MOD, P251; Homann PS, 1998, SOIL SCI SOC AM J, V62, P789, DOI 10.2136/sssaj1998.03615995006200030036x; Janzen HH, 2004, AGR ECOSYST ENVIRON, V104, P399, DOI 10.1016/j.agee.2004.01.040; Jin Feng, 2001, Acta Pedologica Sinica, V38, P522; Leifeld J, 2005, AGR ECOSYST ENVIRON, V105, P255, DOI 10.1016/j.agee.2004.03.006; Li MM, 2013, CATENA, V101, P11, DOI 10.1016/j.catena.2012.09.012; Liebens J, 2003, SOIL USE MANAGE, V19, P364, DOI 10.1079/SUM2003215; Liu QH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002731; Morisada K, 2004, GEODERMA, V119, P21, DOI 10.1016/S0016-7061(03)00220-9; *NAT SOIL SURV OFF, 1993, SOIL SPEC CHIN, V1; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pan GX., 1999, B SCI TECHNOL, V15, P330, DOI DOI 10.13774/J.CNKI.KJTB.1999.05.002; Rapalee G, 1998, GLOBAL BIOGEOCHEM CY, V12, P687, DOI 10.1029/98GB02336; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Shi X.Z., 2004, SOIL SURVEY HORIZONS, V45, P111; SUN WX, 2003, SOILS, V35, P236; Tan GX, 2003, ECOL MODEL, V168, P357, DOI 10.1016/S0304-3800(03)00146-7; Uri ND, 2000, SCI TOTAL ENVIRON, V256, P23, DOI 10.1016/S0048-9697(00)00462-9; Wang S., 1999, GEOGRAPHICAL RES, V18, P349, DOI [10.11821/yj1999040003, DOI 10.3321/J.ISSN:1000-0585.1999.04.003]; Wang SL, 2004, ENVIRON MANAGE, V33, pS200, DOI 10.1007/s00267-003-9130-5; Wu J, 2001, SOIL SCI SOC AM J, V65, P169, DOI 10.2136/sssaj2001.651169x; Wu JiaPing, 2013, Acta Pedologica Sinica, V50, P30; Xu SX, 2013, CATENA, V104, P67, DOI 10.1016/j.catena.2012.10.017; Yu DS, 2007, J ENVIRON MANAGE, V85, P680, DOI 10.1016/j.jenvman.2006.09.020; Yu Lian-jun, 2008, Yingyong Shengtai Xuebao, V19, P1058; Zhang Y, 2008, GEODERMA, V146, P449, DOI 10.1016/j.geoderma.2008.06.015; Zhao YC, 2005, PEDOSPHERE, V15, P293; Zhao YC, 2006, SOIL SCI SOC AM J, V70, P1377, DOI 10.2136/sssaj2004.0165; Zhejiang Soil Survey Office, 1994, SOILS ZHEJ PROV; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042927	40	10	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97757	10.1371/journal.pone.0097757	http://dx.doi.org/10.1371/journal.pone.0097757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840890	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600070
J	Tann, CJ; Nkurunziza, P; Nakakeeto, M; Oweka, J; Kurinczuk, JJ; Were, J; Nyombi, N; Hughes, P; Willey, BA; Elliott, AM; Robertson, NJ; Klein, N; Harris, KA				Tann, Cally J.; Nkurunziza, Peter; Nakakeeto, Margaret; Oweka, James; Kurinczuk, Jennifer J.; Were, Jackson; Nyombi, Natasha; Hughes, Peter; Willey, Barbara A.; Elliott, Alison M.; Robertson, Nicola J.; Klein, Nigel; Harris, Kathryn A.			Prevalence of Bloodstream Pathogens Is Higher in Neonatal Encephalopathy Cases vs. Controls Using a Novel Panel of Real-Time PCR Assays	PLOS ONE			English	Article							CONGENITAL CYTOMEGALOVIRUS; BRAIN; INJURY	Background: In neonatal encephalopathy (NE), infectious co-morbidity is difficult to diagnose accurately, but may increase the vulnerability of the developing brain to hypoxia-ischemia. We developed a novel panel of species-specific real-time PCR assays to identify bloodstream pathogens amongst newborns with and without NE in Uganda. Methodology: Multiplex real-time PCR assays for important neonatal bloodstream pathogens (gram positive and gram negative bacteria, cytomegalovirus (CMV), herpes simplex virus(HSV) and P. falciparum) were performed on whole blood taken from 202 encephalopathic and 101 control infants. Automated blood culture (BACTEC) was performed for all cases and unwell controls. Principal Findings: Prevalence of pathogenic bacterial species amongst infants with NE was 3.6%, 6.9% and 8.9%, with culture, PCR and both tests in combination, respectively. More encephalopathic infants than controls had pathogenic bacterial species detected (8.9%vs2.0%, p = 0.028) using culture and PCR in combination. PCR detected bacteremia in 11 culture negative encephalopathic infants (3 Group B Streptococcus, 1 Group A Streptococcus, 1 Staphylococcus aureus and 6 Enterobacteriacae). Coagulase negative staphylococcus, frequently detected by PCR amongst case and control infants, was considered a contaminant. Prevalence of CMV, HSV and malaria amongst cases was low (1.5%, 0.5% and 0.5%, respectively). Conclusion/Significance: This real-time PCR panel detected more bacteremia than culture alone and provides a novel tool for detection of neonatal bloodstream pathogens that may be applied across a range of clinical situations and settings. Significantly more encephalopathic infants than controls had pathogenic bacterial species detected suggesting that infection may be an important risk factor for NE in this setting.	[Tann, Cally J.; Willey, Barbara A.; Elliott, Alison M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Nkurunziza, Peter; Oweka, James; Were, Jackson; Elliott, Alison M.] MRC UVRI, Uganda Res Unit AIDS, Entebbe, Uganda; [Hughes, Peter; Robertson, Nicola J.] UCL, Inst Womens Hlth, London, England; [Klein, Nigel; Harris, Kathryn A.] UCL, Inst Child Hlth, London, England; [Tann, Cally J.; Nakakeeto, Margaret; Nyombi, Natasha] Mulago Univ Hosp, Kampala, Uganda; [Kurinczuk, Jennifer J.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England; [Klein, Nigel; Harris, Kathryn A.] Great Ormond St Hosp Sick Children, Dept Microbiol Virol & Infect Control, London WC1N 3JH, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London; Mulago National Referral Hospital; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Tann, CJ (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England.	cally.tann@lshtm.ac.uk	Tann, Cally/ABE-3184-2020; Robertson, Nicola/GWR-2021-2022	Tann, Cally/0000-0003-0131-4952; Elliott, Alison/0000-0003-2818-9549; Harris, Kathryn/0000-0003-3807-9749; Klein, Nigel/0000-0003-3925-9258	Wellcome Trust through the London School of Hygiene & Tropical Medicine Clinical PhD programme [094016/Z/10/Z]	Wellcome Trust through the London School of Hygiene & Tropical Medicine Clinical PhD programme	This work was supported by the Wellcome Trust through the London School of Hygiene & Tropical Medicine Clinical PhD programme [grant 094016/Z/10/Z to CT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Eklind S, 2001, EUR J NEUROSCI, V13, P1101, DOI 10.1046/j.0953-816x.2001.01474.x; Eklind S, 2005, PEDIATR RES, V58, P112, DOI 10.1203/01.PDR.0000163513.03619.8D; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Harris KA, 2008, J CLIN MICROBIOL, V46, P2751, DOI 10.1128/JCM.02462-07; Mallard C, 2003, NEUROCHEM RES, V28, P215, DOI 10.1023/A:1022368915400; Mallard C, 2012, ISRN NEUROLOGY, V2012, P19; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; McAdams RM, 2012, ROLE CYTOKINES INFLA; Pammi M, 2011, PEDIATRICS, V128, pE973, DOI 10.1542/peds.2011-1208; Peebles D. M., 2007, INTRAUTERINE INFECT; Stridh L, 2013, J NEUROSCI, V33, P12041, DOI 10.1523/JNEUROSCI.0673-13.2013; Thompson CM, 1997, ACTA PAEDIATR, V86, P757, DOI 10.1111/j.1651-2227.1997.tb08581.x; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000492	15	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97259	10.1371/journal.pone.0097259	http://dx.doi.org/10.1371/journal.pone.0097259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836781	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800034
J	Rocha, KSO; Martins, JH; Martins, MA; Tinoca, IDF; Saraz, JAO; Lacerda, AF; Fernandes, LHM				Oliveira Rocha, Keller Sullivan; Martins, Jose Helvecio; Martins, Marcio Aredes; Ferrei Tinoca, Ilda De Fatima; Osorio Saraz, Jairo Alexander; Lacerda Filho, Adilio Flauzino; Martins Fernandes, Luiz Henrique			Modeling and Simulation of the Transient Response of Temperature and Relative Humidity Sensors with and without Protective Housing	PLOS ONE			English	Article							MASS-TRANSFER; CFD; ACCURACY; HEAT; FLOW	Based on the necessity for enclosure protection of temperature and relative humidity sensors installed in a hostile environment, a wind tunnel was used to quantify the time that the sensors take to reach equilibrium in the environmental conditions to which they are exposed. Two treatments were used: (1) sensors with polyvinyl chloride (PVC) enclosure protection, and (2) sensors with no enclosure protection. The primary objective of this study was to develop and validate a 3-D computational fluid dynamics (CFD) model for analyzing the temperature and relative humidity distribution in a wind tunnel using sensors with PVC enclosure protection and sensors with no enclosure protection. A CFD simulation model was developed to describe the temperature distribution and the physics of mass transfer related to the airflow relative humidity. The first results demonstrate the applicability of the simulation. For verification, a sensor device was successfully assembled and tested in an environment that was optimized to ensure fast change conditions. The quantification setup presented in this paper is thus considered to be adequate for testing different materials and morphologies for enclosure protection. The results show that the boundary layer flow regime has a significant impact on the heat flux distribution. The results indicate that the CFD technique is a powerful tool which provides a detailed description of the flow and temperature fields as well as the time that the relative humidity takes to reach equilibrium with the environment in which the sensors are inserted.	[Oliveira Rocha, Keller Sullivan; Martins, Jose Helvecio; Martins, Marcio Aredes; Ferrei Tinoca, Ilda De Fatima; Lacerda Filho, Adilio Flauzino; Martins Fernandes, Luiz Henrique] Univ Fed Vicosa, Dept Engn Agr, Vicosa, MG, Brazil; [Osorio Saraz, Jairo Alexander] Univ Nacl Colombia, Dept Ingn Alimentos, Medellin, Colombia	Universidade Federal de Vicosa; Universidad Nacional de Colombia	Rocha, KSO (corresponding author), Univ Fed Vicosa, Dept Engn Agr, Vicosa, MG, Brazil.	kellersullivan@yahoo.com.br	Saraz, Jairo Alexander Osorio/AAV-4900-2020; Martins, Marcio Arêdes/M-4671-2019; Martins, Marcio A/C-1105-2017	Martins, Marcio Arêdes/0000-0001-5705-9431; Martins, Marcio A/0000-0001-5705-9431; Martins, Jose Helvecio/0000-0002-4841-8970; FerreiraTinoco, Ilda de Fatima/0000-0002-4557-8071	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Simon Luke Elliot/PROEX; AUX [CAPES/PROEX 1534/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Simon Luke Elliot/PROEX; AUX; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Simon Luke Elliot/PROEX, AUX CAPES/PROEX 1534/2013, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambaw A, 2012, COMPUTERS ELECT AGR; Awtrey D, 2002, DALLAS SEMICONDUCTOR; Awtrey D, 1997, DALLAS SEMICONDUCTOR; Bird R.B., 2006, TRANSPORT PHENOMENA, DOI 10.1002/aic.690070245; Bjerg B, 2002, COMPUT ELECTRON AGR, V34, P223, DOI 10.1016/S0168-1699(01)00189-2; Monte JE, 2008, ACTA SCI-AGRON, V30, P307, DOI 10.4025/actasciagron.v30i3.3499; Celik HK, 2011, VIRTUAL PHYS PROTOTY, V6, P47, DOI 10.1080/17452759.2010.525215; HUNTER AJ, 1987, J AGR ENG RES, V37, P93, DOI 10.1016/0021-8634(87)90085-0; Katz A, 2011, J COMPUT PHYS, V230, P7670, DOI 10.1016/j.jcp.2011.06.023; Lee IB, 2007, JARQ-JPN AGR RES Q, V41, P53, DOI 10.6090/jarq.41.53; Liu SX, 2005, COMPUT ELECTRON AGR, V49, P309, DOI 10.1016/j.compag.2005.05.003; Lopes Daniela de Carvalho, 2007, Acta Scientiarum Agronomy, V29, P157; Martins MA, 2010, REV FACULDADE MINAS; Norton T, 2010, COMPUT ELECTRON AGR, V73, P17, DOI 10.1016/j.compag.2010.04.002; Rocha KSO, 2013, DRYING TECHNOLOGY; Rocha KSO, 2008, 8 INT LIV ENV S ILES, P1001; Sitompul JP, 2003, DRY TECHNOL, V21, P217, DOI 10.1081/DRT-120017744; Steidle Neto AJ, 2005, ENGENHARIA AGRICOLA, V25, P29; Tu J, 2008, COMPUTATIONAL FLUID DYNAMICS: A PRACTICAL APPROACH, P1; Vaz J, 2011, ENERG BUILDINGS, V43, P2476, DOI 10.1016/j.enbuild.2011.06.003; Wass JA, 2009, SCI COMPUT, V26, P21; Xia B, 2002, COMPUT ELECTRON AGR, V34, P5, DOI 10.1016/S0168-1699(01)00177-6; Younsi R, 2010, DRY TECHNOL, V28, P1148, DOI 10.1080/07373937.2010.483049	23	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e95874	10.1371/journal.pone.0095874	http://dx.doi.org/10.1371/journal.pone.0095874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851994	gold, Green Submitted, Green Published			2022-12-27	WOS:000338323200007
J	Perucci, LO; Gomes, KB; Freitas, LG; Godoi, LC; Alpoim, PN; Pinheiro, MB; Miranda, AS; Teixeria, AL; Dusse, LM; Sousa, LP				Perucci, Luiza O.; Gomes, Karina B.; Freitas, Leticia G.; Godoi, Lara C.; Alpoim, Patricia N.; Pinheiro, Melina B.; Miranda, Aline S.; Teixeria, Antonio L.; Dusse, Luci M.; Sousa, Lirlandia P.			Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia	PLOS ONE			English	Article							CIRCULATING ANTIANGIOGENIC FACTORS; NITRIC-OXIDE; NORMAL-PREGNANCY; PLASMA-LEVELS; SERUM; INFLAMMATION; CYTOKINES; ADHESION; WOMEN; FETAL	Background: Despite intensive research, the etiopathogenesis of preeclampsia (PE) remains uncertain. Inflammatory and angiogenic factors are thought to play considerable roles in this disease. The objective of this study was to investigate the association between soluble endoglin (sEng), transforming growth factor beta-1 (TGF-beta 1) and tumor necrosis factor alpha soluble receptors (sTNF-Rs) and the clinical manifestations of PE. Methods: Plasma levels of sEng, TGF-beta 1 and sTNF-Rs were determined by ELISA in 23 non-pregnant, 21 normotensive pregnant and 43 PE women. PE women were stratified into subgroups according to the severity [mild (n = 12) and severe (n = 31)] and onset-time of the disease [ early (n = 19) and late (n = 24)]. Results: Pregnancy was associated with higher levels of sEng, sTNF-R1 and sTNF-R2 than the non-pregnant state. Moreover, PE women had higher levels of sEng and sTNF-R1 than normotensive pregnant women. No difference was found in TGF-beta 1 levels, comparing the three study groups. Late PE had higher levels of sTNF-R1 and sTNF-R2 than early PE. No significant differences were found in sEng and TGF-beta 1 comparing early and late PE. sEng levels were higher in severe PE than in mild PE and no difference was found for TGF-beta 1, sTNF-R1 and sTNF-R2 levels. There was a positive correlation among sEng, TNF-R1 and sTNF-2 levels. Logistic regression analysis revealed that primiparity and sEng levels are independently associated with the development of PE. Furthermore, sEng levels are independently associated with the disease severity. Conclusions: These results suggest that pregnancy is a condition associated with higher levels of anti-angiogenic and pro-inflammatory factors than the non-pregnant state and that PE is associated with an imbalance of these factors in the maternal circulation.	[Perucci, Luiza O.; Gomes, Karina B.; Freitas, Leticia G.; Godoi, Lara C.; Alpoim, Patricia N.; Dusse, Luci M.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Perucci, Luiza O.; Gomes, Karina B.; Dusse, Luci M.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Programa Grad Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Freitas, Leticia G.; Godoi, Lara C.; Alpoim, Patricia N.; Pinheiro, Melina B.; Dusse, Luci M.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Programa Grad Ciencias Farmaceut, Belo Horizonte, MG, Brazil; [Pinheiro, Melina B.] Univ Fed Sao Joa Del Rei, Fac Med, Sao Joao Del Rei, MG, Brazil; [Miranda, Aline S.; Teixeria, Antonio L.] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Sousa, LP (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil.	lipsousa72@gmail.com	Miranda, Aline Silva de/AFM-2106-2022; Teixeira, Antonio L/N-3315-2014	Miranda, Aline Silva de/0000-0003-2811-7924; Teixeira, Antonio L/0000-0002-9621-5422; Sousa, Lirlandia/0000-0002-1042-9762; Dusse, Luci/0000-0002-7484-1684	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil [APQ00588-11]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil; Pro-Reitoria de Pesquisa da UFMG -PRPq UFMG - Programa de Auxilio a Pesquisa de Doutores Recem-Contratados, Brazil	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa da UFMG -PRPq UFMG - Programa de Auxilio a Pesquisa de Doutores Recem-Contratados, Brazil	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil (APQ00588-11, http://www.fapemig.br/), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil (http://www.cnpq.br/), and Pro-Reitoria de Pesquisa da UFMG -PRPq UFMG - Programa de Auxilio a Pesquisa de Doutores Recem-Contratados, Brazil (https://www.ufmg.br/prpq/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; ARNTZEN KJ, 1995, AM J REPROD IMMUNOL, V34, P163, DOI 10.1111/j.1600-0897.1995.tb00933.x; AUSTGULEN R, 1993, PEDIATR RES, V33, P82, DOI 10.1203/00006450-199301000-00017; Ayatollahi M, 2005, TRANSPL P, V37, P4603, DOI 10.1016/j.transproceed.2005.11.023; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco JCG, 2004, J INTERF CYTOK RES, V24, P21, DOI 10.1089/107999004772719873; Burtis CA, 2006, TIETZ TXB CLIN CHEM; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; Eiland E, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/586578; Feizollahzadeh S, 2012, J REPROD IMMUNOL, V94, P216, DOI 10.1016/j.jri.2012.02.006; Gil-Villa AM, 2012, PROSTAG LEUKOTR ESS, V87, P127, DOI 10.1016/j.plefa.2012.08.003; Halim A, 1996, GYNECOL OBSTET INVES, V41, P106, DOI 10.1159/000292053; Hertig A, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.006; Hupuczi P, 2007, HYPERTENS PREGNANCY, V26, P389, DOI 10.1080/10641950701521221; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kim YN, 2009, PRENATAL DIAG, V29, P464, DOI 10.1002/pd.2203; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; Lau SY, 2013, AM J REPROD IMMUNOL, V70, P412, DOI 10.1111/aji.12138; Leal AM, 2009, ULTRASOUND OBST GYN, V33, P135, DOI 10.1002/uog.6275; Lev PR, 2007, PLATELETS, V18, P35, DOI 10.1080/09537100600800743; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Luft FC, 2006, NEPHROL DIAL TRANSPL, V21, P3052, DOI 10.1093/ndt/gfl439; Madazli R, 2003, ACTA OBSTET GYN SCAN, V82, P797, DOI 10.1034/j.1600-0412.2003.00206.x; Marques FK, 2012, CLIN CHIM ACTA, V414, P253, DOI 10.1016/j.cca.2012.09.023; Masuyama H, 2010, BJOG-INT J OBSTET GY, V117, P314, DOI 10.1111/j.1471-0528.2009.02453.x; Masuyama H, 2007, J CLIN ENDOCR METAB, V92, P2672, DOI 10.1210/jc.2006-2349; OPSJON SL, 1995, J REPROD IMMUNOL, V29, P119, DOI 10.1016/0165-0378(95)00940-M; Parrish MR, 2010, AM J HYPERTENS, V23, P911, DOI 10.1038/ajh.2010.70; Pinheiro MB, 2013, CYTOKINE, V62, P165, DOI 10.1016/j.cyto.2013.02.027; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Robinson CJ, 2007, AM J OBSTET GYNECOL, V197; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Scharpfenecker M, 2012, RADIOTHER ONCOL, V105, P313, DOI 10.1016/j.radonc.2012.08.021; Schroeder BM, 2002, AM FAM PHYSICIAN, V66, P330; Peracoli MTS, 2008, J REPROD IMMUNOL, V79, P79, DOI 10.1016/j.jri.2008.08.001; Sibai B, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.033; Sibai BM, 2008, HYPERTENSION, V52, P805, DOI 10.1161/HYPERTENSIONAHA.108.119115; SLUNGAARD A, 1990, J EXP MED, V171, P2025, DOI 10.1084/jem.171.6.2025; Staff AC, 2009, EUR J OBSTET GYN R B, V143, P29, DOI 10.1016/j.ejogrb.2008.11.003; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Tjwa M, 2003, CELL TISSUE RES, V314, P5, DOI 10.1007/s00441-003-0776-3; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; TRACEY KJ, 1993, CRIT CARE MED, V21, pS415; Troisi R, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.030; VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; VINCE GS, 1995, BRIT J OBSTET GYNAEC, V102, P20, DOI 10.1111/j.1471-0528.1995.tb09020.x; Zhang Li-jun, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P371	54	43	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97632	10.1371/journal.pone.0097632	http://dx.doi.org/10.1371/journal.pone.0097632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851923	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200026
J	Stevanovic, DM; Grefhorst, A; Themmen, APN; Popovic, V; Holstege, J; Haasdijk, E; Trajkovic, V; van der Lely, AJ; Delhanty, PJD				Stevanovic, Darko M.; Grefhorst, Aldo; Themmen, Axel P. N.; Popovic, Vera; Holstege, Joan; Haasdijk, Elize; Trajkovic, Vladimir; van der Lely, Aart-Jan; Delhanty, Patric J. D.			Unacylated Ghrelin Suppresses Ghrelin-Induced Neuronal Activity in the Hypothalamus and Brainstem of Male Rats	PLOS ONE			English	Article							DES-ACYL GHRELIN; FOOD-INTAKE; CONSCIOUS RATS; ENERGY-BALANCE; SOLITARY TRACT; PROMOTE SURVIVAL; DESACYL GHRELIN; ARCUATE NUCLEUS; FOS EXPRESSION; RECEPTOR	Ghrelin, the endogenous growth hormone secretagogue, has an important role in metabolic homeostasis. It exists in two major molecular forms: acylated (AG) and unacylated (UAG). Many studies suggest different roles for these two forms of ghrelin in energy balance regulation. In the present study, we compared the effects of acute intracerebroventricular administration of AG, UAG and their combination (AG+UAG) to young adult Wistar rats on food intake and central melanocortin system modulation. Although UAG did not affect food intake it significantly increased the number of c-Fos positive neurons in the arcuate (ARC), paraventricular (PVN) and solitary tract (NTS) nuclei. In contrast, UAG suppressed AG-induced neuronal activity in PVN and NTS. Central UAG also modulated hypothalamic expression of Mc4r and Bmp8b, which were increased and Mc3r, Pomc, Agrp and Ucp2, which were decreased. Finally, UAG, AG and combination treatments caused activation of c-Fos in POMC expressing neurons in the arcuate, substantiating a physiologic effect of these peptides on the central melanocortin system. Together, these results demonstrate that UAG can act directly to increase neuronal activity in the hypothalamus and is able to counteract AG-induced neuronal activity in the PVN and NTS. UAG also modulates expression of members of the melanocortin signaling system in the hypothalamus. In the absence of an effect on energy intake, these findings indicate that UAG could affect energy homeostasis by modulation of the central melanocortin system.	[Stevanovic, Darko M.; Grefhorst, Aldo; Themmen, Axel P. N.; van der Lely, Aart-Jan; Delhanty, Patric J. D.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stevanovic, Darko M.] Univ Belgrade, Sch Med, Inst Med Physiol, Belgrade, Serbia; [Popovic, Vera] Univ Belgrade, Sch Med, Inst Endocrinol Diabet & Dis Metab, Belgrade, Serbia; [Holstege, Joan; Haasdijk, Elize] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Trajkovic, Vladimir] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia	Erasmus University Rotterdam; Erasmus MC; University of Belgrade; University of Belgrade; Erasmus University Rotterdam; Erasmus MC; University of Belgrade	Stevanovic, DM (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	dstevano@bidmc.harvard.edu; p.delhanty@erasmusmc.nl		Trajkovic, Vladimir/0000-0002-8061-2968	European Society of Endocrinology; Serbian Ministry of Science and Technological Development [III 41025]	European Society of Endocrinology; Serbian Ministry of Science and Technological Development(Ministry of Education, Science & Technological Development, Serbia)	This work was assisted by the ENDO/ESE International Endocrine Scholars Program Fellowship 2011 (DS) supported by the European Society of Endocrinology, and Serbian Ministry of Science and Technological Development proj. no. III 41025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Chen CY, 2005, GASTROENTEROLOGY, V129, P8, DOI 10.1053/j.gastro.2005.04.015; Chen CY, 2005, INT J MOL MED, V16, P695; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; De Jonghe BC, 2011, CELL MOL LIFE SCI, V68, P2569, DOI 10.1007/s00018-011-0707-5; Delhanty PJD, 2013, FASEB J, V27, P1690, DOI 10.1096/fj.12-221143; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Ellacott KLJ, 2006, ENDOCRINOLOGY, V147, P3190, DOI 10.1210/en.2005-0877; Faulconbridge LF, 2008, BRAIN RES, V1218, P151, DOI 10.1016/j.brainres.2008.04.068; Favaro E, 2012, DIABETOLOGIA, V55, P1058, DOI 10.1007/s00125-011-2423-y; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; Fujimiya M, 2008, WORLD J GASTROENTERO, V14, P6318, DOI 10.3748/wjg.14.6318; Granata R, 2012, J MED CHEM, V55, P2585, DOI 10.1021/jm201223m; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Heijboer AC, 2006, J NEUROENDOCRINOL, V18, P883, DOI 10.1111/j.1365-2826.2006.01492.x; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Inhoff T, 2008, PEPTIDES, V29, P2159, DOI 10.1016/j.peptides.2008.09.014; Inhoff T, 2009, PEPTIDES, V30, P991, DOI 10.1016/j.peptides.2009.01.019; Kirchner Henriette, 2012, Handb Exp Pharmacol, P161, DOI 10.1007/978-3-642-24716-3_7; Kobelt P, 2008, BRAIN RES, V1204, P77, DOI 10.1016/j.brainres.2008.01.054; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Li G, 2007, AM J PHYSIOL-ENDOC M, V293, pE252, DOI 10.1152/ajpendo.00451.2006; Matsuda K, 2006, PEPTIDES, V27, P2321, DOI 10.1016/j.peptides.2006.03.028; Muccioli G, 2007, NEUROENDOCRINOLOGY, V86, P147, DOI 10.1159/000105141; Neary NM, 2006, GUT, V55, P135; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pritchard LE, 2007, ENDOCRINOLOGY, V148, P4201, DOI 10.1210/en.2006-1686; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Silva RM, 2001, J PHARMACOL EXP THER, V297, P590; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P1705, DOI 10.1210/en.2008-1316; STARCEVIC VP, 1988, BRAIN RES, V462, P112, DOI 10.1016/0006-8993(88)90592-6; Takayama K, 2007, NEUROSCI LETT, V417, P292, DOI 10.1016/j.neulet.2007.02.089; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang Y, 2010, NEUROSCIENCE, V169, P1662, DOI 10.1016/j.neuroscience.2010.06.001	50	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98180	10.1371/journal.pone.0098180	http://dx.doi.org/10.1371/journal.pone.0098180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852945	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200053
J	Dautova, Y; Kozlova, D; Skepper, JN; Epple, M; Bootman, MD; Proudfoot, D				Dautova, Yana; Kozlova, Diana; Skepper, Jeremy N.; Epple, Matthias; Bootman, Martin D.; Proudfoot, Diane			Fetuin-A and Albumin Alter Cytotoxic Effects of Calcium Phosphate Nanoparticles on Human Vascular Smooth Muscle Cells	PLOS ONE			English	Article							CONTAINING CALCIPROTEIN PARTICLES; CRYSTAL-INDUCED INFLAMMATION; HYDROXYAPATITE NANOPARTICLES; POTENTIAL MECHANISM; CALCIFIED MATRIX; PLASMA-PROTEIN; CALCIFICATION; SERUM; PLAQUE; ATHEROSCLEROSIS	Calcification is a detrimental process in vascular ageing and in diseases such as atherosclerosis and arthritis. In particular, small calcium phosphate (CaP) crystal deposits are associated with inflammation and atherosclerotic plaque de-stabilisation. We previously reported that CaP particles caused human vascular smooth muscle cell (VSMC) death and that serum reduced the toxic effects of the particles. Here, we found that the serum proteins fetuin-A and albumin (>= 1 mu M) reduced intracellular Ca2+ elevations and cell death in VSMCs in response to CaP particles. In addition, CaP particles functionalised with fetuin-A, but not albumin, were less toxic than naked CaP particles. Electron microscopic studies revealed that CaP particles were internalised in different ways; via macropinocytosis, membrane invagination or plasma membrane damage, which occurred within 10 minutes of exposure to particles. However, cell death did not occur until approximately 30 minutes, suggesting that plasma membrane repair and survival mechanisms were activated. In the presence of fetuin-A, CaP particle-induced damage was inhibited and CaP/plasma membrane interactions and particle uptake were delayed. Fetuin-A also reduced dissolution of CaP particles under acidic conditions, which may contribute to its cytoprotective effects after CaP particle exposure to VSMCs. These studies are particularly relevant to the calcification observed in blood vessels in patients with kidney disease, where circulating levels of fetuin-A and albumin are low, and in pathological situations where CaP crystal formation outweighs calcification-inhibitory mechanisms.	[Dautova, Yana; Proudfoot, Diane] Babraham Inst, Signalling ISP, Cambridge, England; [Kozlova, Diana; Epple, Matthias] Univ Duisburg Essen, Essen, Germany; [Kozlova, Diana; Epple, Matthias] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CeNIDE, Essen, Germany; [Skepper, Jeremy N.] Univ Cambridge, Cambridge Adv Imaging Ctr, Cambridge, England; [Bootman, Martin D.] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Duisburg Essen; University of Duisburg Essen; University of Cambridge; Open University - UK	Proudfoot, D (corresponding author), Babraham Inst, Signalling ISP, Cambridge, England.	diane.proudfoot@babraham.ac.uk	Bootman, Martin/AAB-3330-2019; Epple, Matthias/AAX-9694-2020	Bootman, Martin/0000-0002-6447-3451; Epple, Matthias/0000-0002-1641-7068	British Heart Foundation [FS/11/21/28691]; BBSRC [BBS/E/B/0000H330] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a British Heart Foundation Career Re-entry Fellowship (FS/11/21/28691, to Diane Proudfoot). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P126, DOI 10.1101/pdb.prot072827; BURT HM, 1991, SCANNING MICROSCOPY, V5, P273; DENGLER WA, 1995, ANTI-CANCER DRUG, V6, P522, DOI 10.1097/00001813-199508000-00005; Dietzel E, 2013, DEV CELL, V25, P106, DOI 10.1016/j.devcel.2013.03.001; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dweck MR, 2012, J AM COLL CARDIOL, V59, P1539, DOI 10.1016/j.jacc.2011.12.037; Ea HK, 2008, ANN RHEUM DIS, V67, P1617, DOI 10.1136/ard.2008.087718; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; KEELEY FW, 1985, ATHEROSCLEROSIS, V55, P63, DOI 10.1016/0021-9150(85)90166-2; KEELEY FW, 1983, ATHEROSCLEROSIS, V46, P29, DOI 10.1016/0021-9150(83)90161-2; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; MCCARTHY GM, 1991, ARTHRITIS RHEUM-US, V34, P1021, DOI 10.1002/art.1780340812; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Molloy ES, 2006, RHEUM DIS CLIN N AM, V32, P383, DOI 10.1016/j.rdc.2006.02.001; Motskin M, 2011, BIOMATERIALS, V32, P9470, DOI 10.1016/j.biomaterials.2011.08.060; Muller KH, 2014, BIOMATERIALS, V35, P1074, DOI 10.1016/j.biomaterials.2013.10.041; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Neumann S, 2009, BIOMATERIALS, V30, P6794, DOI 10.1016/j.biomaterials.2009.08.043; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Proudfoot D, 2002, CIRCULATION, V106, P3044, DOI 10.1161/01.CIR.0000041429.83465.41; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 2001, HERZ, V26, P245, DOI 10.1007/PL00002027; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Smith ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060904; Smith ER, 2013, NEPHROLOGY, V18, P215, DOI 10.1111/nep.12021; Sokolova V, 2013, ACTA BIOMATER, V9, P7527, DOI 10.1016/j.actbio.2013.02.034; TERKELTAUB R, 1983, ARTHRITIS RHEUM, V26, P775, DOI 10.1002/art.1780260612; TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Virmani Renu, 2003, J Interv Cardiol, V16, P267, DOI 10.1034/j.1600-0854.2003.8042.x; Visser M, 2005, AM J CLIN NUTR, V82, P531; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Wang FJ, 2013, NANOMED-NANOTECHNOL, V9, P1159, DOI 10.1016/j.nano.2013.04.010; WOOLF AD, 1987, BRIT MED BULL, V43, P429, DOI 10.1093/oxfordjournals.bmb.a072192	43	47	50	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97565	10.1371/journal.pone.0097565	http://dx.doi.org/10.1371/journal.pone.0097565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849210	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000336730600036
J	Li, RK; Tan, JL; Chen, LT; Feng, JS; Liang, WX; Guo, XJ; Liu, P; Chen, Z; Sha, JH; Wang, YF; Chen, SJ				Li, Ren-Ke; Tan, Jue-Ling; Chen, Li-Ting; Feng, Jing-Sheng; Liang, Wen-Xue; Guo, Xue-Jiang; Liu, Ping; Chen, Zhu; Sha, Jia-Hao; Wang, Yi-Fei; Chen, Sai-Juan			Iqcg Is Essential for Sperm Flagellum Formation in Mice	PLOS ONE			English	Article							SEMINIFEROUS EPITHELIUM; ACROSOME FORMATION; MALE-INFERTILITY; MOUSE MODELS; CALMODULIN; SPERMATOGENESIS; GENE; MANCHETTE; DEFICIENT; DEFECTS	Mammalian spermatogenesis comprises three successive phases: mitosis phase, meiosis phase, and spermiogenesis. During spermiogenesis, round spermatid undergoes dramatic morphogenesis to give rise to mature spermatozoon, including the condensation and elongation of nucleus, development of acrosome, formation of flagellum, and removal of excessive cytoplasm. Although these transformations are well defined at the morphological level, the mechanisms underlying these intricate processes are largely unknown. Here, we report that Iqcg, which was previously characterized to be involved in a chromosome translocation of human leukemia, is highly expressed in the spermatogenesis of mice and localized to the manchette in developing spermatids. Iqcg knockout causes male infertility, due to severe defects of spermiogenesis and resultant total immobility of spermatozoa. The axoneme in the Iqcg knockout sperm flagellum is disorganized and hardly any typical ("9+2") pattern of microtubule arrangement could be found in Iqcg knockout spermatids. Iqcg interacts with calmodulin in a calcium dependent manner in the testis, suggesting that Iqcg may play a role through calcium signaling. Furthermore, cilia structures in the trachea and oviduct, as well as histological appearances of other major tissues, remain unchanged in the Iqcg knockout mice, suggesting that Iqcg is specifically required for spermiogenesis in mammals. These results might also provide new insights into the genetic causes of human infertility.	[Li, Ren-Ke; Tan, Jue-Ling; Chen, Li-Ting; Liu, Ping; Chen, Zhu; Chen, Sai-Juan] Chinese Acad Sci, Inst Hlth Sci, State Key Lab Med Genom, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Ren-Ke; Tan, Jue-Ling; Chen, Li-Ting; Liu, Ping; Chen, Zhu; Chen, Sai-Juan] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Li, Ren-Ke; Tan, Jue-Ling; Chen, Li-Ting; Liu, Ping; Chen, Zhu; Chen, Sai-Juan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Feng, Jing-Sheng; Wang, Yi-Fei] Shanghai Jiao Tong Univ, Sch Med, Dept Histol & Embryol, Shanghai 200030, Peoples R China; [Guo, Xue-Jiang; Sha, Jia-Hao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu Provinc, Peoples R China; [Liang, Wen-Xue] Lianyungang First Peoples Hosp, Cent Lab, Lianyungang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University	Sha, JH (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu Provinc, Peoples R China.	shajh@njmu.edu.cn; wangyf@shsmu.edu.cn; sjchen@stn.sh.cn	Guo, Xuejiang/J-9600-2014	Guo, Xuejiang/0000-0002-0475-5705	Chinese National Key Basic Research Project [973: 2013CB966800]; MOH [201202003]; Mega-projects of Scientific Research for the 12th Five-Year Plan [2013ZX09303302]; State Key Laboratories Project of Excellence [81123005]	Chinese National Key Basic Research Project(National Basic Research Program of China); MOH; Mega-projects of Scientific Research for the 12th Five-Year Plan; State Key Laboratories Project of Excellence	This work was supported by the Chinese National Key Basic Research Project (973: 2013CB966800, http://www.973.gov.cn/English/Index.aspx), the Special Grant of MOH (201202003), the Mega-projects of Scientific Research for the 12th Five-Year Plan (2013ZX09303302), the State Key Laboratories Project of Excellence (81123005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSTEIN RS, 1982, CELL, V30, P349, DOI 10.1016/0092-8674(82)90232-X; Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Baccetti B, 2001, HUM REPROD, V16, P1365, DOI 10.1093/humrep/16.7.1365; BACCETTI B, 1993, ANDROLOGIA, V25, P331; Berrios J, 1998, BIOL CELL, V90, P391, DOI 10.1016/S0248-4900(98)80088-9; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Cho C, 2003, BIOL REPROD, V69, P211, DOI 10.1095/biolreprod.102.015115; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hammer John A 3rd, 2011, Nat Rev Mol Cell Biol, V13, P13, DOI 10.1038/nrm3248; Harris TP, 2013, IQ MOTIF CONTAINING; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; JONES HP, 1980, P NATL ACAD SCI-BIOL, V77, P2772, DOI 10.1073/pnas.77.5.2772; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; KANN ML, 1991, ANAT REC, V230, P481, DOI 10.1002/ar.1092300407; KEITH CH, 1986, ANN NY ACAD SCI, V466, P375, DOI 10.1111/j.1749-6632.1986.tb38407.x; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2011, DEV DYNAM, V240, P723, DOI 10.1002/dvdy.22563; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kierszenbaum AL, 2001, MOL REPROD DEV, V59, P347, DOI 10.1002/mrd.1040; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Lorenzetti D, 2004, P NATL ACAD SCI USA, V101, P8402, DOI 10.1073/pnas.0401832101; MEANS AR, 1982, ANN NY ACAD SCI, V383, P69, DOI 10.1111/j.1749-6632.1982.tb23162.x; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Pan Q, 2008, ONCOGENE, V27, P3414, DOI 10.1038/sj.onc.1210999; SANO M, 1987, J EXP ZOOL, V241, P51, DOI 10.1002/jez.1402410107; SLAUGHTER GR, 1987, BIOL REPROD, V37, P1259, DOI 10.1095/biolreprod37.5.1259; SLAUGHTER GR, 1989, BIOL REPROD, V40, P395, DOI 10.1095/biolreprod40.2.395; Sperry AO, 2012, BIOL CELL, V104, P297, DOI 10.1111/boc.201100102; Tanaka H, 2004, MOL CELL BIOL, V24, P7958, DOI 10.1128/MCB.24.18.7958-7964.2004; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; WEINMAN S, 1986, J HISTOCHEM CYTOCHEM, V34, P1181, DOI 10.1177/34.9.3734420; WOLOSEWICK JJ, 1977, AM J ANAT, V150, P301, DOI 10.1002/aja.1001500206; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhang ZB, 2009, P NATL ACAD SCI USA, V106, P17055, DOI 10.1073/pnas.0906414106; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019; Zhou J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002516; Zhou J, 2009, DEVELOPMENT, V136, P373, DOI 10.1242/dev.030858	55	26	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98053	10.1371/journal.pone.0098053	http://dx.doi.org/10.1371/journal.pone.0098053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849454	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600080
J	Li, W; Li, YJ; Li, WZ; Yang, JP; Song, MX; Diao, RN; Jia, HL; Lu, YX; Zheng, J; Zhang, XC; Xiao, LH				Li, Wei; Li, Yijing; Li, Weizhi; Yang, Jinping; Song, Mingxin; Diao, Ruinan; Jia, Honglin; Lu, Yixin; Zheng, Jun; Zhang, Xichen; Xiao, Lihua			Genotypes of Enterocytozoon bieneusi in Livestock in China: High Prevalence and Zoonotic Potential	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; MICROSPORIDIOSIS; IDENTIFICATION; EPIDEMIOLOGY; ANIMALS; SAMPLES; LIMA	Despite many recent advances in genotype characterization of Enterocytozoon bieneusi worldwide and the exploration of the extent of cross-species transmission of microsporidiosis between humans and animals, the epidemiology of this neglected disease in China is poorly understood. In this study, a very high prevalence (60.3%; 94/156) of E. bieneusi infections in farmed pigs in Jilin province was detected by PCR of the ribosomal internal transcribed spacer (ITS). DNA sequence analysis of 88 E. bieneusi-positive specimens identified 12 distinct genotypes (11 known: CHN7, CS-1, CS-4, CS-6, EbpA, EbpB, EbpC, EbpD, EBITS3, G, and Henan-I; one novel: CS-9). Frequent appearance of mixed genotype infections was seen in the study animals. Weaned (74.6%; 53/71) or pre-weaned (68.8%; 22/32) pigs have infection rates significantly higher than growing pigs (35.8%; 19/53) (p<0.01). Likewise, E. bieneusi was detected in 2 of 45 sheep fecal specimens (4.4%) in Heilongjiang province, belonging to the known genotype BEB6. Genotypes EbpA, EbpC, EbpD, and Henan-I examined herein have been documented in the cases of human infections and BEB6, EbpA, EbpC, and EbpD in wastewater in central China. Infections of EbpA and EbpC in humans were also reported in other areas of the world. The other known genotypes (CHN7, CS-1, CS-4, CS-6, EBITS3, EbpB, and G) and the new genotype CS-9 were genetically clustered into a group of existing E. bieneusi genotypes with zoonotic potential. Thus, pigs could be a potential source of human E. bieneusi infections in China.	[Li, Wei; Jia, Honglin; Zheng, Jun] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China; [Li, Wei; Li, Yijing; Yang, Jinping; Song, Mingxin; Diao, Ruinan; Lu, Yixin] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Li, Weizhi; Zhang, Xichen] Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Jilin, Peoples R China; [Xiao, Lihua] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Agricultural University - China; Jilin University; Centers for Disease Control & Prevention - USA	Zhang, XC (corresponding author), Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Jilin, Peoples R China.	xczhang@jlu.edu.cn; lax0@cdc.gov	Xiao, Lihua/B-1704-2013; Li, Wei/H-7214-2013	Xiao, Lihua/0000-0001-8532-2727; Li, Wei/0000-0002-4264-1864	State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute [SKLVBF201307]; National Natural Science Foundation of China [31302081]; Natural Science Foundation of Heilongjiang Province [QC2013C015]; 54th Postdoctoral Scientific Foundation of China [2013M540266]; Heilongjiang Postdoctoral Research Fund [LBH-Z13024]	State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); 54th Postdoctoral Scientific Foundation of China; Heilongjiang Postdoctoral Research Fund	This study was supported by the State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute (SKLVBF201307), the National Natural Science Foundation of China (No. 31302081), the Natural Science Foundation of Heilongjiang Province (No. QC2013C015), the 54th Postdoctoral Scientific Foundation of China (No. 2013M540266), and the Heilongjiang Postdoctoral Research Fund (No. LBH-Z13024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbo FO, 2012, AM J TROP MED HYG, V86, P441, DOI 10.4269/ajtmh.2012.11-0548; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Bern C, 2005, J INFECT DIS, V191, P1658, DOI 10.1086/429674; Breitenmoser AC, 1999, PARASITOLOGY, V118, P447, DOI 10.1017/S0031182099004229; Cama VA, 2007, J CLIN MICROBIOL, V45, P2708, DOI 10.1128/JCM.00725-07; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; Fayer R, 2007, PARASITOL RES, V102, P15, DOI 10.1007/s00436-007-0746-x; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; Leelayoova S, 2006, J CLIN MICROBIOL, V44, P3001, DOI 10.1128/JCM.00945-06; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2013, INFECT GENET EVOL, V14, P111, DOI 10.1016/j.meegid.2012.11.021; Li W, 2012, INT J PARASITOL, V42, P287, DOI 10.1016/j.ijpara.2012.01.003; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Lores B, 2002, MEM I OSWALDO CRUZ, V97, P941, DOI 10.1590/S0074-02762002000700003; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Nemejc K, 2014, PARASITOL RES, V113, P761, DOI 10.1007/s00436-013-3707-6; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, VET PARASITOL, V178, P246, DOI 10.1016/j.vetpar.2010.12.044; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2008, VET PARASITOL, V153, P220, DOI 10.1016/j.vetpar.2008.01.043; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Sulaiman IM, 2003, J EUKARYOT MICROBIOL, V50, P591, DOI 10.1111/j.1550-7408.2003.tb00642.x; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Wagnerova P, 2012, VET PARASITOL, V190, P573, DOI 10.1016/j.vetpar.2012.07.013; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11	31	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97623	10.1371/journal.pone.0097623	http://dx.doi.org/10.1371/journal.pone.0097623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845247	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400040
J	Reddy, PBJ; Sehrawat, S; Suryawanshi, A; Rajasagi, NK; Khatri, M; Rouse, BT				Reddy, Pradeep B. J.; Sehrawat, Sharvan; Suryawanshi, Amol; Rajasagi, Naveen K.; Khatri, Madhu; Rouse, Barry T.			An Approach to Control Relapse of Inflammatory Lesions after Discontinuation of Primary Therapy	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; SPHINGOSINE 1-PHOSPHATE; IMMUNOPATHOLOGY; FINGOLIMOD; FTY720; T(H)17; DIFFERENTIATION; STABILIZATION	Long-term treatment with the fungal metabolite drug FTY720 (Fingolimod) was shown to be highly effective in controlling viral immunopathological lesions. However, in this report we show that the anti-inflammatory effect of FTY720 in herpes simplex virus-1 (HSV-1) induced ocular inflammation is lost upon the discontinuation of treatment and lesions rapidly recurred. The lesions that developed after FTY720 treatment withdrawal involved mainly Th17 cells rather than Th1 cells explained in part by differential expression of surface CD103, an integrin that permits migration of effector cells to inflammatory sites. The expression of IL-6, a proinflammatory cytokine involved in the generation of Th17 cells, was found to be increased in FTY treated mice as compared to controls and this effect could be abrogated upon administration of neutralizing antibody to IL-6. Furthermore, IL-17RKO mice failed to show the recurrence of stromal keratitis (SK) lesions upon FTY720 withdrawal. These results indicate that approaches such as neutralization of proinflammatory cytokines might be considered along with FTY720 treatment if interruption of drug therapy becomes necessary.	[Reddy, Pradeep B. J.; Sehrawat, Sharvan; Suryawanshi, Amol; Rajasagi, Naveen K.; Khatri, Madhu; Rouse, Barry T.] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Rouse, BT (corresponding author), Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37901 USA.	btr@utk.edu	Suryawanshi, Amol/J-3787-2019	Suryawanshi, Amol/0000-0001-5031-5818	National Institute of Allergy and Infectious Diseases [AI 063365]; National Eye Institute [EY 005093]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063365] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases Grant AI 063365 and National Eye Institute Grant EY 005093 to BTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Garris CS, 2013, NAT IMMUNOL, V14, P1166, DOI 10.1038/ni.2730; Halford WP, 1996, J IMMUNOL, V157, P3542; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayashi K, 2006, J GEN VIROL, V87, P2161, DOI 10.1099/vir.0.81772-0; HENDRICKS RL, 1992, J IMMUNOL, V149, P3023; Ingwersen J, 2012, CLIN IMMUNOL, V142, P15, DOI [10.1016/j.clim.2011.05.005, 10.1016/j.clim.2011.10.008]; Kanangat S, 1996, VIROLOGY, V219, P295, DOI 10.1006/viro.1996.0250; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; NIEMIALTOWSKI MG, 1992, J IMMUNOL, V149, P3035; NIEMIALTOWSKI MG, 1992, J IMMUNOL, V148, P1864; Penaranda C, 2010, DIABETES, V59, P1461, DOI 10.2337/db09-1129; Rajasagi NK, 2011, J IMMUNOL, V186, P1735, DOI 10.4049/jimmunol.1003456; Reddy PBJ, 2012, J VIROL, V86, P10606, DOI 10.1128/JVI.01391-12; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Rowe AM, 2013, PROG RETIN EYE RES, V32, P88, DOI 10.1016/j.preteyeres.2012.08.002; Sehrawat S, 2008, J VIROL, V82, P6838, DOI 10.1128/JVI.00697-08; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Veiga-Parga T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002427; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yoshida Y, 2011, BIOL PHARM BULL, V34, P933, DOI 10.1248/bpb.34.933; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98051	10.1371/journal.pone.0098051	http://dx.doi.org/10.1371/journal.pone.0098051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846129	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400085
J	Yamashita, Y; Ueyama, T; Nishi, T; Yamamoto, Y; Kawakoshi, A; Sunami, S; Iguchi, M; Tamai, H; Ueda, K; Ito, T; Tsuruo, Y; Ichinose, M				Yamashita, Yasunobu; Ueyama, Takashi; Nishi, Toshio; Yamamoto, Yuta; Kawakoshi, Akatsuki; Sunami, Shogo; Iguchi, Mikitaka; Tamai, Hideyuki; Ueda, Kazuki; Ito, Takao; Tsuruo, Yoshihiro; Ichinose, Masao			Nrf2-Inducing Anti-Oxidation Stress Response in the Rat Liver - New Beneficial Effect of Lansoprazole	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; DRUG-METABOLIZING-ENZYMES; CANCER CHEMOPREVENTION; OXIDATIVE STRESS; SIGNALING SYSTEM; HEME OXYGENASE-1; GENE-EXPRESSION; PHASE-I; PATHWAY; INDUCTION	Lansoprazole is a potent anti-gastric ulcer drug that inhibits gastric proton pump activity. We identified a novel function for lansoprazole, as an inducer of anti-oxidative stress responses in the liver. Gastric administration of lansoprazole (10-100 mg/kg) to male Wistar rats produced a dose-dependent increase in hepatic mRNA levels of nuclear factor, erythroid-derived 2, - like 2 (Nrf2), a redox-sensitive transcription factor, at 3 h and Nrf2 immunoreactivity (IR) in whole hepatic lysates at 6 h. Conversely, the levels of Kelch-like ECH-associated protein (Keap1), which sequesters Nrf2 in the cytoplasm under un-stimulated conditions, were unchanged. Translocation of Nrf2 into the nuclei of hepatocytes was observed using western blotting and immunohistochemistry. Expression of mRNAs for Nrf2-dependent antioxidant and phase II enzymes, such as heme oxygenase 1 (HO-1), NAD (P) H dehydrogenase, quinone 1 (Nqo1), glutathione S-transferase A2 (Gsta2), UDP glucuronosyltransferase 1 family polypeptide A6 (Ugt1a6), were dose-dependently up-regulated at 3 h. Furthermore, the levels of HO-1 IR were dose-dependently increased in hepatocytes at 6 h. Subcutaneous administration of lansoprazole (30 mg/kg/day) for 7 successive days resulted in up-regulation and nuclear translocation of Nrf2 IR in hepatocytes and up-regulation of HO-1 IR in the liver. Pretreatment with lansoprazole attenuated thioacetamide (500 mg/kg)-induced acute hepatic damage via both HO-1-dependent and -independent pathways. Up-stream networks related to Nrf2 expression were investigated using microarray analysis, followed by data mining with Ingenuity Pathway Analysis. Up-regulation of the aryl hydrocarbon receptor (AhR)-cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1) pathway was associated with up-regulation of Nrf2 mRNA. In conclusion, lansoprazole might have an alternative indication in the prevention and treatment of oxidative hepatic damage through the induction of both phase I and phase II drug-metabolizing systems, i.e. the AhR/Cyp1a1/Nrf2 pathway in hepatocytes.	[Yamashita, Yasunobu; Iguchi, Mikitaka; Tamai, Hideyuki; Ueda, Kazuki; Ichinose, Masao] Wakayama Med Univ, Grad Sch Med, Dept Internal Med 2, Wakayama, Japan; [Ueyama, Takashi; Nishi, Toshio; Yamamoto, Yuta; Kawakoshi, Akatsuki; Sunami, Shogo; Ito, Takao; Tsuruo, Yoshihiro] Wakayama Med Univ, Grad Sch Med, Dept Anat & Cell Biol, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Ueyama, T (corresponding author), Wakayama Med Univ, Grad Sch Med, Dept Anat & Cell Biol, Wakayama, Japan.	tueyama@wakayama-med.ac.jp	Ichinose, Masao/HAB-1645-2022; Yamamoto, Yuta/R-1143-2019	Yamamoto, Yuta/0000-0001-5225-6989	Japan Society for the Promotion of Science (JSPS KAKENHI) [23592229]; Grants-in-Aid for Scientific Research [24590895, 26462316] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	1) The paper was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 23592229) 2) The paper was also supported by annual research expenses provided by Wakayama Medical University 3) Lansoprazole used in this study was supplied by Takeda Pharmaceutical Co. Ltd. No other supports was received from Takeda Pharmaceutical Co. Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JC, 2006, BIOCHEM BIOPH RES CO, V345, P1014, DOI 10.1016/j.bbrc.2006.04.170; Bown RL, 2002, INT J CLIN PRACT, V56, P132; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; CURIPEDROSA R, 1994, J PHARMACOL EXP THER, V269, P384; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Inatomi N, 1997, JPN PHARMACOL THER, V25, P2445; Kawai H, 2009, J TOXICOL SCI, V34, P27, DOI 10.2131/jts.34.27; Keum YS, 2011, ANN NY ACAD SCI, V1229, P184, DOI 10.1111/j.1749-6632.2011.06092.x; Masubuchi N, 1997, DRUG METAB DISPOS, V25, P584; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Murakami I, 1996, JPN J PHARMACOL, V72, P137, DOI 10.1254/jjp.72.137; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Pearce RE, 1996, J PHARMACOL EXP THER, V277, P805; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009; Satoh H, 2013, CURR PHARM DESIGN, V19, P67; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Stedman CAM, 2000, ALIMENT PHARM THERAP, V14, P963, DOI 10.1046/j.1365-2036.2000.00788.x; Takagi T, 2009, J PHARMACOL EXP THER, V331, P255, DOI 10.1124/jpet.109.152702; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Ueda K, 2008, AM J PHYSIOL-GASTR L, V295, pG460, DOI 10.1152/ajpgi.00204.2007; Ueda K, 2009, J PHARMACOL SCI, V110, P285, DOI 10.1254/jphs.09056FP; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065685; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; Yamamoto Y, 2009, PHYSIOL GENOMICS, V39, P227, DOI 10.1152/physiolgenomics.00082.2009; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Yoda Y, 2010, J PHYSIOL PHARMACOL, V61, P287; Yoshinari K, 2008, BIOCHEM PHARMACOL, V76, P139, DOI 10.1016/j.bcp.2008.04.005; Zenkov NK, 2013, BIOCHEMISTRY-MOSCOW+, V78, P19, DOI 10.1134/S0006297913010033	34	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97419	10.1371/journal.pone.0097419	http://dx.doi.org/10.1371/journal.pone.0097419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846271	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400028
J	Fabrick, JA; Ponnuraj, J; Singh, A; Tanwar, RK; Unnithan, GC; Yelich, AJ; Li, XC; Carriere, Y; Tabashnik, BE				Fabrick, Jeffrey A.; Ponnuraj, Jeyakumar; Singh, Amar; Tanwar, Raj K.; Unnithan, Gopalan C.; Yelich, Alex J.; Li, Xianchun; Carriere, Yves; Tabashnik, Bruce E.			Alternative Splicing and Highly Variable Cadherin Transcripts Associated with Field-Evolved Resistance of Pink Bollworm to Bt Cotton in India	PLOS ONE			English	Article							ARMIGERA LEPIDOPTERA-NOCTUIDAE; THURINGIENSIS TOXIN CRY1AC; EUROPEAN CORN-BORER; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; TRANSGENIC COTTON; PECTINOPHORA-GOSSYPIELLA; CROSS-RESISTANCE; CONFERRING RESISTANCE; OSTRINIA-NUBILALIS	Evolution of resistance by insect pests can reduce the benefits of insecticidal proteins from Bacillus thuringiensis (Bt) that are used extensively in sprays and transgenic crops. Despite considerable knowledge of the genes conferring insect resistance to Bt toxins in laboratory-selected strains and in field populations exposed to Bt sprays, understanding of the genetic basis of field-evolved resistance to Bt crops remains limited. In particular, previous work has not identified the genes conferring resistance in any cases where field-evolved resistance has reduced the efficacy of a Bt crop. Here we report that mutations in a gene encoding a cadherin protein that binds Bt toxin Cry1Ac are associated with field-evolved resistance of pink bollworm (Pectinophora gossypiella) in India to Cry1Ac produced by transgenic cotton. We conducted laboratory bioassays that confirmed previously reported resistance to Cry1Ac in pink bollworm from the state of Gujarat, where Bt cotton producing Cry1Ac has been grown extensively. Analysis of DNA from 436 pink bollworm from seven populations in India detected none of the four cadherin resistance alleles previously reported to be linked with resistance to Cry1Ac in laboratory-selected strains of pink bollworm from Arizona. However, DNA sequencing of pink bollworm derived from resistant and susceptible field populations in India revealed eight novel, severely disrupted cadherin alleles associated with resistance to Cry1Ac. For these eight alleles, analysis of complementary DNA (cDNA) revealed a total of 19 transcript isoforms, each containing a premature stop codon, a deletion of at least 99 base pairs, or both. Seven of the eight disrupted alleles each produced two or more different transcript isoforms, which implicates alternative splicing of messenger RNA (mRNA). This represents the first example of alternative splicing associated with field-evolved resistance that reduced the efficacy of a Bt crop.	[Fabrick, Jeffrey A.] ARS, USDA, US Arid Land Agr Res Ctr, Maricopa, AZ 85238 USA; [Ponnuraj, Jeyakumar] Natl Inst Plant Hlth Management, Hyderabad, Andhra Pradesh, India; [Singh, Amar; Tanwar, Raj K.] Indian Agr Res Inst, Natl Ctr Integrated Pest Management, Delhi, India; [Unnithan, Gopalan C.; Yelich, Alex J.; Li, Xianchun; Carriere, Yves; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	United States Department of Agriculture (USDA); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Research Centre for Integrated Pest Management; University of Arizona	Fabrick, JA (corresponding author), ARS, USDA, US Arid Land Agr Res Ctr, Maricopa, AZ 85238 USA.	jeff.fabrick@ars.usda.gov		Fabrick, Jeffrey/0000-0002-3893-9545	U.S. Department of Agriculture [5347-22620-021-00D]; U.S. Department of Agriculture Agriculture and Food Research Initiative [2008-35302-0390]; Biotechnology Risk Assessment Research Grants Program [2011-33522-30729]; Department of Science and Technology (India) Better Opportunities for Young Scientists in Chosen Areas of Science and Technology (BOYSCAST) fellowship	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. Department of Agriculture Agriculture and Food Research Initiative; Biotechnology Risk Assessment Research Grants Program; Department of Science and Technology (India) Better Opportunities for Young Scientists in Chosen Areas of Science and Technology (BOYSCAST) fellowship(Department of Science & Technology (India))	This work was funded by U.S. Department of Agriculture base funding (Project Number 5347-22620-021-00D) to J.A.F., research grants from the U.S. Department of Agriculture Agriculture and Food Research Initiative (2008-35302-0390) and Biotechnology Risk Assessment Research Grants Program (2011-33522-30729) to B. E. T., and the Department of Science and Technology (India) Better Opportunities for Young Scientists in Chosen Areas of Science and Technology (BOYSCAST) fellowship to J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Bel Y, 2009, INSECT BIOCHEM MOLEC, V39, P218, DOI 10.1016/j.ibmb.2008.11.005; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2001, J ECON ENTOMOL, V94, P1571, DOI 10.1603/0022-0493-94.6.1571; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Carriere Y, 2001, J ECON ENTOMOL, V94, P935, DOI 10.1603/0022-0493-94.4.935; Carriere Y, 2006, J ECON ENTOMOL, V99, P1925, DOI 10.1603/0022-0493-99.6.1925; Choudhary B., 2013, BT COTTON INDIA COUN; Coates BS, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2101; Coates BS, 2013, INSECT BIOCHEM MOLEC, V43, P1152, DOI 10.1016/j.ibmb.2013.09.003; Coates BS, 2005, INSECT BIOCHEM MOLEC, V35, P129, DOI 10.1016/j.ibmb.2004.10.008; Desh Gujarat, 2013, STAT WIS FIG COTT PR; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Fabrick JA, 2011, INSECT MOL BIOL, V20, P651, DOI 10.1111/j.1365-2583.2011.01095.x; Fabrick JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035658; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; FFRENCHCONSTANT RH, 1993, J NEUROCHEM, V60, P2323, DOI 10.1111/j.1471-4159.1993.tb03523.x; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Hemingway J, 1998, PHILOS T ROY SOC B, V353, P1695, DOI 10.1098/rstb.1998.0320; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Hernandez-Martinez P, 2012, APPL ENVIRON MICROB, V78, P6759, DOI 10.1128/AEM.01689-12; Herring RJ, 2007, J DEV STUD, V43, P130, DOI 10.1080/00220380601055601; Higginson DM, 2005, EVOLUTION, V59, P915, DOI 10.1111/j.0014-3820.2005.tb01765.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jin L, 2013, EVOL APPL, V6, P1222, DOI 10.1111/eva.12099; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Lalitha N, 2009, ROUTL EXPLOR ENVIRON, V19, P135; Liu YB, 2001, J ECON ENTOMOL, V94, P248, DOI 10.1603/0022-0493-94.1.248; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Mahon RJ, 2010, J ECON ENTOMOL, V103, P472, DOI 10.1603/EC09225; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Monsanto, 2010, COTT IND; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nair R, 2013, CURR SCI INDIA, V104, P215; National Research Council, 2010, IMP GEN ENG CROPS FA; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Rinkevich FD, 2010, INVERTEBR NEUROSCI, V10, P25, DOI 10.1007/s10158-010-0102-1; Roy SW, 2009, TRENDS ECOL EVOL, V24, P447, DOI 10.1016/j.tree.2009.04.005; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stone GD, 2014, HUM ORGAN, V63, P127; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik B., 2012, GM CROPS FOOD, V3, P1; Tabashnik BE, 2000, APPL ENVIRON MICROB, V66, P4582, DOI 10.1128/AEM.66.10.4582-4584.2000; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 2004, J ECON ENTOMOL, V97, P721, DOI 10.1603/0022-0493(2004)097[0721:SGBORT]2.0.CO;2; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P2125, DOI 10.1603/0022-0493-99.6.2125; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhang HN, 2013, PESTIC BIOCHEM PHYS, V107, P148, DOI 10.1016/j.pestbp.2013.06.007; Zhang HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053418; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029084, 10.1371/journal.pone.0031868]; Zhang X, 2013, INSECT BIOCHEM MOLEC, V43, P712, DOI 10.1016/j.ibmb.2013.05.007; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	84	109	116	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97900	10.1371/journal.pone.0097900	http://dx.doi.org/10.1371/journal.pone.0097900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840729	gold, Green Published			2022-12-27	WOS:000340948600089
J	Zhao, C; Ji, NJ; Zhang, BL; Sun, P; Feng, WP; Wei, J; Chang, YQ				Zhao, Chong; Ji, Nanjing; Zhang, Binglong; Sun, Ping; Feng, Wenping; Wei, Jing; Chang, Yaqing			Effects of Covering Behavior and Exposure to a Predatory Crab Charybdis japonica on Survival and HSP70 Expression of Juvenile Sea Urchins Strongylocentrotus intermedius	PLOS ONE			English	Article							PARACENTROTUS-LIVIDUS; CARASSIUS-AURATUS; STRESS-PROTEINS; SWIMMING CRAB; RADIATION; GENE; RECRUITMENT; SETTLEMENT; MORTALITY; ABUNDANCE	Predation is a complex process among predator, prey and environment. Juvenile sea urchins are more susceptible to predators than adults, which affects community structure. Behavior is involved in anti-predator responses by changes in the expression of anti-predator responsive genes. Here, we investigated the effects of exposure to a predatory crab Charybdis japonica and covering behavior on survival and HSP70 expression of juvenile sea urchins Strongylocentrotus intermedius. C. japonica consumed large numbers of juvenile S. intermedius in 12 hours with a mortality of 34.17 +/- 11.43%. Covering behavior did not significantly reduce predation. Exposure to C. japonica did not significantly upregulate HSP70 expression of juvenile S. intermedius in 12 hours. Covering behavior showed no significant regulative effect on the gene expression of HSP70 of juvenile S. intermedius exposed to C. japonica for 12 hours. The results indicate that the anti-predator function of covering behavior is limited and that HSP70 expression does not appear to play an important role in the anti-predator process of S. intermedius.	[Zhao, Chong; Ji, Nanjing; Zhang, Binglong; Sun, Ping; Feng, Wenping; Wei, Jing; Chang, Yaqing] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China; [Zhao, Chong] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Ocean University of China	Chang, YQ (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China.	changlab@hotmail.com			Chinese National 863 Project [2012AA10A412]	Chinese National 863 Project(National High Technology Research and Development Program of China)	This work was supported by the Chinese National 863 Project (2012AA10A412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NL, 2001, MAR ECOL PROG SER, V213, P87, DOI 10.3354/meps213087; Agatsuma Y, 2001, FISHERIES SCI, V67, P1181, DOI 10.1046/j.1444-2906.2001.00379.x; Agatsuma Y, 2013, DEV AQUAC FISH SCI, V38, P437, DOI 10.1016/B978-0-12-396491-5.00028-9; Amsler CD, 1999, MAR ECOL PROG SER, V183, P105, DOI 10.3354/meps183105; Bacher S, 2005, FUNCT ECOL, V19, P263, DOI 10.1111/j.1365-2435.2005.00954.x; Bonaventura R, 2006, MAR BIOL, V149, P79, DOI 10.1007/s00227-005-0213-0; Briffa M, 2000, ANIM BEHAV, V59, P159, DOI 10.1006/anbe.1999.1273; Chang Y. Q., 2004, BIOL RES BREEDING SE, P217; Clemente S, 2013, MAR BIOL, V160, P579, DOI 10.1007/s00227-012-2114-3; Crook AC, 2003, MAR ECOL-P S Z N I, V24, P275, DOI 10.1046/j.1439-0485.2003.00846.x; DOUGLAS CA, 1976, PAC SCI, V30, P83; Duffy JE, 2001, MARINE COMMUNITY ECOLOGY, P131; Dumont CP, 2007, ANIM BEHAV, V73, P979, DOI 10.1016/j.anbehav.2006.11.008; Frost AJ, 2013, ANIM BEHAV, V85, P1199, DOI 10.1016/j.anbehav.2013.03.006; Guidetti P, 2005, MAR ENVIRON RES, V59, P333, DOI 10.1016/j.marenvres.2004.05.008; Hereu B, 2005, MAR BIOL, V146, P293, DOI 10.1007/s00227-004-1439-y; Jennings LB, 2010, MAR BIOL, V157, P307, DOI 10.1007/s00227-009-1318-7; Jiang WM, 1998, MAR FISH RES, V19, P54; Kagawa N, 2002, ZOOL SCI, V19, P735, DOI 10.2108/zsj.19.735; Kagawa N, 1999, FISH PHYSIOL BIOCHEM, V21, P103, DOI 10.1023/A:1007785707501; Kawai T, 1996, FISHERIES SCI, V62, P317, DOI 10.2331/fishsci.62.317; LAWRENCE JM, 1976, NATURE, V262, P490, DOI 10.1038/262490a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez S, 1998, MAR ECOL PROG SER, V172, P239, DOI 10.3354/meps172239; Matranga V, 2002, CELL MOL BIOL, V48, P345; Mesa MG, 2002, NORTHWEST SCI, V76, P118; MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Osovitz CJ, 2005, J EXP MAR BIOL ECOL, V327, P134, DOI 10.1016/j.jembe.2005.06.011; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; Pawson DL, 2013, DEEP-SEA RES PT II, V92, P207, DOI 10.1016/j.dsr2.2013.01.023; Pearse JS, 2006, SCIENCE, V314, P940, DOI 10.1126/science.1131888; Richner H, 2000, MAR ECOL PROG SER, V205, P307, DOI 10.3354/meps205307; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; Scheibling RE, 2008, J EXP MAR BIOL ECOL, V365, P59, DOI 10.1016/j.jembe.2008.07.041; Shang Y C., 2005, ETHOLOGY, P168; Sigg JE, 2007, J MAR BIOL ASSOC UK, V87, P1257, DOI 10.1017/S0025315407055865; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Slos S, 2009, ECOL ENTOMOL, V34, P297, DOI 10.1111/j.1365-2311.2008.01077.x; Smith PJ, 2003, NEW ZEAL J MAR FRESH, V37, P753, DOI 10.1080/00288330.2003.9517205; Sorensen JG, 2011, CAN J ZOOL, V89, P1249, DOI 10.1139/Z11-105; Sudo H, 2008, FISH RES, V89, P49, DOI 10.1016/j.fishres.2007.08.012; Verling E, 2002, MAR BIOL, V140, P391, DOI 10.1007/s002270100689; Williams JL, 2006, BEHAV ECOL, V17, P586, DOI 10.1093/beheco/ark003; Yu Zong-he, 2010, Marine Sciences (Beijing), V34, P62; Zhao C, 2013, MAR FRESHW BEHAV PHY, V46, P337, DOI 10.1080/10236244.2013.834119; Zhou Zun-Chun, 2008, Yichuan, V30, P1453, DOI 10.3724/SP.J.1005.2008.01453	47	9	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97840	10.1371/journal.pone.0097840	http://dx.doi.org/10.1371/journal.pone.0097840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837036	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800075
J	Plaza-Diaz, J; Gomez-Llorente, C; Abadia-Molina, F; Saez-Lara, MJ; Campana-Martin, L; Munoz-Quezada, S; Romero, F; Gil, A; Fontana, L				Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Abadia-Molina, Francisco; Jose Saez-Lara, Maria; Campana-Martin, Laura; Munoz-Quezada, Sergio; Romero, Fernando; Gil, Angel; Fontana, Luis			Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on Hepatic Steatosis in Zucker Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HIGH-CHOLESTEROL DIET; INSULIN-RESISTANCE; METABOLIC SYNDROME; GUT MICROBIOTA; INTESTINAL MICROBIOTA; PROBIOTIC STRAINS; LIPID-METABOLISM; OBESITY; CELLS	We have previously described the safety and immunomodulatory effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 in healthy volunteers. The scope of this work was to evaluate the effects of these probiotic strains on the hepatic steatosis of obese rats. We used the Zucker rat as a genetic model of obesity. Zucker-Lepr(fa/fa) rats received one of three probiotic strains, a mixture of L. paracasei CNCM I-4034 and B. breve CNCM I-4035, or a placebo for 30 days. An additional group of Zucker-lean(+/fa) rats received a placebo for 30 days. No alterations in intestinal histology, in the epithelial, lamina propria, muscular layers of the ileal or colonic mucosa, or the submucosae, were observed in any of the experimental groups. Triacylglycerol content decreased in the liver of Zucker-Lepr(fa/fa) rats that were fed L. rhamnosus, B. breve, or the mixture of B. breve and L. paracasei. Likewise, the area corresponding to neutral lipids was significantly smaller in the liver of all four groups of Zucker-Lepr(fa/fa) rats that received probiotics than in rats fed the placebo. Zucker-Lepr(fa/fa) rats exhibited significantly greater serum LPS levels than Zuckerlean(+/fa) rats upon administration of placebo for 30 days. In contrast, all four groups of obese Zucker-Lepr(fa/fa) rats that received LAB strains exhibited serum LPS concentrations similar to those of Zucker-lean(+/fa) rats. Serum TNF-alpha levels decreased in the Zucker-Lepr(fa/fa) rats that received B. breve, L. rhamnosus, or the mixture, whereas L. paracasei feeding decreased IL-6 levels in the serum of Zucker-Lepr(fa/fa) rats. In conclusion, the probiotic strains reduced hepatic steatosis in part by lowering serum LPS, and had an anti-inflammatory effect in obese Zucker rats.	[Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Munoz-Quezada, Sergio; Gil, Angel; Fontana, Luis] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol II, Granada, Spain; [Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Campana-Martin, Laura; Munoz-Quezada, Sergio; Gil, Angel; Fontana, Luis] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix, Granada, Spain; [Abadia-Molina, Francisco] Univ Granada, Sch Sci, Dept Cell Biol, Granada, Spain; [Jose Saez-Lara, Maria] Univ Granada, Sch Sci, Dept Biochem & Mol Biol I, Granada, Spain; [Romero, Fernando] Hero Global Technol Ctr, Murcia, Spain	University of Granada; University of Granada; University of Granada; University of Granada	Fontana, L (corresponding author), Univ Granada, Sch Pharm, Dept Biochem & Mol Biol II, Granada, Spain.	fontana@ugr.es	Gil, Angel/ABA-7621-2020; Plaza-Diaz, Julio/C-8094-2016; Llorente, Carolina Gomez/K-7484-2015; Fontana, Luis/K-5528-2015; Gil, Angel/L-2275-2014	Gil, Angel/0000-0001-7663-0939; Plaza-Diaz, Julio/0000-0002-5171-9408; Llorente, Carolina Gomez/0000-0003-3948-1473; Fontana, Luis/0000-0001-8395-8393; Gil, Angel/0000-0001-7663-0939	Hero Spain, S.A. [3545]	Hero Spain, S.A.	Part of the research currently in progress in the authors' laboratory is funded by the company Hero Spain, S.A. through the grant #3545 managed by the Fundacion General Empresa-Universidad de Granada. No additional external funding was received for this study. The funders played a role in the study design, but had no role in the decision to publish or preparation of the manuscript.	ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Awaisheh SS, 2013, J DAIRY SCI, V96, P9, DOI 10.3168/jds.2012-5442; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bermudez-Brito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059370; Bermudez-Brito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043197; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Collins JK, 1998, INT DAIRY J, V8, P487, DOI 10.1016/S0958-6946(98)00073-9; D'Angelo G, 2006, HYPERTENSION, V48, P1109, DOI 10.1161/01.HYP.0000247306.53547.d4; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Dokken BB, 2006, AM J PHYSIOL-ENDOC M, V291, pE207, DOI 10.1152/ajpendo.00628.2005; Erdos B, 2004, DIABETES, V53, P1352, DOI 10.2337/diabetes.53.5.1352; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Farhadi A, 2008, LIVER INT, V28, P1026, DOI 10.1111/j.1478-3231.2008.01723.x; Food and Agriculture Organization of the United Nations; World Health Organization, 2002, GUID EV PROB FOOD RE; Frick JS, 2007, INFLAMM BOWEL DIS, V13, P83, DOI 10.1002/ibd.20009; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Knaapen M, 2013, CLIN MICROBIOL INFEC, V19, P331, DOI 10.1111/1469-0691.12170; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS51, DOI 10.1017/S0007114512005211; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Neyrinck AM, 2009, BIOCHEM BIOPH RES CO, V385, P351, DOI 10.1016/j.bbrc.2009.05.070; Nolan J P, 1978, Gastroenterology, V75, P765; NOLAN JP, 1979, YALE J BIOL MED, V52, P127; Obeid OA, 2000, INT J OBESITY, V24, P508, DOI 10.1038/sj.ijo.0801189; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Paik HD, 2005, BIOL PHARM BULL, V28, P1270, DOI 10.1248/bpb.28.1270; Plaza-Diaz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078111; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Xie N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-53; Yadav H, 2008, J DAIRY RES, V75, P189, DOI 10.1017/S0022029908003129; Yoo SR, 2013, OBESITY, V21, P2571, DOI 10.1002/oby.20428	53	49	50	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98401	10.1371/journal.pone.0098401	http://dx.doi.org/10.1371/journal.pone.0098401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852284	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200069
J	Bergmann, N; Ballegaard, S; Bech, P; Hjalmarson, A; Krogh, J; Gyntelberg, F; Faber, J				Bergmann, Natasha; Ballegaard, Soren; Bech, Per; Hjalmarson, Ake; Krogh, Jesper; Gyntelberg, Finn; Faber, Jens			The Effect of Daily Self-Measurement of Pressure Pain Sensitivity Followed by Acupressure on Depression and Quality of Life versus Treatment as Usual in Ischemic Heart Disease: A Randomized Clinical Trial	PLOS ONE			English	Article							INTEGRATED REHABILITATION; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; PSYCHOLOGICAL STRESS; ANGINA-PECTORIS; ASSOCIATION; MORTALITY; THERAPY; RISK	Background: Depressive symptoms and reduced quality of life (QOL) are parts of the chronic stress syndrome and predictive of adverse outcome in patients with ischemic heart disease (IHD). Chronic stress is associated with increased sensitivity for pain, which can be measured by algometry as Pressure Pain Sensitivity (PPS) on the sternum. Aim: To evaluate if stress focus by self-measurement of PPS, followed by stress reducing actions including acupressure, can decrease depressive symptoms and increase psychological well-being in people with stable IHD. Design: Observer blinded randomized clinical trial over 3 months of either intervention or treatment as usual (TAU). Statistical analysis: Intention to treat. Methods: Two hundred and thirteen participants with IHD were included: 106 to active treatment and 107 to TAU. Dropout: 20 and 12, respectively. The active intervention included self-measurement of PPS twice daily followed by acupressure as mandatory action, aiming at a reduction in PPS. Primary endpoint: change in depressive symptoms as measured by Major depression inventory (MDI). Other endpoints: changes in PPS, Well-being (WHO-5) and mental and physical QOL (SF-36). Results: At 3 months PPS decreased 28%, to 58, in active and 11%, to 72, in TAU, p<0.001. MDI decreased 22%, to 6.5, in active group vs. 12%, to 8.3 in TAU, p = 0.040. WHO-5 increased to 71.0 and 64.8, active group and TAU, p = 0.015. SF-36 mental score sum increased to 55.3 and 53.3, active and TAU, p = 0.08. Conclusions: PPS measurements followed by acupressure reduce PPS, depressive symptoms and increase QOL in patients with stable IHD.	[Bergmann, Natasha; Krogh, Jesper; Faber, Jens] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark; [Ballegaard, Soren] Ull Care AS, Hellerup, Denmark; [Bech, Per] Psychiat Ctr North Zealand, Psychiat Res Unit, Hillerod, Denmark; [Hjalmarson, Ake] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Gyntelberg, Finn] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Faber, Jens] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Sahlgrenska University Hospital; National Research Centre for the Working Environment; University of Copenhagen	Bergmann, N (corresponding author), Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark.	n.c.bergmann@hotmail.com		Bergmann, Natasha Chidekel/0000-0002-6797-8041; Ballegaard, soeren/0000-0002-4253-6909; Krogh, Jesper/0000-0003-4834-6724; Bech, Per/0000-0002-4948-6115	Johan Schroder's Family and Business Foundation; Lundbeck Foundation; Else and Mogens Wedell-Wedellsborg's Foundation	Johan Schroder's Family and Business Foundation; Lundbeck Foundation(Lundbeckfonden); Else and Mogens Wedell-Wedellsborg's Foundation	This work was supported by the Johan Schroder's Family and Business Foundation. Natasha Bergmann held a pre-graduate scholarship sponsored by the Lundbeck Foundation. Grants from Else and Mogens Wedell-Wedellsborg's Foundation, and Carpenter Sophus Jacobsen and Wife Astrid Jacobsen's Foundation were used to cover travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2697; [Anonymous], 2012, CLIN PSYCHOMETRICS; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Arendt-Nielsen L, 2009, J PAIN, V10, P556, DOI 10.1016/j.jpain.2009.02.002; Ballegaard S, 2004, J ALTERN COMPLEM MED, V10, P777; Ballegaard S, 2013, PSYCHOTHER PSYCHOSOM, V82, P9; Ballegaard S, 1999, J ALTERN COMPLEM MED, V5, P405, DOI 10.1089/acm.1999.5.405; Ballegaard S, 2009, SCAND J CLIN LAB INV, V69, P713, DOI 10.1080/00365510903042734; Ballegaard S, 2012, SCAND J CLIN LAB INV, V72, P459, DOI 10.3109/00365513.2012.695023; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Bayer L, 2010, HDB CLIN RATING SCAL; Bech P, 2007, PHARMACOPSYCHIATRY, V40, P163, DOI 10.1055/s-2007-984400; Bech P, 2011, DEPRESS RES TREAT, V2011; Bergmann N, 2013, SCAND J CLIN LAB INV, V73, P373, DOI 10.3109/00365513.2013.785588; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Grippo AJ, 2009, STRESS, V12, P1, DOI 10.1080/10253890802046281; Gulliksson M, 2011, ARCH INTERN MED, V171, P134, DOI 10.1001/archinternmed.2010.510; Hedges LV, 2014, STAT METHODS META AN; Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696; Hsieh LLC, 2006, BMJ-BRIT MED J, V332, P696, DOI 10.1136/bmj.38744.672616.AE; Lichtman JH, 2009, PROG CARDIOVASC NURS, V24, P19; Magnusson G, 2010, J ALTERN COMPLEM MED, V16, P369, DOI 10.1089/acm.2009.0097; Matsubara T, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/543291; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Netterstrom B, 2002, STRESS; Reidler JS, 2012, J PAIN, V13, P450, DOI 10.1016/j.jpain.2012.01.005; Richebe P, 2011, ANESTHESIOLOGY, V114, P1280, DOI 10.1097/ALN.0b013e31821c112b; ROSENGREN A, 1991, AM J CARDIOL, V68, P1171, DOI 10.1016/0002-9149(91)90189-R; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Adachi LNS, 2012, BRAIN RES, V1489, P17, DOI 10.1016/j.brainres.2012.10.009; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Van DT, 2011, HLTH ED BEHAV; Whalley B, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002902.pub3, 10.1002/14651858.CD002902]	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97553	10.1371/journal.pone.0097553	http://dx.doi.org/10.1371/journal.pone.0097553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3AL	24849077	gold, Green Submitted, Green Published			2022-12-27	WOS:000336730600035
J	Bergs, JW; Neuendorff, N; van der Heijden, G; Wassenaar, E; Rexin, P; Elsasser, HP; Moll, R; Baarends, WM; Brehm, A				Bergs, Judith W.; Neuendorff, Nina; van der Heijden, Godfried; Wassenaar, Evelyne; Rexin, Peter; Elsaesser, Hans-Peter; Moll, Roland; Baarends, Willy M.; Brehm, Alexander			Differential Expression and Sex Chromosome Association of CHD3/4 and CHD5 during Spermatogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PSEUDOAUTOSOMAL REGION; MI-2/NURD COMPLEX; MALE MEIOSIS; PHD FINGERS; CHROMATIN; MOUSE; RECOMBINATION; ATPASE; GENE	ATP-dependent nucleosome remodelers of the CHD family play important roles in chromatin regulation during development and differentiation. The ubiquitously expressed CHD3 and CHD4 proteins are essential for stem cell function and serve to orchestrate gene expression in different developmental settings. By contrast, the closely related CHD5 is predominantly expressed in neural tissue and its role is believed to be restricted to neural differentiation. Indeed, loss of CHD5 contributes to neuroblastoma. In this study, we first demonstrate that CHD5 is a nucleosome-stimulated ATPase. We then compare CHD3/4 and CHD5 expression in mouse brain and show that CHD5 expression is restricted to a subset of cortical and hippocampal neurons whereas CHD3/4 expression is more widespread. We also uncover high levels of CHD5 expression in testis. CHD5 is transiently expressed in differentiating germ cells. Expression is first detected in nuclei of postmeiotic round spermatids, reaches a maximum in stage VIII spermatids and then falls to undetectable levels in stage IX spermatids. Surprisingly, CHD3/4 and CHD5 show complementary expression patterns during spermatogenesis with CHD3/4 levels progressively decreasing as CHD5 expression increases. In spermatocytes, CHD3/4 localizes to the pseudoautosomal region, the X centromeric region and then spreads into the XY body chromatin. In postmeiotic cells, CHD5 colocalises with macroH2A1.2 in association with centromeres and part of the Y chromosome. The subnuclear localisations of CHD4 and CHD5 suggest specific roles in regulation of sex chromosome chromatin and pericentromeric chromatin structure prior to the histone-protamine switch.	[Bergs, Judith W.; Neuendorff, Nina; Brehm, Alexander] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [van der Heijden, Godfried; Wassenaar, Evelyne; Baarends, Willy M.] Erasmus MC Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands; [Rexin, Peter; Moll, Roland] Univ Marburg, Inst Pathol, Marburg, Germany; [Elsaesser, Hans-Peter] Univ Marburg, Inst Zytobiol & Zytopathol, Marburg, Germany	Philipps University Marburg; Erasmus University Rotterdam; Erasmus MC; Philipps University Marburg; Philipps University Marburg	Baarends, WM (corresponding author), Erasmus MC Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands.	w.baarends@erasmusmc.nl; brehm@imt.uni-marburg.de	van der Heijden, Godfried/ABC-5623-2021	van der Heijden, Godfried/0000-0001-5894-7027; Bergs, Judith/0000-0003-2497-3248; Bergs, Judith/0000-0002-6859-5202	LOEWE Schwerpunkt "Tumor und Entzundung";  [Transregio 17];  [TRR81]	LOEWE Schwerpunkt "Tumor und Entzundung"; ; 	J.B, N.N, P. R, R. M, H.-P. E. and A. B. acknowledge support from Transregio 17, TRR81 and LOEWE Schwerpunkt "Tumor und Entzundung". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Carofiglio F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003538; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Garcia I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-277; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Gotoh H, 1999, ANN NY ACAD SCI, V870, P351, DOI 10.1111/j.1749-6632.1999.tb08901.x; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Koyama H, 2012, CLIN CANCER RES, V18, P1588, DOI 10.1158/1078-0432.CCR-11-2644; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Moens PB, 2002, J CELL SCI, V115, P1611; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Montellier E, 2013, GENE DEV, V27, P1680, DOI 10.1101/gad.220095.113; Morra R, 2012, FEBS LETT, V586, P2513, DOI 10.1016/j.febslet.2012.06.017; Murawska M, 2012, TRANSCRIPTION, V2, P244; Musselman CA, 2012, P NATL ACAD SCI USA, V109, P787, DOI 10.1073/pnas.1113655109; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Oliver SS, 2012, BIOCHEMISTRY-US, V51, P6534, DOI 10.1021/bi3006972; PALMER DK, 1990, CHROMOSOMA, V100, P32, DOI 10.1007/BF00337600; Paul S, 2013, CELL REP, V3, P92, DOI 10.1016/j.celrep.2012.12.009; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Rathke C., 2013, BIOCHIM BIOPHYS ACTA, V1839, P155; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sims JK, 2011, MOL BIOL CELL, V22, P3094, DOI 10.1091/mbc.E11-03-0258; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; SODERSTROM KO, 1976, MOL CELL ENDOCRINOL, V5, P181, DOI 10.1016/0303-7207(76)90082-4; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2001, J CELL SCI, V114, P3367; Van Den Tweel ERW, 2006, PEDIATR RES, V59, P232, DOI 10.1203/01.pdr.0000196807.10122.5f; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; Wang HB, 2001, NUCLEIC ACIDS RES, V29, P2517, DOI 10.1093/nar/29.12.2517; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Zhuang T, 2013, MECH DEVELOP, V131, P652	60	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98203	10.1371/journal.pone.0098203	http://dx.doi.org/10.1371/journal.pone.0098203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849318	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600098
J	Bucardo, F; Reyes, Y; Svensson, L; Nordgren, J				Bucardo, Filemon; Reyes, Yaoska; Svensson, Lennart; Nordgren, Johan			Predominance of Norovirus and Sapovirus in Nicaragua after Implementation of Universal Rotavirus Vaccination	PLOS ONE			English	Article							SAPPORO-VIRUS GASTROENTERITIS; GENETIC DIVERSITY; CHILDREN; DIARRHEA; INFECTIONS; PCR; IMMUNIZATION; ASSOCIATION; POPULATION; SPECIMENS	Background: Despite significant reduction of rotavirus (RV) infections following implementation of RotaTeq vaccination in Nicaragua, a large burden of patients with diarrhea persists. Methods: We conducted a community-and hospital-based study of the burden of RV, norovirus (NV) and sapovirus (SV) infections as cause of sporadic acute gastroenteritis (GE) among 330 children <= 5 years of age between September 2009 and October 2010 in two major cities of Nicaragua with a RotaTeq coverage rate of 95%. Results: We found that NV, SV and RV infections altogether accounted for 45% of cases of GE. Notably, NV was found in 24% (79/330) of the children, followed by SV (17%, 57/330) and RV (8%, 25/330). The detection rate in the hospital setting was 27%, 15% and 14% for NV, SV and RV respectively, whereas in the community setting the detection rate of RV was < 1%. Among each of the investigated viruses one particular genogroup or genotype was dominant; GII.4 (82%) for NV, GI (46%) for SV and G1P[8] (64%) in RV. These variants were also found in higher proportions in the hospital setting compared to the community setting. The GII.4.2006 Minerva strain circulating globally since 2006 was the most common among genotyped NV in this study, with the GII.4-2010 New Orleans emerging in 2010. Conclusions: This study shows that NV has become the leading viral cause of gastroenteritis at hospital and community settings in Nicaragua after implementation of RV vaccination.	[Bucardo, Filemon; Reyes, Yaoska] Univ Leon UNAN Leon, Dept Microbiol, Leon, Nicaragua; [Svensson, Lennart; Nordgren, Johan] Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Nordgren, J (corresponding author), Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden.	johan.nordgren@liu.se	svensson, lennart/K-6163-2019; Bucardo, Filemon/AFK-4817-2022	Bucardo, Filemon/0000-0002-9819-870X	Network for Research and Training in Tropical Diseases in Central America (NeTropica) [05-N-2010]; Swedish Research Council [10392, 348-2011-7420]	Network for Research and Training in Tropical Diseases in Central America (NeTropica); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Network for Research and Training in Tropical Diseases in Central America (NeTropica, Grant:05-N-2010) and Swedish Research Council (grants 10392 and 348-2011-7420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker-Dreps S, 2013, AM J TROP MED HYG, V89, P246, DOI 10.4269/ajtmh.13-0026; Becker-Dreps S, 2011, AM J TROP MED HYG, V85, P957, DOI 10.4269/ajtmh.2011.11-0401; Becker-Dreps S, 2011, PEDIATR INFECT DIS J, V30, P243, DOI 10.1097/INF.0b013e3181f87ffe; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Bucardo F, 2012, EMERG INFECT DIS, V18, P1875, DOI 10.3201/eid1811.111581; Bucardo F, 2012, INFECT GENET EVOL, V12, P1282, DOI 10.1016/j.meegid.2012.03.007; Bucardo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025962; Bucardo F, 2010, PEDIATR INFECT DIS J, V29, P934, DOI 10.1097/INF.0b013e3181ed9f2f; Chan MCW, 2006, J VIROL METHODS, V134, P146, DOI 10.1016/j.jviromet.2005.12.013; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hemming M, 2013, EUR J PEDIATR, V172, P739, DOI 10.1007/s00431-013-1945-3; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Johnsen CK, 2009, J CLIN VIROL, V46, P265, DOI 10.1016/j.jcv.2009.07.008; Khamrin P, 2007, J MED VIROL, V79, P1921, DOI 10.1002/jmv.21004; Khawaja S, 2012, HUM VACC IMMUNOTHER, V8, P777, DOI 10.4161/hv.19757; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Koo Hoonmo L, 2013, J Pediatric Infect Dis Soc, V2, P57, DOI 10.1093/jpids/pis070; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Moreno-Espinosa Sarbelio, 2004, Semin Pediatr Infect Dis, V15, P237, DOI 10.1053/j.spid.2004.07.004; Nordgren J, 2008, J CLIN MICROBIOL, V46, P164, DOI 10.1128/JCM.01316-07; Okada M, 2006, ARCH VIROL, V151, P2503, DOI 10.1007/s00705-006-0820-1; Pang XL, 2001, PEDIATR INFECT DIS J, V20, P295, DOI 10.1097/00006454-200103000-00015; Pang XL, 1999, J PEDIATR GASTR NUTR, V29, P366, DOI 10.1097/00005176-199909000-00026; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Podkolzin AT, 2009, J INFECT DIS, V200, pS228, DOI 10.1086/605054; Sakai Y, 2001, PEDIATR INFECT DIS J, V20, P849, DOI 10.1097/00006454-200109000-00005; Samajdar S, 2006, J CLIN VIROL, V36, P183, DOI 10.1016/j.jcv.2006.03.006; Simpson R, 2003, J MED VIROL, V70, P258, DOI 10.1002/jmv.10386; Soares-Weiser K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008521.pub3; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2010, EUR J PEDIATR, V169, P1379, DOI 10.1007/s00431-010-1242-3; Vinje J, 2000, J CLIN MICROBIOL, V38, P530; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zeng SQ, 2010, SCAND J INFECT DIS, V42, P540, DOI 10.3109/00365541003652556; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	44	125	127	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98201	10.1371/journal.pone.0098201	http://dx.doi.org/10.1371/journal.pone.0098201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849288	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600097
J	Ishizu-Higashi, S; Seno, H; Nishi, E; Matsumoto, Y; Ikuta, K; Tsuda, M; Kimura, Y; Takada, Y; Kimura, Y; Nakanishi, Y; Kanda, K; Komekado, H; Chiba, T				Ishizu-Higashi, Shoko; Seno, Hiroshi; Nishi, Eiichiro; Matsumoto, Yoshihide; Ikuta, Kozo; Tsuda, Motoyuki; Kimura, Yoshito; Takada, Yutaka; Kimura, Yuto; Nakanishi, Yuki; Kanda, Keitaro; Komekado, Hideyuki; Chiba, Tsutomu			Deletion of Nardilysin Prevents the Development of Steatohepatitis and Liver Fibrotic Changes	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; GROWTH-FACTOR; TNF-ALPHA; ACTIVATION; INFLIXIMAB; OBESITY	Nonalcoholic steatohepatitis (NASH) is an inflammatory form of nonalcoholic fatty liver disease that progresses to liver cirrhosis. It is still unknown how only limited patients with fatty liver develop NASH. Tumor necrosis factor (TNF)-alpha is one of the key molecules in initiating the vicious circle of inflammations. Nardilysin (N-arginine dibasic convertase; Nrd1), a zinc metalloendopeptidase of the M16 family, enhances ectodomain shedding of TNF-alpha, resulting in the activation of inflammatory responses. In this study, we aimed to examine the role of Nrd1 in the development of NASH. Nrd1(+/+) and Nrd1(-/-) mice were fed a control choline-supplemented amino acid-defined (CSAA) diet or a choline-deficient amino acid-defined (CDAA) diet. Fatty deposits were accumulated in the livers of both Nrd1(+/+) and Nrd1(-/-) mice by the administration of the CSAA or CDAA diets, although the amount of liver triglyceride in Nrd1(-/-) mice was lower than that in Nrd1(+/+) mice. Serum alanine aminotransferase levels were increased in Nrd1(+/+) mice but not in Nrd1(-/-) mice fed the CDAA diet. mRNA expression of inflammatory cytokines were decreased in Nrd1(-/-) mice than in Nrd1(+/+) mice fed the CDAA diet. While TNF-alpha protein was detected in both Nrd1(+/+) and Nrd1(-/-) mouse livers fed the CDAA diet, secretion of TNF-alpha in Nrd1(-/-) mice was significantly less than that in Nrd1(+/+) mice, indicating the decreased TNF-alpha shedding in Nrd1(-/-) mouse liver. Notably, fibrotic changes of the liver, accompanied by the increase of fibrogenic markers, were observed in Nrd1(+/+) mice but not in Nrd1(-/-) mice fed the CDAA diet. Similar to the CDAA diet, fibrotic changes were not observed in Nrd1(-/-) mice fed a high-fat diet. Thus, deletion of nardilysin prevents the development of diet-induced steatohepatitis and liver fibrogenesis. Nardilysin could be an attractive target for anti-inflammatory therapy against NASH.	[Ishizu-Higashi, Shoko; Seno, Hiroshi; Matsumoto, Yoshihide; Ikuta, Kozo; Tsuda, Motoyuki; Kimura, Yoshito; Takada, Yutaka; Kimura, Yuto; Nakanishi, Yuki; Kanda, Keitaro; Komekado, Hideyuki; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Nishi, Eiichiro] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan	Kyoto University; Kyoto University	Seno, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	seno@kuhp.kyoto-u.ac.jp; nishi@kuhp.kyoto-u.ac.jp	Nishi, Eiichiro/A-8246-2019	Nishi, Eiichiro/0000-0002-8188-8026; Seno, Hiroshi/0000-0002-8509-8128	Japan Society for the Promotion of Science (JSPS) KAKENHI [21229009, 23300117, 23590937, 24229005, 24590914, 24590916, 24659363, 25112707, 25130706, 25461021, 25860533, 26293173]; Research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Research on Intractable Diseases, Hepatitis; Funding Program for Next-Generation World-leading Researchers [LS075]; Ministry of Education, Culture, Science, Sports and Technology of Japan; Kobayashi Foundation for Cancer Research; Naito Foundation; Princess Takamatsu Cancer Research Foundation [13-24514]; Grants-in-Aid for Scientific Research [26670139, 26116715, 26293173] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Research on Intractable Diseases, Hepatitis; Funding Program for Next-Generation World-leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Naito Foundation(Naito Memorial Foundation); Princess Takamatsu Cancer Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI 21229009, 23300117, 23590937, 24229005, 24590914, 24590916, 24659363, 25112707, 25130706, 25461021, 25860533, and 26293173; Research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Research on Intractable Diseases, Hepatitis, and The innovative development and the practical application of new drugs for hepatitis B from the Ministry of Health, Labour and Welfare, Japan; the Funding Program for Next-Generation World-leading Researchers (LS075), Grants-in Aid from the Ministry of Education, Culture, Science, Sports and Technology of Japan; Kobayashi Foundation for Cancer Research; The Naito Foundation; and Princess Takamatsu Cancer Research Foundation (13-24514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Fujita K, 2008, GUT, V57, P1583, DOI 10.1136/gut.2007.144550; Hiraoka Y, 2008, BIOCHEM BIOPH RES CO, V370, P154, DOI 10.1016/j.bbrc.2008.03.050; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Ito M, 2006, HEPATOL RES, V34, P92, DOI 10.1016/j.hepres.2005.12.001; Kanda K, 2012, EMBO MOL MED, V4, P396, DOI 10.1002/emmm.201200216; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Kudo H, 2009, J HEPATOL, V51, P168, DOI 10.1016/j.jhep.2009.02.032; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Younossi ZM, 2008, ALIMENT PHARM THER, V28, P2, DOI 10.1111/j.1365-2036.2008.03710.x	22	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98017	10.1371/journal.pone.0098017	http://dx.doi.org/10.1371/journal.pone.0098017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849253	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600077
J	Yu, CJ; Kancha, RK; Duyster, J				Yu, Chuanjiang; Kancha, Rama Krishna; Duyster, Justus			Targeting Oncoprotein Stability Overcomes Drug Resistance Caused by FLT3 Kinase Domain Mutations	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; CLINICAL RESISTANCE; TANDEM DUPLICATION; INHIBITOR PKC412; SENSITIVITY; IDENTIFICATION; SORAFENIB; SUNITINIB; CELLS	FLT3 is the most frequently mutated kinase in acute myeloid leukemia (AML). Internal tandem duplications (ITDs) in the juxta-membrane region constitute the majority of activating FLT3 mutations. Several FLT3 kinase inhibitors were developed and tested in the clinic with significant success. However, recent studies have reported the development of secondary drug resistance in patients treated with FLT3 inhibitors. Since FLT3-ITD is an HSP90 client kinase, we here explored if targeting the stability of drug-resistant FLT3 mutant protein could be a potential therapeutic option. We observed that HSP90 inhibitor treatment resulted in the degradation of inhibitor-resistant FLT3-ITD mutants and selectively induced toxicity in cells expressing FLT3-ITD mutants. Thus, HSP90 inhibitors provide a potential therapeutic choice to overcome secondary drug resistance following TKI treatment in FLT3-ITD positive AML.	[Yu, Chuanjiang; Kancha, Rama Krishna; Duyster, Justus] Univ Med Ctr Freiburg, Dept Med 1, Freiburg, Germany	University of Freiburg	Duyster, J (corresponding author), Univ Med Ctr Freiburg, Dept Med 1, Freiburg, Germany.	direktion-med1@uniklinik-freiburg.de	Kancha, Rama Krishna/B-5992-2009	Kancha, Rama Krishna/0000-0001-8146-1551	Jose Carreras Leukamie-Stiftung	Jose Carreras Leukamie-Stiftung	JD is supported by a grant from the Jose Carreras Leukamie-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers C, 2013, LEUKEMIA, V27, P1416, DOI 10.1038/leu.2013.14; Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148; George P, 2004, CANCER RES, V64, P3645, DOI 10.1158/0008-5472.CAN-04-0006; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Kancha RK, 2007, EXP HEMATOL, V35, P1522, DOI 10.1016/j.exphem.2007.07.008; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Lierman E, 2007, HAEMATOL-HEMATOL J, V92, P27, DOI 10.3324/haematol.10692; Minami Y, 2002, LEUKEMIA, V16, P1535, DOI 10.1038/sj.leu.2402558; Moore AS, 2012, LEUKEMIA, V26, P1462, DOI 10.1038/leu.2012.52; Pauwels D, 2012, HAEMATOLOGICA, V35, P1522; Smith CC, 2013, BLOOD, V121, P3165, DOI 10.1182/blood-2012-07-442871; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; von Bubnoff N, 2010, LEUKEMIA, V24, P1523, DOI 10.1038/leu.2010.122; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Wagner K, 2011, HAEMATOL-HEMATOL J, V96, P681, DOI 10.3324/haematol.2010.034074; Williams AB, 2013, LEUKEMIA, V27, P48, DOI 10.1038/leu.2012.191; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yao Q, 2005, LEUKEMIA, V19, P1605, DOI 10.1038/sj.leu.2403881; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Zhang WG, 2008, JNCI-J NATL CANCER I, V100, P184, DOI 10.1093/jnci/djm328	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97116	10.1371/journal.pone.0097116	http://dx.doi.org/10.1371/journal.pone.0097116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849514	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600021
J	Eguchi, T; Yoshizawa, A; Kawakami, S; Kumeda, H; Umesaki, T; Agatsuma, H; Sakaizawa, T; Tominaga, Y; Toishi, M; Hashizume, M; Shiina, T; Yoshida, K; Asaka, S; Matsushita, M; Koizumi, T				Eguchi, Takashi; Yoshizawa, Akihiko; Kawakami, Satoshi; Kumeda, Hirotaka; Umesaki, Tetsuya; Agatsuma, Hiroyuki; Sakaizawa, Takao; Tominaga, Yoshiaki; Toishi, Masayuki; Hashizume, Masahiro; Shiina, Takayuki; Yoshida, Kazuo; Asaka, Shiho; Matsushita, Mina; Koizumi, Tomonobu			Tumor Size and Computed Tomography Attenuation of Pulmonary Pure Ground-Glass Nodules Are Useful for Predicting Pathological Invasiveness	PLOS ONE			English	Article							HIGH-RESOLUTION CT; THIN-SECTION CT; LUNG-CANCER; FLEISCHNER-SOCIETY; FOLLOW-UP; ADENOCARCINOMA; OPACITY; CLASSIFICATION; EFFICACY; SCREEN	Objectives: Pulmonary ground-glass nodules (GGNs) are occasionally diagnosed as invasive adenocarcinomas. This study aimed to evaluate the clinicopathological features of patients with pulmonary GGNs to identify factors predictive of pathological invasion. Methods: We retrospectively evaluated 101 pulmonary GGNs resected between July 2006 and November 2013 and pathologically classified them as adenocarcinoma in situ (AIS; n = 47), minimally invasive adenocarcinoma (MIA; n = 30), or invasive adenocarcinoma (I-ADC; n = 24). The age, sex, smoking history, tumor size, and computed tomography (CT) attenuation of the 3 groups were compared. Receiver operating characteristic (ROC) curve analyses were performed to identify factors that could predict the presence of pathologically invasive adenocarcinomas. Results: Tumor size was significantly larger in the MIA and I-ADC groups than in the AIS group. CT attenuation was significantly greater in the I-ADC group than in the AIS and MIA groups. In ROC curve analyses, the sensitivity and specificity of tumor size (cutoff, 11 mm) were 95.8% and 46.8%, respectively, and those for CT attenuation (cutoff, -680 HU) were 95.8% and 35.1%, respectively; the areas under the curve (AUC) were 0.75 and 0.77, respectively. A combination of tumor size and CT attenuation (cutoffs of 11 mm and -680 HU for tumor size and CT attenuation, respectively) yielded in a sensitivity and specificity of 91.7% and 71.4%, respectively, with an AUC of 0.82. Conclusions: Tumor size and CT attenuation were predictive factors of pathological invasiveness for pulmonary GGNs. Use of a combination of tumor size and CT attenuation facilitated more accurate prediction of invasive adenocarcinoma than the use of these factors independently.	[Eguchi, Takashi; Kumeda, Hirotaka; Umesaki, Tetsuya; Agatsuma, Hiroyuki; Sakaizawa, Takao; Tominaga, Yoshiaki; Toishi, Masayuki; Hashizume, Masahiro; Shiina, Takayuki; Yoshida, Kazuo] Shinshu Univ, Dept Surg, Div Thorac Surg, Matsumoto, Nagano 390, Japan; [Yoshizawa, Akihiko; Asaka, Shiho] Shinshu Univ, Dept Pathol, Matsumoto, Nagano 390, Japan; [Kawakami, Satoshi; Matsushita, Mina] Shinshu Univ, Dept Radiol, Matsumoto, Nagano 390, Japan; [Koizumi, Tomonobu] Shinshu Univ, Ctr Comprehens Canc, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University	Eguchi, T (corresponding author), Shinshu Univ, Dept Surg, Div Thorac Surg, Matsumoto, Nagano 390, Japan.	tks1976@shinshu-u.ac.jp	Asaka, Shiho/W-2061-2018; Yoshizawa, Akihiko/AAM-9519-2020; Eguchi, Takashi/AAS-9215-2021	Asaka, Shiho/0000-0003-2697-114X; Eguchi, Takashi/0000-0001-9460-0696				Chang B, 2013, CHEST, V143, P172, DOI 10.1378/chest.11-2501; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kondo R, 2011, LUNG CANCER, V74, P433, DOI 10.1016/j.lungcan.2011.05.007; Kondo R, 2011, LUNG CANCER, V74, P426, DOI 10.1016/j.lungcan.2011.05.006; Lee HJ, 2007, KOREAN J RADIOL, V8, P22, DOI 10.3348/kjr.2007.8.1.22; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakajima R, 2002, J COMPUT ASSIST TOMO, V26, P323, DOI 10.1097/00004728-200205000-00001; Noguchi M, 2010, CANCER METAST REV, V29, P15, DOI 10.1007/s10555-010-9210-y; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Park CM, 2007, RADIOGRAPHICS, V27, P391, DOI 10.1148/rg.272065061; Suzuki K, 2000, ANN THORAC SURG, V69, P893, DOI 10.1016/S0003-4975(99)01331-4; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Yang ZG, 2001, AM J ROENTGENOL, V176, P1399, DOI 10.2214/ajr.176.6.1761399; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232	15	47	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97867	10.1371/journal.pone.0097867	http://dx.doi.org/10.1371/journal.pone.0097867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846292	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400068
J	Oh-oka, K; Kono, H; Ishimaru, K; Miyake, K; Kubota, T; Ogawa, H; Okumura, K; Shibata, S; Nakao, A				Oh-oka, Kyoko; Kono, Hiroshi; Ishimaru, Kayoko; Miyake, Kunio; Kubota, Takeo; Ogawa, Hideoki; Okumura, Ko; Shibata, Shigenobu; Nakao, Atsuhito			Expressions of Tight Junction Proteins Occludin and Claudin-1 Are under the Circadian Control in the Mouse Large Intestine: Implications in Intestinal Permeability and Susceptibility to Colitis	PLOS ONE			English	Article							DIRECT ASSOCIATION; EPITHELIAL-CELLS; BARRIER FUNCTION; GENE-EXPRESSION; DISEASE; CLOCK; MICE; LIVER; COMPONENT; REVEALS	Background & Aims: The circadian clock drives daily rhythms in behavior and physiology. A recent study suggests that intestinal permeability is also under control of the circadian clock. However, the precise mechanisms remain largely unknown. Because intestinal permeability depends on tight junction (TJ) that regulates the epithelial paracellular pathway, this study investigated whether the circadian clock regulates the expression levels of TJ proteins in the intestine. Methods: The expression levels of TJ proteins in the large intestinal epithelium and colonic permeability were analyzed every 4, 6, or 12 hours between wild-type mice and mice with a mutation of a key clock gene Period2 (Per2; mPer2(m/m)). In addition, the susceptibility to dextran sodium sulfate (DSS)-induced colitis was compared between wild-type mice and mPer2(m/m) mice. Results: The mRNA and protein expression levels of Occludin and Claudin-1 exhibited daily variations in the colonic epithelium in wild-type mice, whereas they were constitutively high in mPer2(m/m) mice. Colonic permeability in wild-type mice exhibited daily variations, which was inversely associated with the expression levels of Occludin and Claudin-1 proteins, whereas it was constitutively low in mPer2(m/m) mice. mPer2(m/m) mice were more resistant to the colonic injury induced by DSS than wild-type mice. Conclusions: Occludin and Claudin-1 expressions in the large intestine are under the circadian control, which is associated with temporal regulation of colonic permeability and also susceptibility to colitis.	[Oh-oka, Kyoko; Ishimaru, Kayoko; Nakao, Atsuhito] Univ Yamanashi, Fac Med, Dept Immunol, Yamanashi, Japan; [Kono, Hiroshi] Univ Yamanashi, Fac Med, Dept Surg 1, Yamanashi, Japan; [Miyake, Kunio; Kubota, Takeo] Univ Yamanashi, Fac Med, Dept Epigenet Med, Yamanashi, Japan; [Ogawa, Hideoki; Okumura, Ko; Nakao, Atsuhito] Juntendo Univ, Sch Med, Atopy Res Ctr, Tokyo 113, Japan; [Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Tokyo, Japan	University of Yamanashi; University of Yamanashi; University of Yamanashi; Juntendo University; Waseda University	Nakao, A (corresponding author), Univ Yamanashi, Fac Med, Dept Immunol, Yamanashi, Japan.	anakao@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [H25]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (H25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop BL, 2010, BIOCHEM BIOPH RES CO, V394, P254, DOI 10.1016/j.bbrc.2010.02.091; COOPER HS, 1993, LAB INVEST, V69, P238; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hoogerwerf Willemijntje A, 2006, Curr Gastroenterol Rep, V8, P353, DOI 10.1007/s11894-006-0019-3; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kono H, 2003, ANN SURG, V237, P246, DOI 10.1097/00000658-200302000-00014; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pan XY, 2013, J BIOL CHEM, V288, P20464, DOI 10.1074/jbc.M113.473454; Ramirez SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055972; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Summa KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067102; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takamura T, 2010, IMMUNOL CELL BIOL, V88, P685, DOI 10.1038/icb.2010.35; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	32	73	78	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98016	10.1371/journal.pone.0098016	http://dx.doi.org/10.1371/journal.pone.0098016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845399	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400081
J	Walia, RR; Xue, LC; Wilkins, K; El-Manzalawy, Y; Dobbs, D; Honavar, V				Walia, Rasna R.; Xue, Li C.; Wilkins, Katherine; El-Manzalawy, Yasser; Dobbs, Drena; Honavar, Vasant			RNABindRPlus: A Predictor that Combines Machine Learning and Sequence Homology-Based Methods to Improve the Reliability of Predicted RNA-Binding Residues in Proteins	PLOS ONE			English	Article							LONG NONCODING RNAS; CD-HIT; SITES; INTERFACE; TRANSLATION; SERVER; IDENTIFICATION; INFORMATION; PROPENSITY; GENERATION	Protein-RNA interactions are central to essential cellular processes such as protein synthesis and regulation of gene expression and play roles in human infectious and genetic diseases. Reliable identification of protein-RNA interfaces is critical for understanding the structural bases and functional implications of such interactions and for developing effective approaches to rational drug design. Sequence-based computational methods offer a viable, cost-effective way to identify putative RNA-binding residues in RNA-binding proteins. Here we report two novel approaches: (i) HomPRIP, a sequence homology-based method for predicting RNA-binding sites in proteins; (ii) RNABindRPlus, a new method that combines predictions from HomPRIP with those from an optimized Support Vector Machine (SVM) classifier trained on a benchmark dataset of 198 RNA-binding proteins. Although highly reliable, HomPRIP cannot make predictions for the unaligned parts of query proteins and its coverage is limited by the availability of close sequence homologs of the query protein with experimentally determined RNA-binding sites. RNABindRPlus overcomes these limitations. We compared the performance of HomPRIP and RNABindRPlus with that of several state-of-the-art predictors on two test sets, RB44 and RB111. On a subset of proteins for which homologs with experimentally determined interfaces could be reliably identified, HomPRIP outperformed all other methods achieving an MCC of 0.63 on RB44 and 0.83 on RB111. RNABindRPlus was able to predict RNA-binding residues of all proteins in both test sets, achieving an MCC of 0.55 and 0.37, respectively, and outperforming all other methods, including those that make use of structure-derived features of proteins. More importantly, RNABindRPlus outperforms all other methods for any choice of tradeoff between precision and recall. An important advantage of both HomPRIP and RNABindRPlus is that they rely on readily available sequence and sequence-derived features of RNA-binding proteins. A webserver implementation of both methods is freely available at http://einstein.cs.iastate.edu/RNABindRPlus/.	[Walia, Rasna R.; Dobbs, Drena] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Walia, Rasna R.] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Xue, Li C.; Honavar, Vasant] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [Wilkins, Katherine] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Wilkins, Katherine] Cornell Univ, Grad Field Computat Biol, Ithaca, NY USA; [El-Manzalawy, Yasser] Al Azhar Univ, Dept Syst & Comp Engn, Cairo, Egypt; [Dobbs, Drena] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Honavar, Vasant] Penn State Univ, Bioinformat & Genom Grad Program, University Pk, PA 16802 USA; [Honavar, Vasant] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Iowa State University; Iowa State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; Cornell University; Egyptian Knowledge Bank (EKB); Al Azhar University; Iowa State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Walia, RR (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA.	rwalia@iastate.edu	Xue, LI C./ABG-4802-2021; Honavar, Vasant G/K-9835-2015; El-Manzalawy, Yasser/ABE-3489-2020	Xue, LI C./0000-0002-2613-538X; Honavar, Vasant G/0000-0001-5399-3489; Walia, Rasna/0000-0001-7088-5535; Dobbs, Drena/0000-0003-4404-9554	National Institutes of Health [GM066387]; Iowa State University Center for Computational Intelligence, Learning, and Discovery; National Science Foundation [DGE 0504304]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM066387, R33GM066387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa State University Center for Computational Intelligence, Learning, and Discovery; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health grant GM066387 to VH and DD and by a research assistantship to RRW and LCX funded by the Iowa State University Center for Computational Intelligence, Learning, and Discovery. This research was also supported in part by an Integrative Graduate Education and Research Training (IGERT) fellowship to KW, provided by the National Science Foundation grant (DGE 0504304). The research of VH, while working at the National Science Foundation (during 2010-2013) was supported by the Foundation, and at Pennsylvania State University by the Edward Frymoyer Chair of Information Sciences and Technology. Any opinions, findings, and conclusions contained in this article are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade MA, 1999, ISMB, P28; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Caragea C, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P320; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Galicia-Vazquez G, 2009, ANAL BIOCHEM, V384, P180, DOI 10.1016/j.ab.2008.09.037; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Jeong EN, 2006, LECT NOTES COMPUT SC, V3939, P123; Jeong Euna, 2004, Genome Inform, V15, P105; Jordan RA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-41; Kauffman C, 2009, BIOINFORMATICS, V25, P3099, DOI 10.1093/bioinformatics/btp561; Ke A, 2004, METHODS, V34, P408, DOI 10.1016/j.ymeth.2004.03.027; Kechavarzi B, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r14; Khalil AM, 2011, SEMIN CELL DEV BIOL, V22, P359, DOI 10.1016/j.semcdb.2011.02.016; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Leung DW, 2012, TRENDS MICROBIOL, V20, P139, DOI 10.1016/j.tim.2011.12.005; Lewis BA, 2011, NUCLEIC ACIDS RES, V39, pD277, DOI 10.1093/nar/gkq1108; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma X, 2011, PROTEINS, V79, P1230, DOI 10.1002/prot.22958; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mitra Sheetal A., 2012, Frontiers in Genetics, V3, P17, DOI 10.3389/fgene.2012.00017; Muers M, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2494; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Schonrock N, 2012, CELL MOL LIFE SCI, V69, P3543, DOI 10.1007/s00018-012-1125-z; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Spriggs RV, 2009, BIOINFORMATICS, V25, P1492, DOI 10.1093/bioinformatics/btp257; Spriggs RV, 2009, COMPUT BIOL CHEM, V33, P397, DOI 10.1016/j.compbiolchem.2009.07.012; STANDART N, 1994, BIOCHIMIE, V76, P867, DOI 10.1016/0300-9084(94)90189-9; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Terribilini M, 2006, RNA, V12, P1450, DOI 10.1261/rna.2197306; Towfic F, 2010, INT J DATA MIN BIOIN, V4, P21, DOI 10.1504/IJDMB.2010.030965; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Van Roosbroeck K, 2013, EXPERT REV MOL DIAGN, V13, P183, DOI [10.1586/ERM.12.134, 10.1586/erm.12.134]; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Wang CC, 2011, AMINO ACIDS, V40, P239, DOI 10.1007/s00726-010-0639-7; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; WANG L, 2006, C P IEEE ENG MED BIO, V1, P5830, DOI DOI 10.1109/IEMBS.2006.260025; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Wu HH, 2005, METHOD ENZYMOL, V394, P525, DOI 10.1016/S0076-6879(05)94022-6; Xue LC, 2014, PROTEINS, V82, P250, DOI 10.1002/prot.24370; Xue LC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-244; Zehetner G, 2003, NUCLEIC ACIDS RES, V31, P3799, DOI 10.1093/nar/gkg555; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266	70	69	70	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97725	10.1371/journal.pone.0097725	http://dx.doi.org/10.1371/journal.pone.0097725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846307	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400050
J	Wu, SQ; Tao, AZ; Jiang, H; Xu, Z; Perez, V; Wang, JH				Wu, Shuangqing; Tao, Aizhu; Jiang, Hong; Xu, Zhe; Perez, Victor; Wang, Jianhua			Vertical and Horizontal Corneal Epithelial Thickness Profile Using Ultra-High Resolution and Long Scan Depth Optical Coherence Tomography	PLOS ONE			English	Article							FREQUENCY DIGITAL ULTRASOUND; IN-VIVO; BOWMANS LAYER; TOPOGRAPHICAL THICKNESS; HIGH-SPEED; REPEATABILITY; EYES; ARTEMIS; MYOPIA; WEAR	Purpose: To determine the vertical and horizontal thickness profiles of the corneal epithelium in vivo using ultra-long scan depth and ultra-high resolution spectral domain optical coherence tomography (SD-OCT). Methods: A SD-OCT was developed with an axial resolution of similar to 3.3 mu m in tissue and an extended scan depth. Forty-two eyes of 21 subjects were imaged twice. The entire horizontal and vertical corneal epithelial thickness profiles were evaluated. The coefficient of repeatability (CoR) and intraclass correlation (ICC) of the tests and interobserver variability were analyzed. Results: The full width of the horizontal epithelium was detected, whereas part of the superior epithelium was not shown for the covered super eyelid. The mean central epithelial corneal thickness was 52.0 +/- 3.2 mu m for the first measurement and 52.36 +/- 3.4 mu m for the second measurement (P>.05). In the central zone (0-3.0 mm), the paracentral zones (3.0-6.0 mm) and the peripheral zones (6.0-10.0 mm), the mean epithelial thickness ranged from 51 to 53 mu m, 52 to 57 mu m, and 58 to 72 mu m, respectively. There was no difference between the two tests at both meridians and in the right and left eyes (P>.05). The ICCs of the two tests ranged from 0.70 to 0.97 and the CoRs ranged from 2.5 mu m to 7.8 mu m from the center to the periphery, corresponding to 5.6% to 10.6% (CoR%). The ICCs of the two observers ranged from 0.72 to 0.93 and the CoRs ranged from 4.5 mu m to 10.4 mu m from the center to the periphery, corresponding to 8.7% to 15.2% (CoR%). Conclusions: This study demonstrated good repeatability of ultra-high resolution and long scan depth SD-OCT to evaluate the entire thickness profiles of the corneal epithelium. The epithelial thickness increases from the center toward the limbus.	[Wu, Shuangqing] Red Cross Hosp, Dept Ophthalmol, Hangzhou, Zhejiang, Peoples R China; [Wu, Shuangqing; Tao, Aizhu; Jiang, Hong; Xu, Zhe; Perez, Victor; Wang, Jianhua] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Tao, Aizhu; Xu, Zhe] Wenzhou Med Coll, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China	Bascom Palmer Eye Institute; University of Miami; Wenzhou Medical University	Wang, JH (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jwang3@med.miami.edu	Perez, Victor L./AAY-8633-2020		NIH [EY021012, EY021336, EY020607S]; NIH Center [P30 EY014801]; Research to Prevent Blindness (RPB); Hangzhou Red-Cross Hospital, Hangzhou, China; NATIONAL EYE INSTITUTE [P30EY014801, R21EY021012, R21EY021336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Hangzhou Red-Cross Hospital, Hangzhou, China; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by research grants in part from the NIH EY021012, EY021336 and EY020607S, NIH Center Grant P30 EY014801, Research to Prevent Blindness (RPB). A visiting scholar award for Dr. Shuangqing Wu was provided by the Hangzhou Red-Cross Hospital, Hangzhou, China. The funding organizations had no role in the design or conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WL, 2011, INVEST OPHTH VIS SCI, V52, P3640, DOI 10.1167/iovs.10-6390; Du CX, 2012, CORNEA, V31, P1036, DOI 10.1097/ICO.0b013e31823f8d56; Feng YW, 2001, CORNEA, V20, P480, DOI 10.1097/00003226-200107000-00008; Francoz M, 2011, INVEST OPHTH VIS SCI, V52, P9116, DOI 10.1167/iovs.11-7988; Ge LL, 2013, INVEST OPHTH VIS SCI, V54, P746, DOI 10.1167/iovs.11-9308; Haque S, 2008, OPTOMETRY VISION SCI, V85, P963, DOI 10.1097/OPX.0b013e318188892c; Hutchings N, 2010, INVEST OPHTH VIS SCI, V51, P4579, DOI 10.1167/iovs.09-4676; IZATT JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1584, DOI 10.1001/archopht.1994.01090240090031; Kanellopoulos AJ, 2014, AM J OPHTHALMOL, V157, P63, DOI 10.1016/j.ajo.2013.08.025; Li Y, 2012, OPHTHALMOLOGY, V119, P2425, DOI 10.1016/j.ophtha.2012.06.023; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Lohmann CP, 1999, J CATARACT REFR SURG, V25, P712, DOI 10.1016/S0886-3350(99)00014-0; Ma XJ, 2013, CORNEA, V32, P1544, DOI 10.1097/ICO.0b013e3182a7f39d; Maldonado MJ, 2000, OPHTHALMOLOGY, V107, P81, DOI 10.1016/S0161-6420(99)00022-6; Prakash G, 2012, INVEST OPHTH VIS SCI, V53, P2580, DOI 10.1167/iovs.11-8981; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Reinstein DZ, 2010, J REFRACT SURG, V26, P646, DOI 10.3928/1081597X-20091105-01; Rocha KM, 2013, J REFRACT SURG, V29, P173, DOI 10.3928/1081597X-20130129-08; Schmoll T, 2012, OPTOMETRY VISION SCI, V89, pE795, DOI 10.1097/OPX.0b013e3182504346; Shen MX, 2010, EYE CONTACT LENS, V36, P73, DOI 10.1097/ICL.0b013e3181d0423e; Sin S, 2006, OPTOMETRY VISION SCI, V83, P360, DOI 10.1097/01.opx.0000221388.26031.23; Tao AZ, 2013, EYE CONTACT LENS, V39, P329, DOI 10.1097/ICL.0b013e31829fae00; Tao AZ, 2013, CLIN OPHTHALMOL, V7, P1623, DOI 10.2147/OPTH.S45122; Tao AZ, 2011, INVEST OPHTH VIS SCI, V52, P3901, DOI 10.1167/iovs.09-4748; Wang JH, 2003, INVEST OPHTH VIS SCI, V44, P4742, DOI 10.1167/iovs.03-0239; Wang JH, 2003, INVEST OPHTH VIS SCI, V44, P1070, DOI 10.1167/iovs.02-0343; Wang JH, 2002, AM J OPHTHALMOL, V133, P315, DOI 10.1016/S0002-9394(01)01382-4; Westphal V, 2002, OPT EXPRESS, V10, P397, DOI 10.1364/OE.10.000397; WILSON G, 1980, INVEST OPHTH VIS SCI, V19, P414	29	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97962	10.1371/journal.pone.0097962	http://dx.doi.org/10.1371/journal.pone.0097962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844566	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400075
J	Zhang, L; Zhao, MG; Fu, WH; Gao, XQ; Shen, J; Zhang, ZY; Xian, M; Jiao, YZ; Jiang, J; Wang, JQ; Gao, GM; Tang, B; Chen, L; Li, WM; Zhou, CH; Deng, SP; Gu, JW; Zhang, D; Zheng, Y; Chen, XM				Zhang, Li; Zhao, Minggang; Fu, Wenhao; Gao, Xinqiang; Shen, Ji; Zhang, Zuyun; Xian, Ming; Jiao, Yunzhi; Jiang, Jian; Wang, Jinqian; Gao, Guomin; Tang, Bin; Chen, Liang; Li, Weimin; Zhou, Changhua; Deng, Shaoping; Gu, Jianwen; Zhang, Dong; Zheng, Ying; Chen, Xiangmei			Epidemiological Analysis of Trauma Patients following the Lushan Earthquake	PLOS ONE			English	Article							2008 WENCHUAN EARTHQUAKE; 2010 YUSHU EARTHQUAKE; WOUND INFECTIONS; MANAGEMENT; DISASTER; VICTIMS; RESCUE; EVACUATION; CHINA; NEEDS	Background: A 7.0-magnitude earthquake hit Lushan County in China's Sichuan province on April 20, 2013, resulting in 196 deaths and 11,470 injured. This study was designed to analyze the characteristics of the injuries and the treatment of the seismic victims. Methods: After the earthquake, an epidemiological survey of injured patients was conducted by the Health Department of Sichuan Province. Epidemiological survey tools included paper-and-pencil questionnaires and a data management system based on the Access Database. Questionnaires were completed based on the medical records of inpatients with earthquake-related injuries. Outpatients or non-seismic injured inpatients were excluded. A total of 2010 patients from 140 hospitals were included. Results: The most common type of injuries involved bone fractures (58.3%). Children younger than 10 years of age suffered fewer fractures and chest injuries, but more skin and soft -tissue injuries. Patients older than 80 years were more likely to suffer hip and thigh fractures, pelvis fractures, and chest injuries, whereas adult patients suffered more ankle and foot fractures. A total of 207 cases of calcaneal fracture were due to high falling injuries related to extreme panic. The most common type of infection in hospitalized patients was pulmonary infections. A total of 70.5% patients had limb dysfunction, and 60.1% of this group received rehabilitation. Most patients received rehabilitation within 1 week, and the median duration of rehabilitation was 3 weeks. The cause of death of all seven hospitalized patients who died was severe traumatic brain injuries; five of this group died within 24 h after the earthquake. Conclusions: Injuries varied as a function of the age of the victim. As more injuries were indirectly caused by the Lushan earthquake, disaster education is urgently needed to avoid secondary injuries.	[Zhang, Li; Zhang, Dong; Zheng, Ying; Chen, Xiangmei] Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Zhang, Li; Zhang, Dong; Zheng, Ying; Chen, Xiangmei] Mil Med Coll, Beijing, Peoples R China; [Zhao, Minggang; Fu, Wenhao; Gao, Xinqiang] Natl Hlth & Family Planning Commiss Peoples Repub, Beijing, Peoples R China; [Shen, Ji; Zhang, Zuyun; Xian, Ming; Jiao, Yunzhi; Jiang, Jian; Wang, Jinqian] Hlth & Family Planning Commiss Sichuan Prov, Chengdu, Peoples R China; [Gao, Guomin; Tang, Bin; Chen, Liang] United Logist Minist, Dept Hlth, Chengdu, Chengdu Militar, Peoples R China; [Li, Weimin] Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China; [Zhou, Changhua] Publ Hlth Bur Yaan City, Yaan, Peoples R China; [Deng, Shaoping] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Gu, Jianwen] Chengdu Mil Command, Gen Hosp, Chengdu, Peoples R China	Chinese People's Liberation Army General Hospital; Air Force Military Medical University; Sichuan University; Sichuan Provincial People's Hospital	Chen, XM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	xmchen301@126.com		Zhang, Dong/0000-0002-6521-9586	Chinese PLA 12th FiveYear Plan for Medical Sciences [BWS11J027]; National Science & Technology Pillar Program [2011BAI10B00, 2013BAI09B05]	Chinese PLA 12th FiveYear Plan for Medical Sciences; National Science & Technology Pillar Program	The study was funded by grants from Chinese PLA 12th FiveYear Plan for Medical Sciences (BWS11J027) and National Science & Technology Pillar Program (No. 2011BAI10B00, 2013BAI09B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardagh MW, 2012, LANCET, V379, P2109, DOI 10.1016/S0140-6736(12)60313-4; Bartels SA, 2012, LANCET, V379, P748, DOI 10.1016/S0140-6736(11)60887-8; Chen EQ, 2011, J HUAZHONG U SCI-MED, V31, P83, DOI 10.1007/s11596-011-0155-3; [陈锦 CHEN Jin], 2009, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V9, P1267; DEBRUYCKER M, 1983, B WORLD HEALTH ORGAN, V61, P1021; Emily YY., 2008, LANCET, V372, P359; Jiang Jie, 2012, J Evid Based Med, V5, P114, DOI 10.1111/j.1756-5391.2012.01186.x; Kang P, 2012, J TRAUMA ACUTE CARE, V72, P1626, DOI 10.1097/TA.0b013e3182479e07; Landry MD, 2010, PHYSIOTHER RES INT, V15, P123, DOI 10.1002/pri.488; Li SS, 2013, J REHABIL MED, V45, P603, DOI 10.2340/16501977-1176; Li Yuanfeng, 2009, J Evid Based Med, V2, P258, DOI 10.1111/j.1756-5391.2009.01045.x; Liu X, 2013, J EMERG MED, V45, P865, DOI 10.1016/j.jemermed.2013.05.054; Lushan earthquake medical expert team, 2013, CHINESE MED J, V93, P1527; Mace SE, 2007, AM J EMERG MED, V25, P762, DOI 10.1016/j.ajem.2006.12.011; Miskin IN, 2010, NEW ENGL J MED, V363, P2571, DOI 10.1056/NEJMc1005578; Oda J, 1997, J TRAUMA, V42, P470, DOI 10.1097/00005373-199703000-00015; Ouyang Y, 2013, LANCET, V381, P1801, DOI 10.1016/S0140-6736(13)61105-8; Raissi GR, 2007, J SPINAL CORD MED, V30, P369, DOI 10.1080/10790268.2007.11753954; Ran YC, 2010, SCAND J INFECT DIS, V42, P347, DOI 10.3109/00365540903510682; Sever MS, 2001, KIDNEY INT, V60, P1114, DOI 10.1046/j.1523-1755.2001.0600031114.x; Shen Ji, 2012, J Evid Based Med, V5, P75, DOI 10.1111/j.1756-5391.2012.01176.x; Sugihara G, 2011, LANCET, V378, P485, DOI 10.1016/S0140-6736(11)61250-6; Tang BH, 2013, LANCET, V381, P1984, DOI 10.1016/S0140-6736(13)61201-5; Tao C, 2009, DIAGN MICR INFEC DIS, V63, P268, DOI 10.1016/j.diagmicrobio.2008.11.009; van der Tol A, 2009, NEPHROL DIAL TRANSPL, V24, P907, DOI 10.1093/ndt/gfn557; Wang Y, 2010, EMERG INFECT DIS, V16, P974, DOI 10.3201/eid1606.091523; Zhang H, 2013, CHIN J TRAUMATOL, V16, P10, DOI 10.3760/cma.j.issn.1008-1275.2013.01.002; Zhang L, 2014, CHINESE MED J-PEKING, V127, P995, DOI 10.3760/cma.j.issn.0366-6999.20131708; Zhang L, 2012, INJURY, V43, P1470, DOI 10.1016/j.injury.2010.11.036; Zhang LL, 2012, LANCET, V379, P853, DOI 10.1016/S0140-6736(11)61876-X	30	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97416	10.1371/journal.pone.0097416	http://dx.doi.org/10.1371/journal.pone.0097416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846207	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400027
J	Chen, Q; Zhang, XB; Zhao, YL; Zhou, X; Sun, LN; Zeng, SJ; Zuo, MX; Zhang, XW				Chen, Qiong; Zhang, Xuebo; Zhao, Yueliu; Zhou, Xin; Sun, Lina; Zeng, Shaoju; Zuo, Mingxue; Zhang, Xinwen			Sexual Differences in Cell Proliferation in the Ventricular Zone, Cell Migration and Differentiation in the HVC of Juvenile Bengalese Finch	PLOS ONE			English	Article							SONG-CONTROL NUCLEUS; ZEBRA FINCH; NEUROTROPHIC FACTOR; NEURONS BORN; DIMORPHIC EXPRESSION; GANGLIONIC EMINENCE; BRAIN; ESTROGEN; BDNF; SYSTEM	Song control nuclei have distinct sexual differences and thus are an ideal model to address how brain areas are sexually differentiated. Through a combination of histological analysis and electrical lesions, we first identified the ventricle site for HVC progenitor cells. We then found that there were significant sex differences in the cellular proliferation activity in the ventricular zone of the HVC, the number of migrating cells along the radial cells (positive immunoreactions to vimentin) and differentiation towards neurons. Through co-culturing of male and female slices containing the developing HVC in the same well, we found that the male slices could produce diffusible substances to masculinize the female HVC. By adding estrogen, an estrogen antagonist, brain-derived neurotrophic factor (BDNF) or its antibody into the culture medium, separately or in combination, we found that these diffusible substances may include estrogen and BDNF. Finally, we found that 1) estrogen-induced BDNF upregulation could be detected 48 hr after estrogen treatment and could not be blocked by a vascular endothelial growth factor (VEGF) receptor inhibitor and 2) the amount of VEGF mRNA expressed in the developing HVC and its adjacent area did not display any significant sex differences, as did the distribution of VEGF and laminin-expressing endothelial cells in the developing HVC. Because these findings are largely different from previous reports on the adult female HVC, it is suggested that our estrogen-induced BDNF up-regulation and the resultant sexual differentiation might not be mediated by VEGF and endothelial cells, but instead, may result from the direct effects of estrogen on BDNF.	[Chen, Qiong; Zhang, Xuebo; Zhao, Yueliu; Zhou, Xin; Sun, Lina; Zeng, Shaoju; Zuo, Mingxue] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Zhang, Xuebo; Zhang, Xinwen] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China; [Chen, Qiong] Guangzhou Med Univ, Affiliated Hosp 3, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Beijing Normal University; Hainan Normal University; Guangzhou Medical University	Zeng, SJ (corresponding author), Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.	sjzeng@bnu.edu.cn; mxzuo@bnu.edu.cn			National Natural Science Foundation of China [31172082, 31372200, 31160205, 31360517, 31360243, 37212310]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [85032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Science Foundation of China to SJ Zeng (No: 31172082 and 31372200), XW Zhang (No: 31160205 and 31360517), XB Zhang (No: 31360243), and MX Zuo (No: 37212310), and by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry to SJ Zeng (No: 85032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINSREGAN E, 1994, J NEUROBIOL, V25, P865, DOI 10.1002/neu.480250710; Akutagawa E, 1998, P NATL ACAD SCI USA, V95, P11429, DOI 10.1073/pnas.95.19.11429; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ALVAREZBUYLLA A, 1994, J COMP NEUROL, V347, P233, DOI 10.1002/cne.903470207; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Arnold AP, 2012, TRENDS GENET, V28, P55, DOI 10.1016/j.tig.2011.10.004; BALABAN E, 1988, SCIENCE, V241, P1339, DOI 10.1126/science.3413496; BREEDLOVE SM, 2002, BEHAV ENDOCRINOLOGY, P75; BROWN SD, 1993, J NEUROSCI, V13, P2024; BUREK MJ, 1995, DEV BRAIN RES, V85, P220, DOI 10.1016/0165-3806(94)00215-L; Burek MJ, 1997, J NEUROBIOL, V33, P61; BUREK MJ, 1994, DEV BRAIN RES, V78, P57, DOI 10.1016/0165-3806(94)90009-4; Chen XQ, 2005, P NATL ACAD SCI USA, V102, P7730, DOI 10.1073/pnas.0408350102; Chue J, 2011, FEBS J, V278, P1027, DOI 10.1111/j.1742-4658.2011.08032.x; Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DeWulf V, 2005, J COMP NEUROL, V481, P70, DOI 10.1002/cne.20352; DeWulf V, 2002, J NEUROSCI, V22, P4080, DOI 10.1523/JNEUROSCI.22-10-04080.2002; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Fridolfsson AK, 1998, P NATL ACAD SCI USA, V95, P8147, DOI 10.1073/pnas.95.14.8147; Gahr M, 1999, J NEUROSCI, V19, P2628; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; GRISHAM W, 1995, J NEUROBIOL, V26, P163, DOI 10.1002/neu.480260202; Hartog TE, 2009, J NEUROSCI, V29, P15511, DOI 10.1523/JNEUROSCI.2564-09.2009; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6; Kalman M, 1998, ANAT EMBRYOL, V198, P213, DOI 10.1007/s004290050179; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kirn JR, 1999, J COMP NEUROL, V411, P487; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; MOONEY R, 1994, J NEUROSCI, V14, P6532; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; NORDEEN EJ, 1989, DEV BRAIN RES, V49, P27, DOI 10.1016/0165-3806(89)90056-4; NORDEEN EJ, 1988, J NEUROSCI, V8, P2869; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Peng Z, 2012, BRAIN RES BULL, V89, P211, DOI 10.1016/j.brainresbull.2012.09.004; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; Scott BB, 2007, J COMP NEUROL, V502, P202, DOI 10.1002/cne.21296; SIMPSON HB, 1991, J NEUROBIOL, V22, P777, DOI 10.1002/neu.480220711; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; Striedter GF, 1998, J NEUROSCI, V18, P5839; Tang YP, 2012, PLOS ONE, V7, pe4368; Tobari Y, 2005, ZOOL SCI, V22, P1089, DOI 10.2108/zsj.22.1089; Vellema M, 2010, J COMP NEUROL, V518, P1442, DOI 10.1002/cne.22281; Wade J, 2000, J CHEM NEUROANAT, V19, P33, DOI 10.1016/S0891-0618(00)00051-X; Wang Q, 1998, J NEUROSCI, V18, P4973; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wu H, 2004, J NEUROSCI RES, V76, P76, DOI 10.1002/jnr.20060; Zeng SJ, 2007, NEUROSCI RES, V58, P207, DOI 10.1016/j.neures.2007.02.001; Zeng Shao-Ju, 2001, Zoological Research, V22, P51; Zeng SJ, 2001, ACTA ZOOLOGICAL SINI, V47, P552; Zheng G.M, 2002, CHECKLIST CLASSIFICA, P214	64	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97403	10.1371/journal.pone.0097403	http://dx.doi.org/10.1371/journal.pone.0097403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841082	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600030
J	Wu, NC; De La Cruz, J; Al-Mawsawi, LQ; Olson, CA; Qi, HF; Luan, HH; Nguyen, N; Du, YS; Le, S; Wu, TT; Li, XM; Lewis, MJ; Yang, OO; Sun, R				Wu, Nicholas C.; De La Cruz, Justin; Al-Mawsawi, Laith Q.; Olson, C. Anders; Qi, Hangfei; Luan, Harding H.; Nguyen, Nguyen; Du, Yushen; Le, Shuai; Wu, Ting-Ting; Li, Xinmin; Lewis, Martha J.; Yang, Otto O.; Sun, Ren			HIV-1 Quasispecies Delineation by Tag Linkage Deep Sequencing	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; COMPENSATORY MUTATIONS; GENETIC DIVERSITY; RESISTANT HIV-1; RECOMBINATION; EPISTASIS; EVOLUTION; FITNESS; RECONSTRUCTION; REPLICATION	Trade-offs between throughput, read length, and error rates in high-throughput sequencing limit certain applications such as monitoring viral quasispecies. Here, we describe a molecular-based tag linkage method that allows assemblage of short sequence reads into long DNA fragments. It enables haplotype phasing with high accuracy and sensitivity to interrogate individual viral sequences in a quasispecies. This approach is demonstrated to deduce similar to 2000 unique 1.3 kb viral sequences from HIV-1 quasispecies in vivo and after passaging ex vivo with a detection limit of similar to 0.005% to similar to 0.001%. Reproducibility of the method is validated quantitatively and qualitatively by a technical replicate. This approach can improve monitoring of the genetic architecture and evolution dynamics in any quasispecies population.	[Wu, Nicholas C.; Al-Mawsawi, Laith Q.; Olson, C. Anders; Qi, Hangfei; Luan, Harding H.; Nguyen, Nguyen; Du, Yushen; Wu, Ting-Ting; Sun, Ren] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Nicholas C.; Sun, Ren] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [De La Cruz, Justin; Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Le, Shuai] Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China; [Li, Xinmin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lewis, Martha J.; Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Lewis, Martha J.; Yang, Otto O.; Sun, Ren] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA; [Yang, Otto O.] AIDS Healthcare Fdn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Army Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Sun, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	RSun@mednet.ucla.edu	Wu, Nicholas/H-3822-2015	Wu, Nicholas/0000-0002-9078-6697; Le, Shuai/0000-0003-3748-5454	UCLA Molecular Biology Whitcome Fellowship; National Institutes of Health [R01 AI043203]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043203] Funding Source: NIH RePORTER	UCLA Molecular Biology Whitcome Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by UCLA Molecular Biology Whitcome Fellowship (N.C.W.), National Institutes of Health R01 AI043203 (O.O.Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1; Baird HA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-91; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Clotet B, 2004, AIDS REV, V6, P123; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Froissart R, 2005, PLOS BIOL, V3, P389, DOI 10.1371/journal.pbio.0030089; Fumero E, 2003, CLIN MICROBIOL INFEC, V9, P1077, DOI 10.1046/j.1469-0691.2003.00730.x; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lewis MJ, 2012, J VIROL, V86, P7459, DOI 10.1128/JVI.06724-11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Michalakis Y, 2004, SCIENCE, V306, P1492, DOI 10.1126/science.1106677; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Piana S, 2002, PROTEIN SCI, V11, P2393, DOI 10.1110/ps.0206702; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; Simon-Loriere E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000418; Skums P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S9-S2; Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232; Verheyen J, 2006, ANTIVIR THER, V11, P879; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; WONG JT, 1987, J IMMUNOL, V139, P1369; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Wu NC, 2013, J VIROL, V87, P1193, DOI 10.1128/JVI.01658-12; Yim HJ, 2006, HEPATOLOGY, V44, P703, DOI 10.1002/hep.21290; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zhang J, 2010, P NATL ACAD SCI USA, V107, P1321, DOI 10.1073/pnas.0907304107; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	56	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97505	10.1371/journal.pone.0097505	http://dx.doi.org/10.1371/journal.pone.0097505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842159	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600037
J	Drake, BL; Wills, WH; Hamilton, MI; Dorshow, W				Drake, Brandon Lee; Wills, Wirt H.; Hamilton, Marian I.; Dorshow, Wetherbee			Strontium Isotopes and the Reconstruction of the Chaco Regional System: Evaluating Uncertainty with Bayesian Mixing Models	PLOS ONE			English	Article							CANYON; MAIZE; SR-87/SR-86; CONSTRUCTION; VEGETATION; ANASAZI	Strontium isotope sourcing has become a common and useful method for assigning sources to archaeological artifacts. In Chaco Canyon, an Ancestral Pueblo regional center in New Mexico, previous studies using these methods have suggested that significant portion of maize and wood originate in the Chuska Mountains region, 75 km to the East. In the present manuscript, these results were tested using both frequentist methods (to determine if geochemical sources can truly be differentiated) and Bayesian methods (to address uncertainty in geochemical source attribution). It was found that Chaco Canyon and the Chuska Mountain region are not easily distinguishable based on radiogenic strontium isotope values. The strontium profiles of many geochemical sources in the region overlap, making it difficult to definitively identify any one particular geochemical source for the canyon's pre-historic maize. Bayesian mixing models support the argument that some spruce and fir wood originated in the San Mateo Mountains, but that this cannot explain all Sr-87/Sr-86 values in Chaco timber. Overall radiogenic strontium isotope data do not clearly identify a single major geochemical source for maize, ponderosa, and most spruce/fir timber. As such, the degree to which Chaco Canyon relied upon outside support for both food and construction material is still ambiguous.	[Drake, Brandon Lee; Wills, Wirt H.; Hamilton, Marian I.; Dorshow, Wetherbee] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of New Mexico	Drake, BL (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	b.lee.drake@gmail.edu			National Science Foundation [DGE-0903444]	National Science Foundation(National Science Foundation (NSF))	The University of New Mexico Department of Anthropology provided support that assisted with the initial databasing of strontium isotope data. This material is based in part upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-0903444. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert D, 2002, APPL GEOCHEM, V17, P285, DOI 10.1016/S0883-2927(01)00080-4; Auguie B, 2012, GRIDEXTRA FUNCTIONS; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Benson L, 2003, P NATL ACAD SCI USA, V100, P13111, DOI 10.1073/pnas.2135068100; Benson LV, 2009, J ARCHAEOL SCI, V36, P387, DOI 10.1016/j.jas.2008.09.023; Benson LV, 2012, J ARCHAEOL SCI, V39, P791, DOI 10.1016/j.jas.2011.08.022; Benson LV, 2011, J ARCHAEOL METHOD TH, V18, P61, DOI 10.1007/s10816-010-9083-y; Benson LV, 2010, J ARCHAEOL SCI, V37, P621, DOI 10.1016/j.jas.2009.10.027; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; BETANCOURT JL, 1981, SCIENCE, V214, P656, DOI 10.1126/science.214.4521.656; BETANCOURT JL, 1986, AM ANTIQUITY, V51, P370, DOI 10.2307/279950; Cameron CM, 2001, AM ANTIQUITY, V66, P79, DOI 10.2307/2694319; Crown PL, 2009, P NATL ACAD SCI USA, V106, P2110, DOI 10.1073/pnas.0812817106; Dean JS, 1983, REPORTS CHACO CTR, V6, P105; Dorshowa WB, 2012, J ARCHAEOL SCI, V39, P2098, DOI 10.1016/j.jas.2012.02.004; Duff AI, 2012, J ARCHAEOL SCI, V39, P2995, DOI 10.1016/j.jas.2012.04.032; Durand SR, 1999, J ARCHAEOL SCI, V26, P185, DOI 10.1006/jasc.1998.0315; Earle T, 2001, AM ANTIQUITY, V66, P26, DOI 10.2307/2694315; English NB, 2001, P NATL ACAD SCI USA, V98, P11891, DOI 10.1073/pnas.211305498; Erhardt EB, 2013, ENVIRON ECOL STAT, V20, P377, DOI 10.1007/s10651-012-0224-1; Graustein W.C., 1989, STABLE ISOTOPES ECOL, P491; Grebinger P, 1973, KIVA, V39, P3; GrissinoMayer HD, 1996, TREE RINGS, ENVIRONMENT AND HUMANITY, P191; HALL SA, 1977, GEOL SOC AM BULL, V88, P1593, DOI 10.1130/0016-7606(1977)88<1593:LQSAPH>2.0.CO;2; HALL SA, 1988, AM ANTIQUITY, V53, P582, DOI 10.2307/281219; Hodell DA, 2004, J ARCHAEOL SCI, V31, P585, DOI 10.1016/j.jas.2003.10.009; Hughes R. E., 1998, UNIT ISSUES ARCHAEOL, P103; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Judd N, 1954, SMITHSONIAN MISCELLA, V147; Kantner J, 1996, J ANTHROPOL ARCHAEOL, V15, P41, DOI 10.1006/jaar.1996.0003; Kantner J, 2007, ARCHAEOLOGY CHACO CA, P153; Kirby S, 2004, SW REGIONAL GAP ANAL; LEKSON SH, 1988, SCI AM, V259, P100, DOI 10.1038/scientificamerican0788-100; Lekson SH, 1984, PUBLICATIONS ARCHA B; Love D.W., 1983, CHACO CANYON COUNTRY, P195; Montgomery J, 2005, GEOPH RES ABSTR, V7, P10020; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Neitzel JillE., 2003, PUEBLO BONITO CTR CH, P143; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Poszwa A, 2002, BIOGEOCHEMISTRY, V60, P97, DOI 10.1023/A:1016548113624; Reynolds AC, 2005, J ARCHAEOL SCI, V32, P1061, DOI 10.1016/j.jas.2005.01.016; Sebastian L., 1992, CHACO ANASAZI SOCIOP; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Toll H.Wolcott., 2006, ARCHAEOLOGY CHACO CA, P117; Toll HW, 2001, AM ANTIQUITY, V66, P56, DOI 10.2307/2694318; U. S. Geological Survey National Gap Analysis Program, 2004, PROV DIG LAND COV MA; Van Dyke R., 2007, CHACO EXPERIENCE LAN; Vivian R.G., 2006, ARCHAEOLOGY CHACO CA, P45; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wills WH, 2012, J ANTHROPOL ARCHAEOL, V31, P138, DOI 10.1016/j.jaa.2011.11.002; Wills WirtH., 2000, ALTERNATIVE LEADERSH, P19; Windes TC, 2001, AM ANTIQUITY, V66, P119, DOI 10.2307/2694321; Windes TC, 1996, AM ANTIQUITY, V61, P295, DOI 10.2307/282427	57	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e95580	10.1371/journal.pone.0095580	http://dx.doi.org/10.1371/journal.pone.0095580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854352	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200004
J	Astorino, TA; Schubert, MM				Astorino, Todd A.; Schubert, Matthew M.			Individual Responses to Completion of Short-Term and Chronic Interval Training: A Retrospective Study	PLOS ONE			English	Article							MAXIMAL FAT OXIDATION; METABOLIC ADAPTATIONS; SKELETAL-MUSCLE; OXYGEN-UPTAKE; EXERCISE; CAPACITY; SEDENTARY; FITNESS; VO2MAX; VOLUME	Alterations in maximal oxygen uptake (VO(2)max), heart rate (HR), and fat oxidation occur in response to chronic endurance training. However, many studies report frequent incidence of "non-responders'' who do not adapt to continuous moderate exercise. Whether this is the case in response to high intensity interval training (HIT), which elicits similar adaptations as endurance training, is unknown. The aim of this retrospective study was to examine individual responses to two paradigms of interval training. In the first study (study 1), twenty active men and women (age and baseline VO(2)max=24.0 +/- 4.6 yr and 42.8 +/- 4.8 mL/kg/min) performed 6 d of sprint interval training (SIT) consisting of 4-6 Wingate tests per day, while in a separate study (study 2), 20 sedentary women (age and baseline VO(2)max=23.7 +/- 6.2 yr and 30.0 +/- 4.9 mL/kg/min) performed 12 wk of high-volume HIT at workloads ranging from 60-90% maximal workload. Individual changes in VO(2)max, HR, and fat oxidation were examined in each study, and multiple regression analysis was used to identify predictors of training adaptations to SIT and HIT. Data showed high frequency of increased VO(2)max (95%) and attenuated exercise HR (85%) in response to HIT, and low frequency of response for VO(2)max (65%) and exercise HR (55%) via SIT. Frequency of improved fat oxidation was similar (60-65%) across regimens. Only one participant across both interventions showed non-response for all variables. Baseline values of VO(2)max, exercise HR, respiratory exchange ratio, and body fat were significant predictors of adaptations to interval training. Frequency of positive responses to interval training seems to be greater in response to prolonged, higher volume interval training compared to similar durations of endurance training.	[Astorino, Todd A.] Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92078 USA; [Schubert, Matthew M.] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia	California State University System; California State University San Marcos; Griffith University	Astorino, TA (corresponding author), Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92078 USA.	astorino@csusm.edu	Schubert, Matthew/A-9799-2017	Schubert, Matthew/0000-0002-0994-8805				[Anonymous], 1994, AM J HEALTH PROMOT, DOI DOI 10.4278/0890-1171-8.4.279; Astorino T.A., 2004, J EXERC PHYSL, V7, P1; Astorino TA, 2013, MED SCI SPORT EXER, V45, P1878, DOI 10.1249/MSS.0b013e3182936261; Astorino TA, 2013, EUR J APPL PHYSIOL, V113, P2361, DOI 10.1007/s00421-013-2672-1; Astorino TA, 2009, CLIN PHYSIOL FUNCT I, V29, P60, DOI 10.1111/j.1475-097X.2008.00835.x; Astorino TA, 2011, EUR J APPL PHYSIOL, V111, P1279, DOI 10.1007/s00421-010-1741-y; Bacon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073182; Bailey SJ, 2009, J APPL PHYSIOL, V106, P1875, DOI 10.1152/japplphysiol.00144.2009; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Blaak EE, 2004, P NUTR SOC, V63, P323, DOI 10.1079/PNS2004361; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gist NH, 2013, SPORTS MED IN PRESS; Goedecke JH, 2000, AM J PHYSIOL-ENDOC M, V279, pE1325, DOI 10.1152/ajpendo.2000.279.6.E1325; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; HEYWARD VH, 2006, ADV FITNESS ASSESSME, P202; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; KOHRT WM, 1991, J APPL PHYSIOL, V71, P2004, DOI 10.1152/jappl.1991.71.5.2004; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; LORTIE G, 1984, INT J SPORTS MED, V5, P232, DOI 10.1055/s-2008-1025911; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Midgley AW, 2006, APPL PHYSIOL NUTR ME, V31, P541, DOI 10.1139/H06-023; Moholdt TT, 2009, AM HEART J, V158, P1031, DOI 10.1016/j.ahj.2009.10.003; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nybo L, 2010, MED SCI SPORT EXER, V42, P1951, DOI 10.1249/MSS.0b013e3181d99203; Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011; Saltin B, 2010, COMPR PHYSIOL, P555; Scharhag-Rosenberger F, 2012, SCAND J MED SCI SPOR, V22, P113, DOI 10.1111/j.1600-0838.2010.01139.x; Sisson SB, 2009, MED SCI SPORT EXER, V41, P539, DOI 10.1249/MSS.0b013e3181896c4e; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Stisen AB, 2006, EUR J APPL PHYSIOL, V98, P497, DOI 10.1007/s00421-006-0290-x; Talanian JL, 2007, J APPL PHYSIOL, V102, P1439, DOI 10.1152/japplphysiol.01098.2006; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Wilmore JH, 2011, MED SCI SPORTS EXERC, V33, P107	40	51	51	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97638	10.1371/journal.pone.0097638	http://dx.doi.org/10.1371/journal.pone.0097638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847797	gold, Green Published			2022-12-27	WOS:000336730600045
J	Chen, KC; Yang, TY; Wu, CC; Cheng, CC; Hsu, SL; Hung, HW; Chen, JW; Chang, GC				Chen, Kun-Chieh; Yang, Tsung-Ying; Wu, Chun-Chi; Cheng, Chi-Chih; Hsu, Shih-Lan; Hung, Hsiao-Wen; Chen, Jian-Wei; Chang, Gee-Chen			Pemetrexed Induces S-Phase Arrest and Apoptosis via a Deregulated Activation of Akt Signaling Pathway	PLOS ONE			English	Article							CELL LUNG-CANCER; KINASE-C-DELTA; MULTITARGETED ANTIFOLATE LY231514; HUMAN TUMOR XENOGRAFTS; DNA-DAMAGE; SYNERGISTIC INTERACTION; CYCLIN-A; THYMIDYLATE SYNTHASE; HEMATOPOIETIC-CELLS; UP-REGULATION	Pemetrexed is approved for first-line and maintenance treatment of patients with advanced or metastatic non-small-cell lung cancer (NSCLC). The protein kinase Akt/protein kinase B is a well-known regulator of cell survival which is activated by pemetrexed, but its role in pemetrexed-mediated cell death and its molecular mechanisms are unclear. This study showed that stimulation with pemetrexed induced S-phase arrest and cell apoptosis and a parallel increase in sustained Akt phosphorylation and nuclear accumulation in the NSCLC A549 cell line. Inhibition of Akt expression by Akt specific siRNA blocked S-phase arrest and protected cells from apoptosis, indicating an unexpected proapoptotic role of Akt in the pemetrexed-mediated toxicity. Treatment of A549 cells with pharmacological inhibitors of phosphatidylinositol 3-kinase (PI3K), wortmannin and Ly294002, similarly inhibited pemetrexed-induced S-phase arrest and apoptosis and Akt phosphorylation, indicating that PI3K is an upstream mediator of Akt and is involved in pemetrexed-mediated cell death. Previously, we identified cyclin A-associated cyclin-dependent kinase 2 (Cdk2) as the principal kinase that was required for pemetrexed-induced S-phase arrest and apoptosis. The current study showed that inhibition of Akt function and expression by pharmacological inhibitors as well as Akt siRNA drastically inhibited cyclin A/Cdk2 activation. These pemetrexed-mediated biological and molecular events were also observed in a H1299 cell line. Overall, our results indicate that, in contrast to its normal prosurvival role, the activated Akt plays a proapoptotic role in pemetrexed-mediated S-phase arrest and cell death through a mechanism that involves Cdk2/cyclin A activation.	[Chen, Kun-Chieh; Yang, Tsung-Ying; Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chen, Kun-Chieh; Chen, Jian-Wei; Chang, Gee-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Wu, Chun-Chi] Chung Shang Med Univ, Inst Med, Taichung, Taiwan; [Wu, Chun-Chi; Hsu, Shih-Lan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Chi-Chih; Hsu, Shih-Lan; Hung, Hsiao-Wen] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Hsu, Shih-Lan] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Chang, Gee-Chen] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Yang Ming Chiao Tung University	Chen, JW (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.	jwchen@dragon.nchu.edu.tw; august@vghtc.gov.tw		Chen, Jeremy J.W./0000-0003-1049-3825	Taichung Veterans General Hospital [TCVGH1003205D, TCVGH-1007322D, TCVGH-NCNU1017901]	Taichung Veterans General Hospital	This work was supported in part by grants from the Taichung Veterans General Hospital (TCVGH1003205D) to Dr. Gee-Chen Chang; and Taichung Veterans General Hospital (TCVGH-1007322D) and TCVGH-NCNU1017901 to Dr. Shih-Lan Hsu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2001, CIRC RES, V88, P408, DOI 10.1161/01.res.88.4.408; Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Bischof M, 2004, INT J RADIAT ONCOL, V60, P1220, DOI 10.1016/j.ijrobp.2004.07.689; Britten CD, 1999, CANCER CHEMOTH PHARM, V44, P105, DOI 10.1007/s002800050953; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Choi JS, 2007, APOPTOSIS, V12, P1229, DOI 10.1007/s10495-006-0047-3; Dai Y, 2003, CURR OPIN PHARMACOL, V3, P362, DOI 10.1016/S1471-4892(03)00079-1; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Ding HM, 2008, INT J CANCER, V123, P2931, DOI 10.1002/ijc.23895; Eapen AK, 2001, MOL CELL BIOL, V21, P6113, DOI 10.1128/MCB.21.18.6113-6121.2001; Edelman MJ, 2012, J THORAC ONCOL, V7, P1331, DOI 10.1097/JTO.0b013e3182629e37; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Gadgeel SM, 2013, CLIN LUNG CANCER, V14, P322, DOI 10.1016/j.cllc.2012.12.001; Giovannetti E, 2005, MOL PHARMACOL, V68, P110, DOI 10.1124/mol.104.009373; Giovannetti E, 2011, BRIT J CANCER, V105, P1542, DOI 10.1038/bjc.2011.400; Gonen N, 2012, DRUG RESIST UPDATE, V15, P183, DOI 10.1016/j.drup.2012.07.002; GRANA X, 1995, ONCOGENE, V11, P211; Greenhalgh J, 2010, HEALTH TECHNOL ASSES, V14, P33, DOI 10.3310/hta14suppl2/05; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; JACKSON RC, 1984, PHARMACOL THERAPEUT, V25, P61, DOI 10.1016/0163-7258(84)90024-X; Jin YH, 2000, J BIOL CHEM, V275, P30256, DOI 10.1074/jbc.M001902200; Jin YH, 2003, BIOCHEM BIOPH RES CO, V305, P974, DOI 10.1016/S0006-291X(03)00870-2; Khan KH, 2013, CHIN J CANCER, V32, P253, DOI 10.5732/cjc.013.10057; Lee YC, 2002, J THORAC CARDIOV SUR, V123, P502, DOI 10.1067/mtc.2002.119334; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lu B, 2006, J IMMUNOL, V176, P6785, DOI 10.4049/jimmunol.176.11.6785; Ma X, 2013, CURR MED CHEM, V20, P2991, DOI 10.2174/09298673113209990124; Maddika S, 2007, CELL PROLIFERAT, V40, P835, DOI 10.1111/j.1365-2184.2007.00475.x; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Maddika S, 2009, MOL CELL BIOL, V29, P1235, DOI 10.1128/MCB.00668-08; Narayan RS, 2013, CURR PHARM DESIGN, V19, P951; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Nimbalkar D, 2003, CANCER RES, V63, P1034; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Ramalingam S, 2008, ONCOLOGIST, V13, P5, DOI 10.1634/theoncologist.13-S1-5; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; Shack S, 2003, MOL CELL BIOL, V23, P2407, DOI 10.1128/MCB.23.7.2407-2414.2003; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Takezawa K, 2011, BRIT J CANCER, V104, P1594, DOI 10.1038/bjc.2011.129; Teicher BA, 1999, SEMIN ONCOL, V26, P55; Teicher BA, 2000, CLIN CANCER RES, V6, P1016; Tekle C, 2008, BRIT J CANCER, V99, P750, DOI 10.1038/sj.bjc.6604566; Tonkinson JL, 1997, CANCER CHEMOTH PHARM, V39, P521, DOI 10.1007/s002800050608; Tonkinson JL, 1999, CANCER RES, V59, P3671; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Vadlakondalf L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00085; van Gorp AGM, 2006, CANCER RES, V66, P10760, DOI 10.1158/0008-5472.CAN-06-1111; Volm M, 1998, BRIT J CANCER, V77, P663, DOI 10.1038/bjc.1998.106; Wakelee H, 2005, ONCOLOGIST, V10, P1, DOI 10.1634/theoncologist.10-90003-1; Welker ME, 2013, BIOORGAN MED CHEM, V21, P4063, DOI 10.1016/j.bmc.2013.04.083; Welsh SJ, 2000, CLIN CANCER RES, V6, P2538; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yang TY, 2013, MOL CARCINOGEN, V52, P183, DOI 10.1002/mc.21842; Yang TY, 2011, EUR J PHARMACOL, V663, P17, DOI 10.1016/j.ejphar.2011.04.057; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Zhan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044923	60	31	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97888	10.1371/journal.pone.0097888	http://dx.doi.org/10.1371/journal.pone.0097888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847863	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600066
J	Liao, P; Wang, H; Wang, MF; Hsiao, AS; Bach, TJ; Chye, ML				Liao, Pan; Wang, Hui; Wang, Mingfu; Hsiao, An-Shan; Bach, Thomas J.; Chye, Mee-Len			Transgenic Tobacco Overexpressing Brassica juncea HMG-CoA Synthase 1 Shows Increased Plant Growth, Pod Size and Seed Yield	PLOS ONE			English	Article							METHYLGLUTARYL COENZYME-A; ISOPENTENYL DIPHOSPHATE ISOMERASES; ISOPRENOID BIOSYNTHESIS; SQUALENE SYNTHASE; BINDING PROTEIN; STEROL BIOSYNTHESIS; MEVALONATE PATHWAY; MOLECULAR CHARACTERIZATION; METHYLTRANSFERASE TYPE-1; REDUCTASE-ACTIVITY	Seeds are very important not only in the life cycle of the plant but they represent food sources for man and animals. We report herein a mutant of 3-hydroxy-3-methylglutaryl-coenzyme A synthase (HMGS), the second enzyme in the mevalonate (MVA) pathway that can improve seed yield when overexpressed in a phylogenetically distant species. In Brassica juncea, the characterisation of four isogenes encoding HMGS has been previously reported. Enzyme kinetics on recombinant wild-type (wt) and mutant BjHMGS1 had revealed that S359A displayed a 10-fold higher enzyme activity. The overexpression of wt and mutant (S359A) BjHMGS1 in Arabidopsis had up-regulated several genes in sterol biosynthesis, increasing sterol content. To quickly assess the effects of BjHMGS1 overexpression in a phylogenetically more distant species beyond the Brassicaceae, wt and mutant (S359A) BjHMGS1 were expressed in tobacco (Nicotiana tabacum L. cv. Xanthi) of the family Solanaceae. New observations on tobacco OEs not previously reported for Arabidopsis OEs included: (i) phenotypic changes in enhanced plant growth, pod size and seed yield (more significant in OE-S359A than OE-wtBjHMGS1) in comparison to vector-transformed tobacco, (ii) higher NtSQS expression and sterol content in OE-S359A than OE-wtBjHMGS1 corresponding to greater increase in growth and seed yield, and (iii) induction of NtIPPI2 and NtGGPPS2 and downregulation of NtIPPI1, NtGGPPS1, NtGGPPS3 and NtGGPPS4. Resembling Arabidopsis HMGS-OEs, tobacco HMGS-OEs displayed an enhanced expression of NtHMGR1, NtSMT1-2, NtSMT2-1, NtSMT2-2 and NtCYP85A1. Overall, increased growth, pod size and seed yield in tobacco HMGS-OEs were attributed to the up-regulation of native NtHMGR1, NtIPPI2, NtSQS, NtSMT1-2, NtSMT2-1, NtSMT2-2 and NtCYP85A1. Hence, S359A has potential in agriculture not only in improving phytosterol content but also seed yield, which may be desirable in food crops. This work further demonstrates HMGS function in plant reproduction that is reminiscent to reduced fertility of hmgs RNAi lines in let-7 mutants of Caenorhabditis elegans.	[Liao, Pan; Wang, Hui; Wang, Mingfu; Hsiao, An-Shan; Chye, Mee-Len] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Bach, Thomas J.] CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France	University of Hong Kong; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chye, ML (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	mlchye@hkucc.hku.hk	LIAO, Pan/AAV-8138-2020; Wang, Mingfu/AAT-3292-2021; Liao, Pan/GSM-8793-2022; Chye, Mee Len/A-2740-2010	Wang, Mingfu/0000-0003-1469-3963; Liao, Pan/0000-0002-1156-8916; Chye, Mee Len/0000-0003-3505-3674	Wilson and Amelia Wong Endowment Fund; University of Hong Kong [CRCG 10400945, CRCG 104001061]	Wilson and Amelia Wong Endowment Fund; University of Hong Kong(University of Hong Kong)	This work was supported by the Wilson and Amelia Wong Endowment Fund and the University of Hong Kong (CRCG 10400945, CRCG 104001061, University Postgraduate Fellowship (PL) and studentships (HW and ASH)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; Ahumada I, 2008, FUNCT PLANT BIOL, V35, P1100, DOI 10.1071/FP08012; Alex D, 2000, PLANT J, V22, P415, DOI 10.1046/j.1365-313X.2000.00751.x; Babiychuk E, 2008, P NATL ACAD SCI USA, V105, P3163, DOI 10.1073/pnas.0712190105; BACH TJ, 1986, LIPIDS, V21, P82, DOI 10.1007/BF02534307; BACH TJ, 1983, PHYSIOL PLANTARUM, V59, P50, DOI 10.1111/j.1399-3054.1983.tb06570.x; BACH TJ, 1995, LIPIDS, V30, P191, DOI 10.1007/BF02537822; Bae H, 2009, MOL CELLS, V28, P57, DOI 10.1007/s10059-009-0101-4; BALASUBRAMANIAM S, 1977, P NATL ACAD SCI USA, V74, P1421, DOI 10.1073/pnas.74.4.1421; Bouvier-Nave P, 1998, EUR J BIOCHEM, V256, P88, DOI 10.1046/j.1432-1327.1998.2560088.x; BouvierNave P, 1997, EUR J BIOCHEM, V246, P518, DOI 10.1111/j.1432-1033.1997.t01-1-00518.x; Bradford PG, 2007, MOL NUTR FOOD RES, V51, P161, DOI 10.1002/mnfr.200600164; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; BUSH PB, 1972, PLANT PHYSIOL, V50, P69, DOI 10.1104/pp.50.1.69; CHAPPELL J, 1991, PLANT PHYSIOL, V97, P693, DOI 10.1104/pp.97.2.693; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337, DOI 10.1104/pp.109.4.1337; Chen QF, 2008, PLANT PHYSIOL, V148, P304, DOI 10.1104/pp.108.123331; Choe S, 2000, PLANT J, V21, P431, DOI 10.1046/j.1365-313x.2000.00693.x; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Chye ML, 1999, PLANT J, V18, P205, DOI 10.1046/j.1365-313X.1999.00443.x; Closa M, 2010, PLANT J, V63, P512, DOI 10.1111/j.1365-313X.2010.04253.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Devarenne TP, 2002, PLANT PHYSIOL, V129, P1095, DOI 10.1104/pp.001438; Devarenne TP, 1998, ARCH BIOCHEM BIOPHYS, V349, P205, DOI 10.1006/abbi.1997.0463; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Eisenreich W, 2001, TRENDS PLANT SCI, V6, P78, DOI 10.1016/S1360-1385(00)01812-4; Fang ZM, 2013, PLANT BIOTECHNOL J, V11, P446, DOI 10.1111/pbi.12031; FERGUSON JJ, 1959, J BIOL CHEM, V234, P1072; FONTENEAU P, 1977, PLANT SCI LETT, V10, P147, DOI 10.1016/0304-4211(77)90122-5; Gevaudant F, 2007, PLANT PHYSIOL, V144, P1763, DOI 10.1104/pp.107.103762; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; He JX, 2003, PLANT PHYSIOL, V131, P1258, DOI 10.1104/pp.014605; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Hemmerlin A, 2000, PLANT PHYSIOL, V123, P1257, DOI 10.1104/pp.123.4.1257; Hemmerlin A, 2004, LIPIDS, V39, P723, DOI 10.1007/s11745-004-1289-0; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; Hemmerlin A, 2013, PLANT SCI, V203, P41, DOI 10.1016/j.plantsci.2012.12.008; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Holmberg N, 2003, PLANT J, V36, P12, DOI 10.1046/j.1365-313X.2003.01851.x; Holmberg N, 2002, PLANT PHYSIOL, V130, P303, DOI 10.1104/pp.004226; Horsch R., 1989, PLANT MOL BIOL MANUA, P63, DOI DOI 10.1007/978-94-009-0951-9_5; Huchelmann A, 2014, PLANT PHYSIOL, V164, P935, DOI 10.1104/pp.113.232546; Perez-Espana VH, 2011, PLANT SIGNAL BEHAV, V6, P321, DOI 10.4161/psb.6.3.13206; Ishiguro S, 2010, PLANT CELL PHYSIOL, V51, P896, DOI 10.1093/pcp/pcq068; Jin HN, 2012, PLANT J, V70, P1015, DOI 10.1111/j.1365-313X.2012.04942.x; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lee MH, 2004, PLANT CELL PHYSIOL, V45, P976, DOI 10.1093/pcp/pch126; Li D, 2009, PLANT BIOTECHNOL J, V7, P791, DOI 10.1111/j.1467-7652.2009.00444.x; Li FL, 2007, PLANT PHYSIOL, V145, P87, DOI 10.1104/pp.107.100560; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; LYNEN F., 1967, PURE APPL CHEM, V14, P137, DOI 10.1351/pac196714010137; Masferrer A, 2002, PLANT J, V30, P123, DOI 10.1046/j.1365-313X.2002.01273.x; Merret R, 2007, FEBS LETT, V581, P5295, DOI 10.1016/j.febslet.2007.10.023; Montoya T, 2005, PLANT J, V42, P262, DOI 10.1111/j.1365-313X.2005.02376.x; Moreau RA, 2002, PROG LIPID RES, V41, P457, DOI 10.1016/S0163-7827(02)00006-1; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murray JAH, 2012, PLANT CELL, V24, P3907, DOI 10.1105/tpc.112.102194; Nagegowda DA, 2005, PLANTA, V221, P844, DOI 10.1007/s00425-005-1497-5; Nagegowda DA, 2004, BIOCHEM J, V383, P517, DOI 10.1042/BJ20040721; Nakamura A, 2001, FEBS LETT, V506, P61, DOI 10.1016/S0014-5793(01)02870-8; Nguyen HTM, 2013, PLANT PHYSIOL BIOCH, V73, P23, DOI 10.1016/j.plaphy.2013.07.018; Nomura T, 2005, J BIOL CHEM, V280, P17873, DOI 10.1074/jbc.M414592200; Okada K, 2008, PLANT CELL PHYSIOL, V49, P604, DOI 10.1093/pcp/pcn032; Orlova I, 2009, PLANT CELL, V21, P4002, DOI 10.1105/tpc.109.071282; Pojer F, 2006, P NATL ACAD SCI USA, V103, P11491, DOI 10.1073/pnas.0604935103; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; RUDNEY H, 1959, J BIOL CHEM, V234, P1076; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schaller H, 1998, PLANT PHYSIOL, V118, P461, DOI 10.1104/pp.118.2.461; SCHALLER H, 1995, PLANT PHYSIOL, V109, P761, DOI 10.1104/pp.109.3.761; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seo JW, 2005, PHYTOCHEMISTRY, V66, P869, DOI 10.1016/j.phytochem.2005.02.016; Shani E, 2010, PLANT CELL, V22, P3206, DOI 10.1105/tpc.110.078253; Shi Z, 2012, P NATL ACAD SCI USA, V109, P4568, DOI 10.1073/pnas.1202421109; Sitbon F, 2001, PLANTA, V212, P568, DOI 10.1007/s004250000417; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; STEWART PR, 1966, J BIOL CHEM, V241, P1222; Sun F, 2012, NEW PHYTOL, V194, P206, DOI 10.1111/j.1469-8137.2011.04026.x; Suwanmanee P, 2013, ISOPRENOID SYNTHESIS, P315; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Suzuki M, 2009, J EXP BOT, V60, P2055, DOI 10.1093/jxb/erp073; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; Wang H, 2012, PLANT BIOTECHNOL J, V10, P31, DOI 10.1111/j.1467-7652.2011.00631.x; Wentzinger L, 2013, ISOPRENOID SYNTHESIS, P347; Woyengo TA, 2009, EUR J CLIN NUTR, V63, P813, DOI 10.1038/ejcn.2009.29; Xiao S, 2008, PLANT MOL BIOL, V68, P571, DOI 10.1007/s11103-008-9392-7; Xiao S, 2010, PLANT CELL, V22, P1463, DOI 10.1105/tpc.110.075333; Zhang YJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-19	97	26	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98264	10.1371/journal.pone.0098264	http://dx.doi.org/10.1371/journal.pone.0098264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847714	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600104
J	Lindsey, PA; Nyirenda, VR; Barnes, JI; Becker, MS; McRobb, R; Tambling, CJ; Taylor, WA; Watson, FG; t'Sas-Rolfes, M				Lindsey, Peter A.; Nyirenda, Vincent R.; Barnes, Jonathan I.; Becker, Matthew S.; McRobb, Rachel; Tambling, Craig J.; Taylor, W. Andrew; Watson, Frederick G.; t'Sas-Rolfes, Michael			Underperformance of African Protected Area Networks and the Case for New Conservation Models: Insights from Zambia	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; BUSHMEAT TRADE; IMPACTS; RAINFALL; BUSINESS; BIOMASS	Many African protected areas (PAs) are not functioning effectively. We reviewed the performance of Zambia's PA network and provide insights into how their effectiveness might be improved. Zambia's PAs are under-performing in ecological, economic and social terms. Reasons include: a) rapidly expanding human populations, poverty and open-access systems in Game Management Areas (GMAs) resulting in widespread bushmeat poaching and habitat encroachment; b) underfunding of the Zambia Wildlife Authority (ZAWA) resulting in inadequate law enforcement; c) reliance of ZAWA on extracting revenues from GMAs to cover operational costs which has prevented proper devolution of user-rights over wildlife to communities; d) on-going marginalization of communities from legal benefits from wildlife; e) under-development of the photo-tourism industry with the effect that earnings are limited to a fraction of the PA network; f) unfavourable terms and corruption which discourage good practice and adequate investment by hunting operators in GMAs; g) blurred responsibilities regarding anti-poaching in GMAs resulting in under-investment by all stakeholders. The combined effect of these challenges has been a major reduction in wildlife densities in most PAs and the loss of habitat in GMAs. Wildlife fares better in areas with investment from the private and/or NGO sector and where human settlement is absent. There is a need for: elevated government funding for ZAWA; greater international donor investment in protected area management; a shift in the role of ZAWA such that they focus primarily on national parks while facilitating the development of wildlife-based land uses by other stakeholders elsewhere; and new models for the functioning of GMAs based on joint-ventures between communities and the private and/or NGO sector. Such joint-ventures should provide defined communities with ownership of land, user-rights over wildlife and aim to attract long-term private/donor investment. These recommendations are relevant for many of the under-funded PAs occurring in other African countries.	[Lindsey, Peter A.] Panthera, New York, NY USA; [Lindsey, Peter A.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, Gauteng, South Africa; [Nyirenda, Vincent R.] Zambia Wildlife Author, Lusaka, Zambia; [Barnes, Jonathan I.] Design & Dev Serv, Windhoek, Namibia; [Becker, Matthew S.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Becker, Matthew S.; Watson, Frederick G.] Zambian Carnivore Programme, Mfuwe, Zambia; [McRobb, Rachel] South Luangwa Conservat Soc, Mfuwe, Zambia; [Tambling, Craig J.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Taylor, W. Andrew] Univ Pretoria, Fac Vet Sci, Ctr Vet Wildlife Studies, ZA-0002 Pretoria, South Africa; [Watson, Frederick G.] Calif State Univ Monterey Bay, Div Sci & Environm Policy, Seaside, CA USA	University of Pretoria; Montana State University System; Montana State University Bozeman; Nelson Mandela University; University of Pretoria; California State University System; California State University Monterey Bay	Lindsey, PA (corresponding author), Panthera, New York, NY USA.	plindsey@panthera.org	Tambling, Craig/H-3554-2019; Lindsey, Peter A/J-8368-2012; Sas-Rolfes, Michael t/ABC-7132-2020	Tambling, Craig/0000-0001-9830-5985; Lindsey, Peter A/0000-0002-9197-2897; Sas-Rolfes, Michael t/0000-0002-2220-6072; Nyirenda, Vincent Raphael/0000-0002-3506-3912	Wildlife Producers Association of Zambia; Claude Leon Fellowship	Wildlife Producers Association of Zambia; Claude Leon Fellowship	The funding for this research was provided by the Wildlife Producers Association of Zambia. CJT was funded with a Claude Leon Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, RECREATIONAL HUNTING; [Anonymous], EVOLUTION INNOVATION; Bandyopadhyay S., 2010, J NAT RESOUR POLICY, V2, P39, DOI [10.1080/19390450903350838, DOI 10.1080/19390450903350838]; Becker M, 2013, BIOL CONSERV, V158, P26, DOI 10.1016/j.biocon.2012.08.017; Becker MS, 2013, J WILDLIFE MANAGE, V77, P128, DOI 10.1002/jwmg.446; Bond I, 2009, COMMUNITY MANAGEMENT, P95; Caro TM, 1998, AFR J ECOL, V36, P303, DOI 10.1046/j.1365-2028.1998.00147.x; Chemonics International Inc, 2011, SIT LIV AN STUD 9 GA; Chomba C., 2012, Journal of Ecology and the Natural Environment, V4, P303; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Cumming D., 2004, PARKS TRANSITION BIO; Cumming DH, 2008, LARGE SCALE CO UNPUB; Douglas-Hamilton I., 2009, PACHYDERM, V45, P154; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Fernandez A, 2010, MICHIGAN STATE U FOO; Frederick H., 2011, AERIAL SURVEY KAFUE; Frederick H, 2013, AERIAL SURVEY REPORT; Government of Zambia, 2010, RECL EFF MAN NAT PRO; Hamilton K., 2007, REAL EC IMPACT NATUR; Ingram J, EVIDENCE PA IN PRESS; Jones A., 2013, SOIL ATLAS AFRICA; Lewis D, 2011, P NATL ACAD SCI USA, V108, P13957, DOI 10.1073/pnas.1011538108; Lindsey P, 2013, KAFUE NATL PARK RESO; Lindsey P., 2013, REASONS WHY ZAMBIAN; Lindsey P, 2014, SEVERE IMPACTS WILDL; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2011, ORYX, V45, P96, DOI 10.1017/S0030605310000153; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081761; Lindsey PA, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P215, DOI 10.1007/978-1-4614-0902-1_12; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Makochekanwa A., 2013, BOTSWANA J EC BOJE, V11, P42; Manning I, 2011, THESIS U PRETORIA PR; Manning IPA, 2012, NAT RESOUR J, V52, P195; Nelson F, 2013, ORYX, V47, P509, DOI 10.1017/S0030605313001178; Nyirenda V. R., 2013, COLLABORATIVE GOVERN; OECD, 2013, DEV AID GLANC; Owen-Smith Norman, 2003, P310; P du, 2010, GAME RANCH MANAGEMEN; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Pfeifer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039337; Phelps J, 2011, CONSERV LETT, V4, P88, DOI 10.1111/j.1755-263X.2010.00155.x; Poulsen JR, 2009, CONSERV BIOL, V23, P1597, DOI 10.1111/j.1523-1739.2009.01251.x; Pye-Smith C, 2013, STORY NO RANGELANDS; Reid H, 2001, HUM ECOL, V29, P135, DOI 10.1023/A:1011072213331; Secretariat of the Convention on Biological Diversity, 2008, PROT AR TOD WORLD TH; Sichilongo M., 2013, ZAMBIAN WILDLIFE SEC; Simasiku P, 2008, IMPACT WILDLIFE MANA; Simukonda C, 2011, WET SEASON SURVEY AF; Simukonda C, 2008, COUNTRY WIDE SURVEY; Simwanza H, 2004, AERIAL SURVEY LARGE; Simwanza H, 2004, AERIAL SURVEY ESTABL; Simwanza H, 2005, AERIAL SURVEY LARGE; Snyman SL, 2012, J SUSTAIN TOUR, V20, P395, DOI 10.1080/09669582.2012.657202; Spierenburg M, 2010, ANTIPODE, V42, P647, DOI 10.1111/j.1467-8330.2010.00767.x; Taylor R, 2009, BIODIVERS CONSERV, V18, P2563, DOI 10.1007/s10531-009-9612-8; Viljoen P, 2013, LIUWA PLAIN NATL PAR; Vinya R., 2011, PRELIMINARY STUDY DR; Watson FGR, ENV CHANGE IN PRESS; Wels, 2003, PRIVATE WILDLIFE CON; Whyte Ian J., 2003, P332; *Wild H., 1967, VEGETATION MAP FLORA; World Bank, 2007, EC POV IMP NAT BAS T; WTTC, 2021, TRAV TOUR EC IMP 202; WTTC, 2013, EC IMP TRAV TOUR MID; Yamazaki K, 1996, J WILDLIFE MANAGE, V60, P490, DOI 10.2307/3802066; Zambia Central Statistical Office, 2011, 2010 CENS POP HOUS P; ZAWA, 2013, LIUW PLAIN NAT PARK; ZAWA (Zambia Wildlife Authority), 2013, KAF NAT PARK GEN MAN	71	88	90	0	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e94109	10.1371/journal.pone.0094109	http://dx.doi.org/10.1371/journal.pone.0094109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847712	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600004
J	Meng, FC; Zhang, JH; Yao, FM; Hao, C				Meng, Fanchao; Zhang, Jiahua; Yao, Fengmei; Hao, Cui			Interactive Effects of Elevated CO2 Concentration and Irrigation on Photosynthetic Parameters and Yield of Maize in Northeast China	PLOS ONE			English	Article							WATER-USE EFFICIENCY; CARBON-DIOXIDE CONCENTRATION; OPEN-AIR ELEVATION; ACUTE HEAT-STRESS; ATMOSPHERIC CO2; STOMATAL CONDUCTANCE; GAS-EXCHANGE; NET PHOTOSYNTHESIS; RISING CO2; GROWTH	Maize is one of the major cultivated crops of China, having a central role in ensuring the food security of the country. There has been a significant increase in studies of maize under interactive effects of elevated CO2 concentration ([CO2]) and other factors, yet the interactive effects of elevated [CO2] and increasing precipitation on maize has remained unclear. In this study, a manipulative experiment in Jinzhou, Liaoning province, Northeast China was performed so as to obtain reliable results concerning the later effects. The Open Top Chambers (OTCs) experiment was designed to control contrasting [CO2] i.e., 390, 450 and 550 mu mol.mol(-1), and the experiment with 15% increasing precipitation levels was also set based on the average monthly precipitation of 5-9 month from 1981 to 2010 and controlled by irrigation. Thus, six treatments, i.e. C550W+15%, C550(W0), C450(W+15%), C450(W0), C390(W+15%) and C-390W0 were included in this study. The results showed that the irrigation under elevated [CO2] levels increased the leaf net photosynthetic rate (P-n) and intercellular CO2 concentration (C-i) of maize. Similarly, the stomatal conductance (G(s)) and transpiration rate (T-r) decreased with elevated [CO2], but irrigation have a positive effect on increased of them at each [CO2] level, resulting in the water use efficiency (WUE) higher in natural precipitation treatment than irrigation treatment at elevated [CO2] levels. Irradiance-response parameters, e.g., maximum net photosynthetic rate (P-nmax) and light saturation points (LSP) were increased under elevated [CO2] and irrigation, and dark respiration (R-d) was increased as well. The growth characteristics, e.g., plant height, leaf area and aboveground biomass were enhanced, resulting in an improved of yield and ear characteristics except axle diameter. The study concluded by reporting that, future elevated [CO2] may favor to maize when coupled with increasing amount of precipitation in Northeast China.	[Meng, Fanchao; Zhang, Jiahua; Hao, Cui] Chinese Acad Meteorol Sci, Inst Ecoenvironm & Agrometeorol, Beijing, Peoples R China; [Meng, Fanchao] Nanjing Univ Informat Sci & Technol, Coll Atmospher Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Jiahua] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China; [Yao, Fengmei] Chinese Acad Sci, Key Lab Computat Geodynam, Beijing, Peoples R China	Chinese Academy of Meteorological Sciences (CAMS); Nanjing University of Information Science & Technology; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences	Zhang, JH (corresponding author), Chinese Acad Meteorol Sci, Inst Ecoenvironm & Agrometeorol, Beijing, Peoples R China.	jhzhang@ceode.ac.cn			Global Change Research Key Project of MOST 973 Program [2010CB951302]; Hundred Talents Program of CAS [Y24002101A]; Social Commonweal Meteorological Research Project [GYHY201106027]; CAS-RADI [Y3ZZ15101A]; CAS-TWAS	Global Change Research Key Project of MOST 973 Program; Hundred Talents Program of CAS(Chinese Academy of Sciences); Social Commonweal Meteorological Research Project; CAS-RADI; CAS-TWAS(Chinese Academy of Sciences)	This work was supported by Global Change Research Key Project of MOST 973 Program (No. 2010CB951302), the Hundred Talents Program of CAS (Y24002101A), the Social Commonweal Meteorological Research Project (No. GYHY201106027), 1-3-5 Innovation Project of CAS-RADI (Y3ZZ15101A) and CAS-TWAS project for drought monitoring and assessment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2008, GLOBAL CHANGE BIOL, V14, P1642, DOI 10.1111/j.1365-2486.2008.01594.x; Ainsworth EA, 2008, PLANT PHYSIOL, V147, P13, DOI 10.1104/pp.108.117101; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Allen LH, 2011, J PLANT PHYSIOL, V168, P1909, DOI 10.1016/j.jplph.2011.05.005; ALLEN SG, 1990, AGR ECOSYST ENVIRON, V30, P81, DOI 10.1016/0167-8809(90)90185-G; AMTHOR JS, 1994, NEW PHYTOL, V128, P443, DOI 10.1111/j.1469-8137.1994.tb02990.x; [Anonymous], 2013, SUMM POL MAK IMPL NE; [白向历 BAI Xiang-li], 2009, [玉米科学, Maize Science], V17, P60; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; Burkart S, 2004, EUR J AGRON, V21, P401, DOI 10.1016/j.eja.2004.07.003; CURE JD, 1986, AGR FOREST METEOROL, V38, P127, DOI 10.1016/0168-1923(86)90054-7; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; ELLIS RH, 1995, ANN BOT-LONDON, V75, P193, DOI 10.1006/anbo.1995.1012; Geissler N, 2009, ENVIRON EXP BOT, V65, P220, DOI 10.1016/j.envexpbot.2008.11.001; Ghannoum O, 2000, PLANT CELL ENVIRON, V23, P931, DOI 10.1046/j.1365-3040.2000.00609.x; Guo JP, 2003, RESPONSES MAINLY PLA; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Han GX, 2007, PLANT SOIL, V291, P15, DOI 10.1007/s11104-006-9170-8; [韩瑞锋 Han Ruifeng], 2012, [生态学报, Acta Ecologica Sinica], V32, P1471; Hattenschwiler S, 2006, OECOLOGIA, V147, P47, DOI 10.1007/s00442-005-0255-5; Houghton RA, 2001, CLIMATIC CHANGE, V48, P525, DOI 10.1023/A:1005658316062; Hu G, 2007, CATENA, V71, P321, DOI 10.1016/j.catena.2007.02.004; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; IDSO SB, 1993, ENVIRON EXP BOT, V33, P367, DOI 10.1016/0098-8472(93)90038-H; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Jones PD, 1996, INT J CLIMATOL, V16, P361, DOI [10.1002/(SICI)1097-0088(199604)16:4<361::AID-JOC53>3.0.CO;2-F, 10.1002/(SICI)1097-0088(199604)16:4&lt;361::AID-JOC53&gt;3.0.CO;2-F]; Kang ShaoZhong, 1999, Acta Agronomica Sinica, V25, P55; Kang SZ, 2002, PLANT SOIL, V238, P69, DOI 10.1023/A:1014244413067; Kim HY, 2001, NEW PHYTOL, V150, P223, DOI 10.1046/j.1469-8137.2001.00111.x; Kim HY, 2003, FIELD CROP RES, V83, P261, DOI 10.1016/S0378-4290(03)00076-5; Kim SH, 2007, ENVIRON EXP BOT, V61, P224, DOI 10.1016/j.envexpbot.2007.06.005; Kirschbaum MUF, 2011, PLANT PHYSIOL, V155, P117, DOI 10.1104/pp.110.166819; LEADLEY PW, 1993, VEGETATIO, V104, P3, DOI 10.1007/BF00048141; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Lee JS, 2011, AGR ECOSYST ENVIRON, V140, P484, DOI 10.1016/j.agee.2011.01.013; Liang NS, 1995, ENVIRON EXP BOT, V35, P353, DOI 10.1016/0098-8472(95)00009-8; Liu JL, 2008, ANHUI AGR SCI B, V14, P126; Liu X, 1998, SCI GEOGRAPHICA SINI, V18, P18; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; [马树庆 MA ShuQing], 2008, [生态学报, Acta Ecologica Sinica], V28, P2131; Manderscheid R, 2014, EUR J AGRON, V52, P11, DOI 10.1016/j.eja.2011.12.007; MARC J, 1984, CAN J BOT, V62, P9, DOI 10.1139/b84-002; Markelz RJC, 2011, J EXP BOT, V62, P3235, DOI 10.1093/jxb/err056; Maroco JP, 1999, PLANTA, V210, P115, DOI 10.1007/s004250050660; Mason TG, 1928, ANN BOT-LONDON, V42, P571, DOI 10.1093/oxfordjournals.aob.a090131; MAUNEY JR, 1978, CROP SCI, V18, P259, DOI 10.2135/cropsci1978.0011183X001800020016x; Milcu A, 2011, BASIC APPL ECOL, V12, P600, DOI 10.1016/j.baae.2011.08.004; MURRAY DR, 1995, AM J BOT, V82, P690, DOI 10.2307/2445426; Newton PCD, 1996, J EXP BOT, V47, P771, DOI 10.1093/jxb/47.6.771; Olszyk DM, 1997, AGR ECOSYST ENVIRON, V66, P1, DOI 10.1016/S0167-8809(97)00085-6; Olszyk DM, 2001, ENVIRON POLLUT, V115, P447, DOI 10.1016/S0269-7491(01)00234-2; Onoda Y, 2007, ECOL RES, V22, P475, DOI 10.1007/s11284-006-0030-z; Reddy AR, 2010, CURR SCI INDIA, V99, P46; Reddy KR, 2005, FIELD CROP RES, V94, P201, DOI 10.1016/j.fcr.2005.01.004; REEVES DW, 1994, J PLANT NUTR, V17, P1939, DOI 10.1080/01904169409364856; Robredo A, 2007, ENVIRON EXP BOT, V59, P252, DOI 10.1016/j.envexpbot.2006.01.001; Roden JS, 1996, PLANT PHYSIOL, V111, P909, DOI 10.1104/pp.111.3.909; Rogers A, 2009, PLANT PHYSIOL, V151, P1009, DOI 10.1104/pp.109.144113; SAMARAKOON AB, 1995, AUST J PLANT PHYSIOL, V22, P33, DOI 10.1071/PP9950033; Samarakoon AB, 1995, J BIOGEOGR, V22, P193, DOI 10.2307/2845910; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; [石耀辉 Shi Yaohui], 2013, [生态学报, Acta Ecologica Sinica], V33, P4478; Temperton VM, 2003, GLOBAL CHANGE BIOL, V9, P286, DOI 10.1046/j.1365-2486.2003.00568.x; Wall GW, 2011, AGR ECOSYST ENVIRON, V144, P390, DOI 10.1016/j.agee.2011.07.006; Wall GW, 2001, NEW PHYTOL, V152, P231, DOI 10.1046/j.0028-646X.2001.00260.x; Wallace JS, 2000, AGR ECOSYST ENVIRON, V82, P105, DOI 10.1016/S0167-8809(00)00220-6; Wang Chunyi, 1996, ACTA SCIENTICE CIRCU, V16, P331; Wang D, 2008, AM J BOT, V95, P165, DOI 10.3732/ajb.95.2.165; Wang Hui, 2012, Chinese Journal of Plant Ecology, V36, P597, DOI 10.3724/SP.J.1258.2012.00597; Wang Jian-Lin, 2012, Chinese Journal of Plant Ecology, V36, P438, DOI 10.3724/SP.J.1258.2012.00438; [王润佳 Wang Runjia], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P32; Wang XL, 1998, SCI AGR SIN, V31, P55; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604; Wu J-D, 2000, RESOURCES SCI, V22, P36; Xu Ling, 2008, Journal of Triticeae Crops, V28, P867; Xu ZZ, 2014, PLANTA, V239, P421, DOI 10.1007/s00425-013-1987-9; Yang J, 2003, CHIN AGR SCI B, V19, P28; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; Ye ZP, 2008, PHOTOSYNTHETICA, V46, P637, DOI 10.1007/s11099-008-0110-0; Zhang Q, 2006, GBT204812006 PEOPL R; Zhou HQ, 2006, J NE AGR U, V4, P5; Ziska L, 2013, WEED RES, V53, P140, DOI 10.1111/wre.12005; Ziska LH, 1997, PHOTOSYNTH RES, V54, P199, DOI 10.1023/A:1005947802161; Ziska LH, 1999, PHYSIOL PLANTARUM, V105, P74, DOI 10.1034/j.1399-3054.1999.105112.x; Zong YZ, 2014, PHOTOSYNTHETICA, V52, P63, DOI 10.1007/s11099-014-0009-x	89	28	31	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98318	10.1371/journal.pone.0098318	http://dx.doi.org/10.1371/journal.pone.0098318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848097	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600109
J	Barnett, C; Bril, V; Kapral, M; Kulkarni, A; Davis, AM				Barnett, Carolina; Bril, Vera; Kapral, Moira; Kulkarni, Abhaya; Davis, Aileen M.			A Conceptual Framework for Evaluating Impairments in Myasthenia Gravis	PLOS ONE			English	Article							RELIABILITY; DISABILITY	Background: Myasthenia gravis is characterized by weakness and fatigability of different muscle groups, including ocular, bulbar and the limbs. Therefore, a measure of disease severity at the impairment level in myasthenia needs to reflect all the relevant impairments, as well as their variations with activity and fatigue. We conducted a qualitative study of patients with myasthenia, to explore their experiences and related impairments, aimed at developing a conceptual framework of disease severity at the impairment level in myasthenia gravis. Methods: Twenty patients representing the spectrum of disease participated in semi-structured interviews. Interviews were recorded and the transcripts were analyzed by content analysis using an inductive approach with line-by-line open coding. Themes were generated from these codes. Results: Two main themes were identified: the severity of the impairments and fatigability (i.e., triggering or worsening of an impairment with activity). The impairments were further classified within body regions (ocular, bulbar and axial/limbs). Fatigability was described as a phenomenon affecting the whole body but also affecting specific impairments, and was associated with fluctuation of the symptoms. Patients were concerned that clinical examination at a single point in time might not reflect their true clinical state due to fatigability and fluctuations in severity. Conclusions: This conceptual framework reflects the relevance of both severity and fatigability in understanding impairment-based disease severity in myasthenia. This framework could inform the development of impairment measures in myasthenia gravis.	[Barnett, Carolina; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Barnett, Carolina; Bril, Vera; Kapral, Moira] Univ Hlth Network, Toronto, ON, Canada; [Barnett, Carolina; Kapral, Moira; Kulkarni, Abhaya; Davis, Aileen M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kapral, Moira] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kulkarni, Abhaya] Hosp Sick Children, Dept Neurosurg, Toronto, ON M5G 1X8, Canada; [Davis, Aileen M.] Univ Hlth Network, Toronto Western Res Inst, Div Hlth Care & Outcomes Res, Toronto, ON, Canada; [Davis, Aileen M.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Davis, Aileen M.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Barnett, C (corresponding author), Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada.	c.barnetttapia@utoronto.ca	Barnett, Carolina/AFM-9470-2022; BRIL, vera/ABA-6509-2020	Barnett, Carolina/0000-0001-5546-0221; Davis, Aileen/0000-0002-9903-9399	AAN; American Brain foundation; Grifols; CSL; Bionevia; Lilly; Pfizer; Dainippon Sumitomo; Eisai	AAN; American Brain foundation; Grifols; CSL; Bionevia; Lilly(Eli Lilly); Pfizer(Pfizer); Dainippon Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Eisai(Eisai Co Ltd)	1. Dr. Barnett holds a clinical research fellowship award by the AAN and American Brain foundation. 2. Dr. Bril has acted as consultant for Grifols, CSL, Bionevia, Lilly, Pfizer, Dainippon Sumitomo, Eisai, and has received research grant support from all of these. 3. Dr. Kapral has no disclosures. 4. Dr. Kulkarni has no disclosures. 5. Dr. Davis has no disclosures. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barnett TC, 2013, NEUROMUSCULAR DISORD, V23, P413, DOI 10.1016/j.nmd.2013.02.008; Barohn RJ, 1998, ANN NY ACAD SCI, V841, P769, DOI 10.1111/j.1749-6632.1998.tb11015.x; BESINGER UA, 1983, NEUROLOGY, V33, P1316, DOI 10.1212/WNL.33.10.1316; Burns TM, 2008, MUSCLE NERVE, V38, P1553, DOI 10.1002/mus.21185; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; de Vet HC, 2011, MEASUREMENT MED, P30; Dobkin BH, 2008, NEUROREHAB NEURAL RE, V22, P105, DOI 10.1177/1545968308315046; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; GAJDOS P, 1983, PRESSE MED, V12, P939; Gajdos P, 2003, ANN NY ACAD SCI, V998, P445, DOI 10.1196/annals.1254.058; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Howard JF, 2012, MYASTHENIA GRAVIS MY, P108; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kuks JMB, 2009, MYASTHENIA GRAVIS RE, P93; Lashley D, 2010, NEUROLOGY, V74, P1517, DOI 10.1212/WNL.0b013e3181dd43bf; Leonardi M, 2009, DISABIL REHABIL, V31, P2041, DOI 10.3109/09638280902893634; Leonardi M, 2009, INT J REHABIL RES, V32, P167, DOI 10.1097/MRR.0b013e32831e4587; MANTEGAZZA R, 1988, J NEUROL, V235, P449, DOI 10.1007/BF00314245; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Okochi Jiro, 2005, Health Qual Life Outcomes, V3, P46, DOI 10.1186/1477-7525-3-46; Romani A, 2002, FUNCT NEUROL, V17, P137; Sanders DB, 2003, ANN NY ACAD SCI, V998, P440, DOI 10.1196/annals.1254.057; Sharshar T, 2000, J NEUROL, V247, P286, DOI 10.1007/s004150050585; TINDALL RSA, 1987, NEW ENGL J MED, V316, P719, DOI 10.1056/NEJM198703193161205; Twork S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-129; WHO, 2001, WHO INT CLASS FUNCT; Zhang Y, 2009, QUALITATIVE ANAL CON, DOI DOI 10.1002/HBM.20661	30	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98089	10.1371/journal.pone.0098089	http://dx.doi.org/10.1371/journal.pone.0098089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844418	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400094
J	Carvalho, RS; Abreu, RBV; Velkova, A; Marsillac, S; Rodarte, RS; Suarez-Kurtz, G; Iversen, ES; Monteiro, ANA; Carvalho, MA				Carvalho, Renato S.; Abreu, Renata B. V.; Velkova, Aneliya; Marsillac, Sylvia; Rodarte, Renato S.; Suarez-Kurtz, Guilherme; Iversen, Edwin S.; Monteiro, Alvaro N. A.; Carvalho, Marcelo A.			Probing Structure-Function Relationships in Missense Variants in the Carboxy-Terminal Region of BRCA1	PLOS ONE			English	Article							GERM-LINE BRCA1; TRANSCRIPTIONAL ACTIVATION; BREAST; MUTATIONS; PHOSPHORYLATION; CLASSIFICATION; SUSCEPTIBILITY; INDIVIDUALS; ALLELE; ASSAY	Germline inactivating variants in BRCA1 lead to a significantly increased risk of breast and ovarian cancers in carriers. While the functional effect of many variants can be inferred from the DNA sequence, determining the effect of missense variants present a significant challenge. A series of biochemical and cell biological assays have been successfully used to explore the impact of these variants on the function of BRCA1, which contribute to assessing their likelihood of pathogenicity. It has been determined that variants that co-localize with structural or functional motifs are more likely to disrupt the stability and function of BRCA1. Here we assess the functional impact of 37 variants chosen to probe the functional impact of variants in phosphorylation sites and in the BRCT domains. In addition, we perform a meta-analysis of 170 unique variants tested by the transcription activation assays in the carboxy-terminal domain of BRCA1 using a recently developed computation model to provide assessment for functional impact and their likelihood of pathogenicity.	[Carvalho, Renato S.; Velkova, Aneliya; Marsillac, Sylvia; Monteiro, Alvaro N. A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA; [Carvalho, Renato S.; Abreu, Renata B. V.; Suarez-Kurtz, Guilherme; Carvalho, Marcelo A.] Inst Nacl Canc, Programa Farmacol, Rio De Janeiro, RJ, Brazil; [Rodarte, Renato S.] Univ Fed Alagoas, Maceio, AL, Brazil; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Carvalho, Marcelo A.] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro, Rio De Janeiro, RJ, Brazil	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; National Cancer Institute (Inca); Universidade Federal de Alagoas; Duke University; Instituto Federal do Rio de Janeiro (IFRJ)	Monteiro, ANA (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA.	alvaro.monteiro@moffitt.org; marcelo.carvalho@ifrj.edu.br	Suarez-Kurtz, Guilherme/P-4620-2019; Carvalho, Renato/AAK-3890-2020; Barbosa Vahia de Abreu, Renata/V-5594-2018; Carvalho, Marcelo/T-2014-2019; Carvalho, Marcelo A/J-7144-2012; Suarez-Kurtz, Guilherme/J-6648-2012; Monteiro, Alvaro N. A./A-7566-2009	Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Barbosa Vahia de Abreu, Renata/0000-0002-3183-1195; Carvalho, Marcelo A/0000-0002-7053-0053; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Monteiro, Alvaro N. A./0000-0002-8448-4801	National Institutes of Health [CA116167]; Florida Breast Cancer Foundation; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); INCT para o Controle do Cancer (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Department of Defense [W81XWH-08-1-0509]; NATIONAL CANCER INSTITUTE [U01CA116167, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Breast Cancer Foundation; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCT para o Controle do Cancer (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health award CA116167, and grants from the Florida Breast Cancer Foundation, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and INCT para o Controle do Cancer (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). A.V. was the recipient of a predoctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-08-1-0509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Carvalho MA, 2007, INT J BIOCHEM CELL B, V39, P298, DOI 10.1016/j.biocel.2006.08.002; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Concolino P, 2014, CLIN CHEM LAB MED, V52, P1119, DOI 10.1515/cclm-2013-1114; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gatei M, 2000, CANCER RES, V60, P3299; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Hayes F, 2000, CANCER RES, V60, P2411; Iversen ES, 2011, CANCER EPIDEM BIOMAR, V20, P1078, DOI 10.1158/1055-9965.EPI-10-1214; Jackson SA, 2014, CANCER-AM CANCER SOC, V120, P1557, DOI 10.1002/cncr.28577; JOHNSON DH, 2003, PCR PRACTICAL APPROA; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Malander S, 2004, EUR J CANCER, V40, P422, DOI 10.1016/j.ejca.2003.09.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Ouchi T, 2006, CANCER BIOL THER, V5, P470, DOI 10.4161/cbt.5.5.2845; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; Spurdle AB, 2011, HUM MUTAT; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Tomlinson GE, 1998, CANCER RES, V58, P3237; Tram E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062468; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Worley T, 2002, CANCER BIOL THER, V1, P497, DOI 10.4161/cbt.1.5.164	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97766	10.1371/journal.pone.0097766	http://dx.doi.org/10.1371/journal.pone.0097766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845084	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400059
J	Castelli, MP; Madeddu, C; Casti, A; Casu, A; Casti, P; Scherma, M; Fattore, L; Fadda, P; Ennas, MG				Castelli, M. Paola; Madeddu, Camilla; Casti, Alberto; Casu, Angelo; Casti, Paola; Scherma, Maria; Fattore, Liana; Fadda, Paola; Ennas, M. Grazia			Delta 9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED DOPAMINERGIC NEUROTOXICITY; FOCAL CEREBRAL-ISCHEMIA; ENDOCANNABINOID SYSTEM; MICROGLIAL ACTIVATION; N-ACYLETHANOLAMINES; CANNABINOID CB1; MENTAL-HEALTH; BRAIN-DAMAGE; MDMA ECSTASY	Methamphetamine (METH) is a potent psychostimulant with neurotoxic properties. Heavy use increases the activation of neuronal nitric oxide synthase (nNOS), production of peroxynitrites, microglia stimulation, and induces hyperthermia and anorectic effects. Most METH recreational users also consume cannabis. Preclinical studies have shown that natural (Delta 9-tetrahydrocannabinol, Delta 9-THC) and synthetic cannabinoid CB1 and CB2 receptor agonists exert neuroprotective effects on different models of cerebral damage. Here, we investigated the neuroprotective effect of Delta 9-THC on METH-induced neurotoxicity by examining its ability to reduce astrocyte activation and nNOS overexpression in selected brain areas. Rats exposed to a METH neurotoxic regimen (4x10 mg/kg, 2 hours apart) were pre- or post-treated with Delta 9-THC (1 or 3 mg/kg) and sacrificed 3 days after the last METH administration. Semi-quantitative immunohistochemistry was performed using antibodies against nNOS and Glial Fibrillary Acidic Protein (GFAP). Results showed that, as compared to corresponding controls (i) METH-induced nNOS overexpression in the caudate-putamen (CPu) was significantly attenuated by pre- and post-treatment with both doses of Delta 9-THC (219% and 228% for 1 mg/kg pre- and post-treated animals; 225% and 221% for 3 mg/kg pre- and post-treated animals); (ii) METH-induced GFAP-immunoreactivity (IR) was significantly reduced in the CPu by post-treatment with 1 mg/kg Delta 9-THC1 (250%) and by pre-treatment with 3 mg/kg Delta 9-THC (253%); (iii) METH-induced GFAP-IR was significantly decreased in the prefrontal cortex (PFC) by pre- and post-treatment with both doses of Delta 9-THC (234% and 247% for 1 mg/kg pre- and post-treated animals; 237% and 229% for 3 mg/kg pre- and post-treated animals). The cannabinoid CB1 receptor antagonist SR141716A attenuated METH-induced nNOS overexpression in the CPu, but failed to counteract the Delta 9-THC-mediated reduction of METH-induced GFAP-IR both in the PFC and CPu. Our results indicate that Delta 9-THC reduces METH-induced brain damage via inhibition of nNOS expression and astrocyte activation through CB1-dependent and independent mechanisms, respectively.	[Castelli, M. Paola; Madeddu, Camilla; Casti, Alberto; Casu, Angelo; Casti, Paola; Scherma, Maria; Fadda, Paola; Ennas, M. Grazia] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Castelli, M. Paola; Fadda, Paola] Univ Cagliari, Ctr Excellence Neurobiol Addict, Cagliari, Italy; [Fadda, Paola] Univ Cagliari, Natl Inst Neurosci INN, Cagliari, Italy; [Fattore, Liana] Cittadella Univ Monserrato, Natl Res Council Italy, CNR Inst Neurosci Cagliari, Cagliari, Italy	University of Cagliari; University of Cagliari; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Cagliari	Castelli, MP (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	castelli@unica.it	Scherma, Maria/AAJ-7294-2020; Castelli, Maria Paola/F-9295-2012; Fattore, Liana/AAC-6996-2021	Castelli, Maria Paola/0000-0003-3249-4706; Ennas, Maria Grazia/0000-0002-9448-715X; FADDA, PAOLA/0000-0002-0642-6710; FATTORE, LIANA/0000-0002-2663-666X	Fondazione Banco di Sardegna	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was partially supported by Grant to MPC from Fondazione Banco di Sardegna. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2007, FEBS J, V274, P4464, DOI 10.1111/j.1742-4658.2007.05975.x; Anderson KL, 2006, ANN NY ACAD SCI, V1074, P225, DOI 10.1196/annals.1369.021; Asanuma M, 2003, NEUROSCI LETT, V352, P13, DOI 10.1016/j.neulet.2003.08.015; Ayata C, 1997, J NEUROSCI, V17, P6908; Baker D, 2008, CURR PHARM DESIGN, V14, P2326, DOI 10.2174/138161208785740036; Berger C, 2004, J NEUROCHEM, V88, P1159, DOI 10.1046/j.1471-4159.2003.02244.x; Bisogno T, 2008, CURR PHARM DESIGN, V14, P2299, DOI 10.2174/138161208785740027; Blackshaw S, 2003, NEUROSCIENCE, V119, P979, DOI 10.1016/S0306-4522(03)00217-3; Bortolato M, 2010, J PSYCHIATR RES, V44, P944, DOI 10.1016/j.jpsychires.2010.03.002; Bortolato M, 2009, NEUROTOX RES, V15, P232, DOI 10.1007/s12640-009-9024-2; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Callahan BT, 1998, NEUROREPORT, V9, P2691, DOI 10.1097/00001756-199808240-00001; Cernak I, 2004, J CEREBR BLOOD F MET, V24, P564, DOI 10.1097/00004647-200405000-00011; Churchwell JC, 2012, DEV NEUROSCI-BASEL, V34, P310, DOI 10.1159/000337724; Cohen M, 2012, INT J NEUROPSYCHOPH, V15, P297, DOI 10.1017/S146114571100068X; Davidson C, 2001, BRAIN RES REV, V36, P1, DOI 10.1016/S0165-0173(01)00054-6; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; Deng XL, 1999, BRAIN RES, V851, P254, DOI 10.1016/S0006-8993(99)02087-9; El-Remessy AB, 2003, AM J PATHOL, V163, P1997, DOI 10.1016/S0002-9440(10)63558-4; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Fernandez-Ruiz J, 2010, EXPERT OPIN THER TAR, V14, P387, DOI 10.1517/14728221003709792; Fishbein M, 2012, EXP BRAIN RES, V221, P437, DOI 10.1007/s00221-012-3186-5; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; Garcia-Arencibia M, 2009, CNS NEUROL DISORD-DR, V8, P432, DOI 10.2174/187152709789824642; Goncalves J, 2010, EUR J NEUROSCI, V31, P315, DOI 10.1111/j.1460-9568.2009.07059.x; Gonzalez R, 2004, DRUG ALCOHOL DEPEN, V76, P181, DOI 10.1016/j.drugalcdep.2004.04.014; Gruber SA, 2009, DRUG ALCOHOL DEPEN, V105, P139, DOI 10.1016/j.drugalcdep.2009.06.019; Hampson AJ, 2001, EUR J NEUROSCI, V13, P1529, DOI 10.1046/j.0953-816x.2001.01536.x; Hansen HH, 2002, J NEUROCHEM, V82, P154, DOI 10.1046/j.1471-4159.2002.00961.x; Hansen HS, 1998, BIOCHEM PHARMACOL, V55, P719, DOI 10.1016/S0006-2952(97)00396-1; Imam SZ, 2001, J NEUROCHEM, V76, P745, DOI 10.1046/j.1471-4159.2001.00029.x; Itzhak Y, 2000, NEUROREPORT, V11, P2943, DOI 10.1097/00001756-200009110-00022; Kim SH, 2006, MOL PHARMACOL, V69, P691, DOI 10.1124/mol.105.016428; Kim SH, 2006, J PHARMACOL EXP THER, V319, P150, DOI 10.1124/jpet.106.107698; Kofalvi A, 2003, EUR J NEUROSCI, V18, P1973, DOI 10.1046/j.1460-9568.2003.02897.x; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Landa L, 2006, NEUROENDOCRINOL LETT, V27, P63; LaVoie MJ, 2004, EXP NEUROL, V187, P47, DOI 10.1016/j.expneurol.2004.01.010; Lawston J, 2000, BRAIN RES, V877, P407, DOI 10.1016/S0006-8993(00)02739-6; Marinelli S, 2002, J PHYSIOL-LONDON, V543, P531, DOI 10.1113/jphysiol.2002.022863; Marshall JF, 2012, TRENDS NEUROSCI, V35, P536, DOI 10.1016/j.tins.2012.05.006; Marsicano G, 2002, J NEUROCHEM, V80, P448, DOI 10.1046/j.0022-3042.2001.00716.x; Massi P, 2008, CURR PHARM DESIGN, V14, P2289, DOI 10.2174/138161208785740135; Maxwell JC, 2011, ADDICT BEHAV, V36, P1168, DOI 10.1016/j.addbeh.2011.07.017; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Morley KC, 2004, NEUROPHARMACOLOGY, V46, P954, DOI 10.1016/j.neuropharm.2004.01.002; Muthian S, 2004, NEUROSCIENCE, V129, P743, DOI 10.1016/j.neuroscience.2004.08.044; Nagayama T, 1999, J NEUROSCI, V19, P2987; O'Shea M, 2006, J PSYCHOPHARMACOL, V20, P611, DOI 10.1177/0269881106065188; Oddi S, 2012, J MOL MED, V90, P371, DOI 10.1007/s00109-011-0846-z; Ortega-Gutierrez S, 2005, GLIA, V52, P163, DOI 10.1002/glia.20229; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pegorini S, 2006, BRIT J PHARMACOL, V147, P552, DOI 10.1038/sj.bjp.0706656; Pellegrini-Giampietro DE, 2009, FEBS J, V276, P2, DOI 10.1111/j.1742-4658.2008.06765.x; Pope C, 2010, NEUROTOXICOLOGY, V31, P562, DOI 10.1016/j.neuro.2009.12.002; Rubino T, 2009, NEUROTOX RES, V15, P291, DOI 10.1007/s12640-009-9031-3; Sarne Y, 2011, BRIT J PHARMACOL, V163, P1391, DOI 10.1111/j.1476-5381.2011.01280.x; Scott LA, 2012, ADDICT BEHAV, V37, P1058, DOI 10.1016/j.addbeh.2012.04.012; Simon SL, 2002, J ADDICT DIS, V21, P61; Solowij N, 2011, PSYCHOL MED, V41, P2349, DOI 10.1017/S003329171100050X; Sung YH, 2013, BEHAV BRAIN RES, V246, P154, DOI 10.1016/j.bbr.2013.02.028; Thomas DM, 2004, NEUROSCI LETT, V367, P349, DOI 10.1016/j.neulet.2004.06.065; Torres E, 2010, J NEUROCHEM, V113, P67, DOI 10.1111/j.1471-4159.2010.06578.x; Tourino C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009143; United Nations Office on Drugs and Crime (UNODC), 2013, WORLD DRUG REP 2013; Valdeolivas S, 2012, ACS CHEM NEUROSCI, V3, P400, DOI 10.1021/cn200114w; Voytek B, 2005, SYNAPSE, V57, P113, DOI 10.1002/syn.20155; Wang J, 2011, BRAIN RES, V1369, P131, DOI 10.1016/j.brainres.2010.11.017; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x	72	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98079	10.1371/journal.pone.0098079	http://dx.doi.org/10.1371/journal.pone.0098079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844285	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400092
J	Hill, JM; Egan, JF; Stauffer, GE; Diefenbach, DR				Hill, Jason M.; Egan, J. Franklin; Stauffer, Glenn E.; Diefenbach, Duane R.			Habitat Availability Is a More Plausible Explanation than Insecticide Acute Toxicity for US Grassland Bird Species Declines	PLOS ONE			English	Article							LAND-USE; AGRICULTURAL LANDSCAPES; BREEDING BIRDS; FARMLAND BIRDS; CONSERVATION; POPULATIONS; SONGBIRDS; ABUNDANCE; CONSEQUENCES; MANAGEMENT	Grassland bird species have experienced substantial declines in North America. These declines have been largely attributed to habitat loss and degradation, especially from agricultural practices and intensification (the habitat-availability hypothesis). A recent analysis of North American Breeding Bird Survey (BBS) "grassland breeding'' bird trends reported the surprising conclusion that insecticide acute toxicity was a better correlate of grassland bird declines in North America from 1980-2003 (the insecticide-acute-toxicity hypothesis) than was habitat loss through agricultural intensification. In this paper we reached the opposite conclusion. We used an alternative statistical approach with additional habitat covariates to analyze the same grassland bird trends over the same time frame. Grassland bird trends were positively associated with increases in area of Conservation Reserve Program (CRP) lands and cropland used as pasture, whereas the effect of insecticide acute toxicity on bird trends was uncertain. Our models suggested that acute insecticide risk potentially has a detrimental effect on grassland bird trends, but models representing the habitat-availability hypothesis were 1.3-21.0 times better supported than models representing the insecticide-acute-toxicity hypothesis. Based on point estimates of effect sizes, CRP area and agricultural intensification had approximately 3.6 and 1.6 times more effect on grassland bird trends than lethal insecticide risk, respectively. Our findings suggest that preserving remaining grasslands is crucial to conserving grassland bird populations. The amount of grassland that has been lost in North America since 1980 is well documented, continuing, and staggering whereas insecticide use greatly declined prior to the 1990s. Grassland birds will likely benefit from the de-intensification of agricultural practices and the interspersion of pastures, Conservation Reserve Program lands, rangelands and other grassland habitats into existing agricultural landscapes.	[Hill, Jason M.; Stauffer, Glenn E.] Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Egan, J. Franklin] ARS, USDA, Pasture Syst & Watershed Management Res Unit, University Pk, PA USA; [Diefenbach, Duane R.] Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, US Geol Survey, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey	Hill, JM (corresponding author), Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA.	jmh656@psu.edu			ARS [ARS-0424215] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		[Anonymous], 2008, REV INDIRECT EFFECTS; [Anonymous], 2013, NY TIMES; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Askins Robert A., 2007, Ornithological Monographs, V64, pi; Atwell RC, 2011, ECOL SOC, V16; Barton K., 2013, MUMIN MULTIMODEL INF; BEST LB, 1995, AM MIDL NAT, V134, P1, DOI 10.2307/2426479; Boody G, 2005, BIOSCIENCE, V55, P27, DOI 10.1641/0006-3568(2005)055[0027:MAITUS]2.0.CO;2; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carson R., 2002, SILENT SPRING; Coppedge BR, 2001, ECOL APPL, V11, P47, DOI 10.1890/1051-0761(2001)011[0047:ARTLCI]2.0.CO;2; Dale BC, 1997, WILDLIFE SOC B, V25, P616; Daugherty AB, 1995, MAJOR USES LAND US 1; Davis SK, 2004, AUK, V121, P1130, DOI 10.1642/0004-8038(2004)121[1130:ASIGPE]2.0.CO;2; Davis SK, 2006, AUK, V123, P807, DOI 10.1642/0004-8038(2006)123[807:MPPEWA]2.0.CO;2; DECHANT J. A., 2003, EFFECTS MANAGEMENT P; Dechant JA, 2003, EFFECTS MANAGMEMENT; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frey HT, 1982, MAJOR USES LAND US 1; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Geiger F, 2010, AGR ECOSYST ENVIRON, V139, P571, DOI 10.1016/j.agee.2010.09.018; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Helzer CJ, 1999, ECOL APPL, V9, P1448; Herkert J. R., 1996, MANAGEMENT MIDWESTER; Herkert JR, 2009, CONSERV BIOL, V23, P1036, DOI 10.1111/j.1523-1739.2009.01234.x; Hiron M, 2013, AGR ECOSYST ENVIRON, V176, P9, DOI 10.1016/j.agee.2013.05.013; Johnson DH, 1995, WILSON BULL, V107, P709; Johnson Douglas H., 1996, U S Forest Service General Technical Report NC, V187, P53; Jordan N, 2010, BIOSCIENCE, V60, P60, DOI 10.1525/bio.2010.60.1.10; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Koford Rolf R., 1996, U S Forest Service General Technical Report NC, V187, P68; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; Link WA, 1997, BIOMETRICS, V53, P488, DOI 10.2307/2533952; Link WA, 1996, ECOLOGY, V77, P1633, DOI 10.2307/2265557; Lubowski RN, 2006, MAJOR USES LAND US 2; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; MCEWEN LC, 1972, J RANGE MANAGE, V25, P188, DOI 10.2307/3897053; Mela CF, 2002, APPL ECON, V34, P667, DOI 10.1080/00036840110058482; Mineau P, 2005, ECOSCIENCE, V12, P267, DOI 10.2980/i1195-6860-12-2-267.1; Mineau P, 2002, ENVIRON TOXICOL CHEM, V21, P1497, DOI 10.1897/1551-5028(2002)021&lt;1497:ETPOBM&gt;2.0.CO;2; Mineau P, 1999, POISONING RAPTORS OR; Mineau P, 2006, ENVIRON TOXICOL CHEM, V25, P1214, DOI 10.1897/05-035R.1; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Murphy MT, 2003, AUK, V120, P20, DOI 10.1642/0004-8038(2003)120[0020:APTWTE]2.0.CO;2; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Nickerson C., 2012, EC INFORM B; Nickerson C, 2011, MAJOR LAND USES US 2; North American Bird Conservation Initiative U.S. Committee, 2011, US FISH WILDL PUBL, V48; Osteen CD, 2013, PEST MANAG SCI, V69, P1001, DOI 10.1002/ps.3529; Pabian SE, 2013, J WILDLIFE MANAGE, V77, P616, DOI 10.1002/jwmg.514; Perlut NG, 2008, ECOLOGY, V89, P1941, DOI 10.1890/07-0900.1; Perlut NG, 2006, ECOL APPL, V16, P2235, DOI 10.1890/1051-0761(2006)016[2235:GSIADM]2.0.CO;2; Perlut NG, 2014, WILDLIFE SOC B, V38, P574, DOI 10.1002/wsb.415; Perlut NG, 2008, BIOL CONSERV, V141, P3139, DOI 10.1016/j.biocon.2008.09.011; Piha M, 2007, BIOL CONSERV, V140, P50, DOI 10.1016/j.biocon.2007.07.021; Powell AFLA, 2006, AUK, V123, P183, DOI 10.1642/0004-8038(2006)123[0183:EOPBAB]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Renfrew RB, 2005, AUK, V122, P618, DOI 10.1642/0004-8038(2005)122[0618:EABNGB]2.0.CO;2; Riffell Sam, 2010, Open Ornithology Journal, V3, P112, DOI 10.2174/1874453201003010112; Risebrough R.W., 1986, Current Ornithology, V3, P397; Robertson GP, 2014, BIOSCIENCE, V64, P404, DOI 10.1093/biosci/biu037; Samson F.B., 2004, GREAT PLAINS ECOSYST; Sauer JR, 2012, N AM BREEDING BIRD S; Scherr SJ, 2003, ECOAGRICULTURE STRAT, P115; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Smith C. R., 1997, GRASSLANDS NE N AM, P171; Smith HG, 2010, OECOLOGIA, V162, P1071, DOI 10.1007/s00442-010-1588-2; U.S. Department of Agriculture, 2009, SUMM REP 2007 NAT RE; U.S. Department of Agriculture, 2004, 2002 CENS AGR US SUM; U.S. Department of Commerce, 1981, 1978 CENS AGR US SUM; USDA Farm Service Agency, 2007, CONS RES PROGR SUMM; USDA Farm Service Agency, 2013, CONS RES PROGR NOV 2; Veech JA, 2006, CONSERV BIOL, V20, P1422, DOI 10.1111/j.1523-1739.2006.00487.x; Vickery PD, 1999, STUD AVIAN BIOL, P2; VICKERY PD, 1994, CONSERV BIOL, V8, P1087, DOI 10.1046/j.1523-1739.1994.08041087.x; Virkkala R, 2004, ECOGRAPHY, V27, P273, DOI 10.1111/j.0906-7590.2004.03810.x; Walk JW, 2000, BIOL CONSERV, V94, P165, DOI 10.1016/S0006-3207(99)00182-2; Wretenberg J, 2010, BIOL CONSERV, V143, P375, DOI 10.1016/j.biocon.2009.11.001; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	82	38	38	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98064	10.1371/journal.pone.0098064	http://dx.doi.org/10.1371/journal.pone.0098064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846309	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400090
J	Beogo, I; Liu, CY; Chou, YJ; Chen, CY; Huang, N				Beogo, Idrissa; Liu, Chieh-Yu; Chou, Yiing-Jenq; Chen, Chuan-Yu; Huang, Nicole			Health-Care-Seeking Patterns in the Emerging Private Sector in Burkina Faso: A Population-Based Study of Urban Adult Residents in Ouagadougou	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; OUTPATIENT CARE; MEDICAL-CARE; QUALITY; SERVICES; ACCESS; DETERMINANTS; EXPENDITURE; INSURANCE; HOSPITALS	Background: The private medical care sector is expanding in urban cities in Sub-Saharan Africa (SSA). However, people's health-care-seeking behaviors in this new landscape remain poorly understood; furthermore, distinguishing between public and private providers and among various types of private providers is critical in this investigation. This study assessed, by type, the healthcare providers urban residents in Burkina Faso visit, and their choice determinants. Method: We conducted a population-based survey of a representative sample of 1,600 households in Ouagadougou from July to November 2011, consisting of 5,820 adults. We assessed the types of providers people typically sought for severe and non-severe conditions. We applied generalized estimating equations in this study. Results: Among those surveyed, 97.7% and 53.1% indicated that they seek a formal provider for treating severe and non-severe conditions, respectively. Among the formal provider seekers, 20.5% and 17.0% chose for-profit (FP) providers for treating severe and non-severe conditions, respectively. Insurance coverage was held by 2.0% of those surveyed. Possessing insurance was the strongest predictor for seeking FP, for both severe (odds ratio [OR] = 1.15, 95% confidence interval [CI] = 1.04-1.28), and non-severe conditions (OR = 1.22, 95% CI = 1.07-1.39). Other predictors included being a formal jobholder and holding a higher level education. By contrast, we observed no significant difference in predisposing, enabling, or need characteristics between not-for-profit (NFP) provider seekers and public provider seekers. Proximity was the primary reason for choosing a provider. Conclusion: The results suggested that FP providers play a crucial role in the urban healthcare market in SSA. Socioeconomic status and insurance status are significant predictors of provider choice. The findings can serve as a crucial reference for policymakers in response to the emergence of FP providers in SSA.	[Beogo, Idrissa] Natl Yang Ming Univ, Int Hlth Program, Taipei 112, Taiwan; [Beogo, Idrissa] Ecole Natl Sante Publ, Ouagadougou, Burkina Faso; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei, Taiwan; [Chou, Yiing-Jenq; Chen, Chuan-Yu] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, N (corresponding author), Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Sch Med, Taipei 112, Taiwan.	syhuang@ym.edu.tw	Liu, Chieh-Yu/AAR-9654-2021; Liu, Chieh-Yu/J-3789-2019; Chen, Chuan-Yu/C-7697-2011	Liu, Chieh-Yu/0000-0003-3283-028X; Huang, Nicole/0000-0002-6629-1176; Beogo, Idrissa/0000-0003-1467-2169; Chen, Chuan-Yu/0000-0001-8937-1171	International Health Program of National Yang Ming University; Taiwan-ICDF; APRHC; African Doctoral Dissertation Research Fellowship	International Health Program of National Yang Ming University; Taiwan-ICDF; APRHC; African Doctoral Dissertation Research Fellowship	The authors are indebted to International Health Program of National Yang Ming University and to Taiwan-ICDF for their scholarships. The authors address many thanks to APRHC and the 2012 African Doctoral Dissertation Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2009, INT J QUAL HEALTH C, V21, P87, DOI 10.1093/intqhc/mzp002; Ahmed SM, 2003, HEALTH POLICY PLANN, V18, P306, DOI 10.1093/heapol/czg037; Amaghionyeodiwe LA, 2008, HEALTH CARE MANAG SC, V11, P215, DOI 10.1007/s10729-007-9038-3; Andaleeb SS, 2000, HEALTH POLICY PLANN, V15, P95, DOI 10.1093/heapol/15.1.95; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Basu S, 2012, PLOS MED, V9, P1; Bayala ALL, 2009, MONOGRAPHIE COMMUNE; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; BENNETT S, 1992, HEALTH POLICY PLANN, V7, P97, DOI 10.1093/heapol/7.2.97; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Berlan D, 2011, HLTH POLICY PLAN; BITRAN R, 1995, HEALTH POLICY PLANN, V10, P271, DOI 10.1093/heapol/10.3.271; Blay SL, 2008, MED CARE, V46, P930, DOI 10.1097/MLR.0b013e318179254c; Bryant J, 2005, HEALTH POLICY, V73, P160, DOI 10.1016/j.healthpol.2004.11.011; Buchmueller TC, 2004, HEALTH ECON, V13, P669, DOI 10.1002/hec.879; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; De Allegri M, 2011, HEALTH POLICY, V99, P210, DOI 10.1016/j.healthpol.2010.10.010; Develay A, 1996, SOC SCI MED, V43, P1611, DOI 10.1016/S0277-9536(96)00061-5; Diallo I, 1996, World Health Forum, V17, P382; Dilip TR, 2010, HEALTH POLICY PLANN, V25, P437, DOI 10.1093/heapol/czq012; Ergler CR, 2011, SOC SCI MED, V72, P327, DOI 10.1016/j.socscimed.2010.09.042; Farsi M, 2008, HEALTH ECON, V17, P335, DOI 10.1002/hec.1268; Faso Mdls-B, 2011, REP 2010 EST PRIV SO, P162; Fatusi AO, 2010, J ADOLESCENCE, V33, P499, DOI 10.1016/j.adolescence.2010.05.019; Fernando DN, 2009, J COLL COMMUNITY PHY, V14, P1; Fiedler JL, 2003, INT J HEALTH PLAN M, V18, P179, DOI 10.1002/hpm.709; Fotso JC, 2011, HLTH POLICY PLAN; Frederick Mugisha KB, 2004, B WORLD HEALTH ORGAN, V82, P572; Gash T., 2013, MAKING PUBLIC SERVIC; Gauthier B, 2011, SOC SCI MED, V73, P540, DOI 10.1016/j.socscimed.2011.06.008; Ha NTH, 2002, HEALTH POLICY PLANN, V17, P61, DOI 10.1093/heapol/17.1.61; Habtom GK, 2007, HEALTH POLICY, V80, P202, DOI 10.1016/j.healthpol.2006.02.012; HADDAD S, 1995, SOC SCI MED, V40, P743, DOI 10.1016/0277-9536(94)00134-F; Hall JJ, 2003, MED J AUSTRALIA, V178, P17, DOI 10.5694/j.1326-5377.2003.tb05033.x; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harpham T, 2007, BACKGROUND PAPER INO; Hjortsberg C, 2003, HEALTH ECON, V12, P755, DOI 10.1002/hec.839; INSD Burkina Faso, 2012, DEMOGRAPHIE INDLSEDL, P550; INSD Burkina Faso, 2008, RECENSEMENT GEN POPU, P52; Janjua Naveed Z., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1242; Kessler D, 2001, RES NBOE; Kin L. M., 2002, ROLE SCOPE PRIVATE M; Konde-Lule J, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-29; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Lawson D, 2004, DETERMINANTS HLTH SE, P30; Lemeshow S, 1985, World Health Stat Q, V38, P65; Levesque JF, 2006, HEALTH POLICY PLANN, V21, P289, DOI 10.1093/heapol/czl013; Liaropoulos L, 2008, HEALTH POLICY, V87, P72, DOI 10.1016/j.healthpol.2007.12.005; Marek T., 2005, TRENDS OPPORTUNITIES; Matthews Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000327; Meremikwu M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-55; Ministere de la sante-Burkina Faso, 2010, DOC AN CART OFFR SOI; Ministere Sante Burkina Faso, 2011, REP 2010 EST PRIV SO, P162; Ministere Sante-Burkina Faso, 2011, EV SECT PRIV SANT BU; Ministere Sante-Burkina Faso, 2010, DEUX ETATS GEN SANT, P300; Ministere Sante-Burkina Faso, 2012, ANN STAT 2011; Montagu D, 2002, HEALTH POLICY PLANN, V17, P121, DOI 10.1093/heapol/17.2.121; Nuwaha F, 2006, SEX TRANSM DIS, V33, P422, DOI 10.1097/01.olq.0000204574.78135.9f; Palmer N, 2003, B WORLD HEALTH ORGAN, V81, P292; Perin I, 2003, LANCET, V361, P1216, DOI 10.1016/S0140-6736(03)12956-X; Perlman F, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-68; Prata N, 2005, B WORLD HEALTH ORGAN, V83, P274; Rodriguez M, 2004, HEALTH ECON, V13, P689, DOI 10.1002/hec.832; Rutebemberwa E, 2009, MALARIA J, V8, P1; Saksena P, 2012, TROP MED INT HEALTH, V17, P23, DOI 10.1111/j.1365-3156.2011.02894.x; Sambo LG, 2011, INT ARCH MED, V4, P1, DOI DOI 10.1186/1755-7682-4-1; Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Tembon AC, 1996, INT J HEALTH PLAN M, V11, P53; Tipke M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-266; Tuan T, 2005, HEALTH POLICY PLANN, V20, P319, DOI 10.1093/heapol/czi037; Van den Heever AM, 2012, BMC PUBLIC HEALTH, V12, P1; Varenne B, 2005, B WORLD HEALTH ORGAN, V83, P650; Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065; Vlahov D, 2002, J URBAN HEALTH, V79, pS1, DOI 10.1093/jurban/79.suppl_1.S1; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; Vlahov David, 2005, Cad. Saúde Pública, V21, P949, DOI 10.1590/S0102-311X2005000300031; Walker D, 2001, HEALTH POLICY PLANN, V16, P35, DOI 10.1093/heapol/16.1.35; Waters HR, 2008, HEALTH ECON, V17, P21, DOI 10.1002/hec.1239; WHO, 2010, WOR HEALT REP, P1; WHO, 2008, PHARMAFORUM 0121; Wong SYS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-397; World Bank, 2015, LEVERAGING URBANIZAT; World Health Organization, 2010, WATER AND HEALTH; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2010, 63 WHO ASS RES DEC; Yanagisawa S, 2004, PUBLIC HEALTH, V118, P21, DOI 10.1016/S0033-3506(03)00140-9; Yoong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013243	89	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97521	10.1371/journal.pone.0097521	http://dx.doi.org/10.1371/journal.pone.0097521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842536	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600039
J	Yasser, M; Shaikh, R; Chilakapati, MK; Teni, T				Yasser, Mohd; Shaikh, Rubina; Chilakapati, Murali Krishna; Teni, Tanuja			Raman Spectroscopic Study of Radioresistant Oral Cancer Sublines Established by Fractionated Ionizing Radiation	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; IN-VITRO; INCREASED EXPRESSION; ANTIOXIDANT ENZYMES; OPTICAL PATHOLOGY; APOPTOSIS; TUMOR; RADIOTHERAPY; RESISTANCE; PHENOTYPE	Radiotherapy is an important treatment modality for oral cancer. However, development of radioresistance is a major hurdle in the efficacy of radiotherapy in oral cancer patients. Identifying predictors of radioresistance is a challenging task and has met with little success. The aim of the present study was to explore the differential spectral profiles of the established radioresistant sublines and parental oral cancer cell lines by Raman spectroscopy. We have established radioresistant sublines namely, 50Gy-UPCI:SCC029B and 70Gy-UPCI:SCC029B from its parental UPCI:SCC029B cell line, by using clinically admissible 2Gy fractionated ionizing radiation (FIR). The developed radioresistant character was validated by clonogenic cell survival assay and known radioresistance-related protein markers like Mcl-1, Bcl-2, Cox-2 and Survivin. Altered cellular morphology with significant increase (p < 0.001) in the number of filopodia in radioresistant cells with respect to parental cells was observed. The Raman spectra of parental UPCI:SCC029B, 50Gy-UPCI:SCC029B and 70Gy-UPCI:SCC029B cells were acquired and spectral features indicate possible differences in biomolecules like proteins, lipids and nucleic acids. Principal component analysis (PCA) provided three clusters corresponding to radioresistant 50Gy, 70Gy-UPCI:SCC029B sublines and parental UPCI: SCC029B cell line with minor overlap, which suggest altered molecular profile acquired by the radioresistant cells due to multiple doses of irradiation. The findings of this study support the potential of Raman spectroscopy in prediction of radioresistance and possibly contribute to better prognosis of oral cancer.	[Yasser, Mohd; Teni, Tanuja] Tata Mem Hosp, ACTREC, Teni Lab, Kharghar Node, Navi Mumbai, India; [Shaikh, Rubina; Chilakapati, Murali Krishna] Tata Mem Hosp, ACTREC, Chilakapati Lab, Kharghar Node, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Chilakapati, MK (corresponding author), Tata Mem Hosp, ACTREC, Chilakapati Lab, KS-04, Kharghar Node, Navi Mumbai, India.	mchilakapati@actrec.gov.in; tteni@actrec.gov.in	shaikh, rubina/AAS-2776-2020	Multhoff, Gabriele/0000-0002-2616-3137; Shaikh, Dr Rubina/0000-0003-4184-8254; C, Murali Krishna/0000-0002-4974-8533	Department of Biotechnology, Government of India [BT/PRI11282/MED/32/83/2008]; University Grants Commission (UGC) - India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission (UGC) - India(University Grants Commission, India)	The Raman spectrometer employed in the study was procured from DBT project BT/PRI11282/MED/32/83/2008, entitled "Development of in vivo laser Raman spectroscopy methods for diagnosis of oral precancerous and cancerous conditions," Department of Biotechnology, Government of India. Mohd Yasser is funded by a fellowship from the University Grants Commission (UGC) - India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bates S, 1996, CURR OPIN GENET DEV, V6, P12, DOI 10.1016/S0959-437X(96)90004-0; Bessell A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD006205.PUB3; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bucci B, 2006, ANTICANCER RES, V26, P4549; Chapman JD, 1998, RADIOTHER ONCOL, V46, P229, DOI 10.1016/S0167-8140(97)00186-2; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; De Veld DCG, 2005, ORAL ONCOL, V41, P117, DOI 10.1016/j.oraloncology.2004.07.007; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Fenton RG, 2011, HARRISONS PRINCIPLES, P294; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreira DS, 2010, IEEE ENG MED BIO, P1210, DOI 10.1109/IEMBS.2010.5626448; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ghanate AD, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548303; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; Ishigami T, 2007, INT J CANCER, V120, P2262, DOI 10.1002/ijc.22561; John-Aryankalayil M, 2010, RADIAT RES, V174, P446, DOI 10.1667/RR2105.1; Kitada S, 1993, Antisense Res Dev, V3, P157; Koljenovic S, 2002, LAB INVEST, V82, P1265, DOI 10.1097/01.LAB.0000032545.96931.B8; Krishna CM, 2006, BIOPOLYMERS, V82, P462, DOI 10.1002/bip.20485; Krishna CM, 2005, BBA-GEN SUBJECTS, V1726, P160, DOI 10.1016/j.bbagen.2005.08.006; Krishna CM, 2004, APPL SPECTROSC, V58, P1128, DOI 10.1366/0003702041959460; Lee HC, 2004, INT J MOL MED, V13, P883; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malini R, 2006, BIOPOLYMERS, V81, P179, DOI 10.1002/bip.20398; Mallick S, 2009, J PATHOL, V217, P398, DOI 10.1002/path.2459; Martin CL, 2008, ORAL ONCOL, V44, P369, DOI 10.1016/j.oraloncology.2007.05.003; Carrillo MM, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-103; Matthews Q, 2011, PHYS MED BIOL, V56, P6839, DOI 10.1088/0031-9155/56/21/006; Matthews Q, 2011, PHYS MED BIOL, V56, P19, DOI 10.1088/0031-9155/56/1/002; Moosmann B, 2000, EUR J BIOCHEM, V267, P5687, DOI 10.1046/j.1432-1327.2000.01658.x; Nijssen A, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2750287; Nijsssen A, 2009, J BIOPHOTONICS, V2, P29, DOI 10.1002/jbio.200810055; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Palve VC, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-135; Rajendran R., 2009, SHAFERS TXB ORAL PAT; Rubina S, 2013, VIB SPECTROSC, V68, P115, DOI 10.1016/j.vibspec.2013.06.002; Rubina S, 2013, J INNOV OPT HEAL SCI, V6, DOI 10.1142/S1793545813500144; Sahu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078921; Sahu A, 2013, ANALYST, V138, P4161, DOI 10.1039/c3an00308f; Shannan B, 2006, J MOL HISTOL, V37, P183, DOI 10.1007/s10735-006-9052-7; SINGH AD, 1966, AMER J ROENTGENOL RA, V96, P6, DOI 10.2214/ajr.96.1.6; Singh SP, 2013, ANALYST, V138, P4175, DOI 10.1039/c3an36761d; Singh SP, 2012, J CANCER RES THER, V8, P126, DOI 10.4103/0973-1482.92227; Singh SP, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.105002; SKLAR MD, 1991, MOL CELL BIOL, V11, P3699, DOI 10.1128/MCB.11.7.3699; Skvara H, 2005, ANTICANCER RES, V25, P2697; Sun J, 1998, FREE RADICAL BIO MED, V24, P586, DOI 10.1016/S0891-5849(97)00291-8; Terakado N, 2004, ORAL ONCOL, V40, P383, DOI 10.1016/j.oraloncology.2003.09.005; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Venkatakrishna K, 2001, CURR SCI INDIA, V80, P665; Wang B, 2014, CELL DEATH DIFFER, V21, P1160, DOI 10.1038/cdd.2014.42; Wu JG, 2001, BIOPOLYMERS, V62, P185, DOI 10.1002/bip.1013; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yasuda H, 2008, NITRIC OXIDE-BIOL CH, V19, P205, DOI 10.1016/j.niox.2008.04.026	55	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97777	10.1371/journal.pone.0097777	http://dx.doi.org/10.1371/journal.pone.0097777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841281	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600072
J	Laurence, M; Hatzis, C; Brash, DE				Laurence, Martin; Hatzis, Christos; Brash, Douglas E.			Common Contaminants in Next-Generation Sequencing That Hinder Discovery of Low-Abundance Microbes	PLOS ONE			English	Article							PROSTATE-CANCER; SAMPLES; FUNGAL; DNA	Unbiased high-throughput sequencing of whole metagenome shotgun DNA libraries is a promising new approach to identifying microbes in clinical specimens, which, unlike other techniques, is not limited to known sequences. Unlike most sequencing applications, it is highly sensitive to laboratory contaminants as these will appear to originate from the clinical specimens. To assess the extent and diversity of sequence contaminants, we aligned 57 "1000 Genomes Project'' sequencing runs from six centers against the four largest NCBI BLAST databases, detecting reads of diverse contaminant species in all runs and identifying the most common of these contaminant genera (Bradyrhizobium) in assembled genomes from the NCBI Genome database. Many of these microorganisms have been reported as contaminants of ultrapure water systems. Studies aiming to identify novel microbes in clinical specimens will greatly benefit from not only preventive measures such as extensive UV irradiation of water and cross-validation using independent techniques, but also a concerted effort to sequence the complete genomes of common contaminants so that they may be subtracted computationally.	[Laurence, Martin] Shipshaw Labs, Montreal, PQ, Canada; [Hatzis, Christos] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA; [Brash, Douglas E.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA	Yale University; Yale University	Brash, DE (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	douglas.brash@yale.edu	Hatzis, Christos/M-3867-2015	Hatzis, Christos/0000-0002-8120-2290	NIH Skin Cancer SPORE [5P50CA121974]; Yale University; Shipshaw Labs Inc.; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER	NIH Skin Cancer SPORE; Yale University; Shipshaw Labs Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DEB is supported by NIH Skin Cancer SPORE grant 5P50CA121974, CH was supported by Yale University, and ML was supported by Shipshaw Labs Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No patents, products in development or marketed products are related to the findings reported in this paper. These affiliations do not alter the authors adherence to PLOS ONE Policies on sharing data and materials. The Leif Microbiome Analyzer is a commercial product of Shipshaw labs.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Duncan CG, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-22; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kulakov LA, 2002, APPL ENVIRON MICROB, V68, P1548, DOI 10.1128/AEM.68.4.1548-1555.2002; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076142; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Percudani R, 2013, BIOINFORM BIOL INSIG, V7, P55, DOI 10.4137/BBI.S11064; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Stott-Miller M, 2013, PROSTATE, V73, P1803, DOI 10.1002/pros.22719; Sutcliffe S, 2014, PROSTATE, V74, P569, DOI 10.1002/pros.22778	18	186	190	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97876	10.1371/journal.pone.0097876	http://dx.doi.org/10.1371/journal.pone.0097876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837716	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800079
J	Caito, S; Zeng, H; Aschner, JL; Aschner, M				Caito, Samuel; Zeng, Heng; Aschner, Judy L.; Aschner, Michael			Methylmercury Alters the Activities of Hsp90 Client Proteins, Prostaglandin E Synthase/p23 (PGES/23) and nNOS	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HEAT-SHOCK-PROTEIN; PHOSPHOLIPASE A(2) EXPRESSION; ARACHIDONIC-ACID RELEASE; CULTURED ASTROCYTES; EXCITOTOXIC LESION; OXIDATIVE STRESS; E-2 SYNTHASE; GLUTAMATE; MERCURY	Methylmercury (MeHg) is a persistent pollutant with known neurotoxic effects. We have previously shown that astrocytes accumulate MeHg and play a prominent role in mediating MeHg toxicity in the central nervous system (CNS) by altering glutamate signaling, generating oxidative stress, depleting glutathione (GSH) and initiating lipid peroxidation. Interestingly, all of these pathways can be regulated by the constitutively expressed, 90-kDa heat shock protein, Hsp90. As Hsp90 function is regulated by oxidative stress, we hypothesized that MeHg disrupts Hsp90-client protein functions. Astrocytes were treated with MeHg and expression of Hsp90, as well as the abundance of complexes of Hsp90-neuronal nitric oxide synthase (nNOS) and Hsp90-prostaglandin E synthase/p23 (PGES/p23) were assessed. MeHg exposure decreased Hsp90 protein expression following 12 h of treatment while shorter exposures had no effect on Hsp90 protein expression. Interestingly, following 1 or 6 h of MeHg exposure, Hsp90 binding to PGES/p23 or nNOS was significantly increased, resulting in increased prostaglandin E-2 (PGE(2)) synthesis from MeHg-treated astrocytes. These effects were attenuated by the Hsp90 antagonist, geldanmycin. NOS activity was increased following MeHg treatment while cGMP formation was decreased. This was accompanied by an increase in center dot O-2(-) and H2O2 levels, suggesting that MeHg uncouples NO formation from NO-dependent signaling and increases oxidative stress. Altogether, our data demonstrates that Hsp90 interactions with client proteins are increased following MeHg exposure, but over time Hsp90 levels decline, contributing to oxidative stress and MeHg-dependent excitotoxicity.	[Caito, Samuel; Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Zeng, Heng; Aschner, Michael] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Aschner, Judy L.; Aschner, Michael] Yeshiva Univ, Albert Einstein Coll Med, Dept Pediat & Obstet & Gynecol, Bronx, NY USA; [Aschner, Michael] Albert Einstein Coll Med, Kennedy Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Aschner, M (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	michael.aschner@einstein.yu.edu			NIEHS [R01 ES007331]; Vanderbilt University Center in Molecular Toxicology [P30 ES000267]; Vanderbilt University Training Program in Environmental Toxicology [5T32 ES007028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, R01ES007331, P30ES000267] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Vanderbilt University Center in Molecular Toxicology; Vanderbilt University Training Program in Environmental Toxicology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIEHS R01 ES007331, the Vanderbilt University Center in Molecular Toxicology (P30 ES000267), and the Vanderbilt University Training Program in Environmental Toxicology (5T32 ES007028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2001, BRAIN RES, V902, P92, DOI 10.1016/S0006-8993(01)02375-7; ASCHNER M, 1993, BRAIN RES, V602, P181, DOI 10.1016/0006-8993(93)90680-L; Aschner M, 2000, NEUROCHEM INT, V37, P199, DOI 10.1016/S0197-0186(00)00023-1; Aschner M, 1998, BRAIN RES, V811, P133, DOI 10.1016/S0006-8993(98)00629-5; ASCHNER M, 1990, BRAIN RES, V530, P245, DOI 10.1016/0006-8993(90)91290-W; Beck R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040795; Beck R, 2009, BIOCHEM PHARMACOL, V77, P375, DOI 10.1016/j.bcp.2008.10.019; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BROOKES N, 1992, TOXICOLOGY, V76, P245, DOI 10.1016/0300-483X(92)90193-I; BROOKES N, 1989, J NEUROCHEM, V53, P1228, DOI 10.1111/j.1471-4159.1989.tb07419.x; Caplan AJ, 1999, TRENDS CELL BIOL, V9, P262, DOI 10.1016/S0962-8924(99)01580-9; Carvalho CML, 2008, J BIOL CHEM, V283, P11913, DOI 10.1074/jbc.M710133200; Charleston JS, 1996, NEUROTOXICOLOGY, V17, P127; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Ekino S, 2007, J NEUROL SCI, V262, P131, DOI 10.1016/j.jns.2007.06.036; Farina M, 2011, TOXICOL APPL PHARM, V256, P405, DOI 10.1016/j.taap.2011.05.001; Farina M, 2009, TOXICOL SCI, V112, P416, DOI 10.1093/toxsci/kfp219; GARMAN RH, 1975, ACTA NEUROPATHOL, V32, P61, DOI 10.1007/BF00686067; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; Goering PL, 2000, TOXICOL SCI, V53, P447, DOI 10.1093/toxsci/53.2.447; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Grandjean P, 2010, ENVIRON HEALTH PERSP, V118, P1137, DOI 10.1289/ehp.0901757; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Helmcke KJ, 2010, TOXICOL APPL PHARM, V248, P156, DOI 10.1016/j.taap.2010.07.023; Herculano AM, 2006, BRAZ J MED BIOL RES, V39, P415, DOI 10.1590/S0100-879X2006000300013; Horn TFW, 2002, FASEB J, V16, P1611, DOI 10.1096/fj.02-0126com; Ikeda M, 1999, J NEUROSCI RES, V55, P352, DOI 10.1002/(SICI)1097-4547(19990201)55:3<352::AID-JNR10>3.0.CO;2-3; Jeon GS, 2004, GLIA, V48, P250, DOI 10.1002/glia.20075; Lecanu L, 1998, BRIT J PHARMACOL, V125, P584, DOI 10.1038/sj.bjp.0702119; Lee M, 2001, ARIEL-REV INT ENGL, V32, P90; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; MAILHOS C, 1994, J NEUROCHEM, V63, P1787; Mori N, 2007, ARCH TOXICOL, V81, P769, DOI 10.1007/s00204-007-0209-2; Morken TS, 2005, TOXICOL SCI, V87, P169, DOI 10.1093/toxsci/kfi227; MULLANEY KJ, 1994, BRAIN RES, V641, P1, DOI 10.1016/0006-8993(94)91808-2; Mutkus L, 2005, BIOL TRACE ELEM RES, V107, P231, DOI 10.1385/BTER:107:3:231; Nardai G, 2000, ARCH BIOCHEM BIOPHYS, V384, P59, DOI 10.1006/abbi.2000.2075; Ni Mingwei, 2010, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1217s43; Ni MW, 2011, GLIA, V59, P810, DOI 10.1002/glia.21153; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Papaconstantinou AD, 2003, BIRTH DEFECTS RES B, V68, P456, DOI 10.1002/bdrb.10044; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rameau GA, 2003, NEUROBIOL AGING, V24, P1123, DOI 10.1016/j.neurobiolaging.2003.07.002; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Shanker G, 2004, MOL BRAIN RES, V128, P48, DOI 10.1016/j.molbrainres.2004.05.022; Shanker G, 2004, NEUROTOXICOLOGY, V25, P399, DOI 10.1016/j.neuro.2003.08.008; Shanker G, 2003, MOL BRAIN RES, V110, P85, DOI 10.1016/S0169-328X(02)00642-3; Shanker G, 2002, MOL BRAIN RES, V106, P1, DOI 10.1016/S0169-328X(02)00403-5; Shanker G, 2001, J NEUROSCI RES, V66, P998, DOI 10.1002/jnr.10066; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; Sullivan JC, 2006, CIRC RES, V98, P717, DOI 10.1161/01.RES.0000217594.97174.c2; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tani M, 1996, AM J PATHOL, V148, P889; Tanioka T, 2003, BIOCHEM BIOPH RES CO, V303, P1018, DOI 10.1016/S0006-291X(03)00470-4; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Wormser U, 2012, NEUROTOXICOLOGY, V33, P763, DOI 10.1016/j.neuro.2011.12.004; Xia Y, 2007, ANTIOXID REDOX SIGN, V9, P1773, DOI 10.1089/ars.2007.1733; Yao SY, 2010, J NEUROIMMUNOL, V229, P146, DOI 10.1016/j.jneuroim.2010.07.023; YU ACH, 1987, J NEUROSCI RES, V17, P424, DOI 10.1002/jnr.490170414; Zemolin APP, 2012, TOXICOLOGY, V302, P60, DOI 10.1016/j.tox.2012.07.013	68	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98161	10.1371/journal.pone.0098161	http://dx.doi.org/10.1371/journal.pone.0098161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852575	Green Submitted, gold, Green Published			2022-12-27	WOS:000338323200051
J	Kato, T; Kawai, K; Egami, Y; Kakehi, Y; Araki, N				Kato, Takuma; Kawai, Katsuhisa; Egami, Youhei; Kakehi, Yoshiyuki; Araki, Nobukazu			Rac1-Dependent Lamellipodial Motility in Prostate Cancer PC-3 Cells Revealed by Optogenetic Control of Rac1 Activity	PLOS ONE			English	Article							SMALL GTPASES; RHO-GTPASE; MIGRATION; ACTIVATION; MACROPINOCYTOSIS; FIBROBLASTS; METASTASIS; COMPLETION; EXPRESSION; INHIBITOR	The lamellipodium, an essential structure for cell migration, plays an important role in the invasion and metastasis of cancer cells. Although Rac1 recognized as a key player in the formation of lamellipodia, the molecular mechanisms underlying lamellipodial motility are not fully understood. Optogenetic technology enabled us to spatiotemporally control the activity of photoactivatable Rac1 (PA-Rac1) in living cells. Using this system, we revealed the role of phosphatidylinositol 3-kinase (PI3K) in Rac1-dependent lamellipodial motility in PC-3 prostate cancer cells. Through local blue laser irradiation of PA-Rac1-expressing cells, lamellipodial motility was reversibly induced. First, outward extension of a lamellipodium parallel to the substratum was observed. The extended lamellipodium then showed ruffling activity at the periphery. Notably, PI(3,4,5)P-3 and WAVE2 were localized in the extending lamellipodium in a PI3K-dependent manner. We confirmed that the inhibition of PI3K activity greatly suppressed lamellipodial extension, while the ruffling activity was less affected. These results suggest that Rac1-induced lamellipodial motility consists of two distinct activities, PI3K-dependent outward extension and PI3K-independent ruffling.	[Kato, Takuma; Kakehi, Yoshiyuki] Kagawa Univ, Sch Med, Dept Urol, Miki, Kagawa, Japan; [Kawai, Katsuhisa; Egami, Youhei; Araki, Nobukazu] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan	Kagawa University; Kagawa University	Araki, N (corresponding author), Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan.	naraki@med.kagawa-u.ac.jp		Araki, Nobukazu/0000-0001-6160-210X	Japan Society for the Promotion of Science (JSPS) KAKENHI [25861427, 24659087, 23390039, 26860136, 24890154, 25860142, 24390369]; Grants-in-Aid for Scientific Research [23390039, 26860136] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html) 25861427 to TK; 24659087 and 23390039 to NA; 26860136 and 24890154 to KK; 25860142 to YE; 24390369 to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Araki N, 2014, MICROSCOPY-JPN, V63, P255, DOI 10.1093/jmicro/dfu003; Claesson-Welsh Lena, 1994, Progress in Growth Factor Research, V5, P37, DOI 10.1016/0955-2235(94)90016-7; Costa C, 2010, THESCIENTIFICWORLDJO, V10, P1826, DOI 10.1100/tsw.2010.178; Frankenberry KA, 2004, AM J SURG, V188, P560, DOI 10.1016/j.amjsurg.2004.07.031; Fujii M, 2013, CHEM PHYS, V419, P1, DOI 10.1016/j.chemphys.2013.04.003; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040594; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Knight-Krajewski S, 2004, ONCOGENE, V23, P5513, DOI 10.1038/sj.onc.1207708; Kobayashi T, 2010, MOL ENDOCRINOL, V24, P722, DOI 10.1210/me.2009-0326; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Maekawa M, 2014, P NATL ACAD SCI USA, V111, pE978, DOI 10.1073/pnas.1311029111; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Oda A, 2013, SEMIN CELL DEV BIOL, V24, P308, DOI 10.1016/j.semcdb.2013.03.002; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rikitake Y, 2011, INT REV CEL MOL BIO, V287, P97, DOI 10.1016/B978-0-12-386043-9.00003-7; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 2006, J CELL BIOL, V173, P571, DOI 10.1083/jcb.200509067; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152; Wu YI, 2011, METHOD ENZYMOL, V497, P393, DOI 10.1016/B978-0-12-385075-1.00016-0; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Yu HM, 2004, MOL CARCINOGEN, V41, P85, DOI 10.1002/mc.20041	34	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97749	10.1371/journal.pone.0097749	http://dx.doi.org/10.1371/journal.pone.0097749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848679	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600053
J	Neill, DR; Saint, GL; Bricio-Moreno, L; Fothergill, JL; Southern, KW; Winstanley, C; Christmas, SE; Slupsky, JR; McNamara, PS; Kadioglu, A; Flanagan, BF				Neill, Daniel R.; Saint, Gemma L.; Bricio-Moreno, Laura; Fothergill, Joanne L.; Southern, Kevin W.; Winstanley, Craig; Christmas, Stephen E.; Slupsky, Joseph R.; McNamara, Paul S.; Kadioglu, Aras; Flanagan, Brian F.			The B Lymphocyte Differentiation Factor (BAFF) Is Expressed in the Airways of Children with CF and in Lungs of Mice Infected with Pseudomonas aeruginosa	PLOS ONE			English	Article							CELL-ACTIVATING FACTOR; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; INDUCTION; IMMUNITY; VACCINE	Background: Chronic lung infection with Pseudomonas aeruginosa remains a major cause of mortality and morbidity among individuals with CF. Expression of mediators promoting recruitment and differentiation of B cells, or supporting antibody production is poorly understood yet could be key to controlling infection. Methods: BAFF was measured in BAL from children with CF, both with and without P. aeruginosa, and controls. Mice were intra-nasally infected with P. aeruginosa strain LESB65 for up to 7 days. Cellular infiltration and expression of B cell chemoattractants and B cell differentiation factor, BAFF were measured in lung tissue. Results: BAFF expression was elevated in both P. aeruginosa negative and positive CF patients and in P. aeruginosa infected mice post infection. Expression of the B cell chemoattractants CXCL13, CCL19 and CCL21 increased progressively post infection. Conclusions: In a mouse model, infection with P. aeruginosa was associated with elevated expression of BAFF and other B cell chemoattractants suggesting a role for airway B cell recruitment and differentiation in the local adaptive immune response to P. aeruginosa. The paediatric CF airway, irrespective of pseudomonal infection, was found to be associated with an elevated level of BAFF implying that BAFF expression is not specific to pseudomonas infection and may be a feature of the CF airway. Despite the observed presence of a potent B cell activator, chronic colonisation is common suggesting that this response is ineffective.	[Neill, Daniel R.; Bricio-Moreno, Laura; Fothergill, Joanne L.; Winstanley, Craig; Christmas, Stephen E.; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Saint, Gemma L.; Southern, Kevin W.; McNamara, Paul S.; Flanagan, Brian F.] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Slupsky, Joseph R.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Liverpool	Flanagan, BF (corresponding author), Univ Liverpool, Alder Hey Childrens NHS Fdn Trust Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	fla1@liverpool.ac.uk	Bricio-Moreno, Laura/AAD-2781-2019; Slupsky, Joseph/H-2843-2019; Neill, Daniel/Q-6290-2019; Neill, Daniel/E-1403-2012; Fothergill, Joanne L/B-8284-2011	Slupsky, Joseph/0000-0002-7410-9004; Neill, Daniel/0000-0002-7911-8153; Neill, Daniel/0000-0002-7911-8153; Fothergill, Joanne L/0000-0002-7012-1508; Bricio Moreno, Laura/0000-0002-4956-7142; Winstanley, Craig/0000-0002-2662-8053; Christmas, Steve/0000-0001-8925-3204; kadioglu, aras/0000-0003-1137-6321; Saint, Gemma/0000-0003-4031-4939; McNamara, Paul/0000-0002-7055-6034; Christmas, Stephen/0000-0001-5909-0280	Liverpool Cancer Research UK Centre	Liverpool Cancer Research UK Centre	This work was supported in part by Research Development Funding from the Liverpool Cancer Research UK Centre. The authors would also like to acknowledge Alder Hey charitable funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann U, 2004, VACCINE, V22, P840, DOI 10.1016/j.vaccine.2003.11.029; Carter MEK, 2010, J INFECT DIS, V202, P935, DOI 10.1086/655781; Eddens T, 2012, CURR OPIN IMMUNOL, V24, P424, DOI 10.1016/j.coi.2012.07.005; Eppert BL, 2010, INFECT IMMUN, V78, P2099, DOI 10.1128/IAI.00962-09; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Hart CA, 2002, BRIT MED BULL, V61, P81, DOI 10.1093/bmb/61.1.81; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kamei A, 2011, INFECT IMMUN, V79, P1289, DOI 10.1128/IAI.01139-10; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Liu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038429; McNamara PS, 2013, THORAX, V68, P76, DOI 10.1136/thoraxjnl-2012-202288; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Moser C, 2002, CLIN EXP IMMUNOL, V127, P206, DOI 10.1046/j.1365-2249.2002.01731.x; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Parker D, 2012, AM J RESP CELL MOL, V46, P6, DOI 10.1165/rcmb.2011-0080OC; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Tan HL, 2013, THORAX, V68, P788, DOI 10.1136/thoraxjnl-2013-203307; Tertilt C, 2009, INFECT IMMUN, V77, P3044, DOI 10.1128/IAI.00927-08; Vareille M, 2012, THORAX, V67, P517, DOI 10.1136/thoraxjnl-2011-200405; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Wu WH, 2012, AM J RESP CRIT CARE, V186, P420, DOI 10.1164/rccm.201202-0182OC	23	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e95892	10.1371/journal.pone.0095892	http://dx.doi.org/10.1371/journal.pone.0095892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847941	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600007
J	Xiang, Y; Eyers, F; Young, IG; Rosenberg, HF; Foster, PS; Yang, M				Xiang, Yang; Eyers, Fiona; Young, Ian G.; Rosenberg, Helene F.; Foster, Paul S.; Yang, Ming			Identification of MicroRNAs Regulating the Developmental Pathways of Bone Marrow Derived Mast Cells	PLOS ONE			English	Article							C-KIT LIGAND; IMMUNE-RESPONSES; EXPRESSION; MURINE; DISEASE; MASTOCYTOSIS; ACTIVATION; LINEAGES; DECREASE; SURVIVAL	Background: MicroRNAs (miRNAs) play important roles in leukocyte differentiation, although those utilised for specific programs and key functions remain incompletely characterised. As a global approach to gain insights into the potential regulatory role of miRNA in mast cell differentiation we characterised expression in BM cultures from the initiation of differentiation. In cultures enriched in differentiating mast cells we characterised miRNA expression and identified miRNA targeting the mRNA of putative factors involved in differentiation pathways and cellular identity. Detailed pathway analysis identified a unique miRNA network that is intimately linked to the mast cell differentiation program. Methodology/Principal Findings: We identified 86 unique miRNAs with expression patterns that were up-or downregulated at 5-fold or more during bone marrow derived mast cells (BMMC) development. By employing TargetScan and MeSH databases, we identified 524 transcripts involved in 30 canonical pathways as potentially regulated by these specific 86 miRNAs. Furthermore, by applying miRanda and IPA analyses, we predict that 7 specific miRNAs of this group are directly associated with the expression of c-Kit and Fc epsilon RI alpha and likewise, that 18 miRNAs promote expression of Mitf, GATA1 and c/EBP alpha three core transcription factors that direct mast cell differentiation. Furthermore, we have identified 11 miRNAs that may regulate the expression of STATs-3, -5a/b, GATA2 and GATA3 during differentiation, along with 13 miRNAs that target transcripts encoding Ndst2, mMCP4 and mMCP6 and thus may regulate biosynthesis of mast cell secretory mediators. Conclusions/Significance: This investigation characterises changes in miRNA expression in whole BM cultures during the differentiation of mast cells and predicts functional links between miRNAs and their target mRNAs for the regulation of development. This information provides an important resource for further investigations of the contributions of miRNAs to mast cell differentiation and function.	[Xiang, Yang; Eyers, Fiona; Foster, Paul S.; Yang, Ming] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; [Xiang, Yang; Eyers, Fiona; Foster, Paul S.; Yang, Ming] Hunter Med Res Inst, Callaghan, NSW, Australia; [Xiang, Yang] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China; [Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Mol Biosci, Canberra, ACT 2601, Australia; [Rosenberg, Helene F.] NIAID, Inflammat Immunobiol Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Central South University; Australian National University; John Curtin School of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Foster, PS (corresponding author), Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	Paul.Foster@newcastle.edu.au; Ming.Yang@newcastle.edu.au	Foster, Paul/G-5057-2013	, Paul/0000-0002-0827-8299	National Health and Medical Research Council of Australia; Australian Research Council; Cooperative Research Centre for Asthma and Airways; National Institute of Allergy and Infectious Diseases Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000941] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Institute of Allergy and Infectious Diseases Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are supported by the National Health and Medical Research Council of Australia, the Australian Research Council, the Cooperative Research Centre for Asthma and Airways and National Institute of Allergy and Infectious Diseases Division of Intramural Research. The funding bodies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058; Furumoto Y, 2011, BLOOD, V118, P5466, DOI 10.1182/blood-2010-09-309955; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Hofmann AM, 2009, CURR OPIN IMMUNOL, V21, P679, DOI 10.1016/j.coi.2009.09.007; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; KITAMURA Y, 1978, BLOOD, V52, P447; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Larsen MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058454; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Lee YN, 2011, BLOOD, V117, P3629, DOI 10.1182/blood-2010-07-293548; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Ma PL, 2011, BLOOD, V118, P3459, DOI 10.1182/blood-2011-04-351809; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Maruotti N, 2007, CLIN RHEUMATOL, V26, P1, DOI 10.1007/s10067-006-0305-3; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mayoral RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026133; Mayoral RJ, 2009, J IMMUNOL, V182, P433, DOI 10.4049/jimmunol.182.1.433; Merkerova MD, 2011, EUR J HUM GENET, V19, P313, DOI 10.1038/ejhg.2010.209; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; Molnar V, 2012, CELL MOL LIFE SCI, V69, P793, DOI 10.1007/s00018-011-0786-3; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Sakai H, 1999, ARCH DERMATOL RES, V291, P224, DOI 10.1007/s004030050398; Shin J, 2012, BLOOD, V119, P3306, DOI 10.1182/blood-2011-05-353342; Siemens H, 2013, ONCOTARGET, V4, P1399, DOI 10.18632/oncotarget.1202; Takemoto CM, 2008, BLOOD CELL MOL DIS, V41, P82, DOI 10.1016/j.bcmd.2008.02.005; TRAVIS WD, 1985, AM J CLIN PATHOL, V84, P710, DOI 10.1093/ajcp/84.6.710; TSUJI K, 1991, J CELL PHYSIOL, V148, P362, DOI 10.1002/jcp.1041480306; Yang M, 2008, PHARMACOL THERAPEUT, V117, P94, DOI 10.1016/j.pharmthera.2007.08.004	47	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98139	10.1371/journal.pone.0098139	http://dx.doi.org/10.1371/journal.pone.0098139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848502	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600091
J	Chan, TC; Chiang, PH; Su, MD; Wang, HW; Liu, MSY				Chan, Ta-Chien; Chiang, Po-Huang; Su, Ming-Daw; Wang, Hsuan-Wen; Liu, Michael Shi-yung			Geographic Disparity in Chronic Obstructive Pulmonary Disease (COPD) Mortality Rates among the Taiwan Population	PLOS ONE			English	Article							AIR-POLLUTION; HOSPITAL ADMISSIONS; LIFE EXPECTANCY; RISK; TUBERCULOSIS; OUTDOOR; HEALTH; CITY	Chronic obstructive pulmonary disease (COPD) causes a high disease burden among the elderly worldwide. In Taiwan, the long-term temporal trend of COPD mortality is declining, but the geographical disparity of the disease is not yet known. Nationwide COPD age-adjusted mortality at the township level during 1999-2007 is used for elucidating the geographical distribution of the disease. With an ordinary least squares (OLS) model and geographically weighted regression (GWR), the ecologic risk factors such as smoking rate, area deprivation index, tuberculosis exposure, percentage of aborigines, density of health care facilities, air pollution and altitude are all considered in both models to evaluate their effects on mortality. Global and local Moran's I are used for examining their spatial autocorrelation and identifying clusters. During the study period, the COPD age-adjusted mortality rates in males declined from 26.83 to 19.67 per 100,000 population, and those in females declined from 8.98 to 5.70 per 100,000 population. Overall, males' COPD mortality rate was around three times higher than females'. In the results of GWR, the median coefficients of smoking rate, the percentage of aborigines, PM10 and the altitude are positively correlated with COPD mortality in males and females. The median value of density of health care facilities is negatively correlated with COPD mortality. The overall adjusted R-squares are about 20% higher in the GWR model than in the OLS model. The local Moran's I of the GWR's residuals reflected the consistent high-high cluster in southern Taiwan. The findings indicate that geographical disparities in COPD mortality exist. Future epidemiological investigation is required to understand the specific risk factors within the clustering areas.	[Chan, Ta-Chien; Liu, Michael Shi-yung] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Chiang, Po-Huang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Su, Ming-Daw] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Wang, Hsuan-Wen] Natl Taiwan Univ, Sch Publ Hlth, Master Publ Hlth Program, Taipei 10764, Taiwan; [Wang, Hsuan-Wen] Fangliao Gen Hosp, Div Family Med, Pingtung, Taiwan; [Liu, Michael Shi-yung] Acad Sinica, Inst Taiwan Hist, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Liu, MSY (corresponding author), Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan.	liumike@gate.sinica.edu.tw	Chiang, Po-Huang/E-3996-2010	SU, MING-DAW/0000-0001-5555-9598	National Science Council, R.O.C. [NSC-102-2627-M-001-006, NSC-102-2627-M-001-007]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council, R.O.C. (NSC-102-2627-M-001-006 and NSC-102-2627-M-001-007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentayeb M, 2012, INT J TUBERC LUNG D, V16, P1149, DOI 10.5588/ijtld.11.0666; Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Brown D. W., 2008, Morbidity and Mortality Weekly Report, V57, P1229; Centers for Disease Control R.O.C. (Taiwan), 2012, TAIW TUB CONTR REP 2; Chakrabarti Biswajit, 2007, Int J Chron Obstruct Pulmon Dis, V2, P263; Chan Ta-Chien, 2010, INFECT DIS INFORM BI, P208; Chiang CH, 2008, RESPIROLOGY, V13, P689, DOI 10.1111/j.1440-1843.2008.01308.x; Chiang CY, 2005, INT J TUBERC LUNG D, V9, P1006; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Foster Talia S, 2006, COPD, V3, P211, DOI 10.1080/15412550601009396; Fotheringham AS, 1999, GEOGR ANAL, V31, P340; Gershon AS, 2012, COPD, V9, P216, DOI 10.3109/15412555.2011.648030; Health Promotion Administration Ministry of Health and Welfare, 2013, SURV AD SMOK BEH; Holt JB, 2011, INT J CHRONIC OBSTR, V6, P321, DOI 10.2147/COPD.S19945; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Ko FWS, 2012, RESPIROLOGY, V17, P395, DOI 10.1111/j.1440-1843.2011.02112.x; Kuo LC, 2005, J FORMOS MED ASSOC, V104, P89; Lee CH, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0037978; Lee IM, 2007, INHAL TOXICOL, V19, P393, DOI 10.1080/08958370601174818; Lee YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-225; Lin HC, 2001, AREA DEPRIVATION MOR; Liu Y, 2008, INT J TUBERC LUNG D, V12, P115; Mannino David M, 2006, Int J Chron Obstruct Pulmon Dis, V1, P219; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nakaya T, 2005, STAT MED, V24, P2695, DOI 10.1002/sim.2129; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Reilly KH, 2008, AM J EPIDEMIOL, V167, P998, DOI 10.1093/aje/kwm393; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; Schikowski T, 2014, EUR RESPIR J, V43, P250, DOI 10.1183/09031936.00100112; Sun YC, 2013, CHINESE MED J-PEKING, V126, P2203, DOI 10.3760/cma.j.issn.0366-6999.20131159; Tachikawa T, 2011, NASA LAND PROCESSES; Tan WC, 2003, RESPIROLOGY, V8, P192; The Ministry of Health and Welfare of the Republic of China, 2009, CAUS DEATHS; van Durme YMTA, 2009, CHEST, V135, P368, DOI 10.1378/chest.08-0684; Wang SC, 2009, J PUBLIC HEALTH-UK, V31, P406, DOI 10.1093/pubmed/fdp052; Wen CP, 2004, INT J EPIDEMIOL, V33, P320, DOI 10.1093/ije/dyh009; World Health Organization, 2008, CAUS DEATH GLOB BU 2; Yang CY, 2007, J TOXICOL ENV HEAL A, V70, P1214, DOI 10.1080/15287390701380880	40	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98170	10.1371/journal.pone.0098170	http://dx.doi.org/10.1371/journal.pone.0098170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845852	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400103
J	Mangalam, M; Desai, N; Singh, M				Mangalam, Madhur; Desai, Nisarg; Singh, Mewa			Do Right-Handed Monkeys Use the Right Cheek Pouch before the Left?	PLOS ONE			English	Article							CAPUCHIN MONKEYS; BEHAVIORAL LATERALITY; FACIAL EXPRESSION; ASYMMETRIES; METAANALYSIS; EVOLUTION; MOUTH	There can be several factors that are likely to have played a role in the evolution of hand preference in humans and non-human primates, which the existing theories do not consider. There exists a possibility that hand preference in non-human primates evolved from the pre-existing lateralities in more elementary brain functions and behavior, or alternatively, the two coevolved. A basic example can be a hand-mouth command system that could have evolved in the context of ingestion. In the present study, we examined the relationship between lateralities in prehension and mastication processes, that is, hand and cheek pouch usage, in free-ranging bonnet macaques, Macaca radiata. The macaques preferentially used one hand-the 'preferred' hand, to pick up the bananas lying on the ground. Lateralities in hand and cheek pouch usage (for both filling and emptying) were positively related with each other, that is, the macaques used the cheek pouch corresponding to the preferred hand predominantly and before the other. Moreover, when the macaques used the non-preferred hand to pick up the bananas, the frequency of contralateral cheek pouch usage was higher than the frequency of ipsilateral cheek pouch usage, that is, the combined structure of hand, mouth, and food did not influence the relationship between laterality in hand usage and laterality in cheek pouch usage. These findings demonstrate laterality in a relatively more involuntary function than those explored previously in any non-human primate species (e. g., facial expressions and manual gestures).	[Mangalam, Madhur; Singh, Mewa] Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India; [Desai, Nisarg] Indian Inst Sci Educ & Res Pune, Pune, Maharashtra, India; [Singh, Mewa] Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore, Karnataka, India	University of Mysore; Indian Institute of Science Education & Research (IISER) Pune; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Singh, M (corresponding author), Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India.	mewasinghltm@gmail.com						Anfora G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018903; Annett M., 1985, LEFT RIGHT HAND BRAI; Bradshaw JL., 1993, EVOLUTION LATERAL AS; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Corballis MC, 2002, HAND MOUTH ORIGINS L; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; FAGOT J, 1991, PSYCHOL BULL, V109, P76, DOI 10.1037/0033-2909.109.1.76; Fernandez-Carriba S, 2002, NEUROPSYCHOLOGIA, V40, P1523, DOI 10.1016/S0028-3932(02)00028-3; Frasnelli E, 2012, NEUROSCI BIOBEHAV R, V36, P1273, DOI 10.1016/j.neubiorev.2012.02.006; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; HAUSER MD, 1993, SCIENCE, V261, P475, DOI 10.1126/science.8332914; Hauser MD, 2001, ANIM BEHAV, V61, P391, DOI 10.1006/anbe.2000.1588; Hook-Costigan MA, 1998, NEUROPSYCHOLOGIA, V36, P1265, DOI 10.1016/S0028-3932(98)00037-2; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P403, DOI 10.1037/0735-7036.107.4.403; Hopkins WD, 2000, NEUROPSYCHOLOGIA, V38, P493, DOI 10.1016/S0028-3932(99)00090-1; Hopkins WD, 2003, DEVELOPMENTAL SCI, V6, P55, DOI 10.1111/1467-7687.00254; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; HOPKINS WD, 1995, INT J PRIMATOL, V16, P261, DOI 10.1007/BF02735481; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; MACNEILAGE PF, 1987, BEHAV BRAIN SCI, V10, P247, DOI 10.1017/S0140525X00047695; Mangalam M, 2014, AM J PRIMATOL, V76, P576, DOI 10.1002/ajp.22250; Martinez-Gomis J, 2009, ARCH ORAL BIOL, V54, P101, DOI 10.1016/j.archoralbio.2008.09.006; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; Meguerditchian A, 2006, BEHAV BRAIN RES, V171, P170, DOI 10.1016/j.bbr.2006.03.018; Nissan J, 2004, J ORAL REHABIL, V31, P412, DOI 10.1111/j.1365-2842.2004.01256.x; Papademetriou E, 2005, J COMP PSYCHOL, V119, P33, DOI 10.1037/0735-7036.119.1.33; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Phillips KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000792; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2398, DOI 10.1016/j.neuropsychologia.2007.02.021; Raymond M, 2004, LATERALITY, V9, P35, DOI 10.1080/13576500244000274; Rogers LJ, 2002, COMP VERTEBRATE LATE; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105	33	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97971	10.1371/journal.pone.0097971	http://dx.doi.org/10.1371/journal.pone.0097971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844660	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400076
J	Matsui, S; Yamane, T; Kobayashi-Hattori, K; Oishi, Y				Matsui, Sho; Yamane, Takumi; Kobayashi-Hattori, Kazuo; Oishi, Yuichi			Ultraviolet B Irradiation Reduces the Expression of Adiponectin in Ovarial Adipose Tissues through Endocrine Actions of Calcitonin Gene-Related Peptide-Induced Serum Amyloid A	PLOS ONE			English	Article							INSULIN SENSITIVITY; FAT DIET; PROTEIN; RADIATION; HYALURONAN; ACTIVATION; RESISTANCE; INCREASES; ALPHA; RNA	Ultraviolet (UV) B irradiation decreases blood adiponectin levels, but the mechanism is not well understood. This study investigated how UVB irradiation reduces adiponectin expression in ovarial adipose tissues. Female Hos:HR-1 hairless mice were exposed to UVB (1.6 J/cm(2)) irradiation and were killed 24 h later. UVB irradiation decreased the adiponectin protein level in the serum and the adiponectin mRNA level in ovarial adipose tissues. UVB irradiation also decreased the mRNA levels of peroxisome proliferator-activated receptor (PPAR) gamma, CCAAT/enhancer binding protein (C/EBP) alpha, C/EBP beta, and fatty acid binding protein 4 (aP2) in ovarial adipose tissues. In contrast, UVB irradiation increased the mRNA levels of interleukin (IL)-6 and monocyte chemoattractant protein (MCP)-1 in ovarial adipose tissues. In the serum and liver, the levels of serum amyloid A (SAA), involved in PPAR gamma, C/EBP alpha, C/EBP beta, aP2, IL-6, and MCP-1 regulation, increased after UVB irradiation. The SAA gene is regulated by IL-1 beta, IL-6, and tumor necrosis factor-alpha, but only IL-6 expression increased in the liver after UVB irradiation. Additionally, in the liver, hypothalamus, and epidermis, UVB irradiation increased the expression of calcitonin gene-related peptide (CGRP), which upregulates SAA in the liver. Collectively, our results suggest that the CGRP signal induced by skin exposure to UVB transfers to the liver, possibly through the brain, and increases SAA production via IL-6 in the liver. In turn, serum SAA acts in an endocrine manner to decreases the serum adiponectin level by downregulating factors that regulate adiponectin expression in adipose tissues.	[Matsui, Sho; Yamane, Takumi; Kobayashi-Hattori, Kazuo; Oishi, Yuichi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutrit Sci, Tokyo, Japan	Tokyo University of Agriculture	Oishi, Y (corresponding author), Tokyo Univ Agr, Fac Appl Biosci, Dept Nutrit Sci, Tokyo, Japan.	y3oishi@nodai.ac.jp	Yamane, Takumi/N-7442-2019	, Kazuo/0000-0002-0921-2128	JSPS KAKENHI [24580199]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (grant numbers 24580199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2011, CONNECT TISSUE RES, V52, P322, DOI 10.3109/03008207.2010.528566; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; Arita Y, 2012, BIOCHEM BIOPH RES CO, V425, P560, DOI 10.1016/j.bbrc.2012.08.024; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Duivenvoorde LP, 2014, J GERONTOL A; Ezure T, 2010, EXP DERMATOL, V19, P878, DOI 10.1111/j.1600-0625.2009.00970.x; Ezure T, 2007, BIOFACTORS, V31, P229, DOI 10.1002/biof.5520310310; Faty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034031; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Harada N, 2007, NEUROPHARMACOLOGY, V52, P1303, DOI 10.1016/j.neuropharm.2007.01.016; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim EJ, 2011, J INVEST DERMATOL, V131, P1720, DOI 10.1038/jid.2011.106; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Matsui S, 2013, BIOSCI BIOTECH BIOCH, V77, P2151, DOI 10.1271/bbb.130450; Mayer JM, 2002, BRIT J SURG, V89, P163, DOI 10.1046/j.1365-2168.2002.01972.x; Meeran SM, 2009, TOXICOL APPL PHARM, V241, P303, DOI 10.1016/j.taap.2009.09.003; Polefka TG, 2012, J COSMET DERMATOL-US, V11, P134, DOI 10.1111/j.1473-2165.2012.00614.x; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Ruan H, 2004, CURR OPIN LIPIDOL, V15, P297, DOI 10.1097/00041433-200406000-00009; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918; Sleijffers A, 2003, J PHOTOCH PHOTOBIO B, V69, P149, DOI 10.1016/S1011-1344(03)00002-2; SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823; Terra XM, 2011, EUR J ENDOCRINOL, V164, P539, DOI 10.1530/EJE-10-1195; Tran MT, 2000, J IMMUNOL, V164, P4307, DOI 10.4049/jimmunol.164.8.4307; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009; Yamamoto Y, 2004, J CLIN ENDOCR METAB, V89, P87, DOI 10.1210/jc.2003-031163; Yamane T, 2011, BIOCHEM BIOPH RES CO, V415, P235, DOI 10.1016/j.bbrc.2011.09.151; Yamane T, 2010, MOL NUTR FOOD RES, V54, pS53, DOI 10.1002/mnfr.201000022; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1; Young Antony R, 2006, Prog Biophys Mol Biol, V92, P80, DOI 10.1016/j.pbiomolbio.2006.02.005; Zhang J, 2012, INVEST OPHTH VIS SCI, V53, P7276, DOI 10.1167/iovs.12-10482; Zoico E, 2009, INT J MOL MED, V24, P847, DOI 10.3892/ijmm_00000302	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98040	10.1371/journal.pone.0098040	http://dx.doi.org/10.1371/journal.pone.0098040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845824	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400083
J	Milner, JJ; Wang, J; Sheridan, PA; Ebbels, T; Beck, MA; Saric, J				Milner, J. Justin; Wang, Jue; Sheridan, Patricia A.; Ebbels, Tim; Beck, Melinda A.; Saric, Jasmina			H-1 NMR-Based Profiling Reveals Differential Immune-Metabolic Networks during Influenza Virus Infection in Obese Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; OXIDATIVE STRESS; H1N1 INFLUENZA; RISK-FACTOR; MOUSE; RESPONSES; MODEL; CHEMOMETRICS; MORTALITY; IMPACT	Obese individuals are at greater risk for death from influenza virus infection. Paralleling human evidence, obese mice are also more susceptible to influenza infection mortality. However, the underlying mechanisms driving greater influenza severity in the obese remain unclear. Metabolic profiling has been utilized in infectious disease models to enhance prognostic or diagnostic methods, and to gain insight into disease pathogenesis by providing a more global picture of dynamic infection responses. Herein, metabolic profiling was used to develop a deeper understanding of the complex processes contributing to impaired influenza protection in obese mice and to facilitate generation of new explanatory hypotheses. Diet-induced obese and lean mice were infected with influenza A/Puerto Rico/8/34. H-1 nuclear magnetic resonance-based metabolic profiling of urine, feces, lung, liver, mesenteric white adipose tissue, bronchoalveolar lavage fluid and serum revealed distinct metabolic signatures in infected obese mice, including perturbations in nucleotide, vitamin, ketone body, amino acid, carbohydrate, choline and lipid metabolic pathways. Further, metabolic data was integrated with immune analyses to obtain a more comprehensive understanding of potential immune-metabolic interactions. Of interest, uncovered metabolic signatures in urine and feces allowed for discrimination of infection status in both lean and obese mice at an early influenza time point, which holds prognostic and diagnostic implications for this methodology. These results confirm that obesity causes distinct metabolic perturbations during influenza infection and provide a basis for generation of new hypotheses and use of this methodology in detection of putative biomarkers and metabolic patterns to predict influenza infection outcome.	[Milner, J. Justin; Sheridan, Patricia A.; Beck, Melinda A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27514 USA; [Wang, Jue; Ebbels, Tim; Saric, Jasmina] Univ London Imperial Coll Sci Technol & Med, Sect Computat & Syst Med, Dept Surg & Canc, Fac Med, London, England	University of North Carolina; University of North Carolina Chapel Hill; Imperial College London	Beck, MA (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27514 USA.	Melinda_beck@med.unc.edu; jasmina.saric05@imperial.ac.uk	Ebbels, Tim/ABB-2627-2021; , UNC Flow Cytometry Core/AGU-9839-2022	Ebbels, Tim/0000-0002-3372-8423; 	National Institutes of Health [DK56350]; Faculty of Medicine at Imperial College; National Cancer Institute at the National Institutes of Health Center Core Support Grant [P30CA06086]; NIH Tetramer Core Facility [HHSN272201300006C]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty of Medicine at Imperial College; National Cancer Institute at the National Institutes of Health Center Core Support Grant; NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health supported Nutrition Obesity Research Center [DK56350]. The Faculty of Medicine at Imperial College provided financial support for the Mres studentship funds for JW. Flow Cytometry was performed in the Flow Cytometer Core Facility at the University of North Carolina at Chapel Hill. The UNC Flow Cytometry Core Facility is supported in part by the National Cancer Institute at the National Institutes of Health Center Core Support Grant [P30CA06086] to the UNC Lineberger Comprehensive Cancer Center. The authors acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of MHCI restricted DbNP366-74 and DbPA224-233 tetramers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Campitelli MA, 2014, INT J OBESITY, V38, P113, DOI 10.1038/ijo.2013.57; Chen LJ, 2014, BIOMED CHROMATOGR, V28, P468, DOI 10.1002/bmc.3055; Choi AMK, 1996, AM J PHYSIOL-LUNG C, V271, pL383, DOI 10.1152/ajplung.1996.271.3.L383; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; De Tullio Mario C, 2012, Subcell Biochem, V56, P49, DOI 10.1007/978-94-007-2199-9_4; Easterbrook JD, 2011, INFLUENZA OTHER RESP, V5, P418, DOI 10.1111/j.1750-2659.2011.00254.x; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Fanos V, 2013, EARLY HUM DEV, V89, pS58, DOI 10.1016/S0378-3782(13)70017-3; Ferrannini E, 2011, DIABETES, V60, P695, DOI 10.2337/db10-1667; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Glasser SW, 2009, AM J PHYSIOL-LUNG C, V297, pL64, DOI 10.1152/ajplung.90640.2008; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harrison FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035623; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jackson JA, 2005, J ORTHOMOL MED, V20, P259; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Jung JY, 2012, BMB REP, V45, P419, DOI 10.5483/BMBRep.2012.45.7.248; Karasawa H, 2009, METABOLISM, V58, P296, DOI 10.1016/j.metabol.2008.09.028; Karisson EA, 2010, J IMMUNOL, V184, P3127, DOI 10.4049/jimmunol.0903220; Karlsson EA, 2010, J NUTR, V140, P1691, DOI 10.3945/jn.110.123653; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kim Yejin, 2013, Immune Netw, V13, P70, DOI 10.4110/in.2013.13.2.70; Kim YH, 2012, J INFECT DIS, V205, P244, DOI 10.1093/infdis/jir731; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Li JV, 2009, INT J PARASITOL, V39, P547, DOI 10.1016/j.ijpara.2008.10.010; Li W, 2006, J NUTR, V136, P2611, DOI 10.1093/jn/136.10.2611; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Milner JJ, 2013, J IMMUNOL, V191, P2474, DOI 10.4049/jimmunol.1202429; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; O'Brien KB, 2012, J INFECT DIS, V205, P252, DOI 10.1093/infdis/jir729; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Ren YY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-149; Saric J, 2010, PARASITOLOGY, V137, P1451, DOI 10.1017/S0031182010000697; Saric J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000254; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Saric J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.49; Saric J, 2010, J PROTEOME RES, V9, P2255, DOI 10.1021/pr901019z; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Smith AG, 2009, IMMUNOLOGY, V126, P268, DOI 10.1111/j.1365-2567.2008.02895.x; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Veselkov KA, 2011, ANAL CHEM, V83, P5864, DOI 10.1021/ac201065j; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Wang YL, 2010, ADV PARASIT, V73, P373, DOI 10.1016/S0065-308X(10)73012-8; World Health Organization, INFL SEAS; World Health Organization, OB OV; Wortham BW, 2012, J IMMUNOL, V188, P4468, DOI 10.4049/jimmunol.1102643; Zhang AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064381; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031	63	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97238	10.1371/journal.pone.0097238	http://dx.doi.org/10.1371/journal.pone.0097238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844920	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400017
J	Regel, S; Meyer, L; Gunter, TC				Regel, Stefanie; Meyer, Lars; Gunter, Thomas C.			Distinguishing Neurocognitive Processes Reflected by P600 Effects: Evidence from ERPs and Neural Oscillations	PLOS ONE			English	Article							BRAIN POTENTIALS; LANGUAGE COMPREHENSION; SYNTACTIC VIOLATIONS; WORKING-MEMORY; SENTENCE-LEVEL; WORD; INFORMATION; INTEGRATION; CONTEXT; EXPECTANCY	Research on language comprehension using event-related potentials (ERPs) reported distinct ERP components reliably related to the processing of semantic (N400) and syntactic information (P600). Recent ERP studies have challenged this well-defined distinction by showing P600 effects for semantic and pragmatic anomalies. So far, it is still unresolved whether the P600 reflects specific or rather common processes. The present study addresses this question by investigating ERPs in response to a syntactic and pragmatic (irony) manipulation, as well as a combined syntactic and pragmatic manipulation. For the syntactic condition, a morphosyntactic violation was applied, whereas for the pragmatic condition, such as "That is rich", either an ironic or literal interpretation was achieved, depending on the prior context. The ERPs at the critical word showed a LAN-P600 pattern for syntactically incorrect sentences relative to correct ones. For ironic compared to literal sentences, ERPs showed a P200 effect followed by a P600 component. In comparison of the syntax-related P600 to the irony-related P600, distributional differences were found. Moreover, for the P600 time window (i.e., 500-900 ms), different changes in theta power between the syntax and pragmatics effects were found, suggesting that different patterns of neural activity contributed to each respective effect. Thus, both late positivities seem to be differently sensitive to these two types of linguistic information, and might reflect distinct neurocognitive processes, such as reanalysis of the sentence structure versus pragmatic reanalysis.	[Regel, Stefanie; Meyer, Lars; Gunter, Thomas C.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Saxony, Germany	Max Planck Society	Regel, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Saxony, Germany.	regel@cbs.mpg.de		Meyer, Lars/0000-0002-7487-5518				Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; Bastiaansen MCM, 2002, NEUROIMAGE, V17, P1479, DOI 10.1006/nimg.2002.1275; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Burkhardt P, 2006, BRAIN LANG, V98, P159, DOI 10.1016/j.bandl.2006.04.005; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Coulson S, 2002, MEM COGNITION, V30, P958, DOI 10.3758/BF03195780; Coulson S, 2007, BRAIN RES, V1146, P128, DOI 10.1016/j.brainres.2007.03.008; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; Federmeier KD, 2005, MEM COGNITION, V33, P871, DOI 10.3758/BF03193082; FISCHLER I, 1983, PSYCHOPHYSIOLOGY, V20, P400, DOI 10.1111/j.1469-8986.1983.tb00920.x; Friederici AD, 2004, BRAIN RES, V1000, P72, DOI 10.1016/j.brainres.2003.10.057; Friederici AD, 2002, J PSYCHOLINGUIST RES, V31, P45, DOI 10.1023/A:1014376204525; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Friederici AD, 2007, BRAIN RES, V1146, P50, DOI 10.1016/j.brainres.2006.08.038; Frisch S, 2003, CLIN NEUROPHYSIOL, V114, P336, DOI 10.1016/S1388-2457(02)00366-8; Gouvea AC, 2010, LANG COGNITIVE PROC, V25, P149, DOI 10.1080/01690960902965951; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Gunter TC, 2000, J COGNITIVE NEUROSCI, V12, P556, DOI 10.1162/089892900562336; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hoeks JCJ, 2004, COGNITIVE BRAIN RES, V19, P59, DOI 10.1016/j.cogbrainres.2003.10.022; Holle H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00074; Juottonen K, 1996, COGNITIVE BRAIN RES, V4, P99; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kemmerer D, 2007, BRAIN LANG, V100, P238, DOI 10.1016/j.bandl.2005.12.002; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; Kuperberg GR, 2003, J COGNITIVE NEUROSCI, V15, P272, DOI 10.1162/089892903321208204; KUTAS M, 1983, MEM COGNITION, V11, P539, DOI 10.3758/BF03196991; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Meyer L, 2013, CORTEX, V49, P711, DOI 10.1016/j.cortex.2012.03.006; Molinaro N, 2008, BRAIN RES, V1228, P161, DOI 10.1016/j.brainres.2008.06.064; Munte TF, 1998, NEUROPSYCHOLOGIA, V36, P217, DOI 10.1016/S0028-3932(97)00119-X; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Nieuwand MS, 2005, COGNITIVE BRAIN RES, V24, P691, DOI 10.1016/j.cogbrainres.2005.04.003; Oostenveld R., 2011, COMPUTATIONAL INTELL; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P1, DOI 10.1080/016909699386356; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Otten L. J., 2004, EVENT RELATED POTENT, P3; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Regel S, 2010, BRAIN RES, V1311, P121, DOI 10.1016/j.brainres.2009.10.077; Rohm D, 2001, NEUROSCI LETT, V310, P137, DOI 10.1016/S0304-3940(01)02106-1; Rossi S, 2005, NEUROSCI LETT, V384, P228, DOI 10.1016/j.neulet.2005.04.077; Salmon N, 2002, BRAIN LANG, V83, P367, DOI 10.1016/S0093-934X(02)00507-2; Spotorno N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066839; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; VANPETTEN C, 1990, MEM COGNITION, V18, P380, DOI 10.3758/BF03197127; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Wlotko EW, 2007, NEUROPSYCHOLOGIA, V45, P3001, DOI 10.1016/j.neuropsychologia.2007.05.013	69	57	59	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96840	10.1371/journal.pone.0096840	http://dx.doi.org/10.1371/journal.pone.0096840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844290	Green Published, gold			2022-12-27	WOS:000339563400012
J	Riess, TH; Achieng', MM; Bailey, RC				Riess, Thomas H.; Achieng', Maryline M.; Bailey, Robert C.			Women's Beliefs about Male Circumcision, HIV Prevention, and Sexual Behaviors in Kisumu, Kenya	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SUB-SAHARAN AFRICA; RANDOMIZED-TRIAL; NEGATIVE MEN; NYANZA PROVINCE; RAKAI; RISK; ACCEPTABILITY; TRANSMISSION; IMPACT	It is important to understand how women's sexual practices may be influenced by male circumcision (MC) as an HIV prevention effort. Women's beliefs about MC and sexual behaviour will likely influence the scale-up and uptake of medical MC. We conducted qualitative interviews with 30 sexually active women in Kisumu, Kenya. Women discussed MC related to perceived health benefits, condom use, sexual behaviour, knowledge of susceptibility to HIV and sexually transmitted infections (STIs), circumcision preference, and influence on circumcision uptake. Respondents had a good understanding of the partial protection of MC for acquisition of HIV for men. Women perceived circumcised men as cleaner, carrying fewer diseases, and taking more time to reach ejaculation. Male's circumcision status is a salient factor for women's sexual decision making, including partner choice, and condom use. It will be important that educational information affirms that MC provides only partial protection against female to male transmission of HIV and some STIs; that other HIV and STI prevention methods such as condoms need to be used in conjunction with MC; that MC does not preclude a man from having HIV; and that couples should develop plans for not having sex while the man is healing.	[Riess, Thomas H.; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Chicago, IL 60607 USA; [Achieng', Maryline M.] Liverpool VCT Care & Treatment, Res & Policy Dept, Nairobi, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Riess, TH (corresponding author), Univ Illinois, Sch Publ Hlth, Chicago, IL 60607 USA.	vonriess@yahoo.com			Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [AI50440]; U.S. Centers for Disease Control and Prevention [2 T01 CD000189-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050440] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION [T01CD000189] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported in part by Grant No. AI50440 from the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). THR was supported in part by the U.S. Centers for Disease Control and Prevention Training Program Grant #2 T01 CD000189-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SS, 1993, CANCER, V72, P166; [Anonymous], 2008, ATLAS TI VERS 5 2 CO; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Baeten JM, 2009, LANCET, V374, P182, DOI 10.1016/S0140-6736(09)61311-8; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bailey RC, 1999, 13 M INT SOC SEX TRA; Bailey RC, 2007, LANCET, V369, P1; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Feuer C., 2010, ALQ MUJERES AIDS JUL; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2539, DOI 10.1001/jama.2008.752; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Gray RH, 2009, J INFECT DIS, V199, P1, DOI 10.1086/595568; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hankins C, 2007, REPROD HEALTH MATTER, V15, P62, DOI 10.1016/S0968-8080(07)29311-5; Herman-Roloff A, 2011, 16 INT C AIDS STIS A; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Kigozi G, 2009, BJU INT, V104, P1698, DOI 10.1111/j.1464-410X.2009.08683.x; Krieger JN, 2008, J SEX MED, V5, P2610, DOI 10.1111/j.1743-6109.2008.00979.x; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; Nielson CM, 2009, J INFECT DIS, V199, P7, DOI 10.1086/595567; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Obure A, 2011, GLOBAL J COMMUNITY P, V1, P1; Odoyo-June E, 2013, JAIDS-J ACQ IMM DEF, V62, P465, DOI [10.1097/QAI.0b013e3182800710, 10.1097/QAI.]; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rain-Taljaard RC, 2003, AIDS CARE, V15, P315, DOI 10.1080/0954012031000105379; Riess TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012366; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Strauss A., 1998, BASICS QUALITATIVE R; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; UNAIDS, 2010, GLOB REP UNAIDS REP; Waldinger MD, 2009, J SEX MED, V6, P2888, DOI 10.1111/j.1743-6109.2009.01392.x; Waldinger MD, 2005, J SEX MED, V2, P492, DOI 10.1111/j.1743-6109.2005.00070.x; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Westercamp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015552; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; White RG, 2008, JAIDS-J ACQ IMM DEF, V47, P346, DOI 10.1097/QAI.0b013e318160d56a	53	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97748	10.1371/journal.pone.0097748	http://dx.doi.org/10.1371/journal.pone.0097748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844845	Green Published, gold			2022-12-27	WOS:000339563400057
J	Takashima, T; Sanai, T; Miyazono, M; Fukuda, M; Kishi, T; Nonaka, Y; Yoshizaki, M; Sato, S; Ikeda, Y				Takashima, Tsuyoshi; Sanai, Toru; Miyazono, Motoaki; Fukuda, Makoto; Kishi, Tomoya; Nonaka, Yasunori; Yoshizaki, Mai; Sato, Sae; Ikeda, Yuji			A Comparison of the Long-Term Effects of Lanthanum Carbonate and Calcium Carbonate on the Course of Chronic Renal Failure in Rats with Adriamycin-Induced Nephropathy	PLOS ONE			English	Article							PHOSPHATE-BINDER; MAINTENANCE HEMODIALYSIS; DISEASE; EFFICACY; TOLERABILITY; PROGRESSION; THERAPY; SAFETY; BONE; HYPERPHOSPHATEMIA	Lanthanum carbonate (LA) is an effective phosphate binder. Previous study showed the phosphate-binding potency of LA was twice that of calcium carbonate (CA). No study in which LA and CA were given at an equivalent phosphate-binding potency to rats or humans with chronic renal failure for a long period has been reported to date. The objective of this study was to compare the phosphate level in serum and urine and suppression of renal deterioration during long-term LA and CA treatment when they were given at an equivalent phosphate-binding potency in rats with adriamycin (ADR)-induced nephropathy. Rats were divided into three groups: an untreated group (ADR group), a CA-treated (ADR-CA) group and a LA-treated (ADR-LA) group. The daily oral dose of LA was 1.0 g/kg/day and CA was 2.0 g/kg/day for 24 weeks. The serum phosphate was lower in the ADR-CA or ADR-LA group than in the ADR group and significantly lower in the ADR-CA group than in the ADR group at each point, but there were no significant differences between the ADR and ADR-LA groups. The serum phosphate was also lower in the ADR-CA group than in the ADR-LA group, and there was significant difference at week 8. The urinary phosphate was significantly lower in the ADR-CA group than in the ADR or ADR-LA group at each point. The urinary phosphate was also lower in the ADR-LA group than in the ADR group at each point, and significant difference at week 8. There were no significant differences in the serum creatinine or blood urea nitrogen among the three groups. In conclusion, this study indicated the phosphate-binding potency of LA isn't twice as strong as CA, and neither LA nor CA suppressed the progression of chronic renal failure in the serum creatinine and blood urea nitrogen, compared to the untreated group.	[Takashima, Tsuyoshi; Miyazono, Motoaki; Fukuda, Makoto; Kishi, Tomoya; Yoshizaki, Mai; Sato, Sae; Ikeda, Yuji] Saga Univ, Fac Med, Dept Nephrol, Saga 840, Japan; [Sanai, Toru] Fukumitsu Hosp, Dept Nephrol, Fukuoka, Japan; [Nonaka, Yasunori] Ureshino Med Ctr, Dept Nephrol, Ureshino, Japan	Saga University	Takashima, T (corresponding author), Saga Univ, Fac Med, Dept Nephrol, Saga 840, Japan.	takashim@cc.saga-u.ac.jp			Bayer Yakuhin, Ltd. (Osaka, Japan)	Bayer Yakuhin, Ltd. (Osaka, Japan)	This study was supported by a grant from Bayer Yakuhin, Ltd. (Osaka, Japan). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Behets GJ, 2004, J AM SOC NEPHROL, V15, P2219, DOI 10.1097/01.ASN.0000133022.32912.95; BERTANI T, 1986, KIDNEY INT, V30, P488, DOI 10.1038/ki.1986.212; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Burke SK, 1997, NEPHROL DIAL TRANSPL, V12, P1640, DOI 10.1093/ndt/12.8.1640; Chiang SS, 2005, CLIN NEPHROL, V63, P461; D'Haese PC, 2003, KIDNEY INT, V63, pS73, DOI 10.1046/j.1523-1755.63.s85.18.x; Damment SJP, 2011, RENAL FAILURE, V33, P217, DOI 10.3109/0886022X.2011.552821; Danese MD, 2008, CLIN J AM SOC NEPHRO, V3, P1423, DOI 10.2215/CJN.01060308; Daugirdas JT, 2011, SEMIN DIALYSIS, V24, P41, DOI 10.1111/j.1525-139X.2011.00849.x; Finn WF, 2006, CLIN NEPHROL, V65, P191; GIMENEZ LF, 1987, KIDNEY INT, V31, P93, DOI 10.1038/ki.1987.14; Gonzalez-Parra E, 2011, NEPHROL DIAL TRANSPL, V26, P2567, DOI 10.1093/ndt/gfr144; Hutchison AJ, 2006, NEPHRON CLIN PRACT, V102, P61, DOI 10.1159/000088932; Hutchison AJ, 2005, NEPHRON CLIN PRACT, V100, pC8, DOI 10.1159/000084653; Hutchison AJ, 2004, NEPHROL DIAL TRANSPL, V19, pI19, DOI 10.1093/ndt/gfh1004; Hutchison AJ, 2008, NEPHRON CLIN PRACT, V110, pC15, DOI 10.1159/000149239; IBELS LS, 1978, NEW ENGL J MED, V298, P122, DOI 10.1056/NEJM197801192980302; ISRAEL Y, 1975, J PHARMACOL EXP THER, V192, P565; KARLINSKY ML, 1980, KIDNEY INT, V17, P293, DOI 10.1038/ki.1980.35; KATZ AI, 1968, NEW ENGL J MED, V278, P253, DOI 10.1056/NEJM196802012780506; KLAHR S, 1983, KIDNEY INT, V24, P579, DOI 10.1038/ki.1983.197; LAOUARI D, 1982, CLIN SCI, V63, P539, DOI 10.1042/cs0630539; LINS LE, 1978, ACTA MED SCAND, V203, P309; LUMLERTGUL D, 1986, KIDNEY INT, V29, P658, DOI 10.1038/ki.1986.49; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Pennick M, 2012, RENAL FAILURE, V34, P263, DOI 10.3109/0886022X.2011.649657; Persy VP, 2006, SEMIN DIALYSIS, V19, P195, DOI 10.1111/j.1525-139X.2006.00169.x; Russo D, 2007, KIDNEY INT, V72, P1255, DOI 10.1038/sj.ki.5002518; SANAI T, 1989, NEPHRON, V51, P530, DOI 10.1159/000185388; SERROS ER, 1981, AM J PHYSIOL, V241, pF224, DOI 10.1152/ajprenal.1981.241.3.F224; Spasovski Goce, 2008, Recent Pat Cardiovasc Drug Discov, V3, P222, DOI 10.2174/157489008786263961; Sprague SM, 2009, CLIN J AM SOC NEPHRO, V4, P178, DOI 10.2215/CJN.02830608; WALSER M, 1979, CLIN NEPHROL, V11, P66	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97859	10.1371/journal.pone.0097859	http://dx.doi.org/10.1371/journal.pone.0097859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846276	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400067
J	Ang, M; Ng, X; Wong, C; Yan, P; Chee, SP; Venkatraman, SS; Wong, TT				Ang, Marcus; Ng, Xuwen; Wong, Cheewai; Yan, Peng; Chee, Soon-Phaik; Venkatraman, Subbu S.; Wong, Tina T.			Evaluation of a Prednisolone Acetate-Loaded Subconjunctival Implant for the Treatment of Recurrent Uveitis in a Rabbit Model	PLOS ONE			English	Article							DEXAMETHASONE INTRAVITREAL IMPLANT; SUSTAINED-RELEASE; POSTERIOR UVEITIS; DRUG-DELIVERY; ANIMAL-MODEL; INTERMEDIATE; PENETRATION; SURGERY	Aim: To assess the efficacy of a biodegradable, prednisolone acetate implant in a rabbit uveitis model. Methods: Randomized, controlled study of biodegradable microfilms preloaded with prednisolone acetate (PA) in a rabbit uveitis model. Experimental uveitis was induced by unilateral intravitreal injection of Mycobacterium tuberculosis H37Ra antigen (50 ug; 1 ug/uL) in preimmunized rabbits. PA-loaded poly[d,l-lactide-co-epsilon-caprolactone] (PLC) microfilms (n = 10) and blank microfilms (n = 6) were implanted subconjunctivally. An estimate of PA release in vivo was calculated from measured residual PA amounts in microfilms after the rabbits were sacrificed. The eyes were clinically monitored for ocular inflammation for 28 days. Histopathological examination of the enucleated eyes was performed at the end of the study period. Results: In vitro studies revealed that sandwich PA-loaded microfilm formulations exhibited higher release kinetic compared to homogenous PA-loaded microfilms. The 60-40-60% microfilm released an average of 0.034 mg/day of PA over the period of 60 days in vitro; and we found that approximately 0.12 mg/day PA was released in vivo. Animals implanted with the PA-loaded microfilms exhibited significantly lowered median inflammatory scores when compared against the control group in this model for recurrent uveitis (P < 0.001). The implants were clinically well tolerated by all the animals. Histology results showed no significant scarring or inflammation around the PA-loaded microfilms. Conclusion: Our pilot study demonstrated that a subconjunctival PA-loaded implant is effective in suppressing inflammation in the rabbit model of uveitis, by providing therapeutic levels of PA that attenuated the inflammatory response even after a rechallenge. Longer term studies are now needed to establish the therapeutic potential of such a delivery system for treatment of ocular inflammation.	[Ang, Marcus; Wong, Cheewai; Chee, Soon-Phaik; Wong, Tina T.] Singapore Natl Eye Ctr, Singapore, Singapore; [Ang, Marcus; Wong, Cheewai; Chee, Soon-Phaik; Wong, Tina T.] Singapore Eye Res Inst, Singapore, Singapore; [Ng, Xuwen; Yan, Peng; Venkatraman, Subbu S.; Wong, Tina T.] Nanyang Technol Univ, Singapore 639798, Singapore	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Venkatraman, SS (corresponding author), Nanyang Technol Univ, Singapore 639798, Singapore.	ASSubbu@ntu.edu.sg; tina.wong.t.l@snec.com.sg	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070	National Medical Research Council/Early Development Grant (Singapore) [0064/2010]	National Medical Research Council/Early Development Grant (Singapore)	The authors report funding from the National Medical Research Council/Early Development Grant/ 0064/2010 (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2011, CURR EYE RES, V36, P1123, DOI 10.3109/02713683.2011.627489; Awan MA, 2009, BRIT J OPHTHALMOL, V93, P708, DOI 10.1136/bjo.2008.154906; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Chang-Lin JE, 2011, INVEST OPHTH VIS SCI, V52, P80, DOI 10.1167/iovs.10-5285; CHENG CK, 1995, INVEST OPHTH VIS SCI, V36, P442; Dandona L, 2000, BRIT J OPHTHALMOL, V84, P706, DOI 10.1136/bjo.84.7.706; Eperon S, 2013, INT J PHARMACEUT, V443, P254, DOI 10.1016/j.ijpharm.2012.12.033; Ghosn CR, 2011, INVEST OPHTH VIS SCI, V52, P2917, DOI 10.1167/iovs.10-5939; Gutteridge IF, 2007, CLIN EXP OPTOM, V90, P70, DOI 10.1111/j.1444-0938.2006.00128.x; Haghjou Nahid, 2011, J Ophthalmic Vis Res, V6, P317; HYNDIUK RA, 1969, ARCH OPHTHALMOL-CHIC, V82, P259, DOI 10.1001/archopht.1969.00990020261021; Lao LL, 2008, EUR J PHARM BIOPHARM, V70, P796, DOI 10.1016/j.ejpb.2008.05.024; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070419; Liu YC, 2013, INVEST OPHTH VIS SCI, V54, P2607, DOI 10.1167/iovs.12-11466; Lowder C, 2011, ARCH OPHTHALMOL-CHIC, V129, P545, DOI 10.1001/archophthalmol.2010.339; NUSSENBLATT RB, 1985, OPHTHALMOLOGY, V92, P467; Paivonsalo-Hietanen T, 1997, ACTA OPHTHALMOL SCAN, V75, P76; Peng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022507; Siddique SS, 2011, EXPERT OPIN INV DRUG, V20, P1497, DOI 10.1517/13543784.2011.617741	19	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97555	10.1371/journal.pone.0097555	http://dx.doi.org/10.1371/journal.pone.0097555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842851	Green Published, gold			2022-12-27	WOS:000340948600043
J	Coogan, SCP; Raubenheimer, D; Stenhouse, GB; Nielsen, SE				Coogan, Sean C. P.; Raubenheimer, David; Stenhouse, Gordon B.; Nielsen, Scott E.			Macronutrient Optimization and Seasonal Diet Mixing in a Large Omnivore, the Grizzly Bear: A Geometric Analysis	PLOS ONE			English	Article							NUTRITIONAL ECOLOGY; BODY-COMPOSITION; ENERGY; FOOD; MASS; HIBERNATION; REPRODUCTION; CONSERVATION; CONSTRAINTS; SELECTION	Nutrient balance is a strong determinant of animal fitness and demography. It is therefore important to understand how the compositions of available foods relate to required balance of nutrients and habitat suitability for animals in the wild. These relationships are, however, complex, particularly for omnivores that often need to compose balanced diets by combining their intake from diverse nutritionally complementary foods. Here we apply geometric models to understand how the nutritional compositions of foods available to an omnivorous member of the order Carnivora, the grizzly bear (Ursus arctos L.), relate to optimal macronutrient intake, and assess the seasonal nutritional constraints on the study population in west-central Alberta, Canada. The models examined the proportion of macronutrients that bears could consume by mixing their diet from food available in each season, and assessed the extent to which bears could consume the ratio of protein to nonprotein energy previously demonstrated using captive bears to optimize mass gain. We found that non-selective feeding on ungulate carcasses provided a non-optimal macronutrient balance with surplus protein relative to fat and carbohydrate, reflecting adaptation to an omnivorous lifestyle, and that optimization through feeding selectively on different tissues of ungulate carcasses is unlikely. Bears were, however, able to dilute protein intake to an optimal ratio by mixing their otherwise high-protein diet with carbohydrate-rich fruit. Some individual food items were close to optimally balanced in protein to non-protein energy (e. g. Hedysarum alpinum roots), which may help explain their dietary prevalence. Ants may be consumed particularly as a source of lipids. Overall, our analysis showed that most food available to bears in the study area were high in protein relative to lipid or carbohydrate, suggesting the lack of non-protein energy limits the fitness (e. g. body size and reproduction) and population density of grizzly bears in this ecosystem.	[Coogan, Sean C. P.; Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Stenhouse, Gordon B.] Foothills Res Inst, Grizzly Bear Program, Hinton, AB, Canada	University of Alberta; University of Sydney; University of Sydney	Coogan, SCP (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	scoogan@ualberta.ca	Nielsen, Scott/O-7482-2019; Nielsen, Scott/C-2842-2013	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630; Coogan, Sean/0000-0003-2694-8468; Raubenheimer, David/0000-0001-9050-1447	Foothills Research Institute Grizzly Bear Program; Natural Sciences and Engineering Research Council (NSERC) of Canada; Alberta Innovates - Bio Solutions; Applied Conservation Ecology lab	Foothills Research Institute Grizzly Bear Program; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates - Bio Solutions; Applied Conservation Ecology lab	Funding for S. C. P. Coogan was provided by the Foothills Research Institute Grizzly Bear Program, Natural Sciences and Engineering Research Council (NSERC) of Canada, Alberta Innovates - Bio Solutions, and the Applied Conservation Ecology lab (http://www.ace-lab.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Grizzly Bear Inventory Team, 2005, 2004 POP INV DENS ES; Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; [Anonymous], 2013, USDA NAT NUTR DAT ST; [Anonymous], 1987, BEARS BIOL MANAG; Beckingham J. D., 1996, FIELD GUIDE ECOSITES; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Coogan Sean C.P., 2012, ISRN Ecology, P1; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Cristescu B, 2013, THESIS U ALBERTA EDM; DELGIUDICE GD, 1990, J WILDLIFE MANAGE, V54, P539, DOI 10.2307/3809347; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Erlenbach JA, 2014, J MAMMAL, V95, P160, DOI 10.1644/13-MAMM-A-161; Farley SD, 1995, CAN J ZOOL, V73, P2216, DOI 10.1139/z95-262; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Hewson-Hughes AK, 2013, J COMP PHYSIOL B, V183, P525, DOI 10.1007/s00360-012-0727-y; Hewson-Hughes AK, 2013, BEHAV ECOL, V24, P293, DOI 10.1093/beheco/ars168; Hilderbrand GV, 2000, J WILDLIFE MANAGE, V64, P178, DOI 10.2307/3802988; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hilderbrand GV, 1999, CAN J ZOOL, V77, P1623, DOI 10.1139/cjz-77-10-1623; Hundertmark K. J., 1997, ESTIMATION BODY COMP; Jensen K, 2012, P ROY SOC B-BIOL SCI, V279, P2212, DOI 10.1098/rspb.2011.2410; Johnson CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070383; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; KUHNLEIN H V, 1990, Journal of Food Composition and Analysis, V3, P38, DOI 10.1016/0889-1575(90)90007-9; Kuipers RS, 2010, BRIT J NUTR, V104, P1666, DOI 10.1017/S0007114510002679; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lopez-Alfaro C, 2013, ECOL MODEL, V270, P1, DOI 10.1016/j.ecolmode1.2013.09.002; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; MCCULLOUGH DR, 1983, J WILDLIFE MANAGE, V47, P430, DOI 10.2307/3808516; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; Merrill AL, 1973, AGR HDB, V74, P105; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; Raubenheimer D, 2013, ANNU REV ENTOMOL, V58, P141, DOI 10.1146/annurev-ento-120710-100713; Raubenheimer D, 2012, PHILOS T R SOC B, V367, P1628, DOI 10.1098/rstb.2012.0007; Raubenheimer D, 2011, ECOL MONOGR, V81, P407, DOI 10.1890/10-1707.1; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; REDFORD KH, 1984, J ZOOL, V203, P385, DOI 10.1111/j.1469-7998.1984.tb02339.x; Robbins CT, 2007, OIKOS, V116, P1675, DOI 10.1111/j.0030-1299.2007.16140.x; Rode KD, 2006, ECOLOGY, V87, P2636, DOI 10.1890/0012-9658(2006)87[2636:SDRSAH]2.0.CO;2; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2012, NATURE NUTR UNIFYING; Wehi PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084641; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; WORDEN KA, 1995, CAN J ZOOL, V73, P452, DOI 10.1139/z95-052	60	53	53	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97968	10.1371/journal.pone.0097968	http://dx.doi.org/10.1371/journal.pone.0097968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841821	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600095
J	Iovino, F; Molema, G; Bijlsma, JJE				Iovino, Federico; Molema, Grietje; Bijlsma, Jetta J. E.			Streptococcus pneumoniae Interacts with pIgR Expressed by the Brain Microvascular Endothelium but Does Not Co-Localize with PAF Receptor	PLOS ONE			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; ACTIVATING-FACTOR-RECEPTOR; CULTURED HIPPOCAMPAL; EPITHELIAL-CELLS; PROTEIN; TRANSCYTOSIS; INVASION; BINDING; PATHOPHYSIOLOGY; PATHOGENESIS	Streptococcus pneumoniae is thought to adhere to the blood-brain barrier (BBB) endothelium prior to causing meningitis. The platelet activating factor receptor (PAFR) has been implicated in this adhesion but there is a paucity of data demonstrating direct binding of the bacteria to PAFR. Additionally, studies that inhibit PAFR strongly suggest that alternative receptors for pneumococci are present on the endothelium. Therefore, we studied the roles of PAFR and pIgR, an established epithelial pneumococcal receptor, in pneumococcal adhesion to brain endothelial cells in vivo. Mice were intravenously infected with pneumococci and sacrificed at various time points before meningitis onset. Co-localization of bacteria with PAFR and pIgR was investigated using immunofluorescent analysis of the brain tissue. In vitro blocking with antibodies and incubation of pneumococci with endothelial cell lysates were used to further probe bacteria-receptor interaction. In vivo as well as in vitro pneumococci did not co-localize with PAFR. On the other hand the majority of S. pneumoniae co-localized with endothelial pIgR and pIgR blocking reduced pneumococcal adhesion to endothelial cells. Pneumococci physically interacted with pIgR in endothelial cell lysates. In conclusion, bacteria did not associate with PAFR, indicating an indirect role of PAFR in pneumococcal adhesion to endothelial cells. In contrast, pIgR on the BBB endothelium may represent a novel pneumococcal adhesion receptor.	[Iovino, Federico; Bijlsma, Jetta J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Molema, Grietje] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen	Bijlsma, JJE (corresponding author), MSD Anim Hlth, Intervet Int BV, Boxmeer, Netherlands.	bijlsmajje@gmail.com	Iovino, Federico/R-2721-2017; Iovino, Federico/AGW-9968-2022	Iovino, Federico/0000-0001-5249-9120; Iovino, Federico/0000-0001-5249-9120; Molema, Grietje/0000-0002-4147-6676				Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; Agarwal V, 2010, J BIOL CHEM, V285, P35615, DOI 10.1074/jbc.M110.172999; Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Asgeirsdottir SA, 2010, J CONTROL RELEASE, V141, P241, DOI 10.1016/j.jconrel.2009.09.008; BITO H, 1994, EUR J BIOCHEM, V221, P211, DOI 10.1111/j.1432-1033.1994.tb18731.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; DEHOOP M, 1995, J CELL BIOL, V130, P1447, DOI 10.1083/jcb.130.6.1447; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gradstedt H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065626; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hemar A, 1997, J NEUROSCI, V17, P9026; IKONEN E, 1993, CURR BIOL, V3, P635, DOI 10.1016/0960-9822(93)90061-R; Iovino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068408; Iovino F, 2013, CELL MICROBIOL, V15, P870, DOI 10.1111/cmi.12129; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Jen FEC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003377; Kim KJ, 2003, AM J PHYSIOL-LUNG C, V284, pL247, DOI 10.1152/ajplung.00235.2002; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Lu L, 2003, J BIOL CHEM, V278, P48178, DOI 10.1074/jbc.M306906200; Luo RS, 2005, EMBO J, V24, P34, DOI 10.1038/sj.emboj.7600490; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Romero-Steiner S, 2006, VACCINE, V24, P3224, DOI 10.1016/j.vaccine.2006.01.042; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Woehrl B, 2011, EXPERT REV ANTI-INFE, V9, P1053, DOI [10.1586/ERI.11.129, 10.1586/eri.11.129]; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	32	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97914	10.1371/journal.pone.0097914	http://dx.doi.org/10.1371/journal.pone.0097914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841255	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600092
J	Li, GL; Su, H; Zhou, ZJ; Yao, W				Li, Genlai; Su, Hao; Zhou, Zhenjin; Yao, Wen			Identification of the Porcine G Protein-Coupled Receptor 41 and 43 Genes and Their Expression Pattern in Different Tissues and Development Stages	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PROTEIN-COUPLED RECEPTOR; GASTROINTESTINAL-TRACT; ADIPOSE-TISSUE; GUT MICROBIOTA; HUMAN COLON; GPR43; PROPIONATE; ADIPOGENESIS; FERMENTATION	Short-chain fatty acids (SCFAs) are not only an important energy source, but they also play a regulatory role in various physiological processes in humans and rodents. Current studies, mostly in humans and rodents, have revealed that SCFAs acted as endogenous ligands for G protein-coupled receptor GPR41 and GPR43. Whether proteins similar to human GPR41 and GPR43 mediate the regulatory effects of SCFAs in swine remains unclear to date. The aims of this study were to determine whether GPR41 and GPR43 genes are expressed in porcine different tissues; and whether the expression of GPR41 and GPR43 is tissue-specific and/or time-associated. The alignment results showed that pig chromosome 6 contained GPR41 and GPR43 genes. Reverse transcription polymerase chain reaction (RT-PCR) indicated that GPR41 and GPR43 were expressed in porcine various tissues. The 2218 bp and 1908 bp nucleotide sequence representing the full-length cDNA sequence of porcine GPR41 and GPR43 was obtained from the ileum and spleen using rapid amplification of cDNA ends (RACE), which were capable of encoding 335 and 329 amino acid sequences, respectively. The structure prediction revealed that porcine GPR41 and GPR43 proteins had seven putative trans-membrane domains. The real-time PCR results indicated that GPR41 and GPR43 were expressed throughout the developmental stages in a tissue-specific and time-associated manner. GPR41 and GPR43 were most highly expressed in the ileum (P < 0.01) and the spleen (P < 0.01), respectively. Western blot results showed that porcine GPR41 and GPR43 proteins were expressed in a variety of porcine tissues, including the spleen, ileum, colon, and adipose tissue. In situ GPR41 and GPR43 immunoreactivities were observed through immunohistochemistry in the spleen, ileum, colon, and adipose tissue. In conclusion, the pig genome encoded GPR41 and GPR43 genes, and these two genes were detected in a variety of porcine tissues and expressed in tissue-specific and time-associated manner.	[Li, Genlai; Su, Hao; Zhou, Zhenjin; Yao, Wen] Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Gastrointestinal Microbiol, Nanjing, Jiangsu, Peoples R China; [Yao, Wen] Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs	Yao, W (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Gastrointestinal Microbiol, Nanjing, Jiangsu, Peoples R China.	yaowen67jp@njau.edu.cn			National Natural Science Foundation of China [31072035]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; Novus International	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Novus International	National Natural Science Foundation of China (No.: 31072035), Special Fund for Agro-scientific Research in the Public Interest (No.: 201003011), and Novus International. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; ANDERSON DB, 1973, J LIPID RES, V14, P160; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Bourdu S, 2005, GASTROENTEROLOGY, V128, P1996, DOI 10.1053/j.gastro.2005.03.082; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; BUGAUT M, 1993, ANNU REV NUTR, V13, P217, DOI 10.1146/annurev.nu.13.070193.001245; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; FARNINGHAM DAH, 1993, BRIT J NUTR, V70, P37, DOI 10.1079/BJN19930103; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Gilbert ER, 2008, J NUTR, V138, P262, DOI 10.1093/jn/138.2.262; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hou Zengmiao, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1361; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; LUNDBERG JM, 1982, P NATL ACAD SCI-BIOL, V79, P4471, DOI 10.1073/pnas.79.14.4471; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCBURNEY MI, 1993, J NUTR, V123, P721, DOI 10.1093/jn/123.4.721; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Scheppach W, 2004, CURR OPIN CLIN NUTR, V7, P563, DOI 10.1097/00075197-200409000-00009; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Wang A, 2009, J DAIRY SCI, V92, P2696, DOI 10.3168/jds.2009-2037; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; YEN JT, 1991, J ANIM SCI, V69, P2001, DOI 10.2527/1991.6952001x	31	41	41	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97342	10.1371/journal.pone.0097342	http://dx.doi.org/10.1371/journal.pone.0097342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840136	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600025
J	Modulevsky, DJ; Lefebvre, C; Haase, K; Al-Rekabi, Z; Pelling, AE				Modulevsky, Daniel J.; Lefebvre, Cory; Haase, Kristina; Al-Rekabi, Zeinab; Pelling, Andrew E.			Apple Derived Cellulose Scaffolds for 3D Mammalian Cell Culture	PLOS ONE			English	Article							BACTERIAL CELLULOSE; DECELLULARIZED MATRIX; POTENTIAL SCAFFOLD; IN-VIVO; TISSUE; CHONDROCYTES; MEMBRANE; POLYMER; MICROENVIRONMENTS; DIFFERENTIATION	There are numerous approaches for producing natural and synthetic 3D scaffolds that support the proliferation of mammalian cells. 3D scaffolds better represent the natural cellular microenvironment and have many potential applications in vitro and in vivo. Here, we demonstrate that 3D cellulose scaffolds produced by decellularizing apple hypanthium tissue can be employed for in vitro 3D culture of NIH3T3 fibroblasts, mouse C2C12 muscle myoblasts and human HeLa epithelial cells. We show that these cells can adhere, invade and proliferate in the cellulose scaffolds. In addition, biochemical functionalization or chemical cross-linking can be employed to control the surface biochemistry and/or mechanical properties of the scaffold. The cells retain high viability even after 12 continuous weeks of culture and can achieve cell densities comparable with other natural and synthetic scaffold materials. Apple derived cellulose scaffolds are easily produced, inexpensive and originate from a renewable source. Taken together, these results demonstrate that naturally derived cellulose scaffolds offer a complementary approach to existing techniques for the in vitro culture of mammalian cells in a 3D environment.	[Modulevsky, Daniel J.; Lefebvre, Cory; Haase, Kristina; Al-Rekabi, Zeinab; Pelling, Andrew E.] Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada; [Modulevsky, Daniel J.; Pelling, Andrew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Haase, Kristina; Al-Rekabi, Zeinab; Pelling, Andrew E.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Pelling, Andrew E.] Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Pelling, AE (corresponding author), Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada.	a@pellinglab.net		Pelling, Andrew/0000-0003-3732-7472; Haase, Kristina/0000-0003-3321-4286	University of Ottawa; Natural Science and Engineering Research Council (NSERC); NSERC; NSERC-CREATE Training Program in Quantitative; Canada Research Chairs Program; Province of Ontario Early Researcher Award	University of Ottawa; Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-CREATE Training Program in Quantitative; Canada Research Chairs Program(Canada Research Chairs); Province of Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	This work was made possible by support from the University of Ottawa and a Natural Science and Engineering Research Council (NSERC) Discovery Grant. C. L. was supported by an NSERC Undergraduate Student Research Award, Z.A.R. was supported by a graduate fellowship from the NSERC-CREATE Training Program in Quantitative. A. E. P. acknowledges generous support from the Canada Research Chairs Program and a Province of Ontario Early Researcher Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FK, 2013, J BIOACT COMPAT POL, V28, P97, DOI 10.1177/0883911512467643; Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148; [Anonymous], 1985, BIOCH PLANT CELL WAL; Arenas-Herrera JE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014106; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bancroft G. N., 2003, TISSUE ENG, V9; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bourgine PE, 2013, BIOMATERIALS, V34, P6099, DOI 10.1016/j.biomaterials.2013.04.058; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569; Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d; Derda R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018940; Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106; Dorothee K, 2011, TISSUE ENG REGEN MED, DOI [10.5772/21197, DOI 10.5772/21197]; Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024; Esau K, 1965, PLANT ANANTOMY; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Fong ELS, 2013, P NATL ACAD SCI USA, V110, P6500, DOI 10.1073/pnas.1221403110; FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104; FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Grotte M, 2002, INT J FOOD PROP, V5, P333, DOI 10.1081/JFP-120005789; Guolla L, 2012, J CELL SCI, V125, P603, DOI 10.1242/jcs.088302; Haase K, 2013, CYTOSKELETON, V70, P494, DOI 10.1002/cm.21129; Hansen P, 2009, CONNECT TISSUE RES, V50, P211, DOI 10.1080/03008200802610040; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hirayama K, 2013, BIOMATERIALS, V34, P2421, DOI 10.1016/j.biomaterials.2012.12.013; Hulbary RL, 1944, AM J BOT, V31, P561, DOI 10.2307/2437380; Hutter JL, 2005, J MICROSC-OXFORD, V219, P61, DOI 10.1111/j.1365-2818.2005.01497.x; ISHIHARA K, 1995, J BIOMED MATER RES, V29, P181, DOI 10.1002/jbm.820290207; Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421, DOI 10.1177/039139880302600508; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Masoudi H., 2007, Canadian Biosystems Engineering, V49; McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048; McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014; Milotti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013942; Modulevsky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045329; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Nilsen Timothy W, 2013, Cold Spring Harb Protoc, V2013, P579, DOI 10.1101/pdb.prot075176; Orlando G, 2011, TRANSPLANTATION, V91, P1310, DOI 10.1097/TP.0b013e318219ebb5; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Ou KL, 2011, J MECH BEHAV BIOMED, V4, P618, DOI 10.1016/j.jmbbm.2011.02.001; Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; Pelling AE, 2009, CELL MOTIL CYTOSKEL, V66, P409, DOI 10.1002/cm.20391; Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010; Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Rai R, 2011, MAT SCI ENG R, V72, P29, DOI 10.1016/j.mser.2010.11.002; Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Schaffner JH, 1916, OHIO J SCI, V16, P360; Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033; Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y; Soares CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038147; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; TERRY RA, 1969, J SCI FOOD AGR, V20, P317, DOI 10.1002/jsfa.2740200514; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zdunek A, 2013, INS S	84	102	106	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97835	10.1371/journal.pone.0097835	http://dx.doi.org/10.1371/journal.pone.0097835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842603	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600080
J	Gao, YQ; Liu, CS; Ding, YM; Sun, C; Zhang, RB; Xian, M; Zhao, G				Gao, Yongqiang; Liu, Changshui; Ding, Yamei; Sun, Chao; Zhang, Rubing; Xian, Mo; Zhao, Guang			Development of Genetically Stable Escherichia coli Strains for Poly(3-Hydroxypropionate) Production	PLOS ONE			English	Article							BACILLUS-SUBTILIS; CONSTRUCTION; EXPRESSION; 3-HYDROXYPROPIONATE; BIOSYNTHESIS; PURIFICATION; INSERTIONS; CHROMOSOME; POLYESTERS; VECTORS	Poly(3-hydroxypropionate) (P3HP) is a biodegradable and biocompatible thermoplastic. In our previous study, a pathway for P3HP production was constructed in recombinant Esecherichia coli. Seven exogenous genes in P3HP synthesis pathway were carried by two plasmid vectors. However, the P3HP production was severely suppressed by strain instability due to plasmid loss. In this paper, two strategies, chromosomal gene integration and plasmid addiction system (PAS) based on amino acid anabolism, were applied to construct a genetically stable strain. Finally, a combination of those two methods resulted in the best results. The resultant strain carried a portion of P3HP synthesis genes on chromosome and the others on plasmid, and also brought a tyrosine-auxotrophy based PAS. In aerobic fed-batch fermentation, this strain produced 25.7 g/L P3HP from glycerol, about 2.5-time higher than the previous strain with two plasmids. To the best of our knowledge, this is the highest P3HP production from inexpensive carbon sources.	[Gao, Yongqiang; Liu, Changshui; Sun, Chao; Zhang, Rubing; Xian, Mo; Zhao, Guang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biobased Mat, Qingdao, Peoples R China; [Gao, Yongqiang; Liu, Changshui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ding, Yamei] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Xian, Mo; Zhao, Guang] Collaborat Innovat Ctr Marine Biomass Fibers Mat, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Xian, M (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biobased Mat, Qingdao, Peoples R China.	xianmo@qibebt.ac.cn; zhaoguang@qibebt.ac.cn	zhao, guang/E-4702-2013; GAO, YQ/AAD-8468-2022	zhao, guang/0000-0003-0002-5972; Gao, Yongqiang/0000-0002-5871-8651; ding, yamei/0000-0002-8972-9468	100-Talent Project of CAS; Natural Science Foundation of Shandong Province [ZR2013EMZ002]; National Natural Science Foundation of China [21206185, 21376255]; Qingdao Sci-Tech Development Programme [12-1-4-9-(3)-jch]	100-Talent Project of CAS; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qingdao Sci-Tech Development Programme	This research was financially supported by the 100-Talent Project of CAS (for GZ), Natural Science Foundation of Shandong Province (ZR2013EMZ002), National Natural Science Foundation of China (21206185, 21376255), and Qingdao Sci-Tech Development Programme (12-1-4-9-(3)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreessen B, 2010, APPL ENVIRON MICROB, V76, P4919, DOI 10.1128/AEM.01015-10; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; BURNS DT, 1991, FRESEN J ANAL CHEM, V340, P53, DOI 10.1007/BF00324392; DOPHEIDE TA, 1972, J BIOL CHEM, V247, P4447; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; GAY P, 1983, J BACTERIOL, V153, P1424, DOI 10.1128/JB.153.3.1424-1431.1983; Green PR, 2002, BIOMACROMOLECULES, V3, P208, DOI 10.1021/bm015620m; Ichikawa M, 1996, MACROMOL CHEM PHYS, V197, P2467, DOI 10.1002/macp.1996.021970811; Jones KL, 1998, BIOTECHNOL BIOENG, V59, P659, DOI 10.1002/(SICI)1097-0290(19980920)59:6<659::AID-BIT1>3.3.CO;2-1; Koma D, 2012, APPL MICROBIOL BIOT, V93, P815, DOI 10.1007/s00253-011-3735-z; Kroll J, 2010, MICROB BIOTECHNOL, V3, P634, DOI 10.1111/j.1751-7915.2010.00170.x; Kroll J, 2009, METAB ENG, V11, P168, DOI 10.1016/j.ymben.2009.01.007; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; Meng DC, 2012, METAB ENG, V14, P317, DOI 10.1016/j.ymben.2012.04.003; Ohta K, 1990, J BACTERIOL, V57, P893; Peredelchuk MY, 1997, GENE, V187, P231, DOI 10.1016/S0378-1119(96)00760-3; Roland K, 1999, AVIAN DIS, V43, P429, DOI 10.2307/1592640; SAMPATHKUMAR P, 1982, BIOCHIM BIOPHYS ACTA, V702, P204, DOI 10.1016/0167-4838(82)90504-0; Shen HY, 2005, ANAL CHIM ACTA, V535, P33, DOI 10.1016/j.aca.2004.12.027; TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674; Vidal L, 2008, J BIOTECHNOL, V134, P127, DOI 10.1016/j.jbiotec.2008.01.011; Vollenweider S, 2003, J AGR FOOD CHEM, V51, P3287, DOI 10.1021/jf021086d; Wang Q, 2013, BIORESOURCE TECHNOL, V131, P548, DOI 10.1016/j.biortech.2013.01.096; Wang ZJ, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-34; WOJCIK K, 1993, ACTA MICROBIOL POL, V42, P127; ZABRISKIE DW, 1986, ENZYME MICROB TECH, V8, P706, DOI 10.1016/0141-0229(86)90157-2; Zhou Q, 2011, METAB ENG, V13, P777, DOI 10.1016/j.ymben.2011.10.002	29	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97845	10.1371/journal.pone.0097845	http://dx.doi.org/10.1371/journal.pone.0097845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837211	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800076
J	Boubaker, G; Gottstein, B; Hemphill, A; Babba, H; Spiliotis, M				Boubaker, Ghalia; Gottstein, Bruno; Hemphill, Andrew; Babba, Hamouda; Spiliotis, Markus			Echinococcus P29 Antigen: Molecular Characterization and Implication on Post-Surgery Follow-Up of CE Patients Infected with Different Species of the Echinococcus granulosus Complex	PLOS ONE			English	Article							CYSTIC ECHINOCOCCOSIS; RECOMBINANT ANTIGENS; BREEDING SYSTEMS; MESSENGER-RNA; STRAINS; VACCINE; GENE; MULTILOCULARIS; G6; FERTILIZATION	The protein P29 is a potential serological marker for post-treatment monitoring of cystic echinococcosis (CE) especially in young patients. We now have demonstrated that P29 is encoded in the Echinococcus genus by a single gene consisting of 7 exons spanning 1.2 kb of DNA. Variability of the p29 gene at inter- and intra-species level was assessed with 50 cDNA and 280 genomic DNA clones isolated from different E. granulosus s. l. isolates (E. granulosus sensu stricto (G1), E. equinus (G4), E. ortleppi (G5), E. canadensis (G6), E. canadensis (G7) and E. canadensis (G10)) as well as four E. multilocularis isolates. Scarce interspecies polymorphism at the p29 locus was observed and affected predominantly E. granulosus s. s. (G1), where we identified two alleles (A1 and A2) coding for identical P29 proteins and yielding in three genotypes (A1/A1, A2/A2 and A1/A2). Genotypic frequencies expected under Hardy-Weinberg equilibrium revealed a high rate of heterozygosity (47%) that strongly supports the hypothesis that E. granulosus s. s. (G1) is predominantly outbreeding. Comparative sequence analyses of the complete p29 gene showed that phylogenetic relationships within the genus Echinococcus were in agreement with those of previous nuclear gene studies. At the protein level, the deduced P29 amino acid (AA) sequences exhibited a high level of conservation, ranging from 97.9% AA sequence identity among the whole E. granulosus s. l. group to 99.58% identity among E. multilocularis isolates. We showed that P29 proteins of these two species differ by three AA substitutions without implication for antigenicity. In Western-blot analyses, serum antibodies from a human CE patient infected with E. canadensis (G6) strongly reacted with recombinant P29 from E. granulosus s. s. (G1) (recEg(G1)P29). In the same line, human anti-Eg(G1) P29 antibodies bound to recEcnd(G6)P29. Thus, minor AA sequence variations appear not to impair the prognostic serological use of P29.	[Boubaker, Ghalia; Gottstein, Bruno; Hemphill, Andrew; Spiliotis, Markus] Univ Bern, Inst Parasitol, Bern, Switzerland; [Boubaker, Ghalia] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Boubaker, Ghalia; Babba, Hamouda] Univ Monastir, Dept Clin Biol B, Lab Parasitol & Mycol, Monastir, Tunisia	University of Bern; University of Bern; Universite de Monastir	Gottstein, B (corresponding author), Univ Bern, Inst Parasitol, Bern, Switzerland.	bruno.gottstein@vetsuisse.unibe.ch		Hemphill, Andrew/0000-0002-0622-2128	Swiss National Science Foundation [31003A_141039/1]; UNESCO-L'OREAL international "For women in science" Fellowships	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UNESCO-L'OREAL international "For women in science" Fellowships	This work was supported by the Swiss National Science Foundation (grant no. 31003A_141039/1) and the UNESCO-L'OREAL international "For women in science" Fellowships (http://www.unesco.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Alvarez Rojas CA, 2012, MOL BIOCHEM PARASIT, V183, P115, DOI 10.1016/j.molbiopara.2012.02.005; Arend AC, 2004, EXP PARASITOL, V108, P76, DOI 10.1016/j.exppara.2004.07.009; Ben Nouir N, 2008, J CLIN MICROBIOL, V46, P1631, DOI 10.1128/JCM.01689-07; Ben Nouir N, 2009, T ROY SOC TROP MED H, V103, P355, DOI 10.1016/j.trstmh.2008.09.020; Boubaker G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002017; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Brehm K, 2000, J BIOL CHEM, V275, P38311, DOI 10.1074/jbc.M006091200; Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Chemale G, 2001, MOL BIOCHEM PARASIT, V116, P233, DOI 10.1016/S0166-6851(01)00316-4; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Chow C, 2001, MOL BIOCHEM PARASIT, V118, P83, DOI 10.1016/S0166-6851(01)00373-5; Chow C, 2008, EXP PARASITOL, V119, P499, DOI 10.1016/j.exppara.2008.01.004; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; El Malki HO, 2010, J GASTROINTEST SURG, V14, P1121, DOI 10.1007/s11605-010-1220-0; Fernandez V, 1996, MOL BIOCHEM PARASIT, V77, P247, DOI 10.1016/0166-6851(96)02602-3; FROSCH P, 1994, MOL BIOCHEM PARASIT, V64, P171, DOI 10.1016/0166-6851(94)90145-7; Galitza Z, 2006, T ROY SOC TROP MED H, V100, P126, DOI 10.1016/j.trstmh.2005.05.014; Gonzalez G, 2000, MOL BIOCHEM PARASIT, V105, P177, DOI 10.1016/S0166-6851(99)00166-8; Gonzalez LM, 2011, MOL BIOCHEM PARASIT, V176, P131, DOI 10.1016/j.molbiopara.2010.12.014; Haag KL, 2006, INFECT GENET EVOL, V6, P251, DOI 10.1016/j.meegid.2005.07.003; Haag KL, 2011, PARASITOLOGY, V138, P298, DOI 10.1017/S0031182010001307; Haag KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005362; Haag KL, 1999, PARASITOLOGY, V118, P63, DOI 10.1017/S0031182098003485; Haag KL, 2004, GENE, V333, P157, DOI 10.1016/j.gene.2004.02.027; Haag KL, 1998, MEM I OSWALDO CRUZ, V93, P695, DOI 10.1590/S0074-02761998000500024; Hernandez-Gonzalez A, 2008, CLIN VACCINE IMMUNOL, V15, P147, DOI 10.1128/CVI.00363-07; Kamenetzky L, 2005, PARASITOLOGY, V131, P805, DOI 10.1017/S0031182005008474; Kamenetzky L, 2002, INFECT GENET EVOL, V2, P129, DOI 10.1016/S1567-1348(02)00131-4; Knapp J, 2011, MOL PHYLOGENET EVOL, V61, P628, DOI 10.1016/j.ympev.2011.07.022; Lightowlers MW, 1999, INT J PARASITOL, V29, P531, DOI 10.1016/S0020-7519(99)00003-X; LIGHTOWLERS MW, 1990, INT J PARASITOL, V20, P471, DOI 10.1016/0020-7519(90)90194-R; Lymbery AJ, 1997, EVOLUTION, V51, P289, DOI [10.2307/2410983, 10.1111/j.1558-5646.1997.tb02411.x]; LYMBERY AJ, 1990, PARASITOLOGY, V101, P283, DOI 10.1017/S0031182000063344; Maass DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000597; Maillard S, 2011, VET PARASITOL, V175, P80, DOI 10.1016/j.vetpar.2010.09.014; Mamuti W, 2006, EXP PARASITOL, V113, P75, DOI 10.1016/j.exppara.2005.12.007; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Rigano R, 2001, INFECT IMMUN, V69, P288, DOI 10.1128/IAI.69.1.288-296.2001; Rigano R, 2007, INFECT IMMUN, V75, P1667, DOI 10.1128/IAI.01156-06; Rojas CAA, 2013, PARASITE IMMUNOL, V35, P99, DOI 10.1111/pim.12009; Saarma U, 2009, PARASITOLOGY, V136, P317, DOI 10.1017/S0031182008005453; Sambrook J, 1989, MOL CLONING LAB MANU; Siles-Lucas M, 2001, PARASITOLOGY, V122, P281, DOI 10.1017/S0031182001007405; Stojkovic M, 2009, PLOS NEGLECT TROP D, V3, P1; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Verani JR, 2009, AM J TROP MED HYG, V80, P410; Virginio VG, 2003, CLIN EXP IMMUNOL, V132, P309, DOI 10.1046/j.1365-2249.2003.02123.x; WHO Informal Working Group on Echinococcosis, 1996, B WORLD HEALTH ORGAN, P74231; Wulamu M, 2007, PARASITOL INT, V56, P313, DOI 10.1016/j.parint.2007.06.003; Zhang WB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001166	53	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98357	10.1371/journal.pone.0098357	http://dx.doi.org/10.1371/journal.pone.0098357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851904	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200066
J	Huang, JC; Lee, TY; Teng, TY; Chen, YC; Huang, CY; Lee, CT				Huang, Jr-Chuan; Lee, Tsung-Yu; Teng, Tse-Yang; Chen, Yi-Chin; Huang, Cho-Ying; Lee, Cheing-Tung			Validating the Operational Bias and Hypothesis of Universal Exponent in Landslide Frequency-Area Distribution	PLOS ONE			English	Article							SEDIMENT; MAGNITUDE; DYNAMICS; HAZARD	The exponent decay in landslide frequency-area distribution is widely used for assessing the consequences of landslides and with some studies arguing that the slope of the exponent decay is universal and independent of mechanisms and environmental settings. However, the documented exponent slopes are diverse and hence data processing is hypothesized for this inconsistency. An elaborated statistical experiment and two actual landslide inventories were used here to demonstrate the influences of the data processing on the determination of the exponent. Seven categories with different landslide numbers were generated from the predefined inverse-gamma distribution and then analyzed by three data processing procedures (logarithmic binning, LB, normalized logarithmic binning, NLB and cumulative distribution function, CDF). Five different bin widths were also considered while applying LB and NLB. Following that, the maximum likelihood estimation was used to estimate the exponent slopes. The results showed that the exponents estimated by CDF were unbiased while LB and NLB performed poorly. Two binning-based methods led to considerable biases that increased with the increase of landslide number and bin width. The standard deviations of the estimated exponents were dependent not just on the landslide number but also on binning method and bin width. Both extremely few and plentiful landslide numbers reduced the confidence of the estimated exponents, which could be attributed to limited landslide numbers and considerable operational bias, respectively. The diverse documented exponents in literature should therefore be adjusted accordingly. Our study strongly suggests that the considerable bias due to data processing and the data quality should be constrained in order to advance the understanding of landslide processes.	[Huang, Jr-Chuan; Lee, Tsung-Yu; Teng, Tse-Yang; Huang, Cho-Ying; Lee, Cheing-Tung] Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan; [Chen, Yi-Chin] Taiwan Typhoon & Flood Res Inst, Taipei, Taiwan	National Taiwan University	Huang, JC (corresponding author), Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan.	riverhuang@ntu.edu.tw	Huang, Cho-ying/E-6573-2012	Huang, Cho-ying/0000-0002-9174-7542; Huang, Jr-Chuan/0000-0001-6589-4963; LEE, CHEING-TUNG/0000-0003-3611-3499	NSC Taiwan [NSC 102-2116-M-002-019, 102-2923-M-002-001-MY3]; National Taiwan University [10R70604-2]	NSC Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was sponsored by NSC Taiwan grants (NSC 102-2116-M-002-019, 102-2923-M-002-001-MY3) and National Taiwan University (10R70604-2). The websites of NSC and NTU are http://www.most.gov.tw/ and www.ntu.edu.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATURAL HAZARDS ENV; Brardinoni F, 2004, EARTH SURF PROC LAND, V29, P115, DOI 10.1002/esp.1029; Brunetti MT, 2009, NONLINEAR PROC GEOPH, V16, P179, DOI 10.5194/npg-16-179-2009; Buckman RC, 2001, 01443 US GEOL SURV; Chen YH, 2012, THESIS NATL TAIWAN U; Christensen K., 2005, COMPLEXITY CRITICALI, V1, DOI DOI 10.1142/P365; CLAUSET A, 2007, POWER LAW DISTRIBUTI; Dussauge C, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000650; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Florsheim JL, 2013, CATENA, V109, P129, DOI 10.1016/j.catena.2013.04.005; Guthrie RH, 2004, EARTH SURF PROC LAND, V29, P1321, DOI 10.1002/esp.1095; Guthrie RH, 2004, NAT HAZARD EARTH SYS, V4, P475, DOI 10.5194/nhess-4-475-2004; Guzzetti F, 2005, GEOMORPHOLOGY, V72, P272, DOI 10.1016/j.geomorph.2005.06.002; Guzzetti F, 2003, NAT HAZARD EARTH SYS, V3, P491, DOI 10.5194/nhess-3-491-2003; Guzzetti F, 2002, EARTH PLANET SC LETT, V195, P169, DOI 10.1016/S0012-821X(01)00589-1; Hergarten S, 1998, GEOPHYS RES LETT, V25, P801, DOI 10.1029/98GL50419; Hovius N, 2000, J GEOL, V108, P73, DOI 10.1086/314387; Huang JC, 2006, NAT HAZARD EARTH SYS, V6, P803; Kao SJ, 2011, IAHS-AISH P, V349, P114; Korup O, 2005, LANDSLIDES, V2, P43, DOI 10.1007/s10346-004-0042-0; Korup O, 2009, QUATERNARY SCI REV, V28, P977, DOI 10.1016/j.quascirev.2009.02.021; Malamud BD, 2004, EARTH PLANET SC LETT, V229, P45, DOI 10.1016/j.epsl.2004.10.018; Malamud BD, 2004, EARTH SURF PROC LAND, V29, P687, DOI 10.1002/esp.1064; Martin Y, 2002, CAN J EARTH SCI, V39, P189, DOI 10.1139/E01-068; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pelletier JD, 1997, ENG GEOL, V48, P255, DOI 10.1016/S0013-7952(97)00041-0; Rice JA, 1994, MATH STAT DATA ANAL; Rouai M, 2003, ENG GEOL, V68, P353, DOI 10.1016/S0013-7952(02)00237-5; Stark CP, 2001, GEOPHYS RES LETT, V28, P1091, DOI 10.1029/2000GL008527; Tsai ZX, 2013, EARTH SURF PROC LAND, V38, P661, DOI 10.1002/esp.3309; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1	31	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98125	10.1371/journal.pone.0098125	http://dx.doi.org/10.1371/journal.pone.0098125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852019	gold, Green Published			2022-12-27	WOS:000338323200047
J	Schwingshackl, L; Hoffmann, G				Schwingshackl, Lukas; Hoffmann, Georg			Comparison of High vs. Normal/Low Protein Diets on Renal Function in Subjects without Chronic Kidney Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GLOMERULAR-FILTRATION-RATE; LOW-FAT DIETS; CARBOHYDRATE HIGH-PROTEIN; CORONARY-HEART-DISEASE; 3RD NATIONAL-HEALTH; PURINE-RICH FOODS; URIC-ACID; SERUM CREATININE; ALL-CAUSE; RISK	Background: It was the aim of the present systematic review and meta-analysis to investigate the effects of high protein (HP) versus normal/low protein (LP/NP) diets on parameters of renal function in subjects without chronic kidney disease. Methods: Queries of literature were performed using the electronic databases MEDLINE, EMBASE, and the Cochrane Trial Register until 27th February 2014. Study specific weighted mean differences (MD) were pooled using a random effect model by the Cochrane software package Review Manager 5.1. Findings: 30 studies including 2160 subjects met the objectives and were included in the meta-analyses. HP regimens resulted in a significantly more pronounced increase in glomerular filtration rate [MD: 7.18 ml/min/1.73 m(2), 95% CI 4.45 to 9.91, p<0.001], serum urea [MD: 1.75 mmol/l, 95% CI 1.13 to 237, p<0.001], and urinary calcium excretion [MD: 25.43 mg/24h, 95% CI 13.62 to 37.24, p<0.001] when compared to the respective LP/NP protocol. Conclusion: HP diets were associated with increased GFR, serum urea, urinary calcium excretion, and serum concentrations of uric acid. In the light of the high risk of kidney disease among obese, weight reduction programs recommending HP diets especially from animal sources should be handled with caution.	[Schwingshackl, Lukas; Hoffmann, Georg] Univ Vienna, Fac Life Sci, Dept Nutr Sci, Vienna, Austria	University of Vienna	Schwingshackl, L (corresponding author), Univ Vienna, Fac Life Sci, Dept Nutr Sci, Vienna, Austria.	lukas.schwingshackl@univie.ac.at	Hoffmann, Georg/B-9201-2013; Schwingshackl, Lukas/B-9220-2013; Schwingshackl, Lukas/AAC-4119-2019	Schwingshackl, Lukas/0000-0003-3407-7594; Schwingshackl, Lukas/0000-0003-3407-7594				Adam-Perrot A, 2006, OBES REV, V7, P49, DOI 10.1111/j.1467-789X.2006.00222.x; Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; Bernstein AM, 2007, J AM DIET ASSOC, V107, P644, DOI 10.1016/j.jada.2007.01.002; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; BOSCH JP, 1983, AM J MED, V75, P943, DOI 10.1016/0002-9343(83)90873-2; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Calvez J, 2012, EUR J CLIN NUTR, V66, P281, DOI 10.1038/ejcn.2011.196; Cao JJ, 2011, J NUTR, V141, P391, DOI 10.3945/jn.110.129361; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Crowe TC, 2005, OBES REV, V6, P235, DOI 10.1111/j.1467-789X.2005.00196.x; Du Bois D, 1989, Nutrition, V5, P303; FLISER D, 1995, SEMIN NEPHROL, V15, P463; Food and Nutrition Board IoM, 2002, DIET REF INT EN CARB, P207; Fouque D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001892.pub3; Frank H, 2009, AM J CLIN NUTR, V90, P1509, DOI 10.3945/ajcn.2009.27601; Friedman AN, 2012, CLIN J AM SOC NEPHRO, V7, P1103, DOI 10.2215/CJN.11741111; Friedman AN, 2004, AM J KIDNEY DIS, V44, P950, DOI 10.1053/j.ajkd.2004.08.020; Griffin KA, 2008, AM J PHYSIOL-RENAL, V294, pF695, DOI 10.1152/ajprenal.00324.2007; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; HALLYNCK TH, 1981, BRIT J CLIN PHARMACO, V11, P523, DOI 10.1111/j.1365-2125.1981.tb01163.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jenkins DJA, 2001, AM J CLIN NUTR, V74, P57; Jia Y, 2010, J NUTR, V140, P1646, DOI 10.3945/jn.110.123034; Kesteloot H, 1996, J HUM HYPERTENS, V10, P245; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Knight EL, 2003, ANN INTERN MED, V138, P460, DOI 10.7326/0003-4819-138-6-200303180-00009; Krebs JD, 2012, DIABETOLOGIA, V55, P905, DOI 10.1007/s00125-012-2461-0; Levey AS, 1999, J AM SOC NEPHROL, V10, P2426; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Martin William F, 2005, Nutr Metab (Lond), V2, P25, DOI 10.1186/1743-7075-2-25; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Noto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055030; Parmar MS, 2004, BMJ-BRIT MED J, V328, P1420, DOI 10.1136/bmj.328.7453.1420; Reddy ST, 2002, AM J KIDNEY DIS, V40, P265, DOI 10.1053/ajkd.2002.34504; Santesso N, 2012, EUR J CLIN NUTR, V66, P780, DOI 10.1038/ejcn.2012.37; Schwingshackl L, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-48; Skov AR, 1999, INT J OBESITY, V23, P1170, DOI 10.1038/sj.ijo.0801048; Snyder JJ, 2009, AM J KIDNEY DIS, V53, P218, DOI 10.1053/j.ajkd.2008.07.034; Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tirosh A, 2013, DIABETES CARE; Wakefield AP, 2011, BRIT J NUTR, V106, P656, DOI 10.1017/S0007114511000730; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586	50	67	69	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97656	10.1371/journal.pone.0097656	http://dx.doi.org/10.1371/journal.pone.0097656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852037	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200027
J	Parkinson, E; Skipp, P; Aleksic, M; Garrow, A; Dadd, T; Hughes, M; Clough, G; O'Connor, CD				Parkinson, Erika; Skipp, Paul; Aleksic, Maja; Garrow, Andrew; Dadd, Tony; Hughes, Michael; Clough, Geraldine; O'Connor, C. David			Proteomic Analysis of the Human Skin Proteome after In Vivo Treatment with Sodium Dodecyl Sulphate	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HUMAN SERUM-ALBUMIN; LAURYL SULFATE; BICINCHONINIC ACID; P-PHENYLENEDIAMINE; IDENTIFICATION; BINDING; MODEL; SENSITIZATION; IRRITATION	Background: Skin has a variety of functions that are incompletely understood at the molecular level. As the most accessible tissue in the body it often reveals the first signs of inflammation or infection and also represents a potentially valuable source of biomarkers for several diseases. In this study we surveyed the skin proteome qualitatively using gel electrophoresis, liquid chromatography tandem mass spectrometry (GeLC-MS/MS) and quantitatively using an isobaric tagging strategy (iTRAQ) to characterise the response of human skin following exposure to sodium dodecyl sulphate (SDS). Results: A total of 653 skin proteins were assigned, 159 of which were identified using GeLC-MS/MS and 616 using iTRAQ, representing the most comprehensive proteomic study in human skin tissue. Statistical analysis of the available iTRAQ data did not reveal any significant differences in the measured skin proteome after 4 hours exposure to the model irritant SDS. Conclusions: This study represents the first step in defining the critical response to an irritant at the level of the proteome and provides a valuable resource for further studies at the later stages of irritant exposure.	[Parkinson, Erika; Skipp, Paul; O'Connor, C. David] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Parkinson, Erika; Skipp, Paul; O'Connor, C. David] Univ Southampton, Inst Life Sci, Ctr Prote Res, Southampton, Hants, England; [Aleksic, Maja; Garrow, Andrew; Hughes, Michael] Unilever, Safety & Environm Assurance Ctr, Sharnbrook, Beds, England; [Dadd, Tony] Unilever Res, Unilever Clin, Sharnbrook, Beds, England; [Clough, Geraldine] Univ Southampton, Sch Med, Inst Dev Sci, Southampton, Hants, England	University of Southampton; University of Southampton; Unilever; Unilever; University of Southampton	Parkinson, E (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	epp@soton.ac.uk	Parkinson, Erika/AAG-5798-2019	Parkinson, Erika/0000-0002-3130-2445	SEAC, Unilever plc. [KOM060136]	SEAC, Unilever plc.	This study was funded by SEAC, Unilever plc. study KOM060136. The funder provided support in the form of salaries for authors EP, MA, AG, TS and MW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aleksic M, 2008, TOXICOL IN VITRO, V22, P1169, DOI 10.1016/j.tiv.2008.03.006; Aleksic M, 2007, TOXICOL IN VITRO, V21, P723, DOI 10.1016/j.tiv.2007.01.008; Aleksic M, 2009, TOXICOL SCI, V108, P401, DOI 10.1093/toxsci/kfp030; Alvarez-Sanchez R, 2004, CHEM RES TOXICOL, V17, P1280, DOI 10.1021/tx049935+; Basketter D, 1997, CONTACT DERMATITIS, V37, P218, DOI 10.1111/j.1600-0536.1997.tb02438.x; Boxman ILA, 2002, BRIT J DERMATOL, V146, P777, DOI 10.1046/j.1365-2133.2002.04714.x; Broccardo CJ, 2011, J ALLERGY CLIN IMMUN, V127, P186, DOI 10.1016/j.jaci.2010.10.033; Broccardo CJ, 2009, J ALLERGY CLIN IMMUN, V124, P1113, DOI 10.1016/j.jaci.2009.07.057; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Celis JE, 1998, FEBS LETT, V430, P64, DOI 10.1016/S0014-5793(98)00527-4; Delattre C, 2012, EXP DERMATOL, V21, P205, DOI 10.1111/j.1600-0625.2011.01434.x; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Divkovic M, 2005, CONTACT DERMATITIS, V53, P189, DOI 10.1111/j.0105-1873.2005.00683.x; Fletcher ST, 2006, TOXICOL IN VITRO, V20, P975, DOI 10.1016/j.tiv.2005.12.007; Hill EG, 2008, J PROTEOME RES, V7, P3091, DOI 10.1021/pr070520u; Hoste E, 2011, J INVEST DERMATOL, V131, P2233, DOI 10.1038/jid.2011.153; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jansen Bastiaan J. H., 2003, Briefings in Functional Genomics & Proteomics, V1, P326, DOI 10.1093/bfgp/1.4.326; Jenkinson C, 2010, J INVEST DERMATOL, V130, P732, DOI 10.1038/jid.2009.271; Jenkinson C, 2009, CHEM RES TOXICOL, V22, P1172, DOI 10.1021/tx900095r; Landsteiner K, 1935, J EXP MED, V61, P643, DOI 10.1084/jem.61.5.643; Lepoittevin JP, 1998, HAPTEN PROTEIN INTER, P82; Masaki H, 2010, J DERMATOL SCI, V58, P85, DOI 10.1016/j.jdermsci.2010.03.003; Oberg AL, 2008, J PROTEOME RES, V7, P225, DOI 10.1021/pr700734f; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Schwarz T, 2003, BRIT J DERMATOL, V149, P2, DOI 10.1046/j.0366-077X.2003.05624.x; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Torma H, 2008, J INVEST DERMATOL, V128, P1212, DOI 10.1038/sj.jid.5701170; White GM, 2007, COLOUR ATLAS DERMATO; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Zhang QH, 2011, J APPL TOXICOL, V31, P762, DOI 10.1002/jat.1630	40	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97772	10.1371/journal.pone.0097772	http://dx.doi.org/10.1371/journal.pone.0097772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849295	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000336730600058
J	Peng, XJ; Teng, LH; Wang, XM; Wang, YC; Shen, SH				Peng Xianjun; Teng Linhong; Wang Xiaoman; Wang Yucheng; Shen Shihua			De Novo Assembly of Expressed Transcripts and Global Transcriptomic Analysis from Seedlings of the Paper Mulberry (Broussonetia kazinoki x Broussonetia papyifera)	PLOS ONE			English	Article							LIGNIN BIOSYNTHESIS; PAPYRIFERA; ANTIOXIDANT; RESPONSES; GROWTH	The paper mulberry is one of the multifunctional tree species in agroforestry systems and is also commonly utilized in traditional medicine in China and other Asian countries. However, little is known about its molecular genetics, which hinders research on and exploitation of this valuable resource. To discern the correlation between gene expression and the essential properties of the paper mulberry, we performed a transcriptomics analysis, assembling a total of 37,725 unigenes from 54,638,676 reads generated by RNA-seq. Among these, 22,692 unigenes showed greater than 60% similarity with genes from other species. The lengths of 13,566 annotated unigenes were longer than 1,000 bp. Functional clustering analysis with COG (Cluster of Orthologous Groups) revealed that 17,184 unigenes are primarily involved in transcription, translation, signal transduction, carbohydrate metabolism, secondary metabolism, and energy metabolism. GO (Gene Ontology) annotation suggests enrichment of genes encoding antioxidant activity, transporter activity, biosynthesis, metabolism and stress response, with a total of 30,659 unigenes falling in these categories. KEGG (Kyoto Encyclopedia of Genes and Genomes) metabolic pathway analysis showed that 7,199 unigenes are associated with 119 metabolic pathways. In addition to the basic metabolism, these genes are enriched for plant pathogen interaction, flavonoid metabolism and other secondary metabolic processes. Furthermore, differences in the transcriptomes of leaf, stem and root tissues were analyzed and 7,233 specifically expressed unigenes were identified. This global expression analysis provided novel insights about the molecular mechanisms of the biosynthesis of flavonoid, lignin and cellulose, as well as on the response to biotic and abiotic stresses including the remediation of contaminated soil by the paper mulberry.	[Peng Xianjun; Teng Linhong; Wang Xiaoman; Wang Yucheng; Shen Shihua] Chinese Acad Sci, Key Lab Plant Resources, Inst Bot, Beijing, Peoples R China; [Teng Linhong; Wang Xiaoman; Wang Yucheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shen, SH (corresponding author), Chinese Acad Sci, Key Lab Plant Resources, Inst Bot, Beijing, Peoples R China.	shshen@ibcas.ac.cn	wang, xiaoman/GQH-0836-2022		foundation of the knowledge innovation project in the Chinese academy [KZCX2-YW-359-2]; National Natural Science Foundation of China [31270653]	foundation of the knowledge innovation project in the Chinese academy; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by foundation of the knowledge innovation project in the Chinese academy (KZCX2-YW-359-2) and the National Natural Science Foundation of China (31270653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Bosu PP, 2013, AFR J ECOL, V51, P528, DOI 10.1111/aje.12063; Cheng ZJ, 2001, BIOCHEM PHARMACOL, V61, P939, DOI 10.1016/S0006-2952(01)00543-3; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Endo A, 2012, PLANT CELL PHYSIOL, V53, P16, DOI 10.1093/pcp/pcr171; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Gandotra N, 2013, PLANT J, V74, P48, DOI 10.1111/tpj.12100; Ge G., 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0021220; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo FJ, 2013, PHYTOCHEM LETT, V6, P331, DOI 10.1016/j.phytol.2013.03.017; Gupta D.K., 2013, HEAVY METAL STRESS P, P73, DOI DOI 10.1007/978-3-642-38469-1_4; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He L, 2001, J GUANGXI U NATL, V7, P121; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jiang L, 2007, J SW FORESTRY COLL, V7, P71; Kampa A, 2013, P NATL ACAD SCI USA, V110, pE3129, DOI 10.1073/pnas.1305867110; Khraiwesh B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060774; Ko HH, 2008, J NAT PROD, V71, P1930, DOI 10.1021/np800564z; Ko HJ, 2013, BIOMOL THER, V21, P66, DOI 10.4062/biomolther.2012.081; Kuang Y.W., 2012, OPEN J FOR, V2, P71, DOI [DOI 10.4236/OJF.2012.22010, 10.4236/ojf.2012.22010]; Li GY, 2011, B ENVIRON CONTAM TOX, V86, P646, DOI 10.1007/s00128-011-0291-2; Liu ZhaoGang, 2009, Scientia Silvae Sinicae, V45, P54; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Morgan EC, 2004, WILDLAND WEEDS PAPER; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagpal UMK, 2011, WATER AIR SOIL POLL, V215, P177, DOI 10.1007/s11270-010-0468-z; Ryu HW, 2012, FOOD CHEM, V132, P1244, DOI 10.1016/j.foodchem.2011.11.093; Ryu HW, 2010, J AGR FOOD CHEM, V58, P202, DOI 10.1021/jf903068k; Saito K, 2009, AGROFOREST SYST, V76, P525, DOI 10.1007/s10457-009-9206-1; Skipper M, 2013, NAT REV GENET, V14, DOI 10.1038/nrg3518; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Sohn HY, 2004, PHYTOMEDICINE, V11, P666, DOI 10.1016/j.phymed.2003.09.005; Stanton-Geddes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065688; Sun XL, 2013, J PLANT PHYSIOL, V170, P505, DOI 10.1016/j.jplph.2012.11.017; Thaiutsa B, 2001, PAPER MULBERRY ALTER, P19; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Wang LianJun, 2012, African Journal of Biotechnology, V11, P8196, DOI 10.5897/AJB11.243; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Wei Hui, 2005, Yingyong Shengtai Xuebao, V16, P1086; Weng JK, 2010, PLANT J, V64, P898, DOI 10.1111/j.1365-313X.2010.04391.x; Xiang XZ, 2007, PROGR TEXTILE SCI TE, V5, P1; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3; Xue CY, 2006, CHINA PULP PAPER; Yan J, 2011, PLANT DIS, V95, P880, DOI 10.1094/PDIS-03-11-0186; Zhai X., 2012, J NE FORESTRY U, V11; Zhang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048183; Zhang Y.M., 2008, FEED IND, V29, P54; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005	50	23	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97487	10.1371/journal.pone.0097487	http://dx.doi.org/10.1371/journal.pone.0097487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848504	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600031
J	Diraviyam, T; Zhao, B; Wang, Y; Schade, R; Michael, A; Zhang, XY				Diraviyam, Thirumalai; Zhao, Bin; Wang, Yuan; Schade, Ruediger; Michael, Antonysamy; Zhang, Xiaoying			Effect of Chicken Egg Yolk Antibodies (IgY) against Diarrhea in Domesticated Animals: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; ROTAVIRUS-INDUCED DIARRHEA; SPRAY-DRIED PORCINE; EARLY-WEANED PIGS; INFECTIOUS BURSAL DISEASE; ORAL PASSIVE-IMMUNIZATION; SALMONELLA-ENTERITIDIS; BOVINE ROTAVIRUS; IMMUNOGLOBULIN IGY; BROILER-CHICKENS	Background: IgY antibodies are serum immunoglobulin in birds, reptiles and amphibians, and are transferred from serum to egg yolk to confer passive immunity to their embryos and offspring. Currently, the oral passive immunization using chicken IgY has been focused as an alternative to antibiotics for the treatment and control of diarrhea in animals and humans. This systematic review was focused to determine the effect of IgY in controlling and preventing diarrhea in domesticated animals including Piglets, Mice, Poultry and Calves. Methods and Results: Previous research reports focused on treatment effect of Chicken IgY against diarrhea were retrieved from different electronic data bases (MEDLINE, EMBASE, SPRINGER-LINK, WILEY, AGRICOLA, MEDWELL Journals, Scientific Publish, Chinese articles from Core periodicals in 2012). A total of 61 studies in 4 different animal classes met the inclusion criteria. Data on study characteristics and outcome measures were extracted. The pooled relative risk (RR) of 49 studies of different animals [Piglets - 22; Mice - 14; Poultry - 7 and Calves - 6] in meta-analyses revealed that, IgY significantly reduced the risk of diarrhea in treatment group when compare to the placebo. However, the 95% confidence intervals of the majority of studies in animal class piglets and calves embrace RR of one. The same results were obtained in sub group analyses (treatment regiment - prophylactic or therapeutic; pathogen type - bacterial or viral). Perhaps, this inconsistency in the effect of IgY at the individual study level and overall effect measures could be influenced by the methodological heterogeneity. Conclusion: The present systematic review (SR) and meta-analysis demonstrated the beneficial effect of IgY. This supports the opinion that IgY is useful for prophylaxis and treatment. However, more intensive studies using the gold standard animal experiments with the focus to use IgY alone or in combination with other alternative strategies are indispensable.	[Diraviyam, Thirumalai; Zhao, Bin; Wang, Yuan; Zhang, Xiaoying] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Zhao, Bin] Northwest A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China; [Schade, Ruediger] Charite, Inst Pharmacol, D-13353 Berlin, Germany; [Michael, Antonysamy] Bharathiar Univ, PSG Coll Arts & Sci, Coimbatore, Tamil Nadu, India	Northwest A&F University - China; Northwest A&F University - China; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bharathiar University; PSG College of Arts & Science	Zhang, XY (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	zhang.xy@nwsuaf.edu.cn	Zhang, Xiaoying/O-2606-2016; Zhang, Xiaoying/O-2606-2016	Zhang, Xiaoying/0000-0002-0055-7322; Antonysamy, Michael/0000-0002-7991-9479; Zhang, Xiaoying/0000-0001-6491-6550; Thirumalai, Diraviyam/0000-0002-0364-1837	Research Fellowship for International Young Scientists [31350110512]; National Natural Science Foundation of China (NSFC); International S&T Cooperation Project of Northwest AF University; Key Program for International S&T Cooperation Projects of Shaanxi Province [2012KW-20]; Ministry of Education and State Administration of Foreign Experts Affairs "Overseas Teacher" project, China [MS2011XBNL057]	Research Fellowship for International Young Scientists; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Project of Northwest AF University; Key Program for International S&T Cooperation Projects of Shaanxi Province; Ministry of Education and State Administration of Foreign Experts Affairs "Overseas Teacher" project, China	This work was supported by the Research Fellowship for International Young Scientists (Grant No. 31350110512), National Natural Science Foundation of China (NSFC), the International S&T Cooperation Project of Northwest A&F University (2013), Key Program for International S&T Cooperation Projects of Shaanxi Province (2012KW-20) and Ministry of Education and State Administration of Foreign Experts Affairs "Overseas Teacher" project (No. MS2011XBNL057), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriana C, 2007, LUCRARI STIINTIFICE, V40; [Anonymous], 2013, MEDCALC STAT SOFTW V; BARTZ CR, 1980, J INFECT DIS, V142, P439, DOI 10.1093/infdis/142.3.439; Buragohain M, 2012, WORLD, V2, P73, DOI DOI 10.4236/WJV.2012.22010; Chalghoumi R, 2009, POULTRY SCI, V88, P2081, DOI 10.3382/ps.2009-00173; Chernysheva LV, 2004, J SWINE HEALTH PROD, V12, P119; Chu WeiHua, 2006, Chinese Journal of Veterinary Science, V26, P616; Cook SR, 2005, CAN J ANIM SCI, V85, P291, DOI 10.4141/A04-076; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Cui HZ JH, 2012, CHINA ANIMAL HUSBAND, V39, P173; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2008, SYSTEMATIC REV HLTH; El-Ghany W. A. A., 2011, Global Veterinaria, V6, P16; Erhard MH, 1996, J VET MED A, V43, P217, DOI 10.1111/j.1439-0442.1996.tb00447.x; European Medicines Agency, 2013, EMA2365012013; Farooq A, 2012, AFR J MICROBIOL RES, V6, P2993, DOI 10.5897/AJMR12.049; Feng Y, 2013, CURRENT MICROBIOLOGY, P1; Fulton RM, 2002, POULTRY SCI, V81, P34, DOI 10.1093/ps/81.1.34; Germine SS, 2011, BENHA VET MED J, P108; Girard F, 2006, FEMS IMMUNOL MED MIC, V46, P340, DOI 10.1111/j.1574-695X.2005.00030.x; Gurtler M, 2004, J VET MED B, V51, P129, DOI 10.1111/j.1439-0450.2004.00739.x; HATTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1077, DOI 10.1271/bbb.57.1077; Hirai K, 2010, ACTA MED OKAYAMA, V64, P163; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hooijmans CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048811; Ikemori Y, 1997, VET MICROBIOL, V58, P105, DOI 10.1016/S0378-1135(97)00144-2; Imberechts H, 1997, VET MICROBIOL, V54, P329, DOI 10.1016/S0378-1135(96)01293-X; Jacoby H. I., 2001, Journal of Nutraceuticals, Functional & Medical Foods, V3, P47, DOI 10.1300/J133v03n02_05; Kariyawasam S, 2004, VET MICROBIOL, V98, P273, DOI 10.1016/j.vetmic.2003.10.022; Kellner J, 1993, JAHRGANG, V94, P31; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kovacs-Nolan J, 2012, ANNU REV FOOD SCI T, V3, P163, DOI 10.1146/annurev-food-022811-101137; KUROKI M, 1994, ARCH VIROL, V138, P143, DOI 10.1007/BF01310045; KUROKI M, 1993, VET MICROBIOL, V37, P135, DOI 10.1016/0378-1135(93)90188-D; Kuroki M, 1997, ARCH VIROL, V142, P843, DOI 10.1007/s007050050123; Kweon CH, 2000, J VET MED SCI, V62, P961, DOI 10.1292/jvms.62.961; Lee CR, 2013, INT J ENV RES PUB HE, V10, P4274, DOI 10.3390/ijerph10094274; Lee SH, 2009, VET PARASITOL, V163, P123, DOI 10.1016/j.vetpar.2009.04.020; Lee SH, 2009, POULTRY SCI, V88, P562, DOI 10.3382/ps.2008-00340; Li XY, 2009, VET IMMUNOL IMMUNOP, V129, P132, DOI 10.1016/j.vetimm.2008.12.016; Liou JF, 2011, J ANIM VET ADV, V10, P2349; Liou JF, 2010, VACCINE, V28, P8189, DOI 10.1016/j.vaccine.2010.09.089; Mahdavi AH, 2010, POULTRY SCI, V89, P484, DOI 10.3382/ps.2009-00541; Malik MW, 2006, J VET SCI, V7, P43, DOI 10.4142/jvs.2006.7.1.43; Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Muhammad K., 2001, International Journal of Agriculture and Biology, V3, P413; Neri P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026526; Nguyen HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010152; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1781; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1790; Owusu-Asiedu A, 2002, J ANIM SCI, V80, P2895; Ozpinar H, 1996, PREV VET MED, V27, P67, DOI 10.1016/0167-5877(95)00561-7; Parma YR, 2011, TOXICON, V58, P380, DOI 10.1016/j.toxicon.2011.07.009; PERALTA RC, 1994, J MED MICROBIOL, V41, P29, DOI 10.1099/00222615-41-1-29; Rahimi S., 2007, International Journal of Poultry Science, V6, P207; Rahimi S., 2007, International Journal of Poultry Science, V6, P230; Sarandan M, 2010, DOUBLE CIT, Vxliii, 1; Sarker SA, 2007, J HEALTH POPUL NUTR, V25, P465; Song WeiPing, 2003, Acta Agriculturae Boreali-Sinica, V18, P114; Tamilzarasan K. B., 2009, Tamilnadu Journal of Veterinary and Animal Sciences, V5, P264; Tsubokura K, 1997, CLIN EXP IMMUNOL, V108, P451, DOI 10.1046/j.1365-2249.1997.3901288.x; Turner J.L., 2001, PROF ANIM SCI, V17, P217, DOI [https://doi.org/10.15232/S1080-7446(15)31633-8, DOI 10.15232/S1080-7446(15)31633-8]; Vega C, 2011, VET IMMUNOL IMMUNOP, V142, P156, DOI 10.1016/j.vetimm.2011.05.003; Vega CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042788; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Wang Q, 2010, CAN J MICROBIOL, V56, P1003, DOI 10.1139/W10-087; Wu GM WZ, 2013, HEILONGJIANG ANIMAL, P140; Xiao C, 1998, CHINESE J VET SCI TE, V28, P21; [徐福洲 Xu Fuzhou], 2002, [华北农学报, Acta Agriculturae Boreali-Sinica], V17, P108; Xu JJ, 2013, IRAN J PARASITOL, V8, P449; Xu YP, 2011, BIOTECHNOL ADV, V29, P860, DOI 10.1016/j.biotechadv.2011.07.003; Yang BL, 2002, ANIMAL SCI VET MED, V10, P37; Yokoyama H, 1998, VACCINE, V16, P388, DOI 10.1016/S0264-410X(97)80916-4; YOKOYAMA H, 1992, INFECT IMMUN, V60, P998, DOI 10.1128/IAI.60.3.998-1007.1992; Yokoyama H, 1997, J VET MED SCI, V59, P917, DOI 10.1292/jvms.59.917; Zuniga A, 1997, FEMS IMMUNOL MED MIC, V18, P153, DOI 10.1016/S0928-8244(97)00035-7; Zuo Yuzhu, 2009, Front Agric China, V3, P104, DOI 10.1007/s11703-008-0080-9	78	52	56	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97716	10.1371/journal.pone.0097716	http://dx.doi.org/10.1371/journal.pone.0097716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846286	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400049
J	Gagliano, SA; Barnes, MR; Weale, ME; Knight, J				Gagliano, Sarah A.; Barnes, Michael R.; Weale, Michael E.; Knight, Jo			A Bayesian Method to Incorporate Hundreds of Functional Characteristics with Association Evidence to Improve Variant Prioritization	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PSORIASIS SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; ANNOTATION; REGULARIZATION; INFORMATION	The increasing quantity and quality of functional genomic information motivate the assessment and integration of these data with association data, including data originating from genome-wide association studies (GWAS). We used previously described GWAS signals ("hits'') to train a regularized logistic model in order to predict SNP causality on the basis of a large multivariate functional dataset. We show how this model can be used to derive Bayes factors for integrating functional and association data into a combined Bayesian analysis. Functional characteristics were obtained from the Encyclopedia of DNA Elements (ENCODE), from published expression quantitative trait loci (eQTL), and from other sources of genome-wide characteristics. We trained the model using all GWAS signals combined, and also using phenotype specific signals for autoimmune, brain-related, cancer, and cardiovascular disorders. The non-phenotype specific and the autoimmune GWAS signals gave the most reliable results. We found SNPs with higher probabilities of causality from functional characteristics showed an enrichment of more significant p-values compared to all GWAS SNPs in three large GWAS studies of complex traits. We investigated the ability of our Bayesian method to improve the identification of true causal signals in a psoriasis GWAS dataset and found that combining functional data with association data improves the ability to prioritise novel hits. We used the predictions from the penalized logistic regression model to calculate Bayes factors relating to functional characteristics and supply these online alongside resources to integrate these data with association data.	[Gagliano, Sarah A.; Knight, Jo] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Gagliano, Sarah A.; Knight, Jo] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Barnes, Michael R.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Weale, Michael E.] Guys Hosp, Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Knight, Jo] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Toronto	Knight, J (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON, Canada.	jo.knight@camh.ca	Knight, Jo/F-4946-2011; Weale, Michael E/F-2587-2010	Weale, Michael E/0000-0003-4593-1186; Barnes, Michael/0000-0001-9097-7381; Knight, Joanne/0000-0002-7148-1660	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; charitable donors at the CAMH Foundation; Higher Education Funding Council for England (HEFCE); National Institute for Health Cardiovascular Biomedical Research Unit at Barts; ArmstrongFamily via the CAMH Foundation; Canada Foundation for Innovation, Research Hospital Fund; Medical Research Council [MR/K006584/1] Funding Source: researchfish	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; charitable donors at the CAMH Foundation; Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Cardiovascular Biomedical Research Unit at Barts; ArmstrongFamily via the CAMH Foundation; Canada Foundation for Innovation, Research Hospital Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation trust. JK was previously funded by this source. JK is currently funded by charitable donors at the CAMH Foundation: http://www.supportcamh.ca. MEW is funded by the Higher Education Funding Council for England (HEFCE): http://www.hefce.ac.uk/. MRB is funded by the National Institute for Health Cardiovascular Biomedical Research Unit at Barts. SAG is funded through the ArmstrongFamily via the CAMH Foundation. Computations were performed on the CAMH Specialized Computing Cluster (SCC) which is funded by: The Canada Foundation for Innovation, Research Hospital Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrans JD, 2006, METH MOLEC MED, V126, P157; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Center for Statistical Genetics, 2012, METABOCHIP SNP DET; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Darnell G, 2012, BIOINFORMATICS, V28, pI147, DOI 10.1093/bioinformatics/bts235; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff L. A., 2010, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kindt ASD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-108; Knight J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014808; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, 2018, R LANG ENV STAT COMP; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tang CS, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1784; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	40	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98122	10.1371/journal.pone.0098122	http://dx.doi.org/10.1371/journal.pone.0098122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844982	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000339563400098
J	Suda, M; Brooks, SJ; Giampietro, V; Uher, R; Mataix-Cols, D; Brammer, MJ; Williams, SCR; Treasure, J; Campbell, IC				Suda, Masashi; Brooks, Samantha J.; Giampietro, Vincent; Uher, Rudolf; Mataix-Cols, David; Brammer, Michael J.; Williams, Steven C. R.; Treasure, Janet; Campbell, Iain C.			Provocation of Symmetry/Ordering Symptoms in Anorexia nervosa: A Functional Neuroimaging Study	PLOS ONE			English	Article							EATING-DISORDERS; BODY-IMAGE; BULIMIA-NERVOSA; BRAIN; STIMULI; FOOD; VOXEL; VALIDATION; DIMENSIONS; SATIETY	Anorexia nervosa (AN), obsessive-compulsive disorder (OCD), and obsessive-compulsive personality disorder (OCPD) are often co-morbid; however, the aetiology of such co-morbidity has not been well investigated. This study examined brain activation in women with AN and in healthy control (HC) women during the provocation of symmetry/ordering-related anxiety. During provocation, patients with AN showed more anxiety compared to HCs, which was correlated with the severity of symmetry/ordering symptoms. Activation in the right parietal lobe and right prefrontal cortex (rPFC) in response to provocation was reduced in the AN group compared with the HC group. The reduced right parietal activation observed in the AN group is consistent with parietal lobe involvement in visuospatial cognition and with studies of OCD reporting an association between structural abnormalities in this region and the severity of 'ordering' symptoms. Reduced rPFC activation in response to symmetry/ordering provocation has similarities with some, but not all, data collected from patients with AN who were exposed to images of food and bodies. Furthermore, the combination of data from the AN and HC groups showed that rPFC activation during symptom provocation was inversely correlated with the severity of symmetry/ordering symptoms. These data suggest that individuals with AN have a diminished ability to cognitively deal with illness-associated symptoms of provocation. Furthermore, our data also suggest that symptom provocation can progressively overload attempts by the rPFC to exert cognitive control. These findings are discussed in the context of the current neurobiological models of AN.	[Suda, Masashi; Uher, Rudolf; Treasure, Janet; Campbell, Iain C.] Kings Coll London, Inst Psychiat, Sect Eating Disorders, London WC2R 2LS, England; [Brooks, Samantha J.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Giampietro, Vincent; Brammer, Michael J.; Williams, Steven C. R.] Kings Coll London, Inst Psychiat, Ctr Neuroimaging Studies, London WC2R 2LS, England; [Mataix-Cols, David] Kings Coll London, Dept Psychosis Studies, London WC2R 2LS, England; [Mataix-Cols, David] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England	University of London; King's College London; Uppsala University; University of London; King's College London; University of London; King's College London; University of London; King's College London	Suda, M (corresponding author), Kings Coll London, Inst Psychiat, Sect Eating Disorders, London WC2R 2LS, England.	sudamasashi7@gmail.com	Giampietro, Vincent P/D-1279-2011; Brooks, Samantha/AAJ-2159-2020; Williams, Steve C/D-6979-2011; Uher, Rudolf/A-5477-2008; Mataix-Cols, David/AAF-3347-2021; Mataix-Cols, David/G-3843-2010	Giampietro, Vincent P/0000-0002-9381-8201; Williams, Steve C/0000-0003-4299-1941; Uher, Rudolf/0000-0002-2998-0546; Mataix-Cols, David/0000-0002-4545-0924; Mataix-Cols, David/0000-0002-4545-0924; Brooks, Samantha/0000-0002-9146-6257; Treasure, Janet/0000-0003-0871-4596; opoku, anita/0000-0001-7243-8157	Canon Foundation in Europe Fellowship; Nina Jackson Fellowship (Research Into Eating Disorders)	Canon Foundation in Europe Fellowship; Nina Jackson Fellowship (Research Into Eating Disorders)	Masashi Suda was financially supported by Canon Foundation in Europe Fellowship, and Samantha J. Brooks was financially supported by the Nina Jackson Fellowship (Research Into Eating Disorders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholdy S, 2013, EUR EAT DIS IN PRESS; Boghi A, 2011, PSYCHIAT RES-NEUROIM, V192, P154, DOI 10.1016/j.pscychresns.2010.12.008; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Brooks SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022259; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Castellini G, 2013, EUR PSYCHIAT, V28, P427, DOI 10.1016/j.eurpsy.2012.06.006; Castro-Fornieles J, 2010, PROG NEURO-PSYCHOPH, V34, P1049, DOI 10.1016/j.pnpbp.2010.05.020; de Vries FE, 2013, CNS SPECTRUMS, V1, P1; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Favaro A, 2012, BIOL PSYCHIAT, V72, P864, DOI 10.1016/j.biopsych.2012.04.025; First M. B., 1997, STRUCTURED CLIN INTE; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Frank GKW, 2012, NEUROPSYCHOPHARMACOL, V37, P2031, DOI 10.1038/npp.2012.51; Friederich HC, 2010, NEUROPSYCHOLOGIA, V48, P2878, DOI 10.1016/j.neuropsychologia.2010.04.036; Frieling H, 2012, J PSYCHIATR RES, V46, P1237, DOI 10.1016/j.jpsychires.2012.06.005; Geliebter A, 2006, APPETITE, V46, P31, DOI 10.1016/j.appet.2005.09.002; Gilbert AR, 2009, J AM ACAD CHILD PSY, V48, P936, DOI 10.1097/CHI.0b013e3181b2163c; Gizewski ER, 2010, NEUROPSYCHOBIOLOGY, V62, P182, DOI 10.1159/000319360; Goethals I, 2007, J PSYCHIATR RES, V41, P1005, DOI 10.1016/j.jpsychires.2006.09.003; Joos AAB, 2011, PSYCHIAT RES-NEUROIM, V191, P189, DOI 10.1016/j.pscychresns.2010.11.008; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Koskina A, 2013, NEUROSCI BIOBEHAV R, V37, P193, DOI 10.1016/j.neubiorev.2012.11.010; Lao-Kaim N, 2013, EUR PSYCHIAT; Lawrence NS, 2006, NEUROPSYCHOLOGY, V20, P409, DOI 10.1037/0894-4105.20.4.409; Lilenfeld LR, 1998, ARCH GEN PSYCHIAT, V55, P603, DOI 10.1001/archpsyc.55.7.603; Mataix-Cols D, 2009, PSYCHIAT RES, V168, P238, DOI 10.1016/j.psychres.2008.05.007; Matsunaga H, 1999, PSYCHOL MED, V29, P407, DOI 10.1017/S003329179800796X; McAdams CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P54, DOI 10.1016/j.pscychresns.2011.06.016; McClelland J, 2013, EUR EAT DIS IN PRESS; McFadden KL, 2013, J PSYCHIATR NEUROSCI, V38; Micali N, 2011, PSYCHOL MED, V41, P2507, DOI 10.1017/S003329171100078X; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Mohr HM, 2010, PSYCHOL MED, V40, P1519, DOI 10.1017/S0033291709991826; Naruo T, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-2; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Rastam M, 2001, DEV MED CHILD NEUROL, V43, P239, DOI 10.1017/S0012162201000457; Rosenberg M. S., 2007, METAWIN STAT SOFTWAR; Sachdev P, 2008, NEUROPSYCHOLOGIA, V46, P2161, DOI 10.1016/j.neuropsychologia.2008.02.031; Santel S, 2006, BRAIN RES, V1114, P138, DOI 10.1016/j.brainres.2006.07.045; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Schulte-Ruther M, 2012, J AM ACAD CHILD PSY, V51, P832, DOI 10.1016/j.jaac.2012.06.007; SRINIVASAGAM NM, 1995, AM J PSYCHIAT, V152, P1630; Suchan B, 2012, BEHAV BRAIN RES; Suda M, 2013, INT J EAT DISORD; Suda M, 2011, BIOL PSYCHIAT, V70, pE35, DOI 10.1016/j.biopsych.2011.03.034; Swinbourne JM, 2007, EUR EAT DISORD REV, V15, P253, DOI 10.1002/erv.784; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; van den Eynde F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-302; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; Vocks S, 2011, PSYCHOL MED, V41, P1651, DOI 10.1017/S0033291710002382; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; Zhu YK, 2012, EUR EAT DISORD REV, V20, P439, DOI 10.1002/erv.2197; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	59	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97998	10.1371/journal.pone.0097998	http://dx.doi.org/10.1371/journal.pone.0097998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844926	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400078
J	Wu, QW; Yang, QM; Huang, YF; She, HQ; Liang, J; Yang, QL; Zhang, ZM				Wu, Qiu-Wan; Yang, Qing-Mo; Huang, Yu-Fan; She, Hong-Qiang; Liang, Jing; Yang, Qiao-Lu; Zhang, Zhi-Ming			Expression and Clinical Significance of Matrix Metalloproteinase-9 in Lymphatic Invasiveness and Metastasis of Breast Cancer	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; MMP-9; INVASION; MARKER; D2-40; METALLOPROTEINASES; PODOPLANIN; CARCINOMA; SERUM; NODE	Background: Matrix metalloproteinase 9 (MMP-9) is a type-IV collagenase that is highly expressed in breast cancer, but its exact role in tumor progression and metastasis is unclear. Methods: MMP-9 mRNA and protein expression was examined by real-time reverse transcriptase PCR and immunohistochemical staining, respectively, in 41 breast cancer specimens with matched peritumoral benign breast epithelial tissue and suspicious metastatic axillary lymph nodes. Lymph vessels were labeled with D2-40 and lymphatic microvessel density (LMVD) was calculated. Correlation of MMP-9 protein expression with clinicopathological parameters and LMVD was also evaluated. Results: MMP-9(+) staining in breast cancer specimens (35/41, 85.4%) was higher than in matched epithelium (21/41, 51.2%; P<0.05) and lymph nodes (13/41, 31.7%; P<0.001). Higher MMP-9 mRNA expression was also detected in tumor specimens compared with matched epithelial tissues and lymph nodes (P<0.05). Elevated MMP-9 expression was correlated with lymph node metastasis and LMVD (P<0.05). Conclusion: MMP-9 was overexpressed in breast cancer specimens compared with peritumoral benign breast epithelium and lymph nodes. Moreover, its expression in the matched epithelium and lymph nodes was positively associated with lymph node metastasis, and its expression in lymph nodes was positively associated with lymphangiogenesis in breast cancer. Thus, MMP-9 is a potential marker for breast cancer progression.	[Zhang, Zhi-Ming] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Xiamen, Peoples R China; Xiamen Univ, Affiliated Hosp 1, Dept Breast Surg, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhang, ZM (corresponding author), Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Xiamen, Peoples R China.	zhangzhiming164@aliyun.com			Young Foundation of the Health Department of Fujian Province, China [2011-2-61]; Young Foundation of the Science and Technology Department of Fujian Province, China [2012D053]; Science and Technology Bureau of Xiamen, China [3502Z20104024]	Young Foundation of the Health Department of Fujian Province, China; Young Foundation of the Science and Technology Department of Fujian Province, China; Science and Technology Bureau of Xiamen, China	This work was supported by Young Foundation of the Health Department of Fujian Province, China (No. 2011-2-61), Young Foundation of the Science and Technology Department of Fujian Province, China (No. 2012D053) and Science and Technology Bureau of Xiamen, China (No. 3502Z20104024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Daniele A, 2010, ANTICANCER RES, V30, P3521; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Gohary YM, 2008, AM J CLIN PATHOL, V129, P578, DOI 10.1309/2HGNJ1GU57JMBJAQ; Elston C W, 2002, Histopathology, V41, P154; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Fohn LE, 2011, J AM ACAD DERMATOL, V64, P336, DOI 10.1016/j.jaad.2010.03.005; Hasebe T, 2008, HUM PATHOL, V39, P427, DOI 10.1016/j.humpath.2007.07.016; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Mylona E, 2007, HISTOPATHOLOGY, V50, P338, DOI 10.1111/j.1365-2559.2007.02615.x; Niakosari F, 2005, ARCH DERMATOL, V141, P440, DOI 10.1001/archderm.141.4.440; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Rabban JT, 2008, HUM PATHOL, V39, P175, DOI 10.1016/j.humpath.2007.06.018; Ran Sophia, 2010, Pathophysiology, V17, P229, DOI 10.1016/j.pathophys.2009.11.003; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suzuki H, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-287; Van der Auwera I, 2006, BRIT J CANCER, V95, P1611, DOI 10.1038/sj.bjc.6603445; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337	20	83	86	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97804	10.1371/journal.pone.0097804	http://dx.doi.org/10.1371/journal.pone.0097804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845596	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400062
J	Kim, B; Kang, S; Jeong, G; Park, SB; Kim, SJ				Kim, Byungtak; Kang, Seongeun; Jeong, Gookjoo; Park, Sung-Bin; Kim, Sun Jung			Identification and Comparison of Aberrant Key Regulatory Networks in Breast, Colon, Liver, Lung, and Stomach Cancers through Methylome Database Analysis	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENES; PROMOTER HYPERMETHYLATION; DOWN-REGULATION; OVARIAN-CANCER; IN-VIVO; METHYLATION; EXPRESSION; PTEN; BRCA1; ACTIVATION	Aberrant methylation of specific CpG sites at the promoter is widely responsible for genesis and development of various cancer types. Even though the microarray-based methylome analyzing techniques have contributed to the elucidation of the methylation change at the genome-wide level, the identification of key methylation markers or top regulatory networks appearing common in highly incident cancers through comparison analysis is still limited. In this study, we in silico performed the genome-wide methylation analysis on each 10 sets of normal and cancer pairs of five tissues: breast, colon, liver, lung, and stomach. The methylation array covers 27,578 CpG sites, corresponding to 14,495 genes, and significantly hypermethylated or hypomethylated genes in the cancer were collected (FDR adjusted p-value <0.05; methylation difference >0.3). Analysis of the dataset confirmed the methylation of previously known methylation markers and further identified novel methylation markers, such as GPX2, CLDN15, and KL. Cluster analysis using the methylome dataset resulted in a diagram with a bipartite mode distinguishing cancer cells from normal cells regardless of tissue types. The analysis further revealed that breast cancer was closest with lung cancer, whereas it was farthest from colon cancer. Pathway analysis identified that either the "cancer" related network or the "cancer" related bio-function appeared as the highest confidence in all the five cancers, whereas each cancer type represents its tissue-specific gene sets. Our results contribute toward understanding the essential abnormal epigenetic pathways involved in carcinogenesis. Further, the novel methylation markers could be applied to establish markers for cancer prognosis.	[Kim, Byungtak; Kang, Seongeun; Jeong, Gookjoo; Park, Sung-Bin; Kim, Sun Jung] Dongguk Univ Seoul, Dept Life Sci, Seoul, South Korea	Dongguk University	Kim, SJ (corresponding author), Dongguk Univ Seoul, Dept Life Sci, Seoul, South Korea.	sunjungk@dongguk.edu	kim, sun jung/T-1013-2019		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A2040830]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A2040830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Moundhri M S, 2013, Gulf J Oncolog, V1, P45; Barekati Z, 2010, HUM MOL GENET, V19, P2936, DOI 10.1093/hmg/ddq199; Buckingham L, 2010, INT J CANCER, V126, P1630, DOI 10.1002/ijc.24896; Carney Walter P, 2013, Biomark Cancer, V5, P31, DOI 10.4137/BIC.S12389; Chimonidou M, 2011, CLIN CHEM, V57, P1169, DOI 10.1373/clinchem.2011.165902; Chou HL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-100; Delgado-Cruzata L, 2013, EPIGENETICS, V9; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dmitriev AA, 2012, EPIGENETICS-US, V7, P502, DOI 10.4161/epi.19801; EASTON DF, 1993, AM J HUM GENET, V52, P678; Gu SC, 2011, MOL MED, V17, P48, DOI 10.2119/molmed.2010.00120; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim JH, 2011, BMB REP, V44, P523, DOI 10.5483/BMBRep.2011.44.8.523; Kim SJ, 2011, CANCER LETT, V302, P47, DOI 10.1016/j.canlet.2010.12.010; Lee SJ, 2013, ANN SURG ONCOL; LeRoy G, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-20; Liu Y, 2013, J APPL GENET; Mardin WA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-549; Mayor R, 2009, BRIT J CANCER, V100, P1534, DOI 10.1038/sj.bjc.6605045; Montiel-Duarte C, 2008, LEUKEMIA RES, V32, P709, DOI 10.1016/j.leukres.2007.09.005; Moya P, 2013, TUMOR BIOL, V34, P471, DOI 10.1007/s13277-012-0572-3; Muller I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-297; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Patsialou A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3344; Paul I, 2011, J PATHOL, V224, P564, DOI 10.1002/path.2925; Sabater L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060438; Sebova K, 2011, CANCER BIOMARK, V10, P13, DOI 10.3233/CBM-2012-0230; Seniski GG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-80; Stefansson OA, 2011, EPIGENETICS-US, V6, P638, DOI 10.4161/epi.6.5.15667; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YQ, 2013, J OBSTET GYNAECOL RE, V39, P549, DOI 10.1111/j.1447-0756.2012.01979.x; Xu Y, 2013, ANN ONCOL, V24, P1498, DOI 10.1093/annonc/mdt011; Xu Y, 2011, J CELL BIOCHEM, V112, P3440, DOI 10.1002/jcb.23271; Yin DT, 2012, DISCOV MED, V14, P33; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312	39	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97818	10.1371/journal.pone.0097818	http://dx.doi.org/10.1371/journal.pone.0097818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842468	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600079
J	Tschumi, M; Schaub, M; Arlettaz, R				Tschumi, Matthias; Schaub, Michael; Arlettaz, Raphael			Territory Occupancy and Parental Quality as Proxies for Spatial Prioritization of Conservation Areas	PLOS ONE			English	Article							BREEDING PERFORMANCE; POPULATION; SETTLEMENT; FECUNDITY; BIRD; AGE	In order to maximize their fitness, individuals aim at choosing territories offering the most appropriate combination of resources. As population size fluctuates in time, the frequency of breeding territory occupancy reflects territory quality. We investigated the relationships between the frequency of territory occupancy (2002-2009) vs. habitat characteristics, prey abundance, reproductive success and parental traits in hoopoes Upupa epops L., with the objective to define proxies for the delineation of conservation priority areas. We predicted that the distribution of phenotypes is despotic and sought for phenotypic characteristics expressing dominance. Our findings support the hypothesis of a despotic distribution. Territory selection was non-random: frequently occupied territories were settled earlier in the season and yielded higher annual reproductive success, but the frequency of territory occupancy could not be related to any habitat characteristics. Males found in frequently occupied territories showed traits expressing dominance (i.e. larger body size and mass, and older age). In contrast, morphological traits of females were not related to the frequency of territory occupancy, suggesting that territory selection and maintenance were essentially a male's task. Settlement time in spring, reproductive success achieved in a given territory, as well as phenotypic traits and age of male territory holders reflected territory quality, providing good proxies for assessing priority areas for conservation management.	[Tschumi, Matthias; Schaub, Michael; Arlettaz, Raphael] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Schaub, Michael] Swiss Ornithol Inst, Sempach, Switzerland; [Arlettaz, Raphael] Swiss Ornithol Inst, Valais Field Stn, Sion, Switzerland	University of Bern; Swiss Ornithological Institute; Swiss Ornithological Institute	Tschumi, M (corresponding author), Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland.	matthias.tschumi@agroscope.admin.ch	Arlettaz, Raphaël/O-2182-2016; Tschumi, Matthias/H-6010-2019	Arlettaz, Raphaël/0000-0001-6360-5339; Tschumi, Matthias/0000-0002-7991-7780; Schaub, Michael/0000-0003-2745-0557	Division of Conservation Biology (University of Bern); Swiss Ornithological Institute	Division of Conservation Biology (University of Bern); Swiss Ornithological Institute	The study has been jointly funded by the Division of Conservation Biology (University of Bern) and the Swiss Ornithological Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Arlettaz R, 2000, CONSERVATION HUPPE F; Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Botsch Y, 2012, AUK, V129, P283, DOI 10.1525/auk.2012.11079; Brambilla M, 2013, ORNIS FENNICA, V90, P50; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dafond L, 2008, THESIS U ZURICH; ESRI, 2008, ARCGIS 9 X; Ferrer M, 2006, J ANIM ECOL, V75, P111, DOI 10.1111/j.1365-2656.2005.01026.x; Ferrer M, 2003, AUK, V120, P180, DOI 10.1642/0004-8038(2003)120[0180:AATEOF]2.0.CO;2; Fournier J, 2001, IBIS, V143, P2, DOI 10.1111/j.1474-919X.2001.tb04163.x; FRANCIS CM, 1986, AUK, V103, P548; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Germain RR, 2014, ECOLOGY, V95, P436, DOI 10.1890/13-0467.1; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Keller V., 2010, ROTE LISTE BRUTVOGEL; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; KORPIMAKI E, 1988, J ANIM ECOL, V57, P97, DOI 10.2307/4766; LANYON SM, 1986, CONDOR, V88, P206, DOI 10.2307/1368917; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martinez JA, 2008, IBIS, V150, P223, DOI 10.1111/j.1474-919X.2007.00774.x; Mermod M, 2009, IBIS, V151, P731, DOI 10.1111/j.1474-919X.2009.00956.x; NEWTON I, 1991, IBIS, V133, P76, DOI 10.1111/j.1474-919X.1991.tb07671.x; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; R Core Team, 2012, R LANG ENV STAT COMP; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Sergio F, 2007, BEHAV ECOL, V18, P811, DOI 10.1093/beheco/arm052; Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x; Serrano D, 2007, AM NAT, V169, pE53, DOI 10.1086/510598; Tagmann-Ioset A, 2012, ACTA OECOL, V39, P25, DOI 10.1016/j.actao.2011.11.003; Tregenza T., 1995, Advances in Ecological Research, V26, P253, DOI 10.1016/S0065-2504(08)60067-7; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	36	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97679	10.1371/journal.pone.0097679	http://dx.doi.org/10.1371/journal.pone.0097679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836965	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800060
J	Ge, YH; Wu, FX; Sun, XJ; Xiang, ZH; Yang, LQ; Huang, SD; Lu, ZJ; Sun, YM; Yu, WF				Ge, Yanhu; Wu, Feixiang; Sun, Xuejun; Xiang, Zhenghua; Yang, Liqun; Huang, Shengdong; Lu, Zhijie; Sun, Yuming; Yu, Wei-Feng			Intrathecal Infusion of Hydrogen-Rich Normal Saline Attenuates Neuropathic Pain via Inhibition of Activation of Spinal Astrocytes and Microglia in Rats	PLOS ONE			English	Article							REACTIVE OXYGEN; TACTILE ALLODYNIA; OXIDATIVE STRESS; NERVE INJURY; HYPERALGESIA; CORD; INVOLVEMENT; CONTRIBUTE; MODEL; SENSITIZATION	Background: Reactive oxygen and nitrogen species are key molecules that mediate neuropathic pain. Although hydrogen is an established antioxidant, its effect on chronic pain has not been characterized. This study was to investigate the efficacy and mechanisms of hydrogen-rich normal saline induced analgesia. Methodology/Principal findings: In a rat model of neuropathic pain induced by L5 spinal nerve ligation (L5 SNL), intrathecal injection of hydrogen-rich normal saline relieved L5 SNL-induced mechanical allodynia and thermal hyperalgesia. Importantly, repeated administration of hydrogen-rich normal saline did not lead to tolerance. Preemptive treatment with hydrogen-rich normal saline prevented development of neuropathic pain behavior. Immunofluorochrome analysis revealed that hydrogen-rich normal saline treatment significantly attenuated L5 SNL-induced increase of 8-hydroxyguanosine immunoreactive cells in the ipsilateral spinal dorsal horn. Western blot analysis of SDS/PAGE-fractionated tyrosine-nitrated proteins showed that L5 SNL led to increased expression of tyrosine-nitrated Mn-containing superoxide dismutase (MnSOD) in the spinal cord, and hydrogen-rich normal saline administration reversed the tyrosine-nitrated MnSOD overexpression. We also showed that the analgesic effect of hydrogen-rich normal saline was associated with decreased activation of astrocytes and microglia, attenuated expression of interleukin-1 beta (IL-1 beta) and tumor necrosis factor-a (TNF-alpha) in the spinal cord. Conclusion/Significance: Intrathecal injection of hydrogen-rich normal saline produced analgesic effect in neuropathic rat. Hydrogen-rich normal saline-induced analgesia in neuropathic rats is mediated by reducing the activation of spinal astrocytes and microglia, which is induced by overproduction of hydroxyl and peroxynitrite.	[Ge, Yanhu; Wu, Feixiang; Yang, Liqun; Lu, Zhijie; Sun, Yuming; Yu, Wei-Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Changhai Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Ge, Yanhu] 309th Hosp CPLA, Dept Anesthesiol, Beijing, Peoples R China; [Sun, Xuejun] Second Mil Med Univ, Fac Naval Med, Dept Diving Med, Shanghai, Peoples R China; [Xiang, Zhenghua] Second Mil Med Univ, Dept Neurobiol, Shanghai, Peoples R China; [Huang, Shengdong] Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Yu, WF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Changhai Hosp, Dept Anesthesiol, Shanghai, Peoples R China.	ywf808@sohu.com	sun, xuejun/A-5561-2010; Yu, Wei/GZL-3831-2022	sun, xuejun/0000-0003-2387-5531; 	National Natural Science Foundation of China [30901403, 31171013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (30901403, 31171013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmoaty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075543; ADAMS MWW, 1980, BIOCHIM BIOPHYS ACTA, V594, P105, DOI 10.1016/0304-4173(80)90007-5; ASTIZ M, 2013, NEUROTOX RES; BALAZS L, 1994, NEUROCHEM RES, V19, P1131, DOI 10.1007/BF00965146; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Chen ZM, 2010, PAIN, V149, P100, DOI 10.1016/j.pain.2010.01.015; Chiang CY, 2012, NEUROCHEM RES, V37, P2419, DOI 10.1007/s11064-012-0801-6; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dhainaut A, 2000, J MED CHEM, V43, P2165, DOI 10.1021/jm991154w; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Fidanboylu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025212; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8; Hackel D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063564; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hald A, 2009, CELL MOL NEUROBIOL, V29, P609, DOI 10.1007/s10571-009-9390-6; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; HUANG ZX, 2014, PAIN; JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7; Ji RR, 2013, PAIN; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Ji XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060733; Khalil Z, 1999, PAIN, V79, P31, DOI 10.1016/S0304-3959(98)00143-2; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Kim HK, 2006, PAIN, V122, P53, DOI 10.1016/j.pain.2006.01.013; Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008; KIM JA, 2013, NEUROPHARMACOLOGY; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073948; Lee KY, 2010, J NEUROPHYSIOL, V103, P382, DOI 10.1152/jn.90906.2008; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Little JW, 2013, PAIN, V154, P978, DOI 10.1016/j.pain.2013.02.018; Liu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075804; Lu RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029240; Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x; Muscoli C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/950947; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073640; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Okada-Ogawa A, 2009, J NEUROSCI, V29, P11161, DOI 10.1523/JNEUROSCI.3365-09.2009; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; Salvemini D, 2010, LIFE SCI, V86, P604, DOI 10.1016/j.lfs.2009.06.011; Sun QA, 2011, J SURG RES, V165, pE43, DOI 10.1016/j.jss.2010.09.024; Swartjes M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-13; Tal M, 1996, NEUROREPORT, V7, P1382, DOI 10.1097/00001756-199605310-00010; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Watkins LR, 1997, PAIN, V71, P225, DOI 10.1016/S0304-3959(97)03369-1; Wei H, 2013, PHARMACOL BIOCHEM BE, V111, P30, DOI 10.1016/j.pbb.2013.08.003; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yang CM, 2013, MOL NEUROBIOL, V47, P1020, DOI 10.1007/s12035-013-8402-1; Zhang FX, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-15; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072943; Zhang YF, 2011, INT J CARDIOL, V148, P91, DOI 10.1016/j.ijcard.2010.08.058	65	27	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97436	10.1371/journal.pone.0097436	http://dx.doi.org/10.1371/journal.pone.0097436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857932	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400015
J	Domin, M; Langner, S; Hosten, N; Lotze, M				Domin, Martin; Langner, Soenke; Hosten, Norbert; Lotze, Martin			Comparison of Parameter Threshold Combinations for Diffusion Tensor Tractography in Chronic Stroke Patients and Healthy Subjects	PLOS ONE			English	Article							RICIAN NOISE REMOVAL; WHITE-MATTER TRACTS; CORTICOSPINAL TRACT; SUBCORTICAL STROKE; PYRAMIDAL TRACT; MOTOR CORTEX; BRAIN; MRI; REPRODUCIBILITY; ANISOTROPY	Background: Although quantitative evaluation of diffusion tensor imaging (DTI) data seemed to be extremely important for clinical research its application is under debate. Besides fractional anisotropy (FA) the quantitative comparison between hemispheres of the number of fibers reconstructed by means of diffusion tensor tractography (DTT) is commonly used. However, the tractography-related parameters FA, minimum tract length (LENGTH) and the angle between two contiguous tracking steps (ANGLE) are inconsistently applied. Using 18 combinations we tested for the influence of parameter thresholds on the amount of reconstructed fibers for the posterior pyramidal tract in both hemispheres in order to obtain meaningful thresholds for DTT. Results: In 14 chronic stroke patients with unilateral lesions of the pyramidal tract around the height of the internal capsule and considerable motor deficits a 3-way repeated-measures ANOVA showed a significant interaction between the effects of FA and ANGLE level on reconstructed fiber lateralization, F (2.9, 37.67) = 3.01, p = 0.044, and a significant main effect FA, F (1.4, 18.1) = 11.58, p = 0.001. Post-hoc pairwise comparisons showed that this interaction was completely driven by FA. In 22 right-handed healthy subjects no significant interactions or main effects could be found. Conclusion: The parameter threshold combinations with highest FA showed highest effect. ANGLE and LENGTH insofar influenced the lateralization effect when selected as liberal as possible, short LENGTH and large ANGLE thresholds. The DTT approach should be used with great care since results are highly dependent on the thresholds applied.	[Domin, Martin; Lotze, Martin] Univ Med, Ctr Diagnost Radiol & Neuroradiol, Funct Imaging Unit, Greifswald, MV, Germany; [Langner, Soenke; Hosten, Norbert] Univ Med, Ctr Diagnost Radiol & Neuroradiol, Greifswald, MV, Germany		Domin, M (corresponding author), Univ Med, Ctr Diagnost Radiol & Neuroradiol, Funct Imaging Unit, Greifswald, MV, Germany.	martin.domin@uni-greifswald.de	Lotze, Martin/D-2964-2012; Langner, Soenke/ABB-6744-2021	Lotze, Martin/0000-0003-4519-4956; Langner, Soenke/0000-0001-7241-1173	Deutsche Forschungsgesellschaft [LO795/12, LO 795/7]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	Martin Lotze was supported by the Deutsche Forschungsgesellschaft (LO795/12, LO 795/7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Bach DR, 2011, J NEUROSCI, V31, P618, DOI 10.1523/JNEUROSCI.2744-10.2011; Balci A, 2012, AM J ROENTGENOL, V198, P1167, DOI 10.2214/AJR.11.7404; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basu S, 2006, LECT NOTES COMPUT SC, V4190, P117; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Borich MR, 2012, NEUROIMAGE, V59, P2393, DOI 10.1016/j.neuroimage.2011.09.009; Bray S, 2013, NEUROIMAGE, V82, P137, DOI 10.1016/j.neuroimage.2013.05.080; Chung AW, 2013, MAGN RESON IMAGING, V31, P742, DOI 10.1016/j.mri.2012.11.014; D'Andrea G, 2012, NEUROSURG REV, V35, P401, DOI 10.1007/s10143-012-0373-6; Dauguet J, 2006, LECT NOTES COMPUT SC, V4190, P109; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Gonzalez-Darder JM, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.11.FOCUS09234; Gyengesi E, 2013, BRAIN STRUCTURE FUNC; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Liu F, 2010, BRAIN RES, V1343, P37, DOI 10.1016/j.brainres.2010.04.064; Lotze M, 2012, NEUROREHAB NEURAL RE, V26, P594, DOI 10.1177/1545968311427706; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nelles M, 2008, AM J NEURORADIOL, V29, P488, DOI 10.3174/ajnr.A0855; Nowinski WL, 2012, NEUROINFORMATICS, V10, P33, DOI 10.1007/s12021-011-9118-x; Ohue S, 2012, NEUROSURGERY, V70, P283, DOI 10.1227/NEU.0b013e31823020e6; Onu M, 2012, EUR J RADIOL, V81, pE386, DOI 10.1016/j.ejrad.2011.12.014; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Radlinska B, 2010, NEUROLOGY, V75, P1048, DOI 10.1212/WNL.0b013e3181f39aa0; Reich DS, 2006, AM J NEURORADIOL, V27, P2168; Schwartzman A, 2010, J AM STAT ASSOC, V105, P588, DOI 10.1198/jasa.2010.ap07291; Skare S, 2000, MAGN RESON IMAGING, V18, P659, DOI 10.1016/S0730-725X(00)00153-3; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sullivan EV, 2010, NEUROPSYCHOLOGIA, V48, P4155, DOI 10.1016/j.neuropsychologia.2010.10.023; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tymofiyeva O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063310; Vassal F, 2013, BRIT J NEUROSURGERY; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Whitcher B, 2007, MAGN RESON MED, V57, P1065, DOI 10.1002/mrm.21229; Wiest-Daessle N, 2008, LECT NOTES COMPUT SC, V5242, P171, DOI 10.1007/978-3-540-85990-1_21	45	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98211	10.1371/journal.pone.0098211	http://dx.doi.org/10.1371/journal.pone.0098211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853163	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200055
J	Liao, WY; Ke, TY; Wu, HY				Liao, Wei-Yu; Ke, Ting-Yung; Wu, Hung-Yi			The 3 '-Terminal 55 Nucleotides of Bovine Coronavirus Defective Interfering RNA Harbor Cis-Acting Elements Required for Both Negative- and Positive-Strand RNA Synthesis	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; 3' UNTRANSLATED REGION; RESPIRATORY SYNDROME CORONAVIRUS; SYNTHESIS IN-VITRO; STEM-LOOP-IV; 5'-UNTRANSLATED REGION; MURINE CORONAVIRUS; DENGUE VIRUS; VIRAL-RNA; STRUCTURAL ELEMENTS	The synthesis of the negative-strand [(-)-strand] complement of the similar to 30 kilobase, positive-strand [(+)-strand] coronaviral genome is a necessary early step for genome replication. The identification of cis-acting elements required for (-)-strand RNA synthesis in coronaviruses, however, has been hampered due to insufficiencies in the techniques used to detect the (-)-strand RNA species. Here, we employed a method of head-to-tail ligation and real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) to detect and quantitate the synthesis of bovine coronavirus (BCoV) defective interfering (DI) RNA (-) strands. Furthermore, using the aforementioned techniques along with Northern blot assay, we specifically defined the cis-acting RNA elements within the 3'-terminal 55 nucleotides (nts) which function in the synthesis of (-)- or (+)-strand BCoV DI RNA. The major findings are as follows: (i) nts from -5 to -39 within the 3'-terminal 55 nts are the cis-acting elements responsible for (-)-strand BCoV DI RNA synthesis, (ii) nts from -3 to -34 within the 3'-terminal 55 nts are cis-acting elements required for (+)-strand BCoV DI RNA synthesis, and (iii) the nucleotide species at the 3'-most position (-1) is important, but not critical, for both (-)- and (+)-strand BCoV DI RNA synthesis. These results demonstrate that the 3'-terminal 55 nts in BCoV DI RNA harbor cis-acting RNA elements required for both (-)- and (+)-strand DI RNA synthesis and extend our knowledge on the mechanisms of coronavirus replication. The method of head-to-tail ligation and qRT-PCR employed in the study may also be applied to identify other cis-acting elements required for (-)-strand RNA synthesis in coronaviruses.	[Liao, Wei-Yu; Ke, Ting-Yung; Wu, Hung-Yi] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan	National Chung Hsing University	Wu, HY (corresponding author), Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan.	hwu2@dragon.nchu.edu.tw		Wu, Hung-Yi/0000-0002-1260-6259	National Science Council (NSC) of Republic of China [99-2313-B-005-024]	National Science Council (NSC) of Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grant 99-2313-B-005-024 from the National Science Council (NSC) of Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; BARIC RS, 1990, VIROLOGY, V177, P646, DOI 10.1016/0042-6822(90)90530-5; Brown CG, 2007, J VIROL, V81, P7716, DOI 10.1128/JVI.00549-07; Chang RY, 1996, J VIROL, V70, P2720, DOI 10.1128/JVI.70.5.2720-2729.1996; CHANG RY, 1994, J VIROL, V68, P8223, DOI 10.1128/JVI.68.12.8223-8231.1994; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Fischer F, 1997, J VIROL, V71, P5148, DOI 10.1128/JVI.71.7.5148-5160.1997; FU KS, 1994, J VIROL, V68, P7458, DOI 10.1128/JVI.68.11.7458-7466.1994; Goebel SJ, 2007, J VIROL, V81, P1274, DOI 10.1128/JVI.00803-06; Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004; Guan BJ, 2012, J VIROL, V86, P4631, DOI 10.1128/JVI.06265-11; Guan BJ, 2011, J VIROL, V85, P5593, DOI 10.1128/JVI.00263-11; Gustin KM, 2009, J VIROL, V83, P6087, DOI 10.1128/JVI.00160-09; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Herold J, 2001, MOL CELL, V7, P581, DOI 10.1016/S1097-2765(01)00205-2; HOFMANN MA, 1990, J VIROL, V64, P4108, DOI 10.1128/JVI.64.9.4108-4114.1990; Hsue B, 1997, J VIROL, V71, P7567, DOI 10.1128/JVI.71.10.7567-7578.1997; Hsue B, 2000, J VIROL, V74, P6911, DOI 10.1128/JVI.74.15.6911-6921.2000; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; JACOBSON SJ, 1993, J VIROL, V67, P2961, DOI 10.1128/JVI.67.6.2961-2971.1993; Kang HJ, 2006, J VIROL, V80, P10600, DOI 10.1128/JVI.00455-06; Kao CC, 1996, J VIROL, V70, P6826, DOI 10.1128/JVI.70.10.6826-6830.1996; Ke TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082176; KIM YN, 1993, VIROLOGY, V197, P53, DOI 10.1006/viro.1993.1566; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; KING B, 1982, J VIROL, V42, P700, DOI 10.1128/JVI.42.2.700-707.1982; LAI MMC, 1992, CURR TOP MICROBIOL, V176, P21; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; Li LC, 2008, J MOL BIOL, V377, P790, DOI 10.1016/j.jmb.2008.01.068; LIN YJ, 1994, J VIROL, V68, P8131, DOI 10.1128/JVI.68.12.8131-8140.1994; LIN YJ, 1993, J VIROL, V67, P6110, DOI 10.1128/JVI.67.10.6110-6118.1993; Liu PH, 2007, RNA, V13, P763, DOI 10.1261/rna.261807; Liu PH, 2009, J VIROL, V83, P12084, DOI 10.1128/JVI.00915-09; Liu Q, 2001, J VIROL, V75, P12105, DOI 10.1128/JVI.75.24.12105-12113.2001; MILLER WA, 1986, J MOL BIOL, V187, P537, DOI 10.1016/0022-2836(86)90332-3; Ooms M, 2007, NUCLEIC ACIDS RES, V35, P5253, DOI 10.1093/nar/gkm564; Ozdarendeli A, 2001, J VIROL, V75, P7362, DOI 10.1128/JVI.75.16.7362-7374.2001; Raman S, 2005, J VIROL, V79, P12434, DOI 10.1128/JVI.79.19.12434-12446.2005; Raman S, 2003, J VIROL, V77, P6720, DOI 10.1128/JVI.77.12.6720-6730.2003; SCHENBORN ET, 1985, NUCLEIC ACIDS RES, V13, P6223, DOI 10.1093/nar/13.17.6223; Singh RN, 1997, VIROLOGY, V233, P430, DOI 10.1006/viro.1997.8621; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Spagnolo JF, 2000, J VIROL, V74, P5053, DOI 10.1128/JVI.74.11.5053-5065.2000; TOMPKINS WA, 1974, J NATL CANCER I, V52, P1101, DOI 10.1093/jnci/52.4.1101; VANDERMOST RG, 1995, J VIROL, V69, P3744, DOI 10.1128/JVI.69.6.3744-3751.1995; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Williams GD, 1999, J VIROL, V73, P8349, DOI 10.1128/JVI.73.10.8349-8355.1999; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Wu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070548; Wu HY, 2010, P NATL ACAD SCI USA, V107, P12257, DOI 10.1073/pnas.1000378107; Wu HY, 2006, J VIROL, V80, P2183, DOI 10.1128/JVI.80.5.2183-2193.2006; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; YU W, 1995, VIROLOGY, V214, P128, DOI 10.1006/viro.1995.9947; YU W, 1995, J VIROL, V69, P2016, DOI 10.1128/JVI.69.4.2016-2023.1995; Zhang GH, 2004, J VIROL, V78, P7619, DOI 10.1128/JVI.78.14.7619-7633.2004; Zhang JC, 2005, VIROLOGY, V333, P301, DOI 10.1016/j.virol.2004.12.015; Zhang X, 2003, RNA, V9, P555, DOI 10.1261/rna.2190803	59	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98422	10.1371/journal.pone.0098422	http://dx.doi.org/10.1371/journal.pone.0098422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852421	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200070
J	Pang, SL; Wu, HL; Wang, Q; Cai, MX; Shi, WM; Shang, J				Pang, Silin; Wu, Huali; Wang, Qian; Cai, Minxuan; Shi, Weimin; Shang, Jing			Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic-Pituitary-Adrenocortical Axis Elements and Melanogenesis	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; CHRONIC RESTRAINT STRESS; MESSENGER-RNA; HPA AXIS; DIFFERENTIAL EXPRESSION; EPIDERMAL-KERATINOCYTES; ULTRAVIOLET-RADIATION; PREFRONTAL CORTEX; ATOPIC-DERMATITIS	Chronic stress can affect skin function, and some skin diseases might be triggered or aggravated by stress. Stress can activate the central hypothalamic-pituitary-adrenocortical (HPA) axis, which causes glucocorticoid levels to increase. The skin has HPA axis elements that react to environmental stressors to regulate skin functions, such as melanogenesis. This study explores the mechanism whereby chronic stress affects skin pigmentation, focusing on the HPA axis, and investigates the role of glucocorticoids in this pathway. We exposed C57BL/6 male mice to two types of chronic stress, chronic restraint stress (CRS) and chronic unpredictable mild stress (CUMS). Mice subjected to either stress condition showed reduced melanogenesis. Interestingly, CRS and CUMS triggered reductions in the mRNA expression levels of key factors involved in the HPA axis in the skin. In mice administered corticosterone, decreased melanin synthesis and reduced expression of HPA axis elements were observed. The reduced expression of HPA axis elements and melanogenesis in the skin of stressed mice were reversed by RU486 (a glucocorticoid receptor antagonist) treatment. Glucocorticoids had no significant inhibitory effect on melanogenesis in vitro. These results suggest that, high levels of serum corticosterone induced by chronic stress can reduce the expression of elements of the skin HPA axis by glucocorticoid-dependent negative feedback. These activities can eventually result in decreased skin pigmentation. Our findings raise the possibility that chronic stress could be a risk factor for depigmentation by disrupting the cutaneous HPA axis and should prompt dermatologists to exercise more caution when using glucocorticoids for treatment.	[Pang, Silin; Wu, Huali; Wang, Qian; Cai, Minxuan; Shang, Jing] China Pharmaceut Univ, New Drug Screening Ctr, Nanjing, Jiangsu, Peoples R China; [Pang, Silin; Wu, Huali; Wang, Qian; Cai, Minxuan; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Shi, Weimin] Shanghai First People Hosp, Shanghai, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Shang, J (corresponding author), China Pharmaceut Univ, New Drug Screening Ctr, Nanjing, Jiangsu, Peoples R China.	shangjing21cn@163.com			National Science and Technology Infrastructure Program [2012BAI30B001]; Mega-projects of Science Research for the 12th Five-Year Plan of China [2011ZX09401-007]	National Science and Technology Infrastructure Program; Mega-projects of Science Research for the 12th Five-Year Plan of China	This work was supported by 2012-2014 National Science and Technology Infrastructure Program (2012BAI30B001), PI 2011-2013 Mega-projects of Science Research for the 12th Five-Year Plan of China (2011ZX09401-007), PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar N, 2005, MUTAT RES-FUND MOL M, V571, P121, DOI 10.1016/j.mrfmmm.2004.11.016; Aguilera G, 1996, ENDOCR RES, V22, P433, DOI 10.1080/07435809609043729; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Asadi S, 2012, J INVEST DERMATOL, V132, P324, DOI 10.1038/jid.2011.334; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Bujalska IJ, 2002, J CLIN ENDOCR METAB, V87, P1205, DOI 10.1210/jc.87.3.1205; Bujalska O, 1997, STEROIDS, V62, P77, DOI 10.1016/S0039-128X(96)00163-8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen A, 2005, MOL ENDOCRINOL, V19, P441, DOI 10.1210/me.2004-0300; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Dhabhar FS, 2013, CLIN DERMATOL, V31, P18, DOI 10.1016/j.clindermatol.2011.11.003; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Ermak G, 1997, J INVEST DERMATOL, V108, P160, DOI 10.1111/1523-1747.ep12332925; Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Flint MS, 2003, STRESS, V6, P59, DOI 10.1080/1025389031000088426; Hadshiew IM, 2004, J INVEST DERMATOL, V123, P455, DOI 10.1111/j.0022-202X.2004.23237.x; Hall JMF, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/403908; Hunter HJA, 2013, BRIT J DERMATOL, V169, P965, DOI 10.1111/bjd.12478; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Joels M, 2004, STRESS, V7, P221, DOI 10.1080/10253890500070005; Kato JS, 2003, J INVEST DERMATOL, V120, P456, DOI 10.1046/j.1523-1747.2003.12053.x; Kauser S, 2006, FASEB J, V20, P882, DOI 10.1096/fj.05-5257com; Kim NS, 2000, ARCH DERMATOL RES, V292, P233, DOI 10.1007/s004030050480; Kourosh AS, 2010, AM J DRUG ALCOHOL AB, V36, P284, DOI 10.3109/00952990.2010.491883; Krause K, 2007, HORM METAB RES, V39, P166, DOI 10.1055/s-2007-961811; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061574; Lonne-Rahm SB, 2008, J EUR ACAD DERMATOL, V22, P11, DOI 10.1111/j.1468-3083.2007.02202.x; Luger Thomas, 2004, J Dtsch Dermatol Ges, V2, P629; Manolache L, 2007, J EUR ACAD DERMATOL, V21, P921, DOI 10.1111/j.1468-3083.2006.02106.x; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Meyer U, 2001, HIPPOCAMPUS, V11, P329, DOI 10.1002/hipo.1047; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Ping FF, 2012, INT J BIOCHEM CELL B, V44, P2342, DOI 10.1016/j.biocel.2012.09.025; Raone A, 2007, NEUROSCIENCE, V146, P1734, DOI 10.1016/j.neuroscience.2007.03.027; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; Rousseau K, 2007, FASEB J, V21, P1844, DOI 10.1096/fj.06-7398com; Schafer-Korting M, 2005, SKIN PHARMACOL PHYS, V18, P103, DOI 10.1159/000084907; Schut C, 2013, ACTA DERM-VENEREOL, V93, P57, DOI 10.2340/00015555-1415; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2013, GENE, V530, P1, DOI 10.1016/j.gene.2013.08.035; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 1996, INT J DERMATOL, V35, P849, DOI 10.1111/j.1365-4362.1996.tb05049.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Slominski A, 1996, J CLIN ENDOCR METAB, V81, P2746, DOI 10.1210/jc.81.7.2746; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski A, 2007, J CLIN INVEST, V117, P3166, DOI 10.1172/JCI33508; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski AT, 2012, INT J BIOCHEM CELL B, V44, P2003, DOI 10.1016/j.biocel.2012.07.027; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Spencer JD, 2007, J INVEST DERMATOL, V127, P411, DOI 10.1038/sj.jid.5700538; Sulaimon SS, 2003, VET DERMATOL, V14, P57, DOI 10.1046/j.1365-3164.2003.00327.x; Talaber G, 2013, MOL CELL ENDOCRINOL, V380, P89, DOI 10.1016/j.mce.2013.05.007; Tanida M, 2007, BRAIN RES, V1184, P210, DOI 10.1016/j.brainres.2007.09.058; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Werth VP, 2013, J AM ACAD DERMATOL, V68, P177, DOI 10.1016/j.jaad.2012.09.002; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; YASUMOTO KI, 1995, MOL CELL BIOL, V15, P1833; Zhang XQ, 2009, J INVEST DERMATOL, V129, P1527, DOI 10.1038/jid.2008.371; Zhao X, 2013, NEUROSCIENCE, V246, P82, DOI 10.1016/j.neuroscience.2013.04.046; Zoller NN, 2008, TOXICOL IN VITRO, V22, P747, DOI 10.1016/j.tiv.2007.11.022	74	12	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98283	10.1371/journal.pone.0098283	http://dx.doi.org/10.1371/journal.pone.0098283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854026	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200060
J	Curson, ARJ; Burns, OJ; Voget, S; Daniel, R; Todd, JD; McInnis, K; Wexler, M; Johnston, AWB				Curson, Andrew R. J.; Burns, Oliver J.; Voget, Sonja; Daniel, Rolf; Todd, Jonathan D.; McInnis, Kathryn; Wexler, Margaret; Johnston, Andrew W. B.			Screening of Metagenomic and Genomic Libraries Reveals Three Classes of Bacterial Enzymes That Overcome the Toxicity of Acrylate	PLOS ONE			English	Article							PROPIONYL-COENZYME-A; ESCHERICHIA-COLI; DIMETHYLSULFONIOPROPIONATE LYASE; RHIZOBIUM-LEGUMINOSARUM; CLONING VECTORS; TREATMENT-PLANT; ACID; COA; CATABOLISM; REDUCTASE	Acrylate is produced in significant quantities through the microbial cleavage of the highly abundant marine osmoprotectant dimethylsulfoniopropionate, an important process in the marine sulfur cycle. Acrylate can inhibit bacterial growth, likely through its conversion to the highly toxic molecule acrylyl-CoA. Previous work identified an acrylyl-CoA reductase, encoded by the gene acuI, as being important for conferring on bacteria the ability to grow in the presence of acrylate. However, some bacteria lack acuI, and, conversely, many bacteria that may not encounter acrylate in their regular environments do contain this gene. We therefore sought to identify new genes that might confer tolerance to acrylate. To do this, we used functional screening of metagenomic and genomic libraries to identify novel genes that corrected an E. coli mutant that was defective in acuI, and was therefore hyper-sensitive to acrylate. The metagenomic libraries yielded two types of genes that overcame this toxicity. The majority encoded enzymes resembling AcuI, but with significant sequence divergence among each other and previously ratified AcuI enzymes. One other metagenomic gene, arkA, had very close relatives in Bacillus and related bacteria, and is predicted to encode an enoyl-acyl carrier protein reductase, in the same family as FabK, which catalyses the final step in fatty-acid biosynthesis in some pathogenic Firmicute bacteria. A genomic library of Novosphingobium, a metabolically versatile alphaproteobacterium that lacks both acuI and arkA, yielded vutD and vutE, two genes that, together, conferred acrylate resistance. These encode sequential steps in the oxidative catabolism of valine in a pathway in which, significantly, methacrylyl-CoA is a toxic intermediate. These findings expand the range of bacteria for which the acuI gene encodes a functional acrylyl-CoA reductase, and also identify novel enzymes that can similarly function in conferring acrylate resistance, likely, again, through the removal of the toxic product acrylyl-CoA.	[Curson, Andrew R. J.; Burns, Oliver J.; Todd, Jonathan D.; McInnis, Kathryn; Wexler, Margaret; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Voget, Sonja; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, D-37073 Gottingen, Germany; [Voget, Sonja; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, D-37073 Gottingen, Germany	University of East Anglia; University of Gottingen; University of Gottingen	Curson, ARJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	andrew.curson@uea.ac.uk	Curson, Andrew RJ/B-8964-2009; Todd, Jonathan/B-8967-2009; Johnston, Andrew W B/D-1859-2009; Daniel, Rolf/AAQ-5933-2021	Todd, Jonathan/0000-0003-0777-9312; Daniel, Rolf/0000-0002-8646-7925	BBSRC Research Council of the United Kingdom [BB/H002642/1]; NERC Research Council of the United Kingdom [NE/H008586/1]; BBSRC [BB/H002642/1] Funding Source: UKRI; NERC [NE/H008586/1, NE/J01138X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002642/1] Funding Source: researchfish; Natural Environment Research Council [NE/H008586/1, NE/J01138X/1] Funding Source: researchfish	BBSRC Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC Research Council of the United Kingdom; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the BBSRC (http://www.bbsrc.ac.uk) and NERC (http://www.nerc.ac.uk/) Research Councils of the United Kingdom under grants BB/H002642/1 and NE/H008586/1 respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber BE, 2002, J BIOL CHEM, V277, P12137, DOI 10.1074/jbc.M110802200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arya AS, 2013, BIOTECHNOL LETT, V35, P1839, DOI 10.1007/s10529-013-1282-7; Asao M, 2013, J BACTERIOL, V195, P4716, DOI 10.1128/JB.00685-13; BALDWIN RL, 1965, BIOCHIM BIOPHYS ACTA, V97, P202, DOI 10.1016/0304-4165(65)90084-X; Balkwill DL, 1997, INT J SYST BACTERIOL, V47, P191, DOI 10.1099/00207713-47-1-191; BERGLER H, 1994, J BIOL CHEM, V269, P5493; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Clayden J., 2001, ORGANIC CHEM; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Curson ARJ, 2011, ISME J, V5, P1191, DOI 10.1038/ismej.2010.203; Curson ARJ, 2010, ISME J, V4, P144, DOI 10.1038/ismej.2009.93; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong CH, 2009, MOL PLANT, V2, P59, DOI 10.1093/mp/ssn063; Ferrer M, 2009, J MOL MICROB BIOTECH, V16, P109, DOI 10.1159/000142898; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Francis K, 2009, BIOCHEMISTRY-US, V48, P2403, DOI 10.1021/bi802238j; Fujii K, 2003, INT J SYST EVOL MICR, V53, P47, DOI 10.1099/ijs.0.02301-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; Herrmann G, 2005, FEBS J, V272, P813, DOI 10.1111/j.1742-4658.2004.04518.x; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kandasamy V, 2013, APPL MICROBIOL BIOT, V97, P1191, DOI 10.1007/s00253-012-4274-y; KUCHTA RD, 1985, J BIOL CHEM, V260, P3181; Lee SW, 2004, APPL MICROBIOL BIOT, V65, P720, DOI 10.1007/s00253-004-1722-3; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; MARTIN RR, 1973, J BACTERIOL, V115, P198, DOI 10.1128/JB.115.1.198-204.1973; MASSEY LK, 1974, J BACTERIOL, V118, P112, DOI 10.1128/JB.118.1.112-120.1974; Moran MA, 2012, ANNU REV MAR SCI, V4, P523, DOI 10.1146/annurev-marine-120710-100827; Nacke H, 2011, FEMS MICROBIOL ECOL, V78, P188, DOI 10.1111/j.1574-6941.2011.01088.x; Noordkamp DJB, 2000, J SEA RES, V43, P287, DOI 10.1016/S1385-1101(00)00021-6; OOIWA T, 1995, BBA-GEN SUBJECTS, V1243, P216, DOI 10.1016/0304-4165(94)00061-2; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Pang H, 2009, CURR MICROBIOL, V58, P404, DOI 10.1007/s00284-008-9346-y; PATEL SS, 1987, J BIOL CHEM, V262, P7132; Payne DJ, 2002, ANTIMICROB AGENTS CH, V46, P3118, DOI 10.1128/AAC.46.10.3118-3124.2002; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Reisch CR, 2013, MOL MICROBIOL, V89, P774, DOI 10.1111/mmi.12314; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; Rosenthal RG, 2014, NAT CHEM BIOL, V10, P50, DOI [10.1038/NCHEMBIO.1385, 10.1038/nchembio.1385]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato K, 1999, J BIOCHEM-TOKYO, V126, P668, DOI 10.1093/oxfordjournals.jbchem.a022501; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schneider K, 2012, J BACTERIOL, V194, P225, DOI 10.1128/JB.05959-11; Seeliger S, 2002, FEMS MICROBIOL LETT, V211, P65, DOI 10.1111/j.1574-6968.2002.tb11204.x; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; SIEBURTH JM, 1961, J BACTERIOL, V82, P72, DOI 10.1128/JB.82.1.72-79.1961; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; SIMON R, 1989, GENE, V80, P161, DOI 10.1016/0378-1119(89)90262-X; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; Sullivan MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015972; Sulzenbacher G, 2004, ACTA CRYSTALLOGR D, V60, P1855, DOI 10.1107/S0907444904020220; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan DZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063870; Taniguchi K, 1996, HEPATOLOGY, V24, P1395, DOI 10.1002/hep.510240614; Tapiolas DM, 2010, CORAL REEFS, V29, P621, DOI 10.1007/s00338-010-0608-3; TAYLOR BF, 1991, APPL ENVIRON MICROB, V57, P3581, DOI 10.1128/AEM.57.12.3581-3584.1991; TCHORZEWSKI M, 1994, EUR J BIOCHEM, V226, P841, DOI 10.1111/j.1432-1033.1994.00841.x; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Todd JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035947; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; Wanders RJA, 2012, J INHERIT METAB DIS, V35, P5, DOI 10.1007/s10545-010-9236-x; Warnecke T, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-25; Wexler M, 2005, ENVIRON MICROBIOL, V7, P1917, DOI 10.1111/j.1462-2920.2005.00854.x; Wexler M, 2001, MOL MICROBIOL, V41, P801, DOI 10.1046/j.1365-2958.2001.02556.x; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zhou FL, 2011, APPL BIOCHEM BIOTECH, V165, P1770, DOI 10.1007/s12010-011-9393-x	83	14	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97660	10.1371/journal.pone.0097660	http://dx.doi.org/10.1371/journal.pone.0097660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848004	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600048
J	Lim, CS; Alkon, DL				Lim, Chol Seung; Alkon, Daniel L.			PKC epsilon Promotes HuD-Mediated Neprilysin mRNA Stability NE and Enhances Neprilysin-Induced All Degradation in Brain Neurons	PLOS ONE			English	Article							BETA-DEGRADING ENZYMES; ENDOTHELIN-CONVERTING ENZYME; ALZHEIMERS-DISEASE; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; PEPTIDE; ACTIVATION; PROTEINS; EXPRESSION	Amyloid-beta (A beta) peptide accumulation in the brain is a pathological hallmark of all forms of Alzheimer's disease. An imbalance between A beta production and clearance from the brain may contribute to accumulation of neurotoxic A beta and subsequent synaptic loss, which is the strongest correlate of the extent of memory loss in AD. The activity of neprilysin (NEP), a potent A beta-degrading enzyme, is decreased in the AD brain. Expression of HuD, an mRNA-binding protein important for synaptogenesis and neuronal plasticity, is also decreased in the AD brain. HuD is regulated by protein kinase C epsilon (PKC epsilon), and we previously demonstrated that PKC epsilon activation decreases A beta levels. We hypothesized that PKC epsilon acts through HuD to stabilize NEP mRNA, modulate its localization, and support NEP activity. Conversely, loss of PKC epsilon-activated HuD in AD leads to decreased NEP activity and accumulation of A beta. Here we show that HuD is associated with NEP mRNA in cultures of human SK-N-SH cells. Treatment with bryostatin, a PKC epsilon-selective activator, enhanced NEP association with HuD and increased NEP mRNA stability. Activation of PKC epsilon also increased NEP protein levels, increased NEP phosphorylation, and induced cell surface expression. In addition, specific PKC epsilon activation directly stimulated NEP activity, leading to degradation of a monomeric form of A beta peptide and decreased A beta neuronal toxicity, as measured by cell viability. Bryostatin treatment also rescued A beta-mediated inhibition of HuD-NEP mRNA binding, NEP protein expression, and NEP cell membrane translocation. These results suggest that PKC epsilon activation reduces A beta by up-regulating, via the mRNA-binding protein HuD, A beta-degrading enzymes such as NEP. Thus, PKC epsilon activation may have therapeutic efficacy for AD by reducing neurotoxic A beta accumulation as well as having direct anti-apoptotic and synaptogenic effects.	[Lim, Chol Seung; Alkon, Daniel L.] W Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA	West Virginia University	Lim, CS (corresponding author), W Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA.	clim@brni.org						Amadio M, 2009, J ALZHEIMERS DIS, V16, P409, DOI 10.3233/JAD-2009-0967; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Choi DS, 2006, P NATL ACAD SCI USA, V103, P8215, DOI 10.1073/pnas.0509725103; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; El-Amouri SS, 2007, BRAIN RES, V1152, P191, DOI 10.1016/j.brainres.2007.03.072; Hongpaisan J, 2013, NEUROBIOL DIS, V55, P44, DOI 10.1016/j.nbd.2013.03.012; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kakiya N, 2012, J BIOL CHEM, V287, P29362, DOI 10.1074/jbc.M112.340372; Kasashima K, 1999, GENES CELLS, V4, P667, DOI 10.1046/j.1365-2443.1999.00292.x; Lee W, 2004, MOL CELL NEUROSCI, V26, P222, DOI 10.1016/j.mcn.2003.10.020; LI CW, 1995, METHOD ENZYMOL, V248, P253; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Lim CS, 2005, J NEUROSCI RES, V82, P831, DOI 10.1002/jnr.20692; Longo Frank M, 2004, NeuroRx, V1, P117, DOI 10.1602/neurorx.1.1.117; Malter JS, 2001, J NEUROSCI RES, V66, P311, DOI 10.1002/jnr.10021; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Perrone-Bizzozero Nora, 2013, Front Biosci (Schol Ed), V5, P554; Reilly CE, 2001, J NEUROL, V248, P159; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Siepmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013134; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X	38	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97756	10.1371/journal.pone.0097756	http://dx.doi.org/10.1371/journal.pone.0097756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848988	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600055
J	Nakavachara, P; Pooliam, J; Weerakulwattana, L; Kiattisakthavee, P; Chaichanwattanakul, K; Manorompatarasarn, R; Chokephaibulkit, K; Viprakasit, V				Nakavachara, Pairunyar; Pooliam, Julaporn; Weerakulwattana, Linda; Kiattisakthavee, Pornpimol; Chaichanwattanakul, Katharee; Manorompatarasarn, Racahnee; Chokephaibulkit, Kulkanya; Viprakasit, Vip			A Normal Reference of Bone Mineral Density (BMD) Measured by Dual Energy X-Ray Absorptiometry in Healthy Thai Children and Adolescents Aged 5-18 Years: A New Reference for Southeast Asian Populations	PLOS ONE			English	Article							BETA-THALASSEMIA; GROWTH-HORMONE; CALCIUM INTAKE; LUMBAR SPINE; TOTAL-BODY; MASS; OSTEOPOROSIS; PREVALENCE; ADJUSTMENT; PUBERTY	Ethnic-specific normative data of bone mineral density (BMD) is essential for the accurate interpretation of BMD measurement. There have been previous reports of normative BMD data for Caucasian and Asian children including Japanese, Chinese, Korean and Indian. However, the normative BMD data for Southeast Asian including Thai children and adolescents are not currently available. The goals of our study were 1) to establish normative data of BMD, bone mineral content (BMC), bone area (BA) and lean body mass (LBM) for healthy Thai children and adolescents; aged 5-18 years measured by dual energy X-ray absorptiometry (DXA, Lunar Prodigy) and 2) to evaluate the relationships between BMD vs. age, sex, puberty, weight, height, calcium intake and the age of menarche in our population. Gender and age-specific BMD (L2-4; LS and total body; TB), BMADLS (apparent BMD of the lumbar spine), BMC (L2-4 and total body), BA (L2-4 and total body) and LBM were evaluated in 367 children (174 boys and 193 girls). All parameters increased progressively with age. A rapid increase in BMD, BMC and BMADLS was observed at earlier ages in girls. Gender and Tanner stage-specific BMD normative data were also generated. The dynamic changes of BMD values from childhood to early and late puberty of Thai children appeared to be consistent with those of Caucasian and Asian populations. Using a multiple-regression, weight and Tanner stage significantly affected BMDLS, BMDTB and BMADLS in both genders. Only in girls, height was found to have significant influence on BMDTB and BMADLS. The positive correlation between BMD and several demographic parameters, except the calcium intake, was observed. In summary, we established a normal BMD reference for Thai children and adolescents and this will be of useful for clinicians and researchers to appropriately assess BMD in Thais and other Southeast Asian children.	[Nakavachara, Pairunyar; Weerakulwattana, Linda; Kiattisakthavee, Pornpimol; Chaichanwattanakul, Katharee] Mahidol Univ, Fac Med, Siriraj Hosp, Div Pediat Endocrinol, Bangkok 10700, Thailand; [Pooliam, Julaporn] Mahidol Univ, Fac Med, Siriraj Hosp, Clin Epidemiol Unit,Off Res & Dev, Bangkok 10700, Thailand; [Manorompatarasarn, Racahnee; Chokephaibulkit, Kulkanya] Mahidol Univ, Fac Med, Siriraj Hosp, Div Pediat Infect Dis, Bangkok 10700, Thailand; [Viprakasit, Vip] Mahidol Univ, Fac Med, Siriraj Hosp, Div Pediat Hematol Oncol,Dept Pediat, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Nakavachara, P (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Div Pediat Endocrinol, Bangkok 10700, Thailand.	pairunyar.nak@mahidol.ac.th			Routine to Research (R2R) Grant, Faculty of Medicine Siriraj Hospital, Mahidol University [R2R086/08]	Routine to Research (R2R) Grant, Faculty of Medicine Siriraj Hospital, Mahidol University	This study was funded by Routine to Research (R2R) Grant (R2R086/08), Faculty of Medicine Siriraj Hospital, Mahidol University to PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwis G, 2010, ACTA PAEDIATR, V99, P1091, DOI 10.1111/j.1651-2227.2010.01713.x; Babu US, 2010, MOL NUTR FOOD RES, V54, P1134, DOI 10.1002/mnfr.200900480; Bachrach LK, 2005, ENDOCRIN METAB CLIN, V34, P521, DOI 10.1016/j.ecl.2005.04.001; Baroncelli GI, 1998, J CLIN ENDOCR METAB, V83, P3150, DOI 10.1210/jc.83.9.3150; Boot AM, 1997, J CLIN ENDOCR METAB, V82, P57, DOI 10.1210/jc.82.1.57; Chailurkit LO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-853; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; Crabtree NJ, 2004, BONE, V35, P965, DOI 10.1016/j.bone.2004.06.009; DELRIO LD, 1994, PEDIATR RES, V35, P362, DOI 10.1203/00006450-199403000-00018; Department of Health Ministry of Public Health, 2000, REF WEIGHT HEIGHT NU; Department of Health Ministry of Public Health Thailand, 2001, NUTR VAL THAI FOOD; Fewtrell MS, 2005, BONE, V37, P413, DOI 10.1016/j.bone.2005.04.028; Fewtrell MS, 2003, ARCH DIS CHILD, V9, P22; Gilsanz V, 1998, J CLIN ENDOCR METAB, V83, P1420, DOI 10.1210/jc.83.5.1420; Griffin LM, 2012, PEDIATR NEPHROL, V27, P1139, DOI 10.1007/s00467-012-2116-x; Henderson RC, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e5; Khadilkar AV, 2011, BONE, V48, P810, DOI 10.1016/j.bone.2010.12.013; KROGER H, 1995, BONE, V17, P157, DOI 10.1016/S8756-3282(95)00162-X; Lee SH, 2007, J BONE MINER METAB, V25, P423, DOI 10.1007/s00774-007-0775-7; Mahachoklertwattana P, 2003, CLIN ENDOCRINOL, V58, P273, DOI 10.1046/j.1365-2265.2003.01707.x; MATKOVIC V, 1992, NEW ENGL J MED, V327, P119, DOI 10.1056/NEJM199207093270210; Matsukura T, 2000, OSTEOPOROSIS INT, V11, P858, DOI 10.1007/s001980070045; Maynard LM, 1998, AM J CLIN NUTR, V68, P1111, DOI 10.1093/ajcn/68.5.1111; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; Mazziotti G, 2006, TRENDS ENDOCRIN MET, V17, P144, DOI 10.1016/j.tem.2006.03.009; Molgaard C, 1997, ARCH DIS CHILD, V76, P9, DOI 10.1136/adc.76.1.9; NELSON DA, 1995, J BONE MINER RES, V10, P782; Oldroyd B, 2003, EUR J CLIN NUTR, V57, P977, DOI 10.1038/sj.ejcn.1601633; POLLITZER WS, 1989, AM J CLIN NUTR, V50, P1244, DOI 10.1093/ajcn/50.6.1244; Puthanakit T, 2012, JAIDS-J ACQ IMM DEF, V61, P477, DOI 10.1097/QAI.0b013e31826ea89b; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Rose SR, 2011, PEDIATR BLOOD CANCER, V57, P1034, DOI 10.1002/pbc.22956; SLOOTWEG MC, 1993, HORM METAB RES, V25, P335, DOI 10.1055/s-2007-1002115; Soliman AT, 1998, METABOLISM, V47, P541, DOI 10.1016/S0026-0495(98)90237-2; Wacker W, 2001, ANN M INT SOC CLIN D; Xu H, 2007, J CLIN DENSITOM, V10, P266, DOI 10.1016/j.jocd.2007.05.005; Zemel BS, 2010, J CLIN ENDOCR METAB, V95, P1265, DOI 10.1210/jc.2009-2057; Zhu ZW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-126	38	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97218	10.1371/journal.pone.0097218	http://dx.doi.org/10.1371/journal.pone.0097218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847716	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600024
J	Rundle, CH; Chen, ST; Coen, MJ; Wergedal, JE; Stiffel, V; Lau, KHW				Rundle, Charles H.; Chen, Shin-Tai; Coen, Michael J.; Wergedal, Jon E.; Stiffel, Virginia; Lau, Kin-Hing William			Direct Lentiviral-Cyclooxygenase 2 Application to the Tendon-Bone Interface Promotes Osteointegration and Enhances Return of the Pull-Out Tensile Strength of the Tendon Graft in a Rat Model of Biceps Tenodesis	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; MESENCHYMAL STEM-CELLS; GENE-THERAPY; PATELLAR TENDON; INSERTION SITE; GROWTH-FACTOR; RABBIT MODEL; INDOMETHACIN; CELECOXIB; REGENERATION	This study sought to determine if direct application of the lentiviral (LV)-cyclooxygenase 2 (COX2) vector to the tendon-bone interface would promote osteointegration of the tendon graft in a rat model of biceps tenodesis. The LV-COX2 gene transfer strategy was chosen for investigation because a similar COX2 gene transfer strategy promoted bony bridging of the fracture gap during bone repair, which involves similar histologic transitions that occur in osteointegration. Briefly, a 1.14-mm diameter tunnel was drilled in the mid-groove of the humerus of adult Fischer 344 rats. The LV-COX2 or beta gal control vector was applied directly into the bone tunnel and onto the end of the tendon graft, which was then pulled into the bone tunnel. A poly-L-lactide pin was press-fitted into the tunnel as interference fixation. Animals were sacrificed at 3, 5, or 8 weeks for histology analysis of osteointegration. The LV-COX2 gene transfer strategy enhanced neo-chondrogenesis at the tendon-bone interface but with only marginal effect on de novo bone formation. The tendon-bone interface of the LV-COX2-treated tenodesis showed the well-defined tendon-to-fibrocartilage-to-bone histologic transitions that are indicative of osteointegration of the tendon graft. The LV-COX2 in vivo gene transfer strategy also significantly enhanced angiogenesis at the tendon-bone interface. To determine if the increased osteointegration was translated into an improved pull-out mechanical strength property, the pull-out tensile strength of the LV-COX2-treated tendon grafts was determined with a pull-out mechanical testing assay. The LV-COX2 strategy yielded a significant improvement in the return of the pull-out strength of the tendon graft after 8 weeks. In conclusion, the COX2-based in vivo gene transfer strategy enhanced angiogenesis, osteointegration and improved return of the pull-out strength of the tendon graft. Thus, this strategy has great potential to be developed into an effective therapy to promote tendon-to-bone healing after tenodesis or related surgeries.	[Rundle, Charles H.; Chen, Shin-Tai; Coen, Michael J.; Wergedal, Jon E.; Stiffel, Virginia; Lau, Kin-Hing William] JL Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Rundle, Charles H.; Chen, Shin-Tai; Wergedal, Jon E.; Lau, Kin-Hing William] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; [Chen, Shin-Tai; Wergedal, Jon E.; Lau, Kin-Hing William] Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA; [Coen, Michael J.] Loma Linda Univ, Sch Med, Dept Orthoped Surg, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University	Lau, KHW (corresponding author), JL Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA.	William.Lau@med.va.gov		Lau, Kin-Hing/0000-0003-1109-5052	Veterans Affair Medical Research RR&D Merit Review grant	Veterans Affair Medical Research RR&D Merit Review grant	This work was supported by a Veterans Affair Medical Research RR&D Merit Review grant. The funders (Department of Veterans Affairs) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Bolt P, 2007, J BONE JOINT SURG AM, V89A, P1315, DOI 10.2106/JBJS.F.00257; Busconi BB, 2008, SPORTS MED ARTHROSC, V16, P187, DOI 10.1097/JSA.0b013e318183c134; Campbell BH, 2004, BIOMECH MODEL MECHAN, V2, P239, DOI [10.1007/s10237-004-0041-z, 10.1007/S10237-004-0041-Z]; Coen MJ, 2011, J GENE MED, V13, P511, DOI 10.1002/jgm.1604; COFIELD RH, 1985, J BONE JOINT SURG AM, V67A, P974, DOI 10.2106/00004623-198567060-00024; Cohen DB, 2009, AM J SPORTS MED, V34, P362; COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1; Dimmen S, 2009, J BONE JOINT SURG BR, V91B, P259, DOI 10.1302/0301-620X.91B2.21471; Dimmen S, 2009, KNEE SURG SPORT TR A, V17, P835, DOI 10.1007/s00167-009-0763-7; DINES D, 1982, CLIN ORTHOP RELAT R, P165; Elder CL, 2001, AM J SPORT MED, V29, P801, DOI 10.1177/03635465010290062101; Ferry ST, 2007, AM J SPORT MED, V35, P1326, DOI 10.1177/0363546507301584; Forslund C, 2003, ACTA ORTHOP SCAND, V74, P465, DOI 10.1080/00016470310017802; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Gulotta LV, 2010, AM J SPORT MED, V38, P1429, DOI 10.1177/0363546510361235; Heckman DS, 2010, SPORTS MED ARTHROSC, V18, P173, DOI 10.1097/JSA.0b013e3181e892c1; Hettrich CM, 2012, J ORTHOP RES, V30, P769, DOI 10.1002/jor.22006; Klepps S, 2002, ARTHROSCOPY, V18, P1040, DOI 10.1053/jars.2002.36467; Koch BS, 2012, ARTHROSCOPY, V28, P735, DOI 10.1016/j.arthro.2012.02.019; Lau KHW, 2013, BONE, V53, P369, DOI 10.1016/j.bone.2013.01.003; Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035; Lyras D, 2010, INT ORTHOP, V34, P143, DOI 10.1007/s00264-009-0728-y; Ma Y, 2009, AM J SPORT MED, V37, P599, DOI 10.1177/0363546508325960; Marsolais D, 2003, LAB INVEST, V83, P991, DOI 10.1097/01.LAB.0000078688.07696.AC; Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703; Morrison KD, 2002, HAND CLIN, V18, P169, DOI 10.1016/S0749-0712(02)00009-4; Nakase J, 2010, ARTHROSCOPY, V26, P84, DOI 10.1016/j.arthro.2009.06.029; Nedelec B, 2000, HAND CLIN, V16, P289; Pierre PS, 1995, J BONE JOINT SURG AM, V77A, P1858; Rodeo SA, 1999, AM J SPORT MED, V27, P476, DOI 10.1177/03635465990270041201; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627; Rundle CH, 2008, J GENE MED, V10, P229, DOI 10.1002/jgm.1148; RUSSELL JE, 1989, CONNECT TISSUE RES, V23, P51, DOI 10.3109/03008208909103903; Simon S, 2000, ORTHOPAEDIC BASIC SC, P731; Thomopoulos S, 2003, J ORTHOP RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3; Thomopoulos S, 2002, J ORTHOP RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Tsai WC, 2007, CONNECT TISSUE RES, V48, P46, DOI 10.1080/03008200601071295; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yoshikawa T, 2006, AM J SPORT MED, V34, P1918, DOI 10.1177/0363546506294469; Zhao J, 2011, INT ORTHOP, V35, P925, DOI 10.1007/s00264-010-1157-7	41	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98004	10.1371/journal.pone.0098004	http://dx.doi.org/10.1371/journal.pone.0098004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848992	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600075
J	Sugiyama, N; Murayama, A; Suzuki, R; Watanabe, N; Shiina, M; Liang, TJ; Wakita, T; Kato, T				Sugiyama, Nao; Murayama, Asako; Suzuki, Ryosuke; Watanabe, Noriyuki; Shiina, Masaaki; Liang, T. Jake; Wakita, Takaji; Kato, Takanobu			Single Strain Isolation Method for Cell Culture-Adapted Hepatitis C Virus by End-Point Dilution and Infection	PLOS ONE			English	Article							TRANS-ENCAPSIDATION; MUTATIONS; PROTEIN; IDENTIFICATION; CHIMPANZEES; ADAPTATION; PARTICLES; SYSTEM; RNA; NS3	The hepatitis C virus (HCV) culture system has enabled us to clarify the HCV life cycle and essential host factors for propagation. However, the virus production level of wild-type JFH-1 (JFH-1/wt) is limited, and this leads to difficulties in performing experiments that require higher viral concentrations. As the cell culture-adapted JFH-1 has been reported to have robust virus production, some mutations in the viral genome may play a role in the efficiency of virus production. In this study, we obtained cell culture-adapted virus by passage of full-length JFH-1 RNA-transfected Huh-7.5.1 cells. The obtained virus produced 3 log-fold more progeny viruses as compared with JFH-1/wt. Several mutations were identified as being responsible for robust virus production, but, on reverse-genetics analysis, the production levels of JFH-1 with these mutations did not reach the level of cell culture-adapted virus. By using the single strain isolation method by end-point dilution and infection, we isolated two strains with additional mutations, and found that these strains have the ability to produce more progeny viruses. On reverse-genetics analysis, the strains with these additional mutations were able to produce robust progeny viruses at comparable levels as cell culture-adapted JFH-1 virus. The strategy used in this study will be useful for identifying strains with unique characteristics, such as robust virus production, from a diverse population, and for determining the responsible mutations for these characteristics.	[Sugiyama, Nao; Murayama, Asako; Suzuki, Ryosuke; Watanabe, Noriyuki; Wakita, Takaji; Kato, Takanobu] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Shiina, Masaaki] Shin Yurigaoka Gen Hosp, Dept Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan; [Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kato, T (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	takato@nih.go.jp		Shiina, Masaaki/0000-0002-7807-6844	Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054504, ZIADK054505] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, from the Ministry of Health, Labour and Welfare of Japan, and from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dhillon S, 2010, J VIROL, V84, P5494, DOI 10.1128/JVI.02153-09; Feld JJ, 2006, HEPATOLOGY, V43, pS194, DOI 10.1002/hep.21065; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; Ishii K, 2008, BIOCHEM BIOPH RES CO, V371, P446, DOI 10.1016/j.bbrc.2008.04.110; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055; Kato T, 2008, HEPATOLOGY, V48, P732, DOI 10.1002/hep.22422; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Ma YH, 2011, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10; Matsumura T, 2012, HEPATOLOGY, V56, P1231, DOI 10.1002/hep.25763; Mishima K, 2010, VIROLOGY, V405, P361, DOI 10.1016/j.virol.2010.06.020; Murayama A, 2012, J CLIN MICROBIOL, V50, P1943, DOI 10.1128/JCM.00487-12; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Saeed M, 2011, HEPATOLOGY, V54, P425, DOI 10.1002/hep.24399; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Suzuki R, 2012, VIROLOGY, V432, P29, DOI 10.1016/j.virol.2012.05.033; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	38	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98168	10.1371/journal.pone.0098168	http://dx.doi.org/10.1371/journal.pone.0098168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848954	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600094
J	Arnberg, FK; Linton, SJ; Hultcrantz, M; Heintz, E; Jonsson, U				Arnberg, Filip K.; Linton, Steven J.; Hultcrantz, Monica; Heintz, Emelie; Jonsson, Ulf			Internet-Delivered Psychological Treatments for Mood and Anxiety Disorders: A Systematic Review of Their Efficacy, Safety, and Cost-Effectiveness	PLOS ONE			English	Article							COGNITIVE-BEHAVIOR THERAPY; RANDOMIZED CONTROLLED-TRIAL; SOCIAL PHOBIA; SELF-HELP; PANIC DISORDER; MENTAL-DISORDERS; PRIMARY-CARE; FOLLOW-UP; DEPRESSION; INTERVENTIONS	Background: Greater access to evidence-based psychological treatments is needed. This review aimed to evaluate whether internet-delivered psychological treatments for mood and anxiety disorders are efficacious, noninferior to established treatments, safe, and cost-effective for children, adolescents and adults. Methods: We searched the literature for studies published until March 2013. Randomized controlled trials (RCTs) were considered for the assessment of short-term efficacy and safety and were pooled in meta-analyses. Other designs were also considered for long-term effect and cost-effectiveness. Comparisons against established treatments were evaluated for noninferiority. Two reviewers independently assessed the relevant studies for risk of bias. The quality of the evidence was graded using an international grading system. Results: A total of 52 relevant RCTs were identified whereof 12 were excluded due to high risk of bias. Five cost-effectiveness studies were identified and three were excluded due to high risk of bias. The included trials mainly evaluated internet-delivered cognitive behavioral therapy (I-CBT) against a waiting list in adult volunteers and 88% were conducted in Sweden or Australia. One trial involved children. For adults, the quality of evidence was graded as moderate for the short-term efficacy of I-CBT vs. waiting list for mild/moderate depression (d = 0.83; 95% CI 0.59, 1.07) and social phobia (d = 0.85; 95% CI 0.66, 1.05), and moderate for no efficacy of internet-delivered attention bias modification vs. sham treatment for social phobia (d = 20.04; 95% CI 20.24, 0.35). The quality of evidence was graded as low/very low for other disorders, interventions, children/adolescents, noninferiority, adverse events, and cost-effectiveness. Conclusions: I-CBT is a viable treatment option for adults with depression and some anxiety disorders who request this treatment modality. Important questions remain before broad implementation can be supported. Future research would benefit from prioritizing adapting treatments to children/adolescents and using noninferiority designs with established forms of treatment.	[Arnberg, Filip K.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Linton, Steven J.] Univ Orebro, Dept Law Psychol & Social Work, Ctr Hlth & Med Psychol, SE-70182 Orebro, Sweden; [Hultcrantz, Monica; Heintz, Emelie; Jonsson, Ulf] Swedish Council Hlth Technol Assessment, Stockholm, Sweden; [Heintz, Emelie] Linkoping Univ, Dept Med & Hlth Sci, Ctr Med Technol Assessment CMT, Linkoping, Sweden; [Jonsson, Ulf] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden	Uppsala University; Orebro University; Linkoping University; Karolinska Institutet	Arnberg, FK (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	filip.arnberg@neuro.uu.se	Heintz, Emelie/GYD-4031-2022; Arnberg, Filip/I-5756-2019	Heintz, Emelie/0000-0002-0715-7591; Arnberg, Filip/0000-0002-1317-2093	Swedish Council on Health Technology Assessment	Swedish Council on Health Technology Assessment	This work was funded by the Swedish Council on Health Technology Assessment (www.sbu.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2012, PSYCHOL MED, V42, P2193, DOI 10.1017/S0033291712000244; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P55, DOI 10.1080/16506070902916400; Andersson G, 2013, J MENT HEALTH, V22, P155, DOI 10.3109/09638237.2011.608747; Andersson G, 2012, PSYCHOTHER PSYCHOSOM, V81, P344, DOI 10.1159/000339371; Andersson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037411; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P114, DOI 10.1080/16506070902931326; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Arnberg FK, 2013, J PSYCHOSOM RES, V75, P401, DOI 10.1016/j.jpsychores.2013.08.019; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Barak A, 2008, J TECHNOL HUMAN SERV, V26, P109, DOI 10.1080/15228830802094429; Bell CJ, 2012, AUST NZ J PSYCHIAT, V46, P630, DOI 10.1177/0004867412437345; Berger Thomas, 2011, Cognitive Behaviour Therapy, V40, P251, DOI 10.1080/16506073.2011.616531; Berger T, 2009, J CLIN PSYCHOL, V65, P1021, DOI 10.1002/jclp.20603; Bergstrom J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-54; Boettcher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071760; Boettcher J, 2012, COGNITIVE THER RES, V36, P522, DOI 10.1007/s10608-011-9374-y; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; Carlbring P, 2001, BEHAV THER, V32, P751, DOI 10.1016/S0005-7894(01)80019-8; Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107; Carlbring P, 2006, AM J PSYCHIAT, V163, P2119, DOI 10.1176/appi.ajp.163.12.2119; Carlbring P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-66; Carlbring P, 2013, J AFFECT DISORDERS, V148, P331, DOI 10.1016/j.jad.2012.12.020; Carlbring P, 2011, BEHAV RES THER, V49, P18, DOI 10.1016/j.brat.2010.10.002; Carlbring P, 2009, BEHAV RES THER, V47, P848, DOI 10.1016/j.brat.2009.06.012; Chambless D.L., 1998, CLIN PSYCHOL-UK, V51, P3, DOI 10.1037/e619622010-001; Choi I, 2012, J AFFECT DISORDERS, V136, P459, DOI 10.1016/j.jad.2011.11.003; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collaboration TC, 2014, COCHR ED PUBL POL RE; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Cuijpers P, 2011, AM J PSYCHIAT, V168, P581, DOI 10.1176/appi.ajp.2010.10101411; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; Griffiths KM, 2010, MED J AUSTRALIA, V192, pS4, DOI 10.5694/j.1326-5377.2010.tb03685.x; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hedman E, 2011, BEHAV RES THER, V49, P729, DOI 10.1016/j.brat.2011.07.009; Hedman E, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1776; Hedman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018001; Hey SP, 2013, PERSPECT BIOL MED, V56, P1, DOI 10.1353/pbm.2013.0002; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hollinghurst S, 2010, BRIT J PSYCHIAT, V197, P297, DOI 10.1192/bjp.bp.109.073080; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2000, E10 ICH; James AC, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004690.pub3, 10.1002/14651858.CD004690.pub4]; Johansson R, 2012, EXPERT REV NEUROTHER, V12, P861, DOI [10.1586/ERN.12.63, 10.1586/ern.12.63]; Johansson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036905; Johnston L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028079; Jonsson U, 2014, CONTEMP CLIN TRIALS, V38, P1, DOI 10.1016/j.cct.2014.02.005; Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2010, CURR TOP BEHAV NEURO, V2, P21, DOI 10.1007/7854_2009_9; Kimmelman J, 2009, LANCET, V373, P13, DOI 10.1016/S0140-6736(08)61936-4; Klein B, 2006, J BEHAV THER EXP PSY, V37, P213, DOI 10.1016/j.jbtep.2005.07.001; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; March S, 2009, J PEDIATR PSYCHOL, V34, P474, DOI 10.1093/jpepsy/jsn099; McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; National Institute for Health and Care Excellence, 2013, SOC ANX DIS REC ASS; Neubauer K, 2013, BEHAV RES THER, V51, P87, DOI 10.1016/j.brat.2012.10.006; Newby JM, 2013, PSYCHOL MED, V43, P2635, DOI 10.1017/S0033291713000111; Osenbach JE, 2013, DEPRESS ANXIETY, V30, P1058, DOI 10.1002/da.22165; Palmqvist Bjorn, 2007, Expert Rev Pharmacoecon Outcomes Res, V7, P291, DOI 10.1586/14737167.7.3.291; Paxling Bjorn, 2011, Cognitive Behaviour Therapy, V40, P159, DOI 10.1080/16506073.2011.576699; Peterson AL, 2013, CONTEMP CLIN TRIALS, V34, P152, DOI 10.1016/j.cct.2012.10.009; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; Rothmann MD, 2011, DESIGN ANAL NONINFER; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Shedler J, 2010, AM PSYCHOL, V65, P98, DOI 10.1037/a0018378; Shemilt I, 2010, EVID POLICY, V6, P51, DOI 10.1332/174426410X482999; Sloan Denise M., 2011, Cognitive Behaviour Therapy, V40, P111, DOI 10.1080/16506073.2010.550058; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Spence J, 2011, DEPRESS ANXIETY, V28, P541, DOI 10.1002/da.20835; Stein MB, 2004, AM J PSYCHIAT, V161, P2230, DOI 10.1176/appi.ajp.161.12.2230; Swedish Council on Health Technology Assessment (SBU), 2013, UTV MET HALS SJUKVA; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P595, DOI 10.1080/00048670802119820; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P585, DOI 10.1080/00048670802119762; Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007; Titov N, 2010, BEHAV RES THER, V48, P890, DOI 10.1016/j.brat.2010.05.014; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P905, DOI 10.1080/00048670903179269; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107; Tolin DF, 2010, CLIN PSYCHOL REV, V30, P710, DOI 10.1016/j.cpr.2010.05.003; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005; WHO, 2018, INT STAT CLASS DIS R; Wims E, 2010, AUST NZ J PSYCHIAT, V44, P599, DOI 10.3109/00048671003614171; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	97	204	207	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98118	10.1371/journal.pone.0098118	http://dx.doi.org/10.1371/journal.pone.0098118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844847	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400097
J	Bode, M; Kreiner, A; van der Plas, AK; Louw, DC; Horaeb, R; Auel, H; Hagen, W				Bode, Maya; Kreiner, Anja; van der Plas, Anja K.; Louw, Deon C.; Horaeb, Richard; Auel, Holger; Hagen, Wilhelm			Spatio-Temporal Variability of Copepod Abundance along the 20 degrees S Monitoring Transect in the Northern Benguela Upwelling System from 2005 to 2011	PLOS ONE			English	Article							CALANOIDES-CARINATUS; COMMUNITY STRUCTURE; CALANUS-CHILENSIS; HUMBOLDT CURRENT; CURRENT REGION; ZOOPLANKTON; ECOSYSTEM; DYNAMICS; MESOZOOPLANKTON; CALIFORNIA	Long-term data sets are essential to understand climate-induced variability in marine ecosystems. This study provides the first comprehensive analysis of longer-term temporal and spatial variations in zooplankton abundance and copepod community structure in the northern Benguela upwelling system from 2005 to 2011. Samples were collected from the upper 200 m along a transect at 20 degrees S perpendicular to the coast of Namibia to 70 nm offshore. Based on seasonal and interannual trends in surface temperature and salinity, three distinct time periods were discernible with stronger upwelling in spring and extensive warm-water intrusions in late summer, thus, high temperature amplitudes, in the years 2005/06 and 2010/11, and less intensive upwelling followed by weaker warm-water intrusions from 2008/09 to 2009/10. Zooplankton abundance reflected these changes with higher numbers in 2005/06 and 2010/11. In contrast, zooplankton density was lower in 2008/09 and 2009/10, when temperature gradients from spring to late summer were less pronounced. Spatially, copepod abundance tended to be highest between 30 and 60 nautical miles off the coast, coinciding with the shelf break and continental slope. The dominant larger calanoid copepods were Calanoides carinatus, Metridia lucens and Nannocalanus minor. On all three scales studied, i.e. spatially from the coast to offshore waters as well as temporally, both seasonally and interannually, maximum zooplankton abundance was not coupled to the coldest temperature regime, and hence strongest upwelling intensity. Pronounced temperature amplitudes, and therefore strong gradients within a year, were apparently important and resulted in higher zooplankton abundance.	[Bode, Maya; Auel, Holger; Hagen, Wilhelm] Univ Bremen, BreMarE Bremen Marine Ecol, D-28359 Bremen, Germany; [Kreiner, Anja; van der Plas, Anja K.; Louw, Deon C.; Horaeb, Richard] Natl Marine Informat & Res Ctr NatMIRC, Swakopmund, Namibia	University of Bremen	Bode, M (corresponding author), Univ Bremen, BreMarE Bremen Marine Ecol, D-28359 Bremen, Germany.	mabode@uni-bremen.de		Hagen, Wilhelm/0000-0002-7462-9931	German Federal Ministry of Education and Research (BMBF) [03F0650E]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study is embedded in the GENUS project (03F0650E), which is funded by the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barange M, 1989, COLLN SCI PAP INT CO, V16, P31; BOYD AJ, 1987, S AFR J MARINE SCI, V5, P107, DOI 10.2989/025776187784522577; Boyer D, 2000, MAR POLLUT BULL, V41, P123, DOI 10.1016/S0025-326X(00)00106-5; Brenning U., 1985, BEITR MEERESKD, V52, P3; BROWN PC, 1991, S AFR J MARINE SCI, V11, P537, DOI 10.2989/025776191784287673; CRAWFORD RJM, 1987, OCEANOGR MAR BIOL, V25, P353; Escribano R, 2000, J MAR BIOL ASSOC UK, V80, P283, DOI 10.1017/S002531549900185X; Escribano R, 1998, FISH OCEANOGR, V7, P245, DOI 10.1046/j.1365-2419.1998.00078.x; Hansen FC, 2005, AFR J MAR SCI, V27, P55, DOI 10.2989/18142320509504068; Heileman S, 2008, UNEP LARGE MARINE EC, V182, P100; Hidalgo P, 2007, PROG OCEANOGR, V75, P501, DOI 10.1016/j.pocean.2007.08.028; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Hutchings L, 2006, LARGE MARINE ECOSYST; Kollmer WE, 1963, PILCHARD S W AFRICA; Lass HU, 2000, J PHYS OCEANOGR, V30, P2589, DOI 10.1175/1520-0485(2000)030<2589:HACMIT>2.0.CO;2; LONGHURST AR, 1985, PROG OCEANOGR, V15, P1, DOI 10.1016/0079-6611(85)90036-9; Mohrholz V, 2008, CONT SHELF RES, V28, P424, DOI 10.1016/j.csr.2007.10.001; Monteiro P. M. S., 2010, CARBON NUTR FLUXES C, P65; Morgan CA, 2003, MAR ECOL PROG SER, V249, P223, DOI 10.3354/meps249223; O'Toole MJ, 1980, INVESTL REP SEA FISH, P121; OLIVAR MP, 1990, J PLANKTON RES, V12, P1023, DOI 10.1093/plankt/12.5.1023; PETERSON WT, 1988, PROG OCEANOGR, V20, P1, DOI 10.1016/0079-6611(88)90052-3; POSTEL L, 1995, HELGOLANDER MEERESUN, V49, P829, DOI 10.1007/BF02368406; Rebstock GA, 2002, GLOBAL CHANGE BIOL, V8, P71, DOI 10.1046/j.1365-2486.2002.00456.x; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Schlitzer R, 2013, OCEAN DATA VIEW, V4; SHANNON LV, 1987, S AFR J MARINE SCI, V5, P11, DOI 10.2989/025776187784522261; SHANNON LV, 1992, S AFR J MARINE SCI, V12, P271; Shannon LV, 2003, LARGE MARINE ECOSYST; Shannon LV, 1986, OCEANOGRAPHY MARINE, P65; Shannon V, 2006, LAR MAR ECOSYST, V14, P1; Stander GH, 1964, BENGUELA CURRENT S W; Stander GH, 1962, PILCHARD S W AFRICA; Stander GH, 1969, INVESTIGATIONAL REPO, V81, P46; Timonin A.G., 1993, Russian Journal of Aquatic Ecology, V1, P103; TIMONIN AG, 1992, S AFR J MARINE SCI, V12, P545; Timonin AG, 1991, OCEANOLOGY, V31, P181; Unteruberbacher HK, 1964, 11 INV REP MAR RES L, V11; Verheye HM, 1998, S AFR J MARINE SCI, V19, P317; VERHEYE HM, 1991, PROG OCEANOGR, V28, P91, DOI 10.1016/0079-6611(91)90022-E; VERHEYE HM, 1992, S AFR J MARINE SCI, V12, P561	41	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97738	10.1371/journal.pone.0097738	http://dx.doi.org/10.1371/journal.pone.0097738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844305	Green Submitted, gold, Green Published			2022-12-27	WOS:000339563400053
J	Imamura, K; Kawakami, N; Furukawa, TA; Matsuyama, Y; Shimazu, A; Umanodan, R; Kawakami, S; Kasai, K				Imamura, Kotaro; Kawakami, Norito; Furukawa, Toshi A.; Matsuyama, Yutaka; Shimazu, Akihito; Umanodan, Rino; Kawakami, Sonoko; Kasai, Kiyoto			Effects of an Internet-Based Cognitive Behavioral Therapy (iCBT) Program in Manga Format on Improving Subthreshold Depressive Symptoms among Healthy Workers: A Randomized Controlled Trial	PLOS ONE			English	Article							SELF-HELP; PSYCHOLOGICAL TREATMENTS; OVERCOMING DEPRESSION; JAPANESE VERSION; MENTAL-HEALTH; STRESS; DISORDERS; ANXIETY; MOOD; INTERVENTIONS	Objective: The purpose of this study was to develop a new Internet-based computerized cognitive behavior therapy (iCBT) program in Manga format, the Japanese cartoon, for workers and to examine the effects of the iCBT program on improving subthreshold depression using a randomized controlled trial (RCT) design among workers employed in private companies in Japan. Method: All workers in a company (n = 290) and all workers in three departments (n = 1,500) at the headquarters of another large company were recruited by an invitation e-mail. Participants who fulfilled the inclusion criteria were randomly allocated to intervention or control groups (N = 381 for each group). A six-week, six-lesson iCBT program using Manga (Japanese comic) story was developed. The program included several CBT skills: self-monitoring, cognitive restructuring, assertiveness, problem solving, and relaxation. The intervention group studied the iCBT program at a frequency of one lesson per week. Depression (Beck Depression Inventory II; BDI-II) was assessed as a primary outcome at baseline, and three- and six-month follow-ups for both intervention and control groups were performed. Results: The iCBT program showed a significant intervention effect on BDI-II (t = -1.99, p < 0.05) with small effect sizes (Cohen's d: -0.16, 95% Confidence Interval: -0.32 to 0.00, at six-month follow-up). Conclusions: The present study first demonstrated that a computerized cognitive behavior therapy delivered via the Internet was effective in improving depression in the general working population. It seems critical to improve program involvement of participants in order to enhance the effect size of an iCBT program.	[Imamura, Kotaro; Kawakami, Norito; Shimazu, Akihito] Univ Tokyo, Dept Mental Hlth, Grad Sch Med, Tokyo, Japan; [Furukawa, Toshi A.] Kyoto Univ, Dept Hlth Promot & Human Behav, Grad Sch Med, Sch Publ Hlth, Kyoto, Japan; [Furukawa, Toshi A.] Kyoto Univ, Dept Clin Epidemiol, Grad Sch Med, Sch Publ Hlth, Kyoto, Japan; [Matsuyama, Yutaka] Univ Tokyo, Dept Biostat, Grad Sch Med, Tokyo, Japan; [Umanodan, Rino] Hlth Wave Co Ltd, Kyoto Off, Kyoto, Japan; [Kawakami, Sonoko] Nippon Univ, Coll Arts, Tokyo, Japan; [Kasai, Kiyoto] Univ Tokyo, Dept Neuropsychiat, Grad Sch Med, Tokyo, Japan	University of Tokyo; Kyoto University; Kyoto University; University of Tokyo; Nihon University; University of Tokyo	Kawakami, N (corresponding author), Univ Tokyo, Dept Mental Hlth, Grad Sch Med, Tokyo, Japan.	nkawakami@m.u-tokyo.ac.jp	Furukawa, Toshi A./B-9259-2011	Furukawa, Toshi A./0000-0003-2159-3776; Kasai, Kiyoto/0000-0002-4443-4535	Ministry of Education, Culture, Sports, Science and Technology, Japan [20240062]; Grants-in-Aid for Scientific Research [25293150] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by a Grant-in-Aid for Scientific Research (A) 2009 and 2010 (No. 20240062) obtained from the Ministry of Education, Culture, Sports, Science and Technology, Japan. http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Beck A, 1979, COGNITIVE THERAPY DE; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, V6; Beck AT, 1967, DEPRESSION CLIN EXPT, Vxiv; Billings DW, 2008, J OCCUP ENVIRON MED, V50, P960, DOI 10.1097/JOM.0b013e31816c435b; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Clarke G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.3.e14; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P434, DOI 10.1111/j.1600-0447.2007.00998.x; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Delp C, 1996, ACAD EMERG MED, V3, P264, DOI 10.1111/j.1553-2712.1996.tb03431.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gega L, 2004, J CLIN PSYCHOL, V60, P147, DOI 10.1002/jclp.10241; Grime PR, 2004, OCCUP MED-OXFORD, V54, P353, DOI 10.1093/occmed/kqh077; Hiroe T, 2005, PSYCHIAT RES, V135, P229, DOI 10.1016/j.psychres.2004.03.014; Hutchinson KH, 1949, J EDUC SOCIOL, V23, P236, DOI 10.2307/2264559; Jakobsen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028299; Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kishi Y, 2011, HEALTH COMMUN, V26, P676, DOI 10.1080/10410236.2011.563352; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Limm H, 2011, OCCUP ENVIRON MED, V68, P126, DOI 10.1136/oem.2009.054148; McDermott T J, 1989, J Biocommun, V16, P20; Morgan AJ, 2012, BRIT J PSYCHIAT, V200, P412, DOI 10.1192/bjp.bp.111.101394; Peters L, 1998, PSYCHOL MED, V28, P893, DOI 10.1017/S0033291798006655; POWER MJ, 1994, J RES PERS, V28, P263, DOI 10.1006/jrpe.1994.1019; Richardson KM, 2008, J OCCUP HEALTH PSYCH, V13, P69, DOI 10.1037/1076-8998.13.1.69; Ruwaard Jeroen, 2007, Cognitive Behaviour Therapy, V36, P179, DOI 10.1080/16506070701381863; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Sones WWD, 1944, J EDUC SOCIOL, V18, P232, DOI 10.2307/2262696; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Spurgeon JA, 2010, CURR PSYCHIAT REP, V12, P547, DOI 10.1007/s11920-010-0152-4; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Tajima M, 2007, ACTA NEUROPSYCHIATR, V19, P362, DOI 10.1111/j.1601-5215.2007.00203.x; Titov N, 2010, F1000 MED REP; van der Klink JJL, 2001, AM J PUBLIC HEALTH, V91, P270, DOI 10.2105/AJPH.91.2.270; Wantland DJ, 2004, J MED INTERNET RES, V6, P67; WHO, 2001, ATL MENT HLTH RES WO; WHO, 2020, MENT HLTH ATL 2011; World Health Organization, 2005, MENT HLTH ATL; Wright JH, 2005, AM J PSYCHIAT, V162, P1158, DOI 10.1176/appi.ajp.162.6.1158	44	56	56	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97167	10.1371/journal.pone.0097167	http://dx.doi.org/10.1371/journal.pone.0097167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844530	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400014
J	Xu, SZ; Lin, XJ; Tong, X; Wang, XW				Xu, San-Zhong; Lin, Xiang-Jin; Tong, Xiang; Wang, Xuan-Wei			Minimally Invasive Midvastus versus Standard Parapatellar Approach in Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							MEDIAL PARAPATELLAR; MINI-MIDVASTUS; PATELLAR TRACKING; REPLACEMENT; OUTCOMES; STRENGTH; VASTUS	Objective: Minimally invasive midvastus approach (mini-midvastus) has been widely used in total knee arthroplasty (TKA). However, the clinical effects still remains controversial. This meta-analysis was based on randomized controlled trials (RCTs) aiming to quantitatively analyze the clinical efficacy of mini-midvastus versus standard parapatellar approach in TKA. Methods: This meta-analysis was performed according to the PRISMA guidelines. A literature search for the eligible RCTs was carried out in the databases of PubMed, the Cochrane library, EMBASE and Web of Science. Two independent reviewers independently completed the study selection, data extraction, and the assessment of methodological quality. Meta-analysis was conducted by the RevMan 5.2 software. Results: A total of 18 RCTs (937 patients with 1093 TKAs) published from 2007 to 2013 were included. The meta-analysis suggested that the mini-midvastus approach significantly improved knee range of motion (ROM) and decreased visual analog score (VAS) at postoperative 1-2 weeks (p<0.05), and there were no statistical differences in terms of knee society score (KSS) (6 weeks to 1 year), VAS (6 weeks to 6 months), ROM (6 weeks to 6 months), lateral retinacular release, blood loss, straight leg raise, hospital stay and postoperative complications between the mini-midvastus and standard parapatellar approach (p>0.05). However, the operative time was significantly longer when performing the mini-midvastus group than the parapartellar approach (p<0.05). Conclusion: This meta-analysis found that compared with the standard parapatellar approach, the mini-midvastus approach had early advantages in the VAS and ROM, but had the disadvantage in the operative time.	[Xu, San-Zhong; Lin, Xiang-Jin; Tong, Xiang; Wang, Xuan-Wei] Zhejiang Univ, Dept Orthopaed, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Lin, XJ (corresponding author), Zhejiang Univ, Dept Orthopaed, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	xuszzju@126.com		Xu, Sanzhong/0000-0002-1881-2723				Adams J, 2012, J BONE JOINT SURG BR, V94B, P1305, DOI 10.1302/0301-620X.94B10.29035; Alcelik I, 2012, KNEE, V19, P229, DOI 10.1016/j.knee.2011.07.010; Alshryda S, 2011, J BONE JOINT SURG BR, V93B, P1577, DOI 10.1302/0301-620X.93B12.26989; Bathis H, 2005, KNEE SURG SPORT TR A, V13, P545, DOI 10.1007/s00167-004-0574-9; Chang CH, 2010, KNEE SURG SPORT TR A, V18, P934, DOI 10.1007/s00167-010-1066-8; Chin PL, 2007, J ARTHROPLASTY, V22, P800, DOI 10.1016/j.arth.2006.10.009; Cho KY, 2014, KNEE SURG SPORT TR A, V22, P1759, DOI 10.1007/s00167-013-2556-2; Costa CR, 2013, J KNEE SURG, V26, P41, DOI 10.1055/s-0032-1313751; Dalury DF, 2008, J ARTHROPLASTY, V23, P136, DOI 10.1016/j.arth.2007.01.020; Dalury DF, 1999, J ARTHROPLASTY, V14, P33, DOI 10.1016/S0883-5403(99)90199-7; [Fu Peiliang 符培亮], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P1793; Granchi D, 2012, J BONE JOINT SURG BR, V94B, P1126, DOI 10.1302/0301-620X.94B8.28135; Guy SP, 2012, KNEE, V19, P866, DOI 10.1016/j.knee.2012.04.009; Heekin RD, 2014, J ARTHROPLASTY, V29, P339, DOI 10.1016/j.arth.2013.05.016; Hernandez-Vaquero D, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-27; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Juosponis R, 2009, INT ORTHOP, V33, P1233, DOI 10.1007/s00264-008-0630-z; Karachalios T, 2008, J BONE JOINT SURG BR, V90B, P584, DOI 10.1302/0301-620X.90B5.20122; Karpman RR, 2009, J ARTHROPLASTY, V24, P681, DOI 10.1016/j.arth.2008.03.011; Keating EM, 1999, J ARTHROPLASTY, V14, P29, DOI 10.1016/S0883-5403(99)90198-5; Kelly MJ, 2006, J BONE JOINT SURG AM, V88A, P715, DOI 10.2106/JBJS.E.00107; Kim JG, 2011, KNEE, V18, P443, DOI 10.1016/j.knee.2010.08.008; Kolisek FR, 2007, J ARTHROPLASTY, V22, P8, DOI 10.1016/j.arth.2006.06.004; Lee DH, 2011, KNEE SURG SPORT TR A, V19, P66, DOI 10.1007/s00167-010-1130-4; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nestor BJ, 2010, J ARTHROPLASTY, V25, P5, DOI 10.1016/j.arth.2010.04.003; Ozkoc G, 2005, KNEE SURG SPORT TR A, V13, P654, DOI 10.1007/s00167-004-0605-6; Pongcharoen B, 2013, CLIN ORTHOP RELAT R, V471, P1654, DOI 10.1007/s11999-012-2778-5; Varela-Egocheaga JR, 2010, CLIN ORTHOP RELAT R, V468, P1200, DOI 10.1007/s11999-009-1160-8; Tria Alfred J Jr, 2007, Am J Orthop (Belle Mead NJ), V36, P6; Varnell Michelle S, 2011, J Knee Surg, V24, P117; Walter F, 2007, J ARTHROPLASTY, V22, P509, DOI 10.1016/j.arth.2006.06.015; Wegrzyn J, 2013, CLIN ORTHOP RELAT R, V471, P46, DOI 10.1007/s11999-012-2486-1; Yin ZG, 2012, J BONE JOINT SURG BR, V94B, P1077, DOI 10.1302/0301-620X.94B8.28998; Zhang ZX, 2013, ARCH ORTHOP TRAUM SU, V133, P389, DOI 10.1007/s00402-012-1645-x	36	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e95311	10.1371/journal.pone.0095311	http://dx.doi.org/10.1371/journal.pone.0095311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845859	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400003
J	Butler, CL; Lucas, O; Wuchty, S; Xue, B; Uversky, VN; White, M				Butler, Carrie L.; Lucas, Olivier; Wuchty, Stefan; Xue, Bin; Uversky, Vladimir N.; White, Michael			Identifying Novel Cell Cycle Proteins in Apicomplexa Parasites through Co-Expression Decision Analysis	PLOS ONE			English	Article							TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; FUNCTIONAL-ANALYSIS; INTRINSIC DISORDER; MALARIA; REVEALS; SEQUENCE; GENES; IDENTIFICATION; CYTOSKELETON	Hypothetical proteins comprise roughly half of the predicted gene complement of Toxoplasma gondii and Plasmodium falciparum and represent the largest class of uniquely functioning proteins in these parasites. Following the idea that functional relationships can be informed by the timing of gene expression, we devised a strategy to identify the core set of apicomplexan cell division cycling genes with important roles in parasite division, which includes many uncharacterized proteins. We assembled an expanded list of orthologs from the T. gondii and P. falciparum genome sequences (2781 putative orthologs), compared their mRNA profiles during synchronous replication, and sorted the resulting set of dual cell cycle regulated orthologs (744 total) into protein pairs conserved across many eukaryotic families versus those unique to the Apicomplexa. The analysis identified more than 100 ortholog gene pairs with unknown function in T. gondii and P. falciparum that displayed co-conserved mRNA abundance, dynamics of cyclical expression and similar peak timing that spanned the complete division cycle in each parasite. The unknown cyclical mRNAs encoded a diverse set of proteins with a wide range of mass and showed a remarkable conservation in the internal organization of ordered versus disordered structural domains. A representative sample of cyclical unknown genes (16 total) was epitope tagged in T. gondii tachyzoites yielding the discovery of new protein constituents of the parasite inner membrane complex, key mitotic structures and invasion organelles. These results demonstrate the utility of using gene expression timing and dynamic profile to identify proteins with unique roles in Apicomplexa biology.	[Butler, Carrie L.; Lucas, Olivier; Xue, Bin; Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [White, Michael] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA; [White, Michael] Univ S Florida, Florida Ctr Drug Discovery & Innovat, Tampa, FL USA; [Wuchty, Stefan] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA	White, M (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.	mwhite.usf@gmail.com	Uversky, Vladimir N./F-4515-2011; xue, bin/E-5617-2011	Uversky, Vladimir N./0000-0002-4037-5857; xue, bin/0000-0002-6344-0623	National Institutes of Health [R01-AI077662, R01-AI089885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089885, R01AI077662, R01AI109843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health to MWW (R01-AI077662 and R01-AI089885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Anderson-White B, 2012, INT REV CEL MOL BIO, V298, P1, DOI 10.1016/B978-0-12-394309-5.00001-8; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; ARNOT DE, 1998, ANN TROP MED PARASIT, V92, P361; Balu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013282; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brehelin L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-35; Brehelin L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-440; Camejo A, 2013, INT J PARASITOLOGY; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; DeBarry JD, 2011, MOL BIOL EVOL, V28, P2855, DOI 10.1093/molbev/msr103; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; DUBREMETZ JF, 1993, PARASITOL RES, V79, P402, DOI 10.1007/BF00931830; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Francia ME, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001444; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilk SD, 2006, EUKARYOT CELL, V5, P1622, DOI 10.1128/EC.00114-06; Gubbels MJ, 2008, INT J PARASITOL, V38, P1343, DOI 10.1016/j.ijpara.2008.06.004; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Huang F, 2012, BIOCOMPUT-PAC SYM, P128; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Hyman RW, 2002, NATURE, V419, P534, DOI 10.1038/nature01102; Jacot D, 2012, INT J MED MICROBIOL, V302, P195, DOI 10.1016/j.ijmm.2012.07.012; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lorestani A, 2012, CYTOSKELETON, V69, P1069, DOI 10.1002/cm.21077; Lu Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r146; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Radke JR, 1998, MOL BIOCHEM PARASIT, V94, P237, DOI 10.1016/S0166-6851(98)00074-7; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Sims PFG, 2006, EXPERT REV PROTEOMIC, V3, P87, DOI 10.1586/14789450.3.1.87; Sivashankari S, 2006, BIOINFORMATION, V1, P335, DOI 10.6026/97320630001335; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Suvorova ES, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003305; Tedder PMR, 2010, BIOINFORMATICS, V26, P2431, DOI 10.1093/bioinformatics/btq450; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Toth-Petroczy A, 2008, OPEN PROTEOM J, V1, P46, DOI [10.2174/1875039700801010046, DOI 10.2174/1875039700801010046]; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Walhout AJM, 2000, YEAST, V17, P88, DOI 10.1002/1097-0061(20000630)17:2<88::AID-YEA20>3.0.CO;2-Y; Weiss LM, 2009, EXPERT REV PROTEOMIC, V6, P303, DOI [10.1586/epr.09.16, 10.1586/EPR.09.16]; Williams Robert W, 2013, Intrinsically Disord Proteins, V1, pe25724, DOI 10.4161/idp.25724; Xue B, 2013, BBA-PROTEINS PROTEOM, V1834, P725, DOI 10.1016/j.bbapap.2013.01.012; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145	66	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97625	10.1371/journal.pone.0097625	http://dx.doi.org/10.1371/journal.pone.0097625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841368	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600052
J	Fujimichi, Y; Hamada, N				Fujimichi, Yuki; Hamada, Nobuyuki			Ionizing Irradiation Not Only Inactivates Clonogenic Potential in Primary Normal Human Diploid Lens Epithelial Cells but Also Stimulates Cell Proliferation in a Subset of This Population	PLOS ONE			English	Article							PARTIALLY SHIELDED LENS; X-RAYS; CATARACT-SURGERY; STEM-CELLS; RADIATION; DIFFERENTIATION; SENESCENCE; APOPTOSIS; SURVIVAL	Over the past century, ionizing radiation has been known to induce cataracts in the crystalline lens of the eye, but its mechanistic underpinnings remain incompletely understood. This study is the first to report the clonogenic survival of irradiated primary normal human lens epithelial cells and stimulation of its proliferation. Here we used two primary normal human cell strains: HLEC1 lens epithelial cells and WI-38 lung fibroblasts. Both strains were diploid, and a replicative lifespan was shorter in HLEC1 cells. The colony formation assay demonstrated that the clonogenic survival of both strains decreases similarly with increasing doses of X-rays. A difference in the survival between two strains was actually insignificant, although HLEC1 cells had the lower plating efficiency. This indicates that the same dose inactivates the same fraction of clonogenic cells in both strains. Intriguingly, irradiation enlarged the size of clonogenic colonies arising from HLEC1 cells in marked contrast to those from WI-38 cells. Such enhanced proliferation of clonogenic HLEC1 cells was significant at >= 2 Gy, and manifested as increments of <= 2.6 population doublings besides sham-irradiated controls. These results suggest that irradiation of HLEC1 cells not only inactivates clonogenic potential but also stimulates proliferation of surviving uniactivated clonogenic cells. Given that the lens is a closed system, the stimulated proliferation of lens epithelial cells may not be a homeostatic mechanism to compensate for their cell loss, but rather should be regarded as abnormal. This is because these findings are consistent with the early in vivo evidence documenting that irradiation induces excessive proliferation of rabbit lens epithelial cells and that suppression of lens epithelial cell divisions inhibits radiation cataractogenesis in frogs and rats. Thus, our in vitro model will be useful to evaluate the excessive proliferation of primary normal human lens epithelial cells that may underlie radiation cataractogenesis, warranting further investigations.	[Fujimichi, Yuki; Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Nucl Technol Res Lab, Radiat Safety Res Ctr, Komae, Tokyo 201, Japan	Central Research Institute of Electric Power Industry - Japan	Hamada, N (corresponding author), Cent Res Inst Elect Power Ind, Nucl Technol Res Lab, Radiat Safety Res Ctr, 2-11-1 Iwato Kita, Komae, Tokyo 201, Japan.	hamada-n@criepi.denken.or.jp		Hamada, Nobuyuki/0000-0003-2518-6131				ALTER AJ, 1953, AMA ARCH OPHTHALMOL, V49, P257, DOI 10.1001/archopht.1953.00920020264002; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; [Anonymous], 1980, BRIT J RADIOL, V53, P816; [Anonymous], 1984, Ann ICRP, V14, P1; [Anonymous], 1955, J Radiol Electrol Arch Electr Medicale, V36, P1; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; BROWN N, 1974, T OPHTHAL SOC UK, V94, P29; Clement Christopher, 2012, Ann ICRP, V41, P1, DOI 10.1016/j.icrp.2012.06.009; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Endlich B, 2000, RADIAT RES, V153, P36, DOI 10.1667/0033-7587(2000)153[0036:CVTLMS]2.0.CO;2; Goldmann H, 1938, A VONGRAEFES ARCH OP, V138, P722; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; Hamada N, 2008, MUTAT RES-FUND MOL M, V637, P190, DOI 10.1016/j.mrfmmm.2007.07.002; Hamada N, 2006, RADIAT RES, V166, P24, DOI 10.1667/RR3579.1; Hamada N, 2014, J RADIAT RES, V55, P831, DOI 10.1093/jrr/rru036; Hamada N, 2014, J RADIAT RES, V55, P629, DOI 10.1093/jrr/rru019; Hamada N, 2014, RADIAT RES, V181, P9, DOI 10.1667/RR13505.1; HAYDEN JH, 1980, EXPERIENTIA, V36, P116, DOI 10.1007/BF02004009; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; ICRP, 1969, ICRP PUBL, V14; Jinno-Oue A, 2010, INT J RADIAT ONCOL, V76, P229, DOI 10.1016/j.ijrobp.2009.08.054; LEINFELDER PJ, 1956, ARCH OPHTHALMOL-CHIC, V55, P84; MERRIAM GR, 1957, AMER J ROENTGENOL RA, V77, P759; Minamoto A, 2004, INT J RADIAT BIOL, V80, P339, DOI 10.1080/09553000410001680332; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Nakashima E, 2006, HEALTH PHYS, V90, P154, DOI 10.1097/01.HP.0000175442.03596.63; Neriishi K, 2012, RADIOLOGY, V265, P167, DOI 10.1148/radiol.12111947; Oka M, 2010, MOL VIS, V16, P945; Osman IM, 2011, BRIT J OPHTHALMOL, V95, P227, DOI 10.1136/bjo.2009.173401; PIRIE A, 1957, ARCH OPHTHALMOL-CHIC, V57, P849; PIRIE A, 1959, INT J RADIAT BIOL RE, V1, P293, DOI 10.1080/09553005914550391; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; ROTHSTEIN H, 1982, OPHTHALMIC RES, V14, P215, DOI 10.1159/000265195; Sakashita T, 2014, J RADIAT RES, V55, P423, DOI 10.1093/jrr/rrt129; Sakashita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070291; VONSALLMANN L, 1953, AMA ARCH OPHTHALMOL, V50, P727; VONSALLMANN L, 1955, ARCH OPHTHALMOL-CHIC, V54, P489; VONSALLMANN L, 1950, T AM OPHTHAL SOC, V48, P228; Wadman M, 2013, NATURE, V498, P422, DOI 10.1038/498422a; Wiley LA, 2011, DIS MODEL MECH, V4, P484, DOI 10.1242/dmm.006593; Woraul BV, 2007, RADIAT RES, V167, P233, DOI 10.1667/RR0298.1; Worgul B. V., 1975, OPHTHAL RES, V7, P21; WORGUL BV, 1976, ARCH OPHTHALMOL-CHIC, V94, P996, DOI 10.1001/archopht.1976.03910030506013; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Yamauchi M, 2014, J RADIAT RES, V55, P381, DOI 10.1093/jrr/rrt123; Yang CB, 2010, FASEB J, V24, P3274, DOI 10.1096/fj.10-157255	48	29	29	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98154	10.1371/journal.pone.0098154	http://dx.doi.org/10.1371/journal.pone.0098154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840866	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600110
J	Howard, TD; Mathias, RA; Seeds, MC; Herrington, DM; Hixson, JE; Shimmin, LC; Hawkins, GA; Sellers, M; Ainsworth, HC; Sergeant, S; Miller, LR; Chilton, FH				Howard, Timothy D.; Mathias, Rasika A.; Seeds, Michael C.; Herrington, David M.; Hixson, James E.; Shimmin, Lawrence C.; Hawkins, Greg A.; Sellers, Matthew; Ainsworth, Hannah C.; Sergeant, Susan; Miller, Leslie R.; Chilton, Floyd H.			DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver	PLOS ONE			English	Article							AFRICAN-AMERICANS; ACID-METABOLISM; LOCI; VARIANTS; DISEASES; IMPACT; RISK	Levels of omega-6 (n-6) and omega-3 (n-3), long chain polyunsaturated fatty acids (LcPUFAs) such as arachidonic acid (AA; 20:4, n-6), eicosapentaenoic acid (EPA; 20: 5, n-3) and docosahexaenoic acid (DHA; 22: 6, n-3) impact a wide range of biological activities, including immune signaling, inflammation, and brain development and function. Two desaturase steps (Delta 6, encoded by FADS2 and Delta 5, encoded by FADS1) are rate limiting in the conversion of dietary essential 18 carbon PUFAs (18C-PUFAs) such as LA (18: 2, n-6) to AA and a-linolenic acid (ALA, 18: 3, n-3) to EPA and DHA. GWAS and candidate gene studies have consistently identified genetic variants within FADS1 and FADS2 as determinants of desaturase efficiencies and levels of LcPUFAs in circulating, cellular and breast milk lipids. Importantly, these same variants are documented determinants of important cardiovascular disease risk factors (total, LDL, and HDL cholesterol, triglycerides, CRP and proinflammatory eicosanoids). FADS1 and FADS2 lie head-to-head (5' to 5') in a cluster configuration on chromosome 11 (11q12.2). There is considerable linkage disequilibrium (LD) in this region, where multiple SNPs display association with LcPUFA levels. For instance, rs174537, located similar to 15 kb downstream of FADS1, is associated with both FADS1 desaturase activity and with circulating AA levels (p-value for AA levels = 5.95X10(-46)) in humans. To determine if DNA methylation variation impacts FADS activities, we performed genome-wide allele-specific methylation (ASM) with rs174537 in 144 human liver samples. This approach identified highly significant ASM with CpG sites between FADS1 and FADS2 in a putative enhancer signature region, leading to the hypothesis that the phenotypic associations of rs174537 are likely due to methylation differences. In support of this hypothesis, methylation levels of the most significant probe were strongly associated with FADS1 and, to a lesser degree, FADS2 activities.	[Howard, Timothy D.; Hawkins, Greg A.] Wake Forest Sch Med, Ctr Publ Hlth Genom, Ctr Genom & Personalized Med Res, Winston Salem, NC 27157 USA; [Mathias, Rasika A.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Seeds, Michael C.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC USA; [Seeds, Michael C.] Wake Forest Sch Med, Sect Pulm Crit Care & Allerg & Immunol Dis, Winston Salem, NC USA; [Herrington, David M.; Sellers, Matthew] Wake Forest Sch Med, Dept Cardiol, Winston Salem, NC USA; [Hixson, James E.; Shimmin, Lawrence C.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Sergeant, Susan] Wake Forest Sch Med, Program Mol Genet & Gen, Winston Salem, NC USA; [Seeds, Michael C.; Miller, Leslie R.; Chilton, Floyd H.] Wake Forest Hlth Sci, Dept Physiol Pharmacol, Winston Salem, NC USA; [Seeds, Michael C.; Sergeant, Susan; Chilton, Floyd H.] Wake Forest Univ Hlth Sci, Wake Forest Ctr Bot Lipids & Inflammatory Dis Pre, Winston Salem, NC USA	Wake Forest University; Johns Hopkins University; Wake Forest University; Wake Forest University; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University School of Medicine	Howard, TD (corresponding author), Wake Forest Sch Med, Ctr Publ Hlth Genom, Ctr Genom & Personalized Med Res, Winston Salem, NC 27157 USA.	tdhoward@wakehealth.edu		Hixson, James/0000-0002-0849-9315	National Institutes of Health [P50 AT002782]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a grant from the National Institutes of Health, P50 AT002782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanchard H, 2011, BIOCHIMIE, V93, P87, DOI 10.1016/j.biochi.2010.03.002; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Lattka E, 2009, J NUTRIGENET NUTRIGE, V2, P119, DOI 10.1159/000235559; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Sigurdsson MI, 2009, GENOME RES, V19, P581, DOI 10.1101/gr.086181.108; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WISSLER RW, 1991, AM J MED, V91, pS3, DOI 10.1016/0002-9343(91)90050-8; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	29	51	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97510	10.1371/journal.pone.0097510	http://dx.doi.org/10.1371/journal.pone.0097510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842322	Green Published, gold			2022-12-27	WOS:000340948600038
J	Ide, K; Yamada, H; Matsushita, K; Ito, M; Nojiri, K; Toyoizumi, K; Matsumoto, K; Sameshima, Y				Ide, Kazuki; Yamada, Hiroshi; Matsushita, Kumi; Ito, Miki; Nojiri, Kei; Toyoizumi, Kiichiro; Matsumoto, Keiji; Sameshima, Yoichi			Effects of Green Tea Gargling on the Prevention of Influenza Infection in High School Students: A Randomized Controlled Study	PLOS ONE			English	Article							NEW-YORK-CITY; PANDEMIC INFLUENZA; NONPHARMACEUTICAL INTERVENTIONS; PRODUCTION CAPACITY; CATECHIN EXTRACTS; A H1N1; OUTBREAK; VACCINE; ADULTS	Background: The anti-influenza virus activity of green tea catechins has been demonstrated in experimental studies, but clinical evidence has been inconclusive. School-aged children play an important role in the infection and spread of influenza in the form of school-based outbreaks. Preventing influenza infection among students is essential for reducing the frequency of epidemics and pandemics. As a non-pharmaceutical intervention against infection, gargling is also commonly performed in Asian countries but has not yet been extensively studied. Methods and Findings: A randomized, open label, 2-group parallel study of 757 high school students (15 to 17 years of age) was conducted for 90 days during the influenza epidemic season from December 1st, 2011 to February 28th, 2012, in 6 high schools in Shizuoka Prefecture, Japan. The green tea gargling group gargled 3 times a day with bottled green tea, and the water gargling group did the same with tap water. The water group was restricted from gargling with green tea. The primary outcome measure was the incidence of laboratory-confirmed influenza using immunochromatographic assay for antigen detection. 757 participants were enrolled and 747 participants completed the study (384 in the green tea group and 363 in the water group). Multivariate logistic regression indicated no significant difference in the incidence of laboratory-confirmed influenza between the green tea group (19 participants; 4.9%) and the water group (25 participants; 6.9%) (adjusted OR, 0.69; 95% CI, 0.37 to 1.28; P = 0.24). The main limitation of the study is the adherence rate among high school students was lower than expected. Conclusions: Among high school students, gargling with green tea three times a day was not significantly more efficacious than gargling with water for the prevention of influenza infection. In order to adequately assess the effectiveness of such gargling, additional large-scale randomized studies are needed.	[Ide, Kazuki; Yamada, Hiroshi; Ito, Miki; Nojiri, Kei; Toyoizumi, Kiichiro; Matsumoto, Keiji] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan; [Matsushita, Kumi] Kikugawa Gen Hosp, Dept Pharm, Shizuoka, Japan; [Sameshima, Yoichi] Omaezaki Municipal Hosp, Dept Internal Med, Shizuoka, Japan	University of Shizuoka	Yamada, H (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan.	hyamada@u-shizuoka-ken.ac.jp	Ide, Kazuki/H-3154-2018; Ide, Kazuki/D-7289-2015; Toyoizumi, Kiichuro/Q-6570-2019	Ide, Kazuki/0000-0001-6377-1361; Ide, Kazuki/0000-0001-6377-1361; Toyoizumi, Kiichuro/0000-0002-4893-3526	 [23590887]; Grants-in-Aid for Scientific Research [23590887] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) Grant Number 23590887. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029744; Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Bell D, 2006, EMERG INFECT DIS, V12, P81; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; Cabinet Secretariat (Japan), 2013, SHING INF TAIS GAID; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Clement Y, 2009, PREV MED, V49, P83, DOI 10.1016/j.ypmed.2009.05.005; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Dalton CB, 2008, COMMUN DIS INTELL, V32, P261; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Iwata M, 1997, Kansenshogaku Zasshi, V71, P487; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Johnson R, 2012, MATURITAS, V73, P280, DOI 10.1016/j.maturitas.2012.08.008; Kaiser L, 2000, CLIN INFECT DIS, V30, P587, DOI 10.1086/313696; Langley JM, 2004, CAN MED ASSOC J, V171, P1169, DOI 10.1503/cmaj.1041375; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-15; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Park M, 2011, J NUTR, V141, P1862, DOI 10.3945/jn.110.137547; Partridge J, 2013, VACCINE, V31, P728, DOI 10.1016/j.vaccine.2012.10.111; Satomura K, 2005, AM J PREV MED, V29, P302, DOI 10.1016/j.amepre.2005.06.013; Song JM, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P1185, DOI 10.1016/B978-0-12-384937-3.00099-9; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134; Yamada H, 2006, J ALTERN COMPLEM MED, V12, P669, DOI 10.1089/acm.2006.12.669	31	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96373	10.1371/journal.pone.0096373	http://dx.doi.org/10.1371/journal.pone.0096373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836780	gold, Green Submitted, Green Published			2022-12-27	WOS:000339614800015
J	Thompson, MJ; Timmermans, MJTN				Thompson, Martin J.; Timmermans, Martijn J. T. N.			Characterising the Phenotypic Diversity of Papilio dardanus Wing Patterns Using an Extensive Museum Collection	PLOS ONE			English	Article							THEORETICAL GENETICS; BATESIAN MIMICRY; EVOLUTION; BROWN; POLYTROPHUS; DIVERGENCE; DOMINANCE; GENOME	The history of 20th Century evolutionary biology can be followed through the study of mimetic butterflies. From the initial findings of discontinuous polymorphism through the debates regarding the evolution of mimicry and the step-size of evolutionary change, to the studies on supergene evolution and molecular characterisation of butterfly genomes, mimetic butterflies have been at the heart of evolutionary thought for over 100 years. During this time, few species have received as much attention and in-depth study as Papilio dardanus. To assist all aspects of mimicry research, we present a complete data-derived overview of the extent of polymorphism within this species. Using historical samples permanently held by the NHM London, we document the extent of phenotypic variation and characterise the diversity present in each of the subspecies and how it varies across Africa. We also demonstrate an association between "imperfect" mimetic forms and the transitional race formed in the area where Eastern and Western African populations meet around Lake Victoria. We present a novel portal for access to this collection, www.mimeticbutterflies.org, allowing remote access to this unique repository. It is hoped that this online resource can act as a nucleus for the sharing and dissemination of other collections databases and imagery connected with mimetic butterflies.	[Thompson, Martin J.; Timmermans, Martijn J. T. N.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Thompson, Martin J.] Univ Cambridge, Dept Zool, Cambridge, England; [Timmermans, Martijn J. T. N.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England	Natural History Museum London; University of Cambridge; Imperial College London	Thompson, MJ (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	martt@nhm.ac.uk			NERC [NE/I021578/1]; Entomology department of the NHM London; Natural Environment Research Council [NE/I021578/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Entomology department of the NHM London; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC (www.nerc.ac.uk). MJT is funded by a NERC studentship and MJTNT by a NERC Postdoctoral Fellowship (NE/I021578/1). Part of this work was funded by the former Entomology department of the NHM London (www.nhm.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Bernardi G., 1985, Bulletin de la Societe Entomologique de France, V90, P1106; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; Carpenter G. D. H., 1948, Proceedings of the Royal Entomological Society of London (B), V17, P11; Carpenter G. D. H, 1933, MIMICRY; Carroll SB, 2011, SCIENCE, V333, P1100, DOI 10.1126/science.1211025; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P325, DOI 10.1016/S0022-5193(75)80083-X; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P305, DOI 10.1016/S0022-5193(75)80082-8; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P283, DOI 10.1016/S0022-5193(75)80081-6; Clark R, 2008, P R SOC B, V275, P1181, DOI 10.1098/rspb.2007.1762; Clark R, 2009, MOL ECOL, V18, P3872, DOI 10.1111/j.1365-294X.2009.04259.x; CLARKE C A, 1991, Journal of the Lepidopterists' Society, V45, P222; CLARKE C. A., 1960, HEREDITY, V14, P73, DOI 10.1038/hdy.1960.6; CLARKE CA, 1963, EVOLUTION, V17, P404, DOI 10.2307/2407091; CLARKE CA, 1962, GENETICS, V47, P909; CLARKE CA, 1959, GENETICS, V44, P1347; CLARKE CA, 1960, GENETICS, V45, P683; CLARKE CA, 1960, GENETICS, V45, P439; Cohen A, 2002, NOTES REC ROY SOC, V56, P206, DOI 10.1098/rsnr.2002.0179; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Davis FR, 2009, T AM PHILOS SOC, V99, P221; Dobzhansky T., 1937; ESRI, 2011, ARCMAP 10; FISHER R. A., 1927, TRANS ENT SOC LONDON, V75, P269; Fisher RA, 1930, AM NAT, V64, P385, DOI 10.1086/280325; Fisher RA, 1930, GENETICAL THEORY NAT; FORD E, 1964, ECOLOGICAL GENETICS; Ford E. B., 1936, Transactions of the Royal Entomological Society of London, V85, P435; Ford E. B., 1931, MENDELISM EVOLUTION; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; GOLDSCHMIDT RB, 1945, Q REV BIOL, V20, P205, DOI 10.1086/394883; Grimaldi David, 2005, pi; Jordan K., 1905, Zeitschrift fuer Wissenschaftliche Zoologie, Vlxxxiii, P151; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Larsen TB, 1990, BUTTERFLIES KENYA TH; Le Cerf F., 1924, Bulletin of the Hill Museum Witley, V1, P369; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; Nijhout HF, 2003, EVOL DEV, V5, P579, DOI 10.1046/j.1525-142X.2003.03063.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Poulton E. B., 1924, Journal of the East Africa and Uganda Natural History Society Nairobi no, V20, P4; Punnett, 1905, MENDELISM; Punnett R.C., 1915, MIMICRY BUTTERFLIES; Thompson MJ, 2014, HEREDITY, V113, P1, DOI 10.1038/hdy.2014.20; Trimen R., 1869, Transactions of the Linnean Society of London, Vvol. xxvi, P497; TRIMEN R, 1874, T ENTOMOLOGICAL SOC, V22, P137; Turner J. R. G., 1963, Transactions of the Royal Entomological Society of London, V115, P239; TURNER JRG, 1987, ECOL ENTOMOL, V12, P81, DOI 10.1111/j.1365-2311.1987.tb00987.x; TURNER JRG, 1979, P NATL ACAD SCI USA, V76, P1924, DOI 10.1073/pnas.76.4.1924; United States Geological Survey, 2009, AFR IS	56	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96815	10.1371/journal.pone.0096815	http://dx.doi.org/10.1371/journal.pone.0096815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837717	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000339614800021
J	Abdul Wahab, MA; de Nys, R; Webster, N; Whalan, S				Abdul Wahab, Muhammad Azmi; de Nys, Rocky; Webster, Nicole; Whalan, Steve			Larval Behaviours and Their Contribution to the Distribution of the Intertidal Coral Reef Sponge Carteriospongia foliascens	PLOS ONE			English	Article							GREAT-BARRIER-REEF; DIEL VERTICAL MIGRATION; UNDERSTANDING RECRUITMENT; POPULATION-DYNAMICS; SETTLEMENT; CONSEQUENCES; DISPERSAL; ECOLOGY; GROWTH; DEPTH	Sponges (Phylum Porifera) are an evolutionary and ecologically significant group; however information on processes influencing sponge population distributions is surprisingly limited. Carteriospongia foliascens is a common Indo-Pacific sponge, which has been reported from the intertidal to the mesophotic. Interestingly, the distribution of C. foliascens at inshore reefs of the Great Barrier Reef is restricted to the intertidal with no individuals evident in adjacent subtidal habitats. The abundance of C. foliascens and substrate availability was first quantified to investigate the influence of substrate limitation on adult distribution. Pre-settlement processes of larval spawning, swimming speeds, phototaxis, vertical migration, and settlement to intertidal and subtidal substrate cues were also quantified. Notably, suitable settlement substrate (coral rubble) was not limiting in subtidal habitats. C. foliascens released up to 765 brooded larvae sponge(-1) day(-1) during the day, with larvae (80%+/- 5.77) being negatively phototactic and migrating to the bottom within 40 minutes from release. Subsequently, larvae (up to 58.67%+/- 2.91) migrated to the surface after the loss of the daylight cue (nightfall), and after 34 h post-release >98.67% (+/- 0.67) of larvae had adopted a benthic habit regardless of light conditions. Intertidal and subtidal biofilms initiated similar settlement responses, inducing faster (as early 6 h post-release) and more successful metamorphosis (>60%) than unconditioned surfaces. C. foliascens has a high larval supply and larval behaviours that support recruitment to the subtidal. The absence of C. foliascens in subtidal habitats at inshore reefs is therefore proposed to be a potential consequence of post-settlement mortalities.	[Abdul Wahab, Muhammad Azmi] James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia; [Abdul Wahab, Muhammad Azmi; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Abdul Wahab, Muhammad Azmi; Webster, Nicole] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Whalan, Steve] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia	James Cook University; James Cook University; Australian Institute of Marine Science; Southern Cross University	Abdul Wahab, MA (corresponding author), James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia.	muhammad.abdulwahab@jcu.edu.au	de Nys, Rocky/D-6741-2012; Webster, Nicole S/G-4980-2011	de Nys, Rocky/0000-0003-3869-4928; Webster, Nicole S/0000-0002-4753-5278; Abdul Wahab, Muhammad Azmi/0000-0003-4088-9652; Whalan, Steve/0000-0001-6786-8945	AIMS@JCU; JCUPRS; Australian Research Council [FT120100480]; Reef HQ [LP0990664]	AIMS@JCU; JCUPRS; Australian Research Council(Australian Research Council); Reef HQ	MAAW is supported by an AIMS@JCU and JCUPRS scholarships. NSW is funded through an Australian Research Council Future Fellowship (FT120100480). The study was partly funded through an Australian Research Council linkage grant with Reef HQ (LP0990664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Wahab MA, 2014, CORAL REEFS, V33, P381, DOI 10.1007/s00338-013-1119-9; Abdul Wahab MA, 2014, MOL PHYLOGENET EVOL, V73, P23, DOI 10.1016/j.ympev.2014.01.004; Abdul Wahab MA, 2011, CORAL REEFS, V30, P451, DOI 10.1007/s00338-011-0727-5; Aerts LAM, 2000, MAR ECOL-P S Z N I, V21, P191, DOI 10.1046/j.1439-0485.2000.00685.x; AMANO S, 1988, BIOL BULL, V175, P181, DOI 10.2307/1541557; AMANO S, 1986, BIOL BULL, V171, P371, DOI 10.2307/1541679; Anderson M. J., 2005, PERMANOVA FORTRAN CO, P24; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Bannister RJ, 2012, CONT SHELF RES, V32, P86, DOI 10.1016/j.csr.2011.10.018; BARILE PJ, 1994, J EXP MAR BIOL ECOL, V183, P147; Becerro MA, 1998, MAR ECOL PROG SER, V168, P187, DOI 10.3354/meps168187; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; Cetina-Heredia P, 2011, CORAL REEFS, V30, P593, DOI 10.1007/s00338-011-0749-z; Collin R, 2010, INVERTEBR BIOL, V129, P121, DOI 10.1111/j.1744-7410.2010.00196.x; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; DAYTON PK, 1989, SCIENCE, V245, P1484, DOI 10.1126/science.245.4925.1484; Diaz MC, 2001, B MAR SCI, V69, P535; dos Santos A, 2008, MAR ECOL PROG SER, V359, P171, DOI 10.3354/meps07341; Duckworth AR, 2011, J EXP MAR BIOL ECOL, V402, P49, DOI 10.1016/j.jembe.2011.03.017; Duran S, 2004, MOL ECOL, V13, P511, DOI 10.1046/j.1365-294X.2004.2080.x; Eckman JE, 1996, J EXP MAR BIOL ECOL, V200, P207, DOI 10.1016/S0022-0981(96)02644-5; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Figueiredo J, 2013, ECOLOGY, V94, P650, DOI 10.1890/12-0767.1; FORWARD RB, 1984, LIMNOL OCEANOGR, V29, P146, DOI 10.4319/lo.1984.29.1.0146; Frohlich H, 1997, MAR BIOL, V128, P115, DOI 10.1007/s002270050075; Gonzalez-Rivero M, 2012, MAR ECOL PROG SER, V444, P133, DOI 10.3354/meps09424; Ilan M., 1988, P745; ILAN M, 1990, BIOL BULL, V179, P279, DOI 10.2307/1542319; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; KIMURA M, 1964, GENETICS, V49, P561; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lopez-Victoria M, 2006, MAR ECOL PROG SER, V312, P113, DOI 10.3354/meps312113; Maldonado M, 1996, MAR ECOL PROG SER, V138, P169, DOI 10.3354/meps138169; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; Maldonado M, 1998, MAR ECOL PROG SER, V174, P141, DOI 10.3354/meps174141; Maldonado M, 1999, NATURE, V398, P476, DOI 10.1038/19007; Maldonado M, 1997, MAR ECOL PROG SER, V148, P115, DOI 10.3354/meps148115; Maldonado M, 2008, MAR ECOL-EVOL PERSP, V29, P298, DOI 10.1111/j.1439-0485.2008.00244.x; Maldonado M, 2008, MAR BIOL, V154, P631, DOI 10.1007/s00227-008-0956-5; Manuel JL, 1997, VERTICAL MIGRATION H; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; McCarthy DA, 2002, MAR ECOL PROG SER, V241, P215, DOI 10.3354/meps241215; Morgan SG, 2010, MAR ECOL PROG SER, V404, P109, DOI 10.3354/meps08476; Pawlik JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062573; Pineda J, 2010, J EXP MAR BIOL ECOL, V392, P9, DOI 10.1016/j.jembe.2010.04.008; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P537, DOI DOI 10.1017/CBO9780511806384; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stake JL, 2003, J EXP MAR BIOL ECOL, V288, P181, DOI 10.1016/S0022-0981(03)00018-2; Thacker RW, 2005, INTEGR COMP BIOL, V45, P369, DOI 10.1093/icb/45.2.369; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; WAPSTRA M, 1987, TAXONOMY PORIFERA, P281; WARBURTON FE, 1966, ECOLOGY, V47, P672, DOI 10.2307/1933952; Webster NS, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00444; Whalan S, 2008, MAR ECOL PROG SER, V368, P145, DOI 10.3354/meps07573; Whalan S, 2008, AQUAT BIOL, V3, P111, DOI 10.3354/ab00066; Whalan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04072; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1989, CORAL REEFS, V8, P1, DOI 10.1007/BF00304685; WILKINSON CR, 1988, PSZNI MAR ECOL, V9, P321, DOI 10.1111/j.1439-0485.1988.tb00210.x; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; WULFF JL, 1995, MAR BIOL, V123, P313; Young Craig M., 1995, P249	72	26	26	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98181	10.1371/journal.pone.0098181	http://dx.doi.org/10.1371/journal.pone.0098181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853091	Green Published, gold, Green Accepted			2022-12-27	WOS:000338323200054
J	Girard, N; Bazille, C; Lhuissier, E; Benateau, H; Llombart-Bosch, A; Boumediene, K; Bauge, C				Girard, Nicolas; Bazille, Celine; Lhuissier, Eva; Benateau, Herve; Llombart-Bosch, Antonio; Boumediene, Karim; Bauge, Catherine			3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells	PLOS ONE			English	Article							ZESTE HOMOLOG 2; GROUP PROTEIN EZH2; CANCER-CELLS; PROSTATE-CANCER; STEM-CELLS; TUMOR; PROLIFERATION; ENHANCER; METHYLATION; EXPRESSION	Objective: Growing evidences indicate that the histone methyltransferase EZH2 (enhancer of zeste homolog 2) may be an appropriate therapeutic target in some tumors. Indeed, a high expression of EZH2 is correlated with poor prognosis and metastasis in many cancers. In addition, 3-Deazaneplanocin A (DZNep), an S-adenosyl-L homocysteine hydrolase inhibitor which induces EZH2 protein depletion, leads to cell death in several cancers and tumors. The aim of this study was to determine whether an epigenetic therapy targeting EZH2 with DZNep may be also efficient to treat chondrosarcomas. Methods: EZH2 expression was determined by immunohistochemistry and western-blot. Chondrosarcoma cell line CH2879 was cultured in the presence of DZNep, and its growth and survival were evaluated by counting adherent cells periodically. Apoptosis was assayed by cell cycle analysis, Apo2.7 expression using flow cytometry, and by PARP cleavage using western-blot. Cell migration was assessed by wound healing assay. Results: Chondrosarcomas (at least with high grade) highly express EZH2, at contrary to enchondromas or chondrocytes. In vitro, DZNep inhibits EZH2 protein expression, and subsequently reduces the trimethylation of lysine 27 on histone H3 (H3K27me3). Interestingly, DZNep induces cell death of chondrosarcoma cell lines by apoptosis, while it slightly reduces growth of normal chondrocytes. In addition, DZNep reduces cell migration. Conclusion: These results indicate that an epigenetic therapy that pharmacologically targets EZH2 via DZNep may constitute a novel approach to treat chondrosarcomas.	[Girard, Nicolas; Bazille, Celine; Lhuissier, Eva; Benateau, Herve; Boumediene, Karim; Bauge, Catherine] Normandie Univ, Caen, France; [Girard, Nicolas; Bazille, Celine; Lhuissier, Eva; Benateau, Herve; Boumediene, Karim; Bauge, Catherine] UNICAEN, MILPAT, EA4652, Caen, France; [Bazille, Celine] CHU Caen, Serv Anat Pathol, F-14000 Caen, France; [Benateau, Herve] CHU Caen, Serv Chirurg Maxillofaciale, F-14000 Caen, France; [Llombart-Bosch, Antonio] Univ Valencia, Dept Pathol, Valencia, Spain	Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Valencia	Bauge, C (corresponding author), Normandie Univ, Caen, France.	catherine.bauge@unicaen.fr	Girard, Nicolas/ABE-3618-2021; BAUGE, Catherine/T-7491-2017	Girard, Nicolas/0000-0001-9909-2299; BAUGE, Catherine/0000-0001-5642-998X; BOUMEDIENE, Karim/0000-0001-6517-8318; Girard, Nicolas/0000-0002-7636-6688	Canceropole Nord-Ouest; Conseil Regional Basse-Normandie; La Ligue contre le cancer; Conseil Regional de Basse-Normandie	Canceropole Nord-Ouest; Conseil Regional Basse-Normandie(Region Normandie); La Ligue contre le cancer(Ligue nationale contre le cancer); Conseil Regional de Basse-Normandie(Region Normandie)	This study was funding by Canceropole Nord-Ouest, Conseil Regional Basse-Normandie and La Ligue contre le cancer. NG is recipient of a fellowship from Conseil Regional de Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Angelini A, 2012, J SURG ONCOL, V106, P929, DOI 10.1002/jso.23173; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen YH, 2012, AM J TRANSL RES, V4, P364; Chen YC, 2010, CANCER LETT, V297, P109, DOI 10.1016/j.canlet.2010.05.003; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Chiba T, 2012, INT J CANCER, V130, P2557, DOI 10.1002/ijc.26264; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; Crea F, 2012, CANCER METAST REV, V31, P753, DOI 10.1007/s10555-012-9387-3; Crea F, 2012, CRIT REV ONCOL HEMAT, V83, P184, DOI 10.1016/j.critrevonc.2011.10.007; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Ding XL, 2014, STEM CELLS DEV, V23, P931, DOI 10.1089/scd.2013.0267; Duchman KR, 2014, CLIN ORTHOP RELAT R, V472, P2516, DOI 10.1007/s11999-014-3600-3; Eskander RN, 2013, INT J GYNECOL CANCER, V23, P997, DOI 10.1097/IGC.0b013e318296a265; Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Fujiwara T, 2014, J BIOL CHEM, V289, P8121, DOI 10.1074/jbc.M114.548651; Gil-Benso R, 2003, LAB INVEST, V83, P877, DOI 10.1097/01.LAB.0000073131.34648.EA; Hayden A, 2011, BREAST CANCER RES TR, V127, P109, DOI 10.1007/s10549-010-0982-0; Holm K, 2012, MOL ONCOL, V6, P494, DOI 10.1016/j.molonc.2012.06.002; HUNG SC, 2013, PLOS ONE, V8; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallen-St Clair J, 2012, GENE DEV, V26, P439, DOI 10.1101/gad.181800.111; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wagner T, 2012, NAT BIOTECHNOL, V30, P622, DOI 10.1038/nbt.2300; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Zhao X, 2013, LEUKEMIA, V27, P2341, DOI 10.1038/leu.2013.94; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	46	50	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98176	10.1371/journal.pone.0098176	http://dx.doi.org/10.1371/journal.pone.0098176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852755	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200052
J	Huang, JH; Ding, XX; Savini, G; Jiang, ZX; Pan, C; Hua, YJ; Wu, F; Feng, YF; Yu, Y; Wang, QM				Huang, Jinhai; Ding, Xixia; Savini, Giacomo; Jiang, Zhengxuan; Pan, Chao; Hua, Yanjun; Wu, Fan; Feng, Yifan; Yu, Ye; Wang, Qinmei			Central and Midperipheral Corneal Thickness Measured with Scheimpflug Imaging and Optical Coherence Tomography	PLOS ONE			English	Article							ANTERIOR SEGMENT MEASUREMENTS; PACHYMETRY MEASUREMENTS; ULTRASONIC PACHYMETRY; DIURNAL-VARIATION; CONTACT-LENS; REPEATABILITY; REPRODUCIBILITY; AGREEMENT; GALILEI; INTRAOBSERVER	Purpose: To compare corneal thickness measurements using Pentacam (Oculus, Germany), Sirius (CSO, Italy), Galilei (Ziemer, Switzerland), and RTVue-100 OCT (Optovue Inc., USA). Methods: Sixty-six eyes of 66 healthy volunteers were enrolled. Three consecutive measurements were performed with each device. The mean value of the three measurements was used for subsequent analysis. Central corneal thickness (CCT), thinnest corneal thickness (TCT), and midperipheral corneal thickness (MPCT; measured at superior, inferior, nasal, and temporal locations with a distance of 1 mm (CT2mm) or 2.5 mm (CT5mm) from the corneal apex) were analyzed. Differences and agreement between measurements were assessed using the repeated-measures analysis of variance (ANOVA) and Bland-Altman analyses, respectively. Results: Statistically significant differences (p<0.001) among the four devices were revealed in CCT, TCT and CT2mm measurements. The CCT, TCT, and CT2mm values were ranked from the thickest to the thinnest as follows: Galilei>Sirius>Pentacam>RTVue OCT. For these measurements, agreement between measurements by Sirius and Pentacam was good, whereas Galilei overestimated and RTVue underestimated corneal thickness compared to Sirius and Pentacam. As regards CT5mm measurements, Pentacam provided the largest values, whereas RTVue OCT yielded the smallest values. Agreement of the CT5mm measurements was good between the Pentacam, Sirius, moderate between Galilei and the other two Scheimpflug systems, and poor between the RTVue OCT and the remaining devices. Conclusions: The Pentacam and Sirius can be used interchangeably for CCT measurements, while the Galilei and RTVue systematically over- and underestimate CCT, respectively. The three Scheimpflug cameras, but not the RTVue, may be used interchangeably for MPCT measurements.	[Huang, Jinhai; Ding, Xixia; Savini, Giacomo; Pan, Chao; Hua, Yanjun; Wu, Fan; Feng, Yifan; Yu, Ye; Wang, Qinmei] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Ding, Xixia; Savini, Giacomo; Pan, Chao; Hua, Yanjun; Wu, Fan; Feng, Yifan; Yu, Ye; Wang, Qinmei] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Ding, Xixia; Wang, Qinmei] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Savini, Giacomo] Studio Oculist DAzeglio, Bologna, Italy; [Jiang, Zhengxuan] Anhui Med Univ, Affiliated Hosp 2, Hefei, Anhui, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Anhui Medical University	Wang, QM (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	wqm6@mail.eye.ac.cn	Savini, Giacomo/J-9196-2018; Huang, Jinhai/ABH-4519-2020	Savini, Giacomo/0000-0003-0075-3582; Huang, Jinhai/0000-0001-9952-3175; HUA, YANJUN/0000-0001-6461-3576	Foundation of Wenzhou City Science & Technology Bureau [Y20110045]; health Bureau of Zhejiang Province [2012KYB135]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201223147]	Foundation of Wenzhou City Science & Technology Bureau; health Bureau of Zhejiang Province; Scientific Research Fund of Zhejiang Provincial Education Department	This work was supported in part by the Foundation of Wenzhou City Science & Technology Bureau (Y20110045; www.wzkj.gov.cn); the health Bureau of Zhejiang Province (2012KYB135; www.zjmed.org.cn); and the Scientific Research Fund of Zhejiang Provincial Education Department (Y201223147; www.zjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedei A, 2012, EUR J OPHTHALMOL, V22, pS29, DOI 10.5301/ejo.5000102; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brautaset RL, 2013, CORNEA, V32, P257, DOI 10.1097/ICO.0b013e31825240d7; Chen SH, 2012, ACTA OPHTHALMOL, V90, P449, DOI 10.1111/j.1755-3768.2010.01947.x; Cho P, 2000, CURR EYE RES, V21, P799, DOI 10.1076/ceyr.21.4.799.5542; Ehlers N, 2004, EXP EYE RES, V78, P543, DOI 10.1016/j.exer.2003.09.017; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hosseini HRJ, 2010, CORNEA, V29, P1091, DOI 10.1097/ICO.0b013e3181cf98e5; Huang JH, 2013, OPHTHALMOLOGY, V120, P1951, DOI 10.1016/j.ophtha.2013.02.022; Huang JH, 2011, OPTOMETRY VISION SCI, V88, P940, DOI 10.1097/OPX.0b013e31821ffe2c; Huang JH, 2011, J CATARACT REFR SURG, V37, P341, DOI 10.1016/j.jcrs.2010.08.044; Ishibazawa A, 2011, CORNEA, V30, P615, DOI 10.1097/ICO.0b013e3181d00800; Jonuscheit S, 2009, J CATARACT REFR SURG, V35, P2127, DOI 10.1016/j.jcrs.2009.07.012; Karimian F, 2012, EUR J OPHTHALMOL, V22, pS33, DOI 10.5301/ejo.5000056; Khoramnia R, 2007, J CATARACT REFR SURG, V33, P830, DOI 10.1016/j.jcrs.2006.12.025; Li HF, 1997, CURR EYE RES, V16, P214, DOI 10.1076/ceyr.16.3.214.15412; Marsich MM, 2000, CORNEA, V19, P792, DOI 10.1097/00003226-200011000-00007; Martin R, 2008, CORNEA, V27, P976, DOI 10.1097/ICO.0b013e318172fc2c; Martin R, 2007, INVEST OPHTH VIS SCI, V48, P3043, DOI 10.1167/iovs.06-1372; Menassa N, 2008, J CATARACT REFR SURG, V34, P1742, DOI 10.1016/j.jcrs.2008.06.024; Miglior S, 2004, BRIT J OPHTHALMOL, V88, P174, DOI 10.1136/bjo.2003.023416; Milla M, 2011, J CATARACT REFR SURG, V37, P310, DOI 10.1016/j.jcrs.2010.08.038; Miranda MA, 2009, OPTOMETRY VISION SCI, V86, P266, DOI 10.1097/OPX.0b013e318196a737; Mohamed S, 2007, INVEST OPHTH VIS SCI, V48, P5499, DOI 10.1167/iovs.07-0591; Nam SM, 2010, OPHTHALMOLOGY, V117, P2096, DOI 10.1016/j.ophtha.2010.03.002; Ou RJ, 2002, AM J OPHTHALMOL, V134, P771, DOI 10.1016/S0002-9394(02)01656-2; Price FW, 1999, OPHTHALMOLOGY, V106, P2216, DOI 10.1016/S0161-6420(99)90508-0; Ponce CMP, 2009, J CATARACT REFR SURG, V35, P1055, DOI 10.1016/j.jcrs.2009.01.022; Rabsilber TM, 2005, J CATARACT REFR SURG, V31, P1607, DOI 10.1016/j.jcrs.2005.01.013; Randleman JB, 2008, OPHTHALMOLOGY, V115, P37, DOI 10.1016/j.ophtha.2007.03.073; Read SA, 2008, INVEST OPHTH VIS SCI, V49, P2911, DOI 10.1167/iovs.08-1833; Read SA, 2009, OPTOMETRY VISION SCI, V86, P170, DOI 10.1097/OPX.0b013e3181981b7e; Savini G, 2011, J CATARACT REFR SURG, V37, P1809, DOI 10.1016/j.jcrs.2011.04.033; Savini G, 2011, J CATARACT REFR SURG, V37, P1679, DOI 10.1016/j.jcrs.2011.03.055	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98316	10.1371/journal.pone.0098316	http://dx.doi.org/10.1371/journal.pone.0098316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854348	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200062
J	Liu, HT; Yu, SJ; Zhang, H; Xu, J				Liu, Hongtao; Yu, Shujie; Zhang, Hua; Xu, Jian			Identification of Nitric Oxide as an Endogenous Inhibitor of 26S Proteasomes in Vascular Endothelial Cells	PLOS ONE			English	Article							UBIQUITIN/PROTEASOME-DEPENDENT PROTEOLYSIS; O-GLCNAC; PROTEIN MODIFICATION; NEUTRAL CERAMIDASE; S-NITROSYLATION; SMOOTH-MUSCLE; MOUSE MODEL; UBIQUITIN; DEGRADATION; SYNTHASE	The 26S proteasome plays a fundamental role in almost all eukaryotic cells, including vascular endothelial cells. However, it remains largely unknown how proteasome functionality is regulated in the vasculature. Endothelial nitric oxide (NO) synthase (eNOS)-derived NO is known to be essential to maintain endothelial homeostasis. The aim of the present study was to establish the connection between endothelial NO and 26S proteasome functionality in vascular endothelial cells. The 26S proteasome reporter protein levels, 26S proteasome activity, and the O-GlcNAcylation of Rpt2, a key subunit of the proteasome regulatory complex, were assayed in 26S proteasome reporter cells, human umbilical vein endothelial cells (HUVEC), and mouse aortic tissues isolated from 26S proteasome reporter and eNOS knockout mice. Like the other selective NO donors, NO derived from activated eNOS (by pharmacological and genetic approach) increased O-GlcNAc modification of Rpt2, reduced proteasome chymotrypsin-like activity, and caused 26S proteasome reporter protein accumulation. Conversely, inactivation of eNOS reversed all the effects. SiRNA knockdown of O-GlcNAc transferase (OGT), the key enzyme that catalyzes protein O-GlcNAcylation, abolished NO-induced effects. Consistently, adenoviral overexpression of O-GlcNAcase (OGA), the enzyme catalyzing the removal of the O-GlcNAc group, mimicked the effects of OGT knockdown. Finally, compared to eNOS wild type aortic tissues, 26S proteasome reporter mice lacking eNOS exhibited elevated 26S proteasome functionality in parallel with decreased Rpt2 O-GlcNAcylation, without changing the levels of Rpt2 protein. In conclusion, the eNOS-derived NO functions as a physiological suppressor of the 26S proteasome in vascular endothelial cells.	[Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Endocrinol Sect, Oklahoma City, OK 73107 USA; Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Xu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Endocrinol Sect, Oklahoma City, OK 73107 USA.	jian-xu@ouhsc.edu			National Institutes of Health Grant from the COBRE Program of the National Center for Research Resources [P20 RR 024215-05]; National Institute of General Medical Sciences [9P20GM104934-06]; American Heart Association [10SDG2600164]; American Diabetes Association [1-12-JF-58]; Oklahoma Center for Advancement of Science and Technology [HR11-200]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	National Institutes of Health Grant from the COBRE Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); Oklahoma Center for Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an National Institutes of Health Grant from the COBRE Program of the National Center for Research Resources (P20 RR 024215-05) and of the National Institute of General Medical Sciences (9P20GM104934-06) (JX, Project 2). This work was also supported by a National Scientist Development Grant (10SDG2600164) from the American Heart Association (JX), a Junior Faculty Award (1-12-JF-58) from the American Diabetes Association (JX), and a Research Award (HR11-200) from the Oklahoma Center for Advancement of Science and Technology (JX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balligand JL, 2002, CIRC RES, V90, P838, DOI 10.1161/01.RES.0000018173.10175.FF; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Caramori ML, 2012, DIABETES, V61, P739, DOI 10.2337/db11-0617; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Edwards CM, 2009, AM J HEMATOL, V84, P268, DOI 10.1002/ajh.21374; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Franzen R, 2002, FEBS LETT, V532, P441, DOI 10.1016/S0014-5793(02)03727-4; Franzen R, 2002, J BIOL CHEM, V277, P46184, DOI 10.1074/jbc.M204034200; Fu YN, 1998, ANN NY ACAD SCI, V842, P138, DOI 10.1111/j.1749-6632.1998.tb09642.x; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Glockzin S, 1999, J BIOL CHEM, V274, P19581, DOI 10.1074/jbc.274.28.19581; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heessen S, 2003, FEBS LETT, V555, P397, DOI 10.1016/S0014-5793(03)01296-1; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Kapadia MR, 2009, NITRIC OXIDE-BIOL CH, V20, P279, DOI 10.1016/j.niox.2009.02.005; Kibbe MR, 2000, J VASC SURG, V31, P364, DOI 10.1016/S0741-5214(00)90166-6; Kim HJ, 2006, MOL PHARMACOL, V69, P1633, DOI 10.1124/mol.105.020487; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Liu HT, 2012, ARTERIOSCL THROM VAS, V32, P2131, DOI 10.1161/ATVBAHA.112.253385; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Magill L, 2004, HAEMATOLOGICA, V89, P1428; Mannick JB, 2002, ARCH BIOCHEM BIOPHYS, V408, P1, DOI 10.1016/S0003-9861(02)00490-3; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Noman Abu Shadat M, 2009, Innate Immun, V15, P33, DOI 10.1177/1753425908099317; Ooboshi H, 1997, AM J PHYSIOL-HEART C, V273, pH265, DOI 10.1152/ajpheart.1997.273.1.H265; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Overath T, 2012, MOL CELL PROTEOMICS, V11, P467, DOI 10.1074/mcp.M111.015966; Peng ZF, 2008, NITRIC OXIDE-BIOL CH, V18, P136, DOI 10.1016/j.niox.2007.11.002; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Rex-Mathes M, 2001, BIOCHIMIE, V83, P583, DOI 10.1016/S0300-9084(01)01305-0; Rogers PA, 2001, J BIOL CHEM, V276, P30980, DOI 10.1074/jbc.M101037200; Ryu IH, 2011, BIOCHEM BIOPH RES CO, V408, P52, DOI 10.1016/j.bbrc.2011.03.115; Schmidt M., 2013, BIOCH BIOPHYS ACTA; Schroder H, 2006, MOL PHARMACOL, V69, P1507, DOI 10.1124/mol.106.023416; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shang TS, 2005, FREE RADICAL BIO MED, V39, P1059, DOI 10.1016/j.freeradbiomed.2005.05.022; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Stangl K, 2010, CARDIOVASC RES, V85, P281, DOI 10.1093/cvr/cvp315; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tanioka T, 2011, J BIOL CHEM, V286, P29388, DOI 10.1074/jbc.M110.192732; Tsihlis ND, 2012, NITRIC OXIDE-BIOL CH, V27, P50, DOI 10.1016/j.niox.2012.04.006; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Wang WJ, 2008, INT J ONCOL, V33, P1037, DOI 10.3892/ijo_00000092; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Whitsett J, 2007, ARTERIOSCL THROM VAS, V27, P2340, DOI 10.1161/ATVBAHA.107.153742; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Xu J, 2006, ARTERIOSCL THROM VAS, V26, P2688, DOI 10.1161/01.ATV.0000249394.94588.82; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036717; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029649; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736; Zachara N. E., 2011, CURR PROTOC MOL BIOL, DOI [DOI 10.1002/0471142727.MB1706S95, 10.1002/0471142727.mb1706s95]; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang FX, 2012, AM J PHYSIOL-CELL PH, V302, pC1786, DOI 10.1152/ajpcell.00004.2012; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	86	15	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98486	10.1371/journal.pone.0098486	http://dx.doi.org/10.1371/journal.pone.0098486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853093	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200074
J	Vis, DJ; Westerhuis, JA; Hoefsloot, HCJ; Roelfsema, F; Van der Greef, J; Hendriks, MMWB; Smilde, AK				Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Roelfsema, Ferdinand; Van der Greef, Jan; Hendriks, Margriet M. W. B.; Smilde, Age K.			Network Identification of Hormonal Regulation	PLOS ONE			English	Article							GASTRIC BYPASS-SURGERY; INSULIN-RESISTANCE; NEGATIVE FEEDBACK; SECRETION; PULSATILE; GLUCOSE; OBESITY; STRESS; THYROTROPIN; RESPONSES	Relations among hormone serum concentrations are complex and depend on various factors, including gender, age, body mass index, diurnal rhythms and secretion stochastics. Therefore, endocrine deviations from healthy homeostasis are not easily detected or understood. A generic method is presented for detecting regulatory relations between hormones. This is demonstrated with a cohort of obese women, who underwent blood sampling at 10 minute intervals for 24-hours. The cohort was treated with bromocriptine in an attempt to clarify how hormone relations change by treatment. The detected regulatory relations are summarized in a network graph and treatment-induced changes in the relations are determined. The proposed method identifies many relations, including well-known ones. Ultimately, the method provides ways to improve the description and understanding of normal hormonal relations and deviations caused by disease or treatment.	[Vis, Daniel J.; Hendriks, Margriet M. W. B.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Van der Greef, Jan; Hendriks, Margriet M. W. B.; Smilde, Age K.] Netherlands Metabol Ctr, Leiden, Netherlands; [Roelfsema, Ferdinand] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Van der Greef, Jan] TNO Qual Life, Zeist, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Vis, DJ (corresponding author), Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands.	science@danielvis.nl		Smilde, Age/0000-0002-3052-4644	TNO Quality of Life; Netherlands Metabolomics Center, part of the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research	TNO Quality of Life; Netherlands Metabolomics Center, part of the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research	TNO Quality of Life supported this research from the systems biology program (www.tno.nl) and The Netherlands Metabolomics Center, which is part of the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research (http://www.metabolomicscentre.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict C, 2009, PSYCHONEUROENDOCRINO, V34, P455, DOI 10.1016/j.psyneuen.2008.10.010; BERGER M, 1975, BIOCHEM J, V146, P231, DOI 10.1042/bj1460231; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; Carroll TB, 2010, REV ENDOCR METAB DIS, V11, P147, DOI 10.1007/s11154-010-9143-3; CINCOTTA AH, 1991, METABOLISM, V40, P639, DOI 10.1016/0026-0495(91)90057-4; Cordido F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/434562; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Falken Y, 2011, J CLIN ENDOCR METAB, V96, P2227, DOI 10.1210/jc.2010-2876; Johnson ML, 2008, ANAL BIOCHEM, V381, P8, DOI 10.1016/j.ab.2008.07.001; Keenan DM, 1997, AM J PHYSIOL-REG I, V273, pR1182, DOI 10.1152/ajpregu.1997.273.3.R1182; Keenan DM, 2004, AM J PHYSIOL-ENDOC M, V287, pE652, DOI 10.1152/ajpendo.00167.2004; Keenan DM, 1998, AM J PHYSIOL-REG I, V275, pR1939, DOI 10.1152/ajpregu.1998.275.6.R1939; Kok P, 2008, J CLIN ENDOCRINOL ME; Kok P, 2006, AM J PHYSIOL-ENDOC M, V291, pE1038, DOI 10.1152/ajpendo.00567.2005; Kok P, 2006, J CLIN ENDOCR METAB, V91, P3236, DOI 10.1210/jc.2005-2529; Lin E, 2010, AM J PHYSIOL-ENDOC M, V299, pE706, DOI 10.1152/ajpendo.00405.2010; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Murphy KP., 2002, THESIS UC BERKELEY; Pearl J, 1988, MORGAN KAUFMANN SERI, P521; PEREZLOPEZ FR, 1981, ACTA ENDOCRINOL-COP, V97, P7, DOI 10.1530/acta.0.0970007; PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685; RE RN, 1976, J CLIN ENDOCR METAB, V43, P338, DOI 10.1210/jcem-43-2-338; Roelfsema F, 2001, J CLIN ENDOCR METAB, V86, P2459, DOI 10.1210/jc.86.6.2459; Roelfsema F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031305; Roelfsema F, 2009, EUR J ENDOCRINOL, V161, P695, DOI 10.1530/EJE-09-0580; Roelfsema F, 2009, J CLIN ENDOCR METAB, V94, P2991, DOI 10.1210/jc.2009-0350; Souhami RL, 2002, TXB MED; Veldhuis JD, 2011, AM J PHYSIOL-REG I, V301, pR1143, DOI 10.1152/ajpregu.00293.2011; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P2874, DOI 10.1210/jc.2011-0084; Veldhuis JD, 2011, AM J PHYSIOL-ENDOC M, V300, pE1158, DOI 10.1152/ajpendo.00054.2011; Veldhuis JD, 2010, AM J PHYSIOL-ENDOC M, V299, pE675, DOI 10.1152/ajpendo.00300.2010; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Vis DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032985; Vis DJ, 2009, AM J PHYSL ENDOCRINO; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402	39	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96284	10.1371/journal.pone.0096284	http://dx.doi.org/10.1371/journal.pone.0096284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852517	gold, Green Published			2022-12-27	WOS:000338323200011
J	Akl, MR; Ayoub, NM; Mohyeldin, MM; Busnena, BA; Foudah, AI; Liu, YY; El Sayed, KA				Akl, Mohamed R.; Ayoub, Nehad M.; Mohyeldin, Mohamed M.; Busnena, Belnaser A.; Foudah, Ahmed I.; Liu, Yong-Yu; El Sayed, Khalid A.			Olive Phenolics as c-Met Inhibitors: (-)-Oleocanthal Attenuates Cell Proliferation, Invasiveness, and Tumor Growth in Breast Cancer Models	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; RECEPTOR MET; TAU-PROTEIN; OLEOCANTHAL; OIL; KINASE; MIGRATION; FIBRILLIZATION	Dysregulation of the Hepatocyte growth factor (HGF)/c-Met signaling axis upregulates diverse tumor cell functions, including cell proliferation, survival, scattering and motility, epithelial-to-mesenchymal transition (EMT), angiogenesis, invasion, and metastasis. (-)-Oleocanthal is a naturally occurring secoiridoid from extra-virgin olive oil, which showed antiproliferative and antimigratory activity against different cancer cell lines. The aim of this study was to characterize the intracellular mechanisms involved in mediating the anticancer effects of (-)-oleocanthal treatment and the potential involvement of c-Met receptor signaling components in breast cancer. Results showed that (-)-oleocanthal inhibits the growth of human breast cancer cell lines MDA-MB-231, MCF-7 and BT-474 while similar treatment doses were found to have no effect on normal human MCF10A cell growth. In addition, (-)-oleocanthal treatment caused a dose-dependent inhibition of HGF-induced cell migration, invasion and G1/S cell cycle progression in breast cancer cell lines. Moreover, (-)-oleocanthal treatment effects were found to be mediated via inhibition of HGF-induced c-Met activation and its downstream mitogenic signaling pathways. This growth inhibitory effect is associated with blockade of EMT and reduction in cellular motility. Further results from in vivo studies showed that (-)-oleocanthal treatment suppressed tumor cell growth in an orthotopic model of breast cancer in athymic nude mice. Collectively, the findings of this study suggest that (-)-oleocanthal is a promising dietary supplement lead with potential for therapeutic use to control malignancies with aberrant c-Met activity.	[Akl, Mohamed R.; Mohyeldin, Mohamed M.; Busnena, Belnaser A.; Foudah, Ahmed I.; Liu, Yong-Yu; El Sayed, Khalid A.] NE Louisiana Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71209 USA; [Ayoub, Nehad M.] Jordan Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Irbid, Jordan	University of Louisiana System; University of Louisiana Monroe; Jordan University of Science & Technology	El Sayed, KA (corresponding author), NE Louisiana Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71209 USA.	elsayed@ulm.edu	Mohyeldin, Mohamed/AAA-5232-2019; Foudah, Ahmed I./AGZ-2587-2022; Mohyeldin, Mohamed/K-5059-2017	Ayoub, Nehad/0000-0003-2284-4370; Mohyeldin, Mohamed/0000-0001-9052-7620; Liu, Yong-Yu/0000-0002-7968-0162	National Cancer Institute of the National Institutes of Health [R15CA167475]; NATIONAL CANCER INSTITUTE [R15CA167475] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R15CA167475. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuznait AH, 2013, ACS CHEM NEUROSCI, V4, P973, DOI 10.1021/cn400024q; Agarwal S, 2009, BRIT J CANCER, V100, P941, DOI 10.1038/sj.bjc.6604937; Akl MR, 2013, FITOTERAPIA, V84, P347, DOI 10.1016/j.fitote.2012.12.013; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Busnena BA, 2013, BIOORGAN MED CHEM, V21, P2117, DOI 10.1016/j.bmc.2012.12.050; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Cicerale S, 2009, CHEM SENSES, V34, P333, DOI 10.1093/chemse/bjp006; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Elliott BE, 2002, CAN J PHYSIOL PHARM, V80, P91, DOI 10.1139/y02-010; Elnagar AY, 2011, PLANTA MED, V77, P1013, DOI 10.1055/s-0030-1270724; Fogliano V, 2006, MOL NUTR FOOD RES, V50, P5, DOI 10.1002/mnfr.200690002; Francone TD, 2007, MOL CANCER THER, V6, P1460, DOI 10.1158/1535-7163.MCT-06-0466; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Iacono A, 2010, ARTHRITIS RHEUM-US, V62, P1675, DOI 10.1002/art.27437; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim EJ, 2012, MOL CELL BIOCHEM, V359, P431, DOI 10.1007/s11010-011-1039-3; Lawrence RE, 2010, CELL ADHES MIGR, V4, P146, DOI 10.4161/cam.4.1.10973; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lucas L, 2011, CURR PHARM DESIGN, V17, P754, DOI 10.2174/138161211795428911; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Margarucci L, 2013, CHEM COMMUN, V49, P5844, DOI 10.1039/c3cc41858h; Monti MC, 2012, J NAT PROD, V75, P1584, DOI 10.1021/np300384h; Monti MC, 2011, FOOD FUNCT, V2, P423, DOI 10.1039/c1fo10064e; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Nuwer R, 2013, SCI AM, V308, P22, DOI 10.1038/scientificamerican0613-22; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Reshetnikova G, 2007, CELL BIOL INT, V31, P366, DOI 10.1016/j.cellbi.2007.01.022; Rho OK, 2011, MOL CARCINOGEN, V50, P264, DOI 10.1002/mc.20665; Rosignoli P, 2013, J NUTR BIOCHEM, V24, P1513, DOI 10.1016/j.jnutbio.2012.12.011; Sattler M, 2003, CANCER RES, V63, P5462; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Sattler Martin, 2009, Update Cancer Ther, V3, P109, DOI 10.1016/j.uct.2009.01.001; Scotece M, 2013, CURR MED CHEM, V20, P2467, DOI 10.2174/0929867311320190006; Scotece M, 2012, LIFE SCI, V91, P1229, DOI 10.1016/j.lfs.2012.09.012; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Tuck AB, 1996, AM J PATHOL, V148, P225; Vougogiannopoulou K, 2014, J NAT PROD; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309	47	87	88	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97622	10.1371/journal.pone.0097622	http://dx.doi.org/10.1371/journal.pone.0097622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849787	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600042
J	Borsch-Haubold, AG; Montero, I; Konrad, K; Haubold, B				Boersch-Haubold, Angelika G.; Montero, Inka; Konrad, Kathryn; Haubold, Bernhard			Genome-Wide Quantitative Analysis of Histone H3 Lysine 4 Trimethylation in Wild House Mouse Liver: Environmental Change Causes Epigenetic Plasticity	PLOS ONE			English	Article							DIETARY-PROTEIN RESTRICTION; HIGH-FAT DIET; DNA METHYLATION; GENE-EXPRESSION; PREGNANT RATS; TRANSGENERATIONAL ACTIONS; GLUCOCORTICOID-RECEPTOR; SEX-RATIO; MICE; INHERITANCE	In mammals, exposure to toxic or disease-causing environments can change epigenetic marks that are inherited independently of the intrauterine environment. Such inheritance of molecular phenotypes may be adaptive. However, studies demonstrating molecular evidence for epigenetic inheritance have so far relied on extreme treatments, and are confined to inbred animals. We therefore investigated whether epigenomic changes could be detected after a non-drastic change in the environment of an outbred organism. We kept two populations of wild-caught house mice (Mus musculus domesticus) for several generations in semi-natural enclosures on either standard diet and light cycle, or on an energyenriched diet with longer daylight to simulate summer. As epigenetic marker for active chromatin we quantified genome-wide histone-3 lysine-4 trimethylation (H3K4me3) from liver samples by chromatin immunoprecipitation and high-throughput sequencing as well as by quantitative polymerase chain reaction. The treatment caused a significant increase of H3K4me3 at metabolic genes such as lipid and cholesterol regulators, monooxygenases, and a bile acid transporter. In addition, genes involved in immune processes, cell cycle, and transcription and translation processes were also differently marked. When we transferred young mice of both populations to cages and bred them under standard conditions, most of the H3K4me3 differences were lost. The few loci with stable H3K4me3 changes did not cluster in metabolic functional categories. This is, to our knowledge, the first quantitative study of an epigenetic marker in an outbred mammalian organism. We demonstrate genome-wide epigenetic plasticity in response to a realistic environmental stimulus. In contrast to disease models, the bulk of the epigenomic changes we observed were not heritable.	[Boersch-Haubold, Angelika G.; Haubold, Bernhard] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany; [Montero, Inka] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany; [Konrad, Kathryn] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	Max Planck Society; Eberhard Karls University of Tubingen; University of Cologne	Borsch-Haubold, AG (corresponding author), Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany.	aboersch@evolbio.mpg.de			Max Planck Society, Germany	Max Planck Society, Germany(Max Planck Society)	This study was supported by the Max Planck Society, Germany. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Cropley JE, 2012, P ROY SOC B-BIOL SCI, V279, P2347, DOI 10.1098/rspb.2011.2646; Crowcroft P., 1966, MICE ALL; CROWCROFT PETER, 1963, PROC ZOOL SOC LONDON, V140, P517; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fan Z, 2011, MOL CELL ENDOCRINOL, V333, P62, DOI 10.1016/j.mce.2010.12.010; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gervin K, 2011, GENOME RES, V21, P1813, DOI 10.1101/gr.119685.110; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Hoile SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021668; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Jablonka E, 2002, ANN NY ACAD SCI, V981, P82; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Ka SO, 2009, INT J MOL MED, V23, P633, DOI 10.3892/ijmm_00000174; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Kuzawa CW, 2011, EPIGENOMICS-UK, V3, P221, DOI [10.2217/EPI.11.11, 10.2217/epi.11.11]; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Li CCY, 2013, EPIGENETICS-US, V8, P602, DOI 10.4161/epi.24656; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lumey L H, 1992, Paediatr Perinat Epidemiol, V6, P240, DOI 10.1111/j.1365-3016.1992.tb00764.x; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; McGowan PO, 2010, ESSAYS BIOCHEM, V48, P275, DOI [10.1042/BSE0480275, 10.1042/bse0480275]; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montero I, 2013, MOL ECOL, V22, P2549, DOI 10.1111/mec.12271; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Rakyan VK, 2006, CURR OPIN GENET DEV, V16, P573, DOI 10.1016/j.gde.2006.09.002; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805; SELANDER RK, 1970, AM ZOOL, V10, P53; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Williams RP, 2009, IBM J RES DEV, V53, P1, DOI 10.1147/JRD.2009.5429026; Wilson IM, 2006, CELL CYCLE, V5, P155, DOI 10.4161/cc.5.2.2367; WRIGHT SL, 1988, BEHAV ECOL SOCIOBIOL, V23, P357, DOI 10.1007/BF00303709; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yeh TC, 2011, MOL CELL BIOL, V31, P43, DOI 10.1128/MCB.00801-10; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Youngson NA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0337; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	84	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97568	10.1371/journal.pone.0097568	http://dx.doi.org/10.1371/journal.pone.0097568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849289	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600037
J	Cao, BB; Hu, Y; Duan, JH; Ma, J; Xu, DK; Yang, XD				Cao, Beibei; Hu, Yan; Duan, Jinhong; Ma, Jie; Xu, Danke; Yang, Xian-Da			Selection of a Novel DNA Aptamer for Assay of Intracellular Interferon-Gamma	PLOS ONE			English	Article							LINKED IMMUNOSORBENT ASSAYS; ANTIBODY-SECRETING CELLS; FLOW-CYTOMETRY ASSAYS; EMERGING CLASS; ELISPOT ASSAY; T-CELLS; CYTOKINE; OPTIMIZATION; ENUMERATION; PROTEIN	Interferon-gamma (IFN-gamma) is a glycoprotein generated by lymphocytes that possesses anti-tumor, antiviral and immunomodulatory functions. IFN-gamma assays are broadly employed in immunological research and clinical diagnostic tests. Intracellular IFN-gamma staining, in particular, is an important immune assay that allows simultaneous determination of cellular phenotype and antigen-specific T cell response. Aptamers have great potential for molecule detection and can bind to target molecules with high affinity and specificity. In this study, a novel 59-mer DNA aptamer (B1-4) was developed for assay of intracellular IFN-gamma. The selected aptamer bound to IFN-gamma with a Kd of 74.5 nM, with minimal cross-reactivity to albumin. The aptamer was also found capable of binding with paraformaldehyde-fixed IFN-gamma. Moreover, B1-4 could enter permeated and paraformaldehyde-fixed lymphocytes, and bound to intracellular IFN-gamma produced by these cells. When FITC-labeled B1-4 was used to stain a group of lymphocytes, the average fluorescence of the cells was positively correlated with the number of PMA-stimulated lymphocytes within the group. A standard curve could thus be established for assessing the fraction of IFN-gamma-producing cells in a cluster of lymphocytes. The selected aptamer hence provides a novel approach for assaying intracellular IFN-gamma generated by a group of lymphocytes, and may have application potential in both scientific research and clinical laboratory test.	[Cao, Beibei; Hu, Yan; Duan, Jinhong; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Cao, Beibei; Hu, Yan; Duan, Jinhong; Ma, Jie; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Xu, Danke] Nanjing Univ, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Nanjing University	Hu, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	hyjy2008@hotmail.com; ayangmd@gmail.com			Chinese Ministry of Science and Technology [2011CB911003, 2011CB911004, 2011CB933504]; Chinese Ministry of Education	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the Chinese Ministry of Science and Technology (2011CB911003, 2011CB911004, 2011CB933504), and the 111 project of the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apilux A, 2013, LAB CHIP, V13, P126, DOI 10.1039/c2lc40690j; Balasubrananian V, 1998, MOL PHARMACOL, V53, P926; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Carothers JM, 2006, J AM CHEM SOC, V128, P7929, DOI 10.1021/ja060952q; Cox JH, 2006, METHODS, V38, P274, DOI 10.1016/j.ymeth.2005.11.006; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Davis KA, 1996, NUCLEIC ACIDS RES, V24, P702, DOI 10.1093/nar/24.4.702; Dixit CK, 2010, ANAL CHEM, V82, P7049, DOI 10.1021/ac101339q; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Han K, 2010, SENSORS-BASEL, V10, P4541, DOI 10.3390/s100504541; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lee PP, 1996, TRANSPLANTATION, V62, P1297, DOI 10.1097/00007890-199611150-00021; Lovelace P, 2011, METHODS MOL BIOL, V699, P165, DOI 10.1007/978-1-61737-950-5_8; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Mascini M, 2008, ANAL BIOANAL CHEM, V390, P987, DOI 10.1007/s00216-007-1769-y; Min K, 2008, BIOSENS BIOELECTRON, V23, P1819, DOI 10.1016/j.bios.2008.02.021; Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Nomura L, 2008, CYTOM PART A, V73A, P984, DOI 10.1002/cyto.a.20602; Nomura LE, 2000, CYTOMETRY, V40, P60, DOI 10.1002/(SICI)1097-0320(20000501)40:1<60::AID-CYTO8>3.0.CO;2-J; Nylander S, 1999, J IMMUNOL METHODS, V224, P69, DOI 10.1016/S0022-1759(99)00010-1; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; Proske D, 2005, APPL MICROBIOL BIOT, V69, P367, DOI 10.1007/s00253-005-0193-5; Reinsmoen Nancy L, 2013, Methods Mol Biol, V1034, P353, DOI 10.1007/978-1-62703-493-7_22; SEDGWICK JD, 1983, J IMMUNOL METHODS, V57, P301, DOI 10.1016/0022-1759(83)90091-1; Tombelli S, 2005, BIOELECTROCHEMISTRY, V67, P135, DOI 10.1016/j.bioelechem.2004.04.011; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tuleuova N, 2010, CELL MOL BIOENG, V3, P337, DOI 10.1007/s12195-010-0148-5; Tuleuova N, 2010, ANAL CHEM, V82, P1851, DOI 10.1021/ac9025237; Yan GP, 2013, BIOSENS BIOELECTRON, V44, P57, DOI 10.1016/j.bios.2013.01.010; Yanagisawa N, 2012, ANAL CHEM, V84, P7029, DOI 10.1021/ac3011632; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102	36	14	14	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98214	10.1371/journal.pone.0098214	http://dx.doi.org/10.1371/journal.pone.0098214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849390	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600099
J	Leclair, P; Lim, CJ				Leclair, Pascal; Lim, Chinten James			CD47-Independent Effects Mediated by the TSP-Derived 4N1K Peptide	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; C-TERMINAL DOMAIN; CELL-BINDING DOMAIN; T-CELL; VASCULAR ENDOTHELIUM; CD47; ADHESION; RECEPTOR; THROMBOSPONDIN-1; ACTIVATION	4N1K is a peptide fragment derived from the C-terminal, globular domain of thrombospondin which has been shown to mediate integrin-dependent cell adhesion and promote integrin activation acting via the cell-surface receptor, CD47. However, some studies found that 4N1K could act independently of CD47, putting in question the specificity of 4N1K for CD47. This led us to characterize the cellular and non-cellular effects of 4N1K. We found that 4N1K stimulated a potent increase in binding of a variety of non-specific IgG antibodies to cells in suspension. We also found that these same antibodies, as well as CD47-deficient cells, could bind substrate-immobilized 4N1K significantly better than a control peptide, 4NGG. Furthermore, we found that cells treated with 4N1K at higher concentrations inhibited, while lower concentrations promoted cell adhesion to immobilized fibronectin as an integrin substrate. Importantly, both the stimulatory and the inhibitory activity of 4N1K occurred as efficiently in the CD47-deficient JinB8 cells, as it did in the CD47-expressing parental or in JinB8 cells reconstituted with CD47 expression. Given these results, we suggest that 4N1K interacts non-specifically with epitopes commonly found on the cell surface, and conclude that it is not a suitable peptide for use to study the consequences of CD47 receptor ligation.	[Leclair, Pascal; Lim, Chinten James] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Leclair, Pascal] Univ British Columbia, Dept Cell & Dev Biol, Vancouver, BC V5Z 1M9, Canada; [Leclair, Pascal; Lim, Chinten James] BC Childrens Hosp, Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia	Lim, CJ (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada.	cjlim@mail.ubc.ca	Lim, Chinten James/G-3777-2013	Lim, Chinten James/0000-0001-6381-7585; Leclair, Pascal/0000-0002-0791-7028	Canadian Institutes of Health Research; National Science and Engineering Research Council; Canadian Foundation for Innovation; Child and Family Research Institute-Michael Cuccione Graduate award; Michael Cuccione Foundation; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Child and Family Research Institute-Michael Cuccione Graduate award; Michael Cuccione Foundation; Child and Family Research Institute	This study was supported by grants from the Canadian Institutes of Health Research, National Science and Engineering Research Council, and the Canadian Foundation for Innovation awarded to C.J.L. P.L. received a Child and Family Research Institute-Michael Cuccione Graduate award. C.J.L. was supported by the Michael Cuccione Foundation and holds an investigatorship from the Child and Family Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Adams JC, 2008, J CELL SCI, V121, P784, DOI 10.1242/jcs.021006; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Anilkumar N, 2002, J CELL SCI, V115, P2357; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Brittain JE, 2004, J BIOL CHEM, V279, P42393, DOI 10.1074/jbc.M407631200; Brittain JE, 2001, J CLIN INVEST, V107, P1555, DOI 10.1172/JCI10817; Brittain JE, 2001, BLOOD, V97, P2159, DOI 10.1182/blood.V97.7.2159; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chung J, 1997, J BIOL CHEM, V272, P14740, DOI 10.1074/jbc.272.23.14740; Floquet N, 2008, ARCH BIOCHEM BIOPHYS, V478, P103, DOI 10.1016/j.abb.2008.07.015; Frazier WA, 2010, PAGES UNM; Fujimoto TT, 2003, J BIOL CHEM, V278, P26655, DOI 10.1074/jbc.M302194200; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; GAO AG, 1994, J BIOL CHEM, V269, P29650; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; KOSFELD MD, 1993, J BIOL CHEM, V268, P8808; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Lagadec P, 2003, BLOOD, V101, P4836, DOI 10.1182/blood-2002-11-3483; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; Lindberg FP, 1996, J CELL BIOL, V134, P1313, DOI 10.1083/jcb.134.5.1313; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; McDonald JF, 2004, J BIOL CHEM, V279, P17301, DOI 10.1074/jbc.M312782200; McDonald JF, 2003, BIOCHEMISTRY-US, V42, P10001, DOI 10.1021/bi0341408; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; Rock MJ, 2010, MOL CELL BIOCHEM, V338, P215, DOI 10.1007/s11010-009-0355-3; Romzek NC, 1998, MOL BIOL CELL, V9, P2715, DOI 10.1091/mbc.9.10.2715; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; ROSEMBLATT M, 1991, J CLIN INVEST, V87, P6, DOI 10.1172/JCI115002; SCOPSI L, 1986, J HISTOCHEM CYTOCHEM, V34, P1469, DOI 10.1177/34.11.2877024; Sick E, 2012, BRIT J PHARMACOL, V167, P1415, DOI 10.1111/j.1476-5381.2012.02099.x; Ticchioni M, 2001, FASEB J, V15, P341, DOI 10.1096/fj.99-0833com; Tulasne D, 2001, BLOOD, V98, P3346, DOI 10.1182/blood.V98.12.3346; Wandersee NJ, 2004, BLOOD, V103, P710, DOI 10.1182/blood-2003-02-0492; Wang XQ, 1999, J CELL BIOL, V147, P389, DOI 10.1083/jcb.147.2.389	44	19	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98358	10.1371/journal.pone.0098358	http://dx.doi.org/10.1371/journal.pone.0098358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848268	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600110
J	Doerfler, H; Sun, XL; Wang, L; Engelmeier, D; Lyon, D; Weckwerth, W				Doerfler, Hannes; Sun, Xiaoliang; Wang, Lei; Engelmeier, Doris; Lyon, David; Weckwerth, Wolfram			mzGroupAnalyzer-Predicting Pathways and Novel Chemical Structures from Untargeted High-Throughput Metabolomics Data	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; SYSTEMS BIOLOGY; ELEMENTAL COMPOSITIONS; FUNCTIONAL GENOMICS; MOLECULAR FORMULAS; OXIDATIVE STRESS; ARABIDOPSIS; RESOLUTION; IDENTIFICATION; FRAGMENTATION	The metabolome is a highly dynamic entity and the final readout of the genotype x environment x phenotype (GxExP) relationship of an organism. Monitoring metabolite dynamics over time thus theoretically encrypts the whole range of possible chemical and biochemical transformations of small molecules involved in metabolism. The bottleneck is, however, the sheer number of unidentified structures in these samples. This represents the next challenge for metabolomics technology and is comparable with genome sequencing 30 years ago. At the same time it is impossible to handle the amount of data involved in a metabolomics analysis manually. Algorithms are therefore imperative to allow for automated m/z feature extraction and subsequent structure or pathway assignment. Here we provide an automated pathway inference strategy comprising measurements of metabolome time series using LC-MS with high resolution and high mass accuracy. An algorithm was developed, called mzGroupAnalyzer, to automatically explore the metabolome for the detection of metabolite transformations caused by biochemical or chemical modifications. Pathways are extracted directly from the data and putative novel structures can be identified. The detected m/z features can be mapped on a van Krevelen diagram according to their H/C and O/C ratios for pattern recognition and to visualize oxidative processes and biochemical transformations. This method was applied to Arabidopsis thaliana treated simultaneously with cold and high light. Due to a protective antioxidant response the plants turn from green to purple color via the accumulation of flavonoid structures. The detection of potential biochemical pathways resulted in 15 putatively new compounds involved in the flavonoid-pathway. These compounds were further validated by product ion spectra from the same data. The mzGroupAnalyzer is implemented in the graphical user interface (GUI) of the metabolomics toolbox COVAIN (Sun & Weckwerth, 2012, Metabolomics 8: 81-93). The strategy can be extended to any biological system.	[Doerfler, Hannes; Sun, Xiaoliang; Wang, Lei; Engelmeier, Doris; Lyon, David; Weckwerth, Wolfram] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria	University of Vienna	Weckwerth, W (corresponding author), Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria.	wolfram.weckwerth@univie.ac.at	Weckwerth, Wolfram/G-5811-2010	Lyon, David/0000-0001-5794-0456; Weckwerth, Wolfram/0000-0002-9719-6358; Doerfler, Hannes/0000-0002-3596-784X	Austrian Science Fund (FWF) [P25488, P23441]; China Scholarship Council	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); China Scholarship Council(China Scholarship Council)	The authors thank the Austrian Science Fund (FWF) for financial support to Hannes Dorfler and David Lyon (FWF project P25488 and P23441, respectively). Lei Wang was supported by a grant of the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Garcia B, 2009, RAPID COMMUN MASS SP, V23, P2785, DOI 10.1002/rcm.4182; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bashandy T, 2009, MOL PLANT, V2, P249, DOI 10.1093/mp/ssn065; Bloor SJ, 2002, PHYTOCHEMISTRY, V59, P343, DOI 10.1016/S0031-9422(01)00460-5; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Doerfler H, 2013, METABOLOMICS, V9, P564, DOI 10.1007/s11306-012-0470-0; Dong CH, 2009, MOL PLANT, V2, P59, DOI 10.1093/mp/ssn063; Dunn WB, 2012, METABOLOMICS; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Giavalisco P, 2008, ANAL CHEM, V80, P9417, DOI 10.1021/ac8014627; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Huang XX, 2010, STUD FUZZ SOFT COMP, V250, P1; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109; Kai K, 2011, PLANT BIOTECHNOL-NAR, V28, P379, DOI 10.5511/plantbiotechnology.11.0704b; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Kasai HF, 2011, RAPID COMMUN MASS SP, V25, P1051, DOI 10.1002/rcm.4956; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind Tobias, 2010, Bioanal Rev, V2, P23, DOI 10.1007/s12566-010-0015-9; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; Lee KW, 2004, CRIT REV FOOD SCI, V44, P437, DOI 10.1080/10408690490886674; March RE, 2004, INT J MASS SPECTROM, V231, P157, DOI 10.1016/j.ijms.2003.10.008; Mari A, 2013, METABOLOMICS, V9, P599, DOI 10.1007/s11306-012-0473-x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Quenzer T.L., 2002, P 50 ANN C MASS SPEC; Reemtsma T, 2009, J CHROMATOGR A, V1216, P3687, DOI 10.1016/j.chroma.2009.02.033; Rogers S, 2009, BIOINFORMATICS, V25, P512, DOI 10.1093/bioinformatics/btn642; Rohn H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-139; SAITO N, 1995, PHYTOCHEMISTRY, V38, P1027, DOI 10.1016/0031-9422(94)00659-H; Scherling C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012569; Seyoum A, 2006, PHYTOCHEMISTRY, V67, P2058, DOI 10.1016/j.phytochem.2006.07.002; Soga Tomoyoshi, 2007, V358, P129, DOI 10.1007/978-1-59745-244-1_8; Sun XL, 2012, METABOLOMICS, V8, pS81, DOI 10.1007/s11306-012-0399-3; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Van der Greef J, 2006, PHARMACOGENOMICS, V7, P1087, DOI 10.2217/14622416.7.7.1087; Van Krevelen D., 1950, GRAPHICAL STAT METHO, V29, P269, DOI DOI 10.1520/D0850-11.1; Weckwerth W, 2005, DRUG DISCOV TODAY, V10, P1551, DOI 10.1016/S1359-6446(05)03609-3; Weckwerth W, 2011, J PROTEOMICS, V75, P284, DOI 10.1016/j.jprot.2011.07.010; Weckwerth W, 2011, ANAL BIOANAL CHEM, V400, P1967, DOI 10.1007/s00216-011-4948-9; Wu ZG, 2004, ANAL CHEM, V76, P2511, DOI 10.1021/ac0355449	45	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96188	10.1371/journal.pone.0096188	http://dx.doi.org/10.1371/journal.pone.0096188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846183	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400006
J	Loewendorf, AI; Nguyen, TA; Yesayan, MN; Kahn, DA				Loewendorf, Andrea I.; Nguyen, Tina A.; Yesayan, Maria N.; Kahn, Daniel A.			Normal Human Pregnancy Results in Maternal Immune Activation in the Periphery and at the Uteroplacental Interface	PLOS ONE			English	Article							REGULATORY T-CELLS; FOXP3; EXPRESSION; BLOOD; LYMPHOCYTES; SUBSETS; DECIDUA; INDUCTION; MEMORY	Pregnancy poses a unique challenge to the human immune system: the semi-allogeneic fetus must be protected from maternal immune attack while immunity towards pathogens is maintained. Breakdown in maternal-fetal tolerance can lead to pregnancy-specific diseases with potentially high degrees of morbidity and mortality for both the mother and her fetus. Various immune cell-types could mediate these functions, but a comprehensive evaluation of the peripheral and local maternal T cell and regulatory T cell compartments in normal human pregnancy is lacking. In this case-control study, we apply the Human Immunology Project Consortium proposed gating strategies to samples from healthy 3rd trimester human subjects compared with healthy non-pregnant controls. The proportions of HLA-DR+ and CD38+ effector-and effector memory CD8 T cells are significantly increased in the peripheral blood of pregnant women. Utilizing a novel technique that takes advantage of the standard protocol for intrauterine cleanup after cesarean section, we isolate lymphocytes resident at the uteroplacental interface (UPI). At the UPI, the CD4 and CD8 T cell compartments largely mirror the peripheral blood, except that the proportion of HLA-DR+ activated T regulatory cells is significantly increased in direct proportion to an observed increase in the number of activated CD8 T cells. We find that cryopreservation and delayed sample processing (> 12 hours) decreases our ability to identify regulatory T cell subsets. Further, the Consortium proposed method for Treg identification underrepresents Resting and Cytokine Tregs compared with Activated Tregs, thus skewing the entire population. Better understanding of the changes in the immune system during pregnancy in the peripheral blood and at the uteroplacental interface are essential for progress in treatment of pregnancy diseases such as pre-eclampsia and recurrent miscarriage.	[Loewendorf, Andrea I.; Nguyen, Tina A.; Yesayan, Maria N.; Kahn, Daniel A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kahn, DA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.	dkahn@mednet.ucla.edu		Loewendorf, Andrea/0000-0001-7150-3316	National Institutes of Health (NIH) [CA-16042, AI-28697]; Harvey L. Karp Discovery Award; Reproductive Scientist Development Program; NIH/NICHD [2K12HD000849-26]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvey L. Karp Discovery Award; Reproductive Scientist Development Program; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility that is supported by National Institutes of Health (NIH) awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. In addition, the authors acknowledge the support of Harvey L. Karp Discovery Award, Reproductive Scientist Development Program (D.A.K.) NIH/NICHD 2K12HD000849-26 (Moley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; DUDLEY DJ, 1990, AM J OBSTET GYNECOL, V163, P1890, DOI 10.1016/0002-9378(90)90769-4; Filburgs T, 2010, J IMMUNOL, V185, P4470; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x; KESTENS L, 1992, AIDS, V6, P793, DOI 10.1097/00002030-199208000-00004; Kisielewicz A, 2010, CLIN IMMUNOL, V137, P209, DOI 10.1016/j.clim.2010.07.008; Kmieciak M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-89; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; Lissauer D, 2014, CLIN SCI, V126, P347, DOI 10.1042/CS20130247; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Merkenschlager M, 1989, Int Immunol, V1, P450, DOI 10.1093/intimm/1.4.450; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mjosberg J, 2010, BIOL REPROD, V82, P698, DOI 10.1095/biolreprod.109.081208; Nettenstrom L, 2013, J IMMUNOL METHODS, V387, P81, DOI 10.1016/j.jim.2012.09.014; Roederer M, 2001, CYTOMETRY, V45, P56, DOI 10.1002/1097-0320(20010901)45:1<56::AID-CYTO1144>3.0.CO;2-9; Sakaguchi S, 2003, J CLIN INVEST, V112, P1310, DOI 10.1172/JCI200320274; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Scaife PJ, 2006, BIOL REPROD, V75, P562, DOI 10.1095/biolreprod.106.052654; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tilburgs T, 2006, PLACENTA, V27, pS47, DOI 10.1016/j.placenta.2005.11.008; Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zheng Y, 2008, J IMMUNOL, V181, P1683, DOI 10.4049/jimmunol.181.3.1683	27	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96723	10.1371/journal.pone.0096723	http://dx.doi.org/10.1371/journal.pone.0096723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846312	Green Submitted, gold, Green Published			2022-12-27	WOS:000339563400010
J	Lorch, JA; Pollak, VE				Lorch, Jonathan A.; Pollak, Victor E.			Continuous Quality Improvement in Daily Clinical Practice: A Proof of Concept Study	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENT; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; HEMOGLOBIN LEVELS; EPOETIN-ALPHA; MORTALITY; ANEMIA; LEVEL; IRON	Continuous Quality Improvement (CQI) is an iterative process of: planning to improve a product or process, plan implementation, analyzing and comparing results against those expected, and corrective action on differences between actual and expected results. It is little used in clinical medicine. Anemia, a complex problem in End Stage Renal Disease patients, served to test the ability of an unique electronic medical record (EMR) optimized for daily care to empower CQI in practice. We used data collected during daily care, stored in the EMR, and organized to display temporal relationships between clinical, laboratory, and therapeutic events. Our aims were optimal hemoglobin with minimum epoetin, and maintaining stable hemoglobin and epoetin. The study was done on 250 patients treated by maintenance hemodialysis (HD), receiving epoetin prior to February 1, 2010 and followed to July 31, 2011. Repleting iron, ensuring iron sufficiency, slow epoetin reduction, and decision support tools enabling data display over long periods in patient-centered reports were key elements. Epoetin dose, adjusted 6-8 weekly, was based on current clinical conditions and past responses. Hemoglobin increased by months 1-2; epoetin decreased from month 4. By months 16-18, epoetin had decreased 42% to 9,720 units/week while hemoglobin increased 8% to 123.6 g/L. Hemoglobin and epoetin were stable from month 7 onward. New epoetin orders decreased 83%. Transferrin saturation increased after the study start. Individual patient hemoglobin variation decreased by 23%, range by 27%. Mortality, 11.78 per 100 patient years, was 42% less than United States dialysis patient mortality. Allowable epoetin charges decreased by $15.33 per treatment and were $22.88 less than current Medicare allowance. The study validates the hypothesis that an EMR optimized for daily patient care can empower CQI in clinical medicine and serve to monitor medical care quality and cost.	[Lorch, Jonathan A.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Pollak, Victor E.] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA; [Lorch, Jonathan A.] Rogosin Inst, New York, NY USA; [Pollak, Victor E.] MIQS Inc, Boulder, CO USA	Cornell University; University of Colorado System; University of Colorado Anschutz Medical Campus	Pollak, VE (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA.	vpollak@miqs.com			MIQS, Inc.	MIQS, Inc.	VEP received salary support from MIQS, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2010, CLIN J AM SOC NEPHRO, V5, P1340, DOI 10.2215/CJN.02830310; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Besarab A, 2009, ADV CHRONIC KIDNEY D, V16, P131, DOI 10.1053/j.ackd.2008.12.007; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Deming W, 1982, OUT CRISIS; Deming W.E., 1986, STAT METHOD VIEWPOIN; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; ESCHBACH JW, 1967, NEW ENGL J MED, V276, P653, DOI 10.1056/NEJM196703232761202; ESCHBACH JW, 1991, AM J KIDNEY DIS, V18, P3; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Feinstein AR, 1997, AM J MED, V103, P529, DOI 10.1016/S0002-9343(97)00244-1; Fort J, 2010, NEPHROL DIAL TRANSPL, V25, P2702, DOI 10.1093/ndt/gfq073; FRIES JF, 1972, J AMER MED ASSOC, V222, P1536, DOI 10.1001/jama.222.12.1536; Fuller DS, 2013, AM J KIDNEY DIS, V61, P342, DOI 10.1053/j.ajkd.2012.10.002; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Hampl H, 2005, AM J NEPHROL, V25, P211, DOI 10.1159/000085881; Heffler S, 2005, HLTH AFF MILLWOOD S; Hsu CY, 2002, J AM SOC NEPHROL, V13, P2783, DOI 10.1097/01.ASN.0000034200.82278.DC; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; National Research Council, 2012, BEST CAR LOW COST PA; Ofsthun N, 2003, KIDNEY INT, V63, P1908, DOI 10.1046/j.1523-1755.2003.00937.x; POLLAK VE, 1977, ARCH INTERN MED, V137, P446, DOI 10.1001/archinte.137.4.446; Pollak VE, 2001, J INVEST MED, V49, P173, DOI 10.2310/6650.2001.34044; POLLAK VE, 1985, JAMA-J AM MED ASSOC, V253, P62; Pollak VE, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-6; Pollak VE, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-38; Portoles J, 2007, NEPHROL DIAL TRANSPL, V22, P500, DOI 10.1093/ndt/gfl558; Rawlins M, 2008, LANCET, V372, P2152, DOI 10.1016/S0140-6736(08)61930-3; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Servilla KS, 2009, AM J KIDNEY DIS, V54, P498, DOI 10.1053/j.ajkd.2009.05.007; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; U S Renal Data System, 2011, ANN DAT REP ATL CHRO; Weinhandl ED, 2011, AM J NEPHROL, V34, P298, DOI 10.1159/000330693	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97066	10.1371/journal.pone.0097066	http://dx.doi.org/10.1371/journal.pone.0097066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844323	Green Submitted, gold, Green Published			2022-12-27	WOS:000339563400013
J	Mahapatra, B; Battala, M; Porwal, A; Saggurti, N				Mahapatra, Bidhubhusan; Battala, Madhusudana; Porwal, Akash; Saggurti, Niranjan			Non-Disclosure of Violence among Female Sex Workers: Evidence from a Large Scale Cross-Sectional Survey in India	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; HIV PREVENTION; ANDHRA-PRADESH; KARNATAKA STATE; CONDOM USE; RISK; AVAHAN; WOMEN; INTERVENTIONS; VULNERABILITY	Objective: One of the indicators critical to the success of violence reduction programmes among female sex workers (FSWs) is the pattern of disclosure of violence. This study examines the rate of non-disclosure of violence among FSWs in India by perpetrators of violence and programme exposure. Methods: Data were drawn from a cross-sectional study conducted among FSWs in 2009 across four states of India: Andhra Pradesh, Karnataka, Maharashtra and Tamil Nadu. The analytical sample included 1341 FSWs who experienced physical violence in past six months. Multilevel logistic regression stratified by state was conducted to examine predictors of nondisclosure. Results: About 54% of FSWs did not disclose their experience of violence to anyone with considerable variations in the pattern of disclosure across states. Another 36% of FSWs shared the experience with NGO worker/peer. Compared to violence perpetrated by paying partners/stranger, that by non-paying partner were twice more likely to report nondisclosure (53% vs. 68%, Adjusted Odds Ratio [AOR]: 1.8, 95% Confidence Interval [CI]: 1.3-2.4). Similarly, FSWs who were not registered with an NGO/sex worker collective were 40% more likely to report non-disclosure of violence against those registered (58% vs. 53%, AOR: 1.4, 95% CI: 1.1-1.9). Conclusions: Non-disclosure of physical violence is quite high among FSWs which can be a barrier to the success of violence reduction efforts. Immediate efforts are required to understand the reasons behind non-disclosure based on which interventions can be developed. Community collectivisation and designing gender-based interventions with the involvement of non-paying partners should be the way forward.	[Mahapatra, Bidhubhusan; Battala, Madhusudana; Porwal, Akash; Saggurti, Niranjan] Populat Council, HIV & AIDS Program, Delhi, India		Mahapatra, B (corresponding author), Populat Council, HIV & AIDS Program, Delhi, India.	bbmahapatra@gmail.com	Mahapatra, Bidhubhusan/M-1411-2019	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Saggurti, Niranjan/0000-0002-5267-8425				[Anonymous], 2007, NAT FAM HLTH SURV 3; Asthana S, 1996, SOC SCI MED, V43, P133, DOI 10.1016/0277-9536(95)00348-7; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Coast E, 2012, GENDER BASED VIOLENC; Dandona L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-I1; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Deering K, 2011, SEX TRANSM INFECT, V87, pA66, DOI 10.1136/sextrans-2011-050109.98; Deering KN, 2013, SEX TRANSM DIS, V40, P168, DOI 10.1097/OLQ.0b013e31827df174; Erausquin JT, 2011, J INFECT DIS, V204, pS1223, DOI 10.1093/infdis/jir539; George A, 2011, J INFECT DIS, V204, pS1235, DOI 10.1093/infdis/jir542; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Karandikar S, 2013, J ETHN CULT DIVERSIT, V22, P112, DOI 10.1080/15313204.2013.785349; Karnataka Health Promotion Trust (KHPT), 2012, EV COMM MOB EMP REL; Laga M, 2010, SEX TRANSM INFECT, V86, pI6, DOI 10.1136/sti.2009.039255; Panchanadeswaran S, 2008, WOMEN HEALTH ISS, V18, P35, DOI 10.1016/j.whi.2007.10.007; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Popoola BI, 2013, HEALTH CARE WOMEN IN, V34, P139, DOI 10.1080/07399332.2011.646366; Ramesh S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-764; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Rhodes T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a811; Saggurti N, 2013, AIDS CARE, V25, pS55, DOI 10.1080/09540121.2012.749334; Saidel T, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000343761.77702.04; Simic M, 2009, SOCIOL HEALTH ILL, V31, P1, DOI 10.1111/j.1467-9566.2008.01112.x; Stockman JK, 2013, AIDS CARE, V25, P472, DOI 10.1080/09540121.2012.722602; Stockman JK, 2013, AIDS BEHAV, V17, P832, DOI 10.1007/s10461-012-0361-4; World Health Organization, 2005, WHO INF B SER	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98321	10.1371/journal.pone.0098321	http://dx.doi.org/10.1371/journal.pone.0098321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24846145	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400105
J	Mullin, BH; Mamotte, C; Prince, RL; Wilson, SG				Mullin, Benjamin H.; Mamotte, Cyril; Prince, Richard L.; Wilson, Scott G.			Influence of ARHGEF3 and RHOA Knockdown on ACTA2 and Other Genes in Osteoblasts and Osteoclasts	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CELL-LINES; SUGGESTIVE LINKAGE; PROMOTER ACTIVITY; MASS; OSTEOPOROSIS; WOMEN; ACTIN; TWIN; DIFFERENTIATION	Osteoporosis is a common bone disease that has a strong genetic component. Genome-wide linkage studies have identified the chromosomal region 3p14-p22 as a quantitative trait locus for bone mineral density (BMD). We have previously identified associations between variation in two related genes located in 3p14-p22, ARHGEF3 and RHOA, and BMD in women. In this study we performed knockdown of these genes using small interfering RNA (siRNA) in human osteoblast-like and osteoclast-like cells in culture, with subsequent microarray analysis to identify genes differentially regulated from a list of 264 candidate genes. Validation of selected findings was then carried out in additional human cell lines/cultures using quantitative real-time PCR (qRT-PCR). The qRT-PCR results showed significant down-regulation of the ACTA2 gene, encoding the cytoskeletal protein alpha 2 actin, in response to RHOA knockdown in both osteoblast-like (P<0.001) and osteoclast-like cells (P = 0.002). RHOA knockdown also caused up-regulation of the PTH1R gene, encoding the parathyroid hormone 1 receptor, in Saos-2 osteoblast-like cells (P<0.001). Other findings included down-regulation of the TNFRSF11B gene, encoding osteoprotegerin, in response to ARHGEF3 knockdown in the Saos-2 and hFOB 1.19 osteoblast-like cells (P = 0.003-0.02), and down-regulation of ARHGDIA, encoding the Rho GDP dissociation inhibitor alpha, in response to RHOA knockdown in osteoclast-like cells (P<0.001). These studies identify ARHGEF3 and RHOA as potential regulators of a number of genes in bone cells, including TNFRSF11B, ARHGDIA, PTH1R and ACTA2, with influences on the latter evident in both osteoblast-like and osteoclast-like cells. This adds further evidence to previous studies suggesting a role for the ARHGEF3 and RHOA genes in bone metabolism.	[Mullin, Benjamin H.; Prince, Richard L.; Wilson, Scott G.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Mullin, Benjamin H.; Mamotte, Cyril] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA, Australia; [Mullin, Benjamin H.; Mamotte, Cyril] Curtin Univ, Fac Hlth Sci, CHIRI Biosci Res Precinct, Bentley, WA, Australia; [Mullin, Benjamin H.; Prince, Richard L.; Wilson, Scott G.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Wilson, Scott G.] Kings Coll London, Twin & Genet Epidemiol Res Unit, London, England	University of Western Australia; Curtin University; Curtin University; University of Western Australia; University of London; King's College London	Mullin, BH (corresponding author), Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia.	Benjamin.Mullin@uwa.edu.au	Mamotte, Cyril/AAF-9603-2020; Mullin, Benjamin/H-5493-2014	Mullin, Benjamin/0000-0003-0743-770X; Wilson, Scott/0000-0002-0357-1373; Mamotte, Cyril/0000-0003-1831-3921	Arthritis Australia [0402067]; Curtin University	Arthritis Australia; Curtin University	This study was supported by Arthritis Australia (Grant 0402067) and Curtin University Postgraduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2005, J BONE MINER RES, V20, P67, DOI 10.1359/JBMR.041015; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilbe G, 1996, BONE, V19, P437, DOI 10.1016/S8756-3282(96)00254-2; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Deng HW, 2000, J BONE MINER RES, V15, P1243, DOI 10.1359/jbmr.2000.15.7.1243; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; EVANS RA, 1988, ANN INTERN MED, V109, P870, DOI 10.7326/0003-4819-109-11-870; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; FLICKER L, 1995, J BONE MINER RES, V10, P1607; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Illumina, 2007, ILL TECHN B PUB; Illumina, 2008, ILL TECHN B PUB; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Lee YH, 2006, J HUM GENET, V51, P480, DOI 10.1007/s10038-006-0390-9; LOWIK CWGM, 1989, BIOCHEM BIOPH RES CO, V162, P1546, DOI 10.1016/0006-291X(89)90851-6; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Mullin BH, 2008, AM J HUM GENET, V82, P1262, DOI 10.1016/j.ajhg.2008.04.016; Mullin BH, 2009, BONE, V45, P387, DOI 10.1016/j.bone.2009.04.254; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pautke C, 2004, ANTICANCER RES, V24, P3743; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Prince RL, 1997, OSTEOPOROSIS INT, V7, P150, DOI 10.1007/BF03194362; Radeff JM, 2004, J BONE MINER RES, V19, P1882, DOI 10.1359/JBMR.040806; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seeman E, 1996, AM J PHYSIOL-ENDOC M, V270, pE320, DOI 10.1152/ajpendo.1996.270.2.E320; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Wang J, 2010, J CELL BIOCH; Wilkins TD, 1996, TRENDS MICROBIOL, V4, P49, DOI 10.1016/0966-842X(96)81508-3; Wilson SG, 2003, AM J HUM GENET, V72, P144, DOI 10.1086/345819; Wynne F, 2003, CALCIFIED TISSUE INT, V72, P651, DOI 10.1007/s00223-002-2086-2; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	46	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98116	10.1371/journal.pone.0098116	http://dx.doi.org/10.1371/journal.pone.0098116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840563	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600108
J	van Hees, NJM; Giltay, EJ; Geleijnse, JM; Janssen, N; van der Does, W				van Hees, Nathalie J. M.; Giltay, Erik J.; Geleijnse, Johanna M.; Janssen, Nadine; van der Does, Willem			DHA Serum Levels Were Significantly Higher in Celiac Disease Patients Compared to Healthy Controls and Were Unrelated to Depression	PLOS ONE			English	Article							GLUTEN-FREE DIET; FATTY-ACID-COMPOSITION; MAJOR DEPRESSION; BODY-COMPOSITION; CHILDREN; OMEGA-3-FATTY-ACIDS; PREVALENCE; DIAGNOSIS; CYTOKINES; ANXIETY	Objectives: Celiac disease (CD), a genetically predisposed intolerance for gluten, is associated with an increased risk of major depressive disorder (MDD). We investigated whether dietary intake and serum levels of the essential n-3 polyunsaturated fatty acids (PUFA) eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA) found in fatty fish play a role in this association. Methods: Cross-sectional study in 71 adult CD patients and 31 healthy volunteers, matched on age, gender and level of education, who were not using n-3 PUFA supplements. Dietary intake, as assessed using a 203-item food frequency questionnaire, and serum levels of EPA and DHA were compared in analyses of covariance, adjusting for potential confounders. Serum PUFA were determined using gas chromatography. Results: Mean serum DHA was significantly higher in CD patients (1.72 mass%) than controls (1.28 mass%) after multivariable adjustment (mean diff. 0.45 mass%; 95% CI: 0.22-0.68; p = 0.001). The mean intake of EPA plus DHA did not differ between CD patients and controls after multivariable adjustment (0.15 and 0.22 g/d, respectively; p = 0.10). There were no significant differences in intake or serum levels of EPA and DHA between any of the CD patient groups (never depressed, current MDD, minor/partially remitted MDD, remitted MDD) and controls. Conclusions: Patients on a long term gluten-free diet had similar intakes of EPA plus DHA compared to controls. Contrary to expectations, DHA serum levels were significantly higher in CD patients compared to healthy controls and were unrelated to MDD status.	[van Hees, Nathalie J. M.; Janssen, Nadine; van der Does, Willem] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Giltay, Erik J.; van der Does, Willem] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [van der Does, Willem] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC)	van Hees, NJM (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	heesnjmvan@fsw.leidenuniv.nl	Giltay, Erik J./AAL-9948-2021; Geleijnse, Johanna Marianna M/B-5749-2012; Van der Does, Willem/B-1465-2008	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Van der Does, Willem/0000-0002-9753-2454; /0000-0001-6716-0023; Giltay, Erik/0000-0001-8874-2292	Netherlands Science Foundation (N.W.O-MaGW Vici grant) [453-06-005]; Leiden University Fund (LUF); Gratama Foundation	Netherlands Science Foundation (N.W.O-MaGW Vici grant); Leiden University Fund (LUF); Gratama Foundation	This project was funded by a grant from the Netherlands Science Foundation (N.W.O-MaGW Vici grant #453-06-005 to WVDD) (http://www.nwo.nl/en), and grants from the Leiden University Fund (LUF) and Gratama Foundation (http://www.luf.nl/subsidies/information-in-english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenavoli L, 2006, WORLD J GASTROENTERO, V12, P843, DOI 10.3748/wjg.v12.i6.843; Addolorato G, 2008, INT J CLIN PRACT, V62, P1063, DOI 10.1111/j.1742-1241.2008.01763.x; Addolorato G, 2001, SCAND J GASTROENTERO, V36, P502, DOI 10.1080/00365520119754; Addolorato G, 1996, HEPATO-GASTROENTEROL, V43, P1513; Addolorato G, 2008, DIGEST DIS, V26, P140, DOI 10.1159/000116772; Alvarez-Jubete L, 2009, INT J FOOD SCI NUTR, V60, P240, DOI 10.1080/09637480902950597; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Bardella MT, 2000, AM J CLIN NUTR, V72, P937; Biagi F, 2010, ANN MED, V42, P557, DOI 10.3109/07853890.2010.523229; Biagi F, 2009, BRIT J NUTR, V102, P882, DOI 10.1017/S0007114509301579; Bloch MH, 2012, MOL PSYCHIATR, V17, P1272, DOI 10.1038/mp.2011.100; Capristo E, 2000, AM J CLIN NUTR, V72, P76; Capristo E, 1997, SCAND J GASTROENTERO, V32, P1222, DOI 10.3109/00365529709028151; Carta MG, 2002, J PSYCHOSOM RES, V53, P789, DOI 10.1016/S0022-3999(02)00328-8; Chambrier C, 2002, CLIN NUTR, V21, P67, DOI 10.1054/clnu.2001.0505; Ciacci C, 1998, SCAND J GASTROENTERO, V33, P247; Corvaglia L, 1999, AM J GASTROENTEROL, V94, P839, DOI 10.1111/j.1572-0241.1999.00956.x; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; EMKEN EA, 1987, LIPIDS, V22, P495, DOI 10.1007/BF02540365; FARKKILA MA, 1987, SCAND J GASTROENTERO, V22, P411, DOI 10.3109/00365528708991483; Ferrara P, 2009, ACTA GASTRO-ENT BELG, V72, P296; Fornari MC, 1998, AM J GASTROENTEROL, V93, P413, DOI 10.1016/S0002-9270(97)00115-9; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Forsberg G, 2007, INT IMMUNOL, V19, P993, DOI 10.1093/intimm/dxm077; Freeman M P, 2000, Ann Clin Psychiatry, V12, P159, DOI 10.1023/A:1009069002816; Giltay EJ, 2011, AM J CLIN NUTR, V94, P1442, DOI 10.3945/ajcn.111.018259; Hallert C, 2002, ALIMENT PHARM THER, V16, P1333, DOI 10.1046/j.1365-2036.2002.01283.x; HALLERT C, 1983, GUT, V24, P389, DOI 10.1136/gut.24.5.389; HERNANZ A, 1991, GUT, V32, P1478, DOI 10.1136/gut.32.12.1478; Holub BJ, 2002, CAN MED ASSOC J, V166, P608; Innis SM, 2000, DEV NEUROSCI-BASEL, V22, P474, DOI 10.1159/000017478; Jakobsdottir G, 2013, SCAND J GASTROENTERO, V48, P696, DOI 10.3109/00365521.2013.786128; Jans LAW, 2010, BRIT J NUTR, V104, P1577, DOI 10.1017/S0007114510004125; JASKIEWICZ J, 1987, Acta Physiologica Polonica, V38, P22; Karwautz A, 2008, PSYCHOSOMATICS, V49, P399, DOI 10.1176/appi.psy.49.5.399; KEMPPAINEN T, 1995, SCAND J GASTROENTERO, V30, P575, DOI 10.3109/00365529509089792; Lahat N, 1999, SCAND J IMMUNOL, V49, P441; Leffler DA, 2008, DIGEST DIS SCI, V53, P1573, DOI 10.1007/s10620-007-0055-3; Leffler DA, 2009, CLIN GASTROENTEROL H, V7, P530, DOI 10.1016/j.cgh.2008.12.032; LEPAGE G, 1986, J LIPID RES, V27, P114; Lesperance F, 2011, J CLIN PSYCHIAT, V72, P1054, DOI 10.4088/JCP.10m05966blu; Lin PY, 2010, BIOL PSYCHIAT, V68, P140, DOI 10.1016/j.biopsych.2010.03.018; Maes M, 1996, J AFFECT DISORDERS, V38, P35, DOI 10.1016/0165-0327(95)00092-5; Mariani P, 1998, J PEDIATR GASTR NUTR, V27, P519, DOI 10.1097/00005176-199811000-00004; Peet M, 2002, ARCH GEN PSYCHIAT, V59, P913, DOI 10.1001/archpsyc.59.10.913; Pynnonen PA, 2002, PSYCHOSOMATICS, V43, P331, DOI 10.1176/appi.psy.43.4.331; REY J, 1965, REV FR ETUD CLIN BIO, V10, P488; ROSENTHAL E, 1990, J PEDIATR GASTR NUTR, V11, P58, DOI 10.1097/00005176-199007000-00012; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Rush AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1841, DOI 10.1038/sj.npp.1301131; Schulte-van Maaren YWM, 2013, J EVAL CLIN PRACT, V19, P342, DOI 10.1111/j.1365-2753.2012.01830.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Siguel EN, 1996, METABOLISM, V45, P12, DOI 10.1016/S0026-0495(96)90194-8; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Solakivi T, 2011, SCAND J GASTROENTERO, V46, P299, DOI 10.3109/00365521.2010.533380; Solakivi T, 2009, SCAND J GASTROENTERO, V44, P826, DOI 10.1080/00365520902912589; Steel DM, 2006, J PEDIATR GASTR NUTR, V43, P318, DOI 10.1097/01.mpg.0000228107.98863.45; Stichting Nederlands Voedingsstoffenbestand (NEVO foundation), DUTCH FOOD COMP TABL; Thompson T, 2000, J AM DIET ASSOC, V100, P1389, DOI 10.1016/S0002-8223(00)00386-2; Thompson T, 2005, J HUM NUTR DIET, V18, P163, DOI 10.1111/j.1365-277X.2005.00607.x; Tiemeier H, 2003, AM J CLIN NUTR, V78, P40, DOI 10.1093/ajcn/78.1.40; van Hees NJM, 2013, J PSYCHOSOM RES, V74, P155, DOI 10.1016/j.jpsychores.2012.11.007; van Vliet I M, 2007, Tijdschr Psychiatr, V49, P393; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wild D, 2010, ALIMENT PHARM THER, V32, P573, DOI 10.1111/j.1365-2036.2010.04386.x	68	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97778	10.1371/journal.pone.0097778	http://dx.doi.org/10.1371/journal.pone.0097778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841484	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600073
J	Wang, YJ; Koster, K; Lummer, M; Ragg, H				Wang, Yunjie; Koester, Katharina; Lummer, Martina; Ragg, Hermann			Origin of Serpin-Mediated Regulation of Coagulation and Blood Pressure	PLOS ONE			English	Article							HEPARIN-COFACTOR-II; SERINE-PROTEASE INHIBITOR; ANGIOTENSIN-II; THROMBIN; EVOLUTION; RECEPTOR; ACTIVATION; ROLES; LAMPREY; SYSTEM	Vertebrates evolved an endothelium-lined hemostatic system and a pump-driven pressurized circulation with a finely-balanced coagulation cascade and elaborate blood pressure control over the past 500 million years. Genome analyses have identified principal components of the ancestral coagulation system, however, how this complex trait was originally regulated is largely unknown. Likewise, little is known about the roots of blood pressure control in vertebrates. Here we studied three members of the serpin superfamily that interfere with procoagulant activity and blood pressure of lampreys, a group of basal vertebrates. Angiotensinogen from these jawless fish was found to fulfill a dual role by operating as a highly selective thrombin inhibitor that is activated by heparin-related glycosaminoglycans, and concurrently by serving as source of effector peptides that activate type 1 angiotensin receptors. Lampreys, uniquely among vertebrates, thus use angiotensinogen for interference with both coagulation and osmo- and pressure regulation. Heparin cofactor II from lampreys, in contrast to its paralogue angiotensinogen, is preferentially activated by dermatan sulfate, suggesting that these two serpins affect different facets of thrombin's multiple roles. Lampreys also express a lineage-specific serpin with anti-factor Xa activity, which demonstrates that another important procoagulant enzyme is under inhibitory control. Comparative genomics suggests that orthologues of these three serpins were key components of the ancestral hemostatic system. It appears that, early in vertebrate evolution, coagulation and osmo-and pressure regulation crosstalked through antiproteolytically active angiotensinogen, a feature that was lost during vertebrate radiation, though in gnathostomes interplay between these traits is effective.	[Wang, Yunjie; Koester, Katharina; Ragg, Hermann] Univ Bielefeld, Fac Technol, D-33615 Bielefeld, Germany; [Lummer, Martina] Univ Bielefeld, Fac Biol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Ragg, H (corresponding author), Univ Bielefeld, Fac Technol, D-33615 Bielefeld, Germany.	hermann.ragg@uni-bielefeld.de			Bielefeld University	Bielefeld University	This work was supported by Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin M, 2009, J MOL CELL CARDIOL, V46, P15, DOI 10.1016/j.yjmcc.2008.09.123; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bentele C, 2006, BIOCHEM J, V395, P449, DOI 10.1042/BJ20051947; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Brinkmeyer S, 2004, EUR J BIOCHEM, V271, P4275, DOI 10.1111/j.1432-1033.2004.04367.x; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Doolittle RF, 2009, COLD SH Q B, V74, P35, DOI 10.1101/sqb.2009.74.001; Doolittle RF, 2013, EVOLUTION VERTEBRATE, P142; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; Evans AN, 2010, COMP BIOCHEM PHYS B, V157, P423, DOI 10.1016/j.cbpb.2010.09.006; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Han X, 2000, BLOOD, V96, P3049; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Huang PH, 2007, INT J CARDIOL, V114, P152, DOI 10.1016/j.ijcard.2005.12.009; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huntington JA, 2013, J THROMB HAEMOST, V11, P254, DOI 10.1111/jth.12252; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Ikeda Y, 2012, J BIOL CHEM, V287, P34256, DOI 10.1074/jbc.M112.353532; Janvier P, 2006, NATURE, V443, P921, DOI 10.1038/443921a; Le MT, 2002, J BIOL CHEM, V277, P23107, DOI 10.1074/jbc.C200201200; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Monahan-Earley R, 2013, J THROMB HAEMOST, V11, P46, DOI 10.1111/jth.12253; Mushunje A, 2003, BLOOD, V102, P4028, DOI 10.1182/blood-2003-05-1560; Oley M, 2004, FEBS LETT, V577, P165, DOI 10.1016/j.febslet.2004.10.003; Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x; Ponczek MB, 2012, J MOL EVOL, V74, P319, DOI 10.1007/s00239-012-9509-0; Pulakat L, 2004, BIOCHEM BIOPH RES CO, V319, P1138, DOI 10.1016/j.bbrc.2004.05.092; RAGG H, 1990, J BIOL CHEM, V265, P5211; Ragg H, 2001, MOL BIOL EVOL, V18, P577, DOI 10.1093/oxfordjournals.molbev.a003838; Ragg H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-208; Salzet M, 2001, BRAIN RES REV, V36, P35, DOI 10.1016/S0165-0173(01)00063-7; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Siller-Matula JM, 2011, THROMB HAEMOSTASIS, V106, P1020, DOI 10.1160/TH10-11-0711; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; Wang YJ, 2011, FEBS LETT, V585, P2395, DOI 10.1016/j.febslet.2011.06.021; Wei MC, 2010, ANAL CHEM, V82, P6303, DOI 10.1021/ac100797t; Wong MKS, 2011, J ENDOCRINOL, V209, P127, DOI 10.1530/JOE-10-0422; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97879	10.1371/journal.pone.0097879	http://dx.doi.org/10.1371/journal.pone.0097879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840053	Green Submitted, gold, Green Published			2022-12-27	WOS:000340948600085
J	Dumont, AO; Goursaud, S; Desmet, N; Hermans, E				Dumont, Amelie O.; Goursaud, Stephanie; Desmet, Nathalie; Hermans, Emmanuel			Differential Regulation of Glutamate Transporter Subtypes by Pro-Inflammatory Cytokine TNF-alpha in Cortical Astrocytes from a Rat Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; NEUROLOGICAL DISORDERS; DISEASE PROGRESSION; FAMILIAL ALS; EXPRESSION; BRAIN; GLAST; EAAT2; TRANSCRIPTION	Dysregulation of the astroglial glutamate transporters GLAST and GLT-1 has been implicated in several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) where a loss of GLT-1 protein expression and activity is reported. Furthermore, the two principal C-terminal splice variants of GLT-1 (namely GLT-1a and GLT-1b) show altered expression ratio in animal models of this disease. Considering the putative link between inflammation and excitotoxicity, we have here characterized the influence of TNF-alpha on glutamate transporters in cerebral cortical astrocyte cultures from wild-type rats and from a rat model of ALS (hSOD1(G93A)). Contrasting with the down-regulation of GLAST, a 72 h treatment with TNF-alpha substantially increased the expression of GLT-1a and GLT-1b in both astrocyte cultures. However, as the basal level of GLT-1a appeared considerably lower in hSOD1(G93A) astrocytes, its up-regulation by TNF-alpha was insufficient to recapitulate the expression observed in wild-type astrocytes. Also the glutamate uptake activity after TNF-alpha treatment was lower for hSOD1(G93A) astrocytes as compared to wild-type astrocytes. In the presence of the protein synthesis inhibitor cycloheximide, TNF-alpha did not influence GLT-1 isoform expression, suggesting an active role of dynamically regulated protein partners in the adaptation of astrocytes to the inflammatory environment. Confirming the influence of inflammation on the control of glutamate transmission by astrocytes, these results shed light on the regulation of glutamate transporter isoforms in neurodegenerative disorders.	[Dumont, Amelie O.; Goursaud, Stephanie; Desmet, Nathalie; Hermans, Emmanuel] Catholic Univ Louvain, Inst Neurosci, Grp Neuropharmacol, B-1200 Brussels, Belgium	Universite Catholique Louvain	Hermans, E (corresponding author), Catholic Univ Louvain, Inst Neurosci, Grp Neuropharmacol, B-1200 Brussels, Belgium.	emmanuel.hermans@uclouvain.be	Hermans, Emmanuel/A-1654-2015; Hermans, Emmanuel/V-3040-2019		DIANE research program of the Belgian Walloon Region Ministry (DGTRE); Association belge pour les maladies neuromusculaires (ABMM); Ministry of Scientific Policy (Belgium) [ARC 10/15-026]	DIANE research program of the Belgian Walloon Region Ministry (DGTRE); Association belge pour les maladies neuromusculaires (ABMM); Ministry of Scientific Policy (Belgium)	This work was supported by the DIANE research program of the Belgian Walloon Region Ministry (DGTRE), by the Association belge pour les maladies neuromusculaires (ABMM) and by a grant of Ministry of Scientific Policy (Belgium, ARC 10/15-026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Aoki M, 2005, NEUROPATHOLOGY, V25, P365, DOI 10.1111/j.1440-1789.2005.00611.x; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Berger JV, 2012, NEUROSCIENCE, V205, P29, DOI 10.1016/j.neuroscience.2011.12.044; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Boycott HE, 2008, GLIA, V56, P998, DOI 10.1002/glia.20673; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Cereda C, 2008, J NEUROIMMUNOL, V194, P123, DOI 10.1016/j.jneuroim.2007.10.028; Chadwick W, 2008, TRENDS NEUROSCI, V31, P504, DOI 10.1016/j.tins.2008.07.005; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dumont AO, 2013, NEUROCHEM INT; Focant MC, 2011, NEUROCHEM INT; Ghosh M, 2011, J NEUROSCI, V31, P9159, DOI 10.1523/JNEUROSCI.0302-11.2011; Gonzalez-Gonzalez IM, 2008, J NEUROCHEM, V105, P1834, DOI 10.1111/j.1471-4159.2008.05281.x; Goursaud S, 2011, FASEB J, V25, P3674, DOI 10.1096/fj.11-182337; Goursaud S, 2009, NEUROCHEM INT, V55, P28, DOI 10.1016/j.neuint.2009.02.003; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hensley K, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-2; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Korn T, 2005, FASEB J, V19, P1878, DOI 10.1096/fj.05-3748fje; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lauriat TL, 2007, MOL PSYCHIATR, V12, P1065, DOI 10.1038/sj.mp.4002065; Liu YP, 2008, J NEUROCHEM, V105, P137, DOI 10.1111/j.1471-4159.2007.05118.x; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Martinez-Villarreal J, 2012, GLIA; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; McCombe PA, 2011, CURR MOL MED, V11, P246; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; Ramirez-Sotelo G, 2007, NEUROCHEM RES, V32, P73, DOI 10.1007/s11064-006-9227-3; Rodriguez-Kern A, 2003, NEUROCHEM INT, V43, P363, DOI 10.1016/S0197-0186(03)00023-8; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Sogaard R, 2013, J BIOL CHEM; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tilleux S, 2008, J NEUROCHEM, V105, P2224, DOI 10.1111/j.1471-4159.2008.05305.x; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Tilleux S, 2009, NEUROCHEM INT, V55, P35, DOI 10.1016/j.neuint.2008.12.021; Tolosa L, 2011, MOL CELL NEUROSCI, V46, P176, DOI 10.1016/j.mcn.2010.09.001; Zelenaia OA, 2000, J NEUROCHEM, V75, P2252, DOI 10.1046/j.1471-4159.2000.0752252.x	44	25	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97649	10.1371/journal.pone.0097649	http://dx.doi.org/10.1371/journal.pone.0097649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836816	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800059
J	Xianjun, P; Linhong, T; Xiaoman, W; Yucheng, W				Xianjun, P.; Linhong, T.; Xiaoman, W.; Yucheng, W.			De Novo Assembly of Expressed Transcripts and Global Transcriptomic Analysis from Seedlings of the Paper Mulberry (Broussonetia kazinoki x Broussonetia papyifera) (vol 9, e97487, 2014)	PLOS ONE			English	Correction													wang, xiaoman/GQH-0836-2022					Peng XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0108613, 10.1371/journal.pone.0097487]; XIANJUN P, 2014, PLOS ONE, V0009	2	23	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e108613	10.1371/journal.pone.0108613	http://dx.doi.org/10.1371/journal.pone.0108613			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	24848504	Green Published, gold			2022-12-27	WOS:000341774300096
J	Benzinger, P; Rapp, K; Maetzler, W; Konig, HH; Jaensch, A; Klenk, J; Buchele, G				Benzinger, Petra; Rapp, Kilian; Maetzler, Walter; Koenig, Hans-Helmut; Jaensch, Andrea; Klenk, Jochen; Buechele, Gisela			Risk for Femoral Fractures in Parkinson's Disease Patients with and without Severe Functional Impairment	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; OSTEOPOROTIC FRACTURES; HIP FRACTURE; OLDER MEN; FALLS; BONE; ASSOCIATION; POPULATION; DISABILITY; DIAGNOSIS	Background: Impaired balance is a major problem in patients with idiopathic Parkinson's disease (PD) resulting in an increased risk of falls and fall-related fractures. Most studies which analyzed the risk of femoral fractures in patients with idiopathic PD were performed either in specialized centers or excluded very frail patients. The current study used a large population-based dataset in order to analyze the risk of femoral fractures in patients with idiopathic PD. Methods: Data from more than 880.000 individuals aged 65 years or older and insured between 2004 and 2009 at a large German health insurance company were used for the analyses. Persons with idiopathic PD were identified by the dispensing of Parkinson-specific medication and by hospital diagnoses, if available. People without PD served as the reference group. Incident femoral fractures were obtained from hospital diagnoses. Analyses were stratified by gender and information on severe functional impairment (care need) as provided by reimbursement claims. Results: Compared with the reference group, persons with idiopathic PD had a more than doubled risk to sustain a femoral fracture. The risk was higher in men (HR = 2.61; 95%-CI: 2.28-2.98) than in women (HR = 1.79; 95%-CI: 1.66-1.94). The increased risk was only observed in people without severe functional impairment. The sensitivity analysis using a refined definition of idiopathic PD patients yielded similar results. Conclusion: The findings confirm the increased risk of femoral fractures in patients with idiopathic PD. The relative risk is particularly high in male PD patients and in patients without severe functional impairment.	[Benzinger, Petra; Rapp, Kilian; Klenk, Jochen] Robert Bosch Krankenhaus Stuttgart, Dept Clin Gerontol & Rehabil, Stuttgart, Germany; [Rapp, Kilian; Jaensch, Andrea; Klenk, Jochen; Buechele, Gisela] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Maetzler, Walter] Univ Hosp Tuebingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Maetzler, Walter] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	Bosch; Robert Bosch Krankenhaus; Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Hamburg; University Medical Center Hamburg-Eppendorf	Benzinger, P (corresponding author), Robert Bosch Krankenhaus Stuttgart, Dept Clin Gerontol & Rehabil, Stuttgart, Germany.	petra.benzinger@rbk.de	Maetzler, Walter/AAE-5831-2020; König, Hans-Helmut/P-1211-2018; Klenk, Jochen/C-2164-2012; Maetzler, Walter/A-6796-2011; Klenk, Jochen/R-3614-2019; Rapp, Kilian/AAJ-3370-2020	Maetzler, Walter/0000-0002-5945-4694; König, Hans-Helmut/0000-0001-5711-6862; Maetzler, Walter/0000-0002-5945-4694; Klenk, Jochen/0000-0002-5987-447X; Rapp, Kilian/0000-0003-1625-2571	Bundesministerium fur Bildung und Forschung [Forderkennzeichen: 01EC1007A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The analysis was supported by the Bundesministerium fur Bildung und Forschung (Forderkennzeichen: 01EC1007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Raya S, 2009, AGE AGEING, V38, P675, DOI 10.1093/ageing/afp137; Arbouw MEL, 2011, OSTEOPOROSIS INT, V22, P2197, DOI 10.1007/s00198-010-1455-3; Balash Y, 2005, J NEUROL, V252, P1310, DOI 10.1007/s00415-005-0855-3; Becker C, 1998, FACT RES INTERV GER, P55; Benzinger P, 2013, J AM MED DIR ASSOC, V14, P673, DOI 10.1016/j.jamda.2013.03.012; Bhattacharya RK, 2012, MOVEMENT DISORD, V27, P1440, DOI 10.1002/mds.25073; Bleibler F, 2013, OSTEOPOROSIS INT, V24, P835, DOI 10.1007/s00198-012-2020-z; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Cirillo DJ, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-39; Clubb VJ, 2006, INJURY, V37, P929, DOI 10.1016/j.injury.2005.11.013; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Fink HA, 2008, OSTEOPOROSIS INT, V19, P1277, DOI 10.1007/s00198-008-0584-4; Fink HA, 2005, J AM GERIATR SOC, V53, P1559, DOI 10.1111/j.1532-5415.2005.53464.x; Genever RW, 2005, AGE AGEING, V34, P21, DOI 10.1093/ageing/afh203; Harrison MB, 2009, MOVEMENT DISORD, V24, P224, DOI 10.1002/mds.22335; Healy GN, 2010, REV ESP CARDIOL, V63, P261, DOI 10.1016/S0300-8932(10)70083-X; Hening W, 2004, SLEEP MED, V5, P237, DOI 10.1016/j.sleep.2004.03.006; Hogl B, 2005, NEUROLOGY, V64, P1920, DOI 10.1212/01.WNL.0000163996.64461.A3; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Icks A, 2008, OSTEOPOROSIS INT, V19, P1139, DOI 10.1007/s00198-007-0534-6; Icks AIA, 2013, ARCH OSTEOPOROS, V8, P1; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; JOHNELL O, 1992, AGE AGEING, V21, P32, DOI 10.1093/ageing/21.1.32; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Matinolli M, 2011, ACTA NEUROL SCAND, V123, P193, DOI 10.1111/j.1600-0404.2010.01386.x; Melton LJ, 2006, MOVEMENT DISORD, V21, P1361, DOI 10.1002/mds.20946; Pickering RM, 2007, MOVEMENT DISORD, V22, P1892, DOI 10.1002/mds.21598; Plotnik M, 2011, EXP BRAIN RES, V210, P529, DOI 10.1007/s00221-011-2551-0; Rapp K, 2012, AGE AGEING, V41, P653, DOI 10.1093/ageing/afs044; Schneider JL, 2008, OSTEOPOROSIS INT, V19, P1093, DOI 10.1007/s00198-008-0583-5; Temlett JA, 2006, INTERN MED J, V36, P524, DOI 10.1111/j.1445-5994.2006.01123.x; Trenkwalder C, 2008, MOVEMENT DISORD, V23, P2267, DOI 10.1002/mds.22254; van de Vijver DAMC, 2001, PHARM WORLD SCI, V23, P148, DOI 10.1023/A:1011807919632; van den Bos F, 2013, AGE AGEING, V42, P156, DOI 10.1093/ageing/afs161; Vestergaard P, 2007, CALCIFIED TISSUE INT, V81, P153, DOI 10.1007/s00223-007-9065-6; Wielinski CL, 2005, MOVEMENT DISORD, V20, P410, DOI 10.1002/mds.20347; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721	40	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97073	10.1371/journal.pone.0097073	http://dx.doi.org/10.1371/journal.pone.0097073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853110	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200015
J	Alves, M; Reinach, PS; Paula, JS; Cruz, AAVE; Bachette, L; Faustino, J; Aranha, FP; Vigorito, A; de Souza, CA; Rocha, EM				Alves, Monica; Reinach, Peter Sol; Paula, Jayter Silva; Vellasco e Cruz, Antonio Augusto; Bachette, Leticia; Faustino, Jacqueline; Aranha, Francisco Penteado; Vigorito, Afonso; de Souza, Carmino Antonio; Rocha, Eduardo Melani			Comparison of Diagnostic Tests in Distinct Well-Defined Conditions Related to Dry Eye Disease	PLOS ONE			English	Article							OCULAR SURFACE DISEASE; TEAR FILM FUNCTION; LACRIMAL GLAND; SJOGRENS-SYNDROME; INFLAMMATION; PREVALENCE; CORNEAL; TRIALS; INDEX	Purpose: This study compares signs, symptoms and predictive tools used to diagnose dry eye disease (DED) and ocular surface disorders in six systemic well-defined and non-overlapping diseases. It is well known that these tests are problematic because of a lack of agreement between them in identifying these conditions. Accordingly, we provide here a comparative clinical profile analysis of these different diseases. Methods: A spontaneous and continuous sample of patients with Sjogren's syndrome (SS) (n = 27), graft-versus-host-disease (GVHD) (n = 28), Graves orbitopathy (n = 28), facial palsy (n = 8), diabetes mellitus without proliferative retinopathy (n = 14) and glaucoma who chronically received topical drugs preserved with benzalkonium chloride (n = 20) were enrolled. Evaluation consisted of a comprehensive protocol encompassing: (1) structured questionnaire - Ocular Surface Disease Index (OSDI); (2) tear osmolarity (TearLab Osmolarity System - Ocusense); (3) tear film break-up time (TBUT); (4) fluorescein and lissamine green staining; (5) Schirmer test and (6) severity grading. Results: One hundred and twenty five patients (aged 48.8 years-old +/- 14.1, male:female ratio = 0.4) were enrolled in the study, along with 24 age and gender matched controls. Higher scores on DED tests were obtained in Sjogren Syndrome (P<0.05), except for tear film osmolarity that was higher in diabetics (P<0.001) and fluorescein staining, that was higher in facial palsy (P<0.001). TFBUT and OSDI correlated better with other tests. The best combination of diagnostic tests for DED was OSDI, TBUT and Schirmer test (sensitivity 100%, specificity 95% and accuracy 99.3%). Conclusions: DED diagnostic test results present a broad range of variability among different conditions. Vital stainings and TBUT correlated best with one another whereas the best test combination to detect DED was: OSDI/TBUT/Schirmer.	[Alves, Monica; Reinach, Peter Sol; Paula, Jayter Silva; Vellasco e Cruz, Antonio Augusto; Bachette, Leticia; Faustino, Jacqueline; Rocha, Eduardo Melani] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil; [Alves, Monica] Pontific Catholic Univ Campinas, Campinas, SP, Brazil; [Aranha, Francisco Penteado; Vigorito, Afonso; de Souza, Carmino Antonio] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil	Universidade de Sao Paulo; Pontificia Universidade Catolica de Campinas; Universidade Estadual de Campinas	Alves, M (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.	monicalves1@uol.com.br	Rocha, Eduardo Melani/D-6002-2011; PAULA, JAYTER S/D-1249-2013; Reinach, Peter/AAI-3582-2021; Alves, Monica/J-1499-2014	Rocha, Eduardo Melani/0000-0001-9888-7313; PAULA, JAYTER S/0000-0002-8111-3810; Alves, Monica/0000-0001-7940-0194; De Souza, Carmino/0000-0001-8656-8374	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Apoio ao Ensino, Pesquisa e AssistAancia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); NAP-FTO USP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino, Pesquisa e AssistAancia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); NAP-FTO USP	This study was supported by grants from the following Brazilian governmental agencies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Apoio ao Ensino, Pesquisa e AssistAancia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA) and NAP-FTO USP. The funders had no role in study design, data collection and analysis, decision to public, or preparation of the manuscript.	Alves M, 2013, OCUL SURF, V11, P181, DOI 10.1016/j.jtos.2013.02.002; Alves MD, 2008, ARQ BRAS OFTALMOL, V71, P96, DOI 10.1590/S0004-27492008000700018; Barabino S, 2013, EUR J OPHTHALMOL; Baudouin C, 1999, OPHTHALMOLOGY, V106, P556, DOI 10.1016/S0161-6420(99)90116-1; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Dias AC, 2007, INVEST OPHTH VIS SCI, V48, P3038, DOI 10.1167/iovs.06-1309; Dogru M, 2001, OPHTHALMOLOGY, V108, P586, DOI 10.1016/S0161-6420(00)00599-6; Goebbels M, 2000, BRIT J OPHTHALMOL, V84, P19, DOI 10.1136/bjo.84.1.19; Kaiserman I, 2005, AM J OPHTHALMOL, V139, P498, DOI 10.1016/j.ajo.2004.10.022; Khanal S, 2008, INVEST OPHTH VIS SCI, V49, P1407, DOI 10.1167/iovs.07-0635; Kim J, 2000, Curr Opin Ophthalmol, V11, P241, DOI 10.1097/00055735-200008000-00005; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; Labbe A, 2013, INVEST OPHTH VIS SCI, V54, P5144, DOI 10.1167/iovs.13-12370; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Lee SY, 2012, OPHTHAL PHYSL OPT, V32, P518, DOI 10.1111/j.1475-1313.2012.00931.x; Lemp Michael A., 1995, CLAO Journal, V21, P221; Lemp MA, 2007, OCUL SURF, V5, P75; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Li MY, 2012, INVEST OPHTH VIS SCI, V53, P5722, DOI 10.1167/iovs.11-9094; Manaviat MR, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-10; McGinnigle S, 2012, SURV OPHTHALMOL, V57, P293, DOI 10.1016/j.survophthal.2011.11.003; Messmer EM, 2010, DEV OPHTHALMOL, V45, P129, DOI 10.1159/000315026; Modulo CM, 2009, ENDOCRINE, V36, P161, DOI 10.1007/s12020-009-9208-9; Novaes P, 2010, ENVIRON RES, V110, P372, DOI 10.1016/j.envres.2010.03.003; Pflugfelder SC, 1998, CORNEA, V17, P38, DOI 10.1097/00003226-199801000-00007; Prigol AM, 2012, ARQ BRAS OFTALMOL, V75, P24, DOI 10.1590/S0004-27492012000100005; Rocha EM, 2008, OCUL SURF, V6, P162, DOI 10.1016/S1542-0124(12)70177-5; Rocha EM, 2000, BONE MARROW TRANSPL, V25, P1101, DOI 10.1038/sj.bmt.1702334; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Smith J, 2008, CORNEA, V27, P656, DOI 10.1097/QAI.0b013e3181605b95; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; Sullivan BD, 2012, ACTA OPHTHALMOL; Sullivan BD, 2012, CORNEA, V31, P1000, DOI 10.1097/ICO.0b013e318242fd60; Sullivan DA, 1997, J RHEUMATOL, V24, P17; Sullivan DA, 1999, INVEST OPHTH VIS SCI, V40, P1261; Versura P, 2010, CURR EYE RES, V35, P553, DOI 10.3109/02713683.2010.484557; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Walsh NP, 2012, INVEST OPHTH VIS SCI, V53, P6622, DOI 10.1167/iovs.12-10175; Wong J, 2011, OCUL SURF, V9, P212, DOI 10.1016/S1542-0124(11)70034-9; Yu L, 2008, OPHTHALMOLOGICA, V222, P284, DOI 10.1159/000140256; Zoukhri D, 2006, EXP EYE RES, V82, P885, DOI 10.1016/j.exer.2005.10.018	44	65	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97921	10.1371/journal.pone.0097921	http://dx.doi.org/10.1371/journal.pone.0097921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848115	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600069
J	Daros, RR; Costa, JHC; von Keyserlingk, MAG; Hotzel, MJ; Weary, DM				Daros, Rolnei R.; Costa, Joao H. C.; von Keyserlingk, Marina A. G.; Hoetzel, Maria J.; Weary, Daniel M.			Separation from the Dam Causes Negative Judgement Bias in Dairy Calves	PLOS ONE			English	Article							BEEF-CALVES; COGNITIVE BIAS; BEHAVIOR; PAIN; STRESS	Negative emotional states in humans are associated with a negative (pessimistic) response bias towards ambiguous cues in judgement tasks. Every mammalian young is eventually weaned; this period of increasing nutritional and social independence from the dam is associated with a pronounced behavioural response, especially when weaning is abrupt as commonly occurs in farm animals. The aim of the current study was to test the effect of separation from the cow on the responses of dairy calves in a judgement task. Thirteen Holstein calves were reared with their dams and trained to discriminate between red and white colours displayed on a computer monitor. These colours predicted reward or punishment outcomes using a go/no-go task. A reward was provided when calves approached the white screen and calves were punished with a timeout when they approached the red screen. Calves were then tested with non-reinforced ambiguous probes (screen colours intermediate to the two training colours). "GO" responses to these probes averaged (6 SE) 72 +/- 3.6 % before separation but declined to 62 +/- 3.6 % after separation from the dam. This bias was similar to that shown by calves experiencing pain in the hours after hot-iron dehorning. These results provide the first evidence of a pessimistic judgement bias in animals following maternal separation and are indicative of low mood.	[Daros, Rolnei R.; Costa, Joao H. C.; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada; [Daros, Rolnei R.; Hoetzel, Maria J.] Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada & Bem Estar Anim, Florianopolis, SC, Brazil	University of British Columbia; Universidade Federal de Santa Catarina (UFSC)	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	danweary@mail.ubc.ca	Hötzel, Maria José/H-6975-2014; von Keyserlingk, Marina/AAB-6353-2019; Costa, Joao H. C./M-6660-2014; Daros, Ruan R./L-6395-2019; Costa, Joao H. C./ABD-4749-2021; Weary, Daniel M/A-8868-2010	Hötzel, Maria José/0000-0003-1034-3202; von Keyserlingk, Marina/0000-0002-1427-3152; Costa, Joao H. C./0000-0001-9311-4741; Daros, Ruan R./0000-0003-2331-1648; Costa, Joao H. C./0000-0001-9311-4741; Weary, Daniel M/0000-0002-0917-3982	Natural Sciences and Engineering Research Council of Canada (NSERC); CAPES (Coordenacao de aperfeicoamento de pessoal de nivel superior); ELAP (Emerging Leaders in the Americas Program); CNPq (Conselho Nacional de Desenvolvimento Cientifcco e Tecnologico); CNPq [304123/2012-9]; BBSRC [BB/J004197/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J004197/1] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CAPES (Coordenacao de aperfeicoamento de pessoal de nivel superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ELAP (Emerging Leaders in the Americas Program); CNPq (Conselho Nacional de Desenvolvimento Cientifcco e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). RRD was supported by scholarships from CAPES (Coordenacao de aperfeicoamento de pessoal de nivel superior) and ELAP (Emerging Leaders in the Americas Program). JHCC was supported by a scholarship from CNPq (Conselho Nacional de Desenvolvimento Cientifcco e Tecnologico). MJH thanks CNPq for their general support through grant number 304123/2012-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adobe Systems Inc, 2010, AD PHOT EL 9 0; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Daros RR, 2014, SEPARATION DAM CAUSE; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Eisenberger NI, 2012, PSYCHOSOM MED, V74, P126, DOI 10.1097/PSY.0b013e3182464dd1; Enriquez DH, 2010, LIVEST SCI, V128, P20, DOI 10.1016/j.livsci.2009.10.007; Enriquez D, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-28; Flower FC, 2003, ANIM WELFARE, V12, P339; Haley DB, 2005, J ANIM SCI, V83, P2205; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hickey MC, 2003, J ANIM SCI, V81, P2847; Hotzel MJ, 2010, ANIM PROD SCI, V50, P909, DOI 10.1071/AN09136; HUDSON SJ, 1977, APPL ANIM ETHOL, V3, P271, DOI 10.1016/0304-3762(77)90008-6; Loberg JM, 2008, APPL ANIM BEHAV SCI, V111, P222, DOI 10.1016/j.applanim.2007.06.011; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; MARTIN P, 1984, ANIM BEHAV, V32, P1257, DOI 10.1016/S0003-3472(84)80245-6; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Neave HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080556; Panksepp J, 2003, SCIENCE, V302, P237, DOI 10.1126/science.1091062; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pomerantz O, 2012, ANIM COGN, V15, P689, DOI 10.1007/s10071-012-0497-7; *SAS I INC, 2007, SAS ONLINEDOC 9 1 3; Stafford KJ, 2011, APPL ANIM BEHAV SCI, V135, P226, DOI 10.1016/j.applanim.2011.10.018; Veissier I, 2013, APPL ANIM BEHAV SCI, V147, P11, DOI 10.1016/j.applanim.2013.05.002; von Keyserlingk MAG, 2007, HORM BEHAV, V52, P106, DOI 10.1016/j.yhbeh.2007.03.015; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025	31	60	60	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98429	10.1371/journal.pone.0098429	http://dx.doi.org/10.1371/journal.pone.0098429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848635	Green Published, gold			2022-12-27	WOS:000336730600113
J	Hossain, MDT; Yamada, N; Yamamoto, K				Hossain, M. D. Tofazzal; Yamada, Naotaka; Yamamoto, Kohji			Glutathione-Binding Site of a Bombyx mori Theta-Class Glutathione Transferase	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; S-TRANSFERASES; EPSILON-CLASS; ACTIVE-SITE; DROSOPHILA-MELANOGASTER; CATALYTIC MECHANISM; STRUCTURAL BASIS; EXPRESSION; SILKWORM; IDENTIFICATION	The glutathione transferase (GST) superfamily plays key roles in the detoxification of various xenobiotics. Here, we report the isolation and characterization of a silkworm protein belonging to a previously reported theta-class GST family. The enzyme (bmGSTT) catalyzes the reaction of glutathione with 1-chloro-2,4-dinitrobenzene, 1,2-epoxy-3-(4-nitrophenoxy)-propane, and 4-nitrophenethyl bromide. Mutagenesis of highly conserved residues in the catalytic site revealed that Glu66 and Ser67 are important for enzymatic function. These results provide insights into the catalysis of glutathione conjugation in silkworm by bmGSTT and into the metabolism of exogenous chemical agents.	[Hossain, M. D. Tofazzal; Yamada, Naotaka; Yamamoto, Kohji] Kyushu Univ, Grad Sch, Fac Agr, Fukuoka 812, Japan	Kyushu University	Yamamoto, K (corresponding author), Kyushu Univ, Grad Sch, Fac Agr, Fukuoka 812, Japan.	yamamok@agr.kyushu-u.ac.jp	Yamamoto, Kohji/AAD-9097-2019		KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, Tokyo, Japan) [24580078]	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, Tokyo, Japan)	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI, 24580078) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; Awasthi YC, 2005, METHOD ENZYMOL, V401, P379, DOI 10.1016/S0076-6879(05)01024-4; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BOARD PG, 1995, BIOCHEM J, V311, P247, DOI 10.1042/bj3110247; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Caccuri AM, 1997, J BIOL CHEM, V272, P29681, DOI 10.1074/jbc.272.47.29681; DANIEL V, 1993, CRIT REV BIOCHEM MOL, V28, P173, DOI 10.3109/10409239309086794; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HABIG WH, 1974, J BIOL CHEM, V249, P7130; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kakuta Y, 2011, BBA-GEN SUBJECTS, V1810, P1355, DOI 10.1016/j.bbagen.2011.06.022; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson AK, 2010, ARCH BIOCHEM BIOPHYS, V497, P28, DOI 10.1016/j.abb.2010.03.001; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; LISTOWSKY I, 1988, DRUG METAB REV, V19, P305, DOI 10.3109/03602538808994138; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Nay B, 1999, INSECT BIOCHEM MOLEC, V29, P71, DOI 10.1016/S0965-1748(98)00106-4; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shokeer A, 2010, BBA-GEN SUBJECTS, V1800, P466, DOI 10.1016/j.bbagen.2010.01.003; Shokeer A, 2010, J BIOL CHEM, V285, P5639, DOI 10.1074/jbc.M109.074757; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Tan KL, 1996, BIOCHEM J, V319, P315, DOI 10.1042/bj3190315; Tars K, 2006, J MOL BIOL, V355, P96, DOI 10.1016/j.jmb.2005.10.049; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Winayanuwattikun P, 2005, J BIOL CHEM, V280, P31776, DOI 10.1074/jbc.M502612200; Winayanuwattikun P, 2007, BIOCHEM J, V402, P339, DOI 10.1042/BJ20061253; Yamamoto K, 2006, J APPL ENTOMOL, V130, P515, DOI 10.1111/j.1439-0418.2006.01092.x; Yamamoto K, 2013, INSECT MOL BIOL, V22, P523, DOI 10.1111/imb.12041; Yamamoto K, 2005, COMP BIOCHEM PHYS B, V141, P340, DOI 10.1016/j.cbpc.2005.04.012; Yamamoto K, 2007, BIOSCI BIOTECH BIOCH, V71, P553, DOI 10.1271/bbb.60592; Yamamoto K, 2012, BBA-GEN SUBJECTS, V1820, P1469, DOI 10.1016/j.bbagen.2012.04.022; Yamamoto K, 2011, BBA-GEN SUBJECTS, V1810, P420, DOI 10.1016/j.bbagen.2011.01.003; Yamamoto K, 2009, COMP BIOCHEM PHYS C, V149, P461, DOI 10.1016/j.cbpc.2008.10.108; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008	44	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97740	10.1371/journal.pone.0097740	http://dx.doi.org/10.1371/journal.pone.0097740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848539	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600052
J	Voigt, RM; Forsyth, CB; Green, SJ; Mutlu, E; Engen, P; Vitaterna, MH; Turek, FW; Keshavarzian, A				Voigt, Robin M.; Forsyth, Christopher B.; Green, Stefan J.; Mutlu, Ece; Engen, Phillip; Vitaterna, Martha H.; Turek, Fred W.; Keshavarzian, Ali			Circadian Disorganization Alters Intestinal Microbiota	PLOS ONE			English	Article							GUT MICROBIOTA; RUMINOCOCCUS-BROMII; METABOLIC SYNDROME; CROHNS-DISEASE; OBESITY; HOMEOSTASIS; CLOCK; DIET; RISK; POPULATIONS	Intestinal dysbiosis and circadian rhythm disruption are associated with similar diseases including obesity, metabolic syndrome, and inflammatory bowel disease. Despite the overlap, the potential relationship between circadian disorganization and dysbiosis is unknown; thus, in the present study, a model of chronic circadian disruption was used to determine the impact on the intestinal microbiome. Male C57BL/6J mice underwent once weekly phase reversals of the light: dark cycle (i.e., circadian rhythm disrupted mice) to determine the impact of circadian rhythm disruption on the intestinal microbiome and were fed either standard chow or a high-fat, high-sugar diet to determine how diet influences circadian disruption-induced effects on the microbiome. Weekly phase reversals of the light: dark (LD) cycle did not alter the microbiome in mice fed standard chow; however, mice fed a high-fat, high-sugar diet in conjunction with phase shifts in the light: dark cycle had significantly altered microbiota. While it is yet to be established if some of the adverse effects associated with circadian disorganization in humans (e. g., shift workers, travelers moving across time zones, and in individuals with social jet lag) are mediated by dysbiosis, the current study demonstrates that circadian disorganization can impact the intestinal microbiota which may have implications for inflammatory diseases.	[Voigt, Robin M.; Forsyth, Christopher B.; Mutlu, Ece; Engen, Phillip; Keshavarzian, Ali] Rush Univ, Med Ctr, Div Gastroenterol, Dept Internal Med, Chicago, IL 60612 USA; [Green, Stefan J.] Univ Illinois, Res Resources Ctr, DNA Serv Facil, Chicago, IL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Vitaterna, Martha H.; Turek, Fred W.] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL USA; [Forsyth, Christopher B.] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Physiol, Chicago, IL 60612 USA; [Keshavarzian, Ali] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Rush University; Rush University; Rush University; Utrecht University	Voigt, RM (corresponding author), Rush Univ, Med Ctr, Div Gastroenterol, Dept Internal Med, Chicago, IL 60612 USA.	robin_voigt@rush.edu		Green, Stefan/0000-0003-2781-359X	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [R01AA020216]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020216] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Work was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under award number R01AA020216 to A.K. and F.W.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2008, FEMS MICROBIOL ECOL, V66, P505, DOI 10.1111/j.1574-6941.2008.00527.x; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ananthakrishnan AN, 2013, CLIN GASTROENTEROL H, V11, P965, DOI 10.1016/j.cgh.2013.01.021; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bangsgaard Bendtsen K.M., 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231.e46231; Batschelet E, 1981, CIRCULAR STAT BIOL; Bhatti P, 2013, OCCUP ENVIRON MED, V70, P231, DOI 10.1136/oemed-2012-101146; Blaut Michael, 2012, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-24716-3_11; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Braak C.J.F, 2002, CANOCO REFERENCE MAN, P1; Burgess HJ, 2010, SCAND J GASTROENTERO, V45, P759, DOI 10.3109/00365521003749818; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everson CA, 2000, AM J PHYSIOL-REG I, V278, pR905, DOI 10.1152/ajpregu.2000.278.4.R905; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HOLDEMAN LV, 1976, APPL ENVIRON MICROB, V31, P359, DOI 10.1128/AEM.31.3.359-375.1976; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Knowles SR, 2008, BIOL PSYCHOL, V77, P132, DOI 10.1016/j.biopsycho.2007.09.010; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Portaluppi F, 2012, SLEEP MED REV, V16, P151, DOI 10.1016/j.smrv.2011.04.003; Preuss F, 2008, AM J PHYSIOL-REG I, V295, pR2034, DOI 10.1152/ajpregu.00118.2008; Rescigno M, 2011, TRENDS IMMUNOL, V32, P256, DOI 10.1016/j.it.2011.04.003; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Sanz Y, 2010, P NUTR SOC, V69, P434, DOI 10.1017/S0029665110001813; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Summa KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067102; Swanson GR, 2011, EXPERT REV CLIN IMMU, V7, P29, DOI [10.1586/eci.10.83, 10.1586/ECI.10.83]; Tang YM, 2009, SLEEP MED, V10, P597, DOI 10.1016/j.sleep.2008.12.009; TANNOCK GW, 1974, INFECT IMMUN, V9, P591, DOI 10.1128/IAI.9.3.591-598.1974; Teixeira TFS, 2012, NUTR RES, V32, P637, DOI 10.1016/j.nutres.2012.07.003; Tipoe GL, 2008, ALCOHOL CLIN EXP RES, V32, P669, DOI 10.1111/j.1530-0277.2008.00623.x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wright KP, 2013, SLEEP MED REV, V17, P41, DOI 10.1016/j.smrv.2012.02.002; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4	56	234	246	7	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97500	10.1371/journal.pone.0097500	http://dx.doi.org/10.1371/journal.pone.0097500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848969	Green Submitted, gold, Green Published			2022-12-27	WOS:000336730600034
J	Locci, E; Scano, P; Rosa, MF; Nioi, M; Noto, A; Atzori, L; Demontis, R; De-Giorgio, F; d'Aloja, E				Locci, Emanuela; Scano, Paola; Rosa, Maria Francesca; Nioi, Matteo; Noto, Antonio; Atzori, Luigi; Demontis, Roberto; De-Giorgio, Fabio; d'Aloja, Ernesto			A Metabolomic Approach to Animal Vitreous Humor Topographical Composition: A Pilot Study	PLOS ONE			English	Article							ELECTROPHORESIS; MYOINOSITOL; LACTATE	The purpose of this study was to evaluate the feasibility of a 1 H-NMR-based metabolomic approach to explore the metabolomic signature of different topographical areas of vitreous humor (VH) in an animal model. Five ocular globes were enucleated from five goats and immediately frozen at -80 degrees C. Once frozen, three of them were sectioned, and four samples corresponding to four different VH areas were collected: the cortical, core, and basal, which was further divided into a superior and an inferior fraction. An additional two samples were collected that were representative of the whole vitreous body. H-1-NMR spectra were acquired for twenty-three goat vitreous samples with the aim of characterizing the metabolomic signature of this biofluid and identifying whether any site-specific patterns were present. Multivariate statistical analysis (MVA) of the spectral data were carried out, including Principal Component Analysis (PCA), Hierarchical Cluster Analysis (HCA), and Partial Least Squares Discriminant Analysis (PLS-DA). A unique metabolomic signature belonging to each area was observed. The cortical area was characterized by lactate, glutamine, choline, and its derivatives, N-acetyl groups, creatine, and glycerol; the core area was characterized by glucose, acetate, and scyllo-inositol; and the basal area was characterized by branched-chain amino acids (BCAA), betaine, alanine, ascorbate, lysine, and myo-inositol. We propose a speculative approach on the topographic role of these molecules that are mainly responsible for metabolic differences among the as-identified areas. 1 H-NMR-based metabolomic analysis has shown to be an important tool for investigating the VH. In particular, this approach was able to assess in the samples here analyzed the presence of different functional areas on the basis of a different metabolite distribution.	[Locci, Emanuela; Atzori, Luigi] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Scano, Paola] Univ Cagliari, Dept Chem & Geol Sci, Cagliari, Italy; [Rosa, Maria Francesca; Nioi, Matteo; Demontis, Roberto; d'Aloja, Ernesto] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Forens Sci Unit, Cagliari, Italy; [Noto, Antonio] Univ Cagliari, Dept Surg, Cagliari, Italy; [De-Giorgio, Fabio] Univ Cattolica Sacro Cuore, Inst Publ Hlth, I-00168 Rome, Italy	University of Cagliari; University of Cagliari; University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	d'Aloja, E (corresponding author), Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Forens Sci Unit, Cagliari, Italy.	ernestodaloja@gmail.com	d'Aloja, Ernesto/P-4539-2017; demontis, roberto/AAX-7153-2020; Atzori, Luigi/A-6169-2016; Locci, Emanuela/G-6524-2018; Nioi, Matteo/V-8635-2019; Scano, Paola/ABI-5154-2020; De Giorgio, Fabio/AAB-7163-2022	d'Aloja, Ernesto/0000-0003-4456-6252; Atzori, Luigi/0000-0002-0606-4959; Locci, Emanuela/0000-0003-0237-4228; Nioi, Matteo/0000-0002-3645-6005; Scano, Paola/0000-0001-8350-8990; De Giorgio, Fabio/0000-0001-7433-0924; Noto, Antonio/0000-0003-3538-0050; Demontis, Roberto/0000-0003-2306-9767				Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Barba I, 2010, INVEST OPHTH VIS SCI, V51, P4416, DOI 10.1167/iovs.10-5348; Bocaz-Beneventi G, 2002, INT J LEGAL MED, V116, P5, DOI 10.1007/s004140100239; Bollard ME, 2005, NMR BIOMED, V18, P143, DOI 10.1002/nbm.935; Bortolotti F, 2011, MED SCI LAW, V51, pS20, DOI 10.1258/msl.2010.010063; Chebotareva NA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1478, DOI 10.1134/S0006297907130056; Costa JL, 2014, J CHROMATOGR B, V945, P84, DOI 10.1016/j.jchromb.2013.10.014; Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011; DiMaio D, 2001, FORENSIC PATHOLOGY; El-Sherbeny A, 2004, INVEST OPHTH VIS SCI, V45, P694, DOI 10.1167/iovs.03-0503; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Gomase VS, 2008, CURR DRUG METAB, V9, P89, DOI 10.2174/138920008783331149; Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S; Holekamp NM, 2010, AM J OPHTHALMOL, V149, P32, DOI 10.1016/j.ajo.2009.07.036; Holekamp NM, 2005, AM J OPHTHALMOL, V139, P302, DOI 10.1016/j.ajo.2004.09.046; Howell GR, 2013, INVEST OPHTH VIS SCI, V54, P4260, DOI 10.1167/iovs.13-12479; KOLLROS PE, 1990, BRAIN RES, V511, P259, DOI 10.1016/0006-8993(90)90170-G; Langford MP, 2007, CLIN OPHTHALMOL, V1, P43; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Madea B., 2013, ENCY FORENSIC SCI, P229; Osuna E, 2001, AM J FOREN MED PATH, V22, P244, DOI 10.1097/00000433-200109000-00008; Palmiere C, 2012, INT J LEGAL MED, V126, P187, DOI 10.1007/s00414-011-0625-y; Rucker JC, 2003, ARCH OPHTHALMOL-CHIC, V121, P909, DOI 10.1001/archopht.121.6.909; Scano P, 2012, MAGN RESON CHEM, V50, P436, DOI 10.1002/mrc.3819; Siegfried CJ, 2010, INVEST OPHTH VIS SCI, V51, P5731, DOI 10.1167/iovs.10-5666; Skeie JM, 2011, J VIS EXP, V47, P2447; Van de Poll MCG, 2013, ENCY HUMAN NUTR, V1, P79; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Young SP, 2009, MOL VIS, V15, P1210; Zeng KH, 2010, MOL CELL NEUROSCI, V45, P192, DOI 10.1016/j.mcn.2010.06.010	30	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97773	10.1371/journal.pone.0097773	http://dx.doi.org/10.1371/journal.pone.0097773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845217	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400060
J	Xia, JZ; Liang, SL; Chen, JQ; Yuan, WP; Liu, SG; Li, LH; Cai, WW; Zhang, L; Fu, Y; Zhao, TB; Feng, JM; Ma, ZG; Ma, MG; Liu, SM; Zhou, GS; Asanuma, J; Chen, SP; Du, MY; Davaa, G; Kato, T; Liu, Q; Liu, SH; Li, SG; Shao, CL; Tang, YH; Zhao, X				Xia, Jiangzhou; Liang, Shunlin; Chen, Jiquan; Yuan, Wenping; Liu, Shuguang; Li, Linghao; Cai, Wenwen; Zhang, Li; Fu, Yang; Zhao, Tianbao; Feng, Jinming; Ma, Zhuguo; Ma, Mingguo; Liu, Shaomin; Zhou, Guangsheng; Asanuma, Jun; Chen, Shiping; Du, Mingyuan; Davaa, Gombo; Kato, Tomomichi; Liu, Qiang; Liu, Suhong; Li, Shenggong; Shao, Changliang; Tang, Yanhong; Zhao, Xiang			Satellite-Based Analysis of Evapotranspiration and Water Balance in the Grassland Ecosystems of Dryland East Asia	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; NET PRIMARY PRODUCTION; MONGOLIAN PLATEAU; LAND-COVER; CLIMATE; MODIS; CHINA; PRECIPITATION; IMPROVEMENTS; DROUGHTS	The regression tree method is used to upscale evapotranspiration (ET) measurements at eddy-covariance (EC) towers to the grassland ecosystems over the Dryland East Asia (DEA). The regression tree model was driven by satellite and meteorology datasets, and explained 82% and 76% of the variations of ET observations in the calibration and validation datasets, respectively. The annual ET estimates ranged from 222.6 to 269.1 mm yr(-1) over the DEA region with an average of 245.8 mm yr(-1) from 1982 through 2009. Ecosystem ET showed decreased trends over 61% of the DEA region during this period, especially in most regions of Mongolia and eastern Inner Mongolia due to decreased precipitation. The increased ET occurred primarily in the western and southern DEA region. Over the entire study area, water balance (the difference between precipitation and ecosystem ET) decreased substantially during the summer and growing season. Precipitation reduction was an important cause for the severe water deficits. The drying trend occurring in the grassland ecosystems of the DEA region can exert profound impacts on a variety of terrestrial ecosystem processes and functions.	[Xia, Jiangzhou; Liang, Shunlin; Liu, Shaomin; Liu, Qiang; Liu, Suhong; Zhao, Xiang] Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Xia, Jiangzhou; Liang, Shunlin; Liu, Shaomin; Liu, Qiang; Liu, Suhong; Zhao, Xiang] Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Xia, Jiangzhou; Liang, Shunlin; Feng, Jinming; Liu, Qiang; Zhao, Xiang] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Liang, Shunlin] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Chen, Jiquan] Nanjing Univ Informat Sci & Technol, Int Ctr Ecol Meteorol & Environm IceMe, Sch Appl Meteorol, Nanjing, Jiangsu, Peoples R China; [Yuan, Wenping; Cai, Wenwen; Fu, Yang] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Liu, Shuguang] Cent South Univ Forestry & Technol, State Engn Lab Southern Forestry Appl Ecol & Tech, Changsha, Hunan, Peoples R China; [Li, Linghao; Chen, Shiping; Shao, Changliang] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Zhang, Li] Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Zhao, Tianbao; Feng, Jinming; Ma, Zhuguo] Chinese Acad Sci, Inst Atmospher Phys, Key Lab Reg Climate Environm Res Temperate East A, Beijing, Peoples R China; [Ma, Mingguo] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Liu, Shaomin; Liu, Suhong] Beijing Normal Univ, Sch Geog, Beijing 100875, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China; [Asanuma, Jun] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki, Japan; [Du, Mingyuan] Natl Inst Agroenvironm Sci, Dept Agrometeorol, Tsukuba, Ibaraki 305, Japan; [Davaa, Gombo] Inst Meteorol & Hydrol, Juulchin, Ulaanbaatar, Mongolia; [Kato, Tomomichi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan; [Li, Shenggong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Tang, Yanhong] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	Beijing Normal University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Beijing Normal University; University System of Maryland; University of Maryland College Park; Nanjing University of Information Science & Technology; Beijing Normal University; Central South University of Forestry & Technology; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Beijing Normal University; Chinese Academy of Meteorological Sciences (CAMS); University of Tsukuba; National Institute for Agro-Environmental Sciences (NIAES) Japan; Ministry of Nature Environment &Tourism Mongolia; Hokkaido University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; National Institute for Environmental Studies - Japan	Liang, SL (corresponding author), Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Liang, SL (corresponding author), Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	sliang@umd.edu; yuanwpcn@126.com	Chen, Jiquan/D-1955-2009; Asanuma, J/A-2877-2008; Zhao, Tianbao/I-4890-2015; Mingguo, Ma/A-8087-2013; Kato, Tomomichi/F-7766-2010; Kato, Tomomichi/X-7390-2019; Chen, Shiping/AAH-9751-2019; Du, Mingyuan/O-9951-2018; shao, changliang/ACG-3396-2022; Liu, Qiang/HHZ-3181-2022; Tang, Yanhong/B-1699-2010; liang, shunlin/C-2809-2015; Li, Sheng-Gong/H-5101-2012; Du, Mingyuan/AAE-3019-2020	Asanuma, J/0000-0003-1258-5491; Zhao, Tianbao/0000-0002-8295-6537; Kato, Tomomichi/0000-0003-3757-3243; Kato, Tomomichi/0000-0003-3757-3243; Du, Mingyuan/0000-0003-0373-1661; Tang, Yanhong/0000-0001-7207-1965; Li, Sheng-Gong/0000-0003-4889-9927; Du, Mingyuan/0000-0003-0373-1661; Liu, Shaomin/0000-0003-3627-9288; XU, TONGREN/0000-0002-1744-8974; Chen, Jiquan/0000-0003-0761-9458	National High-Technology Research and Development Program of China [2013AA122800]; Freedom Project of the State Key Laboratory of Cryospheric Sciences [SKLCS-ZZ-2013-2-2]; Chinese Academy of Sciences; National Science Foundation for Excellent Young Scholars of China [41322005]; Program for New Century Excellent Talents in University [NCET-12-0060]; NASA-NEWS Program [NN-H-04-Z-YS-005-N]; Cold and Arid Regions Environmental and Engineering Research Institute	National High-Technology Research and Development Program of China(National High Technology Research and Development Program of China); Freedom Project of the State Key Laboratory of Cryospheric Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation for Excellent Young Scholars of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NASA-NEWS Program; Cold and Arid Regions Environmental and Engineering Research Institute(Chinese Academy of Sciences)	This study was supported by the National High-Technology Research and Development Program of China (2013AA122800), the Freedom Project (No. SKLCS-ZZ-2013-2-2) of the State Key Laboratory of Cryospheric Sciences, Cold and Arid Regions Environmental and Engineering Research Institute, the Chinese Academy of Sciences, the National Science Foundation for Excellent Young Scholars of China (41322005), Program for New Century Excellent Talents in University (NCET-12-0060) and NASA-NEWS Program (NN-H-04-Z-YS-005-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; [Anonymous], 2010, J GEOPHYS RES-ATMOS, DOI DOI 10.1029/2010JD013847; Chen JQ, 2013, DRYLAND E ASIA DEA L, P3; Chen Y, 2014, REMOTE SENS ENVIRON, V140, P279, DOI 10.1016/j.rse.2013.08.045; Cong ZT, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006852; Fisher JB, 2008, REMOTE SENS ENVIRON, V112, P901, DOI 10.1016/j.rse.2007.06.025; Foken T, 2008, ECOL APPL, V18, P1351, DOI 10.1890/06-0922.1; Garcia M, 2013, REMOTE SENS ENVIRON, V131, P103, DOI 10.1016/j.rse.2012.12.016; Global Modeling and Assimilation Office, 2004, REPORT; Henebry GM, 2013, DRYLAND E ASIA LAND, DOI DOI 10.1515/9783110287912.23; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; Huang C, 2003, INT J REMOTE SENS, V24, P75, DOI 10.1080/01431160305001; John R, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035033; John R, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045010; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kim HW, 2012, KSCE J CIV ENG, V16, P229, DOI 10.1007/s12205-012-0006-1; Li MX, 2011, CHINESE SCI BULL, V56; Li SG, 2007, J HYDROL, V333, P133, DOI 10.1016/j.jhydrol.2006.07.021; Liu YL, 2013, GLOBAL PLANET CHANGE, V108, P85, DOI 10.1016/j.gloplacha.2013.06.008; Lu N, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045006; McVicar TR, 2012, J HYDROL, V416, P182, DOI 10.1016/j.jhydrol.2011.10.024; Morillas L, 2013, WATER RESOUR RES, V49, P6572, DOI 10.1002/wrcr.20468; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Mueller B, 2013, HYDROL EARTH SYST SC, V17, P3707, DOI 10.5194/hess-17-3707-2013; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Qi JG, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015202; Qian W, 2003, CLIM DYNAM, V21, P77, DOI 10.1007/s00382-003-0319-3; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; [施雅风 Shi Yafeng], 2003, [第四纪研究, Quaternary Sciences], V23, P152; Shi YF, 1989, PHYS GEOGRAPHY INNER; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun G, 2013, DRYLAND E ASIA LAND, P153; Sun G, 2011, ECOHYDROLOGY, V4, P245, DOI 10.1002/eco.194; Vinukollu RK, 2011, REMOTE SENS ENVIRON, V115, P801, DOI 10.1016/j.rse.2010.11.006; Wang Z.W., 2003, ACTA GEOGR SIN, V58, P61; Xiao JF, 2009, EARTH INTERACT, V13, DOI 10.1175/2009EI275.1; Xiao JF, 2008, AGR FOREST METEOROL, V148, P1827, DOI 10.1016/j.agrformet.2008.06.015; Xin XG, 2006, J CLIMATE, V19, P3197, DOI 10.1175/JCLI3794.1; Yu FF, 2003, REMOTE SENS ENVIRON, V87, P42, DOI 10.1016/S0034-4257(03)00144-5; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Yuan WP, 2012, WATER RESOUR MANAG, V26, P2147, DOI 10.1007/s11269-012-0007-3; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Yuan WP, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008119; Zhai JQ, 2010, J CLIMATE, V23, P649, DOI 10.1175/2009JCLI2968.1; Zhang K, 2009, J HYDROL, V379, P92, DOI 10.1016/j.jhydrol.2009.09.047; Zhang K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000621; Zhang L, 2007, REMOTE SENS ENVIRON, V106, P173, DOI 10.1016/j.rse.2006.08.012; Zhang L, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001504; Zhang Q, 2009, THEOR APPL CLIMATOL, V95, P53, DOI 10.1007/s00704-007-0375-4; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; Zou XK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021853	51	21	22	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97295	10.1371/journal.pone.0097295	http://dx.doi.org/10.1371/journal.pone.0097295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845063	gold, Green Published			2022-12-27	WOS:000339563400018
J	Gibbons, SM; Jones, E; Bearquiver, A; Blackwolf, F; Roundstone, W; Scott, N; Hooker, J; Madsen, R; Coleman, ML; Gilbert, JA				Gibbons, Sean M.; Jones, Edwin; Bearquiver, Angelita; Blackwolf, Frederick; Roundstone, Wayne; Scott, Nicole; Hooker, Jeff; Madsen, Robert; Coleman, Maureen L.; Gilbert, Jack A.			Human and Environmental Impacts on River Sediment Microbial Communities	PLOS ONE			English	Article							HYPORHEIC-ZONE; BACTERIAL PRODUCTION; SEASONAL DYNAMICS; MAGNITUDE; DIVERSITY; SEQUENCES; ECOSYSTEM; GENES	Sediment microbial communities are responsible for a majority of the metabolic activity in river and stream ecosystems. Understanding the dynamics in community structure and function across freshwater environments will help us to predict how these ecosystems will change in response to human land-use practices. Here we present a spatiotemporal study of sediments in the Tongue River (Montana, USA), comprising six sites along 134 km of river sampled in both spring and fall for two years. Sequencing of 16S rRNA amplicons and shotgun metagenomes revealed that these sediments are the richest (similar to 65,000 microbial 'species' identified) and most novel (93% of OTUs do not match known microbial diversity) ecosystems analyzed by the Earth Microbiome Project to date, and display more functional diversity than was detected in a recent review of global soil metagenomes. Community structure and functional potential have been significantly altered by anthropogenic drivers, including increased pathogenicity and antibiotic metabolism markers near towns and metabolic signatures of coal and coalbed methane extraction byproducts. The core (OTUs shared across all samples) and the overall microbial community exhibited highly similar structure, and phylogeny was weakly coupled with functional potential. Together, these results suggest that microbial community structure is shaped by environmental drivers and niche filtering, though stochastic assembly processes likely play a role as well. These results indicate that sediment microbial communities are highly complex and sensitive to changes in land use practices.	[Gibbons, Sean M.; Gilbert, Jack A.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Gibbons, Sean M.; Scott, Nicole; Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Lemont, IL USA; [Gibbons, Sean M.; Jones, Edwin; Bearquiver, Angelita; Blackwolf, Frederick; Roundstone, Wayne; Hooker, Jeff; Madsen, Robert] Chief Dull Knife Coll, Dept Biol, Lame Deer, MT USA; [Coleman, Maureen L.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago	Gilbert, JA (corresponding author), Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA.	gilbertjack@anl.gov	Gibbons, Sean M./ABH-2562-2020; Gilbert, Jack/AAF-3270-2019	Gibbons, Sean M./0000-0002-8724-7916; Coleman, Maureen/0000-0001-5065-0106	U.S. Department of Energy [DE-AC02-06CH11357]; National Science Foundation EPSCoR; U.S. Nuclear Regulatory Commission [NRC-27-10-1124]; EPA STAR Graduate Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation EPSCoR(National Science Foundation (NSF)); U.S. Nuclear Regulatory Commission; EPA STAR Graduate Fellowship(United States Environmental Protection Agency); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the U.S. Department of Energy under Contract DE-AC02-06CH11357, by National Science Foundation EPSCoR funds, and by the U.S. Nuclear Regulatory Commission under the grant number NRC-27-10-1124. S.M.G. was supported by an EPA STAR Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Craft JA, 2002, FRESHWATER BIOL, V47, P251, DOI 10.1046/j.1365-2427.2002.00803.x; Darby J, 2009, SPE E REG M; Dionisi HM, 2004, APPL ENVIRON MICROB, V70, P3988, DOI 10.1128/AEM.70.7.3988-3995.2004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel AS, 2010, ISME J, V4, P98, DOI 10.1038/ismej.2009.91; Faris KP, 2009, ENVIRON SCI TECHNOL, V43, P6158, DOI 10.1021/es9005465; Feris KP, 2004, APPL ENVIRON MICROB, V70, P2323, DOI 10.1128/AEM.70.4.2323-2331.2004; Feris KP, 2003, MICROB ECOL, V46, P200, DOI 10.1007/s00248-002-0003-x; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fischer H, 2001, FRESHWATER BIOL, V46, P1335, DOI 10.1046/j.1365-2427.2001.00753.x; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Glass E.M., 2010, COLD SPRING HARB PRO, V2010, DOI DOI 10.1101/PDB.PROT5368; Glass EM, 2011, METAGENOMICS COMPLEM, V8, P325, DOI [10.1002/9781118010518.CH37, DOI 10.1002/9781118010518.CH37, 10.1002/9781118010518.ch37]; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Heffern EL, 2004, INT J COAL GEOL, V59, P25, DOI 10.1016/j.coal.2003.07.002; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Larsen PE, 2012, FEMS MICROBIOL LETT, V332, P91, DOI 10.1111/j.1574-6968.2012.02588.x; Larsen Peter E, 2011, Microb Inform Exp, V1, P4, DOI 10.1186/2042-5783-1-4; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Logue JB, 2008, BIOSCIENCE, V58, P103, DOI 10.1641/B580205; Loy A, 2005, APPL ENVIRON MICROB, V71, P1373, DOI 10.1128/AEM.71.3.1373-1386.2005; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MADSEN EL, 1992, MICROB ECOL, V24, P199, DOI 10.1007/BF00174455; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Naegeli MW, 1997, J N AM BENTHOL SOC, V16, P794, DOI 10.2307/1468172; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pernthaler J, 2013, FRESHWATER MICROBIAL, P97; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pusch M, 1998, FRESHWATER BIOL, V40, P453, DOI 10.1046/j.1365-2427.1998.00372.x; Pusch M, 1997, GROUNDWATER SURFACE; R Core Development Team, 2008, R LANG ENV STAT COMP; Ramsey PW, 2005, ECOL LETT, V8, P1201, DOI 10.1111/j.1461-0248.2005.00821.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VAQUE D, 1992, MAR ECOL PROG SER, V89, P155, DOI 10.3354/meps089155; Waidner LA, 2005, ENVIRON MICROBIOL, V7, P1896, DOI 10.1111/j.1462-2920.2005.00883.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu C, 2009, J MICROBIOL BIOTECHN, V19, P187, DOI 10.4014/jmb.0804.292; Zeglin LH, 2011, MICROB ECOL, V61, P543, DOI 10.1007/s00248-010-9782-7	46	97	107	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97435	10.1371/journal.pone.0097435	http://dx.doi.org/10.1371/journal.pone.0097435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841417	Green Submitted, gold, Green Published			2022-12-27	WOS:000340948600032
J	Kanero, J; Imai, M; Okuda, J; Okada, H; Matsuda, T				Kanero, Junko; Imai, Mutsumi; Okuda, Jiro; Okada, Hiroyuki; Matsuda, Tetsuya			How Sound Symbolism Is Processed in the Brain: A Study on Japanese Mimetic Words	PLOS ONE			English	Article							CORRESPONDENCES; REPRESENTATIONS; PERCEPTION; MOTOR; SHAPE	Sound symbolism is the systematic and non-arbitrary link between word and meaning. Although a number of behavioral studies demonstrate that both children and adults are universally sensitive to sound symbolism in mimetic words, the neural mechanisms underlying this phenomenon have not yet been extensively investigated. The present study used functional magnetic resonance imaging to investigate how Japanese mimetic words are processed in the brain. In Experiment 1, we compared processing for motion mimetic words with that for non-sound symbolic motion verbs and adverbs. Mimetic words uniquely activated the right posterior superior temporal sulcus (STS). In Experiment 2, we further examined the generalizability of the findings from Experiment 1 by testing another domain: shape mimetics. Our results show that the right posterior STS was active when subjects processed both motion and shape mimetic words, thus suggesting that this area may be the primary structure for processing sound symbolism. Increased activity in the right posterior STS may also reflect how sound symbolic words function as both linguistic and non-linguistic iconic symbols.	[Kanero, Junko] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Imai, Mutsumi] Keio Univ Shonan Fujisawa, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Okuda, Jiro] Kyoto Sangyo Univ, Fac Comp Sci & Engn, Dept Intelligent Syst, Kita Ku, Kyoto 603, Japan; [Okada, Hiroyuki] Tamagawa Univ, Coll Engn, Dept Mech Syst, Machida, Tokyo, Japan; [Matsuda, Tetsuya] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Keio University; Kyoto Sangyo University	Matsuda, T (corresponding author), Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan.	tetsuya@lab.tamagawa.ac.jp	Kanero, Junko/Y-1603-2019; Okada, HIroyuki/AAN-8999-2020	Kanero, Junko/0000-0003-1009-5333; 	MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi [15300088, 21300301]; MEXT [23120003]; MEXT Global Center of Excellence (GCOE) program; Grants-in-Aid for Scientific Research [24659546, 26580078, 25330176] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT Global Center of Excellence (GCOE) program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi grant to MI (#15300088) and to TM (#21300301), MEXT Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making to MI (#23120003), and MEXT Global Center of Excellence (GCOE) program awarded to Tamagawa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Kimi, 2009, THESIS KOBE U KOBE; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bodomo Adams B., 2006, SEL P 35 ANN C AFR L, P203; Childs G.T., 1994, SOUND SYMBOLISM, P178; Diffloth Gurard., 1972, CHICAGO LINGUISTIC S, V8, P440; Enfield NJ, 2005, ANNU REV ANTHROPOL, V34, P181, DOI 10.1146/annurev.anthro.34.081804.120406; Fernald A, 2000, PHONETICA, V57, P242, DOI 10.1159/000028477; Firth J. R., 1935, PAPERS LINGUISTICS 1, P34; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hashimoto T, 2006, NEUROIMAGE, V31, P1762, DOI 10.1016/j.neuroimage.2006.02.019; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Hinton L., 1994, SOUND SYMBOLISM; Holmes AP, 1997, NEUROIMAGE, V5, pS480; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Iwasaki N., 2007, JAPANESE LANGUAGE ED, V17, P53; Iwasaki Noriko, 2007, APPLYING THEORY RES, P2; Jakobson R., 1979, SOUND SHAPE LANGUAGE; Kable JW, 2005, J COGNITIVE NEUROSCI, V17, P1855, DOI 10.1162/089892905775008625; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; Kemmerer D, 2008, COGN NEUROPSYCHOL, V25, P601, DOI 10.1080/02643290802247052; Kita S, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P206, DOI 10.1142/9789814295222_0027; Kohler W., 1929, GESTALT PSYCHOL; Kovic V, 2010, COGNITION, V114, P19, DOI 10.1016/j.cognition.2009.08.016; Lee J-S, 1992, THESIS INDIANA U BLO; Martin A. C, 2000, NEW COGNITIVE NEUROS, P1023; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Nygaard LC, 2009, COGNITION, V112, P181, DOI 10.1016/j.cognition.2009.04.001; Ono M., 2007, NIHONGO ONOMATOPOEIA; Osaka N, 2004, BEHAV BRAIN RES, V153, P123, DOI 10.1016/j.bbr.2003.11.013; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Pelphrey KA, 2003, NEUROPSYCHOLOGIA, V41, P156, DOI 10.1016/S0028-3932(02)00146-X; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Saussure F. de., 1983, COURSE GEN LINGUISTI; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Thierry G, 2003, NEURON, V38, P499, DOI 10.1016/S0896-6273(03)00199-5; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Watson Richard L., 2001, IDEOPHONES, P385, DOI DOI 10.1075/TSL.44.29WAT; WE Mok, 2001, THESIS U HAWAII HONO	44	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97905	10.1371/journal.pone.0097905	http://dx.doi.org/10.1371/journal.pone.0097905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840874	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600090
J	Merkestein, M; McTaggart, JS; Lee, S; Kramer, HB; McMurray, F; Lafond, M; Boutens, L; Cox, R; Ashcroft, FM				Merkestein, Myrte; McTaggart, James S.; Lee, Sheena; Kramer, Holger B.; McMurray, Fiona; Lafond, Mathilde; Boutens, Lily; Cox, Roger; Ashcroft, Frances M.			Changes in Gene Expression Associated with FTO Overexpression in Mice	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; OBESITY-ASSOCIATED FTO; DIET-INDUCED OBESITY; MESSENGER-RNA; NUCLEAR-RNA; S-ADENOSYLMETHIONINE; ENERGY-INTAKE; ADIPONECTIN; METHYLATION; N6-METHYLADENOSINE	Single nucleotide polymorphisms in the first intron of the fat-mass-and-obesity-related gene FTO are associated with increased body weight and adiposity. Increased expression of FTO is likely underlying this obesity phenotype, as mice with two additional copies of Fto (FTO-4 mice) exhibit increased adiposity and are hyperphagic. FTO is a demethylase of single stranded DNA and RNA, and one of its targets is the m6A modification in RNA, which might play a role in the regulation of gene expression. In this study, we aimed to examine the changes in gene expression that occur in FTO-4 mice in order to gain more insight into the underlying mechanisms by which FTO influences body weight and adiposity. Our results indicate an upregulation of anabolic pathways and a downregulation of catabolic pathways in FTO-4 mice. Interestingly, although genes involved in methylation were differentially regulated in skeletal muscle of FTO-4 mice, no effect of FTO overexpression on m6A methylation of total mRNA was detected.	[Merkestein, Myrte; McTaggart, James S.; Lee, Sheena; Kramer, Holger B.; Lafond, Mathilde; Boutens, Lily; Ashcroft, Frances M.] Univ Oxford, Dept Physiol, Henry Wellcome Ctr Gene Funct, Oxford, England; [McMurray, Fiona; Cox, Roger] Med Res Council Harwell, Mammalian Genet Unit, Oxford, England	University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Ashcroft, FM (corresponding author), Univ Oxford, Dept Physiol, Henry Wellcome Ctr Gene Funct, Parks Rd, Oxford, England.	frances.ashcroft@dpag.ox.ac.uk	Kramer, Holger/AAL-4433-2020	Kramer, Holger/0000-0002-6400-0945; Cox, Roger/0000-0001-7170-5014; McMurray, Fiona/0000-0003-4147-5064	Wellcome Trust [884655, 089795]; Medical Research Council; Royal Society Research Wolfson Merit Award; Medical Research Council [MC_U142661184] Funding Source: researchfish; MRC [MC_U142661184] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Research Wolfson Merit Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Wellcome Trust (grants no 884655 and 089795) and the Medical Research Council (RDC, and MRC studentships held by JST and FM). FMA held a Royal Society Research Wolfson Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI Y, 1979, J VIROL, V32, P52, DOI 10.1128/JVI.32.1.52-60.1979; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Berulava T, 2012, EUR J HUM GENET; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Bravard A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-4; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; CHENKIANG S, 1979, J MOL BIOL, V135, P733, DOI 10.1016/0022-2836(79)90174-8; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Giller K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0101; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Khemawoot P, 2007, BIOCHEM PHARMACOL, V73, P155, DOI 10.1016/j.bcp.2006.09.006; Kumar KG, 2007, AM J PHYSIOL-REG I, V292, pR207, DOI 10.1152/ajpregu.00491.2006; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Loos RJ, 2013, NAT REV ENDOCRINOL; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; McMurray F, 2012, PLOS GENET; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mulligan MK, 2008, GENES BRAIN BEHAV, V7, P677, DOI 10.1111/j.1601-183X.2008.00405.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Ridley SH, 2001, J CELL SCI, V114, P3991; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; TUCK MT, 1992, INT J BIOCHEM, V24, P379, DOI 10.1016/0020-711X(92)90028-Y; TUCK MT, 1992, BIOCHEM J, V288, P233, DOI 10.1042/bj2880233; Tuck MT, 1999, INT J BIOCHEM CELL B, V31, P837, DOI 10.1016/S1357-2725(99)00041-2; Turyn J, 2008, MOL CELL BIOCHEM, V312, P185, DOI 10.1007/s11010-008-9733-5; van Schothorst EM, 2006, OBESITY, V14, P974, DOI 10.1038/oby.2006.111; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wu Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-397; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200; Zong HH, 2012, AM J PHYSIOL-ENDOC M, V302, pE532, DOI 10.1152/ajpendo.00258.2011	57	22	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97162	10.1371/journal.pone.0097162	http://dx.doi.org/10.1371/journal.pone.0097162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842286	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600018
J	Ogier, JM; Carpinelli, MR; Arhatari, BD; Symons, RCA; Kile, BT; Burt, RA				Ogier, Jacqueline M.; Carpinelli, Marina R.; Arhatari, Benedicta D.; Symons, R. C. Andrew; Kile, Benjamin T.; Burt, Rachel A.			CHD7 Deficiency in "Looper", a New Mouse Model of CHARGE Syndrome, Results in Ossicle Malformation, Otosclerosis and Hearing Impairment	PLOS ONE			English	Article							INNER-EAR; GENE-EXPRESSION; MUTATIONS; MECHANISMS; DEFECTS; MICE; NEUROGENESIS; FEATURES	CHARGE syndrome is a rare human disorder caused by mutations in the gene encoding chromodomain helicase DNA binding protein 7 (CHD7). Characteristics of CHARGE are varied and include developmental ear and hearing anomalies. Here we report a novel mouse model of CHD7 dysfunction, termed Looper. The Looper strain harbours a nonsense mutation (c.5690C>A, p. S1897X) within the Chd7 gene. Looper mice exhibit many of the clinical features of the human syndrome, consistent with previously reported CHARGE models, including growth retardation, facial asymmetry, vestibular defects, eye anomalies, hyperactivity, ossicle malformation, hearing loss and vestibular dysfunction. Looper mice display an otosclerosis-like fusion of the stapes footplate to the cochlear oval window and blepharoconjunctivitis but not coloboma. Looper mice are hyperactive and have vestibular dysfunction but do not display motor impairment.	[Ogier, Jacqueline M.; Carpinelli, Marina R.; Burt, Rachel A.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Carpinelli, Marina R.; Burt, Rachel A.] HEARing Cooperat Res Ctr, Parkville, Vic, Australia; [Carpinelli, Marina R.; Kile, Benjamin T.; Burt, Rachel A.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Carpinelli, Marina R.; Kile, Benjamin T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Kile, Benjamin T.; Burt, Rachel A.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Burt, Rachel A.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Arhatari, Benedicta D.] La Trobe Univ, Dept Phys, ARC Ctr Excellence Coherent X Ray Sci, Bundoora, Vic 3083, Australia; [Symons, R. C. Andrew] Royal Melbourne Hosp, Dept Ophthalmol, Parkville, Vic 3050, Australia	Murdoch Children's Research Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne; La Trobe University; Royal Melbourne Hospital	Burt, RA (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	rachel.burt@mcri.edu.au	Ogier, Jackie/HCH-4868-2022; Kile, Benjamin T/F-6593-2011; Kile, Benjamin/GNP-3246-2022; Symons, Robert Charles Andrew/C-2040-2017; Burt, Rachel/I-7874-2012; Administrator, CMSS/E-3491-2015	Kile, Benjamin T/0000-0002-8836-8947; Kile, Benjamin/0000-0002-8836-8947; Symons, Robert Charles Andrew/0000-0002-8104-881X; Burt, Rachel/0000-0001-8827-8266; Ogier, Jacqueline/0000-0002-7468-4009; Carpinelli, Marina/0000-0001-5115-7831	HEARing CRC - Cooperative Research Centres Program - an Australian Government Initiative; Garnett Passe and Rodney Williams Memorial Foundation; Australian Government's National Health and Medical Research Council [461219, 1016647]; Sylvia and Charles Viertel Foundation; Victorian State Government's Operational Infrastructure Support Program; Australian Government's NHMRC IRIISS; National Collaborative Research Infrastructure Strategy grant	HEARing CRC - Cooperative Research Centres Program - an Australian Government Initiative; Garnett Passe and Rodney Williams Memorial Foundation; Australian Government's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Victorian State Government's Operational Infrastructure Support Program; Australian Government's NHMRC IRIISS; National Collaborative Research Infrastructure Strategy grant(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by the HEARing CRC, established and supported under the Cooperative Research Centres Program - an Australian Government Initiative; the Garnett Passe and Rodney Williams Memorial Foundation (fellowship to MRC); the Australian Government's National Health and Medical Research Council (Program Grants 461219 and 1016647, and a fellowship to BTK); the Sylvia and Charles Viertel Foundation (fellowship to BTK); the Victorian State Government's Operational Infrastructure Support Program; the Australian Government's NHMRC IRIISS; and a National Collaborative Research Infrastructure Strategy grant to the Australian Phenomics Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2000, EUR J PEDIATR, V159, P569, DOI 10.1007/s004319900409; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bergman JEH, 2012, HUM MUTAT, V33, P1251, DOI 10.1002/humu.22106; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Carpinelli MR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.100; Carpinelli MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067479; Carpinelli MR, 2011, HEARING RES, V275, P105, DOI 10.1016/j.heares.2010.12.009; Chordekar S, 2012, HEARING RES, V283, P180, DOI 10.1016/j.heares.2011.10.004; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Graham JM, 2005, AM J MED GENET A, V133A, P240, DOI 10.1002/ajmg.a.30543; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Hurd EA, 2012, MECH DEVELOP, V129, P308, DOI 10.1016/j.mod.2012.06.002; Hurd EA, 2011, HEARING RES, V282, P184, DOI 10.1016/j.heares.2011.08.005; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Issekutz KA, 2005, AM J MED GENET A, V133A, P309, DOI 10.1002/ajmg.a.30560; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Jiang X, 2012, AM J PATHOL, V181, P626, DOI 10.1016/j.ajpath.2012.05.006; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lenz DR, 2010, AUDIOL MED, V8, P110; Mendisco F, 2011, ELECTROPHORESIS, V32, P386, DOI 10.1002/elps.201000483; Nishina S, 2012, AM J MED GENET A, V158A, P514, DOI 10.1002/ajmg.a.34400; Pau H, 2004, OTOL NEUROTOL, V25, P707, DOI 10.1097/00129492-200409000-00010; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Puc J, 2011, NAT GENET, V43, P505, DOI 10.1038/ng.843; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Tellier AL, 1998, AM J MED GENET, V76, P402, DOI 10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O; Tian C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034944; Toriello H. V., 2004, HEREDITARY HEARING L; van den Akker PC, 2011, HUM MUTAT, V32, P1100, DOI 10.1002/humu.21551; Willott JF, 1998, HEARING RES, V115, P162, DOI 10.1016/S0378-5955(97)00189-5	38	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97559	10.1371/journal.pone.0097559	http://dx.doi.org/10.1371/journal.pone.0097559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840056	Green Published, gold			2022-12-27	WOS:000340948600045
J	Sun, FB; Yin, Z; Lun, XX; Zhao, Y; Li, RN; Shi, FT; Yu, XX				Sun, Fengbin; Yin, Zhe; Lun, Xiaoxiu; Zhao, Yang; Li, Renna; Shi, Fangtian; Yu, Xinxiao			Deposition Velocity of PM2.5 in the Winter and Spring above Deciduous and Coniferous Forests in Beijing, China	PLOS ONE			English	Article							OZONE DRY DEPOSITION; SULFUR-DIOXIDE; PARTICLE DEPOSITION; SHORT VEGETATION; TROPICAL FOREST; FLUX; SO2; SULFATE; CANOPY; SEASON	To estimate the deposition effect of PM2.5 (particle matter with aerodynamic diameter <2.5 mu m) in forests in northern China, we used the gradient method to measure the deposition velocity of PM2.5 during the winter and spring above a deciduous forest in Olympic Forest Park and above a coniferous forest in Jiufeng National Forest Park. Six aerosol samplers were placed on two towers at each site at heights of 9, 12 and 15 m above the ground surface. The sample filters were exchanged every four hours at 6: 00 AM, 10: 00 AM, 2: 00 PM, 6: 00 PM, 10: 00 PM, and 2: 00 AM. The daytime and nighttime deposition velocities in Jiufeng Park and Olympic Park were compared in this study. The February deposition velocities in Jiufeng Park were 1.2 +/- 1.3 and 0.7 +/- 0.7 cm s(-1) during the day and night, respectively. The May deposition velocities in Olympic Park were 0.9 +/- 0.8 and 0.4 +/- 0.5 cm s(-1) during the day and night, respectively. The May deposition velocities in Jiufeng Park were 1.1 +/- 1.2 and 0.6 +/- 0.5 cm s(-1) during the day and night, respectively. The deposition velocities above Jiufeng National Forest Park were higher than those above Olympic Forest Park. The measured values were smaller than the simulated values obtained by the Ruijgrok et al. (1997) and Wesely et al. (1985) models. However, the reproducibility of the Ruijgrok et al. (1997) model was better than that of the Wesely et al. (1985) model. The Hicks et al. (1977) model was used to analyze additional forest parameters to calculate the PM2.5 deposition, which could better reflect the role of the forest in PM2.5 deposition. [GRAPHICS] .							Forestry Public Welfare Project of China [20130430104]; CFERN & GENE Award Funds on Ecological Paper; Beijing Forestry University	Forestry Public Welfare Project of China; CFERN & GENE Award Funds on Ecological Paper; Beijing Forestry University	This research was financially supported by grant No. 20130430104 from the Forestry Public Welfare Project of China as well as the CFERN & GENE Award Funds on Ecological Paper. Further funding was also provided by Beijing Forestry University for preparing this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Development and Reforming Office, 2012, BEIJ 12 5 FORM EN PL; Beijing Transportation Research Center, 2006, BEIJ TRANSP ANN REP, P32; Chen JR, 2013, CHINA ENERGY, V35, P5; Cheng Z., 2004, J CHINESE URBAN FORE, V2, P37; DUYZER J, 1995, STUD ENVIRON SCI, V64, P21; ELSHOUT AJ, 1978, ATMOS ENVIRON, V12, P785, DOI 10.1016/0004-6981(78)90260-3; Erisman J.W., 1995, STUDIES ENV SCI, V63, P55; Erisman JW, 1997, ATMOS ENVIRON, V31, P321, DOI 10.1016/S1352-2310(96)00223-3; Feliciano MS, 2001, ATMOS ENVIRON, V35, P3633, DOI 10.1016/S1352-2310(00)00539-2; Fumo Yang, 2002, Journal of Tsinghua University (Science and Technology), V42, P1605; Grace J., 1983, PLANT ATMOSPHERE REL; Guo P, 2009, J ANHUI AGR SCI, V37, P11236; Hayashi K, 2009, WATER AIR SOIL POLL, V200, P33, DOI 10.1007/s11270-008-9891-9; Horvath L, 2003, ATMOS ENVIRON, V37, P4419, DOI 10.1016/S1352-2310(03)00584-3; Lamaud E, 2002, ATMOS ENVIRON, V36, P77, DOI 10.1016/S1352-2310(01)00468-X; Matsuda K, 2005, ATMOS ENVIRON, V39, P2571, DOI 10.1016/j.atmosenv.2005.01.011; MATSUDA K, 2007, J JAPAN SOC ATMOSPHE, V42, P261; MATSUDA K, 2002, J JAPAN SOC ATMOSPHE, V37, P387; Matsuda K, 2006, ATMOS ENVIRON, V40, P7557, DOI 10.1016/j.atmosenv.2006.07.003; Matsuda K, 2010, ATMOS ENVIRON, V44, P4582, DOI 10.1016/j.atmosenv.2010.08.015; Ministry of Agriculture of the People's Republic of China, 2006, STAT DAT NAT RUR REN; National Bureau of Statistics of China, 2007, CHIN EN STAT YB; Parkin CS, 1987, P S AER APPL PEST FO, P69; Ruijgrok W, 1997, ATMOS ENVIRON, V31, P399, DOI 10.1016/S1352-2310(96)00089-1; Schindlbacher A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004590; SLINN WGN, 1982, ATMOS ENVIRON, V16, P1785, DOI 10.1016/0004-6981(82)90271-2; Sorimachi A, 2004, ENVIRON SCI TECHNOL, V38, P3396, DOI 10.1021/es034967p; Sorimachi A, 2003, ATMOS ENVIRON, V37, P3157, DOI 10.1016/S1352-2310(03)00180-8; Tai APK, 2010, ATMOS ENVIRON, V44, P3976, DOI 10.1016/j.atmosenv.2010.06.060; TAKAHASHI A, 2002, J JAPAN SOC ATMOSPHE, V37, P192; The state Department of Environmental Protection, 2012, GB30952012 STAT DEP; Tsai JL, 2010, ATMOS ENVIRON, V44, P1011, DOI 10.1016/j.atmosenv.2009.12.022; WESELY ML, 1985, J GEOPHYS RES-ATMOS, V90, P2131, DOI 10.1029/JD090iD01p02131; WESELY ML, 1977, JAPCA J AIR WASTE MA, V27, P1110, DOI 10.1080/00022470.1977.10470534; WILLIAMS EJ, 1992, J GEOPHYS RES-ATMOS, V97, P7511, DOI 10.1029/92JD00412; Wyers GP, 1997, ATMOS ENVIRON, V31, P333, DOI 10.1016/S1352-2310(96)00188-4; Xu J, 2006, J SAFETY ENV, V6, P79; [杨复沫 Yang Fumo], 2002, [中国环境科学, China Environmental Science], V22, P506; YANG Hao-ming, 2011, ENV SCI TECHNOLOGY C, V24, P98; Zhou ZR, 2009, RENEW SUST ENERG REV, V13, P187, DOI 10.1016/j.rser.2007.05.006	40	37	44	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97723	10.1371/journal.pone.0097723	http://dx.doi.org/10.1371/journal.pone.0097723			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842850	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600063
J	Den Hartigh, RJR; Gernigon, C; Van Yperen, NW; Marin, L; Van Geert, PLC				Den Hartigh, Ruud J. R.; Gernigon, Christophe; Van Yperen, Nico W.; Marin, Ludovic; Van Geert, Paul L. C.			How Psychological and Behavioral Team States Change during Positive and Negative Momentum	PLOS ONE			English	Article							QUESTIONNAIRE SUR LAMBIANCE; COUNTERFACTUAL THINKING; PHASE-TRANSITIONS; DYNAMICS; COORDINATION; SPORT; SATISFACTION; EXPERIENCE; COHESION; VELOCITY	In business and sports, teams often experience periods of positive and negative momentum while pursuing their goals. However, researchers have not yet been able to provide insights into how psychological and behavioral states actually change during positive and negative team momentum. In the current study we aimed to provide these insights by introducing an experimental dynamical research design. Rowing pairs had to compete against a virtual opponent on rowing ergometers, while a screen in front of the team broadcasted the ongoing race. The race was manipulated so that the team's rowing avatar gradually progressed (positive momentum) or regressed (negative momentum) in relation to the victory. The participants responded verbally to collective efficacy and task cohesion items appearing on the screen each minute. In addition, effort exertion and interpersonal coordination were continuously measured. Our results showed negative psychological changes (perceptions of collective efficacy and task cohesion) during negative team momentum, which were stronger than the positive changes during positive team momentum. Moreover, teams' exerted efforts rapidly decreased during negative momentum, whereas positive momentum accompanied a more variable and adaptive sequence of effort exertion. Finally, the interpersonal coordination was worse during negative momentum than during positive momentum. These results provide the first empirical insights into actual team momentum dynamics, and demonstrate how a dynamical research approach significantly contributes to current knowledge on psychological and behavioral processes.	[Den Hartigh, Ruud J. R.; Van Yperen, Nico W.; Van Geert, Paul L. C.] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Den Hartigh, Ruud J. R.; Gernigon, Christophe] Univ Montpellier I, Fac Sport & Phys Educ Sci, Epsylon Lab, Montpellier, France; [Marin, Ludovic] Univ Montpellier I, Fac Sport & Phys Educ Sci, Movement Hlth Lab M2H, Montpellier, France	University of Groningen; Universite de Montpellier; Universite de Montpellier	Den Hartigh, RJR (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	j.r.den.hartigh@rug.nl	Van Yperen, Nico W./C-2341-2012	Van Yperen, Nico W./0000-0003-2116-8841; Gernigon, Christophe/0000-0002-3233-7551; Den Hartigh, Ruud/0000-0002-0094-8307; Marin, Ludovic/0000-0002-9040-8012	French Doctoral School "Human Movement Sciences" [463]	French Doctoral School "Human Movement Sciences"	The research reported in the article was supported by a PhD grant of the French Doctoral School "Human Movement Sciences" (463). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER P, 1978, URBAN LIFE, V7, P153, DOI 10.1177/089124167800700202; Adler P., 1981, MOMENTUM THEORY SOCI; Arrow H., 2000, SMALL GROUPS COMPLEX; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Briki W, 2014, MOTIV EMOTION, V38, P263, DOI 10.1007/s11031-013-9372-3; Briki W, 2014, PSYCHOL SPORT EXERC, V15, P216, DOI 10.1016/j.psychsport.2013.11.006; Briki W, 2013, PSYCHOL SPORT EXERC, V14, P389, DOI 10.1016/j.psychsport.2012.11.009; Briki W, 2012, INT J SPORT PSYCHOL, V43, P365, DOI 10.7352/IJSP2012.43.365; Buton F, 2007, SMALL GR RES, V38, P235, DOI 10.1177/1046496407300476; Carron A. V., 1998, GROUP DYNAMICS SPORT, V2nd; Carron A.V., 1998, ADV SPORT EXERCISE P, V213
226; Carron AV, 2002, J SPORT SCI, V20, P119, DOI 10.1080/026404102317200828; Coey C, 2011, EXP BRAIN RES, V211, P483, DOI 10.1007/s00221-011-2689-9; Cornelius A, 1997, PERCEPT MOTOR SKILL, V84, P475, DOI 10.2466/pms.1997.84.2.475; Eisler L, 1998, J SPORT EXERCISE PSY, V20, P311; Feltz DL, 1998, J APPL PSYCHOL, V83, P557, DOI 10.1037/0021-9010.83.4.557; Gernigon C, 2010, J SPORT EXERCISE PSY, V32, P377, DOI 10.1123/jsep.32.3.377; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Heuze JP, 2002, J SPORT EXERCISE PSY, V24, P42, DOI 10.1123/jsep.24.1.42; HSEE CK, 1994, J EXP SOC PSYCHOL, V30, P96, DOI 10.1006/jesp.1994.1005; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Jones MI, 2008, J APPL SPORT PSYCHOL, V20, P57, DOI 10.1080/10413200701784841; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 1982, JUDGMENT UNCERTAINTY, DOI [10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477]; Kelso S., 1995, DYNAMIC PATTERNS SEL; Lawrence JW, 2002, J APPL SOC PSYCHOL, V32, P788, DOI 10.1111/j.1559-1816.2002.tb00242.x; Lee JC, 2008, IEEE PERVAS COMPUT, V7, P39, DOI 10.1109/MPRV.2008.53; Markman KD, 2007, PERS SOC PSYCHOL B, V33, P800, DOI 10.1177/0146167207301026; Markman KD, 2007, THINK REASONING, V13, P188, DOI 10.1080/13546780600927157; McGrath JE, 2000, PERS SOC PSYCHOL REV, V4, P95, DOI 10.1207/S15327957PSPR0401_8; MEDVEC VH, 1995, J PERS SOC PSYCHOL, V69, P603, DOI 10.1037/0022-3514.69.4.603; Medvec VH, 1997, J PERS SOC PSYCHOL, V72, P1284, DOI 10.1037/0022-3514.72.6.1284; Miller S, 1991, SPORT PSYCHOL, V5, P211, DOI DOI 10.1123/TSP.5.3.211; Moesch K, 2012, SPORT PSYCHOL, V26, P435, DOI 10.1123/tsp.26.3.435; Nowak A., 1998, DYNAMICAL SOCIAL PSY; Perreault S, 1998, J SPORT EXERCISE PSY, V20, P421, DOI 10.1123/jsep.20.4.421; Pikovsky A., 2003, SYNCHRONIZATION UNIV, V12; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Stanimirovic R, 2004, J SPORT EXERCISE PSY, V2, P43, DOI DOI 10.1080/1612197X.2004.9671732; Taylor J, 1994, J APPL SPORT PSYCHOL, V6, P51, DOI DOI 10.1080/10413209408406465; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Todman JB., 2001, SINGLE CASE SMALL N; Van Geert P., 2012, DYNAMICAL SYSTEMS AP, P43; Van Geert P., 1994, DYNAMIC SYSTEMS DEV; van Geert P., 2009, CHAOS COMPLEXITY PSY, P242; van Geert P, 2011, CHILD DEV PERSPECT, V5, P273, DOI 10.1111/j.1750-8606.2011.00197.x; vanGeert P, 1997, PSYCHOL INQ, V8, P143, DOI 10.1207/s15327965pli0802_11	54	33	33	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97887	10.1371/journal.pone.0097887	http://dx.doi.org/10.1371/journal.pone.0097887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24838238	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800082
J	Hanaki, KI; Ike, F; Kajita, A; Yasuno, W; Yanagiba, M; Goto, M; Sakai, K; Ami, Y; Kyuwa, S				Hanaki, Ken-Ichi; Ike, Fumio; Kajita, Ayako; Yasuno, Wataru; Yanagiba, Misato; Goto, Motoki; Sakai, Kouji; Ami, Yasushi; Kyuwa, Shigeru			A Broadly Reactive One-Step SYBR Green I Real-Time RT-PCR Assay for Rapid Detection of Murine Norovirus	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; LABORATORY MICE; CAPSID PROTEIN; INFECTION; VIRUS; INACTIVATION; PREVALENCE; SUFFICIENT; SURROGATES; DIVERSITY	A one-step SYBR Green I real-time RT-PCR assay was developed for the detection and quantification of a broad range of murine noroviruses (MNVs). The primer design was based on the multiple sequence alignments of 101 sequences of the open reading frame (ORF)1-ORF2 junction of MNV. The broad reactivity and quantitative capacity of the assay were validated using 7 MNV plasmids. The assay was completed within 1 h, and the reliable detection limit was 10 copies of MNV plasmid or 0.063 median tissue culture infective doses per milliliter of RAW264 cell culture-propagated viruses. The diagnostic performance of the assay was evaluated using 158 mouse fecal samples, 91 of which were confirmed to be positive. The melting curve analysis demonstrated the diversity of MNV in the samples. This is the first report of a broadly reactive one-step SYBR Green I real-time RT-PCR assay for detecting of MNVs. The rapid and sensitive performance of this assay makes it a powerful tool for diagnostic applications.	[Hanaki, Ken-Ichi] Iwate Med Univ, Inst Biomed Sci, Dept Lab Anim Med, Yahaba, Iwate, Japan; [Hanaki, Ken-Ichi; Yasuno, Wataru; Yanagiba, Misato] Iwate Med Univ, Inst Biomed Sci, Ctr Vivo Sci, Yahaba, Iwate, Japan; [Ike, Fumio; Kajita, Ayako] RIKEN BioResource Ctr, Expt Anim Div, Tsukuba, Ibaraki, Japan; [Goto, Motoki] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan; [Sakai, Kouji] NIID, Dept Virol 3, Musashimurayama, Tokyo, Japan; [Ami, Yasushi] NIID, Div Expt Anim Res, Shinjuku Ku, Tokyo, Japan; [Kyuwa, Shigeru] Univ Tokyo, Dept Biomed Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Iwate Medical University; Iwate Medical University; RIKEN; University of Tokyo; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); University of Tokyo	Hanaki, KI (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Lab Anim Med, Yahaba, Iwate, Japan.	hanaki@iwate-med.ac.jp	SAKAI, KOUJI/J-4436-2018		MEXT; JSPS KAKENHI [22300141, 23500500]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid (2009a(sic)"2013) for the Strategic Medical Science Research Center from MEXT and by JSPS KAKENHI Grant Numbers 22300141, 23500500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann CG, 2009, J VIROL, V83, P13037, DOI 10.1128/JVI.01445-09; Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06; Baert L, 2008, APPL ENVIRON MICROB, V74, P543, DOI 10.1128/AEM.01039-07; Bailey D, 2008, J VIROL, V82, P7725, DOI 10.1128/JVI.00237-08; Barron EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021435; Belliot G, 2008, APPL ENVIRON MICROB, V74, P3315, DOI 10.1128/AEM.02148-07; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Compton SR, 2008, J AM ASSOC LAB ANIM, V47, P25; Doom CM, 2009, VIROLOGY, V392, P153, DOI 10.1016/j.virol.2009.05.035; Farkas T, 2012, VET MICROBIOL, V160, P463, DOI 10.1016/j.vetmic.2012.06.002; Gonzalez-Hernandez MB, 2012, JOVE-J VIS EXP, DOI 10.3791/4297; Hanaki KI, 2014, J VIROL METHODS, V204, P17, DOI 10.1016/j.jviromet.2014.03.025; Hayashimoto N, 2013, EXP ANIM TOKYO, V62, P41, DOI 10.1538/expanim.62.41; Hensley SE, 2009, J VIROL, V83, P7357, DOI 10.1128/JVI.00623-09; Higgins PDR, 2011, COMP IMMUNOL MICROB, V34, P247, DOI 10.1016/j.cimid.2010.12.002; Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005; Hsu CC, 2006, COMPARATIVE MED, V56, P247; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kitagawa Y, 2010, EXP ANIM TOKYO, V59, P47, DOI 10.1538/expanim.59.47; Kitajima M, 2010, J VIROL METHODS, V169, P269, DOI 10.1016/j.jviromet.2010.07.018; Kitajima M, 2009, MICROBIOL IMMUNOL, V53, P531, DOI 10.1111/j.1348-0421.2009.00152.x; Korn K, 2009, J CLIN MICROBIOL, V47, P1238, DOI 10.1128/JCM.02204-08; Lee J, 2008, APPL ENVIRON MICROB, V74, P2111, DOI 10.1128/AEM.02442-07; Lencioni KC, 2008, COMPARATIVE MED, V58, P522; Liu GL, 2009, J VIROL, V83, P6963, DOI 10.1128/JVI.00284-09; Magulski T, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-107; Mathijs E, 2010, J GEN VIROL, V91, P2723, DOI 10.1099/vir.0.024109-0; McInnes EE, 2011, LAB ANIMAL, V40, P341, DOI 10.1038/laban1111-341; Muller B, 2007, ARCH VIROL, V152, P1709, DOI 10.1007/s00705-007-0989-y; Nelson AM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-7; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Richards GP, 2012, FOOD ENVIRON VIROL, V4, P6, DOI 10.1007/s12560-011-9072-7; Shortland A, 2014, J GEN VIROL, V95, P413, DOI 10.1099/vir.0.059188-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith DB, 2012, J GEN VIROL, V93, P259, DOI 10.1099/vir.0.036392-0; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Tajima M, 2013, EXP ANIM TOKYO, V62, P127, DOI 10.1538/expanim.62.127; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Tsunesumi N, 2012, J VET MED SCI, V74, P1221, DOI 10.1292/jvms.12-0106; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Ward JM, 2006, TOXICOL PATHOL, V34, P708, DOI 10.1080/01926230600918876; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	47	17	19	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98108	10.1371/journal.pone.0098108	http://dx.doi.org/10.1371/journal.pone.0098108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847970	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600087
J	Hothersall, B; Caplen, G; Parker, RMA; Nicol, CJ; Waterman-Pearson, AE; Weeks, CA; Murrell, JC				Hothersall, Becky; Caplen, Gina; Parker, Richard M. A.; Nicol, Christine J.; Waterman-Pearson, Avril E.; Weeks, Claire A.; Murrell, Joanna C.			Thermal Nociceptive Threshold Testing Detects Altered Sensory Processing in Broiler Chickens with Spontaneous Lameness	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LEG WEAKNESS; RESPONSES; PAIN; BUTORPHANOL; LOCOMOTION; BEHAVIOR; LESIONS	Lameness is common in commercially reared broiler chickens but relationships between lameness and pain (and thus bird welfare) have proved complex, partly because lameness is often partially confounded with factors such as bodyweight, sex and pathology. Thermal nociceptive threshold (TNT) testing explores the neural processing of noxious stimuli, and so can contribute to our understanding of pain. Using an acute model of experimentally induced articular pain, we recently demonstrated that TNT was reduced in lame broiler chickens, and was subsequently attenuated by administration of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This study extended these findings to a large sample of commercial broilers. It examined factors affecting thermal threshold (Part 1) and the effect of an NSAID drug (meloxicam, 5 mg/kg) and of an opioid (butorphanol; 4 mg/kg) (Part 2). Spontaneously lame and matched non-lame birds (n = 167) from commercial farms were exposed to ramped thermal stimulations via a probe attached to the lateral aspect of the tarsometatarsus. Baseline skin temperature and temperature at which a behavioural avoidance response occurred (threshold) were recorded. In Part 1 bird characteristics influencing threshold were modelled; In Part 2 the effect of subcutaneous administration of meloxicam or butorphanol was investigated. Unexpectedly, after accounting for other influences, lameness increased threshold significantly (Part 1). In Part 2, meloxicam affected threshold differentially: it increased further in lame birds and decreased in non-lame birds. No effect of butorphanol was detected. Baseline skin temperature was also consistently a significant predictor of threshold. Overall, lameness significantly influenced threshold after other bird characteristics were taken into account. This, and a differential effect of meloxicam on lame birds, suggests that nociceptive processing may be altered in lame birds, though mechanisms for this require further investigation.	[Hothersall, Becky; Caplen, Gina; Parker, Richard M. A.; Nicol, Christine J.; Waterman-Pearson, Avril E.; Weeks, Claire A.; Murrell, Joanna C.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England	University of Bristol	Hothersall, B (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	B.Hothersall@bristol.ac.uk	Nicol, Christine J/B-4841-2011; Weeks, Claire/C-9136-2012	Nicol, Christine J/0000-0001-6734-2177; Weeks, Claire/0000-0002-4280-9604; Parker, Richard/0000-0002-3933-9728	Biotechnology and Biological Sciences Research Council [BB/G000921/1]; BBSRC [BB/G000921/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), grant number BB/G000921/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WELF QUAL ASS PROT P; Baert K, 2003, COMP BIOCHEM PHYS C, V134, P25, DOI 10.1016/S1532-0456(02)00184-9; BARDO MT, 1978, PHARMACOL BIOCHEM BE, V9, P147, DOI 10.1016/0091-3057(78)90027-8; Berg C., 2004, Measuring and auditing broiler welfare, P37, DOI 10.1079/9780851998053.0037; Caplen G, 2014, ANIM WELFARE, V23, P179, DOI 10.7120/09627286.23.2.179; Caplen G, 2013, VET J, V196, P477, DOI 10.1016/j.tvjl.2012.12.007; Caplen G, 2013, VET J, V198, P616, DOI 10.1016/j.tvjl.2013.09.013; Fernandes BCD, 2012, REV BRAS ZOOTECN, V41, P1951, DOI 10.1590/S1516-35982012000800021; Di Giminiani P, 2013, EUR J PAIN, V17, P638, DOI 10.1002/j.1532-2149.2012.00228.x; Fuchs PN, 2000, PAIN, V84, P141, DOI 10.1016/S0304-3959(99)00194-3; GENTLE MJ, 1986, J ANAT, V145, P79; Gentle MJ, 1997, PAIN, V70, P245, DOI 10.1016/S0304-3959(97)03324-6; GENTLE MJ, 1987, PHYSIOL BEHAV, V40, P781, DOI 10.1016/0031-9384(87)90283-6; Gentle MJ, 2001, NEUROSCIENCE, V106, P643, DOI 10.1016/S0306-4522(01)00318-9; Hocking PM, 2005, RES VET SCI, V78, P69, DOI 10.1016/j.rvsc.2004.05.005; Hothersall B, 2011, J NEUROSCI METH, V201, P220, DOI 10.1016/j.jneumeth.2011.07.028; Hothersall B., 2012, ASS VET ABAESTHETIST, P26; Janczak AM, 2012, VET ANAESTH ANALG, V39, P628, DOI 10.1111/j.1467-2995.2012.00737.x; Kemp MH, 2008, VET REC, V163, P175, DOI 10.1136/vr.163.6.175; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Kestin SC, 2001, VET REC, V148, P195, DOI 10.1136/vr.148.7.195; Knowles TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001545; Krumova EK, 2012, CURR DIABETES REP, V12, P393, DOI 10.1007/s11892-012-0282-7; Lascelles BDX, 2004, AM J VET RES, V65, P1085, DOI 10.2460/ajvr.2004.65.1085; LEY SJ, 1989, PAIN, V39, P353, DOI 10.1016/0304-3959(89)90049-3; Mc Geown D, 1999, VET REC, V144, P668, DOI 10.1136/vr.144.24.668; McGowan KT, 2013, EQUINE VET J, V45, P503, DOI 10.1111/j.2042-3306.2012.00673.x; McKeegan DEF, 2002, NEUROREPORT, V13, P1033, DOI 10.1097/00001756-200206120-00011; McKeegan DEF, 2002, BRAIN RES, V953, P101, DOI 10.1016/S0006-8993(02)03275-4; McMullan S, 2004, J NEUROSCI METH, V138, P133, DOI 10.1016/j.jneumeth.2004.03.020; McNamee PT, 1998, VET REC, V143, P131, DOI 10.1136/vr.143.5.131; Nasr MAF, 2013, APPL ANIM BEHAV SCI, V147, P127, DOI 10.1016/j.applanim.2013.04.015; Nasr MAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042420; Rasmussen DB, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-32; Sandercock DA, 2011, PHYSIOL BEHAV, V104, P728, DOI 10.1016/j.physbeh.2011.07.018; Sandilands V, 2011, Vet Rec, V168, P77, DOI 10.1136/vr.c5978; Sanotra GS, 2001, WORLD POULTRY SCI J, V57, P55, DOI 10.1079/WPS20010006; Singh PM, 2011, VET REC, V168, DOI 10.1136/vr.d1191; Steele F, 2008, J R STAT SOC A STAT, V171, P5; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Weeks CA, 2000, APPL ANIM BEHAV SCI, V67, P111, DOI 10.1016/S0168-1591(99)00102-1; Whay HR, 1998, VET J, V156, P23, DOI 10.1016/S1090-0233(98)80058-0; Whay HR, 1997, VET J, V154, P155, DOI 10.1016/S1090-0233(97)80053-6; Williams MD, 2012, VET ANAESTH ANALG, V40, P15; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	45	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97883	10.1371/journal.pone.0097883	http://dx.doi.org/10.1371/journal.pone.0097883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847799	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600065
J	Hu, B; Song, JT; Qu, HY; Bi, CL; Huang, XZ; Liu, XX; Zhang, M				Hu, Bo; Song, Jian Tao; Qu, Hai Yan; Bi, Chen Long; Huang, Xiao Zhen; Liu, Xin Xin; Zhang, Mei			Mechanical Stretch Suppresses microRNA-145 Expression by Activating Extracellular Signal-Regulated Kinase 1/2 and Upregulating Angiotensin-Converting Enzyme to Alter Vascular Smooth Muscle Cell Phenotype	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; MOLECULAR-BASIS; SHEAR-STRESS; MODULATION; MYOCARDIN; FLOW; DIFFERENTIATION; PATHWAY; TARGETS	Phenotype modulation of vascular smooth muscle cells (VSMCs) plays an important role in the pathogenesis of various vascular diseases, including hypertension and atherosclerosis. Several microRNAs (miRNAs) were found involved in regulating the VSMC phenotype with platelet-derived growth factor (PDGF) treatment, but the role of miRNAs in the mechanical stretch-altered VSMC phenotype is not clear. Here, we identified miR-145 as a major miRNA contributing to stretch-altered VSMC phenotype by miRNA array, quantitative RT-PCR and gain-and loss-of-function methods. Our data demonstrated that 16% stretch suppressed miR-145 expression, with reduced expression of contractile markers of VSMCs cultured on collagenI; overexpression of miR-145 could partially recover the expression in stretched cells. Serum response factor (SRF), myocardin, and Kruppel-like factor 4 (KLF4) are major regulators of the VSMC phenotype. The effect of stretch on myocardin and KLF4 protein expression was altered by miR-145 mimics, but SRF expression was not affected. In addition, stretch-activated extracellular signal-regulated kinase 1/2 (ERK1/2) and up-regulated angiotensin-converting enzyme (ACE) were confirmed to be responsible for the inhibition of miR-145 expression. Mechanical stretch inhibits miR-145 expression by activating the ERK1/2 signaling pathway and promoting ACE expression, thus modulating the VSMC phenotype.	[Zhang, Mei] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Chinese Minist Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Zhang, M (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China.	daixh@vip.sina.com			National Basic Research Program of China (973 Program) [2010CB732605, 2011CB503906]; National Natural Science Foundation of China [81270404, 30970709]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2010CB732605, 2011CB503906) and the National Natural Science Foundation of China (81270404, 30970709). The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Albinsson S, 2011, PHYSIOL GENOMICS, V43, P529, DOI 10.1152/physiolgenomics.00146.2010; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Barauna VG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Halka AT, 2008, CARDIOVASC PATHOL, V17, P98, DOI 10.1016/j.carpath.2007.03.001; He J, 2013, MOLECULES, V18, P1, DOI 10.3390/molecules18010001; HEDIN U, 1988, J CELL BIOL, V107, P307, DOI 10.1083/jcb.107.1.307; Kohlstedt K, 2013, CIRC RES, V112, P1150, DOI 10.1161/CIRCRESAHA.113.301282; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lu DS, 2011, J R SOC INTERFACE, V8, P1379, DOI 10.1098/rsif.2011.0177; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Mao XQ, 2012, CARDIOVASC RES, V96, P513, DOI 10.1093/cvr/cvs274; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paravicini TM, 2012, J AM SOC HYPERTENS, V6, P169, DOI 10.1016/j.jash.2012.01.002; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rieder MJ, 1997, CIRC RES, V80, P312, DOI 10.1161/01.RES.80.3.312; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; Taurin S, 2009, J BIOL CHEM, V284, P33789, DOI 10.1074/jbc.M109.048983; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang J, 2013, EXP CELL RES, V319, P1165, DOI 10.1016/j.yexcr.2013.03.010; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Zhang C, 2005, CELL CYCLE, V8, P3469; Zhang ZY, 2013, CELL SIGNAL, V25, P332, DOI 10.1016/j.cellsig.2012.10.006; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	42	60	65	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96338	10.1371/journal.pone.0096338	http://dx.doi.org/10.1371/journal.pone.0096338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848371	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600011
J	Lin, J; Zhang, Q; Lu, Y; Xue, WR; Xu, Y; Zhu, YC; Hu, XP				Lin, Jun; Zhang, Qiang; Lu, Yi; Xue, Wenrui; Xu, Yue; Zhu, Yichen; Hu, Xiaopeng			Downregulation of HIPK2 Increases Resistance of Bladder Cancer Cell to Cisplatin by Regulating Wip1	PLOS ONE			English	Article							INTERACTING PROTEIN KINASE-2; DNA-DAMAGE RESPONSE; SYSTEMIC CHEMOTHERAPY; TUMOR-SUPPRESSOR; P53 ACTIVITY; APOPTOSIS; DEGRADATION; CARCINOMA; PHOSPHORYLATION; CHEMORESISTANCE	Cisplatin-based combination chemotherapy regimen is a reasonable alternative to cystectomy in advanced/metastatic bladder cancer, but acquisition of cisplatin resistance is common in patients with bladder cancer. Previous studies showed that loss of homeodomain-interacting protein kinase-2 (HIPK2) contributes to cell proliferation and tumorigenesis. However, the role of HIPK2 in regulating chemoresistance of cancer cell is not fully understood. In the present study, we found that HIPK2 mRNA and protein levels are significantly decreased in cisplatin-resistant bladder cancer cell in vivo and in vitro. Downregulation of HIPK2 increases the cell viability in a dose-and time-dependent manner during cisplatin treatment, whereas overexpression of HIPK2 reduces the cell viability. HIPK2 overexpression partially overcomes cisplatin resistance in RT4-CisR cell. Furthermore, we showed that Wip1 (wild-type p53-induced phosphatase 1) expression is upregulated in RT4-CisR cell compared with RT4 cell, and HIPK2 negatively regulates Wip1 expression in bladder cancer cell. HIPK2 and Wip1 expression is also negatively correlated after cisplatin-based combination chemotherapy in vivo. Finally, we demonstrated that overexpression of HIPK2 sensitizes chemoresistant bladder cancer cell to cisplatin by regulating Wip1 expression. Conclusions: These data suggest that HIPK2/Wip1 signaling represents a novel pathway regulating chemoresistance, thus offering a new target for chemotherapy of bladder cancer.	[Lin, Jun; Lu, Yi; Zhu, Yichen] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China; [Zhang, Qiang; Xue, Wenrui; Xu, Yue; Hu, Xiaopeng] Capital Med Univ, Beijing Chao Yang Hosp, Dept Urol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Hu, XP (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Urol, Beijing, Peoples R China.	xiaopenghu@sohu.com						Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Chang JS, 2012, ADV UROL, V2012, DOI 10.1155/2012/364919; Choi DW, 2013, MOL CELL, V51, P374, DOI 10.1016/j.molcel.2013.06.010; Chung J, 2004, CANCER LETT, V203, P155, DOI 10.1016/j.canlet.2003.07.008; Cohen SM, 2000, SCAND J UROL NEPHROL, V34, P105, DOI 10.1080/00365590050509869; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; Esaki T, 1996, INT J CANCER, V65, P479; Goloudina AR, 2012, P NATL ACAD SCI USA, V109, pE68, DOI 10.1073/pnas.1107017108; Gupta S, 2013, CANCER CONTROL, V20, P200, DOI 10.1177/107327481302000308; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hofmann TG, 2013, BIOESSAYS, V35, P55, DOI 10.1002/bies.201200060; Juffs HG, 2002, LANCET ONCOL, V3, P738, DOI 10.1016/S1470-2045(02)00930-0; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Krieghoff-Henning E, 2008, FUTURE ONCOL, V4, P751, DOI 10.2217/14796694.4.6.751; Lazzari C, 2011, ONCOGENE, V30, P4802, DOI 10.1038/onc.2011.182; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; POLLACK A, 1995, J UROLOGY, V154, P2059, DOI 10.1016/S0022-5347(01)66693-X; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Puca R, 2008, GYNECOL ONCOL, V109, P403, DOI 10.1016/j.ygyno.2008.02.018; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Song JY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.252; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wang L, 2012, MOL CANCER THER, V11, P2401, DOI 10.1158/1535-7163.MCT-12-0448; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yang C, 2012, GENE, V496, P8, DOI 10.1016/j.gene.2012.01.012; Yuan G, 2013, ONCOGENE, V32, P375, DOI 10.1038/onc.2012.40	33	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98418	10.1371/journal.pone.0098418	http://dx.doi.org/10.1371/journal.pone.0098418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846322	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400109
J	Brooks, E; Patel, D; Canal, MM				Brooks, Elisabeth; Patel, Dhruval; Canal, Maria Merce			Programming of Mice Circadian Photic Responses by Postnatal Light Environment	PLOS ONE			English	Article							MPER2 PROTEIN EXPRESSION; SUPRACHIASMATIC NUCLEUS; GANGLION-CELLS; MOTOR-ACTIVITY; BRIGHT LIGHT; TIME-COURSE; ADULT MICE; RHYTHMS; PHASE; ENTRAINMENT	Early life programming has important consequences for future health and wellbeing. A key new aspect is the impact of perinatal light on the circadian system. Postnatal light environment will program circadian behavior, together with cell morphology and clock gene function within the suprachiasmatic nucleus (SCN) of the hypothalamus, the principal circadian clock in mammals. Nevertheless, it is still not clear whether the observed changes reflect a processing of an altered photic input from the retina, rather than an imprinting of the intrinsic molecular clock mechanisms. Here, we addressed the issue by systematically probing the mouse circadian system at various levels. Firstly, we used electroretinography, pupillometry and histology protocols to show that gross retinal function and morphology in the adult are largely independent of postnatal light experiences that modulate circadian photosensitivity. Secondly, we used circadian activity protocols to show that only the animal's behavioral responses to chronic light exposure, but not to constant darkness or the acute responses to a light stimulus depend on postnatal light experience. Thirdly, we used real-time PER2:: LUC rhythm recording to show long-term changes in clock gene expression in the SCN, but also heart, lung and spleen. The data showed that perinatal light mainly targets the long-term adaptive responses of the circadian clock to environmental light, rather than the retina or intrinsic clock mechanisms. Finally, we found long-term effects on circadian peripheral clocks, suggesting far-reaching consequences for the animal's overall physiology.	[Brooks, Elisabeth; Patel, Dhruval; Canal, Maria Merce] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Canal, MM (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Maria.canal@manchester.ac.uk			Research Councils UK; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council [BB/F019718/1] Funding Source: researchfish; BBSRC [BB/F019718/1] Funding Source: UKRI	Research Councils UK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Research Councils UK and the Biotechnology and Biological Sciences Research Council (BBSRC) to MMC. EB was a recipient of a Medical Research Council (MRC) doctoral training award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; al Enezi J, 2011, J BIOL RHYTHM, V26, P314, DOI 10.1177/0748730411409719; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brooks E, 2013, NEUROSCI BIOBEHAV R, V37, P551, DOI 10.1016/j.neubiorev.2013.02.012; Brooks E, 2011, BRAIN STRUCT FUNCT, V216, P357, DOI 10.1007/s00429-011-0318-9; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Caillol M, 2000, EUR J NEUROSCI, V12, P649, DOI 10.1046/j.1460-9568.2000.00961.x; Cambras T, 2005, DEV BRAIN RES, V157, P27, DOI 10.1016/j.devbrainres.2005.02.014; Cambras T, 1997, AM J PHYSIOL-REG I, V272, pR1039, DOI 10.1152/ajpregu.1997.272.4.R1039; Cambras T, 1998, PHYSIOL BEHAV, V63, P875, DOI 10.1016/S0031-9384(98)00006-7; Cameron MA, 2009, MOL VIS, V15, P2209; Cameron M, 2008, J GENET, V87, P459, DOI 10.1007/s12041-008-0068-5; Canal MM, 2009, CHRONOBIOL INT, V26, P1545, DOI 10.3109/07420520903398542; Canal-Corretger MM, 2003, CHRONOBIOL INT, V20, P441, DOI 10.1081/CBI-120021442; Canal-Corretger MM, 2000, AM J PHYSIOL-REG I, V278, pR201, DOI 10.1152/ajpregu.2000.278.1.R201; Canal-Corretger MM, 2001, CHRONOBIOL INT, V18, P683, DOI 10.1081/CBI-100106081; Canal-Corretger MM, 2001, AM J PHYSIOL-REG I, V280, pR1023, DOI 10.1152/ajpregu.2001.280.4.R1023; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; COLWELL CS, 1992, J COMP NEUROL, V324, P135, DOI 10.1002/cne.903240202; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DEPRESBRUMMER P, 1995, AM J PHYSIOL-REG I, V268, pR1111, DOI 10.1152/ajpregu.1995.268.5.R1111; DIEZNOGUERA A, 1994, AM J PHYSIOL-REG I, V267, pR1118, DOI 10.1152/ajpregu.1994.267.4.R1118; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gonzalez-Menendez I, 2010, INVEST OPHTH VIS SCI, V51, P4840, DOI 10.1167/iovs.10-5253; Gonzalez-Menendez I, 2010, HISTOL HISTOPATHOL, V25, P73, DOI 10.14670/HH-25.73; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Hainich EC, 2006, FEBS LETT, V580, P6665, DOI 10.1016/j.febslet.2006.11.019; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HONMA KI, 1978, AM J PHYSIOL, V235, pR243, DOI 10.1152/ajpregu.1978.235.5.R243; Honma S, 1996, NEUROSCI LETT, V216, P49; Laemle LK, 2002, BRAIN RES, V953, P73, DOI 10.1016/S0006-8993(02)03272-9; LANUM J, 1978, SURV OPHTHALMOL, V22, P221, DOI 10.1016/0039-6257(78)90070-X; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; Lavialle M, 2001, GLIA, V34, P88, DOI 10.1002/glia.1044; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; MASON R, 1991, NEUROSCI LETT, V123, P160, DOI 10.1016/0304-3940(91)90920-O; Meijer JH, 2012, PROG BRAIN RES, V199, P143, DOI 10.1016/B978-0-444-59427-3.00009-5; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Morag I, 2011, COCHRANE DATABA 0119, V19, DOI 006910.001002/14651858.CD14006982.pub14651852; Moriya T, 2000, J NEUROSCI RES, V60, P212, DOI 10.1002/(SICI)1097-4547(20000415)60:2<212::AID-JNR10>3.0.CO;2-P; Noell W K, 1966, Invest Ophthalmol, V5, P450; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Ohta H, 2006, PEDIATR RES, V60, P304, DOI 10.1203/01.pdr.0000233114.18403.66; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Perlman JM, 2001, PEDIATRICS, V108, P1339, DOI 10.1542/peds.108.6.1339; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; PROSSER RA, 1994, BRAIN RES, V643, P296, DOI 10.1016/0006-8993(94)90036-1; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Silver AC, 2012, BRAIN BEHAV IMMUN, V26, P407, DOI 10.1016/j.bbi.2011.10.001; Smith L, 2009, J NEUROENDOCRINOL, V21, P946, DOI 10.1111/j.1365-2826.2009.01914.x; Strang-Karlsson S, 2010, CHRONOBIOL INT, V27, P1829, DOI 10.3109/07420528.2010.512689; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Sudo M, 2003, NEUROSCIENCE, V121, P493, DOI 10.1016/S0306-4522(03)00457-3; Sumova A, 2004, PHYSIOL RES, V53, pS167; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; TAKEO Y, 1984, NEUROENDOCRINOLOGY, V39, P97, DOI 10.1159/000123964; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Zhu HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037833	74	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97160	10.1371/journal.pone.0097160	http://dx.doi.org/10.1371/journal.pone.0097160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842115	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600017
J	Drymon, JM; Ajemian, MJ; Powers, SP				Drymon, J. Marcus; Ajemian, Matthew J.; Powers, Sean P.			Distribution and Dynamic Habitat Use of Young Bull Sharks Carcharhinus leucas in a Highly Stratified Northern Gulf of Mexico Estuary	PLOS ONE			English	Article							MOVEMENT PATTERNS; TOP PREDATOR; RECTAL GLAND; FLORIDA; VARIABILITY; AREAS; WATER; AGE	Understanding how animals alter habitat use in response to changing abiotic conditions is important for effective conservation management. For bull sharks (Carcharhinus leucas), habitat use has been widely examined in the eastern and western Gulf of Mexico; however, knowledge of their movements and the factors influencing them is lacking for populations in the more temperate north-central Gulf of Mexico. To examine how changes in hydrographic conditions affected the presence of young bull sharks in Mobile Bay, Alabama, thirty-five sharks were fitted with internal acoustic transmitters and monitored with an acoustic monitoring array consisting of thirty-three receivers between June 2009 and December 2010. Tagged sharks ranged in size from 60 to 114 cm fork length and were detected between the upper and lower portions of Mobile Bay. Despite a variety of freshwater sources associated with this highly productive estuary, sharks were most consistently detected at the largest input to the system - the Mobile and Tensaw Rivers. Our findings suggest a combination of hydrographic factors interact to influence the distribution of juvenile bull sharks in Mobile Bay. The factors affecting the probability of detecting at least one bull shark varied both temporally (2009 vs 2010) and spatially (upper vs lower bay). Electivity analysis demonstrated that bull sharks showed highest affinity for warm water (29-32 degrees C), moderate salinities (10-11 psu) and normoxic waters (5-7 mg/l), although these patterns were not consistent between regions or across years. We suggest future studies coupling telemetry and hydrographic variables should, when possible, consider the interactions of multiple environmental parameters when defining the dynamic factors explaining the spatial distribution of coastal sharks.	[Drymon, J. Marcus; Ajemian, Matthew J.; Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Drymon, J. Marcus; Ajemian, Matthew J.; Powers, Sean P.] Dauphin Isl Sea Lab, Ctr Ecosyst Based Fishery Management, Dauphin Isl, AL USA	University of South Alabama; Dauphin Island Sea Lab	Drymon, JM (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	mdrymon@disl.org	Nisa-Castro-Neto, Walter/L-3235-2014	Nisa-Castro-Neto, Walter/0000-0001-8389-5599; Powers, Sean/0000-0002-4770-9944	Shelby Center for Ecosystem Based Fishery Management	Shelby Center for Ecosystem Based Fishery Management	This work was funded through a grant from the Shelby Center for Ecosystem Based Fishery Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajemian MJ, 2012, ENVIRON BIOL FISH, V95, P79, DOI 10.1007/s10641-011-9858-3; Ajemian MJ, 2011, FORAGING ECOLOGY LAR, P261; Blackburn Jason K., 2007, V50, P331; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Curtis TH, 2013, MAR COAST FISH, V5, P28, DOI 10.1080/19425120.2012.756438; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Drymon JM, 2012, ENVIRON BIOL FISH, V95, P21, DOI 10.1007/s10641-011-9922-z; Dzwonkowski B, 2011, CONT SHELF RES, V31, P939, DOI 10.1016/j.csr.2011.03.001; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Froeschke J, 2010, MAR ECOL PROG SER, V407, P279, DOI 10.3354/meps08546; Froeschke JT, 2010, AQUAT BIOL, V11, P65, DOI 10.3354/ab00290; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Kessel ST, 2014, REV FISH BIOL FISHER, V24, P199, DOI 10.1007/s11160-013-9328-4; Kim CK, 2012, J MARINE SYST, V96-97, P103, DOI 10.1016/j.jmarsys.2012.02.008; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Marr CD, 2013, HYDRODYNAMIC MODELIN, P102; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1049, DOI 10.1017/S0025315405012105; Matich P, 2012, MAR ECOL PROG SER, V447, P165, DOI 10.3354/meps09497; MCCANDLESS CT, 2007, AM FISHERIES SOC S, V50; Munroe SEM, 2014, REV FISH BIOL FISHER, V24, P317, DOI 10.1007/s11160-013-9333-7; Neer JA, 2005, J FISH BIOL, V67, P370, DOI 10.1111/j.0022-1112.2005.00743.x; NOAA, 1985, GULF MEX COAST OC ZO; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; Papsons Glenn R., 2007, V50, P301; Park K, 2007, ESTUAR COAST, V30, P54, DOI 10.1007/BF02782967; Pillans RD, 2005, J COMP PHYSIOL B, V175, P37, DOI 10.1007/s00360-004-0460-2; Pillans RD, 2004, COMP BIOCHEM PHYS A, V138, P363, DOI 10.1016/j.cbpb.2004.05.006; Sanchez-Rubio G, 2011, J HYDROL, V396, P72, DOI 10.1016/j.jhydrol.2010.10.034; Schroeder W. W., 1992, COASTAL ESTUARINE ST, P155; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Simpfendorfer CA, 2004, CRC MAR BIOL SER, P553; Simpfendorfer CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016918; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; Wirsing AJ, 2007, OECOLOGIA, V153, P563, DOI 10.1007/s00442-007-0769-0; Yeiser BG, 2008, MAR FRESHWATER RES, V59, P489, DOI 10.1071/MF07181	41	27	28	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97124	10.1371/journal.pone.0097124	http://dx.doi.org/10.1371/journal.pone.0097124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841925	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600016
J	Ito, T; Bai, T; Tanaka, T; Yoshida, K; Ueyama, T; Miyajima, M; Negishi, T; Kawasaki, T; Takamatsu, H; Kikutani, H; Kumanogoh, A; Yukawa, K				Ito, Takuji; Bai, Tao; Tanaka, Tetsuji; Yoshida, Kenji; Ueyama, Takashi; Miyajima, Masayasu; Negishi, Takayuki; Kawasaki, Takahiko; Takamatsu, Hyota; Kikutani, Hitoshi; Kumanogoh, Atsushi; Yukawa, Kazunori			Estrogen-Dependent Proteolytic Cleavage of Semaphorin 4D and Plexin-B1 Enhances Semaphorin 4D-Induced Apoptosis during Postnatal Vaginal Remodeling in Pubescent Mice	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; GROWTH CONE COLLAPSE; R-RAS; KINASE; CELL; ABNORMALITIES; MORPHOLOGY; RECEPTORS; MIGRATION; SYSTEM	Around the fifth week after birth, the vaginal cavity in female mouse pups opens to the overlaying skin. This postnatal tissue remodeling of the genital tract occurs during puberty, and it largely depends upon hormonally induced apoptosis that mainly occurs in the epithelium at the lower part of the mouse vaginal cavity. Previously, we showed that most BALB/c mice lacking the class IV Semaphorin (Sema4D) develop imperforate vagina and hydrometrocolpos; therefore, we reasoned that the absence of Sema4D-induced apoptosis in vaginal epithelial cells may cause the imperforate vagina. Sema4D signals via the Plexin-B1 receptor; nevertheless detailed mechanisms mediating this hormonally triggered apoptosis are not fully documented. To investigate the estrogen-dependent control of Sema4D signaling during the apoptosis responsible for mouse vaginal opening, we examined structural and functional modulation of Sema4D, Plexin-B1, and signaling molecules by analyzing both wild-type and Sema4D-/- mice with or without ovariectomy. Both the release of soluble Sema4D and the conversion of Plexin-B1 by proteolytic processing in vaginal tissue peaked 5 weeks after birth of wild-type BALB/c mice at the time of vaginal opening. Estrogen supplementation of ovariectomized wild-type mice revealed that both the release of soluble Sema4D and the conversion of Plexin-B1 into an active form were estrogen-dependent and concordant with apoptosis. Estrogen supplementation of ovariectomized Sema4D-/- mice did not induce massive vaginal apoptosis in 5-week-old mice; therefore, Sema4D may be an essential apoptosis-inducing ligand that acts downstream of estrogen action in vaginal epithelium during this postnatal tissue remodeling. Analysis of ovariectomized mice also indicated that Sema4D contributed to estrogen-dependent dephosphorylation of Akt and ERK at the time of vaginal opening. Based on our results, we propose that apoptosis in vaginal epithelium during postnatal vaginal opening is induced by enhanced Sema4D signaling that is caused by estrogen-dependent structural changes of Sema4D and Plexin-B1.	[Ito, Takuji; Yoshida, Kenji; Negishi, Takayuki; Yukawa, Kazunori] Meijo Univ, Fac Pharm, Dept Physiol, Nagoya, Aichi 468, Japan; [Bai, Tao; Tanaka, Tetsuji] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama, Japan; [Ueyama, Takashi] Wakayama Med Univ, Dept Anat & Cell Biol, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan; [Kawasaki, Takahiko] Grad Univ Adv Studies Sokendai, Natl Inst Genet, Div Brain Funct, Mishima, Shizuoka, Japan; [Takamatsu, Hyota; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 565, Japan; [Kikutani, Hitoshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 565, Japan	Meijo University; Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Osaka University; Osaka University	Yukawa, K (corresponding author), Meijo Univ, Fac Pharm, Dept Physiol, Nagoya, Aichi 468, Japan.	kyukawa@meijo-u.ac.jp		Ito, Takuji/0000-0002-5078-0119; Kawasaki, Takahiko/0000-0001-9939-8407	Ministry of Education, Science, Sports and Culture, Japan [19590178]; Research Institute of Meijo University; Grants-in-Aid for Scientific Research [24590895] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Institute of Meijo University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was primarily supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan (#19590178, http://www.jsps.go.jp/j-grantsinaid/index.html), and partly supported by several grants from the Research Institute of Meijo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artigiani S, 2003, J BIOL CHEM, V278, P10094, DOI 10.1074/jbc.M210156200; Atwal JK, 2003, J NEUROSCI, V23, P7602; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Fazzari P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-55; Giacobini P, 2008, J CELL BIOL, V183, P555, DOI 10.1083/jcb.200806160; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Guan F, 2006, KIDNEY INT, V69, P1564, DOI 10.1038/sj.ki.5000313; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; Hubner A, 2010, MOL CELL BIOL, V30, P98, DOI 10.1128/MCB.01155-09; Ito T, 2014, MOL MED REP IN PRESS; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Li L, 2009, INT J ONCOL, V34, P905, DOI 10.3892/ijo_00000216; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Moretti S, 2008, BLOOD, V111, P2290, DOI 10.1182/blood-2007-06-096529; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Rodriguez I, 1997, DEV BIOL, V184, P115, DOI 10.1006/dbio.1997.8522; Saito Y, 2009, EMBO REP, V10, P614, DOI 10.1038/embor.2009.63; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Simpson KJ, 2004, INT J DEV BIOL, V48, P675, DOI 10.1387/ijdb.041849ks; SUNDBERG JP, 1994, LAB ANIM SCI, V44, P380; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Yamaguchi W, 2012, MOL CELL NEUROSCI, V49, P290, DOI 10.1016/j.mcn.2011.12.004	30	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97909	10.1371/journal.pone.0097909	http://dx.doi.org/10.1371/journal.pone.0097909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841081	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600091
J	Yuan, ZH; Mehta, HJ; Mohammed, K; Nasreen, N; Roman, R; Brantly, M; Sadikot, RT				Yuan, Zhihong; Mehta, Hiren J.; Mohammed, Kamal; Nasreen, Najmunissa; Roman, Robert; Brantly, Mark; Sadikot, Ruxana T.			TREM-1 Is Induced in Tumor Associated Macrophages by Cyclo-Oxygenase Pathway in Human Non-Small Cell Lung Cancer	PLOS ONE			English	Article							IMMUNE-RESPONSES; PROGNOSTIC VALUE; KAPPA-B; EXPRESSION; INFLAMMATION; ACTIVATION; ROLES; MICROENVIRONMENT; ANGIOGENESIS; LEUKOCYTOSIS	It is increasingly recognized that the tumor microenvironment plays a critical role in the initiation and progression of lung cancer. In particular interaction of cancer cells, macrophages, and inflammatory response in the tumor microenvironment has been shown to facilitate cancer cell invasion and metastasis. The specific molecular pathways in macrophages that immunoedit tumor growth are not well defined. Triggering receptor expressed on myeloid cells 1 (TREM-1) is a member of the super immunoglobulin family expressed on a select group of myeloid cells mainly monocyte/macrophages. Recent studies suggest that expression of TREM-1 in tumors may predict cancer aggressiveness and disease outcomes in liver and lung cancer however the mechanism of TREM-1 expression in the setting of cancer is not defined. In this study we demonstrate that tumor tissue from patients with non-small cell lung cancer show an increased expression of TREM-1 and PGE2. Immunohistochemistry and immunofluorescence confirmed that the expression of TREM-1 was selectively seen in CD68 positive macrophages. By employing an in vitro model we confirmed that expression of TREM-1 is increased in macrophages that are co-cultured with human lung cancer cells. Studies with COX-2 inhibitors and siCOX-2 showed that expression of TREM-1 in macrophages in tumor microenvironment is dependent on COX-2 signaling. These studies for the first time define a link between tumor COX-2 induction, PGE2 production and expression of TREM-1 in macrophages in tumor microenvironment and suggest that TREM-1 might be a novel target for tumor immunomodulation.	[Yuan, Zhihong; Mohammed, Kamal; Roman, Robert; Brantly, Mark; Sadikot, Ruxana T.] Vet Affairs Med Ctr, Gainesville, FL 32608 USA; [Yuan, Zhihong; Mehta, Hiren J.; Mohammed, Kamal; Nasreen, Najmunissa; Sadikot, Ruxana T.] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; University of Florida	Sadikot, RT (corresponding author), Vet Affairs Med Ctr, Gainesville, FL 32608 USA.	rtsadikot@ufl.edu	Brantly, Mark/AAH-2922-2020	Yuan, Zhihong/0000-0002-2300-0463	Department of Veterans Affairs; Veterans Affairs [I01BX001786] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by the Department of Veterans Affairs (MR to RTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Baird AM, 2013, LUNG CANCER, V79, P83, DOI 10.1016/j.lungcan.2012.10.003; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beane J, 2008, CANCER PREV RES, V1, P56, DOI 10.1158/1940-6207.CAPR-08-0011; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brower V, 2012, J NATL CANCER I, V104, P649, DOI 10.1093/jnci/djs235; Carbone DP, 2011, CLIN LUNG CANCER, V12, P261, DOI 10.1016/j.cllc.2011.06.002; Chen J, 2013, J CANCER RES CLIN, V139, P231, DOI 10.1007/s00432-012-1314-z; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Hallam S, 2009, J PATHOL, V219, P143, DOI 10.1002/path.2602; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Ho CC, 2008, AM J RESP CRIT CARE, V177, P763, DOI 10.1164/rccm.200704-641OC; Holgersson G, 2012, MED ONCOL, V29, P3176, DOI 10.1007/s12032-012-0247-3; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kasuga I, 2001, CANCER-AM CANCER SOC, V92, P2399, DOI 10.1002/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lee Jay M, 2007, Future Oncol, V3, P149, DOI 10.2217/14796694.3.2.149; Liao R, 2012, CANCER SCI, V103, P984, DOI 10.1111/j.1349-7006.2012.02273.x; Lievense LA, 2013, LUNG CANCER, V80, P256, DOI 10.1016/j.lungcan.2013.02.017; Lim BJ, 2010, MOL MED REP, V3, P43, DOI 10.3892/mmr_00000216; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mao JT, 2011, CANCER PREV RES, V4, P984, DOI 10.1158/1940-6207.CAPR-11-0078; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moysich KB, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-31; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ohtaki Y, 2010, J THORAC ONCOL, V5, P1507, DOI 10.1097/JTO.0b013e3181eba692; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qiu R, 2012, J CANCER RES CLIN, V138, P119, DOI 10.1007/s00432-011-1080-3; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Srivastava MK, 2012, IMMUNOTHERAPY-UK, V4, P291, DOI [10.2217/IMT.11.178, 10.2217/imt.11.178]; Stathopoulos GT, 2008, MOL CANCER RES, V6, P364, DOI 10.1158/1541-7786.MCR-07-0309; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Syed MA, 2010, EXP CELL RES, V316, P3140, DOI 10.1016/j.yexcr.2010.08.009; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; Wang XQ, 2013, MOL CARCINOGEN, V52, P218, DOI 10.1002/mc.21846; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Yuan ZH, 2012, INT J BIOCHEM CELL B, V44, P2032, DOI 10.1016/j.biocel.2012.08.001; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270; Zhang BC, 2011, MED ONCOL, V28, P1447, DOI 10.1007/s12032-010-9638-5; Zhang BC, 2011, CLINICS, V66, P1879, DOI 10.1590/S1807-59322011001100006; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	61	45	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e94241	10.1371/journal.pone.0094241	http://dx.doi.org/10.1371/journal.pone.0094241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842612	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600003
J	Riar, AK; Narasimhan, M; Rathinam, ML; Vedpathak, D; Mummidi, S; Henderson, GI; Mahimainathan, L				Riar, Amanjot Kaur; Narasimhan, Madhusudhanan; Rathinam, Mary Latha; Vedpathak, Dhanashree; Mummidi, Srinivas; Henderson, George I.; Mahimainathan, Lenin			Ethanol-Induced Transcriptional Activation of Programmed Cell Death 4 (Pdcd4) Is Mediated by GSK-3 beta Signaling in Rat Cortical Neuroblasts	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PDCD4; FETAL ALCOHOL SYNDROME; SYNTHASE KINASE 3-BETA; NF-KAPPA-B; GENE-EXPRESSION; PRENATAL EXPOSURE; BETA-CATENIN; TRANSLATION INITIATION; PROTEIN TRANSLATION; BINDING	Ingestion of ethanol (ETOH) during pregnancy induces grave abnormalities in developing fetal brain. We have previously reported that ETOH induces programmed cell death 4 (PDCD4), a critical regulator of cell growth, in cultured fetal cerebral cortical neurons (PCNs) and in the cerebral cortex in vivo and affect protein synthesis as observed in Fetal Alcohol Spectrum Disorder (FASD). However, the mechanism which activates PDCD4 in neuronal systems is unclear and understanding this regulation may provide a counteractive strategy to correct the protein synthesis associated developmental changes seen in FASD. The present study investigates the molecular mechanism by which ethanol regulates PDCD4 in cortical neuroblasts, the immediate precursor of neurons. ETOH treatment significantly increased PDCD4 protein and transcript expression in spontaneously immortalized rat brain neuroblasts. Since PDCD4 is regulated at both the post-translational and post-transcriptional level, we assessed ETOH's effect on PDCD4 protein and mRNA stability. Chase experiments demonstrated that ETOH does not significantly impact either PDCD4 protein or mRNA stabilization. PDCD4 promoter-reporter assays confirmed that PDCD4 is transcriptionally regulated by ETOH in neuroblasts. Given a critical role of glycogen synthase kinase 3 beta (GSK-3 beta) signaling in regulating protein synthesis and neurotoxic mechanisms, we investigated the involvement of GSK-3 beta and showed that multifunctional GSK-3 beta was significantly activated in response to ETOH in neuroblasts. In addition, we found that ETOH-induced activation of PDCD4 was inhibited by pharmacologic blockade of GSK-3 beta using inhibitors, lithium chloride (LiCl) and SB-216763 or siRNA mediated silencing of GSK-3 beta. These results suggest that ethanol transcriptionally upregulates PDCD4 by enhancing GSK-3 beta signaling in cortical neuroblasts. Further, we demonstrate that canonical Wnt-3a/GSK-3 beta signaling is involved in regulating PDCD4 protein expression. Altogether, we provide evidence that GSK-3 beta/PDCD4 network may represent a critical modulatory point to manage the protein synthetic anomalies and growth aberrations of neural cells seen in FASD.	[Riar, Amanjot Kaur; Narasimhan, Madhusudhanan; Rathinam, Mary Latha; Vedpathak, Dhanashree; Henderson, George I.; Mahimainathan, Lenin] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79409 USA; [Narasimhan, Madhusudhanan; Henderson, George I.; Mahimainathan, Lenin] Texas Tech Univ, Hlth Sci Ctr, South Plains Alcohol & Addict Res Ctr, Lubbock, TX 79409 USA; [Mummidi, Srinivas] South Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX USA; [Mummidi, Srinivas] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Mahimainathan, L (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79409 USA.	lenin.mahimainathan@ttuhsc.edu	Mummidi, Srinivas/H-3335-2017	Mummidi, Srinivas/0000-0002-4068-6380	National Institutes of Health Research Project Grant Program [RO1 AA010114]; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [1I01BX000975]; NIH [RO1AI043279]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010114] Funding Source: NIH RePORTER	National Institutes of Health Research Project Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by RO1 AA010114 (National Institutes of Health Research Project Grant Program) to George I. Henderson. SM is supported by grants awarded by the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development (1I01BX000975) and by RO1AI043279 (NIH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Anthony B, 2008, ALCOHOL ALCOHOLISM, V43, P261, DOI 10.1093/alcalc/agm166; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Blattner C, 2000, MOL CELL BIOL, V20, P3616, DOI 10.1128/MCB.20.10.3616-3625.2000; Calkhoven CF, 2002, TRENDS MOL MED, V8, P577, DOI 10.1016/S1471-4914(02)02424-3; Carter JJ, 2008, ACTA NEUROPATHOL, V116, P303, DOI 10.1007/s00401-008-0377-z; Cash AC, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-4; Cerezo-Guisado MI, 2007, BIOCHEM J, V401, P175, DOI 10.1042/BJ20060731; Chen G, 2009, NEUROTOX RES, V15, P321, DOI 10.1007/s12640-009-9036-y; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Coles CD, 1997, ALCOHOL CLIN EXP RES, V21, P150, DOI 10.1111/j.1530-0277.1997.tb03743.x; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P220, DOI 10.1097/00000374-200002000-00013; CUSSO R, 1989, ALCOHOL ALCOHOLISM, V24, P291, DOI 10.1093/oxfordjournals.alcalc.a044915; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; DUMAS RM, 1994, NEUROTOXICOL TERATOL, V16, P605, DOI 10.1016/0892-0362(94)90038-8; Elliott EJ, 2008, ARCH DIS CHILD, V93, P732, DOI 10.1136/adc.2007.120220; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; GUERRI C, 1990, NEUROCHEM RES, V15, P559, DOI 10.1007/BF00966217; Guerri C, 1998, ALCOHOL CLIN EXP RES, V22, P304, DOI 10.1111/j.1530-0277.1998.tb03653.x; Handa RK, 2000, METAB BRAIN DIS, V15, P211, DOI 10.1007/BF02674530; Hanlon SE, 2004, CURR OPIN GENET DEV, V14, P697, DOI 10.1016/j.gde.2004.09.008; HENDERSON GI, 1995, ALCOHOL CLIN EXP RES, V19, P714, DOI 10.1111/j.1530-0277.1995.tb01572.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jegou S, 2012, ANN NEUROL, V72, P952, DOI 10.1002/ana.23699; JONES KL, 1975, TERATOLOGY, V12, P1, DOI 10.1002/tera.1420120102; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Kim WY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00044; KOTCH LE, 1995, TERATOLOGY, V52, P128, DOI 10.1002/tera.1420520304; Leupold JH, 2012, BIOSCIENCE REP, V32, P281, DOI 10.1042/BSR20110045; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Luo J, 1998, BRAIN RES REV, V27, P157, DOI 10.1016/S0165-0173(98)00009-5; Luo J, 2009, MOL NEUROBIOL, V40, P108, DOI 10.1007/s12035-009-8075-y; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Mason Stephen, 2012, Int J Proteomics, V2012, P867141, DOI 10.1155/2012/867141; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Matsuhashi S, 2007, EXP DERMATOL, V16, P179, DOI 10.1111/j.1600-0625.2006.00531.x; Mattson SN, 1998, ALCOHOL CLIN EXP RES, V22, P279, DOI 10.1111/j.1530-0277.1998.tb03651.x; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; MILLER MW, 1991, ALCOHOL CLIN EXP RES, V15, P229, DOI 10.1111/j.1530-0277.1991.tb01861.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MUNOZ A, 1993, J CELL BIOL, V121, P423, DOI 10.1083/jcb.121.2.423; Narasimhan M, 2013, ALCOHOL CLIN EXP RES, V37, P96, DOI 10.1111/j.1530-0277.2012.01850.x; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Roebuck TM, 1998, ALCOHOL CLIN EXP RES, V22, P339, DOI 10.1111/j.1530-0277.1998.tb03658.x; Rubert G, 2006, J NEUROSCI RES, V84, P483, DOI 10.1002/jnr.20963; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Schneider Mary L, 2005, Alcohol Clin Exp Res, V29, P1685, DOI 10.1097/01.alc.0000179409.80370.25; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Smartt HJM, 2012, GUT, V61, P1306, DOI 10.1136/gutjnl-2011-300817; Substance Abuse and Mental Health Services Administration (SAMHSA). The National Survey on Drug Use and Health (NSDUH), 2013, NAT SURV DRUG US HLT; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Tang NF, 2006, J NEUROCHEM, V96, P1480, DOI 10.1111/j.1471-4159.2006.03649.x; Vangipuram SD, 2012, ALCOHOL CLIN EXP RES, V36, P788, DOI 10.1111/j.1530-0277.2011.01682.x; Vikhreva PN, 2012, DOKL BIOCHEM BIOPHYS, V442, P49, DOI 10.1134/S1607672912010176; VOLKOW ND, 1990, PSYCHIAT RES-NEUROIM, V35, P39, DOI 10.1016/S0165-1781(06)80006-5; Waby JS, 2008, CURR GENOMICS, V9, P301, DOI 10.2174/138920208785133244; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xu J, 2003, J BIOL CHEM, V278, P26929, DOI 10.1074/jbc.M300401200; Yamada Y, 2005, J CRANIOFAC SURG, V16, P1055, DOI 10.1097/01.scs.0000183470.31202.c9; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Young MR, 2010, MOL INTERV, V10, P76, DOI 10.1124/mi.10.2.5; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	78	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98080	10.1371/journal.pone.0098080	http://dx.doi.org/10.1371/journal.pone.0098080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837604	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800102
J	Gamero, A; Belloch, C; Ibanez, C; Querol, A				Gamero, Amparo; Belloch, Carmela; Ibanez, Clara; Querol, Amparo			Molecular Analysis of the Genes Involved in Aroma Synthesis in the Species S. cerevisiae, S. kudriavzevii and S. bayanus var. uvarum in Winemaking Conditions	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; NATURAL HYBRIDS; VOLATILE COMPOUNDS; ESTER PRODUCTION; WINE; FERMENTATION; STRAINS; TEMPERATURE; EXPRESSION; CRYOTOLERANT	The Saccharomyces genus is the main yeast involved in wine fermentations to play a crucial role in the production and release of aromatic compounds. Despite the several studies done into the genome-wide expression analysis using DNA microarray technology in wine S. cerevisiae strains, this is the first to investigate other species of the Saccharomyces genus. This research work investigates the expression of the genes involved in flavor compound production in three different Saccharomyces species (S. cerevisiae, S. bayanus var. uvarum and S. kudriavzevii) under low (12 degrees C) and moderate fermentation temperatures (28 degrees C). The global genes analysis showed that 30% of genes appeared to be differently expressed in the three cryophilic strains if compared to the reference strain (mesophilic S. cerevisiae), suggesting a very close cold adaptation response. Remarkable differences in the gene expression level were observed when comparing the three species, S. cerevisiae, S. bayanus var. uvarum and S. kudriavzevii, which will result in different aroma profiles. Knowledge of these differences in the transcriptome can be a tool to help modulate aroma to create wines with the desired aromatic traits.	[Gamero, Amparo; Belloch, Carmela; Ibanez, Clara; Querol, Amparo] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Querol, A (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, Jaime Roig 11, E-46010 Valencia, Spain.	aquerol@iata.csic.es	Belloch, Carmela/H-4599-2012; Querol, Amparo/H-3782-2012; Lluna, Amparo Gamero/R-2415-2018; Querol, Amparo/AAW-7469-2020; Ibanez, Clara/K-2946-2014	Belloch, Carmela/0000-0002-5136-0482; Querol, Amparo/0000-0002-6478-6845; Lluna, Amparo Gamero/0000-0002-7226-4844; Querol, Amparo/0000-0002-6478-6845; Ibanez, Clara/0000-0003-4427-2393	Spanish Government; PROMETEO grant from the Generalitat Valenciana [PROMETEO/2009/019];  [AGL2009-12673-CO2-01];  [AGL2012-39937-C02-01]	Spanish Government(Spanish GovernmentEuropean Commission); PROMETEO grant from the Generalitat Valenciana; ; 	AGL2009-12673-CO2-01, AGL2012-39937-C02-01 and from the Spanish Government and PROMETEO grant (Project PROMETEO/2009/019) from the Generalitat Valenciana to A. Querol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerny J., 1996, REV SUISSE VITIC ARB, V28, P161; Antonelli A, 1999, J AGR FOOD CHEM, V47, P1139, DOI 10.1021/jf9807317; Antunovics Z., 2003, Bulletin de l'O.I.V., V76, P380; Backhus LE, 2001, FEMS YEAST RES, V1, P111, DOI 10.1016/S1567-1356(01)00019-8; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Beltran G, 2006, FEMS YEAST RES, V6, P1167, DOI 10.1111/j.1567-1364.2006.00106.x; Bisson LF, 1999, AM J ENOL VITICULT, V50, P107; Coloretti F, 2006, FOOD MICROBIOL, V23, P672, DOI 10.1016/j.fm.2005.11.002; Delcroix Agnes, 1994, American Journal of Enology and Viticulture, V45, P291; Demuyter C, 2004, J APPL MICROBIOL, V97, P1140, DOI 10.1111/j.1365-2672.2004.02394.x; Erasmus DJ, 2003, FEMS YEAST RES, V3, P375, DOI 10.1016/S1567-1356(02)00203-9; Gamero A, 2013, J APPL MICROBIOL, V114, P1405, DOI 10.1111/jam.12126; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Giudici P, 1998, LETT APPL MICROBIOL, V27, P31; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOLDNER MC, 2009, J SENS STUD, V24, P243, DOI 10.1111/j.1745-459X.2009.00208.x; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Henschke PA, 2000, AUST J GRAPE WINE R, V6, P190; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; KONDO K, 1992, J BIOL CHEM, V267, P16259; Lambrechts M. G., 2000, South African Journal of Enology and Viticulture, V21, P97; LEE S, 1995, J AM SOC BREW CHEM, V53, P153; Llaurado J, 2002, J FOOD SCI, V67, P268, DOI 10.1111/j.1365-2621.2002.tb11396.x; Llaurado JM, 2005, J AGR FOOD CHEM, V53, P1003, DOI 10.1021/jf049324n; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Masneuf-Pomarede I, 2010, INT J FOOD MICROBIOL, V139, P79, DOI 10.1016/j.ijfoodmicro.2010.01.038; MRSA V, 1993, J BACTERIOL, V175, P2102, DOI 10.1128/JB.175.7.2102-2106.1993; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Peris D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-407; Pizarro FJ, 2008, APPL ENVIRON MICROB, V74, P6358, DOI 10.1128/AEM.00602-08; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Rojas V, 2001, INT J FOOD MICROBIOL, V70, P283, DOI 10.1016/S0168-1605(01)00552-9; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Saerens SMG, 2008, APPL ENVIRON MICROB, V74, P454, DOI 10.1128/AEM.01616-07; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Schmidt S, 2011, APPL ENVIRON MICROB, V77, P1751, DOI 10.1128/AEM.01125-10; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; TAYLOR GT, 1979, J I BREWING, V85, P219, DOI 10.1002/j.2050-0416.1979.tb03911.x; Torija MJ, 2003, INT J FOOD MICROBIOL, V85, P127, DOI 10.1016/S0168-1605(02)00506-8; Tosi E, 2009, J APPL MICROBIOL, V107, P210, DOI 10.1111/j.1365-2672.2009.04196.x; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; Varela C, 2005, YEAST, V22, P369, DOI 10.1002/yea.1217; Verstrepen KJ, 2003, FEMS YEAST RES, V4, P285, DOI 10.1016/S1567-1356(03)00166-1; VOLLBRECHT D, 1973, ARCH MIKROBIOL, V94, P351, DOI 10.1007/BF00769030; Yoshimoto H, 2002, APPL MICROBIOL BIOT, V59, P501, DOI 10.1007/s00253-002-1041-5	53	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97626	10.1371/journal.pone.0097626	http://dx.doi.org/10.1371/journal.pone.0097626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854353	Green Published, Green Submitted, gold			2022-12-27	WOS:000338323200024
J	Hemmerling, J; Heller, K; Hormannsperger, G; Bazanella, M; Clavel, T; Kollias, G; Haller, D				Hemmerling, Jana; Heller, Katharina; Hoermannsperger, Gabriele; Bazanella, Monika; Clavel, Thomas; Kollias, George; Haller, Dirk			Fetal Exposure to Maternal Inflammation Does Not Affect Postnatal Development of Genetically-Driven Ileitis and Colitis	PLOS ONE			English	Article							CROHNS-DISEASE; BOWEL-DISEASE; EXPRESSION; CELLS; MICROBIOTA; PREGNANCY; SEQUENCES; INTESTINE; PROTEIN; LECTIN	Background: Chronic inflammatory disorders have been increasing in incidence over the past decades following geographical patterns of industrialization. Fetal exposure to maternal inflammation may alter organ functions and the offspring's disease risk. We studied the development of genetically-driven ileitis and colitis in response to maternal inflammation using mouse models. Methods: Disease susceptible (Tnf(Delta ARE/+) and IL10(-/-)) and disease-free (Tnf(+/+) and IL10(-/+)) offspring were raised in inflamed and non-inflamed dams. Ileal, caecal and colonic pathology was evaluated in the offspring at 8 or 12 weeks of age. Ly6G-positive cells in inflamed sections from the distal ileum and distal colon were analysed by immunofluorescence microscopy. Gene expression of pro-inflammatory cytokines was measured in whole tissue specimens by quantitative PCR. Microarray analyses were performed on laser microdissected intestinal epithelium. Caecal bacterial communities were assessed by Illumina sequencing of 16S rRNA amplicons. Results: Disease severity, the number of infiltrated neutrophils as well as Tnf and Il12p40 mRNA expression were independent of maternal inflammation in the offspring of mouse models for ileitis (Tnf(Delta ARE/+)) and colitis (IL10(-/-)). Although TNF-driven maternal inflammation regulated 2,174 (wild type) and 3,345 (Tnf(Delta ARE/+)) genes in the fetal epithelium, prenatal gene expression patterns were completely overwritten after birth. In addition, co-housing experiments revealed no change in phylogenetic diversity of the offspring's caecal microbiota in response to maternal inflammation. This is independent of the offspring's genotype before and after the onset of tissue pathology. Conclusions: Disease risk and activity in mouse models of chronic ileitis and colitis was independent of the fetal exposure to maternal inflammation. Likewise, maternal inflammation did not alter the diversity and composition of offspring's caecal microbiota, clearly demonstrating that changes of the gene expression program in the fetal gut epithelium were not relevant for the development of chronic inflammatory disorders in the gut.	[Hemmerling, Jana; Heller, Katharina; Hoermannsperger, Gabriele; Bazanella, Monika; Clavel, Thomas; Haller, Dirk] Tech Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Bavaria, Germany; [Hemmerling, Jana; Heller, Katharina; Hoermannsperger, Gabriele; Bazanella, Monika; Clavel, Thomas; Haller, Dirk] ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Bavaria, Germany; [Kollias, George] Biomed Sci Res Ctr, Inst Immunol, Athens, Greece	Technical University of Munich	Haller, D (corresponding author), Tech Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Bavaria, Germany.	Dirk.Haller@tum.de	Kollias, George/A-7079-2012	Kollias, George/0000-0003-1867-3150; Clavel, Thomas/0000-0002-7229-5595; Haller, Dirk/0000-0002-6977-4085	'Nutritional Adaptation and Epigenetic Mechanisms' program of ZIEL - Research Center for Nutrition and Food Sciences	'Nutritional Adaptation and Epigenetic Mechanisms' program of ZIEL - Research Center for Nutrition and Food Sciences	This work was supported by the 'Nutritional Adaptation and Epigenetic Mechanisms' program of ZIEL - Research Center for Nutrition and Food Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behm BW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006893; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Dominitz JA, 2002, AM J GASTROENTEROL, V97, P641; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Labonte ED, 2003, PROTEIN EXPRES PURIF, V28, P25, DOI 10.1016/S1046-5928(02)00561-2; Malek A, 2001, PLACENTA, V22, pS45, DOI 10.1053/plac.2001.0635; Matsumoto S, 2012, J COMP NEUROL, V520, P479, DOI 10.1002/cne.22705; Morales M, 2000, HEPATO-GASTROENTEROL, V47, P1595; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Oertli M, 2012, J CLIN INVEST, V122, P1082, DOI 10.1172/JCI61029; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; von Schillde MA, 2012, CELL HOST MICROBE, V11, P387, DOI 10.1016/j.chom.2012.02.006; Wagner SJ, 2013, INFLAMM BOWEL DIS, V19, P1285, DOI 10.1097/MIB.0b013e318281f573; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837; Yan X, 2011, INFLAMM BOWEL DIS, V17, P1513, DOI 10.1002/ibd.21539; Yuan YJ, 2012, INT IMMUNOPHARMACOL, V12, P271, DOI 10.1016/j.intimp.2011.11.022	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98237	10.1371/journal.pone.0098237	http://dx.doi.org/10.1371/journal.pone.0098237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849654	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600101
J	Tatara, AM; Lipner, JH; Das, R; Kim, M; Patel, N; Ntouvali, E; Silva, MJ; Thomopoulos, S				Tatara, Alexander M.; Lipner, Justin H.; Das, Rosalina; Kim, Mike; Patel, Nikunj; Ntouvali, Eleni; Silva, Matthew J.; Thomopoulos, Stavros			The Role of Muscle Loading on Bone (Re)modeling at the Developing Enthesis	PLOS ONE			English	Article							BRACHIAL-PLEXUS PALSY; POSTNATAL-DEVELOPMENT; SHOULDER DYSTOCIA; TENDON ENTHESIS; BISPHOSPHONATES; ALENDRONATE; OSTEOBLAST; RESORPTION; PARALYSIS; OSTEOCYTE	Muscle forces are necessary for the development and maintenance of a mineralized skeleton. Removal of loads leads to malformed bones and impaired musculoskeletal function due to changes in bone (re)modeling. In the current study, the development of a mineralized junction at the interface between muscle and bone was examined under normal and impaired loading conditions. Unilateral mouse rotator cuff muscles were paralyzed using botulinum toxin A at birth. Control groups consisted of contralateral shoulders injected with saline and a separate group of normal mice. It was hypothesized that muscle unloading would suppress bone formation and enhance bone resorption at the enthesis, and that the unloading-induced bony defects could be rescued by suppressing osteoclast activity. In order to modulate osteoclast activity, mice were injected with the bisphosphonate alendronate. Bone formation was measured at the tendon enthesis using alizarin and calcein fluorescent labeling of bone surfaces followed by quantitative histomorphometry of histologic sections. Bone volume and architecture was measured using micro computed tomography. Osteoclast surface was determined via quantitative histomorphometry of tartrate resistant acid phosphatase stained histologic sections. Muscle unloading resulted in delayed initiation of endochondral ossification at the enthesis, but did not impair bone formation rate. Unloading led to severe defects in bone volume and trabecular bone architecture. These defects were partially rescued by suppression of osteoclast activity through alendronate treatment, and the effect of alendronate was dose dependent. Similarly, bone formation rate was increased with increasing alendronate dose across loading groups. The bony defects caused by unloading were therefore likely due to maintained high osteoclast activity, which normally decreases from neonatal through mature timepoints. These results have important implications for the treatment of muscle unloading conditions such as neonatal brachial plexus palsy, which results in shoulder paralysis at birth and subsequent defects in the rotator cuff enthesis and humeral head.	[Tatara, Alexander M.; Lipner, Justin H.; Das, Rosalina; Kim, Mike; Patel, Nikunj; Ntouvali, Eleni; Silva, Matthew J.; Thomopoulos, Stavros] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA	Washington University (WUSTL)	Thomopoulos, S (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.	ThomopoulosS@wudosis.wustl.edu	Lipner, Justin/D-5489-2011	Lipner, Justin/0000-0001-5991-4673; Kim, Hyunmin/0000-0002-5286-5335; Silva, Matthew/0000-0001-7375-4522	National Institutes of Health [R01 AR055580]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055580, P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The research was funded by the National Institutes of Health (R01 AR055580). Micro computed tomography and bone histomorphometry was performed at the Washington University Musculoskeletal Research Center (NIH P30 AR057235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; BIKLE DD, 1994, J BONE MINER RES, V9, P1777; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Carter DR, 1998, SKELETAL GROWTH AND DEVELOPMENT: CLINICAL ISSUES AND BASIC SCIENCE ADVANCES, P99; Das R, 2011, J ORTHOP RES, V29, P281, DOI 10.1002/jor.21234; Evans KD, 2003, BONE, V32, P268, DOI 10.1016/S8756-3282(02)00974-2; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Halasy-Nagy JM, 2001, BONE, V29, P553, DOI 10.1016/S8756-3282(01)00615-9; Iwata K, 2006, BONE, V39, P1053, DOI 10.1016/j.bone.2006.05.006; Kim HM, 2010, J ORTHOP RES, V28, P1391, DOI 10.1002/jor.21128; Kim HM, 2009, J BONE JOINT SURG AM, V91A, P879, DOI 10.2106/JBJS.H.00088; Kirkos JM, 2005, J BONE JOINT SURG BR, V87B, P231, DOI 10.1302/0301-620X.87B2.14739; Liu Y, 2011, J ENG MATER-T ASME, V133, P281; Liu YX, 2012, MECH MATER, V44, P83, DOI 10.1016/j.mechmat.2011.08.005; Mehta SH, 2006, J PERINATOL, V26, P85, DOI 10.1038/sj.jp.7211441; Mollberg M, 2005, ACTA OBSTET GYN SCAN, V84, P654, DOI 10.1111/j.0001-6349.2005.00632.x; Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI [10.1359/jbmr.080617, 10.1359/JBMR.080617]; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; SATO M, 1990, J BONE MINER RES, V5, P31, DOI 10.1002/jbmr.5650050107; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; Schwartz AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048630; Sharir A, 2011, DEVELOPMENT, V138, P3247, DOI 10.1242/dev.063768; Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Wu QQ, 2001, J BIOL CHEM, V276, P35290, DOI 10.1074/jbc.M101055200	30	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97375	10.1371/journal.pone.0097375	http://dx.doi.org/10.1371/journal.pone.0097375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847982	gold, Green Submitted, Green Published			2022-12-27	WOS:000336730600027
J	Carrero-Colon, M; Abshire, N; Sweeney, D; Gaskin, E; Hudson, K				Carrero-Colon, Militza; Abshire, Nathan; Sweeney, Daniel; Gaskin, Erik; Hudson, Karen			Mutations in SACPD-C Result in a Range of Elevated Stearic Acid Concentration in Soybean Seed	PLOS ONE			English	Article							CARRIER-PROTEIN-DESATURASE; OIL; GENE	Soybean oil has a wide variety of uses, and stearic acid, which is a relatively minor component of soybean oil is increasingly desired for both industrial and food applications. New soybean mutants containing high levels of the saturated fatty acid stearate in seeds were recently identified from a chemically mutagenized population. Six mutants ranged in stearate content from 6-14% stearic acid, which is 1.5 to 3 times the levels contained in wild-type seed of the Williams 82 cultivar. Candidate gene sequencing revealed that all of these lines carried amino acid substitutions in the gene encoding the delta-9-stearoyl-acyl-carrier protein desaturase enzyme (SACPD-C) required for the conversion of stearic acid to oleic acid. Five of these missense mutations were in highly conserved residues clustered around the predicted di-iron center of the SACPD-C enzyme. Co-segregation analysis demonstrated a positive association of the elevated stearate trait with the SACPD-C mutation for three populations. These missense mutations may provide additional alleles that may be used in the development of new soybean cultivars with increased levels of stearic acid.	[Carrero-Colon, Militza; Hudson, Karen] ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN 47905 USA; [Abshire, Nathan; Sweeney, Daniel; Gaskin, Erik] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hudson, K (corresponding author), ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN 47905 USA.	hudson@ars.usda.gov		Hudson, Karen/0000-0002-7402-2275	USDA-ARS Current Research Information System [3602-21000-006-00D]; ARS [ARS-0424784] Funding Source: Federal RePORTER	USDA-ARS Current Research Information System(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this work was provided through the USDA-ARS Current Research Information System 3602-21000-006-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma JG, 2012, CROP SCI, V52, P1736, DOI 10.2135/cropsci2011.08.0411; Byfield GE, 2006, CROP SCI, V46, P840, DOI 10.2135/cropsci2005.06-0172; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; HAMMOND EG, 1983, CROP SCI, V23, P192; Head K, 2012, MOL BREEDING, V30, P1519, DOI 10.1007/s11032-012-9707-x; Hudson K., 2012, International Journal of Agronomy, V2012, P569817, DOI 10.1155/2012/569817; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; LUNDEEN PO, 1987, CROP SCI, V27, P1102, DOI 10.2135/cropsci1987.0011183X002700060002x; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pantalone VR, 2002, J AM OIL CHEM SOC, V79, P549, DOI 10.1007/s11746-002-0520-8; Rahman SM, 1997, THEOR APPL GENET, V95, P772, DOI 10.1007/s001220050624; Richards E., 2001, CURRENT PROTOCOLS MO, DOI 10.1002/0471142727.mb0203s27; Ruddle P, 2013, CROP SCI, V53, P1887, DOI 10.2135/cropsci2013.02.0120; Ruddle P, 2013, THEOR APPL GENET, V126, P241, DOI 10.1007/s00122-012-1977-5; Zhang P, 2008, CROP SCI, V48, P2305, DOI 10.2135/cropsci2008.02.0084	17	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97891	10.1371/journal.pone.0097891	http://dx.doi.org/10.1371/journal.pone.0097891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846334	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400070
J	Hansen, ML; Fallentin, E; Lauridsen, C; Law, I; Federspiel, B; Bksgaard, L; Svendsen, LB; Nielsen, MB				Hansen, Martin Lundsgaard; Fallentin, Eva; Lauridsen, Carsten; Law, Ian; Federspiel, Birgitte; Bksgaard, Lene; Svendsen, Lars Bo; Nielsen, Michael Bachmann			Computed Tomography (CT) Perfusion as an Early Predictive Marker for Treatment Response to Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer and Gastric Cancer - A Prospective Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR BLOOD-FLOW; GROWTH-FACTOR EXPRESSION; ESOPHAGOGASTRIC JUNCTION; QUANTITATIVE ASSESSMENT; PREOPERATIVE CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; ESOPHAGEAL-CARCINOMA; MONITORING RESPONSE; 1ST-PASS PERFUSION	Objectives: To evaluate whether early reductions in CT perfusion parameters predict response to pre-operative chemotherapy prior to surgery for gastroesophageal junction (GEJ) and gastric cancer. Materials and Methods: Twenty-eight patients with adenocarcinoma of the gastro-esophageal junction (GEJ) and stomach were included. Patients received three series of chemotherapy before surgery, each consisting of a 3-week cycle of intravenous epirubicin, cisplatin or oxaliplatin, concomitant with capecitabine peroral. The patients were evaluated with a CT perfusion scan prior to, after the first series of, and after three series of chemotherapy. The CT perfusion scans were performed using a 320-detector row scanner. Tumour volume and perfusion parameters (arterial flow, blood volume and permeability) were computed on a dedicated workstation with a consensus between two radiologists. Response to chemotherapy was evaluated by two measures. Clinical response was defined as a tumour size reduction of more than 50%. Histological response was evaluated based on residual tumour cells in the surgical specimen using the standardized Mandard Score 1 to 5, in which values of 1 and 2 were classified as responders, and 3 to 5 were classified as nonresponders. Results: A decrease in tumour permeability after one series of chemotherapy was positively correlated with clinical response after three series of chemotherapy. Significant changes in permeability and tumour volume were apparent after three series of chemotherapy in both clinical and histological responders. A cut-off value of more than 25% reduction in tumour permeability yielded a sensitivity of 69% and a specificity of 58% for predicting clinical response. Conclusion: Early decrease in permeability is correlated with the likelihood of clinical response to pre-operative chemotherapy in GEJ and gastric cancer. As a single diagnostic test, CT Perfusion only has moderate sensitivity and specificity in response assessment of pre-operative chemotherapy making it insufficient for clinical decision purposes.	[Hansen, Martin Lundsgaard; Fallentin, Eva; Lauridsen, Carsten; Nielsen, Michael Bachmann] Rigshosp, Dept Radiol, DK-2100 Copenhagen, Denmark; [Lauridsen, Carsten] Metropolitan Univ Coll, Dept Technol, Bachelors Degree Programme Radiog, Copenhagen, Denmark; [Law, Ian] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Federspiel, Birgitte] Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Bksgaard, Lene] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Svendsen, Lars Bo] Rigshosp, Dept Surg Gastroenterol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hansen, ML (corresponding author), Rigshosp, Dept Radiol, DK-2100 Copenhagen, Denmark.	mlundsgaard@dadlnet.dk	Nielsen, Michael Bachmann/U-2749-2018	Nielsen, Michael Bachmann/0000-0002-9380-1688; Law, Ian/0000-0001-9644-7496; Svendsen, Lars Bo/0000-0002-3216-9121	Poul Lundbeck and wife Fund; Civil engineer Johs. E. Ormstrup and wife Grete Ormstrup Fund	Poul Lundbeck and wife Fund; Civil engineer Johs. E. Ormstrup and wife Grete Ormstrup Fund	The authors acknowledge financial support from Poul Lundbeck and wife Fund and Civil engineer Johs. E. Ormstrup and wife Grete Ormstrup Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomi M, 2007, RADIOLOGY, V244, P486, DOI 10.1148/radiol.2442061189; Chen TW, 2012, CLIN RADIOL, V67, P746, DOI 10.1016/j.crad.2011.07.053; Chen TW, 2009, CLIN RADIOL, V64, P38, DOI 10.1016/j.crad.2008.06.005; Chen YM, 2011, NUCL MED COMMUN, V32, P1005, DOI 10.1097/MNM.0b013e32834a8366; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; d'Assignies G, 2009, RADIOLOGY, V250, P407, DOI 10.1148/radiol.2501080291; Duyndam MCA, 2007, BIOCHEM PHARMACOL, V74, P191, DOI 10.1016/j.bcp.2007.04.003; Fournier LS, 2010, RADIOLOGY, V256, P511, DOI 10.1148/radiol.10091362; Fraioli F, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120174; Goh V, 2008, AM J ROENTGENOL, V191, pW288, DOI 10.2214/AJR.07.3985; Hansen ML, 2013, DIAGNOSTICS, V3, P261, DOI 10.3390/diagnostics3020261; Hayano K, 2007, ONCOL REP, V18, P901; Jiang T, 2012, INVEST RADIOL, V47, P11, DOI 10.1097/RLI.0b013e3182199bb5; Kim DH, 2012, EUR J RADIOL, V81, P3542, DOI 10.1016/j.ejrad.2012.02.012; Koyasu S, 2012, EUR J RADIOL, V81, P43, DOI 10.1016/j.ejrad.2010.11.013; Lee TY, 2003, Q J NUCL MED, V47, P171; Li ZP, 2005, WORLD J GASTROENTERO, V11, P1287, DOI 10.3748/wjg.v11.i9.1287; Lordick F, 2007, LANCET ONCOL, V8, P797, DOI 10.1016/S1470-2045(07)70244-9; Ma GL, 2012, HEPATOB PANCREAT DIS, V11, P407, DOI 10.1016/S1499-3872(12)60199-4; Makari Y, 2007, J SURG ONCOL, V96, P220, DOI 10.1002/jso.20820; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; Mukai Kota, 2006, Gastric Cancer, V9, P192, DOI 10.1007/s10120-006-0374-7; Ng QS, 2006, AM J ROENTGENOL, V187, P1079, DOI 10.2214/AJR.05.0889; Ott K, 2011, ANN SURG ONCOL, V18, P3316, DOI 10.1245/s10434-011-1743-y; Sahani DV, 2005, RADIOLOGY, V234, P785, DOI 10.1148/radiol.2343040286; Satoh A, 2010, DIGEST SURG, V27, P253, DOI 10.1159/000288703; SIU KF, 1986, ANN SURG, V203, P173, DOI 10.1097/00000658-198602000-00011; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Song T, 2012, DIGEST DIS SCI, V57, P2195, DOI 10.1007/s10620-012-2149-9; Stewart EE, 2012, RADIOLOGY, V264, P68, DOI 10.1148/radiol.12110674; Tacelli N, 2013, EUR RADIOL, V23, P2127, DOI 10.1007/s00330-013-2821-2; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Wieder HA, 2007, EUR J NUCL MED MOL I, V34, P1925, DOI 10.1007/s00259-007-0521-3; Yao J, 2011, ABDOM IMAGING, V36, P15, DOI 10.1007/s00261-010-9609-5; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Zhong XS, 2007, BIOCHEM BIOPH RES CO, V358, P92, DOI 10.1016/j.bbrc.2007.04.083; Zum Buschenfelde CM, 2011, J NUCL MED, V52, P1189, DOI 10.2967/jnumed.110.085803	41	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97605	10.1371/journal.pone.0097605	http://dx.doi.org/10.1371/journal.pone.0097605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845062	gold, Green Published, Green Submitted			2022-12-27	WOS:000339563400038
J	Hind, K; Birrell, F; Beck, B				Hind, Karen; Birrell, Fraser; Beck, Belinda			Prevalent Morphometric Vertebral Fractures in Professional Male Rugby Players	PLOS ONE			English	Article							BONE-MINERAL DENSITY; INJURIES; UNION; EPIDEMIOLOGY; PERFORMANCE; SEASON; SPINE; WOMEN; BODY; RISK	There is an ongoing concern about the risk of injury to the spine in professional rugby players. The objective of this study was to investigate the prevalence of vertebral fracture using vertebral fracture assessment (VFA) dual energy X-ray absorptiometry (DXA) imaging in professional male rugby players. Ninety five professional rugby league (n = 52) and union (n = 43) players (n = 95; age 25.9 (SD 4.3) years; BMI: 29.5 (SD 2.9) kg.m(2)) participated in the research. Each participant received one VFA, and one total body and lumbar spine DXA scan (GE Lunar iDXA). One hundred and twenty vertebral fractures were identified in over half of the sample by VFA. Seventy four were graded mild (grade 1), 40 moderate (grade 2) and 6 severe (grade 3). Multiple vertebral fractures (>= 2) were found in 37 players (39%). There were no differences in prevalence between codes, or between forwards and backs (both 1.2 v 1.4; p>0.05). The most common sites of fracture were T8 (n = 23), T9 (n = 18) and T10 (n = 21). The mean (SD) lumbar spine bone mineral density Z-score was 2.7 (1.3) indicating high player bone mass in comparison with age-and sex-matched norms. We observed a high number of vertebral fractures using DXA VFA in professional rugby players of both codes. The incidence, aetiology and consequences of vertebral fractures in professional rugby players are unclear, and warrant timely, prospective investigation.	[Hind, Karen] Leeds Metropolitan Univ, Carnegie Res Inst, Leeds LS1 3HE, W Yorkshire, England; [Birrell, Fraser] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Beck, Belinda] Griffith Univ, Sch Rehabil Sci, Gold Coast, Australia	Leeds Beckett University; Newcastle University - UK; Griffith University	Hind, K (corresponding author), Leeds Metropolitan Univ, Carnegie Res Inst, Leeds LS1 3HE, W Yorkshire, England.	k.hind@leedsmet.ac.uk	Hind, Karen/HII-7471-2022; Beck, Belinda/B-9079-2008; Hind, Karen/AAE-6433-2021	Beck, Belinda/0000-0003-1295-6395; Hind, Karen/0000-0002-4546-5536; Birrell, Fraser/0000-0002-6163-6155				Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Bourke JB, 2006, BRIT MED J, V332, P1281, DOI 10.1136/bmj.332.7552.1281; Brown J, 2013, BMJ OPEN, DOI 10.11.361/bmjopen-2012-002475; Chapurlat RD, 2006, OSTEOPOROSIS INT, V17, P1189, DOI 10.1007/s00198-006-0121-2; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Dennison CR, 2012, BRIT J SPORT MED, V46, P545, DOI 10.1136/bjsports-2012-091257; Diacinti D, 2012, CALCIFIED TISSUE INT, V91, P335, DOI 10.1007/s00223-012-9643-0; Diacinti D, 2010, RADIOL CLIN N AM, V48, P561, DOI 10.1016/j.rcl.2010.02.018; DiVasta AD, 2014, J CLIN DENSITOM, V17, P207, DOI 10.1016/j.jocd.2013.02.011; Elloumi M, 2009, J BONE MINER METAB, V27, P713, DOI 10.1007/s00774-009-0086-2; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Fuller CW, 2007, CLIN J SPORT MED, V17, P10, DOI 10.1097/JSM.0b013e31802e9c28; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gabbett TJ, 2009, J STRENGTH COND RES, V23, P540, DOI 10.1519/JSC.0b013e31818efe8b; Garraway WM, 2000, BRIT J SPORT MED, V34, P348, DOI 10.1136/bjsm.34.5.348; Geffen S, 1997, CLIN J SPORT MED, V7, P144, DOI 10.1097/00042752-199704000-00014; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Georgeson EC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001400; Harley JA, 2011, J STRENGTH COND RES, V25, P1024, DOI 10.1519/JSC.0b013e3181cc21fb; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Hind K, 2010, J CLIN DENSITOM, V13, P413, DOI 10.1016/j.jocd.2010.06.002; Jager PL, 2011, OSTEOPOROSIS INT, V22, P1059, DOI 10.1007/s00198-010-1293-3; Kaplan KM, 2008, BULL HOSP JT DIS, V66, P86; Kerttula LI, 2000, SPINE, V25, P1104, DOI 10.1097/00007632-200005010-00011; Kim N, 2004, AM J ROENTGENOL, V182, P297, DOI 10.2214/ajr.182.2.1820297; Kuster D, 2012, BRIT J SPORT MED, V46, P550, DOI 10.1136/bjsports-2011-090360; LaCroix AZ, 2010, OSTEOPOROSIS INT, V21, P919, DOI 10.1007/s00198-009-1056-1; Lunt M, 1997, J BONE MINER RES, V12, P1883, DOI 10.1359/jbmr.1997.12.11.1883; Meir RA, 2007, BRIT J SPORT MED, V31, P132; MILBURN PD, 1993, SPORTS MED, V16, P168, DOI 10.2165/00007256-199316030-00002; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; Orchard J., 2004, SPORT HLTH, V22, P11; Orchard JW, 2004, SPORTS MED, V34, P209, DOI 10.2165/00007256-200434040-00001; Rugby Football Union, 2011, ENGL RUGB PREM TRAIN; Schousboe JT, 2008, J CLIN DENSITOM, V11, P92, DOI 10.1016/j.jocd.2007.12.008; Silver JR, 2002, SPINAL CORD; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; Waterloo S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-163; Zwiers R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7456	41	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97427	10.1371/journal.pone.0097427	http://dx.doi.org/10.1371/journal.pone.0097427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846310	Green Accepted, Green Published, gold			2022-12-27	WOS:000339563400030
J	Wong, JCY; Jack, MM; Li, Y; O'Neill, C				Wong, Jennifer C. Y.; Jack, Michelle M.; Li, Yan; O'Neill, Christopher			The Epigenetic Bivalency of Core Pancreatic beta-Cell Transcription Factor Genes within Mouse Pluripotent Embryonic Stem Cells Is Not Affected by Knockdown of the Polycomb Repressive Complex 2, SUZ12	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; LYSINE-27 METHYLATION; GLUCOSE-TRANSPORTER; INSULIN-SECRETION; EXPRESSION; CHROMATIN; DIFFERENTIATION; ESTABLISHMENT; ACETYLATION	This study assesses changes in activator and repressor modifications to histones associated with the core transcription factor genes most highly upregulated or downregulated in pancreatic beta-cells relative to expression in an embryonic stem cell line. Epigenetic analysis of the Oct4, Utf1, Nanog and Sox2 (pluripotency) and Pdx1, Nkx6.1, Nkx2.2 and MafA (pancreatic beta-cells) transcription factor genes in embryonic stem cells and a beta-cell line (MIN6) showed the pluripotency genes were enriched for active (histone 3 trimethylated at lysine 4 and histone 3 acetylated at lysine 9) and depleted of repressor modifications (histone 3 trimethylated at lysine 27 and histone 3 trimethylated at lysine 9) around the transcription start site in mouse embryonic stem cells (D3), and this was reversed in MIN6 cells. The beta-cell transcription factors were bivalently enriched for activating (histone 3 trimethylated at lysine 4) and repressor (histone 3 trimethylated at lysine 27) modifications in embryonic stem cells but were monovalent for the activator modification (histone 3 trimethylated at lysine 4) in the beta-cells. The polycomb repressor complex 2 acts as a histone 3 lysine 27 methylase and an essential component of this complex, SUZ12, was enriched at the beta-cell transcription factors in embryonic stem cells and was reduced MIN6. Knockdown of SUZ12 in embryonic stem cells, however, did not reduce the level of histone 3 trimethylated at lysine 27 at beta-cell transcription factor loci or break the transcriptional repression of these genes in embryonic stem cells. This study shows the reduction in the total SUZ12 level was not a sufficient cause of the resolution of the epigenetic bivalency of b-cell transcription factors in embryonic stem cells.	[Wong, Jennifer C. Y.; Li, Yan; O'Neill, Christopher] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Ctr Dev & Regenerat Med, Sydney, NSW 2006, Australia; [Jack, Michelle M.] Royal N Shore Hosp, Dept Endocrinol, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney	O'Neill, C (corresponding author), Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Ctr Dev & Regenerat Med, Sydney, NSW 2006, Australia.	chris.oneill@sydney.edu.au			NHMRC; Favoloro Family Bequest, Royal North Shore Hospital	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Favoloro Family Bequest, Royal North Shore Hospital	This work was supported by grants from the NHMRC to CO and by the Favoloro Family Bequest, Royal North Shore Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ahn JI, 2004, DEV BIOL, V265, P491, DOI 10.1016/j.ydbio.2003.09.041; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Billon N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r80; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Doss MX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r56; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HU ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Juliandi B, 2010, DEV GROWTH DIFFER, V52, P493, DOI 10.1111/j.1440-169X.2010.01175.x; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lunyak VV, 2008, HUM MOL GENET, V17, pR28, DOI 10.1093/hmg/ddn149; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; ORCI L, 1989, SCIENCE, V245, P295, DOI 10.1126/science.2665080; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97820	10.1371/journal.pone.0097820	http://dx.doi.org/10.1371/journal.pone.0097820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845830	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400063
J	Laughery, JM; Knowles, DP; Schneider, DA; Bastos, RG; McElwain, TF; Suarez, CE				Laughery, Jacob M.; Knowles, Donald P.; Schneider, David A.; Bastos, Reginaldo G.; McElwain, Terry F.; Suarez, Carlos E.			Targeted Surface Expression of an Exogenous Antigen in Stably Transfected Babesia bovis	PLOS ONE			English	Article							REACTIVE ANTIBODIES; CATTLE; VACCINATION; PROTEIN; GENE; COLOCALIZATION; INFECTION; PEPTIDES; VACCINES; CLONING	Babesia bovis is a tick-borne intraerythocytic protozoan responsible for acute disease in cattle which can be controlled by vaccination with attenuated B. bovis strains. Emerging B. bovis transfection technologies may increase the usefulness of these live vaccines. One use of transfected B. bovis parasites may be as a vaccine delivery platform. Previous transfection methods for B. bovis were limited by single expression sites and intracellular expression of transfected antigens. This study describes a novel transfection system in which two exogenous genes are expressed: one for selection and the other for a selected antigen designed to be delivered to the surface of the parasites. The strategy for duplicating the number of transfected genes was based on the use of the putative bidirectional promoter of the B. bovis 1.4 Kb ef-1 alpha intergenic region. The ability of this region to regulate two independent expression sites was demonstrated using a luciferase assay on transiently transfected B. bovis parasites and then incorporated into a stable transfection plasmid to control independent expression of the selectable marker GFP-BSD and another gene of interest. A chimeric gene was synthetized using sequences from the protective B-cell epitopes of Rhipicephalus microplus tick antigen Bm86 along with sequences from the surface exposed B. bovis major surface antigen-1. This chimeric gene was then cloned into the additional expression site of the transfection plasmid. Transfection of the B. bovis Mo7 strain with this plasmid resulted in stable insertion into the ef-1 alpha locus and simultaneous expression of both exogenous genes. Expression of the Bm86 epitopes on the surface of transfected merozoites was demonstrated using immunofluorescence analyses. The ability to independently express multiple genes by the inclusion of a bidirectional promoter and the achievement of surface expression of foreign epitopes advances the potential of transfected B. bovis as a future vaccine delivery platform.	[Laughery, Jacob M.; Knowles, Donald P.; Bastos, Reginaldo G.; McElwain, Terry F.; Suarez, Carlos E.] Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA; [Knowles, Donald P.; Schneider, David A.; Suarez, Carlos E.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [McElwain, Terry F.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University	Suarez, CE (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA.	ces@vetmed.wsu.edu	Schneider, David/A-2833-2010	Schneider, David/0000-0001-9659-6731	United States Department of Agriculture-Agriculture Research Service Current Research Information System Project [5348-32000-028-00D]; United States Agency for International Development Grant [PCE-G-0098-00043-00]; USDA [SCA58-5348-7-528, 5348-32000-028-055]	United States Department of Agriculture-Agriculture Research Service Current Research Information System Project; United States Agency for International Development Grant(United States Agency for International Development (USAID)); USDA(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture-Agriculture Research Service Current Research Information System Project No. 5348-32000-028-00D, United States Agency for International Development Grant PCE-G-0098-00043-00, and USDA (SCA58-5348-7-528) agreement 5348-32000-028-055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos RG, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-57; Berens SJ, 2005, INFECT IMMUN, V73, P7180, DOI 10.1128/IAI.73.11.7180-7189.2005; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Bram RA, 2002, J MED ENTOMOL, V39, P405, DOI 10.1603/0022-2585-39.3.405; Brown WC, 1999, PARASITOL TODAY, V15, P275, DOI 10.1016/S0169-4758(99)01471-4; Canales M, 2009, VACCINE, V27, P7244, DOI 10.1016/j.vaccine.2009.09.123; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de la Fuente J, 1999, GENET ANAL-BIOMOL E, V15, P143, DOI 10.1016/S1050-3862(99)00018-2; de la Fuente J, 1998, VACCINE, V16, P366, DOI 10.1016/S0264-410X(97)00208-9; De la Fuente J., 1995, RECOMBINANT VACCINES, P177; de Leon AAP, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-36; de Waal DT, 2006, VET PARASITOL, V138, P88, DOI 10.1016/j.vetpar.2006.01.042; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Florin-Christensen M, 2002, INFECT IMMUN, V70, P2039; HINES SA, 1989, MOL BIOCHEM PARASIT, V37, P1, DOI 10.1016/0166-6851(89)90096-0; HINES SA, 1992, MOL BIOCHEM PARASIT, V55, P85, DOI 10.1016/0166-6851(92)90129-8; LeRoith T, 2006, INFECT IMMUN, V74, P3663, DOI 10.1128/IAI.00032-06; LEVY MG, 1980, SCIENCE, V207, P1218, DOI 10.1126/science.7355284; Odongo D, 2007, VACCINE, V25, P1287, DOI 10.1016/j.vaccine.2006.09.085; PALMER DA, 1982, PARASITOLOGY, V84, P567, DOI 10.1017/S0031182000052835; Patarroyo JH, 2002, VET IMMUNOL IMMUNOP, V88, P163, DOI 10.1016/S0165-2427(02)00154-X; RAND KN, 1989, P NATL ACAD SCI USA, V86, P9657, DOI 10.1073/pnas.86.24.9657; RODRIGUEZ M, 1994, J BIOTECHNOL, V33, P135, DOI 10.1016/0168-1656(94)90106-6; RODRIGUEZ SD, 1983, INFECT IMMUN, V42, P15, DOI 10.1128/IAI.42.1.15-18.1983; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Suarez CE, 2006, INT J PARASITOL, V36, P965, DOI 10.1016/j.ijpara.2006.02.022; Suarez CE, 2012, MOL BIOCHEM PARASIT, V185, P52, DOI 10.1016/j.molbiopara.2012.05.003; Suarez CE, 2011, VET PARASITOL, V180, P109, DOI 10.1016/j.vetpar.2011.05.032; Suarez CE, 2009, INT J PARASITOL, V39, P289, DOI 10.1016/j.ijpara.2008.08.006; Suarez CE, 2000, INFECT IMMUN, V68, P6865, DOI 10.1128/IAI.68.12.6865-6870.2000; Valle MR, 2004, EXP APPL ACAROL, V34, P375, DOI 10.1023/B:APPA.0000049223.92326.02; Willadsen P, 2004, PARASITOLOGY, V129, pS367, DOI 10.1017/S0031182003004657	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97890	10.1371/journal.pone.0097890	http://dx.doi.org/10.1371/journal.pone.0097890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840336	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600087
J	Han, PF; Fan, JQ; Liu, Y; Cuthbertson, AGS; Yan, SQ; Qiu, BL; Ren, SX				Han, Pengfei; Fan, Jiqiao; Liu, Yu; Cuthbertson, Andrew G. S.; Yan, Shaoqiao; Qiu, Bao-Li; Ren, Shunxiang			RNAi-Mediated Knockdown of Serine Protease Inhibitor Genes Increases the Mortality of Plutella xylostella Challenged by Destruxin A	PLOS ONE			English	Article							NEEM-BASED INSECTICIDES; MANDUCA-SEXTA SERPIN-4; METARHIZIUM-ANISOPLIAE; PROTEINASE COMPLEXES; DIAMONDBACK MOTH; IMMUNE-RESPONSE; ACTIVATION; IDENTIFICATION; LEPIDOPTERA; DEFENSE	Destruxin A is a mycotoxin that is secreted by entomopathogenic fungi which has a broad-spectrum insecticidal effect. Previous transcript and protein profiling analysis showed that destruxin A has significant effects on the expression of serine protease inhibitor genes (serpin-2, 4, 5) in the larvae of Plutella xylostella. In the current study, we aimed to understand the role of serpins under application of destruxin A. We obtained two full-length cDNA sequences of P. xylostella serpins, named serpin-4 and serpin-5, and cloned the serpin-2 gene whose full-length has already been published. Phylogenetic analysis indicated that these two serpin genes were highly clustered with other serpins associated with the immune response in other insects. The temporal and spatial expression of serpin-2, serpin-4 and serpin-5 were determined to be the highest in the fat body and hemolymph of 4th larval stage using qRT-PCR and western blot detection techniques. RNA interference (RNAi) mediated knockdown of P. xylostella serpin genes was carried out by microinjection of double-stranded RNA (dsRNA). The expression levels of serpins decreased significantly after RNAi. Results showed that the depletion of serpins induced cecropins expression, increased phenoloxidase (PO) activity, body melanization and mortality in the larvae of P. xylostella under the same lethal concentration of destruxin A. The superimposed effects of serpins RNAi were similar with the destruxin A treatment upon mortality of P. xylostella larvae. We discovered for the first time that serpins play indispensable role in P. xylostella when challenged by destruxin A and deduced the possible function mechanism of destruxin A. Our findings are conducive to fully understanding the potential insecticidal mechanism of destruxin A and constitute a well-defined potential molecular target for novel insecticides.	[Han, Pengfei; Fan, Jiqiao; Liu, Yu; Yan, Shaoqiao; Qiu, Bao-Li; Ren, Shunxiang] South China Agr Univ, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China; [Cuthbertson, Andrew G. S.] Food & Environm Res Agcy, Sand Hutton, N Yorkshire, England	South China Agricultural University; Food & Environment Research Agency	Qiu, BL (corresponding author), South China Agr Univ, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China.	baileyqiu@scau.edu.cn; shxren@scau.edu.cn		Cuthbertson, Andrew/0000-0003-1914-8796	National Basic Research Program of China [2013CB127604]; Guangdong Province Natural Science Foundation in Key Projects [S2012020010951]	National Basic Research Program of China(National Basic Research Program of China); Guangdong Province Natural Science Foundation in Key Projects	This work was supported by National Basic Research Program of China (2013CB127604) and Guangdong Province Natural Science Foundation in Key Projects (S2012020010951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmad N, 2012, CROP PROT, V38, P7, DOI 10.1016/j.cropro.2012.03.006; Ahmad N, 2012, CROP PROT, V34, P18, DOI 10.1016/j.cropro.2011.12.010; Amiri B, 1999, BIOCONTROL SCI TECHN, V9, P487, DOI 10.1080/09583159929451; Amiri-Besheli B, 2000, MYCOL RES, V104, P447, DOI 10.1017/S095375629900146X; Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; Bandani AR, 2001, BBA-BIOMEMBRANES, V1510, P367, DOI 10.1016/S0005-2736(00)00370-9; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butt TM, 2009, RAPID COMMUN MASS SP, V23, P1426, DOI 10.1002/rcm.4018; Castelo Branco M., 1997, Anais da Sociedade Entomologica do Brasil, V26, P75, DOI 10.1590/S0301-80591997000100010; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Christen JM, 2012, INSECT BIOCHEM MOLEC, V42, P946, DOI 10.1016/j.ibmb.2012.09.008; Cui SY, 2006, PEPTIDES, V27, P1226, DOI 10.1016/j.peptides.2005.11.011; Feeroza Khalique, 2005, Pakistan Journal of Biological Sciences, V8, P475, DOI 10.3923/pjbs.2005.475.478; Gan H, 2001, INSECT BIOCHEM MOLEC, V31, P887, DOI 10.1016/S0965-1748(01)00034-0; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004; Han PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060771; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hu QB, 2007, J APPL ENTOMOL, V131, P262, DOI 10.1111/j.1439-0418.2007.01159.x; Hu QB, 2006, TOXICON, V48, P491, DOI 10.1016/j.toxicon.2006.06.018; Hu QB, 2009, TOXICON, V53, P115, DOI 10.1016/j.toxicon.2008.10.019; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KANOST MR, 1995, INSECT BIOCHEM MOLEC, V25, P285, DOI 10.1016/0965-1748(94)00067-R; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Liang GM, 2003, CROP PROT, V22, P333, DOI 10.1016/S0261-2194(02)00175-8; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Lira SP, 2006, J ANTIBIOT, V59, P553, DOI 10.1038/ja.2006.76; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Mitsumasu K, 2008, ZOOL SCI, V25, P693, DOI 10.2108/zsj.25.693; Nappi AJ, 2001, ADV EXP MED BIOL, V484, P329; Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P579, DOI 10.1016/S0031-9422(02)00016-X; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Ragan EJ, 2010, J BIOL CHEM, V285, P29642, DOI 10.1074/jbc.M110.125419; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Roberts TH, 2004, J MOL EVOL, V59, P437, DOI 10.1007/s00239-004-2635-6; Rodriguez-Cabrera L, 2010, ENVIRON MICROBIOL, V12, P2894, DOI 10.1111/j.1462-2920.2010.02259.x; Ruiz-Sanchez E, 2010, TOXICON, V56, P1043, DOI 10.1016/j.toxicon.2010.07.012; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMUELS RI, 1988, COMP BIOCHEM PHYS C, V90, P403, DOI 10.1016/0742-8413(88)90018-7; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sree KS, 2008, PEST MANAG SCI, V64, P119, DOI 10.1002/ps.1480; Suwanchaichinda C, 2013, INSECT BIOCHEM MOLEC, V43, P555, DOI 10.1016/j.ibmb.2013.03.015; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P387, DOI 10.1016/j.ibmb.2003.12.005; Xu YY, 2004, BIOCONTROL SCI TECHN, V14, P713, DOI 10.1080/09583150410001682395; YANG JC, 1994, ENTOMOPHAGA, V39, P397, DOI 10.1007/BF02373045; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	69	25	26	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97863	10.1371/journal.pone.0097863	http://dx.doi.org/10.1371/journal.pone.0097863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837592	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800078
J	Mulcahy, DG; Martinez-Gomez, JE; Aguirre-Leon, G; Cervantes-Pasqualli, JA; Zug, GR				Mulcahy, Daniel G.; Martinez-Gomez, Juan E.; Aguirre-Leon, Gustavo; Cervantes-Pasqualli, Juan A.; Zug, George R.			Rediscovery of an Endemic Vertebrate from the Remote Islas Revillagigedo in the Eastern Pacific Ocean: The Clarion Nightsnake Lost and Found	PLOS ONE			English	Article							CONSERVATION STATUS; HYPSIGLENA-TORQUATA; LIZARD; BIOGEOGRAPHY; TREE	Vertebrates are currently going extinct at an alarming rate, largely because of habitat loss, global warming, infectious diseases, and human introductions. Island ecosystems are particularly vulnerable to invasive species and other ecological disturbances. Properly documenting historic and current species distributions is critical for quantifying extinction events. Museum specimens, field notes, and other archived materials from historical expeditions are essential for documenting recent changes in biodiversity. The Islas Revillagigedo are a remote group of four islands, 700-1100 km off the western coast of mainland Mexico. The islands are home to many endemic plants and animals recognized at the specific-and subspecific-levels, several of which are currently threatened or have already gone extinct. Here, we recount the initial discovery of an endemic snake Hypsiglena ochrorhyncha unaocularus Tanner on Isla Clarion, the later dismissal of its existence, its absence from decades of field surveys, our recent rediscovery, and recognition of it as a distinct species. We collected two novel complete mitochondrial (mt) DNA genomes and up to 2800 base-pairs of mtDNA from several other individuals, aligned these with previously published mt-genome data from samples throughout the range of Hypsiglena, and conducted phylogenetic analyses to infer the biogeographic origin and taxonomic status of this population. We found the Isla Clarion population to be most closely related to populations in the Sonora-Sinaloa state border area of mainland Mexico and Isla Santa Catalina, in the Gulf of California. Based on genetics, morphology, and geographic distributions, we also recognize these two other lineages as distinct species. Our study shows the importance of museum specimens, field notes, and careful surveys to accurately document biodiversity and brings these island endemics (Clarion and Santa Catalina nightsnakes) and mainland population near the Sonora-Sinaloa state border to the attention of conservation biologists currently monitoring biodiversity in these fragile subtropical ecosystems.	[Mulcahy, Daniel G.; Zug, George R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Martinez-Gomez, Juan E.; Aguirre-Leon, Gustavo; Cervantes-Pasqualli, Juan A.] Red Interacc Multitrof, Asociac Civil, Inst Ecol, Xalapa, Veracruz, Mexico	Smithsonian Institution; Smithsonian National Museum of Natural History; Instituto de Ecologia - Mexico	Mulcahy, DG (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA.	MulcahyD@si.edu	Martínez-Gómez, Juan Esteban E/F-3585-2010	Martínez-Gómez, Juan Esteban E/0000-0003-2937-8544; Mulcahy, Daniel G./0000-0001-6614-2405	Smithsonian-NMNH; Island Endemics Foundation; INECOL	Smithsonian-NMNH; Island Endemics Foundation; INECOL	This research was funded by Smithsonian-NMNH grants awarded to GRZ and DGM, RW McDiarmid and DGM, and funds by the Island Endemics Foundation and INECOL were awarded to JEMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAUD G, 1993, OHIO J SCI, V93, P101; Beebe CW, 1938, ZACA VENTURE; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bogert CM, 1944, B AM MUS NAT HIST, V83, P299; BRATTSTROM B. H., 1955, AMER MIDLAND NAT, V54, P219, DOI 10.2307/2422189; BRATTSTROM BH, 1990, J BIOGEOGR, V17, P177, DOI 10.2307/2845325; Carreno Ana Luisa, 2002, P14; Castaneda MD, 2011, MOL PHYLOGENET EVOL, V61, P784, DOI 10.1016/j.ympev.2011.07.004; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; de Queiroz K, 1998, ENDLESS FORMS, P57; DIXON JR, 1986, SOUTHWEST NAT, V31, P307, DOI 10.2307/3671835; Feldman CR, 2011, MOL PHYLOGENET EVOL, V61, P714, DOI 10.1016/j.ympev.2011.08.008; FROST DR, 1990, HERPETOLOGICA, V46, P87; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Hardy L. M., 1969, University of Kansas Publications of the Museum of Natural History, V18, P39; HEDGES SB, 1994, P NATL ACAD SCI USA, V91, P2621, DOI 10.1073/pnas.91.7.2621; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Jepson P., 2011, FRONT BIOGEOGR, V3, P111; Sigala-Rodriguez JJ, 2009, REV MEX BIODIVERS, V80, P231; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Ladle RJ, 2009, NATURE, V461, P723, DOI 10.1038/461723c; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Martinez-Gomez JE, 2004, BIOL CONSERV, V116, P35, DOI 10.1016/S0006-3207(03)00171-X; Martinez-Gomez JE, 2001, IBIS, V143, P456, DOI 10.1111/j.1474-919X.2001.tb04947.x; Martinez-Gomez JE, 1995, WILSON B, V107, P555; Martinez-Gomez Juan E., 1996, Bird Conservation International, V6, P271; Mendez-Guardado P, 2001, ADV GLOB CHANGE RES, V9, P323; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Mulcahy DG, 2011, COPEIA, P407, DOI 10.1643/CH-10-058; Mulcahy DG, 2009, MOL PHYLOGENET EVOL, V53, P537, DOI 10.1016/j.ympev.2009.05.037; Mulcahy DG, 2006, THESIS; Murphy Robert W., 2002, P181; Ochoa-Ochoa LM., 2006, AREAS DIVERSIDAD END; Otte D, 2007, T AM ENTOMOL SOC, V133, P453, DOI 10.3157/0002-8320-133.3.453; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Phillips S.J., 2000, NATURAL HIST SONORAN; Reiserer Randall S., 2013, Amphibian & Reptile Conservation, V7, P74; Rodriguez-Robles JA, 1999, COPEIA, P93; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; TANNER WILMER W., 1966, TRANS SAN DIEGO SOC NATUR HIST, V14, P189; Tanner WW, 1944, GREAT BASIN NAT, V5, P25; Zug GR, 2013, REPTILES AND AMPHIBIANS OF THE PACIFIC ISLANDS: A COMPREHENSIVE GUIDE, P1	46	9	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97682	10.1371/journal.pone.0097682	http://dx.doi.org/10.1371/journal.pone.0097682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837300	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800062
J	Qiu, YW; Lv, XF; Su, HH; Jiang, GH; Li, C; Tian, JZ				Qiu, Yingwei; Lv, Xiaofei; Su, Huanhuan; Jiang, Guihua; Li, Cheng; Tian, Junzhang			Structural and Functional Brain Alterations in End Stage Renal Disease Patients on Routine Hemodialysis: A Voxel-Based Morphometry and Resting State Functional Connectivity Study	PLOS ONE			English	Article							GRAY-MATTER VOLUME; CHRONIC KIDNEY-DISEASE; COGNITIVE IMPAIRMENT; FAILURE; CORTEX; ABNORMALITIES; METABOLISM; SYMPTOMS; ATROPHY	Background and Purpose: Cognitive impairment is a well-described phenomenon in end-stage renal disease (ESRD) patients. However, its pathogenesis remains poorly understood. The primary focus of this study was to examine structural and functional brain deficits in ESRD patients. Materials and Methods: Thirty ESRD patients on hemodialysis (without clinical neurological disease) and 30 age- and gender-matched control individuals (without renal or neurological problems) were recruited in a prospective, single-center study. High-resolution structural magnetic resonance imaging (MRI) and resting state functional MRI were performed on both groups to detect the subtle cerebral deficits in ESRD patients. Voxel-based morphometry was used to characterize gray matter deficits in ESRD patients. The impact of abnormal morphometry on the cerebral functional integrity was investigated by evaluating the alterations in resting state functional connectivity when brain regions with gray matter volume reduction were used as seed areas. Results: A significant decrease in gray matter volume was observed in ESRD patients in the bilateral medial orbito-prefrontal cortices, bilateral dorsal lateral prefrontal cortices, and the left middle temporal cortex. When brain regions with gray matter volume reduction were used as seed areas, the integration was found to be significantly decreased in ESRD patients in the fronto-cerebellum circuits and within prefrontal circuits. In addition, significantly enhanced functional connectivity was found between the prefrontal cortex and the left temporal cortex and within the prefrontal circuits. Conclusions: Our study revealed that both the structural and functional cerebral cortices were impaired in ESRD patients on routine hemodialysis.	[Qiu, Yingwei; Su, Huanhuan; Jiang, Guihua; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Qiu, Yingwei] Gannan Med Univ, Affiliated Hosp 1, Dept Med Imaging, Ganzhou, Peoples R China; [Lv, Xiaofei] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Lv, Xiaofei] Sun Yat Sen Univ, Ctr Canc, Dept Intervent Radiol, Guangzhou, Guangdong, Peoples R China; [Li, Cheng] Guangdong 2 Prov Peoples Hosp, Dept Renal Transplantat, Guangzhou, Guangdong, Peoples R China	Gannan Medical University; Sun Yat Sen University; Sun Yat Sen University	Qiu, YW (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	qiuyw1201@gmail.com		Qiu, Yingwei/0000-0003-1298-8506; Tian, Junzhang/0000-0002-6212-1882	Natural Scientific Foundation of China [81201084]; Planned Science and Technology Project of Guangdong Province, China [2011B031800044]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 81201084 for YQ], and the Planned Science and Technology Project of Guangdong Province, China [Grant No. 2011B031800044 for GJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosco ML, 2013, BRAIN BEHAV, V3, P626, DOI 10.1002/brb3.171; Bremer BA, 1997, ANN BEHAV MED, V19, P348, DOI 10.1007/BF02895153; Burruss JW, 2000, RADIOLOGY, V214, P227, DOI 10.1148/radiology.214.1.r00ja43227; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chiu ML, 2010, EUR RADIOL, V20, P1502, DOI 10.1007/s00330-009-1673-2; Denier Niklaus, 2013, Front Psychiatry, V4, P135, DOI 10.3389/fpsyt.2013.00135; Drew DA, 2013, AM J KIDNEY DIS, V61, P271, DOI 10.1053/j.ajkd.2012.08.035; Etgen T, 2012, AM J NEPHROL, V35, P474, DOI 10.1159/000338135; FAZEKAS G, 1995, J NEUROL SCI, V134, P83, DOI 10.1016/0022-510X(95)00226-7; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Herting MM, 2011, NEUROIMAGE, V54, P2582, DOI 10.1016/j.neuroimage.2010.10.030; Hoekzema E, 2010, HUM BRAIN MAPP, V31, P1942, DOI 10.1002/hbm.20988; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Jenkins G., 1968, SPECTRAL ANAL ITS AP; John John P, 2009, Indian J Psychiatry, V51, P180, DOI 10.4103/0019-5545.55084; Kamata T, 2000, AM J NEPHROL, V20, P27, DOI 10.1159/000013551; Kanai H, 2001, AM J KIDNEY DIS, V38, pS129, DOI 10.1053/ajkd.2001.27421; Kimmel PL, 2007, ADV CHRONIC KIDNEY D, V14, P328, DOI 10.1053/j.ackd.2007.07.007; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; KUPERMAN S, 1990, J AM ACAD CHILD PSY, V29, P159, DOI 10.1097/00004583-199003000-00001; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071507; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Maudsley AA, 2010, EPILEPSY RES, V88, P127, DOI 10.1016/j.eplepsyres.2009.10.009; Miglior M, 2009, ROLE BRAIN DERIVED N; Nasser ME, 2012, SAUDI J KIDNEY DIS T, V23, P1208, DOI 10.4103/1319-2442.103561; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Qiu YW, 2014, DRUG ALCOHOL DEPEN, V134, P314, DOI 10.1016/j.drugalcdep.2013.10.023; Qiu YW, 2013, NEUROSCI LETT, V538, P43, DOI 10.1016/j.neulet.2013.01.019; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Regolisti G, 2013, NEPHROL DIAL TRANSPL, V28, P79, DOI 10.1093/ndt/gfs182; Rogers BP, 2012, ALCOHOL CLIN EXP RES, V36, P294, DOI 10.1111/j.1530-0277.2011.01614.x; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Sehgal AR, 1997, AM J KIDNEY DIS, V30, P41, DOI 10.1016/S0272-6386(97)90563-1; Skinner H, 2005, BRIT J ANAESTH, V94, P203, DOI 10.1093/bja/aei016; Song SH, 2008, PSYCHIAT CLIN NEUROS, V62, P554, DOI 10.1111/j.1440-1819.2008.01849.x; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Tamura MK, 2013, AM J KIDNEY DIS, V61, P228, DOI 10.1053/j.ajkd.2012.09.009; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Tryc AB, 2011, NEPHROL DIAL TRANSPL, V26, P2635, DOI 10.1093/ndt/gfq729; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zelazo P. D., 2010, WILEY BLACKWELL HDB, P574, DOI DOI 10.1002/9781444325485.CH22; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042824	50	43	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98346	10.1371/journal.pone.0098346	http://dx.doi.org/10.1371/journal.pone.0098346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854737	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200064
J	Zhang, L; Zhang, ZZ; Zhang, YR; Hu, G; Chen, LW				Zhang, Lu; Zhang, Zhenzhen; Zhang, Yurong; Hu, Gang; Chen, Liwei			Evaluation of Finnish Diabetes Risk Score in Screening Undiagnosed Diabetes and Prediabetes among US Adults by Gender and Race: NHANES 1999-2010	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; TYPE-2; MELLITUS; PERFORMANCE; POPULATION; TOOL; INDIVIDUALS; PROGRESSION	Objective: To evaluate the performance of Finnish Diabetes Risk Score (FINDRISC) in detecting undiagnosed diabetes and prediabetes among U. S. adults by gender and race. Methods: This cross-sectional analysis included participants (aged >= 20 years) from the National Health and Nutrition Examination Survey (NHANES) 1999-2010. Sensitivity, specificity, area under the receiver operating characteristic (ROC) curve and the optimal cutoff points for identifying undiagnosed diabetes and prediabetes were calculated for FINDRISC by gender and race/ethnicity. Results: Among the 20,633 adults (>= 20 years), 49.8% were women and 53.0% were non-Hispanic White. The prevalence of undiagnosed diabetes and prediabetes was 4.1% and 35.6%, respectively. FINDRISC was positively associated with the prevalence of diabetes (OR = 1.48 for 1 unit increase, p < 0.001) and prediabetes (OR = 1.15 for 1 unit increase, p < 0.001). The area under ROC for detecting undiagnosed diabetes was 0.75 for total population, 0.74 for men and 0.78 for women (p = 0.04); 0.76 for White, 0.76 for Black and 0.72 for Hispanics (p = 0.03 for White vs. Hispanics). The area under ROC for detecting prediabetes was 0.67 for total population, 0.66 for men and 0.70 for women (p < 0.001); 0.68 for White, 0.67 for Black and 0.65 for Hispanics (p < 0.001 for White vs. Hispanics). The optimal cutoff point was 10 (sensitivity = 0.75) for men and 12 (sensitivity = 0.72) for women for detecting undiagnosed diabetes; 9 (sensitivity = 0.61) for men and 10 (sensitivity = 0.69) for women for detecting prediabetes. Conclusions: FINDRISC is a simple and non-invasive screening tool to identify individuals at high risk for diabetes in the U. S. adults.	[Zhang, Lu] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Program Epidemiol, New Orleans, LA USA; [Zhang, Zhenzhen] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Zhang, Yurong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Xian, Shanxi, Peoples R China; [Hu, Gang] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Chen, Liwei] Clemson Univ, Dept Publ Hlth Sci, Clemson, SC 29634 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Michigan State University; Xi'an Jiaotong University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Clemson University	Chen, LW (corresponding author), Clemson Univ, Dept Publ Hlth Sci, Clemson, SC 29634 USA.	liweic@clemson.edu	Hu, Gang/V-7947-2019; Hu, Gang/N-1971-2017	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017; Zhang, Zhenzhen/0000-0002-9440-3892	Clemson University; School of Public Health at Louisiana State University Health Science Center; Pennington Biomedical Research Center	Clemson University; School of Public Health at Louisiana State University Health Science Center; Pennington Biomedical Research Center	The present study is supported in part from the Clemson University, the School of Public Health at Louisiana State University Health Science Center, and the Pennington Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Alebiosu Olutayo C, 2013, Indian J Endocrinol Metab, V17, P653, DOI 10.4103/2230-8210.113756; Alssema M, 2011, DIABETOLOGIA, V54, P1004, DOI 10.1007/s00125-010-1990-7; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; American Diabetes Association, 2004, DIABETES CARE, V27, pS11, DOI [10.2337/diacare.27.2007.S11, DOI 10.2337/DIACARE.27.2007.S11]; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Barengo Noel C, 2013, Diabetes Metab Res Rev, DOI 10.1002/dmrr.2462; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brodovicz KG, 2011, DIABETIC MED, V28, P1078, DOI 10.1111/j.1464-5491.2011.03315.x; Costa B, 2012, DIABETOLOGIA, V55, P1319, DOI 10.1007/s00125-012-2492-6; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Garca-Alcala H, 2012, DIABET METAB SYND OB, V5, P403, DOI 10.2147/DMSO.S35545; Geiss Linda S., 2012, Morbidity and Mortality Weekly Report, V61, P918; Getaneh A, 2011, ENDOCR PRACT, V17, P210, DOI 10.4158/EP10119.OR; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033437; Gurka MJ, 2014, METABOLISM, V63, P218, DOI 10.1016/j.metabol.2013.10.006; HAFFNER SM, 1986, DIABETES CARE, V9, P153, DOI 10.2337/diacare.9.2.153; Heikes KE, 2008, DIABETES CARE, V31, P1040, DOI 10.2337/dc07-1150; Hellgren MI, 2012, DIABETIC MED, V29, P1501, DOI 10.1111/j.1464-5491.2012.03664.x; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Icks A, 2004, DIABETES CARE, V27, P2120, DOI 10.2337/diacare.27.9.2120; Joshi Shashank R, 2005, J Assoc Physicians India, V53, P755; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ku GMV, 2013, PRIM CARE DIABETES, V7, P249, DOI 10.1016/j.pcd.2013.07.004; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Nilsen V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-893; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Rathmann W, 2005, ARCH INTERN MED, V165, P436, DOI 10.1001/archinte.165.4.436; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schwarz PEH, 2009, J CLIN ENDOCR METAB, V94, P920, DOI 10.1210/jc.2007-2427; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vermunt PWA, 2012, DIABETIC MED, V29, pE223, DOI 10.1111/j.1464-5491.2012.03648.x; Wang J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-633; Winkler G, 2013, MED SCI MONITOR, V19, P67, DOI 10.12659/MSM.883747	49	73	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97865	10.1371/journal.pone.0097865	http://dx.doi.org/10.1371/journal.pone.0097865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852786	Green Published, gold			2022-12-27	WOS:000338323200032
J	de Decker, L; Campone, M; Retornaz, F; Berrut, G; Kabeshova, A; Molinie, F; Beauchet, O				de Decker, Laure; Campone, Mario; Retornaz, Frederique; Berrut, Gilles; Kabeshova, Anastasia; Molinie, Florence; Beauchet, Olivier			Association between Oestrogens Receptor Expressions in Breast Cancer and Comorbidities: A Cross-Sectional, Population-Based Study	PLOS ONE			English	Article							HORMONE-RECEPTORS; WOMEN; SURVIVAL; RISK; PROGNOSIS	Background: Breast cancer with oestrogen receptor expression is common in older women. Several factors, such as age and reproductive hormone exposure, have been associated with oestrogen receptor expression in breast cancer. However, the association between comorbidities and the oestrogen receptor expression has been poorly studied. We hypothesized that there was an association between burden comorbidity and breast cancer with oestrogen receptor expression in older women. Objective: To determine whether oestrogen receptor expression in breast cancer was associated with burden comorbidity in community-dwelling women. Methods: A total of 1,707 women with breast cancer registered on the list of a breast cancer registry were included. The recorded data included: age, Charlson Comorbidity Index score >= 1, breast cancer characteristics (coded according to the International Classification of Diseases for Oncology), and breast cancer pathological stage (the pathological-tumour-node-metastasis, Scarff Bloom Richardson, and hormonal status of oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor). Results: Breast cancer with oestrogen receptor expression was identified in 1,378 patients (80.7%). The fully-adjusted logistic regression showed that oestrogen receptor expression was associated with Charlson Comorbidity Index score >= 1 (odds ratio [OR] = 1.91,95%confidence interval [CI] = [1.01-3.61], P = 0.048), progesterone receptor expression (OR = 16.64, 95%CI = [11.62-23.81], P<0.001), human epidermal growth factor receptor (OR = 0.54, 95%CI = [0.34-0.84], P = 0.007), age (OR = 1.02, 95%CI = [1.00-1.03], P = 0.008), Scarff Bloom Richardson grade II and grade III (OR = 0.21with 95%CI = [0.10-0.44] and OR = 0.06 with 95%CI = [0.03-0.12], P<0.001). Conclusion: Our findings provide new data showing an independent positive association between burden comorbidity and breast cancer with oestrogen receptor expression. This result confirms that evaluation of oestrogen receptor expression in breast cancer should not be limited to hormonal factors stratified by age.	[de Decker, Laure; Berrut, Gilles] Nantes Univ Hosp, Div Geriatr Med, Dept Therapeut, EA 1156 12, Nantes, France; [Kabeshova, Anastasia; Beauchet, Olivier] UNAM, Div Geriatr Med, Angers Univ Hosp, Dept Neurosci,UPRES,EA 4638, Angers, France; [Campone, Mario] INSERM, Ouest Canc Inst, UMR U892, Nantes, France; [Retornaz, Frederique] Dept Dept Geriatr, Marseille, France; [Molinie, Florence] Ouest Canc Registry, Nantes, France	Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	de Decker, L (corresponding author), Nantes Univ Hosp, Div Geriatr Med, Dept Therapeut, EA 1156 12, Nantes, France.	laure.dedecker@chu-nantes.fr	Beauchet, Olivier/AAP-8108-2020; MOLINIE, FLORENCE/GRY-6545-2022	MOLINIE, FLORENCE/0000-0002-0645-4017	French Ministry of Health (Projet Hospitalier de Recherche Clinique National) [K20-9]; French National Cancer Institute (INCa)	French Ministry of Health (Projet Hospitalier de Recherche Clinique National); French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France)	This study was financially supported by the French Ministry of Health (Projet Hospitalier de Recherche Clinique National 2005, K20-9) and the French National Cancer Institute (INCa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Anderson WF, 2009, BREAST CANCER RES TR, V113, P189, DOI 10.1007/s10549-008-9918-3; Anderson WF, 2009, J CLIN ONCOL, V27, P5308, DOI 10.1200/JCO.2009.22.9450; Beitelshees AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015180; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chlebowski RT, 2007, JNCI-J NATL CANCER I, V99, P1695, DOI 10.1093/jnci/djm224; Colonna SV, 2012, BREAST CANCER RES TR, V131, P325, DOI 10.1007/s10549-011-1790-x; Crivellari D, 2010, CRIT REV ONCOL HEMAT, V73, P92, DOI 10.1016/j.critrevonc.2009.02.003; Daidone MG, 2003, CRIT REV ONCOL HEMAT, V45, P313, DOI 10.1016/S1040-8428(02)00144-0; Dunbier AK, 2010, J CLIN ONCOL, V28, P1161, DOI 10.1200/JCO.2009.23.9616; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Extermann Martine, 2007, Cancer Control, V14, P13; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; HABEL LA, 1993, EPIDEMIOL REV, V15, P209, DOI 10.1093/oxfordjournals.epirev.a036107; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kallel I, 2012, J RECEPT SIG TRANSD, V32, P304, DOI 10.3109/10799893.2012.739624; Konecny G, 2003, J NATL CANCER I, V95, P142, DOI 10.1093/jnci/95.2.142; Louwman WJ, 2005, EUR J CANCER, V41, P779, DOI 10.1016/j.ejca.2004.12.025; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Pinheiro RL, 2009, BREAST, V18, P8, DOI 10.1016/j.breast.2008.09.001; Raji MA, 2008, ARCH INTERN MED, V168, P2033, DOI 10.1001/archinte.168.18.2033; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Schonberg MA, 2012, J AM GERIATR SOC, V60, P538, DOI 10.1111/j.1532-5415.2011.03820.x; SINGH L, 1988, BRIT J CANCER, V57, P612, DOI 10.1038/bjc.1988.139; Wang N, 2011, BREAST, V20, P519, DOI 10.1016/j.breast.2011.05.009; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526	31	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98127	10.1371/journal.pone.0098127	http://dx.doi.org/10.1371/journal.pone.0098127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848085	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600088
J	Minamikawa, MF; Koyano, R; Kikuchi, S; Koba, T; Sassa, H				Minamikawa, Mai F.; Koyano, Ruriko; Kikuchi, Shinji; Koba, Takato; Sassa, Hidenori			Identification of SFBB-Containing Canonical and Noncanonical SCF Complexes in Pollen of Apple (Malus x domestica)	PLOS ONE			English	Article							GAMETOPHYTIC SELF-INCOMPATIBILITY; NONFUNCTIONAL S-HAPLOTYPES; F-BOX-BROTHERS; SKP1-LIKE PROTEIN; UBIQUITIN LIGASE; NICOTIANA-ALATA; PRUNUS-AVIUM; TUBE GROWTH; RNASE; MULTIPLE	Gametophytic self-incompatibility (GSI) of Rosaceae, Solanaceae and Plantaginaceae is controlled by a single polymorphic S locus. The S locus contains at least two genes, S-RNase and F-box protein encoding gene SLF/SFB/SFBB that control pistil and pollen specificity, respectively. Generally, the F-box protein forms an E3 ligase complex, SCF complex with Skp1, Cullin1 (CUL1) and Rbx1, however, in Petunia inflata, SBP1 (S-RNase binding protein1) was reported to play the role of Skp1 and Rbx1, and form an SCFSLF-like complex for ubiquitination of non-self S-RNases. On the other hand, in Petunia hybrida and Petunia inflata of Solanaceae, Prunus avium and Pyrus bretschneideri of Rosaceae, SSK1 (SLF-interacting Skp1-like protein1) is considered to form the SCFSLF/SFB complex. Here, we isolated pollen-expressed apple homologs of SSK1 and CUL1, and named MdSSK1, MdCUL1A and MdCUL1B. MdSSK1 was preferentially expressed in pollen, but weakly in other organs analyzed, while, MdCUL1A and MdCUL1B were almost equally expressed in all the organs analyzed. MdSSK1 transcript abundance was significantly (> 100 times) higher than that of MdSBP1. In vitro binding assays showed that MdSSK1 and MdSBP1 interacted with MdSFBB1-S-9 and MdCUL1, and MdSFBB1-S-9 interacted more strongly with MdSSK1 than with MdSBP1. The results suggest that both MdSSK1-containing SCFSFBB1 and MdSBP1-containing SCFSFBB1-like complexes function in pollen of apple, and the former plays a major role.	[Minamikawa, Mai F.; Koyano, Ruriko; Kikuchi, Shinji; Koba, Takato; Sassa, Hidenori] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan	Chiba University	Sassa, H (corresponding author), Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan.	sassa@faculty.chiba-u.jp	Koba, Takato/AAV-4512-2020; Sassa, Hidenori/Q-7561-2018; Koba, Takato/I-3708-2017; Kikuchi, Shinji/N-7380-2019		Japan Society for the Promotion of Science (JSPS) [24380004]; JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grants-in-Aid for Scientific Research (B, 24380004) to H. S. from Japan Society for the Promotion of Science (JSPS). M. F. M. was supported by JSPS Research Fellowship for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2009, J JPN SOC HORTIC SCI, V78, P402, DOI 10.2503/jjshs1.78.402; Aguiar B, 2013, J EXP BOT, V64, P2423, DOI 10.1093/jxb/ert098; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen G, 2010, J EXP BOT, V61, P2027, DOI 10.1093/jxb/erp381; Crane MB, 1942, J GENET, V43, P31, DOI 10.1007/BF02982745; De Franceschi P, 2011, TREE GENET GENOMES, V7, P231, DOI 10.1007/s11295-010-0327-5; De Franceschi P, 2012, J EXP BOT, V63, P4015, DOI 10.1093/jxb/ers108; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Golz JF, 2001, P NATL ACAD SCI USA, V98, P15372, DOI 10.1073/pnas.261571598; Hauck NR, 2006, GENETICS, V172, P1191, DOI 10.1534/genetics.105.049395; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hua ZH, 2008, MOL PLANT, V1, P575, DOI 10.1093/mp/ssn032; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huang J, 2006, PLANT J, V46, P780, DOI 10.1111/j.1365-313X.2006.02735.x; Kakui H, 2011, PLANT J, V68, P1028, DOI 10.1111/j.1365-313X.2011.04752.x; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Lee CB, 2008, J BIOL CHEM, V283, P26965, DOI 10.1074/jbc.M804410200; LEWIS D., 1958, HEREDITY, V12, P233, DOI 10.1038/hdy.1958.26; Lewis D, 1942, J GENET, V43, P211, DOI 10.1007/BF02982754; Li S, 2014, PLANT REPROD, V27, P31, DOI 10.1007/s00497-013-0238-3; Li WT, 2014, GENETICS, V196, P439, DOI 10.1534/genetics.113.158279; Li WT, 2010, SCIENCE, V330, P1827, DOI 10.1126/science.1197908; Luu DT, 2000, NATURE, V407, P649, DOI 10.1038/35036623; Mase N, 2013, MOL BREEDING; Matsumoto D, 2012, PLANT PHYSIOL, V159, P1252, DOI 10.1104/pp.112.197343; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; McClure B, 2011, ANN BOT-LONDON, V108, P647, DOI 10.1093/aob/mcr179; Meng XY, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr016; Meng XY, 2011, ANN BOT-LONDON, V108, P637, DOI 10.1093/aob/mcq253; Minamikawa M, 2010, PLANT MOL BIOL, V74, P143, DOI 10.1007/s11103-010-9662-z; Minamikawa MF, 2013, PLANT BIOTECHNOL-NAR, V30, P119, DOI 10.5511/plantbiotechnology.13.0109a; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Brien M, 2004, SEX PLANT REPROD, V17, P81, DOI 10.1007/s00497-004-0218-8; Okada K, 2008, PLANT MOL BIOL, V66, P389, DOI 10.1007/s11103-007-9277-1; Okada K, 2013, PLANT REPROD, V26, P101, DOI 10.1007/s00497-013-0212-0; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Saito T, 2012, TREE GENET GENOMES, V8, P689, DOI 10.1007/s11295-011-0456-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Sassa H, 2007, GENETICS, V175, P1869, DOI 10.1534/genetics.106.068858; Sassa H, 2010, SEX PLANT REPROD, V23, P39, DOI 10.1007/s00497-009-0111-6; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sims TL, 2001, PLANT MOL BIOL, V47, P771, DOI 10.1023/A:1013639528858; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao R, 2010, SCI HORTIC-AMSTERDAM, V124, P423, DOI 10.1016/j.scienta.2010.01.025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukamoto T, 2006, PLANT MOL BIOL, V62, P371, DOI 10.1007/s11103-006-9026-x; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Vilanova S, 2006, PLANT PHYSIOL, V142, P629, DOI 10.1104/pp.106.083865; Xu C, 2013, PLANT MOL BIOL, V81, P245, DOI 10.1007/s11103-012-9995-x; Xue YB, 2009, PLANT MOL BIOL, V70, P499, DOI 10.1007/s11103-009-9487-9; Yamane H, 2009, J JPN SOC HORTIC SCI, V78, P137, DOI 10.2503/jjshs1.78.137; Zhang YJ, 2009, ANNU REV PLANT BIOL, V60, P21, DOI 10.1146/annurev.arplant.043008.092108; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	59	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97642	10.1371/journal.pone.0097642	http://dx.doi.org/10.1371/journal.pone.0097642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847858	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600046
J	Nebenzahl-Guimaraes, H; Borgdorff, MW; Murray, MB; van Soolingen, D				Nebenzahl-Guimaraes, Hanna; Borgdorff, Martien W.; Murray, Megan B.; van Soolingen, Dick			A Novel Approach - The Propensity to Propagate (PTP) Method for Controlling for Host Factors in Studying the Transmission of Mycobacterium Tuberculosis	PLOS ONE			English	Article							DRUG-RESISTANCE; BEIJING GENOTYPE; STRAIN; IDENTIFICATION; EPIDEMIOLOGY; LINEAGE; PRISON	Rationale: Understanding the genetic variations among Mycobacterium tuberculosis (MTB) strains with differential ability to transmit would be a major step forward in preventing transmission. Objectives: To describe a method to extend conventional proxy measures of transmissibility by adjusting for patient-related factors, thus strengthening the causal association found with bacterial factors. Methods: Clinical, demographic and molecular fingerprinting data were obtained during routine surveillance of verified MTB cases reported in the Netherlands between 1993 and 2011, and the phylogenetic lineages of the isolates were inferred. Odds ratios for host risk factors for clustering were used to obtain a measure of each patient's and cluster's propensity to propagate (CPP). Mean and median cluster sizes across different categories of CPP were compared amongst four different phylogenetic lineages. Results: Both mean and median cluster size grew with increasing CPP category. On average, CPP values from Euro-American lineage strains were higher than Beijing and EAI strains. There were no significant differences between the mean and median cluster sizes among the four phylogenetic lineages within each CPP category. Conclusions: Our finding that the distribution of CPP scores was unequal across four different phylogenetic lineages supports the notion that host-related factors should be controlled for to attain comparability in measuring the different phylogenetic lineages' ability to propagate. Although Euro-American strains were more likely to be in clusters in an unadjusted analysis, no significant differences among the four lineages persisted after we controlled for host factors.	[Nebenzahl-Guimaraes, Hanna; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Nebenzahl-Guimaraes, Hanna] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Nebenzahl-Guimaraes, Hanna] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Borgdorff, Martien W.] Publ Hlth Serv, Amsterdam, Netherlands; [Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, NL-1105 AZ Amsterdam, Netherlands; [Murray, Megan B.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Universidade do Minho; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Harvard Medical School; Radboud University Nijmegen	Nebenzahl-Guimaraes, H (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	hanna.guimaraes@gmail.com			Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/33902/2009]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	Portuguese Foundation for Science and Technology (FCT) (SFRH/BD/33902/2009 to HN-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], GLOB TUB CONTR WHO R; Borgdorff MW, 2010, EUR RESPIR J, V36, P339, DOI 10.1183/09031936.00155409; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Tho DQ, 2012, ANTIMICROB AGENTS CH, V56, P3074, DOI 10.1128/AAC.00319-12; de Beer JL, 2013, J CLIN MICROBIOL, V51, P1193, DOI 10.1128/JCM.03061-12; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Dillaha J, 2000, ATS INT C MAY 5 10 2; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Ijaz K, 2004, INT J TUBERC LUNG D, V8, P994; Kiers A, 1997, INT J TUBERC LUNG D, V1, P239; Kik SV, 2008, AM J RESP CRIT CARE, V178, P96, DOI 10.1164/rccm.200708-1256OC; Langlois-Klassen D, 2013, EMERG INFECT DIS, V19, P701, DOI 10.3201/eid1905.121578; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Talarico S, 2011, TUBERCULOSIS, V91, P244, DOI 10.1016/j.tube.2011.01.007; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; Verhagen LM, 2011, J INFECT DIS, V203, P1249, DOI 10.1093/infdis/jir013; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; Weniger T, 2010, NUCL ACIDS RES, V38; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670; Yang ZH, 1998, J CLIN MICROBIOL, V36, P1003, DOI 10.1128/JCM.36.4.1003-1007.1998	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97816	10.1371/journal.pone.0097816	http://dx.doi.org/10.1371/journal.pone.0097816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849817	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600063
J	Qu, LS; Liu, JX; Liu, TT; Shen, XZ; Chen, TY; Ni, ZP; Lu, CH				Qu, Li-Shuai; Liu, Jin-Xia; Liu, Tao-Tao; Shen, Xi-Zhong; Chen, Tao-Yang; Ni, Zheng-Pin; Lu, Cui-Hua			Association of Hepatitis B Virus Pre-S Deletions with the Development of Hepatocellular Carcinoma in Qidong, China	PLOS ONE			English	Article							ADVANCED LIVER-DISEASE; GENOTYPE-C; HIGH PREVALENCE; CORE PROMOTER; DNA LEVELS; INFECTION; MUTATIONS; RISK; MUTANTS; VARIANTS	Background/Aim: To investigate the roles of mutations in pre-S and S regions of hepatitis B virus (HBV) on the progression of hepatocellular carcinoma (HCC) in Qidong, China. Methods: We conducted an age matched case-control study within a cohort of 2387 male HBV carriers who were recruited from August, 1996. The HBV DNA sequence in pre-S/S regions was successfully determined in 96 HCC cases and 97 control subjects. In addition, a consecutive series of samples from 11 HCC cases were employed to evaluate the pre-S deletion patterns before and after the occurrence of HCC. Results: After adjustment for age, history of cigarette smoking and alcohol consumption, HBeAg positivity, pre-S deletions, pre-S2 start codon mutations, and T53C mutation were significantly associated with HCC, showing adjusted odds ratios (ORs) from 1.914 to 3.199. HCC patients also had a lower frequency of T31C mutation in pre-S2 gene, compared with control subjects (0.524; 95% CI 0.280-0.982). HBV pre-S deletions were clustered mainly in the 59 end of pre-S2 region. Multivariate analysis showed that pre-S deletions and pre-S2 start codon mutations were independent risk factors for HCC. The OR (95% CI) were 2.434 (1.063-5.573) and 3.065 (1.099-8.547), respectively. The longitudinal observation indicated that the pre-S deletion mutations were not acquired at the beginning of HBV infection, but that the mutations occurred during the long course of liver disease. Conclusion: Pre-S deletions and pre-S2 start codon mutations were independently associated with the development of HCC. The results also provided direct evidence that pre-S deletion mutations were not acquired from the beginning of infection but arose de novo during the progression of liver disease.	[Qu, Li-Shuai; Liu, Jin-Xia; Lu, Cui-Hua] Nantong Univ, Affiliated Hosp, Dept Gastroenterol, Nantong, Jiangsu, Peoples R China; [Liu, Tao-Tao; Shen, Xi-Zhong] Fudan Univ, Dept Gastroenterol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Chen, Tao-Yang; Ni, Zheng-Pin] Qidong Liver Canc Inst, Qidong, Jiangsu, Peoples R China	Nantong University; Fudan University	Lu, CH (corresponding author), Nantong Univ, Affiliated Hosp, Dept Gastroenterol, Nantong, Jiangsu, Peoples R China.	lucuihua@yeah.net	liu, taotao/GSI-7460-2022	Qu, Lishuai/0000-0001-8562-678X	China Ministry of Health [W201202]; Natural Science Foundation of Jiangsu Province [BK2012225]; Foundation of Jiangsu Province [WS056]; National Nature Science Foundation of China [81302056]	China Ministry of Health; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Foundation of Jiangsu Province; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the China Ministry of Health (W201202), Natural Science Foundation of Jiangsu Province (BK2012225), Foundation of Jiangsu Province (WS056), and National Nature Science Foundation of China (No. 81302056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Choi MS, 2007, J VIRAL HEPATITIS, V14, P161, DOI 10.1111/j.1365-2893.2006.00784.x; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Fang ZL, 2008, J GEN VIROL, V89, P2882, DOI 10.1099/vir.0.2008/002824-0; Fang ZL, 2008, AM J GASTROENTEROL, V103, P2254, DOI 10.1111/j.1572-0241.2008.01974.x; FERRARI C, 1992, GASTROENTEROLOGY, V103, P255, DOI 10.1016/0016-5085(92)91121-J; Guo X, 2008, J HEPATOL, V49, P718, DOI 10.1016/j.jhep.2008.06.026; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huy TTT, 2003, J CLIN MICROBIOL, V41, P5449, DOI 10.1128/JCM.41.12.5449-5455.2003; Ito K, 2006, CLIN INFECT DIS, V42, P1, DOI 10.1086/498522; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu CJ, 2002, J MED VIROL, V68, P50, DOI 10.1002/jmv.10169; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mun HS, 2008, J MED VIROL, V80, P1189, DOI 10.1002/jmv.21208; Pollicino T, 1997, HEPATOLOGY, V26, P495, DOI 10.1002/hep.510260235; Qu LS, 2011, HEPATOL RES, V41, P54, DOI 10.1111/j.1872-034X.2010.00732.x; Qu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059583; Qu LS, 2014, HEPATOL RES IN PRESS; Raimondo G, 2004, J HEPATOL, V40, P515, DOI 10.1016/j.jhep.2003.11.025; Sugauchi F, 2003, J MED VIROL, V70, P537, DOI 10.1002/jmv.10428; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; Zhong S, 1999, J VIRAL HEPATITIS, V6, P195, DOI 10.1046/j.1365-2893.1999.00154.x	31	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98257	10.1371/journal.pone.0098257	http://dx.doi.org/10.1371/journal.pone.0098257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849936	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600103
J	Wojcicka, A; Piekielko-Witkowska, A; Kedzierska, H; Rybicka, B; Poplawski, P; Boguslawska, J; Master, A; Nauman, A				Wojcicka, Anna; Piekielko-Witkowska, Agnieszka; Kedzierska, Hanna; Rybicka, Beata; Poplawski, Piotr; Boguslawska, Joanna; Master, Adam; Nauman, Alicja			Epigenetic Regulation of Thyroid Hormone Receptor Beta in Renal Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; DNA METHYLTRANSFERASE-1; CELL CARCINOMA; METHYLATION; GENE; MICRORNAS; SUPPRESSOR; MIRNA; HYPERMETHYLATION; OVEREXPRESSION	Thyroid hormone receptor beta (THRB) gene is commonly deregulated in cancers and, as strengthened by animal models, postulated to play a tumor-suppressive role. Our previous studies revealed downregulation of THRB in clear cell renal cell carcinoma (ccRCC), but the culpable mechanisms have not been fully elucidated. Since epigenetic regulation is a common mechanism influencing the expression of tumor suppressors, we hypothesized that downregulation of THRB in renal cancer results from epigenetic aberrances, including CpG methylation and microRNA-dependent silencing. Our study revealed that ccRCC tumors exhibited a 56% decrease in THRB and a 37% increase in DNA methyltransferase 1 (DNMT1) expression when compared with paired non-neoplastic control samples. However, THRB CpG methylation analysis performed using BSP, SNaPshot and MSP-PCR consistently revealed no changes in methylation patterns between matched tumor and control samples. In silico analysis resulted in identification of four microRNAs (miR-155, miR-425, miR-592, and miR-599) as potentially targeting THRB transcript. Luciferase assay showed direct binding of miR-155 and miR-425 to 3'UTR of THRB, and subsequent in vivo analyses revealed that transfection of UOK171 cell line with synthetic miR-155 or miR-425 resulted in decreased expression of endogenous TRHB by 22% and 64%, respectively. Finally, real-time PCR analysis showed significant upregulation of miR-155 (354%) and miR-425 (162%) in ccRCC when compared with matched controls. Moreover, microRNA levels were negatively correlated with the amount of THRB transcript in tissue samples. We conclude that CpG methylation is not the major mechanism contributing to decreased THRB expression in ccRCC. In contrast, THRB is targeted by microRNAs miR-155 and miR-425, whose increased expression may be responsible for downregulation of THRB in ccRCC tumors.	[Wojcicka, Anna; Piekielko-Witkowska, Agnieszka; Kedzierska, Hanna; Rybicka, Beata; Poplawski, Piotr; Boguslawska, Joanna; Master, Adam; Nauman, Alicja] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Wojcicka, Anna] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Medical University of Warsaw	Nauman, A (corresponding author), Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	anauman@cmkp.edu.pl	Rybicka, Beata/V-1024-2019; Poplawski, Piotr/V-1030-2019; Bogusławska, Joanna/I-7189-2019; Piekielko-Witkowska, Agnieszka/V-1011-2019; Wojcicka, Anna/K-4134-2012	Rybicka, Beata/0000-0003-1726-0266; Poplawski, Piotr/0000-0002-9477-7595; Piekielko-Witkowska, Agnieszka/0000-0002-5348-0760; Wojcicka, Anna/0000-0001-5803-6397; Master, Adam/0000-0001-9391-8846; Boguslawska, Joanna/0000-0003-2568-1546	National Science Centre [NN401611940, NN401047638, 2012/05/B/NZ5/01541]; UNESCO/FEBS Collaborative Experimental Scholarship for Central Eastern Europe	National Science Centre(National Science Centre, Poland); UNESCO/FEBS Collaborative Experimental Scholarship for Central Eastern Europe	The study was supported by the National Science Centre grants NN401611940 and NN401047638 (to AN), the UNESCO/FEBS Collaborative Experimental Scholarship for Central & Eastern Europe, 2010 (to AW), and the National Science Centre Grant 2012/05/B/NZ5/01541 (to APW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Arai E, 2011, INT J CLIN EXP PATHO, V4, P58; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Boguslawska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024541; Dinda S, 2002, ONCOGENE, V21, P761, DOI 10.1038/sj.onc.1205136; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Hagenkord JM, 2011, CANCER GENET-NY, V204, P285, DOI 10.1016/j.cancergen.2011.06.001; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Iwasaki Y, 2010, ANN SURG ONCOL, V17, P2222, DOI 10.1245/s10434-010-0956-9; Jacques C, 2013, J CLIN ENDOCR METAB, V98, pE981, DOI 10.1210/jc.2012-4006; Jazdzewski K, 2011, J CLIN ENDOCR METAB, V96, pE546, DOI 10.1210/jc.2010-1594; Joseph B, 2007, J CLIN ENDOCR METAB, V92, P4766, DOI 10.1210/jc.2007-0812; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Kamiya Y, 2002, CARCINOGENESIS, V23, P25, DOI 10.1093/carcin/23.1.25; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Kim WG, 2013, BBA-GEN SUBJECTS, V1830, P3928, DOI 10.1016/j.bbagen.2012.04.002; Kim WG, 2013, ENDOCRINOLOGY, V154, P25, DOI 10.1210/en.2012-1728; Kimura F, 2003, INT J CANCER, V104, P568, DOI 10.1002/ijc.10988; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Koul H, 2011, AM J CANCER RES, V1, P240; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li Z, 2002, CANCER RES, V62, P1939; Ling YQ, 2010, CANCER GENET CYTOGEN, V196, P140, DOI 10.1016/j.cancergencyto.2009.09.010; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Master A, 2010, BBA-MOL BASIS DIS, V1802, P995, DOI 10.1016/j.bbadis.2010.07.025; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Neal CS, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-64; Nishi H, 2011, MOL CELL BIOL, V31, P744, DOI 10.1128/MCB.00581-10; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Piekielko-Witkowska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013690; Puzianowska-Kuznicka M, 2000, CANCER LETT, V155, P145, DOI 10.1016/S0304-3835(00)00416-X; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641, DOI 10.18388/abp.2006_3292; Qi JS, 1999, MOL CELL BIOL, V19, P864; R Core Team, 2018, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rio-Machin A, 2013, LEUKEMIA, V27, P925, DOI 10.1038/leu.2012.302; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; SAKURAI A, 1992, BIOCHEM BIOPH RES CO, V185, P78, DOI 10.1016/S0006-291X(05)80957-X; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Su ZX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S15; Takai Daiya, 2003, In Silico Biology, V3, P235; Tryndyak VP, 2006, CANCER BIOL THER, V5, P65, DOI 10.4161/cbt.5.1.2288; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Virtue A, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-66; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004	62	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97624	10.1371/journal.pone.0097624	http://dx.doi.org/10.1371/journal.pone.0097624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849932	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600043
J	Liu, Q; Zhang, ML; Hou, DX; Han, XJ; Jin, Y; Zhao, LH; Nie, XW; Zhou, X; Yun, T; Zhao, YH; Huang, XH; Hou, DR; Yang, N; Wu, ZQ; Li, XL; Li, RF				Liu, Qiang; Zhang, Manling; Hou, Dongxia; Han, Xuejie; Jin, Yong; Zhao, Lihua; Nie, Xiaowei; Zhou, Xin; Yun, Ting; Zhao, Yuhang; Huang, Xianghua; Hou, Daorong; Yang, Ning; Wu, Zhaoqiang; Li, Xueling; Li, Rongfeng			Karyotype Characterization of In Vivo- and In Vitro-Derived Porcine Parthenogenetic Cell Lines	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACTIVATION; GENERATION; DERIVATION; INSTABILITY; EFFICIENCY; OOCYTES	Mammalian haploid cell lines provide useful tools for both genetic studies and transgenic animal production. To derive porcine haploid cells, three sets of experiments were conducted. First, genomes of blastomeres from 8-cell to 16-cell porcine parthenogenetically activated (PA) embryos were examined by chromosome spread analysis. An intact haploid genome was maintained by 48.15% of blastomeres. Based on this result, two major approaches for amplifying the haploid cell population were tested. First, embryonic stem-like (ES-like) cells were cultured from PA blastocyst stage embryos, and second, fetal fibroblasts from implanted day 30 PA fetuses were cultured. A total of six ES-like cell lines were derived from PA blastocysts. No chromosome spread with exactly 19 chromosomes (the normal haploid complement) was found. Four cell lines showed a tendency to develop to polyploidy (more than 38 chromosomes). The karyotypes of the fetal fibroblasts showed different abnormalities. Cells with 19-38 chromosomes were the predominant karyotype (59.48-60.91%). The diploid cells were the second most observed karyotype (16.17%-22.73%). Although a low percentage (3.45-8.33%) of cells with 19 chromosomes were detected in 18.52% of the fetus-derived cell lines, these cells were not authentic haploid cells since they exhibited random losses or gains of some chromosomes. The haploid fibroblasts were not efficiently enriched via flow cytometry sorting. On the contrary, the diploid cells were efficiently enriched. The enriched parthenogenetic diploid cells showed normal karyotypes and expressed paternally imprinted genes at extremely low levels. We concluded that only a limited number of authentic haploid cells could be obtained from porcine cleavage-stage parthenogenetic embryos. Unlike mouse, the karyotype of porcine PA embryo-derived haploid cells is not stable, long-term culture of parthenogenetic embryos, either in vivo or in vitro, resulted in abnormal karyotypes. The porcine PA embryo-derived diploid fibroblasts enriched from sorting might be candidate cells for paternally imprinted gene research.	[Liu, Qiang; Zhang, Manling; Jin, Yong; Zhao, Lihua; Nie, Xiaowei; Hou, Daorong; Yang, Ning; Wu, Zhaoqiang; Li, Rongfeng] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Liu, Qiang; Zhang, Manling; Jin, Yong; Zhao, Lihua; Nie, Xiaowei; Hou, Daorong; Yang, Ning; Wu, Zhaoqiang; Li, Rongfeng] Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing, Jiangsu, Peoples R China; [Hou, Dongxia; Han, Xuejie; Zhou, Xin; Yun, Ting; Zhao, Yuhang; Huang, Xianghua; Li, Xueling] Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot, Inner Mongolia, Peoples R China	Nanjing Medical University; Nanjing Medical University; Inner Mongolia University	Li, XL (corresponding author), Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot, Inner Mongolia, Peoples R China.	lixueling@hotmail.com; lirongfeng@njmu.edu.cn			National Natural Sciences Foundation of China [30871408, 31371487]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Sciences Foundation of China (30871408 and 31371487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brevini TAL, 2012, STEM CELL REV REP, V8, P1076, DOI 10.1007/s12015-012-9379-2; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Delhanty JDA, 2005, CYTOGENET GENOME RES, V111, P237, DOI 10.1159/000086894; ECHARD G, 1974, CHROMOSOMA, V45, P133, DOI 10.1007/BF00362307; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Hao YH, 2006, MOL REPROD DEV, V73, P77, DOI 10.1002/mrd.20358; Harris D, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103390; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KAUFMAN MH, 1978, J EMBRYOL EXP MORPH, V45, P85; KAUFMAN MH, 1982, J EMBRYOL EXP MORPH, V71, P139; KAUFMAN MH, 1974, J EMBRYOL EXP MORPH, V31, P635; Koh S, 2014, THERIOGENOLOGY, V81, P103, DOI 10.1016/j.theriogenology.2013.09.009; Kure-Bayashi S, 2000, THERIOGENOLOGY, V53, P1105, DOI 10.1016/S0093-691X(00)00256-9; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; LIN CC, 1980, CAN J GENET CYTOL, V22, P103, DOI 10.1139/g80-013; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; MODLINSKI JA, 1975, J EMBRYOL EXP MORPH, V33, P897; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Oh SK, 2005, STEM CELLS, V23, P605, DOI 10.1634/stemcells.2004-0297; Park CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022216; Sritanaudomchai H, 2010, HUM REPROD, V25, P1927, DOI 10.1093/humrep/deq144; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; TARKOWSKI AK, 1976, NATURE, V259, P663, DOI 10.1038/259663a0; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Tsai S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-328; VANDERHOEVEN FA, 1985, J REPROD FERTIL, V75, P593, DOI 10.1530/jrf.0.0750593; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Whitworth KM, 2009, MOL REPROD DEV, V76, P490, DOI 10.1002/mrd.20987; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	41	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97974	10.1371/journal.pone.0097974	http://dx.doi.org/10.1371/journal.pone.0097974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844788	gold, Green Submitted, Green Published			2022-12-27	WOS:000339563400077
J	Martinu, T; Kinnier, CV; Sun, J; Kelly, FL; Nelson, ME; Garantziotis, S; Foster, WM; Palmer, SM				Martinu, Tereza; Kinnier, Christine V.; Sun, Jesse; Kelly, Francine L.; Nelson, Margaret E.; Garantziotis, Stavros; Foster, W. Michael; Palmer, Scott M.			Allogeneic Splenocyte Transfer and Lipopolysaccharide Inhalations Induce Differential T Cell Expansion and Lung Injury: A Novel Model of Pulmonary Graft-versus-Host Disease	PLOS ONE			English	Article							IDIOPATHIC PNEUMONIA SYNDROME; ALLERGIC AIRWAY INFLAMMATION; INNATE IMMUNE ACTIVATION; BONE-MARROW TRANSPLANT; INHALED LIPOPOLYSACCHARIDE; BRONCHIOLITIS OBLITERANS; DENDRITIC CELLS; HYPERRESPONSIVENESS; MICE; HYPERREACTIVITY	Background: Pulmonary GVHD (pGVHD) is an important complication of hematopoietic cell transplant (HCT) and is thought to be a consequence of the HCT conditioning regimen, allogeneic donor cells, and posttransplant lung exposures. We have previously demonstrated that serial inhaled lipopolysaccharide (LPS) exposures potentiate the development of pGVHD after murine allogeneic HCT. In the current study we hypothesized that allogeneic lymphocytes and environmental exposures alone, in the absence of a pre-conditioning regimen, would cause features of pGVHD and would lead to a different T cell expansion pattern compared to syngeneic cells. Methods: Recipient Rag1(-/-) mice received a transfer of allogeneic (Allo) or syngeneic (Syn) spleen cells. After 1 week of immune reconstitution, mice received 5 daily inhaled LPS exposures and were sacrificed 72 hours after the last LPS exposure. Lung physiology, histology, and protein levels in bronchoalveolar lavage (BAL) were assessed. Lung cells were analyzed by flow cytometry. Results: Both Allo and Syn mice that undergo LPS exposures (AlloLPS and SynLPS) have prominent lymphocytic inflammation in their lungs, resembling pGVHD pathology, not seen in LPS-unexposed or non-transplanted controls. Compared to SynLPS, however, AlloLPS have significantly increased levels of BAL protein and enhancement of airway hyperreactivity, consistent with more severe lung injury. This injury in AlloLPS mice is associated with an increase in CD8 T cells and effector CD4 T cells, as well as a decrease in regulatory to effector CD4 T cell ratio. Additionally, cytokine analysis is consistent with a preferential Th1 differentiation and upregulation of pulmonary CCL5 and granzyme B. Conclusions: Allogeneic lymphocyte transfer into lymphocyte-deficient mice, followed by LPS exposures, causes features of pGVHD and lung injury in the absence of a pre-conditioning HCT regimen. This lung disease associated with an expansion of allogeneic effector T cells provides a novel model to dissect mechanisms of pGVHD independent of conditioning.	[Martinu, Tereza; Kelly, Francine L.; Nelson, Margaret E.; Foster, W. Michael; Palmer, Scott M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kinnier, Christine V.] Massachusetts Gen Hosp, Dept Gen Surg, Boston, MA 02114 USA; [Sun, Jesse] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Garantziotis, Stavros] NIEHS, Resp Biol Branch, Res Triangle Pk, NC 27709 USA	Duke University; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Martinu, T (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	tereza.martinu@duke.edu	Garantziotis, Stavros/A-6903-2009	Garantziotis, Stavros/0000-0003-4007-375X; Palmer, Scott/0000-0002-1370-3771	Parker B. Francis Fellowship Program Award; division of intramural research, NIEHS;  [NIH/NHLBI 1P50-HL084917-01];  [NIH 1 K24 HL91140-01A2];  [RR024 127-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024127] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL091140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102605] Funding Source: NIH RePORTER	Parker B. Francis Fellowship Program Award; division of intramural research, NIEHS; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the following grants: NIH/NHLBI 1P50-HL084917-01 (SCCOR), Project 3 (SMP), Training core (to TM); NIH 1 K24 HL91140-01A2 (SMP); RR024 127-03 (TM) (KL2); and Parker B. Francis Fellowship Program Award (TM). This research was also supported, in part, by the division of intramural research, NIEHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afessa B, 2005, CLIN CHEST MED, V26, P571, DOI 10.1016/j.ccm.2005.06.012; Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; Brandon JA, 2010, CYTOKINE, V52, P265, DOI 10.1016/j.cyto.2010.08.006; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Domingo-Gonzalez R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00126; Dutt S, 2007, J IMMUNOL, V179, P6547, DOI 10.4049/jimmunol.179.10.6547; Fang Qiaoqiao, 2010, Int J Med Sci, V7, P55; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Garantziotis S, 2007, TRANSPLANTATION, V84, P1012, DOI 10.1097/01.tp.0000286040.85007.89; Hale LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045667; Hasegawa H, 2008, GENE THER, V15, P171, DOI 10.1038/sj.gt.3303051; Hildebrandt GC, 2008, BIOL BLOOD MARROW TR, V14, P385, DOI 10.1016/j.bbmt.2008.01.004; Isogai S, 2004, J ALLERGY CLIN IMMUN, V114, P1345, DOI 10.1016/j.jaci.2004.09.021; John AE, 2003, EUR J IMMUNOL, V33, P1677, DOI 10.1002/eji.200323930; Koya T, 2007, J IMMUNOL, V179, P2787, DOI 10.4049/jimmunol.179.5.2787; Kreisel D, 2011, AM J RESP CELL MOL, V44, P749, DOI 10.1165/rcmb.2010-0099OC; Leong JW, 2011, BLOOD, V117, P2297, DOI 10.1182/blood-2011-01-327247; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu QF, 2010, TRANSPL IMMUNOL, V23, P12, DOI 10.1016/j.trim.2010.02.004; Liu T, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-40; Martinu T, 2011, J HEART LUNG TRANSPL, V30, P717, DOI 10.1016/j.healun.2011.01.711; MICHEL O, 1991, CLIN EXP ALLERGY, V21, P441, DOI 10.1111/j.1365-2222.1991.tb01684.x; Miyahara N, 2004, NAT MED, V10, P865, DOI 10.1038/nm1081; Miyahara N, 2004, J IMMUNOL, V172, P2549, DOI 10.4049/jimmunol.172.4.2549; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moncrieffe H, 2008, IMMUNOLOGY, V125, P459, DOI 10.1111/j.1365-2567.2008.02866.x; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Panoskaltsis-Mortari A, 2007, AM J RESP CRIT CARE, V176, P713, DOI 10.1164/rccm.200702-335OC; Panoskaltsis-Mortari A, 2011, AM J RESP CRIT CARE, V183, P1262, DOI 10.1164/rccm.2007-413ST; Perez J, 2011, AM J PHYSIOL-GASTR L, V300, pG843, DOI 10.1152/ajpgi.00254.2010; Sauter CT, 2013, BONE MARROW TRANSPL, V48, P1237, DOI 10.1038/bmt.2013.47; Savov JD, 2005, AM J PHYSIOL-LUNG C, V289, pL329, DOI 10.1152/ajplung.00014.2005; Savov JD, 2003, AM J PHYSIOL-LUNG C, V285, pL940, DOI 10.1152/ajplung.00102.2003; Schaller MA, 2005, EUR J IMMUNOL, V35, P2061, DOI 10.1002/eji.200425715; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; SCHWARTZ DA, 1994, AM J PHYSIOL-LUNG C, V267, pL609, DOI 10.1152/ajplung.1994.267.5.L609; Terwey TH, 2005, BLOOD, V106, P3322, DOI 10.1182/blood-2005-05-1860; Tomita T, 2008, INFLAMM BOWEL DIS, V14, P1630, DOI 10.1002/ibd.20636; Williams KM, 2009, JAMA-J AM MED ASSOC, V302, P306, DOI 10.1001/jama.2009.1018; Wysocki CA, 2004, J IMMUNOL, V173, P845, DOI 10.4049/jimmunol.173.2.845; Xu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040314; YOUSEM SA, 1995, HUM PATHOL, V26, P668, DOI 10.1016/0046-8177(95)90174-4	46	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97951	10.1371/journal.pone.0097951	http://dx.doi.org/10.1371/journal.pone.0097951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844383	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400074
J	Qi, JJ; Li, N; Fan, K; Yin, P; Zhao, C; Li, ZX; Lin, Y; Wang, LY; Zha, XL				Qi, Jingjing; Li, Na; Fan, Kun; Yin, Peng; Zhao, Chao; Li, Zengxia; Lin, Yi; Wang, Liying; Zha, Xiliang			beta 1,6 GlcNAc Branches-Modified PTPRT Attenuates Its Activity and Promotes Cell Migration by STAT3 Pathway	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-V; PROTEIN-TYROSINE-PHOSPHATASES; SIGNALING PATHWAYS; PANCREATIC-CANCER; BREAST-CARCINOMA; COLON-CANCER; RECEPTOR-T; GLYCOSYLATION; EXPRESSION; ADHESION	Receptor-like protein tyrosine phosphatases (RPTPs) are type I transmembrane glycoproteins with N-glycans whose catalytic activities are regulated by dimerization. However, the intrinsic mechanism involved in dimerizing processes remains obscure. In this study, receptor protein tyrosine phosphatase rho (PTPRT) is identified as a novel substrate of N-Acetylglucosaminyltransferase V (GnT-V). We show that addition of beta 1,6 GlcNAc branches on PTPRT prolongs PTPRT's cell-surface retention time. GnT-V overexpression enhances galectin-3's cell-surface retention and promotes PTPRT's dimerization mediated by galectin-3. Increased dimerization subsequently reduces PTPRT's catalytic activity on the dephosphorylation of signal transducer and activator of transcription 3 (STAT3) at tyrosine residue 705 (pY705 STAT3), then the accumulated pY705 STAT3 translocates into the nucleus. Collectively, these findings provide an insight into the molecular mechanism by which GnT-V promotes cell migration, suggesting that accumulation of beta 1,6 GlcNAc branched N-glycans promotes PTPRT's dimerization and decreases its catalytic activity, resulting in enhanced cell migratory capacity.	[Qi, Jingjing; Li, Na; Fan, Kun; Yin, Peng; Zhao, Chao; Li, Zengxia; Wang, Liying; Zha, Xiliang] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Li, Zengxia; Wang, Liying; Zha, Xiliang] Minist Hlth, Key Lab Glycoconjugate Res, Shanghai, Peoples R China; [Li, Zengxia; Wang, Liying; Zha, Xiliang] Minist Educ, Key Lab Mol Med, Shanghai, Peoples R China; [Qi, Jingjing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Dept Immunol & Microbiol, Shanghai 200030, Peoples R China; [Lin, Yi] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Pediat, Qingdao, Shandong, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Qingdao University	Wang, LY (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.	liying_wang@hotmail.com; xlzha@shmu.edu.cn	Zhao, Chao/AAG-4497-2020	Zhao, Chao/0000-0001-7349-306X	National Basic Research Program of China [2012CB822104]; National Natural Science Foundation of China [31070721, 81000873, 31370809]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the following grant sponsors: National Basic Research Program of China (2012CB822104), National Natural Science Foundation of China (Nos. 31070721, 81000873, 31370809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Gao FL, 2012, DIGEST DIS SCI, V57, P2055, DOI 10.1007/s10620-012-2152-1; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Huang C, 2012, CYTOKINE GROWTH F R, V23, P25, DOI 10.1016/j.cytogfr.2012.01.003; Ito Y, 2001, INT J CANCER, V91, P631, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1118>3.3.CO;2-6; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kim YS, 2006, PROTEOMICS, V6, P1187, DOI 10.1002/pmic.200500400; Lay V, 2012, INT J ONCOL, V41, P759, DOI 10.3892/ijo.2012.1486; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Mendelsohn R, 2007, CANCER RES, V67, P9771, DOI 10.1158/0008-5472.CAN-06-4580; Ou YW, 2012, J BIOL CHEM, V287, P32394, DOI 10.1074/jbc.M112.393900; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Scott A, 2011, BIOSCIENCE REP, V31, P303, DOI 10.1042/BSR20100134; Scott LM, 2010, CURR PHARM DESIGN, V16, P1843; Sun JB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-2; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang C, 2010, J CELL BIOCHEM, V109, P113, DOI 10.1002/jcb.22387; Wang LY, 2007, J CELL BIOCHEM, V100, P230, DOI 10.1002/jcb.21071; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Yang Z, 2012, FEBS LETT, V586, P3013, DOI 10.1016/j.febslet.2012.06.025; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	34	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98052	10.1371/journal.pone.0098052	http://dx.doi.org/10.1371/journal.pone.0098052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846175	Green Published, Green Submitted, gold			2022-12-27	WOS:000339563400086
J	Reeves, RG; Bryk, J; Altrock, PM; Denton, JA; Reed, FA				Reeves, R. Guy; Bryk, Jaroslaw; Altrock, Philipp M.; Denton, Jai A.; Reed, Floyd A.			First Steps towards Underdominant Genetic Transformation of Insect Populations	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DRIVE SYSTEMS; EFFICIENT; SNORNA; SET	The idea of introducing genetic modifications into wild populations of insects to stop them from spreading diseases is more than 40 years old. Synthetic disease refractory genes have been successfully generated for mosquito vectors of dengue fever and human malaria. Equally important is the development of population transformation systems to drive and maintain disease refractory genes at high frequency in populations. We demonstrate an underdominant population transformation system in Drosophila melanogaster that has the property of being both spatially self-limiting and reversible to the original genetic state. Both population transformation and its reversal can be largely achieved within as few as 5 generations. The described genetic construct {Ud} is composed of two genes; (1) a UAS-RpL14.dsRNA targeting RNAi to a haploinsufficient gene RpL14 and (2) an RNAi insensitive RpL14 rescue. In this proof-of-principle system the UAS-RpL14.dsRNA knock-down gene is placed under the control of an Actin5c-GAL4 driver located on a different chromosome to the {Ud} insert. This configuration would not be effective in wild populations without incorporating the Actin5c-GAL4 driver as part of the {Ud} construct (or replacing the UAS promoter with an appropriate direct promoter). It is however anticipated that the approach that underlies this underdominant system could potentially be applied to a number of species.	[Reeves, R. Guy; Bryk, Jaroslaw; Denton, Jai A.; Reed, Floyd A.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany; [Altrock, Philipp M.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Theory, Plon, Germany	Max Planck Society; Max Planck Society	Reeves, RG (corresponding author), Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany.	reeves@evolbio.mpg.de	Denton, Jai/G-4985-2015; Altrock, Philipp/X-9063-2018	Denton, Jai/0000-0002-5259-4221; Reed, Floyd/0000-0003-4703-530X; Bryk, Jaroslaw/0000-0002-2791-9709; Altrock, Philipp/0000-0001-7731-3345; Reeves, Richard/0000-0001-9454-6175	Max Planck Society; Deutsche Forschungsgemeinschaft [RE-3062/2-1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funds from the Max Planck Society and the Deutsche Forschungsgemeinschaft (RE-3062/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059; Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Altrock PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002260; Altrock PM, 2010, J THEOR BIOL, V267, P62, DOI 10.1016/j.jtbi.2010.08.004; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CLARK AG, 1981, HEREDITY, V46, P321, DOI 10.1038/hdy.1981.44; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Davis S, 2001, J THEOR BIOL, V212, P83, DOI 10.1006/jtbi.2001.2357; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Enerly E, 2003, HEREDITAS, V138, P73, DOI 10.1034/j.1601-5223.2003.01710.x; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Holley CL, 2011, CARDIOVASC DRUG THER, V25, P151, DOI 10.1007/s10557-011-6290-z; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Ito K, 1997, DEVELOPMENT, V124, P761; Jasinskiene N, 2007, AM J TROP MED HYG, V76, P1072, DOI 10.4269/ajtmh.2007.76.1072; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5; Lindsley DL, 1972, GENETIC VARIATIONS D, V2nd; Marshall JM, 2012, J THEOR BIOL, V294, P153, DOI 10.1016/j.jtbi.2011.10.032; Marygold SJ, 2005, GENETICS, V169, P683, DOI 10.1534/genetics.104.034124; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Nolan T, 2002, J BIOL CHEM, V277, P8759, DOI 10.1074/jbc.C100766200; Ott RL, 1993, INTRO STAT METHODS A; Ramia M, 2012, BIOINFORMATICS, V28, P595, DOI 10.1093/bioinformatics/btr691; SaeboeLarssen S, 1997, MOL GEN GENET, V255, P141, DOI 10.1007/s004380050482; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; SEAGER RD, 1982, GENETICS, V102, P485; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Sokal R. R., 1981, BIOMETRY; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Wilks SS, 1935, ANN MATH STAT, V6, P190, DOI 10.1214/aoms/1177732564; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Wright S, 1931, GENETICS, V16, P0097; Zar JH, 1999, BIOSTATISTICAL ANAL	45	43	44	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97557	10.1371/journal.pone.0097557	http://dx.doi.org/10.1371/journal.pone.0097557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844466	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000339563400034
J	Woollard, KJ; Lumsden, NG; Andrews, KL; Aprico, A; Harris, E; Irvine, JC; Jefferis, AM; Fang, L; Kanellakis, P; Bobik, A; Chin-Dusting, JPF				Woollard, Kevin J.; Lumsden, Natalie G.; Andrews, Karen L.; Aprico, Andrea; Harris, Emma; Irvine, Jennifer C.; Jefferis, Ann-maree; Fang, Lu; Kanellakis, Peter; Bobik, Alex; Chin-Dusting, Jaye P. F.			Raised Soluble P-Selectin Moderately Accelerates Atherosclerotic Plaque Progression	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; GLYCOPROTEIN LIGAND-1; PLATELET ACTIVATION; LEUKOCYTE ADHESION; VASCULAR-DISEASE; ARTERIAL INJURY; TISSUE FACTOR; MOUSE MODEL; EXPRESSION	Soluble P-selectin (sP-selectin), a biomarker of inflammatory related pathologies including cardiovascular and peripheral vascular diseases, also has pro-atherosclerotic effects including the ability to increase leukocyte recruitment and modulate thrombotic responses in vivo. The current study explores its role in progressing atherosclerotic plaque disease. Apoe(-/-) mice placed on a high fat diet (HFD) were given daily injections of recombinant dimeric murine P-selectin (22.5 mg/kg/day) for 8 or 16 weeks. Saline or sE-selectin injections were used as negative controls. In order to assess the role of sP-selectin on atherothrombosis an experimental plaque remodelling murine model, with sm22 alpha-hDTR Apoe(-/-) mice on a HFD in conjunction with delivery of diphtheria toxin to induce targeted vascular smooth muscle apoptosis, was used. These mice were similarly given daily injections of sP-selectin for 8 or 16 weeks. While plaque mass and aortic lipid content did not change with sP-selectin treatment in Apoe(-/-) or SM22 alpha-hDTR Apoe(-/-) mice on HFD, increased plasma MCP-1 and a higher plaque CD45 content in Apoe(-/-) HFD mice was observed. As well, a significant shift towards a more unstable plaque phenotype in the SM22 alpha-hDTR Apoe(-/-) HFD mice, with increased macrophage accumulation and lower collagen content, leading to a lower plaque stability index, was observed. These results demonstrate that chronically raised sP-selectin favours progression of an unstable atherosclerotic plaque phenotype.	[Woollard, Kevin J.; Lumsden, Natalie G.; Andrews, Karen L.; Aprico, Andrea; Harris, Emma; Irvine, Jennifer C.; Jefferis, Ann-maree; Fang, Lu; Kanellakis, Peter; Bobik, Alex; Chin-Dusting, Jaye P. F.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute	Chin-Dusting, JPF (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	jaye.chin-dusting@bakeridi.edu.au		Woollard, Kevin/0000-0002-9839-5463	National Heart Foundation; British Heart Foundation; NHMRC; Victorian Government's Operational Infrastructure Support Program	National Heart Foundation(National Heart Foundation of Australia); British Heart Foundation(British Heart Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	KJW was supported through National Heart Foundation and British Heart Foundation fellowships and part of this work was supported by a National Heart Foundation project grant. JCD was supported in part through a NHMRC senior fellowship. This study was supported in part by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2000, P NATL ACAD SCI USA, V97, P13835, DOI 10.1073/pnas.250475997; Baltus T, 2003, BLOOD, V102, P1985, DOI 10.1182/blood-2003-04-1175; CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen YC, 2013, CIRC RES, V113, P252, DOI 10.1161/CIRCRESAHA.113.301562; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; CLOWES AW, 1983, LAB INVEST, V49, P327; DAVIES MJ, 1993, BRIT HEART J, V69, P377; ELSTAD MR, 1995, J IMMUNOL, V155, P2109; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; Gaspari T, 2013, DIABETES VASC DIS RE, V10, P353, DOI 10.1177/1479164113481817; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; GENG YJ, 1995, AM J PATHOL, V147, P251; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KhewGoodall Y, 1996, BLOOD, V87, P1432, DOI 10.1182/blood.V87.4.1432.bloodjournal8741432; Kisucka J, 2009, BLOOD, V113, P6015, DOI 10.1182/blood-2008-10-186650; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; Lutgens E, 1999, CARDIOVASC RES, V41, P473, DOI 10.1016/S0008-6363(98)00311-3; Manka D, 2001, CIRCULATION, V103, P1000; Matzdorff AC, 1996, HAEMOSTASIS, V26, P98; Nomura S, 2003, THROMB HAEMOSTASIS, V89, P506; Norman KE, 2000, BLOOD, V96, P3585; Phillips JW, 2003, CIRCULATION, V107, P2244, DOI 10.1161/01.CIR.0000065604.56839.18; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; Ridker PM, 2001, CIRCULATION, V103, P491, DOI 10.1161/01.CIR.103.4.491; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Schaub FJ, 2000, NAT MED, V6, P790, DOI 10.1038/77521; Schaub FJ, 2003, CIRC RES, V93, P515, DOI 10.1161/01.RES.0000093205.42313.7C; Storey RF, 2000, BRIT J HAEMATOL, V110, P925, DOI 10.1046/j.1365-2141.2000.02208.x; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tan KT, 2005, ANN MED, V37, P61, DOI 10.1080/07853890410018943; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Virani SS, 2011, EUR HEART J, V32, P459, DOI 10.1093/eurheartj/ehq367; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Waxman S, 2006, CIRCULATION, V114, P2390, DOI 10.1161/CIRCULATIONAHA.105.540013; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Woollard KJ, 2008, CIRC RES, V103, P1128, DOI 10.1161/CIRCRESAHA.108.180273; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; Woollard KJ, 2010, CURR PHARM DESIGN, V16, P4113; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Woollard KJ, 2006, CIRC RES, V98, P149, DOI 10.1161/01.RES.0000199295.14073.69; Woollard KJ, 2005, CLIN EXP PHARMACOL P, V32, P233, DOI 10.1111/j.1440-1681.2005.04178.x	48	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97422	10.1371/journal.pone.0097422	http://dx.doi.org/10.1371/journal.pone.0097422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846287	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400029
J	Beltran-Beck, B; de la Fuente, J; Garrido, JM; Aranaz, A; Sevilla, I; Villar, M; Boadella, M; Galindo, RC; de la Lastra, JMP; Moreno-Cid, JA; de Mera, IGF; Alberdi, P; Santos, G; Ballesteros, C; Lyashchenko, KP; Minguijon, E; Romero, B; de Juan, L; Dominguez, L; Juste, R; Gortazar, C				Beltran-Beck, Beatriz; de la Fuente, Jose; Garrido, Joseba M.; Aranaz, Alicia; Sevilla, Iker; Villar, Margarita; Boadella, Mariana; Galindo, Ruth C.; Perez de la Lastra, Jose M.; Moreno-Cid, Juan A.; Fernandez de Mera, Isabel G.; Alberdi, Pilar; Santos, Gracia; Ballesteros, Cristina; Lyashchenko, Konstantin P.; Minguijon, Esmeralda; Romero, Beatriz; de Juan, Lucia; Dominguez, Lucas; Juste, Ramon; Gortazar, Christian			Oral Vaccination with Heat Inactivated Mycobacterium bovis Activates the Complement System to Protect against Tuberculosis	PLOS ONE			English	Article							EUROPEAN WILD BOAR; MANDIBULAR LYMPH-NODES; DENDRITIC CELLS; NONOPSONIC PHAGOCYTOSIS; OROPHARYNGEAL TONSILS; IMMUNE-RESPONSES; CYTOKINE PROFILE; RAPID DETECTION; MESSENGER-RNA; COMPONENT C3	Tuberculosis (TB) remains a pandemic affecting billions of people worldwide, thus stressing the need for new vaccines. Defining the correlates of vaccine protection is essential to achieve this goal. In this study, we used the wild boar model for mycobacterial infection and TB to characterize the protective mechanisms elicited by a new heat inactivated Mycobacterium bovis vaccine (IV). Oral vaccination with the IV resulted in significantly lower culture and lesion scores, particularly in the thorax, suggesting that the IV might provide a novel vaccine for TB control with special impact on the prevention of pulmonary disease, which is one of the limitations of current vaccines. Oral vaccination with the IV induced an adaptive antibody response and activation of the innate immune response including the complement component C3 and inflammasome. Mycobacterial DNA/RNA was not involved in inflammasome activation but increased C3 production by a still unknown mechanism. The results also suggested a protective mechanism mediated by the activation of IFN-gamma producing CD8+ T cells by MHC I antigen presenting dendritic cells (DCs) in response to vaccination with the IV, without a clear role for Th1 CD4+ T cells. These results support a role for DCs in triggering the immune response to the IV through a mechanism similar to the phagocyte response to PAMPs with a central role for C3 in protection against mycobacterial infection. Higher C3 levels may allow increased opsonophagocytosis and effective bacterial clearance, while interfering with CR3-mediated opsonic and nonopsonic phagocytosis of mycobacteria, a process that could be enhanced by specific antibodies against mycobacterial proteins induced by vaccination with the IV. These results suggest that the IV acts through novel mechanisms to protect against TB in wild boar.	[Beltran-Beck, Beatriz; de la Fuente, Jose; Villar, Margarita; Boadella, Mariana; Galindo, Ruth C.; Perez de la Lastra, Jose M.; Moreno-Cid, Juan A.; Fernandez de Mera, Isabel G.; Alberdi, Pilar; Santos, Gracia; Ballesteros, Cristina; Gortazar, Christian] SaBio IREC CSIC UCLM JCCM, Ciudad Real, Spain; [de la Fuente, Jose; Galindo, Ruth C.] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Garrido, Joseba M.; Sevilla, Iker; Minguijon, Esmeralda; Juste, Ramon] NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain; [Aranaz, Alicia] Univ Complutense Madrid, Fac Vet, Dept Sanidad Anim, Madrid, Spain; [Lyashchenko, Konstantin P.] Chembio Diagnost Syst Inc, New York, NY USA; [Romero, Beatriz; de Juan, Lucia; Dominguez, Lucas] Univ Complutense Madrid, Fac Vet, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater; Complutense University of Madrid; Complutense University of Madrid	Gortazar, C (corresponding author), SaBio IREC CSIC UCLM JCCM, Ciudad Real, Spain.	Christian.Gortazar@uclm.es	Villar-Rayo, Marga M/J-4155-2012; Alberdi, Pilar/K-7788-2014; de Juan, Lucía/I-6465-2016; Sevilla, Iker A/O-6060-2014; Gortazar, Christian/E-7918-2012; de la Lastra, José Manuel Pérez/M-4397-2019; Boadella, Mariana/I-8029-2012; Romero, Beatriz/J-5942-2015; Moreno-Cid, Juan/GVS-4289-2022; GARRIDO, JOSEBA M/L-3202-2014; Pérez de la Lastra, José/F-9184-2013; studies, IT VISAVET Account for bibliometric/C-3115-2014; Juste, Ramon/C-3570-2008; Dominguez Rodriguez, Lucas/B-9668-2014; Garcia Fernandez de Mera, Isabel/F-6623-2013	Villar-Rayo, Marga M/0000-0003-4172-9079; Alberdi, Pilar/0000-0002-6999-9735; de Juan, Lucía/0000-0002-7070-6872; Sevilla, Iker A/0000-0003-3968-3390; Gortazar, Christian/0000-0003-0012-4006; de la Lastra, José Manuel Pérez/0000-0003-4663-5565; Boadella, Mariana/0000-0001-6402-9927; Romero, Beatriz/0000-0001-5263-1806; Pérez de la Lastra, José/0000-0003-4663-5565; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Juste, Ramon/0000-0001-6037-5873; Dominguez Rodriguez, Lucas/0000-0001-8843-0010; Minguijon, Esmeralda/0000-0002-7801-7625; Garcia Fernandez de Mera, Isabel/0000-0001-5936-4018; Beltran-Beck, Beatriz/0000-0001-6689-5773; Joseba M., Garrido/0000-0002-7559-0653	Plan Nacional I+D+I from Ministerio de Economia y Competitividad (MINECO), Spain [AGL2011-30041]; FEDER; EU FP7 grant WildTBvac; EU FP7 ANTIGONE project [278976]; MEC, Spain; MINECO [BES-2009-017401]	Plan Nacional I+D+I from Ministerio de Economia y Competitividad (MINECO), Spain; FEDER(European Commission); EU FP7 grant WildTBvac; EU FP7 ANTIGONE project; MEC, Spain(Spanish Government); MINECO(Spanish Government)	This research was supported by Plan Nacional I+D+I AGL2011-30041 from Ministerio de Economia y Competitividad (MINECO), Spain and FEDER. This is also a contribution to EU FP7 grant WildTBvac and the EU FP7 ANTIGONE project number 278976. R. C. Galindo was funded by MEC, Spain. B. Beltran-Beck was supported by MINECO grant BES-2009-017401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Ballesteros C, 2009, VACCINE, V27, P6662, DOI 10.1016/j.vaccine.2009.08.095; Ballesteros C, 2009, RES VET SCI, V86, P388, DOI 10.1016/j.rvsc.2008.09.003; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751; Carroll MV, 2010, PROTEIN CELL, V1, P859, DOI 10.1007/s13238-010-0101-3; Carroll MV, 2009, MOL IMMUNOL, V46, P3367, DOI 10.1016/j.molimm.2009.07.015; de la Fuente J, 2011, MED HYPOTHESES, V76, P361, DOI 10.1016/j.mehy.2010.10.040; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Galindo RC, 2009, VET IMMUNOL IMMUNOP, V129, P119, DOI 10.1016/j.vetimm.2008.12.012; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Greenwald R, 2009, CLIN VACCINE IMMUNOL, V16, P605, DOI 10.1128/CVI.00038-09; Gupta UD, 2009, INDIAN J MED RES, V129, P11; Hewinson RG, 1996, SCAND J IMMUNOL, V43, P490, DOI 10.1046/j.1365-3083.1996.d01-78.x; Johansson E, 2003, VET IMMUNOL IMMUNOP, V91, P183, DOI 10.1016/S0165-2427(02)00310-0; Johnson RP, 2011, NATURE, V473, P456, DOI 10.1038/473456a; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Le Cabec V, 2000, INFECT IMMUN, V68, P4736, DOI 10.1128/IAI.68.8.4736-4745.2000; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyashchenko KP, 2008, VET MICROBIOL, V132, P283, DOI 10.1016/j.vetmic.2008.05.029; de la Lastra JMP, 2009, VET MICROBIOL, V134, P334, DOI 10.1016/j.vetmic.2008.08.026; Marassi CD, 2011, ACTA TROP, V118, P101, DOI 10.1016/j.actatropica.2011.02.015; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Moon MR, 1999, J SURG RES, V82, P48, DOI 10.1006/jsre.1998.5503; Moon MR, 2000, SHOCK, V13, P374; Naranjo V, 2008, ANIM GENET, V39, P316, DOI 10.1111/j.1365-2052.2008.01725.x; Naranjo V, 2006, FEMS IMMUNOL MED MIC, V46, P298, DOI 10.1111/j.1574-695X.2005.00035.x; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Naranjo V, 2007, PROTEOMICS, V7, P220, DOI 10.1002/pmic.200600527; Naranjo V, 2006, VET MICROBIOL, V116, P224, DOI 10.1016/j.vetmic.2006.03.013; OFEK I, 1995, ANNU REV MICROBIOL, V49, P239, DOI 10.1146/annurev.mi.49.100195.001323; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; PATEL BKR, 1991, J MICROBIOL METH, V13, P99, DOI 10.1016/0167-7012(91)90010-N; RADFORD AJ, 1990, J GEN MICROBIOL, V136, P265, DOI 10.1099/00221287-136-2-265; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STELANDRE M, 1992, GENE, V121, P79, DOI 10.1016/0378-1119(92)90164-K; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; van Kooten C, 2008, MOL IMMUNOL, V45, P4064, DOI 10.1016/j.molimm.2008.07.015; Velasco-Velazquez MA, 2003, MICROB PATHOGENESIS, V35, P125, DOI 10.1016/S0882-4010(03)00099-8; Villeneuve C, 2005, J LIPID RES, V46, P475, DOI 10.1194/jlr.M400308-JLR200; Wedlock DN, 2005, NEW ZEAL VET J, V53, P301, DOI 10.1080/00480169.2005.36564; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; West NP, 2011, VACCINE, V29, P7759, DOI 10.1016/j.vaccine.2011.07.109; Xue T, 2004, INFECT IMMUN, V72, P6324, DOI 10.1128/IAI.72.11.6324-6329.2004; Zar HJ, 2013, THORAX, V68, P283, DOI 10.1136/thoraxjnl-2012-203127	59	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98048	10.1371/journal.pone.0098048	http://dx.doi.org/10.1371/journal.pone.0098048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842853	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000340948600103
J	Jolly, MK; Rizvi, MS; Kumar, A; Sinha, P				Jolly, Mohit Kumar; Rizvi, Mohd Suhail; Kumar, Amit; Sinha, Pradip			Mathematical Modeling of Sub-Cellular Asymmetry of Fat-Dachsous Heterodimer for Generation of Planar Cell Polarity	PLOS ONE			English	Article							DROSOPHILA; GROWTH; SPECIFICATION; MORPHOGENESIS; EXPRESSION; AFFINITY; PATHWAY; KINASE; ROLES	Planar Cell Polarity (PCP) is an evolutionarily conserved characteristic of animal tissues marked by coordinated polarization of cells or structures in the plane of a tissue. In insect wing epithelium, for instance, PCP is characterized by en masse orientation of hairs orthogonal to its apical-basal axis and pointing along the proximal-distal axis of the organ. Directional cue for PCP has been proposed to be generated by complex sets of interactions amongst three proteins -Fat (Ft), Dachsous (Ds) and Four-jointed (Fj). Ft and Ds are two atypical cadherins, which are phosphorylated by Fj, a Golgi kinase. Ft and Ds from adjacent cells bind heterophilically via their tandem cadherin repeats, and their binding affinities are regulated by Fj. Further, in the wing epithelium, sub-cellular levels of Ft-Ds heterodimers are seen to be elevated at the distal edges of individual cells, prefiguring their PCP. Mechanisms generating this sub-cellular asymmetry of Ft-Ds heterodimer in proximal and distal edges of cells, however, have not been resolved yet. Using a mathematical modeling approach, here we provide a framework for generation of this sub-cellular asymmetry of Ft-Ds heterodimer. First, we explain how the known interactions within Ft-Ds-Fj system translate into sub-cellular asymmetry of Ft-Ds heterodimer. Second, we show that this asymmetric localization of Ft-Ds heterodimer is lost when tissue-level gradient of Fj is flattened, or when phosphorylation of Ft by Fj is abolished, but not when tissue-level gradient of Ds is flattened or when phosphorylation of Ds is abrogated. Finally, we show that distal enrichment of Ds also amplifies Ft-Ds asymmetry. These observations reveal that gradient of Fj expression, phosphorylation of Ft by Fj and sub-cellular distal accumulation of Ds are three critical elements required for generating sub-cellular asymmetry of Ft-Ds heterodimer. Our model integrates the known experimental data and presents testable predictions for future studies.	[Jolly, Mohit Kumar; Rizvi, Mohd Suhail; Kumar, Amit; Sinha, Pradip] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Jolly, MK (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.	mj21@rice.edu; pradips@iitk.ac.in	Jolly, Mohit Kumar/A-1826-2014; Rizvi, Mohd Suhail/AAQ-7692-2020; kumar, Amit/GLS-4080-2022	Jolly, Mohit Kumar/0000-0002-6631-2109; kumar, Amit/0000-0001-8983-6792; Rizvi, Mohd Suhail/0000-0002-4130-4671	project entitled 'Epithelial Morphogenesis and wound healing during animal development: Role of Fat cadherin in fruit fly Drosophila' - Department of Science and Technology (DST), New Delhi [SR/SO/AS-24/2008]	project entitled 'Epithelial Morphogenesis and wound healing during animal development: Role of Fat cadherin in fruit fly Drosophila' - Department of Science and Technology (DST), New Delhi	This work was supported by a project entitled 'Epithelial Morphogenesis and wound healing during animal development: Role of Fat cadherin in fruit fly Drosophila' sponsored by the Department of Science and Technology (DST), New Delhi to Pradip Sinha No. SR/SO/AS-24/2008. Date: February 27, 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 1998, DEVELOPMENT, V125, P959; Ambegaonkar AA, 2012, CURR BIOL, V22, P1302, DOI 10.1016/j.cub.2012.05.049; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Axelrod JD, 2011, WIRES SYST BIOL MED, V3, P588, DOI 10.1002/wsbm.138; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Brittle A, 2012, CURR BIOL, V22, P907, DOI 10.1016/j.cub.2012.03.053; Brittle AL, 2010, CURR BIOL, V20, P803, DOI 10.1016/j.cub.2010.03.056; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000628; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060064; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Hazelwood LD, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-20; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Mani M, 2013, P NATL ACAD SCI USA, V110, P20420, DOI 10.1073/pnas.1307459110; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2012, DEVELOPMENT, V139, P1498, DOI 10.1242/dev.070367; Schamberg S, 2010, B MATH BIOL, V72, P645, DOI 10.1007/s11538-009-9464-0; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Simon MA, 2010, CURR BIOL, V20, P811, DOI 10.1016/j.cub.2010.04.016; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Thomas C, 2012, DEV DYNAM, V241, P27, DOI 10.1002/dvdy.22736; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Zhu H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02528; Zhu H, 2009, J THEOR BIOL, V256, P315, DOI 10.1016/j.jtbi.2008.08.029	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97641	10.1371/journal.pone.0097641	http://dx.doi.org/10.1371/journal.pone.0097641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841507	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600053
J	Linas, BP; Barter, DM; Leff, JA; Assoumou, SA; Salomon, JA; Weinstein, MC; Kim, AY; Schackman, BR				Linas, Benjamin P.; Barter, Devra M.; Leff, Jared A.; Assoumou, Sabrina A.; Salomon, Joshua A.; Weinstein, Milton C.; Kim, Arthur Y.; Schackman, Bruce R.			The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUSTAINED VIROLOGICAL RESPONSE; TELAPREVIR COMBINATION TREATMENT; HIGH-RISK POPULATIONS; INJECTION-DRUG USERS; VIRUS-INFECTION; COST-EFFECTIVENESS; UNITED-STATES; NATURAL-HISTORY; PEGINTERFERON ALPHA-2B	Background: As highly effective hepatitis C virus (HCV) therapies emerge, data are needed to inform the development of interventions to improve HCV treatment rates. We used simulation modeling to estimate the impact of loss to follow-up on HCV treatment outcomes and to identify intervention strategies likely to provide good value for the resources invested in them. Methods: We used a Monte Carlo state-transition model to simulate a hypothetical cohort of chronically HCV-infected individuals recently screened positive for serum HCV antibody. We simulated four hypothetical intervention strategies (linkage to care; treatment initiation; integrated case management; peer navigator) to improve HCV treatment rates, varying efficacies and costs, and identified strategies that would most likely result in the best value for the resources required for implementation. Main measures: Sustained virologic responses (SVRs), life expectancy, quality-adjusted life expectancy (QALE), costs from health system and program implementation perspectives, and incremental cost-effectiveness ratios (ICERs). Results: We estimate that imperfect follow-up reduces the real-world effectiveness of HCV therapies by approximately 75%. In the base case, a modestly effective hypothetical peer navigator program maximized the number of SVRs and QALE, with an ICER compared to the next best intervention of $48,700/quality-adjusted life year. Hypothetical interventions that simultaneously addressed multiple points along the cascade provided better outcomes and more value for money than less costly interventions targeting single steps. The 5-year program cost of the hypothetical peer navigator intervention was $14.5 million per 10,000 newly diagnosed individuals. Conclusions: We estimate that imperfect follow-up during the HCV cascade of care greatly reduces the real-world effectiveness of HCV therapy. Our mathematical model shows that modestly effective interventions to improve follow-up would likely be cost-effective. Priority should be given to developing and evaluating interventions addressing multiple points along the cascade rather than options focusing solely on single points.	[Linas, Benjamin P.; Barter, Devra M.; Assoumou, Sabrina A.] Boston Med Ctr, Infect Dis Sect, HIV Epidemiol & Outcomes Res Unit, Boston, MA 02118 USA; [Linas, Benjamin P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Leff, Jared A.; Schackman, Bruce R.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Kim, Arthur Y.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Boston Medical Center; Boston University; Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Linas, BP (corresponding author), Boston Med Ctr, Infect Dis Sect, HIV Epidemiol & Outcomes Res Unit, Boston, MA 02118 USA.	Benjamin.Linas@BMC.org	Leff, Jared A./B-7631-2014; Trajman, Anete/C-7679-2016; Salomon, Joshua/S-1929-2019; Salomon, Joshua A/D-3898-2009; Schackman, Bruce R./J-8208-2019; Assoumou, Sabrina/AAF-2087-2021	Leff, Jared A./0000-0001-6995-6009; Trajman, Anete/0000-0002-4000-4984; Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Schackman, Bruce R./0000-0002-1132-2932; Assoumou, Sabrina/0000-0002-5169-620X	National Institutes on Drug Abuse [R01DA031059, R01DA027379]; National Institute of Allergy and Infectious Disease [K01AI73193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI073193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027379, R01DA031059] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes on Drug Abuse (R01DA031059, R01DA027379) and National Institute of Allergy and Infectious Disease (K01AI73193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2009, TOT HLTH SERV MEAN M; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Barnett PG, 2001, ADDICTION, V96, P1267, DOI 10.1046/j.1360-0443.2001.96912676.x; Bjornsson E, 2009, SCAND J GASTROENTERO, V44, P878, DOI 10.1080/00365520902898135; Blatt LM, 2000, J VIRAL HEPATITIS, V7, P196; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Centers for Disease Control and Prevention, 2005, NHANES 2005 2010 COM; Chan K, 2013, CLIN GASTROENTEROL H, V11, P1503, DOI 10.1016/j.cgh.2013.05.014; Cheung RC, 2006, DIGEST DIS SCI, V51, P976, DOI 10.1007/s10620-006-9100-x; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Daltron-Oliveira R, 2013, ANN HEPATOL, V12, P399, DOI 10.1016/S1665-2681(19)31002-6; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Dias PT, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-208; Drobnik A, 2011, AM J PUBLIC HEALTH, V101, P2151, DOI 10.2105/AJPH.2011.300251; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Fishbein DA, 2004, JAIDS-J ACQ IMM DEF, V37, P1367, DOI 10.1097/01.qai.0000131932.21612.49; Food and Drug Administration, 2012, TEL PACK INS; Foster GR, 2012, EFFICACY SAFETY TELA; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Gao X, 2012, EXPERT REV PHARM OUT, V12, P335, DOI [10.1586/ERP.12.10, 10.1586/erp.12.10]; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Giron-Gonzalez JA, 2007, ANTIVIR THER, V12, P899; Gold MR, 1996, COST EFFECTIVENESS H; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Groom H, 2008, J CLIN GASTROENTEROL, V42, P97, DOI 10.1097/MCG.0b013e31802dc56f; Hilsden RJ, 2013, CLIN INFECT DIS, V57, pS90, DOI 10.1093/cid/cit327; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kamal SM, 2008, AM J GASTROENTEROL, V103, P1283, DOI 10.1111/j.1572-0241.2008.01825.x; Kanwal F, 2014, CLIN GASTROENTEROL H, V12; Lau JYN, 1996, ANN INTERN MED, V124, P868, DOI 10.7326/0003-4819-124-10-199605150-00002; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Linas BP, 2011, J VIRAL HEPATITIS, V18, P506, DOI 10.1111/j.1365-2893.2010.01325.x; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Linas BP, 2013, AIDS IN PRESS; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mark KE, 2007, PUBLIC HEALTH REP, V122, P37, DOI 10.1177/003335490712200105; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Micromedex 2.0, 2011, MICROMEDEX 2 0 DRUG; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Morrill JA, 2005, J GEN INTERN MED, V20, P754, DOI 10.1111/j.1525-1497.2005.0161.x; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Pineda JA, 2009, CLIN INFECT DIS, V49, P1274, DOI 10.1086/605676; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Schackman BR, 2008, MED DECIS MAKING, V28, P233, DOI 10.1177/0272989X07311753; Schackman BR, 2007, J URBAN HEALTH, V84, P455, DOI 10.1007/s11524-007-9180-8; Schackman BR, 2010, JAIDS-J ACQ IMM DEF, V55, pS27, DOI 10.1097/QAI.0b013e3181f9c1da; Scott JD, 2009, AIDS PATIENT CARE ST, V23, P925, DOI 10.1089/apc.2009.0099; Serfaty MA, 1997, DRUG ALCOHOL REV, V16, P339, DOI 10.1080/09595239700186721; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Singer ME, 2001, AM J MED, V111, P614, DOI 10.1016/S0002-9343(01)00951-2; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; STASON WB, 1977, NEW ENGL J MED, V296, P732, DOI 10.1056/NEJM197703312961307; Stein K, 2002, Health Technol Assess, V6, P1; Stopka TJ, 2007, PUBLIC HEALTH REP, V122, P68, DOI 10.1177/00333549071220S213; Sutton AJ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-93; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Swan T, 2012, HEPATITIS C DRUG DEV; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; United States Department of Health and Human Services Center for Medicare Services, 2011, PHYS FEE SCHED; United States Department of Health and Human Services Center for Medicare Services, 2011, CLIN DIAGN LAB FEE S; US Dept of Labor Bureau of Labor Statistics, 2011, CONS PRIC IND ALL UR; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vera-Llonch M, 2013, ALIMENT PHARM THER, V38, P124, DOI 10.1111/apt.12354; Vickerman P, 2009, SEX TRANSM INFECT, V85, P23, DOI 10.1136/sti.2008.034660; Vlahov D, 2004, ADDICTION, V99, P946, DOI 10.1111/j.1360-0443.2004.00780.x; Walensky RP, 2005, MED DECIS MAKING, V25, P321, DOI 10.1177/0272989X05276955; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yawn BP, 2002, J FAM PRACTICE, V51, P135; Zeuzem S, 2013, 64 ANN M AM ASS STUD	88	99	100	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97317	10.1371/journal.pone.0097317	http://dx.doi.org/10.1371/journal.pone.0097317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842841	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600023
J	Ma, J; Chadban, SJ; Zhao, CY; Chen, XC; Kwan, T; Panchapakesan, U; Pollock, CA; Wu, HL				Ma, Jin; Chadban, Steven J.; Zhao, Cathy Y.; Chen, Xiaochen; Kwan, Tony; Panchapakesan, Usha; Pollock, Carol A.; Wu, Huiling			TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; ISCHEMIA/REPERFUSION INJURY; PROINFLAMMATORY STATE; KIDNEY-DISEASE; INFLAMMATION; MACROPHAGES; MICE; GLOMERULOSCLEROSIS; CONTRIBUTES; EXPRESSION	Toll like receptor (TLR) 4 has been reported to promote inflammation in diabetic nephropathy. However the role of TLR4 in the complicated pathophysiology of diabetic nephropathy is not understood. In this study, we report elevated expression of TLR4, its endogenous ligands and downstream cytokines, chemokines and fibrogenic genes in diabetic nephropathy in WT mice with streptozotocin (STZ) diabetes. Subsequently, we demonstrated that TLR4(-/-) mice were protected against the development of diabetic nephropathy, exhibiting less albuminuria, inflammation, glomerular hypertrophy and hypercellularity, podocyte and tubular injury as compared to diabetic wild-type controls. Marked reductions in interstitial collagen deposition, myofibroblast activation (alpha-SMA) and expression of fibrogenic genes (TGF-beta and fibronectin) were also evident in TLR4 deficient mice. Consistent with our in vivo results, high glucose directly promoted TLR4 activation in podocytes and tubular epithelial cells in vitro, resulting in NF-kappa B activation and consequent inflammatory and fibrogenic responses. Our data indicate that TLR4 activation may promote inflammation, podocyte and tubular epithelial cell injury and interstitial fibrosis, suggesting TLR4 is a potential therapeutic target for diabetic nephropathy.	[Chadban, Steven J.; Wu, Huiling] Royal Prince Alfred Hosp, Renal Med & Transplant Res Grp, Sydney, NSW, Australia; [Panchapakesan, Usha; Pollock, Carol A.] Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Grp, Sydney, NSW, Australia; [Ma, Jin; Chadban, Steven J.; Zhao, Cathy Y.; Chen, Xiaochen; Kwan, Tony; Panchapakesan, Usha; Pollock, Carol A.; Wu, Huiling] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney	Wu, HL (corresponding author), Royal Prince Alfred Hosp, Renal Med & Transplant Res Grp, Sydney, NSW, Australia.	huiling.wu@sydney.edu.au			National Health and Medical Research Council of Australia [636273]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (Project Grant #636273) (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Banas MC, 2008, J AM SOC NEPHROL, V19, P704, DOI 10.1681/ASN.2007040395; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Brown HJ, 2006, J AM SOC NEPHROL, V17, P1931, DOI 10.1681/ASN.2005111167; Campbell MT, 2011, J SURG RES, V168, pE61, DOI 10.1016/j.jss.2009.09.053; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lim AKH, 2009, DIABETOLOGIA, V52, P1669, DOI 10.1007/s00125-009-1399-3; Lin M, 2013, KIDNEY INT; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Mauer M, 2002, DIABETES, V51, P1572, DOI 10.2337/diabetes.51.5.1572; MCWHINNIE DL, 1986, TRANSPLANTATION, V42, P352, DOI 10.1097/00007890-198610000-00004; Melhem MF, 2002, J AM SOC NEPHROL, V13, P108, DOI 10.1681/ASN.V131108; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mora Carmen, 2006, Curr Diab Rep, V6, P463, DOI 10.1007/s11892-006-0080-1; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Tuttle KR, 2005, J AM SOC NEPHROL, V16, P1537, DOI 10.1681/ASN.2005040393; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Venkatareddy M, 2013, J AM SOC NEPHROL; Vernon MA, 2010, SEMIN NEPHROL, V30, P302, DOI 10.1016/j.semnephrol.2010.03.004; WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343, DOI 10.1152/jappl.1962.17.2.343; White SL, 2005, ADV CHRONIC KIDNEY D, V12, P5, DOI 10.1053/j.ackd.2004.10.009; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	42	100	108	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97985	10.1371/journal.pone.0097985	http://dx.doi.org/10.1371/journal.pone.0097985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842252	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600097
J	MacLeod, CA; Donaldson, DI				MacLeod, Catherine A.; Donaldson, David I.			PRKCA Polymorphism Changes the Neural Basis of Episodic Remembering in Healthy Individuals	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; RECOGNITION MEMORY; HIPPOCAMPAL ACTIVITY; PERFORMANCE; METAANALYSIS; IMPAIRMENT; RETRIEVAL; INTELLIGENCE; BDNF	Everyday functioning relies on episodic memory, the conscious retrieval of past experiences, but this crucial cognitive ability declines severely with aging and disease. Vulnerability to memory decline varies across individuals however, producing differences in the time course and severity of memory problems that complicate attempts at diagnosis and treatment. Here we identify a key source of variability, by examining gene dependent changes in the neural basis of episodic remembering in healthy adults, targeting seven polymorphisms previously linked to memory. Scalp recorded Event-Related Potentials (ERPs) were measured while participants remembered words, using an item recognition task that requires discrimination between studied and unstudied stimuli. Significant differences were found as a consequence of a Single Nucleotide Polymorphism (SNP) in just one of the tested genes, PRKCA (rs8074995). Participants with the common G/G variant exhibited left parietal old/new effects, which are typically seen in word recognition studies, reflecting recollection-based remembering. During the same stage of memory retrieval participants carrying a rarer A variant exhibited an atypical pattern of brain activity, a topographically dissociable frontally-distributed old/new effect, even though behavioural performance did not differ between groups. Results replicated in a second independent sample of participants. These findings demonstrate that the PRKCA genotype is important in determining how episodic memories are retrieved, opening a new route towards understanding individual differences in memory.	[MacLeod, Catherine A.] Bangor Univ, Inst Med & Social Care Res, Bangor, Gwynedd, Wales; [Donaldson, David I.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland	Bangor University; University of Stirling	MacLeod, CA (corresponding author), Bangor Univ, Inst Med & Social Care Res, Bangor, Gwynedd, Wales.	c.a.macleod@bangor.ac.uk	Donaldson, David I/A-5249-2009	Donaldson, David I/0000-0002-8036-3455; MacLeod, Catherine/0000-0002-9314-7380	Economic and Social Research Council [PTA-030-2006-00337]; University of Stirling Department of Psychology Resources Committee	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Stirling Department of Psychology Resources Committee	This work was primarily funded by the Economic and Social Research Council (http://www.esrc.ac.uk) through award reference PTA-030-2006-00337. Funding for the DNA analysis was provided by the University of Stirling Department of Psychology Resources Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 1999, AM J PSYCHIAT, V156, P1358; [Anonymous], 1983, CANADIAN PSYCHOL; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; de Frias CM, 2004, BEHAV GENET, V34, P533, DOI 10.1023/B:BEGE.0000038491.06972.8c; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; de Quervain DJF, 2012, P NATL ACAD SCI USA, V109, P8746, DOI 10.1073/pnas.1200857109; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Galli G, 2011, J COGNITIVE NEUROSCI, V23, P1405, DOI 10.1162/jocn.2010.21442; Gardiner JM, 1998, CONSCIOUS COGN, V7, P1, DOI 10.1006/ccog.1997.0321; Goldberg TE, 2008, BIOL PSYCHOL, V77, P20, DOI 10.1016/j.biopsycho.2007.08.009; Guillem F, 2005, BRAIN COGNITION, V57, P84, DOI 10.1016/j.bandc.2004.08.026; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Jablensky A, 2011, GENES BRAIN BEHAV, V10, P410, DOI 10.1111/j.1601-183X.2011.00679.x; Kucera H., 1967, COMPUTATIONAL ANAL P; MacKenzie G, 2009, NEUROPSYCHOLOGIA, V47, P2756, DOI 10.1016/j.neuropsychologia.2009.05.025; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sanchez-Perez AM, 2005, NEUROCHEM INT, V47, P84, DOI 10.1016/j.neuint.2005.04.011; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Trachtenberg AJ, 2012, NEUROBIOL AGING, V33, P323, DOI 10.1016/j.neurobiolaging.2010.03.009; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; Zimmerman M., 2002, PSYCHIAT DIAGNOSTIC	40	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98018	10.1371/journal.pone.0098018	http://dx.doi.org/10.1371/journal.pone.0098018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842701	Green Published, gold			2022-12-27	WOS:000340948600100
J	Mao, XG; Dong, J; Hua, PY; He, GM; Zhang, SY; Rossiter, SJ				Mao, Xiuguang; Dong, Ji; Hua, Panyu; He, Guimei; Zhang, Shuyi; Rossiter, Stephen J.			Heteroplasmy and Ancient Translocation of Mitochondrial DNA to the Nucleus in the Chinese Horseshoe Bat (Rhinolophus sinicus) Complex	PLOS ONE			English	Article							D-LOOP REGION; SEQUENCE VARIATION; EVOLUTION; RECOMBINATION; MTDNA; GENOMES; ORIGIN; NUMT; HIPPOSIDEROS; PSEUDOGENES	The utility and reliability of mitochondrial DNA sequences in phylogenetic and phylogeographic studies may be compromised by widespread and undetected nuclear mitochondrial copies (numts) as well as heteroplasmy within individuals. Both numts and heteroplasmy are likely to be common across diverse taxa yet few studies have characterised their frequencies and variation at the intra-specific level. Here we report the presence of both numts and heteroplasmy in the mitochondrial control region of the Chinese horseshoe bat Rhinolophus sinicus. In total we generated 123 sequences from 18 bats, which contained two different numt clades (i.e. Numt-1 and Numt-2) and one mtDNA clade. The sequence divergence between Numt-1 and Numt-2 was 16.8% and each numt type was found in all four R. sinicus taxa, suggesting either two ancient translocations of mitochondrial DNA into the nucleus from the same source taxon, or a single translocation from different source taxa that occurred before the split of R. sinicus into different lineages. Within the mtDNA clade, phylogenetic relationships among the four taxa of R. sinicus were similar to those seen in previous results. Based on PCR comparisons, heteroplasmy was inferred between almost all individuals of R. sinicus with respect to sequence variation. Consistent with introgression of mtDNA between Central sinicus and septentrionalis, individuals from these two taxa exhibited similar signatures of repeated sequences in the control region. Our study highlights the importance of testing for the presence of numts and heteroplasmy when applying mtDNA markers to phylogenetic studies.	[Mao, Xiuguang; Dong, Ji; Hua, Panyu; He, Guimei; Zhang, Shuyi] E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Mao, Xiuguang; Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University of London; Queen Mary University London	Rossiter, SJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	s.j.rossiter@qmul.ac.uk		Rossiter, Stephen/0000-0002-3881-4515; Dong, Ji/0000-0002-8953-5284; He, Guimei/0000-0002-4889-0933	Key Construction Program of the National "985'' Project; 211 Project; Marie Curie International Incoming Fellowship; Royal Society Research Fellowship (UK)	Key Construction Program of the National "985'' Project; 211 Project(Anhui UniversityMinistry of Education, China); Marie Curie International Incoming Fellowship(European Commission); Royal Society Research Fellowship (UK)(Royal Society of London)	This work was funded by a grant awarded to S. Zhang under the Key Construction Program of the National "985'' Project and 211 Project. X. Mao was supported by a Marie Curie International Incoming Fellowship and SJR by a Royal Society Research Fellowship (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bertheau C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/j.1755-0998.2011.03050.x; BIJUDUVAL C, 1991, J MOL EVOL, V33, P92, DOI 10.1007/BF02100200; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Csorba G., 2003, HORSESHOE BATS WORLD; Dool SE, 2013, MOL ECOL, V22, P4055, DOI 10.1111/mec.12373; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017; Hay JM, 2004, HEREDITY, V93, P468, DOI 10.1038/sj.hdy.6800525; Hazkani-Covo E, 2007, MOL BIOL EVOL, V24, P13, DOI 10.1093/molbev/msl149; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066324; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hoarau G, 2002, MOL BIOL EVOL, V19, P2261, DOI 10.1093/oxfordjournals.molbev.a004049; HOELZEL AR, 1994, J MOL EVOL, V39, P191; HOELZEL AR, 1993, J MOL EVOL, V37, P190, DOI 10.1007/BF02407355; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Kmiec B, 2006, CURR GENET, V50, P149, DOI 10.1007/s00294-006-0082-1; Larizza A, 2002, J MOL EVOL, V54, P145, DOI 10.1007/s00239-001-0063-4; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Ling L L, 1991, PCR Methods Appl, V1, P63; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Mao XG, 2013, BIOL J LINN SOC, V110, P346, DOI 10.1111/bij.12138; Mao XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056786; Miraldo A, 2012, MOL ECOL, V21, P1005, DOI 10.1111/j.1365-294X.2011.05422.x; Mjelle KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-10; Morgan JAT, 2013, MITOCHONDRION, V13, P852, DOI 10.1016/j.mito.2013.06.002; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Nei M., 1987, MOL EVOLUTIONARY GEN; Nilsson MA, 2009, MITOCHONDR DNA, V20, P126, DOI 10.3109/19401730903180112; Nunes MDS, 2013, MOL ECOL, V22, P2106, DOI 10.1111/mec.12256; Petri B, 1996, BIOL CHEM, V377, P661, DOI 10.1515/bchm3.1996.377.10.661; Piganeau G, 2004, MOL BIOL EVOL, V21, P2319, DOI 10.1093/molbev/msh244; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puechmaille SJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1582; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Sorenson MD, 1996, P NATL ACAD SCI USA, V93, P15239, DOI 10.1073/pnas.93.26.15239; Spitzenberger F, 2006, ZOOL SCR, V35, P187, DOI 10.1111/j.1463-6409.2006.00224.x; Sun KP, 2013, MITOCHONDR DNA, V24, P451, DOI 10.3109/19401736.2013.766176; Sun KP, 2009, MAMM BIOL, V74, P130, DOI 10.1016/j.mambio.2008.09.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thalmann O, 2005, MOL ECOL, V14, P179, DOI 10.1111/j.1365-294X.2004.02382.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Triant DA, 2007, J MAMMAL, V88, P908, DOI 10.1644/06-MAMM-A-204R1.1; Turmelle AS, 2011, MOL ECOL, V20, P357, DOI 10.1111/j.1365-294X.2010.04947.x; Ujvari B, 2007, BIOL LETTERS, V3, P189, DOI 10.1098/rsbl.2006.0587; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Wilkinson GS, 1997, GENETICS, V146, P1035; WILKINSON GS, 1991, GENETICS, V128, P607; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	58	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98035	10.1371/journal.pone.0098035	http://dx.doi.org/10.1371/journal.pone.0098035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842827	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600102
J	Oh, KH; Kim, DW; Jung, SM; Cho, SH				Oh, Kyung-Hwan; Kim, Dong Wook; Jung, Su-Mi; Cho, Seung-Hak			Molecular Characterization of Enterotoxigenic Escherichia coli Strains Isolated from Diarrheal Patients in Korea during 2003-2011	PLOS ONE			English	Article							COLONIZATION FACTORS; DEVELOPING-COUNTRIES; PHENOTYPIC PROFILES; CHILDREN; INFECTIONS; DISEASE; EGYPT; ETEC	Enterotoxigenic Escherichia coli (ETEC) is one of the major causes of infectious diarrhea in developing countries. In order to characterize the molecular features of human ETEC isolates from Korea, we investigated the profiles of enterotoxin and colonization factor (CF) genes by polymerase chain reaction (PCR) and performed multilocus sequence typing (MLST) with a total of 291 ETEC strains. The specimens comprised 258 domestic strains isolated from patients who had diarrhea and were from widely separated geographic regions in Korea and 33 inflow strains isolated from travelers visiting other Asian countries. Heat-stable toxin (STh)-possessing ETEC strains were more frequent than heat-labile toxin (LT)-possessing ETEC strains in the domestic isolates, while the detection rates of both enterotoxin genes were similar in the inflow isolates. The profile of CF genes of domestic isolates was similar to that of inflow isolates and the major CF types of the strains were CS3-CS21-CS1/PCF071 and CS2-CS3-CS21. Most of these 2 CF types were detected in ETEC strains that possess both lt and sth genes. The major MLSTST types of domestic isolates were ST171 and ST955. Moreover, the 2 major CF types were usually found concomitantly with the 2 major MLST STs, ST171 and ST955. In conclusion, our genotyping results may provide useful information for guiding the development of geographically specific vaccines against human ETEC isolates.	[Oh, Kyung-Hwan; Jung, Su-Mi; Cho, Seung-Hak] Korea Natl Inst Hlth, Ctr Infect Dis, Div Enter Bacterial Infect, Osong Eup, Chungcheongbuk, South Korea; [Kim, Dong Wook] Hanyang Univ, Coll Pharm, Dept Pharm, Ansan, Kyeonggi Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Hanyang University	Cho, SH (corresponding author), Korea Natl Inst Hlth, Ctr Infect Dis, Div Enter Bacterial Infect, Osong Eup, Chungcheongbuk, South Korea.	skcho38@korea.kr	Kim, Dong Wook/H-8253-2015	Kim, Dong Wook/0000-0001-5351-7597	Korean National Institute of Health, Seoul, Republic of Korea [KNIH4800-4845-300]	Korean National Institute of Health, Seoul, Republic of Korea	This study was supported by a grant from the Korean National Institute of Health, Seoul, Republic of Korea (KNIH4800-4845-300 to S.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gallas N, 2007, CURR MICROBIOL, V55, P47, DOI 10.1007/s00284-006-0572-x; Binsztein N, 1999, Rev Latinoam Microbiol, V41, P121; Clemens J, 2004, J INFECT DIS, V189, P2299, DOI 10.1086/386288; Cohen D, 2010, FOODBORNE PATHOG DIS, V7, P1159, DOI 10.1089/fpd.2009.0510; Estrada-Garcia T, 2005, EMERG INFECT DIS, V11, P1306, DOI 10.3201/eid1108.050192; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lasaro MA, 2008, J BACTERIOL, V190, P2400, DOI 10.1128/JB.00988-07; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Nada RA, 2010, DIAGN MICR INFEC DIS, V67, P134, DOI 10.1016/j.diagmicrobio.2010.01.011; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nicklasson M, 2010, EMERG INFECT DIS, V16, P143, DOI 10.3201/eid1601.090979; Nirdnoy W, 1997, J CLIN MICROBIOL, V35, P527, DOI 10.1128/JCM.35.2.527-530.1997; Ochoa TJ, 2009, CLIN INFECT DIS, V49, P1694, DOI 10.1086/648069; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; Rivera FP, 2010, J CLIN MICROBIOL, V48, P3198, DOI 10.1128/JCM.00644-10; Shaheen HI, 2009, J CLIN MICROBIOL, V47, P189, DOI 10.1128/JCM.01282-08; Shaheen HI, 2004, J CLIN MICROBIOL, V42, P5588, DOI 10.1128/JCM.42.12.5588-5595.2004; Sizemore Donata R, 2004, Expert Rev Vaccines, V3, P585, DOI 10.1586/14760584.3.5.585; Sommerfelt H, 1996, J INFECT DIS, V174, P768, DOI 10.1093/infdis/174.4.768; Svennerholm AM, 2008, EXPERT REV VACCINES, V7, P795, DOI 10.1586/14760584.7.6.795; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Valvatne H, 2002, APMIS, V110, P665, DOI 10.1034/j.1600-0463.2002.1100911.x; Viboud GI, 1999, J CLIN MICROBIOL, V37, P2829, DOI 10.1128/JCM.37.9.2829-2833.1999; Walker RI, 2007, VACCINE, V25, P2545, DOI 10.1016/j.vaccine.2006.12.028; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97	30	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96896	10.1371/journal.pone.0096896	http://dx.doi.org/10.1371/journal.pone.0096896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841334	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600012
J	Xu, L; Wang, H; La, Q; Lu, F; Sun, K; Fang, Y; Yang, M; Zhong, Y; Wu, QH; Chen, JJ; Birks, HJB; Zhang, WJ				Xu, Lu; Wang, Hao; La, Qiong; Lu, Fan; Sun, Kun; Fang, Yang; Yang, Mei; Zhong, Yang; Wu, Qianhong; Chen, Jiakuan; Birks, H. John B.; Zhang, Wenju			Microrefugia and Shifts of Hippophae tibetana (Elaeagnaceae) on the North Side of Mt. Qomolangma (Mt. Everest) during the Last 25000 Years	PLOS ONE			English	Article							RECENT CLIMATE-CHANGE; ICE CORE; POPULATION-STRUCTURE; GLACIAL REFUGIA; MIGRATION CAPACITY; GENETIC DIVERSITY; PLANT DIVERSITY; MOUNT EVEREST; PLATEAU; MICROSATELLITES	Microrefugia at high altitudes or high latitudes are thought to play an important role in the post-glacial colonization of species. However, how populations in such microrefugia have responded to climate changes in alternating cold glacial and warm interglacial stages remain unclear. Here we present evidence to indicate the Rongbuk Valley of the Mt. Qomolangma (Mt. Everest) area, the highest region on earth, had microrefugia for Hippophae tibetana and discuss how this low shrub was adapted to the extreme climate fluctuations of the last 25,000 years by shifts. By integrating geological, glaciological, meteorological, and genetic information, we found that the Rongbuk Valley was not only a glacial microrefugium but also an interglacial microrefugium for H. tibetana: the former was located on the riverbank below 4800 m above sea level (asl) or lower area and the latter at similar to 5000 m asl. Our results show that after the Last Glacial Maximum (LGM), H. tibetana in the valley has undergone upward and downward migrations around similar to 5000 m driven by climate fluctuations and the population in the glacial microrefugium has suffered extinction or extreme contraction. Moreover, with the rise of temperature in the last four decades, the upper limit of H. tibetana has shifted at least 30 m upward. Combining population history and recent range shift of this species is important in predicting the fate of this endemic species to future climate changes.	[Xu, Lu; Wang, Hao; La, Qiong; Lu, Fan; Fang, Yang; Yang, Mei; Zhong, Yang; Wu, Qianhong; Chen, Jiakuan; Zhang, Wenju] Fudan Univ, Sch Life Sci, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Xu, Lu; Sun, Kun] Northwest Normal Univ, Coll Life Sci, Lanzhou, Peoples R China; [La, Qiong; Zhong, Yang] Tibet Univ, Dept Biol, Lhasa, Peoples R China; [Birks, H. John B.] Univ Bergen, Dept Biol, Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London, England; [Birks, H. John B.] Univ Oxford, Sch Geog & Environm, Oxford, England	Fudan University; Northwest Normal University - China; Tibet University; University of Bergen; University of London; University College London; University of Oxford	Zhang, WJ (corresponding author), Fudan Univ, Sch Life Sci, Inst Biodivers Sci, Shanghai 200433, Peoples R China.	wjzhang@fudan.edu.cn	Birks, John B/C-3103-2008	Birks, John B/0000-0002-5891-9859	National Basic Research Program of China [2014CB954103]; National Natural Science Foundation of China [41061007, 91131901]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Basic Research Program of China (Grant No. 2014CB954103; http://www.973.gov.cn/AreaMana.aspx) and the National Natural Science Foundation of China (Grant No. 41061007 and Grant No. 91131901; http://isisn.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; BURBANK DW, 1991, QUATERNARY RES, V36, P1, DOI 10.1016/0033-5894(91)90013-U; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Chen XL, 2003, ACTA BOT BOREALI-OCC, V23, P5; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cornuet JM, 1996, GENETICS, V144, P2001; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher PJ, 1996, NUCLEIC ACIDS RES, V24, P4369, DOI 10.1093/nar/24.21.4369; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; GASSE F, 1991, NATURE, V353, P742, DOI 10.1038/353742a0; Geffen E, 2007, MOL ECOL, V16, P4241, DOI 10.1111/j.1365-294X.2007.03507.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Hampe A, 2013, NEW PHYTOL, V197, P16, DOI 10.1111/nph.12059; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hampton JO, 2004, J APPL ECOL, V41, P735, DOI 10.1111/j.0021-8901.2004.00936.x; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Hou SG, 2000, CHINESE SCI BULL, V45, P259, DOI 10.1007/BF02884687; [胡恩 Hu En], 2010, [冰川冻土, Journal of Glaciology and Geocryology], V32, P316; Kang SC, 2001, EPISODES, V24, P176; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2013, ENCY BIODIVERSITY, V4, P599; Li B., 1991, QUATERNARY GLACIAL D; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; McLaughlin BC, 2012, GLOBAL CHANGE BIOL, V18, P2301, DOI 10.1111/j.1365-2486.2011.02630.x; Moeller DA, 2011, AM NAT, V178, pS44, DOI 10.1086/661783; Mosblech NAS, 2011, J BIOGEOGR, V38, P419, DOI 10.1111/j.1365-2699.2010.02436.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nie Y, 2010, J GEOGR SCI, V20, P667, DOI 10.1007/s11442-010-0803-8; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Owen LA, 2009, QUATERNARY SCI REV, V28, P1412, DOI 10.1016/j.quascirev.2009.02.010; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pecci M, 2010, GEOGR FIS DIN QUAT, V33, P79; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pope LC, 2000, MOL ECOL, V9, P2041, DOI 10.1046/j.1365-294X.2000.01110.x; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ren JW, 2004, CHINESE SCI BULL, V49, P65, DOI 10.1360/03wd0148; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruedi M, 2003, MOL ECOL, V12, P1527, DOI 10.1046/j.1365-294X.2003.01828.x; Rull V, 2010, J BIOGEOGR, V37, P1623, DOI 10.1111/j.1365-2699.2010.02340.x; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Shi YF, 2000, CHINESE SCI BULL, V45, P668, DOI 10.1007/BF02886048; Song ZP, 2003, THEOR APPL GENET, V107, P1492, DOI 10.1007/s00122-003-1380-3; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Team of Scientific Expedition to Mt. Qomolangma C, 1962, REP SCI EXP MT QOM; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; Thompson LG, 1997, SCIENCE, V276, P1821, DOI 10.1126/science.276.5320.1821; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang ZY, 2013, PLATEAU METEOROL, V32, P7; Xie ZC, 1975, THESIS, P1; Yang XC, 2006, J GEOGR SCI, V16, P11; Yang XG, 2012, ACTA METEOROL SIN, V70, P12; Yang XG, 2011, ARCT ANTARCT ALP RES, V43, P147, DOI 10.1657/1938-4246-43.1.147; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; Yao TD, 1996, SCI CHINA SER D, V39, P425; Zhang ZR, 1983, DELECTIS FLORAE REIP, P61; Zheng BS, 1976, STUDY QUATERNARY GLA; Zhou YB, 2009, MOL ECOL RESOUR, V9, P370, DOI 10.1111/j.1755-0998.2008.02453.x	87	1	1	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97601	10.1371/journal.pone.0097601	http://dx.doi.org/10.1371/journal.pone.0097601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841004	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600050
J	Bauer, EM; Zheng, H; Lotze, MT; Bauer, PM				Bauer, Eileen M.; Zheng, Han; Lotze, Michael T.; Bauer, Philip M.			Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; I INTERFERON; ARTERIAL-HYPERTENSION; PLEXIFORM LESIONS; APOPTOTIC CELLS; IFN-ALPHA; EFFEROCYTOSIS; PHAGOCYTOSIS; DASATINIB; RECEPTOR	Pulmonary hypertension (PH) is a progressive and fatal disease with no cure. Vascular remodeling in PH involves intraluminal growth of endothelial and smooth muscle cells, leading to obliterative vascular lesions. Cell growth in these lesions is quasi-neoplastic, with evidence of monoclonality, apoptosis resistance and cancer-like metabolic derangements. Herein we tested the effect of human interferon alpha 2b (IFN alpha), a pleiotropic cytokine and anti-cancer therapeutic, on the development and progression of PH in the rat SU5416/hypoxia (SUH) model and mouse hypoxia model of the disease. In both models IFN alpha attenuated the development of PH and reversed established PH as assessed by measuring right ventricular systolic pressure and right ventricular hypertrophy. The effect of IFN alpha was dependent on the type I interferon receptor (IFNAR) since mice lacking a subunit of the IFNAR were not protected by IFN alpha. Morphometric analysis of pulmonary aterioles from hypoxic mice or SUH rats showed that IFN alpha inhibited pulmonary vascular remodeling in both models and that IFN alpha reversed remodeling in SUH rats with established disease. Immunohistochemical staining revealed that IFN alpha decreased the number of PCNA and Tunel positive cells in the wall of pulmonary arterioles. In vitro, IFN alpha inhibited proliferation of human pulmonary artery smooth muscle cells and as well as human pulmonary artery endothelial cell proliferation and apoptosis. Together these findings demonstrate that IFN alpha reverses established experimental PH and provide a rationale for further exploration of the use of IFN alpha and other immunotherpies in PH.	[Bauer, Eileen M.; Zheng, Han; Lotze, Michael T.; Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Bauer, Eileen M.; Lotze, Michael T.] Univ Pittsburgh, Inst Canc, Sch Med, Pittsburgh, PA USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bauer, EM (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	bauerpm@upmc.edu			NIH [R01 HL085134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH R01 HL085134 to PM Bauer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Almagro P, 2002, MEDICINE, V81, P417, DOI 10.1097/00005792-200211000-00002; Banerjee S, 2010, J LEUKOCYTE BIOL, V88, P973, DOI 10.1189/jlb.0510262; Bauer EM, 2012, MOL MED, V18, P1509, DOI 10.2119/molmed.2012.00283; Bauer EM, 2013, J BIOL CHEM, V288, P1365, DOI 10.1074/jbc.M112.434142; Bauer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028578; Cao B, 2008, WORLD J GASTROENTERO, V14, P6802, DOI 10.3748/wjg.14.6802; CHEN BDM, 1987, CELL IMMUNOL, V106, P343, DOI 10.1016/0008-8749(87)90177-8; Cruz JA, 2012, AM J PHYSIOL-HEART C, V302, pH2518, DOI 10.1152/ajpheart.01140.2011; Dhillon S, 2010, DIGEST DIS SCI, V55, P1785, DOI 10.1007/s10620-010-1220-7; Dumitrescu D, 2011, EUR RESPIR J, V38, P218, DOI 10.1183/09031936.00154210; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; Fernandez-Boyanapalli R, 2013, J ALLERGY CLIN IMMUN, V131, P1041, DOI 10.1016/j.jaci.2012.09.028; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Friggeri A, 2010, AM J PHYSIOL-CELL PH, V299, pC1267, DOI 10.1152/ajpcell.00152.2010; Fruehauf S, 2001, ANN HEMATOL, V80, P308; George PM, 2014, CIRC RES, V114, P677, DOI 10.1161/CIRCRESAHA.114.302221; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Jochmann Nicoline, 2005, Cardiovasc Ultrasound, V3, P26, DOI 10.1186/1476-7120-3-26; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; Liang SJ, 2003, CYTOKINE, V23, P190, DOI 10.1016/S1043-4666(03)00226-6; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Mattei D, 2009, BONE MARROW TRANSPL, V43, P967, DOI 10.1038/bmt.2008.415; Mogensen KE, 1999, J INTERF CYTOK RES, V19, P1069, DOI 10.1089/107999099313019; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Olin J, 2011, BMJ CASE REP 2011 BC, V2011; Ormiston ML, 2012, CIRCULATION, V126, P1099, DOI 10.1161/CIRCULATIONAHA.112.110619; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Rasheed W, 2009, LEUKEMIA RES, V33, P861, DOI 10.1016/j.leukres.2008.09.026; ROLLAG H, 1984, SCAND J IMMUNOL, V20, P149, DOI 10.1111/j.1365-3083.1984.tb00988.x; Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje; Siddegowda Nagesh Koregala, 2011, Indian J Psychiatry, V53, P239, DOI 10.4103/0019-5545.86815; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tarhini AA, 2012, J IMMUNOL, V189, P3789, DOI 10.4049/jimmunol.1290060; TUDER RM, 1994, AM J PATHOL, V144, P275; Van Vre EA, 2012, ARTERIOSCL THROM VAS, V32, P887, DOI 10.1161/ATVBAHA.111.224873; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Voelkel NF, 2000, J CLIN INVEST, V106, P733, DOI 10.1172/JCI11144; Voelkel NF, 1995, EUR RESPIR J, V8, P2129, DOI 10.1183/09031936.95.08122129; Wuttge DM, 2013, SCAND J RHEUMATOL, V42, P235, DOI 10.3109/03009742.2012.736532	52	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96720	10.1371/journal.pone.0096720	http://dx.doi.org/10.1371/journal.pone.0096720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837600	Green Accepted, gold, Green Published			2022-12-27	WOS:000339614800020
J	Zhu, M; Li, MY; Zhang, F; Feng, F; Chen, WH; Yang, YT; Cui, JJ; Zhang, D; Linghu, EQ				Zhu, Min; Li, Mingyang; Zhang, Fan; Feng, Fan; Chen, Weihao; Yang, Yutao; Cui, Jiajun; Zhang, Dong; Linghu, Enqiang			FBI-1 Enhances ETS-1 Signaling Activity and Promotes Proliferation of Human Colorectal Carcinoma Cells	PLOS ONE			English	Article							HUMAN BREAST-CARCINOMA; TRANSCRIPTION FACTOR; REPRESSES TRANSCRIPTION; CANCER; PROTOONCOGENE; EXPRESSION; OVEREXPRESSION; POKEMON; GROWTH; GENE	In this study, we investigated a potential regulatory role of FBI-1 in transcription factor activity of ETS-1. The protein interaction was identified between ETS-1 and FBI-1 in lovo cells. The accumulating data showed that FBI-1 promoted the recruitment of ETS-1 to endogenous promoter of its target genes and increase ETS-1 accumulation in the nuclear. Our work also indicated that the FBI-1 enhances ETS-1 transcription factor activity via down-regulating p53-mediated inhibition on ETS-1. Further, FBI-1 plays a role in regulation of colorectal carcinoma cells proliferation. These findings supported that FBI-1 might be a potential molecule target for treating colorectal carcinoma.	[Zhu, Min; Zhang, Dong] Chinese Peoples Liberat Army Gen Hosp, Nan Lou Div, Dept Oncol, Beijing, Peoples R China; [Li, Mingyang] Chinese Peoples Liberat Army Gen Hosp, Nan Lou Div, Dept Gastroenterol, Beijing, Peoples R China; [Zhang, Fan] Chinese Peoples Liberat Army Gen Hosp, Tumor Ctr, Beijing, Peoples R China; [Feng, Fan] Shenyang Mil Command, Gen Hosp, Dept Pharm, Shenyang, Peoples R China; [Chen, Weihao] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing, Peoples R China; [Yang, Yutao] Capital Med Univ, Beijing Inst Neurosci, Beijing, Peoples R China; [Cui, Jiajun] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Linghu, Enqiang] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Capital Medical University; Chinese Academy of Sciences; University System of Ohio; University of Cincinnati; Chinese People's Liberation Army General Hospital	Zhang, D (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Nan Lou Div, Dept Oncol, Beijing, Peoples R China.	zhangd1117@yahoo.com; 13341088278@126.com		Zhang, Fan/0000-0001-6798-2422	Roche's Scientific Corporation Program [03YH606]; Research Fund of Ministry of Public Health [WKJ2006-3-007]	Roche's Scientific Corporation Program; Research Fund of Ministry of Public Health	This work was supported by Roche's Scientific Corporation Program (03YH606), Research Fund of Ministry of Public Health (WKJ2006-3-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2010, EXP MOL PATHOL, V89, P140, DOI 10.1016/j.yexmp.2010.05.002; Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Alipov G, 2005, HISTOPATHOLOGY, V46, P202, DOI 10.1111/j.1365-2559.2005.02059.x; Behrens P, 2001, INT J MOL MED, V8, P149; Behrens P, 2001, J PATHOL, P19443; Buggy Y, 2004, BRIT J CANCER, V91, P1308, DOI 10.1038/sj.bjc.6602128; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Cui JJ, 2011, CELL MOL LIFE SCI, V68, P1091, DOI 10.1007/s00018-010-0511-7; Cui JJ, 2010, MOL BIOL REP, V37, P1627, DOI 10.1007/s11033-009-9575-6; Derer S, 2012, NEOPLASIA, V14, P190, DOI 10.1593/neo.111636; Fang F, 2012, CANCER-AM CANCER SOC, V118, P134, DOI 10.1002/cncr.26251; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Katayama S, 2005, HISTOL HISTOPATHOL, V20, P119, DOI 10.14670/HH-20.119; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lin J, 2009, INT J BIOCHEM CELL B, V41, P1613, DOI 10.1016/j.biocel.2009.02.007; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mishra DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045308; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Qin X, 2008, CELL MOL LIFE SCI, V65, P2752, DOI 10.1007/s00018-008-8273-1; Saeki H, 2002, INT J CANCER, V98, P8, DOI 10.1002/ijc.10163; Shi HJ, 2012, PATHOLOGY, V44, P506, DOI 10.1097/PAT.0b013e3283559cbe; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; Swierczewski A, 2012, GINEKOL POL, V83, P439; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Yeon HP, 2002, BIOCHEM BIOPH RES CO, V377, P389; Zhang F, 2012, INT J BIOCHEM CELL B, V44, P320, DOI 10.1016/j.biocel.2011.11.002; Zheng CN, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-84	30	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98041	10.1371/journal.pone.0098041	http://dx.doi.org/10.1371/journal.pone.0098041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857950	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400036
J	De Minicis, S; Agostinelli, L; Rychlicki, C; Sorice, GP; Saccomanno, S; Candelaresi, C; Giaccari, A; Trozzi, L; Pierantonelli, I; Mingarelli, E; Marzioni, M; Muscogiuri, G; Gaggini, M; Benedetti, A; Gastaldelli, A; Guido, M; Svegliati-Baroni, G				De Minicis, Samuele; Agostinelli, Laura; Rychlicki, Chiara; Sorice, Gian Pio; Saccomanno, Stefania; Candelaresi, Cinzia; Giaccari, Andrea; Trozzi, Luciano; Pierantonelli, Irene; Mingarelli, Eleonora; Marzioni, Marco; Muscogiuri, Giovanna; Gaggini, Melania; Benedetti, Antonio; Gastaldelli, Amalia; Guido, Maria; Svegliati-Baroni, Gianluca			HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; HEPATOCELLULAR-CARCINOMA; METABOLIC SYNDROME; HEPATIC STEATOSIS; IN-VIVO; DISEASE; CANCER; MECHANISMS; NAFLD; INFLAMMATION	NAFLD is the most common liver disease worldwide but it is the potential evolution to NASH and eventually to hepatocellular carcinoma (HCC), even in the absence of cirrhosis, that makes NAFLD of such clinical importance. Aim: we aimed to create a mouse model reproducing the pathological spectrum of NAFLD and to investigate the role of possible co-factors in promoting HCC. Methods: mice were treated with a choline-deficient L-amino-acid-defined-diet (CDAA) or its control (CSAA diet) and subjected to a low-dose i.p. injection of CCl4 or vehicle. Insulin resistance was measured by the euglycemic-hyperinsulinemic clamp method. Steatosis, fibrosis and HCC were evaluated by histological and molecular analysis. Results: CDAA-treated mice showed peripheral insulin resistance at 1 month. At 1-3 months, extensive steatosis and fibrosis were observed in CDAA and CDAA+CCl4 groups. At 6 months, equal increase in steatosis and fibrosis was observed between the two groups, together with the appearance of tumor. At 9 months of treatment, the 100% of CDAA+CCl4 treated mice revealed tumor versus 40% of CDAA mice. Insulin-like Growth Factor-2 (IGF-2) and Osteopontin (SPP-1) were increased in CDAA mice versus CSAA. Furthermore, Immunostaining for p-AKT, p-c-Myc and Glypican-3 revealed increased positivity in the tumors. Conclusions: the CDAA model promotes the development of HCC from NAFLD-NASH in the presence of insulin resistance but in the absence of cirrhosis. Since this condition is increasingly recognized in humans, our study provides a model that may help understanding mechanisms of carcinogenesis in NAFLD.	[De Minicis, Samuele; Agostinelli, Laura; Rychlicki, Chiara; Saccomanno, Stefania; Candelaresi, Cinzia; Trozzi, Luciano; Pierantonelli, Irene; Mingarelli, Eleonora; Marzioni, Marco; Benedetti, Antonio; Svegliati-Baroni, Gianluca] Univ Politecn Marche, Dept Gastroenterol, Ancona, Italy; [Sorice, Gian Pio; Giaccari, Andrea; Muscogiuri, Giovanna] Univ Cattolica Sacro Cuore, Policlin Gemelli, Div Endocrinol & Metab Dis, Rome, Italy; [Sorice, Gian Pio] ACISMOM, Diabet Care Clin, Rome, Italy; [Giaccari, Andrea] Don Gnocchi Fdn Onlus, Milan, Italy; [Gaggini, Melania; Gastaldelli, Amalia] CNR, Inst Clin Physiol, Cardiometabol Risk Unit, I-56100 Pisa, Italy; [Guido, Maria] Univ Padua, Dept Med, Anat Pathol Unit, Padua, Italy; [Svegliati-Baroni, Gianluca] Univ Politecn Marche, Obes Ctr, Ancona, Italy	Marche Polytechnic University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Don Carlo Gnocchi Onlus; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Padua; Marche Polytechnic University	Svegliati-Baroni, G (corresponding author), Univ Politecn Marche, Dept Gastroenterol, Ancona, Italy.	s.deminicis@yahoo.it; g.svegliati@univpm.it	pierantonelli, irene/B-4187-2014; Marzioni, Marco/A-8153-2011; Gaggini, Melania/C-9379-2017; Gastaldelli, Amalia/H-3319-2014; Muscogiuri, Giovanna/K-5817-2016; Giaccari, Andrea/AAA-7824-2022; Benedetti, Antonio/A-8189-2011	Marzioni, Marco/0000-0001-6014-6165; Gaggini, Melania/0000-0002-6311-502X; Gastaldelli, Amalia/0000-0003-2594-1651; Giaccari, Andrea/0000-0002-7462-7792; Benedetti, Antonio/0000-0003-0280-4574; Muscogiuri, Giovanna/0000-0002-8809-4931; svegliati-baroni, gianluca/0000-0003-4399-3359	European Community [HEALTH-F2-2009-241762]; MIUR [2009X84L84_003, 2009YNERCE_002, RBAP10MY35_001]; Ministero della Salute [GR-2010-2306996]	European Community(European Commission); MIUR(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no HEALTH-F2-2009-241762 for the project FLIP, from MIUR grant PRIN 2009 - prot. 2009X84L84_003 and Ministero della Salute grant GR-2010-2306996 to MM, from MIUR grant PRIN 2009 - prot. 2009YNERCE_002, FIRB 2010 - prot RBAP10MY35_001 to GS-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Burgess A, 2012, PROSTAG OTH LIPID M, V97, P1, DOI 10.1016/j.prostaglandins.2011.10.002; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Day C P, 2005, Gastroenterology, V129, P375, DOI 10.1053/j.gastro.2005.05.041; De Minicis S, 2013, HEPATOLOGY; De Minicis S, 2012, LIVER INT; De Minicis S, 2013, CURR PHARM DESIGN, V19, P5239; Denda A, 2002, JPN J CANCER RES, V93, P125, DOI 10.1111/j.1349-7006.2002.tb01250.x; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Ferrannini E, 2012, DIABETES; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; Gastaldelli A, 2011, DIABETES RES CLIN PR, V93, pS60, DOI 10.1016/S0168-8227(11)70015-8; GIACCARI A, 1995, DIABETOLOGIA, V38, P518, DOI 10.1007/BF00400719; GIACCARI A, 1992, J CLIN INVEST, V89, P36, DOI 10.1172/JCI115583; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lehmann R, 2013, DIABETES CARE, V36, P2331, DOI 10.2337/dc12-1760; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Nakano T, 2011, J HEPATOL, V55, P415, DOI 10.1016/j.jhep.2010.11.028; Nobili V, 2013, J HEPATOL, V58, P1218, DOI 10.1016/j.jhep.2012.12.003; Page JM, 2009, CLIN LIVER DIS, V13, P631, DOI 10.1016/j.cld.2009.07.007; Pekow JR, 2007, CANCER-AM CANCER SOC, V109, P2490, DOI 10.1002/cncr.22701; Peyrou M, 2010, WORLD J GASTROENTERO, V16, P4627, DOI 10.3748/wjg.v16.i37.4627; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Suzuki M, 2010, ANTICANCER RES, V30, P5055; Svegliati-Baroni G, 2007, GUT, V56, P1296, DOI 10.1136/gut.2006.107946; Svegliati-Baroni G, 2006, J HEPATOL, V44, P1158, DOI 10.1016/j.jhep.2005.10.032; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Svegliati-Baroni G, 2011, GUT, V60, P108, DOI 10.1136/gut.2010.219741; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Vinciguerra M, 2008, ANN HEPATOL, V7, P192, DOI 10.1016/S1665-2681(19)31848-4; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698	50	55	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97136	10.1371/journal.pone.0097136	http://dx.doi.org/10.1371/journal.pone.0097136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853141	gold, Green Published, Green Submitted			2022-12-27	WOS:000338323200016
J	de Renty, C; DePamphilis, ML; Ullah, Z				de Renty, Christelle; DePamphilis, Melvin L.; Ullah, Zakir			Cytoplasmic Localization of p21 Protects Trophoblast Giant Cells from DNA Damage Induced Apoptosis	PLOS ONE			English	Article							STEM-CELLS; CDK INHIBITORS; MICE LACKING; CYCLE EXIT; DOWN-REGULATION; MOUSE EMBRYOS; DIFFERENTIATION; KINASE; PHOSPHORYLATION; PROLIFERATION	Proliferating trophoblast stem cells (TSCs) can differentiate into nonproliferating but viable trophoblast giant cells (TGCs) that are resistant to DNA damage induced apoptosis. Differentiation is associated with selective up-regulation of the Cip/Kip cyclin-dependent kinase inhibitors p57 and p21; expression of p27 remains constant. Previous studies showed that p57 localizes to the nucleus in TGCs where it is essential for endoreplication. Here we show that p27 also remains localized to the nucleus during TSC differentiation where it complements the role of p57. Unexpectedly, p21 localized to the cytoplasm where it was maintained throughout both the G-and S-phases of endocycles, and where it prevented DNA damage induced apoptosis. This unusual status for a Cip/Kip protein was dependent on site-specific phosphorylation of p21 by the Akt1 kinase that is also up-regulated in TGCs. Although cytoplasmic p21 is widespread among cancer cells, among normal cells it has been observed only in monocytes. The fact that it also occurs in TGCs reveals that p57 and p21 serve nonredundant functions, and suggests that the role of p21 in suppressing apoptosis is restricted to terminally differentiated cells.	[de Renty, Christelle; DePamphilis, Melvin L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Ullah, Zakir] Lahore Univ Management Sci, Sch Sci & Engn, Dept Biol, Lahore, Pakistan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Lahore University of Management Sciences	Ullah, Z (corresponding author), Lahore Univ Management Sci, Sch Sci & Engn, Dept Biol, Lahore, Pakistan.	zakirullah@lums.edu.pk		Ullah, Zakir/0000-0003-2045-6841	NICHD; LUMS University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000507, ZIAHD000506] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); LUMS University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the NICHD intramural research program and by LUMS University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahn J, 2013, APOPTOSIS, V18, P870, DOI 10.1007/s10495-013-0835-5; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Arman E, 1999, P NATL ACAD SCI USA, V96, P11895, DOI 10.1073/pnas.96.21.11895; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Baccini V, 2001, BLOOD, V98, P3274, DOI 10.1182/blood.V98.12.3274; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; de Renty C, 2014, DEV BIOL, V387, P49, DOI 10.1016/j.ydbio.2013.12.034; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Hassel C, 2014, DEVELOPMENT, V141, P112, DOI 10.1242/dev.098871; Hattori N, 2000, MOL BIOL CELL, V11, P1037, DOI 10.1091/mbc.11.3.1037; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Heron-Milhavet L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076987; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Koon JC, 2010, J BIOL CHEM, V285, P13437, DOI 10.1074/jbc.M110.107011; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murohashi M, 2010, STEM CELLS, V28, P113, DOI 10.1002/stem.247; Nacusi LP, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-11; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nicolier M, 2009, BIOL CELL, V101, P455, DOI 10.1042/BC20080164; Oda M, 2010, DEV GROWTH DIFFER, V52, P285, DOI 10.1111/j.1440-169X.2010.01173.x; Rielland M, 2009, DEV BIOL, V334, P325, DOI 10.1016/j.ydbio.2009.07.022; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; Rodriguez-Vilarrupla A, 2002, FEBS LETT, V531, P319, DOI 10.1016/S0014-5793(02)03549-4; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Scott MT, 2000, J BIOL CHEM, V275, P11529, DOI 10.1074/jbc.275.15.11529; Sher N, 2013, P NATL ACAD SCI USA, V110, P9368, DOI 10.1073/pnas.1304889110; Siddiqui K, 2013, COLD SPRING HARB PER, V5; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Soloveva V, 2004, PLACENTA, V25, P29, DOI 10.1016/S0143-4004(03)00215-7; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Susaki E, 2009, P NATL ACAD SCI USA, V106, P5192, DOI 10.1073/pnas.0811712106; Suzuki A, 2000, ONCOGENE, V19, P1346, DOI 10.1038/sj.onc.1203429; Takahashi K, 2000, MOL HUM REPROD, V6, P1019, DOI 10.1093/molehr/6.11.1019; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Tang JJ, 2006, MOL CELL BIOCHEM, V291, P139, DOI 10.1007/s11010-006-9206-7; Tateishi Y, 2012, BIOCHEM BIOPH RES CO, V427, P285, DOI 10.1016/j.bbrc.2012.09.041; Ullah Z, 2014, INTRAMURAL PLURIPOTE; Ullah Z, 2008, GENE DEV, V22, P3024, DOI 10.1101/gad.1718108; Ullah Z, 2011, MOL CELL BIOL, V31, P4129, DOI 10.1128/MCB.05723-11; Ullah Z, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-10; Vazquez R, 2013, BIOCHEM PHARMACOL, V86, P210, DOI 10.1016/j.bcp.2013.04.021; Vincent AJ, 2012, FEBS LETT, V586, P3429, DOI 10.1016/j.febslet.2012.07.063; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Xia X, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-399; Xu XL, 1998, DEVELOPMENT, V125, P753; Yano M, 2013, LIVER INT, V33, P1218, DOI 10.1111/liv.12176; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Yuan TL, 2011, CURR BIOL, V21, P173, DOI 10.1016/j.cub.2010.12.047; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou YQ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-15; Zielke N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012948; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	72	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97434	10.1371/journal.pone.0097434	http://dx.doi.org/10.1371/journal.pone.0097434			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848107	gold, Green Submitted, Green Published			2022-12-27	WOS:000336730600028
J	Kitazawa, D; Matsuo, T; Kaizuka, K; Miyauchi, C; Hayashi, D; Inoue, YH				Kitazawa, Daishi; Matsuo, Tatsuru; Kaizuka, Kana; Miyauchi, Chie; Hayashi, Daisuke; Inoue, Yoshihiro H.			Orbit/CLASP Is Required for Myosin Accumulation at the Cleavage Furrow in Drosophila Male Meiosis	PLOS ONE			English	Article							CONTRACTILE RING; CENTRAL-SPINDLE; POLO KINASE; CENTROSOME SEPARATION; MEIOTIC CYTOKINESIS; CELL; ANILLIN; PROTEIN; PHOSPHORYLATION; RECRUITMENT	Peripheral microtubules (MTs) near the cell cortex are essential for the positioning and continuous constriction of the contractile ring (CR) in cytokinesis. Time-lapse observations of Drosophila male meiosis showed that myosin II was first recruited along the cell cortex independent of MTs. Then, shortly after peripheral MTs made contact with the equatorial cortex, myosin II was concentrated there in a narrow band. After MT contact, anillin and F-actin abruptly appeared on the equatorial cortex, simultaneously with myosin accumulation. We found that the accumulation of myosin did not require centralspindlin, but was instead dependent on Orbit, a Drosophila ortholog of the MT plus-end tracking protein CLASP. This protein is required for stabilization of central spindle MTs, which are essential for cytokinesis. Orbit was also localized in a mid-zone of peripheral MTs, and was concentrated in a ring at the equatorial cortex during late anaphase. Fluorescence resonance energy transfer experiments indicated that Orbit is closely associated with F-actin in the CR. We also showed that the myosin heavy chain was in close proximity with Orbit in the cleavage furrow region. Centralspindlin was dispensable in Orbit ring formation. Instead, the Polo-KLP3A/Feo complex was required for the Orbit accumulation independently of the Orbit MT-binding domain. However, orbit mutations of consensus sites for the phosphorylation of Cdk1 or Polo did not influence the Orbit accumulation, suggesting an indirect regulatory role of these protein kinases in Orbit localization. Orbit was also necessary for the maintenance of the CR. Our data suggest that Orbit plays an essential role as a connector between MTs and the CR in Drosophila male meiosis.	[Kitazawa, Daishi; Matsuo, Tatsuru; Kaizuka, Kana; Miyauchi, Chie; Hayashi, Daisuke; Inoue, Yoshihiro H.] Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto 606, Japan	Kyoto Institute of Technology	Inoue, YH (corresponding author), Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto 606, Japan.	yhinoue@kit.ac.jp			 [2357000400]		This work was supported by Grants-in-Aid for Scientific Research (C) to YHI (2357000400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Akbari OS, 2009, BMC CELL BIOL, V29, P10; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; D'Avino PP, 2008, J CELL SCI, V121, P1151, DOI 10.1242/jcs.026716; D'Avino PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000572; D'Avino PP, 2006, J CELL SCI, V119, P4402, DOI 10.1242/jcs.03210; D'Avino PP, 2009, METHODS MOL BIOL, V545, P99, DOI 10.1007/978-1-60327-993-2_6; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Ebrahimi S, 2010, J BIOL CHEM, V285, P28667, DOI 10.1074/jbc.M110.103887; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Fuller Margaret T., 1993, P71; Giansanti MG, 2012, CYTOSKELETON, V69, P869, DOI 10.1002/cm.21063; Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603; Giansanti MG, 1999, J CELL SCI, V112, P2323; Giansanti MG, 1998, GENE DEV, V12, P396, DOI 10.1101/gad.12.3.396; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Inoue YH, 2004, J CELL BIOL, V166, P49, DOI 10.1083/jcb.200402052; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Inoue YH, 2012, DYNAMIC ALTERATION C; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kitazawa D, 2012, J CELL SCI, V125, P3649, DOI 10.1242/jcs.103317; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Lowery LA, 2010, GENETICS, V185, P1311, DOI 10.1534/genetics.110.115626; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Mathe E, 2003, DEVELOPMENT, V130, P901, DOI 10.1242/dev.00315; Miyauchi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058220; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Shrestha S, 2012, MOL BIOL CELL, V23, P1196, DOI 10.1091/mbc.E11-12-1008; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Szafer-Glusman E, 2011, MOL BIOL CELL, V22, P3779, DOI 10.1091/mbc.E11-06-0569; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Uehara R, 2010, CURR BIOL, V20, P1080, DOI 10.1016/j.cub.2010.04.058; van Impel A, 2009, DEVELOPMENT, V136, P813, DOI 10.1242/dev.026203; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Zhang L, 2010, CURR BIOL, V20, pR135, DOI 10.1016/j.cub.2009.12.017; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	66	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e93669	10.1371/journal.pone.0093669	http://dx.doi.org/10.1371/journal.pone.0093669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24850412	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600002
J	Hall, C; Varley, I; Kay, R; Crundall, D				Hall, Carol; Varley, Ian; Kay, Rachel; Crundall, David			Keeping Your Eye on the Rail: Gaze Behaviour of Horse Riders Approaching a Jump	PLOS ONE			English	Article							EXPERTISE	The gaze behaviour of riders during their approach to a jump was investigated using a mobile eye tracking device (ASL Mobile Eye). The timing, frequency and duration of fixations on the jump and the percentage of time when their point of gaze (POG) was located elsewhere were assessed. Fixations were identified when the POG remained on the jump for 100 ms or longer. The jumping skill of experienced but non-elite riders (n = 10) was assessed by means of a questionnaire. Their gaze behaviour was recorded as they completed a course of three identical jumps five times. The speed and timing of the approach was calculated. Gaze behaviour throughout the overall approach and during the last five strides before take-off was assessed following frame-by-frame analyses. Differences in relation to both round and jump number were found. Significantly longer was spent fixated on the jump during round 2, both during the overall approach and during the last five strides (p<0.05). Jump 1 was fixated on significantly earlier and more frequently than jump 2 or 3 (p<0.05). Significantly more errors were made with jump 3 than with jump 1 (p = 0.01) but there was no difference in errors made between rounds. Although no significant correlations between gaze behaviour and skill scores were found, the riders who scored higher for jumping skill tended to fixate on the jump earlier (p = 0.07), when the horse was further from the jump (p = 0.09) and their first fixation on the jump was of a longer duration (p = 0.06). Trials with elite riders are now needed to further identify sport-specific visual skills and their relationship with performance. Visual training should be included in preparation for equestrian sports participation, the positive impact of which has been clearly demonstrated in other sports.	[Hall, Carol; Kay, Rachel] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Southwell, Notts, England; [Varley, Ian] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England; [Crundall, David] Nottingham Trent Univ, Sch Social Sci Psychol, Nottingham, England	Nottingham Trent University; Nottingham Trent University; Nottingham Trent University	Hall, C (corresponding author), Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Southwell, Notts, England.	carol.hall@ntu.ac.uk		Crundall, David/0000-0002-6030-3631; Kay, Rachel/0000-0003-1050-2816; Hall, Carol/0000-0001-5916-311X	Nottingham Trent University	Nottingham Trent University	Nottingham Trent University supported this study in the provision of facilities, horses and riders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applied Science Laboratories, 2007, OP MAN MOB EYE; Hall C, 2009, VET J, V181, P29, DOI 10.1016/j.tvjl.2009.03.007; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; LAURENT M, 1989, HUM MOVEMENT SCI, V8, P481, DOI 10.1016/0167-9457(89)90032-8; Moran A, 2002, J SPORT SCI, V20, P225, DOI 10.1080/026404102317284781; Smart J, 1997, SHOWJUMPING PREPARAT, V62; Stachurska A, 2002, APPL ANIM BEHAV SCI, V77, P197, DOI 10.1016/S0168-1591(02)00042-4; Vickers JN, 1996, J EXP PSYCHOL HUMAN, V22, P342, DOI 10.1037/0096-1523.22.2.342; Vickers JN., 1997, INT J SPORTS VIS, V4, P18; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Williams AM, 2004, J APPL SPORT PSYCHOL, V16, P350, DOI 10.1080/10413200490518002; Williams AM, 2003, RES Q EXERCISE SPORT, V74, P98, DOI 10.1080/02701367.2003.10609068; Williams AM, 2002, J MOTOR BEHAV, V34, P197, DOI 10.1080/00222890209601941	13	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97345	10.1371/journal.pone.0097345	http://dx.doi.org/10.1371/journal.pone.0097345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24846055	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400024
J	Okumura, K; Saito, M; Isogai, E; Miura, I; Wakana, S; Kominami, R; Wakabayashi, Y				Okumura, Kazuhiro; Saito, Megumi; Isogai, Eriko; Miura, Ikuo; Wakana, Shigeharu; Kominami, Ryo; Wakabayashi, Yuichi			Congenic Mapping and Allele-Specific Alteration Analysis of Stmm1 Locus Conferring Resistance to Early-Stage Chemically Induced Skin Papillomas	PLOS ONE			English	Article							TUMOR SUSCEPTIBILITY LOCI; CANCER; MOUSE; MICE; CELLS; ASSOCIATION; CARCINOGEN; BACKCROSS; GENETICS	Genome-wide association studies have revealed that many low-penetrance cancer susceptibility loci are located throughout the genome; however, a very limited number of genes have been identified so far. Using a forward genetics approach to map such loci in a mouse skin cancer model, we previously identified strong genetic loci conferring resistance to early-stage chemically induced skin papillomas on chromosome 7 with a large number of[(FVB/NxMSM/Ms)xFVB/N] F1 backcross mice. In this report, we describe a combination of congenic mapping and allele-specific alteration analysis of the loci on chromosome 7. We used linkage analysis and congenic mouse strains to refine the location of Stmm1 (Skin tumor modifier of MSM 1) locus within a genetic interval of about 3 cM on proximal chromosome 7. In addition, we used patterns of allele-specific imbalances in tumors from F1 backcross and N10 congenic mice to narrow down further the region of Stmm1 locus to a physical distance of about 5.4 Mb. To gain the insight into the function of Stmm1 locus, we carried out a long term BrdU labelling experiments with congenic mice containing Stmm1 locus. Interestingly, we observed a decrease of BrdU-LRCs (Label Retaining Cells) in a congenic strain heterozygous or homozygous for MSM allele of Stmm1. These results suggest that Stmm1 responsible genes may have an influence on papillomagenesis in the two-stage skin carcinogenesis by regulating epidermal quiescent stem cells.	[Okumura, Kazuhiro; Saito, Megumi; Isogai, Eriko; Wakabayashi, Yuichi] Chiba Canc Ctr Res Inst, Dept Carcinogenesis Res, Div Expt Anim Res, Chiba, Japan; [Miura, Ikuo; Wakana, Shigeharu] Riken Bioresource Ctr, Technol & Dev Team Mouse Phenotype Anal, Japan Mouse Clin, Tsukuba, Ibaraki, Japan; [Kominami, Ryo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata, Japan	Chiba Cancer Center; RIKEN; Niigata University	Wakabayashi, Y (corresponding author), Chiba Canc Ctr Res Inst, Dept Carcinogenesis Res, Div Expt Anim Res, Chiba, Japan.	yuichi_wakabayashi@chiba-cc.jp			MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology at Niigata University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23241066] Funding Source: KAKEN	MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology at Niigata University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology at Niigata University, and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; de Koning JP, 2007, ONCOGENE, V26, P4171, DOI 10.1038/sj.onc.1210206; DIGIOVANNI J, 1992, CARCINOGENESIS, V13, P525, DOI 10.1093/carcin/13.4.525; Dong S, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-10; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fujiwara K, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-39; Fujiwara K, 2010, MOL CARCINOGEN, V49, P653, DOI 10.1002/mc.20635; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Hunter KW, 2008, ANNU REV GENET, V42, P131, DOI 10.1146/annurev.genet.42.110807.091659; Kangsamaksin T, 2007, MOL CARCINOGEN, V46, P579, DOI 10.1002/mc.20355; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morris RJ, 1997, CANCER RES, V57, P3436; MORRIS RJ, 1986, CANCER RES, V46, P3061; MORRIS RJ, 1985, J INVEST DERMATOL, V84, P277, DOI 10.1111/1523-1747.ep12265358; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 2001, CANCER RES, V61, P1305; Okumura K, 2012, CARCINOGENESIS, V33, P2260, DOI 10.1093/carcin/bgs250; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Perez-Losada J, 2011, INTEGR BIOL-UK, V3, P316, DOI 10.1039/c0ib00094a; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Stadler ZK, 2010, J CLIN ONCOL, V28, P4255, DOI 10.1200/JCO.2009.25.7816	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97201	10.1371/journal.pone.0097201	http://dx.doi.org/10.1371/journal.pone.0097201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844776	Green Submitted, Green Published, gold			2022-12-27	WOS:000339563400016
J	Barketi-Klai, A; Monot, M; Hoys, S; Lambert-Bordes, S; Kuehne, SA; Minton, N; Collignon, A; Dupuy, B; Kansau, I				Barketi-Klai, Amira; Monot, Marc; Hoys, Sandra; Lambert-Bordes, Sylvie; Kuehne, Sarah A.; Minton, Nigel; Collignon, Anne; Dupuy, Bruno; Kansau, Imad			The Flagellin FliC of Clostridium difficile Is Responsible for Pleiotropic Gene Regulation during In Vivo Infection	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; CAMPYLOBACTER-JEJUNI; TOXIN-B; STREPTOCOCCUS-MUTANS; DIFFERENT SEROGROUPS; BACILLUS-SUBTILIS; RHO-PROTEINS; P-CRESOL; VIRULENCE; EXPRESSION	Clostridium difficile is the main agent responsible for hospital acquired antibiotic associated diarrhoea. In recent years, epidemic strains have emerged causing more severe infections. Whilst C. difficile has two major virulence factors, toxins TcdA and TcdB, it is generally accepted that other virulence components of the bacterium contribute to disease. Previously, it has been suggested that flagella expression from pathogenic bacteria might be implicated in virulence. In a recent study, we observed an increased mortality in a gnotobiotic mouse model when animals were colonized with an isogenic fliC mutant constructed in the PCR-ribotype 027 (B1/NAP1) strain R20291, while animals survived when colonized by the parental strain or after colonization by other high-toxin-producing C. difficile strains. To understand the reasons for this increased virulence, we compared the global gene expression profiles between the fliC-R20291 mutant and its parental strain using an in vitro and in vivo transcriptomic approach. The latter made use of the gnotobiotic mouse model. Interestingly, in the fliC mutant, we observed considerable up-regulation of genes involved in mobility, membrane transport systems (PTS, ABC transporters), carbon metabolism, known virulence factors and sporulation. A smaller but significant up-regulation of genes involved in cell growth, fermentation, metabolism, stress and antibiotic resistance was also apparent. All of these genes may be associated with the increased virulence of the fliC-R20921 mutant. We confirmed that the fliC mutation is solely responsible for the observed changes in gene expression in the mutant strain since expression profiles were restored to that of the wild-type strain in the fliC-complemented strain. Thus, the absence of FliC is directly or indirectly involved in the high mortality observed in the fliC mutant infected animals. Therefore, we provide the first evidence that when the major structural component of the flagellum is neutralized, deregulation of gene expression can occur during infection.	[Barketi-Klai, Amira; Hoys, Sandra; Lambert-Bordes, Sylvie; Kansau, Imad] Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France; [Monot, Marc; Collignon, Anne; Dupuy, Bruno] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Kuehne, Sarah A.; Minton, Nigel] Univ Nottingham, Sch Life Sci, Ctr Biomol Sci, Clostridia Res Grp, Nottingham NG7 2RD, England	UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Nottingham	Kansau, I (corresponding author), Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France.	imad.kansau@u-psud.fr	Monot, Marc/F-3058-2015; Kansau, Imad/GRX-4789-2022; Kuehne, Sarah/AAV-3481-2021	Monot, Marc/0000-0003-0738-7335; Kansau, Imad/0000-0002-1893-6822; Kuehne, Sarah/0000-0001-6790-8433; Minton, Nigel/0000-0002-9277-1261	European Union [HEALTH-F3-2008-223585]; Medical Research Council [G0601176] Funding Source: researchfish; MRC [G0601176] Funding Source: UKRI	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the European Union (HEALTH-F3-2008-223585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Antunes A, 2012, NUCLEIC ACIDS RES, V40, P10701, DOI 10.1093/nar/gks864; Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; Aubry A, 2012, INFECT IMMUN, V80, P3521, DOI 10.1128/IAI.00224-12; Baban ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073026; Baban ST, 2013, PLOS ONE UNPUB; Barketi-Klai A, 2011, J MED MICROBIOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Boetzkes A, 2012, ARCH MICROBIOL, V194, P675, DOI 10.1007/s00203-012-0802-5; BORGMANN S, 2008, EURO SURVEILL, V13; Brazier JS, 2007, EUROSURVEILLANCE, V12; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Cheknis AK, 2009, ANAEROBE, V15, P230, DOI 10.1016/j.anaerobe.2009.09.001; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Dawson LF, 2008, J MED MICROBIOL, V57, P745, DOI 10.1099/jmm.0.47744-0; Dawson LF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-86; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2; Dietrich C, 2001, INFECT IMMUN, V69, P2116, DOI 10.1128/IAI.69.4.2116-2122.2001; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Eaton KA, 1996, INFECT IMMUN, V64, P2445, DOI 10.1128/IAI.64.7.2445-2448.1996; El Meouche I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083748; Ethapa T., 2013, Journal of Bacteriology, V195, P545; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Hu KY, 2002, RES MICROBIOL, V153, P405, DOI 10.1016/S0923-2508(02)01339-6; Indra A, 2008, J MED MICROBIOL, V57, P702, DOI 10.1099/jmm.0.47476-0; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Johnson M, 2011, INT J MED MICROBIOL, V301, P44, DOI 10.1016/j.ijmm.2010.05.003; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Konings WN, 2006, ANTON LEEUW INT J G, V90, P325, DOI 10.1007/s10482-006-9089-3; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper E J, 2007, Euro Surveill, V12, pE1; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Martin MJ, 2013, J BACTERIOL, V195, P3672, DOI 10.1128/JB.00473-13; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Permpoonpattana P, 2011, J BACTERIOL, V193, P6461, DOI 10.1128/JB.05182-11; Poly F, 2007, INFECT IMMUN, V75, P3859, DOI 10.1128/IAI.00159-07; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Rabaan AA, 2001, INFECT IMMUN, V69, P4257, DOI 10.1128/IAI.69.7.4257-4267.2001; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Song YC, 2004, MOL MICROBIOL, V53, P541, DOI 10.1111/j.1365-2958.2004.04175.x; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Stabler RA, 2010, GUT MICROBES, V1, P269, DOI 10.4161/gmic.1.4.11870; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stephenson K, 2005, FEMS MICROBIOL REV, V29, P281, DOI 10.1016/j.femsre.2004.10.003; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Tasteyre A, 2000, J CLIN MICROBIOL, V38, P3179, DOI 10.1128/JCM.38.9.3179-3186.2000; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Tasteyre A, 2001, J CLIN MICROBIOL, V39, P1178, DOI 10.1128/JCM.39.3.1178-1183.2001; Tsukioka Y, 1997, J BACTERIOL, V179, P1126, DOI 10.1128/jb.179.4.1126-1134.1997; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Yamashita Y, 1999, INFECT IMMUN, V67, P3693, DOI 10.1128/IAI.67.7.3693-3697.1999	80	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96876	10.1371/journal.pone.0096876	http://dx.doi.org/10.1371/journal.pone.0096876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841151	gold, Green Submitted, Green Published			2022-12-27	WOS:000340948600011
J	Sigl, R; Ploner, C; Shivalingaiah, G; Kofler, R; Geley, S				Sigl, Reinhard; Ploner, Christian; Shivalingaiah, Giridhar; Kofler, Reinhard; Geley, Stephan			Development of a Multipurpose GATEWAY-Based Lentiviral Tetracycline-Regulated Conditional RNAi System (GLTR)	PLOS ONE			English	Article							FLUORESCENT PROTEINS; MAMMALIAN-CELLS; GENE-EXPRESSION; INTERFERENCE; MECHANISM; REVEALS	RNA interference (RNAi) has become an essential technology for functional gene analysis. Its success, however, depends on the effective expression of RNAi-inducing small double-stranded interfering RNA molecules (siRNAs) in target cells. In many cell types, RNAi can be achieved by transfection of chemically synthesised siRNAs, which results in transient knockdown of protein expression. Expression of double-stranded short hairpin RNA (shRNA) provides another means to induce RNAi in cells that are hard to transfect. To facilitate the generation of stable, conditional RNAi cell lines, we have developed novel one-and two-component vector GATEWAY-compatible lentiviral tetracycline-regulated RNAi (GLTR) systems. The combination of a modified RNA-polymerase-III-dependent H1 RNA promoter (designated 'THT') for conditional shRNA expression with different lentiviral delivery vectors allows (1) the use of fluorescent proteins for colour-coded combinatorial RNAi or for monitoring RNAi induction (pGLTR-FP), (2) selection of transduced cells (pGLTR-S), and (3) the generation of conditional cell lines using a one vector system (pGLTR-X). All three systems were found to be suitable for the analysis of essential genes, such as CDC27, a component of the mitotic ubiquitin ligase APC/C, in cell lines and primary human cells.	[Sigl, Reinhard; Ploner, Christian; Shivalingaiah, Giridhar; Kofler, Reinhard; Geley, Stephan] Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Kofler, Reinhard] Tyrolean Canc Inst, Innsbruck, Austria; [Ploner, Christian] Med Univ Innsbruck, Univ Clin Plast Reconstruct & Aesthet Surg, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Geley, S (corresponding author), Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria.	Stephan.Geley@i-med.ac.at		Ploner, Christian/0000-0002-0313-2960	FWF [SFB021, P16400, DK W1101-B12]; EU [LSHS-CT-2004-503438]; Tiroler Krebshilfe; Tiroler Zukunftsstiftung; Tiroler Wissenschaftsfonds (TWF); Eva v. Lachmuller, Brixen, Italy	FWF(Austrian Science Fund (FWF)); EU(European Commission); Tiroler Krebshilfe; Tiroler Zukunftsstiftung; Tiroler Wissenschaftsfonds (TWF); Eva v. Lachmuller, Brixen, Italy	This work was supported by FWF grants SFB021 'Cell proliferation and cell death in tumors', P16400, and DK W1101-B12 'MCBO', EU project LSHS-CT-2004-503438 'TRANSFOG' as well as by the Tiroler Krebshilfe, Tiroler Zukunftsstiftung, and Tiroler Wissenschaftsfonds (TWF) and assets of Eva v. Lachmuller, Brixen, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bulliard Y, 2006, J BIOL CHEM, V281, P35742, DOI 10.1074/jbc.M602843200; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Csordas A, 2011, CARDIOVASC RES, V92, P141, DOI 10.1093/cvr/cvr165; DELALUNA S, 1992, METHOD ENZYMOL, V216, P376; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Geley S, 2004, EXP GERONTOL, V39, P985, DOI 10.1016/j.exger.2004.03.040; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kappel S, 2007, NAT PROTOC, V2, P3257, DOI 10.1038/nprot.2007.458; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Tiscornia G, 2004, P NATL ACAD SCI USA, V101, P7347, DOI 10.1073/pnas.0402107101; TUGENDREICH S, 1993, P NATL ACAD SCI USA, V90, P10031, DOI 10.1073/pnas.90.21.10031; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404; Xia XG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng098; Zhang J, 2007, RNA, V13, P1375, DOI 10.1261/rna.520707	33	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97764	10.1371/journal.pone.0097764	http://dx.doi.org/10.1371/journal.pone.0097764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841113	Green Published, Green Submitted, gold			2022-12-27	WOS:000340948600071
J	Zelenchuk, LV; Hedge, AM; Rowe, PSN				Zelenchuk, Lesya V.; Hedge, Anne-Marie; Rowe, Peter S. N.			PHEX Mimetic (SPR4-Peptide) Corrects and Improves HYP and Wild Type Mice Energy-Metabolism	PLOS ONE			English	Article							PLASMA URIC-ACID; EXTRACELLULAR PHOSPHOGLYCOPROTEIN MEPE; INSULIN-RECEPTOR INHIBITOR; CONTROLS BONE-FORMATION; X-LINKED RICKETS; GLUCOSE-TOLERANCE; ASARM-PEPTIDES; RENAL GLUCONEOGENESIS; PHOSPHATE-METABOLISM; PROXIMAL TUBULE	Context: PHEX or DMP1 mutations cause hypophosphatemic-rickets and altered energy metabolism. PHEX binds to DMP1-ASARM-motif to form a complex with alpha(5)beta(3) integrin that suppresses FGF23 expression. ASARM-peptides increase FGF23 by disrupting the PHEX-DMP1-Integrin complex. We used a 4.2 kDa peptide (SPR4) that binds to ASARM-peptide/motif to study the DMP1-PHEX interaction and to assess SPR4 for the treatment of energy metabolism defects in HYP and potentially other bone-mineral disorders. Design: Subcutaneously transplanted osmotic pumps were used to infuse SPR4-peptide or vehicle (VE) into wild-type mice (WT) and HYP-mice (PHEX mutation) for 4 weeks. Results: SPR4 partially corrected HYP mice hypophosphatemia and increased serum 1.25(OH)(2)D-3. Serum FGF23 remained high and PTH was unaffected. WT-SPR4 mice developed hypophosphatemia and hypercalcemia with increased PTH, FGF23 and 1.25(OH)(2)D-3. SPR4 increased GAPDH HYP-bone expression 60x and corrected HYP-mice hyperglycemia and hypoinsulinemia. HYP-VE serum uric-acid (UA) levels were reduced and SPR4 infusion suppressed UA levels in WT-mice but not HYP-mice. SPR4 altered leptin, adiponectin, and sympathetic-tone and increased the fat mass/weight ratio for HYP and WT mice. Expression of perlipin-2 a gene involved in obesity was reduced in HYP-VE and WT-SPR4 mice but increased in HYP-SPR4 mice. Also, increased expression of two genes that inhibit insulin-signaling, ENPP1 and ESP, occurred with HYP-VE mice. In contrast, SPR4 reduced expression of both ENPP1 and ESP in WT mice and suppressed ENPP1 in HYP mice. Increased expression of FAM20C and sclerostin occurred with HYP-VE mice. SPR4 suppressed expression of FAM20C and sclerostin in HYP and WT mice. Conclusions: ASARM peptides and motifs are physiological substrates for PHEX and modulate osteocyte PHEX-DMP1-alpha(5)beta(3)-integrin interactions and thereby FGF23 expression. These interactions also provide a nexus that regulates bone and energy metabolism. SPR4 suppression of sclerostin and/or sequestration of ASARM-peptides improves energy metabolism and may have utility for treating familial rickets, osteoporosis, obesity and diabetes.	[Zelenchuk, Lesya V.; Hedge, Anne-Marie; Rowe, Peter S. N.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Rowe, PSN (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA.	prowe@kumc.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) [5R01AR051598-10]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051598] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by a grant to PSNR from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) under Award Number 5R01AR051598-10. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2006, NAT CLIN PRACT ENDOC, V2, P694, DOI 10.1038/ncpendmet0367; Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Agarwal AR, 2012, AM J PHYSIOL-LUNG C, V303, pL889, DOI 10.1152/ajplung.00219.2012; ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; ALEXANDERBRIDGES M, 1992, ADV ENZYME REGUL, V32, P149; ALLON M, 1992, J AM SOC NEPHROL, V2, P1593; Amling M, 2000, BIOESSAYS, V22, P970; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Azam N, 2003, ENDOCRINOLOGY, V144, P3463, DOI 10.1210/en.2003-0255; Barros NMT, 2013, J BONE MINER RES, V28, P688, DOI 10.1002/jbmr.1766; Bedir A, 2003, JPN HEART J, V44, P527, DOI 10.1536/jhj.44.527; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Billaudel B, 1998, DIABETES METAB, V24, P344; Bonewald L. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P239; Boskey AL, 2010, CALCIFIED TISSUE INT, V86, P42, DOI 10.1007/s00223-009-9313-z; Boudin E, 2013, BONE, V55, P52, DOI 10.1016/j.bone.2013.03.015; Boukpessi T, 2006, CALCIFIED TISSUE INT, V79, P294, DOI 10.1007/s00223-006-0182-4; Boukpessi T, 2010, AM J PATHOL, V177, P803, DOI 10.2353/ajpath.2010.091231; Bresler D, 2004, J ENDOCRINOL, V183, pR1, DOI 10.1677/joe.1.05989; CADE C, 1987, ENDOCRINOLOGY, V120, P1490, DOI 10.1210/endo-120-4-1490; CADE C, 1986, ENDOCRINOLOGY, V119, P84, DOI 10.1210/endo-119-1-84; Campos M, 2003, BIOCHEM J, V373, P271, DOI 10.1042/BJ20030287; CAPPARELLI AW, 1992, ENDOCRINOLOGY, V130, P328, DOI 10.1210/en.130.1.328; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Chang MK, 2014, J BONE MINER RES, V29, P29, DOI 10.1002/jbmr.2059; Chen L, 2013, DIABETIC MED, V30, P309, DOI 10.1111/j.1464-5491.2012.03769.x; Civantos Modino Soralla, 2012, Endocrinol Nutr, V59, P533, DOI 10.1016/j.endonu.2012.06.010; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; David V, 2011, AM J PHYSIOL-RENAL, V300, pF783, DOI 10.1152/ajprenal.00304.2010; David V, 2009, ENDOCRINOLOGY, V150, P4012, DOI 10.1210/en.2009-0216; de Lorenzo C, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/376454; de Oliveira EP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-12; DEFRONZO RA, 1980, NEW ENGL J MED, V303, P1259, DOI 10.1056/NEJM198011273032203; Ditzel J, 2009, DIABETES METAB SYNDR, V2, P173; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Eleftheriadis T, 2013, RENAL FAILURE, V35, P592, DOI 10.3109/0886022X.2013.773836; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Fruehwald-Schultes B, 1999, METABOLISM, V48, P677, DOI 10.1016/S0026-0495(99)90163-4; Fujiwara I, 2003, J BONE MINER RES, V18, P434, DOI 10.1359/jbmr.2003.18.3.434; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; Gaucher C, 2009, CELLS TISSUES ORGANS, V189, P219, DOI 10.1159/000151382; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Goltzman D, 2011, J BONE MINER RES, V26, P1997, DOI 10.1002/jbmr.462; Grassi D, 2013, CURR PHARM DESIGN, V19, P2432, DOI 10.2174/1381612811319130011; Haap M, 2006, EUR J CLIN NUTR, V60, P734, DOI 10.1038/sj.ejcn.1602375; Haglin L, 2001, MED HYPOTHESES, V56, P657, DOI 10.1054/mehy.2000.1272; Hale LJ, 2013, CLIN SCI, V124, P351, DOI 10.1042/CS20120378; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hesse M, 2007, MATRIX BIOL, V26, P75, DOI 10.1016/j.matbio.2006.10.003; HETTLEMAN BD, 1983, J CLIN INVEST, V72, P582, DOI 10.1172/JCI111006; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; HRUSKA KA, 1995, AM J PHYSIOL-RENAL, V268, pF357, DOI 10.1152/ajprenal.1995.268.3.F357; Hsu YH, 2012, J CLIN ENDOCR METAB, V97, pE1958, DOI 10.1210/jc.2012-1890; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Hwang YC, 2012, DIABETES CARE, V35, P1919, DOI 10.2337/dc11-2471; Idelevich A, 2013, J BONE MINER RES, V28, P18, DOI 10.1002/jbmr.1812; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jain A, 2004, J CLIN ENDOCR METAB, V89, P4158, DOI 10.1210/jc.2003-032031; Jankowski M, 2011, BIOCHEM BIOPH RES CO, V416, P64, DOI 10.1016/j.bbrc.2011.10.144; Jemtland R, 2011, J BONE MINER RES, V26, P1793, DOI 10.1002/jbmr.396; Johnson RJ, 2010, EVOL ANTHROPOL, V19, P250, DOI 10.1002/evan.20266; Joshi A, 2013, J OSTEOPOROS, V2013, DOI [10.1155/2013/397814, 10.1155/2013/984626]; Kalaitzidis R, 2005, AM J KIDNEY DIS, V45, P851, DOI 10.1053/j.ajkd.2005.01.005; Kanazawa I, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-51; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Karsenty G, 2001, RECENT PROG HORM RES, V56, P401, DOI 10.1210/rp.56.1.401; Karsenty G, 2011, ANNU REV MED, V62, P323, DOI 10.1146/annurev-med-090710-133426; Kode A, 2012, J BIOL CHEM, V287, P8757, DOI 10.1074/jbc.M111.282897; KUROKAWA K, 1973, BIOCHIM BIOPHYS ACTA, V313, P17, DOI 10.1016/0304-4165(73)90185-2; Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lee B., 2013, REV ENDOCR METAB DIS; Lee GS, 2014, J BONE MINER RES, V29, P976, DOI 10.1002/jbmr.2086; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LEVI E, 1992, ENDOCRINOLOGY, V131, P2182, DOI 10.1210/en.131.5.2182; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Liu SG, 2007, J ENDOCRINOL, V192, P261, DOI 10.1677/joe.1.07059; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Mackenzie NCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032177; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; Magne J, 2013, FASEB J, V27, P3090, DOI 10.1096/fj.13-228759; Makovey J, 2013, BONE, V52, P400, DOI 10.1016/j.bone.2012.10.025; Mangge H, 2013, OBESITY, V21, pE71, DOI 10.1002/oby.20061; Marsenic O, 2009, AM J KIDNEY DIS, V53, P875, DOI 10.1053/j.ajkd.2008.12.031; Martin A, 2008, ENDOCRINOLOGY, V149, P1757, DOI 10.1210/en.2007-1205; MASSRY SG, 1991, KIDNEY INT, V40, P662, DOI 10.1038/ki.1991.258; McIntosh AL, 2012, AM J PHYSIOL-CELL PH, V303, pC728, DOI 10.1152/ajpcell.00448.2011; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Mori K, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-53; Nabipour I, 2011, J BONE MINER RES, V26, P955, DOI 10.1002/jbmr.286; Nanes MS, 2013, CURR OPIN ENDOCRINOL, V20, P523, DOI 10.1097/01.med.0000436189.80104.80; Nesbitt T, 1996, ENDOCRINOLOGY, V137, P943, DOI 10.1210/en.137.3.943; NESBITT T, 1995, J BONE MINER RES, V10, P1327; Osgood K, 2013, METAB SYNDR RELAT D, V11, P157, DOI 10.1089/met.2012.0151; Pan WT, 2011, AM J PHYSIOL-ENDOC M, V301, pE901, DOI 10.1152/ajpendo.00087.2011; Paula FJA, 1998, HORM METAB RES, V30, P281, DOI 10.1055/s-2007-978884; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price Sarah, 2011, Nat Rev Rheumatol, V7, P373, DOI 10.1038/nrrheum.2011.84; Prudente S, 2009, NAT REV ENDOCRINOL, V5, P682, DOI 10.1038/nrendo.2009.215; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ranch D, 2011, J BONE MINER RES, V26, P1883, DOI 10.1002/jbmr.401; RIFAS L, 1995, CALCIFIED TISSUE INT, V57, P60, DOI 10.1007/BF00298998; Robles-Cervantes JA, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/107904; ROOBOL A, 1973, BIOCHEM J, V134, P157, DOI 10.1042/bj1340157; Rowe PSN, 2006, BONE, V39, P773, DOI 10.1016/j.bone.2006.04.012; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; SABINA RL, 1982, BIOCHEM BIOPH RES CO, V109, P649, DOI 10.1016/0006-291X(82)91989-1; Saito T, 2011, BONE; Salmon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056749; Santos RD, 2012, ENDOCRINE, V41, P350, DOI 10.1007/s12020-012-9657-4; Sarkar PD, 2012, ARCH PHYSIOL BIOCHEM, V118, P260, DOI 10.3109/13813455.2012.715651; Schwartz AV, 2013, J BONE MINER RES, V28, P1348, DOI 10.1002/jbmr.1865; Sluijs I, 2013, J NUTR, V143, P80, DOI 10.3945/jn.112.167221; Sortica DA, 2011, ARQ BRAS ENDOCRINOL, V55, P677, DOI 10.1590/S0004-27302011000900002; Sritara C, 2013, J CLIN DENSITOM, V16, P336, DOI 10.1016/j.jocd.2012.05.008; Staines KA, 2012, BONE, V51, P418, DOI 10.1016/j.bone.2012.06.022; Staines KA, 2013, J BONE MINER METAB; Stellato D, 2012, INTERN EMERG MED, V7, P5, DOI 10.1007/s11739-011-0642-3; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Tagliabracci A, 2014, PNAS; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; Thrailkill KM, 2012, OSTEOPOROSIS INT, V23, P1799, DOI 10.1007/s00198-011-1807-7; Tiosano D, 2011, J BONE MINER RES, V26, P2252, DOI 10.1002/jbmr.431; Tiwari S, 2013, J AM SOC NEPHROL, V24, P1209, DOI 10.1681/ASN.2012060628; TRAVIS SF, 1971, NEW ENGL J MED, V285, P763, DOI 10.1056/NEJM197109302851402; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; VAUGHN LK, 1986, ENDOCRINOLOGY, V118, P441, DOI 10.1210/endo-118-1-441; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wojcik M, 2012, J PEDIATR ENDOCR MET, V25, P687, DOI 10.1515/jpem-2012-0064; Wojcik M, 2012, CLIN ENDOCRINOL, V77, P537, DOI 10.1111/j.1365-2265.2011.04299.x; Wu YH, 2012, DERMATOL SIN, V30, P1, DOI 10.1016/j.dsi.2012.02.004; Xi W, 2002, HORM METAB RES, V34, P288, DOI 10.1055/s-2002-33256; Xie W, 1999, BIOCHEM J, V343, P393, DOI [10.1042/0264-6021:3430393, 10.1042/bj3430393]; Xie WS, 2000, BIOCHEM J, V352, P227, DOI 10.1042/0264-6021:3520227; Yadav VK, 2011, J EXP MED, V208, P41, DOI 10.1084/jem.20101940; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yamaguchi T, 2011, ENDOCR J, V58, P613, DOI 10.1507/endocrj.EJ11-0063; Yancovitch A, 2011, J BONE MINER METAB, V29, P621, DOI 10.1007/s00774-011-0260-1; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702; Yuan BZ, 2013, J BONE MINER RES, V28, P56, DOI 10.1002/jbmr.1738; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje; Zhang L, 2013, HUM MOL GENET; ZHOU XJ, 1991, KIDNEY INT, V39, P120, DOI 10.1038/ki.1991.15; Zmuda JM, 2011, OSTEOPOROSIS INT, V22, P1079, DOI 10.1007/s00198-010-1296-0	163	11	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97326	10.1371/journal.pone.0097326	http://dx.doi.org/10.1371/journal.pone.0097326			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24839967	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600024
J	Bogdanov, P; Corraliza, L; Villena, JA; Carvalho, AR; Garcia-Arumi, J; Ramos, D; Ruberte, J; Simo, R; Hernandez, C				Bogdanov, Patricia; Corraliza, Lidia; Villena, Josep A.; Carvalho, Andrea R.; Garcia-Arumi, Jose; Ramos, David; Ruberte, Jesus; Simo, Rafael; Hernandez, Cristina			The db/db Mouse: A Useful Model for the Study of Diabetic Retinal Neurodegeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; APOPTOTIC CELL-DEATH; BARRIER BREAKDOWN; GLUTAMATE RECEPTORS; MULTIFOCAL ERG; MULLER CELLS; EARLY EVENT; RETINOPATHY; EXPRESSION; RAT	Background: To characterize the sequential events that are taking place in retinal neurodegeneration in a murine model of spontaneous type 2 diabetes (db/db mouse). Methods: C57BLKsJ-db/db mice were used as spontaneous type 2 diabetic animal model, and C57BLKsJ-db/+ mice served as the control group. To assess the chronological sequence of the abnormalities the analysis was performed at different ages (8, 16 and 24 weeks). The retinas were evaluated in terms of morphological and functional abnormalities [electroretinography (ERG)]. Histological markers of neurodegeneration (glial activation and apoptosis) were evaluated by immunohistochemistry. In addition glutamate levels and glutamate/aspartate transporter (GLAST) expression were assessed. Furthermore, to define gene expression changes associated with early diabetic retinopathy a transcriptome analyses was performed at 8 week. Furthermore, an additional interventional study to lower blood glucose levels was performed. Results: Glial activation was higher in diabetic than in non diabetic mice in all the stages (p<0.01). In addition, a progressive loss of ganglion cells and a significant reduction of neuroretinal thickness were also observed in diabetic mice. All these histological hallmarks of neurodegeneration were less pronounced at week 8 than at week 16 and 24. Significant ERG abnormalities were present in diabetic mice at weeks 16 and 24 but not at week 8. Moreover, we observed a progressive accumulation of glutamate in diabetic mice associated with an early downregulation of GLAST. Morphological and ERG abnormalities were abrogated by lowering blood glucose levels. Finally, a dysregulation of several genes related to neurotransmission and oxidative stress such as UCP2 were found at week 8. Conclusions: Our results suggest that db/db mouse reproduce the features of the neurodegenerative process that occurs in the human diabetic eye. Therefore, it seems an appropriate model for investigating the underlying mechanisms of diabetes-induced retinal neurodegeneration and for testing neuroprotective drugs.	[Bogdanov, Patricia; Corraliza, Lidia; Simo, Rafael; Hernandez, Cristina] Univ Autonoma Barcelona, Vall dHebron Res Inst, Diabet & Metab Res Unit, E-08193 Barcelona, Spain; [Bogdanov, Patricia; Corraliza, Lidia; Villena, Josep A.; Simo, Rafael; Hernandez, Cristina] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Villena, Josep A.] Univ Autonoma Barcelona, Vall dHebron Res Inst, Lab Metab & Obes, E-08193 Barcelona, Spain; [Carvalho, Andrea R.; Garcia-Arumi, Jose] Univ Autonoma Barcelona, Vall dHebron Res Inst, Ophthalmol Res Lab, Barcelona, Spain; [Carvalho, Andrea R.; Garcia-Arumi, Jose] Inst Salud Carlos III, Red Temat Invest Oftalmol OFTARED, Madrid, Spain; [Ramos, David; Ruberte, Jesus] Univ Autonoma Barcelona, Fac Vet Sci, Dept Anim Hlth & Anat, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; Autonomous University of Barcelona	Hernandez, C (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Diabet & Metab Res Unit, E-08193 Barcelona, Spain.	cristina.hernandez@vhir.org	Villena, Josep A/H-1597-2015; Bogdanov, Patricia/AAF-7831-2021; Ruberte, Jesus/AAS-9240-2021	Bogdanov, Patricia/0000-0003-0669-4958; Hernandez, Cristina/0000-0002-3109-1721; Villena, Josep A/0000-0002-2200-2985; Garcia-Arumi, Jose/0000-0001-8827-1160; Simo Canonge, Rafael/0000-0003-0475-3096; RUBERTE, JESUS/0000-0003-1540-1432	Ministerio de Ciencia e Innovacion [SAF2012-35562]; Ministerio de Economia y Competitividad [PI10/01219, PI13/00603]; European Foundation for the Study of Diabetes (EFSD); Novo-Nordisk	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); European Foundation for the Study of Diabetes (EFSD); Novo-Nordisk(Novo Nordisk)	This study was supported by grants from the Ministerio de Ciencia e Innovacion (SAF2012-35562), the Ministerio de Economia y Competitividad (PI10/01219; PI13/00603), the European Foundation for the Study of Diabetes (EFSD), and Novo-Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 1997, ARCH OPHTHALMOL-CHIC, V115, P1161, DOI 10.1001/archopht.1997.01100160331011; Anderson PJB, 2008, CLIN OPHTHALMOL, V2, P801; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Barnstable C J, 1993, Curr Opin Neurobiol, V3, P520, DOI 10.1016/0959-4388(93)90050-9; Bayer AU, 2001, INVEST OPHTH VIS SCI, V42, P1258; Bearse MA, 2006, PROG RETIN EYE RES, V25, P425, DOI 10.1016/j.preteyeres.2006.07.001; Bronson-Castain KW, 2009, RETINA-J RET VIT DIS, V29, P618, DOI 10.1097/IAE.0b013e31819a988b; Carrasco E, 2007, DIABETES CARE, V30, P2902, DOI 10.2337/dc07-0332; Cervantes-Villagrana AR, 2010, CURR EYE RES, V35, P733, DOI 10.3109/02713683.2010.483312; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Clements RS, 1998, J DIABETES COMPLICAT, V12, P28, DOI 10.1016/S1056-8727(97)00051-2; de Faria JML, 2002, BRIT J OPHTHALMOL, V86, P725; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Garcia-Ramirez M, 2009, DIABETOLOGIA, V52, P2633, DOI 10.1007/s00125-009-1548-8; Han Y, 2004, INVEST OPHTH VIS SCI, V45, P4106, DOI 10.1167/iovs.04-0405; Harrison WW, 2011, INVEST OPHTH VIS SCI, V52, P772, DOI 10.1167/iovs.10-5931; Hernandez C, 2013, DIABETES, V62, P2569, DOI 10.2337/db12-0926; HOLOPIGIAN K, 1992, INVEST OPHTH VIS SCI, V33, P2773; Imai H, 2009, DEV OPHTHALMOL, V44, P56, DOI 10.1159/000223946; Ju WK, 2008, MOL VIS, V14, P2629; Ju WK, 2009, INVEST OPHTH VIS SCI, V50, P707, DOI 10.1167/iovs.08-2499; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Klemp K, 2005, INVEST OPHTH VIS SCI, V46, P2620, DOI 10.1167/iovs.04-1254; KLINE RP, 1978, P NATL ACAD SCI USA, V75, P5727, DOI 10.1073/pnas.75.11.5727; Kowluru RA, 2001, NEUROCHEM INT, V38, P385, DOI 10.1016/S0197-0186(00)00112-1; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293; Lau JCM, 2013, MOL VIS, V19, P1538; Lecleire-Collet A, 2011, INVEST OPHTH VIS SCI, V52, P2861, DOI 10.1167/iovs.10-5960; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Lieth E, 2000, EXP EYE RES, V70, P723, DOI 10.1006/exer.2000.0840; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markowitz Alison J B, 2007, Cellscience, V4, P111; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Ng JS, 2008, INVEST OPHTH VIS SCI, V49, P1622, DOI 10.1167/iovs.07-1157; Ng YK, 2004, BRAIN RES, V1018, P66, DOI 10.1016/j.brainres.2004.05.055; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Santiago AR, 2009, MOL VIS, V15, P1620; Sarthy VP, 2005, GLIA, V49, P184, DOI 10.1002/glia.20097; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Shirao Y, 1998, PROG RETIN EYE RES, V17, P59, DOI 10.1016/S1350-9462(97)00005-0; Silva KC, 2013, INVEST OPHTH VIS SCI, V54, P1325, DOI 10.1167/iovs.12-10647; Simo R, 2008, DIABETOLOGIA, V51, P1574, DOI 10.1007/s00125-008-0989-9; Simo R, 2012, BRIT J OPHTHALMOL, V96, P1285, DOI 10.1136/bjophthalmol-2012-302005; Simo R, 2009, DIABETES CARE, V32, P1556, DOI 10.2337/dc09-0565; Tang L, 2011, EXP BIOL MED, V236, P1051, DOI 10.1258/ebm.2011.010400; Tyrberg M, 2011, DOC OPHTHALMOL, V123, P193, DOI 10.1007/s10633-011-9298-6; Valverde AM, 2013, MOL VIS, V19, P47; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; van Dijk HW, 2011, VISION RES, V51, P224, DOI 10.1016/j.visres.2010.08.024; WACHTMEISTER L, 1987, DOC OPHTHALMOL, V66, P187, DOI 10.1007/BF00145232; Xiao CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030343; Zhang Y, 2011, INVEST OPHTH VIS SCI, V52, P278, DOI 10.1167/iovs.09-4727	64	115	120	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97302	10.1371/journal.pone.0097302	http://dx.doi.org/10.1371/journal.pone.0097302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837086	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800036
J	Cui, H; Liu, XH; Wang, KY; Zhu, CY; Wang, C; Xie, XH				Cui, Hong; Liu, Xiao-hui; Wang, Ke-yong; Zhu, Chun-yan; Wang, Chen; Xie, Xin-hui			Association of Saccade Duration and Saccade Acceleration/Deceleration Asymmetry during Visually Guided Saccade in Schizophrenia Patients	PLOS ONE			English	Article							ALERT SQUIRREL-MONKEY; EYE-MOVEMENTS; BURST NEURONS; PHYSIOLOGY; TRACKING; VELOCITY; ANATOMY	Objective: To examine the difference between schizophrenia patients and normal controls on velocity and acceleration of saccade, by using the basic visually guided saccade (VGS) paradigm. Methods: Eighteen schizophrenia outpatients and fourteen normal controls participated in the VGS task. Multiple indicators, including amplitude, duration, velocity, latency, accuracy rate, acceleration, and deceleration were analyzed. Asymmetric acceleration index (AAI) was introduced to describe the difference between peak acceleration and peak deceleration. The correlation coefficient (R-AD) of AAI and duration was computed to examine the difference between schizophrenia patients and normal controls. Results: No significant difference between patients and normal controls was found on amplitude, duration, latency, and accuracy rate. However, RAD values of schizophrenia patients were significantly lower than the control group. Conclusion: Compared to normal controls, association of saccade duration and saccade acceleration/deceleration asymmetry during visually guided saccade was lower in schizophrenia patients.	[Cui, Hong; Liu, Xiao-hui; Xie, Xin-hui] Chinese Peoples Liberat Army Gen Hosp, Div Med Psychol, Beijing, Peoples R China; [Cui, Hong; Liu, Xiao-hui; Xie, Xin-hui] Med Sch PLA, Beijing, Peoples R China; [Wang, Ke-yong; Wang, Chen; Xie, Xin-hui] Anhui Mental Hlth Ctr, Dept Psychiat, Hefei, Anhui, Peoples R China; [Zhu, Chun-yan; Wang, Chen; Xie, Xin-hui] Anhui Med Univ, Dept Med Psychol, Hefei, Anhui, Peoples R China	Chinese People's Liberation Army General Hospital; Anhui Medical University	Xie, XH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Div Med Psychol, Beijing, Peoples R China.	xxh.med@gmail.com		Xie, Xin-hui/0000-0002-3603-3854	National Science and Technology Pillar Program [2013BAI08B03]; Natural Science Foundation of China [31100812]	National Science and Technology Pillar Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science and Technology Pillar Program (Grant number 2013BAI08B03 http://www.most.gov.cn/) and the Natural Science Foundation of China (Grant number 31100812 http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in data collection, decision to publish, or preparation of manuscript.	ABEL LA, 1988, BIOL PSYCHIAT, V24, P747, DOI 10.1016/0006-3223(88)90250-8; BALOH RW, 1975, NEUROLOGY, V25, P1065, DOI 10.1212/WNL.25.11.1065; Diefendorf AR, 1908, BRAIN, V31, P451, DOI 10.1093/brain/31.3.451; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; HOLZMAN PS, 1974, ARCH GEN PSYCHIAT, V31, P143; Horn AKE, 1998, J COMP NEUROL, V392, P413; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KOJIMA T, 1992, SCHIZOPHRENIA BULL, V18, P85, DOI 10.1093/schbul/18.1.85; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; LEVY DL, 1994, SCHIZOPHRENIA BULL, V20, P47, DOI 10.1093/schbul/20.1.47; Qiu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025805; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; STRASSMAN A, 1986, J COMP NEUROL, V249, P337, DOI 10.1002/cne.902490303; STRASSMAN A, 1986, J COMP NEUROL, V249, P358, DOI 10.1002/cne.902490304; VANOPSTAL AJ, 1987, VISION RES, V27, P731, DOI 10.1016/0042-6989(87)90071-X; Zhao Q, 2013, SCHIZOPHRENIA B	18	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97308	10.1371/journal.pone.0097308	http://dx.doi.org/10.1371/journal.pone.0097308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24837253	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800037
J	Fernandez, R; Kvist, S; Lenihan, J; Giribet, G; Ziegler, A				Fernandez, Rosa; Kvist, Sebastian; Lenihan, Jennifer; Giribet, Gonzalo; Ziegler, Alexander			Sine Systemate Chaos? A Versatile Tool for Earthworm Taxonomy: Non-Destructive Imaging of Freshly Fixed and Museum Specimens Using Micro-Computed Tomography	PLOS ONE			English	Article							SPECIES COMPLEX OLIGOCHAETA; MOUSE EMBRYOS; MORPHOLOGY; CT; VISUALIZATION; LUMBRICIDAE; ANATOMY; DNA; MICROTOMOGRAPHY; RECONSTRUCTION	In spite of the high relevance of lumbricid earthworms ('Oligochaeta': Lumbricidae) for soil structure and functioning, the taxonomy of this group of terrestrial invertebrates remains in a quasi-chaotic state. Earthworm taxonomy traditionally relies on the interpretation of external and internal morphological characters, but the acquisition of these data is often hampered by tedious dissections or restricted access to valuable and rare museum specimens. The present state of affairs, in conjunction with the difficulty of establishing primary homologies for multiple morphological features, has led to an almost unrivaled instability in the taxonomy and systematics of certain earthworm groups, including Lumbricidae. As a potential remedy, we apply for the first time a non-destructive imaging technique to lumbricids and explore the future application of this approach to earthworm taxonomy. High-resolution micro-computed tomography (mu CT) scanning of freshly fixed and museum specimens was carried out using two cosmopolitan species, Aporrectodea caliginosa and A. trapezoides. By combining two-dimensional and three-dimensional dataset visualization techniques, we demonstrate that the morphological features commonly used in earthworm taxonomy can now be analyzed without the need for dissection, whether freshly fixed or museum specimens collected more than 60 years ago are studied. Our analyses show that mCT in combination with soft tissue staining can be successfully applied to lumbricid earthworms. An extension of the approach to other families is poised to strengthen earthworm taxonomy by providing a versatile tool to resolve the taxonomic chaos currently present in this ecologically important, but taxonomically neglected group of terrestrial invertebrates.	[Fernandez, Rosa; Kvist, Sebastian; Lenihan, Jennifer; Giribet, Gonzalo] Harvard Univ, Dept Organism & Evolutionary Biol, Museum Comparat Zool, Cambridge, MA 02138 USA; [Ziegler, Alexander] Ziegler Biosolut, Waldshut Tiengen, Germany	Harvard University	Fernandez, R (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Museum Comparat Zool, Cambridge, MA 02138 USA.	rfernandezgarcia@g.harvard.edu	Giribet, Gonzalo/P-1086-2015; Fernández, Rosa/Q-2294-2016; Fernandez, Rosa/AAR-5567-2021	Giribet, Gonzalo/0000-0002-5467-8429; Fernández, Rosa/0000-0002-4719-6640; Fernandez, Rosa/0000-0002-4719-6640; Trimble, Jennifer/0000-0002-7480-3645; Ziegler, Alexander/0000-0002-7572-6872; Kvist, Sebastian/0000-0003-3200-6207	Ramon Areces Foundation; Wenner-Gren Foundations; Helge Ax:son Johnson's Foundation; Deutsche Forschungsgemeinschaft [ZI-1274/1-1, ZI-1274/1-2]; Museum of Comparative Zoology; Department of Invertebrate Zoology	Ramon Areces Foundation; Wenner-Gren Foundations; Helge Ax:son Johnson's Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Museum of Comparative Zoology; Department of Invertebrate Zoology	Funding for RF was provided by the Ramon Areces Foundation, for SK by the Wenner-Gren Foundations and Helge Ax:son Johnson's Foundation, and for AZ by the Deutsche Forschungsgemeinschaft through grants no. ZI-1274/1-1 and ZI-1274/1-2. Research was also supported by internal funds from the Museum of Comparative Zoology and from the Department of Invertebrate Zoology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Bauder JAS, 2013, BIOL J LINN SOC, V110, P291, DOI 10.1111/bij.12134; Baverstock H, 2013, J ANAT, V223, P46, DOI 10.1111/joa.12059; Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; Blakemore RJ., 2006, COSMOPOLITAN EARTHWO; Boistel R, 2011, MAR ECOL-EVOL PERSP, V32, P438, DOI 10.1111/j.1439-0485.2011.00442.x; Bouche MB, 1972, LOMBRICIENS FRANCE E; Briones MJI, 1996, CAN J ZOOL, V74, P240, DOI 10.1139/z96-030; Cox PG, 2011, ANAT REC, V294, P1612, DOI 10.1002/ar.21483; Csuzdi C, 2007, ACTA ZOOL ACAD SCI H, V53, P347; Csuzdi C, 2007, EUR J SOIL BIOL, V43, pS19, DOI 10.1016/j.ejsobi.2007.08.005; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Eberhard MJB, 2010, ARTHROPOD STRUCT DEV, V39, P230, DOI 10.1016/j.asd.2010.02.002; Edwards C.A., 2004, EARTHWORM ECOLOGY; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO; Faraj KA, 2009, TISSUE ENG PART C-ME, V15, P493, DOI 10.1089/ten.tec.2008.0436; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fender W.M., 1990, P357; Fernandez R, 2012, MOL PHYLOGENET EVOL, V64, P368, DOI 10.1016/j.ympev.2012.04.011; Garwood R, 2009, BIOL LETTERS, V5, P841, DOI 10.1098/rsbl.2009.0464; GATES GE, 1972, T AM PHILOS SOC, V62, P5; Gignac PM, 2014, J EXP ZOOL PART B, V322, P166, DOI 10.1002/jez.b.22561; Golding RE, 2009, J MORPHOL, V270, P558, DOI 10.1002/jmor.10699; Haug JT, 2011, J MICROSC-OXFORD, V244, P259, DOI 10.1111/j.1365-2818.2011.03534.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holliday CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062806; Briones MJI, 2009, SOIL BIOL BIOCHEM, V41, P2257, DOI 10.1016/j.soilbio.2009.07.008; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Johnson JT, 2006, PLOS GENET, V2, P471, DOI 10.1371/journal.pgen.0020061; Kamenz C, 2009, MICRON, V40, P911, DOI 10.1016/j.micron.2009.05.007; Kerbl A, 2013, J EXP MAR BIOL ECOL, V447, P140, DOI 10.1016/j.jembe.2013.02.022; Klussmann-Fricke BJ, 2012, ARTHROPOD STRUCT DEV, V41, P545, DOI 10.1016/j.asd.2012.06.002; Kvist S, 2013, MOL PHYLOGENET EVOL, V69, P39, DOI 10.1016/j.ympev.2013.05.012; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; Lautenschlager S, 2013, J ANAT, V222, P260, DOI 10.1111/joa.12000; Lavelle P., 2001, SOIL ECOLOGY; Lee K. E., 1985, Earthworms: their ecology and relationships with soils and land use.; Lenihan J, 2014, GIGASCIENCE DATABASE, DOI [10.5524/100092, DOI 10.5524/100092]; Lenihan J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-6; LJUNGSTROM P-O, 1972, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V99, P1; Metscher Brian D, 2011, Cold Spring Harb Protoc, V2011, P1462, DOI 10.1101/pdb.prot067033; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Michaelsen W., 1900, Das Tierreich, VLief. x, pUnpaginated; Michalik P, 2013, ZOOKEYS, P101, DOI 10.3897/zookeys.335.6030; Murienne J, 2008, NATURE, V453, P450, DOI 10.1038/453450d; Nickel M, 2006, ZOOMORPHOLOGY, V125, P209, DOI 10.1007/s00435-006-0021-1; OMODEO P, 1991, B ZOOL, V58, P171, DOI 10.1080/11250009109355749; Paredes UM, 2012, J ZOOL SYST EVOL RES, V50, P247, DOI 10.1111/j.1439-0469.2012.00657.x; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Perez-Losada M, 2009, MOL PHYLOGENET EVOL, V52, P293, DOI 10.1016/j.ympev.2009.04.003; Pop AA, 2003, PEDOBIOLOGIA, V47, P428, DOI 10.1016/S0031-4056(04)70217-6; Prajapati SI, 2014, MOUSE MOL EMBRYOLOGY, P291; Ribi W, 2008, J NEUROSCI METH, V171, P93, DOI 10.1016/j.jneumeth.2008.02.010; Richards CS, 2012, FORENSIC SCI INT, V220, P251, DOI 10.1016/j.forsciint.2012.03.012; Saito S, 2012, BRIT J RADIOL, V85, pE973, DOI 10.1259/bjr/13040401; Sharpe J, 2004, ANNU REV BIOMED ENG, V6, P209, DOI 10.1146/annurev.bioeng.6.040803.140210; Stauber Martin, 2008, V455, P273, DOI 10.1007/978-1-59745-104-8_19; Stephenson J. L, 1930, OLIGOCHAETA; Tahara R, 2013, J ANAT, V223, P297, DOI 10.1111/joa.12081; Tsai HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024935; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Vocking O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072660; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Wilhelm G, 2011, BIOL J LINN SOC, V104, P642, DOI 10.1111/j.1095-8312.2011.01751.x; Wilhelmi AP, 2012, ZOOMORPHOLOGY, V131, P325, DOI 10.1007/s00435-012-0162-3; Ziegler Alexander, 2011, BMC Med, V9, P17, DOI 10.1186/1741-7015-9-17; Ziegler A, 2014, COMPUT ANAL SYNTH DE, P235; Ziegler A, 2012, ZOOSYMPOSIA, V7, P53, DOI 10.11646/zoosymposia.7.1.6; Ziegler A, 2011, ZOOMORPHOLOGY, V130, P227, DOI 10.1007/s00435-011-0138-8; Zimmermann D, 2011, ARTHROPOD STRUCT DEV, V40, P571, DOI 10.1016/j.asd.2011.06.003	74	53	55	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96617	10.1371/journal.pone.0096617	http://dx.doi.org/10.1371/journal.pone.0096617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837238	Green Submitted, gold, Green Published			2022-12-27	WOS:000339614800018
J	Halliday, DWR; MacDonald, SWS; Sherf, SK; Tanaka, JW				Halliday, Drew W. R.; MacDonald, Stuart W. S.; Sherf, Suzanne K.; Tanaka, James W.			A Reciprocal Model of Face Recognition and Autistic Traits: Evidence from an Individual Differences Perspective	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; SEX-DIFFERENCES; CHILDREN; DISORDER; SKILLS; POPULATION; PERCEPTION; REGRESSION; IDENTITY; AMYGDALA	Although not a core symptom of the disorder, individuals with autism often exhibit selective impairments in their face processing abilities. Importantly, the reciprocal connection between autistic traits and face perception has rarely been examined within the typically developing population. In this study, university participants from the social sciences, physical sciences, and humanities completed a battery of measures that assessed face, object and emotion recognition abilities, general perceptual-cognitive style, and sub-clinical autistic traits (the Autism Quotient (AQ)). We employed separate hierarchical multiple regression analyses to evaluate which factors could predict face recognition scores and AQ scores. Gender, object recognition performance, and AQ scores predicted face recognition behaviour. Specifically, males, individuals with more autistic traits, and those with lower object recognition scores performed more poorly on the face recognition test. Conversely, university major, gender and face recognition performance reliably predicted AQ scores. Science majors, males, and individuals with poor face recognition skills showed more autistic-like traits. These results suggest that the broader autism phenotype is associated with lower face recognition abilities, even among typically developing individuals.	[Halliday, Drew W. R.; MacDonald, Stuart W. S.; Tanaka, James W.] Univ Victoria, Victoria, BC, Canada; [Sherf, Suzanne K.] Penn State Univ, State Coll, PA USA; [Halliday, Drew W. R.; Tanaka, James W.] Ctr Autism Res Technol & Educ, Victoria, BC, Canada	University of Victoria; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Tanaka, JW (corresponding author), Univ Victoria, Victoria, BC, Canada.	jtanaka@uvic.ca	Scherf, K. Suzanne/H-5911-2019	Scherf, K. Suzanne/0000-0002-0696-6362	Temporal Dynamics of Learning Center (NSF) [SBE-0542013]; National Institute of Child Health and Human Development (NIH) [HD-46526]; Natural Sciences and Engineering Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER	Temporal Dynamics of Learning Center (NSF)(National Science Foundation (NSF)); National Institute of Child Health and Human Development (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Natural Sciences and Engineering Research(Natural Sciences and Engineering Research Council of Canada (NSERC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by grants from the Temporal Dynamics of Learning Center (NSF Grant #SBE-0542013), National Institute of Child Health and Human Development (NIH Grant HD-46526) and the Natural Sciences and Engineering Research.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1998, AUTISM, V2, P297; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Bate S, 2010, PERS INDIV DIFFER, V48, P239, DOI 10.1016/j.paid.2009.10.005; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2005, DEV PSYCHOPATHOL, V17, P679, DOI 10.1017/S0954579405050327; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; Dennett HW, 2012, BEHAV RES METHODS, V44, P587, DOI 10.3758/s13428-011-0160-2; Duchaine B, 2009, COGN NEUROPSYCHOL, V26, P620, DOI 10.1080/02643291003616145; Frith U, 1991, AUTISM ASPERGERS SYN; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Joseph RM, 2002, J CHILD PSYCHOL PSYC, V43, P1, DOI [DOI 10.1111/1469-7610.00142, https://doi.org/10.1111/1469-7610.00142]; Kleinhans NM, 2010, NEUROPSYCHOLOGIA, V48, P3665, DOI 10.1016/j.neuropsychologia.2010.07.022; Lainhart JE, 2002, AM J MED GENET, V113, P231, DOI 10.1002/ajmg.10615; Li Jingguang, 2010, Commun Integr Biol, V3, P295; LORD C, 1982, J AUTISM DEV DISORD, V12, P317, DOI 10.1007/BF01538320; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mars AE, 1998, J PEDIATR-US, V132, P500, DOI 10.1016/S0022-3476(98)70027-7; McGugin RW, 2012, VISION RES, V69, P10, DOI 10.1016/j.visres.2012.07.014; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Rehnman J, 2007, ACTA PSYCHOL, V124, P344, DOI 10.1016/j.actpsy.2006.04.004; Rhodes G, 2013, NEUROPSYCHOLOGIA, V51, P2702, DOI 10.1016/j.neuropsychologia.2013.08.016; Scherf KS, 2008, J CHILD PSYCHOL PSYC, V49, P838, DOI 10.1111/j.1469-7610.2008.01903.x; Scherf KS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00026; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Serra M, 2003, J AUTISM DEV DISORD, V33, P303, DOI 10.1023/A:1024458618172; Spreen O, 1998, COMPENDIUM NEUROPSYC; Swettenham J, 1998, J CHILD PSYCHOL PSYC, V39, P747, DOI 10.1111/1469-7610.00373; Tanaka JW, 2012, J CHILD PSYCHOL PSYC, V53, P1259, DOI 10.1111/j.1469-7610.2012.02571.x; Tanaka JW, 2010, J CHILD PSYCHOL PSYC, V51, P944, DOI 10.1111/j.1469-7610.2010.02258.x; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Wolf JM, 2008, AUTISM RES, V1, P329, DOI 10.1002/aur.56; Yardley L, 2008, J PSYCHOSOM RES, V65, P445, DOI 10.1016/j.jpsychores.2008.03.013	42	26	26	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e94013	10.1371/journal.pone.0094013	http://dx.doi.org/10.1371/journal.pone.0094013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24853862	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200001
J	Yi, JR; Liang, XM; Zhao, G; He, XM				Yi, Jingru; Liang, Xin M.; Zhao, Gang; He, Xiaoming			An Improved Model for Nucleation-Limited Ice Formation in Living Cells during Freezing	PLOS ONE			English	Article							CRYOPRESERVATION; TRANSPORT; MEMBRANES; TISSUES; WATER; HEPATOCYTES; CRYOSURGERY; MECHANISMS; KINETICS; OOCYTES	Ice formation in living cells is a lethal event during freezing and its characterization is important to the development of optimal protocols for not only cryopreservation but also cryotherapy applications. Although the model for probability of ice formation (PIF) in cells developed by Toner et al. has been widely used to predict nucleation-limited intracellular ice formation (IIF), our data of freezing Hela cells suggest that this model could give misleading prediction of PIF when the maximum PIF in cells during freezing is less than 1 (PIF ranges from 0 to 1). We introduce a new model to overcome this problem by incorporating a critical cell volume to modify the Toner's original model. We further reveal that this critical cell volume is dependent on the mechanisms of ice nucleation in cells during freezing, i.e., surface-catalyzed nucleation (SCN) and volume-catalyzed nucleation (VCN). Taken together, the improved PIF model may be valuable for better understanding of the mechanisms of ice nucleation in cells during freezing and more accurate prediction of PIF for cryopreservation and cryotherapy applications.	[Yi, Jingru; Liang, Xin M.; Zhao, Gang] Univ Sci & Technol China, Ctr Biomed Engn, Dept Elect Sci & Technol, Hefei 230026, Anhui, Peoples R China; [Liang, Xin M.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University	Zhao, G (corresponding author), Univ Sci & Technol China, Ctr Biomed Engn, Dept Elect Sci & Technol, Hefei 230026, Anhui, Peoples R China.	ZhaoG@ustc.edu.cn; he.429@osu.edu	He, Xiaoming/C-5499-2008; Zhao, Gang/C-8125-2011	He, Xiaoming/0000-0003-0125-6086; Zhao, Gang/0000-0002-0201-1825	National Natural Science Foundation of China [51076149, 51276179]; Fundamental Research Funds for the Central Universities [WK 2100230009]; XML [WK 2100230013]; National Science Foundation [NSF CBET-1154965]; National Institutes of Health [NIH R01EB012108]; American Cancer Society [120936-RSG-11-109-01-CDD]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012108] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); XML; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Natural Science Foundation of China (Nos. 51076149, 51276179) to GZ and the Fundamental Research Funds for the Central Universities to GZ (WK 2100230009) and XML (WK 2100230013), and was supported by National Science Foundation (NSF CBET-1154965), National Institutes of Health (NIH R01EB012108), and American Cancer Society (120936-RSG-11-109-01-CDD) to XH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya T., 2010, OPEN BIOTECHNOL J, V4, P26, DOI [10.2174/1874070701004010026, DOI 10.2174/1874070701004010026]; Anger JT, 2003, J UROLOGY, V170, P1079, DOI 10.1097/01.ju.0000084820.98430.b8; Berrada MS, 2001, CRYOLETTERS, V22, P353; Bischof JC, 2006, CRYOBIOLOGY, V53, P367; Borini A, 2009, SEMIN REPROD MED, V27, P443, DOI 10.1055/s-0029-1241053; Chao BH, 2004, CRYOBIOLOGY, V49, P10, DOI 10.1016/j.cryobiol.2004.04.005; Gage AA, 2007, J AM COLL SURGEONS, V205, P342, DOI 10.1016/j.jamcollsurg.2007.03.007; He XM, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336304; He Xiaoming, 2011, Open Biomed Eng J, V5, P47, DOI 10.2174/1874120701105010047; Hunt CJ, 2007, TRANSFUS MED HEMOTH, V34, P293, DOI 10.1159/000104458; KARLSSON JOM, 1994, J APPL PHYS, V75, P4442, DOI 10.1063/1.355959; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Li AP, 1999, CHEM-BIOL INTERACT, V121, P17, DOI 10.1016/S0009-2797(99)00088-5; Liu J, 1997, CRYOBIOLOGY, V35, P1, DOI 10.1006/cryo.1997.2018; Liu J, 2009, J NANOSCI NANOTECHNO, V9, P4521, DOI 10.1166/jnn.2009.1264; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1965, ANN NY ACAD SCI, V125, P658, DOI 10.1111/j.1749-6632.1965.tb45420.x; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MAZUR P, 1977, CRYOBIOLOGY, V14, P251, DOI 10.1016/0011-2240(77)90175-4; Muller-Schweinitzer E, 2009, ORGANOGENESIS, V5, P97, DOI 10.4161/org.5.3.9495; PITT RE, 1989, CRYOBIOLOGY, V26, P44, DOI 10.1016/0011-2240(89)90032-1; PITT RE, 1991, CRYOBIOLOGY, V28, P72, DOI 10.1016/0011-2240(91)90009-D; SCHEIWE MW, 1987, CRYOBIOLOGY, V24, P473, DOI 10.1016/0011-2240(87)90051-4; Thirumala S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/19/195104; TONER M, 1992, AICHE J, V38, P1512, DOI 10.1002/aic.690381004; TONER M, 1990, BIOPHYS J, V57, pA76; TONER M, 1990, J MEMBRANE BIOL, V115, P261, DOI 10.1007/BF01868641; Toner Mehmet, 1993, Advances in Low-Temperature Biology, V2, P1; TOSCANO WM, 1975, MECH ENG, V97, P60; Weng LD, 2011, J PHYS CHEM B, V115, P14721, DOI 10.1021/jp2054348; Yan JF, 2008, NANOMED-NANOTECHNOL, V4, P79, DOI 10.1016/j.nano.2007.11.002; Yang G, 2011, CRYOBIOLOGY, V63, P38, DOI 10.1016/j.cryobiol.2011.04.007; Yang G, 2011, ANN BIOMED ENG, V39, P580, DOI 10.1007/s10439-010-0158-4	33	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98132	10.1371/journal.pone.0098132	http://dx.doi.org/10.1371/journal.pone.0098132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852166	Green Submitted, Green Published, gold			2022-12-27	WOS:000338323200048
J	Cardona, A; Pagani, L; Antao, T; Lawson, DJ; Eichstaedt, CA; Yngvadottir, B; Shwe, MTT; Wee, J; Romero, IG; Raj, S; Metspalu, M; Villems, R; Willerslev, E; Tyler-Smith, C; Malyarchuk, BA; Derenko, MV; Kivisild, T				Cardona, Alexia; Pagani, Luca; Antao, Tiago; Lawson, Daniel J.; Eichstaedt, Christina A.; Yngvadottir, Bryndis; Ma Than Than Shwe; Wee, Joseph; Romero, Irene Gallego; Raj, Srilakshmi; Metspalu, Mait; Villems, Richard; Willerslev, Eske; Tyler-Smith, Chris; Malyarchuk, Boris A.; Derenko, Miroslava V.; Kivisild, Toomas			Genome-Wide Analysis of Cold Adaptation in Indigenous Siberian Populations	PLOS ONE			English	Article							POSITIVE SELECTION; BLOOD-PRESSURE; SMOOTH-MUSCLE; BIOINFORMATICS; IDENTIFICATION; ASSOCIATION; PATHWAYS; SOFTWARE; PATTERNS; SEQUENCE	Following the dispersal out of Africa, where hominins evolved in warm environments for millions of years, our species has colonised different climate zones of the world, including high latitudes and cold environments. The extent to which human habitation in (sub-)Arctic regions has been enabled by cultural buffering, short-term acclimatization and genetic adaptations is not clearly understood. Present day indigenous populations of Siberia show a number of phenotypic features, such as increased basal metabolic rate, low serum lipid levels and increased blood pressure that have been attributed to adaptation to the extreme cold climate. In this study we introduce a dataset of 200 individuals from ten indigenous Siberian populations that were genotyped for 730,525 SNPs across the genome to identify genes and non-coding regions that have undergone unusually rapid allele frequency and long-range haplotype homozygosity change in the recent past. At least three distinct population clusters could be identified among the Siberians, each of which showed a number of unique signals of selection. A region on chromosome 11 (chr11: 66-69 Mb) contained the largest amount of clustering of significant signals and also the strongest signals in all the different selection tests performed. We present a list of candidate cold adaption genes that showed significant signals of positive selection with our strongest signals associated with genes involved in energy regulation and metabolism (CPT1A, LRP5, THADA) and vascular smooth muscle contraction (PRKG1). By employing a new method that paints phased chromosome chunks by their ancestry we distinguish local Siberian-specific long-range haplotype signals from those introduced by admixture.	[Cardona, Alexia; Pagani, Luca; Eichstaedt, Christina A.; Yngvadottir, Bryndis; Kivisild, Toomas] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Pagani, Luca; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, England; [Antao, Tiago] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lawson, Daniel J.] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; [Ma Than Than Shwe; Wee, Joseph] Natl Canc Ctr Singapore, Singapore, Singapore; [Romero, Irene Gallego] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Raj, Srilakshmi] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Metspalu, Mait; Villems, Richard] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Metspalu, Mait; Villems, Richard; Kivisild, Toomas] Estonian Bioctr, Tartu, Estonia; [Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Malyarchuk, Boris A.; Derenko, Miroslava V.] Russian Acad Sci, Inst Biol Problems N, Magadan, Russia	University of Cambridge; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; National Cancer Centre Singapore (NCCS); University of Chicago; Cornell University; University of Tartu; Estonian Biocentre; University of Copenhagen; Institute of Biological Problems of the North; Russian Academy of Sciences	Cardona, A (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England.	ac812@cam.ac.uk	Pagani, Luca/G-8511-2017; Derenko, Miroslava/J-1495-2018; Antao, Tiago/C-3615-2009; Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011; Kivisild, Toomas/P-5889-2017; Metspalu, Mait/G-8671-2015; Malyarchuk, Boris/D-5783-2018; Lawson, Daniel/A-8550-2011	Pagani, Luca/0000-0002-6639-524X; Derenko, Miroslava/0000-0002-1849-784X; Antao, Tiago/0000-0002-7269-5513; Willerslev, Eske/0000-0002-7081-6748; Kivisild, Toomas/0000-0002-6297-7808; Metspalu, Mait/0000-0003-3099-9161; Malyarchuk, Boris/0000-0002-0304-0652; Lawson, Daniel/0000-0002-5311-6213; Gallego Romero, Irene/0000-0003-1613-8998; Cardona, Alexia/0000-0002-7877-5565	ERC [FP7 - 261213]; Wellcome Trust [098051]	ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by ERC Starting Investigator grant (FP7 - 261213) to T. K. http://erc.europa.eu/. LP and CTS were supported by The Wellcome Trust (098051). http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjerregaard P, 2003, SCAND J PUBLIC HEALT, V31, P92, DOI 10.1080/14034940210133924; Bluthgen Nils, 2005, Genome Inform, V16, P106; Cann HM, 2002, SCIENCE, V296, P261; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cannon B, 2010, NAT MED, V16, P965, DOI 10.1038/nm0910-965; Chea J, 2012, CELL CYCLE, V11, P2885, DOI 10.4161/cc.21280; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; COCKERHAM CC, 1973, GENETICS, V74, P679; De Lorenzo F, 1999, QJM-INT J MED, V92, P747, DOI 10.1093/qjmed/92.12.747; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Franceschini N, 2013, DIABETOLOGIA; Frisancho A., 1993, HUMAN ADAPTATION ACC, DOI [10.3998/mpub.9951, DOI 10.3998/MPUB.9951]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; Kuzmin YV, 2008, J ARCHAEOL RES, V16, P163, DOI 10.1007/s10814-007-9019-6; Lappalainen S, 2009, CLIN ENDOCRINOL, V70, P725, DOI 10.1111/j.1365-2265.2008.03388.x; Lawson DJ, 2012, ANNU REV GENOM HUM G, V13, P337, DOI 10.1146/annurev-genom-082410-101510; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; LEBLANC J, 1975, J APPL PHYSIOL, V39, P181, DOI 10.1152/jappl.1975.39.2.181; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Leonard WR, 2005, ANNU REV ANTHROPOL, V34, P451, DOI 10.1146/annurev.anthro.34.081804.120558; Levin LPP M. G., 1964, PEOPLES SIBERIA; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Phinney Stephen D, 2004, Nutr Metab (Lond), V1, P2, DOI 10.1186/1743-7075-1-2; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reynolds JE, 2009, ARCTIC, V59; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Shephard R.J., 1996, HLTH CONSEQUENCES MO, DOI [10.1017/CBO9780511983726, DOI 10.1017/CBO9780511983726]; Snodgrass JJ, 2008, AM J PHYS ANTHROPOL, V137, P145, DOI 10.1002/ajpa.20851; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	68	79	91	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98076	10.1371/journal.pone.0098076	http://dx.doi.org/10.1371/journal.pone.0098076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847810	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600085
J	Cruz, GMQ; Metcalfe, CJ; de Setta, N; Cruz, EAO; Vieira, AP; Medina, R; Van Sluys, MA				Cruz, Guilherme M. Q.; Metcalfe, Cushla J.; de Setta, Nathalia; Cruz, Edgar A. O.; Vieira, Andreia Prata; Medina, Rosario; Van Sluys, Marie-Anne			Virus-Like Attachment Sites and Plastic CpG Islands: Landmarks of Diversity in Plant Del Retrotransposons	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TRANSPOSABLE ELEMENTS; LTR-RETROTRANSPOSONS; COPY NUMBER; DNA; GENOME; DIVERSIFICATION; INTEGRASE; EVOLUTION; REVEALS	Full-length Del elements from ten angiosperm genomes, 5 monocot and 5 dicot, were retrieved and putative attachment (att) sites were identified. In the 2432 Del elements, two types of U5 att sites and a single conserved type of U3 att site were identified. Retroviral att sites confer specificity to the integration process, different att sites types therefore implies lineage specificity. While some features are common to all Del elements, CpG island patterns within the LTRs were particular to lineage specific clusters. All eudicot copies grouped into one single clade while the monocots harbour a more diverse collection of elements. Furthermore, full-length Del elements and truncated copies were unevenly distributed amongst chromosomes. Elements of Del lineage are organized in plants into three clusters and each cluster is composed of elements with distinct LTR features. Our results suggest that the Del lineage efficiently amplified in the monocots and that one branch is probably a newly emerging sub-lineage. Finally, sequences in all groups are under purifying selection. These results show the LTR region is dynamic and important in the evolution of LTR-retrotransposons, we speculate that it is a trigger for retrotransposon diversification.	[Cruz, Guilherme M. Q.; Metcalfe, Cushla J.; Cruz, Edgar A. O.; Vieira, Andreia Prata; Medina, Rosario; Van Sluys, Marie-Anne] Univ Sao Paulo, IB, Dept Bot, BR-09500900 Sao Paulo, Brazil; [de Setta, Nathalia] Univ Fed ABC UFABC, Sao Paulo, Brazil	Universidade de Sao Paulo	Van Sluys, MA (corresponding author), Univ Sao Paulo, IB, Dept Bot, BR-09500900 Sao Paulo, Brazil.	mavsluys@usp.br	Metcalfe, Cushla/GSI-8011-2022; de Setta, Nathalia/C-6069-2012; Ochoa Cruz, Andres/H-9670-2012; Metcalfe, Cushla/D-2476-2013; Vieira, Andreia/HGC-4528-2022; Van Sluys, Marie-Anne/A-8483-2012; Setta, Nathalia/D-8780-2015; Metcalfe, Cushla/AAE-4078-2019	de Setta, Nathalia/0000-0002-4807-5410; Ochoa Cruz, Andres/0000-0003-0498-6156; Metcalfe, Cushla/0000-0001-9375-3332; Van Sluys, Marie-Anne/0000-0002-6506-2734; Metcalfe, Cushla/0000-0001-9375-3332; Medina Rodriguez, Rosario Alejandra/0000-0001-9836-5339	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/52074-0, 2009/09217-7, 2009/51632-1, 2012/14610-2, 2008/58243-8, 2012/02671-7 AVP]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308197/2010-0, 565783/2008-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Bioenergy Research Program (2008/52074-0 to MAVS), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo fellowship (2009/09217-7 to CJM, 2009/51632-1 to NS and 2012/14610-2 to RM) and scholarships (2008/58243-8 to GMQC and 2012/02671-7 AVP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (308197/2010-0 to MAVS) and a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico scholarship (565783/2008-4 to EAOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Benachenhou F, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-5; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Bousios A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-89; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brown HEV, 1999, J VIROL, V73, P9011, DOI 10.1128/JVI.73.11.9011-9020.1999; Cantu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-408; Chiu R, 2000, J VIROL, V74, P8292, DOI 10.1128/JVI.74.18.8292-8298.2000; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Domingues DS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-137; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Han MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-520; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; Jordan IK, 1999, J MOL EVOL, V49, P352, DOI 10.1007/PL00006558; Kang SY, 2008, J MICROBIOL BIOTECHN, V18, P1044; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Le Rouzic A, 2013, GENOME BIOL EVOL, V5, P77, DOI 10.1093/gbe/evs130; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Manetti ME, 2009, MOL GENET GENOMICS, V281, P261, DOI 10.1007/s00438-008-0408-4; Masuda T, 1998, J VIROL, V72, P8396, DOI 10.1128/JVI.72.10.8396-8402.1998; Matsuoka Y, 1999, MOL BIOL EVOL, V16, P208, DOI 10.1093/oxfordjournals.molbev.a026103; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Nachman MW, 1996, GENETICS, V142, P537; Navarro-Quezada A, 2002, P NATL ACAD SCI USA, V99, P268, DOI 10.1073/pnas.012422299; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Paterson AH, 2009, PLANT PHYSIOL, V149, P125, DOI 10.1104/pp.108.129262; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perlman PS, 2004, SCIENCE, V303, P182, DOI 10.1126/science.1093514; Senigl F, 2008, J VIROL, V82, P7818, DOI 10.1128/JVI.00419-08; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Suoniemi A, 1997, GENETICA, V100, P219, DOI 10.1023/A:1018398016018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vernhettes S, 1998, MOL BIOL EVOL, V15, P827, DOI 10.1093/oxfordjournals.molbev.a025988; Vitte C, 2005, CYTOGENET GENOME RES, V110, P91, DOI 10.1159/000084941; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao FQ, 2009, GENOME RES, V19, P1384, DOI 10.1101/gr.091363.109	45	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97099	10.1371/journal.pone.0097099	http://dx.doi.org/10.1371/journal.pone.0097099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849372	Green Submitted, Green Published, gold			2022-12-27	WOS:000336730600020
J	de Souza, AR; Mourao, CA; do Nascimento, FS; Lino-Neto, J				de Souza, Andre Rodrigues; Mourao Junior, Carlos Alberto; do Nascimento, Fabio Santos; Lino-Neto, Jose			Sexy Faces in a Male Paper Wasp	PLOS ONE			English	Article							CANADENSIS L HYMENOPTERA; MATE CHOICE; REPRODUCTIVE STATUS; POLISTES-EXCLAMANS; SEXUAL SELECTION; FEMALE CHOICE; SIGNAL; TAIL; RECOGNITION; ORNAMENTS	Sexually selected signals are common in many animals, though little reported in social insects. We investigated the occurrence of male visual signals mediating the dominance relationships among males and female choice of sexual partner in the paper wasp Polistes simillimus. Males have three conspicuous, variable and sexually dimorphic traits: black pigmentation on the head, a pair of yellow abdominal spots and body size differences. By conducting behavioral assays, we found that none of the three visual traits are associated with male-male dominance relationship. However, males with higher proportion of black facial pigmentation and bigger yellow abdominal spots are more likely chosen as sexual partners. Also, after experimentally manipulating the proportion of black pigment on males' face, we found that females may evaluate male facial coloration during the choice of a sexual partner. Thus, the black pigmentation on P. simillimus male's head appears to play a role as a sexually selected visual signal. We suggest that sexual selection is a common force in Polistes and we highlight the importance of this group as a model for the study of visual communication in insects.	[de Souza, Andre Rodrigues] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Mourao Junior, Carlos Alberto] Univ Fed Juiz de Fora, Dept Fisiol, Juiz De Fora, MG, Brazil; [do Nascimento, Fabio Santos] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Lino-Neto, Jose] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Juiz de Fora; Universidade de Sao Paulo; Universidade Federal de Vicosa	de Souza, AR (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	andrebioufjf@gmail.com	Mourao-Junior, Carlos Alberto/GLT-3294-2022; de Souza, André Rodrigues/C-9069-2015; Nascimento, Fabio S/E-4191-2013	Mourao-Junior, Carlos Alberto/0000-0001-7199-5365; de Souza, André Rodrigues/0000-0002-1124-4874; Nascimento, Fabio S/0000-0002-3731-7111	CNPq [143246/2011-9]; Fapesp [2010/10027-5]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by CNPq (143246/2011-9) to A.R. de Souza and Fapesp (2010/10027-5) to F.S. Nascimento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1982, NATURE, V299, P818, DOI 10.1038/299818a0; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Backwell PRY, 1996, BEHAV ECOL SOCIOBIOL, V38, P407, DOI 10.1007/s002650050258; Baer B, 2003, BEHAV ECOL SOCIOBIOL, V54, P521, DOI 10.1007/s00265-003-0673-5; BEANI L, 1992, J KANSAS ENTOMOL SOC, V65, P211; BEANI L, 1988, BEHAV ECOL SOCIOBIOL, V22, P257, DOI 10.1007/BF00299840; Beani Laura, 1996, P113; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Birkhead TR, 1998, SPERM COMPETITION SE; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; BORGIA G, 1995, ANIM BEHAV, V49, P1291, DOI 10.1006/anbe.1995.0161; Cappa F, 2013, ANIM BEHAV, V86, P801, DOI 10.1016/j.anbehav.2013.07.020; Cole BJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P79, DOI 10.1007/s002650050318; Dapporto L, 2007, CURR BIOL, V17, pR504, DOI 10.1016/j.cub.2007.05.002; de Heij ME, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.48; De Souza AR, 2012, ENTOMOL EXP APPL, V144, P244, DOI 10.1111/j.1570-7458.2012.01285.x; EICKWORT K, 1969, INSECT SOC, V16, P67, DOI 10.1007/BF02224464; Enteman W, 1904, COLORATION POLISTES; EVANS MR, 1992, BEHAV ECOL SOCIOBIOL, V29, P421; Fitzpatrick S, 1998, AM NAT, V151, P157, DOI 10.1086/286109; Gamboa GJ, 2004, ANN ZOOL FENN, V41, P789; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hebets EA, 2005, BEHAV ECOL, V16, P75, DOI 10.1093/beheco/arh133; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Ishay JS, 2002, J ELECTRON MICROSC, V51, P401, DOI 10.1093/jmicro/51.6.401; Izzo AS, 2012, ANIM BEHAV, V83, P839, DOI 10.1016/j.anbehav.2012.01.005; Izzo AS, 2011, THESIS U MICHIGAN; Land MF, 1972, ANNU REV ENTOMOL, V42, P147; MOLLER AP, 1989, NATURE, V339, P132; Monnin T, 2006, ANN ZOOL FENN, V43, P515; POLAK M, 1992, J INSECT BEHAV, V5, P531, DOI 10.1007/BF01058198; POLAK M, 1993, BEHAV ECOL, V4, P325, DOI 10.1093/beheco/4.4.325; Reeve H.K., 1991, P99; SEARCY WA, 1992, AM ZOOL, V32, P71; Sledge MF, 2001, BEHAV ECOL SOCIOBIOL, V49, P401, DOI 10.1007/s002650000311; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Tannure-Nascimento IC, 2008, P ROY SOC B-BIOL SCI, V275, P2555, DOI 10.1098/rspb.2008.0589; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2011, ETHOLOGY, V117, P1138, DOI 10.1111/j.1439-0310.2011.01967.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	44	23	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98172	10.1371/journal.pone.0098172	http://dx.doi.org/10.1371/journal.pone.0098172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849073	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600095
J	Eggers, C; Schwartz, F; Pedrosa, DJ; Kracht, L; Timmermann, L				Eggers, Carsten; Schwartz, Frank; Pedrosa, David J.; Kracht, Lutz; Timmermann, Lars			Parkinson's Disease Subtypes Show a Specific Link between Dopaminergic and Glucose Metabolism in the Striatum	PLOS ONE			English	Article							BASAL GANGLIA; RESTING TREMOR; PROGRESSION; DYSFUNCTION; PET	Background: Previous studies have shown different clinical and imaging pattern in tremordominant and akinetic-rigid Parkinson's disease (PD) subtypes. The association between dopaminergic and glucose metabolism has in contrast not been investigated yet. Therefore, this study compared PD subtypes with respect to clinical and imaging findings with the aim of establishing a relationship between clinical subtypes, dopamine and glucose metabolism. Methods: Two groups of a total of 64 idiopathic PD patients (42 male, 22 female, mean age 56 +/- 10.9 years) were analysed: akinetic-rigid (AR, n = 32) and tremor-dominant (TD, n = 32) patients. Both were compared with respect to differential involvement of local striatal dopamine and glucose metabolism using [F-18]-fluoro-L-dopa (F-dopa) and [F-18]-fluorodeoxyglucose (FDG)-PET. Results: The analysis of PD subgroups showed significant differences in the F-dopa uptake in the anterior putamen. Using the results of the local striatal dopamine difference as a volume of interest for the FDG-analysis, analysis of AR patients revealed a significantly lower normalised cerebral metabolic rate of glucose (nCMRGlc) within the ventral striatum. Conclusions: The dual tracer study illlustrates clear differences between TD and AR subtypes in the ventral striatum. In accordance with previous FP-CIT-SPECT studies, it discloses congruent results for the presynaptic dopaminergic system and extends the knowledge about an additional involvement of local metabolic activity in the caudate and anterior putamen. The findings corroborate the specific role of distinct PD subtypes within the cerebello-thalamo-cortical-circuits. Multitracer PET imaging may thus enhance the knowledge about the clinical segregation into subtypes.	[Eggers, Carsten; Schwartz, Frank; Pedrosa, David J.; Timmermann, Lars] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Kracht, Lutz] Max Planck Inst Neurol Res, D-50931 Cologne, Germany	University of Cologne; Max Planck Society	Eggers, C (corresponding author), Univ Hosp Cologne, Dept Neurol, Cologne, Germany.	carsten.eggers@uk-koeln.de		Timmermann, Lars/0000-0002-5301-3580; Pedrosa, David/0000-0002-5403-1959	German Research Foundation (DFG) [Klinische Forschergruppe KFO 219, EG 350/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG, Klinische Forschergruppe KFO 219; (EG 350/1-1)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BARON JC, 1994, REV NEUROL-FRANCE, V150, P599; Benninger DH, 2009, J NEUROL, V256, P256, DOI 10.1007/s00415-009-0092-2; Borghammer P, 2012, ACTA NEUROL SCAND, V125, P303, DOI 10.1111/j.1600-0404.2011.01556.x; Borghammer P, 2009, NEUROIMAGE, V47, P1514, DOI 10.1016/j.neuroimage.2009.05.040; Breit S, 2006, J NEURAL TRANSM, V113, P187, DOI 10.1007/s00702-005-0311-7; Dhawan V, 2002, J NUCL MED, V43, P1324; Eckert T, 2007, LANCET NEUROL, V6, P926, DOI 10.1016/S1474-4422(07)70245-4; Eggers C, 2009, J NEUROL SCI, V276, P27, DOI 10.1016/j.jns.2008.08.029; Eggers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046813; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; Ghaemi M, 2002, MOVEMENT DISORD, V17, P782, DOI 10.1002/mds.10125; Hallett Mark, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS85, DOI 10.1016/S1353-8020(11)70027-X; Halliday GM, 2010, ANN NY ACAD SCI, V1184, P188, DOI 10.1111/j.1749-6632.2009.05118.x; Herman T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055193; Hilker R, 2005, NEUROLOGY, V65, P1716, DOI 10.1212/01.wnl.0000191154.78131.f6; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; Jokinen P, 2009, PARKINSONISM RELAT D, V15, P88, DOI 10.1016/j.parkreldis.2008.03.005; Kaasinen V, 2006, J NEUROL, V253, P340, DOI 10.1007/s00415-005-0993-7; Kassubek J, 2002, NEUROSCI LETT, V323, P29, DOI 10.1016/S0304-3940(02)00111-8; Kostic VS, 2012, NEUROLOGY, V78, P409, DOI 10.1212/WNL.0b013e318245d23c; Lozza C, 2002, NEUROIMAGE, V17, P688, DOI 10.1006/nimg.2002.1245; Ma Y, 2002, SYNAPSE, V45, P125, DOI 10.1002/syn.10090; Mure H, 2011, NEUROIMAGE, V54, P1244, DOI 10.1016/j.neuroimage.2010.09.028; Niethammer M, 2013, NEUROIMAGE, V78, P204, DOI 10.1016/j.neuroimage.2013.03.070; PEPPARD RF, 1992, ARCH NEUROL-CHICAGO, V49, P1262, DOI 10.1001/archneur.1992.00530360060019; Polito C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.004; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Rosenberg-Katz K, 2013, NEUROLOGY, V80, P1476, DOI 10.1212/WNL.0b013e31828cfaa4; Rossi C, 2010, EUR J NEUROL, V17, P626, DOI 10.1111/j.1468-1331.2009.02898.x; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346	35	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96629	10.1371/journal.pone.0096629	http://dx.doi.org/10.1371/journal.pone.0096629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848641	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600013
J	Liu, M; Zhao, R; Chen, Y; Zhang, J; Compton, SG; Chen, XY				Liu, Min; Zhao, Rui; Chen, Yan; Zhang, Jian; Compton, Stephen G.; Chen, Xiao-Yong			Competitive Exclusion among Fig Wasps Achieved via Entrainment of Host Plant Flowering Phenology	PLOS ONE			English	Article							POLLINATOR SPECIFICITY; COEVOLVING FIG; FICUS; MUTUALISM; CONSEQUENCES; LONGEVITY; EVOLUTION; BREAKDOWN; SOFTWARE; HISTORY	Molecular techniques are revealing increasing numbers of morphologically similar but co-existing cryptic species, challenging the niche theory. To understand the co-existence mechanism, we studied phenologies of morphologically similar species of fig wasps that pollinate the creeping fig (F. pumila) in eastern China. We compared phenologies of fig wasp emergence and host flowering at sites where one or both pollinators were present. At the site where both pollinators were present, we used sticky traps to capture the emerged fig wasps and identified species identity using mitochondrial DNA COI gene. We also genotyped F. pumila individuals of the three sites using polymorphic microsatellites to detect whether the host populations were differentiated. Male F. pumila produced two major crops annually, with figs receptive in spring and summer. A small partial third crop of receptive figs occurred in the autumn, but few of the second crop figs matured at that time. Hence, few pollinators were available to enter third crop figs and they mostly aborted, resulting in two generations of pollinating wasps each year, plus a partial third generation. Receptive figs were produced on male plants in spring and summer, timed to coincide with the release of short-lived adult pollinators from the same individual plants. Most plants were pollinated by a single species. Plants pollinated by Wiebesia sp. 1 released wasps earlier than those pollinated by Wiebesia sp. 3, with little overlap. Plants occupied by different pollinators were not spatially separated, nor genetically distinct. Our findings show that these differences created mismatches with the flight periods of the other Wiebesia species, largely 'reserving' individual plants for the resident pollinator species. This pre-emptive competitive displacement may prevent long term co-existence of the two pollinators.	[Liu, Min; Zhao, Rui; Zhang, Jian; Chen, Xiao-Yong] E China Normal Univ, Sch Ecol & Environm Sci, Tiantong Natl Field Stn Forest Ecosyst, Shanghai 200062, Peoples R China; [Chen, Yan] Mianyang Normal Univ, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang, Sichuan, Peoples R China; [Compton, Stephen G.] Univ Leeds, Fac Biol Sci, Sch Biol, Leeds, W Yorkshire, England	East China Normal University; Mianyang Teachers' College; University of Leeds	Chen, XY (corresponding author), E China Normal Univ, Sch Ecol & Environm Sci, Tiantong Natl Field Stn Forest Ecosyst, Shanghai 200062, Peoples R China.	xychens@hotmail.com	Chen, Xiao-Yong/B-1467-2009	Chen, Xiao-Yong/0000-0002-4795-8940; Compton, Stephen/0000-0002-1247-8058; Liu, Min/0000-0001-7672-7482	National Natural Science Foundation of China [31270416]; Ministry of Education of China [20110076110013]; Leader Fund of Minhang Human Resources and Social Security Bureau; Graduate School of East China Normal University [CX2011003, XRZZ2011023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Leader Fund of Minhang Human Resources and Social Security Bureau; Graduate School of East China Normal University	Funding came from the National Natural Science Foundation of China (31270416); Doctoral Program of the Ministry of Education of China (20110076110013); the Leader Fund of Minhang Human Resources and Social Security Bureau; Graduate School of East China Normal University (CX2011003 and XRZZ2011023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; Anstett MC, 1996, J BIOGEOGR, V23, P459, DOI 10.1111/j.1365-2699.1996.tb00007.x; BRONSTEIN JL, 1990, ECOLOGY, V71, P2145, DOI 10.2307/1938628; Chen Y, 2014, ACTA OECOL, V57, P142, DOI 10.1016/j.actao.2013.10.001; Chen Y, 2012, MOL ECOL, V21, P1687, DOI 10.1111/j.1365-294X.2012.05491.x; Chen Yan, 2010, Shengwu Duoyangxing, V18, P1, DOI 10.3724/SP.J.1003.2010.001; Compton SG, 2009, AFR ENTOMOL, V17, P215, DOI 10.4001/003.017.0212; CONDIT IRA J., 1955, HILGARDIA, V23, P323; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Cornille A, 2012, P ROY SOC B-BIOL SCI, V279, P1731, DOI 10.1098/rspb.2011.1972; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Dambroski HR, 2007, J EVOLUTION BIOL, V20, P2101, DOI 10.1111/j.1420-9101.2007.01435.x; Dull C, 1992, THESIS U MIAMI CORAL; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Fenner Michael, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P78, DOI 10.1078/1433-8319-00053; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harrison RD, 2000, P ROY SOC B-BIOL SCI, V267, P911, DOI 10.1098/rspb.2000.1089; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Kerdelhue C, 1997, BIOTROPICA, V29, P69, DOI 10.1111/j.1744-7429.1997.tb00007.x; KJELLBERG F, 1987, EVOLUTION, V41, P693, DOI 10.1111/j.1558-5646.1987.tb05846.x; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; Kjellberg F, 2005, BIOL ECOLOGY EVOLUTI, V1, P539; Kjellberg F, 2014, ACTA OECOL, V57, P73, DOI 10.1016/j.actao.2013.11.002; Lin RC, 2011, BIOTROPICA, V43, P200, DOI 10.1111/j.1744-7429.2010.00686.x; Liu M, 2013, MOL ECOL, V22, P4384, DOI 10.1111/mec.12406; Liu M, 2009, CONSERV GENET RESOUR, V1, P189, DOI 10.1007/s12686-009-9046-3; Luo GT, 2000, CHINESE J ECOL, V19, P73; Ma Weiliang, 1989, Acta Ecologica Sinica, V9, P9; Michaloud G, 1996, J BIOGEOGR, V23, P513, DOI 10.1111/j.1365-2699.1996.tb00013.x; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Molbo D, 2004, MOL ECOL, V13, P1613, DOI 10.1111/j.1365-294X.2004.02158.x; Ni J, 2010, PALAEOGEOGR PALAEOCL, V289, P44, DOI 10.1016/j.palaeo.2010.02.008; OLLERTON J, 1992, TRENDS ECOL EVOL, V7, P274, DOI 10.1016/0169-5347(92)90175-B; Patel A, 1996, J ECOL, V84, P667, DOI 10.2307/2261330; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Ronsted N, 2008, SYMBIOSIS, V45, P45; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith CM, 1996, J BIOGEOGR, V23, P477, DOI 10.1111/j.1365-2699.1996.tb00009.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suleman N, 2011, PLANT SYST EVOL, V296, P245, DOI 10.1007/s00606-011-0491-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; Tzeng HY, 2006, BOT STUD, V47, P307; VALDEYRON G, 1979, EVOLUTION, V33, P673, DOI 10.1111/j.1558-5646.1979.tb04720.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang R, 2009, POPUL ECOL, V51, P307, DOI 10.1007/s10144-008-0126-0; WARE AB, 1992, BIOTROPICA, V24, P544, DOI 10.2307/2389018; Whipple AV, 2009, J EVOLUTION BIOL, V22, P793, DOI 10.1111/j.1420-9101.2009.01690.x; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x; Zhang J, 2011, AM J BOT, V98, pE170, DOI 10.3732/ajb.1000340; Zhang Y, 2012, EVOL ECOL, V26, P513, DOI 10.1007/s10682-011-9525-3; 李宏庆, 2001, 生态学报, V21, P1385	55	15	18	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97783	10.1371/journal.pone.0097783	http://dx.doi.org/10.1371/journal.pone.0097783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849458	Green Published, Green Submitted, gold			2022-12-27	WOS:000336730600060
J	Rhodes, HJ; Stevenson, RJ; Ego, CL				Rhodes, Heather J.; Stevenson, Rachel J.; Ego, Courtney L.			Male-Male Clasping May Be Part of an Alternative Reproductive Tactic in Xenopus laevis	PLOS ONE			English	Article							FROG CRINIA-GEORGIANA; VOCAL COMMUNICATION; SEX RECOGNITION; BEHAVIOR; COMPETITION; STRATEGIES; POLYANDRY; DIVERSITY; ANURANS; BUFO	Male Xenopus laevis frogs have been observed to clasp other males in a sustained, amplectant position, the purpose of which is unknown. We examined three possible hypotheses for this counter-intuitive behavior: 1) clasping males fail to discriminate the sex of the frogs they clasp; 2) male-male clasping is an aggressive or dominant behavior; or 3) that males clasp other males to gain proximity to breeding events and possibly engage in sperm competition. Our data, gathered through a series of behavioral experiments in the laboratory, refute the first two hypotheses. We found that males did not clasp indiscriminately, but showed a sex preference, with most males preferentially clasping a female, but a proportion preferentially clasping another male. Males that clasped another male when there was no female present were less likely to "win'' reproductive access in a male-male-female triad, indicating that they did not establish dominance through clasping. However, those males did gain proximity to oviposition by continued male-male clasping in the presence of the female. Thus, our findings are consistent with, but cannot confirm, the third hypothesis of male-male clasping as an alternative reproductive tactic.	[Rhodes, Heather J.; Stevenson, Rachel J.; Ego, Courtney L.] Denison Univ, Dept Biol, Granville, OH 43023 USA; [Stevenson, Rachel J.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Denison University; Brown University	Rhodes, HJ (corresponding author), Denison Univ, Dept Biol, Granville, OH 43023 USA.	rhodesh@denison.edu		Rhodes, Heather J./0000-0003-0333-683X	Denison University; J. Reid and Polly Anderson Endowed Fund	Denison University; J. Reid and Polly Anderson Endowed Fund	This work has been supported by Denison University start up funds to HJR; Denison University Research Fund award to HJR; and J. Reid and Polly Anderson Endowed Fund awards to RJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arak A., 1983, P181; Belanger RM, 2009, J HERPETOL, V43, P184, DOI 10.1670/08-054R1.1; Bowcock H, 2009, COPEIA, P29, DOI 10.1643/CE-08-036; CREWS D, 1986, SCIENCE, V231, P121, DOI 10.1126/science.3941893; Darwin C., 1871, P423; Donner KO, 1965, SOC SCI FENNICA COMM, V28, P1; ELEPFANDT A, 1996, BIOL XENOPUS, P97; Elliott TM, 2007, J EXP BIOL, V210, P2836, DOI 10.1242/jeb.003988; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Halliday T.R., 1983, P3; Hettyey A., 2005, Herpetological Review, V36, P33; Hettyey A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1303, DOI 10.1007/s00265-007-0361-y; JENNIONS MD, 1992, ANIM BEHAV, V44, P1091, DOI 10.1016/S0003-3472(05)80321-5; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; KELLEY DB, 1982, HORM BEHAV, V16, P158, DOI 10.1016/0018-506X(82)90016-2; Kelley DB, 1999, DESIGN OF ANIMAL COMMUNICATION, P9; KELLEY DB, 1996, BIOL XENOPUS; Koenig WD, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P451, DOI 10.1017/CBO9780511542602.020; LUCAS JR, 1995, AM NAT, V146, P365, DOI 10.1086/285805; Marco A, 2002, ETHOL ECOL EVOL, V14, P1; PICKER MD, 1983, BEHAVIOUR, V84, P74, DOI 10.1163/156853983X00291; Rhen T, 2002, J NEUROENDOCRINOL, V14, P517, DOI 10.1046/j.1365-2826.2002.00820.x; Roberts JD, 2011, ADV STUD BEHAV, V43, P1, DOI 10.1016/B978-0-12-380896-7.00001-0; Roberts JD, 1999, ANIM BEHAV, V57, P721, DOI 10.1006/anbe.1998.1019; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602.002; TINSLEY RC, 1996, BIOL XENOPUS, P35; Tobias ML, 2010, BEHAV ECOL SOCIOBIOL, V64, P1791, DOI 10.1007/s00265-010-0991-3; Tobias ML, 2004, ANIM BEHAV, V67, P353, DOI 10.1016/j.anbehav.2003.03.016; Vignal C, 2007, P ROY SOC B-BIOL SCI, V274, P479, DOI 10.1098/rspb.2006.3744; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Xu F, 2012, BEHAV ECOL, V23, P307, DOI 10.1093/beheco/arr187; YAGER DD, 1996, BIOL XENOPUS, P121; Yu TL, 2012, ZOOL SCI, V29, P347, DOI 10.2108/zsj.29.347; Zamudio KR, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P300, DOI 10.1017/CBO9780511542602.012	36	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97761	10.1371/journal.pone.0097761	http://dx.doi.org/10.1371/journal.pone.0097761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849114	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600056
J	Du, MW; Li, Y; Tian, XL; Duan, LS; Zhang, MC; Tan, WM; Xu, DY; Li, ZH				Du, Mingwei; Li, Yi; Tian, Xiaoli; Duan, Liusheng; Zhang, Mingcai; Tan, Weiming; Xu, Dongyong; Li, Zhaohu			The Phytotoxin Coronatine Induces Abscission-Related Gene Expression and Boll Ripening during Defoliation of Cotton	PLOS ONE			English	Article							ETHYLENE BIOSYNTHESIS; FRUIT ABSCISSION; DIFFERENTIAL EXPRESSION; METHYL JASMONATE; LEAF ABSCISSION; IN-VITRO; QUALITY; ACID; INDUCTION; SYNTHASE	Defoliants can increase machine harvest efficiency of cotton (Gossypium hirusutum L.), prevent lodging and reduce the time from defoliation to harvest. Coronatine (COR) is a chlorosis-inducing non-host-specific phytotoxin that induces leaf and/or fruit abscission in some crops. The present study investigates how COR might induce cotton leaf abscission by modulating genes involved in cell wall hydrolases and ACC (ethylene precursor) in various cotton tissues. The effects of COR on cotton boll ripening, seedcotton yield, and seed development were also studied. After 14 d of treatment with COR, cells within the leaf abscission zone (AZ) showed marked differentiation. Elevated transcripts of GhCEL1, GhPG and GhACS were observed in the AZs treated with COR and Thidiazuron (TDZ). The relative expression of GhCEL1 and GhACS in TDZ treated plants was approximately twice that in plants treated with COR for 12 h. However, only GhACS expression increased in leaf blade and petiole. There was a continuous increase in the activity of hydrolytic enzymes such as cellulase (CEL) and polygalacturonase (PG), and ACC accumulation in AZs following COR and TDZ treatments, but there was greater increase in ACC activity of COR treated boll crust, indicating that COR had greater ripening effect than TDZ. Coronatine significantly enhanced boll opening without affecting boll weight, lint percentage and seed quality. Therefore, COR can be a potential cotton defoliant with different physiological mechanism of action from the currently used TDZ.	[Du, Mingwei; Li, Yi; Tian, Xiaoli; Duan, Liusheng; Zhang, Mingcai; Tan, Weiming; Li, Zhaohu] China Agr Univ, Coll Agron & Biotechnol, Engn Res Ctr Plant Growth Regulator, State Key Lab Plant Physiol & Biochem,Minist Educ, Beijing 100094, Peoples R China; [Xu, Dongyong] Hebei Prov Engn Res Ctr Cotton Seed, Hejian, Hebei, Peoples R China	China Agricultural University	Li, ZH (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Engn Res Ctr Plant Growth Regulator, State Key Lab Plant Physiol & Biochem,Minist Educ, Beijing 100094, Peoples R China.	lizhaohu@cau.edu.cn	Duan, Liusheng/F-8954-2011; li, zh/HII-5698-2022	Duan, Liusheng/0000-0003-0323-9378	National Natural Science Foundation of China [31301257]; Special Fund for Agro-scientific Research in the Public Interest [201203057-02]; China Agriculture Research System [CARS-18-18]; China Postdoctoral Science Foundation [2013M530077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; China Agriculture Research System; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31301257), the Special Fund for Agro-scientific Research in the Public Interest (201203057-02), China Agriculture Research System (CARS-18-18), and China Postdoctoral Science Foundation (2013M530077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Ayala F, 2001, PHYSL COTTON DEFOLIA, P1240; Bange MP, 2011, AGRON J, V103, P390, DOI 10.2134/agronj2010.0293; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Benedetti CE, 1998, PLANT PHYSIOL, V116, P1037, DOI 10.1104/pp.116.3.1037; Braun Y, 2009, SENSORS-BASEL, V9, P4272, DOI 10.3390/s90604272; Brown KM, 1997, PHYSIOL PLANTARUM, V100, P567, DOI 10.1034/j.1399-3054.1997.1000319.x; Brummell DA, 1999, PLANT MOL BIOL, V40, P615, DOI 10.1023/A:1006269031452; Burns JK, 2003, J AM SOC HORTIC SCI, V128, P309, DOI 10.21273/JASHS.128.3.0309; Cintas NA, 2002, PLANT DIS, V86, P992, DOI 10.1094/PDIS.2002.86.8.921A; Collins GD, 2007, COTT RES C; Faircloth JC, 2004, CROP SCI, V44, P165, DOI 10.2135/cropsci2004.0165; Fan XT, 1998, PLANTA, V204, P444, DOI 10.1007/s004250050278; FERGUSON IB, 1985, PLANT PHYSIOL, V77, P969, DOI 10.1104/pp.77.4.969; Garcia-Garrido JM, 2000, J EXP BOT, V51, P1443, DOI 10.1093/jexbot/51.349.1443; Gonzalez-Carranza ZH, 2002, PLANT PHYSIOL, V128, P534, DOI 10.1104/pp.010610; Gonzalez-Carranza ZH, 2007, J EXP BOT, V58, P3719, DOI 10.1093/jxb/erm222; Gwathmey C. O., 1997, Journal of Cotton Science, V1, P1; Gwathmey CO, 2006, ENCY PEST MANAGEMENT, V1, P1; Haider G, 2000, BIOL CHEM, V381, P741, DOI 10.1515/BC.2000.094; Hartmond U, 2000, J AM SOC HORTIC SCI, V125, P547, DOI 10.21273/JASHS.125.5.547; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; KENYON JS, 1992, PLANT PHYSIOL, V100, P219, DOI 10.1104/pp.100.1.219; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; Koda Y, 1996, PHYTOCHEMISTRY, V41, P93, DOI 10.1016/0031-9422(95)00517-X; Kumar A, 1996, PLANT J, V9, P147, DOI 10.1046/j.1365-313X.1996.09020147.x; LANAHAN MB, 1994, PLANT CELL, V6, P521, DOI 10.1105/tpc.6.4.521; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malladi A, 2008, J EXP BOT, V59, P3729, DOI 10.1093/jxb/ern224; METZGER JD, 1984, J PLANT GROWTH REGUL, V3, P141, DOI 10.1007/BF02041999; Mishra A, 2008, S AFR J BOT, V74, P282, DOI 10.1016/j.sajb.2007.12.001; Miyamoto K, 1997, PHYSIOL PLANTARUM, V100, P631, DOI 10.1034/j.1399-3054.1997.1000326.x; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; PALMER DA, 1993, APPL ENVIRON MICROB, V59, P1619, DOI 10.1128/AEM.59.5.1619-1626.1993; Parra-Lobato MC, 2011, J EXP BOT, V62, P4447, DOI 10.1093/jxb/err124; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; PERNER B, 1994, J PHYTOPATHOL, V142, P27, DOI 10.1111/j.1439-0434.1994.tb00004.x; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Sakamoto M, 2008, PLANT J, V56, P13, DOI 10.1111/j.1365-313X.2008.03577.x; Schuler G, 2004, FEBS LETT, V563, P17, DOI 10.1016/S0014-5793(04)00239-X; Siebert JD, 2006, J COTTON SCI, V10, P146; SMITH CW, 1986, AGRON J, V78, P814, DOI 10.2134/agronj1986.00021962007800050014x; SNIPES CE, 1992, FIELD CROP RES, V28, P327, DOI 10.1016/0378-4290(92)90018-5; SNIPES CE, 1994, FIELD CROP RES, V37, P137, DOI 10.1016/0378-4290(94)90042-6; SNIPES CE, 1994, WEED SCI, V42, P13, DOI 10.1017/S0043174500084095; Stelmach BA, 1999, PHYTOCHEMISTRY, V51, P187, DOI 10.1016/S0031-9422(99)00017-5; Stewart EM, 2000, FIELD CROP RES, V67, P83, DOI 10.1016/S0378-4290(00)00093-9; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; SUTTLE JC, 1985, PLANT PHYSIOL, V78, P272, DOI 10.1104/pp.78.2.272; SUTTLE JC, 1988, PLANT PHYSIOL, V86, P241, DOI 10.1104/pp.86.1.241; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; van Nocker SJSPR., 2009, STEWART POSTHARVEST, V5, P5, DOI DOI 10.2212/SPR.2009.1.5; Wang HF, 2010, PROTOPLASMA, V247, P111, DOI 10.1007/s00709-010-0159-z; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Wu HL, 2012, J PLANT GROWTH REGUL, V31, P113, DOI 10.1007/s00344-011-9224-x; Xia XJ, 2011, NEW PHYTOL, V191, P706, DOI 10.1111/j.1469-8137.2011.03745.x; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Yuan RC, 2005, J EXP BOT, V56, P1867, DOI 10.1093/jxb/eri176	61	15	21	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97652	10.1371/journal.pone.0097652	http://dx.doi.org/10.1371/journal.pone.0097652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845465	Green Published, gold, Green Submitted			2022-12-27	WOS:000339563400041
J	McMillan, M; Pereg, L				McMillan, Mary; Pereg, Lily			Evaluation of Reference Genes for Gene Expression Analysis Using Quantitative RT-PCR in Azospirillum brasilense	PLOS ONE			English	Article							IN-VITRO GROWTH; HOUSEKEEPING GENES; SURFACE COLONIZATION; FLOCCULATION; SELECTION; DIFFERENTIATION; QUANTIFICATION; NORMALIZATION; STRESS; FLCA	Azospirillum brasilense is a nitrogen fixing bacterium that has been shown to have various beneficial effects on plant growth and yield. Under normal conditions A. brasilense exists in a motile flagellated form, which, under starvation or stress conditions, can undergo differentiation into an encapsulated, cyst-like form. Quantitative RT-PCR can be used to analyse changes in gene expression during this differentiation process. The accuracy of quantification of mRNA levels by qRT-PCR relies on the normalisation of data against stably expressed reference genes. No suitable set of reference genes has yet been described for A. brasilense. Here we evaluated the expression of ten candidate reference genes (16S rRNA, gapB, glyA, gyrA, proC, pykA, recA, recF, rpoD, and tpiA) in wild-type and mutant A. brasilense strains under different culture conditions, including conditions that induce differentiation. Analysis with the software programs BestKeeper, NormFinder and GeNorm indicated that gyrA, glyA and recA are the most stably expressed reference genes in A. brasilense. The results also suggested that the use of two reference genes (gyrA and glyA) is sufficient for effective normalisation of qRT-PCR data.	[McMillan, Mary; Pereg, Lily] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia	University of New England	Pereg, L (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	lily.pereg@une.edu.au		McMillan, Mary/0000-0002-2336-3985	University of New England	University of New England	Funding provided by the University of New England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bashan Y, 2002, APPL ENVIRON MICROB, V68, P2637, DOI 10.1128/AEM.68.6.2637-2643.2002; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Edwards KJ, 2001, J APPL MICROBIOL, V91, P29, DOI 10.1046/j.1365-2672.2001.01339.x; Gerk LP, 2000, APPL ENVIRON MICROB, V66, P2175, DOI 10.1128/AEM.66.5.2175-2184.2000; Gonzalez A, 2013, FEBS LETT, V587, P2682, DOI 10.1016/j.febslet.2013.07.007; Hansen M, 2001, J BACTERIOOGY, V183; Herschkovitz Y, 2005, MICROB ECOL, V50, P277, DOI 10.1007/s00248-004-0148-x; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jacob TR, 2011, BIOTECHNOL LETT, V33, P1177, DOI 10.1007/s10529-011-0552-5; Joo MY, 2013, MED MYCOL, V51, P892, DOI 10.3109/13693786.2013.824623; KATUPITIYA S, 1995, APPL ENVIRON MICROB, V61, P1987, DOI 10.1128/AEM.61.5.1987-1995.1995; Kozera Bo, 2013, J APPL GENET, P1; Neretin LN, 2003, ENVIRON MICROBIOL, V5, P660, DOI 10.1046/j.1462-2920.2003.00452.x; Nielsen KK, 2005, APPL ENVIRON MICROB, V71, P2949, DOI 10.1128/AEM.71.6.2949-2954.2005; Pereg-Gerk L, 1998, MOL PLANT MICROBE IN, V11, P177, DOI 10.1094/MPMI.1998.11.3.177; Pereg-Gerk L, 2004, SOIL BIOL BIOCHEM, V36, P1245, DOI 10.1016/j.soilbio.2004.04.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; SADASIVAN L, 1987, J BACTERIOL, V169, P1670, DOI 10.1128/jb.169.4.1670-1677.1987; SADASIVAN L, 1985, J BACTERIOL, V163, P716, DOI 10.1128/JB.163.2.716-723.1985; Schloter M, 1998, SYMBIOSIS, V25, P159; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; Suslov O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni176; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Theis T, 2007, J MICROBIOL METH, V70, P355, DOI 10.1016/j.mimet.2007.05.011; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3	34	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98162	10.1371/journal.pone.0098162	http://dx.doi.org/10.1371/journal.pone.0098162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841066	Green Published, gold, Green Submitted			2022-12-27	WOS:000340948600111
J	McBride, SH; McKenzie, JA; Bedrick, BS; Kuhlmann, P; Pasteris, JD; Rosen, V; Silva, MJ				McBride, Sarah H.; McKenzie, Jennifer A.; Bedrick, Bronwyn S.; Kuhlmann, Paige; Pasteris, Jill D.; Rosen, Vicki; Silva, Matthew J.			Long Bone Structure and Strength Depend on BMP2 from Osteoblasts and Osteocytes, but Not Vascular Endothelial Cells	PLOS ONE			English	Article							DISTRACTION OSTEOGENESIS; RAT ULNA; PERIOSTEUM; GENE; DIFFERENTIATION; CALCIFICATION; ANGIOGENESIS; PROGENITORS; EXPRESSION; MOUSE	The importance of bone morphogenetic protein 2 (BMP2) in the skeleton is well known. BMP2 is expressed in a variety of tissues during development, growth and healing. In this study we sought to better identify the role of tissue-specific BMP2 during post-natal growth and to determine if BMP2 knockout affects the ability of terminally differentiated cells to create high quality bone material. We targeted BMP2 knockout to two differentiated cell types known to express BMP2 during growth and healing, early-stage osteoblasts and their progeny (osterix promoted Cre) and vascular endothelial cells (vascular-endothelial-cadherin promoted Cre). Our objectives were to assess post-natal bone growth, structure and strength. We hypothesized that removal of BMP2 from osteogenic and vascular cells (separately) would result in smaller skeletons with inferior bone material properties. At 12 and 24 weeks of age the osteoblast knockout of BMP2 reduced body weight by 20%, but the vascular knockout had no effect. Analysis of bone in the tibia revealed reductions in cortical and cancellous bone size and volume in the osteoblast knockout, but not in the vascular endothelial knockout. Furthermore, forelimb strength testing revealed a 30% reduction in ultimate force at both 12 and 24 weeks in the osteoblast knockout of BMP2, but no change in the vascular endothelial knockout. Moreover, mechanical strength testing of femurs from osteoblast knockout mice demonstrated an increased Young's modulus (greater than 35%) but decreased post-yield displacement (greater than 50%) at both 12 and 24 weeks of age. In summary, the osteoblast knockout of BMP2 reduced bone size and altered mechanical properties at the whole-bone and material levels. Osteoblast-derived BMP2 has an important role in post-natal skeletal growth, structure and strength, while vascular endothelial-derived BMP2 does not.	[McBride, Sarah H.; McKenzie, Jennifer A.; Kuhlmann, Paige; Silva, Matthew J.] Washington Univ, Dept Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63130 USA; [McBride, Sarah H.] St Louis Univ, Dept Orthopaed Surg, St Louis, MO 63103 USA; [Bedrick, Bronwyn S.; Pasteris, Jill D.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Rosen, Vicki] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Harvard University; Harvard School of Dental Medicine	McBride, SH (corresponding author), Washington Univ, Dept Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63130 USA.	SMcBrid9@SLU.edu		Pasteris, Jill/0000-0001-7041-6966; Silva, Matthew/0000-0001-7375-4522	Washington University T32 Metabolic Skeletal Disorders Training Program [NIH 1T32AR060719-01]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [AR050211]; Washington University Musculoskeletal Research Center [NIH P30 AR057235]; Amgen Scholars Program; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR060719, P30AR057235, R01AR050211] Funding Source: NIH RePORTER	Washington University T32 Metabolic Skeletal Disorders Training Program; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Washington University Musculoskeletal Research Center; Amgen Scholars Program(Amgen); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the following sources: Washington University T32 Metabolic Skeletal Disorders Training Program (NIH 1T32AR060719-01) (SM), National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) AR050211 (SM, JM, MJS), Washington University Musculoskeletal Research Center (NIH P30 AR057235), and Amgen Scholars Program (PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; [Anonymous], METABOLISM, V58, P644; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Colnot C, 2012, J ORTHOP RES, V30, P1869, DOI 10.1002/jor.22181; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Doss MX, 2012, STEM CELL REV REP, V8, P43, DOI 10.1007/s12015-011-9263-5; Feng JS, 2011, CELLS TISSUES ORGANS, V194, P216, DOI 10.1159/000324644; Fritz DT, 2006, MOL ENDOCRINOL, V20, P1574, DOI 10.1210/me.2005-0469; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Jacobsen KA, 2008, J BONE MINER RES, V23, P596, DOI [10.1359/jbmr.080103, 10.1359/JBMR.080103]; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Li Z, 2014, AM MINERAL IN PRESS; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Martinez MD, 2010, BONE, V46, P1604, DOI 10.1016/j.bone.2010.02.030; Matsubara H, 2012, BONE, V51, P168, DOI 10.1016/j.bone.2012.02.017; McGuigan FE, 2007, CALCIFIED TISSUE INT, V81, P254, DOI 10.1007/s00223-007-9054-9; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Medici M, 2006, J BONE MINER RES, V21, P845, DOI [10.1359/jbmr.060306, 10.1359/JBMR.060306]; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nyman JS, 2012, CURR OSTEOPOROS REP, V10, P169, DOI 10.1007/s11914-012-0101-8; Oh JH, 2012, BIOCHEM BIOPH RES CO, V418, P634, DOI 10.1016/j.bbrc.2012.01.064; Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Seeman E, 2007, OSTEOPOROSIS INT, V18, P123, DOI 10.1007/s00198-006-0296-6; SIMPSON AHRW, 1985, J ANAT, V140, P697; Skinner HCW, 2005, MINERAL MAG, V69, P621, DOI 10.1180/0026461056950275; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Tomlinson RE, 2013, J APP PHYSL; Tomlinson RE, 2013, BONE, V52, P212, DOI 10.1016/j.bone.2012.09.035; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Varanasi SS, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/243465; Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010; Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179; Wu LA, 2011, CELL TISSUE RES, V343, P545, DOI 10.1007/s00441-010-1120-3; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yang WC, 2013, J CELL SCI, V126, P4085, DOI 10.1242/jcs.118596; Zhang HB, 1996, DEVELOPMENT, V122, P2977	43	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96862	10.1371/journal.pone.0096862	http://dx.doi.org/10.1371/journal.pone.0096862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24837969	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800022
J	Yue, H; Yu, JB; He, JW; Zhang, Z; Fu, WZ; Zhang, H; Wang, C; Hu, WW; Gu, JM; Hu, YQ; Li, M; Liu, YJ; Zhang, ZL				Yue, Hua; Yu, Jin-bo; He, Jin-wei; Zhang, Zeng; Fu, Wen-zhen; Zhang, Hao; Wang, Chun; Hu, Wei-wei; Gu, Jie-mei; Hu, Yun-qiu; Li, Miao; Liu, Yu-juan; Zhang, Zhen-lin			Identification of Two Novel Mutations in the PHEX Gene in Chinese Patients with Hypophosphatemic Rickets/Osteomalacia	PLOS ONE			English	Article							X-LINKED HYPOPHOSPHATEMIA; PEX GENE; FAMILIES; RICKETS; EXPRESSION; FGF23; DMP1	Objective: X-linked dominant hypophosphatemia (XLH) is the most prevalent form of inherited rickets/osteomalacia in humans. The aim of this study was to identify PHEX gene mutations and describe the clinical features observed in 6 unrelated Chinese families and 3 sporadic patients with hypophosphatemic rickets/osteomalacia. Methods: For this study, 45 individuals from 9 unrelated families of Chinese Han ethnicity (including 16 patients and 29 normal phenotype subjects), and 250 healthy donors were recruited. All 22 exons and exon-intron boundaries of the PHEX gene were amplified by polymerase chain reaction (PCR) and directly sequenced. Results: The PHEX mutations were detected in 6 familial and 3 sporadic hypophosphatemic rickets/osteomalacia. Altogether, 2 novel mutations were detected: 1 missense mutation c.1183G>C in exon 11, resulting in p.Gly395Arg and 1 missense mutation c.1751A>C in exon 17, resulting in p.His584Pro. No mutations were found in the 250 healthy controls. Conclusions: Our study increases knowledge of the PHEX gene mutation types and clinical phenotypes found in Chinese patients with XLH, which is important for understanding the genetic basis of XLH. The molecular diagnosis of a PHEX genetic mutation is of great importance for confirming the clinical diagnosis of XLH, conducting genetic counseling, and facilitating prenatal intervention, especially in the case of sporadic patients.	[Yue, Hua; He, Jin-wei; Zhang, Zeng; Fu, Wen-zhen; Zhang, Hao; Wang, Chun; Hu, Wei-wei; Gu, Jie-mei; Hu, Yun-qiu; Li, Miao; Liu, Yu-juan; Zhang, Zhen-lin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Osteoporosis, Metab Bone Dis & Genet Res Unit, Shanghai 200030, Peoples R China; [Yu, Jin-bo] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Pediat, Shanghai 200030, Peoples R China; [Zhang, Zeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, ZL (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Osteoporosis, Metab Bone Dis & Genet Res Unit, Shanghai 200030, Peoples R China.	ZZL2002@medmail.com.cn			National Natural ScienceFoundation of China [81000360, 81170803, 81070692, 81370978]; Shanghai Rising-Star Program [11QA1404900]; Academic Leaders in Health Sciences in Shanghai [XBR2011014]	National Natural ScienceFoundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Academic Leaders in Health Sciences in Shanghai	The study was supported by grants from the National Natural ScienceFoundation of China (No. 81000360, 81170803, 81070692, and 81370978), Shanghai Rising-Star Program (No. 11QA1404900), and Academic Leaders in Health Sciences in Shanghai (No XBR2011014). The founder (Prof. Zhen-lin Zhang(with the National Natural Science Foundation of China (81170803 and 81070692) and Academic Leaders in Health Sciences in Shanghai (No XBR2011014) played a role in conceiving, designing, revising the study and data collection as well. The founder (Dr. Hua Yue) with the National Natural Science Foundation of China (No. 81000360) and Shanghai Rising-Star Program (No. 11QA1404900) was responsible for data analysis, writing, and preparation of the manuscript. The founder with the National Natural Science Foundation of China (No. 81370978) had a role in data collection.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albright F, 1937, AM J DIS CHILD, V54, P529; Beck-Nielsen SS, 2012, J HUM GENET, V57, P453, DOI 10.1038/jhg.2012.56; Beck-Nielsen SS, 2009, EUR J ENDOCRINOL, V160, P491, DOI 10.1530/EJE-08-0818; Clausmeyer S, 2009, CALCIFIED TISSUE INT, V85, P211, DOI 10.1007/s00223-009-9260-8; DAVIES M, 1981, CLIN RHEUM DIS, V7, P595; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; Durmaz E, 2013, BONE, V52, P286, DOI 10.1016/j.bone.2012.10.012; Filisetti D, 1999, EUR J HUM GENET, V7, P615, DOI 10.1038/sj.ejhg.5200341; Francis F, 1997, GENOME RES, V7, P573, DOI 10.1101/gr.7.6.573; Goetting-Minesky MP, 2006, J MOL EVOL, V63, P537, DOI 10.1007/s00239-005-0308-8; Jap TS, 2011, CALCIFIED TISSUE INT, V88, P370, DOI 10.1007/s00223-011-9465-5; Kang QL, 2012, BIOCHEM BIOPH RES CO, V423, P793, DOI 10.1016/j.bbrc.2012.06.042; Lo FS, 2006, NEPHRON PHYSIOL, V103, P157, DOI 10.1159/000092916; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Qiu GR, 2010, GENET TEST MOL BIOMA, V14, P385, DOI 10.1089/gtmb.2009.0175; Quarles LD, 2001, J CLIN ENDOCR METAB, V86, P494, DOI 10.1210/jc.86.2.494; Quinlan C, 2012, PEDIATR NEPHROL, V27, P581, DOI 10.1007/s00467-011-2046-z; ROWE PSN, 1994, HUM GENET, V94, P457; Rowe PSN, 1998, CURR OPIN NEPHROL HY, V7, P367, DOI 10.1097/00041552-199807000-00004; Rowe PSN, 1997, HUM MOL GENET, V6, P539, DOI 10.1093/hmg/6.4.539; Ruppe MD, 2011, CLIN ENDOCRINOL, V74, P312, DOI 10.1111/j.1365-2265.2010.03919.x; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Thompson DL, 2002, J BONE MINER RES, V17, P311, DOI 10.1359/jbmr.2002.17.2.311; Xia WB, 2007, CALCIFIED TISSUE INT, V81, P415, DOI 10.1007/s00223-007-9067-4; Yang LL, 2013, J PEDIATR ENDOCR MET, V26, P1179, DOI 10.1515/jpem-2013-0101; Zhu XW, 2010, J CHILD NEUROL, V25, P842, DOI 10.1177/0883073809350722	30	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97830	10.1371/journal.pone.0097830	http://dx.doi.org/10.1371/journal.pone.0097830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836714	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800073
J	Zhu, JH; Hua, RX; Jiang, J; Zhao, LQ; Sun, XW; Luan, JW; Lang, YG; Sun, YQ; Shang, K; Peng, SY; Ma, JQ				Zhu, Jinhong; Hua, Rui-Xi; Jiang, Jing; Zhao, Li-Qin; Sun, Xiuwei; Luan, Jinwei; Lang, Yaoguo; Sun, Yanqi; Shang, Kun; Peng, Shiyun; Ma, Jianqun			Association Studies of ERCC1 Polymorphisms with Lung Cancer Susceptibility: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							DNA-REPAIR GENES; SINGLE NUCLEOTIDE POLYMORPHISMS; CHINESE POPULATION; RISK; HAPLOTYPES; CAPACITY; SMOKING	Background: Excision repair cross-complimentary group 1 (ERCC1) is an essential component of the nucleotide excision repair system that is responsible for repairing damaged DNA. Functional genetic variations in the ERCC1 gene may alter DNA repair capacity and modulate cancer risk. The putative roles of ERCC1 gene polymorphisms in lung cancer susceptibility have been widely investigated. However, the results remain controversial. Objectives: An updated meta-analysis was conducted to explore whether lung cancer risk could be attributed to the following ERCC1 polymorphisms: rs11615 (T>C), rs3212986 (C>A), rs3212961 (A>C), rs3212948 (G>C), rs2298881 (C>A). Methods: Several major databases (MEDLINE, EMBASE and Scopus) and the Chinese Biomedical database were searched for eligible studies. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to measure the strength of associations. Results: Sixteen studies with 10,106 cases and 13,238 controls were included in this meta-analysis. Pooled ORs from 11 eligible studies (8,215 cases vs. 11,402 controls) suggested a significant association of ERCC1 rs11615 with increased risk for lung cancer (homozygous: CC versus TT, OR = 1.24, 95% CI: 1.04-1.48, P = 0.02). However, such an association was disproportionately driven by a single study. Removal of that study led to null association. Moreover, initial analyses suggested that ERCC1 rs11615 exerts a more profound effect on the susceptibility of non-smokers to lung cancer than that of smokers. Moreover, no statistically significant association was found between remaining ERCC1 polymorphisms of interest and lung cancer risk, except for rs3212948 variation (heterozygous: CG vs. GG, OR = 0.78, 95% CI: 0.67-0.90, P = 0.001; dominant: CG/CC vs. GG, OR = 0.79, 95% CI: 0.69-0.91, P= 0.001). Conclusion: Overall, this meta-analysis suggests that ERCC1 rs3212948 G>C, but not others, is a lung cancer risk-associated polymorphism. Carefully designed studies with large sample size involving different ethnicity, smoking status, and cancer types are needed to validate these findings.	[Zhu, Jinhong] Harbin Med Univ, Canc Hosp, Mol Epidemiol Lab, Harbin, Heilongjiang, Peoples R China; [Hua, Rui-Xi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Jing; Sun, Xiuwei] Harbin Med Univ, Canc Hosp, Dept Oncol, Harbin, Heilongjiang, Peoples R China; [Zhao, Li-Qin] Univ South China, Affiliated Hosp 1, Dept Hematol, Hengyang, Hunan, Peoples R China; [Luan, Jinwei] Harbin Med Univ, Canc Hosp, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Lang, Yaoguo; Sun, Yanqi; Ma, Jianqun] Harbin Med Univ, Canc Hosp, Dept Thorac Surg, Harbin, Heilongjiang, Peoples R China; [Shang, Kun] Capital Med Univ, Xuanwu Hosp, Dept Nucl Med, Beijing, Peoples R China; [Peng, Shiyun] Harbin Med Univ, Canc Hosp, Dept Lab Med, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Sun Yat Sen University; Harbin Medical University; University of South China; Harbin Medical University; Harbin Medical University; Capital Medical University; Harbin Medical University	Peng, SY (corresponding author), Harbin Med Univ, Canc Hosp, Dept Lab Med, Harbin, Heilongjiang, Peoples R China.	hydzlyyjyk@126.com; jianqunma@gmail.com	Zhang, Min/ACY-2759-2022; Thakolwiboon, Smathorn/S-1183-2019; Zhu, Jianhui/H-4665-2011	Zhang, Min/0000-0003-3331-3583; , Jianqun/0000-0002-7021-1298; Hua, Rui-Xi/0000-0001-5319-656X; Zhu, Jianhui/0000-0002-0051-7777; Zhu, Jinhong/0000-0002-0408-3101; Thakolwiboon, Smathorn/0000-0003-0607-904X	Heilongjiang Education Department of China [1252HQ016]; Harbin Medical University Cancer Hospital	Heilongjiang Education Department of China; Harbin Medical University Cancer Hospital	This research was supported by a grant (1252HQ016) funded by Heilongjiang Education Department of China and a grant funded by Harbin Medical University Cancer Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao C, 2011, CHINESE MED J-PEKING, V124, P2203, DOI 10.3760/cma.j.issn.0366-6999.2011.14.022; Deng QH, 2011, MED ONCOL, V28, P667, DOI 10.1007/s12032-010-9507-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gorlova OY, 2008, CANCER EPIDEM BIOMAR, V17, P1322, DOI 10.1158/1055-9965.EPI-07-2591; He J, 2013, INT J CANCER, V133, P1765, DOI 10.1002/ijc.28089; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Jones NR, 2011, CANCER EPIDEMIOL, V35, P175, DOI 10.1016/j.canep.2010.08.007; Kang H, 2011, MODERN ONCOLOGY, V19, P1275; Kazma R, 2012, CARCINOGENESIS, V33, P1059, DOI 10.1093/carcin/bgs116; Kietthubthew S, 2006, INT J HYG ENVIR HEAL, V209, P21, DOI 10.1016/j.ijheh.2005.06.002; Li YC, 2007, EUR J HUM GENET, V15, P967, DOI 10.1038/sj.ejhg.5201855; Ma HX, 2007, PHARMACOGENET GENOM, V17, P417, DOI 10.1097/01.fpc.0000239975.77088.17; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Sakoda LC, 2012, INT J MOL EPIDEMIOL, V3, P1; Shen HB, 2003, INT J CANCER, V107, P84, DOI 10.1002/ijc.11346; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Vogel U, 2004, MUTAT RES-FUND MOL M, V546, P65, DOI 10.1016/j.mrfmmm.2003.11.001; Yin JY, 2008, MUTAT RES-FUND MOL M, V641, P12, DOI 10.1016/j.mrfmmm.2008.02.004; Yin JY, 2012, LUNG CANCER, V76, P286, DOI 10.1016/j.lungcan.2012.01.001; Yin JY, 2011, MUTAT RES-FUND MOL M, V713, P1, DOI 10.1016/j.mrfmmm.2011.05.003; Yin JY, 2006, CANCER GENET CYTOGEN, V164, P66, DOI 10.1016/j.cancergencyto.2005.07.003; Yin JY, 2005, BIOCHEM GENET, V43, P543, DOI 10.1007/s10528-005-8170-3; Yin ZH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-439; Yu DK, 2008, CLIN CANCER RES, V14, P2878, DOI 10.1158/1078-0432.CCR-07-1612; Zhang LQ, 2012, MUTAGENESIS, V27, P67, DOI 10.1093/mutage/ger062; Zhang Zengli, 2008, Zhongguo Fei Ai Za Zhi, V11, P183, DOI 10.3779/j.issn.1009-3419.2008.02.022; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P491, DOI 10.1158/1055-9965.EPI-04-0612; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	32	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97616	10.1371/journal.pone.0097616	http://dx.doi.org/10.1371/journal.pone.0097616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	25536077	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600051
J	Wang, HJ; Wang, RZ; Xu, SH; Lakshmana, MK				Wang, Hongjie; Wang, Ruizhi; Xu, Shaohua; Lakshmana, Madepalli K.			RanBP9 Overexpression Accelerates Loss of Pre and Postsynaptic Proteins in the AP Delta E9 Transgenic Mouse Brain	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; SCAFFOLDING PROTEIN; TEMPORAL CORTEX; SYNAPTIC LOSS; HIPPOCAMPUS; SYNAPTOPHYSIN; ABNORMALITIES; DEPOSITION; DENDRITE	There is now compelling evidence that the neurodegenerative process in Alzheimer's disease (AD) begins in synapses. Loss of synaptic proteins and functional synapses in the amyloid precursor protein (APP) transgenic mouse models of AD is well established. However, what is the earliest age at which such loss of synapses occurs, and whether known markers of AD progression accelerate functional deficits is completely unknown. We previously showed that RanBP9 overexpression leads to robustly increased amyloid beta peptide (A beta) generation leading to enhanced amyloid plaque burden in a mouse model of AD. In this study we compared synaptic protein levels among four genotypes of mice, i.e., RanBP9 single transgenic (Ran), AP Delta E9 double transgenic (Dbl), AP Delta E9/RanBP9 triple transgenic (Tpl) and wild-type (WT) controls. We found significant reductions in the levels of synaptic proteins in both cortex and hippocampus of 5-and 6-months-old but not 3-or 4-months- old mice. Specifically, at 5-months of age, rab3A was reduced in the triple transgenic mice only in the cortex by 25% (p<0.05) and gap43 levels were reduced only in the hippocampus by 44% (p<0.01) compared to wild-type (WT) controls. Interestingly, RanBP9 overexpression in the Tpl mice reduced gap43 levels by a further 31% (p<0.05) compared to AP Delta E9 mice. RanBP9 also further decreased the levels of drebrin in the hippocampus by 32% (p<0.01) and chromogranin in the cortex by 24% (p<0.05) compared to APDE9 mice. At 6-months of age, RanBP9 expression in the cortex led to further reduction of rab3A by 30% (p<0.05) and drebrin by 38% (p<0.01) compared to APDE9 mice. RanBP9 also increased Ab oligomers in the cortex at 6 months. Similarly, in the hippocampus, RanBP9 expression further reduced rab3A levels by 36% (p<0.01) and drebrin levels by 33% (p<0.01). Taken together these data suggest that RanBP9 overexpression accelerates loss of synaptic proteins in the mouse brain.	[Wang, Hongjie; Wang, Ruizhi; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port Saint Lucie, FL USA; [Xu, Shaohua] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Torrey Pines Institute for Molecular Studies, Florida; Florida Institute of Technology	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, Neurobiol Sect, Port Saint Lucie, FL USA.	mlakshmana@tpims.org		Xu, Shaohua/0000-0003-1221-6354; Tang, Yamei/0000-0002-6353-6107	National Institutes of Health [1R03AG032064-01, 1R01AG036859-01]; NATIONAL INSTITUTE ON AGING [R03AG032064, R01AG036859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health grant numbers: 1R03AG032064-01, M. K. Lakshmana; 1R01AG036859-01, M. K. Lakshmana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Brasnjevic I, 2013, TRANSL NEUROSCI, V4, P8, DOI 10.2478/s13380-013-0111-8; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Heffernan JM, 1998, EXP NEUROL, V150, P235, DOI 10.1006/exnr.1997.6772; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Lakshmana MK, 2012, FASEB J, V26, P2072, DOI 10.1096/fj.11-196709; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Nistico R, 2012, EUR J NEURODEG DIS, V1, P21; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Palavicini JP, 2013, J ALZHEIMER IN PRESS; Provoda CJ, 2000, J BIOL CHEM, V275, P7004, DOI 10.1074/jbc.275.10.7004; Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Roh S-E, 2013, FASEB J; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Sze CI, 2000, J NEUROL SCI, V175, P81, DOI 10.1016/S0022-510X(00)00285-9; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Wang H, 2013, J BIOL CHEM, V7; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	43	59	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85484	10.1371/journal.pone.0085484	http://dx.doi.org/10.1371/journal.pone.0085484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454876	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800047
J	Lin, Y; Fang, ZF; Che, LQ; Xu, SY; Wu, D; Wu, CM; Wu, XQ				Lin, Yan; Fang, Zheng-feng; Che, Lian-qiang; Xu, Sheng-yu; Wu, De; Wu, Cai-mei; Wu, Xiu-qun			Use of Sodium Butyrate as an Alternative to Dietary Fiber: Effects on the Embryonic Development and Anti-Oxidative Capacity of Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SUBSTRATE-INDUCED REGULATION; OXIDATIVE STRESS; MONOCARBOXYLATE TRANSPORTER; CELL PROLIFERATION; GENE-EXPRESSION; IMPROVES; SUPPLEMENTATION; MECHANISMS; PLACENTA	In this study, we evaluated the effect of replacing dietary fiber with sodium butyrate on reproductive performance and antioxidant defense in a high fat diet during pregnancy by using a rat model. Eighty virgin female Sprague Dawley rats were fed one of four diets-(1) control diet (C group), (2) high fat + high fiber diet (HF group), (3) high-fat + 5% sodium butyrate diet (SB group), and (4) HF diet + alpha-cyano-4-hydroxy cinnamic acid (CHC group)-intraperitoneally on days 8, 10, 12, 14, and 16 of gestation. SB and dietary fiber had similar effects on improving fetal number and reducing the abortion rate; however, the anti-oxidant capacity of maternal serum, placenta, and fetus was superior in the HF group than in the SB group. In comparison, CHC injection decreased reproductive performance and antioxidant defense. Both dietary fiber (DF) and SB supplementation had a major but different effect on the expression of anti-oxidant related genes and nutrient transporters genes. In summary, our data indicate that SB and DF showed similar effect on reproductive performance, but SB cannot completely replace the DF towards with respect to redox regulation in high-fat diet; and SB might influence offspring metabolism and health differently to DF.	[Wu, De] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan, Sichuan, Peoples R China; Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wu, D (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan, Sichuan, Peoples R China.	pig2pig@sina.com		Lin, Yu-Hsuan/0000-0001-9393-3886; Chen, Sue-Huie/0000-0001-6737-2966; CHANG, LI-REN/0000-0003-0853-3904				Abrahamse SL, 1999, CARCINOGENESIS, V20, P629, DOI 10.1093/carcin/20.4.629; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Andoh A, 1999, JPEN-PARENTER ENTER, V23, pS70, DOI 10.1177/014860719902300518; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BOERNER P, 1988, J CELL PHYSIOL, V137, P117, DOI 10.1002/jcp.1041370114; Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012; Buege J A, 1978, Methods Enzymol, V52, P302; Che L, 2011, REPROD DOMEST ANIM, V46, P1061, DOI 10.1111/j.1439-0531.2011.01787.x; Chung HW, 2012, NEPHROL DIAL TRANSPL, V27, P2213, DOI 10.1093/ndt/gfr613; CLAUSEN MR, 1994, GASTROENTEROLOGY, V106, P423, DOI 10.1016/0016-5085(94)90601-7; Clemens R, 2012, J NUTR, V142, p1390S, DOI 10.3945/jn.112.160176; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1113/jphysiol.2001.014241; da Silva CS, 2013, PHYSIOL BEHAV, V110, P148, DOI 10.1016/j.physbeh.2013.01.006; Dalmasso G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002476; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dgen L, 2009, ACTA AGR SCAND, V59, P150; Lopez-Oliva ME, 2013, BRIT J NUTR, V109, P4, DOI 10.1017/S0007114512000517; FERNANDEZMEJIA C, 1993, PANCREAS, V8, P589, DOI 10.1097/00006676-199309000-00010; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Goicoa S, 2006, CLONING STEM CELLS, V8, P140, DOI 10.1089/clo.2006.8.140; GOODGER AM, 1993, J REPROD FERTIL, V99, P451, DOI 10.1530/jrf.0.0990451; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hamer HM, 2009, CLIN NUTR, V28, P88, DOI 10.1016/j.clnu.2008.11.002; Hara H, 1999, J NUTR, V129, P942, DOI 10.1093/jn/129.5.942; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Ichikawa H, 2002, DIGEST DIS SCI, V47, P1141, DOI 10.1023/A:1015014829605; Kirat D, 2010, J COMP PHYSIOL B, V180, P57, DOI 10.1007/s00360-009-0382-0; Kumar AP, 2010, J FOOD BIOCHEM, V34, P15, DOI 10.1111/j.1745-4514.2009.00284.x; Kuo Dar-Chih, 2009, J Biomed Sci, V16, P15, DOI 10.1186/1423-0127-16-15; Le Gall M, 2009, BRIT J NUTR, V102, P1285, DOI 10.1017/S0007114509990213; Lecumberri E, 2007, NUTRITION, V23, P332, DOI 10.1016/j.nut.2007.01.013; Lee SH, 2002, J ANIM SCI, V80, P2840; Li N, 2010, J PEDIATR GASTR NUTR, V51, P414, DOI 10.1097/MPG.0b013e3181dd913a; Lin Y, 2012, NUTRITION, V28, P1037, DOI 10.1016/j.nut.2012.01.002; Lin Y, 2011, BRIT J NUTR, V106, P510, DOI 10.1017/S0007114511000614; Liu LM, 2012, J EXP ZOOL PART B, V318B, P224, DOI 10.1002/jez.b.22440; Lu H, 2012, J ANIM SCI, V90, P430, DOI 10.2527/jas.53817; Mangian HF, 2009, JPEN-PARENTER ENTER, V33, P607, DOI 10.1177/0148607109336599; Marzioni D, 1998, HUM REPROD, V13, P1717, DOI 10.1093/humrep/13.6.1717; Moslehi M, 2013, CELL BIOCHEM BIOPHYS, V66, P817, DOI 10.1007/s12013-013-9526-7; MURASE M, 1995, J CHROMATOGR B, V664, P415, DOI 10.1016/0378-4347(94)00491-M; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; REMESY C, 1992, NUTR RES, V12, P1235, DOI 10.1016/S0271-5317(05)80780-8; Russo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032841; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Sauer J, 2007, J NUTR BIOCHEM, V18, P736, DOI 10.1016/j.jnutbio.2006.12.012; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Sharma B, 2011, PSYCHOPHARMACOLOGY, V215, P677, DOI 10.1007/s00213-011-2164-0; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shin JH, 2013, GENE REGUL SYST BIO, V7, P57, DOI 10.4137/GRSB.S11243; Tappenden KA, 1998, AM J CLIN NUTR, V68, P118, DOI 10.1093/ajcn/68.1.118; Tzanetakou IP, 2011, OPEN CARDIOVASC MED, V5, P103, DOI 10.2174/1874192401105010103; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200; Zubova S G, 2008, Tsitologiia, V50, P964	58	163	166	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97838	10.1371/journal.pone.0097838	http://dx.doi.org/10.1371/journal.pone.0097838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24896252	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200031
J	Zhu, JH; Thakolwiboon, S; Liu, XH; Zhang, M; Lubman, DM				Zhu, Jianhui; Thakolwiboon, Smathorn; Liu, Xinhua; Zhang, Min; Lubman, David M.			Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment	PLOS ONE			English	Article							CANCER STEM-CELLS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; EXPRESSION; POPULATION; FIBROBLASTS; LIVER	CD90 (Thy-1) plays important roles in oncogenesis and shows potential as a candidate marker for cancer stem cells (CSCs) in various malignancies. Herein, we investigated the expression of CD90 in pancreatic adenocarcinoma (PDAC), with a comparison to normal pancreas and non-malignant pancreatic disease, by immunohistochemical (IHC) analysis of tissue microarrays containing 183 clinical tissue specimens. Statistical analysis was performed to evaluate the correlation between CD90 expression and the major clinicopathological factors after adjustment of age and gender. The IHC data showed that CD90 was significantly overexpressed in PDAC and its metastatic cancers as compared to chronic pancreatitis and benign islet tumors, while it was negati ve in normal pancreas and 82.7% of adjacent normal pancreas tissues. The abundant CD90 expression was predominantly present in PDAC stroma, such as fibroblasts and vascular endothelial cells, which could serve as a promising marker to distinguish pancreatic adenocarcinoma from normal pancreas and non-malignant pancreatic diseases. Double immunostaining of CD90 with CD24, a CSC marker for PDAC, showed that there was little overlap between these two markers. However, CD90(+) fibroblast cells were clustered around CD24(+) malignant ducts, suggesting that CD90 may be involved in the tumor-stroma interactions and promote pancreatic cancer development. Furthermore, CD90 mostly overlapped with alpha-smooth muscle actin (alpha SMA, a marker of activated pancreatic stellate cells (PSCs)) in PDAC stroma, which demonstrated that CD90(+) stromal cells consist largely of activated PSCs. Double immunostaining of CD90 and a vascular endothelial cell marker CD31 demonstrated that CD90 expression on vascular endothelial cells was significantly increased in PDACs as compared to normal pancreas and non-malignant pancreatic diseases. Our findings suggest that CD90 could serve as a promising marker for pancreatic adenocarcinoma where desmoplastic stroma plays an important role in tumor growth and angiogenesis.	[Zhu, Jianhui; Thakolwiboon, Smathorn; Liu, Xinhua; Lubman, David M.] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Thakolwiboon, Smathorn] Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok 10700, Thailand; [Liu, Xinhua] Shanghai Univ Tradit Chinese Med, Expt Ctr Sci & Technol, Shanghai 201203, Peoples R China; [Zhang, Min] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Mahidol University; Shanghai University of Traditional Chinese Medicine; University of Michigan System; University of Michigan	Lubman, DM (corresponding author), Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA.	dmlubman@umich.edu	Zhang, Min/ACY-2759-2022; Thakolwiboon, Smathorn/S-1183-2019; Zhu, Jianhui/H-4665-2011	Zhang, Min/0000-0003-3331-3583; , Jianqun/0000-0002-7021-1298; Hua, Rui-Xi/0000-0001-5319-656X; Zhu, Jianhui/0000-0002-0051-7777; Zhu, Jinhong/0000-0002-0408-3101; Thakolwiboon, Smathorn/0000-0003-0607-904X	National Cancer Institute [1R01CA154455]; National Institutes of Health [R01 GM 49500]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Cancer Institute grant 1R01CA154455 (DML) and the National Institutes of Health grant R01 GM 49500 (DML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaheeb S, 2005, J CLIN PATHOL, V58, P987, DOI 10.1136/jcp.2004.025221; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bartholin L, 2012, PANCREATIC CANC TUMO; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Davies Karen, 2009, Curr Gastroenterol Rep, V11, P119; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Foygel K, 2013, GASTROENTEROLOGY, V145, P885, DOI 10.1053/j.gastro.2013.06.011; Guillot-Delost M, 2012, J IMMUNOL, V188, P981, DOI 10.4049/jimmunol.1101592; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Jiang J, 2012, ONCOGENE, V31, P671, DOI 10.1038/onc.2011.282; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Rasheed ZA, 2012, PATHOLOGY PANCREATIC; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Saalbach A, 1999, CELL TISSUE RES, V298, P307, DOI 10.1007/s004419900079; Samaniego R, 2013, J INVEST DERMATOL, V133, P2255, DOI 10.1038/jid.2013.88; Schubert K, 2013, AM J PATHOL, V182, P266, DOI 10.1016/j.ajpath.2012.10.003; Scognamiglio G, 2014, AM J CLIN PATHOL, V141, P841, DOI 10.1309/AJCP8Y0EBQMKWQEI; Subramaniam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068923; Sukowati CHC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076830; Tang KH, 2013, CANCER RES, V73, P2322, DOI 10.1158/0008-5472.CAN-12-2991; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhu JH, 2013, J PROTEOME RES, V12, P2791, DOI 10.1021/pr400139c; Zhu JH, 2012, J PROTEOME RES, V11, P2272, DOI 10.1021/pr201059g	34	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115507	10.1371/journal.pone.0115507	http://dx.doi.org/10.1371/journal.pone.0115507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536077	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300046
J	Mishra, S; Singh, BR; Singh, A; Keswani, C; Naqvi, AH; Singh, HB				Mishra, Sandhya; Singh, Braj Raj; Singh, Akanksha; Keswani, Chetan; Naqvi, Alim H.; Singh, H. B.			Biofabricated Silver Nanoparticles Act as a Strong Fungicide against Bipolaris sorokiniana Causing Spot Blotch Disease in Wheat	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; EXTRACELLULAR BIOSYNTHESIS; PHOTOCATALYTIC ACTIVITY; CULTURE SUPERNATANT; ANTIFUNGAL ACTIVITY; BACTERIA; STRAIN; NANOCOMPOSITE; LIGNIFICATION; PROTECTION	The present study is focused on the extracellular synthesis of silver nanoparticles (AgNPs) using culture supernatant of an agriculturally important bacterium, Serratia sp. BHU-S4 and demonstrates its effective application for the management of spot blotch disease in wheat. The biosynthesis of AgNPs by Serratia sp. BHU-S4 (denoted as bsAgNPs) was monitored by UV-visible spectrum that showed the surface plasmon resonance (SPR) peak at 410 nm, an important characteristic of AgNPs. Furthermore, the structural, morphological, elemental, functional and thermal characterization of bsAgNPs was carried out using the X-ray diffraction (XRD), electron and atomic microscopies, energy dispersive X-ray (EDAX) spectrometer, FTIR spectroscopy and thermogravimetric analyzer (TGA), respectively. The bsAgNPs were spherical in shape with size range of similar to 10 to 20 nm. The XRD and EDAX analysis confirmed successful biosynthesis and crystalline nature of AgNPs. The bsAgNPs exhibited strong antifungal activity against Bipolaris sorokiniana, the spot blotch pathogen of wheat. Interestingly, 2, 4 and 10 mu g/ml concentrations of bsAgNPs accounted for complete inhibition of conidial germination, whereas in the absence of bsAgNPs, conidial germination was 100%. A detached leaf bioassay revealed prominent conidial germination on wheat leaves infected with B. sorokiniana conidial suspension alone, while the germination of conidia was totally inhibited when the leaves were treated with bsAgNPs. The results were further authenticated under green house conditions, where application of bsAgNPs significantly reduced B. sorokiniana infection in wheat plants. Histochemical staining revealed a significant role of bsAgNPs treatment in inducing lignin deposition in vascular bundles. In summary, our findings represent the efficient application of bsAgNPs in plant disease management, indicating the exciting possibilities of nanofungicide employing agriculturally important bacteria.	[Mishra, Sandhya; Singh, Akanksha; Keswani, Chetan; Singh, H. B.] Banaras Hindu Univ, Inst Agr Sci, Dept Mycol & Plant Pathol, Varanasi 221005, Uttar Pradesh, India; [Singh, Braj Raj; Naqvi, Alim H.] Aligarh Muslim Univ, ZH Coll Engn & Technol, Dept Appl Phys, Ctr Excellence Mat Sci Nanomat, Aligarh, Uttar Pradesh, India	Banaras Hindu University (BHU); Aligarh Muslim University; Zakir Husain College Of Engineering & Technology	Singh, HB (corresponding author), Banaras Hindu Univ, Inst Agr Sci, Dept Mycol & Plant Pathol, Varanasi 221005, Uttar Pradesh, India.	hbs1@rediffmail.com	KESWANI, CHETAN/I-4311-2014; De Groot, Annie/B-6221-2013	KESWANI, CHETAN/0000-0002-2786-121X; Singh, Akanksha/0000-0001-7206-3965; De Groot, Annie/0000-0001-5911-1459	NIAID NIH HHS [U19 AI082642] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakshi M, 2014, CURR SCI INDIA, V106, P350; Balaji DS, 2009, COLLOID SURFACE B, V68, P88, DOI 10.1016/j.colsurfb.2008.09.022; Benhamou N, 2000, PHYTOPATHOLOGY, V90, P45, DOI 10.1094/PHYTO.2000.90.1.45; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Choi M, 2010, J COLLOID INTERF SCI, V341, P83, DOI 10.1016/j.jcis.2009.09.037; Domiciano GP, 2013, TROP PLANT PATHOL, V38, P258, DOI http://dx.doi.org/10.1590/s1982-56762013005000006; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Ghormade V, 2011, BIOTECHNOL ADV, V29, P792, DOI 10.1016/j.biotechadv.2011.06.007; Gopinath V, 2013, SPECTROCHIM ACTA A, V106, P170, DOI 10.1016/j.saa.2012.12.087; He LL, 2011, MICROBIOL RES, V166, P207, DOI 10.1016/j.micres.2010.03.003; HOLT J. G., 1994, BERGEYS MANUAL DETER, P544; Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400; Jensen WA., 1962, BOT HISTOCHEMISTRY P; Jeyaraj M, 2013, J IND ENG CHEM, V19, P1299, DOI 10.1016/j.jiec.2012.12.031; KAMENSKY M, 2003, SOIL BOIL BIOCH, V79, P584; Kanchana A, 2011, DIG J NANOMATER BIOS, V6, P1741; Kasthuri J, 2009, COLLOID SURFACE B, V68, P55, DOI 10.1016/j.colsurfb.2008.09.021; Khan JA, 2014, CR CHIM, V17, P91, DOI 10.1016/j.crci.2013.08.006; Khan JA, 2013, SPECTROCHIM ACTA A, V109, P313, DOI 10.1016/j.saa.2013.03.011; Kim SW, 2009, J MICROBIOL BIOTECHN, V19, P760, DOI 10.4014/jmb.0812.649; KLEEMANN W, 1993, INT J MOD PHYS B, V7, P2469, DOI 10.1142/S0217979293002912; Koo SY, 2009, J MICROBIOL BIOTECHN, V19, P1431, DOI 10.4014/jmb.0904.04014; Krishnaraj C, 2012, SPECTROCHIM ACTA A, V93, P95, DOI 10.1016/j.saa.2012.03.002; Kumar CG, 2011, COLLOID SURFACE B, V84, P462, DOI 10.1016/j.colsurfb.2011.01.042; Kumar J, 2002, MOL PLANT PATHOL, V3, P185, DOI 10.1046/j.1364-3703.2002.00120.x; Kumar U, 2009, THEOR APPL GENET, V118, P783, DOI 10.1007/s00122-008-0938-5; Lee KJ, 2013, MATER LETT, V105, P128, DOI 10.1016/j.matlet.2013.04.076; Malhotra A, 2013, BIORESOURCE TECHNOL, V142, P727, DOI 10.1016/j.biortech.2013.05.109; Mandal S, 2007, PHYSIOL MOL PLANT P, V71, P201, DOI 10.1016/j.pmpp.2008.02.003; Mehta S, 2001, CURR MICROBIOL, V43, P51, DOI 10.1007/s002840010259; Mehta YR, 1994, MANEJO INTEGRADO ENF, P314; Mishra S, 2012, PLANT GROWTH REGUL, V66, P155, DOI 10.1007/s10725-011-9639-1; MOERSCHBACHER BM, 1990, PLANT PHYSIOL, V93, P465, DOI 10.1104/pp.93.2.465; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Musarrat J, 2010, BIORESOURCE TECHNOL, V101, P8772, DOI 10.1016/j.biortech.2010.06.065; Nair R, 2010, PLANT SCI, V179, P154, DOI 10.1016/j.plantsci.2010.04.012; Navrotsky A, 2000, J NANOPART RES, V2, P321, DOI 10.1023/A:1010007023813; Long NV, 2013, J NANOMATER, V2013, DOI 10.1155/2013/793125; Oves M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059140; Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017; Quester K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077486; Rao RAK, 2014, J ENVIRON CHEM ENG, V2, P199, DOI 10.1016/j.jece.2013.12.011; Saari E.E., 1998, HELMINTHOSPORIUM BLI, P37; Sarkar A, 2010, J PROTEOME RES, V9, P4565, DOI 10.1021/pr1002824; Shi HY, 2012, ACTA BIOCH BIOPH SIN, V44, P555, DOI 10.1093/abbs/gms035; Shivaji S, 2011, PROCESS BIOCHEM, V46, P1800, DOI 10.1016/j.procbio.2011.06.008; Shoeb M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035015; Siddique YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080944; Singh BR, 2012, BIOMATERIALS, V33, P5753, DOI 10.1016/j.biomaterials.2012.04.045; Singh RV, 1997, P INT WORKSH HELM BL, P59; Singh S, 2014, J MOL STRUCT, V1056, P194, DOI 10.1016/j.molstruc.2013.10.020; Tian J, 2007, CHEMMEDCHEM, V2, P129, DOI 10.1002/cmdc.200600171	53	123	139	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97881	10.1371/journal.pone.0097881	http://dx.doi.org/10.1371/journal.pone.0097881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	25111185	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600086
J	Santos, J; Gouveia, MJ; Vale, N; Delgado, MD; Goncalves, A; da Silva, JMT; Oliveira, C; Xavier, P; Gomes, P; Santos, LL; Lopes, C; Barros, A; Rinaldi, G; Brindley, PJ; da Costa, JMC; Sousa, M; Botelho, MC				Santos, Julio; Gouveia, Maria Joao; Vale, Nuno; Delgado, Maria de Lurdes; Goncalves, Ana; Teixeira da Silva, Jose M.; Oliveira, Cristiano; Xavier, Pedro; Gomes, Paula; Santos, Lucio L.; Lopes, Carlos; Barros, Alberto; Rinaldi, Gabriel; Brindley, Paul J.; Correia da Costa, Jose M.; Sousa, Mario; Botelho, Monica C.			Urinary Estrogen Metabolites and Self-Reported Infertility in Women Infected with Schistosoma haematobium	PLOS ONE			English	Article							HUMAN CANCERS; HEALTH; BREAST; QUANTIFICATION; BIOMARKERS; QUINONES; PROSTATE; MANSONI; DISEASE; EGGS	Background: Schistosomiasis is a neglected tropical disease, endemic in 76 countries, that afflicts more than 240 million people. The impact of schistosomiasis on infertility may be underestimated according to recent literature. Extracts of Schistosoma haematobium include estrogen-like metabolites termed catechol-estrogens that down regulate estrogen receptors alpha and beta in estrogen responsive cells. In addition, schistosome derived catechol-estrogens induce genotoxicity that result in estrogen-DNA adducts. These catechol estrogens and the catechol-estrogen-DNA adducts can be isolated from sera of people infected with S. haematobium. The aim of this study was to study infertility in females infected with S. haematobium and its association with the presence of schistosome-derived catechol-estrogens. Methodology/Principal Findings: A cross-sectional study was undertaken of female residents of a region in Bengo province, Angola, endemic for schistosomiasis haematobia. Ninety-three women and girls, aged from two (parents interviewed) to 94 years were interviewed on present and previous urinary, urogenital and gynecological symptoms and complaints. Urine was collected from the participants for egg-based parasitological assessment of schistosome infection, and for liquid chromatography diode array detection electron spray ionization mass spectrometry (LC/UV-DAD/ESI-MSn) to investigate estrogen metabolites in the urine. Novel estrogen-like metabolites, potentially of schistosome origin, were detected in the urine of participants who were positive for eggs of S. haematobium, but not detected in urines negative for S. haematobium eggs. The catechol-estrogens/DNA adducts were significantly associated with schistosomiasis (OR 3.35; 95% CI 2.32-4.84; P <= 0.001). In addition, presence of these metabolites was positively associated with infertility (OR 4.33; 95% CI 1.13-16.70; P <= 0.05). Conclusions/Significance: Estrogen metabolites occur widely in diverse metabolic pathways. In view of the statistically significant association between catechol-estrogens/DNA adducts and self-reported infertility, we propose that an estrogen-DNA adduct mediated pathway in S. haematobium-induced ovarian hormonal deregulation could be involved. In addition, the catechol-estrogens/DNA adducts described here represent potential biomarkers for schistosomiasis haematobia.	[Santos, Julio; Santos, Lucio L.; Lopes, Carlos] Clin Sagrada Esperanca, Luanda, Angola; [Gouveia, Maria Joao; Vale, Nuno; Gomes, Paula] Univ Porto, Fac Sci, Dept Chem & Biochem, CIQUP, P-4100 Oporto, Portugal; [Delgado, Maria de Lurdes; Correia da Costa, Jose M.; Botelho, Monica C.] INSA, Natl Inst Hlth, Oporto, Portugal; [Goncalves, Ana; Teixeira da Silva, Jose M.; Oliveira, Cristiano; Xavier, Pedro; Barros, Alberto] Ctr Reprod Genet Prof Alberto Barros, Oporto, Portugal; [Santos, Lucio L.] Portuguese Inst Oncol, Expt Therapeut & Pathol Res Grp, Oporto, Portugal; [Lopes, Carlos] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Barros, Alberto] Univ Porto, Fac Med, Dept Genet, P-4100 Oporto, Portugal; [Rinaldi, Gabriel; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Rinaldi, Gabriel; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Res Ctr Neglected Dis Poverty, Washington, DC 20052 USA; [Rinaldi, Gabriel] Univ Republica, Fac Med, Dept Genet, UDELAR, Montevideo, Uruguay; [Correia da Costa, Jose M.; Botelho, Monica C.] Univ Porto, Ctr Study Anim Sci, CECA ICETA, P-4100 Oporto, Portugal; [Sousa, Mario] Univ Porto, Multidisciplinary Unit Biomed Res UMIB, Inst Biomed Sci Abel Salazar ICBAS, Dept Microscopy,Lab Cell Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Universidade do Porto; George Washington University; George Washington University; Universidad de la Republica, Uruguay; Universidade do Porto; Universidade do Porto	Botelho, MC (corresponding author), INSA, Natl Inst Hlth, Oporto, Portugal.	monicabotelho@hotmail.com	Sousa, Mário/A-7340-2019; Gouveia, Maria/AAV-9144-2020; Botelho, Monica C/E-7170-2014; Santos, Lúcio Lara/AAE-2822-2021; Santos, Magda/J-4509-2015; Gomes, Paula/C-6698-2008; Barros, Alberto/L-3094-2013	Sousa, Mário/0000-0002-3009-3290; Botelho, Monica C/0000-0003-0466-8465; Santos, Lúcio Lara/0000-0002-0521-5655; Santos, Magda/0000-0003-0626-3015; Xavier, Pedro/0000-0002-3871-5568; Rinaldi, Gabriel/0000-0002-7767-4922; Gomes, Paula/0000-0002-6018-4724; Barros, Alberto/0000-0002-8700-3698; Brindley, Paul J./0000-0003-1765-0002; Gouveia, Maria/0000-0003-3747-5520; Vale, Nuno/0000-0002-1283-1042	National Funds through FCT-Foundation for Science and Technology [PEst-OE/AGR/UI0211/2011, Fcomp-01-0124-FEDER-015893]	National Funds through FCT-Foundation for Science and Technology	Centre for the Study of Animal Science (CECA) is funded by National Funds through FCT-Foundation for Science and Technology, under the "PEst-OE/AGR/UI0211/2011" project. Multidisciplinary Unit of Biomedical Research (UMIB) is funded by National Funds through FCT-Foundation for Science and Technology, under the "Fcomp-01-0124-FEDER-015893" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa J, 2012, AFR HEALTH SCI, V12, P563, DOI 10.4314/ahs.v12i4.26; Bailey SL, 2011, J TRAVEL MED, V18, P61, DOI 10.1111/j.1708-8305.2010.00476.x; BALASCH J, 1995, HUM REPROD, V10, P1725, DOI 10.1093/oxfordjournals.humrep.a136163; Bindseil E, 1991, In Vivo, V5, P175; Botelho MC, 2009, EXP PARASITOL, V122, P250, DOI 10.1016/j.exppara.2009.04.001; Botelho MC, 2013, INT J PARASITOL, V43, P17, DOI 10.1016/j.ijpara.2012.10.023; Botelho MC, 2011, VIRULENCE, V2, P267, DOI 10.4161/viru.2.4.16734; Botelho MC, 2010, EXP PARASITOL, V126, P526, DOI 10.1016/j.exppara.2010.06.012; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brindley PJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001961; BULLOUGH CHW, 1976, BRIT J OBSTET GYNAEC, V83, P819, DOI 10.1111/j.1471-0528.1976.tb00751.x; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Cavalieri E, 2006, ANN NY ACAD SCI, V1089, P286, DOI 10.1196/annals.1386.042; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Cavalieri EL, 2011, J STEROID BIOCHEM, V125, P169, DOI 10.1016/j.jsbmb.2011.03.008; Dzeing-Ella A, 2009, AM J TROP MED HYG, V81, P549, DOI 10.4269/ajtmh.2009.08-0498; ELMAHGOUB S, 1982, INT J GYNECOL OBSTET, V20, P201, DOI 10.1016/0020-7292(82)90072-8; FELDMEIER H, 1979, TROPENMED PARASITOL, V30, P417; Goverde AJ, 1996, HUM REPROD, V11, P531, DOI 10.1093/HUMREP/11.3.531; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000559; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Pharmaceuticals, 2012, IARC MONOGR EVAL CAR, V100, P1; Jourdan PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001170; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kini Suresh, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.01.2009.1481; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Kjetland EF, 2010, FERTIL STERIL, V94, P1551, DOI 10.1016/j.fertnstert.2009.12.050; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Leutscher P, 1998, TROP MED INT HEALTH, V3, P327, DOI 10.1046/j.1365-3156.1998.00230.x; Lopes LV, 2012, PAN AFR MED J, V12; Lu Weiqin, 2007, Drug Discov Today Dis Models, V4, P67, DOI 10.1016/j.ddmod.2007.10.005; Markushin Y, 2006, PROSTATE, V66, P1565, DOI 10.1002/pros.20484; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Poggensee G, 1999, PARASITOL TODAY, V15, P378, DOI 10.1016/S0169-4758(99)01497-0; Ramarakoto CE, 2008, T ROY SOC TROP MED H, V102, P767, DOI 10.1016/j.trstmh.2008.03.007; Rinaldi G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001348; Schanz A, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.05.043; Shiff C, 2006, T ROY SOC TROP MED H, V100, P847, DOI 10.1016/j.trstmh.2005.10.010; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Takougang Innocent, 2004, Afr J Health Sci, V11, P111; The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO), 2009, REV GLOSS ART TERM; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065; Zahid M, 2013, INT J CANCER, V133, P2642, DOI 10.1002/ijc.28275	45	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96774	10.1371/journal.pone.0096774	http://dx.doi.org/10.1371/journal.pone.0096774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25334008	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600015
J	Chen, Y; Yang, J; Shu, HZ; Shi, LY; Wu, JS; Luo, LM; Coatrieux, JL; Toumoulin, C				Chen, Yang; Yang, Jian; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin; Coatrieux, Jean-Louis; Toumoulin, Christine			2-D Impulse Noise Suppression by Recursive Gaussian Maximum Likelihood Estimation	PLOS ONE			English	Article							MEDIAN FILTER; TOMOGRAPHIC RECONSTRUCTION; REMOVAL; DETECTOR; SIMILARITY; ALGORITHM; WEIGHTS	An effective approach termed Recursive Gaussian Maximum Likelihood Estimation (RGMLE) is developed in this paper to suppress 2-D impulse noise. And two algorithms termed RGMLE-C and RGMLE-CS are derived by using spatially-adaptive variances, which are respectively estimated based on certainty and joint certainty & similarity information. To give reliable implementation of RGMLE-C and RGMLE-CS algorithms, a novel recursion stopping strategy is proposed by evaluating the estimation error of uncorrupted pixels. Numerical experiments on different noise densities show that the proposed two algorithms can lead to significantly better results than some typical median type filters. Efficient implementation is also realized via GPU (Graphic Processing Unit)-based parallelization techniques.	[Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin] Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin] Southeast Univ, Minist Educ, Key Lab Comp Network & Informat Integrat, Beijing, Peoples R China; [Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin; Coatrieux, Jean-Louis; Toumoulin, Christine] Ctr Rech Informat Biomed Sino Francais LIA CRIBs, Rennes, France; [Yang, Jian] Beijing Inst Technol, Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China; [Coatrieux, Jean-Louis; Toumoulin, Christine] INSERM, U1099, Rennes, France; [Coatrieux, Jean-Louis; Toumoulin, Christine] Univ Rennes 1, LTSI, Rennes, France	Southeast University - China; Southeast University - China; Beijing Institute of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Luo, LM (corresponding author), Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China.	luo.list@seu.edu.cn	Coatrieux, Jean-Louis/ABC-8154-2020; Shi, Luyao/AAH-1342-2019	CHEN, YI-KUAN/0000-0002-0219-4756	National Basic Research Program of China [2010CB732503]; National Natural Science Foundation [81000636, 81370040]; Natural Science Foundations of Jiangsu Province [BK2011593]; Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education	This research was supported by National Basic Research Program of China under grant (2010CB732503), National Natural Science Foundation under grants (81000636, 81370040), and the Project supported by Natural Science Foundations of Jiangsu Province (BK2011593). This work was also supported by the Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS DF, 1974, J ROY STAT SOC B MET, V36, P99; [Anonymous], NVIDIA CUDATM PROGR; Arce GR, 1998, IEEE T SIGNAL PROCES, V46, P3195, DOI 10.1109/78.735296; Astola J., 1997, FUNDAMENTALS NONLINE; Bovik A., 2000, HDB IMAGE VIDEO PROC; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Cai JF, 2011, INVERSE PROBL IMAG, V2, P187; Chan RH, 2005, IEEE T IMAGE PROCESS, V14, P1479, DOI 10.1109/TIP.2005.852196; Chaudhury KN, 2012, IEEE SIGNAL PROC LET, V19, P745, DOI 10.1109/LSP.2012.2217329; Chen Y, 2008, J MATH IMAGING VIS, V30, P133, DOI 10.1007/s10851-007-0042-5; Chen Y, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2667; Chen Y, 2011, MULTISCALE MODEL SIM, V9, P1399, DOI 10.1137/100814184; Deledalle CA, 2009, IEEE T IMAGE PROCESS, V18, P2661, DOI 10.1109/TIP.2009.2029593; Dong YQ, 2007, IEEE T IMAGE PROCESS, V16, P1112, DOI 10.1109/TIP.2006.891348; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Esakkirajan S, 2011, IEEE SIGNAL PROC LET, V18, P287, DOI 10.1109/LSP.2011.2122333; Harris JW, 1998, HDB MATH COMPUTATION, P824; HWANG H, 1995, IEEE T IMAGE PROCESS, V4, P499, DOI 10.1109/83.370679; Justusson BI, 1981, P 2 DIM DIG SIGN PRO; LEE YH, 1991, IEEE T SIGNAL PROCES, V39, P984, DOI 10.1109/78.80931; Lin CH, 2010, IEEE T IMAGE PROCESS, V19, P2307, DOI 10.1109/TIP.2010.2047906; Ng PE, 2006, IEEE T IMAGE PROCESS, V15, P1506, DOI 10.1109/TIP.2005.871129; Sree PSJ, 2013, SIGNAL IMAGE VIDEO P, V7, P111, DOI 10.1007/s11760-011-0210-3; Srinivasan KS, 2007, IEEE SIGNAL PROC LET, V14, P189, DOI 10.1109/LSP.2006.884018; Takeda H, 2007, IEEE T IMAGE PROCESS, V16, P349, DOI 10.1109/TIP.2006.888330; Ville DVD, 2011, IEEE T IMAGE PROCESS, V20, P2683; Wainwright MJ, ADV NEUROALINFORMATI; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang SQ, 2002, IEEE SIGNAL PROC LET, V9, P360, DOI 10.1109/LSP.2002.805310; Zhang XM, 2009, IEEE SIGNAL PROC LET, V16, P295, DOI 10.1109/LSP.2009.2014293	30	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96386	10.1371/journal.pone.0096386	http://dx.doi.org/10.1371/journal.pone.0096386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836960	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800016
J	Chen, YK; Han, LZ; Xue, F; Shen, CH; Lu, J; Yang, TH; Zhang, JJ; Xia, Q				Chen, Yi-kuan; Han, Long-zhi; Xue, Feng; Shen, Cong-huan; Lu, Jun; Yang, Tai-hua; Zhang, Jian-jun; Xia, Qiang			Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ATP-BINDING CASSETTE; RENAL-TRANSPLANTATION; DOSAGE REQUIREMENTS; DOSING REQUIREMENTS; SUBFAMILY B; PHARMACOKINETICS; IMPACT; PHARMACOGENETICS; AGE	Tacrolimus (TAC) is the backbone of an immunosuppressive drug used in most solid organ transplant recipients. A single nucleotide polymorphism (SNP) at position 6986G>A in CYP3A5 has been notably involved in the pharmacokinetic variability of TAC. It is hypothesized that CYP3A5 genotyping in patients may provide a guideline for TAC therapeutic regimen. To further evaluate the impact of CYP3A5 variants in donors and recipients, ABCB1 and ACE SNPs in recipients on TAC disposition, clinical and laboratory data were retrospectively reviewed from 90 pediatric patients with liver transplantation and their corresponding donors after 1 year of transplantation. The recipients with CYP3A5 *1/*1 or *1/*3 required more time to achieve TAC therapeutic range during the induction phase, and needed more upward dose during the late induction and the maintained phases, with lower C/D ratio, compared with those with CYP3A5 *3/*3. And donor CYP3A5 genotypes were found to impact on TAC trough concentrations after liver transplantation. No association between ABCB1 or ACE genotypes and TAC disposition post-transplantation was found. These results strongly suggest that CYP3A5 genotyping both in recipient and donor, not ABCB1 or ACE is necessary for establishing a personalized TAC dosage regimen in pediatric liver transplant patients.	[Chen, Yi-kuan; Han, Long-zhi; Xue, Feng; Shen, Cong-huan; Lu, Jun; Yang, Tai-hua; Zhang, Jian-jun; Xia, Qiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg & Liver Transplantat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xue, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg & Liver Transplantat, Shanghai 200030, Peoples R China.	fengxue6879@163.com; xiaqiang@medmail.com.cn	Coatrieux, Jean-Louis/ABC-8154-2020; Shi, Luyao/AAH-1342-2019	CHEN, YI-KUAN/0000-0002-0219-4756	National Ministry of Public Health [IHECCO8-201213]; Shanghai Science and Technology Committee [12ZR1418300]	National Ministry of Public Health; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This project was supported by National Ministry of Public Health grant (IHECCO8-201213) (http://www.nhfpc.gov.cn/gjhzs/index.shtml) and Shanghai Science and Technology Committee grant (12ZR1418300) (http://www.stcsm.gov.cn/). The funders had roles in study design, data collection and analysis.	Gomez-Bravo MA, 2013, J CLIN PHARMACOL, V53, P1146, DOI 10.1002/jcph.154; Chen DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073405; Cho JH, 2012, TRANSPL P, V44, P109, DOI 10.1016/j.transproceed.2011.11.004; de Wildt SN, 2011, EUR J CLIN PHARMACOL, V67, P1231, DOI 10.1007/s00228-011-1083-7; Ferraris JR, 2011, PEDIATR TRANSPLANT, V15, P525, DOI 10.1111/j.1399-3046.2011.01513.x; Fukudo M, 2006, CLIN PHARMACOL THER, V80, P331, DOI 10.1016/j.clpt.2006.06.008; Gijsen V, 2011, J HEART LUNG TRANSPL, V30, P1352, DOI 10.1016/j.healun.2011.08.001; Gijsen VMGJ, 2012, ANN TRANSPL, V17, P111; Glowacki F, 2011, NEPHROL DIAL TRANSPL, V26, P3046, DOI 10.1093/ndt/gfr253; Grenda R, 2009, ANN TRANSPL, V14, P18; Hawwa AF, 2011, EXPERT OPIN DRUG SAF, V10, P9, DOI 10.1517/14740338.2010.505600; Hawwa AF, 2009, BRIT J CLIN PHARMACO, V68, P413, DOI 10.1111/j.1365-2125.2009.03461.x; Hesselink DA, 2014, CLIN PHARMACOKINET, V53, P123, DOI 10.1007/s40262-013-0120-3; Hosohata K, 2009, DRUG METAB PHARMACOK, V24, P458, DOI 10.2133/dmpk.24.458; Hosohata K, 2009, DRUG METAB DISPOS, V37, P821, DOI 10.1124/dmd.108.025833; Iwasaki K, 2007, DRUG METAB PHARMACOK, V22, P328, DOI 10.2133/dmpk.22.328; Jacobson PA, 2011, TRANSPLANTATION, V91, P300, DOI 10.1097/TP.0b013e318200e991; Kausman JY, 2008, PEDIATR TRANSPLANT, V12, P329, DOI 10.1111/j.1399-3046.2007.00821.x; Kim JS, 2005, PEDIATR TRANSPLANT, V9, P162, DOI 10.1111/j.1399-3046.2005.00263.x; Li L, 2011, EUR J CLIN PHARMACOL, V67, P787, DOI 10.1007/s00228-011-1010-y; MacPhee IAM, 2005, TRANSPLANTATION, V79, P499, DOI 10.1097/01.TP.0000151766.73249.12; Min SI, 2010, TRANSPLANTATION, V90, P1394, DOI 10.1097/TP.0b013e3181fa93a4; Penninga L, 2010, EUR J CLIN PHARMACOL, V66, P1177, DOI 10.1007/s00228-010-0902-6; Provenzani A, 2009, ANN TRANSPL, V14, P23; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Satoh S, 2008, BRIT J CLIN PHARMACO, V66, P207, DOI 10.1111/j.1365-2125.2008.03188.x; Shilbayeh Sireen, 2013, Saudi J Kidney Dis Transpl, V24, P1125, DOI 10.4103/1319-2442.121268; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P207, DOI 10.2165/11317550-000000000-00000; Uesugi M, 2013, BIOL PHARM BULL, V36, P1814; Vannaprasaht S, 2013, CLIN THER, V35, P1762, DOI 10.1016/j.clinthera.2013.08.019; Wang WL, 2006, LIVER TRANSPLANT, V12, P775, DOI 10.1002/lt.20709; Xue F, 2010, TRANSPLANTATION, V89, P620, DOI 10.1097/TP.0b013e3181c690fa; Yu SF, 2006, TRANSPLANTATION, V81, P46, DOI 10.1097/01.tp.0000188118.34633.bf	33	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109464	10.1371/journal.pone.0109464	http://dx.doi.org/10.1371/journal.pone.0109464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	24836960	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300051
J	Smith, RG; Atwood, LW; Warren, ND				Smith, Richard G.; Atwood, Lesley W.; Warren, Nicholas D.			Increased Productivity of a Cover Crop Mixture Is Not Associated with Enhanced Agroecosystem Services	PLOS ONE			English	Article							WEED MANAGEMENT; FUNCTIONAL-ROLE; SECALE-CEREALE; DIVERSITY; STABILITY; SYSTEMS; BIODIVERSITY; AGRICULTURE; TERMINATION; RESILIENCE	Cover crops provide a variety of important agroecological services within cropping systems. Typically these crops are grown as monocultures or simple graminoid-legume bicultures; however, ecological theory and empirical evidence suggest that agroecosystem services could be enhanced by growing cover crops in species-rich mixtures. We examined cover crop productivity, weed suppression, stability, and carryover effects to a subsequent cash crop in an experiment involving a five-species annual cover crop mixture and the component species grown as monocultures in SE New Hampshire, USA in 2011 and 2012. The mean land equivalent ratio (LER) for the mixture exceeded 1.0 in both years, indicating that the mixture over-yielded relative to the monocultures. Despite the apparent over-yielding in the mixture, we observed no enhancement in weed suppression, biomass stability, or productivity of a subsequent oat (Avena sativa L.) cash crop when compared to the best monoculture component crop. These data are some of the first to include application of the LER to an analysis of a cover crop mixture and contribute to the growing literature on the agroecological effects of cover crop diversity in cropping systems.	[Smith, Richard G.; Atwood, Lesley W.; Warren, Nicholas D.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Smith, RG (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	richard.smith@unh.edu	Atwood, Lesley/GQZ-8910-2022; Johnston, Emma/B-7210-2009	Smith, Richard G./0000-0002-3571-5888; Johnston, Emma/0000-0002-2117-366X; Atwood, Lesley/0000-0001-9022-2181	NERA (North East Regional Association of agricultural experiment station) [NE-1047]; New Hampshire Agricultural Experiment Station	NERA (North East Regional Association of agricultural experiment station); New Hampshire Agricultural Experiment Station	This work was supported by NERA (North East Regional Association of agricultural experiment station directors) project NE-1047 http://nimss.umd.edu/lgu_v2/homepages/home.cfm?trackID = 13656. Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is scientific contribution number 2533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ateh CM, 1996, WEED TECHNOL, V10, P347, DOI 10.1017/S0890037X00040070; Cardinale BJ, 2013, ECOLOGY, V94, P1697, DOI 10.1890/12-1334.1; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Clark A., 2007, SUSTAINABLE AGR RES; Creamer NG, 1997, HORTSCIENCE, V32, P866, DOI 10.21273/HORTSCI.32.5.866; Freyre R., 2000, HortTechnology, V10, P374; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Kumar V, 2009, HORTSCIENCE, V44, P730, DOI 10.21273/HORTSCI.44.3.730; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Liebman M, 2000, WEED RES, V40, P27, DOI 10.1046/j.1365-3180.2000.00164.x; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mirsky SB, 2013, WEED TECHNOL, V27, P193, DOI 10.1614/WT-D-12-00078.1; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; MOHLER CL, 1993, WEED RES, V33, P487, DOI 10.1111/j.1365-3180.1993.tb01965.x; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Smith RG, 2010, WEED RES, V50, P37, DOI 10.1111/j.1365-3180.2009.00745.x; Smith RG, 2008, ECOSYSTEMS, V11, P355, DOI 10.1007/s10021-008-9124-5; Smith RG, 2011, WEED TECHNOL, V25, P680, DOI 10.1614/WT-D-10-00156.1; Snapp SS, 2005, AGRON J, V97, P322; Teasdale JR, 1998, HORTSCIENCE, V33, P1163, DOI 10.21273/HORTSCI.33.7.1163; Teasdale JR, 1996, J PROD AGRIC, V9, P475, DOI 10.2134/jpa1996.0475; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tooker JF, 2012, J APPL ECOL, V49, P974, DOI 10.1111/j.1365-2664.2012.02173.x; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; TRENBATH BR, 1993, FIELD CROP RES, V34, P381, DOI 10.1016/0378-4290(93)90123-5; Trenbath BR, 1999, AGROFOREST SYST, V45, P81, DOI 10.1023/A:1006285319817; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Wortman SE, 2012, AGRON J, V104, P699, DOI 10.2134/agronj2011.0422; Wortman SE, 2013, WEED SCI, V61, P162, DOI 10.1614/WS-D-12-00066.1; Wortman SE, 2012, AGRON J, V104, P1425, DOI 10.2134/agronj2012.0185	34	122	122	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97351	10.1371/journal.pone.0097351	http://dx.doi.org/10.1371/journal.pone.0097351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25054325	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600026
J	Liu, Y; Wang, FY; Wu, Y; Tan, SN; Wen, QL; Wang, J; Zhu, XM; Wang, X; Li, CM; Ma, X; Pan, H				Liu, Yan; Wang, Fengyu; Wu, Yuan; Tan, Sainan; Wen, Qiaolian; Wang, Jing; Zhu, Xiaomei; Wang, Xi; Li, Congmin; Ma, Xu; Pan, Hong			Variations of CITED2 Are Associated with Congenital Heart Disease (CHD) in Chinese Population	PLOS ONE			English	Article							PITX2C EXPRESSION; DEFECTS; MUTATIONS; MICE; MALFORMATIONS; HIF-1-ALPHA; ATRIAL; GROWTH; CELLS; GATA4	CITED2 was identified as a cardiac transcription factor which is essential to the heart development. Cited2-deficient mice showed cardiac malformations, adrenal agenesis and neural crest defects. To explore the potential impact of mutations in CITED2 on congenital heart disease (CHD) in humans, we screened the coding region of CITED2 in a total of 700 Chinese people with congenital heart disease and 250 healthy individuals as controls. We found five potential disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p.Ser192_Gly193delAGCGGC. Two mammalian two-hybrid assays showed that the last four mutations significantly affected the interaction between p300CH1 and CITED2 or HIF1A. Further studies showed that four CITED2 mutations recovered the promoter activity of VEGF by decreasing its competitiveness with HIF1A for binding to p300CH1 and three mutations decreased the consociation of TFAP2C and CITED2 in the transactivation of PITX2C. Both VEGF and PITX2C play very important roles in cardiac development. In conclusion, we demonstrated that CITED2 has a potential causative impact on congenital heart disease.	[Liu, Yan; Wen, Qiaolian; Zhu, Xiaomei; Wang, Xi; Ma, Xu; Pan, Hong] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Liu, Yan; Wen, Qiaolian; Zhu, Xiaomei; Wang, Xi; Ma, Xu; Pan, Hong] Natl Res Inst Family Planning, Beijing, Peoples R China; [Wang, Fengyu; Li, Congmin] Henan Res Inst Populat & Family Planning, Key Lab Populat Defects Intervent Technol Henan P, Zhengzhou, Peoples R China; [Wu, Yuan] Xiamen Univ, Dept Cardiac Surg, Xiamen Heart Ctr, Organ Transplantat Inst, Xiamen, Peoples R China; [Tan, Sainan] Family Planning Inst Hunan Prov, Key Lab Genet & Birth Hlth Hunan Prov, Chang Sha, Peoples R China; [Wang, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Med Genet, Beijing, Peoples R China; [Ma, Xu] World Hlth Org, Collaborating Ctr Res Human Reprod, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; Xiamen University; Capital Medical University; World Health Organization	Li, CM (corresponding author), Henan Res Inst Populat & Family Planning, Key Lab Populat Defects Intervent Technol Henan P, Zhengzhou, Peoples R China.	13838377996@163.com; nicgr@263.net; 13174483538@126.com		Liu, Yali/0000-0003-0037-6326; Zhang, Junjie/0000-0001-8809-1485; Liu, Yehao/0000-0002-6381-6440; Li, Yuhui/0000-0002-9778-4512	National Basic Research Program of China [2010CB529504]; National Natural Science Foundation of China [81300131]; Applied Basic Research Program of Qinghai Province [QH2013-z-744]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Program of Qinghai Province	This work was supported by the National Basic Research Program of China (2010CB529504), the National Natural Science Foundation of China (81300131) and the Applied Basic Research Program of Qinghai Province (QH2013-z-744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Amati F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-497; Andrews JE, 2000, MECH DEVELOP, V95, P305, DOI 10.1016/S0925-4773(00)00362-2; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bentham J, 2010, HUM MOL GENET, V19, P3394, DOI 10.1093/hmg/ddq251; Bhattacherjee V, 2009, INT J DEV BIOL, V53, P1097, DOI 10.1387/ijdb.072489vb; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046256; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Crider KS, 2011, GENOME MED, V3, DOI 10.1186/gm223; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Li DY, 2010, STROKE, V41, pS92, DOI 10.1161/STROKEAHA.110.594929; Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099; MacDonald ST, 2013, EUR HEART J, V34, P2557, DOI 10.1093/eurheartj/ehs056; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Xiong F, 2013, CARDIOVASC PATHOL, V22, P141, DOI 10.1016/j.carpath.2012.07.001; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Xu M, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-7; Yang Xiao-fei, 2010, Zhonghua Er Ke Za Zhi, V48, P293; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799	26	255	264	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98157	10.1371/journal.pone.0098157	http://dx.doi.org/10.1371/journal.pone.0098157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25237849	gold, Green Published, Green Submitted			2022-12-27	WOS:000336730600093
J	Fan, YT; Cheng, YW				Fan, Yang-Teng; Cheng, Yawei			Atypical Mismatch Negativity in Response to Emotional Voices in People with Autism Spectrum Conditions	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ASPERGER-SYNDROME; CHILDREN; SPEECH; BRAIN; PERCEPTION; ATTENTION; DISCRIMINATION; LANGUAGE; DISORDER	Autism Spectrum Conditions (ASC) are characterized by heterogeneous impairments of social reciprocity and sensory processing. Voices, similar to faces, convey socially relevant information. Whether voice processing is selectively impaired remains undetermined. This study involved recording mismatch negativity (MMN) while presenting emotionally spoken syllables dada and acoustically matched nonvocal sounds to 20 subjects with ASC and 20 healthy matched controls. The people with ASC exhibited no MMN response to emotional syllables and reduced MMN to nonvocal sounds, indicating general impairments of affective voice and acoustic discrimination. Weaker angry MMN amplitudes were associated with more autistic traits. Receiver operator characteristic analysis revealed that angry MMN amplitudes yielded a value of 0.88 (p<.001). The results suggest that people with ASC may process emotional voices in an atypical fashion already at the automatic stage. This processing abnormality can facilitate diagnosing ASC and enable social deficits in people with ASC to be predicted.	[Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Cheng, Yawei] Natl Yang Ming Univ Hosp, Dept Rehabil, Yilan, Taiwan; [Cheng, Yawei] Taipei City Hosp, Dept Res & Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Cheng, YW (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	ywcheng2@ym.edu.tw			Ministry of Science and Technology [MOST 103-2401-H-010-003-MY3]; National Yang-Ming University Hospital [RD2014-003]; Health Department of Taipei City Government [10301-62-009]; Ministry of Education (Aim for the Top University Plan)	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Yang-Ming University Hospital; Health Department of Taipei City Government; Ministry of Education (Aim for the Top University Plan)(Ministry of Education, Taiwan)	The study was funded by the Ministry of Science and Technology (MOST 103-2401-H-010-003-MY3), National Yang-Ming University Hospital (RD2014-003), Health Department of Taipei City Government (10301-62-009), and Ministry of Education (Aim for the Top University Plan). The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2010, NEURON, V65, P733, DOI 10.1016/j.neuron.2010.03.018; Boersma Paul, 2002, GLOT INT, V5, P341; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Cheng YW, 2012, J COGNITIVE NEUROSCI, V24, P1411, DOI 10.1162/jocn_a_00214; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Dawson G., 1989, AUTISM NATURE DIAGNO; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunn MA, 2008, J AUTISM DEV DISORD, V38, P52, DOI 10.1007/s10803-007-0359-3; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Fan YT, 2013, NEUROREPORT, V24, P457, DOI 10.1097/WNR.0b013e32836169b9; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Gomot M, 2002, PSYCHOPHYSIOLOGY, V39, P577, DOI 10.1017/S0048577202394058; Griffin R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-61; Grossmann T, 2012, SOC NEUROSCI-UK, V7, P369, DOI 10.1080/17470919.2011.628758; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; HOBSON RP, 1989, BRIT J DEV PSYCHOL, V7, P237, DOI 10.1111/j.2044-835X.1989.tb00803.x; Hung AY, 2014, NEUROREPORT, V25, P464, DOI 10.1097/WNR.0000000000000115; Hung AY, 2013, J CHILD PSYCHOL PSYC, V54, P1016, DOI 10.1111/jcpp.12076; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jansson-Verkasalo E, 2003, NEUROSCI LETT, V338, P197, DOI 10.1016/S0304-3940(02)01405-2; Jarvinen-Pasley A, 2008, DEVELOPMENTAL SCI, V11, P109, DOI 10.1111/j.1467-7687.2007.00644.x; KEMNER C, 1995, BIOL PSYCHIAT, V38, P150, DOI 10.1016/0006-3223(94)00247-Z; Khalfa S, 2004, HEARING RES, V198, P87, DOI 10.1016/j.heares.2004.07.006; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2001, CLIN NEUROPHYSIOL, V112, P1712, DOI 10.1016/S1388-2457(01)00625-3; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Lepisto T, 2008, BIOL PSYCHOL, V77, P25, DOI 10.1016/j.biopsycho.2007.08.010; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Lepisto T, 2005, BRAIN RES, V1066, P147, DOI 10.1016/j.brainres.2005.10.052; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; LINCOLN AJ, 1993, J AUTISM DEV DISORD, V23, P37, DOI 10.1007/BF01066417; Locke J.L., 1993, CHILDS PATH SPOKEN L; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maestro S, 2002, J AM ACAD CHILD PSY, V41, P1239, DOI 10.1097/00004583-200210000-00014; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Mottron L, 2000, J CHILD PSYCHOL PSYC, V41, P1057, DOI 10.1111/1469-7610.00693; Mottron L, 2011, NATURE, V479, P33, DOI 10.1038/479033a; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Paul R, 2005, J AUTISM DEV DISORD, V35, P205, DOI 10.1007/s10803-004-1999-1; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Roberts TPL, 2011, BIOL PSYCHIAT, V70, P263, DOI 10.1016/j.biopsych.2011.01.015; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schirmer A, 2008, NEUROIMAGE, V40, P1402, DOI 10.1016/j.neuroimage.2008.01.018; Schirmer A, 2007, BRAIN RES, V1176, P103, DOI 10.1016/j.brainres.2007.08.008; Seri S, 1999, CLIN NEUROPHYSIOL, V110, P1825, DOI 10.1016/S1388-2457(99)00137-6; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Sussman ES, 2013, BRAIN TOPOGR; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wechsler D., 2012, WAIS 4 KASIKIRJA; Winer B.J., 1991, STAT PRINCIPLES EXPT	67	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102471	10.1371/journal.pone.0102471	http://dx.doi.org/10.1371/journal.pone.0102471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	24475058	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200061
J	Zhu, LL; Fan, Y; Zou, QH; Wang, J; Gao, JH; Niu, ZD				Zhu, Linlin; Fan, Yang; Zou, Qihong; Wang, Jue; Gao, Jia-Hong; Niu, Zhendong			Temporal Reliability and Lateralization of the Resting-State Language Network	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; TEST-RETEST RELIABILITY; HUMAN BRAIN; CORTICAL ORGANIZATION; ALZHEIMERS-DISEASE; COMPONENT ANALYSIS; CINGULATE CORTEX; FMRI; SCHIZOPHRENIA; ASYMMETRIES	The neural processing loop of language is complex but highly associated with Broca's and Wernicke's areas. The left dominance of these two areas was the earliest observation of brain asymmetry. It was demonstrated that the language network and its functional asymmetry during resting state were reproducible across institutions. However, the temporal reliability of resting-state language network and its functional asymmetry are still short of knowledge. In this study, we established a seed-based resting-state functional connectivity analysis of language network with seed regions located at Broca's and Wernicke's areas, and investigated temporal reliability of language network and its functional asymmetry. The language network was found to be temporally reliable in both short-and long-term. In the aspect of functional asymmetry, the Broca's area was found to be left lateralized, while the Wernicke's area is mainly right lateralized. Functional asymmetry of these two areas revealed high short-and long-term reliability as well. In addition, the impact of global signal regression (GSR) on reliability of the resting-state language network was investigated, and our results demonstrated that GSR had negligible effect on the temporal reliability of the resting-state language network. Our study provided methodology basis for future cross-culture and clinical researches of resting-state language network and suggested priority of adopting seed-based functional connectivity for its high reliability.	[Zhu, Linlin; Niu, Zhendong] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing 100081, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Wang, Jue] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou 310015, Zhejiang, Peoples R China; [Gao, Jia-Hong] Peking Univ, McGovern Inst Brain Res, Beijing 100871, Peoples R China	Beijing Institute of Technology; Peking University; Peking University; Hangzhou Normal University; Peking University	Zou, QH (corresponding author), Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China.	zouqihong@pku.edu.cn; zniu@bit.edu.cn			China's National Strategic Basic Research Program (973) [2012CB720700]; National Key Technology R D Program [2011BAI12B01]; Natural Science Foundation of China [81201142, 81227003]	China's National Strategic Basic Research Program (973); National Key Technology R D Program(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China's National Strategic Basic Research Program (973) (2012CB720700), the National Key Technology R& D Program (2011BAI12B01), and the Natural Science Foundation of China (81201142, 81227003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2013, NEUROIMAGE; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chen G, 2012, MAGN RESON MED, V68, P1828, DOI 10.1002/mrm.24201; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; Dollfus S, 2005, BIOL PSYCHIAT, V57, P1020, DOI 10.1016/j.biopsych.2005.01.009; Dronkers NF, 2011, NEUROLOGY, V76, pA162; Egidi G, 2013, NEUROIMAGE, V71, P59, DOI 10.1016/j.neuroimage.2013.01.003; Fiecas M, 2013, NEUROIMAGE, V65, P231, DOI 10.1016/j.neuroimage.2012.09.052; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; HEILMAN KM, 1976, CORTEX, V12, P258, DOI 10.1016/S0010-9452(76)80007-X; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hirnstein M, 2007, LATERALITY, V12, P87, DOI 10.1080/13576500600959247; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jung WH, 2012, PLOS ONE, V7; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; KERTESZ A, 1986, CORTEX, V22, P117, DOI 10.1016/S0010-9452(86)80036-3; Kim JY, 2012, INT J AUDIOL, V51, P413, DOI 10.3109/14992027.2011.652677; Kollndorfer K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00095; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; LEMAY M, 1978, J COMPUT ASSIST TOMO, V2, P471; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Marcotte K, 2013, BRAIN LANG, V124, P45, DOI 10.1016/j.bandl.2012.11.004; MOHR JP, 1978, NEUROLOGY, V28, P311, DOI 10.1212/WNL.28.4.311; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narr KL, 2001, AM J PSYCHIAT, V158, P244, DOI 10.1176/appi.ajp.158.2.244; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; Petridou N, 2009, MAGN RESON IMAGING, V27, P1046, DOI 10.1016/j.mri.2009.02.006; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pravata E, 2011, AM J NEURORADIOL, V32, P532, DOI 10.3174/ajnr.A2311; PREVIC FH, 1991, PSYCHOL REV, V98, P299, DOI 10.1037/0033-295X.98.3.299; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Proverbio AM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-116; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Thirion B, 2006, NEUROIMAGE, V29, P321, DOI 10.1016/j.neuroimage.2005.06.054; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel M, 2008, PLOS ONE, P3; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zuo X-N, 2012, NEUROIMAGE; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	90	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85880	10.1371/journal.pone.0085880	http://dx.doi.org/10.1371/journal.pone.0085880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475058	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800018
J	Liu, J; Gaj, T; Patterson, JT; Sirk, SJ; Barbas, CF				Liu, Jia; Gaj, Thomas; Patterson, James T.; Sirk, Shannon J.; Barbas, Carlos F., III			Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; VECTOR TOOLKIT; KNOCKOUT RATS; GENE-TRANSFER; BASIC DOMAIN; IN-VIVO; DNA; RECOGNITION; EFFECTORS	Transcription activator-like (TAL) effector nucleases (TALENs) have enabled the introduction of targeted genetic alterations into a broad range of cell lines and organisms. These customizable nucleases are comprised of programmable sequence-specific DNA-binding modules derived from TAL effector proteins fused to the non-specific FokI cleavage domain. Delivery of these nucleases into cells has proven challenging as the large size and highly repetitive nature of the TAL effector DNA-binding domain precludes their incorporation into many types of viral vectors. Furthermore, viral and non-viral gene delivery methods carry the risk of insertional mutagenesis and have been shown to increase the off-target activity of site-specific nucleases. We previously demonstrated that direct delivery of zinc-finger nuclease proteins enables highly efficient gene knockout in a variety of mammalian cell types with reduced off-target effects. Here we show that conjugation of cell-penetrating poly-Arg peptides to a surface-exposed Cys residue present on each TAL effector repeat imparted cell-penetrating activity to purified TALEN proteins. These modifications are reversible under reducing conditions and enabled TALEN-mediated gene knockout of the human CCR5 and BMPR1A genes at rates comparable to those achieved with transient transfection of TALEN expression vectors. These findings demonstrate that direct protein delivery, facilitated by conjugation of chemical functionalities onto the TALEN protein surface, is a promising alternative to current non-viral and viral-based methods for TALEN delivery into mammalian cells.	[Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell & Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Barbas, CF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	carlos@scripps.edu	Liu, Jia/E-5758-2014	Patterson, James/0000-0001-6006-7184; liu, juanjuan/0000-0001-6941-0372; Ma, Leina/0000-0003-3964-632X; Lin, Xiukun/0000-0002-0306-4953; Spincemaille, Pascal/0000-0002-8821-1341; Prince, Martin/0000-0002-9883-0584; Saloner, David/0000-0002-6989-8547	US National Institutes for Health [DP1CA174426]; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes for Health (DP1CA174426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mitsui H, 2006, J INVEST DERMATOL, V126, P1804, DOI 10.1038/sj.jid.5700335; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ru Renli, 2013, Cell Regen, V2, P5, DOI 10.1186/2045-9769-2-5; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	48	200	240	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85755	10.1371/journal.pone.0085755	http://dx.doi.org/10.1371/journal.pone.0085755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24626155	gold, Green Published			2022-12-27	WOS:000330240500068
